5,947 Matching Annotations
  1. Jan 2025
    1. Author response:

      Reviewer #1 (Public review):

      Summary:

      The topic of nanobody-based PET imaging is important and holds great potential for real-world applications since nanobodies have many advantages over full sized immunoglobulins and small molecules.

      Strengths:

      The submitted manuscript contains quite a bit of interesting data from a collaborative team of well-respected researchers. The authors are to be congratulated for presenting results that may not have turned out the way they had hoped, and doing so in a transparent fashion.

      Weaknesses:

      However, the manuscript could be considered to be a collection of exploratory findings rather than a complete and mature scientific exposition. Most of the sample sizes were 3 per group, which is fine for exploratory work, but insufficient to draw strong statistically robust conclusions for definitive results.

      We thank reviewer #1 for the  review of our work. We appreciate reviewer’s #1 comment on our intent to publish our results in the most transparent fashion, which is the case. We would point out that due to the technical challenges and cost of generating all the different nanobody-radiometal tracer conjugates, we included 3 repeats per group, which is the minimum required  to perform statistical comparisons. We plan to add additional controls to the manuscript that were not initially included to limit the length of the manuscript. These additional controls  will lend more weight to our conclusions.

      Reviewer #2 (Public review):

      Summary:

      This is a strong and well-described study showing for the first time the use and publicly available resources to use a specific PET tracer to track proliferating transplanted cells in vivo, in a full murine immunecompetent environment.

      In this study the authors described a previously developed set of VHH-based PET tracers to track transplants (cancer cells, embryo's) in a murine immune-competent environment.

      Strengths:

      Unique set of PET tracer and mouse strain to track transplanted cells in vivo without genetic modification of the transplanted cells. This is a unique asset, and a first-in-kind.

      Weaknesses:

      - Some methodological aspects and controls are missing

      - No clinical relevance?

      We thank reviewer #2 for their review of our work. We support reviewer’s 2 view on the strength of being able to track transplanted cells in vivo without the need of any sort of manipulation of the transferred cells.  We plan to add additional controls to the manuscript that were not initially included to limit the length of the manuscript. These additional controls will lend more weight to our conclusions. We emphasize that although no clear clinical applications immediately derive  from our studies, this work  still offers better-suited tools for pre-clinical studies that require the ability to track transplanted cells in in vivo . We will resubmit a revised version shortly.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public review):

      In this manuscript, the authors recorded cerebellar unipolar brush cells (UBCs) in acute brain slices. They confirmed that mossy fiber (MF) inputs generate a continuum of UBC responses. Using systematic and physiological trains of MF electrical stimulation, they demonstrated that MF inputs either increased or decreased UBC firing rates (UBC ON vs. OFF) or induced complex, long-lasting modulation of their discharges. The MF influence on UBC firing was directly associated with a specific combination of metabotropic glutamate receptors, mGluR2/3 (inhibitory) and mGluR1 (excitatory). Ultimately, the amount and ratio of these two receptors controlled the time course of the effect, yielding specific temporal transformations such as phase shifts.

      Overall, the topic is compelling, as it broadens our understanding of temporal processing in the cerebellar cortex. The experiments are well-executed and properly analyzed.

      Strengths:

      (1) A wide range of MF stimulation patterns was explored, including burst duration and frequency dependency, which could serve as a valuable foundation for explicit modeling of temporal transformations in the granule cell layer.

      (2) The pharmacological blockade of mGluR2/3, mGluR1, AMPA, and NMDA receptors helped identify the specific roles of these glutamate receptors.

      (3) The experiments convincingly demonstrate the key role of mGluR1 receptors in temporal information processing by UBCs.

      Weaknesses:

      (1) This study is largely descriptive and represents only a modest incremental advance from the previous work (Guo et al., Nat. Commun., 2021). 

      We feel that the present study is a major advance.  It builds on (Guo et al., Nat. Commun., 2021) in which we examined the effects of bursts of 20 stimuli at 100 spk/s.  In that study we found that differential expression of mGluR1 and mGluR2 let to a continuum of temporal responses in UBCs, but AMPARs make a minimal contribution for such bursts. It was not known how UBCs transform realistic mossy fiber input patterns. Here we provide a comprehensive evaluation of a wide range of input patterns that include a range of bursts comprised of 1-20 stimuli, sustained stimulation with stimulation of 1 spk/s to 60 spk/s. This more thorough assessment of UBC transformations combined with a pharmacological assessment of the contributions of different glutamate receptor subtypes provided many new insights: 

      • We found that UBC transformations are comprised of two different components: a slow temporally filtered component controlled by an interplay of mGluR1 and mGluR2, and a second component mediated by AMPARs that can convey spike timing information. NMDARs do not make a major contribution to UBC firing. The finding that UBCs simultaneously convey two types of signals, a slow filtered response and responses to single stimuli, has important implications for the computational potential of UBCs and fundamentally changes the way we think about UBCs.  

      • We found that with regard to the slow filtered component mediated by mGluR1 and mGluR2, we could extend the concept of a continuum of responses evoked by 20 stimuli at 100 spk/s (Guo et al., Nat. Commun., 2021) to a wide range of stimuli. It was not a given that this would be the case.   

      • The contributions of AMPARs was surprising. Even though snRNAseq data did not reveal a gradient of AMPAR expression across the population of UBCs (Guo et al., Nat. Commun., 2021), we found that there was a gradient of AMPA-mediated responses, and that the AMPA component was also most prominent in cells with a large mGluR1 component. Our finding that AMPAR accessory proteins exhibit a gradient across the population, which could account for the gradient of AMPAR responses, will prompt additional studies to test their involvement. 

      (2) The MF activity used to mimic natural stimulation was previously collected in primates, while the recordings were conducted in mice.

      Our first task was to determine the firing properties of mossy fibers under physiological conditions in UBC rich cerebellar regions. Previous studies have estimated this in anesthetized mice using whole cell granule cell recordings (Arenz et al., 2008; Witter & De Zeeuw 2015). However, for assessing firing patterns during awake behavior, we felt that the most comprehensive data set available in a UBC rich cerebellar region was for mossy fibers involved in smooth pursuit in monkeys (David J. Herzfeld and Stephen G. Lisberger). This revealed the general features of mossy fiber firing that helped us design stimulus patterns to thoroughly probe the properties of MF to UBC transformations. The firing patterns are designed to investigate the transformations for a wide range of activity patterns and have important general implications for UBC transformations that are likely applicable to UBCs in different species that are activated in different ways.   

      (3) Inhibition was blocked throughout the study, reducing its physiological relevance.

      The reviewer correctly brings up the very important issue of inhibition in shaping UBC responses.  It is well established that UBCs are inhibited by Golgi cells (Rousseau et al., 2012), and we recently showed that some UBCs are also inhibited by PCs (Guo et al., eLife, 2021). This will undoubtedly influence the firing of UBCs in vivo. We considered examining this issue, but felt that brain slice experiments are not well suited to this. In contrast to MF inputs that can be activated with a realistic activity pattern, it is exceedingly difficult to know how Golgi cells and Purkinje cells are activated under physiological conditions. Each UBC is activated by a single mossy fiber, but inhibition is provided by Golgi cells that are activated by many mossy fibers and granule cells, and PCs that are controlled by many granule cells and many other PCs. In addition, we found that many Golgi cells do not survive very well in slices, and the axons of many PCs are severed in brain slice. Although limitations of the slice preparation prevent us from determining the role of inhibition in shaping UBC responses, we have added a section to the discussion in which we address the important issue of inhibition and UBC responses.   

      Reviewer #2 (Public review):

      This study addresses the question of how UBCs transform synaptic input patterns into spiking output patterns and how different glutamate receptors contribute to their transformations. The first figure utilizes recorded patterns of mossy fiber firing during eye movements in the flocculus of rhesus monkeys obtained from another laboratory. In the first figure, these patterns are used to stimulate mossy fibers in the mouse cerebellum during extracellular recordings of UBCs in acute mouse brain slices. The remaining experiments stimulate mossy fiber inputs at different rates or burst durations, which is described as 'mossy-fiber like', although they are quite simpler than those recorded in vivo. As expected from previous work, AMPA mediates the fast responses, and mGluR1 and mGluR2/3 mediate the majority of longer-duration and delayed responses. The manuscript is well organized and the discussion contextualizes the results effectively.

      The authors use extracellular recordings because the washout of intracellular molecules necessary for metabotropic signaling may occur during whole-cell recordings. These cell-attached recordings do not allow one to confirm that electrical stimulation produces a postsynaptic current on every stimulus. Moreover, it is not clear that the synaptic input is monosynaptic, as UBCs synapse on one another. This leaves open the possibility that delays in firing could be due to disynaptic stimulation. Additionally, the result that AMPAmediated responses were surprisingly small in many UBCs, despite apparent mRNA expression, suggests the possibility that spillover from other nearby synapses activated the higher affinity extrasynaptic mGluRs and that that main mossy fiber input to the UBC was not being stimulated. For these reasons, some whole-cell recordings (or perforated patch) would show that when stimulation is confirmed to be monosynaptic and reliable it can produce the same range of spiking responses seen extracellularly and that AMPA receptormediated currents are indeed small or absent in some UBCs.

      We appreciate the reviewer’s concerns regarding the reliability of mossy fiber activation, the possibility of glutamate spillover from other synapses, and the possibility of disynaptic activation involving stimulation of MFàUBCàUBC connections. We examined these issues in a previous study (Guo et al., Nat. Commun., 2021).  We did on-cell recordings and followed that up with whole cell voltage clamp recordings from the same cell (Guo et al., Nat. Commun., 2021, Fig. 5), and there was good agreement with the amplitude and timing of spiking and the time course and amplitudes of the synaptic currents.  We also compared responses evoked by focal glutamate uncaging over the brush and MF stimulation (Guo et al., Nat. Commun., 2021, Fig. 4). We found that the time courses and amplitudes of the responses were remarkably similar. This strongly suggests that the responses we observe do not reflect disynaptic activation (MFàUBCàUBC connections). We also showed that the responses were all-or-none: at low intensities no response was evoked, as the intensity of extracellular stimulation was increased a large response was suddenly evoked at a threshold intensity and further increases in intensity did not increase the amplitude of the response (Guo et al., Nat. Commun., 2021, Extended data Fig. 1).  We can be well above threshold and still excite the same response, and as a result we do not see stereotyped indications of an inability to stimulate during prolonged high frequency activation.  We recognize the importance of these issues, so we have  added a section dealing explicitly with these issues (pp. 15-16).  

      A discussion of whether the tested glutamate receptors affected the spontaneous firing rates of these cells would be informative as standing currents have been reported in UBCs. It is unclear whether the firing rate was normalized for each stimulation, each drug application, or each cell. It would also be informative to report whether UBCs characterized as responding with Fast, Mid-range, Slow, and OFF responses have different spontaneous firing rates or spontaneous firing patterns (regular vs irregular).

      The spontaneous firing of UBCs is indeed an interesting issue that is deserving of further investigation. It is not currently known how spontaneous firing at rest is regulated in UBCs, however, in previous work we have shown that there is great diversity in the rates across the population of UBCs in the dorsal cochlear nucleus (Huson & Regehr, JNeurosci, 2023, Fig. 4). Unfortunately, during the kind of sustained high-frequency stimulation protocols (as used in this study) spontaneous firing rates tend to increase. This is likely an effect of residual receptor activation. As such, our current dataset is not suitable to performing in depth analysis of the effects of the different glutamate receptors on spontaneous firing rates. As this study aims to explore UBC responses to MF inputs we feel that specific experiments to address the issue of spontaneous firing rates are outside of the scope.

      As the reviewers points out there are indeed different ways the firing rates can be normalized for display in the heatmaps, and different normalizations have been used in different figures. We have made sure that the method for normalization is clearly indicated in the figure legends for each of the heatmaps on display, specifying the protocol and drug application used for normalization.

      Figure 1 shows examples of how Fast, Mid-range, Slow, and OFF UBCs respond to in vivo MF firing patterns, but lacks a summary of how the input is transformed across a population of UBCs. In panel d, it looks as if the phase of firing becomes more delayed across the examples from Fast to OFF UBCs. Quantifying this input/output relationship more thoroughly would strengthen these results.

      The UBC responses to in vivo MF firing patterns are intriguing and we agree that there appears to be increasing delays for slower UBCs visible in Figure 1. However, we feel that the true in vivo MF firing patterns are too complex and irregular for rigorous interpretation. Therefore, we only tested simplified burst and smooth pursuit-like input patterns on the full population of UBCs. Here we indeed do see increasingly delayed responses as UBCs get slower (Fig. 4).

      Inhibition was pharmacologically blocked in these studies. Golgi cells and other inhibitory interneurons likely contribute to how UBCs transform input signals. Speculation of how GABAergic and glycinergic synaptic inhibition may contribute additional context to help readers understand how a circuit with intact inhibition may behave. 

      As indicated in our response to reviewer 1, we have added a section discussing the very important issue of inhibition and UBC responses in vivo.   

      Recommendations for the authors:

      Reviewer #1 (Recommendations for the authors):

      (1) Including recordings without inhibition blocked would strengthen the study and provide a more comprehensive view of the transformations made by UBCs at the input stage of the cerebellar cortex.

      See response to public comments.   

      (2) The authors claim that a continuum of temporal responses was observed in UBCs, but they also distinguish between fast, mid-range, slow, and OFF UBCs. While some UBCs fire spontaneously, others are activated by MF inputs. A more thorough classification effort would clarify the various response profiles observed under specific MF stimulation regimes. Have the authors considered using machine learning algorithms to aid in classification? 

      We fundamentally feel that these response properties do not conform to rigid categories. In our previous work we have shown that UBC population constitutes a continuum in terms of gene expression, and in terms of spontaneous and evoked firing patterns. While in order to answer some questions empirically it may still be useful to apply advanced algorithms to enforce separate groups to be compared, in this work we aimed to present the full range of UBC responses without introducing any additional biases that such methods would produce.

      (3) A robust classification could assist in quantifying the temporal shifts observed during smooth pursuit-like MF stimulation, a critical outcome of the study.

      As stated above, we prefer to present an unbiased overview of the continuous nature of the UBC population, as we believe that this is fundamentally the most accurate representation. While it is true that this prevents us from providing a quantification in the different temporal shifts, we believe that the range of shifts across the population is sufficiently large and continuously varying the be convincing (see Figure 4d).  

      (4) In Figure 5, contrary to what is described on page 10, Cells 10 and 11 (OFF UBCs) appear to behave differently, as mGluR1 does not seem to affect their firing rates. A specific case should be made for OFF UBCs. 

      Indeed, cells 10 and 11 do not show clear increases in firing and are not strongly affected by blocking of mGluR1. However, as discussed above and explored in our previous work, we feel that the range of UBC increases in firing is best described as a continuum, including the extreme where increases in firing are no longer clearly observable. As the aim in this work is to describe this continuum of responses for physiologically relevant inputs, we do not feel there is a benefit to creating a specific case for OFF UBCs here. It should be pointed out that the number of “pure” OFF UBCs completely lacking an mGluR1 component is very small.  

      (5) A summary diagram should be added at the end of the manuscript to highlight the key temporal features observed in this study. 

      This is a great suggestion and we have prepared such a summary diagram (Figure 6).

      Reviewer #2 (Recommendations for the authors):

      (1) Page 3- "Assed" should be "assessed"

      (2) Page 19- "by integrating" is repeated twice

      (3) It was not noted whether the data would be made available. It could be useful for those interested in implementing UBCs in models of the cerebellar cortex.

      We agree that this data set is invaluable to those interested in implementing UBCs in models of the cerebellar cortex.  We will make the dataset available as described in the text.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Reviewer #1:

      (1) “…Given that the focus in the paper is on tissue-specific immune training, it would be helpful to know whether the ongoing presence of BCG at low levels in the profiled tissue contributes to the trained immunity phenotypes observed.”….“To address point 1, the authors could treat with anti-BCG antibiotics at 2 or 4 weeks post-BCG exposure and profile the impact on trained immunity phenotypes.”

      We thank the reviewer for this important comment. The experiment suggested by the reviewer is to treat with abx to remove BCG from the tissue from the first week post challenge for the duration of four weeks. In previous work, Kaufmann et al (PMID: 29328912) showed that after a month of antibiotics, BCG levels are reduced, but residual BCG levels still remains. Accroding to their results, while antibiotic treatment reduces the training phenotype of LKS<sup>+</sup> HSC expansion in the bone marrow, protection against TB was maintained during ex-vivo challenge of BMDMs.

      In our experiments, we are concerned that antibiotic treatment will only change the dynamics of BCG clearance, but residual BCG will remain and will limit our interpretation. Furthermore, examining the transcriptional changes we observed at early timeponts after BCG may not be relavant at 1 month post antibiotics.

      As an alternative approach, we refer to our results with an antibody to block early IFNg signaling (1-5 days; Figure S4 K-M). Here, although BCG levels are comparable between treatment and control groups, we were unable to detect any TI-related transcriptional signatures upon early aIFNg treatment. This indicates that that residual BCG is not sufficient for the TI phenotype in the spleen. We now emphasize this point in the revised version of the manuscript (see lines 335-339).

      (2) “Related to the point about BCG above, it would be helpful to understand whether this is a specifically time-limited requirement when trained immunity is first induced, or whether ongoing signaling through this axis is required for maintenance of the observed trained immunity phenotypes.”… “To address point 2, authors could treat with the inhibitor at 2 weeks and/or 4 weeks post-BCG and profiling later transcriptional and/or salmonella growth phenotypes.”

      We thank the reviewer for his comment, but respectfully claim that this experiment might not be feasible. As IFNg signaling is directly required for control of Salmonella infection,  we are concerned that late IFNg inhibition will also directly affect the response to Salmonella challenge and control. Thus, in our experiments, to ensure that treatment only affects the response to BCG challenge, we were careful to limit aIFNg treatment to the early time points and allowed long resting period before Salmonella challenge.

      Furthermore, inhibition of IFNg at late time point was already tested in both Lee et al, and Tran et al. (PMID: 38036767, 38302603). The authors show that late blockage of IFNg signalling (days 14-21) is sufficient to prevent protection during a viral challenge. This would indeed imply that ongoing signalling is necessary in this context to generate protection, specifically also late signalling events. Furthermore, Lee at al., also observed a biphasic activation pattern of cytokines and recruited cells, suggesting that rather than continuous activation, sequential cell activation and signalling may be occurring.

      Respectfully, in our experiments we focus on the early time points based on our observations of early recruitment of CM-T cells (Figure S2. C-D). This was our main findings of this paper. We agree with the reviewer that future experiments are required to compare the differences in cell populations that are invovled in the early vs. late trained phenotpe dynamics.

      Minor points:

      Experimental conditions for the shown data are not consistently clear from the figure legends- would add more detail about the biological conditions.

      OK – done

      Figure 3E missing units on the legend

      OK – done

      Figure 4C middle panel missing y-axis label

      OK – done

      Line 40- remove "both"

      OK- done

      Line 156- Language could be clearer about what was described previously in contrast to the results shown in this work

      We have modified the text accordingly in the revised manuscript

      Reviewer #2:

      “A significant amount of work has already been performed for this study. The work is rich with data and description.”

      We thank the reviewer for acknowledging the importance of our work.

      Minor comments for the authors to consider:

      “BCG is widely recognised to induce trained immunity. In this study, Salmonella is used as secondary infection event. Why? What is role of Salmonella in this study? Does this study contribute to our understanding of the Salmonella infection process? What does this tell us about Salmonella/vaccines? Is there any evidence that BCG protects against Salmonella infection? “

      We thank the reviewer for this important comment. We now added to the introduction and the discussion the relevance of our study to the potential of BCG and trained immunity as an alternative heterologous vaccine approach to traditional vaccines that require strain-specific vaccine for each pathogen (lines 49-55 of the revised manuscript).

      “Figure 1E. RPM cannot be detected by scRNAseq?”

      The reviewer is correct. we excluded RPMs from the scRNA-seq analysis. As we discuss in the manuscript (lines 94-96), and in our previous publication (PMID: 34788598), RPM activation involves rapid cell death. As we are analyzing by scRNA-seq two weeks after BCG challenge, we only measured scRNA-seq of CD11b+ cells, which exclude RPMs, as we were worried that our transcriptional data would represent transcriptional signatures of dying cells, making interpretation of the data difficult.

      “Figures 1H and I. The CM-T macrophages are not represented? Are they contemplated within the CM population? Would be useful to see the contribution of CM-T to the total CM DEGs/pathways.”

      The reviewer is correct. CM-T cells are evident only after BCG challenge. Because of this, our analysis of DEGs induced in monocytes by BCG requires analysis of all monocytes together. Thus, we were careful throughout the manuscript to refer to CM when analyzing bulk RNA-seq data.

      “Lines 104-117. Can the authors summarise or move the text in this paragraph to discussion? Although it provides important context, it cuts the line of thought and reduces comprehension of this section. “

      OK – we moved this section to the discussion in the revised manuscript.

      “Line 127. Is it Fig 1I or 1F that the authors are referring to? “

      The reviewer is correct, and we changed the text in the revised manuscipt accordingly.

      “Figure 1J. x-axis labels CM cells but both text and figure legend refer to this panel as CM-T. If this is the case, please show data for CM and CM-T separately.”

      Please see our earlier point above that limits these analyses. As such we have also edited the text and figure legend to reflect this.

      “Lines 136-139. Please indicate that this can be found in Fig 1J.”

      OK – indicated in the revised manuscript

      “Line 152. Please add that STm infection occurred at 14 and 60 days post training.”

      OK – added

      “Lines 162-163. This is repeated from lines 89-90, maybe the reduction of RPMs can be only highlighted in this section so that the previous section can be just focused on the new CM-T population?”

      The reviewer is correct - we removed the mention of RPMs here, and mention them only later in the revised manuscript.

      “Line 163. The recruitment is CM or CM-T cells? Since they express CXCL9 (line 165 and Fig1J) could this be used as a marker for the CM-T population at this time point?”

      The reviewer is correct, and we thank him for this important comment. We now indicate that CXCL9+ is a marker for the CM-Ts population here and throughout the revised manuscript (lines 153-155 of the revised manuscript).

      “Line 173. The loss of CXCL9 at 60 dpi means that CM-T population disappears/reduces or returns to CM only? If the population is reduced, could it be related to the reduced STm infection control at 60 days?”

      OK– done. Referred to these cells as CM-Ts and suggested a correlation with protection loss in the text (lines 160-162 of the revised manuscript).

      “Figure 2D. Can the authors show if there is variation in the myeloid populations after PBS injection at different time points? Are the percentages shown only at 3 dpi? It is curious that at 30 dpi the transcriptome has a significant change for certain genes.”

      There are indeed variations across the PBS time points samples, which we demonstrate in Figure S2B. The percentages shown in the main figure for PBS reflect the mean of all time points, this is now stated in greater clarity in the revised manuscript (lines 151-152). We also noted an increase in the cell cycling genes at D30 for the control mice as well, and while still significant in BCG, we limited interpretation accordingly.

      “Line 208. The authors can highlight that the expression of STAT1 follows the same pattern as IFNg. Maybe even present the graphs side by side?”

      The reviewer is correct, and we have implemented their suggestion as such in the updated text (lines 192-195) and figure (Fig. 2H).

      “Line 213. Authors mention a replenishment of the RPM population - what time point are you referring to? At 60 dpi the population seems to be halved compared to 14 dpi. Later (line 230), authors refer to the replenishment as a repopulation by other cell types - is repopulation more correct than replenishment?”

      The reviewer is correct, and we thank the reviewer for this important comment. We now changed replenishment to repopulation (lines 95, 201), which is more accurate given the continued decreased percentage at later time points.

      Lines 214-222. It is not clear what is the conclusion from these experiments: is the recruitment of progenitors from the BM or by local signals?

      The reviewer is correct, we agree that the wording in the initial manuscript was imprecise. This experiment specifically tests whether trained bone marrow progenitors can sustain the observed TI signatures in a naive environment. By transplanting trained bone marrow into naive hosts, we demonstrate that progenitor programming alone is sufficient to maintain long-term SCA-1 expression in NCMs, without requiring ongoing local tissue signals. We now better clarify this text in the revised manuscript (lines 202-212).

      “Line 333-334. Where is the data that shows that upon Fedratinib RPMs have enhanced survival?”

      OK – We now indicate the figure in the revised manuscript.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Reviewer #1:

      Chemogenetics validation

      Little validation is provided for the chemogenetic manipulations. The authors report that animals were excluded due to lack of expression but do not quantify/document the extent of expression in the animals that were included in the study.

      We thank the reviewer for raising this oversight. We have added additional examples of virus expression in sections from included and excluded animals in Figure 1 – Supplement 1. We also added additional comments on the extent of expression we observed in lines 92-95: “Post-experiment histology confirmed overlapping virus expression and TH-positive neurons in putative VTA near the injection site (-5.6 mm AP from bregma), as well as approximately 0.5 mm anterior and posterior (-5 to -6 mm AP).”

      There's no independent verification that VTA was actually inhibited by the chemogenetic manipulation besides the experimental effects of interest.

      While we did include animals expressing control virus to control for any effect of CNO administration itself, the reviewer is correct that we did not independently verify VTA neurons were inhibited. We have noted this limitation of the current study on lines 513-522 in the Discussion: “We did not directly measure the suppression of VTA neurons after CNO injection. Previous work in other brain areas found hM4Di activation suppressed firing rates to around 60% of baseline (Mahler et al., 2014; Chang et al., 2015), in addition to diminishing synaptic transmission even when spikes occurred (Stachniak et al., 2014). Combined with the incomplete expression of hM4Di in TH-positive neurons in our animals, we expect VTA activity was significantly but not completely suppressed. Because our results depend only on any degree of blunting differences in dopamine release at different reward locations, rather than the total absence of dopamine signaling, measuring the magnitude of suppression was not essential for our conclusions.”

      The authors report a range of CNO doses. What determined the dose that each rat received? Was it constant for an individual rat? If not, how was the dose determined? The authors may wish to examine whether any of their CNO effects were dependent on dose.

      The reviewer is completely correct that we omitted sufficient information regarding the dosage of CNO used in each animal and each session. We have included more details in the Methods lines 676-694, detailing both the doses and the rationale.

      The authors tested the same animal multiple times per day with relatively little time between recording sessions. Can they be certain that the effect of CNO wore off between sessions? Might successive CNO injections in the same day have impacted neural activity in the VTA differently? Could the chemogenetic manipulation have grown stronger with each successive injection (or maybe weaker due to something like receptor desensitization)? The authors could test statistically whether the effects of CNO that they report do not depend on the number of CNO injections a rat received over a short period of time.

      We thank the reviewer for bringing up the question of whether the order of sessions had an influence on the efficacy of CNO in inactivating VTA activity. To address this, we split our dataset in Experiment 1 into two based on what number session of the particular day it was: 1st sessions of the day vs. all subsequent sessions (2nd+ session of the day). Then, we examined the difference in sharp-wave ripple rate between the reward ends in Epoch 2, as in Figure 2D of the manuscript. Though the resulting number of sessions in each split of the dataset is too low to draw strong statistical conclusions, particularly for novel sessions, we see little evidence there is any systematic change in the effect of VTA inactivation as a function of session number in the day. We include this in the revised manuscript as Figure 2 – Supplement 3 and in the Results lines 255-258.

      Motivational considerations

      In a similar vein, running multiple sessions per day raises the possibility that rats' motivation was not constant across all data collection time points. The authors could test whether any measures of motivation (laps completed, running speed) changed across the sessions conducted within the same day.

      We thank the reviewer for this suggestion. We examined behavioral measures of motivation across sessions conducted within the same day. First, we calculated how many total laps each animal completed each session as a function of the session number of the day. In individual animals, this ranged from -2.8 to 4.1 laps per additional session number (mean 2.01), with an average total laps per session of 43.2 laps. Second, we calculated the median running velocity per session, across both running directions and all epochs, and checked how it varied across session number of the day. Per additional session in the day, this ranged from -3.6 to 8.6 cm/s difference across animals (mean 2.7 cm/s), with an average running velocity of 34.1 cm/s in total. Taken together, while we found little behavioral evidence of strong motivational changes across session, our animals may have been slightly more motivated in later sessions in the day, which also corresponded to later in the light cycle and closer to the dark cycle. We mention this information in Results lines 255-258, related to Figure 2 – Supplement 3.

      This is a particularly tricky issue, because my read of the methods is that saline sessions were only conducted as the first session of any recording day, which means there's a session order/time of day and potential motivational confound in comparing saline to CNO sessions.

      We have clarified the ordering of CNO and saline sessions in the Methods lines 697-702. Briefly, we avoided running CNO sessions before saline sessions in the same day, but either could be the first session of a day. That is, saline -> saline, saline -> CNO, and CNO -> CNO were all valid orderings. On days with more than two sessions, any number of repeated saline and CNO sessions was permitted, provided that as soon as a CNO session occurred, any subsequent sessions were also CNO.

      More generally, we shared this reviewer’s concern about potential confounds between drug and motivation. For novel sessions in Experiment 1, each animal had equal numbers of saline and CNO 1st and 2nd sessions of the day. For familiar sessions, animals had similar counts for 1st sessions of the day (experimental rats: 20 saline, 16 CNO; control rats: 17 saline, 15 CNO) but more CNO 2nd sessions of the day (experimental rats: 5 saline, 13 CNO; control rats: 5 saline, 10 CNO). There were occasionally 3rd or 4th sessions in a given day for some rats, and these were also approximately equal (experimental rat 2, 3rd sessions: 2 each of saline and CNO, 4th session: 1 saline; experimental rat 3 and 4, 3rd sessions: 1 each of saline and CNO; control rat 2, 3rd session: 1 saline).

      Statistics, statistical power, and effect sizes

      Throughout the manuscript, the authors employ a mixture of t-tests, ANOVAs, and mixed-effects models. Only the mixed effects models appropriately account for the fact that all of this data involves repeated measurements from the same subject. The t-tests are frequently doubly inappropriate because they both treat repeated measures as independent and are not corrected for multiple comparisons.

      We thank the reviewer for pointing out these issues with our statistical analyses in places. We have made the following improvements:

      Figure 1F-I, S1, reward end visit durations: We now use a linear mixed-effects model to analyze the difference in stopping period durations between epochs. For each session, we calculated the mean stopping duration for each reward end in each epoch, then modeled the difference between epochs as a function of drug and novelty, with animal-specific intercepts. For example, related to Figure 1F and also described in the Results, we modeled the stopping duration difference at the Unchanged reward end, Epoch 2 – Epoch 1, and found experimental rats had a significant intercept (Epoch 2 stops shorter than Epoch 1) and the drug × novelty interaction, while control rats had a significant intercept and novelty main effect. The other visit duration analysis shown in Figure 1 – Supplement 1 have similarly been updated.

      Figure 2D-E, ripple rate difference between reward ends in Epoch 2: We now use a linear mixed-effects model to analyze the difference between ripple rates at the Incr. and Unch. reward ends in Epoch 2. For each session, we calculated the mean ripple rate at each end in Epoch 2, then modeled the difference as a function of drug and novelty, with animal-specific intercepts. With the full stopping periods, for experimental rats, there was a significant intercept (ripple rate at Incr. greater than Unch.) and the model with drug included performed significantly better than the one without it (AIC<sub>nodrug</sub> – AIC<sub>full</sub> = 5.22). Control rats had a significant intercept and effect of novelty (greater difference with novelty), and the model excluding drug terms performed better (AIC<sub>nodrug</sub> – AIC<sub>full</sub> = -3.54). Results with the trimmed stopping periods were similar. These analyses are described in Results lines 253-266.   

      Figure 3D-E, ripple rate as a function of reward history: We now use a mixed-effects model that incorporates animal-specific intercepts. The results remained similar and have been updated in the text and legend.

      Figure 4D-K, replay rates as a function of drug, novelty, and directionality: We now use mixed-effects models that incorporate animal-specific intercepts rather than three-way ANOVA. The results remained similar and have been updated in the text and legend.

      The number of animals in these studies is on the lower end for this sort of work, raising questions about whether all of these results are statistically reliable and likely to generalize. This is particularly pronounced in the reward volatility experiment, where the number of rats in the experimental group is halved to just two. The results of this experiment are potentially very exciting, but the sample size makes this feel more like pilot data than a finished product.

      We have added additional emphasis in the text that the experimental group results of CNO inactivation in the volatile reward task should be confirmed with future work, in Discussion line 529-533. Because these experiments were performed on familiar tracks, we see them as corroborating/complementing the results from Experiment 1. Although the analysis assumes VTA inactivation had no effect, our pooling of all Experiment 2 data to display in Figure 3 – Supplement 2 maximized our ability to analyze the effects of volatile reward deliveries on sharp-wave ripple rates, lending further support to the main results shown in Figure 3.

      The effect sizes of the various manipulations appear to be relatively modest, and I wonder if the authors could help readers by contextualizing the magnitude of these results further. For instance, when VTA inactivation increases mis-localization of SWRs to the unchanged end of the track, roughly how many misplaced sharp-waves are occurring within a session, and what would their consequence be? On this particular behavioral task, it's not clear that the animals are doing worse in any way despite the mislocalization of sharp-waves. And it seems like the absolute number of extra sharp-waves that occur in some of these conditions would be quite small over the course of a session, so it would be helpful if the authors could speculate on how these differences might translate to meaningful changes in processes like consolidation, for instance.

      We thank the reviewer for this helpful suggestion to give some context to the difference in sharp-wave ripple numbers and the functional consequence of these changes. We agree completely that this task is almost certainly too simple for animals to show any performance deficit from these changes. We chose this precisely so we could examine the consequences of VTA inactivation to the sharp-wave ripple response to reward changes per se, without any confound of performance or memory changes that could also conceivably alter sharp-wave ripples. We have added both more context about the magnitude and consequence of these sharp-wave ripple changes as well as comments about the choice of this particular task (Discussion lines 522-529).  

      How directly is reward affecting sharp-wave rate?

      Changes in reward magnitude on the authors' task cause rats to reallocate how much time they spent at each end. Coincident with this behavioral change, the authors identify changes in the sharp-wave rate, and the assumption is that changing reward is altering the sharp-wave rate. But it also seems possible that by inducing longer pauses, increased reward magnitude is affecting the hippocampal network state and creating an occasion for more sharp-waves to occur. It's possible that any manipulation so altering rats' behavior would similarly affect the sharp-wave rate.

      For instance, in the volatility experiment, on trials when no reward is given sharp-wave rate looks like it is effectively zero. But this rate is somewhat hard to interpret. If rats hardly stopped moving on trials when no reward was given, and the hippocampus remained in a strong theta network state for the full duration of the rat's visit to the feeder, the lack of sharp-waves might not reflect something about reward processing so much as the fact that the rat's hippocampus didn't have the occasion to emit a sharp-wave. A better way to compute the sharp-wave rate might be to use not the entire visit duration in the denominator, but rather the total amount of time the hippocampus spends in a non-theta state during each visit. Another approach might be to include visit duration as a covariate with reward magnitude in some of the analyses. Increasing reward magnitude seems to increase visit duration, but these probably aren't perfectly correlated, so the authors might gain some leverage by showing that on the rare long visit to a low-reward end sharp-wave rate remains reliably low. This would help exclude the explanation that sharp-wave rate follows increases in reward magnitude simply because longer pauses allow a greater opportunity for the hippocampus to settle into a non-theta state.

      We thank the reviewer for these important comments. We have better clarified the analysis of sharp-wave ripple rate in the Results (lines 172-173). To speak to the main concern of the reviewer, we do only consider times during “stopping periods” when the rat is actually stationary. That is, ripple rate for each visit is calculated as (# of ripples / total stationary time), rather than the full duration the rat is at the track end. With respect to including visit duration as a covariate, the Poisson model takes the total stationary time of each visit into account, so that it is effectively predicting the number of events (ripples) per unit of time (seconds) given the particular experimental variables (reward condition, drug condition, etc.). We have added additional clarification of this in the Methods (line 834-836).

      The authors seem to acknowledge this issue to some extent, as a few analyses have the moments just after the rat's arrival at a feeder and just before departure trimmed out of consideration. But that assumes these sorts of non-theta states are only occurring at the very beginning and very end of visits when in fact rats might be doing all sorts of other things during visits that could affect the hippocampus network state and the propensity to observe sharp-waves.

      We hope that with the clarification provided above, this control analysis helps remove any potential effects of approaching/leaving behavior or differences in movement at the reward end that could alter sharp-wave ripple rates. 

      Minor issues

      The title/abstract should reflect that only male animals were used in this study.

      We have added this important information to the Abstract line 21.

      The title refers to hippocampal replay, but for much of the paper the authors are measuring sharp-wave rate and not replay directly, so I would favor a more nuanced title.

      We thank the reviewer for this suggestion. In the context of our work, we consider sharp-wave ripples as more-easily-detected markers for the occurrence of replay. Previous work from our lab (Ambrose et al., 2016) showed the effect of reward changes had very similar effects to both sharp-wave ripple rate and replay rate. We try to be explicit about viewing ripples as markers of replay content in both the Introduction and Discussion. Nevertheless, we do also demonstrate the title claim directly – by measuring replay and its spatial localization – therefore we feel comfortable with the title as it is.

      Relatedly, the interpretation of the mislocalization of sharp-waves following VTA inactivation suggests that the hippocampus is perhaps representing information inappropriately/incorrectly for consolidation, as the increased rate is observed both for a location that has undergone a change in reward and one that has not. However, the authors are measuring replay rate, not replay content. It's entirely possible that the "mislocalized" replays at the unchanged end are, in fact, replaying information about the changed end of the track. A bit more nuance in the discussion of this effect would be helpful.

      While we do show that replay content, in the form of reverse vs. forward replays, is altered with VTA inactivation, we take the reviewers point and completely agree. Especially in the context of the linear track, replays at either end could certainly be updating/consolidating information about both ends. We would argue our results suggest VTA is critical to localizing ripples and replay in more complex environments where this is not the case, but this is a hypothesis. We have added clarification and discussion of this point (Discussion lines 522-529).

      However, in response to the reviewer’s comment, we have now also examined non-locally-initiated replays specifically to determine whether the increased ripple rate at the Unch. reward end in novel CNO sessions was likely due to more non-local replay, but found no significant increases in non-local replay at either reward end in either drug condition or novelty condition. We have included this result as Figure 4 – Supplement 3, and note it in the Results lines 487-488.

      The authors use decoding accuracy during movement to determine which sessions should be included for decoding of replay direction. Details on cross-validation are omitted and would be appreciated. Also, the authors assume that sessions failed to meet inclusion criteria because of ensemble size, but this information is not reported anywhere directly. More info on the ensemble size of included/excluded sessions would be helpful.

      We have added additional information about the run decoding procedure and related session inclusion criteria, as well as about recorded ensemble sizes (lines 417-421). Briefly, mean ensemble sizes were significantly smaller for excluded sessions (cell count, mean±sem; included sessions: 26.1±1.1, excluded sessions: 9.5±1.6; two-sample t-test, t(133)=5.3, p<10<sup>-5</sup>). The average field size, defined as the number of spatial bins with greater than 1 hz firing rate, in excluded sessions was also larger (mean±sem, included sessions: 47.7±1.3, excluded sessions: 57.7±5.8; two-sample t-test, t(133)=-2.33, p<0.05), though the difference was less dramatic. Using a mixed effects model to predict position decoding error (as in Figure 4 – Supplement 2A) as a function of drug, novelty, cell count, and mean place field size, in both experimental and control groups cell count and field size were significant predictors: more cells and smaller average field size led to lower error. A similar model that instead predicted the fraction of running bins with correctly decoded running direction (as in Figure 4 – Supplement 2B), in neither group was field size significant, while cell count remained so: more cells led to more bins with running direction correctly classified. We include these analyses in the legend for the figure. With respect to cross validation of run decoding, because both the contribution of spikes in any single time bin to a neuron’s place field is extremely small and because we used run decoding accuracy simply to filter out sessions with poorer decoding, we did not use cross validation here.

      For most of the paper, the authors detect sharp-waves using ripple power in the LFP, but for the analysis of replay direction, they use a different detection procedure based on the population firing rate of recorded neurons. Was there a reason for this switch? It's somewhat difficult to compare reported sharpwave/replay rates of the analyses given that different approaches were used.

      We have added clarification for this change in detecting candidate events (lines 787-789). Briefly, sharp-wave ripples and spike density events are often but not always overlapping, such that there can be strong ripples with little spiking in the recorded ensemble or weak/absent ripples during vigorous spiking in the recorded ensemble. Because the decoding of replay content relies on spiking, our lab and others often use spike density or population burst events as candidate events. We have confirmed that the main results of Experiment 1 (e.g., Figure 2) remain the same if we use spike density events rather than sharp-wave ripples, but prefer to keep the use of sharp-wave ripples here for better comparison with Experiment 2 and to allow the inclusion of animals and sessions with low cell yield but clear ripples in the LFP.  

      Reviewer #2 (Recommendations For The Authors):

      Include additional histological data to confirm the extent of viral spread and precise tetrode placements. Providing detailed figures that clearly illustrate these aspects would strengthen the validity of the neural recordings and the specificity of the chemogenetic silencing.

      We thank the reviewer for this suggestion and have added additional information regarding virus expression in Figure 1 – Supplement 1. We also added additional comments on the extent of expression we observed in lines 92-95: “Post-experiment histology confirmed overlapping virus expression and TH-positive neurons in putative VTA near the injection site (-5.6 mm AP from bregma), as well as approximately 0.5 mm anterior and posterior (-5 to -6 mm AP).”

      While we do not show histological confirmation of hippocampal recording sites, the presence of sharp-wave ripples with upward deflections, presence of place cells, and recording coordinates and depth typical of dorsal CA1 made us confident in our recording location. We have noted these characteristics of our recordings in lines 128-131 in the Results: “Tetrodes were lowered to the pyramidal cell layer of dCA1, using the presence of sharp-wave ripples with upward deflections in the LFP, recording depth characteristic of dCA1, and spatially-restricted firing of place cells to confirm the recording location.”

      Address the variability in CNO dosing and timing before recordings. It is recommended to standardize the dose and ensure a consistent timing interval between CNO administration and the start of recordings to minimize variability in the effects observed across different subjects. Instead of collecting new data, the authors could report the data for each animal, indicating the dose and interval between the injection and the recording.

      We have further clarified the CNO dosing and timings in lines 676-702.

      In Figure 1F, explicitly state whether the data represent averages across multiple sessions and confirm if these observations are primarily from the initial novel sessions. This clarification will help in accurately interpreting the effects of novelty on the measured neural activities.

      We have changed the analyses shown in Figure 1F-I and Figure 1 – Supplement 1 thanks to the suggestions of Reviewer #1, but also more clearly spell out the analysis. Briefly, we average the durations for each condition within session (e.g., take the mean Unch. duration in Epoch 1), then perform the analysis across sessions. These data come from all sessions in Experiment 1, as described in lines 141-147, meaning there are around 2-3 times as many familiar sessions as novel sessions.

      Reconsider the reporting of marginal p-values (e.g., p=0.055). If the results are borderline significant, either more data should be collected to robustly demonstrate the effects or a statistical discussion should be included to address the implications of these marginal findings.

      We have removed the reporting of marginal p-values.

      Ensure that the axes and scales are consistent across similar figures (specifically mentioned for Figure 2A) to prevent misinterpretation of the data. Consider showing the average across all animals in 2A, similar to 2B and 2C.

      We have adjusted these axes to be consistent across all panels.

      Add a legend to the heatmap in Figure 4A to facilitate understanding of the data presented.

      We have added a heatmap to the figure and legend.

      Provide a detailed examination and discussion of the apparent contradictions observed in control data, particularly where experimental conditions with saline show increased reverse replay in novel environments, which is absent in familiar sessions. See Figures 4E and 4I.

      We thank the reviewer for noting that this feature of our data deserved discussion. We confirmed that the lack of an effect of reward on reverse replay rates in familiar sessions in control rats was due to generally low replay rates in these sessions. Replay rates have been observed to decrease as the familiarity of an environment or behavior increases, and the presence of the reward-related modulation of reverse replay in novel sessions in these animals is consistent with this observation. We now report in the Results lines 458-459 and 485-486 the low replay rates in this group in familiar sessions, and the likelihood that this is preventing any reward-related modulation from being detected.

      Include a more detailed analysis of place cell properties, such as firing rates and field sizes, especially in novel environments where VTA inactivation appears to alter spatial coding. Decoding error is lower during CNO administration - does this mean place fields are smaller/more accurate? This analysis could offer deeper insights into the mechanisms by which dopamine influences hippocampal neural representations and memory processes.

      We thank the reviewer for this helpful suggestion. We have expanded on our analysis of place field properties and decoding accuracy, describing properties of sessions with good enough decoding to be included compared to those that were excluded (lines 417-421). We also directly tested how decoding quality depended on several factors, including drug condition, novelty, number of cells recorded, and the average place field size of recorded cells (see legend for Figure 4 – Supplement 2). We found a small but significant effect of drug in experimental rats, but larger effects of number of recorded cells and average field size, that were also present in control animals.

      Correct the typo on line 722 from "In ANOVA" to "An ANOVA".

      We reworded this section and have corrected this error.

      Reviewer #3 (Recommendations For The Authors):

      The manuscript is clear and exciting. As a main criticism, I would have liked to see the effects on ripple duration not just the rate.

      We thank the reviewer for this interesting idea. We performed a new analysis, similar to our analysis on SWR rate, probing the effect of our experimental manipulations on SWR duration in experimental rats. We have added the results in Figure 2 – Supplement 4, and note them in the main text lines 195-198: “SWR duration was reduced in novel sessions, consistent with replays becoming longer with increased familiarity  (Berners-Lee et al., 2021), as well as in Epoch 2, but was otherwise unaffected by reward or drug (Figure 2 – Supplement 4).”

      I have a few other minor comments:

      (1) I find it a little disturbing and counterintuitive that statistical differences are not always depicted in the figure graphs (for example Figures 2A-E). If the authors don't like to use the traditional *, ** or *** they could either just use one symbol to depict significance or simply depict the actual p values.

      We thank the reviewer for this suggestion. We struggled with indicating significance values graphically in an intuitive way for interaction terms in the figures. We now added significance indicators in Figures 1F-I, added the significant model coefficients directly into Figure 2B-C, changed the analysis depicted in Figure 2D-E per Reviewer 1’s suggestions, and added significance indicators where previously missing in Figures 3 and 4.

      (2) Related to the point above: in the page 7 legend D and E, it would be advantageous for clarity of the experimental results to also perform post-hoc analyses as depicted in the graphs, rather than just describe the p-value of the 3way ANOVA;

      We thank the reviewer for this suggestion. Because the figure includes the mean and standard error of each condition, in addition to the significant effects of the mixed-effects model, we prefer the current format as it makes clearer the statistical tests that were performed while still allowing visual appreciation of differences between specific experimental conditions of interest to the reader.

      (3) According to Figure 1H, the duration of the reward visits can go up to 15s (or more). Yet in Figure 2A only the first 10sec were analyzed. While I understand the rationale for using the initial 10 seconds where there is a lot more data, the results of graphs of Figures A to C will not have the same data/rate as Figures D-F where I assume the entire duration of the visit is taken into account.

      A figure showing what happening to the ripple rate during the visits >10sec would help interpret the results of Figure 2.

      We thank the reviewer for these interesting suggestions. We clarify now that all these analyses of Experiment 1 use only the first 10 s of each stopping period in Method line 758-764. However, examining the longer stopping periods is an excellent suggestion, and we re-analyzed the Experiment 1 dataset using up to the first 20 s of each stopping period. The main results (e.g., Figure 2) remain the same:

      (1) Related to Figure 2B-C: For experimental rats, a mixed-effects generalized linear model predicting sharp-wave ripple rate as a function of reward end, block, drug, novelty, and interactions, had the following significant terms: drug (p<10<sup>-5</sup>), novelty (p<10<sup>-10</sup>), reward end × block (p<10<sup>-10</sup>), and reward end × block × drug (p<0.05). The same model in control rats had significant terms: reward end (p<0.05), novelty (p<10<sup>-4</sup>), reward end × block (p<10<sup>-10</sup>).

      (2) Related to Figure 2D-E: For experimental rats, we used a mixed-effects generalized linear model predicting the difference in sharp-wave ripple rate between the Incr. and Unch. reward ends in Epoch 2 as a function of novelty, drug, and their interaction. Model comparison found the full model performed better than a model removing the drug terms (AIC<sub>nodrug</sub> – AIC<sub>full</sub> = 2.94), while a model with only the intercept performed even worse (AIC<sub>intercept</sub> – AIC<sub>full</sub> = 13.76). For control rats, model comparison found the full model was equivalent to a model with only the intercept (AICintercept – AICfull = -0.36), with both modestly better than a model with no drug terms (AIC<sub>nodrug</sub> – AIC<sub>full</sub> = 1.38).

      We have added a remark that results remain the same using this longer time window in Methods line 758-764.

    1. Author response:

      The following is the authors’ response to the previous reviews.

      Reviewer #2 (Public review):

      Summary:

      Yamawaki et al., conducted a series of neuroanatomical tracing and whole cell recording experiments to elucidate and characterise a relatively unknown pathway between the endopiriform (EN) and CA1 of the ventral hippocampus (vCA1) and to assess its functional role in social and object recognition using fibre photometry and dual vector chemogenetics. The main findings were that the EN sends robust projections to the vCA1 that collateralise to the prefrontal cortex, lateral entorhinal cortex and piriform cortex, and these EN projection neurons terminate in the stratum lacunosum-moleculare (SLM) layer of distal vCA1, synapsing onto GABAergic neurons that span across the Pyramidal-Stratum Radiatum (SR) and SR-SML borders. It was also demonstrated that EN input disynaptically inhibits vCA1 pyramidal neurons. vCA1 projecting EN neurons receive afferent input from piriform cortex, and from within EN. Finally, fibre photometry experiments revealed that vCA1 projecting EN neurons are most active when mice explore novel objects or conspecifics, and pathway-specific chemogenetic inhibition led to an impairment in the ability to discriminate between novel vs. familiar objects and conspecifics.

      The authors have addressed most of my concerns, but a few weaknesses remain :<br /> (1) I expected to see the addition of raw interaction times with objects and conspecifics for each phase of social testing (pre-test, sociability test, social discrimination), as per my comment on including raw data. However, the authors only provided total distance traveled and velocity, and total interaction time in Figure S9, which is less informative.

      We apologies for missing the request. We have added the raw interaction times in Fig. S9G.

      (2) The authors observed increased activity in vCA1-projecting EN neurons tracking with the preferred object during the pre-test (object-object exploration) phase of the social tests, and the summary schematic (Figure 9A) depicts animals as showing a preference for one object over the other (although they are identical) in both the social and object recognition tests. However, in the chemogenetic experiment, the data (Fig S9B) indicate that animals did not show this preference for one object over another, making the expected baseline for this task unclear. This also raises an important question of whether the lack of effect from chemogenetic inhibition of vCA1-projecting EN neurons could be attributed to the absence of this baseline preference.

      We appreciate the comments. In Fig. S9B, although the group median at baseline (pretest) showed no preference for one object, individual subjects displayed a preference for one object (i.e., each data point deviated positively or negatively from 0.5) in saline condition. Therefore, we do not think that a lack of baseline preference accounts for the absence of the inhibition effect in the pretest.

      Additionally, the finding that vCA1-projecting EN activity is associated with the preferred object exploration appears to counter the authors' argument that novelty engages this circuit (since both objects are novel in this instance). This discrepancy warrants further discussion.

      This is an interesting point. One possibility is that during the pretest, EN activity simply "reports" or "represents" the interaction time without driving exploratory preference. This aligns with our DREADD experiment data, which show that inhibition of EN neurons produced no overall behavioral effect. Innate exploratory behavior has been attributed to various circuits, including the medial preoptic area → PAG circuit (Ryoo et al., 2021, Front. Neuro.) and the Septal → VTA circuit (Mocellin et al., 2024, Neuron). We found no direct projection from these areas to EN (Fig. 6), but such connections could be established di- or polysynaptically. Moreover, these circuits could be driven by common inputs, such as the locus coeruleus or the cholinergic system for arousal, with only specific downstream targets, excluding EN, playing a key role in driving innate exploration and preference.

      We have inserted the following sentence in discussion (line 253-255):

      “The correlation of ENvCA1-proj. activity with novel object preference in the pretest nevertheless suggests that these neurons 'represent' the innate preference without driving it.”

      Recommendations for the authors:

      Reviewer #2 (Recommendations for the authors):

      Line 209: Please remove the reference to neural activity 'predicting' behavior, as correlation analysis does not imply predictive power.

      We now have changed the phrase to “Although EN<sup>vCA1-proj.</sup> activity was correlated with the behavior…”

      Line 236: It is unclear what is meant by: 'This circuit motif may predict the predominant role of ENvCA1-proj. neurons in social recognition memory'

      We have changed the sentence to the following for the clarity:

      “Since social odor information is crucial for discriminating conspecifics in rodents, this circuit motif may predict the predominant role of ENvCA1-proj. neurons in social recognition memory, given that social odor can engage multiple olfactory pathways innervating the piriform cortex.”

      Fig 7 title: insert 'with' after correlates: 'Activity of ENvCA1-proj. neurons correlates social/object discrimination performance'

      Corrected.

      Fig S1 title: 'Projecing' typo.

      Corrected.

      Fig S8: Please rephrase for clarity: 'In pretest, the object was aligned by longer interaction time (preferred object is plotted in right side)'

      We now have rephrased the sentence to:

      “In the pretest plot, the object that the mice interacted with more is placed on the right side.”

      References:

      A septal-ventral tegmental area circuit drives exploratory behavior. Mocellin, Petra et al. Neuron, Volume 112, Issue 6, 1020-1032.e7

      An inhibitory medial preoptic circuit mediates innate exploration. Ryoo, Jia et al. Front. Neurosci., 23 August 221. Volume 15- 2021

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:  

      Reviewer #1 (Public Review): 

      Summary: 

      The authors use an innovative behavior assay (chamber preference test) and standard calcium imaging experiments on cultured dorsal root ganglion (DRG) neurons to evaluate the consequences of global knockout of TRPV1 and TRPM2, and overexpression of TRPV1, on warmth detection. They find a profound effect of TRPM2 elimination in the behavioral assay, whereas elimination of TRPV1 has the largest effect on neuronal responses. These findings are of importance, as there is still substantial discussion in the field regarding the contribution of TRP channels to different aspects of thermosensation. 

      Strengths: 

      The chamber preference test is an important innovation compared to the standard two-plate test, as it depends on thermal information sampled from the entire skin, as opposed to only the plantar side of the paws. With this assay, and the detailed analysis, the authors provide strong supporting evidence for the role of TRPM2 in warmth avoidance. The conceptual framework using the Drift Diffusion Model provides a first glimpse of how this decision of a mouse to change between temperatures can be interpreted and may form the basis for further analysis of thermosensory behavior. 

      Weaknesses: 

      The authors juxtapose these behavioral data with calcium imaging data using isolated DRG neurons. Here, there are a few aspects that are less convincing. 

      (1) The authors study warmth responses using DRG neurons after three days of culturing. They propose that these "more accurately reflect the functional properties and abundance of warm-responsive sensory neurons that are found in behaving animals." However, the only argument to support this notion is that the fraction of neurons responding to warmth is lower after three days of culture. This could have many reasons, including loss of specific subpopulations of neurons, or any other (artificial?) alterations to the neurons' transcriptome due to the culturing. The isolated DRGs are not selected in any way, so also include neurons innervating viscera not involved in thermosensation. If the authors wish to address actual changes in sensory nerves involved in warmth sensing in TRPM2 or TRPV1 KO mice without disturbing the response profile as a result of the isolation procedure, other approaches would be needed (e.g. skin-nerve recordings or in vivo DRG imaging).  

      We agree that there could be several reasons as to why the responses of cultured DRGs are reduced compared to the acute/short-term cultures. It is possible ––and likely–– that transcriptional changes happen over the course of the culturing period. It is also possible that it is a mere coincidence that the 3-day cultures have a response profile more similar to the in vivo situation than the acute cultures. In the revised manuscript, we have therefore toned down the claim that the 3-day cultures mirror the native conditions more appropriately and included the sentence “However, whether 3-day cultures resemble native sensory neurons more closely than acute cultures in terms of their (transcriptional) identity is currently unknown.” (page 5). 

      We now also included a section “Limitations of the study” and bring this point up there as well and acknolwedge that longer culturing periods may cause changes in the neurons and may result in a drift away from their native state. 

      Nevertheless, our results clearly show that acute cultures have a response profile that is much more similar to damaged/”inflamed” neurons, irrespective of any comparison to the 3 daycultures. Therefore, we believe, it is helpful to include this data to make scientists aware that acute cultures are very different to non-inflamed native/in vivo DRG neurons that many researchers use in their experiments.

      (2) The authors state that there is a reduction in warmth-sensitive DRG neurons in the TRPM2 knockout mice based on the data presented in Figure 2D. This is not convincing for the following reasons. First, the authors used t-tests (with FDR correction - yielding borderline significance) whereas three groups are compared here in three repetitive stimuli. This would require different statistics (e.g. ANOVA), and I am not convinced (based on a rapid assessment of the data) that such an analysis would yield any significant difference between WT and TRPM2 KO. Second, there seems to be a discrepancy between the plot and legend regarding the number of LOV analysed (21, 17, and 18 FOV according to the legend, compared to 18, 10, and 12 dots in the plot). Therefore, I would urge the authors to critically assess this part of the study and to reconsider whether the statement (and discussion) that "Trpm2 deletion reduces the proportion of warmth responders" should be maintained or abandoned. . 

      Yes, we agree that the statistical tests indicated by the referee are more appropriate/robust for the data shown in Figures 1F, 2D, and 4G.

      When we perform 2-way repeated measures ANOVA and subsequent multiple comparison test (with Dunnets correction) against Wildtype, for data shown in Fig. 2D, both the main effect (Genotype) and the interaction term (Stimulus x Genotype) are significant. The multiple comparison yields very similar result as in the current manuscript, with the difference that the TRPM2-KO data for the second stimulus (~36°C) is borderline significant (with a p-value of p=0.050).

      Due to the possible dependence of the repeated temperature stimuli and the variability of each stimulus between FOVs (Fig. 2C), it is possible that a mixed-effect model that accounts for these effects is more appropriate. 

      Similarly, for plots 1F and 4G, Genotype (either as main effect or as interaction with Time) is significant after a repeated measures two-way ANOVA. The multiple comparisons (with Bonferroni correction) only changed the results marginally at individual timepoints, without affecting the overall conclusions. The exception is Fig. 4G at 38°C, where the interaction of Time and Genotype is significant, but no individual timepoint-comparison is significant after Bonferroni correction.

      The main difference between the results presented above and the ones presented in the manuscript is the choice of the multiple comparison correction. We originally opted for the falsediscovery rate (FDR) approach as it is less prone to Type II errors (false negatives) than other methods such as Sidaks or Bonferroni, particularly when correcting for a large number of tests.

      However, we are mainly interested in whether the genotypes differ in their behavior in each temperature combination and the significant ANOVA tests for Fig. 1F and 4G support that point. The statistical test and comparison used in the original/previous version of the manuscript, comparing behavior at individual/distinct timepoints, are interesting, but less relevant (and potentially distracting), as we do not go into the details about the behavior at any given/distinct timepoint in the assay.

      Therefore, and per suggestion of the reviewer, we have updated the statistics in the revised version of the manuscript. Also, we now report the correct number of FOVs in the legend. The statistical details are now found in the legends of the respective figures.

      (3) It remains unclear whether the clear behavioral effect seen in the TRPM2 knockout animals is at all related to TRPM2 functioning as a warmth sensor in sensory neurons. As discussed above, the effects of the TRPM2 KO on the proportion of warmth-sensing neurons are at most very subtle, and the authors did not use any pharmacological tool (in contrast to the use of capsaicin to probe for TRPV1 in Figures S3 and S4) to support a direct involvement of TRPM2 in the neuronal warmth responses. Behavioral experiments on sensory-neuron-specific TRPM2 knockout animals will be required to clarify this important point

      As mentioned above, we have toned down the correlation between the cellular and behavioral data. 

      In the discussion we now clearly describe three possibilities as to why the Trpm2 knockout animals only show a subtle cellular thermal phenotype but a strong behavioral thermal preference phenotype: (i) permanent deletion of Trpm2 may result in developmental defects and/or compensatory mechanisms; (ii) The DRG population expressing Trpm2 may be more relevant for autonomic thermoregulation rather than behavioral responses to temperature; (iii) Trpm2 expression outside DRGs (possibly in the hypothalamic POA) may account for the altered thermal behavior. 

      (4) The authors only use male mice, which is a significant limitation, especially considering known differences in warmth sensing between male and female animals and humans. The authors state "For this study, only male animals were used, as we aimed to compare our results with previous studies which exclusively used male animals (7, 8, 17, 43)." This statement is not correct: all four mentioned papers include behavioral data from both male and female mice! I recommend the authors to either include data from female mice or to clearly state that their study (in comparison with these other studies) only uses male mice.  

      This is a valid point -- when our study started 7-8 years ago, we only used male mice (as did many other researchers) and this we would now do differently. We have now newly included a statement concerning this limitation in the “Limitations of this study” section of the manuscript. 

      Nevertheless, in the studies by Tan et al. And Vandevauw et al. only male animals were used for the behavioral experiments. Yarmolinsky et al.  And Paricio-Montesinons et al. used both males and females while, as far as we can tell, only Paricio-Montesions et al. Reported that no difference was observed between the sexes. 

      Wildtypes are all C57bl/6N from the provider Janvier. Generally, all lines are backcrossed to C57bl/6 mice and additionally inbreeding was altered every 4-6 generations by crossing to C57bl/6. Exactly how many times the Trp channel KOs have been backcrossed to C57bl/6 mice we cannot exactly state.

      Reviewer #2 (Public Review): 

      Summary: 

      The authors of the study use a technically well-thought-out approach to dissect the question of how far TRPV1 and TRPM2 are involved in the perception of warm temperatures in mice. They supplement the experimental data with a drift-diffusion model. They find that TRPM2 is required to trigger the preference for 31{degree sign}C over warmer temperatures while TRPV1 increases the fidelity of afferent temperature information. A lack of either channel leads to a depletion of warm-sensing neurons and in the case of TRPV1 to a deficit in rapid responses to temperature changes. The study demonstrates that mouse phenotyping can only produce trustworthy results if the tools used to test them measure what we believe they are measuring. 

      Strengths: 

      The authors tackle a central question in physiology to which we have not yet found sufficient answers. They take a pragmatic approach by putting existing experimental methods to the test and refining them significantly. 

      Weaknesses: 

      It is difficult to find weaknesses. Not only the experimental methods but also the data analysis have been refined meticulously. There is no doubt that the authors achieved their aims and that the results support their conclusions. 

      There will certainly be some lasting impact on the future use of DRG cultures with respect to (I) the incubation periods, (II) how these data need to be analyzed, and (III) the numbers of neurons to be looked at. 

      As for the CPT assay, the future will have to show if mouse phenotyping results are more accurate with this technique. I'm more fond of full thermal gradient environments. However, behavioural phenotyping is still one of the most difficult fields in somatosensory research.  

      We thank the referee and were happy to read that the referee finds our study valuable and insightful. 

      Reviewer #3 (Public Review):  

      Summary and strengths: 

      In the manuscript, Abd El Hay et al investigate the role of thermally sensitive ion channels TRPM2 and TRPV1 in warm preference and their dynamic response features to thermal stimulation. They develop a novel thermal preference task, where both the floor and air temperature are controlled, and conclude that mice likely integrate floor with air temperature to form a thermal preference. They go on to use knockout mice and show that TRPM2-/- mice play a role in the avoidance of warmer temperatures. Using a new approach for culturing DRG neurons they show the involvement of both channels in warm responsiveness and dynamics. This is an interesting study with novel methods that generate important new information on the different roles of TRPV1 and TRPM2 on thermal behavior. 

      Open questions and weaknesses: 

      (1) Differences in the response features of cells expressing TRPM2 and TRPV1 are central and interesting findings but need further validation (Figures 3 and 4). To show differences in the dynamics and the amplitude of responses across different lines and stimulus amplitudes more clearly, the authors should show the grand average population calcium response from all responsive neurons with error bars for all 3 groups for the different amplitudes of stimuli (as has been presented for the thermal stimuli traces). The authors should also provide a population analysis of the amplitude of the responses in all groups to all stimulus amplitudes. Prior work suggests that thermal detection is supported by an enhancement or suppression of the ongoing activity of sensory fibers innervating the skin. The authors should present any data on cells with ongoing activity. 

      We have now included grand average population analysis of the different groups in the revised version, this is found in Figure 2E and F. Based on the referee’s suggestion and the new analysis, we now can report a (subtle) cellular phenotype observed in DRG cultures of Trpm2 deficient animals: when averaging all warmth responses, the new analysis suggests that Trpm2-deficient cultures lack modulation of the response magnitude across the three increasing consecutive warmth stimuli (33°C, 36°C and 39°C).

      Concerning the point about ongoing activity: We are not sure if it is possible in neuronal cultures to faithfully recapitulate ongoing activity. Ongoing activity has been mostly recorded in skinnerve preparations (or in older studies in other types of nerve recordings) and there are only very few studies that show ongoing activity in cultured neurons and in those instances the ongoing activity only starts in sensory neuron cultures when cultured for even longer time periods than 3 days (Ref.: doi: 10.1152/jn.00158.2018). We have very few cells that show some spontaneous activity, but these are too few to draw any conclusions. In any case, nerve fibers might be necessary to drive ongoing activity which are absent from our cultures.

      (2) The authors should better place their findings in context with the literature and highlight the novelty of their findings. The introduction builds a story of a 'disconnect' or 'contradictory' findings about the role of TRPV1 and TRPM2 in warm detection. While there are some disparate findings in the literature, Tan and McNaughton (2016) show a role for TRPM2 in the avoidance of warmth in a similar task, Paricio et al. (2020) show a significant reduction in warm perception in TRPM2 and TRPV1 knock out lines and Yarmolinksy et al. (2016) show a reduction in warm perception with TRPV1 inactivation. All these papers are therefore in agreement with the authors finding of a role for these channels in warm behavior. The authors should change their introduction and discussion to more correctly discuss the findings of these studies and to better pinpoint the novelty of their own work.  

      Paricio-Montesinos et al. argue that TRPM8 is crucial for the detection of warmth, as TRPM8KO animals are incapable of learning the operant task. TRPM2-KO animals and, to a smaller extent TRPV1-KO animals, have reduced sensitivity in the task, but are still capable of learning/performing the task. However, in our chamber preference assay this is reversed: TRPM2-KO animals lose the ability to differentiate warm temperatures while TRPM8 appears to play no major role. A commonality between the two studies is that while TRPV1 affects the detection of warm temperatures in the different assays, this ion channel appears not to be crucial. 

      Similarly, Yarmolinsky et al. show that Trpv1-inactivation only increases the error rate in their operant assay (from ~10% to ~30%), without testing TRPM2. And Tan et al. show the importance of TRPM2 in the preference task, without testing for TRPV1. 

      More generally, the choice of the assay, being either an operant task (Paricio-Montesinos et al. and Yarmolinsky et al.) or a preference assay without training of the mice (Tan et al. and our data here), might be important and different TRP receptors may be relevant for different types of temperature assays, which we have now included at the end of the discussion section in the revised manuscript. While our results generally agree with the previous studies, they add a different perspective on the analysis of the behavior (with correlation to cellular data). We now edited the manuscript to highlight the advances more clearly. 

      Nevertheless, we believe that a discrepancy between cellular and behavioral data in the former studies exists and we kept this in the introduction. We hope that our data and suggestions of more nuanced analysis of cellular and behavioral responses, in particular also differences in their kinetics, may be helping to guide future studies.  

      (3) The responses of 60 randomly selected cells are shown in Figure 2B. But, looking at the TRPM2-/- data, warm responses appear more obvious than in WTs and the weaker responders of the WT group appear weaker than the equivalent group in the TRPV1-/- and TRPM2-/- data. This does not necessarily invalidate the results, but it may suggest a problem in the data selection. Because the correct classification of warm-sensitive neurons is central to this part of the study more validation of the classifier should be presented. For example, the authors could state if they trained the classifier using equal amounts of cells, show some randomly selected cells that are warm-insensitive for all genotypes, and show the population average responses of warm-insensitive neurons.  

      The classifier was trained on a balanced dataset of 1000 (500 responders and 500 nonresponders), manually labelled traces across all 5 temperature stimuli. The prediction accuracy was 98%. We have now described more clearly how the classifier was trained (See Materials and Methods) and include examples of responders and non-responders, the population averages of each class as well as a confusion matrix of the classification in the revised manuscript (Suppl. Figure 4A and B).

      (4) The interpretation of the main behavioral results and justification of the last figure is presented as the result of changes in sensing but differences in this behavior could be due to many factors and this needs clarification and discussion. (i) The authors mention that 'crucially temperature perception is not static' and suggest that there are fluctuating changes in perception over time and conclude that their modelling approach helps show changes in temperature detection. They imply that temperature perceptual threshold changes over time, but the mouse could just as easily have had exactly the same threshold throughout the task but their motivation (or some other cognitive variable) might vary causing them to change chamber. The authors should correct this. (ii) Likewise, from their fascinating and high-profile prior work the authors suggest a model of internal temperature sensing whereby TRPM2 expression in the hypothalamus acts as an internal sensory of body temperature. Given this, and the slow time course of the behavior in chambers with different ambient temperatures, couldn't the reason for the behavioral differences be due to central changes in hypothalamic processing rather than detection by skin temperature? If TRPM2-/- were selectively ablated from the skin or the hypothalamus (these experiments are not necessary for this paper) it might be possible to conclude whether sensation or body temperature is more likely the root cause of these effects but, without further experiments it is tough to conclude either way. (iii) Because the ambient temperature is controlled in this behavior, another hypothesis is that warm avoidance could be due to negative valence associated with breathing warm air, i.e. a result of sensation within the body in internal pathways, rather than sensing from the external skin. Overall, the authors should tone down conclusions about sensation and present a more detailed discussion of these points.  

      We are sorry that the statement including the phrase “crucially temperature perception is not static” was ambiguous; We have now deleted this statement and instead included different possibilities as to why mice may switch from one chamber to the other stochastically. 

      As the referee mentioned, it is possible that some other variable (motivation etc.) makes the mouse change the chamber; Nevertheless, we hypothesize that this variable (whatever it might be) is still modulated by temperature (at least this would be the likeliest explanation that we see).

      As for the aspect of internal/hypothalamic temperature sensing and its dependence on Trpm2: we have included this possibility in the discussion in the manuscript. 

      As for the point of negative valence mediated by breathing in warm air: yes, presumably this could also be possible. The aspect of valence is in interesting aspect by itself: would the mice be rather repelled from the (uncomfortable) hot plate or more attracted to the (more comfortable) thermoneutral plate, or both? Something to elucidate in a different study.

      (5) It is an excellent idea to present a more in-depth analysis of the behavioral data collected during the preference task, beyond 'the mouse is on one side or the other'. However, the drift-diffusion approach is complex to interpret from the text in the results and the figures. The results text is not completely clear on which behavioral parameters are analyzed and terms like drift, noise, estimate, and evidence are not clearly defined. Currently, this section of the paper slightly confuses and takes the paper away from the central findings about dynamics and behavioral differences. It seems like they could come to similar conclusions with simpler analysis and simpler figures. 

      We have now reassessed the description of the drift diffusion model and explain it more clearly, this can be found on page 5 – 8. We have considered whether it will be better to introduce the drift diffusion model at the beginning of the study, subsequent to Figure 1 but we believe this to better suited at the end, because, indeed, the cellular results (and differences in kinetic response parameters observed in DRG cultures of Trpv1 KO mice) prompted us to assess the behavior in this way. Thus, the order of experiments presented here, represents also more the natural path the study took. 

      (6) In Figure 2D the % of warm-sensitive neurons are shown for each genotype. Each data point is a field of view, however, reading the figure legend there appear to be more FOVs than data points (eg 10 data points for the TRPV1-/- but 17 FOVs). The authors should check this. 

      We have checked and corrected the number of FOVs mentioned in the legend, and the number shown in the Figure 2D and its legend are now in agreement. 

      (7) Can the authors comment on why animals with over-expression of TRPV1 spend more time in the warmest chamber to start with at 38C and not at 34C?  

      This is an interesting observation that we did not consider before. A closer look at Figure 4H reveals that the majority of the TRPV1-OX animals, have a proportionally long first visit to the 38°C room. We can only speculate why this is the case. We cannot rule out that this a technical shortcoming of the assay and how we conduced it – but we did not observe this for the wildtype mice, thus it is rather unlikely a technical problem. It is possible that this is a type of “freezing-” (or “startle-“) behavior when the animals first encounter the 38°C temperature. Freezing behaviors in mice can be observed when sudden/threatening stimuli are applied. It is possible that, in the TRPV1-overexpressing animals, the initial encounter with 38°C leads to activation of a larger proportion of cells (compared to WT controls), possibly signaling a “threatening” stimulus, and thus leading to this startle effect. However, such a claim would require additional experiments to test such a hypothesis more rigorously.

    1. Author response:

      The following is the authors’ response to the previous reviews.

      eLife Assessment

      This study presents valuable findings on the potential of short-movie viewing fMRI protocol to explore the functional and topographical organization of the visual system in awake infants and toddlers. Although the data are compelling given the difficulty of studying this population, the evidence presented is incomplete and would be strengthened by additional analyses to support the authors' claims. This study will be of interest to cognitive neuroscientists and developmental psychologists, especially those interested in using fMRI to investigate brain organisation in pediatric and clinical populations with limited fMRI tolerance.

      We are grateful for the thorough and thoughtful reviews. We have provided point-bypoint responses to the reviewers’ comments, but first, we summarize the major revisions here. We believe these revisions have substantially improved the clarity of the writing and impact of the results.

      Regarding the framing of the paper, we have made the following major changes in response to the reviews:

      (1) We have clarified that our goal in this paper was to show that movie data contains topographic, fine-grained details of the infant visual cortex. In the revision, we now state clearly that our results should not be taken as evidence that movies could replace retinotopy and have reworded parts of the manuscript that could mislead the reader in this regard.

      (2) We have added extensive details to the (admittedly) complex methods to make them more approachable. An example of this change is that we have reorganized the figure explaining the Shared Response Modelling methods to divide the analytic steps more clearly.

      (3) We have clarified the intermediate products contributing to the results by adding 6 supplementary figures that show the gradients for each IC or SRM movie and each infant participant.

      In response to the reviews, we have conducted several major analyses to support our findings further:

      (1) To verify that our analyses can identify fine-grained organization, we have manually traced and labeled adult data, and then performed the same analyses on them. The results from this additional dataset validate that these analyses can recover fine-grained organization of the visual cortex from movie data.

      (2) To further explore how visual maps derived from movies compare to alternative methods, we performed an anatomical alignment control analysis. We show that high-quality maps can be predicted from other participants using anatomical alignment.

      (3) To test the contribution of motion to the homotopy analyses, we regressed out the motion effects in these analyses. We found qualitatively similar results to our main analyses, suggesting motion did not play a substantial role.

      (4) To test the contribution of data quantity to the homotopy analyses, we correlated the amount of movie data collected from each participant with the homotopy results. We did not find a relationship between data quantity and the homotopy results. 

      Public Reviews:

      Reviewer #1 (Public Review):

      Summary:

      Ellis et al. investigated the functional and topographical organization of the visual cortex in infants and toddlers, as evidenced by movie-viewing data. They build directly on prior research that revealed topographic maps in infants who completed a retinotopy task, claiming that even a limited amount of rich, naturalistic movie-viewing data is sufficient to reveal this organization, within and across participants. Generating this evidence required methodological innovations to acquire high-quality fMRI data from awake infants (which have been described by this group, and elsewhere) and analytical creativity. The authors provide evidence for structured functional responses in infant visual cortex at multiple levels of analyses; homotopic brain regions (defined based on a retinotopy task) responded more similarly to one another than to other brain regions in visual cortex during movie-viewing; ICA applied to movie-viewing data revealed components that were identifiable as spatial frequency, and to a lesser degree, meridian maps, and shared response modeling analyses suggested that visual cortex responses were similar across infants/toddlers, as well as across infants/toddlers and adults. These results are suggestive of fairly mature functional response profiles in the visual cortex in infants/toddlers and highlight the potential of movie-viewing data for studying finer-grained aspects of functional brain responses, but further evidence is necessary to support their claims and the study motivation needs refining, in light of prior research.

      Strengths:

      - This study links the authors' prior evidence for retinotopic organization of visual cortex in human infants (Ellis et al., 2021) and research by others using movie-viewing fMRI experiments with adults to reveal retinotopic organization (Knapen, 2021).

      - Awake infant fMRI data are rare, time-consuming, and expensive to collect; they are therefore of high value to the community. The raw and preprocessed fMRI and anatomical data analyzed will be made publicly available.

      We are grateful to the reviewer for their clear and thoughtful description of the strengths of the paper, as well as their helpful outlining of areas we could improve.

      Weaknesses:

      - The Methods are at times difficult to understand and in some cases seem inappropriate for the conclusions drawn. For example, I believe that the movie-defined ICA components were validated using independent data from the retinotopy task, but this was a point of confusion among reviewers. 

      We acknowledge the complexity of the methods and wish to clarify them as best as possible for the reviewers and the readers. We have extensively revised the methods and results sections to help avoid potential misunderstandings. For instance, we have revamped the figure and caption describing the SRM pipeline (Figure 5).

      To answer the stated confusion directly, the ICA components were derived from the movie data and validated on the (completely independent) retinotopy data. There were no additional tasks. The following text in the paper explains this point:

      “To assess the selected component maps, we correlated the gradients (described above) of the task-evoked and component maps. This test uses independent data: the components were defined based on movie data and validated against task-evoked retinotopic maps.” Pg. 11

      In either case: more analyses should be done to support the conclusion that the components identified from the movie reproduce retinotopic maps (for example, by comparing the performance of movie-viewing maps to available alternatives (anatomical ROIs, group-defined ROIs). 

      Before addressing this suggestion, we want to restate our conclusions: features of the retinotopic organization of infant visual cortex could be predicted from movie data. We did not conclude that movie data could ‘reproduce’ retinotopic maps in the sense that they would be a replacement. We recognize that this was not clear in our original manuscript and have clarified this point throughout, including in this section of the discussion:

      “To be clear, we are not suggesting that movies work well enough to replace a retinotopy task when accurate maps are needed. For instance, even though ICA found components that were highly correlated with the spatial frequency map, we also selected some components that turned out to have lower correlations. Without knowing the ground truth from a retinotopy task, there would be no way to weed these out. Additionally, anatomical alignment (i.e., averaging the maps from other participants and anatomically aligning them to a held-out participant) resulted in maps that were highly similar to the ground truth. Indeed, we previously[23] found that adult-defined visual areas were moderately similar to infants. While functional alignment with adults can outperform anatomical alignment methods in similar analyses[27], here we find that functional alignment is inferior to anatomical alignment. Thus, if the goal is to define visual areas in an infant that lacks task-based retinotopy, anatomical alignment of other participants’ retinotopic maps is superior to using movie-based analyses, at least as we tested it.” Pg. 21

      As per the reviewer’s suggestion and alluded to in the paragraph above, we have created anatomically aligned visual maps, providing an analogous test to the betweenparticipant analyses like SRM. We find that these maps are highly similar to the ground truth. We describe this result in a new section of the results:

      “We performed an anatomical alignment analog of the functional alignment (SRM) approach. This analysis serves as a benchmark for predicting visual maps using taskbased data, rather than movie data, from other participants. For each infant participant, we aggregated all other infant or adult participants as a reference. The retinotopic maps from these reference participants were anatomically aligned to the standard surface template, and then averaged. These averages served as predictions of the maps in the test participant, akin to SRM, and were analyzed equivalently (i.e., correlating the gradients in the predicted map with the gradients in the task-based map). These correlations (Table S4) are significantly higher than for functional alignment (using infants to predict spatial frequency, anatomical alignment > functional alignment: ∆<sub>Fisher Z</sub> M=0.44, CI=[0.32–0.58], p<.001; using infants to predict meridians, anatomical alignment > functional alignment: ∆<sub>Fisher Z</sub> M=0.61, CI=[0.47–0.74], p<.001; using adults to predict spatial frequency, anatomical alignment > functional alignment: ∆<sub>Fisher Z</sub> M=0.31, CI=[0.21–0.42], p<.001; using adults to predict meridians, anatomical alignment > functional alignment: ∆<sub>Fisher Z</sub> M=0.49, CI=[0.39–0.60], p<.001). This suggests that even if SRM shows that movies can be used to produce retinotopic maps that are significantly similar to a participant, these maps are not as good as those that can be produced by anatomical alignment of the maps from other participants without any movie data.” Pg. 16–17

      Also, the ROIs used for the homotopy analyses were defined based on the retinotopic task rather than based on movie-viewing data alone - leaving it unclear whether movie-viewing data alone can be used to recover functionally distinct regions within the visual cortex.

      We agree with the reviewer that our approach does not test whether movie-viewing data alone can be used to recover functionally distinct regions. The goal of the homotopy analyses was to identify whether there was functional differentiation of visual areas in the infant brain while they watch movies. This was a novel question that provides positive evidence that these regions are functionally distinct. In subsequent analyses, we show that when these areas are defined anatomically, rather than functionally, they also show differentiated function (e.g., Figure 2). Nonetheless, our intention was not to use the homotopy analyses to define the regions. We have added text to clarify the goal and novelty of this analysis.

      “Although these analyses cannot define visual maps, they test whether visual areas have different functional signatures.” Pg. 6

      Additionally, even if the goal were to define areas based on homotopy, we believe the power of that analysis would be questionable. We would need to use a large amount of the movie data to define the areas, leaving a low-powered dataset to test whether their function is differentiated by these movie-based areas.

      - The authors previously reported on retinotopic organization of the visual cortex in human infants (Ellis et al., 2021) and suggest that the feasibility of using movie-viewing experiments to recover these topographic maps is still in question. They point out that movies may not fully sample the stimulus parameters necessary for revealing topographic maps/areas in the visual cortex, or the time-resolution constraints of fMRI might limit the use of movie stimuli, or the rich, uncontrolled nature of movies might make them inferior to stimuli that are designed for retinotopic mapping, or might lead to variable attention between participants that makes measuring the structure of visual responses across individuals challenging. This motivation doesn't sufficiently highlight the importance or value of testing this question in infants. Further, it's unclear if/how this motivation takes into account prior research using movie-viewing fMRI experiments to reveal retinotopic organization in adults (e.g., Knapen, 2021). Given the evidence for retinotopic organization in infants and evidence for the use of movie-viewing experiments in adults, an alternative framing of the novel contribution of this study is that it tests whether retinotopic organization is measurable using a limited amount of movie-viewing data (i.e., a methodological stress test). The study motivation and discussion could be strengthened by more attention to relevant work with adults and/or more explanation of the importance of testing this question in infants (is the reason to test this question in infants purely methodological - i.e., as a way to negate the need for retinotopic tasks in subsequent research, given the time constraints of scanning human infants?).

      We are grateful to the reviewer for giving us the opportunity to clarify the innovations of this research. We believe that this research contributes to our understanding of how infants process dynamic stimuli, demonstrates the viability and utility of movie experiments in infants, and highlights the potential for new movie-based analyses (e.g., SRM). We have now consolidated these motivations in the introduction to more clearly motivate this work:

      “The primary goal of the current study is to investigate whether movie-watching data recapitulates the organization of visual cortex. Movies drive strong and naturalistic responses in sensory regions while minimizing task demands[12, 13, 24] and thus are a proxy for typical experience. In adults, movies and resting-state data have been used to characterize the visual cortex in a data-driven fashion[25–27]. Movies have been useful in awake infant fMRI for studying event segmentation[28], functional alignment[29], and brain networks[30]. However, this past work did not address the granularity and specificity of cortical organization that movies evoke. For example, movies evoke similar activity in infants in anatomically aligned visual areas[28], but it remains unclear whether responses to movie content differ between visual areas (e.g., is there more similarity of function within visual areas than between31). Moreover, it is unknown whether structure within visual areas, namely visual maps, contributes substantially to visual evoked activity. Additionally, we wish to test whether methods for functional alignment can be used with infants. Functional alignment finds a mapping between participants using functional activity – rather than anatomy – and in adults can improve signal-to-noise, enhance across participant prediction, and enable unique analyses[27, 32–34].” Pg. 3-4

      Furthermore, the introduction culminates in the following statement on what the analyses will tell us about the nature of movie-driven activity in infants:

      “These three analyses assess key indicators of the mature visual system: functional specialization between areas, organization within areas, and consistency between individuals.” Pg. 5

      Furthermore, in the discussion we revisit these motivations and elaborate on them further:

      [Regarding homotopy:] “This suggests that visual areas are functionally differentiated in infancy and that this function is shared across hemispheres[31].” Pg. 19

      [Regarding ICA:] “This means that the retinotopic organization of the infant brain accounts for a detectable amount of variance in visual activity, otherwise components resembling these maps would not be discoverable.” Pg. 19–20

      [Regarding SRM:] “This is initial evidence that functional alignment may be useful for enhancing signal quality, like it has in adults[27,32,33], or revealing changing function over development[45].” Pg. 21

      Additionally, we have expanded our discussion of relevant work that uses similar methods such as the excellent research from Knapen (2021) and others:

      “In adults, movies and resting-state data have been used to characterize the visual cortex in a data-driven fashion[25-27].” Pg. 4

      “We next explored whether movies can reveal fine-grained organization within visual areas by using independent components analysis (ICA) to propose visual maps in individual infant brains[25,26,35,42,43].” Pg. 9

      Reviewer #2 (Public Review):

      Summary:

      This manuscript shows evidence from a dataset with awake movie-watching in infants, that the infant brain contains areas with distinct functions, consistent with previous studies using resting state and awake task-based infant fMRI. However, substantial new analyses would be required to support the novel claim that movie-watching data in infants can be used to identify retinotopic areas or to capture within-area functional organization.

      Strengths:

      The authors have collected a unique dataset: the same individual infants both watched naturalistic animations and a specific retinotopy task. These data position the authors to test their novel claim, that movie-watching data in infants can be used to identify retinotopic areas.

      Weaknesses:

      To claim that movie-watching data can identify retinotopic regions, the authors should provide evidence for two claims:

      - Retinotopic areas defined based only on movie-watching data, predict retinotopic responses in independent retinotopy-task-driven data.

      - Defining retinotopic areas based on the infant's own movie-watching response is more accurate than alternative approaches that don't require any movie-watching data, like anatomical parcellations or shared response activation from independent groups of participants.

      We thank the reviewer for their comments. Before addressing their suggestions, we wish to clarify that we do not claim that movie data can be used to identify retinotopic areas, but instead that movie data captures components of the within and between visual area organization as defined by retinotopic mapping. We recognize that this was not clear in our original manuscript and have clarified this point throughout, including in this section of the discussion:

      “To be clear, we are not suggesting that movies work well enough to replace a retinotopy task when accurate maps are needed. For instance, even though ICA found components that were highly correlated with the spatial frequency map, we also selected some components that turned out to have lower correlations. Without knowing the ground truth from a retinotopy task, there would be no way to weed these out. Additionally, anatomical alignment (i.e., averaging the maps from other participants and anatomically aligning them to a held-out participant) resulted in maps that were highly similar to the ground truth. Indeed, we previously[23] found that adult-defined visual areas were moderately similar to infants. While functional alignment with adults can outperform anatomical alignment methods in similar analyses[27], here we find that functional alignment with infants is inferior to anatomical alignment. Thus, if the goal is to define visual areas in an infant that lacks task-based retinotopy, anatomical alignment of other participants’ retinotopic maps is superior to using movie-based analyses, at least as we tested it.” Pg. 21

      In response to the reviewer’s suggestion, we compare the maps identified by SRM to the averaged, anatomically aligned maps from infants. We find that these maps are highly similar to the task-based ground truth and we describe this result in a new section:

      “We performed an anatomical alignment analog of the functional alignment (SRM) approach. This analysis serves as a benchmark for predicting visual maps using taskbased data, rather than movie data, from other participants. For each infant participant, we aggregated all other infant or adult participants as a reference. The retinotopic maps from these reference participants were anatomically aligned to the standard surface template, and then averaged. These averages served as predictions of the maps in the test participant, akin to SRM, and were analyzed equivalently (i.e., correlating the gradients in the predicted map with the gradients in the task-based map). These correlations (Table S4) are significantly higher than for functional alignment (using infants to predict spatial frequency, anatomical alignment < functional alignment: ∆<sub>Fisher Z</sub> M=0.44, CI=[0.32–0.58], p<.001; using infants to predict meridians, anatomical alignment < functional alignment: ∆<sub>Fisher Z</sub> M=0.61, CI=[0.47–0.74], p<.001; using adults to predict spatial frequency, anatomical alignment < functional alignment: ∆<sub>Fisher Z</sub> M=0.31, CI=[0.21–0.42], p<.001; using adults to predict meridians, anatomical alignment < functional alignment: ∆<sub>Fisher Z</sub> M=0.49, CI=[0.39–0.60], p<.001). This suggests that even if SRM shows that movies can be used to produce retinotopic maps that are significantly similar to a participant, these maps are not as good as those that can be produced by anatomical alignment of the maps from other participants without any movie data.” Pg. 16–17

      Note that we do not compare the anatomically aligned maps with the ICA maps statistically. This is because these analyses are not comparable: ICA is run withinparticipant whereas anatomical alignment is necessarily between-participant — either infant or adults. Nonetheless, an interested reader can refer to the Table where we report the results of anatomical alignment and see that anatomical alignment outperforms ICA in terms of the correlation between the predicted and task-based maps.

      Both of these analyses are possible, using the (valuable!) data that these authors have collected, but these are not the analyses that the authors have done so far. Instead, the authors report the inverse of (1): regions identified by the retinotopy task can be used to predict responses in the movies. The authors report one part of (2), shared responses from other participants can be used to predict individual infants' responses in the movies, but they do not test whether movie data from the same individual infant can be used to make better predictions of the retinotopy task data, than the shared response maps.

      So to be clear, to support the claims of this paper, I recommend that the authors use the retinotopic task responses in each individual infant as the independent "Test" data, and compare the accuracy in predicting those responses, based on:

      -  The same infant's movie-watching data, analysed with MELODIC, when blind experimenters select components for the SF and meridian boundaries with no access to the ground-truth retinotopy data.

      -  Anatomical parcellations in the same infant.

      -  Shared response maps from groups of other infants or adults.

      -  (If possible, ICA of resting state data, in the same infant, or from independent groups of infants).

      Or, possibly, combinations of these techniques.

      If the infant's own movie-watching data leads to improved predictions of the infant's retinotopic task-driven response, relative to these existing alternatives that don't require movie-watching data from the same infant, then the authors' main claim will be supported.

      These are excellent suggestions for additional analyses to test the suitability for moviebased maps to replace task-based maps. We hope it is now clear that it was never our intention to claim that movie-based data could replace task-based methods. We want to emphasize that the discoveries made in this paper — that movies evoke fine-grained organization in infant visual cortex — do not rely on movie-based maps being better than alternative methods for producing maps, such as the newly added anatomical alignment.

      The proposed analysis above solves a critical problem with the analyses presented in the current manuscript: the data used to generate maps is identical to the data used to validate those maps. For the task-evoked maps, the same data are used to draw the lines along gradients and then test for gradient organization. For the component maps, the maps are manually selected to show the clearest gradients among many noisy options, and then the same data are tested for gradient organization. This is a double-dipping error. To fix this problem, the data must be split into independent train and test subsets.

      We appreciate the reviewer’s concern; however, we believe it is a result of a miscommunication in our analytic strategy. We have now provided more details on the analyses to clarify how double-dipping was avoided. 

      To summarize, a retinotopy task produced visual maps that were used to trace both area boundaries and gradients across the areas. These data were then fixed and unchanged, and we make no claims about the nature of these maps in this paper, other than to treat them as the ground truth to be used as a benchmark in our analyses. The movie data, which are collected independently from the same infant in the session, used the boundaries from the retinotopy task (in the case of homotopy) or were compared with the maps from the retinotopy task (in the case of ICA and SRM). In other words, the statement that “the data used to generate maps is identical to the data used to validate those maps” is incorrect because we generated the maps with a retinotopy task and validated the maps with the movie data. This means no double dipping occurred.

      Perhaps a cause of the reviewer’s interpretation is that the gradients used in the analysis are not clearly described. We now provide this additional description:  “Using the same manually traced lines from the retinotopy task, we measured the intensity gradients in each component from the movie-watching data. We can then use the gradients of intensity in the retinotopy task-defined maps as a benchmark for comparison with the ICA-derived maps.” Pg. 10

      Regarding the SRM analyses, we take great pains to avoid the possibility of data contamination. To emphasize how independent the SRM analysis is, the prediction of the retinotopic map from the test participant does not use their retinotopy data at all; in fact, the predicted maps could be made before that participant’s retinotopy data were ever collected. To make this prediction for a test participant, we need to learn the inversion of the SRM, but this only uses the movie data of the test participant. Hence, there is no double-dipping in the SRM analyses. We have elaborated on this point in the revision, and we remade the figure and its caption to clarify this point:

      We also have updated the description of these results to emphasize how double-dipping was avoided:

      “We then mapped the held-out participant's movie data into the learned shared space without changing the shared space (Figure 5c). In other words, the shared response model was learned and frozen before the held-out participant’s data was considered.

      This approach has been used and validated in prior SRM studies[45].” Pg. 14

      The reviewer suggests that manually choosing components from ICA is double-dipping. Although the reviewer is correct that the manual selection of components in ICA means that the components chosen ought to be good candidates, we are testing whether those choices were good by evaluating those components against the task-based maps that were not used for the ICA. Our statistical analyses evaluate whether the components chosen were better than the components that would have been chosen by random chance. Critically: all decisions about selecting the components happen before the components are compared to the retinotopic maps. Hence there is no double-dipping in the selection of components, as the choice of candidate ICA maps is not informed by the ground-truth retinotopic maps. We now clarify what the goal of this process is in the results:

      “Success in this process requires that 1) retinotopic organization accounts for sufficient variance in visual activity to be identified by ICA and 2) experimenters can accurately identify these components.” Pg. 10

      The reviewer also alludes to a concern that the researcher selecting the maps was not blind to the ground-truth retinotopic maps from participants and this could have influenced the results. In such a scenario, the researcher could have selected components that have the gradients of activity in the places that the infant has as ground truth. The researcher who made the selection of components (CTE) is one of the researchers who originally traced the areas in the participants approximately a year prior to the identification of ICs. The researcher selecting the components didn’t use the ground-truth retinotopic maps as reference, nor did they pay attention to the participant IDs when sorting the IC components. Indeed, they weren’t trying to find participant specific maps per se, but rather aimed to find good candidate retinotopic maps in general. In the case of the newly added adult analyses, the ICs were selected before the retinotopic mapping was reviewed or traced; hence, no knowledge about the participant-specific ground truth could have influenced the selection of ICs. Even with this process from adults, we find results of comparable strength as we found in infants, as shown below. Nonetheless, there is a possibility that this researcher’s previous experience of tracing the infant maps could have influenced their choice of components at the participant-specific level. If so, it was a small effect since the components the researcher selected were far from the best possible options (i.e., rankings of the selected components averaged in the 64th percentile for spatial frequency maps and the 68th percentile for meridian maps). We believe all reasonable steps were taken to mitigate bias in the selection of ICs.

      Reviewer #3 (Public Review):

      The manuscript reports data collected in awake toddlers recording BOLD while watching videos. The authors analyse the BOLD time series using two different statistical approaches, both very complex but do not require any a priori determination of the movie features or contents to be associated with regressors. The two main messages are that 1) toddlers have occipital visual areas very similar to adults, given that an SRM model derived from adult BOLD is consistent with the infant brains as well; 2) the retinotopic organization and the spatial frequency selectivity of the occipital maps derived by applying correlation analysis are consistent with the maps obtained by standard and conventional mapping.

      Clearly, the data are important, and the author has achieved important and original results. However, the manuscript is totally unclear and very difficult to follow; the figures are not informative; the reader needs to trust the authors because no data to verify the output of the statistical analysis are presented (localization maps with proper statistics) nor so any validation of the statistical analysis provided. Indeed what I think that manuscript means, or better what I understood, may be very far from what the authors want to present, given how obscure the methods and the result presentation are.

      In the present form, this reviewer considers that the manuscript needs to be totally rewritten, the results presented each technique with appropriate validation or comparison that the reader can evaluate.

      We are grateful to the reviewer for the chance to improve the paper. We have broken their review into three parts: clarification of the methods, validation of the analyses, and enhancing the visualization.

      Clarification of the methods

      We acknowledge that the methods we employed are complex and uncommon in many fields of neuroimaging. That said, numerous papers have conducted these analyses on adults (Beckman et al., 2005; Butt et al., 2015; Guntupalli et al., 2016; Haak & Beckman, 2018; Knapen, 2021; Lu et al., 2017) and non-human primates (Arcaro & Livingstone, 2017; Moeller et al., 2009). We have redoubled our efforts in the revision to make the methods as clear as possible, expanding on the original text and providing intuitions where possible. These changes have been added throughout and are too vast in number to repeat here, especially without context, but we hope that readers will have an easier time following the analyses now. 

      Additionally, we updated Figures 3 and 5 in which the main ICA and SRM analyses are described. For instance, in Figure 3’s caption we now add details about how the gradient analyses were performed on the components: 

      “We used the same lines that were manually traced on the task-evoked map to assess the change in the component’s response. We found a monotonic trend within area from medial to lateral, just like we see in the ground truth.” Pg. 11

      Regarding Figure 5, we reconsidered the best way to explain the SRM analyses and decided it would be helpful to partition the diagram into steps, reflecting the analytic process. These updates have been added to Figure 5, and the caption has been updated accordingly.

      We hope that these changes have improved the clarity of the methods. For readers interested in learning more, we encourage them to either read the methods-focused papers that debut the analyses (e.g., Chen et al., 2015), read the papers applying the methods (e.g., Guntupalli et al., 2016), or read the annotated code we publicly release which implements these pipelines and can be used to replicate the findings.

      Validation of the analyses

      One of the requests the reviewer makes is to validate our analyses. Our initial approach was to lean on papers that have used these methods in adults or primates (e.g., Arcaro, & Livingstone, 2017; Beckman et al., 2005; Butt et al., 2015; Guntupalli et al., 2016; Haak & Beckman, 2018; Knapen, 2021; Moeller et al., 2009) where the underlying organization and neurophysiology is established. However, we have made changes to these methods that differ from their original usage (e.g., we used SRM rather than hyperalignment, we use meridian mapping rather than traveling wave retinotopy, we use movie-watching data rather than rest). Hence, the specifics of our design and pipeline warrant validation. 

      To add further validation, we have rerun the main analyses on an adult sample. We collected 8 adult participants who completed the same retinotopy task and a large subset of the movies that infants saw. These participants were run under maximally similar conditions to infants (i.e., scanned using the same parameters and without the top of the head-coil) and were preprocessed using the same pipeline. Given that the relationship between adult visual maps and movie-driven (or resting-state) analyses has been shown in many studies (Beckman et al., 2005; Butt et al., 2015; Guntupalli et al., 2016; Haak & Beckman, 2018; Knapen, 2021; Lu et al., 2017), these adult data serve as a validation of our analysis pipeline. These adult participants were included in the original manuscript; however, they were previously only used to support the SRM analyses (i.e., can adults be used to predict infant visual maps). The adult results are described before any results with infants, as a way to engender confidence. Moreover, we have provided new supplementary figures of the adult results that we hope will be integrated with the article when viewing it online, such that it will be easy to compare infant and adult results, as per the reviewer’s request. 

      As per the figures and captions below, the analyses were all successful with the adult participants: 1) Homotopic correlations are higher than correlations between comparable areas in other streams or areas that are more distant within stream. 2) A multidimensional scaling depiction of the data shows that areas in the dorsal and ventral stream are dissimilar. 3) Using independent components analysis on the movie data, we identified components that are highly correlated with the retinotopy task-based spatial frequency and meridian maps. 4) Using shared response modeling on the movie data, we predicted maps that are highly correlated with the retinotopy task-based spatial frequency and meridian maps.

      These supplementary analyses are underpowered for between-group comparisons, so we do not statistically compare the results between infants and adults. Nonetheless, the pattern of adult results is comparable overall to the infant results. 

      We believe these adult results provide a useful validation that the infant analyses we performed can recover fine-grained organization.

      Enhancing the visualization

      The reviewer raises an additional concern about the lack of visualization of the results. We recognize that the plots of the summary statistics do not provide information about the intermediate analyses. Indeed, we think the summary statistics can understate the degree of similarity between the components or predicted visual maps and the ground truth. Hence, we have added 6 new supplementary figures showing the intensity gradients for the following analyses: 1. spatial frequency prediction using ICA, 2. meridian prediction using ICA, 3. spatial frequency prediction using infant SRM, 4. meridian prediction using infant SRM, 5. spatial frequency prediction using adult SRM, and 6. meridian prediction using adult SRM.

      We hope that these visualizations are helpful. It is possible that the reviewer wishes us to also visually present the raw maps from the ICA and SRM, akin to what we show in Figure 3A and 3B. We believe this is out of scope of this paper: of the 1140 components that were identified by ICA, we selected 36 for spatial frequency and 17 for meridian maps. We also created 20 predicted maps for spatial frequency and 20 predicted meridian maps using SRM. This would result in the depiction of 93 subfigures, requiring at least 15 new full-page supplementary figures to display with adequate resolution. Instead, we encourage the reader to access this content themselves: we have made the code to recreate the analyses publicly available, as well as both the raw and preprocessed data for these analyses, including the data for each of these selected maps.

      Recommendations for the authors:

      Reviewer #1 (Recommendations For The Authors):

      (1) As mentioned in the public review, the authors should consider incorporating relevant adult fMRI research into the Introduction and explain the importance of testing this question in infants.

      Our public response describes the several citations to relevant adult research we have added, and have provided further motivation for the project.

      (2) The authors should conduct additional analyses to support their conclusion that movie data alone can generate accurate retinotopic maps (i.e., by comparing this approach to other available alternatives).

      We have clarified in our public response that we did not wish to conclude that movie data alone can generate accurate retinotopic maps, and have made substantial edits to the text to emphasize this. Thus, because this claim is already not supported by our analyses, we do not think it is necessary to test it further.

      (3) The authors should re-do the homotopy analyses using movie-defined ROIs (i.e., by splitting the movie-viewing data into independent folds for functional ROI definition and analyses).

      As stated above, defining ROIs based on the movie content is not the intended goal of this project. Even if that were the general goal, we do not believe that it would be appropriate to run this specific analysis with the data we collected. Firstly, halving the data for ROI definition (e.g., using half the movie data to identify and trace areas, and then use those areas in the homotopy analysis to run on the other half of data) would qualitatively change the power of the analyses described here. Secondly, we would be unable to define areas beyond hV4/V3AB with confidence, since our retinotopic mapping only affords specification of early visual cortex. Thus we could not conduct the MDS analyses shown in Figure 2.

      (4) If the authors agree that a primary contribution of this study and paper is to showcase what is possible to do with a limited amount of movie-viewing data, then they should make it clearer, sooner, how much usable movie data they have from infants. They could also consider conducting additional analyses to determine the minimum amount of fMRI data necessary to reveal the same detailed characteristics of functional responses in the visual cortex.

      We agree it would be good to highlight the amount of movie data used. When the infant data is first introduced in the results section, we now state the durations:

      “All available movies from each session were included (Table S2), with an average duration of 540.7s (range: 186--1116s).” Pg. 5

      Additionally, we have added a homotopy analysis that describes the contribution of data quantity to the results observed. We compare the amount of data collected with the magnitude of same vs. different stream effect (Figure 1B) and within stream distance effect (Figure 1C). We find no effect of movie duration in the sample we tested, as reported below:

      “We found no evidence that the variability in movie duration per participant correlated with this difference [of same stream vs. different stream] (r=0.08, p=.700).” Pg. 6-7

      “There was no correlation between movie duration and the effect (Same > Adjacent: r=-0.01, p=.965, Adjacent > Distal: r=-0.09, p=.740).” Pg. 7

      (5) If any of the methodological approaches are novel, the authors should make this clear. In particular, has the approach of visually inspecting and categorizing components generated from ICA and movie data been done before, in adults/other contexts?

      The methods we employed are similar to others, as described in the public review.

      However, changes were necessary to apply them to infant samples. For instance, Guntupalli et al. (2016) used hyperalignment to predict the visual maps of adult participants, whereas we use SRM. SRM and hyperalignment have the same goal — find a maximally aligned representation between participants based on brain function — but their implementation is different. The application of functional alignment to infants is novel, as is their use in movie data that is relatively short by comparison to standard adult data. Indeed, this is the most thorough demonstration that SRM — or any functional alignment procedure — can be usefully applied to infant data, awake or sleeping. We have clarified this point in the discussion.

      “This is initial evidence that functional alignment may be useful for enhancing signal quality, like it has in adults[27,32,33], or revealing changing function over development[45], which may prove especially useful for infant fMRI[52].” Pg. 21

      (6) The authors found that meridian maps were less identifiable from ICA and movie data and suggest that this may be because these maps are more susceptible to noise or gaze variability. If this is the case, you might predict that these maps are more identifiable in adult data. The authors could consider running additional analyses with their adult participants to better understand this result.

      As described in the manuscript, we hypothesize that meridian maps are more difficult to identify than spatial frequency maps because meridian maps are a less smooth, more fine-grained map than spatial frequency. Indeed, it has previously been reported (Moeller et al., 2009) that similar procedures can result in meridian maps that are constituted by multiple independent components (e.g., a component sensitive to horizontal orientations, and a separate component sensitive to vertical components). Nonetheless, we have now conducted the ICA procedure on adult participants and again find it is easier to identify spatial frequency components compared to meridian maps, as reported in the public review.

      Minor corrections:

      (1) Typo: Figure 3 title: "Example retintopic task vs. ICA-based spatial frequency maps.".

      Fixed

      (2) Given the age range of the participants, consider using "infants and toddlers"? (Not to diminish the results at all; on the contrary, I think it is perhaps even more impressive to obtain awake fMRI data from ~1-2-year-olds). Example: Figure 3 legend: "A) Spatial frequency map of a 17.1-monthold infant.".

      We agree with the reviewer that there is disagreement about the age range at which a child starts being considered a toddler. We have changed the terms in places where we refer to a toddler in particular (e.g., the figure caption the reviewer highlights) and added the phrase “infants and toddlers” in places where appropriate. Nonetheless, we have kept “infants” in some places, particularly those where we are comparing the sample to adults. Adding “and toddlers” could imply three samples being compared which would confuse the reader.

      (3) Figure 6 legend: The following text should be omitted as there is no bar plot in this figure: "The bar plot is the average across participants. The error bar is the standard error across participants.".

      Fixed

      (4) Table S1 legend: Missing first single quote: Runs'.

      Fixed

      Reviewer #2 (Recommendations For The Authors):

      I request that this paper cite more of the existing literature on the fMRI of human infants and toddlers using task-driven and resting-state data. For example, early studies by (first authors) Biagi, Dehaene-Lambertz, Cusack, and Fransson, and more recent studies by Chen, Cabral, Truzzi, Deen, and Kosakowski.

      We have added several new citations of recent task-based and resting state studies to the second sentence of the main text:

      “Despite the recent growth in infant fMRI[1-6], one of the most important obstacles facing this research is that infants are unable to maintain focus for long periods of time and struggle to complete traditional cognitive tasks[7].”

      Reviewer #3 (Recommendations For The Authors):

      In the following, I report some of my main perplexities, but many more may arise when the material is presented more clearly.

      The age of the children varies from 5 months to about 2 years. While the developmental literature suggests that between 1 and 2 years children have a visual system nearly adult-like, below that age some areas may be very immature. I would split the sample and perhaps attempt to validate the adult SRM model with the youngest children (and those can be called infants).

      We recognize the substantial age variability in our sample, which is why we report participant-specific data in our figures. While splitting up the data into age bins might reveal age effects, we do not think we can perform adequately powered null hypothesis testing of the age trend. In order to investigate the contribution of age, larger samples will be needed. That said, we can see from the data that we have reported that any effect of age is likely small. To elaborate: Figures 4 and 6 report the participant-specific data points and order the participants by age. There are no clear linear trends in these plots, thus there are no strong age effects.

      More broadly, we do not think there is a principled way to divide the participants by age. The reviewer suggests that the visual system is immature before the first year of life and mature afterward; however, such claims are the exact motivation for the type of work we are doing here, and the verdict is still out. Indeed, the conclusion of our earlier work reporting retinotopy in infants (Ellis et al., 2021) suggests that the organization of the early visual cortex in infants as young as 5 months — the youngest infant in our sample — is surprisingly adult-like.

      The title cannot refer to infants given the age span.

      There is disagreement in the field about the age at which it is appropriate to refer to children as infants. In this paper, and in our prior work, we followed the practice of the most attended infant cognition conference and society, the International Congress of Infant Studies (ICIS), which considers infants as those aged between 0-3 years old, for the purposes of their conference. Indeed, we have never received this concern across dozens of prior reviews for previous papers covering a similar age range. That said, we understand the spirit of the reviewer’s comment and now refer to the sample as “infants and toddlers” and to older individuals in our sample as “toddlers” wherever it is appropriate (the younger individuals would fairly be considered “infants” under any definition).

      Figure 1 is clear and an interesting approach. Please also show the average correlation maps on the cortical surface.

      While we would like to create a figure as requested, we are unsure how to depict an area-by-area correlation map on the cortical surface. One option would be to generate a seed-based map in which we take an area and depict the correlation of that seed (e.g., vV1) with all other voxels. This approach would result in 8 maps for just the task-defined areas, and 17 maps for anatomically-defined areas. Hence, we believe this is out of scope of this paper, but an interested reader could easily generate these maps from the data we have released.

      Figure 2 results are not easily interpretable. Ventral and dorsal V1-V3 areas represent upper or lower VF respectively. Higher dorsal and ventral areas represent both upper and lower VF, so we should predict an equal distance between the two streams. Again, how can we verify that it is not a result of some artifacts?

      In adults, visual areas differ in their functional response properties along multiple dimensions, including spatial coding. The dorsal/ventral stream hypothesis is derived from the idea that areas in each stream support different functions, independent of spatial coding. The MDS analysis did not attempt to isolate the specific contribution of spatial representations of each area but instead tested the similarity of function that is evoked in naturalistic viewing. Other covariance-based analyses specifically isolate the contribution of spatial representations (Haak et al., 2013); however, they use a much more constrained analysis than what was implemented here. The fact that we find broad differentiation of dorsal and ventral visual areas in infants is consistent with adults (Haak & Beckman, 2018) and neonate non-human primates (Arcaro & Livingstone, 2017). 

      Nonetheless, we recognize that we did not mention the differences in visual field properties across areas and what that means. If visual field properties alone drove the functional response then we would expect to see a clustering of areas based on the visual field they represent (e.g., hV4 and V3AB should have similar representations). Since we did not see that, and instead saw organization by visual stream, the result is interesting and thus warrants reporting. We now mention this difference in visual fields in the manuscript to highlight the surprising nature of the result.

      “This separation between streams is striking when considering that it happens despite differences in visual field representations across areas: while dorsal V1 and ventral V1 represent the lower and upper visual field, respectively, V3A/B and hV4 both have full visual field maps. These visual field representations can be detected in adults[41]; however, they are often not the primary driver of function[39]. We see that in infants too: hV4 and V3A/B represent the same visual space yet have distinct functional profiles.” Pg. 8

      The reviewer raises a concern that the MDS result may be spurious and caused by noise. Below, we present three reasons why we believe these results are not accounted for by artifacts but instead reflect real functional differentiation in the visual cortex. 

      (1) Figure 2 is a visualization of the similarity matrix presented in Figure S1. In Figure S1, we report the significance testing we performed to confirm that the patterns differentiating dorsal and ventral streams — as well as adjacent areas from distal areas — are statistically reliable across participants. If an artifact accounted for the result then it would have to be a kind of systematic noise that is consistent across participants.

      (2) One of the main sources of noise (both systematic and non-systematic) with infant fMRI is motion. Homotopy is a within-participant analysis that could be biased by motion. To assess whether motion accounts for the results, we took a conservative approach of regressing out the framewise motion (i.e., how much movement there is between fMRI volumes) from the comparisons of the functional activity in regions. Although the correlations numerically decreased with this procedure, they were qualitatively similar to the analysis that does not regress out motion:

      “Additionally, if we control for motion in the correlation between areas --- in case motion transients drive consistent activity across areas --- then the effects described here are negligibly different (Figure S5).” Pg. 7

      (3) We recognize that despite these analyses, it would be helpful to see what this pattern looks like in adults where we know more about the visual field properties and the function of dorsal and ventral streams. This has been done previously (e.g., Haak & Beckman, 2018), but we have now run those analyses on adults in our sample, as described in the public review. As with infants, there are reliable differences in the homotopy between streams (Figure S1). The MDS results show that the adult data was more complex than the infant data, since it was best described by 3 dimensions rather than 2. Nonetheless, there is a rotation of the MDS such that the structure of the ventral and dorsal streams is also dissociable. 

      Figure 3 also raises several alternative interpretations. The spatial frequency component in B has strong activity ONLY at the extreme border of the VF and this is probably the origin of the strong correlation. I understand that it is only one subject, but this brings the need to show all subjects and to report the correlation. Also, it is important to show the putative average ICA for retinotopy and spatial frequencies across subjects and for adults. All methods should be validated on adults where we have clear data for retinotopy and spatial frequency.

      The reviewer notes that the component in Figure 3 shows strong negative response in the periphery. It is often the case, as reported elsewhere (Moeller et al., 2009), that ICA extracts portions of visual maps. To make a full visual map would require combining components into a composite (e.g., a component that has a high response in the periphery and another component that has a high response in the fovea). If we were to claim that this component, or others like it, could replace the need for retinotopic mapping, then we would want to produce these composite maps; however, our conclusion in this project is that the topographic information of retinotopic maps manifest in individual components of ICA. For this purpose, the analysis we perform adequately assesses this topography.

      Regarding the request to show the results for all subjects, we address this in the public response and repeat it here briefly: we have added 6 new figures to show results akin to Figure 3C and D. It is impractical to show the equivalent of Figure 3A and B for all participants, yet we do release the data necessary to see to visualize these maps easily.

      Finally, the reviewer suggests that we validate the analyses on adult participants. As shown in Figure S3 and reported in the public response, we now run these analyses on adult participants and observe qualitatively similar results to infants.

      How much was the variation in the presumed spatial frequency map? Is it consistent with the acuity range? 5-month-old infants should have an acuity of around 10c/deg, depending on the mean luminance of the scene.

      The reviewer highlights an important weakness of conducting ICA: we cannot put units on the degree of variation we see in components. We now highlight this weakness in the discussion:

      “Another limitation is that ICA does not provide a scale to the variation: although we find a correlation between gradients of spatial frequency in the ground truth and the selected component, we cannot use the component alone to infer the spatial frequency selectivity of any part of cortex. In other words, we cannot infer units of spatial frequency sensitivity from the components alone.” Pg. 20

      Figure 5 pipeline is totally obscure. I presumed that I understood, but as it is it is useless. All methods should be clearly described, and the intermediate results should be illustrated in figures and appropriately discussed. Using such blind analyses in infants in principle may not be appropriate and this needs to be verified. Overall all these techniques rely on correlation activities that are all biased by head movement, eye movement, and probably the dummy sucking. All those movements need to be estimated and correlated with the variability of the results. It is a strong assumption that the techniques should work in infants, given the presence of movements.

      We recognize that the SRM methods are complex. Given this feedback, we remade Figure 5 with explicit steps for the process and updated the caption (as reported in the public review).

      Regarding the validation of these methods, we have added SRM analyses from adults and find comparable results. This means that using these methods on adults with comparable amounts of data as what we collected from infants can predict maps that are highly similar to the real maps. Even so, it is not a given that these methods are valid in infants. We present two considerations in this regard. 

      First, as part of the SRM analyses reported in the manuscript, we show that control analyses are significantly worse than the real analyses (indicated by the lines on Figure 6). To clarify the control analysis: we break the mapping (i.e., flip the order of the data so that it is backwards) between the test participant and the training participants used to create the SRM. The fact that this control analysis is significantly worse indicates that SRM is learning meaningful representations that matter for retinotopy. 

      Second, we believe that this paper is a validation of SRM for infants. Infant fMRI is a nascent field and SRM has the potential to increase the signal quality in this population. We hope that readers will see these analyses as a proof of concept that SRM can be used in their work with infants. We have stated this contribution in the paper now.

      “Additionally, we wish to test whether methods for functional alignment can be used with infants. Functional alignment finds a mapping between participants using functional activity -- rather than anatomy -- and in adults can improve signal-to-noise, enhance across participant prediction, and enable unique analyses[27,32-34].” Pg. 4

      “This is initial evidence that functional alignment may be useful for enhancing signal quality, like it has in adults[27,32,33], or revealing changing function over development[45].” Pg. 21

      Regarding the reviewer’s concern that motion may bias the results, we wish to emphasize the nature of the analyses being conducted here: we are using data from a group of participants to predict the neural responses in a held-out participant. For motion to explain consistency between participants, the motion would need to be timelocked across participants. Even if motion was time-locked during movie watching, motion will impair the formation of an adequate model that can contain retinotopic information. Thus, motion should only hurt the ability for a shared response to be found that can be used for predicting retinotopic maps. Hence, the results we observed are despite motion and other sources of noise.

      What is M??? is it simply the mean value??? If not, how it is estimated?

      M is an abbreviation for mean. We have now expanded the abbreviation the first time we use it.

      Figure 6 should be integrated with map activity where the individual area correlation should be illustrated. Probably fitting SMR adult works well for early cortical areas, but not for more ventral and associative, and the correlation should be evaluated for the different masks.

      With the addition of plots showing the gradients for each participant and each movie (Figures S10–S13) we hope we have addressed this concern. We additionally want to clarify that the regions we tested in the analysis in Figure 6 are only the early visual areas V1, V2, V3, V3A/B, and hV4. The adult validation analyses show that SRM works well for predicting the visual maps in these areas. Nonetheless, it is an interesting question for future research with more extensive retinotopic mapping in infants to see if SRM can predict maps beyond extrastriate cortex.

      Occipital masks have never been described or shown.

      The occipital mask is from the MNI probabilistic structural atlas (Mazziotta et al., 2001), as reported in the original version and is shared with the public data release. We have added the additional detail that the probabilistic atlas is thresholded at 0% in order to be liberally inclusive. 

      “We used the occipital mask from the MNI structural atlas[63] in standard space -- defined liberally to include any voxel with an above zero probability of being labelled as the occipital lobe -- and used the inverted transform to put it into native functional space.” Pg. 27–28

      Methods lack the main explanation of the procedures and software description.

      We hope that the additions we have made to address this reviewer’s concerns have provided better explanations for our procedures. Additionally, as part of the data and code release, we thoroughly explain all of the software needed to recreate the results we have observed here.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public Review):

      My main concern is the use of the 700K SNP dataset. This set of SNPs suffers from a heavy ascertainment bias, which can be seen in the PCA in the supplementary material where all the aurochs cluster in the center within the variation of cattle. Given the coverage of some of the samples, multiple individuals would have less than 10K SNP covered. The majority of these are unlikely to be informative here given that they would just represent fixed positions between taurine and indicine or SNPs mostly variable in milk cattle breeds. The authors would get a much better resolution (i.e. many more SNPs to work with their very low genome coverage data) using the 1000 bull genome project VCF data set:

      https://www.ebi.ac.uk/ena/browser/view/PRJEB42783 which based on whole genome resequencing data from many cattle. This will certainly help with improving the resolution of qpAdm and f4 analysis, which have huge confidence intervals in most cases. Right now some individuals have huge confidence intervals ranging from 0 to 80% auroch ancestry...

      We thank the reviewer for this suggestion. We repeated our analyses with a SNP panel from Run 6 of the 1000 Bulls project presented in Naval-Sanchez et al 2020. This panel reduced standard errors and narrowed down confidence intervals for the ancient samples. Another consequence is that more single-source qpAdm models can now be rejected highlighting the abundance of hybridization. For our comparison to modern breeds, we still use the 700K dataset as it provides a set of different modern European cattle breeds.

      I agree with the authors that qpAdm is likely to give quite a noisy estimate of ancestry here (likely explain part of the issue I mentioned above). Although qpAdm is good for model testing here for ancestry proportion the authors instead could use an explicit f4 ratio - this would allow them to specify a model which would make the result easier to interpret.

      We have added ancestry estimates from f4 ratios to the manuscript and display them together with qpAdm and Struct-f4 (as suggested by reviewer #3) in our new Table 1. We decided to keep all three different estimates to illustrate that results are not consistent for all analyses. An additional feature of qpAdm is the possibility that two source models can be rejected and additional ancestries can be identified.

      The interpretation of the different levels of allele sharing on X vs autosome being the result of sex-bias admixture is not very convincing. Could these differences simply be due to a low recombination rate on the X chromosome and/or lower effective population size, which would lead to less efficient purifying selection?

      Following this comment (and another comment referring to the X chromosome analysis by reviewer #2), we decided to remove sex bias from the title of our study and add more information on the caveats of this analysis. While estimating ancestry on the X chromosome can be difficult, we also add that our patterns are consistent with what has been suggested based on ancient mitochondrial data (Verdugo et al 2019). For Neolithic Anatolia, it has been suggested that the insemination of domestic cows by auroch bulls has been intentional or even ritual (Peters et al 2012). A recent parallel archaeogenomic study also concluded sex-biased introgression from autosomal, X-chromosomal and Y-chromosomal data (Rossi et al 2024). As our results are consistent with these previous studies as well as the lower differentiation of modern breeds on the X chromosome (da Fonseca et al 2019), we still consider the general pattern of our results valid even if the exact extent of sex bias is difficult to assess.

      The authors suggest that 2 pop model rejection in some domestic population might be due to indicine ancestry, this seems relatively straightforward to test.

      We had already performed this analysis of modeling their ancestry from three sources using qpAdm. The results are shown in Supplementary Table S6 and we now refer to this more explicitly in the text: “The presence of indicine ancestry can be confirmed in a qpAdm analysis using three sources resulting in fitting models for all breeds (Supplementary Table S6).”

      The first sentence of the paper is a bit long-winded, also dogs were domesticated before the emergence of farming societies.

      We rephrased the first sentence to “Domestication of livestock and crops has been the dominant and most enduring innovation of the transition from a hunter-gathering lifestyle to farming societies.”

      It would be good to be specific about the number of genomes and coverage info in the last paragraph of the intro.

      This information is included in the first paragraph of the results section and we decided to not duplicate the numbers in the preceding introduction paragraph to retain a flow for the readers.

      Reviewer #2 (Public Review):

      Summary:

      In this paper, the authors investigated the admixture history of domestic cattle since they were introduced into Iberia, by studying genomic data from 24 ancient samples dated to ~2000-8000 years ago and comparing them to modern breeds. They aimed to (1) test for introgression from (local) wild aurochs into domestic cattle; (2) characterize the pattern of admixture (frequency, extent, sex bias, directionality) over time; (3) test for correlation between genetic ancestry and stable isotope levels (which are indicative of ecological niche); and (4) test for the hypothesized higher aurochs ancestry in a modern breed of fighting bulls.

      Strengths:

      Overall, this study collects valuable new data that are useful for testing interesting hypotheses, such as admixture between domestic and wild populations, and correlation between genome-wide aurochs ancestry and aggressiveness.

      Thank you for highlighting the importance of our study and the potential of our dataset.

      Weaknesses:

      Most conclusions are partially supported by the data presented. The presence of admixed individuals in prehistorical periods supports the hypothesized introgression, although this conclusion needs to be strengthened with an analysis of potential contamination. The frequency, sex-bias, and directionality of admixture remain highly uncertain due to limitations of the data or issues with the analysis. There is considerable overlap in stable isotope values between domestic and wild groups, indicating a shared ecological niche, but variation in classification criteria for domestic vs wild groups and in skeletal elements sampled for measurements significantly weakens this claim. Lastly, the authors presented convincing evidence for relatively constant aurochs ancestry across all modern breeds, including the Lidia breed which has been bred for aggressiveness for centuries. My specific concerns are outlined below.

      Contamination is a common concern for all ancient DNA studies. Contamination by modern samples is perhaps unlikely for this specific study of ancient cattle, but there is still the possibility of cross-sample contamination. The authors should estimate and report contamination estimates for each sample (based on coverage of autosomes and sex chromosomes, or heterozygosity of Y or MT DNA). Such contamination estimates are particularly important to support the presence of individuals with admixed ancestry, as a domestic sample contaminated with a wild sample (or vice versa) could appear as an admixed individual.

      We thank the reviewer for this suggestion. Due to our low coverage data, we focused on estimating contamination from the mitochondrial data by implementing the approach used by Green et al (2008). We make the code for this step available on Github. While most samples displayed low levels of contamination, we identified one sample (moo013a) with a surprisingly high (~50%) level of contamination which was excluded from further analysis.

      A major limitation of this study is uncertainty in the "population identity" for most sampled individuals (i.e., whether an individual belonged to the domesticated or wild herd when they were alive). Based on chronology, morphology, and genetic data, it is clear the Mesolithic samples from the Artusia and Mendandia sites are bona fide aurochs, but the identities of individuals from the other two sites are much less certain. Indeed, archeological and morphological evidence from El Portalon supports the presence of both domestic animals and wild aurochs, which is echoed by the inter-individual heterogeneity in genetic ancestry. Based on results shown in Fig 1C and Fig 2 it seems that individuals moo017, moo020, and possibly moo012a are likely wild aurochs that had been hunted and brought back to the site by humans. Although the presence of individuals (e.g., moo050, moo019) that can only be explained by two-source models strongly supports that interbreeding happened (if cross-contamination is ruled out), it is unclear whether these admixed individuals were raised in the domestic population or lived in the wild population and hunted.

      The reviewer is pointing out an important topic, the unknown identity of the studied individuals. We have revised the text making clear that we do not know whether the individuals were hunted or herded. At the same time, their genomic ancestry speaks for itself showing that there was hybridization between wild and domestic and that different individuals carried different degrees of wild ancestry. In the revised version, we have added the unknown identity as well as the fact that our results can be affected by both, changes in human hunting and herding practices over time. Regardless of the exact identity of the individuals, our results can still be seen as (a) evidence for hybridization and (b) changes in human practices (hunting and/or herding) and their relationship to bovids over time.

      Such uncertainty in "population identity" limits the authors' ability to make conclusions regarding the frequency, sex bias, and directionality of gene flow between domestic and wild populations. For instance, the wide range of ancestry estimates in Neolithic and Chalcolithic samples could be interpreted as evidence of (1) frequent recent gene flow or (2) mixed practices of herding and hunting and less frequent gene flow. Similarly, the statement about "bidirection introgression" (on pages 8 and 11) is not directly supported by data. As the genomic, morphological, and isotope data cannot confidently classify an individual as belonging to the domesticated or wild population, it seems impossible to conclude the direction of gene flow (if by "bidirection introgression" the authors mean something other than "bidirectional gene flow", they need to clearly explain this before reaching the conclusion.)

      We have removed “bidirectional introgression” from the text and replaced it with the more neutral term “hybridization”. Furthermore, we used the revision to mention at several places in the text that it is not clear whether the sequenced individuals were hunted and herded and that the observed pattern likely reflects changes in both hunting and herding practices.

      The f4 statistics shown in Fig 3B are insufficient to support the claim regarding sex-biased hybridization, as the f4 statistic values are not directly comparable between the X chromosome and autosomes. Because the effective population size is different for the X chromosome and autosomes (roughly 3:4 for populations with equal numbers of males and females), the expected amount of drift is different, hence the fraction of allele sharing (f4) is expected to be different. In fact, the observation that moo004 whose autosomal genome can be modeled as 100% domestic ancestry still shows a higher f4 value for the X chromosome than autosomes hints at this issue. A more robust metric to test for sex-biased admixture is the admixture proportion itself, which can be estimated by qpAdm or f4-ratio (see Patterson et al 2012). However, even with this method, criticism has been raised (e.g., Lazaridis and Reich 2017; Pfennig and Lachance, 2023). In general, detecting sex-bias admixture is a tough problem.

      In response to this comment and another comment by reviewer #1, we decided to remove sex bias from the title. In the revised version of our study, we have now switched this analysis from f4 statistics to comparing f4 ratios between the X chromosome and autosomes (Figure 3). Furthermore, we have added more information on the caveats of this analysis citing the articles mentioned by the reviewer. At the same time, we highlight that our patterns are consistent with what has been suggested based on ancient mitochondrial data (Verdugo et al 2019). Unfortunately, the low coverage data does not allow to call Y chromosomal haplotypes which would also allow an analysis of the paternal lineage. But our results are consistent with additional examples from the literature: For Neolithic Anatolia, it has been suggested that the insemination of domestic cows by auroch bulls has been intentional or even ritual (Peters et al 2012) and there is a lower differentiation of modern breeds on the X chromosome (da Fonseca et al 2019). A recent parallel archaeogenomic study also concluded sex-biased introgression from autosomal, X-chromosomal and Y-chromosomal data (Rossi et al 2024). Similar to the broader hybridization signal, our interpretation does not depend on the estimates for single individuals as we describe the broader pattern. As our results are consistent with previous results based on other types of data, we still consider the general pattern of our results valid even if the exact extent of sex bias is difficult to assess.

      In general, the stable isotope analysis seems to be very underpowered, due to the issues of variation in classification criteria and skeletal sampling location discussed by the authors in supplementary material. The authors claimed a significant difference in stable nitrogen isotope between (inconsistently defined) domestic cattle and wild aurochs, but no figures or statistics are presented to support this claim. Please describe the statistical method used and the corresponding p-values. The authors can consider including a figure to better show the stable isotope results.

      In combination with updated tables, we have added a supplementary figure showing the stable isotope results (S9). In light of the reanalysis of the genetic data, we have reassessed the genetic models used to assign species in the stable isotope analysis. We have provided more details of the statistical methods used and the p-values are given in the supplementary materials. There is a significant difference in the nitrogen isotope values when comparing B. taurus and B. primigenius (identified on morphology) but no other comparisons are significant at the p = 0.05 threshold. The reviewer highlights what we have mentioned in the supplementary material regarding the varied skeletal elements used for stable isotope analysis and the difficulty of assigning a species identity (as this depends on what criteria are used; morphological or some kind of genetic threshold of ancestry). Indeed, how to identify the species is at the heart of the paper. Given that identity could be defined in many ways, we have used 3 different genetic models to reflect this and the morphological categories, to help explore different possible scenarios. The reviewer is correct to point out that some of this analysis is not helped by the variety of skeletal elements used, but we have been careful not to over-interpret the results. The only samples that have nitrogen values higher than one standard deviation from the mean are domestic cattle, so it is not unreasonable to suggest that only domestic cattle have high nitrogen isotope values.

      Reviewer #3 (Public Review):

      Summary:

      Günther and colleagues leverage ancient DNA data to track the genomic history of one of the most important farm animals (cattle) in Iberia, a region showing peculiarities both in terms of cultural practices as well as a climatic refugium during the LGM, the latter of which could have allowed the survival of endemic lineages. They document interesting trends of hybridisation with wild aurochs over the last 8-9 millennia, including a stabilisation of auroch ancestry ~4000 years ago, at ~20%, a time coincidental with the arrival of domestic horses from the Pontic steppe. Modern breeds such as the iconic Lidia used in bullfighting or bull running retain a comparable level of auroch ancestry.

      Strengths:

      The generation of ancient DNA data has been proven crucial to unravel the domestication history of traditional livestock, and this is challenging due to the environmental conditions of the Iberian peninsula, less favourable to DNA preservation. The authors leverage samples unearthed from key archaeological sites in Spain, including the karstic system of Atapuerca. Their results provide fresher insights into past management practices, and permit characterisation of significant shifts in hybridization with wild aurochs.

      We thank the reviewer for their positive assessment of our work and for highlighting the strength and potential of the study.

      Weaknesses:

      - Treatment of post-mortem damage: the base quality of nucleotide transitions was recalibrated down to a quality score of 2, but for 5bp from the read termini only. In some specimens (e.g. moo022), the damage seems to extend further. Why not use dedicated tools (e.g. mapDamage), or check the robustness by conditioning on nucleotide transversions?

      We agree that using such a non-standard data preparation approach requires some testing. Since our main analyses are all based on f statistics, we compared f4 statistics and f4 ratios of our rescaled base quality data with data only using transversion sites. While estimates are highly correlated, the data set reduced to transversions produces larger confidence intervals in f4 ratios due to the lower number of sites. Consequently, we decided to use the rescaled data for all analyses displayed in main figures. We also prefer not to perform reference based rescaling as implemented in mapDamage as it might be sensitive to mapping bias (Günther & Nettelblad 2019).

      - Their more solid analyses are based on qpAdm, but rely on two single-sample donor populations. As the authors openly discuss, it is unclear whether CPC98 is a good proxy for Iberian aurochs despite possibly forming a monophyletic clade (the number of analysed sites is simply too low to assess this monophyly; Supplementary Table S2). Additionally, it is also unclear whether Sub1 was a fully unadmixed domestic specimen, depleted of auroch ancestry. The authors seem to suggest themselves that sex-biased introgression may have already taken place in Anatolia ("suggesting that sex-biased processes already took place prior to the arrival of cattle to Iberia").

      We expanded the discussion on this topic but removed the analysis of whether European aurochs form a clade due to the low number of sites. We do highlight that a recent parallel study on aurochs genomes confirmed that Western European aurochs form a clade, probably even originating from an Iberian glacial refugium (Rossi et al 2024). Even if minor structure in the gene pool of European aurochs might affect our quantitative results, it should not drive the qualitative pattern. The same should be the case for Sub1 as our tests would detect additional European aurochs ancestry that was not present in Sub1. The corresponding paragraph now reads:

      “A limitation of this analysis is the availability of genomes that can be used as representatives of the source populations as we used German and British aurochs to represent western European aurochs ancestry and a single Anatolian Neolithic to represent the original domestic cattle that was introduced into Europe. Our Mesolithic Iberian aurochs contained too little endogenous DNA to be used as a proxy aurochs reference and all Neolithic and Chalcolithic samples estimated with predominantly aurochs ancestry (including the 2.7x genome of moo014) already carry low (but significant) levels of domestic ancestry. However, the fact that all of these aurochs samples carried P mitochondria strongly suggests that western European aurochs can be considered monophyletic. Furthermore, a recent parallel study also concluded that Western European aurochs all form a clade (27). The Anatolian Sub1 might also not be depleted of any European aurochs ancestry and could not fully represent the original European Neolithic gene pool as also indicated by qpAdm and Struct-f4 identifying small proportions of other Asian ancestries in some Iberian individuals.

      While these caveats should affect our quantitative estimates of European aurochs ancestry, they should not drive the qualitative pattern as our tests would still detect any excess European aurochs ancestry that was not present in Neolithic Anatolia.”

      Alternatively, I recommend using Struct-f4 as it can model the ancestry of all individuals together based on their f4 permutations, including outgroups and modern data, and without the need to define pure "right" and "left" populations such as CPC98 and Sub1. It should work with low-coverage data, and allows us to do f4-based MDS plots as well as to estimate ancestry proportions (including from ghost populations).

      We thank the reviewer for this suggestion. We added Struct-f4 as an analysis but observed that it would not converge in an individual-based analysis due to the low coverage of most of our samples. We added Struct-f4 results for samples with >0.1X to the new Table 1, the results are similar to the results obtained using f4 ratios and (to a lower degree) the qpAdm results.

      - In the admixture graph analyses (supplementary results), the authors use population groups based on a single sample. If these samples are pseudohaploidised (or if coverage is insufficient to estimate heterozygosity - and it is at least for moo004 and moo014), f3 values are biased, implying that the fitted graph may be wrong. The graph shown in Fig S7 is in fact hard to interpret. For example, the auroch Gyu2 from Anatolia but not the auroch CPC98 also from Anatolia received 62% of ancestry from North Africa? The Neolithic samples moo004 and moo014 also show the same shocking disparity. I would consider re-doing this analysis with more than a sample per population group

      There seems to be some confusion relating to the sample identity in these figures. CPC98 is British and not Anatolian while Gyu2 is from the Caucasus and not Anatolia which would explain why they are different. Furthermore, moo004 is mostly of domestic ancestry while, moo014 is mostly of European aurochs ancestry according to our other analyses, which should explain why they also behave differently in this analysis. To avoid confusion and since this is a supplementary analysis from which we are not drawing any major conclusions, we decided to remove the graphs and the analysis from the study.

      Recommendations for the authors:

      Reviewer #2 (Recommendations For The Authors):

      Fig 3A: The red regression line is misleading. It seems to show that the average aurochs ancestry fraction has been steadily decreasing since ~8000 years ago, but the "averaging" is not meaningful as not all samples necessarily represent domestic cattle remains and the sample size is rather small. In other words, the samples are just a small, random collection of domestic and wild animals, and the average ancestry is subject to large sampling noise. I would suggest removing the regression line (along with the associated confidence interval) in this figure. It would also be helpful to label the samples with their IDs and morphology in the plot for cross-reference with other figures. Also, it is said in the legend that "Modern Iberian breeds... are added around date 0 with some vertical jitter". Do the authors mean "horizontal jitter" instead?

      Thank you for noticing this! We have removed the regression line and corrected the figure legend.

      Fig 2 vs Fig 3A: are the error bars the same in these two plots? They seem to be highly similar, if not identical, but the legends read very differently ("95% confidence interval by block-jackknife vs. on standard error"). Please explain.

      The figure legends have been corrected.

      Fig 3B: What do the error bars in Fig 3B mean? 95% confidence interval or one standard error? Please clarify in the legend.

      We have removed this figure and replaced it with a different way of displaying the results (now Figure 3). We ensured that the error bars are displayed consistently across figures.

      According to the f4 statistics shown in Fig 1C and Fig 3B, moo012b carries a relatively high amount of domestic ancestry. How is this compatible with the observation in Fig 2 that this individual can be modeled with 100% aurochs (i.e., aurochs as the single source)? Does this simply reflect the low genome coverage?

      moo012b is indeed one of the lowest coverage samples in our has at <0.02x sequencing depth. Even in our revised analysis using more sites, there is a discrepancy between the results of f4 statistics and qpAdm (suggesting mostly domestic ancestry) and f4 ratio suggesting mostly aurochs ancestry (Figure 1C and Table 1). We believe that this highlights the sensitivity of different methods to assumptions about the relationships of sources and potential “outgroups” which might not be well resolvable with low coverage data and in the presence of potentially complex admixture. Our general results, however, do not depend on the estimates for single individuals as our interpretations are based on the general pattern.

      I don't fully understand the rationale behind the statement "However, at some point, the herding practices must have changed since modern Iberian breeds show approximately 20-25% aurochs ancestry". Can the stable ancestry fraction from 4000 years to the present (relative to the highly variable ancestry before) reflect of discontinuation of hunting rather than changes in herding practices?

      We agree that this statement was not justified here, we rephrased the sentence to “In fact, from the Bronze Age onwards, most estimates overlap with the approximately 25% aurochs ancestry in modern Iberian cattle” and generally tried to make the text more nuanced on the issue of herding and hunting practices.

      Reviewer #3 (Recommendations For The Authors):

      Thanks for this interesting piece of work. The results are clearly presented, and I have no additional concerns other than those reflected in the public report, except perhaps:

      (i) trying to use more informative sample names (eg. including the date and location). It may facilitate reading without going back and forth to the table "Sample List".

      We have now added a main table listing our post-Mesolithic samples together with their age, site and estimated aurochs ancestry proportions. We hope that his table makes it easier for readers to follow our sample IDs.

      (ii) Briefly describe in the main the age of aurochs and Sub1 not generated in this study.

      Fixed.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public Review):

      Summary:

      Meissner et al describe an update on the collection of split-GAL4 lines generated by a consortium led by Janelia Research Campus. This follows the same experimental pipeline described before and presents as a significant increment to the present collection. This will strengthen the usefulness and relevance of "splits" as a standard tool for labs that already use this tool and attract more labs and researchers to use it.

      Strengths:

      This manuscript presents a solid step to establish Split-GAL4 lines as a relevant tool in the powerful Drosophila toolkit. Not only does the raw number of available lines contribute to the relevance of this tool in the "technical landscape" of genetic tools, but additional features of this effort contribute to the successful adoption. These include:

      (1) A description of expression patterns in the adult and larvae, expanding the "audience" for these tools

      (2) A classification of line combination according to quality levels, which provides a relevant criterion while deciding to use a particular set of "splits".

      (3) Discrimination between male and female expression patterns, providing hints regarding the potential role of these gender-specific circuits.

      (4) The search engine seems to be user-friendly, facilitating the retrieval of useful information.

      Overall, the authors employed a pipeline that maximizes the potential of the Split-GAL4 collection to the scientific community.

      Weaknesses:

      The following aspects apply:

      The use of split-GAL4 lines has improved tremendously the genetic toolkit of Drosophila and this manuscript is another step forward in establishing this tool in the genetic repertoire that laboratories use. Thus, this would be a perfect opportunity for the authors to review the current status of this tool, addressing its caveats and how to effectively implement it into the experimental pipeline.

      (1) While the authors do bring up a series of relevant caveats that the community should be aware of while using split-GAL4 lines, the authors should take the opportunity to address some of the genetic issues that frequently arise while using the described genetic tools. This is particularly important for laboratories that lack the experience using split-GAL4 lines and wish to use them. Some of these issues are covertly brought up, but not entirely clarified.

      First, why do the authors (wisely) rescreen the lines using UAS-CsChrimson-mVenus? One reason is that using another transgene (such as UAS-GFP) and/or another genomic locus can drive a different expression pattern or intensities. Although this is discussed, this should be made more explicit and the readers should be aware of this.

      Second, it would be important to include a discussion regarding the potential of hemidriver lines to suffer from transvection effects whenever there is a genetic element in the same locus. These are serious issues that prevent a more reliable use of split-GAL4 lines that, once again, should be discussed.

      We added additional explanatory text to the discussion.

      (2) The authors simply mention that the goal of the manuscript is to "summarize the results obtained over the past decade.". A better explanation would be welcomed in order to understand the need of a dedicated manuscript to announce the availability of a new batch of lines when previous publications already described the Split-GAL4 lines. At the extreme, one might question why we need a manuscript for this when a simple footnote on Janelia's website would suffice.

      We added an additional mention of the cell type split-GAL4 collection at the relevant section and added more emphasis on the curation process adding value to the final selections. We feel that the manuscript is useful to document the methods used for the contained analysis and datasets and gives a starting point to the reader to go through the many split-GAL4 publications and images.

      Reviewer #2 (Public Review):

      Summary: This manuscript describes the creation and curation of a collection of genetic driver lines that specifically label small numbers of neurons, often just a single to handful of cell types, in the central nervous system of the fruit fly, Drosophila melanogaster. The authors screened over 77,000 split hemidriver combinations to yield a collection of 3060 lines targeting a range of cell types in the adult Drosophila central nervous system and 1373 lines characterized in third-instar larvae. These genetic driver lines have already contributed to several important publications and will no doubt continue to do so. It is a truly valuable resource that represents the cooperation of several labs throughout the Drosophila community.

      Strengths:

      The authors have thoughtfully curated and documented the lines that they have created, so that they may be maximally useful to the greater community. This documentation includes confocal images of neurons labeled by each driver line and when possible, a list of cell types labeled by the genetic driver line and their identity in an EM connectome dataset. The authors have also made available some information from the other lines they created and tested but deemed not specific or strong enough to be included as part of the collection. This additional resource will be a valuable aid for those seeking to label cell types that may not be included in the main collection.

      Weaknesses:

      None, this is a valuable set of tools that took many years of effort by several labs. This collection will continue to facilitate important science for years to come.

      We thank the reviewer for their positive feedback.

      Reviewer #3 (Public Review):

      Summary:

      The manuscript by Meissner et al. describes a collection of 3060 Drosophila lines that can be used to genetically target very small numbers of brain cells. The collection is the product of over a decade of work by the FlyLight Project Team at the Janelia Research Campus and their collaborators. This painstaking work has used the intersectional split-Gal4 method to combine pairs of so-called hemidrivers into driver lines capable of highly refined expression, often targeting single cell types. Roughly one-third of the lines have been described and characterized in previous publications and others will be described in manuscripts still in preparation. They are brought together here with many new lines to form one high-quality collection of lines with exceptional selectivity of expression. As detailed in the manuscript, all of the lines described have been made publicly available accompanied by an online database of images and metadata that allow researchers to identify lines containing neurons of interest to them. Collectively, the lines include neurons in most regions of both the adult and larval nervous systems, and the imaging database is intended to eventually permit anatomical searching that can match cell types targeted by the lines to those identified at the EM level in emerging connectomes. In addition, the manuscript introduces a second, freely accessible database of raw imaging data for many lower quality, but still potentially useful, split-Gal4 driver lines made by the FlyLight Project Team.

      Strengths:

      Both the stock collection and the image databases are substantial and important resources that will be of obvious interest to neuroscientists conducting research in Drosophila. Although many researchers will already be aware of the basic resources generated at Janelia, the comprehensive description provided in this manuscript represents a useful summary of past and recent accomplishments of the FlyLight Team and their collaborators and will be very valuable to newcomers in the field. In addition, the new lines being made available and the effort to collect all lines that have been generated that have highly specific expression patterns is very useful to all.

      Weaknesses:

      The collection of lines presented here is obviously somewhat redundant in including lines from previously published collections. Potentially confusing is the fact that previously published split-Gal4 collections have also touted lines with highly selective expression, but only a fraction of those lines have been chosen for inclusion in the present manuscript. For example, the collection of Shuai et al. (2023) describes some 800 new lines, many with specificity for neurons with connectivity to the mushroom body, but only 168 of these lines were selected for inclusion here. This is presumably because of the more stringent criteria applied in selecting the lines described in this manuscript, but it would be useful to spell this out and explain what makes this collection different from those previously published (and those forthcoming).

      We added more description of how this collection is focused on the best cell-type-specific lines across the CNS. An important requirement for inclusion was this degree of specificity across the CNS, while many prior publications had a greater emphasis on lines with a narrower focus of specificity.

      Recommendations for the authors:

      Reviewer #1 (Recommendations For The Authors):

      Luckily for us, genetics is for the most part an exact science. However, there's still some "voodoo" in a lot of genetic combinations that the authors should disclose and be as clear as possible in the manuscript. This allows for the potential users to gauge expectations and devise a priori alternative plans.

      We attempted to comprehensively cover the caveats inherent in our genetic targeting approach.

      Minor points:

      (1) The authors mention that fly age should be controlled as expression can vary. Is there any reference to support this claim?

      We added a reference describing driver expression changes over development.

      (2) There should be a citation for "Flies were typically 1-5 days old at dissection for the cell type collection rescreening, 1-8 days old for other non-MCFO crosses and 3-8 days old for MCFO".

      We clarified that these descriptions were of our experimental preparations, not describing other citable work.

      Reviewer #3 (Recommendations For The Authors):

      General Points:

      Overall, the manuscript is very clear, but there are a couple of points where more explicit information would be useful. One of these is with respect to the issue of selectivity of targeting. The cell type specificity of lines is often referred to, but cell types can range from single pairs of neurons to hundreds of indistinguishable neurons with similar morphology and function. It would be useful if the authors explained whether their use of the term "cell type" distinguishes cell type from cell number. It would also be useful if lines that target many neurons of a single cell type were identified.

      We added further discussion of cell types vs. cell numbers. Our labeling strategy was not optimized for counting cell numbers labeled by each line. We believe EM studies are best positioned to comprehensively evaluate the number of cells making up each type.

      The second point relates to vagueness about the intended schedule for providing resources that will match (or allow matching of) neurons to the connectome. For example, on pp. 5-6 it is stated that: "In the future all of the neurons in these lines will be uniquely identified and linked to neurons reconstructed in the electron microscopy volume of the larva" but no timeline is provided. Similarly, for the adult neurons it is stated on p. 4 that: "Anatomical searching for comparison to other light microscopy (LM) and EM data is being made available." A more explicit statement about what resources are and are not yet available, a timeline for full availability, and an indication of how many lines currently have been matched to EM data would be helpful.

      During the review and revision period we have made progress on processing the images in the collection. We updated the text with the current status and anticipated timeline for completion.

      Specific Points:

      p. 4 "Although the lines used for these comparisons are not a random sample, the areas of greatest difference are in the vicinity of previously described sexual dimorphisms..." In the vicinity of is a very vague statement of localization. A couple of examples of what is meant here would be useful.

      We added example images to Figure 3.

      p. 5 "...may have specific expression outside our regions of interest." It's not clear what "our regions of interest" refers to here. Please clarify.

      We clarified that we were referring to the regions studied in the publications listed in Table 1.

      p. 5 "...lines that were sparse in VNC but dirty in the brain or SEZ..." A more quantitative descriptor than "dirty" would be helpful.

      We unfortunately did not quantify the extent of undesired brain/SEZ expression, but attempted to clarify the statement.

      p. 6 "...the images are being made instantly searchable for LM and EM comparisons at NeuronBridge..." Here again it is hard to know what is meant by "being made instantly searchable." How many have been made searchable and what is the bottleneck in making the rest searchable?

      We updated the text as described above. The bottleneck has been available processing capacity for the hundreds of thousands of included images.

      Figure 1 Supplemental File 2: The movie is beautiful, but it seems more useful as art than as a reference. Perhaps converting it to a pdf of searchable images for each line would make it more useful.

      We replaced the movie with a searchable PDF.

      Fig. 2(B) legend: "Other lines may have more than two types." It is not clear what "other lines" are being referred to.

      As part of making the quality evaluation more robust, we scored lines for the clear presence of three or more cell types. We updated the text accordingly.

      Fig. 2(C): Presumably the image shown is an example of variability in expression rather than weakness, but it is hard to know without a point of comparison. Perhaps show the expression patterns of other samples? Or describe briefly in the legend what other samples looked like?

      We added Figure 2 - figure supplement 1 with examples of variable expression in a split-GAL4 line.

    1. Author response:

      The following is the authors’ response to the previous reviews.

      Comments on revised version: 

      Overall, I thought the authors addressed my comments well with the possible exception of what is actually new here. This was the most important thing that I thought should be included in the revision. Although the authors rewrote the paragraph describing the lines presented in the paper, I still can't tell exactly which ones haven't been previously published. Their revised paragraph says that 40 lines have been "previously used," but Supplemental Table 1 shows references for over 200 of the lines, which sounds more reasonable based on papers that have come out. 

      We have modified the text in line 112-120 as below.

      “Supplementary File 1 lists 859 lines (including split-LexA) and their detailed information, such as genotype, expression specificity, matched EM cell type(s), and recommended driver for each cell type. A small subset of 47 lines from this collection have been previously used in studies (Aso et al., 2023; Dolan et al., 2019; Gao et al., 2019; Scaplen et al., 2021; Schretter et al., 2020; Takagi et al., 2017; Xie et al., 2021; Yamada et al., 2023).”

      For 842 lines among the 859 lines listed in Supplementary File 1, this study is the primary citation for future papers for the following reason: 

      In 2021 December, we deposited the confocal images of new split-GAL4 lines at Janelia Flylight website (http://www.janelia.org/split-gal4) without a publication to describe annotation of expression patterns, and we already started sharing the lines without restrictions. In 2023 September, we released the preprint of this study at bioRxiv (doi: https://doi.org/10.1101/2023.09.15.557808). Up to this point, 47 lines have been used in other studies. In Supplementary File 1, 30 of them attribute the citation credit to both this study and other papers, because this 2023 preprint was cited as the primary citation in those papers. Similarly, the omni paper to summarize all the eWort of generating split-GAL4 lines by Janelia Flylight team (https://doi.org/10.7554/eLife.98405.1) cite many lines from this paper. However, since this summary paper did not provide additional information such as functional characterization by behavioral experiments, we did not include it in Supplementary File 1 to clarify that this study is the primary citation for these lines. The remaining 17 lines were published before 2021. We included them for the convenience of users, and we attributed the primary citation to the already published papers. 

      Also, in the revised paragraph they state that "All transgenic lines newly generated in this study are listed in Supplementary File 2" but that table lists only the 36 LexA hemidriver lines! Confusingly, this comment cites the same 8 references as are cited for the 40 line that they say were previously published. I am thus only more confused about how many previously uncharacterized lines are presented in this paper. 

      We modified the text as below to clarify that “new lines” indicate LexA or DBD lines but not new combination of already published AD and DBD lines. We removed the 8 citations, which were mistakenly placed in the previous manuscript.

      “The newly generated LexA, Gal4DBD and LexADBD lines are listed in Supplementary File 2. “

    1. Author response:

      The following is the authors’ response to the previous reviews.

      Reviewer #1:

      (1) All analyses were performed on trial-averaged neural responses that were pooled across mice. Owing to differences between subjects in behavior, experimental preparation quality, and biological variability, it seems important to perform at least some analyses on individual analyses to assess how behavioral training might differently affect each animal.

      In order to image at a relatively fast rate (30Hz) appropriate to the experimental conditions, we restricted our imaging to a relatively small field of view (412x412um with 512x512 pixels). This entails a smaller number of ROIs per animal, which can lead to an unbalanced distribution of cells responsive to different stimuli for individual fields-of-view. We used the common approach of pooling across animals (Homann et al., 2021; Kim et al., 2019) to overcome limitations imposed by sampling a smaller number of cells per animal. In response to this comment, we included supplemental analyses (Sup.Fig. 6) showing that representational drift (which was not performed on trial-averaged data) looks substantially the same (albeit nosier) for individual animals as at the population level. Additional analyses (PE ratio, etc.) were difficult since the distribution of cells selective for individual stimuli is unbalanced between individual animals and few mice have multiple cells representing all of the different stimuli.

      (2) The correlation analyses presented in Figure 3 (labeled the second Figure 2 in the text) should be conducted on a single-animal basis. Studying population codes constructed by pooling across mice, particularly when there is no behavioral readout to assess whether learning has had similar effects on all animals, appears inappropriate to me. If the results in Figure 3 hold up on single animals, I think that is definitely an interesting result.

      We repeated the correlation analysis performed on mice individually and included them in the supplement (Supp. Fig. 6). The overall result generally mirrors the result found by pooling across animals.

      (3) On Day 0 and Day 5, the reordered stimuli are presented in trial blocks where each image sequence is shown 100 times. Why wasn't the trial ordering randomized as was done in previous studies (e.g. Gavornik and Bear 2014)? Given this lack of reordering, did neurons show reduced predictive responses because the unexpected sequence was shown so many times in quick succession? This might change the results seen in Figure 2, as well as the decoder results where there is a neural encoding of sequence order (Figure 4). It would be interesting if the Figure 4 decoder stopped working when the higher-order block structure of the task was disrupted.

      Our work builds primarily on previous studies (Gavornik & Bear, 2014; Price et al., 2023) that demonstrated clear changes in neural responses over days while employing a similar block structure. Notably, Price et al. found that trial number (within a block) was not a significant factor in the generation of prediction-error responses which strongly suggests short-term plasticity does not play a significant role in shaping responses within the block structure. This finding is consistent with our previous LFP recordings which have not revealed any significant plasticity occurring within a training session, a conclusion bolstered by a collaborative work currently in press (Hosmane et al. 2024, Sleep) revealing the requirement for sleep in sequence plasticity expression.

      It is possible that layer 2/3 adapts to sequences more rapidly than layer 4/5. While manual inspection does not reveal an obvious difference between early and late blocks in this dataset, the n for this subset is too small to draw firm conclusions. It is our view that the block structure provides the strongest comparison to previous work, but agree it would be interesting to randomize or fully interleave sequences in future studies to determine what effect, if any, short-term changes might have. 

      (4) A primary advantage of using two-photon calcium imaging over other techniques like extracellular electrophysiology is that the same neurons can be tracked over many days. This is a standard approach that can be accomplished by using many software packages-including Suite2P (Pachitariu et al. 2017), which is what the authors already used for the rest of their data preprocessing. The authors of this paper did not appear to do this. Instead, it appears that different neurons were imaged on Day 0 (baseline) and Day 5 (test). This is a significant weakness of the current dataset.

      The hypothesis being tested was whether expectation violations, as described in Keller & Mrsic-Flogel 2018, exist under a multi-day sequence learning paradigm. For this, tracking cells across days is not necessary as our PE metric compared responses of individual neurons to multiple stimuli within a single session. Given the speed/FOV tradeoff discussed above, we wanted to consider all cells irrespective of whether they were visible/active or trackable across days, especially since we would expect cells that learn to signal prediction errors to be inactive on day 0 and not selected by our segmentation algorithm. Though we did not compare the responses of single cells before/after training, we did analyze cells from the same field of view on days 0 and 5 (see Supp.Fig. 1) and not distinct populations.

      Reviewer #2:

      (1) There appears to be some confusion regarding the conceptual framing of predictive coding.

      Assuming the mouse learns to expect the sequence ABCD, then ABBD does not probe just for negative prediction errors, and ACBD is not just for positive prediction errors. With ABBD, there is a combination of a negative prediction error for the missing C in the 3rd position, and a positive prediction error for B in the 3rd. Likewise, with ACBD, there is a negative prediction error for the missing B at 2nd and missing C at 3rd, and a positive prediction error for the C in 2nd and B in 3rd. Thus, the authors' experimental design does not have the power to isolate either negative or positive prediction errors. Moreover, looking at the raw data in Figure 2C, this does not look like an "omission" response to C, but more like a stronger response to a longer B. The pitch of the paper as investigating prediction error responses is probably not warranted - we see no way to align the authors' results with this interpretation.

      The reviewer has identified a real problem with the framing of “positive” and “negative” prediction errors in context of sensory stimuli where substitution simultaneously introduces unexpected “positive” violation and “negative” omission. Simply put, even if there are separate mechanisms to represent positive and negative errors, there may be no way to isolate the positive response experimentally since an unexpected input always replaces the unseen expected input. For example, had a cell fired solely to ACBD (and not during either ABCD or ABCD), then whether it was signaling the unexpected occurrence of C or the unexpected absence of B would be inherently ambiguous. In either case, such a cell would have been labeled as C-responsive, and its activity would have been elevated compared with ABCD and would have been included in our substitution-type analysis of prediction errors. We accept that there is some ambiguity regarding the description in this particular case, but overall, this cell’s activity pattern would have informed the PE analysis for which the result was essentially null for the substitution-type violation ACBD.

      Omission, in which the sensory input does not change, may experimentally isolate the negative response though this is only true if there is a temporal expectation of when the change should have occurred. If A is predicting B in an ordinal sense but there is no expectation of when B will occur with respect to A, changing the duration of A would not be expected to produce an error signal since at any point in time B might still be coming and the expectation is not broken until something other than B occurs. With respect specifically to ABBD in our experiments, it is correct that the learned error responses take the form of stronger, sustained responses to B during the time C was expected. This is still in contrast to day 0 in which activation decays after a transient response to ABBD. The data shows that responses during an omitted element are altered with training and take the form of elevated responses to ABBD on day 5.As we say in our discussion, this is somewhat ambiguous evidence of prediction errors since it does emerges only with training and is generally consistent with the hypothesis being tested though it takes a different form than we expected it to.

      (2) Related to the interpretation of the findings, just because something can be described as a prediction error does not mean it is computed in (or even is relevant to) the visual cortex. To the best of our knowledge, it is still unclear where in the visual stream the responses described here are computed. It is possible that this type of computation happens before the signals reach the visual cortex, similar to mechanisms predicting moving stimuli already in the retina (https://pubmed.ncbi.nlm.nih.gov/10192333/). This would also be consistent with the authors' finding (in previous work) that single-cell recordings in V1 exhibit weaker sequence violation responses than the author's earlier work using LFP recordings.

      Our work was aimed at testing the specific hypothesis that PE responses, at the very least, exist in L2/3—a hypothesis that is well-supported under different experimental paradigms (often multisensory mismatch). Our aim was to test this idea under a sequence learning paradigm and connect it with previously found PE responses in L4. We don’t claim that it is the only place in which prediction errors may be computed or useful, especially since (as you mentioned), there is evidence for such responses in layer 4. But it is fundamentally important to predictive processing that we determine whether PE responses can be found in layer 2/3 under this passive sequence learning paradigm, whether or not they reflect upstream processes, feedback from higher areas, or entirely local computations. Our aim was to establish some baseline evidence for or against predictive processing accounts of L2/3 activity during passive exposure to visual sequences.

      (3) Recording from the same neurons over the course of this paradigm is well within the technical standards of the field, and there is no reason not to do this. Given that the authors chose to record from different neurons, it is difficult to distinguish representational drift from drift in the population of neurons recorded.

      Our discussion of drift refers to changes occurring within a population of neurons over the course of a single imaging session. We have added clarifying language to the manuscript to make this clear. Changes to the population-level encoding of stimuli over days are treated separately and with different analytical tools. Re. tracking single across days, please see the response to Reviewer #1, comment 4.

      (4) The block paradigm to test for prediction errors appears ill-chosen. Why not interleave oddball stimuli randomly in a sequence of normal stimuli? The concern is related to the question of how many repetitions it takes to learn a sequence. Can the mice not learn ACBD over 100x repetitions? The authors should definitely look at early vs. late responses in the oddball block. Also, the first few presentations after the block transition might be potentially interesting. The authors' analysis in the paper already strongly suggests that the mice learn rather rapidly. The authors conclude: "we expected ABCD would be more-or-less indistinguishable from ABBD and ACBD since A occurs first in each sequence and always preceded by a long (800 ms) gray period.

      This was not the case. Most often, the decoder correctly identified which sequence stimulus A came from." This would suggest that whatever learning/drift could happen within one block did indeed happen and responses to different sequences are harder to interpret.

      This work builds on previous studies that used a block structure to drive plasticity across days. We previously tested whether there are intra-block effects and found no indication of changes occurring within a block or withing a session (please see the response to Reviewer #1, comment 3 for further discussion). Observed drift does complicate comparison between blocks. There is no indication in our data that this is a learned effect, though future experiments could test this directly.

      (5) Throughout the manuscript, many of the claims are not statistically tested, and where they are the tests do not appear to be hierarchical (https://pubmed.ncbi.nlm.nih.gov/24671065/), even though the data are likely nested.

      We have modified language throughout the manuscript to be more precise about our claims. We used pooled data between mice and common parametric statistics in line with published literature. The referenced paper offers a broad critique of this approach, arguing that it increases the possibility of type 1 errors, though it is not clear to us that our experimental design carries this risk particularly since most of our results were negative. To address the specific concern, however we performed a non-parametric hierarchical bootstrap analysis (https://pmc.ncbi.nlm.nih.gov/articles/PMC7906290/) that re-confirmed the statistical significance of our positive results, see Supplemental Figure 8.

      (6) The manuscript would greatly benefit from thorough proofreading (not just in regard to figure references).

      We apologize for the errors in the manuscript. We caught the issue and passed on a corrected draft, but apparently the uncorrected draft was sent for review. The re-written manuscript addresses all identified issues.

      (7) With a sequence of stimuli that are 250ms in length each, the use of GCaMP6s appears like a very poor choice.

      We started our experiments using GCaMP6f but ultimately switched to GCaMP6s due to its improved sensitivity, brightness, and accuracy in spike detection (Huang et al., 2021). When combined with deconvolution (Pachitariu et al., 2018; Pnevmatikakis et al., 2016), we found GCaMP6s provides the most complete and accurate view of spiking within 40ms time bins. The inherent limitations of calcium imaging are more likely to be addressed using electrophysiology rather than a faster sensor in future studies.

      (8) The data shown are unnecessarily selective. E.g. it would probably be interesting to see how the average population response evolves with days. The relevant question for most prediction error interpretations would be whether there are subpopulations of neurons that selectively respond to any of the oddballs. E.g. while the authors state they "did" not identify a separate population of omission-responsive neurons, they provide no evidence for this. However, it is unclear whether the block structure of the experiments allows the authors to analyze this.

      We concluded that there is no clear dedicated subpopulation of omission-responding cells by inspecting cells with large PE responses (i.e., ABBD, see supplemental figure 3). Out of the 107 B-responsive cells on day 5, only one appeared to fire exclusively during the omitted stimulus. Average traces for all B-responsive cells are included in the supplement and we have updated the manuscript accordingly. Similarly, a single C-responsive cell was found with an apparently unique substitution error profile (ABCD and ACBD , supplemental figure 4).

      Our primary concern was to make sure that days 0 and 5 had the highest quality fields-of-view. In work leading up to this study, there were concerns that imaging on all intermediate days resulted in a degradation of quality due to photobleaching. We agree that an analysis of intermediate days would be interesting, but it was excluded due to these concerns. 

      Reviewer #3:

      (1) Experimental design using a block structure. The use of a block structure on test days (0 and 5) in which sequences were presented in 100 repetition blocks leads to several potential confounds. First, there is the potential for plasticity within blocks, which could alter the responses and induce learned expectations. The ability of the authors to clearly distinguish blocks 1 and 2 on Day 0 with a decoder suggests this change over time may be meaningful.

      Repeating the experiments with fully interleaved sequences on test days would alleviate this concern. With the existing data, the authors should compare responses from the first trials in a block to the last trials in a block.

      This block design likely also accounts for the ability of a decoder to readily distinguish stimulus A in ABCD from A in ABBD. As all ABCD sequences were run in a contiguous block separate from ABBD, the recent history of experience is different for A stimuli in ABCD versus ABBD. Running fully interleaved sequences would also address this point, and would also potentially mitigate the impact of drift over blocks (discussed below).

      As described in other responses, the block structure was chosen to align more closely with previous studies. We take the overall point though, and future studies will employ the suggested randomized or interleaved structure in addition to block structures to investigate the effects of short-term plasticity.

      (2) The computation of prediction error differs significantly for omission as opposed to substitutions, in meaningful ways the authors do not address. For omission errors, PE compares the responses of B1 and B2 within ABBD blocks. These responses are measured from the same trial, within tens of milliseconds of each other. In contrast, substitution PE is computed by comparing C in ABCD to C in ACBD. As noted above, the block structure means that these C responses were recorded in different blocks, when the state of the brain could be different. This may account for the authors' detection of prediction error for omission but not substitution. To address this, the authors should calculate PE for omission using B responses from ABCD.

      We performed the suggested analysis (i.e., ABBD vs ABCD) prior to submission but omitted it from the draft for brevity (the effect was the same as with ABBD vs ABBD). We have added the results of standardizing with ABCD as supplementary figure 3.

      (3) The behavior of responses to B and C within the trained sequence ABCD differs considerably, yet is not addressed. Responses to B in ABCD potentiate from d0-> d5, yet responses to C in the same sequence go down. This suggests there may be some difference in either the representation of B vs C or position 2 vs 3 in the sequence that may also be contributing to the appearance of prediction errors in ABBD but not ACBD. The authors do not appear to consider this point, which could potentially impact their results. Presenting different stimuli for A,B,C,D across mice would help (in the current paper B is 75 deg and C is 165 deg in all cases). Additionally, other omissions or substitutions at different sequence positions should be tested (eg ABCC or ABDC).

      We appreciate the suggestion. Ideally, we could test many different variants, but practical concerns regarding the duration of the imaging sessions prevented us from testing other interesting variations (such as ABCC) in the current study. We are uncertain as to how we should interpret the overall depressed response to element C seen on day 5, but since the effect is shared in both ABCD and ACBD, we don’t think it affected our PE calculations. 

      (4) The authors' interpretation of their PCA results is flawed. The authors write "Experience simplifies activity in principal component space". This is untrue based on their data. The variance explained by the first set of PCs does not change with training, indicating that the data is not residing in a lower dimensional ("simpler") space. Instead, the authors show that the first 5 PCs better align with their a priori expectations of the stimulus structure, but that does not mean these PCs necessarily represent more information about the stimulus (and the fact that the authors fail to see an improvement in decoding performance argues against this case). Addressing such a question would be highly interesting, but is lacking in the current manuscript. Without such analysis, referring to the PCs after training as "highly discretized" and "untangled" are largely meaningless descriptions that lack analytical support.

      We meant the terms “simpler”, “highly-discretized”, and “untangled” as qualitative descriptions of changes in covariance structure that occurred despite the maintenance of overall dimensionality. As the reviewer notes, the obvious changes in PC space appear to have had practically no effect on decodability or dimensionality, and we found this surprising and worth describing.

      (5) The authors report that activity sparsifies, yet provide only the fraction of stimulus-selective cells. Given that cell detection was automated in a manner that takes into account neural activity (using Suite2p), it is difficult to interpret these results as presented. If the authors wish to claim sparsification, they need to provide evidence that the total number of ROIs drawn on each day (the denominator for sparseness in their calculation) is unbiased. Including more (or less) ROIs can dramatically change the calculated sparseness.

      The authors mention sparsification as contributing to coding efficiency but do not test this. Training a decoder on variously sized subsets of their data on days 0 and 5 would test whether redundant information is being eliminated in the network over training.

      First, we provide evidence for sparseness using a visual responsiveness metric in addition to stimulus-selectivity. Second, it is true that Suite2p’s segmentation is informed by activity and therefore may possibly omit cells with very minimal activity. However, we detected a comparable number of cells on day 5 (n=1500) to day 0 (1368). We reportedly roughly half as many cells are stimulus-selective on day 5 compared with day 0. In order for that to have been a result of biased ROI segmentation, we would have needed to have detected closer to 2600 cells on day 5 rather than 1500.  Therefore, we consider any bias in the segmentation to have had little effect on the main findings.

      (6) The authors claim their results show representational drift, but this isn't supported in the data. Rather they show that there is some information in the structure of activity that allows a decoder to learn block ID. But this does not show whether the actual stimulus representations change, and could instead reflect an unrelated artifact that changes over time (responsivity, alertness, bleaching, etc). To actually assess representational drift, the authors should directly compare representations across blocks (one could train a decoder on block 1 and test on blocks 2-5). In the absence of this or other tests of representational drift over blocks, the authors should remove the statement that "These findings suggest that there is a measurable amount of representational drift".

      “To actually assess representational drift, the authors should directly compare representations across blocks (one could train a decoder on block 1 and test on blocks 25)”: This is the exact analysis that was performed. Additionally, our analysis of pairwise correlations directly measures representational drift.

      “But this does not show whether the actual stimulus representations change, and could instead reflect an unrelated artifact that changes over time (responsivity, alertness, bleaching, etc)”: We have repeated the decoder analysis using normalized population vectors (Supplementary Figure 5) which we believe directly addresses whether the observed drift is due to photobleaching or alertness that would affect the overall magnitudes of response vectors.

      Our analysis of block decoding reflects decoders trained on individual stimulus elements, and we show the average over all such decodings (we have clarified this in the text). For example, we trained a decoder on ABCD presentations from block 1 and tested only against ABCD from other blocks, which I believe is the test being suggested by the reviewer. Furthermore, we do show that representational similarity for all stimulus elements reduces gradually and more-or-less monotonically as the time between presentations increases. We believe this is a fairly straightforward test of representational drift as has been reported and used elsewhere (Deitch et al., 2021).

      (7) The authors allude to "temporal echoes" in a subheading. This term is never defined, or substantiated with analysis, and should be removed.

      We hoped the term ‘temporal echo’ would be understood in the context of rebounding activity during gray periods as supported by analysis in figure 6a. We have eliminated the wording in the updated manuscript.

    1. Author response:

      The following is the authors’ response to the previous reviews.

      Public Reviews:

      Reviewer #2 (Public review):

      Summary:

      In this manuscript, the authors provide a method aiming to accurately reflect the individual deviation of longitudinal/temporal change compared to the normal temporal change characterized based on pre-trained population normative model (i.e., a Bayesian linear regression normative model), which was built based on cross-sectional data. This manuscript aims at solving a recently identified problem of using normative models based on cross-sectional data to make inferences about longitudinal change.

      Strengths:

      The efforts of this work make a good contribution to addressing an important question of normative modeling. With the greater availability of cross-sectional studies for normative modeling than longitudinal studies, and the inappropriateness of making inferences about longitudinal subject-specific changes using these cross-sectional data-based normative models, it's meaningful to try to address this gap from the aspect of methodological development.

      In the 1st revision, the authors added a simulation study to show how the performance of the classification based on z-diff scores relatively changes with different disruptions (and autocorrelation). Unfortunately, in my view this is insufficient as it only shows how the performance of using z-diff score relatively changes in different scenarios. I would suggest adding the comparison of performance to using the naïve difference in two simple z-scores to first show its better performance, which should also further highlight the inappropriate use of simple z-scores in inferring within-subject longitudinal changes.

      Thank you for the suggestion for additional comparison, which we have now implemented in the simulated methods comparison, see Figure 2 and the extended text of Section 2.1.4 Simulation study.

      Specifically, we have revised the simulation section to not only illustrate the performance of our z-diff method under various scenarios but also to include a direct comparison with a naïve approach that subtracts two z-scores.

      The updated results demonstrate that, compared to the naïve method, the z-diff score consistently maintains a fixed false-positive rate, making it a more robust and controllable approach. Additionally, we show that under conditions of high autocorrelation, the z-diff method is significantly more sensitive in detecting smaller changes than the subtraction method. Importantly, our analysis of a sample from our dataset indicates that high autocorrelation is a prevalent characteristic in real-world data, further supporting the utility of the z-diff method.

      We believe that these findings strengthen the case for adopting the z-diff method and underscore the limitations of more intuitive approaches, which, while simple, lack mathematical rigour.

      Additionally, Figure 1 is hard to read and obtain the actual values of the performance measure. I would suggest reducing it to several 2-dimensional figures. For example, for several fixed values of rho, how the performance changes with different values of the true disruption (and also adding the comparison to the naïve method (difference in two z-scores)).

      We believe that the Reviewer meant Figure 2; indeed, the 3-dimensional visualization, while attractive to some, may have been difficult to read, so we have now replaced it with several 2-dimensional figures as requested.

      I would also suggest changing the title to reflect that the evaluation of "intra-subject" longitudinal change is the method's focus.

      Thanks for the suggestion. We have now implemented it by changing the title to Using normative models pre-trained on cross-sectional data to evaluate intra-individual longitudinal changes in neuroimaging data.

      We hope the changes implemented fulfill the expectations of the Reviewer.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public Review):

      Summary:

      This work aims to understand the role of thalamus POm in dorsal lateral striatum (DLS) projection in learning a sensorimotor associative task. The authors first confirm that POm forms "en passant" synapses with some of the DLS neuronal subtypes. They then perform a go/no-go associative task that consists of the mouse learning to discriminate between two different textures and to associate one of them with an action. During this task, they either record the activity of the POm to DLS axons using endoscopy or silence their activity. They report that POm axons in the DLS are activated around the sensory stimulus but that the activity is not modulated by the reward. Last, they showed that silencing the POm axons at the level of DLS slows down learning the task.

      The authors show convincing evidence of projections from POm to DLS and that POm inputs to DLS code for whisking whatever the outcome of the task is. However, their results do not allow us to conclude if more neurons are recruited during the learning process or if the already activated fibres get activated more strongly. Last, because POm fibres in the DLS are also projecting to S1, silencing the POm fibres in the DLS could have affected inputs in S1 as well and therefore, the slowdown in acquiring the task is not necessarily specific to the POm to DLS pathway.

      We thank the reviewer for these constructive comments. The points are addressed below.  

      Strengths:

      One of the main strengths of the paper is to go from slice electrophysiology to behaviour to get an in-depth characterization of one pathway. The authors did a comprehensive description of the POm projections to the DLS using transgenic mice to unambiguously identify the DLS neuronal population. They also used a carefully designed sensorimotor association task, and they exploited the results in depth.

      It is a very nice effort to have measured the activity of the axons in the DLS not only after the mice have learned the task but throughout the learning process. It shows the progressive increase of activity of POm axons in the DLS, which could imply that there is a progressive strengthening of the pathway. The results show convincingly that POm axons in the DLS are not activated by the outcome of the task but by the whisker activity, and that this activity on average increases with learning.

      Weaknesses:

      One of the main targets of the striatum from thalamic input are the cholinergic neurons that weren't investigated here, is there information that could be provided?

      This is true of the parafascicular (Pf) thalamic nucleus, which has been well studied in this context. However, there is much less known about the striatal projections of other thalamic nuclei, including POm, and their inputs to cholinergic neurons. Anatomical tracing evidence from Klug et al. (2018), which mapped brain-wide inputs to striatal cholinergic (ChAT) interneurons, suggests that Pf provides the majority of thalamic innervation of striatal ChAT neurons compared to other thalamic nuclei. Many other thalamic nuclei, including POm, showed very little of no labeling, suggesting weak innervation of ChAT interneurons. However, it is possible that these thalamic nuclei, including POm, do provide functional innervation of ChAT interneurons that is not sufficiently assessed by anatomical tracing. Understanding the innervation patterns of POm-striatal projections beyond the three cell types we have studied here would be an important area of further study.

      It is interesting to know that the POm projects to all neuronal types in the DLS, but this information is not used further down the manuscript so the only take-home message of Figure 1 is that the axons that they image or silence in the DLS are indeed connected to DLS neurons and not just passing fibres. In this line, are these axons the same as the ones projecting to S1? If this is the case, why would we expect a different behaviour of the axon activity at the DLS level compared to S1?

      Tracing of single POm axons by Ohno et al. (2012) indicated that POm axons form a branched collateral that innervates striatum, while the main axon continues in the rostral-dorsal direction to innervate cortex. We think it is reasonable, based on the morphology, that our optogenetic suppression experiment restricted the suppression of glutamate release to this branch and avoided the other branches of the axon that project to cortex. However, testing this would require monitoring S1 activity during the POm-striatal axon suppression, which we did not do in this study.

      It is a very interesting question whether there could be different axon activity behavior in striatum versus S1. There is surprising evidence that POm synaptic terminals are different sizes in S1 and M1 and show different synaptic physiological properties depending on these cortical projection targets (Casas-Torremocha et al., 2022). Based on this, it is possible that POm-striatal synapses show distinct properties compared to cortex; however, this will need to be tested in future work.

      The authors used endoscopy to measure the POm axons in the DLS activity, which makes it impossible to know if the progressive increase of POm response is due to an increase of activity from each individual neuron or if new neurons are progressively recruited in the process.

      This is a good point. It would be necessary to perform chronic two-photon imaging of POm neurons (or chronic electrophysiological recordings) to determine whether the activity of individual neurons increased versus whether individual neuron activity levels remained similar but new neurons became active with learning. Even under baseline conditions, it is not known in detail what fraction of the population of POm neurons is active during sensory processing or behavior, highlighting how much is still to be discovered in this exciting area of neuroscience.

      The picture presented in Figure 4 of the stimulation site is slightly concerning as there are hardly any fibres in neocortical layer 1 while there seems to be quite a lot of them in layer 4, suggesting that the animal here was injected in the VB. This is especially striking as the implantation and projection sites presented in Figures 1 and 2 are very clean and consistent with POm injection.

      Although this image was selected to demonstrate the position of the POm injection site and optical fiber implant above striatal axons, the reviewer is correct that there appears to be mixed labeling of axons in L4 and L5a. In some cases, there was expression slightly outside the border of POm (see Fig. 1B, right), which might explain the cortical innervation pattern in this figure. While cortically bound VPM axons pass through the striatum, they do not form synaptic terminals until reaching the cortex (Hunnicutt et al., 2016). If, as may be the case, inhibitory opsins suppress release of neurotransmitter at synaptic terminals more effectively than action potential propagation in axons, it may be likely that optogenetic suppression of POm-striatal terminals is more effective than suppression of action potentials in off-target-labelled VPM axons of passage. Ideally, we could compare effects of suppression of POm-striatal synapses with POm-cortical synapses and VPM-cortical synapses, but this was outside the bandwidth of the present study.

      Reviewer #2 (Public Review):

      Summary:

      Yonk and colleagues show that the posterior medial thalamus (POm), which is interconnected with sensory and motor systems, projects directly to major categories of neurons in the striatum, including direct and indirect pathway MSNs, and PV interneurons. Activity in POm-striatal neurons during a sensory-based learning task indicates a relationship between reward expectation and arousal. Inhibition of these neurons slows reaction to stimuli and overall learning. This circuit is positioned to feed salient event activation to the striatum to set the stage for effective learning and action selection.

      Strengths:

      The results are well presented and offer interesting insight into an understudied thalamostriatal circuit. In general, this work is important as part of a general need for an increased understanding of thalamostriatal circuits in complex learning and action selection processes, which have generally received less attention than corticostriatal systems.

      Weaknesses:

      There could be a stronger connection between the connectivity part of the data - showing that POm neurons context D1, D2, and PV neurons in the striatum but with some different properties - and the functional side of the project. One wonders whether the POm neurons projecting to these subtypes or striatal neurons have unique signaling properties related to learning, or if there is a uniform, bulk signal sent to the striatum. This is not a weakness per se, as it's reasonable for these questions to be answered in future papers.

      We are very interested to understand the potentially distinct learning-related synaptic and circuit changes that potentially occur at the POm synapses with D1- and D2-SPNs and PV interneurons, and other striatal cell types. We agree that this would be an important topic for further investigation.

      All the in vivo activity-related conclusions stem from data from just 5 mice, which is a relatively small sample set. Optogenetic groups are also on the small side.

      We appreciate this point and agree that higher N can be important for observing robust effects. A factor of our experiments that helped reduce the number of animals used was the longitudinal design, with repeated measures in the same subjects. This allowed for the internal control of comparing learning effects in the same subject from naïve to expert stages and therefore increased robustness. Even with relatively small group sizes, results were statistically significant, suggesting that the use of more mice was unnecessary, which we considered consistent with best practice in the use of animals in research. We also note that our group sizes were consistent with other studies in the field.  

      Reviewer #3 (Public Review):

      Yonk and colleagues investigate the role of the thalamostriatal pathway. Specifically, they studied the interaction of the posterior thalamic nucleus (PO) and the dorsolateral striatum in the mouse. First, they characterize connectivity by recording DLS neurons in in-vitro slices and optogenetically activating PO terminals. PO is observed to establish depressing synapses onto D1 and D2 spiny neurons as well as PV neurons. Second, the image PO axons are imaged by fiber photometry in mice trained to discriminate textures. Initially, no trial-locked activity is observed, but as the mice learn PO develops responses timed to the audio cue that marks the start of the trial and precedes touch. PO does appear to encode the tactile stimulus type or outcome. Optogenetic suppression of PO terminals in striatum slow task acquisition. The authors conclude that PO provides a "behaviorally relevant arousal-related signal" and that this signal "primes" striatal circuitry for sensory processing.

      A great strength of this paper is its timeliness. Thalamostriatal processing has received almost no attention in the past, and the field has become very interested in the possible functions of PO. Additionally, the experiments exploit multiple cutting-edge techniques.

      There seem to be some technical/analytical weaknesses. The in vitro experiments appear to have some contamination of nearby thalamic nuclei by the virus delivering the opsin, which could change the interpretation. Some of the statistical analyses of these data also appear inappropriate. The correlative analysis of Pom activity in vivo, licking, and pupil could be more convincingly done.

      The bigger weakness is conceptual - why should striatal circuitry need "priming" by the thalamus in order to process sensory stimuli? Why would such circuitry even be necessary? Why is a sensory signal from the cortex insufficient? Why should the animal more slowly learn the task? How does this fit with existing ideas of striatal plasticity? It is unclear from the experiments that the thalamostriatal pathway exists for priming sensory processing. In fact, the optogenetic suppression of the thalamostriatal pathway seems to speak against that idea.

      We thank the reviewer for these constructive comments. The points are addressed below.

      Recommendations for the authors:

      Reviewer #2 (Recommendations For The Authors):

      Do POm neurons innervate CINs also? The connection between the PF thalamus and CINs is mentioned in a couple of places - one question is how unique are the input patterns for the POm versus adjacent sensorimotor thalamic regions, including the PF? This isn't a weakness per se but knowing the answer to that question would help in forming a more complete picture of how these different thalamostriatal circuits do or do not contribute uniquely to learning and action selection.

      Anatomical tracing evidence from Klug et al. (2018), which mapped brain-wide inputs to striatal cholinergic (ChAT) interneurons, suggests that Pf provides the majority of thalamic innervation of striatal ChAT neurons compared to other thalamic nuclei. Many other thalamic nuclei, including POm, showed very little or no labeling, suggesting weak innervation of ChAT interneurons. However, it is possible that these thalamic nuclei, including POm, do provide functional innervation of ChAT interneurons that is not sufficiently assessed by anatomical tracing.

      Another difference between Pf and other thalamic nuclei (likely including POm) comes from anatomical tracing evidence (Smith et al., 2014; PMID: 24523677) which indicates that Pf inputs form the majority of their synapses onto dendritic shafts of SPNs, while other thalamic nuclei form synapses onto dendritic spines. Understanding the innervation patterns of POm-striatal projections beyond the three cell types we have studied here, including ChAT neurons and subcellular localization, would be an important area of further study.

      It would be useful to know to what extent these POm-striatum neurons are activated generally during movement, versus this discrimination task specifically.

      We agree that distinguishing general movement-related activity from task-specific activity would be very useful. Earlier work (Petty et al., 2021) showed a close relationship between POm neuron activity, spontaneous (task-free) whisker movements, and pupil-indexed arousal in head-restrained mice. Oram et al. (2024; PMID: 39003286) recently recorded VPM and POm in freely moving mice during natural movements, finding that activity of both nuclei correlated with head and whisker movements. These studies indicate that POm is generally coactive with exploratory head and whisker movements.

      During task performance, the situation may change with training and attentional effects. For example, Petty and Bruno (2024) (https://elifesciences.org/reviewed-preprints/97188) showed that POm activity correlates more closely with task demands than tactile or visual stimulus modality. Our data indicate that POm axonal signals are increased at trial start during anticipation of tactile stimulus delivery and through the sensory discrimination period, then decrease to baseline levels during licking and water reward collection (Fig. 3). Results of Petty and Bruno (2024) together with ours suggest that POm is particularly active during the context of behaviorally relevant task performance. Thus, we think it is likely that, while pupil dilation indexes general movement and arousal, POm activity is more specific to movement and arousal associated with task engagement and behavioral performance. We have strengthened this point in the Discussion.

      Many of the data panels and text for legends/axes are quite small, and the stroke on line art is quite faint - overall figures could be improved from a readability standpoint.

      We thank the reviewer for their careful attention to the figures. 

      Reviewer #3 (Recommendations For The Authors):

      Major

      (1) Page 4, the Results regarding PSP and distance from injection site. The r-squared is the wrong thing to look at to test for a relationship. One should look at the p-value on the coefficient corresponding to the slope. The p-value is probably significant given the figures, in which case there may be a relationship contrary to what is stated. All the low r-squared value says is that, if there is a relationship, it does not explain a lot of the PSP variability.

      We thank the reviewer for alerting us this oversight. We have included the p value (p = 0.0293) in the figure and legend, and indicated that the relationship is “small but significant”.

      (2) Figure 1B suggests that the virus injections extend beyond POm and into other thalamic structures. Do any of the results change if the injections contaminating other nuclei are excluded from the analysis? I am not suggesting the authors change the figures/analyses. I am simply suggesting they double-check.

      We selected for injections that were predominantly expressing in POm as determined by post-hoc histological analysis (see Fig. 1, right). As above, we think that axons of passage that do not form striatal synapses are less likely to be suppressed than axons with terminals; however, this would need to be determined in further experiments. Because the preponderance of expression is within POm, we think the results would be similar even with a stricter selection criterion. 

      (3) The authors conclude that POm and licking are not correlated (bottom of page 6 pertaining to Figures 3A-F). The danger of these analyses is that they assume that GCaMP8 is a perfect linear reporter of POm spikes. The reliability of GCaMP8 has been quantified in some cell types, but not thalamic neurons, which have relatively higher firing rates.

      The reviewer is correct that the relationship between GCaMP8 fluorescence changes and spiking has not been sufficiently characterized in thalamic neurons, and that this would be important to do.

      What if the indicator is simply saturated late into the trial (after the average reaction time)? It would look like there is no response and one would conclude no correlation, but there could be a very strong correlation.

      While saturation is worthy of concern, the signal dynamics here argue against this possibility. The reason is that the signal increased in the early part of the trial and decreased by the end. If saturation was an issue, this would have been apparent during the initial increase. When the signal decreased in amplitude at the end of the trial, this indicates that the signal is not saturated because it is returning from a point closer to its maximum (and is becoming less saturated).

      Also, what happens between trials? Are the correlations the same, stronger, weaker? Ideally, the authors would analyze the data during and between trials.

      Between trials the signal did not show further changes in baseline beyond what was displayed at the start and end of behavioral trials. There were no consistent increases or decreases in signals between trials, except perhaps during strong whisking bouts. This is anecdotal because we did not analyze between-trial data. However, it is interesting and important to note that signals increased dramatically in amplitude from naïve, early learning to expert behavioral performance (Fig. 3), highlighting that POm-axonal signals relate to behavioral engagement and performance rather than spontaneous behaviors.  

      (4) Axonal activity could also appear more correlated with the pupil than licking because pupil dynamics are slow like the dynamics of calcium indicators. These kernels could artificially inflate the correlation. Ideally, the authors could consider these temporal effects. Perhaps they could deconvolve the temporal profiles of calcium and pupil before correlating? Or equivalently incorporate the profiles into their analysis?

      We analyzed the lick probability histograms, which had a temporal profile similar to the calcium signals (Fig. 3D,E), ruling out concerns about effects of temporal effects on correlations. It is also worth noting that we observed changes in correlations between calcium signals and pupil with learning stage (Fig. 3I), even though the temporal profiles (signal dynamics) are not changing. Thus, temporal effects of the signals themselves are not the driver of correlations, but rather the changes in relative timing between calcium signals and pupil, as occur with learning.

      (5) The authors conclude that PO provides a "behaviorally relevant arousal-related signal" and that this signal "primes" striatal circuitry for sensory processing. The data here support the first part. It is not clear that the data support the second part, largely because it is vague what "priming" of sensory processing or "a key role in the initial stages of action selection (p.9) even means here. Why would such circuitry even be necessary? Why is a sensory signal from the cortex insufficient? Why should the animal more slowly learn the task? How does this fit with existing ideas of striatal plasticity? Some conceptual proposals from the authors, even if speculative and not offered as a conclusion, would be helpful.

      We appreciate these good points and have added further consideration and revision of the concept of priming and potential roles in an extensively revised Discussion section.

      (6) The photometry shows that PO turns on about 2 seconds before the texture presentation. PO's activity seems locked to the auditory cue, not the texture (Figure 2). This means that the attempt to suppress the thalamostriatal pathway with JAWS (Figure 4) is rather late, isn't it? Some PO signals surely go through. This seems to contradict the idea of priming above. It would be good if the authors could factor this into their narrative. Perhaps labelling the time of the auditory cue in Figure 4C would also be helpful.

      The start of texture presentation (movement of the texture panel toward the mouse) and auditory cue occur at the same time. To clarify this, we added a label “start tone” in Figure 4C and also in Figure 2C.

      For optogenetic (JAWS) suppression, we intentionally chose a time window between start tone onset and texture presentation, because our photometry experiments showed that this was when the preponderance of the signal occurred. However, the reviewer is correct that our chosen optogenetic suppression (JAWS) onset occurs shortly after the photometry signal has already started, potentially leaving the early photometry signal un-suppressed. Our motivation for choosing a restricted time window surrounding the texture presentation time was 1) to minimize illumination and potential heating of brain tissue; 2) to target a time window that avoids the auditory cue but covers stimulus presentation. We did not want to extend the duration of the suppression to before the trial started, because this could produce task-non-specific effects, such as distraction or loss of attention before the start of the trial.

      Even if some signal were getting through before suppression, we don’t think this contradicts the possibility of ‘priming’, because the process underlying priming would still be disrupted even if not totally suppressed. This would alter the temporal relationship between POm-striatal inputs and further corticostriatal inputs (from S1 and M1 cortex, for example). We have included further consideration of these points and possible relation to the priming concept in the Discussion.

      Minor

      (1) Page 5, "the sensitivity metric is artificially increased". What do you mean "artificially"? The mice are discriminating better. It is true that either a change in HR or FAR can cause the sensitivity metric to change, but there is nothing artificial or misleading about this.

      We removed the word artificial and clarified our definition of behaviorally Expert in this context:

      “Mice were considered Expert once they had reached ≥ 0.80 Hit Rate and ≤ 0.30 FA Rate for two consecutive sessions in lieu of a strict sensitivity (d’) threshold; we found this definition more intuitive because d’ is enhanced as Hit Rate and FA Rate approach their extremes (0 or 1)”

      (2) Page 7, "Upon segmentation (Figure S4G-J)". Do you mean "segregation by trial outcome"?

      Corrected.

      (3) Page 9, "POm projections may have discrete target-specific functions, such that POm-striatal inputs may play a distinct role in sensorimotor behavior compared to POm-cortical inputs". Would POm-cortical inputs not also be sensorimotor? The somatosensory cortex contains a lot of corticostriatal cells. It also has various direct and indirect links to the motor cortex as well.

      We have clarified the wording here to convey the possibility that POm signals could be received and processed differently by striatal versus cortical circuitry, and have moved this statement to later in the discussion for better elaboration.

      (4) The Methods state that male and female mice were used. Why not say how many of each and whether or not there are any sex-specific differences?

      We added the following information to the Methods:

      The number of male and female mice were as follows, by experiment type: 6 male, 4 female (electrophysiology); 3 male, 2 female (fiber photometry); 4 male, 5 female (optogenetics). Data were not analyzed for sex differences.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public Review):

      Summary:

      In this series of studies, Locantore et al. investigated the role of SST-expressing neurons in the entopeduncular nucleus (EPNSst+) in probabilistic switching tasks, a paradigm that requires continued learning to guide future actions. In prior work, this group had demonstrated EPNSst+ neurons co-release both glutamate and GABA and project to the lateral habenula (LHb), and LHb activity is also necessary for outcome evaluation necessary for performance in probabilistic decision-making tasks. Previous slice physiology works have shown that the balance of glutamate/GABA co-release is plastic, altering the net effect of EPN on downstream brain areas and neural circuit function. The authors used a combination of in vivo calcium monitoring with fiber photometry and computational modeling to demonstrate that EPNSst+ neural activity represents movement, choice direction, and reward outcomes in their behavioral task. However, viral-genetic manipulations to synaptically silence these neurons or selectively eliminate glutamate release had no effect on behavioral performance in well-trained animals. The authors conclude that despite their representation of task variables, EPN Sst+ neuron synaptic output is dispensable for task performance.

      Strengths and Weaknesses:

      Overall, the manuscript is exceptionally scholarly, with a clear articulation of the scientific question and a discussion of the findings and their limitations. The analyses and interpretations are careful and rigorous. This review appreciates the thorough explanation of the behavioral modeling and GLM for deconvolving the photometry signal around behavioral events, and the transparency and thoroughness of the analyses in the supplemental figures. This extra care has the result of increasing the accessibility for non-experts, and bolsters confidence in the results.

      (1) To bolster a reader's understanding of results, we suggest it would be interesting to see the same mouse represented across panels (i.e. Figures 1 F-J, Supplementary Figures 1 F, K, etc i.e via the inclusion of faint hash lines connecting individual data points across variables.

      Thank you for the suggestion. The same mouse is now represented in Fig 1 and Fig 1—Figure Supplement 1 as a darkened circle so it can be followed across different panels. Photometry from this mouse was used as sample date in Figure 2b and Figure 2—figure supplement 1a-b.

      (2) Additionally, Figure 3E demonstrates that eliminating the 'reward' and 'choice and reward' terms from the GLM significantly worsens model performance; to demonstrate the magnitude of this effect, it would be interesting to include a reconstruction of the photometry signal after holding out of both or one of these terms, alongside the 'original' and 'reconstructed' photometry traces in panel D. This would help give context for how the model performance degrades by exclusion of those key terms.

      We have now added analyses and reconstructed photometry signals from GLMs excluding important predictors in Figure 3—figure supplement 1 and 2. We use the model where both “Direction and reward” were omitted as predictors for the GLM and showed photometry reconstructions aligned to behavioral events used for the full model (Figure 3—figure supplement 1) and partial model (Figure 3—figure supplement 2) to compare model performance.  

      (3) Finally, the authors claimed calcium activity increased following ipsilateral movements. However, Figure 3C clearly shows that both SXcontra and SXipsi increase beta coefficients. Instead, the choice direction may be represented in these neurons, given that beta coefficients increase following CXipsi and before SEipsi, presumably when animals make executive decisions. Could the authors clarify their interpretation on this point?

      We observe that calcium activity increases during ipsilateral choices as the animal moves toward the ipsilateral side port (e.g. CX<sub>ipsi</sub> to SE<sub>ipsi</sub>; Fig 2C and Fig 3C). The animal also makes other ipsiversive movements not during the “choice” phase of a trial such as when it is returning to the center port following a contralateral choice (e.g. SX<sub>Contra</sub> to CE; Fig 2—figure supplement 1F and Fig 3C). We also observe an increase in calcium activity during these ipsiversive movements (e.g. SX<sub>Contra</sub> to CE), but they are not as large as those observed during the choice phase (Fig 2—figure supplement 1G). Therefore, during the choice phase of a trial, activity contains signals related to ipsilateral movement and additional factors (e.g. executive decision making).    

      (4) Also, it is not clear if there is a photometry response related to motor parameters (i.e. head direction or locomotion, licking), which could change the interpretation of the reward outcome if it is related to a motor response; could the authors show photometry signal from representative 'high licking' or 'low licking' reward trials, or from spontaneous periods of high vs. low locomotor speeds (if the sessions are recorded) to otherwise clarify this point?

      Unfortunately, neither licks nor locomotion were recorded during the behavioral sessions when photometry was recorded. In Figure 2—figure supplement 1a we now show individual trials sorted by trial duration (time elapsed between CE and SE) to illustrate the dynamics of the photometry signal on fast vs slow trials within a session.  

      (5) There are a few limitations with the design and timing of the synaptic manipulations that would improve the manuscript if discussed or clarified. The authors take care to validate the intersectional genetic strategies: Tetanus Toxin virus (which eliminates synaptic vesicle fusion) or CRISPR editing of Slc17a6, which prevents glutamate loading into synaptic vesicles. The magnitude of effect in the slice physiology results is striking. However, this relies on the co-infection of a second AAV to express channelrhodopsin for the purposes of validation, and it is surely the case that there will not be 100% overlap between the proportion of cells infected.

      For the Tet-tox experiments in Figure 4 we estimate approximately 70±15% of EP<sup>Sst+</sup> neurons expressed Tet-tox based on our histological counts and published stereological counts in EP (Miyamoto and Fukuda, 2015). It is true that channelrhodopsin expression will not overlap 100% with cells infected by the other virus, indeed our in vitro synaptic physiology shows small residual postsynaptic currents following optogenetic stimulation either from incomplete blockade of synaptic release or neurons that expressed channelrhodopsin but not Tettx (Figure 4—figure supplement 1J-K). The same is shown for CRISPR mediated deletion of Slc17a6 (Fig 5 – Fig supplement 1J-K).  

      (6) Alternative means of glutamate packaging (other VGluT isoforms, other transporters, etc) could also compensate for the partial absence of VGluT2, which should be discussed.

      While single cell sequencing (Wallace et al, 2017) has shown EP<sup>Sst+</sup> neurons do not express Slc17a7/8 (vGlut1 or vGlut3) it is possible that these genes could be upregulated following CRISPR mediated deletion of Slc17a6, however we do not see evidence of this with our in vitro synaptic physiology (EPSCs are significant suppressed, Figure 5 – Fig supplement 1J-K) and therefore can conclude it is highly unlikely to occur to a significant degree in our experiments. This is now included in the Discussion.

      (7) The authors do not perform a complimentary experiment to delete GABA release (i.e. via VGAT editing), which is understandable, given the absence of an effect with the pan-synaptic manipulation. A more significant concern is the timing of these manipulations as the authors acknowledge. The manipulations are all done in well-trained animals, who continue to perform during the length of viral expression. Moreover, after carefully showing that mice use different strategies on the 70/30 version vs the 90/10 version of the task, only performance on the 90/10 version is assessed after the manipulation. Together, the observation that EPNsst activity does not alter performance on a well-learned, 90/10 switching task decreases the impact of the findings, as this population may play a larger role during task acquisition or under more dynamic task conditions. Additional experiments could be done to strengthen the current evidence, although the limitation is transparently discussed by the authors.

      As mentioned above, it is possible that a requirement for EP<sup>Sst+</sup> neurons could be revealed if the experiment was conducted with different parameters (either different reward probabilities, fluctuating reward probabilities within a session, or withholding additional training during viral expression). It is difficult to predict which version of the task, if any, would be most likely to reveal a requirement for EP<sup>Sst+</sup> neurons based on our results. We favor testing for EP<sup>Sst+</sup> function using a new behavioral paradigm that allows us to carefully examine task learning following EP manipulations in an independent study.

      (8) Finally, intersectional strategies target LHb-projecting neurons, although in the original characterization, it is not entirely clear that the LHb is the only projection target of EPNsst neurons. A projection map would help clarify this point.

      In a previous study we confirmed that EP<sup>Sst+</sup> neurons project exclusively to the LHb using cell-type specific rabies infection and examining all reported downstream regions for axon collaterals (Wallace et al 2017, Suppl. Fig 6F-G). When EP<sup>Sst+</sup> neurons were labeled we did not observe axon collaterals in known targets of EP such as ventro-antero lateral thalamus, red nucleus, parafasicular nucleus of the thalamus, or the pedunculopontine tegmental nucleus, only in the LHb. Additionally, using single cell tracing techniques, others have shown EP neurons that exclusively project to the LHb (Parent et al, 2001).

      Overall, the authors used a pertinent experimental paradigm and common cell-specific approaches to address a major gap in the field, which is the functional role of glutamate/GABA co-release from the major basal ganglia output nucleus in action selection and evaluation. The study is carefully conducted, their analyses are thorough, and the data are often convincing and thought-provoking. However, the limitations of their synaptic manipulations with respect to the behavioral assays reduce generalizability and to some extent the impact of their findings.

      Reviewer #2 (Public Review):

      Summary:

      This paper aimed to determine the role EP sst+ neurons play in a probabilistic switching task.

      Strengths:

      The in vivo recording of the EP sst+ neuron activity in the task is one of the strongest parts of this paper. Previous work had recorded from the EP-LHb population in rodents and primates in head-fixed configurations, the recordings of this population in a freely moving context is a valuable addition to these studies and has highlighted more clearly that these neurons respond both at the time of choice and outcome.

      The use of a refined intersectional technique to record specifically the EP sst+ neurons is also an important strength of the paper. This is because previous work has shown that there are two genetically different types of glutamatergic EP neurons that project to the LHb. Previous work had not distinguished between these types in their recordings so the current results showing that the bidirectional value signaling is present in the EP sst+ population is valuable.

      Weaknesses:

      (1) One of the main weaknesses of the paper is to do with how the effect of the EP sst+ neurons on the behavior was assessed.

      (a) All the manipulations (blocking synaptic release and blocking glutamatergic transmission) are chronic and more importantly the mice are given weeks of training after the manipulation before the behavioral effect is assessed. This means that as the authors point out in their discussion the mice will have time to adjust to the behavioral manipulation and compensate for the manipulations. The results do show that mice can adapt to these chronic manipulations and that the EP sst+ are not required to perform the task. What is unclear is whether the mice have compensated for the loss of EP sst+ neurons and whether they play a role in the task under normal conditions. Acute manipulations or chronic manipulations without additional training would be needed to assess this.

      Unfortunately, when mice are given a three week break from behavioral training (the time required to allow for adequate viral expression) behavioral performance on the task (p(highport), p(switch), trial number, trial time, etc.) is significantly degraded. Animals do eventually recover to previous performance levels, but this takes place during a 4-5 day “relearning” period. Here we sought to examine if EP<sup>Sst+</sup> neurons are required for continued task performance and chose to continue to train the animals following viral injection to avoid the “relearning” period that occurs following an extended break from behavioral training which may have made it difficult to interpret changes in behavioral performance due to the viral manipulation vs relearning.  

      Acute manipulations were not used because we planned to compare complete synaptic ablation (Tettx) and single neurotransmitter ablation (CRISPR Slc17a6) over similar time courses and we know of no acute manipulation that could achieve single neurotransmitter ablation. 

      (b) Another weakness is that the effect of the manipulations was assessed in the 90/10 contingency version of the task. Under these contingencies, mice integrate past outcomes over fewer trials to determine their choice and animals act closer to a simple win-stay-lose switch strategy. Due to this, it is unclear if the EP sst+ neurons would play a role in the task when they must integrate over a larger number of conditions in the less deterministic 70/30 version of the task.

      It is possible that a requirement for EP<sup>Sst+</sup> neurons could be revealed if the experiment was conducted with different parameters (either different reward probabilities, fluctuating reward probabilities within a session, or withholding additional training during viral expression). It is difficult to predict which version of the task, if any, would be most likely to reveal a requirement for EP<sup>Sst+</sup> neurons based on our results. We favor testing for EP<sup>Sst+</sup> function using a new behavioral paradigm that allows us to carefully examine task learning following EP manipulations in an independent study.

      The authors show an intriguing result that the EP sst+ neurons are excited when mice make an ipsilateral movement in the task either toward or away from the center port. This is referred to as a choice response, but it could be a movement response or related to the predicted value of a specific action. Recordings while mice perform movement outside the task or well-controlled value manipulations within the session would be needed to really refine what these responses are related to.

      If activity of EP<sup>Sst+</sup> neurons included a predicted value component, we would expect to see a change in activity during ipsilateral movements when the previous trial was rewarded vs unrewarded. This is examined in Fig 2—figure suppl. 2C, where we compare EP<sup>Sst+</sup> responses during ipsilateral trials when the previous trials were either rewarded (blue) or unrewarded (gray). We show that EP<sup>Sst+</sup> activity prior to side port entry (SE) is identical in these two trial types indicating that EP<sup>Sst+</sup> neurons do not show evidence of predicted value of an action in this context. Therefore, we conclude that increased EP<sup>Sst+</sup> activity during ipsilateral trials is primarily related to ipsilateral movement following CX (we call this the “choice” phase of the trial). We also show that other ipsiversive movements outside of the “choice” phase of a trial (such as the return to center port following a contralateral trial) show a smaller but significant increase in activity (Figure 2—figure supplement 1F-G). Therefore, whereas the activity observed during ipsilateral choice contains signals related to ipsilateral movement and additional factors, our data suggest that predicted value is not one of those factors. We will clarify this point and our definition of “choice” in the narrative.  

      (2) The authors conclude that they do not see any evidence for bidirectional prediction errors. It is not possible to conclude this. First, they see a large response in the EP sst+ neurons to the omission of an expected reward. This is what would be expected of a negative reward prediction error. There are much more specific well-controlled tests for this that are commonplace in head-fixed and freely moving paradigms that could be tested to probe this. The authors do look at the effect of previous trials on the response and do not see strong consistent results, but this is not a strong formal test of what would be expected of a prediction error, either a positive or negative. The other way they assess this is by looking at the size of the responses in different recording sessions with different reward contingencies. They claim that the size of the reward expectation and prediction error should scale with the different reward probabilities. If all the reward probabilities were present in the same session this should be true as lots of others have shown for RPE. Because however this data was taken from different sessions it is not expected that the responses should scale, this is because reward prediction errors have been shown to adaptively scale to cover the range of values on offer (Tobler et al., Science 2005). A better test of positive prediction error would be to give a larger-than-expected reward on a subset of trials. Either way, there is already evidence that responses reflect a negative prediction error in their data and more specific tests would be needed to formally rule in or out prediction error coding especially as previous recordings have shown it is present in previous primate and rodent recordings.

      We do not conclude that we see no evidence for RPE and the reviewer is correct in stating that a large increase in EP<sup>Sst+</sup> activity following omission of an expected reward would be expected of a negative reward prediction error. However, this observation alone is not strong enough evidence that EP<sup>Sst+</sup> neurons signal RPE. When we looked for additional evidence of RPE within our experiments we did not find consistent demonstrations of its existence in our data. When performing photometry measurements of dopamine release in the striatum, RPE signals are readily observed with a task identical to ours using trial history to as a modifier of reward prediction (Chantranupong, et al 2023). Of course, there could be a weaker more heterogeneous RPE signal in EP<sup>Sst+</sup> neurons that we cannot detect with our methods. As we state in the discussion, RPE signals may be present in a subset of individual neurons (as observed in Stephenson-Jones et al, 2016 and Hong and Hikosaka, 2008) which are below our detection threshold using fiber photometry. Additionally, Hong and Hikosaka, 2008 show that LHb-projecting GPi neurons show both positive and negative reward modulations which may obscure observation of RPE signals with photometry recordings that arise from population activity of genetically defined neurons.   

      (3) There are a lot of variables in the GLM that occur extremely close in time such as the entry and exit of a port. If two variables occur closely in time and are always correlated it will be difficult if not impossible for a regression model to assign weights accurately to each event. This is not a large issue, but it is misleading to have regression kernels for port entry and exits unless the authors can show these are separable due to behavioral jitter or a lack of correlation under specific conditions, which does not seem to be the case.

      It is true that two variables that are always correlated are redundant in a GLM. For example, center entry (CE) and center exit (CX) occur in quick succession in most trials and are highly correlated (Figure 1C). For this reason, when only one is removed as a predictor from the model but not the other there is a very small change in the MSE of the fit (Figure 3E, -CE or -CX). However, when both are removed model performance decreases further indicating that center-port nose-pokes do contribute to model performance (Figure 3E, -CE/CX). Due to the presence/absence of reward following side port entry there is substantial behavioral jitter (due to water consumption in rewarded trials) that the SE and SX are not always correlated, therefore the model performs worse when either are omitted alone, but even worse still when both SE/SX are omitted together (Figure 3E, -SE/SX). We will update Figure 3 and the narrative to make this more explicit.

      Reviewer #3 (Public Review):

      Summary:

      The authors find that Sst-EPN neurons, which project to the lateral habenula, encode information about response directionality (left vs right) and outcome (rewarded vs unrewarded). Surprisingly, impairment of vesicular signaling in these neurons onto their LHb targets did not impair probabilistic choice behavior.

      Strengths:

      Strengths of the current work include extremely detailed and thorough analysis of data at all levels, not only of the physiological data but also an uncommonly thorough analysis of behavioral response patterns.

      Weaknesses:

      Overall, I saw very few weaknesses, with only two issues, both of which should be possible to address without new experiments:

      (1) The authors note that the neural response difference between rewarded and unrewarded trials is not an RPE, as it is not affected by reward probability. However, the authors also show the neural difference is partly driven by the rapid motoric withdrawal from the port. Since there is also a response component that remains different apart from this motoric difference (Figure 2, Supplementary Figure 1E), it seems this is what needs to be analyzed with respect to reward probability, to truly determine whether there is no RPE component. Was this done?

      We thank the reviewer for this comment, we believe this is particularly important for unrewarded trials as SE and SX occur in rapid succession. In Figure 2—figure supplement 2A-B we now show the photometry signal from Rewarded and Unrewarded ipsilateral trials aligned to SX for different reward probabilities. We quantify the signals for different reward probabilities during a 500ms window immediately prior to SX but find no differences between groups.  

      (2) The current study reaches very different conclusions than a 2016 study by Stephenson-Jones and colleagues despite using a similar behavioral task to study the same Sst-EPN-LHb circuit. This is potentially very interesting, and the new findings likely shed important light on how this circuit really works. Hence, I would have liked to hear more of the authors' thoughts about possible explanations of the differences. I acknowledge that a full answer might not be possible, but in-depth elaboration would help the reader put the current findings in the context of the earlier work, and give a better sense of what work still needs to be done in the future to fully understand this circuit.

      For example, the authors suggest that the Sst-EPN-LHb circuit might be involved in initial learning, but play less of a role in well-trained animals, thereby explaining the lack of observed behavioral effect. However, it is my understanding that the probabilistic switching task forces animals to continually update learned contingencies, rendering this explanation somewhat less persuasive, at least not without further elaboration (e.g. maybe the authors think it plays a role before the animals learn to switch?).

      Also, as I understand it, the 2016 study used manipulations that likely impaired phasic activity patterns, e.g. precisely timed optogenetic activation/inhibition, and/or deletion of GABA/glutamate receptors. In contrast, the current study's manipulations - blockade of vesicle release using tetanus toxin or deletion of VGlut2, would likely have blocked both phasic and tonic activity patterns. Do the authors think this factor, or any others they are aware of, could be relevant?

      We have added further discussion of the Stephenson-Jones, et al 2016 study as well as the Lazaridis, et al 2019 study which shows no effect of phasic stimulation of EP when specifically manipulating EP<sup>Sst+</sup> (vGat+/vGlut2+) neurons rather than vGlut2+ neurons as in the Stephenson-Jones study.  

      Recommendations for the authors:

      Reviewer #1 (Recommendations For The Authors):

      In some places, there seems to be a mismatch between referenced figures and texts. For example:

      (1) The authors described that 'This increase in activity was seen for all three reward probabilities tested (90/10, 80/20, and 70/30) and occurred while the animal was engaged in ipsiversive movements as similar increases were observed following side exit (SX) on contralateral trials as the animal was moving from the contralateral side port back to the center port (Figure 2-Figure Supplement 1c)', but supplement 1c is not about calcium dynamics around the SX event. I presume they mean Figure 2-Figure Supplement 1d.

      Yes, this will be corrected in the revised manuscript.

      (2) The authors explained that increased EPSst+ neuronal activity following an unrewarded outcome was partially due to the rapid withdrawal of the animal's snout following an unrewarded outcome however, differences in rewarded and unrewarded trials were still distinguishable when signals were aligned to side port exit indicating that these increases in EPSst+ neuronal activity on unrewarded trials were a combination of outcome evaluation (unrewarded) and side port withdrawal occurring in quick succession (SX, Figure 2 - Figure Supplement 1d). I presume that they mean Figure 2 - Figure Supplement 1e.

      Yes, this will be corrected in the revised manuscript.

      Minor suggestions related to specific figure presentation are below:

      Figure 2 and supplement figures:

      (1) Figure 2B: the authors may consider presenting outcome-related signals recorded from all trials, including both ipsilateral and contralateral events, and align signals to SE when reward consumption presumably begins, rather than aligning to CE.

      We have added sample recordings from ipsilateral and contralateral trials and sorted them by trial duration to allow for clearer presentation of activity following CE and SE (Figure 2—figure supplement 1a-b).

      (2) The authors described that 'This increase in activity was seen for all three reward probabilities tested (90/10, 80/20, and 70/30) and occurred while the animal was engaged in ipsiversive movements as similar increases were observed following side exit (SX) on contralateral trials as the animal was moving from the contralateral side port back to the center port (Figure 2-Figure Supplement 1c)', but supplement 1c is not about calcium dynamics around the SX event. I presume they mean Figure 2-Figure Supplement 1d.

      Yes, this will be corrected in the revised manuscript.

      (3) The authors explained that increased EPSst+ neuronal activity following an unrewarded outcome was partially due to the rapid withdrawal of the animal's snout following an unrewarded outcome however, differences in rewarded and unrewarded trials were still distinguishable when signals were aligned to side port exit indicating that these increases in EPSst+ neuronal activity on unrewarded trials were a combination of outcome evaluation (unrewarded) and side port withdrawal occurring in quick succession (SX, Figure 2 -Figure Supplement 1d). I presume that they mean Figure 2 -Figure Supplement 1e.

      Yes, this will be corrected in the revised manuscript.

      Figure 3 and supplement figures:

      (1) Figure 3C-F: it is hard to compare the amplitude of calcium signals between different behaviour events without a uniform y-axis.

      The scale for the y-axis on Figure 3C-D is uniform for all panels. Figure 3E is also uniform for all boxplots. The reviewer may be referring to Figure 2C-F, but the y-axis for all of the photometry data is uniform for all panels and the horizontal line represents zero. The y-axis for the quantification on the right of each panel is scaled to the max/min for each comparison.

      (2) Figure 3E is difficult to follow. The authors explained that the 'SE' variable is generated by collapsing the ipsilateral and contralateral port entries, and hence the variable has no choice of direction information. I assumed that the 'SX', 'CE', and 'CX' variables are generated similarly. It is not clear if this is the case for the 'side', 'centre' and 'choice' variables. The authors explained that 'omitting center port entry/exit together or individually also resulted in decreased GLM performance but to a smaller degree than the omission of choice direction (Figure 3e, "-Center")'. My understanding is that they created the Centre variable by collapsing ipsilateral and contralateral centre port entry/exit together. The Centre variable should have no choice of direction information. How is the Center variable generated differently from omitting centre port entry/exit together? I would ask the authors to explain the model and different variables a bit more thoroughly in the text.

      We apologize for the confusion. All ten variables used to train the full GLM are listed in Fig. 3C. In Figure 3E variable(s) were omitted to test how they contributed to GLM performance (data labeled “None” is the full model with all variables). Omitted variables are now defined as follows: -Rew = Rew+Unrew removed, -Direction = Ipsi/Contra designation removed and collapsed into CE, CX, SE, SX, -Direction & Rew = Ipsi/Contra info removed from all variables + Rew/Unrew removed, -CE/CX = Ipsi/Contra CE and CX removed, -CE = Ipsi/contra CE removed, -CX = Ipsi/contra CX removed, -SE/SX = Ipsi/Contra SE and SX removed, -SE = Ipsi/contra SE removed, -SX = Ipsi/contra SX removed. This clarification has also been added to the Generalized Linear Model section of Materials and Methods.

      Figure 5 and supplement figures:

      There are no representative and summary figures show the specificity and efficiency of oChief-tdTomato or Tetx-GFP expression. Body weight changes following virus injection are not well described.

      A representative image of Tettx GFP expression are shown in Fig. 4A and percent of infected EP<sup>Sst+</sup> neurons is described in the text (70±15.1% (mean±SD), 1070±230 neurons/animal, n=6 mice). Most oChief-tdTom animals were used for post-hoc electrophysiology experiments and careful quantification of viral expression was not possible. However, Slc17a6 deletion was confirmed in these animals (Fig. 5 – Fig supplement 1J-K) to confirm the manipulation was effective in the experimental group. A representative image of oChief-tdTom expression is shown in Fig. 5A.

      We now mention the body weight changes observed following Tettx injection in the narrative.

      Reviewer #2 (Recommendations For The Authors):

      (1) In the RFLR section you state that "this variable decays...", a variable can't decay only the value of a variable can change. Also, it is not mentioned what variable is being discussed. There are lots of variables in the model so this should be made clear.

      We now state, “This variable (β) changes over trials and is updated with new evidence from each new trial’s choice and outcome with an additional bias towards or away from its most recent choice (Figure 1-figure supplement 2A-C).”

      (2) I couldn't find in the results section, or the methods section the details for the Tet tx experiments, were mice trained and tested on 90/10 only? Were they trained while the virus was expressing etc? This should be added.

      In the methods section we state, ”For experiments where we manipulated synaptic release in EP<sup>Sst+</sup> neurons (Figures 4-5) we trained mice (reward probabilities 90/10, no transparent barrier present) to the following criteria for the 5 days prior to virus injection: 1) p(highport) per session was greater than or equal to 0.80 with a variance less than 0.003, 2) p(switch) per session was less than or equal to 0.15 with a variance less than 0.001, 3) the p(left port) was between 0.45-0.55 with a variance less than 0.005, and 4) the animal performed at least 200 trials in a session. The mean and variance for these measurements was calculated across the five session immediately preceding surgery. The criterion were determined by comparing performance profiles in separate animals and chosen based on when animals first showed stable and plateaued behavioral performance. Following surgery, mice were allowed to recover for 3 days and then continued to train for 3 weeks during viral expression. Data collected during the 5 day pre-surgery period was then compared to data collected for 10 sessions following the 3 weeks allotted for viral expression (i.e. days 22-31 post-surgery).”

      Reviewer #3 (Recommendations For The Authors):

      (1) The kernel in Figure 3C shows an activation prior to CE on "contra" trials that is not apparent in Figure 2C which shows no activation prior to CE on either contra or ipsi trials. Given that movement directionality prior to CE is dictated by the choice on the PREVIOUS trial, is the "contra" condition in 3C actually based on the previous trial? If so, this should be clarified.

      On most “contra” trials the animal is making an ipsiversive movement just prior to CE as it returns to the center from the contralateral side-port (as most trials are no “switch” trials). Therefore, an increase in activity is expected and shown most clearly following SX for contralateral trials in Fig 2 –Fig suppl 1F. A significant increase in activity prior to CE on contra trials compared to ipsi trials can also be seen in Fig 2C, its just not as large a change as the increase observed following CE for ipsi. trials. The comparison between activity observed during the two types of ipsiversive movements is now shown directly in Figure 2—figure supplement 1G.

      (2) Paragraph 7 of the discussion uses a phrase "by-in-large", which probably should be "by and large".

      Thank you for the correction.

      Editor's note:

      Should you choose to revise your manuscript, if you have not already done so, please include full statistical reporting including exact p-values wherever possible alongside the summary statistics (test statistic and df) and 95% confidence intervals. These should be reported for all key questions and not only when the p-value is less than 0.05 in the main manuscript.

      Readers would also benefit from coding individual data points by sex and noting N/sex.

      Sex breakdown has been added to figure legends for each experiment, full statistical reporting is now also include in the figure legends.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public Review):

      Summary:

      The manuscript by Bell et. al. describes an analysis of the effects of removing one of two mutually exclusive splice exons at two distinct sites in the Drosophila CaV2 calcium channel Cacophony (Cac). The authors perform imaging and electrophysiology, along with some behavioral analysis of larval locomotion, to determine whether these alternatively spliced variants have the potential to diversify Cac function in presynaptic output at larval neuromuscular junctions. The author provided valuable insights into how alternative splicing at two sites in the calcium channel alters its function.

      Strengths:

      The authors find that both of the second alternatively spliced exons (I-IIA and I-IIB) that are found in the intracellular loop between the 1st and second set of transmembrane domains can support Cac function. However, loss of the I-IIB isoform (predicted to alter potential beta subunit interactions) results in 50% fewer channels at active zones and a decrease in neurotransmitter release and the ability to support presynaptic homeostatic potentiation. Overall, the study provides new insights into Cac diversity at two alternatively spliced sites within the protein, adding to our understanding of how regulation of presynaptic calcium channel function can be regulated by splicing.

      Weaknesses:

      The authors find that one splice isoform (IS4B) in the first S4 voltage sensor is essential for the protein's function in promoting neurotransmitter release, while the other isoform (IS4A) is dispensable. The authors conclude that IS4B is required to localize Cac channels to active zones. However, I find it more likely that IS4B is required for channel stability and leads to the protein being degraded, rather than any effect on active zone localization. More analysis would be required to establish that as the mechanism for the unique requirement for IS4B.

      (1) We thank the reviewer for this important point. In fact, all three reviewers raised the same question, and the reviewing editor pointed out that caution or additional experiments were required to distinguish between IS4 splicing being important for cac channel localization versus channel stability/degradation. We provide multiple sets of experiments as well as text and figure revisions to strengthen our claim that the IS4B exon is required for cacophony channels to enter motoneuron presynaptic boutons and localize to active zones.

      a. If IS4B was indeed required for cac channel stability (and not for localization to active zones) IS4A channels should be instable wherever they are. This is not the case because we have recorded somatodendritic cacophony currents from IS4A expressing adult motoneurons that were devoid of cac channels with the IS4B exon. Therefore, IS4A cac channels are not instable but underlie somatodendritic voltage dependent calcium currents in these motoneurons. These new data are now shown in the revised figure 3C and referred to in the text on page 7, line 42 to page 8 line 9.

      b. Similarly, if IS4B was required for channel stability, it should not be present anywhere in the nervous system. We tested this by immunohistochemistry for GFP tagged IS4A channels in the larval CNS. Although IS4A channels are sparsely expressed, which is consistent with low expression levels seen in the Western blots (Fig. 1E), there are always defined and reproducible patterns of IS4A label in the larval brain lobes as well as in the anterior part of the VNC. This again shows that the absence of IS4A from presynaptic active zones is not caused by channel instability, because the channel is expressed in other parts of the nervous system. These data are shown in the new supplementary figure 1 and referred to in the text on page 15, lines 3 to 8.

      c. As suggested in a similar context by reviewers 1 and 2, we now show enlargements of the presence of IS4B channels in presynaptic active zones as well as enlargements of the absence of IS4A channels in presynaptic active zones in the revised figures 2A-C and 3A. In these images, no IS4A label is detectable in active zones or anywhere else throughout the axon terminals, thus indicating that IS4B is required for expressing cac channels in the axon terminal boutons and localizing it to active zones. Text and figure legends have been adjusted accordingly.

      d. Related to this, reviewer 1 also recommended to quantify the IS4A and ISB4 channel intensity and co-localization with the active zone marker brp (recommendation for authors). After following the reviewers’ suggestion to adjust the background values in IS4A and IS4B immunolabels to identical (revised Figs. 2A-C), it becomes obvious that IS4A channel are not detectable above background in presynaptic terminals or active zones, thus intensity is close to zero. We still calculated the Pearsons co-localization coefficient for both IS4 variants with the active zone marker brp. For IS4B channels the Pearson’s correlation coefficient is control like, just above 0.6, whereas for IS4A channels we do not find colocalization with brp (Pearson’s below 0.25). These new analyses are now shown in the revised figure 2D and referred to on page 6, lines 33 to 38.

      e. Consistent with our finding that IS4B is required for cac channel localization to presynaptic active zones, upon removal of IS4B we find no evoked synaptic transmission (Fig. 2 in initial submission, now Fig. 3B).

      Together these data are in line with a unique requirement of IS4B at presynaptic active zones (not excluding additional functions of IS4B), whereas IS4A containing cac isoforms are not found in presynaptic active zones and mediate different functions.

      Reviewer #2 (Public Review):

      This study by Bell et al. focuses on understanding the roles of two alternatively spliced exons in the single Drosophila Cav2 gene cac. The authors generate a series of cac alleles in which one or the other mutually exclusive exons are deleted to determine the functional consequences at the neuromuscular junction. They find alternative splicing at one exon encoding part of the voltage sensor impacts the activation voltage as well as localization to the active zone. In contrast, splicing at the second exon pair does not impact Cav2 channel localization, but it appears to determine the abundance of the channel at active zones.

      Together, the authors propose that alternative splicing at the Cac locus enables diversity in Cav2 function generated through isoform diversity generated at the single Cav2 alpha subunit gene encoded in Drosophila.

      Overall this is an excellent, rigorously validated study that defines unanticipated functions for alternative splicing in Cav2 channels. The authors have generated an important toolkit of mutually exclusive Cac splice isoforms that will be of broad utility for the field, and show convincing evidence for distinct consequences of alternative splicing of this single Cav2 channel at synapses. Importantly, the authors use electrophysiology and quantitative live sptPALM imaging to determine the impacts of Cac alternative splicing on synaptic function. There are some outstanding questions regarding the mechanisms underlying the changes in Cac localization and function, and some additional suggestions are listed below for the authors to consider in strengthening this study. Nonetheless, this is a compelling investigation of alternative splicing in Cav2 channels that should be of interest to many researchers.

      (2) We believe that the additional data on cac IS4A isoform localization and function as detailed above (response to public review 1) has strengthened the manuscript and answered some of the remaining questions the reviewer refers to. We are also grateful for the specific additional reviewer suggestions which we have addressed point-by-point and refer to below (section recommendations for authors).

      Reviewer #3 (Public Review):

      Summary:

      Bell and colleagues studied how different splice isoforms of voltage-gated CaV2 calcium channels affect channel expression, localization, function, synaptic transmission, and locomotor behavior at the larval Drosophila neuromuscular junction. They reveal that one mutually exclusive exon located in the fourth transmembrane domain encoding the voltage sensor is essential for calcium channel expression, function, active zone localization, and synaptic transmission. Furthermore, a second mutually exclusive exon residing in an intracellular loop containing the binding sites for Caβ and G-protein βγ subunits promotes the expression and synaptic localization of around ~50% of CaV2 channels, thereby contributing to ~50% of synaptic transmission. This isoform enhances release probability, as evident from increased short-term depression, is vital for homeostatic potentiation of neurotransmitter release induced by glutamate receptor impairment, and promotes locomotion. The roles of the two other tested isoforms remain less clear.

      Strengths:

      The study is based on solid data that was obtained with a diverse set of approaches. Moreover, it generated valuable transgenic flies that will facilitate future research on the role of calcium channel splice isoforms in neural function.

      Weaknesses:

      (1) Based on the data shown in Figures 2A-C, and 2H, it is difficult to judge the localization of the cac isoforms. Could they analyze cac localization with regard to Brp localization (similar to Figure 3; the term "co-localization" should be avoided for confocal data), as well as cac and Brp fluorescence intensity in the different genotypes for the experiments shown in Figure 2 and 3 (Brp intensity appears lower in the dI-IIA example shown in Figure 3G)? Furthermore, heterozygous dIS4B imaging data (Figure 2C) should be quantified and compared to heterozygous cacsfGFP/+.

      According to the reviewer’s suggestion, we have quantified cac localization relative to brp localization by computing the Pearson’s correlation coefficient for controls and IS4A as well as IS4B animals. These new data are shown in the revised Fig. 2D and referred to on page 6, lines 33-38. Furthermore, we now confirm control-like Pearson’s correlation coefficients for all exon out variants except ΔIS4B and show Pearson’s correlation coefficients for all genotypes side-by-side in the revised Fig. 4D (legend has been adjusted accordingly). In addition, in response to the recommendations to authors, we now provide selective enlargements for the co-labeling of Brp and each exon out variant in the revised figures 2-4. We have also adjusted the background in Fig. 2C (ΔIS4B) to match that in Figs. 2A and B (control and ΔIS4A). This allows a fair comparison of cac intensities following excision of IS4B versus excision of IS4A and control (see also Fig 3). Together, this demonstrates the absence of IS4A label in presynaptic active zones much clearer. As suggested, we have also quantified brp puncta intensity on m6/7 across homozygous exon excision mutants and found no differences (this is now stated for IS4A/IS4B in the results text on page 6, lines 37/38 and for I-IIA/I-IIB on page 8, lines 42-44.). We did not quantify the intensity of cacophony puncta upon excision of IS4B because the label revealed no significant difference from background (which can be seen much better in the images now), but the brp intensities remained control-like even upon excision of IS4B.

      (2) They conclude that I-II splicing is not required for cac localization (p. 13). However, cac channel number is reduced in dI-IIB. Could the channels be mis-localized (e.g., in the soma/axon)? What is their definition of localization? Could cac be also mis-localized in dIS4B? Furthermore, the Western Blots indicate a prominent decrease in cac levels in dIS4B/+ and dI-IIB (Figure 1D). How do the decreased protein levels seen in both genotypes fit to a "localization" defect? Could decreased cac expression levels explain the phenotypes alone?

      We have now precisely defined what we mean by cac localization, namely the selective label of cac channels in presynaptic active zones that are defined as brp puncta, but no cac label elsewhere in the presynaptic bouton (page 6, lines 18 to 20). On the level of CLSM microscopy this corresponds to overlapping cac puncta and brp puncta, but no cac label elsewhere in the bouton. Based on the additional analysis and data sets outlined in our response 1 (see above) we conclude that excision of IS4B does not cause channel mislocalization because we find reproducible expression patterns elsewhere in the nervous system as well as somatodendritic cac current in ΔIS4B (for detail see above). Therefore, the isoforms containing the mutually exclusive IS4A exon are expressed and mediate other functions, but cannot substitute IS4B containing isoforms at the presynaptic AZ. In fact, our Western blots are in line with reduced cac expression if all isoforms that mediate evoked release are missing, again indicating that the presynapse specific cac isoforms cannot be replaced by other cac isoforms. This is also in line with the sparse expression of IS4A throughout the CNS as seen in the new supplementary figure 1 (for detail see above).

      (3) Cac-IS4B is required for Cav2 expression, active zone localization, and synaptic transmission. Similarly, loss of cac-I-IIB reduces calcium channel expression and number. Hence, the major phenotype of the tested splice isoforms is the loss of/a reduction in Cav2 channel number. What is the physiological role of these isoforms? Is the idea that channel numbers can be regulated by splicing? Is there any data from other systems relating channel number regulation to splicing (vs. transcription or post-transcriptional regulation)?

      Our data are not consistent with the idea that splicing regulates channel numbers. Rather, splicing can be used to generate channels with specific properties that match the demand at the site of expression. For the IS4 exon pair we find differences in activation voltage between IS4A and IS4B channels (revised Fig. 3C), with IS4B being required for sustained HVA current. IS4A does not localize to presynaptic active zones at the NMJ and is only sparsely expressed elsewhere in the NS (new supplementary Fig. 1). By contrast, IS4B is abundantly expressed in many neuropils. Therefore, taking out IS4B takes out the more abundant IS4 isoform. This is consistent with different expression levels for IS4 isoforms that have different functions, but we do not find evidence for splicing regulating expression levels per se.

      Similarly, the I-II mutually exclusive exon pair differs markedly in the presence or absence of G-protein βγ binding sites that play a role in acute channel regulation as well the conservation of the sequence for β-subunit binding (see page 5, lines 9-17). Channel number reduction in active zones occurs specifically if expression of the cac channels with the G<sub>βγ</sub>-binding site as well as the more conserved β-subunit binding is prohibited by excision of the I-IIB exon (see Fig. 5F). Vice versa, excision of I-IIA does not result in reduced channel numbers. This scenario is consistent with the hypothesis that conserved β-subunit binding affects channel number in the active zone (see page 17, lines 3 to 6 and lines 33-36), but we have no evidence that I-II splicing per se affects channel number.

      (4) Although not supported by statistics, and as appreciated by the authors (p. 14), there is a slight increase in PSC amplitude in dIS4A mutants (Figure 2). Similarly, PSC amplitudes appear slightly larger (Figure 3J), and cac fluorescence intensity is slightly higher (Figure 3H) in dI-IIA mutants. Furthermore, cac intensity and PSC amplitude distributions appear larger in dI-IIA mutants (Figures 3H, J), suggesting a correlation between cac levels and release. Can they exclude that IS4A and/or I-IIA negatively regulate release? I suggest increasing the sample size for Canton S to assess whether dIS4A mutant PSCs differ from controls (Figure 2E). Experiments at lower extracellular calcium may help reveal potential increases in PSC amplitude in the two genotypes (but are not required). A potential increase in PSC amplitude in either isoform would be very interesting because it would suggest that cac splicing could negatively regulate release.

      There are several possibilities to explain this, but as none of the effects is statistically significant, we prefer to not investigate this in further depth. However, given that we cannot find IS4A in presynaptic active zones (revised figures 2C and 3A plus the new enlargements 2Ci and 3Ai, revised text page 6, lines 22 to 24 and 29 to 31, and page 7, second paragraph, same as public response 1D) IS4A channels cannot have a direct negative effect on release probability. Nonetheless, given that IS4A containing cac isoforms mediate functions in other neuronal compartments (see revised Fig. 3C) it may regulate release indirectly by affecting e.g. action potential shape. Moreover, in response to the more detailed suggestions to authors we provide new data that give additional insight.

      (5) They provide compelling evidence that IS4A is required for the amplitude of somatic sustained HVA calcium currents. However, the evidence for effects on biophysical properties and activation voltage (p. 13) is less convincing. Is the phenotype confined to the sustained phase, or are other aspects of the current also affected (Figure 2J)? Could they also show the quantification of further parameters, such as CaV2 peak current density, charge density, as well as inactivation kinetics for the two genotypes? I also suggest plotting peaknormalized HVA current density and conductance (G/Gmax) as a function of Vm. Could a decrease in current density due to decreased channel expression be the only phenotype? How would changes in the sustained phase translate into altered synaptic transmission in response to AP stimulation?

      Most importantly, sustained HVA current is abolished upon excision of IS4B (not IS4A, we think the reviewer accidentally mixed up the genotype) and presynaptic active zones at the NMJ contain only cac isoforms with the IS4B exon. This indicates that the cac isoforms that mediate evoked release encode HVA channels. The somatodendritic currents shown in the revised figure 3C (previously 2J) that remain upon excision of IS4B are mediated by IS4A containing cac isoforms. Please note that these never localize to the presynaptic active zone, and thus do not contribute to evoked release. Therefore, the interpretation is that specifically sustained HVA current encoded by IS4B cac isoforms is required for synaptic transmission. Reduced cac current density due to decreased channel expression is not the cause for impaired evoked release upon IS4B excision, but instead, the cause is the absence of any cac channels in active zones. IS4B-containing cac isoforms encode sustained HVA current, and we speculate that this might be a well suited current to minimize cacophony channel inactivation in the presynaptic active zone. Given that HVA current shows fast voltage dependent activation and fast inactivation upon repolarization, it is useful at large intraburst firing frequencies as observed during crawling (Kadas et al., 2017) without excessive cac inactivation (see page 15, Kadas, lines 16 to 20).

      However, we agree with the reviewer that a deeper electrophysiological analysis of splice isoform specific cac currents will be instructive. We have now added traces of control and ΔIS4B from a holding potential of -90 mv (revised Fig. 3C, bottom traces and revised text on page 7, line 43 to page 8, lines 1 to 10), and these are also consistent with IS4B mediating sustained HVA cac current. However, further analysis of activation and inactivation voltages and kinetics suffers form space clamp issues in recordings from the somata of such complex neurons (DLM motoneurons of the adult fly contain roughly 6000 µm of dendrites with over 4000 branches, Ryglewski et al., 2017, Neuron 93(3):632-645). Therefore, we will analyze the currents in a heterologous expression system and present these data to the scientific community as a separate study at a later time point.

      (6) Why was the STED data analysis confined to the same optical section, and not to max. intensity z-projections? How many and which optical sections were considered for each active zone? What were the criteria for choosing the optical sections? Was synapse orientation considered for the nearest neighbor Cac - Brp cluster distance analysis? How do the nearest-neighbor distances compare between "planar" and "side-view" Brp puncta?

      Maximum intensity z-projections would be imprecise because they can artificially suggest close proximity of label that is close by in x and y but far away in z. Therefore, the analysis was executed in xy-direction of various planes of entire 3D image stacks. We considered active zones of different orientations (Figs. 5C, D) to account for all planes. In fact, we searched the entire z-stacks until we found active zones of all orientations within the same boutons, as shown in figures 5C1-C6. The same active zone orientations were analyzed for all exon-out mutants with cac localization in active zones. The distance between cac and brp did not change if viewed from the side or any other orientation. We now explain this in more clarity in the results text on page 9, lines 23/24.

      (7) Cac clusters localize to the Brp center (e.g., Liu et al., 2011). They conclude that Cav2 localization within Brp is not affected in the cac variants (p. 8). However, their analysis is not informative regarding a potential offset between the central cac cluster and the Brp "ring". Did they/could they analyze cac localization with regard to Brp ring center localization of planar synapses, as well as Brp-ring dimensions?

      In the top views (planar) we did not find any clear offset in cac orientation to brp between genotypes. In such planar synapses (top views, Fig. 5D, left row) we did not find any difference in Brp ring dimensions. We did not quantify brp ring dimensions rigorously, because this study focusses on cac splice isoform-specific localization and function. Possible effects of different cac isoforms on brp-ring dimensions or other aspects of scaffold structure are not central to our study, in particular given that brp puncta are clearly present even if cac is absent from the synapse (Fig. 3A), indicating that cac is not instructive for the formation of the brp scaffold.

      (8) Given the accelerated PSC decay/ decreased half width in dI-IIA (Fig. 5Q), I recommend reporting PSC charge in Figure 3, and PPR charge in Figures 5A-D. The charge-based PPRs of dI-IIA mutants likely resemble WT more closely than the amplitude-based PPR. In addition, miniature PSC decay kinetics should be reported, as they may contribute to altered decay kinetics. How could faster cac inactivation kinetics in response to single AP stimulation result in a decreased PSC half-width? Is there any evidence for an effect of calcium current inactivation on PSC kinetics? On a similar note, is there any evidence that AP waveform changes accelerate PSC kinetics? PSC decay kinetics are mainly determined by GluR decay kinetics/desensitization. The arguments supporting the role of cac splice isoforms in PSC kinetics outlined in the discussion section are not convincing and should be revised.

      We agree that reporting charge in figure 3 is informative and do so in the revised text. Since the result (no significant difference in the PSCs between between CS, cac<sup>GFP</sup>, <sup>ΔI-IIA</sup>, and transheterozygous I-IIA/I-IIB, but significantly smaller values in ΔI-IIB) remained unchanged no matter whether charge or amplitude were analyzed, we decided to leave the figure as is and report the additional analysis in the text (page 8, lines 40 to 42). This way, both types of analysis are reported. Please note that EPSC amplitude is slightly but not significantly increased upon excision of I-IIA (Fig. 4J), whereas EPSC half amplitude width is significantly smaller (Fig. 5Q, now revised Fig 6R). Together, a tendency of increased EPSC amplitudes and smaller half amplitude width result in statistically insignificant changes in EPSC in ∆I-IIA (now discussed on page 15, lines 37 to 40). We also understand the reviewer’s concern attributing altered EPSC kinetics to presynaptic cac channel properties. We have toned down our interpretation in the discussion and list possible alterations in presynaptic AP shape or cac channel kinetics as alternative explanations (not conclusions; see revised discussion on page 15, line 40 to page 16, line 2). Moreover, we have quantified postsynaptic GluRIIA abundance to test whether altered PSC kinetics are caused by altered GluRIIA expression. In our opinion, the latter is more instructive than mini decay kinetic analysis because this depends strongly on the distance of the recording electrode to the actual site of transmission in these large muscle cells. Although we find no difference in GluRIIA expression levels we now clearly state that we cannot exclude other changes in GluR receptor fields, which of course, could also explain altered PSC kinetics. We have updated the discussion on page 16, lines 2/3 accordingly.

      (9) Paired-pulse ratios (PPRs): On how many sweeps are the PPRs based? In which sequence were the intervals applied? Are PPR values based on the average of the second over the first PSC amplitudes of all sweeps, or on the PPRs of each sweep and then averaged? The latter calculation may result in spurious facilitation, and thus to the large PPRs seen in dI-IIB mutants (Kim & Alger, 2001; doi: 10.1523/JNEUROSCI.21-2409608.2001).

      We agree that the PP protocol and analyses had to be described more precisely in the methods and have done so on page 23, lines 31 to 37 in the methods. Mean PPR values are based on the PPRs of each sweep and then averaged. We are aware of the study of Kim and Alger 2001 and have re-analyzed the PP data in both ways outlined by the reviewer. We get identical results with either analyses method. Spurious facilitation is thus not an issue in our data. We now explain this in the methods section along with the PPR protocol. The large spread seen in dI-IIB is indeed caused by reduced calcium influx into active zones with fewer channels, as anticipated by the reviewer (see next point).

      (10) Could the dI-IIB phenotype be simply explained by a decrease in channel number/ release probability? To test this, I propose investigating PPRs and short-term dynamics during train stimulation at lower extracellular Ca2+ concentration in WT. The Ca2+ concentration could be titrated such that the first PSC amplitude is similar between WT and dI-IIB mutants. This experiment would test if the increased PPR/depression variability is a secondary consequence of a decrease in Ca2+ influx, or specific to the splice isoform.

      In fact, the interpretation that decreased PSC amplitude upon I-IIB excision is caused mainly by reduced channel number is precisely our interpretation (see discussion page 14, last paragraph to page 15, first paragraph in the original submission, now page 16, second paragraph paragraph). In addition, we are grateful for the reviewer’s suggestion to triturate the external calcium such that the first PSC amplitude in matches in ∆I-IIB and control. This experiment tests whether altered short term plasticity is solely a function of altered channel number or whether additional causes, such as altered channel properties, also play into this. We triturated the first pulse amplitude in ∆I-IIB to match control and find that paired pulse ratio and the variance thereof are not different anymore. Therefore, the differences observed in identical external calcium can be fully explained by altered channel numbers. This additional dataset is shown in the revised figures 6D and E and referred to in the results section on page 10, lines 14 to 25 and the discussion on page16, lines 36 to 38.

      (11) How were the depression kinetics analyzed? How many trains were used for each cell, and how do the tau values depend on the first PSC amplitude? Time constants in the range of a few (5-10) milliseconds are not informative for train stimulations with a frequency of 1 or 10 Hz (the unit is missing in Figure 5H). Also, the data shown in Figures 5E-K suggest slower time constants than 5-10 ms. Together, are the data indeed consistent with the idea that dIIIB does not only affect cac channel number, but also PPR/depression variability (p. 9)?

      For each animal the amplitudes of all subsequent PSCs in each train were plotted over time and fitted with a single exponential. For depression at 1 and 10 Hz, we used one train per animal, and 5-6 animals per genotype (as reflected in the data points in Figs. 6I, M). This is now explained in more detail in the revised methods section (page 23, lines 39 to 41). The tau values are not affected by the amplitude of the first PSC. First, we carefully re-fitted new and previously presented depression data and find that the taus for depression at low stimulation frequencies (1 and 10Hz) are not affected by exon excisions at the I-II site. We thank the reviewer for detecting our error in units and tau values in the previous figure panels 5H and L (this has now been corrected in the revised figure panels 6I and M). Given that PSC amplitude upon I-IIB excision is significantly smaller than in controls and following I-IIA excision, we suspected that the time course of depression at low stimulation frequency is not significantly affected by the amount of calcium influx during the first PSC. To further test this, we followed the reviewer ’s suggestion and re-measured depression at 1 and 10 Hz for cac-GFP controls and for delta I-IIB in a higher external calcium concentration (1.8 mM), so that the first PSC was increased in amplitude in both genotypes (1.8 mM external calcium triturates the PSC amplitude in delta I-IIB to match that of controls measured in 0.5 mM external calcium, see revised Figs. 6H, L). Neither in control, nor in delta I-IIB did this affect the time course of synaptic depression (see revised Figs. 6I, M). This indicates that at low stimulation frequencies (1 and 10Hz) the time course of depression is not affected by mean quantal content. This is consistent with the paired pulse ratio at 100 ms interpulse interval shown in figures 6A-D. However, for synaptic depression at 1 Hz stimulation the variability of the data is higher for delta I-IIB (independent of external calcium concentration, see rev. Fig. 6I), which might also be due to reduced channel number in this genotype. Taken together, the data are in line with the idea that altered cac channel numbers in active zones are sufficient to explain all effects that we observe upon I-IIB excision on PPRs and synaptic depression at low stimulation frequencies. This is now clarified in the revised text on page 12, lines 3 to 7.

      (12) The GFP-tagged I-IIA and mEOS4b-tagged I-IIB cac puncta shown in Figure 6N appear larger than the Brp puncta. Endogenously tagged cac puncta are typically smaller than Brp puncta (Gratz et al., 2019). Also, the I-IIA and I-IIB fluorescence sometimes appear to be partially non-overlapping. First, I suggest adding panels that show all three channels merged. Second, could they analyze the area and area overlap of I-IIA and I-IIB with regard to each other and to Brp, and compare it to cac-GFP? Any speculation as to how the different tags could affect localization? Finally, I recommend moving the dI-IIA and dI-IIB localization data shown in Figure 6N to an earlier figure (Figure 1 or Figure 3).

      We now show panels with the two I-II cac isoforms merged in the revised figure 7H (previously 6N). We also tested merging all three labels as suggested, but found this not instructive for the reader. We thank the reviewer for pointing out that the Brp puncta appeared smaller than the cac puncta in some panels. We carefully went through the data and found that the Brp puncta are not systematically smaller than the cac puncta. Please note that punctum size can appear quite differently, depending on different staining qualities as well as different laser intensities and different point spread in different imaging channels. The purpose of this figure was not to analyze punctum size and labeling intensity, but instead, to demonstrate that I-IIA and I-IIB are both present in most active zones, but some active zones show only I-IIB labeling, as quantified in figure 7I. We did not follow the suggestion to conduct additional co-localization analyses and compare it with cac-GFP controls, because Pearson co-localization coefficients for cac-GFP and all exon-out variants analyzed, including delta I-IIA and delta I-IIB are presented in the revised figure 4D. Moreover, delta I-IIA and delta I-IIB show similar Manders 1 and 2 co-localization coefficients with Brp (see Figs. 4E, F). We do not want to speculate whether the different tags have any effect on localization precision. Artificial differences in localization precision can also be suggested by different antibodies, but we know from our STED analyses with identical tags and antibodies for all isoforms that I-IIA and I-IIB co-localize identically with Brp (see Figs. 5A-E). Finally, we prefer to not move the figure because we believe it is informative to show our finding that active zones usually contain both splice I-II variants together with the finding that only I-IIB is required for PHP.

      Recommendations for the authors:

      Reviewing Editor Comments:

      We thank you for your submission. All three reviewers urge caution in interpreting the S4 splice variant playing a role specifically in Cac localization, as opposed to just leading to instability and degradation. There are other issues with the electrophysiological experiments, a need for improved imaging and analyses, and some areas of interpretation detailed in the reviews.

      We agree that additional data was required to conclude that IS4 splicing plays a specific role in cac channel localization and is not just leading to channel instability and degradation. As outlined in detail in our response to reviewer 1, comment 1, we conducted several sets of experiments to support our interpretation. First, electrophysiological experiments show that upon removal of IS4B, which eliminates synaptic transmission at the larval NMJ and cac positive label in presynaptic active zones, somatodendritic cac current is reliably recorded (new data in revised figure 3C). This is not in line with a channel instability or degradation effect, but instead with IS4B containing isoforms being required and sufficient for evoked release from NMJ motor terminals, whereas IS4A isoforms are not sufficient for evoked release from axon terminals, but IS4A isoforms alone can mediate a distinct component of somatodendritic calcium current. Second, immunohostochemical analyses reveal that IS4A, which is not present in NMJ presynaptic active zones, is expressed sparsely, but in reproducible patterns in the larval brain lobes and in specific regions of the anterior VNC parts (new supplementary figure 1). Again, the absence of a IS4A-containing cac isoform from presynaptic active zones but their simultaneous presence in other parts of the nervous system is in accord with isoform specific localization, but not with general channel isoform instability. Third, enlargements of NMJ boutons with brp positive presynaptic active zones confirm the absence of IS4A and the presence of IS4B in active zones (these enlargements are now shown in the revised figures 2A-C, 3A, and 4A-C). Fourth, as suggested we have quantified the Pearson co-localization of IS4 isoforms with Brp in presynaptic active zones (revised Fig. 2D). This confirms quantitatively similar co-localization of IS4B and control with Brp, but no co-localization of IS4A with Brp. In fact, the labeling intensity of IS4A in presynaptic active zones is quantitatively not significantly different from background, no IS4A label is detected anywhere in the axon terminals at the NMJ, but we find IS4 label in the CNS. Together, these data strongly support our interpretation that the IS4 splice site plays a distinct role in cac channel localization. Figure legends as well as results and discussion section have been modified accordingly (the respective page and line numbers are listed in our-point-by-point responses).

      In addition, we have carefully addressed all other public comments as well as all other recommendations for authors by providing multiple new data sets, new image analyses, and revising text. Addressing the insightful comments of all three reviewers and the reviewing editor has greatly helped to make the manuscript better.

      Reviewer #1 (Recommendations For The Authors):

      The conclusion that the IS4B exon controls Cac localization to active zones versus simply being required for channel abundance is not well supported. The authors need to either mention both possibilities or provide stronger support for the active zone localization model if they want to emphasize this point.

      We agree and have included several additional data sets as outlined in our response to point 1 of reviewer 1 and to the reviewing editor (see above). These new data strongly support our interpretation that the IS4B exon controls Cac localization to active zones and is not simply required for channel abundance. The additions to the figures and accompanying text (including the respective figure panel, page, and line numbers) are listed in the point-bypoint responses to the reviewers’ public suggestions.

      Figure 2C staining for Cac localization in the delta 4B line is difficult to compare to the others, as the background staining is so high (muscles are green for example). As such, it is hard to determine whether the arrows in C are just background.

      We had over-emphasized the green label to show that there really is no cacophony label in active zones. However, we agree that this hampered image interpretation. Thus, we have adjusted brightness such that it matches the other genotypes (see new figure panel 2C, and figure 3A, bottom). Revising the figure as suggested by the reviewer shows much more clearly that IS4B puncta are detected exclusively in presynaptic active zones, whereas IS4A channels are not detectable in active zones or anywhere else in the axon terminal boutons. Quantification of IS4A label in brp positive active zones confirms that labeling intensity is not significantly above background (page 6, lines 29 to 31 and page 7, lines 19 to 21). Therefore, IS4A is not detectable in active zones at the NMJ.

      It seems more likely that the removal of the 4B exon simply destabilizes the protein and causes it to be degraded (as suggested by the Western), rather than mislocalizing it away from active zones. It's hard to imagine how some residue changes in the S4 voltage sensor would control active zone localization to begin with. The authors should note that the alternative explanation is that the protein is just degraded when the 4B exon is removed.

      Based on additional data and analyses, we disagree with the interpretation that removal of IS4B disrupts protein integrity and present multiple lines of evidence that support sparse expression of IS4A channels (ΔIS4B). As outlined in our response to reviewer 1 and to the reviewing editor, we show (1) in new immunohistochemical stainings (new supplementary figure 1) that upon removal of IS4B, sparse label is detectable in the VNC and the brain lobes (for detail see above). (2) In our new figure 3C, we show cacophony-mediated somatodendritic calcium currents recorded from adult flight motoneurons in a control situation and upon removal of IS4B that leaves only IS4A channels. This clearly demonstrates that IS4A underlies a substantial component of the HVA somatodendritic calcium current, although it is absence from axon terminals. This is in line with isoform specific functions at different locations, but not with IS4A instability/degradation. (3) We do not agree with the reviewer’s interpretation of the Western Blot data in figure 1E (formerly figure 1D). Together with our immunohistochemical data that show sparse cacophony IS4A expression, we think that the faint band upon removal of IS4B in a heterozygous background (that reduces labeled channels even further) reflects the sparseness of IS4A expression. This sparseness is not due to channel instability, but to IS4A functions that are less abundant than the ubiquitously expressed cac<sup>IS4B</sup> channels at presynaptic active zones of fast chemical synapses (see page 15, lines 24 to 29).

      If they really want to claim the 4B exon governs active zone localization, much higher quality imaging is required (with enlarged views of individual boutons and their AZs, rather than the low-quality full NMJ imaging provided). Similarly, higher resolution imaging of Cac localization at Muscle 12 (Figure 2H) boutons would be very useful, as the current images are blurry and hard to interpret. Figure 6N shows beautiful high-resolution Cac and Brp imaging in single boutons for the I-II exon manipulations - the authors should do the same for the 4B line. For all immuno in Figure 2, it is important to quantify Cac intensity as well. There is no quantification provided, just a sample image. The authors should provide quantification as they do for the delta I-II exons in Figure 3.

      We did as suggested and added figure panels to figure 2A-C and to new figures 3A (formerly part of figure 2 and 4A-C (formerly figure 3) showing magnified label at the NMJ AZs to better judge on cacophony expression after exon excision. These data are now referred to in the results section on page 6, lines 22 to 24, page 7, lines 18 to 21 and page 8, lines 17/18.

      As suggested, we now also provide quantification of co-localization with brp puncta as Pearson’s correlation coefficient for control, IS4B, and IS4A in the new figure panel 2D (text on page 6, lines 34 to 38). This further underscores control-like active zone localization of IS4B but no significant active zone localization of IS4A. As suggested, we quantified now also the intensity of IS4B label in active zones, and it was not different from control (see revised figure 4H and text on page 8, lines 38/39). We did not quantify the intensity of IS4A label, because it was not over background (text, page 6, lines 30/31).

      Reviewer #2 (Recommendations For The Authors):

      (1a) Questions about the engineered Cac splice isoform alleles:

      The authors using CRISPR gene editing to selectively remove the entire alternatively spliced exons of interest. Do the authors know what happens to the cac transcript with the deleted exon? Is the deleted exon just skipped and spliced to the next exon? Or does the transcript instead undergo nonsense-mediated decay?

      We do not believe that there is nonsense mediated mRNA decay, because for all exon excisions the respective mRNA and protein are made. Protein has been detected on the level of Western blotting and immunocytochemistry. Therefore, we are certain that the mRNA is viable for each exon excision (and we have confirmed this for low abundance cac protein isoforms by rt-PCR), but only subsets of cac isoforms can be made from mRNAs that are lacking specific exons. However, we can not make any statements as to whether the lack of specific protein isoforms exerts feedback on mRNA stability, the rate of transcription and translation, or other unknown effects.

      (1b) While it is clear that the IS4 exons encode part of the voltage sensor in the first repeat, are there studies in Drosophila to support the putative Ca-beta and G-protein beta-gamma binding sites in the I-II loop? Or are these inferred from Mammalian studies?

      To the best of our knowledge, there are no studies in Drosophila that unambiguously show Caβ and Gβγ binding sites in the I-II loop of cacophony. However, sequence analysis strongly suggests that I-IIB contains both, a Caβ as well as a Gβγ binding site (AID: α-interacting domain) because the binding motif QXXER is present. In mouse Cav2.1 and Ca<sub>v</sub>2.2 channels the sequence is QQIER, while in Drosophila cacophony I-IIB it is QQLER. In the alternative IIIA, this motif is not present, strongly suggesting that G<sub>βγ</sub> subunits cannot interact at the AID. However, as already suggested by Smith et al. (1998), based on sequence analysis, Ca<sub>β</sub> should still be able to bind, although possibly with a lower affinity. We agree that this information should be given to the reader and have revised the text accordingly on page 5, lines 9 to 17.

      (1c) The authors assert that splicing of Cav2/cac in flies is a means to encode diversity, as mammals obviously have 4 Cav2 genes vs 1 in flies. However, as the authors likely know, mammalian Cav2 channels also have various splice isoforms encoded in each of the 4 Cav2 genes. The authors should discuss in more detail what is known about the splicing of individual mammalian Cav2 channels and whether there are any homologous properties in mammalian channels controlled by alternative splicing.

      We agree and now provide a more comprehensive discussion of vertebrate Ca<sub>v</sub>2 splicing and its impact on channel function. In line to what we report in Drosophila, properties like G<sub>βγ</sub> binding and activation voltage can also be affected by alternative splicing in vertebrate Ca<sub>v</sub>2 channel, through the exon patterns are quite different from Drosophila. We integrated this part on page 14, first paragraph) in the revised discussion. The respective text is below for the reviewer’s convenience:

      “However, alternative splicing increases functional diversity also in mammalian Ca<sub>v</sub>2 channels. Although the mutually exclusive splice site in the S4 segment of the first homologous repeat (IS4) is not present in vertebrate Cav channels, alternative splicing in the extracellular linker region between S3 and S4 is at a position to potentially change voltage sensor properties (Bezanilla 2002). Alternative splice sites in rat Ca<sub>v</sub>2.1 exon 24 (homologous repeat III) and in exon 31 (homologous repeat IV) within the S3-S4 loop modulate channel pharmacology, such as differences in the sensitivity of Ca<sub>v</sub>2.1 to Agatoxin. Alternative splicing is thus a potential cause for the different pharmacological profiles of P- and Q-channels (both Ca<sub>v</sub>2.1; Bourinet et al. 1999). Moreover, the intracellular loop connecting homologous repeats I and II is encoded by 3-5 exons and provides strong interaction with G<sub>βγ</sub>-subunits (Herlitze et al. 1996). In Ca<sub>v</sub>2.1 channels, binding to G<sub>βγ</sub> subunits is potentially modulated by alternative splicing of exon 10 (Bourinet et al. 1999). Moreover, whole cell currents of splice forms α1A-a (no Valine at position 421) and α1A-b (with Valine) represent alternative variants for the I-II intracellular loop in rat Ca<sub>v</sub>2.1 and Ca<sub>v</sub>2.2 channels. While α1A-a exhibits fast inactivation and more negative activation, α1A-b has delayed inactivation and a positive shift in the IV-curve (Bourinet et al. 1999). This is phenotypically similar to what we find for the mutually exclusive exons at the IS4 site, in which IS4B mediates high voltage activated cacophony currents while IS4A channels activate at more negative potentials and show transient current (Fig. 3; see also Ryglewski et al. 2012). Furthermore, altered Ca<sub>β</sub> interaction have been shown for splice isoforms in loop III (Bourinet et al. 1999), similar to what we suspect for the I-II site in cacophony. Finally, in mammalian VGCCs, the C-terminus presents a large splicing hub affecting channel function as well as coupling distance to other proteins. Taken together, Ca<sub>v</sub>2  channel diversity is greatly enhanced by alternative splicing also in vertebrates, but the specific two mutually exclusive exon pairs investigated here are not present in vertebrate Ca<sub>v</sub>2 genes.”

      (1d) In Figure 1, it would be helpful to see the entire cac genomic locus with all introns/exons and the 4 specific exons targeted for deletion.

      We agree and have changed figure 1 accordingly.

      (2a) Cav2.IS4B deletion alleles:

      More work is necessary to explain the localization of Cac controlled by the IS4B exon. First, can the authors determine whether actual Cac channels are present at NMJ boutons? The authors seem to indicate that in the IS4B deletion mutants, some Cac (GFP) signal remains in a diffuse pattern across NMJ boutons. However, from the imaging of wild-type Cac-GFP (and previous studies), there is no Cac signal outside of active zones defined by the BRP signal. It would benefit the study to a) take additional, higher resolution images of the remaining Cac signal at NMJs in IS4B deletion mutants, and b) comment on whether the apparent remaining signal in these mutants is only observed in the absence of IS4Bcontaining Cac channels, or if the IS4A-positive channels are normally observed (but perhaps mis-localized?).

      We have conducted additional analyses to show convincingly that IS4A channels (that remain upon IS4B deletion) are absent from presynaptic active zone. Please see also responses to reviewers 1 and 3. By adjusting the background values in of CLSM images to identical values in control, delta IS4A, and delta IS4B, as well as by providing selective enlargements as suggested, the figure panels 2C, Ci and 3A now show much clearer, that upon deletion of IS4B no cac label remains in active zones or anywhere else in the axon terminal boutons (see text on page 6, lines 22 to 24). This is further confirmed by quantification showing the in IS4B mutants cac labeling intensity in active zones is not above background (see text on page 6, lines 27 to 31). We never intended to indicate that there was cac signal outside of active zones defined by the brp signal, and we now carefully went through the text to not indicate this possibility unintentionally anywhere in the manuscript.

      (2b) Do the authors know whether any presynaptic Ca2+ influx is contributed by IS4Apositive Cac channels at boutons, given the potential diffuse localization? There are various approaches for doing presynaptic Ca2+ imaging that could provide insight into this question.

      We agree that this is an interesting question. However, based on the revisions made, we now show with more clarity that IS4A channels are absent from the presynaptic terminal at the NMJ. IS4A labeling intensities within active zones and anywhere else in the axon terminals are not different from background (see text on page 6, lines 27 to 31 and revised Figs. 2C, Ci, and 3A with new selective enlargements in response to comments of both other reviewers). This is in line with our finding that evoked synaptic transmission from NMJ axon terminals to muscle cells is mostly absent upon excision of IS4B (see Fig. 3B). The very small amplitude EPSC (below 5 % of the normal amplitude of evoked EPSCs) that can still be recorded in the absence of IS4B is similar to what is observed in cac null mutant junctions and is mediated by calcium influx through another voltage gated calcium channels, a Ca<sub>v</sub>1 homolog named Dmca1D, as we have previously published (Krick et al., 2021, PNAS 118(28):e2106621118. Gathering additional support for the absence of IS4A from presynaptic terminals by calcium imaging experiments would suffer significantly from the presence of additional types of VGCCs in presynaptic terminals (for sure Dmca1D (Krick et al., 2021) and potentially also the Ca<sub>v</sub>3 homolog DmαG or Dm-α1T). Such experiments would require mosaic null mutants for cac and DmαG channels in a mosaic IS4B excision mutant, which, if feasible at all, would be very hard and time consuming to generate. In the light of the additional clarification that IS4A is not located in NMJ axon terminal boutons, as shown by additional labeling intensity analysis, revised figures with selective enlargement, and revised text, we feel confident to state that IS4A is not sufficient for evoked SV release.

      (2c) Mechanistically, how are amino acid changes in one of the voltage sensing domains in Cac related to trafficking/stabilization/localization of Cac to AZs?

      This is an exciting question that has occupied our discussions a lot. Some sorting mechanism must exist that recognizes the correct protein isoforms, just as sorting and transport mechanisms exist that transport other synaptic proteins to the synapse. We do not think that the few amino acid changes in the voltage sensor are directly involved in protein targeting. We rather believe that the cacophony variants that happen to contain this specific voltage sensor are selected for transport out to the synapse. There are possibilities to achieve this cell biological, but we have not further addressed potential mechanisms because we do not want enter the realms of speculation.

      (3) How are auxiliary subunits impacted in the Cac isoform mutants?

      Recent work by Kate O'Connor-Giles has shown that both Stj and Ca-Beta subunits localize to active zones along with Cac at the Drosophila NMJ. Endogenously tagged Stj and CaBeta alleles are now available, so it would be of interest to determine if Stj and particular Cabeta levels or localization change in the various Cac isoform alleles. This would be particularly interesting given the putative binding site for Ca-beta encoded in the I-II linker.

      We agree that the synthesis of the work of Kate O'Connor-Giles group and our study open up new avenues to explore exciting hypotheses about differential coupling of specific cacophony splice isoforms with distinct accessory proteins such as Caβ and α<sub>2</sub>δ subunits. However, this requires numerous full sets of additional experiments and is beyond the scope of this study.

      (4a) Interpretation of short-term plasticity in the I-IIB exon deletion:

      The changes in short-term plasticity presented in Figure 5 are interpreted as an additional phenotype due to the loss of the I-IIB exon, but it seems this might be entirely explained simply due to the reduced Cac levels. Reduced Cac levels at active zones will obviously reduce Ca2+ influx and neurotransmitter release. This may be really the only phenotype/function of the I-IIB exon. Hence, to determine whether loss of the I-IIB exon encodes any functions in short-term plasticity, separate from reduced Cac levels, the authors should compare short-term plasticity in I-IIB loss alleles compared to wild type with starting EPSC amplitudes are equal (for example by reducing extracellular Ca2+ levels in wild type to achieve the same levels at in Cac I-IIB exon deleted alleles). Reduced release probability, simply by reduced Ca2+ influx (either by reduced Cac abundance or extracellular Ca2+) should result in more variability in transmission, so I am not sure there is any particular function of the I-IIB exon in maintaining transmission variability beyond controlling Cac abundance at active zones.

      For two reasons we are particularly grateful for this comment. First, it shows us that we needed to explain much clearer that our interpretation is that changes in paired pulse ratios (PPRs) and in depression at low stimulation frequencies are a causal consequence of lower channel numbers upon I-IIB exon deletion, precisely as pointed out by the reviewer. We have carefully revised the text accordingly on page 10, lines 14-25, page 11, lines 3-7 and 22-28; page 16, lines 36-38. Second, the experiment suggested by the reviewer is superb to provide additional evidence that the cause of altered PPRs is in fact reduced channel number, but not altered channel properties. Accordingly, we have conducted additional TEVC recordings in elevated external calcium (1.8 mM) so that the single PSC amplitudes in I-IIB excision animals match those of controls in 0.5 mM extracellular calcium. This makes the amplitudes and the variance of PPR for all interpulse intervals tested control-like (see revised Figs. 6D, E). This strongly indicates that differences observed in PPRs as well as the variance thereof were caused by the amount of calcium influx during the first EPSC, and thus by different channel numbers in active zones.

      (4b) Another point about the data in Figure 5: If "behaviorally relevant" motor neuron stimulation and recordings are the goal, the authors should also record under physiological Ca2+ conditions (1.8 mM), rather than the highly reduced Ca2+ levels (0.5 mM) they are using in their protocols.

      Although we doubt that the effective extracellular calcium concentration that determines the electromotoric force for calcium to enter the ensheathed motoneuron terminals in vivo during crawling is known, we followed the reviewer’s suggestion partly and have repeated the high frequency stimulation trains for ΔI-IIB in 1.8 mM calcium. As for short-term plasticity this brings the charge conducted to values as observed in control and in ΔI-IIA in 0.5 mM calcium. Therefore, all difference observed in previous figure 5 (now revised figure 6) can be accounted to different channel numbers in presynaptic active zones. This is now explained on page 11, lines 19-28. For controls recordings at high frequency stimulation in higher external calcium (e.g. 2 mM) have previously been published and show significant synaptic depression (e.g. Krick et al., 2021, PNAS). Given that in the exon out variants we do not expect any differences except from those caused by different channel numbers, we did not repeat these experiments for control and ΔI-IIA.

      (5a) Mechanism of Cac's role in PHP :

      As the authors likely know, mutations in Cac were previously reported to disrupt PHP expression (see Frank et al., 2006 Neuron). Inexplicably, this finding and publication were not cited anywhere in this manuscript (this paper should also be cited when introducing PhTx, as it was the first to characterize PhTx as a means of acutely inducing PHP). In the Frank et al. paper (and in several subsequent studies), PHP was shown to be blocked in mutations in Cac, namely the CacS allele. This allele, like the I-IIB excision allele, reduces baseline transmission presumably due to reduced Ca2+ influx through Cac. The authors should at a minimum discuss these previous findings and how they relate to what they find in Figure 6 regarding the block in PHP in the Cac I-IIB excision allele.

      We thank the reviewer for pointing this out and apologize for this oversight. We agree that it is imperative to cite the 2006 paper by Frank et al. when introducing PhTx mediated PHP as well as when discussing cac the effects of cac mutants on PHP together with other published work. We have revised the text accordingly on page 12, lines 9-11 and 21-23 and on page 17, lines 29-33.

      In terms of data presentation in Fig. 6, as is typical in the field, the authors should normalize their mEPSC/QC data as a percentage of baseline (+PhTx/-PhTx). This makes it easier to see the reduction in mEPSC values (the "homeostatic pressure" on the system) and then the homeostatic enhancement in QC. Similarly, in Fig. 6M, the authors should show both mEPSC and QC as a percentage of baseline (wild type or non-GluRIIA mutant background).

      We agree and have changed figure presentation accordingly. Figure 7 (formerly figure 6) was updated as was the accompanying results text on page 12, lines 23-40.

      (6) Cac I-IIA and I-IIB excision allele colocalization at AZs:

      These are very nice and important experiments shown in Figures 6N and O, which I suggest the authors consider analyzing in further detail. Most significantly:

      (6i) The authors nicely show that most AZs have a mix of both Cac IIA and IIB isoforms. Using simple intensity analysis, can the authors say anything about whether there is a consistent stoichiometric ratio of IIA vs IIB at single AZs? It is difficult to extract actual numbers of IIA vs IIB at individual AZs without having both isoforms labeled mEOS4b, but as a rough estimate can the authors say whether the immunofluorescence intensity of IIA:IIB is similar across each AZ? Or is there broad heterogeneity, with some AZs having low vs high ratios of each isoform (as the authors suggest across proximal to distal NMJ AZs)?

      We agree and have conducted experiments and analyses to provide these data. We measured the cac puncta fluorescence intensities for heterozygous cac<sup>sfGFP</sup>/cac, cacIIIA<sup>sfGFP</sup>/cacI-IIB, and cacI-IIB<sup>sfGFP</sup>/cacI-IIA animals. We preferred this strategy, because intensity was always measured from cac puncta with the same GFP tag. Next, we normalized all values to the intensities obtained in active zones from heterozygous cac<sup>sfGFP</sup>/cac controls and then plotted the intensities of I-IIA versus I-IIB containing active zones side by side. Across junctions and animals, we find a consistent ratio 2:1 in the relative intensities of I-IIB and I-IIA, thus indicating on average roughly twice as many I-IIB as compared to I-IIA channels across active zones. This is consistent with the counts in our STED analysis (see Fig. 5F). These new data are shown in the new figure panel 7J and referred to on page 13, lines 10-16 in the revised text.

      (6ii) Intensity analysis of Cac IIA vs IIB after PHP: Previous studies have shown Cac abundance increases at NMJ AZs after PHP. Can the authors determine whether both Cac IIA vs IIB isoforms increase after PHP or whether just one isoform is targeted for this enhancement?

      We already show that PHP is not possible in the absence of I-IIB channels (see figure 7). However, we agree that it is an interesting question to test whether I-IIA channel are added in the presence of I-IIB channels during PHP, but we consider this a detail beyond the scope of this study.

      Minor points:

      (1) Including line numbers in the manuscript would help to make reviewing easier.

      We agree and now provide line numbers.

      (2) Several typos (abstract "The By contrast", etc).

      We carefully double checked for typos.

      (3) Throughout the manuscript, the authors refer to Cac alleles and channels as "Cav2", which is unconventional in the field. Unless there is a compelling reason to deviate, I suggest the authors stick to referring to "Cac" (i.e. cacdIS4B, etc) rather than Cav2. The authors make clear in the introduction that Cac is the sole fly Cav2 channel, so there shouldn't be a need to constantly reinforce that cac=Cav2.

      We agree and have changed all fly Ca<sub>v</sub>2 reference to cac.

      (4) In some figures/text the authors use "PSC" to refer to "postsynaptic current", while in others (i.e. Figure 6) they switch to the more conventional terms of mEPSC or EPSC. I suggest the authors stick to a common convention (mEPSC and EPSC).

      We have changed PSC to EPSC throughout.

      Reviewer #3 (Recommendations For The Authors):

      (1) The abstract could focus more on the results at the expense of the background.

      We agree and have deleted the second introductory background sentence and added information on PPRs and depression during low frequency stimulation.

      (2) What does "strict" active zone localization refer to? Could they please define the term strict?

      Strict active zone localization means that cac puncta are detected in active zones but no cac label above background is found anywhere else throughout the presynaptic terminal, now defined on page 6, lines 27-29.

      (3) Single boutons/zoomed versions of the confocal images shown in Figures 2A-C, 2H, and 3A-C would be very helpful.

      We have provided these panels as suggested (see above and revised figures 2-4). Figure 3 is now figure 4.

      (4) The authors cite Ghelani et al. (2023) for increased cac levels during homeostatic plasticity. I recommend citing earlier work making similar observations (Gratz et al., 2019; DOI: 10.1523/JNEUROSCI.3068-18.2019), and linking them to increased presynaptic calcium influx (Müller & Davis, 2012; DOI: 10.1016/j.cub.2012.04.018).

      We agree and have added Gratz et al. 2019 and Davis and Müller 2012 to the results section on page 12, lines 17/18 and lines 21-23, in the discussion on page 17, lines 29-33.

      (5) The data shown in Figure 3 does not directly support the conclusion of altered release probability in dI-IIB. I therefore suggest changing the legend's title.

      We have reworded to “Excisions at the I-II exon do not affect active zone cacophony localization but can alter cacsfGFP label intensity in active zones and PSC amplitude” as this is reflecting the data shown in the figure panels more directly.

      (6) It would be helpful to specify "adult flight muscle" in Figure 2J.

      We agree that it is helpful to specify in the figure (now revised figure 3C) that the voltage clamp recordings of somatodendritic calcium current were conducted in adult flight motoneurons and have revised the headline of figure panel 3C and the legend accordingly. Please note, these are not muscle cells but central neurons.

      (7) Do dIS4B/Cav2null MNs indeed show an inward or outward current at -90 to -70 mV/-40 and -50 mV, or is this an analysis artifact?

      No, this is due to baseline fluctuations as typical for voltage clamp in central neurons with more than 6000 µm dendritic length and more than 4000 dendritic branches.

      (8) Loss of several presynaptic proteins, including Brp (Kittel et al., 2006), and RBP (Liu et al., 2011), induce changes in GluR field size (without apparent changes in miniature amplitude). The statement regarding the Cav2 isoform and possible effects on GluR number (p. 8) should be revised accordingly.

      We understand and have done two things. First, we measured the intensity of GluRIIA immunolabel in ΔI-IIA, ΔI-IIB, and controls and found no differences. Second, we reworded the statement. It now reads on page 9, lines 1-6: “It seems unlikely that presynaptic cac channel isoform type affects glutamate receptor types or numbers, because the amplitude of spontaneous miniature postsynaptic currents (mEPSCs, Fig. 4K) and the labeling intensity of postsynaptic GluRIIA receptors are not significantly different between controls, I-IIA, and I-IIB junctions (see suppl. Fig. 2, p = 0.48, ordinary one-way ANOVA, mean and SD intensity values are 61.0 ± 6.9 (control), 55.8 ± 8.5 (∆I-IIA), 61.1 ± 17.3 (∆I-IIB)). However, we cannot exclude altered GluRIIB numbers and have not quantified GluR receptor field sizes.”

      (9) The statement relating miniature frequency to RRP size is unclear (p. 8). Is there any evidence for a correlation between miniature frequency to RRP size? Could the authors please clarify?

      We agree that this statement requires caution. Although there is some published evidence for a correlation of RRP size and mini frequency (Neuron, 2009 61(3):412-24. doi: 10.1016/j.neuron.2008.12.029 and Journal of Neuroscience 44 (18) e1253232024; doi: 10.1523/JNEUROSCI.1253-23.2024), which we now refer to on page 9, it is not clear whether this is true for all synapses and how linear such a relationship may be. Therefore, we have revised the text on page 9, lines 6-9. It now reads: “Similarly, the frequency of miniature postsynaptic currents (mEPSCs) remains unaltered. Since mEPSCs frequency has been related to RRP size at some synapses (Pan et al., 2009; Ralowicz et al., 2024) this indicates unaltered RRP size upon I-IIB excision, but we have not directly measured RRP size.”

      (10) Please define the "strict top view" of synapses (p. 8).

      Top view is what this reviewer referred to as “planar view” in the public review points 6 and 7. In our responses to these public review points we now also define “strict top view”, see page 9, lines 17-19.

      (11) Two papers are cited regarding a linear relationship between calcium channel number and release probability (p. 15). Many more papers could be cited to demonstrate a supralinear relationship (e.g., Dodge & Rahaminoff, 1967; Weyhersmüller et al., 2011 doi: 10.1523/JNEUROSCI.6698-10.2011). The data of the present study were collected at an extracellular calcium concentration of 0.5 mM, whereas Meideiros et al. (2023) used 1.5 mM. The relationship between calcium and release is supra-linear around 0.5 mM extracellular calcium (Weyhersmüller et al. 2011). This should be discussed/the statements be revised. Also, the reference to Meideiros et al. (2023) should be included in the reference list.

      We have now updated the Medeiros reference (updated version of that paper appeared in eLife in 2024) in the text and reference list. We agree that the relationship of the calcium concentration and P<sub>r</sub> can also be non-linear and refer to this on page 16, lines 26-32, but the point we want to make is to relate defined changes in calcium channel number (not calcium influx) as assessed by multiple methods (CLSM intensity measures and sptPALM channel counting) to release probability. We now also clearly state that we measured at 0.5 mM external calcium (page 16, lines 27/28) whereas Medeiros et al. 2024 measured at 1.5 mM calcium (page 16, lines 31/32).

      (12) Figure 6: Quantal content does not have any units - please remove "n vesicles".

      We have revised this figure in response to reviewer 2 (comment 5) and quantal content is now expressed as percent baseline, thus without units (see revised figure 7).

      (13) Figure 6C should be auto-scaled from zero.

      This has been fixed by revising that figure in response to reviewer 2 (comment 5)

      (14) The data supporting the statement on impaired motor behavior and reduced vitality of adult IS4A should be either shown, or the statement should be removed (p. 13). Any hypotheses as to why IS4A is important for behavior and or viability?

      As suggested, we have removed that statement.

      (15) They do not provide any data supporting the statement that changes in PSC decay kinetics "counteract" the increase in PSC amplitude (p. 14). The sentence should be changed accordingly.

      We agree and have down toned. It now reads on page 16, lines 7-9: “During repetitive firing, the median increase of PSC amplitude by ~10 % is potentially counteracted by the significant decrease in PSC half amplitude width by ~25 %...”.

      (16) How do they explain the net locomotion speed increase in dI    -IIA larvae? Although the overall charge transfer is not affected during the stimulus protocols used, could the accelerated PSC decay affect PSP summation (I would actually expect a decrease in summation/slower speed)? Independent of the voltage-clamp data, is muscle input resistance changed in dI-IIA mutants?

      Muscle input resistance is not altered in I-II mutants. We refer to potential causes of the locomotion effects of I-IIA excision in the discussion. On page 16, lines 12 to 21 it reads: “there is no difference in charge transfer from the motoneuron axon terminal to the postsynaptic muscle cell between ∆I-IIA and control. Surprisingly, crawling is significantly affected by the removal of I-IIA, in that the animals show a significantly increased mean crawling speed but no significant change in the number of stops. Given that the presynaptic function at the NMJ is not strongly altered upon I-IIA excision, and that I-IIA likely mediates also Ca<sub>v</sub>2 functions outside presynaptic AZs (see above) and in other neuron types than motoneurons, and that the muscle calcium current is mediated by Ca<sub>v</sub>1>/i> and Ca<sub>v</sub>3, the effects of I-IIA excision of increasing crawling speed is unlikely caused by altered pre- or postsynaptic function at the NMJ. We judge it more likely that excision of I-IIA has multiple effects on sensory and pre-motor processing, but identification of these functions is beyond the scope of this study.”

    1. Author response:

      Provisional Responses to Review #1's comments:

      We thank the reviewer for the comments, which highlight both strengths and weaknesses.

      We acknowledge that the optimized parameter values are somewhat specific to Plasmodium, as demographic and mutation/recombination rates can vary across species. However, we would like to emphasize that our simulation and benchmarking framework, along with associated tools like the efficient ibdutils, should be broadly applicable to many species, such as Apicomplexan parasites and other high-recombining eukaryotes, especially when their demographic and evolutionary parameters can be provided or estimated. We will update relevant paragraphs in the disucssion to highlight this point.

      Results related to Refined IBD may not seem unexpected, but our work demonstrates that its direct application to malaria parasites without species-specific optimization can be suboptimal, as has previously occurred in malaria research with their validity not formally evaluated. We believe it is crucial for the research community focusing on non-standard model organisms to validate assumptions made in methods developed for standard models, such as humans, before they are applided to new species.

      Although standard deviations (SDs) are not provided for many analyses, we argue that simulating 14 chromosomes independently serves as repeats (data were shown as means over chromosomes), particularly when assessing the accuracy of IBD segments or scanning for selection signals. For analyses that aggregate information across chromosomes, we are planning to conduct additional repeated simulations or analyses to quantify the uncertainty of estimates. In the upcoming revised version, we will provide SDs where appropriate and explanations when repeated simulation are not necessary given a large number of data points have well captured their empirical distributions.

      Provisional response to review #2's comment:

      Thank you to the reviewer for the suggestions. We agree with the comments, and addressing the mentioned weakness will improve the manuscript's clarity and impact. We plan to enhance the introduction by highlighting the significance of studying malaria and specifically focusing on P. falciparum in this work. We will also update the discussion to reinforce the connection between our findings and malaria research and control and further emphasize the broader implications for the field.

    1. Author response:

      The following is the authors’ response to the original reviews.

      (1) Reviewer 3: Moreover, the conclusion that preBötC NMBR and GRPR activations are unnecessary for sighing is not fully supported by the current experimental design. While the study shows that sighing can still be induced despite pharmacological inhibition of NMBR and GRPR, this does not conclusively prove that these receptors are not required under natural conditions. 

      We concluded that “NMBR and GRPR receptors are not necessary for sigh generation”. We acknowledge that under normal conditions these receptors almost certainly play a role; in fact, microinjection of saporin conjugated to bombesin, which presumably ablates NMBR<sup>+</sup> and GRPR<sup>+</sup> preBötC neurons, completely eliminated endogenous sighing activity in awake mice (Li et al., Nature, 2015). However, that study did not establish that the receptors per se are essential in this context, since the protocol ablated not just the receptors but also the preBötC neurons that happened to express these receptors. Here, we show that we could evoke sighs AFTER complete pharmacological blockade of NMBRs and GRPRs. Also, we show that sighs can be elicited by stimulation of a distinct subpopulation of preBötC neurons expressing the peptide somatostatin (SST<sup>+</sup>). These results demonstrate that sighs can be evoked in absence of activation of NMBRs and/or GRPRs, leading to the conclusion that NMBRs and/or GRPRs are not required for sighs but rather contribute to periodic sigh generation under normal conditions.

      (2) Reviewer 1: To make such a novel (and quite surprising) claim requires many more studies and the conclusion is dependent on how the authors have defined a sigh. Moreover, some data within the paper conflicts with this idea.

      Our definition of sighs was carefully chosen so that it applied across different experimental conditions, including in vitro slices, anesthetized or awake in vivo. We defined sighs as transient changes in minute ventilation on a time scale slower than eupneic breathing period, to avoid classifying breathing after vagotomy or under isoflurane anesthesia as “all-sigh breathing”. This is why induction of persistent large amplitude breaths (such as in Figures 5-6) were not counted as sighs.

      (3) Reviewer 2: Several key technical aspects of the study require further clarification to aid in interpreting the experimental results, including issues relating to the validation of the transgenic mouse lines and virally transduced expressions of proteins utilized for optogenetic and chemogenetic experiments, as well as justifying the optogenetic photostimulation paradigms used to evoke sighs.

      The rationale for using SPP and LPP stems from our published observations of the effects of optogenetic stimulation of various preBötC neuronal subpopulations. Thus, SPP and LPP evoke the same responses in GlyT2 (Sherman et al., 2015) and Dbx1 (Cui et al., 2016) neurons, while for other subpopulations, e.g., SST (Cui et al., 2015), the effects of SPP are markedly different from LPP. Hence, in this study we examined both. As effects of SPP and LPP of SST neurons were examined previously (Cui et al., 2016), these protocols were not repeated except for evoking sighs after blockade of NMBR/GRPRs. SPP of pF NMB or GRP did not evoke any respiratory responses and hence were not presented in any figures (see Results, section “Activation of Nmb- or Grp-expressing pF neurons induces sighs”).

      (4) Reviewer 3: however, the rationale and experimental details require further explanation, and their impacts on the conclusion require clarification. For instance, how and why the variability in optogenetic activation conditions could impact the experimental outcomes. 

      Refractory periods reported here for pF NMB, pF GRP, preBötC NMBR and preBötC GRPR were all obtained using the same intensity LPP. We acknowledge the possibility, even the likelihood that higher intensity LPP would shorten refractory periods. In line with this, we observed that ectopic sighs were evoked earlier during the LPP as the sigh phase progressed. As described in RESULTS, such effects were observed for pF NMB, pF GRP, preBötC NMBR and preBötC GRPR only and not for preBötC SST, which might suggest that timing of intrinsically generated sighs depends on the NMB-GRP signaling pathway, yet sigh production depends on the SST pathway.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Reviewer #1 (Public Review):

      This is an elegant didactic exposition showing how dendritic plateau potentials can enable neurons to perform reliable 'binary' computations in the face of realistic spike time jitter in cortical networks. The authors make many good arguments, and the general concept underlying the paper is sound. A strength is their systematic progression from biophiysical to simplified models of single neurons, and their parallel investigation of spiking and binary neural networks, with training happening in the binary neural network.

      Reviewer #2 (Public Review):

      Summary:

      Artificial intelligence (AI) could be useful in some applications and could help humankind. Some forms of AI work on the platform of artificial neural networks (ANN). ANNs are inspired by real brains and real neurons. Therefore understanding the repertoire and logic of real neurons could potentially improve AANs. Cell bodies of real neurons, and axons of real neurons, fire nerve impulses (nerve impulses are very brief ~2 ms, and very tall ~100 mV). Dendrites, which comprise ~80% of the total neuronal membrane (80% of the total neuronal apparatus) typically generate smaller (~50 mV amplitude) but much longer (~100 ms duration) electrical transients, called glutamate-mediated dendritic plateau potentials. The authors have built artificial neurons capable of generating such dendritic plateau potentials, and through computer simulations the authors concluded that long-lasting dendritic signals

      (plateau potentials) reduce negative impact of temporal jitter occurring in real brain, or in

      AANs. The authors showed that in AANs equipped with neurons whose dendrites are capable of generating local dendritic plateau potentials, the sparse, yet reliable spiking computations may not require precisely synchronized inputs. That means, the real world can impose notable fluctuations in the network activity and yet neurons could still recognize and pair the related network events. In the AANs equipped with dendritic plateaus, the computations are very robust even when inputs are only partially synchronized. In summary, dendritic plateau potentials endow neurons with ability to hold information longer and connect two events which did not happen at the same moment of time. Dendritic plateaus circumvent the negative impact, which the short membrane time constants arduously inflict on the action potential generation (in both real neurons and model neurons). Interestingly, one of the indirect conclusions of the current study is that neurons equipped with dendritic plateau potentials may reduce the total number of cells (nodes, units) required to perform robust computations.

      Strengths:

      The majority of published studies are descriptive in nature. Researchers report what they see or measure. A smaller number of studies embark on a more difficult task, which is to explain the logic and rationale of a particular natural design. The current study falls into that second category. The authors first recognize that conduction delays and noise make asynchrony unavoidable in communication between circuits in the real brain. This poses a fundamental problem for the integration of related inputs in real (noisy) world. Neurons with short membrane time constants can only integrate coincident inputs that arrive simultaneously within 2-3 ms of one another. Then the authors considered the role for dendritic plateau potentials. Glutamate-mediated depolarization events within individual dendritic branches, can remedy the situation by widening the integration time window of neurons. In summary, the authors recognized that one important feature of neurons, their dendrites, are built-in to solve the major problems of rapid signal processing: [1] temporal jitter, [2] variation, [3] stochasticity, and [4] reliability of computation. In one word, the dendritic plateau potentials have evolved in the central nervous systems to make rapid CNS computations robust.

      Weaknesses:

      The authors made some unsupported statements, which should either be deleted, or thoroughly defended in the manuscript. But first of all, the authors failed to bring this study to the readers who are not experts in computational modeling or Artificial Neural Networks. Critical terms (syntax) and ideas have not been explained. For example: [1] binary feature space? [2] 13 dimensions binary vectors? [3] the binary network could still cope with the loss of information due to the binarization of the continuous coordinates? [4] accurate summation?

      Recommendations for the authors:

      Reviewer #1 (Recommendations For The Authors):

      However, I have a number of specific points, listed below, that should be addressed. Most of them are relatively minor, but the authors should especially address point 10, which is a major point, by redoing the simulations affected by the erroneous value of the time constant, and by remaking the relevant figures based on the new simulations.

      Specific comments:

      (1) 7f "This feature is conspicuous because it is an order of magnitude longer than unitary synaptic inputs and axonal spikes.": — It is an order of magnitude longer than AMPA receptor-mediated synaptic currents (EPSCs), but more similar in time course to synaptic potentials (EPSPs) whose decay is governed by the passive membrane time constant (about 10 to 20 ms in pyramidal neurons in vivo) and which determines the lifetime of the 'memory' of the neuron for synaptic inputs under conditions of subthreshold, non-spiking dendritic integration. The quoted sentence should be rewritten accordingly.

      Following this suggestion, we have rewritten the sentence (l. 7) to: "This timescale is conspicuous, being many times longer than the fastest signalling processes in the nervous systems, including Excitatory Post-Synaptic Potentials (EPSPs) and axonal spikes."

      (2) 16ff "This is especially relevant to integration of inputs during high conductance states that are prevalent in-vivo. In these states the effective time constant of the neuronal membrane is extremely short and varies substantially depending on synaptic drive [13, 34, 49].": — The time-averaged synaptic conductance driven by sensory input in vivo is much less high than implied by this statement (e.g. see Fig. 4 of Haider et al. 2013 https://www.nature.com/articles/nature11665 ), and reduces the passive membrane time constant only by a small percentage. The energy cost of a high prevalence of highconductance states and extremely short membrane time constants would also exceed the energy budget of the brain (ref. 4). I would therefore suggest dropping this sentence.

      We have clarified this sentence thanks to the reviewer's suggestion. We meant that the instantaneous, rather than the time-averaged, conductance can be very big. To clarify this we have rewritten this section (l. 15): This is especially relevant to integration of inputs during high conductance states that are prevalent in vivo, where a typical neuron receives significant synaptic drive. In these states, the effective membrane time constant can be extremely short, and varies substantially depending on synaptic input.

      (3) l. 17f "As a consequence, computations that rely on passive summation of multiple inputs place punishing constraints on spike timing precision.": — Again, the passive membrane time constant is on the order of 10 ms and I would tone down this statement accordingly, removing the word 'punishing' for example.

      Following the suggestion, we have rewritten the sentence to (l. 18): "As a consequence, computations that rely on passive summation of multiple inputs would place strong constraints on spike timing precision."

      (4) l. 18ff "Dendritic action potentials, by contrast, have a consistently long duration that is ensured by the kinetic properties of voltage gated ion channels and NMDA receptors [54, 47, 10, 3]. These properties are largely determined by the amino acid sequence of receptor and channel proteins that are specifically expressed in dendrites [45, 44, 40]. This suggests dendritic properties are specifically tuned to produce localised, suprathreshold events that outlive rapid membrane fluctuations.": — Yes, but see also Attwell & Gibb 2005 ( https://www.nature.com/articles/nrn1784 ), especially the last two of their key points. The slow NMDA receptor decay kinetics (and therefore their high affinity for binding glutamate) may also be the consequence of a design goal to set the temporal coherence window for NMDA receptor-mediated synaptic plasticity such as STDP to be on the order of tens of milliseconds, somewhat longer than the membrane time constant.

      The reviewer is correct; other functions (e.g. synaptic plasticity) are also part of the dendrite's repertoire. To acknowledge this, we added a section (l. 34) where we mention that our idea does not conflict with, for example, synaptic plasticity.

      (5) l. 32f "Numerous studies point out that nonlinear summation in dendrites can make neurons computationally equivalent to entire networks of simplified point models, or 'units' in a traditional neural network [9, 21, 38, 40, 45, 48, 50, 51].": — See also Beniaguev et al. 2021 ( https://www.cell.com/neuron/pdf/S0896-6273(21)00501-8.pdf ), which also speaks to the next sentence.

      We thank the reviewer for the suggestion; the citation has been added.

      (6) Fig. 2E and F: the top of panel F corresponds to the top of panel E, but the bottom ofpanel F does not correspond to the bottom of panel E - it corresponds to a dendritic neuron with passive dendrites, not a point neuron. Panel E should be changed to reflect this fact.

      We have followed the suggestion to change the figure.

      (7) l. 49f "Despite these dendritic spikes being initiated at different times, they still sum in the soma, leading to a sodium spike there (Figure 2E).": — You probably mean Fig. 2D, and instead of a sodium spike (which could be misunderstood as local and dendritic) you triggered a sodium action potential. Likewise, Fig. 2B (right) shows the timescale of sodium action potentials at the soma (cf. l. 46).

      The error in the referencing to the figure has been corrected. The phrasing has also been changed to "a sodium action potential" (l. 56), following the reviewer's suggestion.

      (8) Please check the scale bars in Fig. 2D. Do they also apply to panel F below? If yes thatshould be stated.

      The scale bars are indeed the same; I have repeated them in the figure to avoid any confusion.

      (9) l. 68 "This time constant is consistent with the high-conductance state of pyramidalneurons in the cortex [6]":

      You do not need to invoke a high-conductance state to justify this time constant, which is indeed typical for the membrane time constant of pyramidal neurons in vivo.

      On a related note, Fig. 3B and its legend seem to assume that tau = 1 ms, and calls that one EPSP duration in the legend. An EPSC may have a decay time constant of 1 ms, but an EPSP will have a decay time constant of about 10 ms, similar to the membrane time constant. Fig. 3B (and therefore also the rest of Figure 3) seems to have been constructed with a value of tau that is too small by a factor of 10, and this should be corrected by remaking the figure. If tau = 1 ms was used also in Figure 4 then this figure also needs to be remade.

      Section 3.3 and Table 1 also use tau = 1 ms. This is unrealistic and needs to be changed an appropriate value of tau = 10 ms is given by the authors themselves in line 67. The incorrect value of tau in Table 1 causes other entries of the Table to be terribly wrong; a leak conductance of 1 µS would imply an input resistance of the neuron of 1 MOhm, but somatic input resistances of pyramidal neurons in vivo are on the order of 20 to 50 MOhm. The total capacitance of 1 nF is slightly too large, and should be adjusted to yield a membrane time constant of 10 ms given an appropriate leak conductance leading to an input resistance of about 20 to 50 MOhm. These are key numbers to get right for both Figures 3 and 4, especially if you want to be able to say "We have been careful to respect the essence of basic physiological facts while trying to build an abstraction of how elementary spiking computations might occur." (l. 215f).

      We thank the reviewer for catching this. We had actually already used tau = 10 ms, but had not yet updated the paper. Moreover, the somatic input resistance was indeed off. To rectify this, we have used the values: $Cm = 0.5 nF$, $\taum = 10 ms$, $Rm = 20 M \Ohm$, $gl = 0.05 \mu S$. Figure 3 was remade using these values, and Table 1 updated accordingly.

      (10) l. 158ff "The assumption that each neuron connects to one dendrite of an upstream neuron is actually grounded in physiology, although it may appear like a strong assumption at first glance: related inputs arrive at local clusters of spines synchronously [60].": — You probably mean "each neuron connects to one dendrite of a downstream neuron." And I would add "But see Beniaguev et al. 2022 https://www.biorxiv.org/content/10.1101/2022.01.28.478132v2.abstract " - your restrictive arrangement of inputs is probably not really needed, especially if postsynaptic neurons have more dendrites.

      The suggested wording was correct, and has been now incorporated (l. 166). I have also added the suggested citation.

      (11) I note that the plateaus in Fig. 4D are much shorter than those in Fig. 2D and F, but thisis a good thing: The experimental and simulation results in Fig. 2 are based on ref. 18, which used microiontophoresis of glutamate, leading to much slower glutamate concentration time courses at the dendritic NMDA receptors than synaptic release of glutamate would. The time courses of plateaus in Fig. 4 are much more in line with the NMDA plateau durations shown in ref. 21, especially their Figure 2B. These faster NMDA plateaus (or NMDA spikes as they are called in ref. 21) are based on synaptic release of glutamate in vivo, and on the faster NMDA receptor kinetics at physiological temperature compared to the old models with room temperature kinetics used in ref. 18.

      Here are two additional references that the authors might find interesting:

      Fisek et al. 2023 https://www.nature.com/articles/s41586-023-06007-6 Dudai et al. 2022 https://www.jneurosci.org/content/42/7/1184.full

      We thank the reviewer for the suggested references. The first has been added to the references in the introduction, on l. 28. The second has been added on l. 78.

      Reviewer #2 (Recommendations For The Authors):

      (1) In Fig. 3A, we observed some animal pictures, which were never explained in the figurecaption, or text of the manuscript. These pictures were probably explained at the lab meeting, so it is unnecessary to waste effort on these pictures in the manuscript draft.

      We agree with the reviewer; the figures have been removed.

      (2) Figure 1 has not been referenced anywhere in the manuscript text!

      Indeed, this had to be corrected, figure is now references on l. 9.

      (3) Line 45. "[18] triggered two NMDA spikes by glutamate uncaging at the indicated (red,blue) sites". [18] triggered one NMDA spike while recording at three locations simultaneously (two locations in dendrite and one location in the soma).

      The reviewer is correct here. The sentence has now been rephrased to "(ref.) triggered an NMDA spike by glutamate microiontophoresis while recording at the soma and the indicated (red, blue) sites in the dendrite." (l. 49)

      (4) Fig. 2B. The two labels, "Dendrite 2" and "Dendrite 1" incorrectly suggest that two traceswere recorded in two dendrites. These two traces were recorded in the same dendrite.

      We agree with the reviewer; labels have now been changed to "Dendrite site".

      (5) Line 45. "[18] triggered two NMDA spikes by glutamate uncaging at the indicated (red,blue) sites". - - One NMDA spike by "glutamate microiontophoresis".

      This is correct, the phrasing on (l. 50) has been changed accordingly.

      (6) Line 47. "... simulated glutamate releases 50 ms apart in the three dendritic sites indicatedin Figure 2C, thereby triggering three NMDA spikes at those sites. Despite these dendritic spikes being initiated at different times, they still sum in the soma, leading to a sodium spike there (Figure 2E)". A similar experiment has been performed in real cortical neurons (KD Oikonomu et al., 2012, PMID: 22934081), and could potentially be cited here. Briefly, Oikonomou et al. generated two dendritic plateau potentials in two dendritic branches and monitored the summation of these dendritic plateau potentials in the cell body.

      The reference has been added, on l. 54

      (7) Line 63. "We compared the behaviour of our simplified model with that of the full, detailedbiophysical model". Which detailed biophysical model? Please cite here the detailed biophysical model that you used for comparisons with your simplified abstract model.

      The reference to the paper has been added.

      (8) Line 65. "Figure 2F shows that spikes arriving at different times are summed in anintegrate and hold-like manner". In Fig. 2F, I am unable to see that spikes arriving at different times are summed in an integrate and hold-like manner. Which feature of Fig. 2F refers to the "hold-like manner"? Please explain in the manuscript.

      To clarify we have added "Figure 2F, top" in the text (l. 71).

      (9) Figure 2 caption. "(F) The voltage traces of the abstract model, with and without plateaus.Because of the extended time duration of the plateau potentials, they sum accurately to produce a somatic spike". I am unable to understand what an "accurate summation" in Fig. 2 is. Could the authors provide an illustrative example of a situation in which the neuronal potentials DID NOT sum accurately?

      To address this confusion, we have changed the wording to "...they are summed to reach threshold."

      (10) Line 75. "This is an important issue we intend to return to in future work". The authorspersonal plans should not be in the text discussing scientific results.

      We believe it is entirely reasonable to discuss scientific plans that are part of ongoing work, and this is quite common throughout the literature. Nonetheless, we have now reworded this to "This is an important issue for future work." (l. 81)

      (11) In Fig. 4F, the full-line and the dashed-line have not been identified! The readers are leftto guess.

      This has now been addressed both with text inserts in the figure, and specification in the figure caption.

      (12) Line 247. "would amount to scaling up the number of cells in a network to performcomputations that could, in principle, be performed by more robust single units". Did the authors mean to say: "would amount to scaling up the number of cells in a network to perform computations that could, in principle, be performed by a fewer (but more robust) single units"?

      We have replaced the sentence with the reviewer's suggestion (l. 259)

      (13) In the abstract, the authors repeat sentences: "the timescale of dendritic potentialsallows reliable integration of asynchronous inputs" and "nonlinear dendritic plateau potentials allow reliable integration of asynchronous spikes". Besides this being a bad writing style, the authors cannot decide if inputs to the model neuron are asynchronous, or spiking of the model neuron is asynchronous. Are these asynchronous spikes occurring in the neuron experiencing dendritic plateau potentials, or these asynchronous spikes occur in the neuronal network? This confusion of terms and ideas must be removed from the abstract.

      We have rewritten the second sentence, which now reads: "Using this model, we show that long-lived, nonlinear dendritic plateau potentials allow neurons to spike reliably when confronted with asynchronous input spikes."

      (14) In the abstract, the authors claim: "Our results provide empirically testable hypothesesfor the role of dendritic action potentials in cortical function". With great anticipation, I read throughout the manuscript, but I was unable to find one single experimental design that could support the authors' bald statement. In the text of the manuscript, the authors must carefully reveal the precise experimental outline that would test their specific hypothesis, or delete the untrue statement.

      We respectfully challenge the rather critical tone of the reviewer. The central hypothesis that plateaus enable robust summation, and that circuit level computations rely on this is an experimentally testable hypothesis. The precise experimental design of how to test such a hypothesis is always best left to an experimentalist to determine, as there are many possible means of doing this and each will depend on the preparation and methodology at hand. At the same time, we understand that there is an increasing culture of expecting explicit "testable hypotheses" spelled out to the reader. To satisfy this expectation while avoiding overly prescriptive ideas for how future work should proceed, we have now added more explicit descriptions of possible experimental tests in l. 231 and onwards.

      (15) Fig. 2F was submitted for review without a time scale, while at the same time the authorsheavily discuss specific numerical values for time intervals. Namely, the authors instruct readers to pay attention to a 10 ms time constant and 2-3 ms input decay (Fig. 2F), but they do not show the time scale in Fig. 2F.

      "We compared this to a situation where all inputs arrive at a soma with standard LIF dynamics and a 10 ms membrane time constant. This time constant is consistent with the high-conductance state of pyramidal neurons in the cortex [6]: Inputs decay after 2-3 ms, and fail to sum to spike threshold (Figure 2F, lower)".

      The time (and voltage) bars have now been added to Fig. 2F.

      (16) Line 75. "In the scope of what remains here we want to ask if integrate-and-hold isminimally feasible". This reviewer is unable to understand the meaning of the syntaxes "integrate-and-hold" and "minimally feasible" in the context of dendritic integration. This reviewer is worried that the majority of the journal readers would feel exactly the same. To alleviate this problem, the authors should explain both terms right here, in line 77.

      Integrate-and-hold is defined on line 57 (to be exact we write: "We refer to this behavior as “Leaky Integrate-and-Hold” (LIH)." To be more clear we could reuse the acronym LIH here, to emphasise that we are referring to the same thing. By 'minimally feasible' we mean biologically plausible given assumptions that are not strong. Can use another term, e.g. "biologically plausible under lenient assumptions".

      To address this point, we have rephrased the sentence as "In the scope of what remains here we want to ask if Leaky-Integrate-and-Hold (LIH) can easily and plausibly facilitate network computations with spikes." (l. 81), repeating the LIH definition.

      (17) Line 91. "Spikes arriving even slightly out of sync with each other introduces noise in themembrane potential ..." Introduce.

      The sentence has been fixed using the reviewer's correction.

      (18) The caption of the Fig. 3B was submitted for review without any explanation of thenormalization procedure used. Also, in the caption of the same figure, one cannot find explanation of the light-gray area surrounding the black curves. Also, the readers are left to wonder how the results of a simulation could possibly be greater than 1 in some simulation trials.

      We have added a description of the normalization and the shaded area to the caption of Fig. 3B.

      (19) Line 117. "We assumed that inputs to a network arrive at the dendrites within some timewindow, and their combined depolarisations are either sufficient to either elicit a dendritic spike or not, as shown in Figure 3". We could potentially compact the current text by deleting one instance of "either".

      We agree this is better writing; one of the occurrences of 'either' has been removed.

      (20) Line 127. "where incoming connections can be represented with a 1 (a spike arrives)..."Did you mean "a presynaptic spike arrives"?

      The sentence has been rewritten following the suggestion.

      (21) Line 134. "with each unit only having ..." Dendrite can be a unit. Dendritic spine can be aunit. Did you mean "with each unit (i.e. neuron) having ..."

      We have incorporated the suggestion.

      (22) Fig. 4, Caption. "Each point is a 2D input vector x, the colors represent the differentclasses". An effort was made to introduce 3 different classes. But then, no mention of "classes" thereafter. The three input vectors, mentioned in Line 170, perhaps represent the remnants of the class concept mentioned in the previous paragraph.

      We have now rewritten the sentence beginning with "These three input vectors ..." on l. 182 to emphasise that a correct answer means a correct classification.

      (23) Line 152. "The 2D input points were first projected onto a binary feature space, to obtain13D binary vectors". Did you mean to say: "The 2D input points (three classes, Fig. A) were first projected onto a binary feature space, to obtain three binary vectors; each 13D binary vector responding to a specific class".

      The sentence has been replaced with the reviewer's suggestion (l. 159).

      (24) Line 163. "Because our focus is to account for how transient signals can be summed andthresholded robustly, we are assuming that inhibition is implicitly accounted for in the lumped abstraction". Could you please explain your two ideas: [1] "inhibition is implicitly accounted for" and [2] "lumped abstraction", because this reviewer did not get neither idea.

      The reviewer is right that as it stood, the sentence was unclear. To clarify the point we have decided to expand upon that sentence and break it out as an individual paragraph (starting l. 171).

    1. Author response:

      The following is the authors’ response to the previous reviews.

      Reviewer 1:

      This study is one in a series of excellent papers by the Forstmann group focusing on the ability of fMRI to reliably detect activity in small subcortical nuclei - in this case, specifically those purportedly involved in the hyper- and indirect inhibitory basal ganglia pathways. I have been very fond of this work for a long time, beginning with the demonstration of De Hollander, Forstmann et al. (HBM 2017) of the fact that 3T fMRI imaging (as well as many 7T imaging sequences) do not afford sufficient signal to noise ratio to reliably image these small subcortical nuclei. This work has done a lot to reshape my view of seminal past studies of subcortical activity during inhibitory control, including some that have several thousand citations.

      Comments on revised version:

      This is my second review of this article, now entitled "Multi-study fMRI outlooks on subcortical BOLD responses in the stop-signal paradigm" by Isherwood and colleagues.

      The authors have been very responsive to the initial round of reviews.

      I still think it would be helpful to see a combined investigation of the available 7T data, just to really drive the point home that even with the best parameters and a multi-study sample size, fMRI cannot detect any increases in BOLD activity on successful stop compared to go trials. However, I agree with the authors that these "sub samples still lack the temporal resolution seemingly required for looking at the processes in the SST." As such, I don't have any more feedback.

      We thank the reviewer for their positive feedback, and for their thorough and constructive comments on our initial submission. 

      Reviewer 2:

      This work aggregates data across 5 openly available stopping studies (3 at 7 tesla and 2 at 3 tesla) to evaluate activity patterns across the common contrasts of Failed Stop (FS) > Go, FS > stop success (SS), and SS > Go. Previous work has implicated a set of regions that tend to be positively active in one or more of these contrasts, including the bilateral inferior frontal gyrus, preSMA, and multiple basal ganglia structures. However, the authors argue that upon closer examination, many previous papers have not found subcortical structures to be more active on SS than FS trials, bringing into question whether they play an essential role in (successful) inhibition. In order to evaluate this with more data and power, the authors aggregate across five datasets and find many areas that are *more* active for FS than SS, including bilateral preSMA, GPE, thalamus, and VTA. They argue that this brings into question the role of these areas in inhibition, based upon the assumption that areas involved in inhibition should be more active on successful stop than failed stop trials, not the opposite as they observed.

      Since the initial submission, the authors have improved their theoretical synthesis and changed their SSRT calculation method to the more appropriate integration method with replacement for go omissions. They have also done a better job of explaining how these fMRI results situate within the broader response inhibition literature including work using other neuroscience methods.

      They have also included a new Bayes Factor analysis. In the process of evaluating this new analysis, I recognized the following comments that I believe justify additional analyses and discussion:

      First, if I understand the author's pipeline, for the ROI analyses it is not appropriate to run FSL's FILM method on the data that were generated by repeating the same time series across all voxels of an ROI. FSL's FILM uses neighboring voxels in parts of the estimation to stabilize temporal correlation and variance estimates and was intended and evaluated for use on voxelwise data. Instead, I believe it would be more appropriate to average the level 1 contrast estimates over the voxels of each ROI to serve as the dependent variables in the ROI analysis.

      We agree with the reviewer’s assertion that this approach could create estimation problems. However, in this instance, we turned off the spatial smoothing procedure that FSL’s FILM normally uses for estimating the amount of autocorrelation – thus, the autocorrelation was estimated based on each voxel’s timeseries individually. We also confirmed that all voxels within each ROI had identical statistics, which would not be the case if the autocorrelation estimates differed per voxel. We have added the following text to the Methods section under fMRI analysis: ROI-wise:

      Note that the standard implementation of FSL FILM uses a spatial smoothing procedure prior to estimating temporal autocorrelations which is suitable for use only on voxelwise data (Woolrich et al., 2001). We therefore turned this spatial smoothing procedure off and instead estimated autocorrelation using each voxel’s individual timeseries.

      Second, for the group-level ROI analyses there seems to be inconsistencies when comparing the z-statistics (Figure 3) to the Bayes Factors (Figure 4) in that very similar zstatistics have very different Bayes Factors within the same contrast across different brain areas, which seemed surprising (e.g., a z of 6.64 has a BF of .858 while another with a z of 6.76 has a BF of 3.18). The authors do briefly discuss some instances in the frequentist and Bayesian results differ, but they do not ever explain by similar z-stats yield very different bayes factors for a given contrast across different brain areas. I believe a discussion of this would be useful.

      We thank the reviewer for their keen observation, and agree that this is indeed a strange inconsistency. Upon reviewing this issue, we came across an error in our analysis pipeline, which led to inconsistent scaling of the parameter estimates between datasets. We corrected this error, and included new tables (Figures 3, 4, and Supplementary Figure 5) which now show improved correspondence between the frequentist results from FSL and the Bayesian results.

      We have updated the text of the Results section accordingly. In this revision, we have also updated all BFs to be expressed in log<sub>10</sub> form, to ensure consistency for the reader. Updates to the manuscript are given below.

      Results: Behavioural Analyses:

      Consistent with the assumptions of the standard horse-race model (Logan & Cowan, 1984), the median failed stop RT is significantly faster within all datasets than the median go RT (Aron_3T: p < .001, BF<sub>log10</sub> = 2.77; Poldrack_3T: p < .001, BF<sub>log10</sub> = 23.49; deHollander_7T: p < .001, B BF<sub>log10</sub> = 8.88; Isherwood_7T: p < .001, BF<sub>log10</sub> = 2.95; Miletic_7T: p = .0019, BF<sub>log10</sub> = 1.35). Mean SSRTs were calculated using the integration method and are all within normal range across the datasets.

      Results: ROI-wise GLMS: 

      To further statistically compare the functional results between datasets, we then fit a set of GLMs using the canonical HRF with a temporal derivative to the timeseries extracted from each ROI. Below we show the results of the group-level ROI analyses over all datasets using z-scores (Fig. 3) and log-transformed Bayes Factors (BF; Fig. 4). Note that these values were time-locked to the onset of the go signal. See Supplementary Figure 5 for analyses where the FS and SS trials were time-locked to the onset of the stop signal. To account for multiple comparisons, threshold values were set using the FDR method for the frequentist analyses. 

      For the FS > GO contrast, the frequentist analysis found significant positive z-scores in all regions bar left and right M1, and the left GPi. The right M1 showed a significant negative z-score; left M1 and GPi showed no significant effect in this contrast. The BFs showed moderate or greater evidence for the alternative hypothesis in bilateral IFG, preSMA, caudate, STN, Tha, and VTA, and right GPe. Bilateral M1 and left GPi showed moderate evidence for the null. Evidence for other ROIs was anecdotal (see Fig 4). 

      For the FS > SS contrast, we found significant positive z-scores in in all regions except the left GPi. The BFs showed moderate or greater evidence for right IFG, right GPi, and bilateral M1, preSMA, Tha, and VTA, and moderate evidence for the null in left GPi. Evidence for other ROIs was anecdotal (see Fig 4). 

      For the SS > GO contrast we found a significant positive z-scores in bilateral IFG, right Tha, and right VTA, and significant negative z-scores in bilateral M1, left GPe, right GPi, and bilateral putamen. The BFs showed moderate or greater evidence for the alternative hypothesis in bilateral M1 and right IFG, and moderate or greater evidence for the null in left preSMA, bilateral caudate, bilateral GPe, left GPi, bilateral putamen, and bilateral SN. Evidence for other ROIs was anecdotal (see Fig 4). 

      Although the frequentist and Bayesian analyses are mostly in line with one another, there were also some differences, particularly in the contrasts with FS. In the FS > GO contrast, the interpretation of the GPi, GPe, putamen, and SN differ. The frequentist models suggests significantly increased activation for these regions (except left GPi) in FS trials. In the Bayesian model, this evidence was found to be anecdotal in the SN and right GPi, and moderate in the right GPe, while finding anecdotal or moderate evidence for the null hypothesis in the left GPe, left GPi, and putamen. For the FS > SS contrast, the frequentist analysis showed significant activation in all regions except for the left GPi, whereas the Bayesian analysis found this evidence to be only anecdotal, or in favour of the null for a large number of regions (see Fig 4 for details).  

      Since the Bayes Factor analysis appears to be based on repeated measures ANOVA and the z-statistics are from Flame1+2, the BayesFactor analysis model does not pair with the frequentist analysis model very cleanly. To facilitate comparison, I would recommend that the same repeated measures ANOVA model should be used in both cases. My reading of the literature is that there is no need to be concerned about any benefits of using Flame being lost, since heteroscedasticity does not impact type I errors and will only potentially impact power.

      We agree with the reviewer that there are differences between the two analyses. The advantage of the z-statistics from FSL’s flame 1+2 is that these are based on a multi-level model in which measurement error in the first level (i.e., subject level) is taken into account in the group-level analysis. This is an advantage especially in the current paper since the datasets differ strongly in the degree of measurement error, both due to the differences in field strength and in the number of trials (and volumes). Although multilevel Bayesian approaches exist, none (except by use of custom code) allow for convolution with the HRF of a design matrix like typical MRI analyses. Thus, we extracted the participant-level parameter estimates (converted to percent signal change), and only estimated the dataset and group level parameters with the BayesFactor package. As such, this approach effectively ignores measurement error. However, despite these differences in the analyses, the general conclusions from the Bayesian and frequentist analyses are very aligned after we corrected for the error described above. The Bayesian results are more conservative, which can be explained by the unfiltered participantlevel measurement error increasing the uncertainty of the group-level parameter estimates. At worst, the BFs represent the lower bounds of the true effect, and are thus safe to interpret. 

      We have also included an additional figure (Supplementary Figure 7) that shows the correspondence between the BFs and the z scores. 

      Though frequentist statistics suggest that many basal ganglia structures are significantly more active in the FS > SS contrast (see 2nd row of Figure 3), the Bayesian analyses are much more equivocal, with no basal ganglia areas showing Log10BF > 1 (which would be indicative of strong evidence). The authors suggest that "the frequentist and Bayesian analyses are monst in line with one another", but in my view, this frequentist vs. Bayesian analysis for the FS > SS contrast seems to suggest substantially different conclusions. More specifically, the frequentist analyses suggest greater activity in FS than SS in most basal ganglia ROIs (all but 2), but the Bayesian analysis did not find *any* basal ganglia ROIs with strong evidence for the alternative hypothesis (or a difference), and several with more evidence for the null than the alternative hypothesis. This difference between the frequentist and Bayesian analyses seems to warrant discussion, but unless I overlooked it, the Bayesian analyses are not mentioned in the Discussion at all. In my view, the frequentist analyses are treated as the results, and the Bayesian analyses were largely ignored.

      The original manuscript only used frequentist statistics to assess the results, and then added Bayesian analyses later in response to a reviewer comment. We agree that the revised discussion did not consider the Bayesian results in enough detail, and have updated the manuscript throughout to more thoroughly incorporate the Bayesian analyses and improve overall readability. 

      In the Methods section, we have updated the fMRI analysis – general linear models (GLMs): ROIwise GLMs section to more thoroughly incorporate the Bayesian analyses as follows: 

      We compared the full model (H1) comprising trial type, dataset and subject as predictors to the null model (H0) comprising only the dataset and subject as predictor. Datasets and subjects were modeled as random factors in both cases. Since effect sizes in fMRI analyses are typically small, we set the scaling parameter on the effect size prior for fixed effects to 0.25, instead of the default of 0.5, which assumes medium effect sizes (note that the same qualitative conclusions would be reached with the default prior setting; Rouder et al., 2009). We divided the resultant BFs from the full model by the null model to provide evidence for or against a difference in beta weights for each trial type. To interpret the BFs, we used a modified version of Jeffreys’ scale (Andraszewicz et al., 2014; Jeffreys, 1939). To facilitate interpretation of the BFs, we converted them to the logarithmic scale. The approximate conversion between the interpretation of logarithmic BFs and standard interpretation on the adjusted Jeffreys’ scale can be found in Table 3.   

      The Bayesian results are also more incorporated into the Discussion as follows: 

      Evidence for the role of the basal ganglia in response inhibition comes from a multitude of studies citing significant activation of either the SN, STN or GPe during successful inhibition trials (Aron, 2007; Aron & Poldrack, 2006; Mallet et al., 2016; Nambu et al., 2002; Zhang & Iwaki, 2019). Here, we re-examined activation patterns in the subcortex across five different datasets, identifying differences in regional activation using both frequentist and Bayesian approaches. Broadly, the frequentist approach found significant differences between most ROIs in FS>GO and FS>SS contrasts, and limited differences in the SS>GO contrast. The Bayesian results were more conservative; while many of the ROIs showed moderate or strong evidence, some with small but significant z scores were considered only anecdotal by the Bayesian analysis. In our discussion, where the findings between analytical approaches differ, we focus mainly on the more conservative Bayesian analysis.

      Here, our multi-study results found limited evidence that the canonical inhibition pathways (the indirect and hyperdirect pathways) are recruited during successful response inhibition in the SST. We expected to find increased activation in the nodes of the indirect pathway (e.g., the preSMA, GPe, STN, SN, GPi, and thalamus) during successful stop compared to go or failed stop trials. We found strong evidence for activation pattern differences in the preSMA, thalamus, and right GPi between the two stop types (failed and successful), and limited evidence, or evidence in favour of the null hypothesis, in the other regions, such as the GPe, STN, and SN. However, we did find recruitment of subcortical nodes (VTA, thalamus, STN, and caudate), as well as preSMA and IFG activation during failed stop trials. We suggest that these results indicate that failing to inhibit one’s action is a larger driver of the utilisation of these nodes than action cancellation itself. 

      These results are in contention to many previous fMRI studies of the stop signal task as well as research using other measurement techniques such as local field potential recordings, direct subcortical stimulation, and animal studies, where activation of particularly the STN has consistently been observed (Alegre et al., 2013b; Aron & Poldrack, 2006; Benis et al., 2014; Fischer et al., 2017; Mancini et al., 2019; Wessel et al., 2016).

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public Review):

      Summary:

      This study analyzed biomarker data from 28 subjects with geographic atrophy (GA) in a Phase I/II clinical trial of PPY988, a subretinal AAV2 complement factor I (CFI) gene therapy, to evaluate pharmacokinetics and pharmacodynamics. Post-treatment, a 2-fold increase in the vitreous humor (VH) FI was observed, correlating with a reduction in FB breakdown product Ba but minimal changes in other complement factors. The aqueous humor (AH) was found to be an unreliable proxy for VH in assessing complement activation. In vitro assays showed that the increase in FI had a minor effect on the complement amplification loop compared to the more potent C3 inhibitor pegcetacoplan. These findings suggest that PPY988 may not provide enough FI protein to effectively modulate complement activation and slow GA progression, highlighting the need for a thorough biomarker review to determine optimal dosing in future studies.

      Strengths:

      This manuscript provides critical data on the efficacy of gene therapy for the eye, specifically introducing complement FI expression. It presents the results from a halted clinical trial, making sharing this data essential for understanding the outcomes of this gene therapy approach. The findings offer valuable insights and lessons for future gene therapy attempts in similar contexts.

      Weaknesses:

      No particular weaknesses. The study was carefully performed and limitations are discussed.

      I have just some concerns about the methodology used. The authors use the MILLIPLEX assays, which allow for multiplexed detection of complement proteins and they mention extensive validation. How are the measurements with this assay correlating with gold standard methods? Is the specificity and the expected normal ranges preserved with this assay? This also stands for the Olink assay. Some of the proteins are measured by both assay and/or by standard ELISA. How do these measurements correlate?

      The authors thank the reviewer for the positive response. Regarding the ELISA assays used to measure the array of complement proteins described, these were extensively validated for the following parameters: specificity, intra-assay and inter-assay precision, accuracy, stability, reference range, and parallelism. All assays were validated in plasma, vitreous and aqueous humour. Due to the limited volume and availability of ocular fluids from individuals in the study, validation in vitreous and aqueous matrices was performed using a pool of several samples from post-mortem donors. At the time this study was initiated, the Millipore Luminex complement panels and the Quidel C3a and Ba EIA were the most sensitive assays and the only commercially available options capable of measuring the proteins of interest in the context of limited vitreous and aqueous humor sample. The concentrations measured were observed at similar ranges as those published in the literature using assays in distinct patient populations e.g. in (Mandava et al, Invest Ophthalmol Vis Sci, 2020).

      Measurements from vitreous and aqueous from subject samples were deemed reportable if they were within the quantifiable ranges defined for these sample types during the validation (coefficient of variation of 20%, or 30% when results were below the lower limit of quantification but above limit of detection). Notably, given the limited amount of biomarker data due to small sample size, we share results from outlier biomarker measurements, to illustrate the heterogeneity in sample quality. We further publish plasma sample biomarker results in supplemental table 5 wherein complement protein concentrations can be observed and compared to normal ranges in the literature.

      Adding confidence to the robustness of our assays was the observation that some of the complement proteins quantified by standard assay (e.g. plate and bead-based ELISAs) were also measured by the OLINK assay, and there was a general trend observed for positive correlation between results from both assays for FI levels post-treatment. However, we did not provide detailed correlative statistical analyses for further complement proteins as OLINK findings were deemed highly exploratory and hypothesis generating, and because the OLINK assay produced normalised results which are challenging to directly compare to ELISA results that were absolute.

      Reviewer #2 (Public Review):

      Summary:

      The results presented demonstrate that AAV2-CFI gene therapy delivers long-term and marginally higher FI protein in vitreous humor that results in a concomitant reduction in the FB activation product Ba. However, the lack of clinical efficacy in the phase I/II study, possibly due to lower in vitro potency when compared to currently approved pegcetacoplan, raises important considerations for the utility of this therapeutic approach. Despite the early termination of the PPY988 clinical development program, the study achieved significant milestones, including the implementation of subretinal gene therapy delivery in older adults, complement biomarker comparison between serial vitreous humor and aqueous humor samples and vitreous humor proteomic assessment via Olink.

      Strengths:

      Long-term augmentation of FI protein in vitreous humor over 96 weeks and reduction of FB breakdown product Ba in vitreous humor suggests modulation of the complement system. Developed a novel in vitro assay suggesting FI's ability to reduce C3 convertase activity is weaker than pegcetacoplan and FH and may suggest a higher dose of FI will be required for clinical efficacy. Warn of the poor correlation between vitreous humor and aqueous humor biomarkers and suggest aqueous humor may not be a reliable proxy for vitreous humor with regard to complement activation/inhibition studies.

      Weaknesses:

      The vitrectomy required for the subretinal route of administration causes a long-term loss of total protein and may influence the interpretation of complement biomarker results even with normalization. The modified in vitro assay of complement activation suggests a several hundred-fold increase in FI protein is required to significantly affect C3a levels. Interestingly, the in vitro assay demonstrates 100% inhibition of C3a with pegcetacoplan and FH therapeutics, but only a 50% reduction with FI even at the highest concentrations tested. This observation suggests FI may not be rate-limiting for negative complement regulation under the in vitro conditions tested and potentially in the eye. It is unclear if pharmacokinetic and pharmacodynamic properties in aqueous humor and vitreous humor compartments are reliable predictors of FI level/activity after subretinal delivery AAV2-CFI gene therapy.

      The authors thank the reviewer for the positive response and we agree that a limitation of the biomarker strategy for ocular gene therapy delivered to the retinal tissues is inferring PK/PD from vitreous and aqueous samples, which are the fluid sample compartments accessible from subjects available to measure molecular treatment response. We agree that these compartments may not accurately represent sub-retinal and tissue level complement turnover. In the discussion, line 508, we state: ‘Overall, the data suggests that fully functional FI is being secreted into the VH, but the regulatory effects on the level of Ba may be representative of convertase formation in the VH and not the macula retina/RPE nor the choroid. To validate this hypothesis, one approach would be to conduct vitreal sampling using an effective drug targeting C3 for GA in a larger cohort’.

      However, the observation of elevation of FI in VH (and AH) post treatment, and changes in levels of downstream complement proteins that align with prior knowledge of control of alternative pathway activation, is compelling evidence that these measurements reflect modest but direct consequences of an FI-gene therapy that was delivered to the subretinal space. We add to the discussion, line 479: ‘the findings of elevated FI in the VH after sub-retinally delivered CFI gene therapy and changes in complement pathway proteins post-treatment build confidence that VH matrix is at least partially reflecting the complement system at the retinal layers and treatment site, and is a valid biomarker for PK/PD insights in response to treatment.’

      Furthermore, the observation of moderately raised FI levels in modelled VH post treatment being insufficient to control CS activation in vitro accords with the lack of clinical response observed at phase II. We note that measuring FI and complement biomarkers in retinal tissues from treated eyes at post-mortem would be one way to explore the PK/PD effects from AAV2-FI gene therapy.

      Reviewer #3 (Public Review):

      Summary:

      The manuscript by Hallam et al describes the analysis of various biomarkers in patients undergoing complement factor I supplementation treatment (PPY988 gene therapy) as part of the FOCUS Phase I/II clinical trial. The authors used validated methods (multiplexed assays and OLINK proteomics) for measuring multiple soluble complement proteins in the aqueous humour (AH) and vitreous humour (VH) of 28 patients over a series of time points, up to and including 96 weeks. Based on biomarker comparisons, the levels of FI synthesised by PPY988 were believed to be insufficient to achieve the desired level of complement inhibition. Subsequent comparative experiments showed that PPY988-delivered FI was much less efficacious than Pegceptacoplan (FDA-approved complement inhibitor under the name SYFORVE) when tested in an artificial VH matrix.

      Strengths:

      The manuscript is well written with data clearly presented and appropriate statistics used for the analysis itself. It's great to see data from real clinical samples that can help support future studies and therapeutic design. The identification that complement biomarker levels present in the AH do not represent the levels found in the VH is an important finding for the field, given the number of complement-targeting therapies in development and the desperate need for good biomarkers for target engagement. This study also provides a wealth of baseline complement protein measurements in both human AH and VH (and companion measurements in plasma) that will prove useful for future studies.

      Weaknesses:

      Perhaps the conclusions drawn regarding the lack of observed efficacy are not fully justified. The authors focus on the hypothesis that not enough FI was synthesised in these patients receiving the PPY988 gene therapy, suggesting a delivery/transduction/expression issue. But beyond rare CFI genetic variants, most genetic associations with AMD imply that it is a FI-cofactor disease. A hypothesis supported by the authors' own experiments when they supplement their artificial VH matrix with FH and achieve a significantly greater breakdown of C3b than achieved with PPY988 treatment alone. Justification around doubling FI levels driving complement turnover refers to studies conducted in blood, which has an entirely different complement protein profile than VH. In Supplemental Table 5 we see there is approx. 10-fold more FH than FI (533ug/ml vs 50ug/ml respectively) so increasing FI levels will have a direct effect. Yet in Supplemental Table 3 we see there is more FI than FH in VH (608ng/ml vs 466ng/ml respectively). Therefore, adding more FI without more co-factors would have a very limited effect. Surely this demonstrates that the study was delivering the wrong payload, i.e. FI, which hit a natural ceiling of endogenous co-factors within the eye?

      See response to reviewer 3’s review after reviewer 3 recommendations section below.

      Recommendations for the authors:

      Reviewer #2 (Recommendations For The Authors):

      The authors present strong evidence using validated complement biomarker assays and comprehensive proteomic profiling that support their findings. The presentation of complement biomarker data in vitreous humor and aqueous humor after FI augmentation is presented in a clear and concise format. The direct comparison of complement biomarkers in vitreous humor and aqueous humor from the same patients and demonstrating similarities and differences is important for the nascent complement gene therapy field. Developing a novel in vitro complement model and comparing pegcetacoplan, FH, and FI inhibitors provides the field with a valuable assay to benchmark other complement therapeutics. As currently designed, the in vitro assay supports why FI augmentation did not contribute to clinical success. It also suggests that non-physiological concentrations of FI protein (over 100 µg/mL) maximally inhibit C3a signal by ~50%, whereas both pegcetacoplan and FH reduce the signal by 100%. Does this suggest that CFI is not an appropriate therapeutic target to control complement overactivation in the eye?

      We agree with the reviewer that the new data from the novel in vitro assay coupled with the clinical findings from the phase II gene therapy trial does now suggest FI is less attractive as a therapeutic target for controlling complement activation in the retinal tissues of subjects with Geographic Atrophy.

      Reviewer #3 (Recommendations For The Authors):

      I think the authors have done a great job collecting and analysing these clinical samples and elucidating the baseline complement protein profile in both the AH and VH. I only have minimal suggested changes.

      Perhaps a more direct discussion around the limitations of adding more FI into environments where there is no excess of FI-cofactors present? And a discussion around the limitations of VH (and VA for that matter) biomarker sampling for a disease that primarily affects the neurosensory retina and outer blood/retinal barrier: perhaps the landscape of complement proteins is different yet again (although, admittedly, impossible to sample in a patient)? Finally, would it not have been better to perform complement activation experiments using the VH of treated patients directly rather than creating an artificial VH matrix (there may, or may not, be a couple of things in human VH that directly affect complement turnover...)?

      We thank the reviewer for the supportive comments. This study is the first to describe FI and FH levels and respective ratios in vitreous humour (plus aqueous and plasma) from GA subjects, before and after sub-retinal gene therapy. It is compelling to observe that in the VH the levels of FI are greater than FH, the primary fluid phase co-factor for FI enzymatic activity. This new information does indeed argue against further FI supplementation (using gene therapy) being of added benefit to controlling the complement system in the broader population in individuals with Geographic Atrophy. We note that at the start of the clinical development of GT005/PPY988 AAV2-FI gene therapy, there was limited information on FI and FH levels in AMD in ocular fluids to inform the pharmacodynamics of complement activation. Now, by running the FOCUS phase I clinical trial and measuring the complement biomarker data using validated assays we have added to our understanding on the levels and ratio of FI to FH and other complement proteins in a larger number of GA subjects’ ocular samples.  We report the levels of complement proteins measured in ocular and systemic samples, to show the ranges and also the differences in ratios between the different matrices.   

      Regarding the statement that FI supplementation could likely be ineffective due to limited FH cofactor; FH is not the only co-factor that FI may partner with at cell surfaces to become enzymatically active (others include MCP (CD46) and CR1 (CD35), although the latter is known to be of limited expression in the eye), as such, it is certainly true that other proteins may be present in the tissue altering the kinetics of FI’s activity after sub-retinal gene-therapy. In addition, the ratio between FI and FH detected in the VH may not be the same as in retinal tissue. As such, we agree that drawing insights from biomarkers in the VH may not fully reflect the disease processes and treatment response at the retinal cell layers, but it is the closest fluid sample available to sample tissue released soluble proteins. We acknowledge that VH biomarkers will not fully capture retinal disease processes and treatment responses, but due to their proximity, will reflect retina-released soluble proteins. The findings of elevated FI in the VH after sub-retinally delivered CFI gene therapy and changes in complement pathway proteins post-treatment build confidence that VH matrix is at least partially reflecting the complement system at the retinal layers and treatment site, and is a valid biomarker for PK/PD insights in response to treatment. We agree modelling different inhibitor effects on complement activation directly using subject’s vitreous would be informative, but this was not possible due to the limitations of very small sample volume.

      We add several sentences to the discussion regarding the points above. Line 473: ‘Notably, that FI does not reduce C3a breakdown to baseline even at supermolecular concentrations suggests cofactor limitation that might be more pronounced in VH given FH is not in excess of FI as is the case in blood 27. Moreover, there are additional cell-bound cofactors for FI that may be present in retinal tissue that are not present in the VH and could further alter the kinetics of the assay, such as MCP (CD46) albeit with disease related changes observed 37. However, the findings of elevated FI in the VH after sub-retinally delivered CFI gene therapy and changes in complement pathway proteins post-treatment build confidence that VH matrix is at least partially reflecting the complement system at the retinal layers and treatment site, and is a valid biomarker for PK/PD insights in response to treatment.’

      Minor comments:

      Line 237: Missing parenthesis at the end of the sentence

      Manuscript updated.

      Line 435: Missing secondary parenthesis after .....Figure 3A)......

      Manuscript updated.

      Line 536: I don't think suggesting the addition of FHR proteins into the neurosensory retina/VH is such a good idea

      The reference to FHRs has been clarified in the manuscript, line 558. The authors note that FHR dimerization domains have been engineered to dimerize Factor H constructs increasing half-life and potency for drugs currently in development.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public Review):

      Summary:

      Chlamydia spp. has a biphasic developmental cycle consisting of an extracellular, infectious form called an elementary body (EB) and an intracellular, replicative form known as a reticular body (RB). The structural stability of EBs is maintained by extensive cross-linking of outer membrane proteins while the outer membrane proteins of RBs are in a reduced state. The overall redox state of EBs is more oxidized than RBs. The authors propose that the redox state may be a controlling factor in the developmental cycle. To test this, alkyl hydroperoxide reductase subunit C (ahpC) was overexpressed or knocked down to examine effects on developmental gene expression. KD of ahpC induced increased expression of EB-specific genes and accelerated EB production. Conversely, overexpression of ahpC delayed differentiation to EBs. The results suggest that chlamydial redox state may play a role in differentiation.

      Strengths:

      Uses modern genetic tools to explore the difficult area of temporal gene expression throughout the chlamydial developmental cycle.

      Weaknesses:

      The environmental signals triggering ahpC expression/activity are not determined.

      Thank you for your comments. Our data and those of others have shown that ahpC is expressed as a mid-developmental cycle gene (i.e., when RBs predominate in the population). This is true of most chlamydial genes, and the factors that determine developmental expression are not fully understood. As we noted in the Discussion, Chlamydia lacks AhpF/D orthologs, so it is not clear how AhpC activity is regulated. Related to determining environmental signals that trigger activity of AhpC, then this is a non-trivial issue in an obligate intracellular bacterium. Our assumption is that AhpC is constitutively active and that the increasing metabolic production of ROS eventually overcomes the innate (and stochastic) activity of AhpC to handle it, hence the threshold hypothesis. Importantly, the stochasticity is consistent with what we know about secondary differentiation in Chlamydia. We have tried to clarify these points in the Discussion.

      Reviewer #2 (Public Review):

      The factors that influence the differentiation of EBs and RBs during Chlamydial development are not clearly understood. A previous study had shown a redox oscillation during the Chlamydial developmental cycle. Based on this observation, the authors hypothesize that the bacterial redox state may play a role in regulating the differentiation in Chlamydia. To test their hypothesis, they make knock-down and overexpression strains of the major ROS regulator, ahpC. They show that the knock-down of ahpC leads to a significant increase in ROS levels leading to an increase in the production of elementary bodies and overexpression leads to a decrease in EB production likely caused by a decrease in oxidation. From their observations, they present an interesting model wherein an increase in oxidation favors the production of EBs.

      Major concern:

      In the absence of proper redox potential measurements, it is not clear if what they observe is a general oxidative stress response, especially when the knock-down of ahpC leads to a significant increase in ROS levels. Direct redox potential measurement in the ahpC overexpression and knock-down cells is required to support the model. This can be done using the roGFP-based measurements mentioned in the Wang et al. 2014 study cited by the authors.

      Thank you for this suggestion. It is definitely something that we are looking to implement. However, our current vectors don’t allow for roGFP2 in combination with inducible expression of a gene of interest. We will need to completely redesign our vectors, and, in Chlamydia, the validation of such new vectors together with ahpC OE or KD may literally take a year or longer.

      In lieu of this, we used the CellRox redox reactive dye to image live chlamydiae during normal growth or ahpC KD. During ahpC KD, these organisms are clearly much brighter than the control, uninduced conditions. These data are included as new Figure 5 to go along with the data we previously reported from the plate reader measurements. These data also clearly indicate that the readings we observed are from Chlamydia and not the host cell.

      As far as a general oxidative stress response, Chlamydia lacks any transcriptional regulators akin to OxyR. The response we’ve measured, earlier expression of genes associated with secondary differentiation, would be an odd stress response not consistent with a focused program to respond to oxidative stress. We added new RNAseq data further showing this effect of a global earlier increase in late gene transcripts.

      Reviewer #3 (Public Review):

      Summary:

      The study reports clearly on the role of the AhpC protein as an antioxidant factor in Chlamydia trachomatis and speculates on the role of AhpC as an indirect regulator of developmental transcription induced by redox stress in this differentiating obligate intracellular bacterium.

      Strengths:

      The question posed and the concluding model about redox-dependent differentiation in chlamydia is interesting and highly relevant. This work fits with other propositions in which redox changes have been reported during bacterial developmental cycles, potentially as triggers, but have not been cited (examples PMID: 2865432, PMID: 32090198, PMID: 26063575). Here, AhpC over-expression is shown to protect Chlamydia towards redox stress imposed by H2O2, CHP, TBHP, and PN, while CRISPRi-mediated depletion of AhpC curbed intracellular replication and resulted in increased ROS levels and sensitivity to oxidizing agents. Importantly, the addition of ROS scavengers mitigated the growth defect caused by AhpC depletion. These results clearly establish the role of AhpC affects the redox state and growth in Ct (with the complicated KO genetics and complementation that are very nicely done).

      Weaknesses:

      However, with respect to the most important implication and claims of this work, the role of redox in controlling the chlamydial developmental cycle rather than simply being a correlation/passenger effect, I am less convinced about the impact of this work. First, the study is largely observational and does not resolve how this redox control of the cell cycle could be achieved, whereas in the case of _Caulobacte_r, a clear molecular link between DNA replication and redox has been proposed. How would progressive oxidation in RBs eventually trigger the secondary developmental genes to induce EB differentiation? Is there an OxyR homolog that could elicit this change and why would the oxidation stress in RBs gradually accumulate during growth despite the presence of AhpC? In other words, the role of AhpC is simply to delay or dampen the redox stress response until the trigger kicks in, again, what is the trigger? Is this caused by increasing oxidative respiration of RBs in the inclusion? But what determines the redox threshold?

      Thank you for your comments. As the reviewer notes, our work clearly demonstrates that AhpC acts as an antioxidant in Chlamydia trachomatis. Further, we have shown that transcription of the late cycle genes is altered upon altered activity of AhpC, which acts as a proof of concept that redox is (one of) the key factor(s) controlling developmental cycle progression in Chlamydia. Our new RNAseq data indicate that a broad swath of well characterized late genes is activated, which contradicts the argument that what we’ve measured is a stress response (unless activation of late genes in Chlamydia is generally a stress response (not the case based on other models of stress) – in which case we would not be able to differentiate between these effects). We hypothesize that ROS production from the metabolic activities of RBs serves as a signal to trigger secondary differentiation from RBs to EBs. How this exact threshold is determined is currently unknown as Chlamydia does not have any annotated homolog for OxyR. It is beyond the scope of the present manuscript to identify and then characterize what specific factor(s) control(s) this response. We fully anticipate that multiple factors are likely impacted by increasing oxidation, so dissecting the exact contributions of any one factor will represent (a) potential separate manuscript(s). Nonetheless, this remains an overarching goal of the lab yet remains challenging given the obligate intracellular nature of Chlamydia. Strategies that would work in a model system, like Caulobacter, that can be grown in axenic media are not easily implemented in Chlamydia.

      As we noted above in another response, ahpC is transcribed as a mid-cycle gene with a peak of transcription corresponding to the RB phase of growth. We hypothesize that the gradual accumulation of ROS from metabolic activity will eventually supercede the ability of AhpC to detoxify it. This would result in any given RB asynchronously and stochastically passing this threshold (and triggering EB formation), which is consistent with what we know about secondary differentiation in Chlamydia.

      I also find the experiment with Pen treatment to have little predictive power. The fact that transcription just proceeds when division is blocked is not unprecedented. This also happens during the Caulobacter cell cycle when FtsZ is depleted for most developmental genes, except for those that are activated upon completion of the asymmetric cell division and that is dependent on the completion of compartmentalization. This is a smaller subset of developmental genes in caulobacter, but if there is a similar subset that depends on division on chlamydia and if these are affected by redox as well, then the argument about the interplay between developmental transcription and redox becomes much stronger and the link more intriguing. Another possibility to strengthen the study is to show that redox-regulated genes are under the direct control of chlamydial developmental regulators such as Euo, HctA, or others and at least show dual regulation by these inputs -perhaps the feed occurs through the same path.

      Comparisons to other model systems are generally of limited value with Chlamydia. All chlamydial cell division genes are mid-cycle (RB-specific) genes, just like ahpC. There is no evidence of a redox-responsive transcription factor (whether EUO, HctA, or another) that activates or represses a subset of genes in Chlamydia. Similarly, there is no evidence that redox directly and specifically impacts transcription of cell division genes based on our new RNAseq data. The types of experiments suggested are not easily implemented in Chlamydia, but we would certainly like to be able to do them.

      As it pertains to penicillin specifically, we and others have shown that treating chlamydiae with Pen blocks secondary differentiation (meaning late genes are not transcribed). Effectively, Pen treatment freezes the organism in an RB state with continued transcription of RB genes. What we have shown is that, even during Pen treatment (which blocks late gene transcription), ahpC KD can overcome this block, which shows that elevated oxidation is able to trigger late gene expression even when the organisms are phenotypically blocked from progressing to EBs. The comparison from our perspective to Caulobacter is of limited value.

      This redox-transcription shortcoming is also reflected in the discussion where most are about the effects and molecular mitigation of redox stress in various systems, but there is little discussion on its link with developmental transcription in bacteria in general and chlamydia.

      We have edited the Discussion to include a broader description of the results and included additional citations as suggested by the reviewer (PMID: 32090198, PMID: 26063575). However, we found one suggested article (PMID: 2865432) is not relevant to our study, so we didn’t cite it in our present manuscript. There may have been a typo, so feel free to provide us the correct PMID that can be cited.

      Reviewer #1 (Recommendations For The Authors):

      (1) Line 146. A minor point, but inclusion-forming units directly measure infectious EBs. In some cases, the particle-to-infectivity ratio approaches unity. I don't believe IFUs are a "proxy".

      Following reviewers comment we have modified the statement.

      (2) Figure 2E. Results are normalized to uninduced. The actual number of IFUs in the uninduced should be provided.

      In the revised version of the manuscript, we have provided actual number of IFUs at 24 and 48 hpi in the uninduced condition of both ahpC OE and EV.

      (3) Figures 3B&D. The shades of gray are not possible to distinguish. I'd suggest color or direct labeling.

      Following reviewer’s suggestion, in the latest version of the manuscript we have replaced gray shaded graphs with RGB colored graphs for better visualization and understanding.

      (4) Lines 217-224, Figure 4. Is it possible to get micrographs of the reporter retention in chlamydiae to demonstrate that it is chlamydial ROS levels that are being measured and not cellular?

      Following reviewer’s comment, we performed live-cell microscopy using uninfected HeLa cells and ahpC KD in the uninduced and induced conditions at 24 and 40 hpi. We have created new Fig. 5A with the quantitative ROS measurement graph done by the plate reader (old figure 4 E) and these new 24 hpi/40 hpi microscopy images (Fig 5B and S4).

      (5) The Discussion is overly long and redundant. Large portions of the discussion are simply a rehash of the Results listing by figure number the relevant conclusions.

      Following reviewer’s suggestion, the discussion is modified.

      Reviewer #2 (Recommendations For The Authors):

      (1) In Figure 2, ahpC is significantly overexpressed at 14 hpi. An IFA as in 2B for 14hpi will be useful. This will help to understand how quick the effect of ahpC overexpression is on development.

      We have added 14 hpi IFA of ahpC and EV as part of Fig 2B.

      (2) In Figure 2E, is there a reason that there is no increase in recoverable IFUs between 24h and 48h for the EV?

      The graph in 2E is % of uninduced. For more clarity, we have mentioned absolute IFUs of uninduced samples in the revised manuscript and IFU level at 48 hpi IFU is higher than the 24 hpi.

      (3) In Figure 3, Can relative levels of RB vs EB measured? This will provide a convincing case for the production of more EBs even when only less/more RBs are present. The same stands for Figure 4.

      We assumed that the comment is for Fig. 2 not the Fig. 3 and following reviewer’s constructive suggestion, we have attempted to resolve the issue. We normalized log10 IFUs/ml with log10 gDNA for 24 hpi and added as figure 2F and 4E. This may resolve the reviewer’s concern about the levels of RBs and EBs.

      (4) A colour-coded Figure 3B and D, instead of various shades of grey, will be easy for the reader to interpret.

      Agreed with the reviewer. For better visualization and understanding of the data, we have replaced gray shaded graphs with RGB colored graphs in the latest version of the manuscript.

      Reviewer #3 (Recommendations For The Authors):

      Other comments:

      (1) The first paragraph of the discussion should be deleted. It's not very useful or revealing and just delivers self-citations.

      Following reviewer’s suggestion, we rewrote the discussion.

      (2) The first paragraph of the results section does not present results. It's an intro.

      We incorporated this information into the Intro as suggested.

      (3) Has the redox difference between RBs and EBs been experimentally verified by these authors as depicted and claimed in Figure 1A with the cell-permeable, fluorogenic dye CellROX Deep Red for example? It is important to confirm this for EBs and RBs in this setup.

      The difference between redox status of RBs and EBs is studied and established before by previous studies such as Wang et al., 2014.

      (4) l77. Obligate intracellular alpha-proteobacteria also differentiate ... not only chlamydiae.

      We have modified the sentence.

      (5) l127. Is the redox state altered upon ahpC overexpression?

      The ahpC overexpression strain showed hyper resistance for the tested oxidizing agents (including the highest concentration tested) indicating highly reduced conditions as a result of higher activity of AhpC.

    1. Author response:

      The following is the authors’ response to the original reviews.

      We sincerely thank the Editor and the Reviewers for their time and effort in thoroughly reviewing our manuscript and providing valuable feedback. We hope we have addressed their comments effectively and improved the clarity of our manuscript as a result.

      The major revisions in the updated manuscript are as follows:

      (1) Immunization experiments using mRNA in Syrian hamsters were performed (Supplementary figures 2A, B and C).

      (2) An ELISPOT assay to evaluate cellular immunity in Syrian hamsters inoculated with BK2102 was conducted (Figure 2F).

      (3) IgA titers in BK2102-inoculated Syrian hamsters were successfully measured (Supplementary figure 2B).

      (4) New immunogenicity data for BK2102 in monkeys was additionally included (Supplementary figure 3B).

      (5) The discussion section has been thoroughly revised to integrate the new data.

      These results have been incorporated into the manuscript, and additional text has been added accordingly.

      Below, we provide point-by-point responses to the reviewers’ comments and concerns.

      Public Reviews:

      Reviewer #1:

      (1) A comparative safety assessment of the available m-RNA and live attenuated vaccines will be necessary. The comparison should include details of the doses, neutralizing antibody titers with duration of protection, tissue damage in the various organs, and other risks, including virulence reversal.

      We agree with the Reviewer’s comment regarding the lack of data to compare BK2102 with an mRNA vaccine. Unfortunately, we were unable to obtain commercially available mRNA vaccines for research purposes and could not produce mRNA vaccines of equivalent quality. As a result, a direct comparison of the safety profiles of BK2102 and mRNA vaccines was not possible. To address this, we conducted a GLP study with an additional twelve monkeys to evaluate the safety of BK2102. Following three intranasal inoculations of BK2102 at two-week intervals, no toxic effects were observed in any of the parameters assessed, including tissue damage, respiratory rate, functional observational battery (FOB), hematology, or fever. These results are detailed in lines 115-117.

      Furthermore, we compared the immunogenicity of BK2102 with that of an in-house prepared mRNA vaccine. The mRNA vaccine was designed to target the spike protein of SARS-CoV-2, and its immunogenicity was evaluated in hamsters. When serum neutralizing antibody titers were found to be comparable between the two, intranasal inoculation of BK2102 induced higher IgA levels in nasal wash samples compared to those from hamsters injected intramuscularly with the self-made mRNA vaccine (Supplementary figures. 2A and B, respectively). Additionally, while the mRNA vaccine induced Th1 and Th2 immune responses, as indicated by the detection of IgG1 and IgG2/3 (Supplementary figure. 2C), BK2102 mainly induced a Th1 response in hamsters. These explanatory sentences have been added to the manuscript (lines 140-150).

      (2) The vaccine's effect on primates is doubtful. The study fails to explain why only two of four monkeys developed neutralizing antibodies. Information about the vaccine's testing in monkeys is also missing: What was the level of protection and duration of the persistence of neutralizing antibodies in monkeys? Were the tissue damages and other risks assessed?

      We believe that the reason neutralizing antibody titers were observed in only 2 out of 4 monkeys in the immunogenicity study reported in the original manuscript is that only a single-dose was administered. We measured the neutralizing antibody titers in sera collected from monkeys used in the GLP study and confirmed the induction of neutralizing antibody in all 6 monkeys that received three inoculations of BK2102. This data has been included in a new figure (Supplementary figure 3B). While we would have liked to evaluate the persistence of immunity and conduct a protection study in monkeys, limitations related to facility availability and cost prevented us from doing so. As noted in (1), tissue injury and other risk assessments were evaluated in the GLP study, which showed no evidence of tissue injury or other toxic effects. These results are described in lines 113-117.

      (3) The vaccine's safety in immunosuppressed individuals or individuals with chronic diseases should be assessed. Authors should make specific comments on this aspect.

      In general, live-attenuated vaccines are contraindicated for immunosuppressed individuals or those with chronic conditions, and therefore BK2102 is also not intended for use in these patients.

      This information has been added to the Discussion section (lines 309-311).

      (4) The candidate vaccine has been tested with a limited number of SARS-CoV-2 strains. Of note, the latest Omicron variants have lesser virulence than many early variants, such as the alfa, beta, and delta strains.

      We have added the results of a protection study against the SARS-CoV-2 gamma strain to Supplementary figures 5A and B. No weight loss was observed in BK2102-inoculated hamsters following infection with the gamma strain. These results are described in lines 109-111, 158-162.

      (5) Limitations of the study have not been discussed.

      We apologize for the ambiguity in the description of the Limitations of this paper. One major limitation of this study is that, despite observing high immunogenicity in hamsters, it remains uncertain whether the same positive results would be achieved in humans. Differences in susceptibility exist between species, which are not solely attributed to weight differences. For instance, while a single dose of 10<sup>3</sup> PFU of BK2102 was sufficient to induce neutralizing antibodies in hamsters, a higher dose of 10<sup>7</sup> PFU in monkeys was required to induce antibodies in only about 50% of the monkeys. Additionally, two more challenges in development of BK2102 were added to the discussion. The first was the limited availability of analytical reagents for hamster models, which restricted the detailed immunological characterization of the response. Second, it took time to gather preclinical data due to the space-related restrictions of BSL3 facilities, which delayed the clinical trials for BK2102 until many individuals had already acquired immunity against SARS-CoV-2. It remains to be seen whether our candidate will be optimal for human use, as the immunogenicity of live-attenuated vaccines is generally influenced by pre-existing immunity.

      We added these considerations to the discussion section (lines 300-309).

      Reviewer #2:

      No major weaknesses were identified, however, this reviewer notes the following:

      The authors missed the opportunity to include a mRNA vaccine to demonstrate that the immunity and protection efficacy of their live attenuated vaccine BK2102 is better than a mRNA vaccine.

      One of the potential advantages of live-attenuated vaccines is their ability to induce mucosal

      immunity. It would be great if the authors included experiments to assess the mucosal immunity of their live-attenuated vaccine BK2102.

      We agree with the Reviewer’s suggestion regarding the importance of comparing BK2102 with the mRNA vaccine modality and evaluating the mucosal immunity induced by BK2102. In hamsters, under conditions where serum neutralizing antibody titers were equivalent, intranasal inoculation of BK2102 induced higher levels of antigen-specific IgA in nasal wash compared to intramuscular injection of the conventional mRNA vaccine. This new data has been added in Supplementary figures 2A and B, and corresponding sentences have been included in the Results and Discussion sections (lines 140-145, 292-299).

      Reviewer #3:

      Lack of a more detailed discussion of this new vaccine approach in the context of reported live-attenuated SARS-CoV-2 vaccines in terms of its advantages and/or weaknesses.

      sCPD9 and CoviLiv<sup>TM</sup>, two previously reported live-attenuated vaccines, achieve attenuation through codon deoptimization or a combination of codon deoptimization and FCS deletion. These two strategies affect viral proliferation but do not directly impact virulence. In contrast, the temperature sensitivity-related substitutions in NSP14 included in BK2102 selectively restrict the infection site, reducing the likelihood of lung infection and providing a safety advantage over the other live-attenuated vaccines. As mentioned in the response to comment (5) of Reviewer #1, a limitation of BK2102 is that its development began later than that of the previously reported live-attenuated vaccines. Consequently, we must consider the impact of pre-existing immunity in future human trials. Based on these points, we have added sentences discussing the advantages and disadvantages to the Discussion section (lines 302-305, 312-319).

      Antibody endpoint titers could be presented.

      Thank you for your suggestion. We calculated the antibody endpoint titers for Figure 2A and included the results in lines 105-107 of the revised manuscript.

      Lack of elaboration on immune mechanisms of protection at the upper respiratory tract (URT) against an immune evasive variant in the absence of detectable neutralizing antibodies.

      We appreciate the comment. The potential role of cellular and mucosal immunity in protection has been discussed in more detail in the revised manuscript, specifically in lines 283-295. According to the reference we initially cited, Hasanpourghadi et al. evaluated their adenovirus vector vaccine candidates and reported that the protection was enhanced by co-expression of the nucleocapsid protein rather than relying solely on the spike protein (Hasanpourghadi et al., Microbes Infect, 2023). Therefore, cellular immunity against the nucleocapsid and/or other viral proteins induced by BK2102 may also contribute to protection, as evidenced by more pronounced cellular immunity to the nucleocapsid detected through ELISPOT assay. Moreover, antigen-specific mucosal immunity was successfully detected in additional studies. The involvement of mucosal immunity in protection against mutant strains has been documented in the previously cited reference (Thwaites et al., Nat Commun, 2023). We have included these new data in Figure 2F and Supplementary figure 2B. Additionally, the results and discussion regarding the mechanisms of protection in the upper respiratory tract, in the absence of detectable neutralizing antibodies, have been incorporated into the revised lines 136-139, 143-145 and 283-295, respectively.

      Recommendations for the authors:

      Reviewer #2:

      Figure 1: Please include the LOD and statistical analysis in both panels. Please consider passaging the virus in Vero cell s, approved for human vaccine production, to assess the stability of BK2102 after serial passage in vitro, which is important for its implementation as a live-attenuated vaccine. The authors should consider evaluating viral replication in different cell lines, and also assessing the plaque phenotype.

      Thank you for your valuable comments. First, we have added the statistical analysis and the limit of detection (LOD) to Figure 1. In response to the comments regarding the stability of BK2102 after serial passage in Vero cells, as well as its replication and plaque phenotype in different cell lines, we manufactured test substances for GLP studies and clinical trials by passaging BK2102 in Vero cells, which are approved for human vaccine production. We confirmed that BK2102 is stable (data not shown). Additionally, we verified that BK2102 replicates in BHK, Vero E6, and Vero E6/TMPRSS2 cells, in addition to Vero cells. Among these options, we selected Vero cells due to their high proliferative capacity and ability to produce clear plaques.

      Figure 2: Please, include statistical analysis in panels A, B, and D. Please, include the LOD in panels A and D. Please, include viral titers from these experiments in hamsters and NHPs.

      First, we would like to note that Figure 2D has been replaced by Figure 2C in the revised manuscript, and the data on neutralizing antibody titers in non-human primates (NHPs), originally presented as Figure 2C, have been moved to the Supplementary figure 3A.

      We have added the statistical analysis to Figure 2B and C, as well as the LOD to Figure 2C. Figure 2A (Spike-specific IgG ELISA) was intended for qualitative evaluation based on OD values, so the LOD was not defined. We have also added a detailed description of virus titer in the Methods section under the headings “Evaluation of Immunogenicity in Hamsters” and “Evaluation of Immunogenicity in Monkeys”, and updated the information in the Figure legends of the revised manuscript (lines 451, 459, 468-474, 566-567, 576-578, 582-584, 661-662).

      Figure 3: Please, include the viral titers of the challenge virus in the NT and lungs.

      We have added the virus titers for the challenge experiments to the Results section under the heading “BK2102 induced protective immunity against SARS-CoV-2 infection” (lines 168-174).

      Figure 4: Please, include statistical analysis in panels B and C and evaluate viral titers.

      We have added the statistical analysis to Figure 4B and C. Unfortunately, all samples in Figure 4 were fixed in formalin for histopathological examination, so virus titers could not be measured. However, in past experiments, we measured viral titers in the nasal wash samples and lungs of hamsters three days post-infection with D614G and BK2102. We confirmed that infectious virus was detected in both the nasal wash and lungs of the hamsters infected with D614G strain (2.9 log10 PFU/mL and 5.3 log10 PFU/g, respectively), but not in the lungs of the hamsters with BK2102. The viral titers in the nasal wash of BK2102-infected hamsters were equivalent to those of the hamsters infected with the D614G wild-type strain (3.0 log10 PFU/mL). However, we did not include this data to the revised manuscript.

      Figure 5: Please, include viral titers in different tissues with the different vaccines (panels A and B). Please, include the body weight changes.  Finally, please, consider the possibility of challenging the vaccinated mice with the same SARS-CoV-2 strains used in the manuscript to demonstrate similar protection efficacy in this new ACE2 transgenic mice.

      The different tissues of Tg mice were not sampled, as no gross abnormalities were observed in organs other than lungs and brains during necropsy. We have added new data on the body weight of Tg mice after infection to Supplementary figures 9B and 9C in the revised manuscript, along with additional lines in the Results section (lines 228-230 and 247-248). Although we do not know the reason, we have observed that immunization of this animal model does not lead to an increase in antibody titers. Therefore, we do not consider this animal model suitable for the protection study as you suggested. However, it could be useful in passive immunization experiments.

      Supplementary Figure 1: Since most of the manuscript focuses on BK2102, the authors should consider removing the other live-attenuated vaccines (Supplementary Figure 1A).

      We agree with the Reviewer’s suggestion and have simplified the description for Supplementary Figure 1A (lines 93-97).

      Supplementary Figure 3: Please, include statistical analysis.

      In the revised manuscript, Supplementary Figure 3 from the original manuscript has been moved to Supplementary Figure 2D. The IgG subclass ELISA was intended for a qualitative evaluation based on OD values, and therefore the results were included in the Supplementary figure. However, we realized the description was not clear, so we added further clarification in the Results section (lines 145-147).

      Supplementary Figure 4: Please, include the viral titers in both infected and contact hamsters from this experiment.

      In the revised manuscript, Supplementary Figure 4 in the original manuscript has been moved to Supplementary Figure 6. Unfortunately, due to limited breeding space for the hamsters, we were unable to prepare groups for the evaluation of viral titer, and instead prioritized evaluation by body weight.

      Reviewer #3:

      (1) It would be helpful to discuss this new vaccine in the context of other reported live-attenuated vaccines in terms of its advantages and/or disadvantages.

      Please refer to our response to the Reviewer’s “first comment” above, as well as to the response in Public comment (5) of Reviewer #1. The modifications made in the manuscript are described in lines 302-305 and 312-319.

      (2) Figure 2A: end-point titers could be presented, other than OD values.

      This comment is addressed in the reviewer’s second public comment. The endpoint titer has been included in lines 105-107 of the revised manuscript.

      (3) Figure 2C: it is unclear why only 2 out of 4 NHPs show neutralization titers. This could be moved to a supplementary figure.

      As suggested by the Reviewer, Figure 2C of the original manuscript has been moved to Supplementary Figure 3A in the revised manuscript. In response Public comment (2) from Reviewer #1, we have also added new data on neutralizing antibodies in the monkeys as Supplementary figure 3B.

      (4) Figures 2E-F: bulk measurement of cytokine production in supernatants is not an optimal way to measure vaccine-induced Ag-specific T cells. ELISPOT or ICS are better. T-cell ELSIPOT for hamsters is available. This should at least be discussed.

      Please refer to our response to this Reviewer’s third public comment. We have added the new results in Figure 2F of the revised manuscript.

      (5) It is quite interesting that no N-specific cellular response was observed, given that it is a live-attenuated vaccine. What about N-specific binding Abs?

      We conducted the ELISPOT assay as suggested by the Reviewer and detected cellular immunity against both spike and nucleocapsid proteins (Figure 2F). We did not examine nucleocapsid-specific antibodies, as they do not contribute to the neutralizing activity; however, nucleocapsid-specific cellular immunity was confirmed.

      (6) Figure 3: limit of detection for virological assays could be labeled.

      We have added the LOD in Figures 3C, D, F and G.

      (7) Figures 3E-F: it is interesting to see that the vaccine elicits almost complete protection at URT against BA.5, despite no BA.5 neutralizing titers being detected at all. What mechanism of URT protection by BK2102 would the authors speculate? T cells or other Ab effector functions?

      Please refer to the response to this Reviewer’s third public comment. We have added new results regarding cellular and mucosal immunity (Figure 2F and Supplementary figure 2B) and discussed the mechanisms of protection in the upper respiratory tract in the absence of detectable neutralizing antibodies (lines 136-139, 143-145 and 283-295, respectively).

      (8) Figure 3I: the durability of protection is a strength of the study. Other than body weight changes, what about viral loads in the animals after the challenge?

      We primarily assessed the effect of the vaccine by monitoring changes in body weight, as the differences compared to the naïve group were clear. Unfortunately, we did not collect samples at different time points throughout the study, which prevented us from evaluating the viral titers.

      In addition, we made corrections to several other sections identified during the revision process. The revised parts are as follows:

      - In the Methods section under the title “Evaluation of BK2102 pathogenicity in hamsters”, the infectious virus titer of D614G strain has been corrected (line 478).

      - In the Methods section under the title “In vivo passage of BK2102 in hamsters”, infectious virus titer of BK2102 and A50-18 strain has been corrected (line 487).

      - The collection time of splenocytes after inoculation has been corrected in the figure legend of Figure 2D, (line 583).

      - There was an error in Figure 2D. The figure has been replaced with the appropriate version.

      - A new reference on NSP1 deletion (Ueno et al., Virology, 2024) has been added to the references.

      - Several methods have been described more clearly.

    1. Author response:

      The following is the authors’ response to the previous reviews.

      Comments on the revised version:

      Concerns flagged about using CRISPR -guide RNA mediated knockdown of viral has yet to be addressed entirely. I understand that the authors could not get knock out despite attempts and hence they have guide RNA mediated knockdown strategy. However, I wondered if the authors looked at the levels of the downstream genes in this knockdown.

      We thank the reviewer for bringing this up since it is known that certain artifacts derived from this approach may be related with changes in expression of downstream genes. We run a qPCR of Rv0432 and Rv0433 and confirmed that no significant differences in expression of virR downstream genes were detected in the virR mutant or the complemented strains relative to WT. This is now indicated in the method section on Generation of the CRISPR mutants. The data is now presented as Supplementary Figure 13.

      Authors have used the virmut-Comp strain for some of the experiments. However, the materials and methods must describe how this strain was generated. Given the mutant is a CRISPR-guide RNA mediated knockdown. The CRISPR construct may have taken up the L5 loci. Did authors use episomal construct for complementation? If so, what is the expression level of virR in the complementation construct? What are the expression levels of downstream genes in mutant and complementation strains? This is important because the transcriptome analysis was redone by considering complementation strain. The complemented strain is written as virmut-C or virmut-Comp. This has to be consistent.

      We apologize for not having included the information about the generation of the complemented strain in our last version of the manuscript. We took the complementing vector from a previous paper on VirR (Rath et al., (2013) PNAS 110(49):E4790). This vector was constructed as follows: Complementation plasmids were cloned using Gateway® Cloning Technology (Invitrogen). E. coli strains expressing the following Gateway vectors were kindly provided by Dirk Schnappinger and Sabine Ehrt: pDO221A, pDO23A, pEN23A-linker1, pEN41A-TO2, pEN21A-Hsp60, pDE43-MEH. PCR was used to amplify the following target sequences from H37Rvgenomic DNA: coding sequence of Rv0431, coding sequence of Rv0431 with a FLAG tag either in its C-terminus or its N-terminus, and the predicted cytosolic sequence of Rv0431 with a FLAG tag in its new C-terminus. The primers used for PCR were designed such that the amplicons would be flanked with Gateway® cloning- specific attachment (att) sites. These PCR products were recombined into Gateway® donor vectors using bacteriophage-derived integrase and integration host factor, resulting in entry vectors. The recombination events are specific to the attB sites on the PCR products and to the attP sequences on the donor vectors, such that the orientation of the target sequence is maintained during the recombination reaction, also known as the BP reaction, for attB-attP recombination. Using the MultiSite Gateway® system, three DNA fragments, derived from each of three distinct entry vectors, can be simultaneously inserted into a final complementation vector called the destination vector in a specific order and orientation. Multisite recombination events are mediated by Integrase and Integrase Host Factor, in a process called the LR reaction (for the attL and attR sites in the entry and destination vectors). The Gateway® entry vectors thus generated were recombined with another entry vector containing either the Hsp60 promoter, an empty entry vector, and a complementation vector (episomal) to give rise to the final destination vector. The destination vector (episomal) was engineered to contain a hygromycin resistance cassette. These vectors were used to transform competent Rv0431-deficient Mtb. The transformation mixture was plated on 7H11 plates containing OADC and hygromycin (50 μg/ml). Colonies, typically observed 3-5 weeks later, were isolated and grown in 7H9 media and characterized.

      For simplicity, we have just referenced our previous paper to indicate that the complementing plasmid is the same used in that study.

      Regarding the virR expression levels in the WT, virR<sup>mut</sup> and complemented virR strains please see previous Figure 6 C.

      Recommendations for the authors:

      Reviewer #1 (Recommendations for the authors):

      The authors have revised the manuscript in light of previous reviews. The authors have addressed some of my concerns appropriately. However, the specific dataset remains unchanged and unclear.

      Fig 8G and H: In response to a comment on the mechanism of how VirR mediates EV release, the authors have added new data showing an increase in the abundance of deacetylated muropeptides in the mutant. This observation is linked to altered lysozyme activity or PG fragility. In my opinion, this is another indirect observation. More concerning is the complemented strain, which also showed a comparable increase in deacetylated muropeptides, indicating that the altered muropeptides could be unrelated to VirR.

      We must disagree here with the reviewer assessment about the fact that the abundance of deacetylated muropeptides is an indirect indication of PG fragility. We consider that this observation and quantitative fact is another additional evidence that indicate a more fragile PG. We believe that considering each of the supporting facts individually may be seen as indirect, but we would like that the reviewer take all the evidence together: (i) sensitivity to lysozyme; (ii) enlargement and altered physicochemical morphological characteristics including porosity or thickness; (iii) altered penetrance of FDAAs; and (iv) increased released of muropeptides. In this later fact, the complemented strain may not display the WT features, but this may be due to some artifacts derived from the complementation.

      Taking all together, we believe that the PG of virR<sup>mut</sup> is more fragile than that of the WT and the complemented strains based on a series of evidence. We hope the reviewer may consider this perspective when analyzing such a complex feature like PG fragility. So far, there is not a direct method to assess this condition.

      Lipid analyses are not comprehensive. The issue related to the need for more clarity of DIMA and DIMB still needs to be addressed. I understand that the authors do not have facilities to perform radioactive assays. However, they could have repeated the experiment to generate a better-quality image. Similarly, the newly generated SL-1, PAT, and DAT TLC could be of better quality. Bands still need to be resolved. The solvent front is irregular. The same is true for PIMs and DPG TLCs. With the evidence provided, the deregulation of cell wall lipids is incomplete.

      We agree with the reviewer that the quality of the TLC is not appropriate. We have no repeated the PDIM TLC (new Fig 7D). In addition, we have repeated the TLCs resolving sulfolipids in a 2D mode. For simplicity we just run the glycerol condition including the three strains. This is now part of a new Supplementary figure 8 B. For PIMs, we have a 1D and a 2D analysis that, after checking previous papers using similar approaches with no radioactivity, we consider that it has the desired quality to identify the indicated lipids.

      We hope this new data and repeated experiments satisfy the reviewer concerns.

      Thank you very much for your assessment and time to review this paper.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Reviewer # 1 (Public Review):

      Summary:

      Inthispreprint, theauthorssystematicallyandrigorouslyinvestigatehowspecificclassesofresiduemutations alter the critical temperature as a proxy for the driving forces for phase separation. The work is well executed, the manuscript well-written, and the results reasonable and insightful.

      Strengths:

      The introductory material does an excellent job of being precise in language and ideas while summarizing the state of the art. The simulation design, execution, and analysis are exceptional and set the standard for these types of large-scale simulation studies. The results, interpretations, and Discussion are largely nuanced, clear, and well-motivated.

      We thank the reviewer for their assessment of our work and for highlighting the key strengths of the paper.

      Weaknesses:

      This is not exactly a weakness, but I think it would future-proof the authors’ conclusions to clarify a few key caveats associated with this work. Most notably, given the underlying implementation of the Mpipi model, temperature dependencies for intermolecular interactions driven by solvent effects (e.g., hydrophobic effect and charge-mediated interactions facilitated by desolvation penalties) are not captured. This itself is not a “weakness” per se, but it means I would imagine CERTAIN types of features would not be wellcaptured; notably, my expectation is that at higher temperatures, proline-rich sequences drive intermolecular interactions, but at lower temperatures, they do not. This is likely also true for the aliphatic residues, although these are found less frequently in IDRs. As such, it may be worth the authors explicitly discussing.

      We also thank the reviewer for pointing out that a more detailed discussion of the model limitations is needed. The original Mpipi model was designed to probe UCST-type transitions (that are associative in nature) of disordered sequences. The reviewer is correct, that in its current form, the model does not capture LCST-type transitions that depend on changes in solvation of hydrophobic residues with temperature. We have amended the discussion to highlight this fact.

      Similarly, prior work has established the importance of an alpha-helical region in TDP-43, as well as the role of aliphatic residues in driving TDP-43’s assembly (see Schmidt et al 2019). I recognize the authors have focussed here on a specific set of mutations, so it may be worth (in the Discussion) mentioning [1] what impact, if any, they expect transient or persistent secondary structure to have on their conclusions and [2] how they expect aliphatic residues to contribute. These can and probably should be speculative as opposed to definitive.

      Again - these are not raised as weaknesses in terms of this work, but the fact they are not discussed is a minor weakness, and the preprint’s use and impact would be improved on such a discussion.

      We agree with the reviewer that the effects of structural changes/propensities on these scaling behaviors would be an interesting and important angle to probe. We also comment on this in the discussion.

      Reviewer # 2 (Public Review):

      This is an interesting manuscript where a CA-only CG model (Mpipi) was used to examine the critical temperature (Tc) of phase separation of a set of 140 variants of prion-like low complexity domains (PLDs). The key result is that Tc of these PLDs seems to have a linear dependence on substitutions of various sticker and space residues. This is potentially useful for estimating the Tc shift when making novel mutations of a PLD. However, I have strong reservations about the significance of this observation as well as some aspects of the technical detail and writing of the manuscript.

      We thank the reviewer for their thoughtful and detailed feedback on the manuscript.

      (1) Writing of the manuscript: The manuscript can be significantly shortened with more concise discussions. The current text reads as very wordy in places. It even appears that the authors may be trying a bit too hard to make a big deal out of the observed linear dependence.

      The manuscript needs to be toned done to minimize self-promotion throughout the text. Some of the glaring examples include the wording “unprecedented”, “our research marks a significant milestone in the field of computational studies of protein phase behavior ..”, “Our work explores a new framework to describe, quantitatively, the phase behavior ...”, and others.

      We thank the reviewer for their suggestions on the writing of the manuscript. We understand the concern regarding the length and tone of the manuscript, and in response to their feedback, we have revised the language throughout the manuscript.

      There is really little need to emphasize the need to manage a large number of simulations for all 140 variants. Yes, some thoughts need to go into designing and managing the jobs and organizing the data, but it is pretty standard in computational studies. For example, large-scale protein ligand-free energy calculations can require one to a few orders of magnitude larger number of runs, and it is pretty routine.

      We fully agree with the reviewer that this aspect of the study is relatively standard in computational research and does not require special emphasis. In response, we have revised the manuscript to shorten the aforementioned section, focusing instead on the scientific insights gained from the simulations rather than the logistical challenges of managing them.

      When discussing the agreement with experimental results on Tm, it should be noted that the values of R > 0.93 and RMSD < 14 K are based on only 16 data points. I am not sure that one should refer to this as “extended validation”. It is more like a limited validation given the small data size.

      We thank the reviewer for their consideration of our validation set. Indeed, the agreement with experimental results is based on 16 data points, as this set represents the available published data at the time of writing of this manuscript. The term “extended validation” is used to signify that our current dataset builds upon previous validations (in Joseph, Reinhardt et al. Nat Comput. Sci. 2021), incorporating additional variants not previously examined. The metrics of an r>0.93 and a low RMSD indicate a strong agreement between the model and experiments, and an improvement with respect to other reported models. We are committed to continue validating our methods.

      Results of linear fitting shown in Eq 4-12 should be summarized in a single table instead of scattering across multiple pages.

      We considered the reviewer’s suggestion to compile all the laws into a single table. However, we believe it would be more effective for readers to reference each relationship directly where it is first discussed in the text. That said, we do include Table 1 in the original manuscript, which provides a summary of all the laws.

      The title may also be toned down a bit given the limited significance of the observed linear dependence.

      We respectfully disagree with the reviewer and believe that the current title accurately captures the scope of the manuscript.

      (2) Significance and reliability of Tc: Given the simplicity of Mpipi (a CA-only model that can only describe polymerchaindimension)andthelowcomplexitynatureofPLDs, thesequencecompositionitselfisexpected to be the key determinant of Tc. This is also reflected in various mean-field theories. It is well known that other factors will contribute, such as patterning (examined in this work as well), residual structures, and conformational preferences in dilute and dense phases. The observed roughly linear dependence is a nice confirmation but really unsurprising by itself. It appears how many of the constructs deviate from the expected linear dependence (e.g., Figure 4A) may be more interesting to explore.

      While linear dependencies in critical solution temperatures may appear expected for certain systems, for example, symmetric hard spheres, the heterogeneity of intrinsically disordered regions (IDRs), like prion-like domains (PLDs), make this finding notable. The simplicity of our linear scaling law belies the underlying complexity of multivalent interactions and sequence-dependent behaviors in a certain sequence regime, which has not been quantitatively characterized in this manner before. Likewise, although linear dependencies may be expected in simplified models, the real-world applicability and empirical validation of these laws in biologically relevant systems are not guaranteed. Our chemically based model provides the robustness needed to do that. The linear relationship observed is significant because it provides a predictive framework for understanding how specific mutations affect a diverse set of PLDs. The framework presented can be extended to other protein families upon the application of a validated model, which might or might not yield linear relationships depending on the cooperative effects of their collective behavior. This extends beyond confirming known theories—it offers a practical tool for predicting phase behavior based on sequence composition

      We agree with the reviewer that, while the overarching linear trend is clear, deviations from linearity observed in constructs like those in Figure 4A point to additional, and interesting, layers of complexity. These deviations offer interesting avenues for future research and suggest that while linearity might dominate PLD critical behavior, other factors may modulate this behavior under specific conditions.

      This is an excellent suggestion from the reviewer that, while it falls outside the scope of the current study, we are interested in exploring in the future.

      Finally, the relationships are all linear, they have been normalized in different ways—the strength of the study also lies in that. Instead of focusing solely on linearity, our study explores the physical mechanisms that underlie these relationships. This approach provides a more complete understanding of how sequence composition and the underlying chemistry of the mutated residues influence T<sub>c</sub.

      The assumption that all systems investigated here belong to the same universality class as a 3D Ising model and the use of Eqn 20 and 21 to derive Tc is poorly justified. Several papers have discussed this issue, e.g., see Pappu Chem Rev 2023 and others. Muthukumar and coworkers further showed that the scaling of the relevant order parameters, including the conserved order parameter, does not follow the 3D Ising model. More appropriate theoretical models including various mean field theories can be used to derive binodal from their data, such as using Rohit Pappu’s FIREBALL toolset. Imposing the physics of the 3D Ising model as done in the current work creates challenges for equivalence relationships that are likely unjustified.

      We thank the reviewer for raising this point and for highlighting the FIREBALL toolset. Based on our understanding, FIREBALL is designed to fit phase diagrams using mean-field theories, such as Flory–Huggins and Gaussian Cluster Theory. Our experience with this toolset suggests that it places a higher weight on the dilute arm of the binodal. However, in our slab simulations, we observe greater uncertainty in the density of the dilute arm. This leads to only a moderate fit of the data to the mean-field theories employed in the toolset. While we agree that there is no reason to assume the phase behavior of these systems is fully captured by the 3D Ising model, we expect that such a model will describe the behavior near the critical point better than mean-field theories. Testing our results further with different critical exponents would be valuable in assessing how these predictions compare to a broader set of experimental data. Additionally, we have made the raw data points for the phase diagrams available on our GitHub, enabling practitioners to apply alternative fitting methods.

      While it has been a common practice to extract Tc when fitting the coexistence densities, it is not a parameter that is directly relevant physiologically. Instead, Csat would be much more relevant to think about if phase separation could occur in cells.

      WhileitistruethatCsatisdirectlyrelevanttowhetherphaseseparationcanoccurincellsunder physiological conditions, T<sub>c</sub> should not be dismissed as irrelevant.T<sub>c</sub> provides fundamental insights into the thermodynamics of phase separation, reflecting the overall stability and strength of interactions driving condensate formation. This stability is crucial for understanding how environmental factors, such as temperature or mutations, might affect phase behavior. In Figure 2C and D we compare experimental C<sub>sat</sub> values with our predicted T<sub>c</sub> from simulations. These quantities are roughly inversely proportional to each other and so we expect that, to a first approximation, the relationships recovered for T<sub>c</sub> should hold when consideringC<sub>sat</sub> at a fixed temperature.

      Reviewer # 3 (Public Review):

      Summary:

      “Decoding Phase Separation of Prion-Like Domains through Data-Driven Scaling Laws” by Maristany et al. offers a significant contribution to the understanding of phase separation in prion-like domains (PLDs). The study investigates the phase separation behavior of PLDs, which are intrinsically disordered regions within proteins that have a propensity to undergo liquid-liquid phase separation (LLPS). This phenomenon is crucial in forming biomolecular condensates, which play essential roles in cellular organization and function. The authors employ a data-driven approach to establish predictive scaling laws that describe the phase behavior of these domains.

      Strengths:

      The study benefits from a robust dataset encompassing a wide range of PLDs, which enhances the generalizability of the findings. The authors’ meticulous curation and analysis of this data add to the study’s robustness. The scaling laws derived from the data provide predictive insights into the phase behavior of PLDs, which can be useful in the future for the design of synthetic biomolecular condensates.

      We thank the reviewer for highlighting the importance of our work and for their critical feedback.

      Weaknesses:

      While the data-driven approach is powerful, the study could benefit from more experimental validation. Experimental studies confirming the predictions of the scaling laws would strengthen the conclusions. For example, in Figure 1, the Tc of TDP-43 is below 300 K even though it can undergo LLPS under standard conditions. Figure 2 clearly highlights the quantitative accuracy of the model for hnRNPA1 PLD mutants, but its applicability to other systems such as TDP-43, FUS, TIA1, EWSR1, etc., may be questionable.

      In the manuscript, we have leveraged existing experimental data for the A1-LCD variants, extracting critical temperatures and saturation concentrations to compare with our model and scaling law predictions. We acknowledge that a larger set of experiments would be beneficial. By selecting sequences that are related, we hypothesize that the scaling laws described herein should remain robust. In the case of TDP-43, to our knowledge this protein does not phase separate on its own under standard conditions. In vitro experiments that report phase separation at/above 300 K involve either the use of crowding agents (such as dextran or PEG) or multicomponent mixtures that include RNA or other proteins. Therefore, our predictions for TDP-43 are consistent with experiments. In general, we hope that the scaling laws presented in our work will inspire other researchers to further test their validity.

      The authors may wish to consider checking if the scaling behavior is only observed for Tc or if other experimentally relevant quantities such as Csat also show similar behavior. Additionally, providing more intuitive explanations could make the findings more broadly accessible.

      In Figure 2C and D we compare experimental C<sub>sat</sub> values with our predicted T<sub>c</sub> from simulations. These quantities are roughly inversely proportional to each other and so we expect that, to a first approximation, the relationships recovered for T<sub>c</sub> should hold when considering C<sub>sat</sub> at a fixed temperature.

      The study focuses on a particular subset of intrinsically disordered regions. While this is necessary for depth, it may limit the applicability of the findings to other types of phase-separating biomolecules. The authors may wish to discuss why this is not a concern. Some statements in the paper may require careful evaluation for general applicability, and I encourage the authors to exercise caution while making general conclusions. For example, “Therefore, our results reveal that it is almost twice more destabilizing to mutate Arg to Lys than to replace Arg with any uncharged, non-aromatic amino acid...” This may not be true if the protein has a lot of negative charges.

      A significant number of proteins, in addition to those mentioned in the manuscript, that contain prion-like low complexity domains have been reported to exhibit phase separation behaviors and/or are constituents of condensates inside cells. We therefore expect these laws to be applicable to such systems and have further revised the text to emphasize this point. As the reviewer suggests, we have also clarified that the reported scaling of various mutations applies to these systems.

      I am surprised that a quarter of a million CPU hours are described as staggering in terms of computational requirements.

      We have removed the note on CPU hours from the manuscript. However, we would like to clarify that the amount of CPU hours was incorrectly reported. The correct estimate is 1.25 million hours, but this value was unfortunately misrepresented during the editing process. We thank the reviewer for catching this mistake on our part.

      Reviewer # 1 (Recommendations For The Authors):

      Some minor points here:

      “illustrating that IDPs indeed behave like a polymer in a good solvent [43]. ” Whether or not an IDP depends as a polymer in a good solvent depends on the amino acid sequence - the referenced paper selected a set of sequences that do indeed appear on average to map to a good-solvent-like polymer, but lest we forget SAXS experiments require high protein concentrations and until the recent advent of SEC-SAXS, your protein essentially needed to be near infinitely soluble to be measured. As such, this paper’s conclusions are, apparently, ignorant of the limitations associated with the data they are describing, drawing sweeping generalizations that are clearly not supported by a multitude of studies in which sequence-dependencies have led to ensembles with a scaling exponent far below 0.59 (See Riback et al 2017, Peng et al 2019, Martin et al 2020, etc).

      We thank the reviewer for raising this point. To avoid making incorrect generalizations and potentially misleading readers, we have removed the quoted statement from our manuscript.

      As of right now, the sequences are provided in a convenient multiple-sequence alignment figure. However, it would be important also to provide all sequences in an Excel table to make it easy for folks to compare.

      In addition to the sequence alignment figure, we now provide all tested sequences in an Excel table format in the GitHub repository.

      Maybe I’m missing it, but it would be extremely valuable if the coexistence points plot in all the figures were provided as so-called source data; this could just be on the GitHub repository, but I’m envisaging a scenario where for each sequence you have a 4 column file where Col1=concentration and Col2=temperature, col3=fit concentration and col4=fit temperature, such that someone could plot col1 vs. col2 and col3 vs. col4 and reproduce the binodals in the various figures. Given the tremendous amount of work done to achieve binodals:

      The coexistence points used to plot the figures are now provided in the GitHub, in a format similar to that suggested by the reviewer.

      It would be nice to visually show how finite size effects are considered/tested for (which they are very nicely) because I think this is something the simulation field should be thinking about more than they are.

      Thank you for highlighting this point. In our previous work (supporting information of the original Mpipi paper), we demonstrated a thorough approach by varying both the cross-sectional area of the box and the long axis while keeping the overall density constant. In this work, we verified that the cross-sectional area was larger than the average R<sub>g</sub> of the protein. We then maintained a fixed cross-sectional area to long-axis ratio, varying the number of proteins while keeping the overall density constant. We have updated Appendix 1–Figure 2 to clarify our procedure and revised the caption to better explain how we ensured the number of proteins was adequate.

      When explaining the law of reticular diameters, it would be good to explain where the 3.06 exponent comes from.

      Based on the reviewer’s suggestion, we have added to the text: “The constant 3.06 in the equation is a dimensionless empirical factor that was derived from simulations of the 3D Ising model.”

      The NCPR scale in Figure 5 being viridis is not super intuitive and may benefit from being seismic or some other r-w-b colormap just to make it easier for a reader to map the color to meaning.

      We thank the reviewer for this suggestion and have replaced the scale with a r-w-b colormap.

      The “sticker and spacer” framework has received critiques recently given its perceived simplicity. However, this work seems to clearly illustrate that certain types of residues have a large effect on Tc when mutated, whereas others have a smaller effect. It may be worth re-phrasing the sticker-spacer introduction not as “everyone knows aromatic/arginine residues are stickers” but as “aromatic and arginine residues have been proposed to be stickers, yet other groups have argued all residues matter equally” and then go on to make the point that while a black-and-white delineation is probably not appropriate, based on the data, certain residues ARE demonstrably more impactful on Tc than others, which is the definition of stickers. With this in mind, it may be useful to separate out a sticker and a spacer distribution in Figure 1D, because the different distribution between the two residues types is not particularly obvious from the overlapping points.

      We have revised the introduction of the sticker–spacer model in the manuscript for clarity. As the reviewer suggests, we have also separated the sticker and spacer distribution, which is now summarized in new Appendix 0–figure 8.

      Reviewer # 3 (Recommendations For The Authors):

      Figure 2 clearly highlights the quantitative accuracy of the model for hnRNPA1 PLD mutants, but its applicability to other systems such as TDP-43, FUS, TIA1, EWSR1, etc., may be questionable. The following sentence may be revised to reflect this: “Our extended validation set confirms that the Mpipi potential can ...”

      Based on the reviewer’s suggestion, we have revised the text: “Our validation set, which expands the range of proteins variants originally tested [32], highlights that the Mpipi potential can effectively capture the thermodynamic behavior of a wide range of hnRNPA1-PLD variants, and suggests that Mpipi is adequate for proteins with similar sequence compositions, as in the set of proteins analyzed in this study. In recent work by others [66], Mpipi was tested against experimental radius of gyration data for 137 disordered proteins and the model produced highly accurate results, which further suggests the applicability of the approach to a broad range of sequences.”

    1. Author response:

      The following is the authors’ response to the previous reviews.

      Reviewer #1 (Public review):

      As a starting point, the authors discuss the so-called "additive partitioning" (AP) method proposed by Loreau & Hector in 2001. The AP is the result of a mathematical rearrangement of the definition of overyielding, written in terms of relative yields (RY) of species in mixtures relative to monocultures. One term, the so-called complementarity effect (CE), is proportional to the average RY deviations from the null expectations that plants of both species "do the same" in monocultures and mixtures. The other term, the selection effect (SE), captures how these RY deviations are related to monoculture productivity. Overall, CE measures whether relative biomass gains differ from zero when averaged across all community members, and SE, whether the "relative advantage" species have in the mixture, is related to their productivity. In extreme cases, when all species benefit, CE becomes positive.

      This is not true; positive CE does not require positive RY deviations of all species. CE is positive as long as average RY deviation is greater than 0. In a 2-species mixture, for example, if the RY deviation of one species is -0.2 and that of the other species is +0.3, CE would be still positive. Positive CE can be associated with negative NE (net biodiversity effects) when more productivity species have smaller negative RY deviation compared to positive RY deviation of less productive species. Therefore, the suggestion by the reviewer “This is intuitively compatible with the idea that niche complementarity mitigates competition (CE>0)” is not correct.   

      When large species have large relative productivity increases, SE becomes positive. This is intuitively compatible with the idea that niche complementarity mitigates competition (CE>0), or that competitively superior species dominate mixtures and thereby driver overyielding (SE>0).

      The use of word “mitigate” indicates that the effects of niche complementarity and competition are in opposite directions, which is not true with biodiversity experiments based on replacement design. We have explained this in detail in our first responses to reviewers.    

      However, it is very important to understand that CE and SE capture the "statistical structure" of RY that underlies overyielding. Specifically, CE and SE are not the ultimate biological mechanisms that drive overyielding, and never were meant to be. CE also does not describe niche complementarity. Interpreting CE and SE as directly quantifying niche complementarity or resource competition, is simply wrong, although it sometimes is done. The criticism of the AP method thus in large part seems unwarranted. The alternative methods the authors discuss (lines 108-123) are based on very similar principles.

      Agree. However, If CE and SE are not meant to be biological mechanisms, as suggested by the reviewer, the argument “This is intuitively compatible with the idea that niche complementarity mitigates competition (CE>0), or that competitively superior species dominate mixtures and thereby driver overyielding (SE>0)” would be invalid.  

      Lines 108-123 are not on our method.   

      The authors now set out to develop a method that aims at linking response patterns to "more true" biological mechanisms.

      Assuming that "competitive dominance" is key to understanding mixture productivity, because "competitive interactions are the predominant type of interspecific relationships in plants", the authors introduce "partial density" monocultures, i.e. monocultures that have the same planting density for a species as in a mixture. The idea is that using these partial density monocultures as a reference would allow for isolating the effect of competition by the surrounding "species matrix".

      The authors argue that "To separate effects of competitive interactions from those of other species interactions, we would need the hypothesis that constituent species share an identical niche but differ in growth and competitive ability (i.e., absence of positive/negative interactions)." - I think the term interaction is not correctly used here, because clearly competition is an interaction, but the point made here is that this would be a zero-sum game.

      We did not say that competition is not an interaction.

      The authors use the ratio of productivity of partial density and full-density monocultures, divided by planting density, as a measure of "competitive growth response" (abbreviated as MG). This is the extra growth a plant individual produces when intraspecific competition is reduced.

      Here, I see two issues: first, this rests on the assumption that there is only "one mode" of competition if two species use the same resources, which may not be true, because intraspecific and interspecific competition may differ. Of course, one can argue that then somehow "niches" are different, but such a niche definition would be very broad and go beyond the "resource set" perspective the authors adopt. Second, this value will heavily depend on timing and the relationship between maximum initial growth rates and competitive abilities at high stand densities.

      True. Research findings indicate that biodiversity effect detected with AP is not constant.    

      The authors then progress to define relative competitive ability (RC), and this time simply uses monoculture biomass as a measure of competitive ability. To express this biomass in a standardized way, they express it as different from the mean of the other species and then divide by the maximum monoculture biomass of all species.

      I have two concerns here: first, if competitive ability is the capability of a species to preempt resources from a pool also accessed by another species, as the authors argued before, then this seems wrong because one would expect that a species can simply be more productive because it has a broader niche space that it exploits. This contradicts the very narrow perspective on competitive ability the authors have adopted. This also is difficult to reconcile with the idea that specialist species with a narrow niche would outcompete generalist species with a broad niche.

      Competitive ability is not necessarily associated with species niche space. Both generalist and specialist species can be more productive at a particular study site, as long as they are more capable of obtaining resources from a local pool. Remember, biodiversity experiments are conducted at a site of particular conditions, not across a range of species niche space at landscape level.

      Second, I am concerned by the mathematical form. Standardizing by the maximum makes the scaling dependent on a single value.

      As explained in lines 370-376, the mathematical form is a linear approximation as the relationship between competitive growth responses and species relative competitive ability is generally unknow but would be likely nonlinear. Once the relationship is determined in future research, the scaling factor is not needed.    

      As a final step, the authors calculate a "competitive expectation" for a species' biomass in the mixture, by scaling deviations from the expected yield by the product MG ⨯ RC. This would mean a species does better in a mixture when (1) it benefits most from a conspecific density reduction, and (2) has a relatively high biomass.

      Put simply, the assumption would be that if a species is productive in monoculture (high RC), it effectively does not "see" the competitors and then grows like it would be the sole species in the community, i.e. like in the partial density monoculture.

      Overall, I am not very convinced by the proposed method.

      Comments on revised version:

      Only minimal changes were made to the manuscript, and they do not address the main points that were raised.

      Reviewer #2 (Public review):

      This manuscript by Tao et al. reports on an effort to better specify the underlying interactions driving the effects of biodiversity on productivity in biodiversity experiments. The authors are especially concerned with the potential for competitive interactions to drive positive biodiversity-ecosystem functioning relationships by driving down the biomass of subdominant species. The authors suggest a new partitioning schema that utilizes a suite of partial density treatments to capture so-called competitive ability. While I agree with the authors that understanding the underlying drivers of biodiversity-ecosystem functioning relationships is valuable - I am unsure of the added value of this specific approach for several reasons.

      No responses.

      Comments on revised version:

      The authors changed only one minor detail in response to the last round of reviews.

      Reviewer #3 (Public review):

      Summary:

      This manuscript claims to provide a new null hypothesis for testing the effects of biodiversity on ecosystem functioning. It reports that the strength of biodiversity effects changes when this different null hypothesis is used. This main result is rather inevitable. That is, one expects a different answer when using a different approach. The question then becomes whether the manuscript's null hypothesis is both new and an improvement on the null hypothesis that has been in use in recent decades.

      Our approach adopts two hypotheses, null hypothesis that is also with the additive partitioning model and competitive hypothesis that is new. Null hypothesis assumes that inter- and intra-specie interactions are the same, while competitive hypothesis assumes that species differ in competitive ability and growth rate. Therefore, our approach is an extension of current approach. Our approach separates effects of competitive interactions from those of other species interactions, while the current approach does not.      

      Strengths:

      In general, I appreciate studies like this that question whether we have been doing it all wrong and I encourage consideration of new approaches.

      Weaknesses:

      Despite many sweeping critiques of previous studies and bold claims of novelty made throughout the manuscript, I was unable to find new insights. The manuscript fails to place the study in the context of the long history of literature on competition and biodiversity and ecosystem functioning.

      We have explained in our first responses that competition and biodiversity effects are studied in different experimental approaches, i.e., additive and replacement designs. Results from one approach are not compatible with those from the other. For example, competition effect with additive design is negative but generally positive with replacement design that is used extensively in biodiversity experiments. We have considered species competitive ability, density-growth relationship, and different effects of competitive interactions between additive and replacement design, while the current method does not reflect any of those.        

      The Introduction claims the new approach will address deficiencies of previous approaches, but after reading further I see no evidence that it addresses the limitations of previous approaches noted in the Introduction. Furthermore, the manuscript does not reproducibly describe the methods used to produce the results (e.g., in Table 1) and relies on simulations, claiming experimental data are not available when many experiments have already tested these ideas and not found support for them.

      We used simulation data, as partial density monocultures are generally not available in previous biodiversity experiments.

      Finally, it is unclear to me whether rejecting the 'new' null hypothesis presented in the manuscript would be of interest to ecologists, agronomists, conservationists, or others.

      Our null hypothesis is the same as the null hypothesis with the additive partitioning assuming that inter- and intra-species interactions are the same, while our competitive hypothesis assumes that species differ in competitive ability and growth rate. Rejecting null hypothesis means that inter- and intra-species interactions are different, whereas rejecting competitive hypothesis indicates existence of positive/negative species interactions. This would be interesting to everyone.       

      Comments on revised version:

      Please see review comments on the previous version of this manuscript. The authors have not revised their manuscript to address most of the issues previously raised by reviewers.

      No responses.

      Recommendations for the authors:

      Reviewer #1 (Recommendations for the authors):

      Do take reviews seriously. Even if you think the reviewers all are wrong and did not understand your work, then this seems to indicate that it was not clearly presented.

      Reviewer #2 (Recommendations for the authors):

      I can understand that the authors are perhaps frustrated with what they perceive as a basic misunderstanding of their goals and approach. This misunderstanding however, provides with it an opportunity to clarify. I believe that the authors have tried to clarify in rebutting our statements but would do better to clarify in the manuscript itself. If we reviewers, who are deeply invested in this field, don't understand the approach and its value, then it is likely that many readers will not as well.

      The additive partitioning has been publicly questioned at least for serval times since the conception of the method in 2001. Our work provides an alternative.

    1. Author response:

      We thank the editor and the three reviewers for the positive assessment and constructive feedback on how to improve our manuscript. We greatly appreciate that our work is considered valuable to the field, the recognition of the high-resolution model we presented, and the comments on our investigation of CisA’s role in the attachment and firing mechanism of the extended assembly. It is truly gratifying to know that our study contributes to expanding the current understanding of the biology of Streptomyces and the role of these functionally diverse and fascinating bacterial nanomachines.

      We have provided specific responses to each reviewer's comments below. In summary, we intend to address the following requested revisions:

      We will expand our bioinformatic analysis of CisA and provide additional information on the oligomeric state of CisA. We will also modify the text, figures, and figure legends to improve the clarity of our work and experimental procedures.

      Some reviewer comments would require additional experimental work, some of which would involve extensive optimization of experimental conditions. Because both lead postdoctoral researchers involved in this work have now left the lab, we currently do not have the capability to perform additional experimental work.

      Reviewer #1 (Public review):

      Contractile Injection Systems (CIS) are versatile machines that can form pores in membranes or deliver effectors. They can act extra or intracellularly. When intracellular they are positioned to face the exterior of the cell and hence should be anchored to the cell envelope. The authors previously reported the characterization of a CIS in Streptomyces coelicolor, including significant information on the architecture of the apparatus. However, how the tubular structure is attached to the envelope was not investigated. Here they provide a wealth of evidence to demonstrate that a specific gene within the CIS gene cluster, cisA, encodes a membrane protein that anchors the CIS to the envelope. More specifically, they show that:

      - CisA is not required for assembly of the structure but is important for proper contraction and CIS-mediated cell death

      - CisA is associated to the membrane (fluorescence microscopy, cell fractionation) through a transmembrane segment (lacZ-phoA topology fusions in E. coli)

      - Structural prediction of interaction between CisA and a CIS baseplate component<br /> - In addition they provide a high-resolution model structure of the >750-polypeptide Streptomyces CIS in its extended conformation, revealing new details of this fascinating machine, notably in the baseplate and cap complexes.

      All the experiments are well controlled including trans-complemented of all tested phenotypes.

      One important information we miss is the oligomeric state of CisA.

      While it would have been great to test the interaction between CisA and Cis11, to perform cryo-electron microscopy assays of detergent-extracted CIS structures to maintain the interaction with CisA, I believe that the toxicity of CisA upon overexpression or upon expression in E. coli render these studies difficult and will require a significant amount of time and optimization to be performed. It is worth mentioning that this study is of significant novelty in the CIS field because, except for Type VI secretion systems, very few membrane proteins or complexes responsible for CIS attachment have been identified and studied.

      We thank this reviewer for their highly supportive and positive comments on our manuscript. We are grateful for this reviewer’s recognition of the novelty of our study, particularly in the context of membrane proteins and complexes involved in CIS attachment.

      We agree that further experimental evidence on the direct interaction between CisA and Cis11 would have strengthened our model of CisA function. However, as noted by this reviewer, this additional work is technically challenging and currently beyond the scope of this study.

      We thank Reviewer #1 for suggesting discussing the potential oligomeric state of CisA. We will perform additional AlphaFold modelling of CisA and discuss the result of this analysis in the revised manuscript.

      Reviewer #2 (Public review):

      Summary:

      The overall question that is addressed in this study is how the S. coelicolor contractile injection system (CISSc) works and affects both cell viability and differentiation, which it has been implicated to do in previous work from this group and others. The CISSc system has been enigmatic in the sense that it is free-floating in the cytoplasm in an extended form and is seen in contracted conformation (i.e. after having been triggered) mainly in dead and partially lysed cells, suggesting involvement in some kind of regulated cell death. So, how do the structure and function of the CISSc system compare to those of related CIS from other bacteria, does it interact with the cytoplasmic membrane, how does it do that, and is the membrane interaction involved in the suggested role in stress-induced, regulated cell death? The authors address these questions by investigating the role of a membrane protein, CisA, that is encoded by a gene in the CIS gene cluster in S. coelicolor. Further, they analyse the structure of the assembled CISSc, purified from the cytoplasm of S. coelicolor, using single-particle cryo-electron microscopy.

      Strengths:

      The beautiful visualisation of the CIS system both by cryo-electron tomography of intact bacterial cells and by single-particle electron microscopy of purified CIS assemblies are clearly the strengths of the paper, both in terms of methods and results. Further, the paper provides genetic evidence that the membrane protein CisA is required for the contraction of the CISSc assemblies that are seen in partially lysed or ghost cells of the wild type. The conclusion that CisA is a transmembrane protein and the inferred membrane topology are well supported by experimental data. The cryo-EM data suggest that CisA is not a stable part of the extended form of the CISSc assemblies. These findings raise the question of what CisA does.

      We thank Reviewer #2 for the overall positive evaluation of our manuscript and the constructive criticism. 

      Weaknesses:

      The investigations of the role of CisA in function, membrane interaction, and triggering of contraction of CIS assemblies, are important parts of the paper and are highlighted in the title. However, the experimental data provided to answer these questions appear partially incomplete and not as conclusive as one would expect.

      We acknowledge that some aspects of our work have not been fully answered. We believe that providing additional experimental data is currently beyond the scope of this study. To improve this study, we will modify the text and clarify experimental procedures and figures where possible in the revised version of our manuscript.

      The stress-induced loss of viability is only monitored with one method: an in vivo assay where cytoplasmic sfGFP signal is compared to FM5-95 membrane stain. Addition of a sublethal level of nisin lead to loss of sfGFP signal in individual hyphae in the WT, but not in the cisA mutant (similarly to what was previously reported for a CIS-negative mutant). Technically, this experiment and the example images that are shown give rise to some concern. Only individual hyphal fragments are shown that do not look like healthy and growing S. coelicolor hyphae. Under the stated growth conditions, S. coelicolor strains would normally have grown as dense hyphal pellets. It is therefore surprising that only these unbranched hyphal fragments are shown in Fig. 4ab.

      We thank Reviewer #2 for their thoughtful criticism regarding our stress-induced viability assay and the data presented in Figure 4. We acknowledge the importance of ensuring that the presented images should reflect the physiological state of S. coelicolor under the stated growth conditions and recognize that hyphal fragments shown in Figure 4 do not fully capture the typical morphology of S. coelicolor. As pointed out by this reviewer, S. coelicolor grows in large hyphal clumps when cultured in liquid media, making the quantification of fluorescence intensities in hyphae expressing cytoplasmic GFP and stained with the membrane dye FM5-95 particularly challenging. To improve the image analysis and quantification of GFP and FM5-95-fluorescent intensities across the three S. coelicolor strains (wildtype, cisA deletion mutant and the complemented cisA mutant), we vortexed the cell samples briefly before imaging to break up hyphal clumps, increasing hyphal fragments. The hyphae shown in our images were selected as representative examples across three biological replicates. 

      Further, S. coelicolor would likely be in a stationary phase when grown 48 h in the rich medium that is stated, giving rise to concern about the physiological state of the hyphae that were used for the viability assay. It would be valuable to know whether actively growing mycelium is affected in the same way by the nisin treatment, and also whether the cell death effect could be detected by other methods.

      The reasoning behind growing S. coelicolor for 48 h before performing the fluorescence-based viability assay was that we (DOI: 10.1038/s41564-023-01341-x ) and others (e.g.: DOI: 10.1038/s41467-023-37087-7 ) previously showed that the levels of CIS particles peak at the transition from vegetative to reproductive/stationary growth, thus indicating that CIS activity is highest during this growth stage. The obtained results in this manuscript are in agreement with our previous study, in which we showed a similar effect on the viability of wildtype versus cis-deficient S. coelicolor strains (DOI: 10.1038/s41564-023-01341-x ) using nisin, the protonophore CCCP and UV light, and supported by biological replicate experiments and appropriate controls. Furthermore, our results are in agreement with the findings reported in a complementary study by Vladimirov et al. (DOI: 10.1038/s41467-023-37087-7 ) that used a different approach (SYTO9/PI staining of hyphal pellets) to demonstrate that CIS-deficient mutants exhibit decreased hyphal death. We agree that it would be interesting to test if actively growing hyphae respond differently to nisin treatment, and such experiments will be considered in future work. 

      Taken together, we believe that the results obtained from our fluorescence-based viability assay are consistent with data reported by others and provide strong experimental evidence that functional CIS mediate hyphal cell death. 

      The model presented in Fig. 5 suggests that stress leads to a CisA-dependent attachment of CIS assemblies to the cytoplasmic membrane, and then triggering of contraction, leading to cell death. This model makes testable predictions that have not been challenged experimentally. Given that sublethal doses of nisin seem to trigger cell death, there appear to be possibilities to monitor whether activation of the system (via CisA?) indeed leads to at least temporally increased interaction of CIS with the membrane.

      We thank this reviewer for their suggestions on how to test our model further. In the meantime, we have performed co-immunoprecipitation experiments using S. coelicolor cells that produced CisA-FLAG as bait and were treated with a sub-lethal nisin concentration for 0/15/45 min.  Mass spectrometry analysis of co-eluted peptides did not show the presence of CIS-associated peptides. While we cannot exclude the possibility that our experimental assay requires further optimization to successfully demonstrate a CisA-CIS interaction (e.g. optimization of the use of detergents to improve the solubilization of CisA from Streptomyces membrane, which is currently not an established method), an alternative and equally valid hypothesis is that the interaction between CIS particles and CisA is transient and therefore difficult to capture. We would like to mention that we did detect CisA peptides in crude purifications of CIS particles from nisin-stressed cells (Supplementary Table 2, manuscript: line 265/266), supporting our model that CisA associates with CIS particles in vivo.

      Further, would not the model predict that stress leads to an increased number of contracted CIS assemblies in the cytoplasm? No clear difference in length of the isolated assemblies if Fig. S7 is seen between untreated and nisin-exposed cells, and also no difference between assemblies from WT and cisA mutant hyphae.

      The reviewer is correct that there is no clear difference in length in the isolated CIS particles shown in Figure S7. This is in line with our results, which show that CisA is not required for the correct assembly of CIS particles and their ability to contract in the presence and absence of nisin treatment. The purpose of Figure S7 was to support this statement. We would like to note that the particles shown in Figure S7 were purified from cell lysates using a crude sheath preparation protocol, during which CIS particles generally contract irrespective of the presence or absence of CisA. Thus, we cannot comment on whether there is an increased number of contracted CIS assemblies in the cytoplasm of nisin-exposed cells. To answer this point, we would need to acquire additional cryo-electron tomograms (cyroET) of the different strains treated with nisin. We appreciate this reviewer's suggestions. However, cryoET is an extremely time and labour-intensive task, and given that we currently don’t know the exact dynamics of the CIS-CisA interaction following exogenous stress, we believe this experiment is beyond the scope of this work.

      The interaction of CisA with the CIS assembly is critical for the model but is only supported by Alphafold modelling, predicting interaction between cytoplasmic parts of CisA and Cis11 protein in the baseplate wedge. An experimental demonstration of this interaction would have strengthened the conclusions.

      We agree that direct experimental evidence of this interaction would have further strengthened the conclusions of our study, and we have extensively tried to provide additional experimental evidence. Unfortunately, due to the toxicity of CisA expression in E. coli and the transient nature of the interaction under our experimental conditions, we were unable to pursue direct biochemical or biophysical validation methods, such as co-purification or bacterial two-hybrid assays. While these challenges limited our ability to experimentally confirm the interaction, the AlphaFold predictions provided a valuable hypothesis and mechanistic insight into the role of CisA.

      The cisA mutant showed a similarly accelerated sporulation as was previously reported for CIS-negative strains, which supports the conclusion that CisA is required for function of CISSc. But the results do not add any new insights into how CIS/CisA affects the progression of the developmental life cycle and whether this effect has anything to do with the regulated cell death that is caused by CIS. The same applies to the effect on secondary metabolite production, with no further mechanistic insights added, except reporting similar effects of CIS and CisA inactivations.

      We thank this reviewer for their thoughtful feedback and for highlighting the connections between CisA, CIS function, and their effects on the developmental life cycle and secondary metabolite production in S. coelicolor. The main focus of this study was to provide further insight into how CIS contraction and firing are mediated in Streptomyces, and we used the analysis of accelerated sporulation and secondary metabolite production to assess the functionality of CIS in the presence or absence of CisA.

      We agree that we still don’t fully understand the nature of the signals that trigger CIS contraction, but we do know that the production of CIS assemblies seems to be an integral part of the Streptomyces multicellular life cycle as demonstrated in two independent previous studies (DOI: 10.1038/s41564-023-01341-x and DOI: 10.1038/s41467-023-37087-7 ). We propose that the assembly and firing of Streptomyces CIS particles could present a molecular mechanism to sacrifice only a part of the mycelium to either prevent the spread of local cellular damage or to provide additional nutrients for the rest of the mycelium and delay the terminal differentiation into spores and affect the production of secondary metabolites.

      We recognize the importance of understanding the regulation and mechanistic details underpinning the proposed CIS-mediated regulated cell death model. This will be further explored in future studies.

      Concluding remarks:

      The work will be of interest to anyone interested in contractile injection systems, T6SS, or similar machineries, as well for people working on the biology of streptomycetes. There is also a potential impact of the work in the understanding of how such molecular machineries could have been co-opted during evolution to become a mechanism for regulated cell death. However, this latter aspect remains still poorly understood. Even though this paper adds excellent new structural insights and identifies a putative membrane anchor, it remains elusive how the Streptomyces CIS may lead to cell death. It is also unclear what the advantage would be to trigger death of hyphal compartments in response to stress, as well as how such cell death may impact (or accelerate) the developmental progression. Finally, it is inescapable to wonder whether the Streptomyces CIS could have any role in protection against phage infection.

      We thank Reviewer #2 for their supportive assessment of our work. In the revised manuscript, we will briefly discuss the impact of functional CIS assemblies on Streptomyces development. We previously tested if Streptomyces could defend against phages but have not found any experimental evidence to support this idea. The analysis of phage defense mechanisms is an underdeveloped area in Streptomyces research, partly due to the currently limited availability of a diverse phage panel.

      Reviewer #3 (Public review):

      Summary:

      In this work, Casu et al. have reported the characterization of a previously uncharacterized membrane protein CisA encoded in a non-canonical contractile injection system of Streptomyces coelicolor, CISSc, which is a cytosolic CISs significantly distinct from both intracellular membrane-anchored T6SSs and extracellular CISs. The authors have presented the first high-resolution structure of extended CISSc structure. It revealed important structural insights in this conformational state. To further explore how CISSc interacted with cytoplasmic membrane, they further set out to investigate CisA that was previously hypothesized to be the membrane adaptor. However, the structure revealed that it was not associated with CISSc. Using fluorescence microscope and cell fractionation assay, the authors verified that CisA is indeed a membrane-associated protein. They further determined experimentally that CisA had a cytosolic N-terminal domain and a periplasmic C-terminus. The functional analysis of cisA mutant revealed that it is not required for CISSc assembly but is essential for the contraction, as a result, the deletion significantly affects CISSc-mediated cell death upon stress, timely differentiation, as well as secondary metabolite production. Although the work did not resolve the mechanistic detail how CisA interacts with CISSc structure, it provides solid data and a strong foundation for future investigation toward understanding the mechanism of CISSc contraction, and potentially, the relation between the membrane association of CISSc, the sheath contraction and the cell death.

      Strengths:

      The paper is well-structured, and the conclusion of the study is supported by solid data and careful data interpretation was presented. The authors provided strong evidence on (1) the high-resolution structure of extended CISSc determined by cryo-EM, and the subsequent comparison with known eCIS structures, which sheds light on both its similarity and different features from other subtypes of eCISs in detail; (2) the topological features of CisA using fluorescence microscopic analysis, cell fractionation and PhoA-LacZα reporter assays, (3) functions of CisA in CISSc-mediated cell death and secondary metabolite production, likely via the regulation of sheath contraction.

      Weaknesses:

      The data presented are not sufficient to provide mechanistic details of CisA-mediated CISSc contraction, as authors are not able to experimentally demonstrate the direct interaction between CisA with baseplate complex of CISSc (hypothesized to be via Cis11 by structural modeling), since they could not express cisA in E. coli due to its potential toxicity. Therefore, there is a lack of biochemical analysis of direct interaction between CisA and baseplate wedge. In addition, there is no direct evidence showing that CisA is responsible for tethering CISSc to the membrane upon stress, and the spatial and temporal relation between membrane association and contraction remains unclear. Further investigation will be needed to address these questions in future.

      We thank Reviewer #3 for the supportive evaluation and constructive criticism of our study in the public and non-public review. We appreciate your recognition of the technical limitations of experimentally demonstrating a direct interaction between CisA and CIS baseplate complex, and we agree that further investigations in the future will hopefully provide a full mechanistic understanding of the spatiotemporal interaction of CisA and CIS particular and the subsequent CIS firing.

      To further improve the manuscript, we will revise the text and clarify figures and figure legends as suggested in the non-public review.

      Discussion:

      Overall, the work provides a valuable contribution to our understanding on the structure of a much less understood subtype of CISs, which is unique compared to both membrane-anchored T6SSs and host-membrane targeting eCISs. Importantly, the work serves as a good foundation to further investigate how the sheath contraction works here. The work contributes to expanding our understanding of the diverse CIS superfamilies.

      Thank you.

    1. Author response:

      Both reviewers made thoughtful and constructive comments, suggesting improvements that we are keen to provide. The comments fall under 3 headings (1) Further validation of the design, regarding both optical performance and utility, for both education and research (2) Further description and facilitation of the build process and (3) Further description of future plans, in particular plans for dissemination and long-term support. We think these requirements will be best served by adding new content to our Github site and our YouTube channel. We will create this new content and provide a revised manuscript in which these materials are linked from our existing narrative.

    1. Author response:

      Reviewer #1 (Public review):

      Summary:

      The authors showed the presence of Mtb in human liver biopsy samples of TB patients and reported that chronic infection of Mtb causes immune-metabolic dysregulation. Authors showed that Mtb replicates in hepatocytes in a lipid rich environment created by up regulating transcription factor PPARγ. Authors also reported that Mtb protects itself from anti-TB drugs by inducing drug metabolising enzymes.

      Strengths:

      It has been shown that Mtb induces storage of triacylglycerol in macrophages by induction of WNT6/ACC2 which helps in its replication and intracellular survival, however, creation of favorable replicative niche in hepatocytes by Mtb is not reported. It is known that Mtb infects macrophages and induces formation of lipid-laden foamy macrophages which eventually causes tissue destruction in TB patients. In a recent article it has been reported that "A terpene nucleoside from M. tuberculosis induces lysosomal lipid storage in foamy macrophages" that shows how Mtb manipulates host defense mechanisms for its survival. In this manuscript, authors reported the enhancement of lipid droplets in Mtb infected hepatocytes and convincingly showed that fatty acid synthesis and triacylglycerol formation is important for growth of Mtb in hepatocytes. The authors also showed the molecular mechanism for accumulation of lipid and showed that the transcription factor associated with lipid biogenesis, PPARγ and adipogenic genes were upregulated in Mtb infected cells.

      The comparison of gene expression data between macrophages and hepatocytes by authors is important which indicates that Mtb modulates different pathways in different cell type as in macrophages it is related to immune response whereas, in hepatocytes it is related to metabolic pathways.

      Authors also reported that Mtb residing in hepatocytes showed drug tolerance phenotype due to up regulation of enzymes involved in drug metabolism and showed that cytochrome P450 monooxygenase that metabolize rifampicin and NAT2 gene responsible for N-acetylation of isoniazid were up regulated in Mtb infected cells.

      We thank the reviewer for the positive feedback and for highlighting the strengths of our study.

      Weaknesses:

      There are reports of hepatic tuberculosis in pulmonary TB patients especially in immune-compromised patients, therefore finding granuloma in human liver biopsy samples is not surprising.

      Mtb infected hepatic cells showed induced DME and NAT and this could lead to enhanced metabolism of drug by hepatic cells as a result Mtb in side HepG2 cells get exposed to reduced drug concentration and show higher tolerance to drug. The authors mentioned that " hepatocyte resident Mtb may display higher tolerance to rifampicin". In my opinion higher tolerance to drugs is possible only when DME of Mtb inside is up regulated or the target is modified. Although, in the end authors mentioned that drug tolerance phenotype can be better attributed to host intrinsic factors rather than Mtb efflux pumps. It may be better if the Drug tolerant phenotype section can be rewritten to clarify the facts.

      We agree that several case studies regarding liver infection in pulmonary TB patients have been reported in the literature, however this report is the first comprehensive study that establishes hepatocytes to be a favourable niche for Mtb survival and growth.

      Drug tolerance is a phenomenon that is exhibited by the bacteria and in the course of host-pathogen interactions, can be influenced by both intrinsic (bacterial) and extrinsic (host-mediated) factors. Multiple examples of tolerance being attributed to host driven factors can be found in literature (PMID 32546788, PMID: 28659799, PMID: 32846197). Our studies demonstrate that Mtb infected hepatocytes create a drug tolerant environment by modulating the expression of Drug modifying enzymes (DMEs) in the hepatocytes.

      As suggested by the reviewer we will rewrite the drug tolerant phenotype section.

      Reviewer #2 (Public review):

      The manuscript by Sarkar et al has demonstrated the infection of liver cells/hepatocytes with Mtb and the significance of liver cells in the replication of Mtb by reprogramming lipid metabolism during tuberculosis. Besides, the present study shows that similar to Mtb infection of macrophages (reviewed in Chen et al., 2024; Toobian et al., 2021), Mtb infects liver cells but with a greater multiplication owing to consumption of enhanced lipid resources mediated by PPARg that could be cleared by its inhibitors. The strength of the study lies in the clinical evaluation of the presence of Mtb in human autopsied liver samples from individuals with miliary tuberculosis and the presence of a clear granuloma-like structure. The interesting observation is of granuloma-like structure in liver which prompts further investigations in the field.

      The modulation of lipid synthesis during Mtb infection, such as PPARg upregulation, appears generic to different cell types including both liver cells and macrophage cells. It is also known that infection affect PPARγ expression and activity in hepatocytes. It is also known that this can lead to lipid droplet accumulation in the liver and the development of fatty liver disease (as shown for HCV). This study is in a similar line for M.tb infection. As the liver is the main site for lipid regulation, the availability of lipid resources is greater and higher is the replication rate. In short, the observations from the study confirm the earlier studies with these additional cell types. It is known that higher the lipid content, the greater are Lipid Droplet-positive Mtb and higher is the drug resistance (Mekonnen et al., 2021). The DMEs of liver cells add further to the phenotype.

      We thank the reviewer for emphasizing on the strengths of our study and how it can lead to further investigations in the field.

      Reviewer #3 (Public review):

      This manuscript by Sarkar et al. examines the infection of the liver and hepatocytes during M. tuberculosis infection. They demonstrate that aerosol infection of mice and guinea pigs leads to appreciable infection of the liver as well as the lung. Transcriptomic analysis of HepG2 cells showed differential regulation of metabolic pathways including fatty acid metabolic processing. Hepatocyte infection is assisted by fatty acid synthesis in the liver and inhibiting this caused reduced Mtb growth. The nuclear receptor PPARg was upregulated by Mtb infection and inhibition or agonism of its activity caused a reduction or increase in Mtb growth, respectively, supporting data published elsewhere about the role of PPARg in lung macrophage Mtb infection. Finally, the authors show that Mtb infection of hepatocytes can cause upregulation of enzymes that metabolize antibiotics, resulting in increased tolerance of these drugs by Mtb in the liver.

      Overall, this is an interesting paper on an area of TB research where we lack understanding. However, some additions to the experiments and figures are needed to improve the rigor of the paper and further support the findings. Most importantly, although the authors show that Mtb can infect hepatocytes in vitro, they fail to describe how bacteria get from the lungs to the liver in an aerosolized infection. They also claim that "PPARg activation resulting in lipid droplets formation by Mtb might be a mechanism of prolonging survival within hepatocytes" but do not show a direct interaction between PPARg activation and lipid droplet formation and lipid metabolism, only that PPARg promotes Mtb growth. Thus, the correlations with PPARg appear to be there but causation, implied in the abstract and discussion, is not proven.

      The human photomicrographs are important and overall, well done (lung and liver from the same individuals is excellent). However, in lines 120-121, the authors comment on the absence of studies on the precise involvement of different cells in the liver. In this study there is no attempt to immunophenotype the nature of the cells harboring Mtb in these samples (esp. hepatocytes). Proving that hepatocytes specifically harbor the bacteria in these human samples would add significant rigor to the conclusions made.

      We thank the reviewer for nicely summarizing our manuscript.

      Our study establishes the involvement of liver and hepatocytes in pulmonary TB infection in mice. Understanding the mechanism of bacterial dissemination from the lung to the liver in aerosol infections demands a detailed separate study.

      Figure 6E and 6F shows how PPARγ agonist and antagonist modulate (increase and decrease respectively) bacterial growth in hepatocytes (further supported by the CFU data in Supplementary Figure 9B). Again, the number of lipid droplets in hepatocytes increase and decrease with the application of PPARγ agonist and antagonist respectively as shown in Figure 6G and 6H. Collectively, these studies provide strong evidence that PPARγ activation leads to more lipid droplets that support better Mtb growth.

      We thank the reviewer for finding our human photomicrographs convincing. In the manuscript, we provide evidence for the direct involvement of the hepatocytes (and liver) in Mtb infection. We perform detailed immunophenotyping of hepatocyte cells in the mice model with ASPGR1 (asialoglycoprotein receptor 1) and in the revised version of record, we will further stain the infected hepatocytes with anti-albumin antibody.

  2. Dec 2024
    1. Author response:

      The following is the authors’ response to the previous reviews.

      Reviewer #3:

      Concerns and comments on current version:

      The revision has improved the manuscript but, in my opinion, remains inadequate. While most of my requested changes have been made, I do not see an expansion of Fig1A legend to incorporate more details about the analysis. Lacking details of methodology was a concern from all reviewers.

      To address this concern, we expanded Fig.1A legend, and also significantly expanded the text describing experimental design, to also include the description of the data analysis approach.

      “BCR repertoires libraries were obtained using the 5’-RACE (Rapid Amplification of cDNA Ends) protocol as previously described21 and sequenced with 150+150 bp read length. This approach allowed us to achieve high coverage for the obtained libraries (Table S1) to reveal information on clonal composition, CDR-H3 properties, IgM/IgG/IgA isotypes and somatic hypermutation load within CDR-H3. For B cell clonal lineage reconstruction and phylogenetic analysis, however, 150+150 bp read length is suboptimal because it does not cover V-gene region outside CDR-H3, where hypermutations also occur. Therefore, to verify our conclusions based on the data obtained by 150+150 bp sequencing (“short repertoires”), for some of our samples we also generated BCR libraries by IG RNA Multiplex protocol (See Materials and Methods) and sequenced them at 250+250 bp read length (“long repertoires”). Libraries obtained by this protocol cover V gene sequence starting from CDR-H1 and capture most of the hypermutations in the V gene. Conclusions about clonal lineage phylogeny were drawn only when they were corroborated by “long repertoire” analysis.

      For BCR repertoire reconstruction from sequencing data, we first performed unique molecular identifier (UMI) extraction and error correction (reads/UMI threshold = 3 for 5`RACE and 4 for IG Multiplex libraries). Then, we used MIXCR58 software to assemble reads into clonotypes, determine germline V, D, and J genes, isotypes, and find the boundaries of target regions, such as CDR-H3. Only

      UMI counts, and not read counts, were used for quantitative analysis. Clonotypes derived from only one UMI were excluded from the analysis of individual clonotype features but were used to analyze clonal lineages and hypermutation phylogeny, where sample size was crucial. Samples with 50 or less clonotypes left after preprocessing were excluded from the analysis.”

      Similarly, the 'fragmented' narrative was a concern of all reviewers. These matters have not been dealt with adequately enough - there are parts of the manuscript which remain fragmented and confusing.

      Unfortunately, the reviewers do not give us a hint as to which parts of the text are the most problematic in their opinion. We identified the parts describing physicochemical properties of CDR3s, Intratumoral heterogeneity and Intra-LN heterogeneity as the most problematic, and edited these parts significantly. Also, we significantly edited the Discussion section (please see the Comparison file for details). Other parts sections were also edited to improve readability and clarity.

      The narrative and analysis does not explain how the plasma cell bias has been dealt with adequately and in fact is simply just confusing. There is a paragraph at the beginning of the discussion re the plasma cell bias, which should be re-written to be clearer and moved to have a prominent place early in the results. Why are these results not properly presented? They are key for interpretation of the manuscript. Furthermore, the sorted plasma cell sequencing analysis also has only been performed on two patients.

      In response to this concern, we moved the section describing plasma cell bias in the bulk BCR repertoires to the main text.

      Another issue is that some disease cohorts are entirely composed of patients with metastasis, some without but metastasis is not mentioned. Metastasis has been shown to impact the immune landscape.

      Intrinsic heterogeneity of the cohort is indeed one of the weaknesses of our work, which could negatively impact the statistical significance of our results and, as a consequence, mask certain observations or make them less statistically significant. We mention this in the discussion section. It should not, in our understanding, lead to any false conclusions. We did not, however, pool data from primary and metastatic tumor samples, and all tumor samples that we mention are primary tumors.

      The following part of a sentence was added to the discussion:

      “...which could negatively impact the statistical significance of our results and, as a consequence, mask certain observations or make them less statistically significant.”

      A reviewer brought up a concern about the overlap analysis and I also asked for an explanation on why this F2 metric was chosen. Part of the rebuttal argues that another metric was explored showing similar results, thus the conclusion reached is reasonable. Remarkably, these data are not only omitted from the manuscript, but are not even provided for the reviewers.

      We did not intend to conceal any data from the reviewers, and we now added the panel for D metric to the S1 figure. We would also like to point out that the panel describing R metric for repertoire overlaps (a measure of similarity of overlapping clonotype frequencies), was included in the first version of the S2 Figure (now S1 Figure), and it also showed a similar trend. We hope that now the data are fully conclusive.

      This manuscript certainly includes some interesting and useful work. Unfortunately, a comprehensive re-write was required to make the work much clearer and easier to understand and this has not been realized.

      Again, we thank the reviewers for their thorough evaluation, and hopefully we could make the text clearer in the second reviewed version.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      In this work, a screening platform is presented for rapid and cost-effective screening of candidate genes involved in Fragile Bone Disorders. The authors validate the approach of using crispants, generating FO mosaic mutants, to evaluate the function of specific target genes in this particular condition. The design of the guide RNAs is convincingly described, while the effectiveness of the method is evaluated to 60% to 92% of the respective target genes being presumably inactivated. Thus, injected F0 larvae can be directly used to investigate the consequences of this inactivation.

      Skeletal formation is then evaluated at 7dpf and 14dpf, first using a transgenic reporter line revealing fluorescent osteoblasts, and second using alizarin-red staining of mineralized structures. In general, it appears that the osteoblast-positive areas are more often affected in the crispants compared to the mineralized areas, an observation that appears to correlate with the observed reduced expression of bglap, a marker for mature osteoblasts, and the increased expression of col1a1a in more immature osteoblasts.

      Finally, the injected fish (except two lines that revealed high mortality) are also analyzed at 90dpf, using alizarin red staining and micro-CT analysis, revealing an increased incidence of skeletal deformities in the vertebral arches, fractures, as well as vertebral fusions and compressions for all crispants except those for daam2. Finally, the Tissue Mineral Density (TMD) as determined by micro-CT is proposed as an important marker for investigating genes involved in osteoporosis.

      Taken together, this manuscript is well presented, the data are clear and well analyzed, and the methods are well described. It makes a compelling case for using the crispant technology to screen the function of candidate genes in a specific condition, as shown here for bone disorders.

      Strengths:

      Strengths are the clever combination of existing technologies from different fields to build a screening platform. All the required methods are comprehe Zebrafish tanks_13062024nsively described.

      We would like to thank the reviewer for highlighting the strengths of our paper.  

      Weaknesses:

      One may have wished to bring one or two of the crispants to the stage of bona fide mutants, to confirm the results of the screening, however, this is done for some of the tested genes as laid out in the discussion.

      We thank the reviewer for their comment. We would like to point out that indeed similar phenotypes have been observed in existing models, as mentioned in the discussion section.

      Reviewer #2 (Public review):

      Summary:

      More and more genes and genetic loci are being linked to bone fragility disorders like osteoporosis and osteogenesis imperfecta through GWAS and clinical sequencing. In this study, the authors seek to develop a pipeline for validating these new candidate genes using crispant screening in zebrafish. Candidates were selected based on GWAS bone density evidence (4 genes) or linkage to OI cases plus some aspect of bone biology (6 genes). NGS was performed on embryos injected with different gRNAs/Cas9 to confirm high mutagenic efficacy and off-target cutting was verified to be low. Bone growth, mineralization, density, and gene expression levels were carefully measured and compared across crispants using a battery of assays at three different stages.

      Strengths:

      (1) The pipeline would be straightforward to replicate in other labs, and the study could thus make a real contribution towards resolving the major bottleneck of candidate gene validation.

      (2) The study is clearly written and extensively quantified.

      (3) The discussion attempts to place the phenotypes of different crispant lines into the context of what is already known about each gene's function.

      (4) There is added value in seeing the results for the different crispant lines side by side for each assay.

      We would like to thank the reviewer for highlighting the strengths of our paper.  

      Weaknesses:

      (1) The study uses only well-established methods and is strategy-driven rather than question/hypothesis-driven.

      We thank the reviewer for this correct remark. The mayor aim of this study was to establish a workflow for rapid in vivo functional screening of candidate genes across a broad range of FBDs. 

      (2) Some of the measurements are inadequately normalized and not as specific to bone as suggested:

      (a) The measurements of surface area covered by osteoblasts or mineralized bone (Figure 1) should be normalized to body size. The authors note that such measures provide "insight into the formation of new skeletal tissue during early development" and reflect "the quantity of osteoblasts within a given structure and [is] a measure of the formation of bone matrix." I agree in principle, but these measures are also secondarily impacted by the overall growth and health of the larva. The surface area data are normalized to the control but not to the size/length of each fish - the esr1 line in particular appears quite developmentally advanced in some of the images shown, which could easily explain the larger bone areas. The fact that the images in Figure S5 were not all taken at the same magnification further complicates this interpretation.

      We thank the reviewer for this detailed and insightful remark. We agree with the reviewer and recognize that the results may be influenced by size differences. However, we do not normalize for size, as variations in growth were considered as part of the phenotypic outcome. This consideration has been addressed in the discussion section.

      Line 335-338: ‘Although the measurements of osteoblast-positive and mineralized surface areas may be influenced by size differences among some of the crispants, normalization to size parameters was not conducted, as variations in growth were considered integral to the phenotypic outcome.’

      Line 369: ‘Phenotypic variability in these zebrafish larvae can be attributed to several factors, including crispant mosaicism, allele heterogeneity, environmental factors, differences in genomic background and development, and slightly variable imaging positioning.’

      (b) Some of the genes evaluated by RT-PCR in Figure 2 are expressed in other tissues in addition to bone (as are the candidate genes themselves); because whole-body samples were used for these assays, there is a nonzero possibility that observed changes may be rooted in other, non-skeletal cell types.

      We thank the reviewer for this valuable comment. We acknowledge that the genes assessed by RT-PCR are expressed in other tissues beyond bone. This consideration has been addressed in the discussion section.

      Line 362-365: “However, it is important to note that the genes evaluated by RT-PCR are not exclusively expressed in bone tissue. Since whole-body samples were used for expression analysis, there is a possibility that the observed changes in gene expression may be influenced by other non-skeletal cell types”.

      (3) Though the assays evaluate bone development and quality at several levels, it is still difficult to synthesize all the results for a given gene into a coherent model of its requirement.

      We appreciate the reviewer’s  remark. We acknowledge that the results for the larval stages exhibit variability, making it challenging to synthesize them into a coherent model. However, it is important to emphasize that all adult crispant consistently display a skeletal phenotype. Consequently, the feasibility and reproducibility of this screening method are primarily focusing on the adult stages. This consideration has been addressed in the discussion section of the manuscript.

      Line 391-399: ‘In adult crispants, the skeletal phenotype was generally more penetrant. All crispants showed malformed arches, a majority displayed vertebral fractures and fusions and some crispants exhibited distinct quantitative variations in vertebral body measurements. This confirmed the role of the selected genes in skeletal development and homeostasis and their involvement in skeletal disease and established the crispant approach as a valid approach for rapidly providing in vivo gene function data to support candidate gene identification.’

      (4) Several additional caveats to crispant analyses are worth noting:

      (a) False negatives, i.e. individual fish may not carry many (or any!) mutant alleles. The crispant individuals used for most assays here were not directly genotyped, and no control appears to have been used to confirm successful injection. The authors therefore cannot rule out that some individuals were not, in fact, mutagenized at the loci of interest, potentially due to human error. While this doesn't invalidate the results, it is worth acknowledging the limitation.

      We thank the reviewer for this valuable remark. We recognize the fact that working with crispants has certain limitations, including the possibility that some individuals may carry few or no mutant alleles. To address this issue, we use 10 individual crispants during the larval stage and 5 during the adult stage. Although some individuals may lack the mutant alleles, using multiple fish helps reduce the risk of false negatives.

      Furthermore, we perform NGS analysis on pools of 10 embryos from the same injection clutch as the fish used in the various assays to assess the indel efficiency. While there remains a possibility of false negatives, the overall indel efficiency, as indicated by our NGS analysis,  is high (>90%), thereby reducing the likelihood of having crispants with very low indel efficiency. We included this in the discussion.

      Line 387-390: ‘While there remains a possibility of false negatives, the overall indel efficiency, as indicated by our NGS analysis,  is high (>90%), thereby reducing the likelihood of having crispants with very low indel efficiency.’

      (b) Many/most loci identified through GWAS are non-coding and not easily associated with a nearby gene. The authors should discuss whether their coding gene-focused pipeline could be applied in such cases and how that might work.

      The authors thank the reviewer for this insightful comment. Our study is focused on strong candidate genes rather than non-coding variants. We recognize that the use of this workflow poses challenges for analyzing non-coding variants, which represents a limitation of the crispant approach. We have addressed this issue in the discussion section of the manuscript.

      Line 131: ‘Gene-based’

      Line 453: ‘Gene-based’

      Line 311-314: ‘It is important to note that this study focused on candidate genes for osteoporosis, not on the role of specific variants identified in GWAS studies. Non-coding variants for instance, which are often identified in GWAS studies,  present significant challenges in terms of functional validation and interpretation.’

      Reviewer #3 (Public review):

      Summary:

      The manuscript "Crispant analysis in zebrafish as a tool for rapid functional screening of disease-causing genes for bone fragility" describes the use of CRISPR gene editing coupled with phenotyping mosaic zebrafish larvae to characterize functions of genes implicated in heritable fragile bone disorders (FBDs). The authors targeted six high-confident candidate genes implicated in severe recessive forms of FBDs and four Osteoporosis GWAS-implicated genes and observed varied developmental phenotypes across all crispants, in addition to adult skeletal phenotypes.

      A major strength of the paper is the streamlined method that produced significant phenotypes for all candidate genes tested.

      We would like to thank the reviewer for highlighting the strengths of our paper.  

      A major weakness is a lack of new insights into underlying mechanisms that may contribute to disease phenotypes, nor any clear commonalities across gene sets. This was most evident in the qRT-PCR analysis of select skeletal developmental genes, which all showed varied changes in fold and direction, but with little insight into the implications of the results.

      We thank the reviewer for this insightful remark. We want to emphasize that this study focusses on establishing a new screening method for candidate genes involved in FBDs, rather than investigating the underlying mechanisms contributing to disease phenotypes. However, to investigate the underlying mechanisms in these crispants, the creation of bona fide mutants is necessary. We have included this consideration in the discussion.

      Furthermore, we acknowledge that the results for the larval stages exhibit variability, which can complicate the interpretation of these findings. This is particularly true for the RT-PCR analysis, where whole-body samples were used, raising the possibility that other tissues may influence the expression results. Therefore, our primary focus is on the adult stages, as all crispants display a skeletal phenotype at this age. We have elaborated on this point in the discussion.

      Line 462-463: ‘Moreover, to explore the underlying mechanisms contributing to disease phenotypes, it is essential to establish stable knockout mutants derived from the crispants’.

      Line 391-399: ‘In adult crispants, the skeletal phenotype was generally more penetrant. All crispants showed malformed arches, a majority displayed vertebral fractures and fusions and some crispants exhibited distinct quantitative variations in vertebral body measurements. This confirmed the role of the selected genes in skeletal development and homeostasis and their involvement in skeletal disease and established the crispant approach as a valid approach for rapidly providing in vivo gene function data to support candidate gene identification.’

      Ultimately, the authors were able to show their approach is capable of connecting candidate genes with perturbation of skeletal phenotypes. It was surprising that all four GWAS candidate genes (which presumably were lower confidence) also produced a result.

      We appreciate the reviewer’s comment. We would like to direct attention to the discussion section, where we offer a possible explanation for the observation that all four GWAS candidate genes produce a skeletal phenotype.

      Line 460-410: 'The more pronounced and earlier phenotypes in these zebrafish crispants are most likely attributed to the quasi knock-out state of the studied genes, while more common less impactful variants in the same genes result in typical late-onset osteoporosis (Laine et al., 2013) . This phenomenon is also observed in knock-out mouse models for these genes (Melville et al., 2014)(Coughlin et al., 2019).’

      These authors have previously demonstrated that crispants recapitulate skeletal phenotypes of stable mutant lines for a single gene, somewhat reducing the novelty of the study.

      We thank the reviewer for this comment and appreciate their concern. We have indeed demonstrated that crispants can recapitulate the skeletal phenotypes observed in stable mutant lines for the osteoporosis gene LRP5. However, we would like to highlight that the current study represents the first large-scale screening of candidate genes associated with bone disorders, including genes related to both OI and osteoporosis. We have included this information in both the abstract and the discussion

      Line 60-62: ‘We advocate for a novel comprehensive approach that integrates various techniques and evaluates distinct skeletal and molecular profiles across different developmental and adult stages.’

      Line 456-457: ‘While this work represents a pioneering effort in establishing a screening platform for skeletal diseases, it offers opportunities for future improvement and refinement.’

      Recommendations for the authors:

      Reviewer #1 (Recommendations for the authors):

      (1) Figure 1a: what does the differential shading of the bone elements represent? Explain in the legend.

      The differential shading doesn't represent anything specific. It's simply used to enhance the visual appeal and to help distinguish between the different structures. We removed the shading in the figure.

      (2) Supplementary Figures 2-5: should the numbering of these figures be also in order of appearance in the text? I understand that the authors prefer to associate the transgenic and the alizarin red-stained specimens, however, the reading would be easier that way.

      We changed this accordingly.

      (3) Lines 275-276: "no significant differences in standard length (Figure 4a)": should be Figure 4b.

      The suggested changes are incorporated in the manuscript.

      Line 276-277: ‘Among the eight crispants that successfully matured into adulthood, none exhibited significant differences in standard length and head size (n=5 fish per crispant) (Figure 4b).’

      (4) Line 277 "larger eye diameter": should be Figure 4b.

      The suggested changes are incorporated in the manuscript.

      Line 378: ‘However, esr1 crispants were observed to have notably larger eye diameters (Figure 4b).’

      (5) Line 280: "no obvious abnormalities were detected (Figure 4b,c)": should be Figure 4a, c. Note that the authors may reconsider the a, b, c numbering in Figure 4 by inverting a and b.

      The suggested changes are incorporated in the manuscript.

      Line 278-281: ‘All these crispants demonstrated various abnormalities in the caudal part of the vertebral column such as fusions, compressions, fractures, or arch malformations, except for daam2 crispants where no obvious abnormalities were detected (Figure 4a,c; Supplementary Figure 6).’

      (6) Table 2: This table, which recapitulates all the results presented in the manuscript, is in the end the centerpiece of the work. It is however difficult to read in its present form. Three suggestions:

      - Transpose it such that each gene has its own column, and the lines give the results for the different measurements

      - Place the measurements that result in "ns" for all crispants at the end (bottom) of the table.

      - Maybe bring the measurements at 7dpf, 14dpf, and 90 dpf together.

      We agree with the reviewer and have added a new table where we transposed the data. However, we chose not to place the measurements that resulted in 'ns' for all crispants at the end of the table, as we believe it is important to track the evolution of the phenotype over time. Where possible, we have grouped the measurements for 7 dpf and 14 dpf together.

      Reviewer #2 (Recommendations for the authors):

      (1) It would help to justify why these particular area measurements are appropriate for this set of candidate genes, which were selected based on putative links to bone quality rather than bone development.

      The selected methods are among the most commonly used to evaluate bone phenotypes. They are straightforward to reproduce, as well as cost- and time-effective. The strength of this approach lies in its use of simple, reproducible techniques that form the foundation for characterizing bone development.  Although the candidate genes were chosen based on their putative links to bone quality, early skeletal phenotypes can already be observed during bone development.

      The mineralized surface area of the total head and specific head structures was selected to evaluate the degree of mineralization in early skeletal development, as mineralization is a direct indicator of bone formation. Additionally, the osteoblast-positive surface areas were measured to provide insight into the formation of new skeletal tissue during early development. Osteoblasts, as active bone-forming cells, are essential for understanding bone growth and the dynamics of skeletal phenotypes.

      Examples in the manuscript:

      Line 212-214: ‘The osteoblast-positive areas in both the total head and the opercle were then quantified to gain insight into the formation of new skeletal tissue during early development.’

      Line 221-223: ‘Subsequently, Alizarin Red S (ARS) staining was conducted on the same 7 and 14 dpf crispant zebrafish larvae in order to evaluate the degree of mineralization in the early skeletal structures.’

      (2) Reword: The opercle bone is the earliest forming bone of the opercular series, and appears to be what the authors are referring to as the "operculum" at 7-14 dpf. The operculum is the larger structure (gill cover) in which the opercle is embedded. It would be more accurate to simply refer to the opercle at these stages.

      We agree with this comment and changed the text accordingly.

      (3) Define BMD and TMD at first usage.

      BMD and TMD are now defined in the manuscript.

      Line 41-43: ‘Six genes associated with severe recessive forms of Osteogenesis Imperfecta (OI) and four genes associated with bone mineral density (BMD), a key osteoporosis indicator, identified through genome-wide association studies (GWAS) were selected.’

      Line 286-288: ‘For each of the vertebral centra, the length, tissue mineral density (TMD), volume, and thickness were determined and tested for statistical differences between groups using a regression-based statistical test (Supplementary Figure 7).’

      (4) It would be helpful to note the grouping of candidates into OI vs. BMD GWAS throughout the figures.

      We agree with this comment and added this to all figure legends.

      ‘The first four genes are associated with the pathogenesis of osteoporosis, while the last six are linked to osteogenesis imperfecta’

      Reviewer #3 (Recommendations for the authors):

      Major points:

      (1) For the Results, it would be useful to the Reader to justify the selection of human candidate genes and their associated zebrafish orthologs to model skeletal functions. For example, what are variants identified from human studies, and do they impact functional domains? Are these domains and/or proteins conserved between humans/zebrafish? Is there evidence of skeletal expression in humans/zebrafish?

      Supplementary Table 4 lists the selected human candidate genes with reported mutations and/or polymorphisms associated with both skeletal and non-skeletal phenotypes. The table also includes additional findings from studies in mice and zebrafish. An extra column was now added to indicate gene conservation between human and zebrafish. We consulted UniProt (https://www.uniprot.org) and ZFIN (https://zfin.org) to assess the skeletal expression of these genes in human and zebrafish. All genes showed expression in the trabecular bone and/or bone marrow in humans, as well as in bone elements in zebrafish. We added this in the discussion.

      Line 309: ‘All selected genes show skeletal expression in both human and zebrafish.’

      Supplemental table 4 legend: ‘The conservation between human and zebrafish is reported in the last column.’

      As part of this, some version of Supplementary Table 4 might be included as a main display to introduce the targeted genes, ideally separated by rare (recessive OI) vs. common disease (osteoporosis). In the case of common disease and GWAS hits, how did authors narrow in on candidate genes (which often have Mbp-scale associated regions spanning multiple genes)? Further, what is the evidence that the mechanism of action of the GWAS variant is haploinsufficiency modeled by their crispant zebrafish?

      We have kept Supplementary Table 4 in the supplementary material but have referred to it earlier in the manuscript’s introduction. Consequently, the table has been renumbered from ‘Supplementary Table 4’  to ‘Supplementary Table 1’.

      The selection of genes potentially involved in the pathogenesis of osteoporosis is based on the data from the GWAS catalog, which annotates SNPs using the Ensemble mapping pipeline. The available annotation on their online search interface includes any Ensemble genes to which a SNP maps, or the closest upstream and downstream gene within a 50kb window. Four genes were selected for this screening method based on the criteria outlined in the results section. In this study, we aim to evaluate the general involvement of specific genes in bone metabolism, rather than to model a specific variant.

      Line 135-136 and 309-311: ‘An overview of the selected genes with observed mutant phenotypes in human, mice and zebrafish is provided in Supplementary Table 1.’

      (2) Using the crispant approach does not impact maternally-deposited RNAs that would dampen early developmental phenotypes. Considering the higher variability in larval phenotypes, perhaps the maternal effect plays a role. The authors might investigate developmental expression profiles of their genes using existing RNA-seq datasets such as from White et al (doi: 10.7554/eLife.30860).

      We thank the reviewer for this comment and agree with the possibility that maternally-deposited RNAs might have an impact on early developmental phenotypes. We included this in the discussion.

      Line 369-372: ‘Phenotypic variability in these zebrafish larvae can be attributed to several factors, including crispant mosaicism, allele heterogeneity, environmental factors, differences in genomic background and development, maternally-deposited RNAs, and slightly variable imaging positioning.’

      (3) While making comparisons within a clutch of mutant vs scrambled control is crucial, it is also important to ensure phenotypes are not specific to a single clutch. Do phenotypes remain consistent across different crosses/clutches?

      Yes, phenotypes remain consistent across different crosses and clutches. We included images from a second clutch in the Supplementary material (Supplementary Figure 8) and refereed to it in the discussion.

      Line 394-397: ‘Additionally, these skeletal malformations were consistently observed in a second clutch of crispants (Supplementary Figure 8), underscoring the reproducibility of these phenotypic features across independent clutches.’

      (4) Understanding that antibodies may not exist for many of the selected genes for zebrafish, authors should verify haploinsufficiency using an RT-qPCR of targeted genes in crispants vs. controls.

      We appreciate the reviewer’s suggestion to use RT-qPCR to examine expression levels of the targeted genes in crispants. However, previous experience suggests that relying on RNA expression to verify haploinsufficiency in zebrafish can be challenging. In zebrafish KO mutants, RT-qPCR often still detects gene transcripts, potentially due to incomplete nonsense-mediated decay (NMD) of the mutated mRNA, which may allow residual expression even in the absence of functional protein. As a more definitive approach, we prefer to use antibodies to confirm haploinsufficiency at the protein level. However, as the reviewer noted, generating and applying specific antibodies in zebrafish remains challenging.

      (5) Please indicate how parametric vs. non-parametric statistical tests were selected for datasets.

      We initially selected the parametric unpaired t-test, assuming the data were normally distributed with similar variances between groups. We verified the assumption of equal variances using the F-test, which was not significant across all assays. However, we did not assess the normality of the data directly, meaning we cannot confirm the normality assumption required for the t-test. Given this, we have opted to use the non-parametric Mann-Whitney U test, which does not require assumptions of normality, to ensure the robustness of our statistical analyses. We changed the Figures, the figure legends and the text accordingly.

      (6) In the figures and tables, I recommend adding notation showing the grouping of the first four genes as GWAS osteoporosis, the next three genes as osteoblast differentiation, the next two genes as bone mineralization, and the final gene as collagen transport to orient the reader. One might expect there to be a clustering of phenotypic outcomes based on the selection of genes, and it would be easier to follow this. This would be particularly useful to include in Table 2.

      Our primary objective is to assess the feasibility and reproducibility of the crispant screen rather than performing an in-depth pathway analysis or categorizing genes by biological processes. For this purpose, we have organized candidate genes based on their relevance to osteoporosis and Osteogenesis Imperfecta, without subdividing them further. We have clarified this focus in the figure legends, as suggested in an earlier recommendation.

      (7) For Figure 1, consider adding a smaller zoomed version of 1a embedded in each sub-figure with each measured element highlighted to improve readability.

      We agree with this comment and changed the figure accordingly.

      Minor points:

      (1) Table 2 could be simplified to improve readability. The headers have redundancies across columns with varied time points and could be merged.

      The suggested changes are incorporated in the manuscript (see earlier comment about this).

      (2) "BMD" is not defined in the Abstract. This is a personal preference, but there were numerous abbreviations in the text that made it difficult to follow at times.

      The suggested changes are incorporated in the manuscript (see earlier comment about this).

    1. Author response:

      The following is the authors’ response to the original reviews.

      eLife Assessment

      This valuable study reveals how a rhizobial effector protein cleaves and inhibits a key plant receptor for symbiosis signaling, while the host plant counters by phosphorylating the effector. The molecular evidence for the protein-protein interaction and modification is solid, though biological evidence directly linking effector cleavage to rhizobial infection is incomplete. With additional functional data, this work could have implications for understanding intricate plant-microbe dynamics during mutualistic interactions.

      Thank you for this positive comment. Our data strongly support the view that NFR5 cleavage by NopT impairs Nod factor signaling resulting in reduced rhizobial infection. However, other mechanisms may also have an effect on the symbiosis, as NopT targets other proteins in addition to NFR5. In our revised manuscript version, we discuss the possibility that negative NopT effects on symbiosis could be due to NopT-triggered immune responses. As mentioned in our point-by-point answers to the Reviewers, we included additional data into our manuscript. We would also like to point out that we are generally more cautious in our revised version in order to avoid over-interpreting the data obtained.

      Public Reviews:

      Reviewer #1 (Public Review):

      Bacterial effectors that interfere with the inner molecular workings of eukaryotic host cells are of great biological significance across disciplines. On the one hand they help us to understand the molecular strategies that bacteria use to manipulate host cells. On the other hand they can be used as research tools to reveal molecular details of the intricate workings of the host machinery that is relevant for the interaction/defence/symbiosis with bacteria. The authors investigate the function and biological impact of a rhizobial effector that interacts with and modifies, and curiously is modified by, legume receptors essential for symbiosis. The molecular analysis revealed a bacterial effector that cleaves a plant symbiosis signaling receptor to inhibit signaling and the host counterplay by phosphorylation via a receptor kinase. These findings have potential implications beyond bacterial interactions with plants.

      Thank you for highlighting the broad significance of rhizobial effectors in understanding legume-rhizobia interactions. We fully agree with your assessment and have expanded our Discussion (and Abstract) regarding the potential implications of our findings beyond bacterial interactions with plants. We mention the prospect of developing specific kinase-interacting proteases to fine-tune cellular signaling processes in general.

      Bao and colleagues investigated how rhizobial effector proteins can regulate the legume root nodule symbiosis. A rhizobial effector is described to directly modify symbiosis-related signaling proteins, altering the outcome of the symbiosis. Overall, the paper presents findings that will have a wide appeal beyond its primary field.

      Out of 15 identified effectors from Sinorhizobium fredii, they focus on the effector NopT, which exhibits proteolytic activity and may therefore cleave specific target proteins of the host plant. They focus on two Nod factor receptors of the legume Lotus japonicus, NFR1 and NFR5, both of which were previously found to be essential for the perception of rhizobial nod factor, and the induction of symbiotic responses such as bacterial infection thread formation in root hairs and root nodule development (Madsen et al., 2003, Nature; Tirichine et al., 2003; Nature). The authors present evidence for an interaction of NopT with NFR1 and NFR5. The paper aims to characterize the biochemical and functional consequences of these interactions and the phenotype that arises when the effector is mutated.

      Thank you for your positive feedback.  We have now emphasized the interdisciplinary significance of our work in the Introduction and Discussion of our revised manuscript. We highlight how the insights gained from our study can contribute to a better understanding of microbial interactions with eukaryotic hosts in general, and hope that our findings could benefit future research in the fields of pathogenesis, immunity, and symbiosis.

      We appreciate your detailed summary of our work, which is focused on NopT and its interaction with Nod factor receptors. To ensure that the readers can easily follow the rationale behind our work, we have included a more detailed explanation of how NopT was identified to target Nod factor receptors. In particular, we now better describe the test system (Nicotiana benthamiana cells co-expressing NFR1/NFR5 with a given effector of Sinorhizobium fredii NGR234). In addition, we provide now a more thorough background on the roles of NFR1 and NFR5 in symbiotic signaling and refer to the two Nature papers from 2003 on NFR1 and NFR5 (Madsen et al., 2003; Radutoiu et al., 2003).

      Evidence is presented that in vitro NopT can cleave NFR5 at its juxtamembrane region. NFR5 appears also to be cleaved in vivo. and NFR1 appears to inhibit the proteolytic activity of NopT by phosphorylating NopT. When NFR5 and NFR1 are ectopically over-expressed in leaves of the non-legume Nicotiana benthamiana, they induce cell death (Madsen et al., 2011, Plant Journal). Bao et al., found that this cell death response is inhibited by the coexpression of nopT. Mutation of nopT alters the outcome of rhizobial infection in L. japonicus. These conclusions are well supported by the data.

      We appreciate your recognition of the robustness of our conclusions. In the context of your comments, we made the following improvements to our manuscript:

      We included a more detailed description of the experimental conditions under which the cleavage of NFR5 by NopT was observed in vitro and in vivo. Furthermore, additional experiments were added to strengthen the evidence for NFR5 cleavage by NopT (Fig 3, S3, S6, and S14).

      We provided more comprehensive data on the phosphorylation of NopT by NFR1, including phosphorylation assays (Fig. 4) and mass spectrometry results (Fig. S7 and Table S1). These data provide additional information on the mechanism by which NFR1 inhibits the proteolytic activity of NopT.

      We expanded the discussion on the cell death response induced by ectopic expression of NFR1 and NFR5 in Nicotiana benthamiana. We also included further details from Madsen et al. (2011) to contextualize our findings within the known literature.

      We believe that these additions and clarifications have improved the significance and impact of our study.

      The authors present evidence supporting the interaction of NopT with NFR1 and NFR5. In particular, there is solid support for cleavage of NFR5 by NopT (Figure 3) and the identification of NopT phosphorylation sites that inhibit its proteolytic activity (Figure 4C). Cleavage of NFR5 upon expression in N. benthamiana (Figure 3A) requires appropriate controls (inactive mutant versions) that have been provided, since Agrobacterium as a closely rhizobia-related bacterium, might increase defense related proteolytic activity in the plant host cells.

      We appreciate your recognition of the importance of appropriate controls in our experimental design. In response to your comments, we revised our manuscript to ensure that the figures and legends provide a clear description of the controls used. We also included a more detailed description of our experimental design at several places. In particular, we have highlighted the use of the protease-dead version of NopT as a control (NopT<sup>C93S</sup>). Therefore, NFR5-GFP cleavage in N. benthamiana clearly depended on protease activity of NopT and not on Agrobacterium (Fig. 3A). In the revised text, we are now more cautious in our wording and don’t conclude at this stage that NopT proteolyzes NFR5. However, our subsequent experiments, including in vitro experiments, clearly show that NopT is able to proteolyze NFR5.

      We are convinced that these changes have improved the quality of our work.

      Key results from N. benthamiana appear consistent with data from recombinant protein expression in bacteria. For the analysis in the host legume L. japonicus transgenic hairy roots were included. To demonstrate that the cleavage of NFR5 occurs during the interaction in plant cells the authors build largely on western blots. Regardless of whether Nicotiana leaf cells or Lotus root cells are used as the test platform, the Western blots indicate that only a small proportion of NFR5 is cleaved when co-expressed with nopT, and most of the NFR5 persists in its full-length form (Figures 3A-D). It is not quite clear how the authors explain the loss of NFR5 function (loss of cell death, impact on symbiosis), as a vast excess of the tested target remains intact. It is also not clear why a large proportion of NFR5 is unaffected by the proteolytic activity of NopT. This is particularly interesting in Nicotiana in the absence of Nod factor that could trigger NFR1 kinase activity.

      Thank you for your comments regarding the cleavage of NFR5 by NopT and its functional implications. We acknowledge that our immunoblots indicate only a relatively small proportion of  the NFR5 cleavage product.  Possible explanations could be as follows:

      (1) The presence of full-length NFR5 does not preclude a significant impact of NopT on function of NFR5, as NopT is able to bind to NFR5. In other words, the NopT-NFR5 and NopT-NFR1 interactions at the plasmamembrane might influence the function of the NFR1/NFR5 receptor without proteolytic cleavage of NFR5. In fact, protease-dead NopT<sup>C93S</sup> expressed in NGR234Δ_nopT_ showed certain effects in L. japonicus (less infection foci were formed compared to NGR234Δ_nopT_ Fig. 5E).  In this context, it is worth mentioning that the non-acylated NopT<sup>C93S</sup> (Fig. 1B) and not<sub>USDA257</sub> (Fig. 6B) proteins were unable to suppress NFR1/NFR5-induced cell death in N. benthamina, but this could be explained by the lack of acylation and altered subcellular localization.

      (2) The cleaved NFR5 fraction, although small, may be sufficient to disrupt signaling pathways, leading to the observed phenotypic changes  (loss of cell death in N. benthamiana; altered infection in L. japonicus).

      (3) The used expression systems produce high levels of proteins in the cell. This may not reflect the natural situation in L. japonicus cells.

      (4) Cellular conditions could impair cleavage of NFR5 by NopT.  Expression of proteins in E. coli may partially result in formation of protein aggregates (inactive NopT; NFR5 resistant to proteolysis).

      (5) In N. benthamiana co-expressing NFR1/NFR5, the NFR1 kinase activity is constitutively active (i.e., does not require Nod factors), suggesting an altered protein conformation of the receptor complex, which may influence the proteolytic susceptibility of NFR5.

      (6) The proteolytic activity of NopT may be reduced by the interaction of NopT with other proteins such as NFR1, which phosphorylates NopT and inactivates its protease activity.

      In our revised manuscript version, we provide now quantitative data for the efficiency of NFR5 cleavage by NopT in different expression systems used (Supplemental Fig.  14).  We have also improved our Discussion in this context. Future research will be necessary to better understand loss of NFR5 function by NopT. 

      It is also difficult to evaluate how the ratios of cleaved and full-length protein change when different versions of NopT are present without a quantification of band strengths normalized to loading controls (Figure 3C, 3D, 3F). The same is true for the blots supporting NFR1 phosphorylation of NopT (Figure 4A).

      Thank you for pointing out this. Following your suggestions, we quantified the band intensities for cleaved and full-length NFR5 in our different expression systems (N. benthamiana, L. japonicus and E. coli). The protein bands were normalized to loading controls. The data are shown in the new Supplemental Fig. 14. Similarly, the bands of immunoblots supporting phosphorylation of NopT by NFR1 were quantified. The data on band intensities are shown in Fig.  4B of our revised manuscript. These improvements provide a clearer understanding of how the ratios of cleaved to full-length proteins change in different protein expression systems, and to which extent NopT was phosphorylated by NFR1.

      Nodule primordia and infection threads are still formed when L. japonicus plants are inoculated with ∆nopT mutant bacteria, but it is not clear if these primordia are infected or develop into fully functional nodules (Figure 5). A quantification of the ratio of infected and non-infected nodules and primordia would reveal whether NopT is only active at the transition from infection focus to thread or perhaps also later in the bacterial infection process of the developing root nodule.

      Thank you for highlighting this aspect of our study. In response to your comment, we have conducted additional inoculation experiments with L. japonicus plants inoculated with NGR234 and NGR234_ΔnopT_ mutant. The new data are shown in Fig 5A, 5E, and 5G. However, we could not find any uninfected nodules (empty) nodules when roots were inoculated with these strains and mention this observation in the Results section of our revised manuscript.

      Reviewer #2 (Public Review):

      Summary:

      This manuscript presents data demonstrating NopT's interaction with Nod Factor Receptors NFR1 and NFR5 and its impact on cell death inhibition and rhizobial infection. The identification of a truncated NopT variant in certain Sinorhizobium species adds an interesting dimension to the study. These data try to bridge the gaps between classical Nod-factor-dependent nodulation and T3SS NopT effector-dependent nodulation in legume-rhizobium symbiosis. Overall, the research provides interesting insights into the molecular mechanisms underlying symbiotic interactions between rhizobia and legumes.

      Strengths:

      The manuscript nicely demonstrates NopT's proteolytic cleavage of NFR5, regulated by NFR1 phosphorylation, promoting rhizobial infection in L. japonicus. Intriguingly, authors also identify a truncated NopT variant in certain Sinorhizobium species, maintaining NFR5 cleavage but lacking NFR1 interaction. These findings bridge the T3SS effector with the classical Nod-factor-dependent nodulation pathway, offering novel insights into symbiotic interactions.

      Weaknesses:

      (1) In the previous study, when transiently expressed NopT alone in Nicotiana tobacco plants, proteolytically active NopT elicited a rapid hypersensitive reaction. However, this phenotype was not observed when expressing the same NopT in Nicotiana benthamiana (Figure 1A). Conversely, cell death and a hypersensitive reaction were observed in Figure S8. This raises questions about the suitability of the exogenous expression system for studying NopT proteolysis specificity.

      We appreciate your attention to these plant-specific differences. Previous studies showed that NopT expressed in tobacco (N. tabacum) or in specific Arabidopsis ecotypes (with PBS1/RPS5 genes) causes rapid cell death (Dai et al. 2008; Khan et al. 2022). Khan et al. 2022 reported recently that cell death does not occur in N. benthamiana unless the leaves were transformed with PBS1/RPS5 constructs. Our data shown in Fig. S15 confirm these findings. As cell death (effector triggered immunity) is usually associated with induction of plant protease activities, we considered N. tabacum and A. thaliana plants as not suitable for testing NFR5 cleavage by NopT. In fact, no NopT/NFR5 experiments were not performed with these plants in our study.  In response to your comment, we now better describe the N. benthamiana expression system and cite the previous articles_. Furthermore,  We have revised the Discussion section to better emphasize effector-induced immunity in non-host plants and the negative effect of rhizobial effectors during symbiosis. Our revisions certainly provide a clearer understanding of the advantages and limitations of the _N.  benthamiana expression system.

      (2) NFR5 Loss-of-function mutants do not produce nodules in the presence of rhizobia in lotus roots, and overexpression of NFR1 and NFR5 produces spontaneous nodules. In this regard, if the direct proteolysis target of NopT is NFR5, one could expect the NGR234's infection will not be very successful because of the Native NopT's specific proteolysis function of NFR5 and NFR1. Conversely, in Figure 5, authors observed the different results.

      Thank you for this comment, which points out that we did not address this aspect precisely enough in the original manuscript version.  We improved our manuscript and now write that nfr1 and nfr5 mutants do not produce nodules (Madsen et al., 2003; Radutoiu et al., 2003) and that over-expression of either NFR1 or NFR5 can activate NF signaling, resulting in formation of spontaneous nodules in the absence of rhizobia (Ried et al., 2014). In fact, compared to the nopT knockout mutant NGR234_ΔnopT_, wildtype NGR234 (with NopT) is less successful in inducing infection foci in root hairs of L. japonicus (Fig. 5). With respect to formation of nodule primordia, we repeated our inoculation experiments with NGR234_ΔnopT_ and wildtype NGR234 and also included a nopT over-expressing NGR234 strain into the analysis. Our data clearly showed that nodule primordium formation was negatively affected by NopT. The new data are shown in Fig. 5 of our revised version. Our data show that NGR234's infection is not really successful, especially when NopT is over-expressed. This is consistent  with our observations that NopT targets Nod factor receptors in L. japonicus and inhibits NF signaling (NIN promoter-GUS experiments). Our findings indicate that NopT is an “Avr effector” for L. japonicus.  However, in other host plants of NGR234, NopT possesses a symbiosis-promoting role (Dai et al. 2008; Kambara et al. 2009). Such differences could be explained by different NopT targets in different plants (in addition to Nod factor receptors), which may influence the outcome of the infection process. Indeed, our work shows hat NopT can interact with various kinase-dead LysM domain receptors, suggesting a role of NopT in suppression or activation of plant immunity responses depending on the host plant. We discuss such alternative mechanisms in our revised manuscript version and emphasize the need for further investigation to elucidate the precise mechanisms underlying the observed infection phenotype and the role of NopT in modulating symbiotic signaling pathways. In this context, we would also like to mention the two new figures of our manuscript which are showing (i) the efficiency of NFR5 cleavage by NopT in different expression systems, (ii) the interaction between NopT<sup>C93S</sup> and His-SUMO-NFR5<sup>JM</sup>-GFP, and (iii) cleavage of His-SUMO-NFP<sup>JM</sup>-GFP by NopT (Supplementary Figs. S8 and S9).

      (3) In Figure 6E, the model illustrates how NopT digests NFR5 to regulate rhizobia infection. However, it raises the question of whether it is reasonable for NGR234 to produce an effector that restricts its own colonization in host plants.

      Thank you for mentioning this point. We are aware of the possible paradox that the broad-host-range strain NGR234 produces an effector that appears to restrict its infection of host plants. As mentioned in our answer to the previous comment, NopT could have additional functions beyond the regulation of Nod factor signaling. In our revised manuscript version, we have modified our text as follows:

      (1) We mention the potential evolutionary aspects of NopT-mediated regulation of rhizobial infection and discuss the possibility that interactions between NopT and Nod factor receptors may have evolved to fine-tune Nod factor signaling to avoid rhizobial hyperinfection in certain host legumes.

      (2) We also emphasize that the presence of NopT may confer selective advantages in other host plants than L. japonicus due to interactions with proteins related to plant immunity. Like other effectors, NopT could suppress activation of immune responses (suppression of PTI) or cause effector-triggered immunity (ETI) responses, thereby modulating rhizobial infection and nodule formation. Interactions between NopT and proteins related to the plant immune system may represent an important evolutionary driving force for host-specific nodulation and explain why the presence of NopT in NGR234 has a negative effect on symbiosis with L. japonicus but a positive one with other legumes.

      (4) The failure to generate stable transgenic plants expressing NopT in Lotus japonicus is surprising, considering the manuscript's claim that NopT specifically proteolyzes NFR5, a major player in the response to nodule symbiosis, without being essential for plant development.

      We also thank for this comment. We have revised the Discussion section of our manuscript and discuss now our failure to generate stable transgenic L. japonicus plants expressing NopT. We observed that the protease activity of NopT in aerial parts of L. japonicus had a negative effect on plant development, whereas NopT expression in hairy roots was possible. Such differences may be explained by different NopT substrates in roots and aerial parts of the plant. In this context, we also discuss our finding that NopT not only cleaves NFR5 but is also able to proteolyze other proteins of L. japonicus such as LjLYS11, suggesting that NopT not only suppresses Nod factor signaling, but may also interfere with signal transduction pathways related to plant immunity. We speculate that, depending on the host legume species, NopT could suppress PTI or induce ETI, thereby modulating rhizobial infection and nodule formation.

      Recommendations for the authors:

      Reviewer #1 (Recommendations For The Authors):

      Overall the text and figure legends must be double-checked for correctness of scientific statements. The few listed here are just examples. There are more that are potentially damaging the perception by the readers and thus the value of the manuscript.

      The nopT mutant leads to more infections. In line 358 the statement: "...and the proteolysis of NFR5 are important for rhizobial infection", is wrong, as the infection works even better without it. It is, according to my interpretation of the results, important for the regulation of infection. Sounds a small difference, but it completely changes the meaning.

      We appreciate your thorough review and have taken the opportunity to correct this error. Following your suggestions, we carefully rephrased the whole text and figure legends to ensure that the scientific statements accurately reflect the findings of our study. We are convinced that these changed have increased the value of this study.

      In line 905 the authors state that NopTC indicates the truncated version of NopT after autocleavage by releasing about 50 a.a. at its N-terminus.

      They do not analyse this cleavage product to support this claim. So better rephrase.

      According to Dai et al. (2008), NopT expressed in E. coli is autocleaved. The N-terminal sequence GCCA obtained by Edman sequencing suggests that NopT was cleaved between M49 and G50.  We improved our manuscript and now write:

      (1) “A previous study has shown that NopT is autocleaved at its N-terminus to form a processed protein that lacks the first 49 amino acid residues (Dai et al., 2008)”

      (2) “However, NopT<sup>ΔN50</sup>, which is similar to autocleaved NopT, retained the ability to interact with NFR5 but not with NFR1 (Fig. S2D).”.

      In line 967: "Both NopT and NopTC after autocleavage exert proteolytic activities" This is confusing as it was suggested earlier that NopTc is a product of the autocleavage. There is no indication of another round of NopTc autocleavage or did I miss something?

      Thank you for bringing this inaccuracy to our attention. There is no second round of NopT autocleavage. We have corrected the text and write: “NopT and not<sup>C</sup> (autocleaved NopT) proteolytically cleave NFR5 at the juxtamembrane domain to release the intracellular domain of NFR5”

      Given the amount of work that went into the research, the presentation of the figures should be considerably improved. For example, in Figure 3F the mutant is not correctly annotated. In figure 5 the term infection foci and IT occur but it is not explained in the legend what these are, where they can be seen in the figure and how the researchers discriminated between the two events.

      In general, the labeling of the figure panels should be improved to facilitate the understanding. For example, in Figure 3 the panels switch between different host plant systems. The plant could be clarified for each panel to aid the reader. The asterisks are not in line with the signal that is supposed to be marked. And so on. I strongly advise to improve the figures.

      Thank you for your valuable suggestions. We acknowledge the importance of clear and informative figure presentation to enhance the understanding of our research findings. In response to your comments, we made a comprehensive revision of the figures to address the mentioned issues:

      (1) We corrected annotations of the mutant in Figure 3F to accurately represent the experimental conditions.

      (2) We revised the legend of Figure 5 and provide clear explanations of the terms "infection foci" and "IT" (infection threads) in the Methods section.

      (3) We improved the labeling of figure panels and improved the writing of the figure legend specifying the protein expression system (N. benthamiana, L. japonicus and E. coli, respectively). . We ensured that the asterisks indicating statistically significant results are properly aligned.

      Furthermore, we carefully reviewed each figure to enhance clarity and readability, including optimizing font size and line thickness. Captions and annotations were also revised.

      Figure 1

      • To verify that the lack of observed cell death is not linked to differential expression levels, an expression control Western blot is essential. In the expression control Western blot given in the supplemental materials (Supplemental fig. 1E), NFR5 is not visible in the first lane.

      We appreciate your comments on the control immunoblot which were made to verify the presence of NFR1, NFR5 and NopT in N. benthamiana.  However, as shown in Supplemental Fig. 1E, the intact NFR5 could not be immuno-detected when co-expressed with NFR1 and NopT. To ensure co-expression of NFR1/NFR5, A. tumefaciens carrying a binary vector with both NFR1 and NFR5 was used. In the revised version, we modified the figure legend accordingly and also included a detailed description of the procedure at lines 165-166

      • Labeling of NFR1/LjNFR1 should be kept consistent between the text and the figures. Currently, the text refers to both NFR1 and LjNFR1 and figures are labelled NFR1. The same is true for NFR5.

      Thank you for pointing out this inconsistency. We revised our manuscript and use now consistently NFR1 and NFR5 without a prefix to avoid any confusions.

      • A clearer description of how cell death was determined would be useful. In the selected pictures in panel D, leaves coexpressing nopT with Bax1 or Cerk1 appear very different from the pictures selected for NopM and AVr3a/R3a.

      We agree that a clearer description of our cell death experiments with N. benthamiana was necessary. We have re-worded the figure legend to provide more detailed information on the criteria used for assessing cell death. Additionally, we show now our images at higher resolution.

      • In panel D, the "Death/Total" ratio is only shown for leaf discs where nopT was coexpressed with the cell-death triggering proteins. Including the ratio for leaf discs where only the cell-death triggering protein (without nopT ) was expressed would make the figure more clear.

      Thank you for this suggestion. To provide a more comprehensive comparison, we included the "Cell death/Total" ratio for all leaf disc images shown in Fig. 1D. 

      Figure 2:

      • A: Split-YFP is not ideal as evidence for colocalization because of the chemical bond formed between the YFP fragments that may lead to artificial trapping/accumulation outside the main expression domains. Overall, the authors should revise if this figure aims to show colocalization or interaction. In the current text, both terms are used, but these are different interpretations.

      We appreciate your concern regarding the use of Split-YFP for colocalization analysis. We carefully reviewed the figure and corresponding text to ensure clarity in the interpretation of the results. The primary aim of this figure was to explore protein-protein interactions rather than strict colocalization. Protein-protein interactions have also been validated by other experiments of our work. We have revised the text accordingly and no longer emphasize on “co-localization”.

      • Given the focus on proteolytic activity in this paper, all blots need to be clearly labeled with size markers, and it would be good to include a supplemental figure with all other bands produced in the Western blot, regardless of their size. Without this, the results in panel 2D seem inconsistent with results presented in figure 3A, since NFR5 does not appear to be cleaved in the Western blot in 2D, but 3A shows cleavage when the same proteins (with different tags) are coexpressed in the same system.

      Thank you for bringing up this point. We ensured that all immunoblots are clearly labeled with size markers in our revised manuscript. We also carefully checked the consistency of the results presented in Figures 2D and Figure 3A and included appropriate clarifications in the revised manuscript. In Figure 2D, we show the bands at around 75 kD  (multi-bands would be detected below, including cleaved NFR5 by NopT, but also other non-specific bands).

      Figure 3:

      • In panel E, NopTC93S cannot cleave His-Sumo-NFR5JM-GFP, but it would be interesting to also show if NopTC93S can bind the NFR5JM fragment. It would also be useful to see this experiment done with the JM of NFP.

      Thank you for the suggestion. We agree that investigating the binding of NopT<sup>C93S</sup> to the NFR5<sup>JM</sup> fragment provides valuable insights into the interaction between NopT and NFR5. In our revised version, we show in the new Supplemental Fig. S4 that NopT interacts with NFR5JM and cleaves NFP<sup>JM</sup>. The Results section has been modified accordingly.

      • The panels in this figure require better labeling. In many panels, asterisks are misplaced relative to the bands they should highlight, and not all blots have size markers or loading controls.

      Thank you for bringing this to our attention. We carefully reviewed the labeling of all panels in Figure 3 to ensure accuracy and clarity. We ensured that asterisks are correctly placed in the figures. We also included size markers and loading controls to improve the quality of the shown immunoblots.

      • Since there is no clear evidence in this figure that the smear in the blot in panel C is phosphorylated NopT, it is recommended to provide a less interpretative label on the blot, and explain the label in the text.

      We appreciate your suggestion regarding the labeling of the blot in panel C of Fig. 3. We revised the label and provided a less interpretative designation in Fig. 3C. We also rephrased the figure legend and the text in the Results section as recommended.

      Figure 4

      • In B, a brief introduction in the text to the function of the Zn-phostag would make the figure easier to understand for more readers.

      Thank you for the suggestion. We agree and have provided a brief explanation in the Results section: “On such gels, a Zn<sup>2+</sup>-Phos-tag bound phosphorylated protein migrates slower than its unbound nonphosphorylated form. Furthermore, we have included the reference (Kato & Sakamoto, 2019) into the Methods section.

      Figure 5:

      • Change "Scar bar" to "Scale bar" in the figure captions

      Thank you for spotting that typo. We have corrected it.

      • Correct the references to the figures in the text

      We carefully reviewed the Figure 5 and made corresponding corrections to improve the quality of our manuscript Please check line 394-451.

      • It should be clarified what was quantified as "infection foci" (C, F, G)

      We revised the legend of Figure 5 and provide now explanations of the terms "infection foci" and "IT" (infection threads) in the Methods section.  Please check line 399-451.

      • It is recommended to use pictures that are from the same region of the plant root (the susceptible zone). The pictures in panel A appear to be from different regions, since the density of root hairs is different.

      Thank you for bringing this to our attention. We ensured that the images selected for panel A were from the same region of the plant root to guarantee consistency and accuracy of the comparison.

      • Panel G should be labeled so it is clearer that nopT is being expressed in L. japonicus transgenic roots.

      We have labeled this panel more clearly to help the reader understand that nopT was expressed in transgenic L. japonicus roots.

      • Panel F is missing statistical tests for ITs

      We apologize and have included the results of our statistical tests for ITs.

      Figure 6:

      • The model presented in panel E misrepresents the role of NFR5 according to the results in the paper. From the evidence presented, it is not clear if the observed rhizobial infection phenotype is due to reduced abundance of full-length NFR5, or if the cleaved NFR5 fragment is suppressing infection. Additionally, S. fredii should not be drawn so close to the plasma membrane, since the bacteria are located outside the cell wall when the T3SS is active.

      We appreciate your comment which helps us to improve the interpretation of our results. We agree that the model should accurately reflect the uncertainties regarding the role of NFR5. We revised the model (positioning of S. fredii etc.) and write in the Discussion:

      “NopT impairs the function of the NFR1/NFR5 receptor complex. Cleavage of NFR5 by NopT reduces its protein levels. Possible inhibitory effects of NFR5 cleavage products on NF signaling are unknown but cannot be excluded.”

      Reviewer #2 (Recommendations For The Authors):

      (1) Some minor weaknesses need addressing: In Figure 5A, the root hair density in the two images appears significantly different. Are these images representative of each treatment?

      We appreciate your attention to detail and the importance of ensuring that the images in Figure 5A are representative. We carefully reviewed our image selection process and confirm that the shown images are indeed representative of each treatment group. In our revised version, we show additional images and also improved the text in the figure legend. Furthermore, we performed additional GUS staining tests and the new data are shown in Fig 5A abd 5B.

      (2) Additionally, please ensure consistency in the format of genotype names throughout the manuscript. For instance, in Line 897, "Italy" should be used in place of "N. benthamiana."

      We thank you for pointing out the format of genotype names and corrected our manuscript as requested.

    1. Author response:

      The following is the authors’ response to the previous reviews.

      Public Reviews:

      Reviewer #1 (Public Review): 

      Summary: 

      The authors introduced their previous paper with the concise statement that "the relationships between lineage-specific attributes and genotypic differences of tumors are not understood" (Chen et al., JEM 2019, PMID: 30737256). For example, it is not clear why combined loss of RB1 and TP53 is required for tumorigenesis in SCLC or other aggressive neuroendocrine (NE) cancers, or why the oncogenic mutations in KRAS or EGFR that drive NSCLC tumorigenesis are found so infrequently in SCLC. This is the main question addressed by the previous and current papers. 

      One approach to this question is to identify a discrete set of genetic/biochemical manipulations that are sufficient to transform non-malignant human cells into SCLC-like tumors. One group reported the transformation of primary human bronchial epithelial cells into NE tumors through a complex lentiviral cocktail involving the inactivation of pRB and p53 and activation of AKT, cMYC, and BCL2 (PARCB) (Park et al., Science 2018, PMID: 30287662). The cocktail previously reported by Chen and colleagues to transform human pluripotent stem-cell (hPSC)-derived lung progenitors (LPs) into NE xenografts was more concise: DAPT to inactivate NOTCH signaling combined with shRNAs against RB1 and TP53. However, the resulting RP xenografts lacked important characteristics of SCLC. Unlike SCLC, these tumors proliferated slowly and did not metastasize, and although small subpopulations expressed MYC or MYCL, none expressed NEUROD1. 

      MYC is frequently amplified or expressed at high levels in SCLC, and here, the authors have tested whether inducible expression of MYC could increase the resemblance of their hPSC-derived NE tumors to SCLC. These RPM cells (or RPM T58A with stabilized cMYC) engrafted more consistently and grew more rapidly than RP cells, and unlike RP cells, formed liver metastases when injected into the renal capsule. Gene expression analyses revealed that RPM tumor subpopulations expressed NEUROD1, ASCL1, and/or YAP1. 

      The hPSC-derived RPM model is a major advance over the previous RP model. This may become a powerful tool for understanding SCLC tumorigenesis and progression and for discovering gene dependencies and molecular targets for novel therapies. However, the specific role of cMYC in this model needs to be clarified. 

      cMYC can drive proliferation, tumorigenesis, or apoptosis in a variety of lineages depending on concurrent mutations. For example, in the Park et al., study, normal human prostate cells could be reprogrammed to form adenocarcinoma-like tumors by activation of cMYC and AKT alone, without manipulation of TP53 or RB1. In their previous manuscript, the authors carefully showed the role of each molecular manipulation in NE tumorigenesis. DAPT was required for NE differentiation of LPs to PNECs, shRB1 was required for expansion of the PNECs, and shTP53 was required for xenograft formation. cMYC expression could influence each of these steps, and importantly, could render some steps dispensable. For example, shRB1 was previously necessary to expand the DAPT-induced PNECs, as neither shTP53 nor activation of KRAS or EGFR had no effect on this population, but perhaps cMYC overexpression could expand PNECs even in the presence of pRB, or even induce LPs to become PNECs without DAPT. Similarly, both shRB1 and shTP53 were necessary for xenograft formation, but maybe not if cMYC is overexpressed. If a molecular hallmark of SCLC, such as loss of RB1 or TP53, has become dispensable with the addition of cMYC, this information is critically important in interpreting this as a model of SCLC tumorigenesis.  

      The reviewer’s suggestion may be possible; indeed, in a recent report from our group (Gardner EE, et al., Science 2024) we have shown, using genetically engineered mouse modeling coupled with lineage tracing, that the cMyc oncogene can selectively expand Ascl1+ PNECs in the lung.

      We agree with the reviewer that not having a better understanding of the individual components necessary and/or sufficient to transform hESC-derived LPs is an important shortcoming of this current work. However, we would like to stress three important points about the comments:  1) tumors were reviewed and the histological diagnoses were certified by a practicing pulmonary pathologist at WCM (our co-author, C. Zhang); 2 )the observed  transcriptional programs were consistent with primary human SCLC; and 3) RB1-proficient SCLC is now recognized as a rare presentation of SCLC (Febrese-Aldana CA, et al., Clin. Can. Res. 2022. PMID: 35792876).

      To interpret the role of cMYC expression in hPSC-derived RPM tumors, we need to know what this manipulation does without manipulation of pRB, p53, or NOTCH, alone or in combination. Seven relevant combinations should be presented in this manuscript: (1) cMYC alone in LPs, (2) cMYC + DAPT, (3) cMYC + shRB1, (4) cMYC + DAPT + shRB1, (5) cMYC + shTP53, (6) cMYC + DAPT + shTP53, and (7) cMYC + shRB1 + shTP53. Wildtype cMYC is sufficient; further exploration with the T58A mutant would not be necessary. 

      We respectfully disagree that an interrogation of the differences between the phenotypes produced by wildtype and Myc(T58A) would not be informative. (Our view is confirmed by the second reviewer; see below.)    It is well established that Myc gene or protein dosage can have profound effects on in vivo phenotypes (Murphy DJ, et al., Cancer Cell 2008. PMID: 19061836). The “RPM” model of variant SCLC developed by Trudy Oliver’s lab relied on the conditional T58A point mutant of cMyc, originally made by Rob Wechsler-Reya. While we do not discuss the differences between Myc and Myc(T58A), it is nonetheless important to present our results with both the WT and mutant MYC constructs, as we are aware of others actively investigating differences between them in GEMM models of SCLC tumor development.

      We agree with the reviewer about the virtues of trying to identify the effects of individual gene manipulations; indeed our original paper (Chen et al., J. Expt. Med. 2019), describing the RUES2derived model of SCLC did just that, carefully dissecting events required to transform LPs towards a SCLC-like state. The central  purpose of the current study was to determine the effects of adding cMyc on the behavior of weakly tumorigenic SCLC-like cells cMyc.  Presenting data with these two alleles to seek effects of different doses of MYC protein seems reasonable.

      This reviewer considers that there should be a presentation of the effects of these combinations on LP differentiation to PNECs, expansion of PNECs as well as other lung cells, xenograft formation and histology, and xenograft growth rate and capacity for metastasis. If this could be clarified experimentally, and the results discussed in the context of other similar approaches such as the Park et al., paper, this study would be a major addition to the field.  

      Reviewer #2 (Public Review): 

      Summary: 

      Chen et al use human embryonic stem cells (ESCs) to determine the impact of wildtype MYC and a point mutant stable form of MYC (MYC-T58A) in the transformation of induced pulmonary neuroendocrine cells (PNEC) in the context of RB1/P53 (RP) loss (tumor suppressors that are nearly universally lost in small cell lung cancer (SCLC)). Upon transplant into immune-deficient mice, they find that RP-MYC and RP-MYC-T58A cells grow more rapidly, and are more likely to be metastatic when transplanted into the kidney capsule, than RP controls. Through single-cell RNA sequencing and immunostaining approaches, they find that these RPM tumors and their metastases express NEUROD1, which is a transcription factor whose expression marks a distinct molecular state of SCLC. While MYC is already known to promote aggressive NEUROD1+ SCLC in other models, these data demonstrate its capacity in a human setting that provides a rationale for further use of the ESC-based model going forward. Overall, these findings provide a minor advance over the previous characterization of this ESC-based model of SCLC published in Chen et al, J Exp Med, 2019. 

      We consider the findings more than a “minor” advance in the development of the model, since any useful model for SCLC would need to form aggressive and metastatic tumors.

      The major conclusion of the paper is generally well supported, but some minor conclusions are inadequate and require important controls and more careful analysis. 

      Strengths:

      (1) Both MYC and MYC-T58A yield similar results when RP-MYC and RP-MYCT58A PNEC ESCs are injected subcutaneously, or into the renal capsule, of immune-deficient mice, leading to the conclusion that MYC promotes faster growth and more metastases than RP controls. 

      (2) Consistent with numerous prior studies in mice with a neuroendocrine (NE) cell of origin (Mollaoglu et al, Cancer Cell, 2017; Ireland et al, Cancer Cell, 2020; Olsen et al, Genes Dev, 2021), MYC appears sufficient in the context of RB/P53 loss to induce the NEUROD1 state. Prior studies also show that MYC can convert human ASCL1+ neuroendocrine SCLC cell lines to a NEUROD1 state (Patel et al, Sci Advances, 2021); this study for the first time demonstrates that RB/P53/MYC from a human neuroendocrine cell of origin is sufficient to transform a NE state to aggressive NEUROD1+ SCLC. This finding provides a solid rationale for using the human ESC system to better understand the function of human oncogenes and tumor suppressors from a neuroendocrine origin. 

      Weaknesses:

      (1) There is a major concern about the conclusion that MYC "yields a larger neuroendocrine compartment" related to Figures 4C and 4G, which is inadequately supported and likely inaccurate. There is overwhelming published data that while MYC can promote NEUROD1, it also tends to correlate with reduced ASCL1 and reduced NE fate (Mollaoglu et al, Cancer Cell, 2017; Zhang et al, TLCR, 2018; Ireland et al, Cancer Cell, 2020; Patel et al, Sci Advances, 2021). Most importantly, there is a lack of in vivo RP tumor controls to make the proper comparison to judge MYC's impact on neuroendocrine identity. RPM tumors are largely neuroendocrine compared to in vitro conditions, but since RP control tumors (in vivo) are missing, it is impossible to determine whether MYC promotes more or less neuroendocrine fate than RP controls. It is not appropriate to compare RPM tumors to in vitro RP cells when it comes to cell fate. Upon inspection of the sample identity in S1B, the fibroblast and basal-like cells appear to only grow in vitro and are not well represented in vivo; it is, therefore, unclear whether these are transformed or even lack RB/P53 or express MYC. Indeed, a close inspection of Figure S1B shows that RPM tumor cells have little ASCL1 expression, consistent with lower NE fate than expected in control RP tumors. 

      We would like to clarify two points related to the conclusions that we draw about MYC’s ability to promote an increase in the neuroendocrine fraction in hESC-derived cultures:  1) The comparisons in Figures 4C were made between cells isolated in culture following the standard 50 day differentiation protocol, where, following generation of LPs around day 25, MYC was added to the other factors previously shown to enrich for a PNEC phenotype (shRB1, shTP53, and DAPT). Therefore, the argument that MYC increased the frequency of “neuroendocrine cells” (which we define by a gene expression signature) is a reasonable conclusion in the system we are using; and 2) following injection of these cells into immunocompromised mice, an ASCL1-low / NEUROD1-high presentation is noted (Supplemental Figures 1F-G). In the few metastases that we were able use to sequence bulk RNA, there is an even more pronounced increase in expression of NEUROD1 with a decrease in ASCL1.

      Some confusion may have arisen from our previous characterization of neuroendocrine (NE) cells using either ASCL1 or NEUROD1 as markers. To clarify, we have now designated cells positive for ASCL1 as classical NE cells and those positive for NEUROD1 as the NE variant. According to this revised classification, our findings indicate that MYC expression leads to an increase in the NEUROD1+ NE variant and a decrease in ASCL1+ classical NE cells. This adjustment has been reflected on the results section titled, “Inoculation of the renal capsule facilitates metastasis of the RUES2-derived RPM tumors” of the manuscript.  

      From the limited samples in hand, we compared the expression of ASCL1 and NEUROD1 in the weakly tumorigenic hESC RP cells after successful primary engraftment into immunocompromised mice. As expected, the RP tumors were distinguished by the lack of expression of NEUROD1, compared to levels observed in the RPM tumors.

      In addition, since MYC appears to require Notch signaling to induce  NE fate (cf Ireland et al), the presence of DAPT in culture could enrich for NE fate despite MYC's presence. It's important to clarify in the legend of Fig 4A which samples are used in the scRNA-seq data and whether they were derived from in vitro or in vivo conditions (as such, Supplementary Figure S1B should be provided in the main figure). Given their conclusion is confusing and challenges robustly supported data in other models, it is critical to resolve this issue properly. I suspect when properly resolved, MYC actually consistently does reduce NE fate compared to RP controls, even though tumors are still relatively NE compared to completely distinct cellular identities such as fibroblasts.

      We have clarified the source of tumor sequencing data and the platform (single cell or bulk) in Figure 4 and Supplemental Figure 1. To reiterate – the RNA sequencing results from paired metastatic and primary tumors from the RPM model are derived from bulk RNA;  the single cell RNA data in RP or RPM datasets are from cells in culture.  These distinctions are clarified in the legend to Supplemental Figure 1.

      (2) The rigor of the conclusions in Figure 1 would be strengthened by comparing an equivalent number of RP animals in the renal capsule assay, which is n = 6 compared to n = 11-14 in the MYC conditions.

      As we did not perform a power calculation to determine a sample size required to draw a level of statistical significance from our conclusions, this comment is not entirely accurate. Our statistical rigor was limited by the availability of samples from the RP tumor model.

      (3) Statistical analysis is not provided for Figures 2A-2B, and while the results are compelling, may be strengthened by additional samples due to the variability observed. 

      We acknowledge that the cohorts are relatively small but we have added statistical comparisons in Figure 2B. 

      (4a) Related to Figure 3, primary tumors and liver metastases from RPM or RPM-T58A-expressing cells express NEUROD1 by immunohistochemistry (IHC) but the putative negative controls (RP) are not shown, and there is no assessment of variability from tumor to tumor, ie, this is not quantified across multiple animals. 

      The results of H&E and IF staining for ASCL1, NEUROD1, CGRP, and CD56 in negative control (RP tumors) are presented in the updated Figure 3F-G.

      (4b) Relatedly, MYC has been shown to be able to push cells beyond NEUROD1 to a double-negative or YAP1+ state (Mollaoglu et al, Cancer Cell, 2017; Ireland et al, Cancer Cell, 2020), but the authors do not assess subtype markers by IHC. They do show subtype markers by mRNA levels in Fig 4B, and since there is expression of ASCL1, and potentially expression of YAP1 and POU2F3, it would be valuable to examine the protein levels by IHC in control RP vs. RPM samples.

      YAP1 positive SCLC is still somewhat controversial, so it is not clear what value staining for YAP1 offers beyond showing the well-established markers, ASCL1 and NEUROD1.  

      (5) Given that MYC has been shown to function distinctly from MYCL in SCLC models, it would have raised the impact and value of the study if MYC was compared to MYCL or MYCL fusions in this context since generally, SCLC expresses a MYC family member. However, it is quite possible that the control RP cells do express MYCL, and as such, it would be useful to show. 

      We now include Supplemental Figure S2 to illustrate four important points raised by this reviewer and others:  1) expression of MYC family members in the merged dataset (RP and RPM) is low or undetectable in the basal/fibroblast cultures; 2) MYC does have a weak correlation with EGFP in the neuroendocrine cluster when either WT MYC or T58A MYC is overexpressed; 3) MYCL and MYCN are detectable, but at low levels compared to CMYC; and 4) Expression of  ASCL1 is anticorrelated with MYC expression across the merged single cell datasets using RP and RPM models.

      Reviewer #3 (Public Review): 

      Summary: 

      The authors continue their study of the experimental model of small cell lung cancer (SCLC) they created from human embryonic stem cells (hESCs) using a protocol for differentiating the hESCs into pulmonary lineages followed by NOTCH signaling inactivation with DAPT, and then knockdown of TP53 and RB1 (RP models) with DOX inducible shRNAs. To this published model, they now add DOX-controlled activation of expression of a MYC or T58A MYC transgenes (RPM and RPMT58A models) and study the impact of this on xenograft tumor growth and metastases. Their major findings are that the addition of MYC increased dramatically subcutaneous tumor growth and also the growth of tumors implanted into the renal capsule. In addition, they only found liver and occasional lung metastases with renal capsule implantation. Molecular studies including scRNAseq showed that tumor lines with MYC or T58A MYC led surprisingly to more neuroendocrine differentiation, and (not surprisingly) that MYC expression was most highly correlated with NEUROD1 expression. Of interest, many of the hESCs with RPM/RPMT58A expressed ASCL1. Of note, even in the renal capsule RPM/RPMT58A models only 6/12 and 4/9 mice developed metastases (mainly liver with one lung metastasis) and a few mice of each type did not even develop a renal sub capsule tumor. The authors start their Discussion by concluding: " In this report, we show that the addition of an efficiently expressed transgene encoding normal or mutant human cMYC can convert weakly tumorigenic human PNEC cells, derived from a human ESC line and depleted of tumor suppressors RB1 and TP53, into highly malignant, metastatic SCLC-like cancers after implantation into the renal capsule of immunodeficient mice.". 

      Strengths: 

      The in vivo study of a human preclinical model of SCLC demonstrates the important role of c-Myc in the development of a malignant phenotype and metastases. Also the role of c-Myc in selecting for expression of NEUROD1 lineage oncogene expression. 

      Weaknesses: 

      There are no data on results from an orthotopic (pulmonary) implantation on generation of metastases; no comparative study of other myc family members (MYCL, MYCN); no indication of analyses of other common metastatic sites found in SCLC (e.g. brain, adrenal gland, lymph nodes, bone marrow); no studies of response to standard platin-etoposide doublet chemotherapy; no data on the status of NEUROD1 and ASCL1 expression in the individual metastatic lesions they identified. 

      We have acknowledged from the outset that our study has significant limitations, as noted by this reviewer, and we explained in our initial letter of response why we need to present this limited, but still consequential, story at this time. 

      In particular, while we have attempted orthotopic transplantations of RPM tumor cells into NSG mice (by tail vein or intra-pulmonary injection, or intra-tracheal instillation of tumor cells), these methods were not successful in colonizing the lung. Additionally, we have compared the efficacy of platinum/etoposide to that of removing DOX in established RPM subcutaneous tumors, but we chose not to include these data as we lacked a chemotherapy responsive tumor model, and thus could not say with confidence that the chemotherapeutic agants were active and that the RPM models were truly resistant to standard SCLC chemotherapy. In a discussion about other metastatic sites, we have now included the following text: 

      “In animals administered DOX, histological examinations showed that approximately half developed metastases in distant organs, including the liver or lung (Figure 1D). No metastases were observed in the bone, brain, or lymph nodes. For a more detailed assessment, future studies could employ more sensitive imaging methods, such as luciferase imaging.”

      Recommendations for the authors:

      Reviewer #2 (Recommendations For The Authors): 

      Technical points related to Major Weakness #1: 

      For Figure 4: Cells were enriched for EGFP-high cells only, under the hypothesis that cells with lower EGFP may have silenced expression of the integrated vector. Since EGFP is expressed only in the shRB1 construct, selection for high EGFP may inadvertently alter/exclude heterogeneity within the transformed population for the other transgenes (shP53, shMYC/MYC-T58A). Can authors include data to show the expression of MYC/MYC T58A in EGFP-high v -med v-low cells? MYC levels may alter the NEdifferentiation status of tumor cells. 

      Please now refer to Supplemental Figure S2.

      Related to the appropriateness of the methods for Figure 4C, the authors state, "We performed differential cluster abundance analysis after accounting for the fraction of cells that were EGFP+". If only EGFP+ cells were accounted for in the analysis for 4C, the majority of RP cells in the "Neuroendocrine differentiated" cluster would not be included in the analysis (according to EGFP expression in Fig S1A-B), and therefore inappropriately reduce NE identity compared to RPM samples that have higher levels of EGFP. 

      There is no consideration or analysis of cell cycling/proliferation until after the conclusion is stated. Yet, increased proliferation of MYC-high vs MYC-low cultures would enhance selection for more tumors (termed "NE-diff") than non-tumors (basal/fibroblast) in 2D cultures. 

      The expression of MYC itself isn't assessed for this analysis but assumed, and whether higher levels of MYC/MYC-T58A may be present in EGFP+ tumor cells that are in the NE-low populations isn't clear. Can MYC-T58A/HA also be included in the reference genome? 

      We did not include an HA tag in our reference transcriptome. For [some] answers to this and other related questions, please refer to Supplemental Figure S2.

      Reviewer #3 (Recommendations For The Authors): 

      (1) The experiments are all technically well done and clearly presented and represent a logical extension exploring the role of c-Myc in the hESC experimental model system. 

      We appreciate this supportive comment!

      (2) It is of great interest that both the initial RP model only forms "benign" tumors and that with the addition of a strong oncogene like c-myc, where expression is known to be associated with a very bad prognosis in SCLC, that while one gets tumor formation there are still occasional mice both for subcutaneous and renal capsule test sites that don't get tumors even with the injection of 500,000 RPM/RPMT58A cells. In addition, of the mice that do form tumors, only ~50% exhibit metastases from the renal sub-capsule site. The authors need to comment on this further in their Discussion. To me, this illustrates both how incredibly resistant/difficult it is to form metastases, thus indicating the need for other pathways to be activated to achieve such spread, and also represents an opportunity for further functional genomic tests using their preclinical model to systematically attack this problem. Obvious candidate genes are those recently identified in genetically engineered mouse models (GEMMs) related to neuronal behavior. In addition, we already know that full-fledged patient-derived SCLC when injected subcutaneously into immune-deprived mice don't exhibit metastases - thus, while the hESC RPM result is not surprising, it indicates to me the power of their model (logs less complicated genetically than a patient SCLC) to sort through a mechanism that would allow metastases to develop from subcutaneous sites. The authors can point these things out in their Discussion section to provide a "roadmap" for future research. 

      Although we remain mindful of the relatively small cohorts we have studied, the thrust of Reviewer #3’s comments is now included in the Discussion. And there is, of course, a lot more to do, and it has taken several years already to get to this point. Additional information about the prolonged gestation of this project and about the difficulties of doing more in the near future was described in our initial response to reviewers/Editor, included near the start of this letter.    

      (3) I will state the obvious that this paper would be much more valuable if they had compared and contrasted at least one of the myc family members (MYCL or MYCN) with the CMYC findings whatever the results would be. Most SCLC patients develop metastases, and most of their tumors don't express high levels of CMYC (and often use MYCL). In any event, as the authors Discuss, this will be an important next stage to test.

      We have acknowledged and explained the limitations of the work in several ways. Further, we were unaware of the relationship between metastases and the expression of MYC and MYCL1 noted by the reviewer; we will look for confirmation of this association in any future studies, although we have not encountered it in current literature.

      (4) Their assays for metastases involved looking for anatomically "gross" lesions. While that is fine, particularly given that the "gross" lesions they show in figures are actually pretty small, we still need to know if they performed straightforward autopsies on mice and looked for other well-known sites of metastases in SCLC patients besides liver and lung - namely lymph nodes, adrenal, bone marrow, and brain. I would guess these would probably not show metastatic growth but with the current report, we don't know if these were looked for or not. Again, while this could be a "negative" result, the paper's value would be increased by these simple data. Let's assume no metastases are seen, then the authors could further strengthen the case for the value of their hESC model in systematically exploring with functional genomics the requirements to achieve metastases to these other sites.

      We have included descriptions of what we found and didn’t find at other potential sites of metastasis in the results section, with the following sentences: 

      “In animals administered DOX, histological examinations showed that approximately half developed metastases in distant organs, including the liver or lung (Figure 1D). No metastases were observed in the bone, brain, or lymph nodes. For a more detailed assessment, future studies could employ more sensitive imaging methods, such as luciferase imaging.”

      (5) Related to this, we have no idea if the mice that developed liver metastases (or the one mouse with lung metastasis) had more than one metastatic site. They will know this and should report it. Again, my guess is that these were isolated metastases in each mouse. Again, they can indicate the value of their model in searching for programs that would increase the number of the various organs. 

      We appreciate the suggestion. We observed that one of the mice developed metastatic tumors in both the liver and lungs. This information has been incorporated into the Results section.

      (6) While renal capsule implantation for testing growth and metastatic behavior is reasonable and based on substantial literature using this site for implantation of patient tumor specimens, what would have increased the value of the paper is knowing the results from orthotopic (lung implantation). Whatever the results were (they occurred or did not occur) they will be important to know. I understand the "future experiments" argument, but in reading the manuscript this jumped out at me as an obvious thing for the authors to try. 

      We conducted orthotopic implantation several ways, including via intra-tracheal instillation of 0.5 million RP or RPM cells in PBS per mouse. However, none of the subjects (0/5 mice) developed tumor-like growths and the number of animals used was small. Further, this outcome could be attributed to biological or physical factors. For instance, the conducting airway is coated with secretory cells producing protective mucins and may not have retained the 0.5 million cells. This is one example that may have hindered effective colonization. Future adjustments, such as increasing the number of cells, embedding them in Matrigel, or damaging the airway to denude secretory cells and trigger regeneration might alter the outcomes. These ideas might guide future work to strengthen the utility of the models.

      (7) Another obvious piece of data that would have improved the value of this manuscript would be to know whether the RPM tumors responded to platin-etoposide chemotherapy. Such data was not presented in their first RP hESC notch inhibition paper (which we now know generated what the authors call "benign" tumors). While I realize chemotherapy responses represent other types of experiments, as the authors point out one of the main reasons they developed their new human model was for therapy testing. Two papers in and we are all still asking - does their model respond or not respond dramatically to platin-etoposide therapy? Whatever the results are they are a vital next step in considering the use of their model. 

      Please see the comments above regarding our decision not to include data from a clinical trial that lacked appropriate controls.

      (8) The finding of RPM cells that expressed NEUROD1, ASCL1, or both was interesting. From the way the data were presented, I don't have a clear idea which of these lineage oncogenes the metastatic lesions from ~11 different mice expressed. Whatever the result is it would be useful to know - all NEUROD1, some ASCL1, some mixed etc.

      Based on the bulk RNA-sequencing of a few metastatic sites (Figure 4H), what we can demonstrate is that all sites were NEUROD1 and expressed low or no detectable  ASCL1.

      (9) While several H&E histologic images were presented, even when I enlarged them to 400% I couldn't clearly see most of them. For future reference, I think it would be important to have several high-quality images of the RP, RPM, RPMT58A subcutaneous tumors, sub-renal capsule tumors, and liver and lung metastatic lesions. If there is heterogeneity in the primary tumors or the metastases it would be important to show this. The quality of the images they have in the pdf file is suboptimal. If they have already provided higher-quality images - great. If not, I think in the long run as people come back to this paper, it will help both the field and the authors to have really great images of their tumors and metastases. 

      We have attempted to improve the quality of the embedded images. Digital resolution is a tradeoff with data size – higher resolution images are always available upon request, but may not be suitable  for generation of figures in a manuscript viewed on-line.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Reviewer 1 (Public Review):

      Summary:

      Here the authors convincingly identify and characterize the SERBP1 interactome and further define its role in the nucleus, where it is associated with complexes involved in splicing, cell division, chromosome structure, and ribosome biogenesis. Many of the SERBP1-associated proteins are RNA-binding proteins and SERBP1 exerts its impact, at least in part, through these players. SERBP1 is mostly disordered but along with its associated proteins displays a preference for G4 binding and can bind to PAR and be PARylated. They present data that strongly suggest that complexes in which SERBP1 participates are assembled through G4 or PAR binding. The authors suggest that because SERBP1 lacks traditional functional domains yet is clearly involved in distinct regulatory complexes, SERBP1 likely acts in the early steps of assembly through the recognition of interacting sites present in RNA, DNA, and proteins.

      Strengths:

      The data is very convincing and demonstrated through multiple approaches.

      Weaknesses:

      No weaknesses were identified by this reviewer.

      Reviewer #2 (Public Review):

      Summary:

      In this study the authors have used pull-down experiments in a cell line overexpressing tagged SERPINE1 mRNA binding protein 1 (SERBP1) followed by mass spectrometry-based proteomics, to establish its interactome. Extensive analyses are performed to connect the data to published resources. The authors attempt to connect SERBP1 to stress granules and Alzheimer's disease-associated tau pathology. Based on the interactome, the authors propose a cross-talk between SERBP1 and PARP1 functions.

      Strengths:

      The main strength of this study lies in the proteomics data analysis, and its effort to connect the data to published studies.

      Weaknesses:

      While the authors propose a feedback regulatory model for SERBP1 and PARP1 functions, strong evidence for PARylation modulating SERBP1 functions is lacking. PARP inhibition decreasing the amount of PARylated proteins associated with SERBP1 and likely all other PARylated proteins is expected. This study is also incomplete in its attempt to establish a connection to Alzheimer's disease related tauopathy. A single AD case is not sufficient, and frozen autopsy tissue shows unexplained punctate staining likely due to poor preservation of cellular structures for immunohistochemistry. There is a lack of essential demographic data, source of the tissue, brain regions shown, and whether there was an IRB protocol for the human brain tissue. The presence of phase-separated transient stress granules in an autopsy brain is unlikely, even if G3BP1 staining is present. Normally, stress granule proteins move to the cytoplasm under cellular stress, whereas SERBP1 becomes nuclear. The co-localization of abundant cytoplasmic G3BP1 and SERBP1 under normal conditions does not indicate an association with stress granules.

      Reviewer #3 (Public Review):

      Summary:

      A survey of SERBP1-associated functions and their impact on the transcriptome upon gene depletion, as well as the identification of chemical inhibitors upon gene over-expression.

      Strengths:

      (1) Provides a valuable resource for the community, supported by statistical analyses.

      (2) Offers a survey of different processes with correlation data, serving as a good starting point for the community to follow up.

      Weaknesses:

      (1) The authors provided numerous correlations on diverse topics, from cell division to RNA splicing and PARP1 association, but did not follow up their findings with experiments, offering little mechanistic insight into the actual role of SERBP1. The model in Figure 5D is entirely speculative and lacks data support in the manuscript.

      Our article includes several pieces of evidence that support SERBP1’s role in splicing, translation, cell division and association with PARP1. We respectfully disagree that the model in Figure 5D is speculative. The goal of our study was to generate initial evidence of SERBP1 involvement in different biological processes based on its interactome. The characterization of molecular mechanisms in all these scenarios requires a substantial amount work and will the topic of follow up manuscripts. 

      (2) Following up with experiments to demonstrate that their findings are real (e.g., those related to splicing defects and the PARylation/PAR-binding association) would be beneficial. For example, whether the association between PARP1 and SERBP1 is sensitive to PAR-degrading enzymes is unclear.

      We included experiments showing the interaction between endogenous SERBP1 and PARP1. Additionally, we demonstrated that SERBP1 interaction with PARP1 was disrupted when cells are treated with PARP inhibitors.

      (3) They did not clearly articulate how experiments were performed. For instance, the drug screen and even the initial experiment involving the pull-down were poorly described. Many in the community may not be familiar with vectors such as pSBP or pUltra without looking up details.

      We provided additional details about the vectors and expanded the description of experiments in results and figure legends.

      (4) The co-staining of SERBP1 with pTau, PARP1, and G3BP1 in the brain is interesting, but it would be beneficial to follow up with immunoprecipitation in normal and patient samples to confirm the increased physical association.

      Thank you for this suggestion. We performed instead a Proximity Ligation Assay (PLA) on human tissue. Data was included in Fig. 7B and C. PLA between pTau and SERBP1 confirmed interaction in AD cortices as well as SERBP1 with PARP1.

      (5) The combination index of 0.7-0.9 for PJ34 + siSERBP1 is weak. Could this be due to the non-specific nature of the drug against other PARPs? Have the authors looked into this possibility?

      The combination index could be considered weak in the case of U251 cells but not in the case of U343 cells. PJ34 has been shown to be mainly a PARP-1 inhibitor. Different PJ34 concentrations and different drugs will be examined in future studies. It is worth mentioning that in a genetic screening, SERBP1 has been shown to increase sensitivity to different PARP inhibitors (PMID: 37160887). This information is included in the manuscript.

      Reviewer #1 (Recommendations For The Authors):

      This is a really well-done piece of research that is written very well. The data are very convincing and the conclusions are well supported. Some wording in Figures 2B and D is pixelated and hard to read. All the figure legends could benefit from being expanded but this is especially true for Figures 2, 3, 7, and 8. There is a ton of data being presented and a very limited description of what was done and what is being concluded. Some of the content may not be fully comprehended by some readers with limited descriptions.

      We revised all figures to assure images are clear and their resolution is high. We expanded all figure legends to provide a better explanation of the experimental design.

      Reviewer #2 (Recommendations For The Authors):

      The "merged" pdf file is the same as the "article".

      Individual files were uploaded this time.

      The abstract should spell out acronyms, such as the name of the protein Serpine1 mRNA-binding protein 1 (SERBP1).

      This was not included since the abstract has a word limit.

      "SERBP1 (Serpine1 mRNA-binding protein 1) is a unique member of this group of RBPs". In what way is it unique?

      The text was modified to better explain SERBP1’s singularities.

      "RBPs containing IDRs and RGG motifs are particularly relevant in the nervous system. Their misfolding contributes to the formation of pathological protein aggregates in Alzheimer's disease (AD), Frontotemporal Lobar Dementia (FTLD), Amyotrophic Lateral Sclerosis (ALS), and Parkinson's disease (PD)" -> while TDP-43 and FUS in ALS/FTD may fit this description, it is not true for tau and amyloid-beta (AD) and alpha-synuclein (PD).

      "SERBP1 is a unique RBPs containing IDRs and RGG motifs yet lacks other readily recognizable, canonical or structured RNA binding motifs. Moreover, SERBP1 has been observed by our study and others as common Tau interactor in Alzheimer’s Disease (AD) brains. RBPs containing IDRs (e.g. TDP-43, FUS, hnRNPs, TIA1) have been shown self-aggregate and co-aggregate with pathogenic amyloids (Tau, Aβ-amyloid and α-Synuclein)  in AD, Frontotemporal Lobar Dementia (FTLD), Amyotrophic Lateral Sclerosis (ALS), and Parkinson's disease (PD) and this suggest that, like other IDRs RBPs, SERBP1 contributes to RNA dysmetabolism in neurodegenerative diseases”.

      While the authors propose a feedback regulatory model for SERBP1 and PARP1 functions, strong evidence for PARylation modulating SERBP1 functions is lacking. The fact that PARP inhibition decreases the amount of PARylated proteins associated with SERBP1 and likely all other PARylated proteins is expected and cannot count as evidence.

      We included data showing that treatment with PJ34 (PARP inhibitor) decreases SERBP1 interaction with PARP1 and G3BP1. We are currently conducting a more extensive analysis to identify SERBP1 PAR binding domain and the impact of PARP inhibition on its interactions and functions. These experiments will be included in a new manuscript.

      A single AD case is not sufficient.

      Sorry for the poor clarity. We included in the study 6 cases from age-matched controls and 6 cases of AD. We summarize all cases demographics, and the experimental application assigned to each case in Table 1. Moreover, we included a paragraph regarding Human tissue harvesting.

      Most western blot data are not quantified from multiple replicates, as required.

      Quantifications are now provided.

      FTLD - frontotemporal lobar degeneration (not dementia).

      This was corrected.

      Frozen autopsy tissue is problematic due to poor preservation. The staining presented here shows unexplained punctate staining likely due to poor preservation of cellular structures for immunohistochemistry.

      We included a paragraph regarding human tissue harvesting. We have successfully used frozen tissues in our previous studies, observing a well preserved neuronal and tissue structure (PMIDs: 32855391, 31532069 and 30367664)

      The presence of phase-separated stress granules in tissue is controversial since these are transient structures.

      Normally, stress granule proteins move to the cytoplasm under cellular stress, whereas SERBP1 becomes nuclear. The co-localization of abundant (and partially overexposed) cytoplasmic G3BP1 and SERBP1 under normal conditions is not evidence for association with stress granules. Does induction of stress granule formation lead to colocalization in stress granules? The H2O2 experiment suggests otherwise.

      RBPs implicated in stress response move to stress granules when cells are exposed to stress. SERBP1 has been shown to shuttle to stress granules and nucleus in stress conditions (PMID: 24205981). Our results are in agreement.

      Using co-IF, we observed some overlap between G3BP1 and SERBP1 in AD tissues. As shown in Fig. S6A and B, 50% of stress granules overlap with SERBP1 signal. On the contrary, it is hard to assess their relationship in aged-matched control brains where stress granules form and accumulate with a lower rate than in AD. SERBP1 is not very abundant in normal brains.  It is known that RNA-Binding Proteins aggregation and/or dysfunctional LLPS dysregulate stress granules formation and accumulation in AD and other proteinopathies (PMIDs 30853299, 27256390 and 31911437). However, it is too early to determine the role of SERBP1 and its contribution to stress granules formation and accumulation. We will examine this topic in future studies.

      There is a lack of essential demographics data (age, clinical diagnosis, path diagnosis, co-pathologies, Braak stage, etc.), source of the tissue (what brain bank?), brain regions shown, and whether there was informed consent for the collection and use of human brain tissue.

      We included the information requested in materials and methods section.

      Reviewer #3 (Recommendations For The Authors):

      The authors need to better explain their experimental rationale and approach in the main text, not just in the supplementary materials.

      We have extensively revised the text to provide a better description of experiments in the results section and figure legends.

    1. Author response:

      Reviewer #1 (Public review):

      Summary:

      In cells undergoing Flavivirus infection, cellular translation is impaired but the viruses themselves escape this inhibition and are efficiently translated. In this study, the authors use very elegant and direct approaches to identify the regions in the 5' and 3' UTRs that are important for this phenomenon and then use them to retrieve two cellular proteins that associate with them and mediate translational shutoff evasion (DDX3 and PABP1). A number of experimental approaches are used with a series of well-controlled experiments that fully support the authors' conclusions.

      Strengths:

      The work identifies the regions in the 5' and 3' UTRs of the viral genome that mediate the escape of JEV from cellular transcriptional shutoff, they evaluate the infectivity of the mutant viruses bearing or not these structures and even explore their pathogenicity in mice. They then identify the cellular proteins that bind to these regions (DDX3 and PABP1) and determine their role in translation blockade escape, in addition to examining and assessing the conservation of the stem-loop identified in JEV in other Flaviviridae.

      In almost all of their systematic analyses, translational effects are put in parallel with the replication kinetics of the different mutant viruses. The experimental thread followed in this study is rigorous and direct, and all experiments are truly well-controlled, fully supporting the authors' conclusions.

      We greatly appreciate the reviewer's recognition of this study. We elucidated the role of UTR in translation blockade escape of JEV from the perspective of the RNA structure of the UTR and its interaction with host proteins (DDX3 and PABP1), and we hope that this study could gain wider recognition.

      Reviewer #2 (Public review):

      Summary:

      The authors use a combination of techniques including viral genetics, in vitro reporters, and purified proteins and RNA to interrogate how the Japanese encephalitis virus maintains translation of its RNA to produce viral proteins after the host cell has shut down general translation as a means to block viral replication. They report a role for the RNA helicase DDX3 in promoting virus translation in a cap-independent manner through binding a dumbbell RNA structure in the 3' untranslated region previously reported to drive Japanese encephalitis virus cap-independent translation and a stem-loop at the viral RNA 5' end.

      Strengths:

      The authors clearly show that the Japanese encephalitis virus does not possess an IRES activity to initiate translation using a range of mono- and bi-cistronic mRNAs. Surprisingly, using a replicon system, the translation of a capped or uncapped viral RNA is reported to have the same translation efficiency when transfected into cells. The authors have applied a broad range of techniques to support their hypotheses.

      We are grateful for the reviewer’s recognition of the thoroughness and multi-faceted nature of our study.

      Weaknesses:

      (1) The authors' original experiments in Figure 1 where the virus is recovered following transfection of in vitro transcribed viral RNA with alternative 5' ends such as capped or uncapped ignore that after a single replication cycle of that transfected RNA, the subsequent viral RNA will be capped by the viral capping proteins making the RNA in all conditions the same.

      Thank you for your suggestion. We share the same viewpoint as the reviewer. After the first round of translation of the uncapped viral RNA, the subsequent viral RNA will inevitably be capped by the viral capping proteins. However, there is no doubt that the transfected cells do not contain viral capping proteins in the initial transfection stage, which directly proved that JEV possesses a cap-independent translation initiation mechanism.

      (2) The authors report that deletion of the dumbbell and the large 3' stem-loop RNA reduce replication of a Japanese encephalitis virus replicon. These structures have been reported for other flaviviruses to be important respectively for the accumulation of short flaviviral RNAs that can regulate replication and stability of the viral RNA that lacks a polyA tail. The authors don't show any assessment of RNA stability or degradation state.

      Thank you for your suggestion. We agree that a rigorous supplementary experiment for the assessment of RNA stability or degradation state is desirable. To address this, the relative amounts of viral RNA with the deletion of DB2 or sHP-SL will be determined by real-time RT-PCR analysis in transfected cells at multiple time points, which will allow us to test whether the deletion of the dumbbell and the large 3' stem-loop RNA reduce the RNA stability of JEV.

      (3) The authors propose a model for DDX3 to drive 5'-3' end interaction of the Japanese encephalitis virus viral genome but no direct evidence for this is presented.

      Thank you for your suggestion. In this study, we did not have direct evidence to suggest that DDX3 can drive the 5'-3' end interaction of the Japanese encephalitis virus viral genome, which is indeed a limitation of our research. In the revision, we will more explicitly discuss the interrelationship between DDX3 and 5'-3' UTR, as well as incorporate a discussion of these points into the main text, acknowledging the limitations of our current models.

      (4) The authors' final model in Figure 10 proposes a switch from a cap-dependent translation system in early infection to cap-independent DDX3-driven translation system late in infection. The replicon data that measures translation directly however shows identical traces for capped and uncapped RNAs in all untreated conditions so that which mechanism is used at different stages of the infection is not clear.

      Thank you for your suggestion. The replicon transfection system was used to evaluate the key viral element for cap-independent translation. We only monitored reporter gene expression from 2 hpt to 12 hpt, which can’t fully recapitulate the different stages of JEV infection. In the experimental results Figure 1 and Figure 1-figure supplement 1, we demonstrated that JEV significantly induced the host translational shutoff at 36 hpi, while the expression level of viral protein gradually increased as infection went on, suggesting that JEV translation could evade the shutoff of cap-dependent translation initiation at the late stage of infection. As shown in the growth curves in Figure 5Q, JEV replicated to similar virus titers in WT and DDX3-KO cells from 12 hpi to 36 hpi, but higher level virus yields were observed in WT cells from 48 hpi, suggesting that DDX3 is important for JEV infection at the late stage. DDX3 was demonstrated to be critical for JEV cap-independent translation. Based on these data, we proposed that the DDX3-dependent cap-independent translation is employed by JEV to maintain efficient infection at the late stage when the cap-dependent translation imitation was suppressed.

      Reviewer #3 (Public review):

      Summary:

      This work is a valuable study that aims to decipher the molecular mechanisms underlying the translation process in Japanese encephalitis virus (JEV), a relevant member of the genus Flavivirus. The authors provide evidence that cap-independent translation, which has already been demonstrated for other flaviviruses, could also account in JEV. This process depends on the genomic 3' UTR, as previously demonstrated in other flaviviruses. Further, the authors find that cellular proteins such as DDX3 or PABP1 could contribute to JEV translation in a cap-independent way. Both DDX3 and PABP1 had previously been described to have a role in cellular protein synthesis and also in the translation step of other flaviviruses distinct from JEV; therefore, this work would expand the cap-independent translation in flaviviruses as a general mechanism to bypass the translation repression exerted by the host cell during viral infection. Further, the findings can be relevant for the development of specific drugs that could interfere with flaviviral translation in the future. Nevertheless, the conclusions are not fully supported by the provided results.

      Strengths:

      The results provide a good starting point to investigate the molecular mechanism underlying the translation in flaviviruses, which even today is an area of knowledge with many limitations.

      Thank you to the reviewer for providing positive feedback. The research on the molecular mechanism underlying cap-independent translation is still a limited field in the flaviviruses, and its mechanism has not been well elucidated at present. We only hope that this study could reveal a novel mechanism of translation initiation for flaviviruses.

      Weaknesses:

      The main limit of the work is related to the fact that the role of the 3' UTR structural elements and DDX3 is not only circumscribed to translation, but also to replication and encapsidation. In fact, some of the provided results suggest this idea. Particularly, it is intriguing why the virus titer can be completely abrogated while the viral protein levels are only partially affected by the knockdown of DDX3. This points to the fact that many of the drawn conclusions could be overestimated or, at least, all the observed effect cannot be attributed only to the DDX3 effect on translation. Finally, it is noteworthy that the use of uncapped transcripts could be misleading, since this is not the natural molecular context of the viral genome.

      Thank you for your suggestion. We agree with the reviewer's comments that the role of the 3' UTR structural elements and DDX3 may not only be circumscribed to translation. However, not as described by the reviewer, DDX3 knockdown did not completely abrogate JEV infection. As indicated in Figure 5E-5F, the recombinant virus was successfully rescued at 36 hpt and 48 hpt using the uncapped viral genomic RNA, although the viral titer rescued with the uncapped genomic RNA at 24 hpt was below the limit of detection. We have confirmed that the DB2 and sHP-SL elements in 3' UTR play a decisive role in the replication of viral RNA in our research (Figure 2G and Figure 2-figure supplement 4C), and we will further analyze the role of DDX3 in viral RNA replication and encapsidation, thereby clarifying the multiple functions of DDX3 in JEV life cycle. Meanwhile, we will incorporate a discussion of these points into the main text, acknowledging the limitations of our current research.

      To eliminate the misleading effects of using uncapped transcripts, we will use a natural molecular background of the viral genome with cap methylation deficiency. The methyltransferase (MTase) of the flavivirus NS5 protein catalyzes  N-7 and 2’-O methylations in the formation of the 5’-end cap of the genome, and the E218 amino acid of the NS5 protein MTase domain is one of the active sites of flavivirus methyltransferase (PLoS Pathogens. 2012. PMID:22496660; Journal of Virology. 2007. PMID: 1866096). We will construct a mutant virus of the E218A mutation to abolish 2'-O methylation activity and significantly reduce N-7 methylation activity and then analyze the roles of UTR structure and DDX3 in recombinant viruses with the type-I cap structure functional deficiency.

    1. Author response:

      Reviewer #1 (Public review):

      Summary:

      The authors revealed the cellular heterogeneity of companion cells (CCs) and demonstrated that the florigen gene FT is highly expressed in a specific subpopulation of these CCs in Arabidopsis. Through a thorough characterization of this subpopulation, they further identified NITRATE-INDUCIBLE GARP-TYPE TRANSCRIPTIONAL REPRESSOR 1 (NIGT1)-like transcription factors as potential new regulators of FT. Overall, these findings are intriguing and valuable, contributing significantly to our understanding of florigen and the photoperiodic flowering pathway. However, there is still room for improvement in the quality of the data and the depth of the analysis. I have several comments that may be beneficial for the authors.

      Strengths:

      The usage of snRNA-seq to characterize the FT-expressing companion cells (CCs) is very interesting and important. Two findings are novel: 1) Expression of FT in CCs is not uniform. Only a subcluster of CCs exhibits high expression level of FT. 2) Based on consensus binding motifs enriched in this subcluster, they further identify NITRATE-INDUCIBLE GARP-TYPE TRANSCRIPTIONAL REPRESSOR 1 (NIGT1)-like transcription factors as potential new regulators of FT.

      We are pleased to hear that reviewer 1 noted the novelty and importance of our work. As reviewer 1 mentioned, we are also excited about the identification of a subcluster of companion cells with very high FT expression. We believe that this work is an initial step to describe the molecular characteristics of these FT-expressing cells. We are also excited to share our new findings on NIGT1_s as potential _FT regulators. We think that this finding attracts broader audiences, as the molecular factor that coordinates plant nutrition status with flowering time remains largely unknown despite its well-known plant phenomenon.

      Weaknesses:

      (1) Title: "A florigen-expressing subpopulation of companion cells". It is a bit misleading. The conclusion here is that only a subset of companion cells exhibit high expression of FT, but this does not imply that other companion cells do not express it at all.

      We agree with this comment, as we also did not intend to say that FT is not produced in other companion cells than the subpopulation we identified. We will revise the title to more accurately reflect the point.

      (2) Data quality: Authors opted for fluorescence-activated nuclei sorting (FANS) instead of traditional cell sorting method. What is the rationale behind this decision? Readers may wonder, especially given that RNA abundance in single nuclei is generally lower than that in single cells. This concern also applies to snRNA-seq data. Specifically, the number of genes captured was quite low, with a median of only 149 genes per nucleus. Additionally, the total number of nuclei analyzed was limited (1,173 for the pFT:NTF and 3,650 for the pSUC2:NTF). These factors suggest that the quality of the snRNA-seq data presented in this study is quite low. In this context, it becomes challenging for the reviewer to accurately assess whether this will impact the subsequent conclusions of the paper. Would it be possible to repeat this experiment and get more nuclei?

      We appreciate this comment; we noticed that we did not clearly explain the rationale of using single-nucleus RNA sequencing (snRNA-seq) instead of single-cell RNA-seq (scRNA-seq). As reviewer 1 mentioned, RNA abundance in scRNA-seq is higher than in snRNA-seq. To conduct scRNA-seq using plant cells, protoplasting is the necessary step. However, in our study, protoplasting has many drawbacks in isolating our target cells from the phloem. It is technically challenging to efficiently isolate protoplasts from highly embedded phloem companion cells from plant tissues. Usually, it requires a minimum of several hours of enzymatic incubation to protoplast companion cells and the efficiencies of protoplasting these cells are still low. For our analysis, restoring the time information within a day is also crucial. Therefore, we performed more speedy isolation method. In the revision, we will explain our rationale of choosing snRNA-seq due to the technical limitations.

      Here, reviewer 1 raised a concern about the quality of our snRNA-seq data, referring to the relatively low readcounts per nucleus. Although we believe that shallow reads do not necessaryily indicate low quality and are confident in the accuracy of our snRNA-seq data, as supported by the detailed follow-up experiments (e.g., imaging analysis in Fig. 4B), we agree that it is important to address this point in the revision and alleviate readers’ concerns regarding the data quality.

      (3) Another disappointment is that the authors did not utilize reporter genes to identify the specific locations of the FT-high expressing cells (cluster 7 cells) within the CC population in vivo. Are there any discernible patterns that can be observed?

      As we previously showed only limited spatial images of overlap between FT-expressing cells and other cluster 7 gene-expressing cells in Fig. 4B, this comment is understandable. To respond to it, we will include whole leaf images of FT- and cluster 7 gene-expressing cells to assess the spatial overlaps between FT and cluster 7 genes within a leaf.

      (4) The final disappointment is that the authors only compared FT expression between the nigtQ mutants and the wild type. Does this imply that the mutant does not have a flowering time defect particularly under high nitrogen conditions?

      To answer this question, we will include the flowering time measurement data of the nigtQ mutants grown on the soil with sufficient nitrogen sources.

      Reviewer #2 (Public review):

      This manuscript submitted by Takagi et al. details the molecular characterization of the FT-expressing cell at a single-cell level. The authors examined what genes are expressed specifically in FT-expressing cells and other phloem companion cells by exploiting bulk nuclei and single-nuclei RNA-seq and transgenic analysis. The authors found the unique expression profile of FT-expressing cells at a single-cell level and identified new transcriptional repressors of FT such as NIGT1.2 and NIGT1.4.

      Although previous researchers have known that FT is expressed in phloem companion cells, they have tended to neglect the molecular characterization of the FT-expressing phloem companion cells. To understand how FT, which is expressed in tiny amounts in phloem companion cells that make up a very small portion of the leaf, can be a key molecule in the regulation of the critical developmental step of floral transition, it is important to understand the molecular features of FT-expressing cells in detail. In this regard, this manuscript provides insight into the understanding of detailed molecular characteristics of the FT-expressing cell. This endeavor will contribute to the research field of flowering time.

      We are grateful that reviewer 2 recognizes the importance of transcriptome profiling of FT-expressing cells at the single-cell level.

      Here are my comments on how to improve this manuscript.

      (1) The most noble finding of this manuscript is the identification of NTGI1.2 as the upstream regulator of FT-expressing cluster 7 gene expression. The flowering phenotypes of the nigtQ mutant and the transgenic plants in which NIGT1.2 was expressed under the SUC2 gene promoter support that NIGT1.2 functions as a floral repressor upstream of the FT gene. Nevertheless, the expression patterns of NIGT1.2 genes do not appear to have much overlap with those of NIGT1.2-downstream genes in the cluster 7 (Figs S14 and F3). An explanation for this should be provided in the discussion section.

      We agree reviewer 2 that spatial expression patterns of NIGT1.2 and cluster 7 genes do not overlap much, and some discussion should be provided in the manuscript. Although we do not have a concrete answer for this phenomenon, NIGT1.2 may suppress FT gene expression in non-cluster 7 cells to prevent the misexpression of FT. Another possible explanation is that NIGT1.2 negatively affects the formation of cluster 7 cells. If so, cells with high NIGT1.2 gene expression hardly become cluster 7 cells. We will discuss it further in the discussion section in our revised manuscript.

      (2) To investigate gene expression in the nuclei of specific cell populations, the authors generated transgenic plants expressing a fusion gene encoding a Nuclear Targeting Fusion protein (NTF) under the control of various cell type-specific promoters. Since the public audience would not know about NTF without reading reference 16, some explanation of NTF is necessary in the manuscript. Please provide a schematic of constructs the authors used to make the transformants.

      As reviewer 2 pointed out, we lacked a clear explanation why we used NTF in this study. NTF is the fusion protein that consists of a nuclear envelope targeting domain, GFP, and biotin acceptor peptide. It was originally designed for the INTACT (isolation of nuclei tagged in specific cell types) method that enables us to isolate bulk nuclei from specific tissues. Although our original intention was profiling the bulk transcriptome of mRNAs that exist in nuclei of the FT-expressing cells using INTACT, we utilized our NTF transgenic lines for snRNA-seq analysis. To explain what NTF is to readers, we will include a schematic diagram of NTF.

    1. Author response:

      The following is the authors’ response to the previous reviews.

      We have carefully addressed all the reviewers' suggestions, and detailed responses are provided at the end of this letter. In summary:

      • We conducted two additional replicates of the study to obtain more robust and reliable data.

      • The Introduction has been revised for greater clarity and conciseness.

      • The Results section was shortened and reorganized to highlight the key findings more effectively.

      • The Discussion was modified according to the reviewers' suggestions, with a focus on reorganization and conciseness.

      We hope you find this revised version of the manuscript satisfactory.

      Reviewer #1 (Public Review):

      Summary:

      This study examines the role of host blood meal source, temperature, and photoperiod on the reproductive traits of Cx. quinquefasciatus, an important vector of numerous pathogens of medical importance. The host use pattern of Cx. quinquefasciatus is interesting in that it feeds on birds during spring and shifts to feeding on mammals towards fall. Various hypotheses have been proposed to explain the seasonal shift in host use in this species but have provided limited evidence. This study examines whether the shifting of host classes from birds to mammals towards autumn offers any reproductive advantages to Cx. quinquefasciatus in terms of enhanced fecundity, fertility, and hatchability of the offspring. The authors found no evidence of this, suggesting that alternate mechanisms may drive the seasonal shift in host use in Cx. quinquefasciatus.

      Strengths:

      Host blood meal source, temperature, and photoperiod were all examined together.

      Weaknesses:

      The study was conducted in laboratory conditions with a local population of Cx. quinquefasciatus from Argentina. I'm not sure if there is any evidence for a seasonal shift in the host use pattern in Cx. quinquefasciatus populations from the southern latitudes.

      Comments on the revision: 

      Overall, I am not quite convinced about the possible shift in host use in the Argentinian populations of Cx. quinquefasciatus. The evidence from the papers that the authors cite is not strong enough to derive this conclusion. Therefore, I think that the introduction and discussion parts where they talk about host shift in Cx. quinquefasciatus should be removed completely as it misleads the readers. I suggest limiting the manuscript to talking only about the effects of blood meal source and seasonality on the reproductive outcomes of Cx. quinquefasciatus

      As mentioned in the previous revision, we agree on the reviewer observation about the lack of evidence on seasonal shift in the host use pattern in Cx. quinquefasciatus populations from Argentina. We include this topic in the discussion.

      Additionally, we also added a paragraph in the discussion section to include the limitations of our study and conclusions. One of them is the fact that our results are based on controlled conditions experiments. Future studies are needed to elucidate if the same trend is found in the field.

      Reviewer #1 (Recommendations for the authors): 

      Abstract

      Line 73: shift in feeding behavior

      Accepted as suggested. 

      Discussion

      Line 258: addressed that Accepted as suggested.

      Line 263: blood is nutritionally richer

      Accepted as suggested.

      Reviewer #2 (Public Review): 

      Summary:

      Conceptually, this study is interesting and is the first attempt to account for the potentially interactive effects of seasonality and blood source on mosquito fitness, which the authors frame as a possible explanation for previously observed host-switching of Culex quinquefasciatus from birds to mammals in the fall. The authors hypothesize that if changes in fitness by blood source change between seasons, higher fitness on birds in the summer and on mammals in the autumn could drive observed host switching. To test this, the authors fed individuals from a colony of Cx. quinquefasciatus on chickens (bird model) and mice (mammal model) and subjected each of these two groups to two different environmental conditions reflecting the high and low temperatures and photoperiod experienced in summer and autumn in Córdoba, Argentina (aka seasonality). They measured fecundity, fertility, and hatchability over two gonotrophic cycles. The authors then used a generalized linear model to evaluate the impact of host species, seasonality, and gonotrophic cycle on fecundity, fertility, and hatchability. The authors were trying to test their hypothesis by determining whether there was an interactive effect of season and host species on mosquito fitness. This is an interesting hypothesis; if it had been supported, it would provide support for a new mechanism driving host switching. While the authors did report an interactive impact of seasonality and host species, the directionality of the effect was the opposite from that hypothesized. The authors have done a very good job of addressing many of the reviewer concerns, with several exception that continue to cause concern about the conclusions of the study. 

      Strengths:

      (1) Using a combination of laboratory feedings and incubators to simulate seasonal environmental conditions is a good, controlled way to assess the potentially interactive impact of host species and seasonality on the fitness of Culex quinquefasciatus in the lab.

      (2) The driving hypothesis is an interesting and creative way to think about a potential driver of host switching observed in the field. 

      (3) The manuscript has become a lot clearer and easier to read with the revisions - thank you to the authors for working hard to make many of the suggested changes. 

      Weaknesses:

      (1) The authors have decided not to follow the suggestion of conducting experimental replicates of the study. This is understandable given the significant investment of resources and time necessary, however, it leaves the study lacking support. Experimental replication is an important feature of a strong study and helps to provide confidence that the observed patterns are real and replicable. Without replication, I continue to lack confidence in the conclusions of the study. 

      We included replicates as suggested.  

      (2) The authors have included some additional discussion about the counterintuitive nature of their results, but the paragraph discussing this in the discussion was confusing. I believe that this should be revised. This is a key point of the paper and needs to be clear to the reader.

      Revised as suggested. 

      (3) There should be more discussion of the host switching observed in the two studies conducted in Argentina referenced by the authors. Since host switching is the foundation for the hypothesis tested in this paper, it is important to fully explain what is currently known in Argentina. 

      Accepted as suggested.

      (4) In some cases, the explanations of referenced papers are not entirely accurate. For example, when referencing Erram et al 2022, I think the authors misrepresented the paper's discussion regarding pre-diuresis- Erram et al. are suggesting that pre-diuresis might be the mechanism by which C. furens compensates for the lower nutritional value of avian blood, leading to no significant difference between avian/mammal blood on fecundity/fertility (rather than leading to higher fecundity on birds, as stated in this manuscript). The study performed by Erram et al. also didn't prove this phenomenon, they just suggest it as a possible mechanism to explain their results, so that should be made clear when referencing the paper. 

      Changed as suggested.

      (5) In some cases, the conclusions continue to be too strongly worded for the evidence available. For example, lines 322-324: I don't think the data is sufficient to conclude that a different physiological state is induced, nor that they are required to feed on a blood source that results in higher fitness. 

      Redaction was modified as suggested to tight our discussion with results.

      (6) There is limited mention of the caveat that this experiment performed with simulated seasonality that does not perfectly replicate seasonality in the field. I think this caveat should be discussed in the discussion (e.g. that humidity is held constant).

      This topic is now included in the discussion as suggested. 

      Reviewer #2 (Recommendations for the authors): 

      59-60: These terms should end with -phagic instead of -philic. These papers study blood feeding patterns, not preference. I understand that the Janssen papers calls it "mammalophilic" in their title, but this was an incorrect use of the term in their paper. There are some review papers that explain the difference in this terminology if it's helpful.

      Accepted as suggested. 

      73: edit to "in" feeding behavior 

      Accepted as suggested.

      77-78: Given that the premise of your study is based on the phenomenon of host switching, I suggest that you expand your discussion of these two papers. What did they observe? Which hosts did they switch from / to and how dramatic was the shift?

      Accepted as suggested. 

      79: replace acknowledged with experienced 

      Accepted as suggested.

      79-80: the way that this is written is misleading. It suggests that Spinsanti showed that seasonal variation in SLEV could be attributed to a host shift, which isn't true. This citation should come before the comma and then you should use more cautious language in the second half. E.g which MIGHT be possible to attribute to .... 

      Accepted as suggested.

      80-82: this is not convincing. Even if the Robin isn't in Argentina, Argentina does have migrating birds, so couldn't this be the case for other species of birds? Do any of the birds observed in previous blood meal analyses in Argentina migrate? If so, couldn't this hypothesis indeed play a role? 

      A paragraph about this topic was added to the discussion as suggested.

      90: hypotheses for what? The fall peak in cases? Or host switching? 

      Changed to be clearer.

      98: where was this mentioned before? I think "as mentioned before" can be removed. 

      Accepted as suggested.

      101: edit to "whether an interaction effect exists" 

      Accepted as suggested.

      104: edit to "We hypothesize that..." 

      Accepted as suggested.

      106: reported host USE changes, not host PREFERENCE changes, right? 

      All the terminology was change to host pattern and not preference to avoid confusion.

      200: Briefly reading Carsey and Harden, it looks like the methodology was developed for social science. Is there anything you can cite to show this applied to other types of data? If not, I think this requires more explanation in your MS. 

      This was removed as replicates were included.

      237-239: I think it is best not to make a definitive statement about greater/higher if it isn't statistically significant; I suggest modifying the sentences to state that the differences you are listing were not significantly different up front rather than at the end, otherwise if people aren't reading carefully, they may get the wrong impression. 

      Accepted as suggested.

      245: you only use the term MS-I once before and I forgot what it meant since it wasn't repeated, so I had to search back through with command-F. I suggest writing this out rather than using the acronym. 

      Accepted as suggested.

      249: edit to: "an interaction exists between the effect of..." 

      Accepted as suggested.

      253-254: greater compared to what? 

      Change for clearness. 258-260: edit for grammar 

      Accepted as suggested.

      260-262: edit for grammar; e.g. "However, this assumption lacks solid evidence; there is a scarcity of studies regarding nutritional quality of avian blood and its impact on mosquito fitness." 

      Accepted as suggested.

      263: edit: blood is nutritionally... 

      Accepted as suggested.

      264-267: This doesn't sound like an accurate interpretation of what the paper suggests regarding pre-diuresis in their discussion - they are suggesting that pre-diuresis might be the mechanism by which C. furens compensates for the lower nutritional value of avian blood, leading to no significant difference between avian/mammal blood on fecundity/fertility. They also don't show this, they just suggest it as a possible mechanism to explain their results. 

      This topic was removed given the restructuring of discussion.

      253-269: You should tie this paragraph back to your results to explicitly compare/contrast your findings with the previous literature. 

      Accepted as suggested.

      270-282: This paragraph would be a good place to explain the caveat of working in the laboratory - for example, humidity was the same across the two seasons which I'm guessing isn't the case in the field in Argentina. You can discuss what aspects of laboratory season simulation do not accurately replicate field conditions and how this can impact your findings. You said in your response to the reviewers that you weren't interested in measuring other variables (which is fair, and not expected!), but the beauty of the discussion section is to be able to think about how your experimental design might impact your results - one possibility is that your season simulation may not have produced the results produced by true seasonal shifts. 

      Accepted as suggested.

      279-281: You say your experiment was conducted within the optimal range, which would suggest that both summer and autumn were within that range, but then you only talk about summer as optimal in the following sentence. 

      Changed for clearness.

      281-282: You should clarify this sentence - state what the interaction has an effect on. 

      Accepted as suggested.

      283-291: I appreciate that your discussion now acknowledges the small sample size and the questions that remain unanswered due to the results being opposite to that of the hypothesis, but this paragraph lacks some details and in places doesn't make sense. 

      I think you need to emphasize which groups had small sample size and which conclusions that might impact. I also think you need to explain why the sample size was substantially smaller for some groups (e.g. did they refuse to feed on the mouse in the autumn?). I appreciate that sample sizes are hard to keep high across many groups and two gonotrophic periods, but unfortunately, that is why fitness experiments are so hard to do and by their nature, take a long time. I understand that other papers have even lower sample size, but I was not asked to review those papers and would have had the same critique of them. I don't believe that creating simulated data via a Monte Carlo approach can make up for generating real data. As I understand it from your explanation, you are parametrizing the Monte Carlo simulations with your original data, which was small to begin with for autumn mouse. Using this simulation doesn't seem like a satisfactory replacement for an experimental replicate in my opinion. I maintain that at least a second replicate is necessary to see whether the patterns that you have observed hold. 

      The performing of a power analysis and addition of more replicates tried to solve the issue of sample size. More about this critic is added in the discussion. The simulation approach was totally removed.

      Regarding the directionality of the interaction effect, I think this warrants more discussion. Lines 287-291 don't make sense to me. You suggest that feeding on birds in the autumn may confer a reproductive advantage when conditions are more challenging. But then why wouldn't they preferentially feed on birds in the autumn, rather than mammals? I suggest rewriting this paragraph to make it clearer. 

      Accepted as suggested.

      297: earlier mentioned treatments? Do you mean compared to the first gonotrophic cycle? This isn't clear. 

      Changed for clearness.

      302-303: Did you clarify whether you are allowed to reference unpublished data in eLife? 

      This was removed to follow the guidelines of eLife.

      316-317: "it becomes apparent" sounds awkward, I suggest rewording and also explaining how this conclusion was made. 

      Accepted as suggested.

      322-324: I think that this statement is too strongly worded. I don't think your data is sufficient to conclude that a different physiological state is induced, nor that they are required to feed on a blood source that results in higher fitness. Please modify this and make your conclusions more cautious and closely linked to what you actually demonstrated. 

      Accepted as suggested.

      325: change will perform to would have 

      Accepted as suggested.

      326: add to the sentence: "and vice versa in the summer" 

      Accepted as suggested.

      330: possible explanations, not explaining scenarios. 

      Accepted as suggested.

      517: I think you should repeat the abbreviation definitions in the caption to make it easier for readers, otherwise they have to flip back and forth which can be difficult depending on formatting.

      Accepted as suggested. 

      In general, I think that your captions need more information. I think the best captions explain the figure relatively thoroughly such that the reader can look at the figure and caption and understand without reading the paper in depth. (e.g. the statistical test used).

      Data availability: The eLife author instructions do say that data must be made available, so there should be a statement on data availability in your MS. I also suggest you make the code available.

      Accepted as suggested.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Reviewer #1 (Public Review):

      Summary:

      BMP signaling is, arguably, best known for its role in the dorsoventral patterning, but not in nematodes, where it regulates body size. In their paper, Vora et al. analyze ChIP-Seq and RNA-Seq data to identify direct transcriptional targets of SMA-3 (Smad) and SMA-9 (Schnurri) and understand the respective roles of SMA-3 and SMA-9 in the nematode model Caenorhabditis elegans. The authors use publicly available SMA-3 and SMA-9 ChIP-Seq data, own RNA-Seq data from SMA-3 and SMA-9 mutants, and bioinformatic analyses to identify the genes directly controlled by these two transcription factors (TFs) and find approximately 350 such targets for each. They show that all SMA-3-controlled targets are positively controlled by SMA-3 binding, while SMA-9-controlled targets can be either up or downregulated by SMA-9. 129 direct targets were shared by SMA-3 and SMA-9, and, curiously, the expression of 15 of them was activated by SMA-3 but repressed by SMA-9. Since genes responsible for cuticle collagen production were eminent among the SMA-3 targets, the authors focused on trying to understand the body size defect known to be elicited by the modulation of BMP signaling. Vora et al. provide compelling evidence that this defect is likely to be due to problems with the BMP signaling-dependent collagen secretion necessary for cuticle formation.

      We thank the reviewer for this supportive summary. We would like to clarify the status of the publicly available ChIP-seq data. We generated the GFP tagged SMA-3 and SMA‑9 strains and submitted them to be entered into the queue for ChIP-seq processing by the modENCODE (later modERN) consortium. Thus, the publicly available SMA-3 and SMA-9 ChIP-seq datasets used here were derived from our efforts.  Due to the nature of the consortium’s funding, the data were required to be released publicly upon completion. Nevertheless, our current manuscript provides the first comprehensive analysis of these datasets. We have updated the text to clarify this point.

      Strengths:

      Vora et al. provide a valuable analysis of ChIP-Seq and RNA-Seq datasets, which will be very useful for the community. They also shed light on the mechanism of the BMP-dependent body size control by identifying SMA-3 target genes regulating cuticle collagen synthesis and by showing that downregulation of these genes affects body size in C. elegans.

      Weaknesses:

      (1) Although the analysis of the SMA-3 and SMA-9 ChIP-Seq and RNA-Seq data is extremely useful, the goal "to untangle the roles of Smad and Schnurri transcription factors in the developing C. elegans larva", has not been reached. While the role of SMA-3 as a transcriptional activator appears to be quite straightforward, the function of SMA-9 in the BMP signaling remains obscure. The authors write that in SMA-9 mutants, body size is affected, but they do not show any data on the mechanism of this effect.

      We thank the reviewer for directing our attention to the lack of clarity about SMA-9’s function. We have revised the text to highlight what this study and others demonstrate about SMA-9’s role in body size. Simply stated, SMA-9 is needed together with SMA-3 to promote the expression of genes involved in one-carbon metabolism, collagens, and chaperones, all of which are required for body size. SMA-3 has additional, SMA-9-independent transcriptional targets, including chaperones and ER secretion factors, that also contribute to body size. Finally, SMA-9 regulates additional targets independent of SMA-3 that likely have a minimal role in body size. We have adjusted Figure 5 with new graphs of the original data to make these points more clear.

      (2) The authors clearly show that both TFs can bind independently of each other, however, by using distances between SMA-3 and SMA-9 ChIP peaks, they claim that when the peaks are close these two TFs act as complexes. In the absence of proof that SMA-3 and SMA-9 physically interact (e.g. that they co-immunoprecipitate - as they do in Drosophila), this is an unfounded claim, which should either be experimentally substantiated or toned down.

      We acknowledge that we have not demonstrated a physical interaction between SMA-3 and SMA-9 through a co-immunoprecipitation, and we have indicated in the text that a formal biochemical demonstration would be required to make this point. Moreover, we toned down the text by stating that our results suggest that either SMA-3 and SMA-9 frequently bind as either subunits in a complex or in close vicinity to each other along the DNA. As the reviewer has indicated, a physical interaction between Smads and Schnurris has been amply demonstrated in other systems. A limitation in these previous studies is that only a small number of target genes were analyzed. Our goal in this study was to determine how widespread this interaction is on a genomic scale. Our analyses demonstrate for the first time that a Schnurri transcription factor has significant numbers of both Smad-dependent and Smad-independent target genes. We have revised the text to clarify this point.

      (3) The second part of the paper (the collagen story) is very loosely connected to the first part. dpy-11 encodes an enzyme important for cuticle development, and it is a differentially expressed direct target of SMA-3. dpy-11 can be bound by SMA-9, but it is not affected by this binding according to RNA-Seq. Thus, technically, this part of the paper does not require any information about SMA-9. However, this can likely be improved by addressing the function of the 15 genes, with the opposing mode of regulation by SMA-3 and SMA-9.

      We appreciate this suggestion and have clarified in the text how SMA-9 contributes to collagen organization and body size regulation.

      (4) The Discussion does not add much to the paper - it simply repeats the results in a more streamlined fashion.

      We thank the reviewer for this suggestion. We have added more context to the Discussion.

      Reviewer #2 (Public Review):

      In the present study, Vora et al. elucidated the transcription factors downstream of the BMP pathway components Smad and Schnurri in C. elegans and their effects on body size. Using a combination of a broad range of techniques, they compiled a comprehensive list of genome-wide downstream targets of the Smads SMA-3 and SMA-9. They found that both proteins have an overlapping spectrum of transcriptional target sites they control, but also unique ones. Thereby, they also identified genes involved in one-carbon metabolism or the endoplasmic reticulum (ER) secretory pathway. In an elaborate effort, the authors set out to characterize the effects of numerous of these targets on the regulation of body size in vivo as the BMP pathway is involved in this process. Using the reporter ROL-6::wrmScarlet, they further revealed that not only collagen production, as previously shown, but also collagen secretion into the cuticle is controlled by SMA-3 and SMA-9. The data presented by Vora et al. provide in-depth insight into the means by which the BMP pathway regulates body size, thus offering a whole new set of downstream mechanisms that are potentially interesting to a broad field of researchers.

      The paper is mostly well-researched, and the conclusions are comprehensive and supported by the data presented. However, certain aspects need clarification and potentially extended data.

      (1) The BMP pathway is active during development and growth. Thus, it is logical that the data shown in the study by Vora et al. is based on L2 worms. However, it raises the question of if and how the pattern of transcriptional targets of SMA-3 and SMA-9 changes with age or in the male tail, where the BMP pathway also has been shown to play a role. Is there any data to shed light on this matter or are there any speculations or hypotheses?

      We agree that these are intriguing questions, and we are interested in the roles of transcriptional targets at other developmental stages and in other physiological functions, but these analyses are beyond the scope of the current study.

      (2) As it was shown that SMA-3 and SMA-9 potentially act in a complex to regulate the transcription of several genes, it would be interesting to know whether the two interact with each other or if the cooperation is more indirect.

      A physical interaction between Smads and Schnurri has been amply demonstrated in other systems. Our goal in this study was not to validate this physical interaction, but to analyze functional interactions on a genome-wide scale.

      (3) It would help the understanding of the data even more if the authors could specifically state if there were collagens among the genes regulated by SMA-3 and SMA-9 and which.

      We thank the reviewer for this suggestion. col-94 and col-153 were identified as direct targets of both SMA-3 and SMA-9. We noted this in the Discussion.

      (4) The data on the role of SMA-3 and SMA-9 in the regulation of the secretion of collagens from the hypodermis is highly intriguing. The authors use ROL-6 as a reporter for the secretion of collagens. Is ROL-6 a target of SMA-9 or SMA-3? Even if this is not the case, the data would gain even more strength if a comparable quantification of the cuticular levels of ROL-6 were shown in Figure 6, and potentially a ratio of cuticular versus hypodermal levels. By that, the levels of secretion versus production can be better appreciated.

      We previously showed that rol-6 mRNA levels are reduced in dbl-1 mutants at L2, but RNA-seq analysis did not find enough of a statistically significant change in rol-6 to qualify it as a transcriptional target and total levels of protein are also not significantly reduced in mutants. We added this information in the text.

      (5) It is known that the BMP pathway controls several processes besides body size. The discussion would benefit from a broader overview of how the identified genes could contribute to body size. The focus of the study is on collagen production and secretion, but it would be interesting to have some insights into whether and how other identified proteins could play a role or whether they are likely to not be involved here (such as the ones normally associated with lipid metabolism, etc.).

      We have added more information to the Discussion.

      Reviewer #1 (Recommendations For The Authors):

      Figure 1 - Figure 3: The authors might want to think about condensing this into two figures.

      To avoid confusion with the different workflows, we prefer to keep these as three separate figures.

      Figure 1a-b: Measurement unit missing on X.

      We added the unit “bps” to these graphs.

      Line 244-246: The authors should stress in the Results that they analyzed publicly available ChIP-Seq data, which was not generated by them, - not just by providing a reference to Kudron et al., 2018. As far as I understood, ChIP was performed with an anti-GFP antibody. Please mention this, and specify the information about the vendor and the catalog number in the Methods.

      We would like to clarify the status of the publicly available ChIP-seq data. We generated the GFP tagged SMA-3 and SMA‑9 strains and submitted them to be entered into the queue for ChIP-seq processing by the modENCODE (later modERN) consortium. Thus, the publicly available SMA-3 and SMA-9 ChIP-seq datasets used here were derived from our efforts.  Due to the nature of the consortium’s funding, the data were required to be released publicly upon completion. Nevertheless, our current manuscript provides the first comprehensive analysis of these datasets. We have clarified these issues in the text.  We have also added information regarding the anti-GFP antibody to the Methods.

      Line 267-270: The authors should either provide experimental evidence that SMA-3 and SMA-9 form complexes or write something like "significant overlap between SMA-3 and SMA-9 peaks may indicate complex formation between these two transcription factors as shown in Drosophila" - but in the absence of proof, this must be a point for the Discussion, not for the Results. Moreover, similar behavior of fat-6 (overlapping ChIP peaks) and nhr-114 (non-overlapping ChIP peaks) in SMA-3 and SMA-9 mutants may be interpreted as a circumstantial argument against SMA-3/SMA-9 complex formation (see Lines 342-348). Importantly, since ChIP-Seq data are available for a wide array of C. elegans TFs, it would be very useful to have an estimate of whether SMA-3/SMA-9 peak overlap is significantly higher than the peak overlap between SMA-3 and several other TFs expressed at the same L2 stage.

      We have clarified our goals regarding SMA-3 and SMA-9 interactions and softened our conclusions by indicating in the text that a formal biochemical demonstration would be required to demonstrate a physical interaction. Moreover, we toned down the text by stating that our results suggest that either SMA-3 and SMA-9 frequently bind as either subunits in a complex or in close vicinity to each other along the DNA. We have added an analysis of HOT sites to address overlap of binding with other transcription factors. We disagree with the interpretation that transcription factors with non-overlapping sites cannot act together to regulate gene expression; however, nhr-114 also has an overlapping SMA-3 and SMA-9 site, so this point becomes less relevant. We have clarified the categorization of nhr-114 in the text.

      Lines 272-292: The authors do not comment on the seemingly quite small overlap between the RNA-Seq and the ChIP-Seq dataset, but I think they should. They have 3205 SMA-3 ChIP peaks and 1867 SMA-3 DEGs, but the amount of directly regulated targets is 367. It is important that the authors provide information on the number of genes to which their peaks have been assigned. Clearly, this will not be one gene per peak, but if it were, this would mean that just 11.5% of bound targets are really affected by the binding. The same number would be 4.7% for the SMA-9 peaks.

      We have added a discussion of the discrepancy between binding sites and DEGs. The high number of additional sites classified as non-functional could represent the detection of weak affinity targets that do not have an actual biological purpose. Alternatively, these sites could have an additional role in DBL-1 signaling besides transcriptional regulation of nearby genes, or they could be regulating the expression of target genes at a far enough distance to not be detected by our BETA analysis as per the constraints chosen for the analysis. The difference between total binding sites and those associated with changes in gene expression underscores the importance of combining RNA-seq with ChIP-seq to identify the most biologically relevant targets. And as the reviewer indicated, more than one gene can be assigned to a single neighboring peak.

      Lines 294-323: I feel like there is a terminology problem, which makes reading very difficult. The authors use "direct targets" as bound genes with significant expression change, but then run into a problem when the gene is bound by SMA-9 and SMA-3, but significant expression change is only associated with one of the two factors. I am not sure this is consistent with the idea of the SMA3/SMA9 complex. Also, different modalities of the SMA3 and SMA9 effect in 15 cases can be explained by co-factors. Reading would be also simplified if the order of the panels in Figure 3 were different. Currently, the authors start their explanation by referring to the shared SMA-3/SMA-9 targets (Figures 3c-d), and only later come to Figure 3b. In general, the authors should start with a clear explanation of what is on the figure (currently starting on Line 313), otherwise, it is unclear why, if the authors only discuss common targets, it is not just 114+15=129 targets, but more.

      We have re-ordered the columns in Figure 3 to match the order discussed in the text. We also incorporated more precise language about regulation by SMA-3 and/or SMA-9 in the text.

      Lines 325-355: The chapter has a rather unfortunate name "Mechanisms of integration of SMA-3 and SMA-9 function", although the authors do not provide any mechanism. Using 3 target genes, they show that if the regulatory modality of SMA-3 and SMA-9 is the same (2 examples), there is no difference in the expression of the targets, but if the modalities are opposing (1 example), SMA-9 repressive action is epistatic to the SMA-3 activating action. Can this be generalized? The authors should test all their 15 targets with opposite regulations. Moreover, it seems obvious to ask whether the intermediate phenotype of the double-mutants can be attributed to the action of these 15 genes activated by SMA-3 and repressed by SMA-9. I would suggest testing this by RNAi. I would also suggest renaming the chapter to something better reflecting its content.

      We have removed the word “mechanism” from the title of this section. We also performed additional RT-PCR experiments on another 5 targets with opposing directions of regulation. The results from these genes are consistent with the result from C54E4.5, demonstrating that the epistasis of sma-9 is generalizable.

      Figure 4b: Why was a two-way ANOVA performed here? With the small number of measurements, I would consider using a non-parametric test.

      These data are parametric and the distribution of the data is normal, so we chose to use a parametric test (ANOVA).

      Lines 354-355. The authors offer two suggestions for the mechanism of the epistatic action of SMA-9 on SMA-3 in the case of C54E4.5, but this is something for the Discussion. If they want to keep it in the Results they should address this experimentally by performing SMA-3 ChIP-seq in the SMA-9 mutants and SMA-9 ChIP-Seq in the SMA-3 mutants.

      We moved these models to the discussion as suggested.

      Lines 365-367: "We expect that clusters of genes involved in fatty acid metabolism and innate immunity mediate the physiological functions of BMP signaling in fat storage and pathogen resistance, respectively." - This is pretty confusing since the Authors claim in the previous sentence that regulation of immunity by SMA-9 is TGF-beta independent.

      Co-regulation of immunity by BMP signaling and SMA-9 is already known. The novel insight is that SMA-9 may have an additional independent role in immunity. We have clarified the language to address this confusion.

      Lines 377, and 380: Please explain in non-C. elegans-specific terminology, what rrf-3 and LON-2 are (e.g. write "glypican LON-2" instead of just "LON-2") and add relevant references.

      We added information on the proteins encoded by these genes.

      Lines 382-384: I am not sure what the Authors mean here by "more limiting".

      We substituted the phrase “might have a more prominent requirement in mediating the exaggerated growth defect of a lon-2 mutant”.

      Lines 388-392: I found this very confusing. What were these 36 genes? Were these direct targets of SMA-3, SMA-9, or both? Top 36 targets? 36 targets for which mutants are available?

      The new Figure 5 clarifies whether target genes are SMA-3-exclusive, SMA-9-exclusive, or co-regulated. The text was also updated for clarity.

      Line 397: This is the first time the authors mention dpy-11 but they do not say what it is until later, and they do not say whether it is a target of SMA3/SMA9. Checking Figure 3, I found that it is among the 238 genes bound by both but upregulated only by SMA3. The authors need to explicitly state this - from this point on, they have a section for which SMA-9 appears to be irrelevant.

      We added the molecular function of dpy-11 at its first mention. Furthermore, we included the hypothesis that SMA-3 may regulate collagen secretion independently of SMA-9. Our subsequent results with sma-9 mutants disprove this hypothesis.

      Line 402: Is ROL-6 a SMA-3/SMA-9 target or just a marker gene?

      We previously showed that rol-6 mRNA levels are reduced in dbl-1 mutants at L2, but RNA-seq analysis did not find enough of a statistically significant change in rol-6 to qualify it as a transcriptional target and total levels of protein are also not significantly reduced in mutants. We added this information in the text.

      Line 421: I am not sure what "more skeletonized" means.

      Replaced with “thinner and skeletonized”

      Figure 2b and 2d legends: "Non-target genes nevertheless showing differential expression are indicated with green squares." (l. 581-582 and again l. 588-589) I think should be "Non-direct target genes...".

      Changed to “non-direct target genes”

      Figure 7 legend: Please indicate the scale bar size in the legend.

      Indicated the scale bar size in the legend.

      Figure 7: The ER marker is referred to as "ssGFP::KDEL" (in the image and Line 700), however in the text it is called "KDEL::oxGFP" (Line 419). Please use consistent naming.

      We fixed the inconsistent naming.

      All the experiment suggestions made are optional and can, in principle, be ignored if the authors tone down their claims (for example, the SMA-3/SMA-9 complex formation).

      Reviewer #2 (Recommendations For The Authors):

      (1) As a control: Have the authors found the known regulated genes among the differentially regulated ones?

      Previously known target genes such as fat-6 and zip-10 were identified here. We have added this information in the text.

      (2) How many repetitions were performed in Figure 4b? I am wondering as the deviation for C54E4.5 is quite large and that makes me worry that the significant differences stated are not robust.

      There were two biologically independent collections from which three cDNA syntheses were analyzed using two technical replicates per point.

      (3) Lines 333-336: Can you really make this claim that the antagonistic effects seen in the regulation of body size can be correlated with some targets being regulated in the opposite direction? I would assume that the situation is far more complex as SMADs also regulate other processes.

      We agree with the reviewer that multiple models could explain this antagonism, and we have added distinct alternatives in the text.

      (4) Lines 367-369: Add the respective reference please.

      We have added the relevant references.

    1. Author response:

      We are both honored and humbled by the high praise our work received from all three reviewers. Below, we address the common comments made by the reviewers:

      (1) Value and Impact of the Resource: We are grateful for the recognition of our dataset as a valuable and high-quality resource. Our primary goal was to generate a comprehensive dataset on protein abundance and phosphorylation dynamics during Xenopus oocyte maturation. We are pleased that this work has been seen as a solid foundation for future studies in Xenopus research and beyond, with broader implications for oocyte and cell cycle biology.

      (2) Focus on Functional Validation and Contextualization with Prior Studies: The manuscript was submitted as a Tools and Resources article, a format that emphasizes the creation and presentation of datasets, tools, and methodological advances to facilitate future discoveries. In alignment with this format, we ensured that the information is accessible and deployable for the broader scientific community. While we did not include functional validation of specific pathways, the dataset provides a robust framework for generating numerous testable hypotheses. We plan to pursue some of these follow-up studies in our labs and encourage the community to explore these further.

      (3) Contextualization with Prior Studies: We appreciate the recognition of our efforts to integrate our findings with the existing body of literature. In conclusion, we would like to thank the reviewers for their evaluation and thoughtful suggestions. We look forward to seeing how this dataset contributes to future discoveries in the field.

    1. Author response:

      eLife Assessment:

      In this important study, the authors combine innovative experimental approaches, including direct compressibility measurements and traction force analyses, with theoretical modeling to propose that wild-type cells exert compressive forces on softer HRasV12-transformed cells, influencing competition outcomes. The data generally provide solid evidence that transformed epithelial cells exhibit higher compressibility than wild-type cells, a property linked to their compaction during mechanical cell competition. However, the study would benefit from further characterization of how compression affects the behavior of HRasV12 cells and clearer causal links between compressibility and competition outcomes.

      We thank the reviewers and the editor for their thoughtful and encouraging feedback on our study and for appreciating the innovation in our experimental and theoretical approaches. We acknowledge the importance of further clarifying the mechanistic links between the compressibility of HRas<sup>V12</sup>-transformed cells, their compaction, and the outcomes of mechanical cell competition. In the revised manuscript, we will include additional experiments and analyses to assess how compression influences the cellular behavior and fate of HRas<sup>V12</sup>-transformed cells during competition. In addition, to strengthen the connection between collective compressibility and competition outcomes, we will integrate quantitative analyses of cell dynamics and additional modeling to explicitly correlate the mechanical properties with the spatial and temporal aspects of cell elimination. These additions will address the reviewer’s concerns comprehensively, further enriching the mechanistic understanding presented in the manuscript.

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      In this article, Gupta and colleagues explore the parameters that could promote the elimination of active Ras cells when surrounded by WT cells. The elimination of active Ras cells by surrounding WT cells was previously described extensively and associated with a process named cell competition, a context dependant elimination of cells. Several mechanisms have been associated with competition, including more recently elimination processes based on mechanical stress. This was explored theoretically and experimentally and was either associated with differential growth and sensitivity to pressure and/or differences in homeostatic density/pressure. This was extensively validated for the case of Scribble mutant cells which are eliminated by WT MDCK cells due to their higher homeostatic density. However, there has been so far very little systematic characterisation of the mechanical parameters and properties of these different cell types and how this could contribute to mechanical competition.

      Here, the authors used the context of active Ras cells in MDCK cells (with some observations in vivo in mice gut which are a bit more anecdotal) to explore the parameters causal to Ras cell elimination. Using for the first time traction force microscopy, stress microscopy combined with Bayesian inference, they first show that clusters of active Ras cells experience higher pressure compared to WT. Interestingly, this occurs in absence of differences in growth rate, and while Ras cells seems to have lower homeostatic density, in contractions with the previous models associated with mechanical cell competition. Using a self-propelled Voronoi model, they explored more systematically the conditions that will promote the compression of transformed cells, showing globally that higher Area compressibility and/or lower junctional tension are associated with higher compressibility. Using then an original and novel experimental method to measure bulk compressibility of cell populations, they confirmed that active Ras cells are globally twice more compressible than WT cells. This compressibility correlates with a disruption of adherens junctions. Accordingly, the higher pressure near transformed Ras cells can be completely rescued by increasing cell-cell adhesion through E-cad overexpression, which also reduces the compressibility of the transformed cells. Altogether, these results go along the lines of a previous theoretical work (Gradeci et al. eLife 2021) which was suggesting that reduced stiffness/higher compressibility was essential to promote loser cell elimination. Here, the authors provide for the first time a very convincing experimental measurement and validation of this prediction. Moreover, their modelling approach goes far beyond what was performed before in terms of exploration of conditions promoting compressibility, and their experimental data point at alternative mechanisms that may contribute to mechanical competition.

      Strengths:

      - Original methodologies to perform systematic characterisation of mechanical properties of Ras cells during cell competition, which include a novel method to measure bulk compressibility.<br /> - A very extensive theoretical exploration of the parameters promoting cell compaction in the context of competition.

      We thank the reviewer for their detailed and thoughtful assessment of our study and for recognizing the originality of our methodologies, including the novel bulk compressibility measurement technique and the extensive theoretical exploration of parameters influencing mechanical competition. We are pleased that the reviewer finds our experimental validation and modeling approach convincing and acknowledges the relevance of our findings in advancing the understanding of mechanical cell competition. We will carefully address all the points raised to further clarify and strengthen the manuscript.

      Weaknesses:

      - Most of the theoretical focus is centred on the bulk compressibility, but so far does not really explain the final fate of the transformed cells. Classic cell competition scenario (including the one involving active Ras cells) lead to the elimination of one cell population either by cell extrusion/cell death or global delamination. This aspect is absolutely not explored in this article, experimentally or theoretically, and as such it is difficult to connect all the observables with the final outcome of cell competition. For instance, higher compressibility may not lead to loser status if the cells can withstand high density without extruding compared to the WT cells (and could even completely invert the final outcome of the competition). Down the line, and as suggested in most of the previous models/experiments, the relationship between pressure/density and extrusion/death will be the key factor that determine the final outcome of competition. However, there is absolutely no characterisation of cell death/cell extrusion in the article so far.

      We thank the reviewer for highlighting this important point. We agree that understanding the relationship between pressure, density, and the final outcomes of cell competition, such as extrusion and cell death, is crucial to connecting the mechanical properties to competition outcomes. While extrusion and cell death have been extensively characterized in previous works (e.g., https://www.nature.com/articles/s41467-021-27896-z; https://www.nature.com/articles/ncb1853), we nevertheless recognize the need to address this aspect more explicitly in our study. To this end, we have indeed performed experiments to characterize cell extrusion and cell death under varying conditions of pressure and density. We will incorporate these data into the revised manuscript. These additions will provide a more comprehensive understanding of how mechanical imbalance drives cell competition and determine the final fate of transformed cells.

      - While the compressibility measurement are very original and interesting, this bulk measurement could be explained by very different cellular processes, from modulation of cell shape, to cell extrusion and tissue multilayering (which by the way was already observed for active Ras cells, see for instance https://pubmed.ncbi.nlm.nih.gov/34644109/). This could change a lot the interpretation of this measurement and to which extend it can explain the compression observed in mixed culture. This compressibility measurement could be much more informative if coupled with an estimation of the change of cell aspect ratio and the rough evaluation of the contribution of cell shape changes versus alternative mechanisms.

      We thank the reviewer for raising this important concern. In our model system and within the experimental timescale of our studies involving gel compression microscopy (GCM) experiments, we do not observe tissue multilayering and cell extrusion, as these measurements are performed on homogeneous populations (pure wild-type or pure transformed cell monolayer). However, to address the reviewer’s suggestion, we will include measurements of cell aspect ratio as well as images eliminating the possibility of multilayering/extrusion in the revised manuscript. These results will provide additional insights into the plausible contributions of cell shape changes. Furthermore, our newer results indicate that the compressibility differences arise from variations in the intracellular organization (changed in nuclear and cytoskeletal organization) between wild-type and transformed cells. While a detailed molecular characterization of these underlying mechanisms is beyond the scope of the current manuscript, we acknowledge its importance and plan to explore it in a future study. These revisions will clarify and strengthen the interpretation of our findings.

      - So far, there is no clear explanation of why transformed Ras cells get more compacted in the context of mixed culture compared to pure Ras culture. Previously, the compaction of mutant Scribble cells could be explained by the higher homeostatic density of WT cells which impose their prefered higher density to Scribble mutant (see Wagstaff et al. 2016 or Gradeci et al 2021), however that is not the case of the Ras cells (which have even slightly higher density at confluency). If I understood properly, the Voronoid model assumes some directional movement of WT cell toward transformed which will actively compact the Ras cells through self-propelled forces (see supplementary methods), but this is never clearly discussed/described in the results section, while potentially being one essential ingredient for observing compaction of transformed cells. In fact, this was already described experimentally in the case of Scribble competition and associated with chemoattractant secretion from the mutant cells promoting directed migration of the WT (https://pubmed.ncbi.nlm.nih.gov/33357449/). It would be essential to show what happens in absence of directional propelled movement in the model and validate experimentally whether there is indeed directional movement of the WT toward the transformed cells. Without this, the current data does not really explain the competition process.

      We introduced directional movement of wild-type cells towards neighbouring transformed cells (and a form of active force to be exerted by them), motivated by the tissue compressibility measurements from the Gel Compression Microscopy experiments (Fig. 4E-L). This allowed us to devise an equivalent method of measuring the material response to isotropic compression within the SPV model framework. While the role of directional propelled movement is an area of ongoing investigation and has not been explored extensively within the current study, we emphasize that even without directional propulsion in the model, our results demonstrate compressive stress or elevated pressure, and increased compaction within the transformed population under suitable conditions reported in this work (when k<1), exhibiting a greater tissue-level compressibility in the transformed cells compared to WT cells (Figs. 4C-D), thereby laying the ground for competition. To clarify these concerns, we will provide additional results as well as detailed discussions on the effect of cell movements in compression.

      - Some of the data lack a bit of information on statistic, especially for all the stress microscopy and traction forces where we do no really know how representative at the stress patterns (how many experiment, are they average of several movies ? integrated on which temporal window ?)

      We thank the reviewer for highlighting the need for additional details regarding the statistical representation of our stress microscopy and traction force data. We will address these concerns in the revised manuscript by providing clear descriptions of the number of experiments, the averaging methodology, and the temporal windows used for analysis. Currently, Figs. 2A and 2C represent data from single time points, as the traction and stress landscapes evolve dynamically as transformed cells begin extruding (as shown in Supplementary movie 1). In contrast, Fig. 2H represents data collected from several samples across three independent experiments, all measured at the 3-hour time point following doxycycline induction. This specific time point is critical because it captures the emergence of compressive stresses before extrusion begins, simplifying the analysis and ensuring consistency. We will ensure these details are clearly articulated in the revised text and figure legends.

      Reviewer #2 (Public review):

      The work by Gupta et al. addresses the role of tissue compressibility as a driver of cell competition. The authors use a planar epithelial monolayer system to study cell competition between wild type and transformed epithelial cells expressing HRasV12. They combine imaging and traction force measurements from which the authors propose that wild type cells generate compressive forces on transformed epithelial cells. The authors further present a novel setup to directly measure the compressibility of adherent epithelial tissues. These measurements suggest a higher compressibility of transformed epithelial cells, which is causally linked to a reduction in cell-cell adhesion in transformed cells. The authors support their conclusions by theoretical modelling using a self-Propelled Voronoi model that supports differences in tissue compressibility can lead to compression of the softer tissue type.

      The experimental framework to measure tissue compressibility of adherent epithelial monolayers establishes a novel tool, however additional controls of this measurement appear required. Moreover, the experimental support of this study is mostly based on single representative images and would greatly benefit from additional data and their quantitative analysis to support the authors' conclusions. Specific comments are also listed in the following:

      Major points:

      It is not evident in Fig2A that traction forces increase along the interface between wild type and transformed populations and stresses in Fig2C also seem to be similar at the interface and surrounding cell layer. Only representative examples are provided and a quantification of sigma_m needs to be provided.

      In Figure 1-3 only panel 2G and 2H provide a quantitative analysis, but it is not clear how many regions of interest and clusters of transform cells were quantified.

      We thank the reviewer for their detailed comments and for highlighting the importance of additional quantitative analyses to support our conclusions. We appreciate their recognition of our novel experimental framework to measure tissue compressibility and the overall approach of our study. Regarding Fig. 2A and Fig. 2C, we acknowledge the need for further clarity. While the traction forces and stress patterns may not appear uniformly distinct at the interface in the representative images, these differences are more evident at specific time points before extrusion begins. Please note that the traction and stress landscapes evolve dynamically as transformed cells begin extruding (as shown in Supplementary movie 1). We will include a quantification of σ<sub>m</sub>​ and additional data from multiple experiments to substantiate the observations and address this concern in the revised manuscript. Currently, the data in Fig. 2G and Fig. 2H represent several regions of interest and transformed cell clusters collected from three independent experiments, all analyzed at the 3-hour time point after doxycycline induction. This time point was chosen because it captures the compressive stress emergence without interference from extrusion processes, simplifying the analysis. We will expand these sections with detailed descriptions of the sample sizes and statistical analyses to ensure greater transparency and reproducibility. These revisions will provide a stronger quantitative foundation for our findings and address the reviewer's concerns.

      Several statements appear to be not sufficiently justified and supported by data.<br /> For example the statement on pg 3. line 38 seems to lack supportive data 'This comparison revealed that the thickness of HRasV12-expressing cells was reduced by more than 1.7-fold when they were surrounded by wild type cells. These observations pointed towards a selective, competition-dependent compaction of HRasV12-expressing transformed cells but not control cells, in the intestinal villi of mice.'  Similarly, the statement about a cell area change of 2.7 fold (pg 3 line 47) lacks support by measurements.

      We thank the reviewer for pointing out the need for more supportive data to justify several statements in the manuscript. Specifically, the observation regarding the reduction in the thickness of HRas<sup>V12</sup>-expressing cells by more than 1.7-fold when surrounded by wild-type cells, and the statement about a 2.7-fold change in cell area, will be supported by detailed measurements. In the revised manuscript, we will include quantitative analyses with additional figures that clearly document these changes. These figures will provide representative images, statistical summaries, and detailed descriptions of the measurements to substantiate these claims. We appreciate the reviewer highlighting these areas and will ensure that all statements are robustly backed by data.

      What is the rationale for setting 𝐾p = 1 in the model assumptions if clear differences in junctional membranes of transformed versus wild type cells occur, including dynamic ruffling? This assumption does not seem to be in line with biological observations.

      While the specific role of K<sub>p</sub> in the differences observed in the junctional membranes of transformed versus WT cells, including dynamical ruffling, is not directly studied in this work, our findings indicate that the lower junctional tension (weaker and less stable cellular junctions) in mutant cells is influenced primarily by competition in the dimensionless cell shape index within the model. This also suggests a larger preferred cell perimeter (P<sub>0</sub>) for mutant cells, corresponding to their softer, unjammed state. Huang et al. (https://doi.org/10.1039/d3sm00327b) have previously argued that a high P<sub>0</sub> may, in some cases, result from elevated cortical tension along cell edges, or reflect weak membrane elasticity, implying a smaller K<sub>p</sub>. While this connection could be an intriguing avenue for future exploration, we emphasize that K<sub>p</sub> is not expected to alter any of the key findings or conclusions reported in this work. We will include any required analysis and corresponding discussions in the revised manuscript.

      The novel approach to measure tissue compressibility is based on pH dependent hydrogels. As the pH responsive hydrogel pillar is placed into a culture medium with different conditions, an important control would be if the insertion of this hydrogel itself would change the pH or conditions of the culture assays and whether this alters tissue compressibility or cell adhesion. The authors could for example insert a hydrogel pillar of a smaller diameter that would not lead to compression or culture cells in a larger ring to assess the influence of the pillar itself.

      We appreciate the reviewer’s insightful comment regarding the potential effects of the pH-responsive hydrogel pillar on the culture conditions and tissue compressibility. In our experiments, the expandable hydrogels are kept separate from the cells until the pH of the hydrogel is elevated to 7.4, ensuring that the hydrogel does not impact the culture environment. However, we acknowledge the concern and will include additional controls in the revised manuscript. Specifically, we will insert a hydrogel pillar with a smaller diameter that would not induce compression on culture cells in a larger ring to assess any potential influence of the hydrogel pillar itself. This will help to further validate our experimental setup.

      The authors focus on the study of cell compaction of the transformed cells, but how does this ultimately lead to a competitive benefit of wild type cells? Is a higher rate of extrusion observed and associated with the compaction of transformed cells or is their cell death rate increased? While transformed cells seem to maintain a proliferative advantage it is not clear which consequences of tissue compression ultimately drive cell competition between wild type and transformed cells.

      We thank the reviewer for highlighting this important point. We agree that understanding how tissue compression leads to a competitive advantage for wild type cells is crucial. While our current study focuses on the mechanical properties of transformed cells leading to the compaction and subsequent extrusion of the transformed cells, we recognize the need to explicitly connect these properties to the final outcomes of cell competition, such as extrusion or cell death. Although extrusion and cell death have been extensively characterized in previous studies (e.g., https://www.nature.com/articles/s41467-021-27896-z; https://www.nature.com/articles/ncb1853), we have indeed performed additional experiments to investigate the relationship between pressure, density, and these processes in our system. In the revised manuscript, we will include these new data, which will help to clarify how mechanical stress, driven by tissue compression, contributes to the competition between wild type and transformed cells and influences their eventual fate.

      The argumentation that softer tissues would be more easily compressed is plausible. However, which mechanism do the authors suggest is generating the actual compressive stress to drive the compaction of transformed cells? They exclude a proliferative advantage of wild type cells, which other mechanisms will generate the compressive forces by wild type cells?

      We thank the reviewer for raising this important question. As rightly pointed out by the reviewer indeed in our model system, we do not observe a proliferative advantage for the wild-type cells, and the compressive forces exerted by the wild-type cells are due to their intrinsic mechanical properties, such as lesser compressibility compared to the transformed cells. This difference in compressibility results in wild-type cells generating compressive stress at the interface with the transformed cells. Regarding the mechanism underlying the increased compressibility of the transformed cells, our newer findings indicate that the differences in compressibility arise from variations in the intracellular organization, specifically changes in nuclear and cytoskeletal organization between wild-type and transformed cells. While a detailed molecular characterization of these mechanisms is beyond the scope of the current manuscript, we acknowledge its significance and plan to investigate it in future work. We will, nevertheless, include a detailed discussion on the mechanism underlying the differential compressibility of wild-type and transformed cells in the revised manuscript.

    1. Author response:

      The following is the authors’ response to the original reviews.

      The revised manuscript contains new results and additional text. Major revisions:

      (1) Additional simulations and analyses of networks with different biophysical parameters and with identical time constants for E and I neurons (Methods, Supplementary Fig. 5).

      (2) Additional simulations and analyses of networks with modifications of connectivity parameters to further analyze effects of E/I assemblies on manifold geometry (Supplementary Fig. 6).

      (3) Analysis of synaptic current components (Figure 3 D-F; to analyze mechanism of modest amplification in Tuned networks). 

      (4) More detailed explanation of pattern completion analysis (Results).

      (5) Analysis of classification performance of Scaled networks (Supplementary Fig.8).

      (6) Additional analysis (Figure 5D-F) and discussion (particularly section “Computational functions of networks with E/I assemblies”) of functional benefits of continuous representations in networks with E-I assemblies. 

      Public Reviews: 

      Reviewer #1 (Public Review): 

      Summary: 

      Meissner-Bernard et al present a biologically constrained model of telencephalic area of adult zebrafish, a homologous area to the piriform cortex, and argue for the role of precisely balanced memory networks in olfactory processing. 

      This is interesting as it can add to recent evidence on the presence of functional subnetworks in multiple sensory cortices. It is also important in deviating from traditional accounts of memory systems as attractor networks. Evidence for attractor networks has been found in some systems, like in the head direction circuits in the flies. However, the presence of attractor dynamics in other modalities, like sensory systems, and their role in computation has been more contentious. This work contributes to this active line of research in experimental and computational neuroscience by suggesting that, rather than being represented in attractor networks and persistent activity, olfactory memories might be coded by balanced excitation-inhibitory subnetworks. 

      Strengths: 

      The main strength of the work is in: (1) direct link to biological parameters and measurements, (2) good controls and quantification of the results, and (3) comparison across multiple models. 

      (1) The authors have done a good job of gathering the current experimental information to inform a biological-constrained spiking model of the telencephalic area of adult zebrafish. The results are compared to previous experimental measurements to choose the right regimes of operation. 

      (2) Multiple quantification metrics and controls are used to support the main conclusions and to ensure that the key parameters are controlled for - e.g. when comparing across multiple models.  (3) Four specific models (random, scaled I / attractor, and two variant of specific E-I networks - tuned I and tuned E+I) are compared with different metrics, helping to pinpoint which features emerge in which model. 

      Weaknesses: 

      Major problems with the work are: (1) mechanistic explanation of the results in specific E-I networks, (2) parameter exploration, and (3) the functional significance of the specific E-I model. 

      (1) The main problem with the paper is a lack of mechanistic analysis of the models. The models are treated like biological entities and only tested with different assays and metrics to describe their different features (e.g. different geometry of representation in Fig. 4). Given that all the key parameters of the models are known and can be changed (unlike biological networks), it is expected to provide a more analytical account of why specific networks show the reported results. For instance, what is the key mechanism for medium amplification in specific E/I network models (Fig. 3)? How does the specific geometry of representation/manifolds (in Fig. 4) emerge in terms of excitatory-inhibitory interactions, and what are the main mechanisms/parameters? Mechanistic account and analysis of these results are missing in the current version of the paper. 

      We agree that further mechanistic insights would be of interest and addressed this issue at different levels:

      (1) Biophysical parameters: to determine whether network behavior depends on specific choices of biophysical parameters in E and I neurons we equalized biophysical parameters across neuron types. The main observations are unchanged, suggesting that the observed effects depend primarily on network connectivity (see also response to comment [2]).

      (2) Mechanism of modest amplification in E/I assemblies: analyzing the different components of the synaptic currents demonstrate that the modest amplification of activity in Tuned networks results from an “imperfect” balance of recurrent excitation and inhibition within assemblies (see new Figures 3D-F and text p.7). Hence, E/I co-tuning substantially reduces the net amplification in Tuned networks as compared to Scaled networks, thus preventing discrete attractor dynamics and stabilizing network activity, but a modest amplification still occurs, consistent with biological observations.

      (3) Representational geometry: to obtain insights into the network mechanisms underlying effects of E/I assemblies on the geometry of population activity we tested the hypothesis that geometrical changes depend, at least in part, on the modest amplification of activity within E/I assemblies (see Supplementary Figure 6). We changed model parameters to either prevent the modest amplification in Tuned networks (increasing I-to-E connectivity within assemblies) or introduce a modest amplification in subsets of neurons by other mechanisms (concentration-dependent increase in the excitability of pseudo-assembly neurons; Scaled I networks with reduced connectivity within assemblies). Manipulations that introduced a modest, input-dependent amplification in neuronal subsets had geometrical effects similar to those observed in Tuned networks, whereas manipulations that prevented a modest amplification abolished these effects (Supplementary Figure 6). Note however that these manipulations generated different firing rate distributions. These results provide a starting point for more detailed analyses of the relationship between network connectivity and representational geometry (see p.12).

      In summary, our additional analyses indicate that effects of E/I assemblies on representational geometry depend primarily on network connectivity, rather than specific biophysical parameters, and that the resulting modest amplification of activity within assemblies makes an important contribution. Further analyses may reveal more specific relationships between E/I assemblies and representational geometry, but such analyses are beyond the scope of this study.

      (2) The second major issue with the study is a lack of systematic exploration and analysis of the parameter space. Some parameters are biologically constrained, but not all the parameters. For instance, it is not clear what the justification for the choice of synaptic time scales are (with E synaptic time constants being larger than inhibition: tau_syn_i = 10 ms, tau_syn_E = 30 ms). How would the results change if they are varying these - and other unconstrained - parameters? It is important to show how the main results, especially the manifold localisation, would change by doing a systematic exploration of the key parameters and performing some sensitivity analysis. This would also help to see how robust the results are, which parameters are more important and which parameters are less relevant, and to shed light on the key mechanisms.  

      We thank the reviewer for raising this point. We chose a relatively slow time constant for excitatory synapses because experimental data indicate that excitatory synaptic currents in Dp and piriform cortex contain a prominent NMDA component. Nevertheless, to assess whether network behavior depends on specific choices of biophysical parameters in E and I neurons, we have performed additional simulations with equal synaptic time constants and equal biophysical parameters for all neurons. Each neuron also received the same number of inputs from each population (see revised Methods). Results were similar to those observed previously (Supplementary Fig.5 and p.9 of main text). We therefore conclude that the main effects observed in Tuned networks cannot be explained by differences in biophysical parameters between E and I neurons but is primarily a consequence of network connectivity.

      (3) It is not clear what the main functional advantage of the specific E-I network model is compared to random networks. In terms of activity, they show that specific E-I networks amplify the input more than random networks (Fig. 3). But when it comes to classification, the effect seems to be very small (Fig. 5c). Description of different geometry of representation and manifold localization in specific networks compared to random networks is good, but it is more of an illustration of different activity patterns than proving a functional benefit for the network. The reader is still left with the question of what major functional benefits (in terms of computational/biological processing) should be expected from these networks, if they are to be a good model for olfactory processing and learning. 

      One possibility for instance might be that the tasks used here are too easy to reveal the main benefits of the specific models - and more complex tasks would be needed to assess the functional enhancement (e.g. more noisy conditions or more combination of odours). It would be good to show this more clearly - or at least discuss it in relation to computation and function. 

      In the previous manuscript, the analysis of potential computational benefits other than pattern classification was limited and the discussion of this issue was condensed into a single itemized paragraph to avoid excessive speculation. Although a thorough analysis of potential computational benefits exceeds the scope of a single paper, we agree with the reviewer that this issue is of interest and therefore added additional analyses and discussion.

      In the initial manuscript we analyzed pattern classification primarily to investigate whether Tuned networks can support this function at all, given that they do not exhibit discrete attractor states. We found this to be the case, which we consider a first important result.

      Furthermore, we found that precise balance of E/I assemblies can protect networks against catastrophic firing rate instabilities when assemblies are added sequentially, as in continual learning. Results from these simulations are now described and discussed in more detail (see Results p.11 and Discussion p.13).

      In the revised manuscript, we now also examine additional potential benefits of Tuned networks and discuss them in more detail (see new Figure 5D-F and text p.11). One hypothesis is that continuous representations provide a distance metric between a given input and relevant (learned) stimuli. To address this hypothesis, we (1) performed regression analysis and (2) trained support vector machines (SVMs) to predict the concentration of a given odor in a mixture based on population activity. In both cases, Tuned E+I networks outperformed Scaled and _rand n_etworks in predicting the concentration of learned odors across a wide range mixtures (Figure 5D-F).  E/I assemblies therefore support the quantification of learned odors within mixtures or, more generally, assessments of how strongly a (potentially complex) input is related to relevant odors stored in memory. Such a metric assessment of stimulus quality is not well supported by discrete attractor networks because inputs are mapped onto discrete network states.

      The observation that Tuned networks do not map inputs onto discrete outputs indicates that such networks do not classify inputs as distinct items. Nonetheless, the observed geometrical modifications of continuous representations support the classification of learned inputs or the assessment of metric relationships by hypothetical readout neurons. Geometrical modifications of odor representations may therefore serve as one of multiple steps in multi-layer computations for pattern classification (and/or other computations). In this scenario, the transformation of odor representations in Dp may be seen as related to transformations of representations between different layers in artificial networks, which collectively perform a given task (notwithstanding obvious structural and mechanistic differences between artificial and biological networks). In other words, geometrical transformations of representations in Tuned networks may overrepresent learned (relevant) information at the expense of other information and thereby support further learning processes in other brain areas. An obvious corollary of this scenario is that Dp does not perform odor classification per se based on inputs from the olfactory bulb but reformats representations of odor space based on experience to support computational tasks as part of a larger system. This scenario is now explicitly discussed (p.14).

      Reviewer #2 (Public Review): 

      Summary: 

      The authors conducted a comparative analysis of four networks, varying in the presence of excitatory assemblies and the architecture of inhibitory cell assembly connectivity. They found that co-tuned E-I assemblies provide network stability and a continuous representation of input patterns (on locally constrained manifolds), contrasting with networks with global inhibition that result in attractor networks. 

      Strengths: 

      The findings presented in this paper are very interesting and cutting-edge. The manuscript effectively conveys the message and presents a creative way to represent high-dimensional inputs and network responses. Particularly, the result regarding the projection of input patterns onto local manifolds and continuous representation of input/memory is very Intriguing and novel. Both computational and experimental neuroscientists would find value in reading the paper. 

      Weaknesses: 

      that have continuous representations. This could also be shown in Figure 5B, along with the performance of the random and tuned E-I networks. The latter networks have the advantage of providing network stability compared to the Scaled I network, but at the cost of reduced network salience and, therefore, reduced input decodability. The authors may consider designing a decoder to quantify and compare the classification performance of all four networks. 

      We have now quantified classification by networks with discrete attractor dynamics (Scaled) along with other networks. However, because the neuronal covariance matrix for such networks is low rank and not invertible, pattern classification cannot be analyzed by QDA as in Figure 5B. We therefore classified patterns from the odor subspace by template matching, assigning test patterns to one of the four classes based on correlations (see Supplementary Figure 8). As expected, Scaled networks performed well, but they did not outperform Tuned networks. Moreover, the performance of Scaled networks, but not Tuned networks, depended on the order in which odors were presented to the network. This hysteresis effect is a direct consequence of persistent attractor states and decreased the general classification performance of Scaled networks (see Supplementary Figure 8 for details). These results confirm the prediction that networks with discrete attractor states can efficiently classify inputs, but also reveal disadvantages arising from attractor dynamics. Moreover, the results indicate that the classification performance of Tuned networks is also high under the given task conditions, which simulate a biologically realistic scenario.

      We would also like to emphasize that classification may not be the only task, and perhaps not even a main task, of Dp/piriform cortex or other memory networks with E/I assemblies. Conceivably, other computations could include metric assessments of inputs relative to learned inputs or additional learning-related computations. Please see our response to comment (3) of reviewer 1 for a further discussion of this issue. 

      Networks featuring E/I assemblies could potentially represent multistable attractors by exploring the parameter space for their reciprocal connectivity and connectivity with the rest of the network. However, for co-tuned E-I networks, the scope for achieving multistability is relatively constrained compared to networks employing global or lateral inhibition between assemblies. It would be good if the authors mentioned this in the discussion. Also, the fact that reciprocal inhibition increases network stability has been shown before and should be cited in the statements addressing network stability (e.g., some of the citations in the manuscript, including Rost et al. 2018, Lagzi & Fairhall 2022, and Vogels et al. 2011 have shown this).  

      We thank the reviewer for this comment. We now explicitly discuss multistability (see p. 12) and refer to additional references in the statements addressing network stability.

      Providing raster plots of the pDp network for familiar and novel inputs would help with understanding the claims regarding continuous versus discrete representation of inputs, allowing readers to visualize the activity patterns of the four different networks. (similar to Figure 1B). 

      We thank the reviewer for this suggestion. We have added raster plots of responses to both familiar and novel inputs in the revised manuscript (Figure 2D and Supplementary Figure 4A).

      Reviewer #3 (Public Review): 

      Summary: 

      This work investigates the computational consequences of assemblies containing both excitatory and inhibitory neurons (E/I assembly) in a model with parameters constrained by experimental data from the telencephalic area Dp of zebrafish. The authors show how this precise E/I balance shapes the geometry of neuronal dynamics in comparison to unstructured networks and networks with more global inhibitory balance. Specifically, E/I assemblies lead to the activity being locally restricted onto manifolds - a dynamical structure in between high-dimensional representations in unstructured networks and discrete attractors in networks with global inhibitory balance. Furthermore, E/I assemblies lead to smoother representations of mixtures of stimuli while those stimuli can still be reliably classified, and allow for more robust learning of additional stimuli. 

      Strengths: 

      Since experimental studies do suggest that E/I balance is very precise and E/I assemblies exist, it is important to study the consequences of those connectivity structures on network dynamics. The authors convincingly show that E/I assemblies lead to different geometries of stimulus representation compared to unstructured networks and networks with global inhibition. This finding might open the door for future studies for exploring the functional advantage of these locally defined manifolds, and how other network properties allow to shape those manifolds. 

      The authors also make sure that their spiking model is well-constrained by experimental data from the zebrafish pDp. Both spontaneous and odor stimulus triggered spiking activity is within the range of experimental measurements. But the model is also general enough to be potentially applied to findings in other animal models and brain regions. 

      Weaknesses: 

      I find the point about pattern completion a bit confusing. In Fig. 3 the authors argue that only the Scaled I network can lead to pattern completion for morphed inputs since the output correlations are higher than the input correlations. For me, this sounds less like the network can perform pattern completion but it can nonlinearly increase the output correlations. Furthermore, in Suppl. Fig. 3 the authors show that activating half the assembly does lead to pattern completion in the sense that also non-activated assembly cells become highly active and that this pattern completion can be seen for Scaled I, Tuned E+I, and Tuned I networks. These two results seem a bit contradictory to me and require further clarification, and the authors might want to clarify how exactly they define pattern completion. 

      We believe that this comment concerns a semantic misunderstanding and apologize for any lack of clarity. We added a definition of pattern completion in the text: “…the retrieval of the whole memory from noisy or corrupted versions of the learned input.”. Pattern completion may be assessed using different procedures. In computational studies, it is often analyzed by delivering input to a subset of the assembly neurons which store a given memory (partial activation). Under these conditions, we find recruitment of the entire assembly in all structured networks, as demonstrated in Supplementary Figure 3. However, these conditions are unlikely to occur during odor presentation because the majority of neurons do not receive any input.

      Another more biologically motivated approach to assess pattern completion is to gradually modify a realistic odor input into a learned input, thereby gradually increasing the overlap between the two inputs. This approach had been used previously in experimental studies (references added to the text p.6). In the presence of assemblies, recurrent connectivity is expected to recruit assembly neurons (and thus retrieve the stored pattern) more efficiently as the learned pattern is approached. This should result in a nonlinear increase in the similarity between the evoked and the learned activity pattern. This signature was prominent in Scaled networks but not in Tuned or rand networks. Obviously, the underlying procedure is different from the partial activation of the assembly described above because input patterns target many neurons (including neurons outside assemblies) and exhibit a biologically realistic distribution of activity. However, this approach has also been referred to as “pattern completion” in the neuroscience literature, which may be the source of semantic confusion here. To clarify the difference between these approaches we have now revised the text and explicitly described each procedure in more detail (see p.6). 

      The authors argue that Tuned E+I networks have several advantages over Scaled I networks. While I agree with the authors that in some cases adding this localized E/I balance is beneficial, I believe that a more rigorous comparison between Tuned E+I networks and Scaled I networks is needed: quantification of variance (Fig. 4G) and angle distributions (Fig. 4H) should also be shown for the Scaled I network. Similarly in Fig. 5, what is the Mahalanobis distance for Scaled I networks and how well can the Scaled I network be classified compared to the Tuned E+I network? I suspect that the Scaled I network will actually be better at classifying odors compared to the E+I network. The authors might want to speculate about the benefit of having networks with both sources of inhibition (local and global) and hence being able to switch between locally defined manifolds and discrete attractor states. 

      We agree that a more rigorous comparison of Tuned and Scaled networks would be of interest. We have added the variance analysis (Fig 4G) and angle distributions (Fig. 4H) for both Tuned I and Scaled networks. However, the Mahalanobis distances and Quadratic Discriminant Analysis cannot be applied to Scaled networks because their neuronal covariance matrix is low rank and not invertible_. To nevertheless compare these networks, we performed template matching by assigning test patterns to one of the four odor classes based on correlations to template patterns (Supplementary Figure 8; see also response to the first comment of reviewer 2). Interestingly, _Scaled networks performed well at classification but did not outperform Tuned networks, and exhibited disadvantages arising from attractor dynamics (Supplementary Figure 8; see also response to the first comment of reviewer 2). Furthermore, in further analyses we found that continuous representational manifolds support metric assessments of inputs relative to learned odors, which cannot be achieved by discrete representations. These results are now shown in Figure 5D-E and discussed explicitly in the text on p.11 (see also response to comment 3 of reviewer 1).

      We preferred not to add a sentence in the Discussion about benefits of networks having both sources of inhibition_,_ as we find this a bit too speculative.

      At a few points in the manuscript, the authors use statements without actually providing evidence in terms of a Figure. Often the authors themselves acknowledge this, by adding the term "not shown" to the end of the sentence. I believe it will be helpful to the reader to be provided with figures or panels in support of the statements.  

      Thank you for this comment. We have provided additional data figures to support the following statements:

      “d<sub>M</sub> was again increased upon learning, particularly between learned odors and reference classes representing other odors (Supplementary Figure 9)”

      “decreasing amplification in assemblies of Scaled networks changed transformations towards the intermediate behavior, albeit with broader firing rate distributions than in Tuned networks (Supplementary Figure 6 B)”  

      Recommendations for the authors:

      Reviewer #1 (Recommendations For The Authors): 

      Meissner-Bernard et al present a biologically constrained model of telencephalic area of adult zebrafish, a homologous area to the piriform cortex, and argue for the role of precisely balanced memory networks in olfactory processing. 

      This is interesting as it can add to recent evidence on the presence of functional subnetworks in multiple sensory cortices. It is also important in deviating from traditional accounts of memory systems as attractor networks. Evidence for attractor networks has been found in some systems, like in the head direction circuits in the flies. However, the presence of attractor dynamics in other modalities, like sensory systems, and their role in computation has been more contentious. This work contributes to this active line of research in experimental and computational neuroscience by suggesting that, rather than being represented in attractor networks and persistent activity, olfactory memories might be coded by balanced excitation-inhibitory subnetworks. 

      The paper is generally well-written, the figures are informative and of good quality, and multiple approaches and metrics have been used to test and support the main results of the paper. 

      The main strength of the work is in: (1) direct link to biological parameters and measurements, (2) good controls and quantification of the results, and (3) comparison across multiple models. 

      (1) The authors have done a good job of gathering the current experimental information to inform a biological-constrained spiking model of the telencephalic area of adult zebrafish. The results are compared to previous experimental measurements to choose the right regimes of operation. 

      (2) Multiple quantification metrics and controls are used to support the main conclusions and to ensure that the key parameters are controlled for - e.g. when comparing across multiple models.   (3) Four specific models (random, scaled I / attractor, and two variant of specific E-I networks - tuned I and tuned E+I) are compared with different metrics, helping to pinpoint which features emerge in which model. 

      Major problems with the work are: (1) mechanistic explanation of the results in specific E-I networks, (2) parameter exploration, and (3) the functional significance of the specific E-I model. 

      (1) The main problem with the paper is a lack of mechanistic analysis of the models. The models are treated like biological entities and only tested with different assays and metrics to describe their different features (e.g. different geometry of representation in Fig. 4). Given that all the key parameters of the models are known and can be changed (unlike biological networks), it is expected to provide a more analytical account of why specific networks show the reported results. For instance, what is the key mechanism for medium amplification in specific E/I network models (Fig. 3)? How does the specific geometry of representation/manifolds (in Fig. 4) emerge in terms of excitatory-inhibitory interactions, and what are the main mechanisms/parameters? Mechanistic account and analysis of these results are missing in the current version of the paper. 

      Precise balancing of excitation and inhibition in subnetworks would lead to the cancellation of specific dynamical modes responsible for the amplification of responses (hence, deviating from the attractor dynamics with an unstable specific mode). What is the key difference in the specific E/I networks here (tuned I or/and tuned E+I) which make them stand between random and attractor networks? Excitatory and inhibitory neurons have different parameters in the model (Table 1). Time constants of inhibitory and excitatory synapses are also different (P. 13). Are these parameters causing networks to be effectively more excitation dominated (hence deviating from a random spectrum which would be expected from a precisely balanced E/I network, with exactly the same parameters of E and I neurons)? It is necessary to analyse the network models, describe the key mechanism for their amplification, and pinpoint the key differences between E and I neurons which are crucial for this. 

      To address these comments we performed additional simulations and analyses at different levels. Please see our reply to comment (1) of the public review (reviewer 1) for a detailed description. We thank the reviewer for these constructive comments.

      (2) The second major issue with the study is a lack of systematic exploration and analysis of the parameter space. Some parameters are biologically constrained, but not all the parameters. For instance, it is not clear what the justification for the choice of synaptic time scales are (with E synaptic time constants being larger than inhibition: tau_syn_i = 10 ms, tau_syn_E = 30 ms). How would the results change if they are varying these - and other unconstrained - parameters? It is important to show how the main results, especially the manifold localisation, would change by doing a systematic exploration of the key parameters and performing some sensitivity analysis. This would also help to see how robust the results are, which parameters are more important and which parameters are less relevant, and to shed light on the key mechanisms.  

      We thank the reviewer for this comment. We have now carried out additional simulations with equal time constants for all neurons. Please see our reply to the public review for more details (comment 2 of reviewer 1).

      (3) It is not clear what the main functional advantage of the specific E-I network model is compared to random networks. In terms of activity, they show that specific E-I networks amplify the input more than random networks (Fig. 3). But when it comes to classification, the effect seems to be very small (Fig. 5c). Description of different geometry of representation and manifold localization in specific networks compared to random networks is good, but it is more of an illustration of different activity patterns than proving a functional benefit for the network. The reader is still left with the question of what major functional benefits (in terms of computational/biological processing) should be expected from these networks, if they are to be a good model for olfactory processing and learning. 

      One possibility for instance might be that the tasks used here are too easy to reveal the main benefits of the specific models - and more complex tasks would be needed to assess the functional enhancement (e.g. more noisy conditions or more combination of odours). It would be good to show this more clearly - or at least discuss it in relation to computation and function.

      Please see our reply to the public review (comment 3 of reviewer 1).

      Specific comments: 

      Abstract: "resulting in continuous representations that reflected both relatedness of inputs and *an individual's experience*" 

      It didn't become apparent from the text or the model where the role of "individual's experience" component (or "internal representations" - in the next line) was introduced or shown (apart from a couple of lines in the Discussion) 

      We consider the scenario that that assemblies are the outcome of an experience-dependent plasticity process. To clarify this, we have now made a small addition to the text: “Biological memory networks are thought to store information by experience-dependent changes in the synaptic connectivity between assemblies of neurons.”.

      P. 2: "The resulting state of "precise" synaptic balance stabilizes firing rates because inhomogeneities or fluctuations in excitation are tracked by correlated inhibition" 

      It is not clear what the "inhomogeneities" specifically refers to - they can be temporal, or they can refer to the quenched noise of connectivity, for instance. Please clarify what you mean. 

      The statement has been modified to be more precise: “…“precise” synaptic balance stabilizes firing rates because inhomogeneities in excitation across the population or temporal variations in excitation are tracked by correlated inhibition…”.

      P. 3 (and Methods): When odour stimulus is simulated in the OB, the activity of a fraction of mitral cells is increased (10% to 15 Hz) - but also a fraction of mitral cells is suppressed (5% to 2 Hz). What is the biological motivation or reference for this? It is not provided. Is it needed for the results? Also, it is not explained how the suppressed 5% are chosen (e.g. randomly, without any relation to the increased cells?). 

      We thank the reviewer for this comment. These changes in activity directly reflect experimental observations. We apologize that we forgot to include the references reporting these observations (Friedrich and Laurent, 2001 and 2004); this is now fixed.

      In our simulation, OB neurons do not interact with each other, and the suppressed 5% were indeed randomly selected. We changed the text in Methods accordingly to read: “An additional 75 randomly selected mitral cells were inhibited” 

      P. 4, L. 1-2: "... sparsely connected integrate-and-fire neurons with conductance-based synapses (connection probability {less than or equal to}5%)." 

      Specify the connection probability of specific subtypes (EE, EI, IE, II).  

      We now refer to the Methods section, where this information can be found. 

      “... conductance-based synapses (connection probability ≤5%, Methods)”  

      P. 4, L. 6-7: "Population activity was odor-specific and activity patterns evoked by uncorrelated OB inputs remained uncorrelated in Dp (Figure 1H)" 

      What would happen to correlated OB inputs (e.g. as a result of mixture of two overlapping odours) in this baseline state of the network (before memories being introduced to it)? It would be good to know this, as it sheds light on the initial operating regime of the network in terms of E/I balance and decorrelation of inputs.  

      This information was present in the original manuscript at (Figure 3) but we improved the writing to further clarify this issue: “ (…) we morphed a novel odor into a learned odor (Figure 3A), or a learned odor into another learned odor (Supplementary Figure 3B), and quantified the similarity between morphed and learned odors by the Pearson correlation of the OB activity patterns (input correlation). We then compared input correlations to the corresponding pattern correlations among E neurons in Dp (output correlation). In rand networks, output correlations increased linearly with input correlations but did not exceed them (Figure 3B and Supplementary Figure 3B)”

      P. 4, L. 12-13: "Shuffling spike times of inhibitory neurons resulted in runaway activity with a probability of ~80%, .."   Where is this shown? 

      (There are other occasions too in the paper where references to the supporting figures are missing). 

      We now provide the statistics: “Shuffling spike times of inhibitory neurons resulted in runaway activity with a probability of 0.79 ± 0.20”

      P. 4: "In each network, we created 15 assemblies representing uncorrelated odors. As a consequence, ~30% of E neurons were part of an assembly ..." 

      15 x 100 / 4000 = 37.5% - so it's closer to 40% than 30%. Unless there is some overlap? 

      Yes: despite odors being uncorrelated and connectivity being random, some neurons (6 % of E neurons) belong to more than one assembly.

      P. 4: "When a reached a critical value of ~6, networks became unstable and generated runaway activity (Figure 2B)." 

      Can this transition point be calculated or estimated from the network parameters, and linked to the underlying mechanisms causing it? 

      We thank the reviewer for this interesting question. The unstability arises when inhibitions fails to counterbalance efficiently the increased recurrent excitation within Dp. The transition point is difficult to estimate, as it can depend on several parameters, including the probability of E to E connections, their strength, assembly size, and others. We have therefore not attempted to estimate it analytically.

      P. 4: "Hence, non-specific scaling of inhibition resulted in a divergence of firing rates that exhausted the dynamic range of individual neurons in the population, implying that homeostatic   global inhibition is insufficient to maintain a stable firing rate distribution." 

      I don't think this is justified based on the results and figures presented here (Fig. 2E) - the interpretation is a bit strong and biased towards the conclusions the authors want to draw. 

      To more clearly illustrate the finding that in Scaled networks, assembly neurons are highly active (close to maximal realistic firing rates) whereas non-assembly neurons are nearly silent we have now added Supplementary Fig. 2B. Moreover, we have toned down the text: “Hence, non-specific scaling of inhibition resulted in a large and biologically unrealistic divergence of firing rates (Supplementary Figure 2B) that nearly exhausted the dynamic range of individual neurons in the population, indicating that homeostatic global inhibition is insufficient to maintain a stable firing rate distribution”

      P. 5, third paragraph: Description of Figure 2I, inset is needed, either in the text or caption. 

      The inset is now referred to in the text: ”we projected synaptic conductances of each neuron onto a line representing the E/I ratio expected in a balanced network (“balanced axis”) and onto an orthogonal line (“counter-balanced axis”; Figure 2I inset, Methods).”

      P. 5, last paragraph: another example of writing about results without showing/referring to the corresponding figures: 

      "In rand networks, firing rates increased after stimulus onset and rapidly returned to a low baseline after stimulus offset. Correlations between activity patterns evoked by the same odor at different time points and in different trials were positive but substantially lower than unity, indicating high variability ..." 

      And the continuation with similar lack of references on P. 6: 

      "Scaled networks responded to learned odors with persistent firing of assembly neurons and high pattern correlations across trials and time, implying attractor dynamics (Hopfield, 1982; Khona and Fiete, 2022), whereas Tuned networks exhibited transient responses and modest pattern correlations similar to rand networks." 

      Please go through the Results and fix the references to the corresponding figures on all instances. 

      We thank the reviewer for pointing out these overlooked figure references, which are now fixed.

      P. 8: "These observations further support the conclusion that E/I assemblies locally constrain neuronal dynamics onto manifolds." 

      As discussed in the general major points, mechanistic explanation in terms of how the interaction of E/I dynamics leads to this is missing. 

      As discussed in the reply to the public review (comment 3 of reviewer 1), we have now provided more mechanistic analyses of our observations.

      P. 9: "Hence, E/I assemblies enhanced the classification of inputs related to learned patterns."   The effect seems to be very small. Also, any explanation for why for low test-target correlation the effect is negative (random doing better than tuned E/I)? 

      The size of the effect (plearned – pnovel = 0.074; difference of means; Figure 5C) may appear small in terms of absolute probability, but it is substantial relative to the maximum possible increase (1 – p<sub>novel</sub> =  0.133; Figure 5C). The fact that for low test-target correlations the effect is negative is a direct consequence of the positive effect for high test-target correlations and the presence of 2 learned odors in the 4-way forced choice task. 

      P. 9: "In Scaled I networks, creating two additional memories resulted in a substantial increase   in firing rates, particularly in response to the learned and related odors"   Where is this shown? Please refer to the figure. 

      We thank the reviewer again for pointing this out. We forgot to include a reference to the relevant figure which has now been added in the revised manuscript (Figure 6C).

      P. 10: "The resulting Tuned networks reproduced additional experimental observations that were not used as constraints including irregular firing patterns, lower output than input correlations, and the absence of persistent activity" 

      It is difficult to present these as "additional experimental observations", as all of them are negative, and can exist in random networks too - hence cannot be used as biological evidence in favour of specific E/I networks when compared to random networks. 

      We agree with the reviewer that these additional experimental observations cannot be used as biological evidence favouring Tuned E+I networks over random networks. We here just wanted to point out that additional observations which we did not take into account to fit the model are not invalidating the existence of E-I assemblies in biological networks. As assemblies tend to result in persistent activity in other types of networks, we feel that this observation is worth pointing out.

      Methods: 

      P. 13: Describe the parameters of Eq. 2 after the equation. 

      Done.

      P. 13: "The time constants of inhibitory and excitatory synapses were 10 ms and 30 ms, respectively." 

      What is the (biological) justification for the choice of these parameters? 

      How would varying them affect the main results (e.g. local manifolds)? 

      We chose a relatively slow time constant for excitatory synapses because experimental data indicate that excitatory synaptic currents in Dp and piriform cortex contain a prominent NMDA component. We have now also simulated networks with equal time constants for excitatory and inhibitory synapses and equal biophysical parameters for excitatory and inhibitory neurons, which did not affect the main results (see also reply to the public review: comment 2 of reviewer 1).

      P. 14: "Care was also taken to ensure that the variation in the number of output connections was low across neurons"   How exactly?

      More detailed explanations have now been added in the Methods section: “connections of a presynaptic neuron y to postsynaptic neurons x were randomly deleted when their total number exceeded the average number of output connections by ≥5%, or added when they were lower by ≥5%.“

      Reviewer #2 (Recommendations For The Authors): 

      Congratulations on the great and interesting work! The results were nicely presented and the idea of continuous encoding on manifolds is very interesting. To improve the quality of the paper, in addition to the major points raised in the public review, here are some more detailed comments for the paper: 

      (1) Generally, citations have to improve. Spiking networks with excitatory assemblies and different architectures of inhibitory populations have been studied before, and the claim about improved network stability in co-tuned E-I networks has been made in the following papers that need to be correctly cited: 

      • Vogels TP, Sprekeler H, Zenke F, Clopath C, Gerstner W. 2011. Inhibitory Plasticity Balances Excitation and Inhibition in Sensory Pathways and Memory Networks. Science 334:1-7. doi:10.1126/science.1212991 (mentions that emerging precise balance on the synaptic weights can result in the overall network stability) 

      • Lagzi F, Bustos MC, Oswald AM, Doiron B. 2021. Assembly formation is stabilized by Parvalbumin neurons and accelerated by Somatostatin neurons. bioRxiv doi: https://doi.org/10.1101/2021.09.06.459211 (among other things, contrasts stability and competition which arises from multistable networks with global inhibition and reciprocal inhibition)   • Rost T, Deger M, Nawrot MP. 2018. Winnerless competition in clustered balanced networks: inhibitory assemblies do the trick. Biol Cybern 112:81-98. doi:10.1007/s00422-017-0737-7 (compares different architectures of inhibition and their effects on network dynamics) 

      • Lagzi F, Fairhall A. 2022. Tuned inhibitory firing rate and connection weights as emergent network properties. bioRxiv 2022.04.12.488114. doi:10.1101/2022.04.12.488114 (here, see the eigenvalue and UMAP analysis for a network with global inhibition and E/I assemblies) 

      Additionally, there are lots of pioneering work about tracking of excitatory synaptic inputs by inhibitory populations, that are missing in references. Also, experimental work that show existence of cell assemblies in the brain are largely missing. On the other hand, some references that do not fit the focus of the statements have been incorrectly cited. 

      The authors may consider referencing the following more pertinent studies on spiking networks to support the statement regarding attractor dynamics in the first paragraph in the Introduction (the current citations of Hopfield and Kohonen are for rate-based networks): 

      • Wong, K.-F., & Wang, X.-J. (2006). A recurrent network mechanism of time integration in perceptual decisions. Journal of Neuroscience, 26(4), 1314-1328. https://doi.org/10.1523/JNEUROSCI.3733-05.2006 

      • Wang, X.-J. (2008). Decision making in recurrent neuronal circuits. Neuron, 60(2), 215-234. https://doi.org/10.1016/j.neuron.2008.09.034  

      • F. Lagzi, & S. Rotter. (2015). Dynamics of competition between subnetworks of spiking neuronal networks in the balanced state. PloS One. 

      • Goldman-Rakic, P. S. (1995). Cellular basis of working memory. Neuron, 14(3), 477-485. 

      • Rost T, Deger M, Nawrot MP. 2018. Winnerless competition in clustered balanced networks: inhibitory assemblies do the trick. Biol Cybern 112:81-98. doi:10.1007/s00422-017-0737-7. 

      • Amit DJ, Tsodyks M (1991) Quantitative study of attractor neural network retrieving at low spike rates: I. substrate-spikes, rates and neuronal gain. Network 2:259-273. 

      • Mazzucato, L., Fontanini, A., & La Camera, G. (2015). Dynamics of Multistable States during Ongoing and Evoked Cortical Activity. Journal of Neuroscience, 35(21), 8214-8231. 

      We thank the reviewer for the references suggestions. We have carefully reviewed the reference list and made the following changes, which we hope address the reviewer’s concerns:

      (1) We adjusted References about network stability in co-tuned E-I networks.

      (2) We added the Lagzi & Rotter (2015), Amit et al. (1991), Mazzucato et al. (2015) and GoldmanRakic (1995) papers in the Introduction as studies on attractor dynamics in spiking neural networks. We preferred to omit the two X.J Wang papers, as they describe attractors in decision making rather than memory processes.

      (3) We added the Ko et al. 2011 paper as experimental evidence for assemblies in the brain. In our view, there are few experimental studies showing the existence of cell assemblies in the brain, which we distinguish from cell ensembles, group of coactive neurons. 

      (4) We also included Hennequin 2018, Brunel 2000, Lagzi et al. 2021 and Eckmann et al. 2024, which we had not cited in the initial manuscript.

      (5) We removed the Wiechert et al. 2010 reference as it does not support the statement about geometry-preserving transformation by random networks.

      (2) The gist of the paper is about how the architecture of inhibition (reciprocal vs. global in this case) can determine network stability and salient responses (related to multistable attractors and variations) for classification purposes. It would improve the narrative of the paper if this point is raised in the Introduction and Discussion section. Also see a relevant paper that addresses this point here: 

      Lagzi F, Bustos MC, Oswald AM, Doiron B. 2021. Assembly formation is stabilized by Parvalbumin neurons and accelerated by Somatostatin neurons. bioRxiv doi: https://doi.org/10.1101/2021.09.06.459211 

      Classification has long been proposed to be a function of piriform cortex and autoassociative memory networks in general, and we consider it important. However, the computational function of Dp or piriform cortex is still poorly understood, and we do not focus only on odor classification as a possibility. In fact, continuous representational manifolds also support other functions such as the quantification of distance relationships of an input to previously memorized stimuli, or multi-layer network computations (including classification). In the revised manuscript, we have performed additional analyses to explore these notions in more detail, as explained above (response to public reviews, comment 3 of reviewer 1). Furthermore, we have now expanded the discussion of potential computational functions of Tuned networks and explicitly discuss classification but also other potential functions. 

      (3) A plot for the values of the inhibitory conductances in Figure 1 would complete the analysis for that section. 

      In Figure 1, we decided to only show the conductances that we use to fit our model, namely the afferent and total synaptic conductances. As the values of the inhibitory conductances can be derived from panel E, we refrained from plotting them separately for the sake of simplicity. 

      (4) How did the authors calculate correlations between activity patterns as a function of time in Figure 2E, bottom row? Does the color represent correlation coefficient (which should not be time dependent) or is it a correlation function? This should be explained in the Methods section. 

      The color represents the Pearson correlation coefficient between activity patterns within a narrow time window (100 ms). We updated the Figure legend to clarify this: “Mean correlation between activity patterns evoked by a learned odor at different time points during odor presentation. Correlation coefficients were calculated between pairs of activity vectors composed of the mean firing rates of E neurons in 100 ms time bins. Activity vectors were taken from the same or different trials, except for the diagonal, where only patterns from different trials were considered.”

      (5) Figure 3 needs more clarification (both in the main text and the figure caption). It is not clear what the axes are exactly, and why the network responses for familiar and novel inputs are different. The gray shaded area in panel B needs more explanation as well.  

      We thank the reviewer for the comment. We have improved Figure 3A, the figure caption, as well as the text (see p.6). We hope that the figure is now clearer.

      (6) The "scaled I" network, known for representing input patterns in discrete attractors, should exhibit clear separation between network responses in the 2D PC space in the PCA plots. However, Figure 4D and Figure 6D do not reflect this, as all network responses are overlapped. Can the authors explain the overlap in Figure 4D? 

      In Figure 4D, activity of Scaled networks is distributed between three subregions in state space that are separated by the first 2 PCs. Two of them indeed correspond to attractor states representing the two learned odors while the third represents inputs that are not associated with these attractor states. To clarify this, please see also the density plot in Figure 4E. The few datapoints between these three subregions are likely outliers generated by the sequential change in inputs, as described in Supplementary Figure 8C.

      (7) The reason for writing about the ISN networks is not clear. Co-tuned E-I assemblies do not necessarily have to operate in this regime. Also, the results of the paper do not rely on any of the properties of ISNs, but they are more general. Authors should either show the paradoxical effect associated with ISN (i.e., if increasing input to I neurons decreases their responses) or show ISN properties using stability analysis (See computational research conducted at the Allen Institute, namely Millman et al. 2020, eLife ). Currently, the paper reads as if being in the ISN regime is a necessary requirement, which is not true. Also, the arguments do not connect with the rest of the paper and never show up again. Since we know it is not a requirement, there is no need to have those few sentences in the Results section. Also, the choice of alpha=5.0 is extreme, and therefore, it would help to judge the biological realism if the raster plots for Figs 2-6 are shown.

      We have toned down the part on ISN and reduced it to one sentence for readers who might be interested in knowing whether activity is inhibition-stabilized or not. We have also added the reference to the Tsodyks et al. 1997 paper from which we derive our stability analysis. The text now reads “Hence, pDp<sub>sim</sub> entered a balanced state during odor stimulation (Figure 1D, E) with recurrent input dominating over afferent input, as observed in pDp (Rupprecht and Friedrich, 2018). Shuffling spike times of inhibitory neurons resulted in runaway activity with a probability of 0.79 ± 0.20, demonstrating that activity was inhibition-stabilized (Sadeh and Clopath, 2020b, Tsodyks et al., 1997).”  

      We have now also added the raster plots as suggested by the reviewer (see Figure 2D, Supplementary Figure 1 G, Supplementary Figure 4). We thank the reviewer for this comment.

      (8) In the abstract, authors mention "fast pattern classification" and "continual learning," but in the paper, those issues have not been addressed. The study does not include any synaptic plasticity. 

      Concerning “continual learning” we agree that we do not simulate the learning process itself. However, Figure 6 show results of a simulation where two additional patterns were stored in a network that already contained assemblies representing other odors. We consider this a crude way of exploring the end result of a “continual learning” process. “Fast pattern classification” is mentioned because activity in balanced networks can follow fluctuating inputs with high temporal resolution, while networks with stable attractor states tend to be slow. This is likely to account for the occurrence of hysteresis effects in Scaled but not Tuned networks as shown in Supplementary

      Fig. 8.

      (9) In the Introduction, the first sentence in the second paragraph reads: "... when neurons receive strong excitatory and inhibitory synaptic input ...". The word strong should be changed to "weak".

      Also, see the pioneering work of Brunel 2000. 

      In classical balanced networks, strong excitatory inputs are counterbalanced by strong inhibitory inputs, leading to a fluctuation-driven regime. We have added Brunel 2000.

      (10) In the second paragraph of the introduction, the authors refer to studies about structural co-tuning (e.g., where "precise" synaptic balance is mentioned, and Vogels et al. 2011 should be cited there) and functional co-tuning (which is, in fact, different than tracking of excitation by inhibition, but the authors refer to that as co-tuning). It makes it easier to understand which studies talk about structural co-tuning and which ones are about functional co-tuning. The paper by Znamenski 2018, which showed both structural and functional tuning in experiments, is missing here. 

      We added the citation to the now published paper by Znamenskyi et al. (2024).  

      (11) The third paragraph in the Introduction misses some references that address network dynamics that are shaped by the inhibitory architecture in E/I assemblies in spiking networks, like Rost et al 2018 and Lagzi et al 2021. 

      These references have been added.

      (12) The last sentence of the fourth paragraph in the Introduction implies that functional co-tuning is due to structural co-tuning, which is not necessarily true. While structural co-tuning results in functional co-tuning, functional co-tuning does not require structural co-tuning because it could arise from shared correlated input or heterogeneity in synaptic connections from E to I cells.  

      We generally agree with the reviewer, but we are uncertain which sentence the reviewer refers to.

      We assume the reviewer refers to the last sentence of the second (rather than the fourth paragraph), which explicitly mentions the “…structural basis of E/I co-tuning…”. If so, we consider this sentence still correct because the “structural basis” refers not specifically to E/I assemblies, but also includes any other connectivity that may produce co-tuning, including the connectivity underlying the alternative possibilities mentioned by the reviewer (shared correlated input or heterogeneity of synaptic connections).

      (13) In order to ensure that the comparison between network dynamics is legit, authors should mention up front that for all networks, the average firing rates for the excitatory cells were kept at 1 Hz, and the background input was identical for all E and I cells across different networks.

      We slightly revised the text to make this more clear “We (…) uniformly scaled I-to-E connection weights by a factor of χ until E population firing rates in response to learned odors matched the corresponding firing rates in rand networks, i.e., 1 Hz”

      (14) In the last paragraph on page 5, my understanding was that an individual odor could target different cells within an assembly in different trials to generate trial to trail variability. If this is correct, this needs to be mentioned clearly. 

      This is not correct, an odor consists of 150 activated mitral cells with defined firing rates. As now mentioned in the Methods, “Spikes were then generated from a Poisson distribution, and this process was repeated to create trial-to-trial variability.”

      (15) The last paragraph on page 6 mentions that the four OB activity patterns were uncorrelated but if they were designed as in Figure 4A, dues to the existing overlap between the patterns, they cannot be uncorrelated. 

      This appears to be a misunderstanding. We mention in the text (and show in Figure 4B) that the four odors which “… were assigned to the corners of a square…” are uncorrelated.  The intermediate odors are of course not uncorrelated. We slightly modified the corresponding paragraph (now on page 7) to clarify this: “The subspace consisted of a set of OB activity patterns representing four uncorrelated pure odors and mixtures of these pure odors. Pure odors were assigned to the corners of a square and mixtures were generated by selecting active mitral cells from each of the pure odors with probabilities depending on the relative distances from the corners (Figure 4A, Methods).”

      (16) The notion of "learned" and "novel" odors may be misleading as there was no plasticity in the network to acquire an input representation. It would be beneficial for the authors to clarify that by "learned," they imply the presence of the corresponding E assembly for the odor in the network, with the input solely impacting that assembly. Conversely, for "novel" inputs, the input does not target a predefined assembly. In Figure 2 and Figure 4, it would be especially helpful to have the spiking raster plots of some sample E and I cells.  

      As suggested by the reviewer, we have modified the existing spiking raster plots in Figure 2, such that they include examples of responses to both learned and novel odors. We added spiking raster plots showing responses of I neurons to the same odors in Supplementary Figure 1F, as well as spiking raster plots of E neurons in Supplementary Figure 4A. To clarify the usage of “learned” and “novel”, we have added a sentence in the Results section: “We thus refer to an odor as “learned” when a network contains a corresponding assembly, and as “novel” when no such assembly is present.”.

      (17) In the last paragraph of page 8, can the authors explain where the asymmetry comes from? 

      As mentioned in the text, the asymmetry comes from the difference in the covariance structure of different classes. To clarify, we have rephrased the sentence defining the Mahalanobis distance: 

      “This measure quantifies the distance between the pattern and the class center, taking into account covariation of neuronal activity within the class. In bidirectional comparisons between patterns from different classes, the mean dM may be asymmetric if neural covariance differs between classes.”

      (18) The first paragraph of page 9: random networks are not expected to perform pattern classification, but just pattern representation. It would have been better if the authors compared Scaled I network with E/I co-tuned network. Regardless of the expected poorer performance of the E/I co-tuned networks, the result would have been interesting. 

      Please see our reply to the public review (reviewer 2).

      (19) Second paragraph on page 9, the authors should provide statistical significance test analysis for the statement "... was significantly higher ...". 

      We have performed a Wilcoxon signed-rank test, and reported the p-value in the revised manuscript (p < 0.01). 

      (20) The last sentence in the first paragraph on page 11 is not clear. What do the authors mean by "linearize input-output functions", and how does it support their claim? 

      We have now amended this sentence to clarify what we mean: “…linearize the relationship between the mean input and output firing rates of neuronal populations…”.

      (21) In the first sentence of the last paragraph on page 11, the authors mentioned “high variability”, but it is not clear compared with which of the other 3 networks they observed high variability.

      Structurally co-tuned E/I networks are expected to diminish network-level variability. 

      “High variability” refers to the variability of spike trains, which is now mentioned explicity in the text. We hope this more precise statement clarifies this point.

      (22) Methods section, page 14: "firing rates decreased with a time constant of 1, 2 or 4 s". How did they decrease? Was it an implementation algorithm? The time scale of input presentation is 2 s and it overlaps with the decay time constant (particularly with the one with 4 s decrease).  

      Firing rates decreased exponentially. We have added this information in the Methods section.

      Reviewer #3 (Recommendations For The Authors): 

      In the following, I suggest minor corrections to each section which I believe can improve the manuscript. 

      - There was no github link to the code in the manuscript. The code should be made available with a link to github in the final manuscript. 

      The code can be found here: https://github.com/clairemb90/pDp-model. The link has been added in the Methods section.

      Figure 1: 

      - Fig. 1A: call it pDp not Dp. Please check if this name is consistent in every figure and the text. 

      Thank you for catching this. Now corrected in Figure 1, Figure 2 and in the text.

      - The authors write: "Hence, pDpsim entered an inhibition-stabilized balanced state (Sadeh and Clopath, 2020b) during odor stimulation (Figure 1D, E)." and then later "Shuffling spike times of inhibitory neurons resulted in runaway activity with a probability of ~80%, demonstrating that activity was indeed inhibition-stabilized. These results were robust against parameter variations (Methods)." I would suggest moving the second sentence before the first sentence, because the fact that the network is in the ISN regime follows from the shuffled spike timing result. 

      Also, I'd suggest showing this as a supplementary figure. 

      We thank the reviewer for this comment. We have removed “inhibition-stabilized” in the first sentence as there is no strong evidence of this in Rupprecht and Friedrich, 2018. And removed “indeed” in the second sentence. We also provided more detailed statistics. The text now reads “Hence, pDpsim entered a balanced state during odor stimulation (Figure 1D, E) with recurrent input dominating over afferent input, as observed in pDp (Rupprecht and Friedrich, 2018). Shuffling spike times of inhibitory neurons resulted in runaway activity with a probability of 0.79 ± 0.20, demonstrating that activity was inhibition-stabilized (Sadeh and Clopath, 2020b).”

      Figure 2: 

      - "... Scaled I networks (Figure 2H." Missing ) 

      Corrected.

      - The authors write "Unlike in Scaled I networks, mean firing rates evoked by novel odors were indistinguishable from those evoked by learned odors and from mean firing rates in rand networks (Figure 2F)." 

      Why is this something you want to see? Isn't it that novel stimuli usually lead to high responses? Eg in the paper Schulz et al., 2021 (eLife) which is also cited by the authors it is shown that novel responses have high onset firing rates. I suggest clarifying this (same in the context of Fig. 3C). 

      In Dp and piriform cortex, firing rates evoked by learned odors are not substantially different from firing rates evoked by novel odors. While small differences between responses to learned versus novel odors cannot be excluded, substantial learning-related differences in firing rates, as observed in other brain areas, have not been described in Dp or piriform cortex. We added references in the last paragraph of p.5. Note that the paper by Schulz et al. (2021) models a different type of circuit.  

      - Fig. 2B: Indicate in figure caption that this is the case "Scaled I" 

      This is not exactly the case “Scaled I”, as the parameter 𝝌𝝌 (increased I to E strength) is set to 1.

      - Suppl Fig. 2I: Is E&F ever used in the manuscript? I couldn't find a reference. I suggest removing it if not needed. 

      Suppl. Fig 2I E&F is now Suppl Fig.1G&H. We now refer to it in the text: “Activity of networks with E assemblies could not be stabilized around 1 Hz by increasing connectivity from subsets of I neurons receiving dense feed-forward input from activated mitral cells (Supplementary Figure 1GH; Sadeh and Clopath, 2020).”

      Figure 3: 

      - As mentioned in my comment in the public review section, I find the arguments about pattern completion a little bit confusing. For me it's not clear why an increase of output correlations over input correlations is considered "pattern completion" (this is not to say that I don't find the nonlinear increase of output correlations interesting). For me, to test pattern completion with second-order statistics one would need to do a similar separation as in Suppl Fig. 3, ie measuring the pairwise correlation at cells in the assembly L that get direct input from L OB with cells in the assembly L that do not get direct input from OB. If the pairwise correlations of assembly cells which do not get direct input from OB increase in correlations, I would consider this as pattern completion (similar to the argument that increase in firing rate in cells which are not directly driven by OB are considered a sign of pattern completion). 

      Also, for me it now seems like that there are contradictory results, in Fig. 3 only Scaled I can lead to pattern completion while in the context of Suppl. Fig. 3 the authors write "We found that assemblies were recruited by partial inputs in all structured pDpsim networks (Scaled and Tuned) without a significant increase in the overall population activity (Supplementary Figure 3A)."   I suggest clarifying what the authors exactly mean by pattern completion, why the increase of output correlations above input correlations can be considered as pattern completion, and why the results differs when looking at firing rates versus correlations. 

      Please see our reply to the public review (reviewer 3).

      - I actually would suggest adding Suppl. Fig. 3 to the main figure. It shows a more intuitive form of pattern completion and in the text there is a lot of back and forth between Fig. 3 and Suppl. Fig. 3 

      We feel that the additional explanations and panels in Fig.3 should clarify this issue and therefore prefer to keep Supplementary Figure 3 as part of the Supplementary Figures for simplicity.  

      - In the whole section "We next explored effects of assemblies ... prevented strong recurrent amplification within E/I assemblies." the authors could provide a link to the respective panel in Fig. 2 after each statement. This would help the reader follow your arguments. 

      We thank the reviewer for pointing this out. The references to the appropriate panels have been added. 

      - Fig. 3A: I guess the x-axis has been shifted upwards? Should be at zero. 

      We have modified the x-axis to make it consistent with panels B and C.  

      - Fig. 3B: In the figure caption, the dotted line is described as the novel odor but it is actually the unit line. The dashed lines represent the reference to the novel odor. 

      Fixed.

      - Fig. 3C: The " is missing for Pseudo-Assembly N

      Fixed.

      - "...or a learned odor into another learned odor." Have here a ref to the Supplementary Figure 3B.

      Added.

      Figure 4:   

      - "This geometry was largely maintained in the output of rand networks, consistent with the notion that random networks tend to preserve similarity relationships between input patterns (Babadi and Sompolinsky, 2014; Marr, 1969; Schaffer et al., 2018; Wiechert et al., 2010)." I suggest adding here reference to Fig. 4D (left). 

      Added.

      - Please add a definition of E/I assemblies. How do the authors define E/I assemblies? I think they consider both, Tuned I and Tuned E+I as E/I assemblies? In Suppl. Fig. 2I E it looks like tuned feedforward input is defined as E/I assemblies. 

      We thank the reviewer for pointing this out. E/I assemblies are groups of E and I neurons with enhanced connectivity. In other words, in E/I assemblies, connectivity is enhanced not only between subsets of E neurons, but also between these E neurons and a subset of I neurons. This is now clarified in the text: “We first selected the 25 I neurons that received the largest number of connections from the 100 E neurons of an assembly. To generate E/I assemblies, the connectivity between these two sets of neurons was then enhanced by two procedures.”. We removed “E/I assemblies” in Suppl. Fig.2, where the term was not used correctly, and apologize for the confusion.

      - Suppl. Fig. 4: Could the authors please define what they mean by "Loadings" 

      The loadings indicate the contribution of each neuron to each principal component, see adjusted legend of Suppl. Fig. 4: “G. Loading plot: contribution of neurons to the first two PCs of a rand and a Tuned E+I network (Figure 4D).”

      - Fig. 4F: The authors might want to normalize the participation ratio by the number of neurons (see e.g. Dahmen et al., 2023 bioRxiv, "relative PR"), so the PR is bound between 0 and 1 and the dependence on N is removed. 

      We thank the reviewer for the suggestion, but we prefer to use the non-normalized PR as we find it more easily interpretable (e.g. number of attractor states in Scaled networks).

      - Fig. 4G&H: as mentioned in the public review, I'd add the case of Scaled I to be able to compare it to the Tuned E+I case. 

      As already mentioned in the public review, we thank the reviewer for this suggestion, which we have implemented.

      - Figure caption Fig. 4H "Similar results were obtained in the full-dimensional space." I suggest showing this as a supplemental panel. 

      Since this only adds little information, we have chosen not to include it as a supplemental panel to avoid overloading the paper with figures.

      Figure 5: 

      - As mentioned in the public review, I suggest that the authors add the Scaled I case to Fig. 5 (it's shown in all figures and also in Fig. 6 again). I guess for Scaled I the separation between L and M will be very good? 

      Please see our reply to the public review (reviewer 3).

      - Fig. 5A&B: I am a bit confused about which neurons are drawn to calculate the Mahalanobis distance. In Fig. 5A, the schematic indicates that the vector B from which the neurons are drawn is distinct from the distribution Q. For the example of odor L, the distribution Q consists of pure odor L with odors that have little mixtures with the other odors. But the vector v for odor L seems to be drawn only from odors that have slightly higher mixtures (as shown in the schematic in Fig. 5A). Is there a reason to choose the vector v from different odors than the distribution Q? 

      The distribution Q and the vector v consist of activity patterns across the same neurons in response to different odors. The reason to choose a different odor for v was to avoid having this test datapoint being included in the distribution Q. We also wanted Q to be the same for all test datapoints. 

      What does "drawn from whole population" mean? Does this mean that the vectors are drawn from any neuron in pDp? If yes, then I don't understand how the authors can distinguish between different odors (L,M,O,N) on the y-axis. Or does "whole population" mean that the vector is drawn across all assemblies as shown in the schematic in Fig. 5A and the case "neurons drawn from (pseudo-) assembly" means that the authors choose only one specific assembly? In any case, the description here is a bit confusing, I think it would help the reader to clarify those terms better.  

      Yes, “drawn from whole population” means that we randomly draw 80 neurons from the 4000 E neurons in pDp. The y-axis means that we use the activity patterns of these neurons evoked by one of the 4 odors (L, M, N, O) as reference. We have modified the Figure legend to clarify this: “d<sub>M</sub> was computed based on the activity patterns of 80 E neurons drawn from the four (pseudo-) assemblies (top) or from the whole population of 4000 E neurons (bottom). Average of 50 draws.”

      - Suppl Fig. 5A: In the schematic the distance is called d_E(\bar{Q},\bar{V}) while the colorbar has d_E(\bar{Q},\bar{Q}) with the Qs in different color. The green Q should be a V. 

      We thank the reviewer for spotting this mistake, it is now fixed.

      - Fig. 5: Could the authors comment on the fact that a random network seems to be very good in classifying patterns on it's own. Maybe in the Discussion? 

      The task shown in Figure 5 is a relatively easy one, a forced-choice between four classes which are uncorrelated. In Supplementary Figure 9, we now show classification for correlated classes, which is already much harder.

      Figure 6: 

      - Is the correlation induced by creating mixtures like in the other Figures? Please clarify how the correlations were induced. 

      We clarified this point in the Methods section: “The pixel at each vertex corresponded to one pure odor with 150 activated and 75 inhibited mitral cells (…) and the remaining pixels corresponded to mixtures. In the case of correlated pure odors (Figure 6), adjacent pure odors shared half of their activated and half of their inhibited cells.”. An explicit reference to the Methods section has also been added to the figure legend.

      - Fig. 6C (right): why don't we see the clear separation in PC space as shown in Fig. 4? Is this related to the existence of correlations? Please clarify. 

      Yes. The assemblies corresponding to the correlated odors X and Y overlap significantly, and therefore responses to these odors cannot be well separated, especially for Scaled networks. We added the overlap quantification in the Results section to make this clear. “These two additional assemblies had on average 16% of neurons in common due to the similarity of the odors.”

      - "Furthermore, in this regime of higher pattern similarity, dM was again increased upon learning, particularly between learned odors and reference classes representing other odors (not shown)." Please show this (maybe as a supplemental figure). 

      We now show the data in Supplementary Figure 9.

      Discussion: 

      - The authors write: "We found that transformations became more discrete map-like when amplification within assemblies was increased and precision of synaptic balance was reduced. Likewise, decreasing amplification in assemblies of Scaled networks changed transformations towards the intermediate behavior, albeit with broader firing rate distributions than in Tuned networks (not shown)." 

      Where do I see the first point? I guess when I compare in Fig. 4D the case of Scaled I vs Tuned E+I, but the sentence above sounds like the authors showed this in a more step-wise way eg by changing the strength of \alpha or \beta (as defined in Fig. 1). 

      Also I think if the authors want to make the point that decreasing amplification in assemblies changes transformation with a different rate distribution in scaled vs tuned networks, the authors should show it (eg adding a supplemental figure). 

      The first point is indeed supported by data from different figures. Please note that the revised manuscript now contains further simulations that reinforce this statement, particularly those shown in Supplementary Figure 6, and that this point is now discussed more extensively in the Discussion. We hope that these revisions clarify this general point.

      The data showing effects of decreasing amplification in assemblies is now shown in Supplementary Figure 6 (Scaled[adjust])

      - I suggest adding the citation Znamenskiy et al., 2024 (Neuron; https://doi.org/10.1016/j.neuron.2023.12.013), which shows that excitatory and inhibitory (PV) neurons with functional similarities are indeed strongly connected in mouse V1, suggesting the existence of E/I assembly structure also in mammals.

      Done.

    1. Author response:

      The following is the authors’ response to the previous reviews.

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      It is evident that studying leukocyte extravasation in vitro is a challenge. One needs to include physiological flow, culture cells and isolate primary immune cells. Timing is of utmost importance and a reproducible setup essential. Extra challenges are met when extravasation kinetics in different vascular beds is required, e.g., across the blood-brain barrier. In this study, the authors describe a reliable and reproducible method to analyze leukocyte TEM under physiological flow conditions, including this analysis. That the software can also detect reverse TEM is a plus.

      Strengths:

      It is quite a challenge to get this assay reproducible and stable, in particular as there is flow included. Also for the analysis, there is currently no clear software analysis program, and many labs have their own methods. This paper gives the opportunity to unify the data and results obtained with this assay under label-free conditions. This should eventually lead to more solid and reproducible results.

      Also, the comparison between manual and software analysis is appreciated.

      Weaknesses:

      The authors stress that it can be done in BBB models, but I would argue that it is much more broadly applicable. This is not necessarily a weakness of the study but more an opportunity to strengthen the method. So I would encourage the authors to rewrite some parts and make it more broadly applicable.

      We thank the Reviewer for this suggestion. The barrier properties of the BBB influence the dynamic behavior of T cells during their multi-step extravasation cascade. The crawling of CD4 T cells against the direction of blood-flow is e.g. a unique behavior of T cells on the BBB  that is also observed in vivo(1-3). Nevertheless we fully agree that in principle UFMTrack is usable for studying in general immune cell interactions with endothelial monolayers under physiological flow. We have thus added a statement in the abstract and expanded the discussion to highlight availability of the framework and the potential necessary adaptations required when using UFMTrack for analyzing different experimental setups. Please also note, UFMTrack has been established as basic framework using the example of brain endothelial monolayers and one flow chamber devices while studying different immune cell subsets. The purpose of the publication is to make UFMTrack available to the community to address their specific questions.

      (1) Kawakami, N., Bartholomäus, I., Pesic, M. & Kyratsous, N. I. Intravital Imaging of Autoreactive T Cells in Living Animals. Methods Cell Biol. 113, 149–168 (2013).

      (2) Schläger, C., Litke, T., Flügel, A. & Odoardi, F. In Vivo Visualization of (Auto)Immune Processes in the Central Nervous System of Rodents. in 117–129 (Humana Press, New York, NY, 2014). doi:10.1007/7651_2014_150

      (3) Haghayegh Jahromi, N. et al. Intercellular Adhesion Molecule-1 (ICAM-1) and ICAM-2 Differentially Contribute to Peripheral Activation and CNS Entry of Autoaggressive Th1 and Th17 Cells in Experimental Autoimmune Encephalomyelitis. Front. Immunol. 10, 3056 (2020).

    1. Author response:

      The following is the authors’ response to the original reviews.

      eLife assessment:

      Developing a reliable method to record ancestry and distinguish between human somatic cells presents significant challenges. I fully acknowledge that my current evidence supporting the claim of lineage tracing with fCpG barcodes is inadequate. I agree with Reviewer 1 that fCpG barcodes are essentially a cellular division clock that diverges over time. A division clock could potentially document when cells cease to divide during development, with immediate daughter cells likely exhibiting more similar barcodes than those that are less related. Although it remains uncertain whether the current fCpG barcodes capture useful biological information, refinement of this type of tool could complement other approaches that reconstruct human brain function, development, and aging.

      Due to my lack of clarity, the fCpG barcode was perceived to be a new type of cell classifier. However, it is fundamentally different. fCpG sites are selected based on their differences between cells of the same type, while traditional cell classifiers focus on sites with consistent methylation patterns in cells of the same type. Despite these opposing criteria, fCpG barcodes and traditional cell classifiers may align because neuron subtypes often share common progenitors. As a result, cells of the same phenotype are also closely related by ancestry, and ex post facto, have similar fCpG barcodes. fCpG barcodes are complementary to cell type classifiers, and potentially provide insights into aspects such as mitotic ages, diversity within a clade, and migration of immediate daughters---information which is otherwise difficult to obtain. The title has been modified to “Human Brain Ancestral Barcodes” to better reflect the function of the fCpG barcodes. The manuscript is edited to correct errors, and a new Supplement is added to further explain fCpG barcode mechanics and present new supporting data.

      Reviewer #1 (Public review):

      I thank Reviewer 1 for his constructive comments. Major noted weaknesses were 1) insufficient clarity and brevity of the methodology, 2) inconsistent or erroneous use of neurodevelopmental concepts, and 3) lack of consideration for alternative explanations.

      (1) The methodology is now outlined in detailed in a new Supplement, including simulations that indicate that the error rate consistent with the experimental data is about 0.01 changes in methylation per fCpG site per division.

      (2) Conceptual and terminology errors noted by the Reviewers are corrected in the manuscript.

      (3) I agree completely with the alternative explanation of Reviewer 1 that fCpGs are “a cellular division clock that diverges over 'time'”. Differences between more traditional cell type classifiers and fCpG barcodes are more fully outlined in the new Supplement.  Ancestry recorded by fCpGs and cell type classifiers are confounded because cells of the same phenotype typically have common progenitors---cells within a clade have similar fCpG barcodes because they are closely related. fCpG barcodes can compliment cell type classifiers with additional information such as mitotic ages, ancestry within a clade, and daughter cell migration.

      Reviewer #1 (Recommendations for the authors):

      (1) A lot of the interpretations suffer from an extremely loose/erroneous use of developmental concepts and a lack of transparency. For instance:

      a) The thalamus is not part of the brain stem

      Corrected.

      b) The pons contains cells other than inhibitory neurons in the data; the same is true for the hippocampus which contains multiple cell types

      Corrected to refer to the specific cell types in these regions.

      c) The author talks about the rostral-caudal timing a lot which is not really discussed to this degree in the cited references. Thus, it is also unclear how interneurons fit in this model as they are distinguished by a ventral-dorsal difference from excitatory neurons. Also, it is unclear whether the timing is really as distinct as claimed. For instance, inhibitory neurons and excitatory neurons significantly overlap in their birth timing. Finally, conceptually, it does not make sense to go by developmental timing as the author proposes that it is the number of divisions that is relevant. While they are somewhat correlated there are potentially stark differences.

      The manuscript attempts to describe what might be broadly expected when barcodes are sampled from different cell types and locations. As a proposed mitotic clock, the fCpG barcode methylation level could time when each neuron ceased division and differentiated. The wide ranges of fCpG barcode methylation of each cell type (Fig 2A) would be consistent with significant overlap between cell types. The manuscript is edited to emphasize overlapping rather than distinct sequential differentiation of the cell types.

      d) Neocortical astrocytes and some oligodendrocytes share a lineage, whereas a subset of oligodendrocytes in the cortex shares an origin with interneurons. This could confound results but is never discussed.

      The manuscript does not assess glial lineages in detail because neurons were preferentially included in the sampling whereas glial cells were non-systematically excluded. This sampling information is now included in the section “fCpG barcode identification”.

      e) Neocortical interneurons should be more closely related in terms of lineage-to-excitatory neurons than other inhibitory neurons of, for instance, the pons. This is not clearly discussed and delineated.

      This is not discussed. It may not be possible analyze these details with the current data. The ancestral tree reconstructions indicate that excitatory neurons that appear earlier in development (and are more methylated) are more often more closely related to inhibitory neurons.

      f) While there is some spread of excitatory neurons tangentially, there is no tangential migration at the scale of interneurons as (somewhat) suggested/implied here.

      The abstract and results have been modified to indicate greater inhibitory than excitatory neuron tangential migration, but that the extent of excitatory neuron tangential migration cannot be determined because of the sparse sampling and that barcodes may be similar by chance.

      g) The nature of the NN cells is quite important as cells not derived from the neocortical anlage are unlikely to share a developmental origin (e.g., microglia, endothelial cells). This should be clarified and clearly stated.

      The manuscript is modified to indicate that NN cells are microglial and endothelial cells. These cells have different developmental origins, and their data are present in Fig 2A, but are not further used for ancestral analysis.  

      (2) The presentation is often somewhat confusing to me and lacks detail. For instance:

      a) The methods are extremely short and I was unable to find a reference for a full pipeline, so other researchers can replicate the work and learn how to use the pipeline.

      The pipeline including python code is outlined in the new Supplement

      b) Often numbers are given as ~XX when the actual number with some indication of confidence or spread would be more appropriate.

      Data ranges are often indicated with the violin plots.

      c) Many figure legends are exceedingly short and do not provide an appropriate level of detail.

      Figure legends have been modified to include more detail

      d) Not defining groups in the figure legends or a table is quite unacceptable to me. I do not think that referring to a prior publication (that does not consistently use these groups anyway) is sufficient.

      The cell groups are based on the annotations provided with each single cell in the public databases.

      e) The used data should be better defined and introduced (number of cells, different subtypes across areas, which cells were excluded; I assume the latter as pons and hippocampus are only mentioned for one type of neuronal cells, see also above).

      The data used are present in Supplemental File 2 under the tab “cell summary H01, H02, H04”.

      f) Why were different upper bounds used for filtering for H01 and H02, and H04 is not mentioned? Why are inhibitory and excitatory neurons specifically mentioned (Lines 61-66)?

      The filtering is used to eliminate, as much as possible, cell type specific methylation, or CpG sites with skewed neuron methylation. The filtering eliminates CpG sites with high or low methylation within each of the three brains, and within the two major neuron subtypes. The goal is to enrich for CpG sites with polymorphic but not cell type specific methylation. This process is ad hoc as success criteria are currently uncertain. The extent of filtering is balanced by the need to retain sufficient numbers of fCpGs to allow comparisons between the neurons.

      g) What 'progenitor' does the author refer to? The Zygote? If yes, can the methylation status be tested directly from a zygote? There is no single progenitor for these cells other than the zygote. Does the assumption hold true when taking this into account? See, for instance, PMID 33737485 for some estimation of lineage bottlenecks.

      A brain progenitor cell can be defined as the common ancestor of all adult neurons, and is the first cell where each of its immediate daughter cell lineages yield adult neurons. The zygote is a progenitor cell to all adult cells, and barcode methylation at the start of conception, from the oocyte to the ICM, was analyzed in the new Supplement. The proposed brain progenitor cell with a fully methylated barcode was not yet evident even in the ICM.

      (3) I am generally not convinced that the fCpGs represent anything but a molecular clock of cell divisions and that many of the similarities are a function of lower division numbers where the state might be more homogenous. This mainly derives from the issues cited above, the lack of convincing evidence to the contrary, and the sparsity of the assessed data.

      Agree that the fCpG barcode is a mitotic clock that becomes polymorphic with divisions. As outlined in the new Supplement, ancestry and cell type are confounded because cells of the same type typically have a common progenitor.

      a) There appears little consideration or modeling of what the ability to switch back does to the lineage reconstruction.

      fCpG methylation flipping is further analyzed and discussed in the new Supplement.

      b) None of the data convinced me that the observations cannot be explained by the aforementioned molecular clock and systematic methylation similarities of cell types due to their cell state.

      See above

      (4) Uncategorized minor issues:

      a) The author should explain concepts like 'molecular clock hypothesis' (line 27) or 'radial unit hypothesis' (line 154), as they are somewhat complex and might not be intuitive to readers.

      The molecular clock hypothesis is deleted and the radial unit hypothesis is explained in more detail in the manuscript.

      b) Line 32: '[...] replication errors are much higher compared to base replication [...]'. I think this is central to the method and should be better explained and referenced. Maybe even through a schematic, as this is a central concept for the entire manuscript.

      The fCpG barcode mechanics are better explained in the new Supplement. With simulations, the fCpG flip rate is about 0.01 per division per fCpG.

      c) Line 41: 'neonatal'. Does the author mean to say prenatal? Most of the cells discussed are postmitotic before birth.

      Corrected to prenatal.

      d) Line 96: what does 'flip' mean in this context? Please also see the comment on Figure 2C.

      Edited to “chage”

      e) Lines 134-135: I am not sure whether the author claims to provide evidence for this question, and I would be careful with claims that this work does resolve the question here.

      Have toned down claims as evidence for my analysis is currently inadequate.

      f) Lines 192-193: I disagree as the fCpGs can switch back and the current data does not convince me that this is an improvement upon mosaic mutation analysis. In my mind, the main advantage is the re-analysis of existing data and the parallel functional insights that can be obtained.

      Lineage analysis is more straightforward with DNA sequencing, but with an error rate of ~10-9 per base per division, one needs to sequence a billion base pairs to distinguish between immediate daughter cells. By contrast, with an inferred error rate of ~10-2 per fCpG per division, much less sequencing (about a million-fold less) is needed to find differences between daughter cells.

      g) Lines 208-209: I would be careful with claims of complexity resolution given many of the limitations and inherent systematic similarities, as well as the potential of fCpGs to change back to an ancestral state later in the lineage.

      Have modified the manuscript to indicate the analysis would be more challenging due to back changes.

      h) There seem to be few figures that assess phenomena across the three brains. Even when they exist there is no attempt to provide any statistical analyses to support the conclusions or permutations to assess outlier status relative to expectations.

      The analysis could be more extensive, but with only three brains, any results, like this study itself, would be rightly judged inadequate.

      Figure 2B: there appears to be a higher number of '0s' for, for instance, inhibitory neurons compared to excitatory neurons. Is that correct and worth mentioning? The changing axes scales also make it hard to assess.

      Inhibitory neurons do appear to have more unmethylated fCpGs compared to excitatory neurons, but in general, most inhibitory fCpGs are methylated with a skew to fully methylated fCpGs, consistent with the barcode starting predominately methylated and inhibitory neurons generally appearing earlier in development relative to excitatory neurons.

      j) Figure 2C: I have several issues with this. A minor one is the use of 'Glial' which, I believe, does not appear anywhere else before this, so I am unclear what this curve represents. Generally, however, I am not sure what the y-axis represents, as it is not described in the methods or figure legend. I initially thought it was the cumulative frequency, but I do not think that this squares with the data shown in B. I appreciate the overall idea of having 'earlier'/samples with fewer divisions being shifted to the left, but it is very confusing to me when I try to understand the details of the plot.

      This graph is now better described in the legend. “Glial” cells are defined as oligodendrocytes and astrocytes. Other non-neuronal cells (such a microglial cells) have now been removed from the graph.

      This graph attempts to illustrate how it may be possible to reconstruct brain development from adult neurons, assuming barcodes are mitotic clocks that become polymorphic with cell division. The X axis is “time”, and the Y axis indicates when different cell types reach their adult levels. The cartoon indicates what is visually present along the X axis during development--- brainstem, then ganglionic eminences with a thin cortex, and finally the mature brain with a robust cortex. Time for the X axis is barcode methylation and starts at 100% and ends at 50% or greater methylation. The fCpG barcode methylation of each cell places it on this timeline and indicates when it ceased dividing and differentiated.

      The Y axis indicates the progressive accumulation of the final adult contents of each cell type during this timeline. Early in development, the brain is rudimentary and adult cells are absent. At 90% methylation, only the inhibitory neurons in the pons are present. At 80% methylation, some excitatory neurons are beginning to appear. Inhibitory neurons in the pons have reached their final adult levels and many other inhibitory neuron types are reaching adult levels. By 70% methylation, most inhibitory neurons have reached their adult levels, and more adult excitatory neurons (mainly low cortical neurons, L4-6) and glial cells are beginning to appear. By 60% methylation, inhibitory neurogenesis has largely finished. Adult excitatory neurons and glial cells are more abundant and reach their adult levels by 50% or greater cell barcode methylation levels.

      The graph illustrates a rough alignment between mitotic ages inferred by barcode methylation levels and the physical appearances of different neuronal types during development. Many neurons die during development, and this graph, if valid, indicates when neurons that survive to adulthood appear during development.

      k) Figure 4Bff: it is confusing to me that the text jumps to these panels after introducing Figure 5. This makes it very hard to read this section of the text.

      The Figures appear in the order they are first referred to in the text.

      l) Figure 5A: could any of this difference be explained by the shared lineage of excitatory neurons and dorsal neocortical glia?

      Not sure

      m) Figure 5B: after stating that interneurons have a higher lineage fidelity, the figure legend here states the opposite and I am somewhat confused by this statement.

      The legend and text have been clarified. Fig 5A restricts fidelity to within inhibitory cell types. Fig 5B compares between neuron subtypes, and illustrates more apparent inhibitory subtype switching, albeit there are more interneuron subtypes than excitatory subtypes.

      n) Figure 5E: generally, the use of tSNE for large pairwise distance analysis is often frowned upon (e.g., PMID 37590228), and I would reconsider this argument.

      This analysis was an attempt to illustrate that cells of the same phenotype based on their tSNE metrics can be either closely or more distantly related. Although the tSNE comparisons were restricted to subtypes (and not to the entire tSNE graph), tSNE are not designed for such comparisons. This graph and discussion are deleted. 

      Reviewer #2 (Public review):

      The manuscript by Shibata proposed a potentially interesting idea that variation in methylcytosine across cells can inform cellular lineage in a way similar to single nucleotide variants (SNVs). The work builds on the hypothesis that the "replication" of methylcytosine, presumably by DNMT1, is inaccurate and produces stochastic methylation variants that are inherited in a cellular lineage. Although this notion can be correct to some extent, it does not account for other mechanisms that modulate methylcytosines, such as active gain of methylation mediated by DNMT3A/B activity and activity demethylation mediated by TET activity. In some cases, it is known that the modulation of methylation is targeted by sequence-specific transcription factors. In other words, inaccurate DNMT1 activity is only one of the many potential ways that can lead to methylation variants, which fundamentally weakens the hypothesis that methylation variants can serve as a reliable lineage marker. With that being said (being skeptical of the fundamental hypothesis), I want to be as open-minded as possible and try to propose some specific analyses that might better convince me that the author is correct. However, I suspect that the concept of methylation-based lineage tracing cannot be validated without some kind of lineage tracing experiment, which has been successfully demonstrated for scRNA-seq profiling but not yet for methylation profiling (one example is Delgado et al., nature. 2022).

      I thank Reviewer 2 for the careful evaluation. The validation experiment example (Delgado et al.) introduced sequence barcodes in mice, which is not generally feasible for human studies.

      (1) The manuscript reported that fCpG sites are predominantly intergenic. The author should also score the overlap between fCpG sites and putative regulatory elements and report p-values. If fCpG sites commonly overlap with regulatory elements, that would increase the possibility that these sites being actively regulated by enhancer mechanisms other than maintenance methyltransferase activity.

      As mentioned for Reviewer 1, fCpGs are filtered to eliminate cell type specific methylation.

      (2) The overlap between fCpG and regulatory sequence is a major alternative explanation for many of the observations regarding the effectiveness of using fCpG sites to classify cell types correctly. One would expect the methylation level of thousands of enhancers to be quite effective in distinguishing cell types based on the published single-cell brain methylome works.

      As mentioned above, the manuscript did not clearly indicate that the fCpG barcode is not a cell type classifier. The distinctions between fCpG barcodes and cell type classifiers are better explained in the new Supplement.

      (3) The methylation level of fCpG sites is higher in hindbrain structures and lower in forebrain regions. This observation was interpreted as the hindbrain being the "root" of the methylation barcodes and, through "progressive demethylation" produced the methylation states in the forebrain. This interpretation does not match what is known about methylation dynamics in mammalian brains, in particular, there is no data supporting the process of "progressive demethylation". In fact, it is known that with the activation of DNMT3A during early postnatal development in mice or humans (Lister et al., 2013. Science), there is a global gain of methylation in both CH and CG contexts. This is part of the broader issue I see in this manuscript, which is that the model might be correct if "inaccurate mC replication" is the only force that drives methylation dynamics. But in reality, active enzymatic processes such as the activation of DNMT3A have a global impact on the methylome, and it is unclear if any signature for "inaccurate mC replication" survives the de novo methylation wave caused by DNMT3A activity.

      Reviewer 2 highlights a critical potential flaw in that any ancestral signal recorded by random replication errors could be overwritten by other active methylation processes. I cannot present data that indicates fCpG replication errors are never overwritten, but new data indicate barcode reproducibility and stability with aging.

      New data are also present where barcodes are compared between daughter cells (zygote to ICM) in the setting of active and passive demethylation, when germline methylation is erased. This new analysis shows that daughter cells in 2 to 8 cell embryos have more related barcodes than morula or ICM cells. The subsequent active remethylation by a wave of DNMT3A activity may underlie the observation that the barcode appears to start predominately methylated in brain progenitors.

      (3) Perhaps one way the author could address comment 3 is to analyze methylome data across several developmental stages in the same brain region, to first establish that the signal of "inaccurate mC replication" is robust and does not get erased during early postnatal development when DNMT3A deposits a large amount of de novo methylation.

      See above

      (4) The hypothesis that methylation barcodes are homogeneous among progenitor cells and more polymorphic in derived cells is an interesting one. However, in this study, the observation was likely an artifact caused by the more granular cell types in the brain stem, intermediate granularity in inhibitory cells, and highly continuous cell types in cortical excitatory cells. So, in other words, single-cell studies typically classify hindbrain cell types that are more homogenous, and cortical excitatory cells that are much more heterogeneous. The difference in cell type granularity across brain structures is documented in several whole-brain atlas papers such as Yao et al. 2023 Nature part of the BICCN paper package.

      As noted above, fCpG barcode polymorphisms and cell type differentiation are confounded because cells of the same phenotype tend to have common progenitors. The fCpG barcode is not a cell type classifier but more a cell division clock that becomes polymorphic with time. Although fCpG barcodes could be more polymorphic in cortical excitatory cells because there are many more types, fCpG barcodes would inherently become more polymorphic in excitatory cells because they appear later in development.

      (5) As discussed in comment 2, the author needs to assess whether the successful classification of cell types (brain lineage) using fCpG was, in fact, driven by fCpG sites overlapping with cell-type specific regulatory elements.

      Although unclear in the manuscript, the fCpG is not a cell classifier and the barcode is polymorphic between cells of the same type. fCpG barcodes can appear to be cell classifiers because cell types appear at different times during development, and therefore different cell types have characteristic average barcode methylation levels.

      (6) In Figure 5E, the author tried to address the question of whether methylation barcodes inform lineage or post-mitotic methylation remodeling. The Y-axis corresponds to distances in tSNE. However, tSNE involves non-linear scaling, and the distances cannot be interpreted as biological distances. PCA distances or other types of distances computed from high-dimensional data would be more appropriate.

      The Figure and discussion are deleted (similar comment by Reviewer 1)

      Reviewer #3 (Public review):

      Summary:

      In the manuscript entitled "Human Brain Barcodes", the author sought to use single-cell CpG methylation information to trace cell lineages in the human brain.

      Strengths:

      Tracing cell lineages in the human brain is important but technically challenging. Lineage tracing with single-cell CpG methylation would be interesting if convincing evidence exists.

      Weaknesses:

      As the author noted, "DNA methylation patterns are usually copied between cell division, but the replication errors are much higher compared to base replication". This unstable nature of CpG methylation would introduce significant problems in inferring the true cell lineage. The unreliable CpG methylation status also raises the question of what the "Barcodes" refer to in the title and across this study. Barcodes should be stable in principle and not dynamic across cell generations, as defined in Reference#1. It is not convincing that the "dynamic" CpG methylation fits the "barcodes" terminology. This problem is even more concerning in the last section of results, where CpG would fluctuate in post-mitotic cells.

      I thank Reviewer 3 for his thoughtful and careful evaluation. I think the “barcode” terminology is appropriate. Dynamic engineered barcodes such as CRISPR/Cas9 mutable barcodes are used in biology to record changes over time. The fCpG barcode appears to start with a single state in a progenitor cell and changes with cell division to become polymorphic in adult cells. Therefore, I think the description of a dynamic fCpG barcode is appropriate.

      Reviewer #3 (Recommendations for the authors):

      (1) As the author noted, "DNA methylation patterns are usually copied between cell division, but the replication errors are much higher compared to base replication". This unstable nature of CpG methylation would introduce significant problems in inferring the true cell lineage. To establish DNA methylation as a means for lineage tracing, one control experiment would be testing whether the DNA methylation patterns can faithfully track cell lineages for in vitro differentiated & visibly tracked cell lineages. Has this kind of experiment been done in the field?

      These types of experiments have not been performed to my knowledge and an appropriate tissue culture model is uncertain. New single cell WGBS data from the zygote to ICM indicate that more immediate daughter cells have more related barcodes even in the setting of active DNA demethylation.

      (2) The study includes assumptions that should be backed with solid rationale, supporting evidence, or reference. Here are a couple of examples:

      a) the author discarded stable CpG sites with <0.2 or >0.8 average methylation without a clear rationale in H02, and then used <0.3 and >0.7 for a specific sample H01.

      The filtering was ad hoc and was used to remove, as much as possible, CpG sites with cell type specific or patient specific methylation. CpG sites with skewed methylation are more likely cell type specific, whereas X chromosome CpG sites with methylation closer to 0.5 in male cells are more likely to be unstable. The ad hoc filtering attempted to remove cell specific CpGs sites while still retaining enough CpG sites to allow comparisons between cells.

      b) The author assumed that the early-formed brain stem would resemble progenitors better and have a higher average methylation level than the forebrain. However, this difference in DNA methylation status could reflect developmental timing or cell type-specific gene expression changes.

      This observation that brain stem neurons that appear early in development have highly methylated fCpG barcodes in all 3 brains supports the idea that the fCpG barcode starts predominately methylated. Alternative explanations are possible.

      (3) The conclusion that excitatory neurons undergo tangential migration is unclear - how far away did the author mean for the tangential direction? Lateral dispersion is known, but it would be striking that the excitatory neurons travel across different brain regions. The question is, how would the author interpret shared or divergent methylation for the same cell type across different brain regions?

      As noted with Reviewer 1, this analysis is modified to indicate that evidence of tangential migration is greater for inhibitory than excitatory neurons, but the extent of excitatory neuron migration is uncertain because of sparse sampling, and because fCpG barcodes can be similar by chance.

      (4) The sparsity and resolution of the single-cell DNA methylation data. The methylation status is detected in only a small fraction (~500/31,000 = 1.6%) of fCpGs per cell, with only 48 common sites identified between cell pairs. Given that the human genome contains over 28 million CpG sites, it is important to evaluate whether these fCpGs are truly representative. How many of these sites were considered "barcodes"?

      fCpG barcodes are distinct from traditional cell type classifiers, and how fCpGs are identified are better outlined in the new Supplement.

      (5) While focusing on the X-chromosome may simplify the identification of polymorphic fCpGs, the confidence in determining its methylation status (0 or 1) is questionable when a CpG site is covered by only one read. Did the author consider the read number of detected fCpGs in each cell when calculating methylation levels? Certain CpG sites on autosomes may also have sufficient coverage and high variability across cells, meeting the selection criteria applied to X-chromosome CpGs.

      In most cases, a fCpG site was covered by only a single read

      (6) The overall writing in the Title, the Main text, Figure legends, and Methods sections are overly simplified, making it difficult to follow. For instance, how did the author perform PWD analysis? How did they handle missing values when constructing lineage trees?

      There is not much introduction to lineage tracing in the human brain or the use of DNA methylation to trace cell lineage.

      These shortcomings are improved in the manuscript and with the new Supplement. The analysis pipeline including the Python programs are outlined and included as new Supplemental materials. IQ tree can handle the binary fCpG barcode data and skips missing values with its standard settings.

      Line 80: it is unclear: "Brain patterns were similar"

      Clarified

      Line 98: The meaning is unclear here: "Outer excitatory and glial progenitor cells are present" What are these glial progenitor cells and when/how they stop dividing?

      The glial cells are the oligodendrocytes and astrocytes. The main take away point is that these glial cells have low barcode methylation, consistent with their appearances later in development.

      Line 104: It is unclear if this is a conclusion or assumption -- "A progenitor cell barcode should become increasingly polymorphic with subsequent divisions." The "polymorphic" happens within the progenitors, their progenies, or their progenies at different time points.

      The statement is now clarified as an assumption in the manuscript.

      Similarly line 134 "Barcodes would record neuronal differentiation and migration." Is this a conclusion from this study or a citation? How is the migration part supported?

      The reasoning is better explained in the manuscript.  Migration can be documented if immediate daughter cells with similar barcodes are found in different parts of the adult brain, albeit analysis is confounded by sparse sampling and because barcodes may be similar by chance.

      Line 148 and 150: "Nearest neighbor ... neuron pairs" in DNA methylation status would conceivably reflect their cell type-specific gene expression, how did the author distinguish this from cell lineage?

      As noted above, because cells with similar phenotypes usually arise from common progenitors, cells within a clade are also usually related. However, the barcodes are still polymorphic within a clade and potentially add complementary information on mitotic ages, ancestry within a clade, and possible cell migration.

      Figure 3C: "Cells that emerge early in development" Where are they on the figure?

      Hindbrain neurons differentiate early in development and their barcodes are more methylated. The figure has been modified to label some of the values with their neuron types. Also, the older figure mistakenly included data from all 3 brains and now the data are only from brain H01.

      Figures 4D and 4E, distinguishing cell subtypes is challenging, as the same color palette is used for both excitatory and inhibitory neurons.

      Unfortunate limitations due to complexity and color limitations

      Figures 4 and 5, what are these abbreviations?

      The abbreviations are presented in Figure 1 and maintained in subsequent figures.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      The authors intended to investigate the earliest mechanisms enabling self-prioritization, especially in the attention. Combining a temporal order judgement task with computational modelling based on the Theory of Visual Attention (TVA), the authors suggested that the shapes associated with the self can fundamentally alter the attentional selection of sensory information into awareness. This self-prioritization in attentional selection occurs automatically at early perceptual stages. Furthermore, the processing benefits obtained from attentional selection via self-relatedness and physical salience were separated from each other.

      Strengths:

      The manuscript is written in a way that is easy to follow. The methods of the paper are very clear and appropriate.

      Thank you for your valuable feedback and helpful suggestions. Please see specific answers below.

      Weaknesses:

      There are two main concerns:

      (1) The authors had a too strong pre-hypothesis that self-prioritization was associated with attention. They used the prior entry to consciousness (awareness) as an index of attention, which is not appropriate. There may be other processing that makes the stimulus prior to entry to consciousness (e.g. high arousal, high sensitivity), but not attention. The self-related/associated stimulus may be involved in such processing but not attention to make the stimulus easily caught. Perhaps the authors could include other methods such as EEG or MEG to answer this question.

      We found the possibility of other mechanisms to be responsible for “prior entry” interesting too, but believe there are solid grounds for the hypothesis that it is indicative of attention:

      First, prior entry has a long-standing history as in index of attention (e.g., Titchener, 1903; Shore et al., 2001; Yates and Nicholls, 2009; Olivers et al. 2011; see Spence & Parise, 2010, for a review.) Of course, other factors (like the ones mentioned) can contribute to encoding speed. However, for the perceptual condition, we systematically varied a stimulus feature that is associated with selective attention (salience, see e.g. Wolfe, 2021) and kept other features that are known to be associated with other factors such as arousal and sensitivity constant across the two variants (e.g. clear over threshold visibility) or varied them between participants (e.g. the colours / shapes used).

      Second, in the social salience condition we used a manipulation that has repeatedly been used to establish social salience effects in other paradigms (e.g., Li et al., 2022; Liu & Sui, 2016; Scheller et al., 2024; Sui et al., 2015; see Humphreys & Sui, 2016, for a review). We assume that the reviewer’s comment suggests that changes in arousal or sensitivity may be responsible for social salience effects, specifically. We have several reasons to interpret the social salience effects as an alteration in attentional selection, rather than a result of arousal or sensitivity:

      Arousal and attention are closely linked. However, within the present model, arousal is more likely linked to the availability of processing resources (capacity parameter C). That is, enhanced arousal is typically not stimulus-specific, and therefore unlikely affects the *relative* advantage in processing weights/rates of the self-associated (vs other-associated) stimuli. Indeed, a recent study showed that arousal does not modulate the relative division of attentional resources (as modelled by the Theory of Visual Attention; Asgeirsson & Nieuwenhuis, 2017). As such, it is unlikely that arousal can explain the observed results in relative processing changes for the self and other identities.

      Further, there is little reason to assume that presenting a different shape enhances perceptual sensitivity. Firstly, all stimuli were presented well above threshold, which would shrink any effects that were resulting from increases in sensitivity alone. Secondly, shape-associations were counterbalanced across participants, reducing the possibility that specific features, present in the stimulus display, lead to the measurable change in processing rates as a result of enhanced shape-sensitivity.

      Taken together, both, the wealth of literature that suggests prior entry to index attention and the specific design choices within our study, strongly support the notion that the observed changes in processing rates are indicative of changes in attentional selection, rather than other mechanisms (e.g. arousal, sensitivity).

      (2) The authors suggested that there are two independent attention processes. I suspect that the brain needs two attention systems. Is there a probability that the social and perceptual (physical properties of the stimulus) salience fired the same attention processing through different processing?

      We appreciate this thought-provoking comment. We conceptualize attention as a process that can facilitate different levels of representation, rather than as separate systems tuned to specific types of information. Different forms of representation, such as the perceptual shape, or the associated social identity, may be impacted by the same attentional process at different levels of representation. Indeed, our findings suggest that both social and perceptual salience effects may result from the same attentional system, albeit at different levels of representation. This is further supported by the additivity of perceptual and social salience effects and the negative correlation of processing facilitations between perceptually and socially salient cues. These results may reflect a trade-off in how attentional resources are distributed between either perceptually or socially salient stimuli.

      Reviewer #2 (Public review):

      Summary:

      The main aim of this research was to explore whether and how self-associations (as opposed to other associations) bias early attentional selection, and whether this can explain well-known self-prioritization phenomena, such as the self-advantage in perceptual matching tasks. The authors adopted the Visual Attention Theory (VAT) by estimating VAT parameters using a hierarchical Bayesian model from the field of attention and applied it to investigate the mechanisms underlying self-prioritization. They also discussed the constraints on the self-prioritization effect in attentional selection. The key conclusions reported were:

      (1) Self-association enhances both attentional weights and processing capacity

      (2) Self-prioritization in attentional selection occurs automatically but diminishes when active social decoding is required, and

      (3) Social and perceptual salience capture attention through distinct mechanisms.

      Strengths:

      Transferring the Theory of Visual Attention parameters estimated by a hierarchical Bayesian model to investigate self-prioritization in attentional selection was a smart approach. This method provides a valuable tool for accessing the very early stages of self-processing, i.e., attention selection. The authors conclude that self-associations can bias visual attention by enhancing both attentional weights and processing capacity and that this process occurs automatically. These findings offer new insights into self-prioritization from the perspective of the early stage of attentional selection.

      Thank you for your valuable feedback and helpful suggestions. Please see specific answers below.

      Weaknesses:

      (1) The results are not convincing enough to definitively support their conclusions. This is due to inconsistent findings (e.g., the model selection suggested condition-specific c parameters, but the increase in processing capacity was only slight; the correlations between attentional selection bias and SPE were inconsistent across experiments), unexpected results (e.g., when examining the impact of social association on processing rates, the other-associated stimuli were processed faster after social association, while the self-associated stimuli were processed more slowly), and weak correlations between attentional bias and behavioral SPE, which were reported without any p-value corrections. Additionally, the reasons why the attentional bias of self-association occurs automatically but disappears during active social decoding remain difficult to explain. It is also possible that the self-association with shapes was not strong enough to demonstrate attention bias, rather than the automatic processes as the authors suggest. Although these inconsistencies and unexpected results were discussed, all were post hoc explanations. To convince readers, empirical evidence is needed to support these unexpected findings.

      Thank you for outlining the specific points that raise your concern. We were happy to address these points as follows:

      a. Replications and Consistency: In our study, we consistently observed trends (relative reduction in processing speed of the self-associated stimulus) in the social salience conditions across experiments. While Experiment 2 demonstrated a significant reduction in processing rate towards self-stimuli, there was a notable trend in Experiment 1 as well.

      b. Condition-specific parameters: The condition-specific C parameters, though presenting a small effect size, significantly improved model fit. Inspecting the HDI ranges of our estimated C parameters indicates a high probability (85-89%) that processing capacity increased due to social associations, suggesting that even small changes (~2Hz) can hold meaningful implications within the context attentional selection.

      Please also note that the main conclusions about relative salience (self/other, salient/non-salient) are based on the relative processing rates. Processing rates are the product of the processing capacity (condition- but not stimulus dependent) and the attentional weight (condition and stimulus dependent). The latter is crucial to judge the *relative* advantage of the salient stimulus. Hence, the self-/salient stimulus advantage that is reflected in the ‘processing rate difference’ is automatically also reflected in the relative attentional weights attributed to the self/other and salient/non-salient stimuli. As such, the overall results of an automatic relative advantage of self-associated stimuli hold, independently of the change in overall processing capacity.

      c. Correlations: Regarding the correlations the reviewer noted, we wish to clarify that these were exploratory, and not the primary focus of our research. The aim of these exploratory analyses was to gauge the contribution of attentional selection to matching-based SPEs. As SPEs measured via the matching task are typically based on multiple different levels of processing, the contribution of early attentional selection to their overall magnitude was unclear. Without being able to gauge the possible effect sizes, corrected analyses may prevent detecting small but meaningful effects. As such, the effect sizes reported serve future studies to estimate power a priori and conduct well-powered replications of such exploratory effects. Additionally, Bayes factors were provided to give an appreciation of the strength of the evidence, all suggesting at least moderate evidence in favour of a correlation. Lastly, please note that effects that were measured within individuals and task (processing rate increase in social and perceptual decision dimensions in the TOJ task) showed consistent patterns, suggesting that the modulations within tasks were highly predictive of each other, while the modulations between tasks were not as clearly linked. We will add this clarification to the revised manuscript.

      d. Unexpected results: The unexpected results concerning the processing rates of other-associated versus self-associated stimuli certainly warrant further discussion. We believe that the additional processing steps required for social judgments, reflected in enhanced reaction times, may explain the slower processing of self-associated stimuli in that dimension. We agree that not all findings will align with initial hypotheses, and this variability presents avenues for further research. We have added this to the discussion of social salience effects.

      e. Whether association strength can account for the findings: We appreciate the scepticism regarding the strength of self-association with shapes. However, our within-participant design and control matching task indicate that the relative processing advantage for self-associated stimuli holds across conditions. This makes the scenario that “the self-association with shapes was not strong enough to demonstrate attention bias” very unlikely. Firstly, the relative processing advantage of self-associated stimuli in the perceptual decision condition, and the absence of such advantage in the social decision condition, were evidenced in the same participants. Hence, the strength of association between shapes and social identities was the same for both conditions. However, we only find an advantage for the self-associated shape when participants make perceptual (shape) judgements. It is therefore highly unlikely that the “association strength” can account for the difference in the outcomes between the conditions in experiment 1. Also, note that the order in which these conditions were presented was counter-balanced across participants, reducing the possibility that the automatic self-advantage was merely a result of learning or fatigue. Secondly, all participants completed the standard matching task to ascertain that the association between shapes and identities did indeed lead to processing advantages (across different levels).

      In summary, we believe that the evidence we provide supports the final conclusions. We do, of course, welcome any further empirical evidence that could enhance our understanding of the contribution of different processing levels to the SPE and are committed to exploring these areas in future work.

      (2) The generalization of the findings needs further examination. The current results seem to rely heavily on the perceptual matching task. Whether this attentional selection mechanism of self-prioritization can be generalized to other stimuli, such as self-name, self-face, or other domains of self-association advantages, remains to be tested. In other words, more converging evidence is needed.

      The reviewer indicates that the current findings heavily rely on the perceptual matching task, and it would be more convincing to include other paradigm(s) and different types of stimuli. We are happy to address these points here: first, we specifically used a temporal order paradigm to tap into specific processes, rather than merely relying on the matching task. Attentional selection is, along with other processes, involved in matching, but the TOJ-TVA approach allows tapping into attentional selection specifically.  Second, self-prioritization effects have been replicated across a wide range of stimuli (e.g. faces: Wozniak et al., 2018; names or owned objects: Scheller & Sui, 2022a, or even fully unfamiliar stimuli: Wozniak & Knoblich, 2019) and paradigms (e.g. matching task: Sui et al., 2012; cross-modal cue integration: e.g. Scheller & Sui, 2022b; Scheller et al., 2023; continuous flash suppression: Macrae et al., 2017; temporal order judgment: Constable et al., 2019; Truong et al., 2017). Using neutral geometric shapes, rather than faces and names, addresses a key challenge in self research: mitigating the influence of stimulus familiarity on results. In addition, these newly learned, simple stimuli can be combined with other paradigms, such as the TOJ paradigm in the current study, to investigate the broader impact of self-processing on perception and cognition.

      To the best of our knowledge, this is the first study showing evidence about the mechanisms that are involved in early attentional selection of socially salient stimuli. Future replications and extensions would certainly be useful, as with any experimental paradigm.

      (3) The comparison between the "social" and "perceptual" tasks remains debatable, as it is challenging to equate the levels of social salience and perceptual salience. In addition, these two tasks differ not only in terms of social decoding processes but also in other aspects such as task difficulty. Whether the observed differences between the tasks can definitively suggest the specificity of social decoding, as the authors claim, needs further confirmation.

      Equating the levels of social and perceptual salience is indeed challenging, but not an aim of the present study. Instead, the present study directly compares the mechanisms and effects of social and perceptual salience, specifically experiment 2. By manipulating perceptual salience (relative colour) and social salience (relative shape association) independently and jointly, and quantifying the effects on processing rates, our study allows to directly delineate the contributions of each of these types of salience. The results suggest additive effects (see also Figure 7). Indeed, the possibility remains that these effects are additive because of the use of different perceptual features, so it would be helpful for future studies to explore whether similar perceptual features lead to (supra-/sub-) additive effects. In either case, the study design allows to directly compare the effects and mechanisms of social and perceptual salience.

      Regarding the social and perceptual decision dimensions, they were not expected to be equated. Indeed, the social decision dimension requires additional retrieval of the associated identity, making it likely more challenging. This additional retrieval is also likely responsible for the slower responses towards the social association compared to the shape itself. However, the motivation to compare the effects of these two decisional dimensions lies in the assumption that the self needs to be task relevant. Some evidence suggests that the self needs to be task-relevant to induce self-prioritization effects (e.g., Woźniak & Knoblich, 2022). However, these studies typically used matching tasks and were powered to detect large effects only (e.g. f = 0.4, n = 18). As it is likely that lacking contribution of decisional processing levels (which interact with task-relevance) will reduce the SPE, smaller self-prioritization effects that result from earlier processing levels may not be detected with sufficient statistical power. Targeting specific processing levels, especially those with relatively early contributions or small effect sizes, requires larger samples (here: n = 70) to provide sufficient power. Indeed, by contrasting the relative attentional selection effects in the present study we find that the self does not need to be task-relevant to produce self-prioritization effects. This is in line with recent findings of prior entry of self-faces (Jubile & Kumar, 2021)

      Reviewer #2 (Recommendations for the authors):

      Suggestions:

      (1) The research questions should be revised to better align with the conclusions. For example, Q2 is phrased as "Does self-relatedness bias attentional selection at the level of the perceptual feature representation (shape) or at the level of the associated identity (social association)," which is unclear in its reference to "levels." A more appropriate phrasing would be whether the self-association bias occurs automatically or whether it depends on explicit social decoding.

      Thank you for this suggestion – we have revised the phrasing accordingly: “Does self-relatedness bias attentional selection automatically or does it require explicit social decoding?”

      (2) After presenting the data, it would be helpful to include one or two sentences summarizing the conclusions drawn from the data and how they relate to the research questions. Currently, readers are left to guess whether the results are consistent with the hypotheses.

      Thank you for this suggestion, which we think will enhance the clarity of the manuscript – we have added summary sentences when presenting the results:<br /> “This cross-experimental parameter inspection revealed that participants exhibited an attentional selection bias towards socially associated information. Interestingly, enhanced processing speed was observed for other-associated rather than self-associated information, a pattern that diverged from our prediction.”

      (1) “Results from experiment 2 demonstrated a faster, more automatic attentional selection for self-associated information when the decision did not require explicit social decoding. When the social identity had to be judged, processing speed for self-associated information decreased. Contrary to the hypothesis that social decoding is necessary for self-prioritization to emerge, these findings suggest that attentional selection can operate automatically to prioritize self-associated information. “

      (2) “Taken together, as also confirmed in the cross-experimental analysis, attentional selection favoured the other-related information when social identity had to be judged. In contrast, perceptual salience, as predicted, led to increased processing speed for the more salient stimulus. “

      (3) The identity of the "other" used in the experiments is unclear, making it uncertain whether the results are self-specific. It would be beneficial to compare the self condition with a control condition, such as a close friend vs. an unfamiliar other. Alternatively, the results may reflect attentional bias for familiar vs. unfamiliar individuals rather than self-specific bias.

      Thank you for this comment. Firstly, we would like to clarify that we have provided participants with a description of who the “other” is (see methods: “At the beginning of this task, participants were told that one of the two geometric shapes that was used in the TOJ task has been assigned to them, and the other shape has been assigned to another participant in the experiment – someone they did not know, but who was of similar age and gender”). We aimed to make the ‘other’ as concrete as possible, while maintaining a ‘stranger’ identity.

      Secondly, this specification is in line with the vast majority of the literature, which typically measures the effects of self-prioritization relative to the association with an unfamiliar other (stranger), or an unfamiliar and familiar other (e.g. friend, family member). They find that processing advantages that affect friend-related stimuli (friend-stimuli being processed faster than stranger-associated stimuli) are likely mediated by self-extension, that is, an association of the friend with the self. As such, SPEs, relative to familiar others, are typically smaller in size (see, e.g., Sui et al., 2012). They, however, are less stable and more variable than the self-prioritization effects measured relative to a stranger (see Scheller & Sui, 2022 JEP:HPP). Importantly, this is driven by the variability of the friend-associated stimulus, rather than the self or other-associated stimulus (see Figure 4 in main text and S5 in supplementary material in Scheller & Sui, 2022: https://durham-repository.worktribe.com/output/1210478/the-power-of-the-self-anchoring-information-processing-across-contexts). Effectively, this would suggest that choosing a familiar other as a reference would not only (a) lead to a smaller effect size, but also (b) be a less stable effect, which likely depends on the association the individual has to the other familiar person. In contrast, by associating the other shape with another participant in this experiment, we provide participants not only with a concrete representation of a stranger, but also maximise our ability to detect true effects, as these are likely to be larger and more stable.

      (4) The key aspects of the procedure (e.g., the order of different conditions) and its rationale need to be clearly explained before or during the presentation of the results. Currently, readers are left to infer certain details.

      Thank you for pointing this out. The methods that provide these details are outlined at the end of the document, however, we agree it would be useful to bring some of these details up. We have therefore revised the methods figure (Figure 3) to include an outline of the task type, order, and trial numbers. Task boxes are colour coded by the conditions that are listed in the results figures of the manuscript. We also added these details to the caption of Figure 3.

      “Task structures of Experiments 1 and 2. Both experiments started with a TOJ baseline task. In Experiment 1, only non-salient targets were presented, while in Experiment 2, perceptually salient and non-salient trials were included. These were presented in randomly intermixed order. Next, targets were associated with social identities. Associations were practiced using the matching task. Following association learning, which attaches social salience to the shapes, participants completed the same TOJ task as before. In Experiment 1, they completed one block using a social decision dimension, and one block using a perceptual decision dimension. The order of these blocks was counterbalanced across participants to reduce the influence of order effects in the results. In Experiment 2, perceptually salient and non-salient stimuli were presented in an intermixed fashion, and participants responded within the social decision dimension. Each task block was preceded by 8 (matching) to 14 (TOJ) practice trials.”

      (5) Certain imprecise terms used to describe the results, such as "slightly," "roughly," and "loosely," create confusion for the readers. The authors should take a clearer stance on the results and provide an explanation for why the data only "slightly," "roughly," or "loosely" support the findings.

      Thank you for highlighting this. We have provided a more concrete wording and details throughout (e.g., “target shapes’ were 30% bigger than the ‘background shapes”).

      Lastly, we have updated the formatting of the manuscript to provide higher fidelity figures, which were previously compromised by file conversion.

    1. Author response:

      The following is the authors’ response to the original reviews.

      eLife Assessment

      This provocative manuscript from presents valuable comparisons of the morphologies of Archaean bacterial microfossils to those of microbes transformed under environmental conditions that mimic those present on Earth during the same Eon, although the evidence in support of the conclusions is currently incomplete. The reasons include that taphonomy is not presently considered, and a greater diversity of experimental environmental conditions is not evaluated -- which is important because we ultimately do not know much about Earth's early environments. The authors may want to reframe their conclusions to reflect this work as a first step towards an interpretation of some microfossils as 'proto-cells,' and less so as providing strong support for this hypothesis. 

      Regarding the taphonomic alterations: The editor and reviewers are correct in pointing out this issue. Taphonomic alteration of the microfossils attains special significance in the case of microorganisms, as they lack rigid structures and are prone to morphological alterations during or after their fossilization. We are acutely aware of this issue and have conducted long-term experiments (lasting two years) to observe how cells die, decay, and get preserved. A large section of the manuscript (pages 11 to 20) and a substantial portion of the supplementary information is dedicated to understanding the taphonomic alterations. To the best of our knowledge, these are among the longest experiments done to understand the taphonomic alterations of the cells within laboratory conditions. 

      Recent reports by Orange et al. (1,2)  showed that under favorable environmental conditions, cells could be fossilized rather rapidly with little morphological modifications. We observed a similar phenomenon in this work. Cells in our study underwent rapid encrustation with cations from the growth media. We have analyzed the morphological changes over a period of 18 months. After 18 months, the softer biofilms got encrusted entirely in salt and turned solid (Fig. ). Despite this transformation, morphologically intact cells could still be observed within these structures. This suggests that the cells inhabiting Archaean coastal marine environments could undergo rather rapid encrustation, and their morphological features could be preserved in the geological record with little taphonomic alteration.    

      Regarding the environmental conditions: We are in total agreement with the reviewers that much is unknown about Archaean geology and its environmental conditions. Like the present-day Earth, Archaean Earth certainly had regions that greatly differed in their environmental conditions—volcanic freshwater ponds, brines, mildly halophilic coastal marine environments, and geothermal and hydrothermal vents, to name a few. Our experimental design focuses on one environment we have a relatively good understanding of rather than the rest of the planet, of which we know little. Below, we list our reasons for restricting to coastal marine environments and studying cells under mildly halophilic experimental conditions.  

      (1) Very little continental crust from Haden and early Archaean Eon exists on the presentday Earth. Much of our geochemical understanding of this time period was a result of studying the Pilbara Iron Formations and the Barberton Greenstone Belt. Geological investigations suggest that these sites were coastal marine environments. The salinity of coastal marine environments is higher than that of open oceans due to the greater water evaporation within these environments. Moreover, brines were discovered within pillow basalts within the Barberton greenstone belt, suggesting that the salinity within these sites is higher or similar to marine environments. 

      (2) We are not certain about the environmental conditions that could have supported the origin of life. However, all currently known Archaean microfossils were reported from coastal marine environments (3.8-2.4Ga). This suggests that proto-life likely flourished in mildly halophilic environments, similar to the experimental conditions employed in our study. 

      (3) The chemical analysis of Archaean microfossils also suggests that they lived in saltrich environments, as most, if not all, microfossils are closely associated, often encrusted in a thin layer of salt.  

      However, we concur with the reviewers that our interpretations should be reassessed if Archaean microfossils that greatly differ from the currently known microfossils are to be discovered or if new microfossils are to be reported from environments other than coastal marine sites.

      Public Reviews: 

      Reviewer #1 (Public Review): 

      Summary: 

      Microfossils from the Paleoarchean Eon represent the oldest evidence of life, but their nature has been strongly debated among scientists. To resolve this, the authors reconstructed the lifecycles of Archaean organisms by transforming a Gram-positive bacterium into a primitive lipid vesicle-like state and simulating early Earth conditions. They successfully replicated all morphologies and life cycles of Archaean microfossils and studied cell degradation processes over several years, finding that encrustation with minerals like salt preserved these cells as fossilized organic carbon. Their findings suggest that microfossils from 3.8 to 2.5 billion years ago were likely liposome-like protocells with energy conservation pathways but without regulated morphology. 

      Strengths: 

      The authors have crafted a compelling narrative about the morphological similarities between microfossils from various sites and proliferating wall-deficient bacterial cells, providing detailed comparisons that have never been demonstrated in this detail before. The extensive number of supporting figures is impressive, highlighting numerous similarities. While conclusively proving that these microfossils are proliferating protocells morphologically akin to those studied here is challenging, we applaud this effort as the first detailed comparison between microfossils and morphologically primitive cells. 

      Weaknesses: 

      Although the species used in this study closely resembles the fossils morphologically, it would be beneficial to provide a clearer explanation for its selection. The literature indicates that many bacteria, if not all, can be rendered cell wall-deficient, making the rationale for choosing this specific species somewhat unclear. While this manuscript includes clear morphological comparisons, we believe the authors do not adequately address the limitations of using modern bacterial species in their study. All contemporary bacteria have undergone extensive evolutionary changes, developing complex and intertwined genetic pathways unlike those of early life forms. Consequently, comparing existing bacteria with fossilized life forms is largely hypothetical, a point that should be more thoroughly emphasized in the discussion. 

      Another weak aspect of the study is the absence of any quantitative data. While we understand that obtaining such data for microfossils may be challenging, it would be helpful to present the frequencies of different proliferative events observed in the bacterium used. Additionally, reflecting on the chemical factors in early life that might cause these distinct proliferation modes would provide valuable context. 

      Regarding our choice of using modern organisms or this particular bacterial species: 

      Based on current scientific knowledge, it is logical to infer that cellular life originated as protocells; nevertheless, there has been no direct geological evidence for the existence of such cells on early Earth. Hence, protocells remain an entirely theoretical concept. Moreover, protocells are considered to have been far more primitive than present-day cells. Surprisingly, this lack of sophistication was the biggest challenge in understanding protocells. Designing experiments in which cells are primitive (but not as primitive as non-living lipid vesicles) and still retain a functional resemblance to a living cell does pose some practical challenges. Laboratory experiments with substitute (proxy) protocells almost always come with some limitations. Although not a perfect proxy, we believe protocells and protoplasts share certain characteristics. Having said that, we would like to reemphasize that protoplasts are not protocells. Our reasons for using protoplasts as model organisms and working with this bacterial species (Exiguobacterium Strain-Molly) are based on several scientific and practical criteria listed below.

      (1) Irrespective of cell physiology and intracellular complexity, we believe that protoplasts and protocells share certain similarities in the biophysical properties of their cytoplasm. We explained our reasoning in the manuscript introduction and in our previous manuscripts (Kanaparthi et al., 2024 & Kanaparthi et al., 2023). In short, to be classified as a cell, even a protocell should possess minimal biosynthetic pathways, a physiological mechanism of harvesting free energy from the surrounding (energy-yielding pathways), and a means of replicating its genetic material and transferring it to the daughter cells. These minimal physiological processes could incorporate considerable cytoplasmic complexity. Hence, the biophysical properties of the protocell cytoplasm could have resembled those of the cytoplasm of protoplasts, irrespective of the genomic complexity. 

      (2) Irrespective of their physiology, protoplasts exhibit several key similarities to protocells, such as their inherent inability to regulate their morphology or reproduction. This similarity was pointed out in previous studies (3). Despite possessing all the necessary genetic information, protoplasts undergo reproduction through simple physiochemical processes independent of canonical molecular biological processes. This method of reproduction is considered to have been erratic and rather primitive, akin to the theoretical propositions on protocells. Although protoplasts are fully evolved cells with considerable physiological complexity, the above-mentioned biophysical similarities suggest that the protoplast life cycle could morphologically resemble that of protocells (in no other aspect except for their morphology and reproduction).  

      (3) Physiologically or genomically different species of Gram-positive protoplasts are shown to exhibit similar morphologies. This suggests that when Gram-positive bacteria lose their cell wall and turn into a protoplast,  they reproduce in a similar manner independent of physiological or genome-based differences. As morphology and only morphology is key to our study, at least from the scope of this study, intracellular complexity is not a key consideration. 

      (4) This specific strain was isolated from submerged freshwater springs in the Dead Sea. This isolate and members of this bacterial genus are known to have been well acclimatized to growing in a wide range of salt concentrations and in different salt species. This is important for our study (this and previous manuscript), in which cells must be grown not only at high salt concentrations (1-15%) but in different salts like NaCl, MgCl<sub>2</sub>, and KCl. 

      (5) Our initial interest in this isolate was due to its ability to reduce iron at high salt concentrations. Given that most spherical microfossils are found in Archaean-banded iron formations covered in pyrite, this suggests that these microfossils could have been reducing oxidized iron species like Fe(III). Nevertheless, over the course of our study, we realized the complexities of live cell staining and imaging under anoxic conditions. Given that the scope of the manuscript is restricted only to comparing the morphologies, not the physiology, we abandoned the idea of growing cells under anoxic conditions.  

      Based on these observations, cell physiology may not be a key consideration, at least within the scope of studying microfossil morphology. However, we want to emphasize again that “We do not claim present-day protoplasts are protocells.”  

      Regarding the absence of quantitative data:

      We are unsure what the reviewer meant by the absence of quantitative data. Is it from the cell size/reproductive pathways perspective or from a microfossil/ecological perspective? At the risk of being portrayed in a bad light, we admit that we did not present quantitative data from either of these perspectives. In our defense, this was not due to our lack of effort but due to the practical limitations imposed by our model organism. 

      If the reviewer means the quantitative data regarding cell sizes and morphology: In our previous work, we studied the relationship between protoplast morphology, growth rate, and environmental conditions. In that study, we proposed that the growth rate is one factor that regulates protoplast morphology. Nevertheless, we did not observe uniformity in the sizes of the cells. This lack of uniformity was not just between the replicates but even among the cells grown within the same culture flask or the cells within the same microscopic field. Moreover, cells are often observed to be reproducing either by forming internal or external or by both these processes at the same time. The size and morphological differences among cells within a growth stage could be explained by the physiological and growth rate heterogenicity among cells. 

      Bacterial growth curves and their partition into different stages (lag, log & stationary), in general, represent the growth dynamics of an entire bacterial population. Nevertheless, averaging the data obscures the behavior of individual cells (4,5). It is known that genetically identical cells within a single bacterial population could exhibit considerable cell-to-cell variation in gene expression (6,7) and growth rates (8). The reason for such stochastic behavior among monoclonal cells has not been well understood. In the case of normal cells, morphological manifestation of these variations is restricted by a rigid cell wall. Given the absence of a cell wall in protoplasts, we assume such cell-to-cell variations in growth rate is manifested in cell morphology. This makes it challenging to quantitatively determine variations in cell sizes or the size increase in a statically robust manner, even in monoclonal cells. 

      Although this lack of uniformity in cell sizes should not be perceived as a limitation, this behavior is consistently observed among microfossils. Spherical microfossils of similar morphology but different sizes were reported from different microfossil sites (9,10). In this regard, both protoplasts and microfossils are very similar. 

      If the reviewer means the quantitative data from an ecological perspective: 

      Based on the elemental composition and the isotopic signatures of the organic carbon, we can deduce if these structures are of biological origin or not. However, any further interpretation of this data to annotate these microfossils to a particular physiology group is fraught with errors. Hence, we refrain from making any inferences about the physiology and ecological function of these microfossils. This lack of clarity on the physiology of microfossils reduces the chance of quantitative studies on their ecological functions. Moreover, we would like to re-emphasize that the scope of this work is restricted to morphological comparison and is not targeted at understanding the ecological function of these microfossils. This narrow objective also limits the nature of the quantitative data we could present.

      Moreover, developing a quantitative understanding of some phenomena could be technically challenging. Many theories on the origin of life, like chemical evolution, started with the qualitative observation that lightning could mediate the synthesis of biologically relevant organic carbon. Our quantitative understanding of this process is still being explored and debated even to this day.     

      Reviewer #2 (Public Review): 

      Summary: 

      In summary, the manuscript describes life-cycle-related morphologies of primitive vesiclelike states (Em-P) produced in the laboratory from the Gram-positive bacterium Exiguobacterium Strain-Molly) under assumed Archean environmental conditions. Em-P morphologies (life cycles) are controlled by the "native environment". In order to mimic Archean environmental conditions, soy broth supplemented with Dead Sea salt was used to cultivate Em-Ps. The manuscript compares Archean microfossils and biofilms from selected photos with those laboratory morphologies. The photos derive from publications on various stratigraphic sections of Paleo- to Neoarchean ages. Based on the similarity of morphologies of microfossils and Em-Ps, the manuscript concludes that all Archean microfossils are in fact not prokaryotes, but merely "sacks of cytoplasm". 

      Strengths: 

      The approach of the authors to recognize the possibility that "real" cells were not around in the Archean time is appealing. The manuscript reflects the very hard work by the authors composing the Em-Ps used for comparison and selecting the appropriate photo material of fossils. 

      Weaknesses: 

      While the basic idea is very interesting, the manuscript includes flaws and falls short in presenting supportive data. The manuscript makes too simplistic assumptions on the "Archean paleoenvironment". First, like in our modern world, the environmental conditions during the Archean time were not globally the same. Second, we do not know much about the Archean paleoenvironment due to the immense lack of rock records. More so, the Archean stratigraphic sections from where the fossil material derived record different paleoenvironments: shelf to tidal flat and lacustrine settings, so differences must have been significant. Finally, the Archean spanned 2.500 billion years and it is unlikely that environmental conditions remained the same. Diurnal or seasonal variations are not considered. Sediment types are not considered. Due to these reasons, the laboratory model of an Archean paleoenvironment and the life therein is too simplistic. Another aspect is that eucaryote cells are described from Archean rocks, so it seems unlikely that prokaryotes were not around at the same time. Considering other fossil evidence preserved in Archean rocks except for microfossils, the many early Archean microbialites that show baffling and trapping cannot be explained without the presence of "real cells". With respect to lithology: chert is a rock predominantly composed of silica, not salt. The formation of Em-Ps in the "salty" laboratory set-up seems therefore not a good fit to evaluate chert fossils. Formation of structures in sediment is one step. The second step is their preservation. However, the second aspect of taphonomy is largely excluded in the manuscript, and the role of fossilization (lithification) of Em-Ps is not discussed. This is important because Archean rock successions are known for their tectonic and hydrothermal overprint, as well as recrystallization over time. Some of the comparisons of laboratory morphologies with fossil microfossils and biofilms are incorrect because scales differ by magnitudes. In general, one has to recognize that prokaryote cell morphologies do not offer many variations. It is possible to arrive at the morphologies described in various ways including abiotic ones. 

      Regarding the simplistic presumptions on the Archaean Eon environmental conditions, we provided a detailed explanation of this issue in our response to the eLife evaluation. In short, we agree with the reviewer that little is known about the Archaean Eon environmental conditions at a planetary scale. Hence, we restricted our study to one particular environment of which we had a comparatively good understanding. The Archaean Eon spanned 2.5 billion years. However, most of the microfossil sites we discussed in the manuscript are older than 3 billion years, with one exception (2.4 billion years old Turee Creek microfossils). We presume that conditions within this niche (coastal marine) environment could not have changed greatly until 2Ga, after which there have been major changes in the ocean salt composition and salinities.

      In the manuscript, we discussed extensively the reasons for restricting our study to these particular environmental conditions. Further explanations of these choices are presented in our response to the eLife evaluation (also see our previous manuscript). In short, the fact that all known microfossils are restricted to coastal marine environments justifies the experimental conditions employed in our study. Nevertheless, we agree with the reviewer that all lab-based studies involve some extent of simplification. This gap/mismatch is even wider when it comes to studies involving origin or early life on Earth.

      We are not arguing that prokaryotes are not around at this time. The key message of the manuscript is that they are present, but they have not developed intracellular mechanisms to regulate their morphology and remained primitive in this aspect.  

      The sizes of the microfossils and cells from our study were similar in most cases. However, we agree with the reviewer that they deviated considerably in some cases, for example, S70, S73, and S83. These size variations are limited to sedimentary structures like laminations rather than cells. These differences should be expected as we try to replicate the real-life morphologies of biofilms that could have extended over large swats of natural environments in a 2ml volume chamber slide. More specifically, in Fig. S70, there is a considerable size mismatch. But, in Fig. S73, the sizes were comparable between A & C (of course, the size of our reproduction did not match B). In the case of Fig. S83, we do not see a huge size mismatch.      

      Reviewer #1 (Recommendations For The Authors): 

      We would like to provide several suggestions for changes in text and additions to data analysis. 

      39-41: It has been stated that reconstructing the lifecycle is the only way of understanding the nature of these microfossils. First of all, I would rephrase this to 'the most promising way', as there are always multiple approaches to comparing phenomena. 

      We agree with the reviewer's suggestion. The suggested changes have been made (line 41). 

      125: Please rephrase "under the environmental condition of early Earth" to "under experimental conditions possibly resembling the conditions of the Paleoarchean Eon". Now it sounds like the exact environmental conditions have been produced, which has already been debated in the discussion. 

      We agree with the reviewer's suggestion. The suggested changes have been made (line 127). 

      125: Please mention the fold change in size, the original size in numbers, and whether this change is statistically significant. 

      In the above sections of this document, we explained our reservations about presenting the exact number.

      128: Have you found a difference in the relative percentages of modes of reproduction? In other words, is there a difference in percentage between forming internal daughter cells or a string of external daughter cells? 

      We explained our reservations about presenting the exact number above. But this has been extensively discussed in our accompaining manuscript. We want to reemphasize that the scope of this manuscript is restricted to comparing morphologies rather than providing a mechanistic explanation of the reproduction process. 

      151: A similar model for endocytosis has already been described in proliferating wall-less cells (Kapteijn et al., 2023). In the discussion, please compare your results with the observations made in that paper. 

      This is an oversight on our part. The manuscript suggested by the reviewer has now been added (line 154 & 155).  

      163: Please use another word for uncanny. We suggest using 'strong resemblance'. 

      We changed this according to the reviewers' suggestion (line 168). 

      433: Please elaborate on why the results are not shown. This sounds like a statement that should be substantiated further. 

      To observe growth and simultaneously image the cells, we conducted these experiments in chamber slides (2ml volume). Over time, we observed cells growing and breaking out of the salt crust (Fig. S86, S87 & Movie 22) and a gradual increase in the turbidity of the media. Although not quantitative, this is a qualitative indication of growth. We did not take precise measurements for several reasons. This sample is precious; it took us almost two years to solidify the biofilm completely, as shown in Fig. S84A. Hence, it was in limited supply, which prevented us from inoculating these salt crusts into large volumes of fresh media. Given a long period of starvation, these cells often exhibited a long lag phase (several days), and there wasn't enough volume to do OD measurements over time. 

      We also crushed the solidified biofilm with a sterile spatula before transferring it into the chamber slide with growth media. This resulted in debris in the form of small solid particles, which interfered with our OD measurements. These practical considerations made it challenging to determine the growth precisely. Despite these challenges, we measured an OD of 4 in some chamber slides after two weeks of incubation. Given that these measurements were done haphazardly, we chose not to present this data. 

      456: Could you please double-check whether the description is correct for the figure? 8C and 8D are part of Figure 8B, but this is stated otherwise in the description. 

      We thank the reviewer for pointing it out. It has now been rectified (line 461-472).

      Reviewer #2 (Recommendations For The Authors): 

      We thank Reviewer #2  for carefully reading the manuscript and such an elaborate list of questions. The revisions suggested have definitely improved the quality of the manuscript. Here, we would like to address some of the questions that came up repeatedly below. One frequently asked question is regarding the letters denoting the individual figures within the images. For comparison purposes, we often reproduced previously published images. To maintain a consistent figure style, we often have to block the previous denotations with an opaque square and give a new letter. 

      The second question that appeared repeatedly below is the missing scale bars in some of the images within a figure. We often did not include a scale bar in the images when this image is an enlarged section of another image within the same figure.     

      Title: Please consider being more precise in the title. Microfossils are only one fossil group of "oldest life". Perhaps better: "On the nature of some microfossils in Archean rocks". (see also Line 37).  

      Authors’ response: The title conveys a broader message without quantitative insinuations. If our manuscript had been titled "On the nature of all known Archaean microfossils,” we should have agreed with the reviewer's suggestion and changed it to "On the nature of some microfossils in Archean rocks". As it is not, we respectfully decline to make this modification.     

      Abstract:  

      Line 41: "one way", not "the only way" 

      We agree with the reviewer’s comment, and necessary changes have been made (line 41).  

      Introduction: 

      Line 58f: "oldest sedimentary rock successions", not "oldest known rock formations". There are rocks of much older ages, but those are not well preserved due to metamorphic overprint, or the rocks are igneous to begin with. Minor issue: please note that "formations" are used as stratigraphic units, not so much to describe a rock succession in the field. 

      We agree with the reviewer’s comment and have made necessary changes (line 58).

      Line 67: Microfossils are widely accepted as evidence of life. Please rephrase. 

      We agree with the reviewer’s comment, and necessary changes have been made.

      Line 71 - 74: perhaps add a sentence of information here.

      We agree with the reviewer’s comment, and necessary changes have been made (line 71).

      Line 76: which "chemical and mineralogical considerations"? 

      This has been rephrased to “Apart from the chemical and δ<sup>13</sup>C-biomass composition” (line 76).

      Line 84ff: This is a somewhat sweeping statement. Please remember that there are microbialites in such rocks that require already a high level of biofilm organization. The existence of cyanobacteria-type microbes in the Archean is also increasingly considered. 

      We are aware of literature that labeled the clusters of Archaean microfossils as biofilms and layered structures as microbialites or stromatolite-like structures. However, the use of these terms is increasingly being discouraged. A more recent consensus among researchers suggests annotating these structures simply as sedimentary structures, as microbially induced sedimentary structures (MISS). 

      We respectfully disagree with the reviewer’s comment that Archaean microfossils exhibit a high level of biofilm organization. We are not aware of any studies that have conducted such comprehensive research on the architecture of Archaean biofilms. We are not even certain if these clusters of Archaean cells could even be labeled as biofilms in the true sense of the term. We presently lack an exact definition of a biofilm. In our study, we do see sedimentation and bacteria and their encapsulation in cell debris. From a broader perspective, any such aggregation of cells enclosed in cell debris could be annotated as a biofilm. However, more in-depth studies show that biofilm is not a random but a highly organized structure. Different bacterial species have different biofilm architectures and chemical composition. The multispecies biofilms in natural environments are even more complex. We do agree with the reviewer that these structures could broadly be labeled as biofilms, but we presently lack a good, if any, understanding of the Archaean biofilm architecture. 

      Regarding the annotation of microfossils as cyanobacteria, we respectfully disagree with the reviewer. This is not a new concept. Many of the Archaean microfossils were annotated as cyanobacteria at the time of their discovery. This annotation is not without controversy. With the advent of genome-based studies, researchers are increasingly moving away from this school of thought.  

      Line 101ff: The conditions on early Earth are unknown - there are many varying opinions. Perhaps simply state that this laboratory model simulates an Archean Earth environment of these conditions outlined. 

      This is a good idea. We thank the reviewer for this suggestion, and we made appropriate changes. 

      Line 112: manuscript to be replaced by "paper"? 

      This change has been made (line 114).

      Line 116: "spanned years" - how many years? 

      We now added the number of years in the brackets (line 118).

      Results: 

      Line 125: see comment for 101ff. 

      we made appropriate changes. 

      Figure 1: Caption: Please write out ICV the first time this abbreviation is used. Images: Note that some lettering appears to not fit their white labels underneath. (G, H, I, J0, and M). 

      We apologize; this is an oversight on our part. We now spell complete expansion of ICV, the first time we used this abbreviation. 

      We took these images from previously published work (references in the figure legend), so we must block out the previous figure captions. This is necessary to maintain a uniform style throughout the manuscript. 

      Line 152ff.: here would be a great opportunity to show in a graph the size variations of modern ICVs and to compare the variations with those in the fossil material. 

      In the above sections of this document, we explained our reservations about presenting the exact number.

      Line 159f.: Fig.1K - what is to see here? Maybe a close-up or - better - a small sketch would help? 

      Fig. 1K shows the surface depressions formed during the vesicle formation. The surface characteristics of EM-P and microfossils is very similar.   

      Line 161f.: reference?  

      The paragraph spanning lines 159 to 172 discusses the morphological similarities between EM-P and SPF microfossils. We rechecked the reference no 35 (Delarue 2019). This is the correct reference. We do not see a mistake if the reviewer meant the reference to the figures.    

      Line 164ff.: A question may be asked, how many fossils of the Strelley Pool population would look similar to the "modeled" ones. Questions may rise in which way the environmental conditions control such morphology variations. Perhaps more details? 

      This relationship between the environmental conditions and the morphology is discussed extensively in our previous work (11).  

      Line 193: what is meant by "similar discontinuous distribution of organic carbon"?

      This statement highlights similarities between EM-P and microfossils. The distribution of cytoplasm within the cells is not uniform. There are regions with and devoid of cytoplasm, which is quite unusual for bacteria. Some previous studies argued that this could indicate that these organic structures are of abiotic origin. Here, we show that EMP-like cells could exhibit such a patchy distribution of cytoplasm within the cell.    

      Line 218 - 291: The observations are very nice, however, the figures of fossil material in Figures 3 A, B, and C appear not to conform. Perhaps use D, E and I to K. Also, S48 does not show features as described here (see below).  

      We did not completely understand the reviewer’s question. As mentioned in the figure legend, both the microfossils and the cells exhibit string with spherical daughter cells within them. Moreover, there are also other similarities like the presence of hollow spherical structures devoid of organic carbon. We also saw several mistakes in the Fig. S48 legend. We have rectified them, and we thank the reviewer for pointing them out.   

      Line 293f: Title with "." at end?

      This change has been made.

      Line 298: predominantly in chert. In clastic material preservation of cells and pores is unlikely due to the common lack of in situ entombment by silica. 

      We rephrased this entire paragraph to better convey our message. Either way, we are not arguing that hollow pore spaces exist. As the reviewer mentioned, they will, of course, be filled up with silica. In this entire paragraph, we did not refer to hollow spaces. So, we are not entirely sure what the question was.     

      Line 324, 328-349: Please see below comments on the supplementary figures 51-62. Some of the interpretations of morphologies may be incorrect. 

      Please find our response to the reviewer’s comments on individual figures below.  

      Figure 5 A to D look interesting, however E to J appear to be unconvincing. What is the grey frame in D (not the white insert). 

      The grey color is just the background that was added during the 3D rendering process.  

      Figure 6 does not appear to be convincing. - Erase? 

      We did not understand the reviewer’s reservations regarding this figure. Images A-F within the figure show the gradual transformation of cells into honeycomb-like structures, and images G-J show such structures from the Archaean that are closely associated with microfossils. Moreover, we did not come up with this terminology (honeycomb-like). Previous manuscripts proposed it.  

      Line 379ff: S66 and 69, please see my comments below. Microfossils "were often discovered" in layers of organic carbon. 

      Please see our response below.   

      Line 393-403: Laminae? There are many ways to arrive at C-rich laminae, especially, if the material was compressed during burial. Basically, any type of biofilm would appear as laminae, if compressed. The appearance of thin layers is a mere coincidence. Note that the scale difference in S70, S73, as well as S83, is way too high (cm versus μm!) to allow any such sweeping conclusions. What are α- and β- laminations, the one described by Tice et al.? The arguments are not convincing.

      We propose that cells be compressed to form laminae. We answered this question above about the differences in the scale bars. Yes, we are referring to α- and β- laminations described by Tice et al.       

      Figure 7: This is an interesting figure, but what are the arguments for B and C, the fossil material, being a membrane? Debris cannot be distinguished with certainty at this scale in the insert of C. B could also be a shriveled-up set of trichomes.  

      We agree with the reviewer that debris cannot be definitely differentiated. Traditionally, annotations given to microfossil structures such as biofilm, intact cells, or laminations were all based on morphological similarities with existing structures observed in microorganisms. Given that the structures observed in our study are very similar to the microfossil structures, it is logical to make such inferences. Scales in A & B match perfectly well. The structure in C is much larger, but, as we mentioned in reply to one of the reviewer’s earlier questions, some of the structures from natural environments could not be reproduced at scale in lab experiments. Working in a 2 ml chamber slides does impose some restrictions.   

      Figure 8: The figure does not show any honeycomb patterns. The "gaps" in the Moodies laminae are known as lenticular particles in biofilms. They form by desiccated and shriveledup biofilm that mineralizes in situ. Sometimes also entrapped gases induce precipitation. Note also that the modelled material shows a kind of skin around the blobs that are not present in the Moodies material.  

      We agree that entrapped gas bubbles could have formed lenticular gaps. In the manuscript, we did not discount this possibility. However, if that is the case, one should explain why we often find clumps of organic carbon within these gaps. As we presented a step-by-step transformation of parallel layers of cells into laminations, which also had similar lenticular gaps, we believe this is a more plausible way such structures could have formed. In the end, there could have been more than one way such structures could have been formed. 

      We do see the honeycomb pattern in the hollow gaps. Often, the 3D-rendering of the STED images obscures some details. Hence, in the figure legend, we referred to the supplementary figures also show the sequence of steps involved in the formation of such a pattern.      

      Line 405-417: During deposition of clastic sediment any hollow space would be compressed during burial and settling. It is rare that additional pore space (except between the graingrain-contacts) remains visible, especially after consolidation. The exception would be if very early silicification took place filling in any pore space. What about EPS being replaced by mineralic substance? The arguments are not convincing. 

      We are suggesting that EPS or cell debris is rapidly encrusted by cations from the surrounding environment and gets solidified into rigid structures. This makes it possible for the structures to be preserved in the fossil record. We believe that hollow structures like the lenticular gaps will be filled up with silica. 

      We do not agree with the reviewer’s comment that all biological structures will be compressed. If this is true, there should be no intact microfossils in the Archaean sedimentary structures, which is definitely not the case.      

      Line 419-430: Lithification takes place within the sediment and therefore is commonly controlled by the chemistry of pore water and chemical compounds that derive from the dissolution of minerals close by. Another aspect to consider is whether "desiccation cracks" on that small scale may be artefacts related to sample preparation (?).  

      We agree that desiccation cracks could have formed during the sample preparation for SEM imaging, as this involves drying the biofilms. However, we observed that the sample we used for SEM is a completely solidified biofilm (Fig. S84), so we expect little change in its morphology during drying. Moreover, visible cracks and pointy edges were also observed in wet samples, as shown in Fig. S87.        

      Line 432 - 439: Please see comments on the supplementary material below.

      Please find our response to the reviewer’s comments on individual figures below.  

      Discussion:  

      Line 477f: "all known microfossil morphologies" - is this a correct statement? Also, would the Archean world provide only one kind of "EM-P type"? Morphologies of prokaryote cells (spherical, rod-shaped, filamentous) in general are very simple, and any researcher of Precambrian material will appreciate the difficulties in concluding on taxonomy. There are papers that investigate putative microfossils in chert as features related to life cycles. Microfossil-papers commonly appear not to be controversial give and take some specific cases.  

      We made a mistake in using the term “all known microfossil morphologies.” We have now changed it to “all known spherical microfossils” from this statement (line 483). However, we do not agree with the statement that microfossil manuscripts tend not to be controversial. Assigning taxonomy to microfossils is anything but controversial. This has been intensely debated among the scientific community.     

      Line 494-496: This statement should be in the Introduction.

      We agree with the reviewer’s comment. In an earlier version of the manuscript this statement was in the introduction. To put this statement in its proper context, it needs to be associated with a discussion about the importance of morphology in the identification of microfossils. The present version of the manuscript do not permit moving an entire paragraph into the introduction. Hence, we think making this statement in the discussion section is appropriate. 

      Line 484ff. The discussion on biogenicity of microfossils is long-standing (e.g., biogenicity criteria by Buick 1990 and other papers), and nothing new. In paleontology, modern prokaryotes may serve as models but everyone working on Archean microfossils will agree that these cannot correspond to modern groups. An example is fossil "cyanobacteria" that is thought to have been around already in the early Archean. While morphologically very similar to modern cyanobacteria, their genetic information certainly differed - how much will perhaps remain undisclosed by material of that high age.  

      Yes, we agree with the reviewer that there has been a longstanding conflict on the topic of biogenicity of microfossils. However, we have never come across manuscripts suggesting that modern microorganisms should only be used as models. If at all, there have been numerous manuscripts suggesting that these microfossils represent cyanobacteria, streptomycetes, and methanotrophs. Regarding the annotation of microfossils as cyanobacteria, we addressed this issue in one of the previous questions raised by the reviewer.    

      Line 498ff: Can the variation of morphology and sizes of the EM-Ps be demonstrated statistically? Line 505ff are very speculative statements. Relabeling of what could be vesicles as "microfossils" appears inappropriate. Contrary to what is stated in the manuscript, the morphologies of the Dresser Formation vesicles do not resemble the S3 to S14 spheroids from the Strelley Pool, the Waterfall, and Mt Goldsworthy sites listed in the manuscript. The spindle-shaped vesicles in Wacey et al are not addressed by this manuscript. What roles in mineral and element composition would have played diagenetic alteration and the extreme hydrothermal overprint and weathering typical for Dresser material? S59, S60 do not show what is stated, and the material derives from the Barberton Greenstone Belt, not the Pilbara.

      Please see the comments below regarding the supplementary images. 

      We did not observe huge variations in the cell morphology. Morphologies, in most cases, were restricted to spherical cells with intracellular vesicles or filamentous extensions. Regarding the sizes of the cells, we see some variations. However, we are reluctant to provide exact numbers. We have presented our reasons above.

      We respectfully disagree with the reviewer’s comments. We see quite some similarities between Dresser formation microfossils and our cells. Not just the similarities, we have provided step-by-step transformation of cells that resulted in these morphologies. We fail to see what exactly is the speculation here. The argument that they should be classified as abiotic structures is based on the opinion that cells do form such structures. We clearly show here that they can, and these biological structures resemble Dresser formation microfossils more closely than the abiotic structures. 

      Regarding the figures S3-S14. We think they are morphologically very similar. Often, it's not just comparing both images or making exact reproductions (which is not possible). We should focus on reproducing the distinctive morphological features of these microfossils.  

      We agree with the reviewer that we did not reproduce all the structures reported by Wacey’s original manuscript, such as spherical structures. We are currently preparing another manuscript to address the filamentous microfossils. These spindle-like structures will be addressed in this subsequent work. 

      We agree with the reviewer, we often have difficulties differentiating between cells and vesicles. This is not a problem in the early stages of growth. During the log phase, a significant volume of the cell consists of the cytoplasm, with hollow vesicles constituting only a minor volume (Fig. 1B or S1A). During the later growth stages (Fig. 1E7F or S11), cells were almost hollow, with numerous daughter cells within them. These cells often resemble hollow vesicles rather than cells. However, given these are biologically formed structures, and one could argue that these vesicles are still alive as there is still a minimal amount of cytoplasm (Fig. S27). Hence, we should consider them as cells until they break apart to release daughter cells. 

      Regarding Figures S59 and S60, we did not claim either of these microfossils is from Pilbara Iron Formations. The legend of Figure S59 clearly states that these structures are from Buck Reef Chert, originally reported by Tice et al., 2006 (Figure 16 in the original manuscript). The legend of Figure S60 says these structures were originally reported by Barlow et al., 2018, from the Turee Creek Formation. 

      Line 546f and 552: The sites including microfossils in the Archean represent different paleoenvironments ranging from marine to terrestrial to lacustrine. References 6 and 66 are well-developed studies focusing on specific stratigraphic successions, but cannot include information covering other Archean worlds of the over 2.5 Ga years Archean time.  

      All the Archaean microfossils reported to date are from volcanic coastal marine environments. We are aware that there are rocky terrestrial environments, but no microfossils have been reported from these sites. We are unaware of any Archaean microfossils reported from freshwater environments. 

      Line 570ff: The statements may represent a hypothesis, but the data presented are too preliminary to substantiate the assumptions.

      We believe this is a correct inference from an evolutionary, genomic, and now from a morphological perspective. 

      Figures:  

      Please check all text and supplementary figures, whether scale bars are of different styles within the figure (minor quibble). 

      S3 (no scale in C, D); S4, S5: Note that scale bars are of different styles. 

      We believe we addressed this issue above. 

      S6 D: depressions here are well visible - perhaps exchange with a photo in the main text? Note that scale bars are of different styles.  

      We agree that depressions are well visible in E. The same image of EM-P cell in E is also present in Fig. 1D in the main text.   

      S7: Scale bars should all be of the same style, if anyhow possible. Scale in D? 

      We believe we addressed this issue above. 

      S9: F appears to be distorted. Is the fossil like this? The figure would need additional indicators (arrows) pointing toward what the reader needs to see - not clear in this version. More explanation in the figure caption could be offered. 

      We rechecked the figure from the original publication to check if by mistake the figure was distorted during the assembly of this image. We can assure you that this is not the case. We are not sure what further could be said in the figure legend.     

      S13: What is shown in the inserts of D and E that is also visible in A and B? Here a sketch of the steps would help. 

      We did not understand the question.  

      S14: Scale in A, B? 

      We believe we addressed this issue above. 

      S15: Scales in A, E, C, D 

      We believe we addressed this issue above. 

      S16: scales in D, E, G, H, I, J?  

      We believe we addressed this issue above. 

      S17: "I" appears squeezed, is that so? If morphology is an important message, perhaps reduce the entire figure so it fits the layout. Note that labels A, B, C, and D are displaced. 

      As shown in several subsequent figures, the hollow spherical vesicles are compressed first into honeycomb-like structures, and they often undergo further compression to form lamination-like structures. Such images often give the impression that the entire figure is squashed, but this is not the case. If one examines the figure closely, you could see perfectly spherical vesicles together with laterally sqeezed structures. Regarding the figure labels, we addressed this issue above. 

      S18: The filamentous feature in C could also be the grain boundaries of the crystals. Can this be excluded as an interpretation? Are there microfossils with the cell membranes? That would be an excellent contribution to this figure. Note that scale bars are of different styles.

      If this is a one-off observation, we could have arrived at the reviewer's opinion. But spherical cells in a “string of beads” configuration were frequently reported from several sites, to be discounted as mere interpretation.    

      S19: The morphologies in A - insert appear to be similar to E - insert in the lower left corner. The chain of cells in A may look similar to the morphologies in E - insert upper right of the image. B - what is to see here? D - the inclusions do not appear spherical (?). Does C look similar to the cluster with the arrow in the lower part of image E? Note that scale bars are of different styles (minor quibble). A, B, C, and D appear compressed. Perhaps reduce the size of the overall image?  

      The structures highlighted (yellow box) in C are similar to the highlighted regions in E—the agglomeration of hollow vesicles. It is hard to get understand this similarity in one figure. The similarities are apparent when one sees the Movie 4 and Fig. S12, clearly showing the spherical daughter cells within the hollow vesicle. We now added the movie reference to the figure legend.    

      S20: A appears not to contribute much. The lineations in B appear to be diagenetic. However, C is suitable. Perhaps use only C, D, E? 

      We believe too many unrecognizable structures are being labeled as diagenetic. Nevertheless, we do not subscribe to the notion that these are too lenient interpretations. These interpretations are justified as such structures have not been reported from live cells. This is the first study to report that cells could form such structures. As we now reproduced these structures, an alternate interpretation that these are organic structures derived from microfossils should be entertained. 

      S 21: Note that scale bars are of different styles.  

      We believe we addressed this issue above. 

      S22: Perhaps add an arrow in F, where the cell opened, and add "see arrow" in the caption? Is this the same situation as shown in C (white arrow)? What is shown by the white arrow in A? Note that scale bars are of different styles.

      We did the necessary changes.  

      S23: In the caption and main text, please replace "&" with "and" (please check also the other figure captions, e.g. S24). Note that scale bars are of different styles. What is shown in F? A, D - what is shown here?

      We replaced “&” with “and.”  

      S24: Note that scale bars are of different styles. Note that Wacey et al. describe the vesicles as abiotic not as "microfossils"; please correct in figure caption [same also S26; 25; 28].

      We are aware of Prof. Dr. Wacey’s interpretations. We discuss it at length in the discussion section our manuscript. Based on the similarities between the Dresser formation structures and structures formed by EM-P, we contest that these are abiotic structures.  

      S25: Appears compressed; note different scale bars. 

      We believe we addressed this issue above. 

      S28: The label in B is still in the upper right corner; scale in D? What is to see in rectangles (blue and red) in A, B? In fossil material, this could be anything. 

      These figures are taken from a previous manuscript cited in the figure legend. We could not erase or modify these figures.  

      S33: "L"ewis; G appears a bit too diffuse - erase? Note that scale bars are of different styles.

      We believe we addressed this issue above. 

      S34: This figure appears unconvincing. Erase? 

      There are considerable similarities between the microfossils and structures formed by EM-P. If the reviewer expands a bit on what he finds unconvincing, we can address his reservations.    

      S35: It would be more convincing to show only the morphological similarities between the cell clusters. B and C are too blurry to distinguish much. Scales in D to F and in sketches? A appears compressed (?). 

      We rechecked the original manuscript to see if image A was distorted while making this figure, but this is not the case. Regarding B & C, cells in this image are faint as they are hollow vesicles and, by nature, do not generate too much contrast when imaged with a phase-contrast microscope. There are some limitations on how much we can improve the contrast. We now added scale bars for D-I. Similarly, faint hollow vesicles can be seen in Fig. S21 C & D, and Fig. 3H.  

      S36: Very nice; in B no purple arrow is visible. Note that scale bars are of different styles. S37 and S36 are very much the same - fuse, perhaps?  

      We are sorry for the confusion. There are purple arrows in Fig. S37B-D. 

      S38: this is a more unconvincing figure - erase? 

      Unconvincing in wahy sense. There are considerable similarities between the microfossils and structures formed by EM-P. If the reviewer expands a bit on what he finds unconvincing, we can address his reservations.

      S39: white rectangle in A? Arrow in A? Note that scale bars are of different styles.

      These are some of the unavoidable remnants from the image from the original publication. 

      S40: in F: CM, V = ?; Note that scale bars are of different style. 

      It’s an oversite on our part. We now added the definitions to the figure legaend. We thank the reviewer for pointing it out.  

      S41: Rectangles in D, E, F, G can be deleted? Scales and labels missing in photos lower right. 

      Those rectangles are added by the image processing software to the 3Drendered images. Regarding the missing scale bars in H & I they are the magnified regions of F. The scale bar is already present in F.   

      S42: appears compressed. G could be trimmed. Labels too small; scale in G? 

      This is a curled-up folded membrane. We needed to lower the resolution of some images to restrict the size of the supplement to journal size restrictions. It is not possible to present 85 figures in high resolution. But we assure you that the image is not laterally compressed in any manner.   

      S43: This figure appears to be unconvincing. Reducing to pairing B, C, D with L, K? Spherical inclusions in B? Scales in E to G? Similar in S44: A, B, E only? Note that scale bars are of different styles. 

      Figures I to K are important. They show not just the morphological similarities but also the sequence of steps through which such structures are formed. We addressed the issue of the scale bars above.  

      S45: A, B, and C appear to show live or subrecent material. How was this isolated of a rock? Note that scale bars are of different styles.  

      It is common to treat rocks with acids to dissolve them and then retrieve organic structures within them. This technique is becoming increasingly common. The procedure is quite extensively discussed in the original manuscript. We don’t see much differences in the scale bars of microfossils and EM-P cells, they are quite similar. 

      S46: A: what is to see here? Note that scale bars are of different styles. 

      There are considerable similarities between the folded fabric like organic structures with spherical inclusions and structures formed by EM-P. If the reviewer expands a bit on what he finds unconvincing, we can address his reservations.    

      S47: Perhaps enlarge B and erase A. Note that scale bars are of different styles. 

      S48: Image B appears to show the fossil material - is the figure caption inconsistent? There are no aggregations visible in the boxes in A. H is described in the figure caption but missing in the figure. Overall, F and G do not appear to mirror anything in A to E (which may be fossil material?). 

      S51; S52 B, C, E; S53: these figures appear unconvincing - erase? 

      Unconvincing in what sense? The structures from our study are very similar to the microfossils.   

      S54: North "Pole; scale bars in A to C =? 

      These figures were borrowed from an earlier publication referenced in the figure legend. That is the reason for the differences in the styles of scale bars.  

      S55: D and E appear not to contribute anything. Perhaps add arrow(s) and more explanation? Check the spelling in the caption, please. 

      D & E show morphological similarities between cells from our study and microfossils (A).   

      S56: Hexagonal morphologies may also be a consequence of diagenesis. Overall, perhaps erase this figure?  

      I certainly agree that could be one of the reasons for the hexagonal morphologies. Such geometric polygonal morphologies have not been observed in living organisms. Nevertheless, as you can see from the figure, such morphologies could also be formed by living organisms. Hence, this alternate interpretation should not be discounted.   

      S57: The figure caption needs improvement. Please add more description. What show arrows in A, what are the numbers in A? What is the relation between the image attached to the right side of A? Is this a close-up? Note that scale bars are of different styles. 

      We expanded a bit on our original description of the figure. However, we request the reviewer to keep in mind that the parts of the figure are taken from previous publication. We are not at liberty to modifiy them, like removing the arrows. This imposes some constrains. 

      S58: There are no honeycomb-shaped features visible. What is to see here? Erase this figure? 

      Clearly, one can see spherical and polygonal shapes within the Archaean organic structures and mat-like structures formed by EM-P.  

      S59 and S60: What is to see here? - Erase? 

      Clearly, one can see spherical and polygonal shapes within the Archaean organic structures and mat-like structures formed by EM-P in Fig. S59. Further disintegration of these honeycomb shaped mats into filamentous struructures with spherical cells attached to them can be seen in both Archaean organic structures and structures formed by EM-P.   

      S61: This figure appears to be unconvincing. B and F may be a good pairing. Note that scale bars are of different styles.  

      There are considerable similarities between the microfossils and structures formed by EM-P. If the reviewer expands a bit on what he finds unconvincing, we might be able to address his reservations.     

      S62: This figure appears to be unconvincing - erase?

      There are considerable similarities between the microfossils and structures formed by EM-P. If the reviewer expands a bit on what he finds unconvincing, we might be able to address his reservations.     

      S66: This figure is unconvincing - erase? 

      There are considerable similarities between the microfossils and structures formed by EM-P. If the reviewer expands a bit on what he finds unconvincing, we might be able to address his reservations.    

      S68: Scale in B, D, and E? 

      Image B is just a magnified image of a small portion of image A. Hence, there is no need for an additional scale bar. The same is true for images D and E. 

      S69: This figure appears to be unconvincing, at least the fossil part. Filamentous features are visible in fossil material as well, but nothing else. 

      We are not sure what filamentous features the reviewer is referring to. Both the figures show morphologically similar spherical cells covered in membrane debris.    

      S70 [as well as S82]: Good thinking here, but scales differ by magnitudes (cm to μm). Erase this figure? Very similar to Figure S73: Insert in C has which scale in comparison to B? Note that scale bars are of different styles.  

      We realize the scale bars are of different sizes. In our defense, our experiments are conducted in 1ml volume chamber slides. We don’t have the luxury of doing these experiments on a scale similar to the natural environments. The size differences are to be expected. 

      S71: Scale in E? 

      Image E is just a magnified image of a small portion of image D. Hence, we believe a scale bar is unnecessary. 

      S72: Scale in insert?  

      The insert is just a magnified region of A & C

      S75: This figure appears to be unconvincing. This is clastic sediment, not chert. Lenticular gaps would collapse during burial by subsequent sediment. - Erase? 

      Regarding the similarities, we see similar lenticular gaps within the parallel layers of organic carbon in both microfossils, and structures formed by EM-P.

      S76: A, C, D do not look similar to B - erase? Similar to S79, also with respect to the differences in scale. Erase? 

      Regarding the similarities, we see similar lenticular gaps within the parallel layers of organic carbon in both microfossils, and structures formed by EM-P. We believe we addressed the issue of scale bars above. 

      S80: A appears to be diagenetic, not primary. Erase? 

      These two structures share too many resemblances to ignore or discount just as diagenic structures - Raised filamentous structures originate out of parallel layers of organic carbon (laminations), with spherical cells within this filamentous organic carbon.  

      S85: What role would diagenesis play here? This figure appears unconvincing. Erase?

      We do believe that diagenesis plays a major role in microfossil preservation. However, we also do not suscribe to the notion that we should by default assign diagenesis to all microfossil features. Our study shows that there could be an alternate explanation to some of the observations.  

      S86 and S87: These appear unconvincing. What is to see here? Erase? 

      The morphological similarities between these two structures. Stellarshaped organic structures with strings of spherical daughter cells growing out of them.  

      S88: Does this image suggest the preservation of "salt" in organic material once preserved in chert?  

      That is one inference we conclude from this observation. Crystaline NaCl was previously reported from within the microfossil cells.    

      S89: What is to see here? Spherical phenomena in different materials? 

      At present, the presence of honeycomb-like structures is often considered to have been an indication of volcanic pumice. We meant to show that biofilms of living organisms could result in honeycomb-shaped patterns similar to volcanic pumice.

      References 

      Please check the spelling in the references. 

      We found a few references that required corrention. We now rectified them. 

      References  

      (1) Orange F, Westall F, Disnar JR, Prieur D, Bienvenu N, Le Romancer M, et al. Experimental silicification of the extremophilic archaea pyrococcus abyssi and methanocaldococcus jannaschii: Applications in the search for evidence of life in early earth and extraterrestrial rocks. Geobiology. 2009;7(4). 

      (2) Orange F, Disnar JR, Westall F, Prieur D, Baillif P. Metal cation binding by the hyperthermophilic microorganism, Archaea Methanocaldococcus Jannaschii, and its effects on silicification. Palaeontology. 2011;54(5). 

      (3) Errington J. L-form bacteria, cell walls and the origins of life. Open Biol. 2013;3(1):120143. 

      (4) Cooper S. Distinguishing between linear and exponential cell growth during the division cycle: Single-cell studies, cell-culture studies, and the object of cell-cycle research. Theor Biol Med Model. 2006; 

      (5) Mitchison JM. Single cell studies of the cell cycle and some models. Theor Biol Med Model. 2005; 

      (6) Kærn M, Elston TC, Blake WJ, Collins JJ. Stochasticity in gene expression: From theories to phenotypes. Nat Rev Genet. 2005; 

      (7) Elowitz MB, Levine AJ, Siggia ED, Swain PS. Stochastic gene expression in a single cell. Science. 2002; 

      (8) Strovas TJ, Sauter LM, Guo X, Lidstrom ME. Cell-to-cell heterogeneity in growth rate and gene expression in Methylobacterium extorquens AM1. J Bacteriol. 2007; 

      (9) Knoll AH, Barghoorn ES. Archean microfossils showing cell division from the Swaziland System of South Africa. Science. 1977;198(4315):396–8. 

      (10) Sugitani K, Grey K, Allwood A, Nagaoka T, Mimura K, Minami M, et al. Diverse microstructures from Archaean chert from the Mount Goldsworthy–Mount Grant area, Pilbara Craton, Western Australia: microfossils, dubiofossils, or pseudofossils? Precambrian Res. 2007;158(3–4):228–62. 

      (11) Kanaparthi D, Lampe M, Krohn JH, Zhu B, Hildebrand F, Boesen T, et al. The reproduction process of Gram-positive protocells. Sci Rep. 2024 Mar 25;14(1):7075.

    1. Author response:

      We genuinely appreciate the reviewer critiques of our submitted paper, “Otoacoustic emissions but not behavioral measurements predict cochlear-nerve frequency tuning in an avian vocal-communication specialist.” We are planning a number of changes based on the reviewers’ helpful comments that we feel will substantially improve the manuscript and clarify its implications.

      We will add more support for the claim that budgerigars show unusual patterns of behavioral frequency tuning compared to other species. The original manuscript relied on previously published studies of budgerigar critical bands and psychophysical tuning curve to make this point (e.g., Fig. 1). Critical bands and psychophysical tuning curves have unfortunately not been studied in many bird species. Consequently, it was somewhat unclear (based on the information originally presented) whether the “unusual” behavioral tuning results shown in Fig. 1 reflect a hearing specialization in budgerigars or perhaps simply a general avian pattern attributable to declining audibility above 3-4 kHz (a point raised by both reviewers). Fortunately, behavioral critical-ratio results are available from a broader range of species. Albeit a less direct correlate of tuning, the results clearly highlight the unique hearing abilities of budgerigars in relation to other bird species as elaborated upon below.

      The critical ratio is the threshold signal-to-noise ratio for tone detection in wideband noise and partly depends on peripheral tuning bandwidth. Critical ratios have been studied in over a dozen bird species, the vast majority of which show similar thresholds to one another and monotonically increasing critical ratios for higher frequencies (by 2-3 dB/octave, similar to most mammals; reviewed by Dooling et al., 2000). By contrast, budgerigar critical ratios diverge markedly from other species at mid-to-high frequencies, with ~8 dB lower (more sensitive) thresholds from 3-4 kHz (Dooling & Saunders, 1975; Okanoya & Dooling, 1987; Farabaugh 1988; see Figs 5 & 6 in Okanoya & Dooling, 1987). The unusual critical-ratio function in budgerigars is not attributable to the audiogram and was hypothesized by Okanoya and Dooling (1987) to reflect specialized cochlear tuning or perhaps central processing mechanisms. A brief discussion of these studies will be added to the introduction, along with a new figure panel (for Fig. 1) illustrating these intriguing species differences in critical ratios.

      Another question was raised as to whether the simultaneous-masking paradigms and classic methods used to estimate behavioral tuning in budgerigars should be considered as valid, given newer forward-masking and notched-noise alternatives. We will expand the discussion of this issue in the revised manuscript. First, many of the methods from the classic budgerigar studies remain widely used in animal behavioral research (e.g., critical bands and ratios: Yost & Shofner, 2009; King et al., 2015; simultaneous masking: Burton et al., 2018). We therefore believe that it remains highly relevant to test and report whether these methods can accurately predict cochlear tuning. While forward-masking behavioral results are hypothesized to more accurately predict cochlear tuning humans (Shera et al., 2002; Joris et al., 2011; Sumner et al., 2018), evidence from nonhumans is controversial, with one study showing a closer match of forward-masking results to auditory-nerve tuning (ferret: Sumner et al., 2018), but several others showing a close match for simultaneous masking results (e.g., guinea pig, chinchilla, macaque; reviewed by Ruggero & Temchin, 2005; see Joris et al., 2011 for macaque auditory-nerve tuning). Moreover, forward- and simultaneous-masking results can often be equated with a simple scaling factor (e.g., Sumner et al., 2018). Given no real consensus on an optimal behavioral method, and seemingly limited potential for the “wrong” method to fundamentally transform the shape of the behavioral tuning quality function, it seems reasonable to accept previously published behavioral tuning estimates as essentially valid while also discussing limitations and remaining open to alternative interpretations.

      We will add clarification throughout the revision as to the specific behavioral measures used to quantify tuning in budgerigars (i.e., critical bands, psychophysical tuning curve, and critical ratios). This avoids potentially disparaging alternative behavioral methods that have not been tested. That the budgerigar behavioral data are “old” seems not particularly relevant considering that the methods are still used in animal behavioral research as noted previously. Rather, it seems important to clarify the specific behavioral techniques used to estimate budgerigar’s frequency tuning in the revised paper.

      Finally, we plan to add discussion of the apical-basal transition from the mammalian otoacoustic-emission literature, as suggested by reviewer 1, including how this concept might apply in budgerigars and other birds.

      References not already cited in the preprint:

      Burton JA, Dylla ME, Ramachandran R. Frequency selectivity in macaque monkeys measured using a notched-noise method. Hear Res. 2018 Jan;357:73-80. doi: 10.1016/j.heares.2017.11.012.

      King J, Insanally M, Jin M, Martins AR, D'amour JA, Froemke RC. Rodent auditory perception: Critical band limitations and plasticity. Neuroscience. 2015 Jun 18;296:55-65. doi: 10.1016/j.neuroscience.2015.03.053.

      Yost WA, Shofner WP. Critical bands and critical ratios in animal psychoacoustics: an example using chinchilla data. J Acoust Soc Am. 2009 Jan;125(1):315-23. doi: 10.1121/1.3037232. PMID: 19173418; PMCID: PMC2719489.

    1. Author response:

      (1) We do not know that the mechanism mediating the behavioral changes observed involves acetylcholine at all. (Reviewer 1)

      The reviewer rightly pointed out the co-release of acetylcholine (ACh) and GABA from cholinergic terminals. We believe that the detected behavioral changes are because of the augmentation of this innate mixed chemical signal. We agree that identifying the receptor specificity is an essential next step; however, addressing this point requires a currently unavailable research tool to block cholinergic receptors for a few hundred milliseconds. This temporal specificity is vital because acetylcholine is released in the medial prefrontal cortex (mPFC) on two distinct timescales, the slow release over tens of minutes from the task onset and the fast release time-locked to salient stimuli (TelesGrilo Ruivo et al., 2017). Moreover, the former slow signal is far more robust than the latter phasic signal. The pharmacological experiments suggested by the reviewer will suppress both the tonic and phasic signals, making it difficult to interpret the results. Given the rapid technological advancement in this field, we hope to investigate the underlying mechanisms in detail in the future. 

      (2) It is unclear whether mPFC cells are signaling predictions versus prediction errors. (Reviewer 2)

      As the reviewer pointed out, mPFC cells signal the prediction of imminent outcomes (Baeg et al., 2001; Mulder et al., 2003; Takehara-Nishiuchi and McNaughton, 2008; Kyriazi et al., 2020).

      However, the key difference between prediction signals and prediction error signals is their time course. The prediction signals begin to arise before the actual outcome occurs, whereas the prediction error signals are emitted after subjects experience the presence or absence of the expected outcome. In all our analyses, cell activity was normalized by the activity during the 1-second window before the threat site entry (i.e., the reveal of actual outcome; Lines 655-659). Also, all the statistical comparisons were made on the normalized activity during the 500-msec window, starting from the threat site entry (Lines 669670). Because this approach isolated the change in cell activity after the actual outcome, we interpret the data in Figure 4C as prediction error signals. 

      (3) The task does not fully dissociate place field coding. (Reviewer 2)

      The present analysis included several strategies to dissociate outcome selectivity from location selectivity (Figure 4). First, we collapsed cell activity on two threat sites to suppress the difference in cell activity between the sites. Second, our analysis compared how cell activity at the same location differed depending on whether outcomes were expected or surprising (Figure 4C). Nevertheless, we can use the present data to investigate the spatial tuning of mPFC cells. Indeed, an earlier version of this manuscript included some characterizations of spatial tuning. However, these data were deemed irrelevant and distracting when this manuscript was reviewed for publication in a different journal. As such, these data were removed from the current version. We are in the process of publishing another paper focusing on the spatial tuning of mPFC cells and their learning-dependent changes. 

      (4) The basic effects of cholinergic terminal stimulation on mPFC cell activity are unclear. (Reviewers 1, 3)

      We acknowledge the lack of characterization of the optogenetic manipulation of cholinergic terminals on mPFC cell activity outside the task context. As outlined in the discussion section (Lines 309-321), cholinergic modulation of mPFC cell activity is highly complex and most likely varies depending on behavioral states. In addition, because we intended to augment naturally occurring threatevoked cholinergic terminal responses (Tu et al., 2022), our optogenetic stimulation parameters were 3-5 times weaker than those used to evoke behavioral changes solely by the optogenetic stimulation of cholinergic terminals (Gritton et al., 2016). Based on these points, we validated the optogenetic stimulation based on its effects on air-puff-evoked cell activity during the task (Figure 2C, 2D). 

      (5) Some choices of statistical analyses are questionable (Reviewers 1, 3)

      We used the Kolmogorov-Smirnov (KS) test to investigate whether the distribution of cell responses differed between the two groups (Figure 2D) or changed with learning (Figure 3Ac, 3Bc). As seen in Figure 3Aa, some mPFC cells increased calcium activity in response to air-puffs, while others decreased. We expected that the manipulation or learning would alter these responses. If they are strengthened, the increased responses will become more positive, while the decreased responses will become more negative. If they are weakened, both responses will become closer to 0. Under such conditions, the shape of the distribution of cell response will change but not the median. The KS test can detect this, but not other tests sensitive to the difference in medians, such as Wilcoxon rank-sum tests. In Figure 2D, KS tests were applied to the independently sampled data from the control and ChrimsonRexpressing mice. In Figure 3Ac and 3Bc, we used all cells imaged in the first and fifth sessions. Considering that ~50% of them were longitudinally registered on both days, we acknowledge the violation in the assumption of independent sampling. In Figure 1D, we detected significant interaction between the group and sessions. Several approaches are appropriate to demonstrate the source of this interaction. We chose to conduct one-way ANOVA separately in each group to demonstrate the significant change in % adaptive choice across the sessions in the control group but not the ChrimsonR group. The cutoff for significance was adjusted with the Bonferroni correction in follow-up paired t-tests used in Figure 1F.

    1. Author response:

      Reviewer #1 (Public review):

      This manuscript presents an interesting exploration of the potential activation mechanisms of DLK following axonal injury. While the experiments are beautifully conducted and the data are solid, I feel that there is insufficient evidence to fully support the conclusions made by the authors.

      In this manuscript, the authors exclusively use the puc-lacZ reporter to determine the activation of DLK. This reporter has been shown to be induced when DLK is activated. However, there is insufficient evidence to confirm that the absence of reporter activation necessarily indicates that DLK is inactive. As with many MAP kinase pathways, the DLK pathway can be locally or globally activated in neurons, and the level of DLK activation may depend on the strength of the stimulation. This reporter might only reflect strong DLK activation and may not be turned on if DLK is weakly activated. The results presented in this manuscript support this interpretation. Strong stimulation, such as axotomy of all synaptic branches, caused robust DLK activation, as indicated by puc-lacZ expression. In contrast, weak stimulation, such as axotomy of some synaptic branches, resulted in weaker DLK activation, which did not induce the puc-lacZ reporter. This suggests that the strength of DLK activation depends on the severity of the injury rather than the presence of intact synapses. Given that this is a central conclusion of the study, it may be worthwhile to confirm this further. Alternatively, the authors may consider refining their conclusion to better align with the evidence presented.

      We wish to further clarify a striking aspect of puc-lacZ induction following injury: it is bimodal. It is either induced (in various injuries that remove all synaptic boutons), or not induced, including in injuries that spared only 1-2 remaining boutons. This was particularly evident for injuries that spared the NMJ on muscle 29, which is comprised of only a few boutons. In some instances, only a single bouton was evident on muscle 29. While our injuries varied enormously in the number of branches and boutons that were lost, we did not see a comparable variability in puc-lacZ induction.  In the revision we will include additional images to better demonstrate this observation.

      The reviewer (and others) fairly point out that our current study focuses on puc-lacZ as a reporter of Wnd signaling in the cell body. We consider this to be a downstream integration of events in axons that are more challenging to detect. It is striking that this integration appears strongly sensitized to the presence of spared synaptic boutons. Examination of Wnd’s activation in axons and synapses is a goal for our future work.

      As noted by the authors, DLK has been implicated in both axon regeneration and degeneration. Following axotomy, DLK activation can lead to the degeneration of distal axons, where synapses are located. This raises an important question: how is DLK activated in distal axons? The authors might consider discussing the significance of this "synapse connection-dependent" DLK activation in the broader context of DLK function and activation mechanisms.

      While it has been noted that inhibition of DLK can mildly delay Wallerian degeneration (Miller et al., 2009), this does not appear to be the case for retinal ganglion cell axons following optic nerve crush (Fernandes et al., 2014). It is also not the case for Drosophila motoneurons and NMJ terminals following peripheral nerve injury (Xiong et al., 2012; Xiong and Collins, 2012). Instead, overexpression of Wnd or activation of Wnd by a conditioning injury leads to an opposite phenotype - an increase in resiliency to Wallerian degeneration for axons that have been previously injured (Xiong et al., 2012; Xiong and Collins, 2012). The downstream outcome of Wnd activation is highly dependent on the context; it may be an integration of the outcomes of local Wnd/DLK activation in axons with downstream consequences of nuclear/cell body signaling.  The current study suggests some rules for the cell body signaling, however, how Wnd is regulated at synapses and why it promotes degeneration in some circumstances but not others are important future questions.

      For the reviewer’s suggestion, it is interesting to consider DLK’s potential contributions to the loss of NMJ synapses in a mouse model of ALS (Le Pichon et al., 2017; Wlaschin et al., 2023). Our findings suggest that the synaptic terminal is an important locus of DLK regulation, while dysfunction of NMJ terminals is an important feature of the ‘dying back’ hypothesis of disease etiology (Dadon-Nachum et al., 2011; Verma et al., 2022). We propose that the regulation of DLK at synaptic terminals is an important area for future study, and may reveal how DLK might be modulated to curtail disease progression. Of note, DLK inhibitors are in clinical trials (Katz et al., 2022; Le et al., 2023; Siu et al., 2018), but at least some have been paused due to safety concerns (Katz et al., 2022). Further understanding of the mechanisms that regulate DLK are needed to understand whether and how DLK and its downstream signaling can be tuned for therapeutic benefit.

      Reviewer #2 (Public review):

      Summary:

      The authors study a panel of sparsely labeled neuronal lines in Drosophila that each form multiple synapses. Critically, each axonal branch can be injured without affecting the others, allowing the authors to differentiate between injuries that affect all axonal branches versus those that do not, creating spared branches. Axonal injuries are known to cause Wnd (mammalian DLK)-dependent retrograde signals to the cell body, culminating in a transcriptional response. This work identifies a fascinating new phenomenon that this injury response is not all-or-none. If even a single branch remains uninjured, the injury signal is not activated in the cell body. The authors rule out that this could be due to changes in the abundance of Wnd (perhaps if incrementally activated at each injured branch) by Wnd, Hiw's known negative regulator. Thus there is both a yet-undiscovered mechanism to regulate Wnd signaling, and more broadly a mechanism by which the neuron can integrate the degree of injury it has sustained. It will now be important to tease apart the mechanism(s) of this fascinating phenomenon. But even absent a clear mechanism, this is a new biology that will inform the interpretation of injury signaling studies across species.

      Strengths:

      (1) A conceptually beautiful series of experiments that reveal a fascinating new phenomenon is described, with clear implications (as the authors discuss in their Discussion) for injury signaling in mammals.

      (2) Suggests a new mode of Wnd regulation, independent of Hiw.

      Weaknesses:

      (1) The use of a somatic transcriptional reporter for Wnd activity is powerful, however, the reporter indicates whether the transcriptional response was activated, not whether the injury signal was received. It remains possible that Wnd is still activated in the case of a spared branch, but that this activation is either local within the axons (impossible to determine in the absence of a local reporter) or that the retrograde signal was indeed generated but it was somehow insufficient to activate transcription when it entered the cell body. This is more of a mechanistic detail and should not detract from the overall importance of the study

      We agree. The puc-lacZ reporter tells us about signaling in the cell body, but whether and how Wnd is regulated in axons and synaptic branches, which we think occurs upstream of the cell body response, remains to be addressed in future studies.

      (2) That the protective effect of a spared branch is independent of Hiw, the known negative regulator of Wnd, is fascinating. But this leaves open a key question: what is the signal?

      This is indeed an important future question, and would still be a question even if Hiw were part of the protective mechanism by the spared synaptic branch. Our current hypothesis (outlined in Figure 4) is that regulation of Wnd is tied to the retrograde trafficking of a signaling organelle in axons. The Hiw-independent regulation complements other observations in the literature that multiple pathways regulate Wnd/DLK (Collins et al., 2006; Feoktistov and Herman, 2016; Klinedinst et al., 2013; Li et al., 2017; Russo and DiAntonio, 2019; Valakh et al., 2013). It is logical for this critical stress response pathway to have multiple modes of regulation that may act in parallel to tune and restrain its activation.

      Reviewer #3 (Public review):

      Summary:

      This manuscript seeks to understand how nerve injury-induced signaling to the nucleus is influenced, and it establishes a new location where these principles can be studied. By identifying and mapping specific bifurcated neuronal innervations in the Drosophila larvae, and using laser axotomy to localize the injury, the authors find that sparing a branch of a complex muscular innervation is enough to impair Wallenda-puc (analogous to DLK-JNK-cJun) signaling that is known to promote regeneration. It is only when all connections to the target are disconnected that cJun-transcriptional activation occurs.

      Overall, this is a thorough and well-performed investigation of the mechanism of spared-branch influence on axon injury signaling. The findings on control of wnd are important because this is a very widely used injury signaling pathway across species and injury models. The authors present detailed and carefully executed experiments to support their conclusions. Their effort to identify the control mechanism is admirable and will be of aid to the field as they continue to try to understand how to promote better regeneration of axons.

      Strengths:

      The paper does a very comprehensive job of investigating this phenomenon at multiple locations and through both pinpoint laser injury as well as larger crush models. They identify a non-hiw based restraint mechanism of the wnd-puc signaling axis that presumably originates from the spared terminal. They also present a large list of tests they performed to identify the actual restraint mechanism from the spared branch, which has ruled out many of the most likely explanations. This is an extremely important set of information to report, to guide future investigators in this and other model organisms on mechanisms by which regeneration signaling is controlled (or not).

      Weaknesses:

      The weakest data presented by this manuscript is the study of the actual amounts of Wallenda protein in the axon. The authors argue that increased Wnd protein is being anterogradely delivered from the soma, but no support for this is given. Whether this change is due to transcription/translation, protein stability, transport, or other means is not investigated in this work. However, because this point is not central to the arguments in the paper, it is only a minor critique.

      We agree and are glad that the reviewer considers this a minor critique; this is an area for future study. In Supplemental Figure 1 we present differences in the levels of an ectopically expressed GFP-Wnd-kinase-dead transgene, which is strikingly increased in axons that have received a full but not partial axotomy. We suspect this accumulation occurs downstream of the cell body response because of the timing. We observed the accumulations after 24 hours (Figure S1F) but not at early (1-4 hour) time points following axotomy (data not shown). Further study of the local regulation of Wnd protein and its kinase activity in axons is an important future direction.

      As far as the scope of impact: because the conclusions of the paper are focused on a single (albeit well-validated) reporter in different types of motor neurons, it is hard to determine whether the mechanism of spared branch inhibition of regeneration requires wnd-puc (DLK/cJun) signaling in all contexts (for example, sensory axons or interneurons). Is the nerve-muscle connection the rule or the exception in terms of regeneration program activation?

      DLK signaling is strongly activated in DRG sensory neurons following peripheral nerve injury (Shin et al., 2012), despite the fact that sensory neurons have bifurcated axons and their projections in the dorsal spinal cord are not directly damaged by injuries to the peripheral nerve. Therefore it is unlikely that protection by a spared synapse is a universal rule for all neuron types. However the molecular mechanisms that underlie this regulation may indeed be shared across different types of neurons but utilized in different ways. For instance, nerve growth factor withdrawal can lead to activation of DLK (Ghosh et al., 2011), however neurotrophins and their receptors are regulated and implemented differently in different cell types. We suspect that the restraint of Wnd signaling by the spared synaptic branch shares a common underlying mechanism with the restraint of DLK signaling by neurotrophin signaling. Further elucidation of the molecular mechanism is an important next step towards addressing this question.

      Because changes in puc-lacZ intensity are the major readout, it would be helpful to better explain the significance of the amount of puc-lacZ in the nucleus with respect to the activation of regeneration. Is it known that scaling up the amount of puc-lacZ transcription scales functional responses (regeneration or others)? The alternative would be that only a small amount of puc-lacZ is sufficient to efficiently induce relevant pathways (threshold response).

      While induction of puc-lacZ expression correlates with Wnd-mediated phenotypes, including sprouting of injured axons (Xiong et al., 2010), protection from Wallerian degeneration (Xiong et al., 2012; Xiong and Collins, 2012) and synaptic overgrowth (Collins et al., 2006), we have not observed any correlation between the degree of puc-lacZ induction (eg modest, medium or high) and the phenotypic outcomes (sprouting, overgrowth, etc). Rather, there appears to be a striking all-or-none difference in whether puc-lacZ is induced or not induced. There may indeed be a threshold that can be restrained through multiple mechanisms. We posit in figure 4 that restraint may take place in the cell body, where it can be influenced by the spared bifurcation.

      References Cited:

      Collins CA, Wairkar YP, Johnson SL, DiAntonio A. 2006. Highwire restrains synaptic growth by attenuating a MAP kinase signal. Neuron 51:57–69.

      Dadon-Nachum M, Melamed E, Offen D. 2011. The “dying-back” phenomenon of motor neurons in ALS. J Mol Neurosci 43:470–477.

      Feoktistov AI, Herman TG. 2016. Wallenda/DLK protein levels are temporally downregulated by Tramtrack69 to allow R7 growth cones to become stationary boutons. Development 143:2983–2993.

      Fernandes KA, Harder JM, John SW, Shrager P, Libby RT. 2014. DLK-dependent signaling is important for somal but not axonal degeneration of retinal ganglion cells following axonal injury. Neurobiol Dis 69:108–116.

      Ghosh AS, Wang B, Pozniak CD, Chen M, Watts RJ, Lewcock JW. 2011. DLK induces developmental neuronal degeneration via selective regulation of proapoptotic JNK activity. J Cell Biol 194:751–764.

      Hao Y, Frey E, Yoon C, Wong H, Nestorovski D, Holzman LB, Giger RJ, DiAntonio A, Collins C. 2016. An evolutionarily conserved mechanism for cAMP elicited axonal regeneration involves direct activation of the dual leucine zipper kinase DLK. Elife 5. doi:10.7554/eLife.14048

      Huntwork-Rodriguez S, Wang B, Watkins T, Ghosh AS, Pozniak CD, Bustos D, Newton K, Kirkpatrick DS, Lewcock JW. 2013. JNK-mediated phosphorylation of DLK suppresses its ubiquitination to promote neuronal apoptosis. J Cell Biol 202:747–763.

      Katz JS, Rothstein JD, Cudkowicz ME, Genge A, Oskarsson B, Hains AB, Chen C, Galanter J, Burgess BL, Cho W, Kerchner GA, Yeh FL, Ghosh AS, Cheeti S, Brooks L, Honigberg L, Couch JA, Rothenberg ME, Brunstein F, Sharma KR, van den Berg L, Berry JD, Glass JD. 2022. A Phase 1 study of GDC-0134, a dual leucine zipper kinase inhibitor, in ALS. Ann Clin Transl Neurol 9:50–66.

      Klinedinst S, Wang X, Xiong X, Haenfler JM, Collins CA. 2013. Independent pathways downstream of the Wnd/DLK MAPKKK regulate synaptic structure, axonal transport, and injury signaling. J Neurosci 33:12764–12778.

      Le K, Soth MJ, Cross JB, Liu G, Ray WJ, Ma J, Goodwani SG, Acton PJ, Buggia-Prevot V, Akkermans O, Barker J, Conner ML, Jiang Y, Liu Z, McEwan P, Warner-Schmidt J, Xu A, Zebisch M, Heijnen CJ, Abrahams B, Jones P. 2023. Discovery of IACS-52825, a potent and selective DLK inhibitor for treatment of chemotherapy-induced peripheral neuropathy. J Med Chem 66:9954–9971.

      Le Pichon CE, Meilandt WJ, Dominguez S, Solanoy H, Lin H, Ngu H, Gogineni A, Sengupta Ghosh A, Jiang Z, Lee S-H, Maloney J, Gandham VD, Pozniak CD, Wang B, Lee S, Siu M, Patel S, Modrusan Z, Liu X, Rudhard Y, Baca M, Gustafson A, Kaminker J, Carano RAD, Huang EJ, Foreman O, Weimer R, Scearce-Levie K, Lewcock JW. 2017. Loss of dual leucine zipper kinase signaling is protective in animal models of neurodegenerative disease. Sci Transl Med 9. doi:10.1126/scitranslmed.aag0394

      Li J, Zhang YV, Asghari Adib E, Stanchev DT, Xiong X, Klinedinst S, Soppina P, Jahn TR, Hume RI, Rasse TM, Collins CA. 2017. Restraint of presynaptic protein levels by Wnd/DLK signaling mediates synaptic defects associated with the kinesin-3 motor Unc-104. Elife 6. doi:10.7554/eLife.24271

      Miller BR, Press C, Daniels RW, Sasaki Y, Milbrandt J, DiAntonio A. 2009. A dual leucine kinase-dependent axon self-destruction program promotes Wallerian degeneration. Nat Neurosci 12:387–389.

      Nihalani D, Merritt S, Holzman LB. 2000. Identification of structural and functional domains in mixed lineage kinase dual leucine zipper-bearing kinase required for complex formation and stress-activated protein kinase activation. J Biol Chem 275:7273–7279.

      Russo A, DiAntonio A. 2019. Wnd/DLK is a critical target of FMRP responsible for neurodevelopmental and behavior defects in the Drosophila model of fragile X syndrome. Cell Rep 28:2581–2593.e5.

      Shin JE, Cho Y, Beirowski B, Milbrandt J, Cavalli V, DiAntonio A. 2012. Dual leucine zipper kinase is required for retrograde injury signaling and axonal regeneration. Neuron 74:1015–1022.

      Siu M, Sengupta Ghosh A, Lewcock JW. 2018. Dual Leucine Zipper Kinase Inhibitors for the Treatment of Neurodegeneration. J Med Chem 61:8078–8087.

      Valakh V, Walker LJ, Skeath JB, DiAntonio A. 2013. Loss of the spectraplakin short stop activates the DLK injury response pathway in Drosophila. J Neurosci 33:17863–17873.

      Verma S, Khurana S, Vats A, Sahu B, Ganguly NK, Chakraborti P, Gourie-Devi M, Taneja V. 2022. Neuromuscular junction dysfunction in amyotrophic lateral sclerosis. Mol Neurobiol 59:1502–1527.

      Wlaschin JJ, Donahue C, Gluski J, Osborne JF, Ramos LM, Silberberg H, Le Pichon CE. 2023. Promoting regeneration while blocking cell death preserves motor neuron function in a model of ALS. Brain 146:2016–2028.

      Xiong X, Collins CA. 2012. A conditioning lesion protects axons from degeneration via the Wallenda/DLK MAP kinase signaling cascade. J Neurosci 32:610–615.

      Xiong X, Hao Y, Sun K, Li J, Li X, Mishra B, Soppina P, Wu C, Hume RI, Collins CA. 2012. The Highwire ubiquitin ligase promotes axonal degeneration by tuning levels of Nmnat protein. PLoS Biol 10:e1001440.

      Xiong X, Wang X, Ewanek R, Bhat P, Diantonio A, Collins CA. 2010. Protein turnover of the Wallenda/DLK kinase regulates a retrograde response to axonal injury. J Cell Biol 191:211–223.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Reviewer 1:

      We thank the reviewer for their comments and suggestions. We have made several edits to the paper to address these comments, including the addition of several new control experiments, corrections to mislabeled figures in Fig 2, and other additions to improve the clarity of several figures.

      This work is missing several controls that are necessary to substantiate their claims. My most important concern is that the optogenetic screen for neurons that alter pathogenic lawn occupancy does not have an accompanying control on non-pathogenic OP50 bacteria. Hence, it remains unclear whether these neuronal inhibition experiments lead to pathogen-specific or generalized lawn-leaving alterations. For strains that show statistical differences between - and + ATR conditions, the authors should perform follow-up validation experiments on non-pathogenic OP50 lawns to ensure that the observed effect is PA14-specific. Similarly, neuronal inhibition experiments in Figures 5E and H are only performed with naïve animals on PA14 - we need to see the latency to re-entry on OP50 as well, to make general conclusions about these neurons' role in pathogen-specific avoidance.

      We have added data from new control experiments to Fig. S1 (subfigures B, C) for both exit and re-entry dynamics on OP50. We find that inhibition of neurons produces different effects on both lawn entry and exit on PA14 compared to OP50. We observed that inhibition of neurons failed to change the re-entry dynamics for any of the lines which showed delayed latency to re-entry on PA14. Our results suggest that the neural control of re-entry dynamics we see are PA14 specific.

      My second major concern is regarding the calcium imaging experiments of candidate neurons involved in lawn re-entry behavior. Although the data shows that AIY, AVK, and SIA/SIB neurons all show reduced activity following pathogen exposure, the authors do not relate these activity changes to changes in behavior. Given the well-established links between these cells and forward locomotion, it is essential to not only report differences in activity but also in the relationship between this activity and locomotory behavior. If animals are paused outside of the pathogen lawn, these neurons may show low activity simply because the animals are not moving forward. Other forward-modulated neurons may also show this pattern of reduced activity if the animals remain paused. Given that the authors have recorded neural activity before and after contact with pathogenic bacteria in freely moving animals, they should also provide an analysis of the relationship between proximity to the lawn and the activity of these neurons.

      In response, we added an additional supplementary figure S7 to illustrate the role of each neuron in navigational control and added text to the discussion to better explain the role of each neuron type in the regulation of re-entry, in light of our previously published work on SIA in speed control.

      This work is missing methodological descriptions that are necessary for the correct interpretation of the results shown here. Figure 2 suggests that the determination of statistical significance across the optogenetic inhibition screen will be found in the Methods, but this information is not to be found there. At various points in the text, authors refer to "exit rate", "rate constant", and "entry rate". These metrics seem derived from an averaged measurement across many individual animals in one lawn evacuation assay plate. However "latency to re-entry" is only defined on a per-animal basis in the lawn re-exposure assay. These differences should be clearly stated in the methods section to avoid confusion and to ensure that statistics are computed correctly.

      Additional details have been added to the methods section to provide more in depth information on the statistical analysis performed. In brief, the latency to re-entry is calculated in the same way across all assays – re-entry events across replicate experiments for a given experimental condition are aggregated together and used to calculate relevant statistics.

      This work also contains mislabeled graphs and incorrect correspondence with the text, which make it difficult to follow the authors 'claims. The text suggests that Pdop-2::Arch3 and Pmpz-1::Arch3 show increased exit rates, whereas Figure 2 shows that Pflp-4::Arch3 but not Pmpz-1::Arch3 has increased exit rate. The authors should also make a greater effort to correctly and clearly label which type of behavioral experiment is used to generate each figure and describe the differences in experimental design in the main text, figure legends, and methods. Figure 2E depicts trajectories of animals leaving a lawn over a 2.5-minute interval but it is unclear when this time window occurs within the 18-hour lawn leaving assay. Likewise, Figure 2H depicts a 30-minute time window which has an unclear relationship to the overall time course of lawn leaving. This figure legend is also mislabeled as "Infected/Healthy", whereas it should be labeled "-/+ ATR".

      In Figures 2C and F, the x-axis labels are in a different order, making it difficult to compare between the 2 plots. Promoter names should be italicized. What does the red ring mean in Figure 2A? Figure 2 legend incorrectly states that four lines showed statistically significant changes for the Exist rate constant - only 2 lines are significant according to the figure.

      We thank the reviewer for identifying this embarrassing error. Figure 2C and F were flipped, and we have corrected this, we are sorry for the error. Promoter names have been italicized, and we have added additional text in the captions that the red ring is a ring light for background illumination of the worms. In addition, we have corrected the error in the figure legends from “Infected/Healthy” to “+/- ATR”.

      Lines in figure 2C and 2F are ordered by significance rather than keeping the same order in both. Majority feedback from colleagues suggested that this ordering was preferred.

      This work raises the interesting possibility that different sets of neurons control lawn exit and lawn re-entry behaviors following pathogen exposure. However, the authors never directly test this claim. To rigorously show this, the authors would need to show that lawn-exit-promoting neurons (CEPs, HSNs, RIAs, RIDs, SIAs) are dispensable for lawn re-entry behavior and that lawn re-entry promoting neurons (AVK, SIA, AIY, MI) are dispensable for lawn exit behavior in pathogen-exposed animals.

      We agree with the reviewer’s comments that there is insufficient evidence to show a complete decoupling of lawn exit and lawn re-entry. However, we note that our screen results show that only 1 line (dop-2) shows changes in both exit and re-entry dynamics upon neural inhibition (Fig. 2). This seems to suggest that at least some degree of neural control of re-entry is decoupled from exit.

      Please label graph axes with units in Figure 1 - instead of "Exit Rate" make it #exits per worm per hour, and make it more clear that Figures 1C and E have a different kind of assay than Figures 1A, B and D. There should be more consistency between the meaning of "pre/post" and "naive/infected/healthy" - and how many hours constitutes post.

      We have edited Figure 1 and made additions to the captions of figure 1 to make both points clearer. We have also standardized our language for subsequent figures (such as figure 5) to provide less ambiguity in pre/post and naïve/infected/healthy.

      Figure 5 - it should be made more clear when the stimulation/inhibition occurred in these experiments and how long they were recorded/analyzed.

      We have added additional details to the figure captions to make it clearer when the data was collected.

      Workspaces and code have been added under a data availability section in the manuscript.

      Reviewer 2:

      However, the paper's main weakness lies in its lack of a detailed mechanism explaining how the delayed reentry process directly influences the actual locomotor output that results in avoidance. The term 'delayed reentry' is used as a dynamic metric for quantifying the screening, yet the causal link between this metric and the mechanistic output remains unclear. Despite this, the study is well-structured, with comprehensive control experiments, and is very well constructed.

      We thank the reviewer for their comments and suggestions. We have added additional data and details to our work to cover these weaknesses, as can be seen in our responses to the suggestions below.

      (1) A key issue in the manuscript is the mechanistic link between the delayed process and locomotor output. AIY is identified as a crucial neuron in this process, but the specifics of how AIY influences this delay are not clear. For instance, does AIY decrease the reversal rate, causing animals to get into long-range search when they leave the bacterial lawn? Is there any relationship between pdf-2 expression and reversal rates? Given that AIY typically promotes long-range motion when activated, the suppression of this function and its implications on motion warrants further clarification.

      We have included additional data to explain how AIY might be able to regulate lawn entry behaviors and have added more to the discussion to explain how neural suppression might lead to changes in the behavior (new figure S7). Both AIY and SIA dynamics have been linked to worm navigation. In previous work (Lee 2019), we have demonstrated that SIA can control locomotory speed. Inhibition of SIA decreases locomotory speed, and as a result may serve to drive the increased latency of re-entry.

      AIY’s role in navigation has been previously established (Zhaoyu 2014), but we have added an additional supplementary figure and edited our discussion to further illustrate this point. As can be seen in the new figure S7, AIY neural activity undergoes a transition after removal from a bacterial lawn, going from low activity to high activity. This activity increase is correlated with a transition from a high reversal rate local search state to a long range search state characterized by longer runs. Inhibition of AIY during this long range search state increased the reversal rate resulting in a higher rate of re-orientations. This might serve as a part of the mechanistic explanation for AIY’s role in preventing lawn re-entry, as inhibition dramatically increased the rate of re-orientation, preventing worms from making directed runs into the bacterial lawn. However, there is an additional effect of the inhibition of AIY, not seen during food search. Inhibition of AIY in the context of a pathogenic bacterial lawn leads to stalling at the edge. Therefore, re-entry AIY could have an additional role in governing the animals movement, post exposure, upon contact with a pathogenic lawn.

      (2) I recommend including supplementary videos to visually demonstrate the process. These videos might help others identify aspects of the mechanism that are currently missing or unclear in the text.

      (4) The authors mention that the worms "left the lawn," but the images suggest that the worms do not stray far and remain around the perimeter. Providing videos could help clarify this observation and strengthen the argument by visually connecting these points

      Additional supplementary videos (1-3) taken at several stages of lawn evacuation have been added to visually demonstrate the process.

      (3) Regarding the control experiments (Figure 1E-G), the manuscript describes testing animals picked from a PA14-seeded plate and retesting them on different plates. It's crucial to clarify the differences between these plates. Specifically, the region just outside the lawn should be considered, as it is not empty and worms can spread bacteria around. Testing animals on a new plate with a pristine proximity region might introduce variables that affect their behavior.

      We have reworded the paper to make it clearer that these new conditions on a fresh PA14 lawn represent a different type of assay from the lawn evacuation assay. Fresh PA14 plates will indeed have a pristine proximity region compared to plates where the worms have spread the bacteria.

      These experiments were done to test if the evacuation effect is purely due to aversive signals left on the lawn or attractive signals left outside of the lawn. Given that worms are known to be able to leave compounds such as ascarosides to communicate with each other, we wanted to test that this lawn re-entry defect was not simply the result of deposited pheromones. Without any other method to remove such compounds, we relied on using fresh PA14 lawns instead to test this. We have updated the manuscript to clarify this point.

      (5) The manuscript notes that the PA14 strain was grown without shaking. Typically, growing this strain without agitation leads to biofilm formation. Clarifying whether there is a link between biofilm formation and avoidance behavior would add depth to the understanding of the experimental conditions and their impact on the observed behaviors.

      As the reviewer has noted, growth of PA14 without shaking might indeed lead to biofilm formation. This does represent a legitimate concern, as evidence from previous work has suggested that biofilm formation could be linked to pathogen avoidance as worms make use of mechanosensation to avoid pathogenic bacteria (Chang et al. 2011).  However, we do not observe substantial formation of biofilm in our cultured bacteria, likely since our growth time might be insufficient for sufficient biofilm formation to occur. We also note that our evacuation dynamics appear to be of similar timescale to results reported in previous work which used different growth conditions. As such, we believe that our growth conditions thus represent similar conditions as to those historically used in the lawn evacuation literature.

      Reviewer 3:

      Weaknesses:

      My only concern is that the authors should be more careful about describing their "compressed sensing-based approach". Authors often cite their previous Nature Methods paper, but should explain more because this method is critical for this manuscript. Also, this analysis is based on the hypothesis that only a small number of neurons are responsible for a given behavior. Authors should explain more about how to determine scarcity parameters, for example.

      We have added more details to our paper outlining some of the details involved in our compressed sensing approach. We go into more detail about how we chose sparsity parameters and note that our discovered neurons for re-entry appear to be robust over choice of sparsity parameters. These additional details can be found in both the paper body and the methods section.

      Line 45: This paragraph tries to mention that there should be "small sets of neurons" that can play key roles in integrating previous information to influence subsequent behavior. Is it valid as an assumption in the nervous systems?

      We want to clarify that what is important is not that there are ‘small sets of neurons’, but rather that these key neurons make up a small fraction of the total number of neurons in the nervous system. More correctly: the compressed sensing approach identifies information bottlenecks in the neural circuits, and the assumption is that the number of neurons in these bottlenecks are small. This is the underlying sparsity assumption being made here that allows us to utilize a compressed sensing based approach to identify these neurons. We have reworded this section to make it clear that what is important is not that the total number of neurons is small, but that they must be a small fraction of the total number of neurons in the nervous system.

      Line 125: "These approaches…" Authors repeatedly mentioned this statement to emphasize that their compressed sensing-based approach is the best choice. Are you really sure?

      We agree that there are several approaches that might allow for faster screening of the nervous system. For example, many studies approach the problem by looking at neurons with synapses onto a neuron already known to be implicated in the behavior or find neurons that express a key gene known to regulate the behavior of interest. These approaches utilize prior information to greatly reduce the pool of candidate neurons needed to be screened.

      In the absence of such prior information, we believe that our compressed sensing based approach allows a rapid way to perform an unbiased interrogation of the entire nervous system to identify key neurons at bottlenecks of neural circuits. Once these key neurons are identified, neurons upstream and downstream of these key neurons can be investigated in the future.  This approach gives us the added advantage of being able to identify neurons that do not connect to neurons that are already implicated in the behavior, or that don’t have clear genetic signatures in the behavior of interest. Our approach further allows for screening of neurons with no clear single genetic marker without the next to utilize intersectional genetic strategies.  We should not use the phrase “best choice” which might not be justified. We have reworded these statements, and we believe that compressed sensing based methods provide a complementary approach to those in the literature.

      Line 42: If authors refer to mushroom bodies and human hippocampus in relation to the significance of their work, authors should go back to these references in the Discussion and explain how their work is important.

      We thank the reviewer for this feedback, and we have added to our discussion to expand upon these points.

      Line 151: "the accelerated pathogen avoidance" Accelerated pathogen avoidance does not necessarily indicate the existence of the neural mechanism that inhibits the association of pathogenicity with microbe-specific cues (during early stages: first two hours).

      We agree with the reviewer’s statements that these results alone do not indicate the presence of an early avoidance mechanism. Other evidence for early avoidance mechanisms exists as seen in two choice assay experiments (Zhang 2005), and our results do seem to support this. However, we agree that early neural inhibition is insufficient evidence towards such a mechanism. We have thus removed this statement for accuracy.

    1. Author response:

      Reviewer #1 (Public review):

      Summary:

      In this manuscript by Lopez-Blanch and colleagues, 21 microexons are selected for a deep analysis of their impacts on behavior, development, and gene expression. The authors begin with a systematic analysis of microexon inclusion and conservation in zebrafish and use these data to select 21 microexons for further study. The behavioral, transcriptomic, and morphological data presented are for the most part convincing. Furthermore, the discussion of the potential explanations for the subtle impacts of individual microexon deletions versus loss-of-function in srrm3 and/or srrm4 is quite comprehensive and thoughtful. One major weakness: data presentation, methods, and jargon at times affect readability / might lead to overstated conclusions. However, overall this manuscript is well-written, easy to follow, and the results are of broad interest.

      We thank the Reviewer for their positive comments on our manuscript. In the revised version, we will try to improve readability, reduce jargon and avoid overstatements. 

      Strengths:

      (1) The study uses a wide variety of techniques to assess the impacts of microexon deletion, ranging from assays of protein function to regulation of behavior and development.

      (2) The authors provide comprehensive analyses of the molecular impact of their microexon deletions, including examining how host-gene and paralog expression is affected.

      Weaknesses / Major Points:

      (1) According to the methods, it seems that srrm3 social behavior is tested by pairing a 3mpf srrm3 mutant with a 30dpf srrm3 het. Is this correct? The methods seem to indicate that this decision was made to account for a slower growth rate of homozygous srrm3 mutant fish. However, the difference in age is potentially a major confound that could impact the way that srrm3 mutants interact with hets and the way that srrm3 mutants interact with one another (lower spread for the ratio of neighbour in front value, higher distance to neighbour value). This reviewer suggests testing het-het behavior at 3 months to provide age-matched comparisons for del-del, testing age-matched rather than size-matched het-del behavior, and also suggests mentioning this in the main text / within the figure itself so that readers are aware of the potential confound.

      Thank you for bringing up this point. For the tests shown in Figure 5, we indeed decided to match the srrm3 pairs by fish size since we thought this would be more comparable to the other lines both biologically and methodologically (in terms of video tracking, etc.). However, we are confident the results would be very similar if matched by age, since the differences in social interactions between the srrm3 homozygous mutants and their control siblings are very dramatic at any age. For example, this can be appreciated, in line with the Reviewer's suggestion, in Videos S2 and S3, which show groups of five 5 mpf fish that are either srrm3 mutants or controls. It can be observed that the behavior of 5 mpf control fish is very similar to those of 1 mpf fish pairs, with very small interindividual distances. We will nonetheless agree that this decision on the experimental design should be clearly stated in the text and figure legend and we will do so in the revised version.

      (2) Referring to srrm3+/+; srrm4-/- controls for double mutant behavior as "WT for simplicity" is somewhat misleading. Why do the authors not refer to these as srrm4 single mutants?

      We thought it made the interpretation of plots easier, but we will change this in the revised version.

      (3) It's not completely clear how "neurally regulated" microexons are defined / how they are different from "neural microexons"? Are these terms interchangeable?

      Yes, they are interchangeable. We will double check the wording to avoid confusion.

      (4) Overexpression experiments driving srrm3 / srrm4 in HEK293 cells are not described in the methods.

      Apologies for this omission. We will briefly described the methods; however, please note that the data was obtained from a previous publication (Torres-Mendez et al, 2019), where the detailed methodology is reported.

      (5) Suggest including more information on how neurite length was calculated. In representative images, it appears difficult to determine which neurites arise from which soma, as they cross extensively. How was this addressed in the quantification?

      We will add further details to the revised version. With regards to the specific question, we would like to mention that this has not been a very common problem for the time points used in the manuscript (10 hap and 24 hap). At those stages, it was nearly always evident how to track each individual neurite. Dubious cases were simply discarded. Of course, such cases become much more common at later time points (48 and 72 hap), not sure in this study.

      Reviewer #2 (Public review):

      Summary:

      This manuscript explores in zebrafish the impact of genetic manipulation of individual microexons and two regulators of microexon inclusion (Srrm3 and Srrm4). The authors compare molecular, anatomical, and behavioral phenotypes in larvae and juvenile fish. The authors test the hypothesis that phenotypes resulting from Srrm3 and 4 mutations might in part be attributable to individual microexon deletions in target genes.

      The authors uncover substantial alterations in in vitro neurite growth, locomotion, and social behavior in Srrm mutants but not any of the individual microexon deletion mutants. The individual mutations are accompanied by broader transcript level changes which may resemble compensatory changes. Ultimately, the authors conclude that the severe Srrm3/4 phenotypes result from additive and/or synergistic effects due to the de-regulation of multiple microexons.

      Strengths:

      The work is carefully planned, well-described, and beautifully displayed in clear, intuitive figures. The overall scope is extensive with a large number of individual mutant strains examined. The analysis bridges from molecular to anatomical and behavioral read-outs. Analysis appears rigorous and most conclusions are well-supported by the data.

      Overall, addressing the function of microexons in an in vivo system is an important and timely question.

      Weaknesses:

      The main weakness of the work is the interpretation of the social behavior phenotypes in the Srrm mutants. It is difficult to conclude that the mutations indeed impact social behavior rather than sensory processing and/or vision which precipitates apparent social alterations as a secondary consequence. Interpreting the phenotypes as "autism-like" is not supported by the data presented.

      The Reviewer is absolutely right and we apologize for this omission, since it was not our intention to imply that these social defects should be interpreted simply as autistic-like. It is indeed very likely that the main reason for the social alterations displayed by the srrm3's mutants are due to their impaired vision. We will add this discussion explicitly in the revised version. 

      Reviewer #3 (Public review):

      Summary:

      Microexons are highly conserved alternative splice variants, the individual functions of which have thus far remained mostly elusive. The inclusion of microexons in mature mRNAs increases during development, specifically in neural tissues, and is regulated by SRRM proteins. Investigation of individual microexon function is a vital avenue of research since microexon inclusion is disrupted in diseases like autism. This study provides one of the first rigorous screens (using zebrafish larvae) of the functions of individual microexons in neurodevelopment and behavioural control. The authors precisely excise 21 microexons from the genome of zebrafish using CRISPR-Cas9 and assay the downstream impacts on neurite outgrowth, larvae motility, and sociality. A small number of mild phenotypes were observed, which contrasts with the more dramatic phenotypes observed when microexon master regulators SRRM3/4 are disrupted. Importantly, this study attempts to address the reasons why mild/few phenotypes are observed and identify transcriptomic changes in microexon mutants that suggest potential compensatory gene regulatory mechanisms.

      Strengths:

      (1) The manuscript is well written with excellent presentation of the data in the figures.

      (2) The experimental design is rigorous and explained in sufficient detail.

      (3) The identification of a potential microexon compensatory mechanism by transcriptional alterations represents a valued attempt to begin to explain complex genetic interactions.

      (4) Overall this is a study with a robust experimental design that addresses a gap in knowledge of the role of microexons in neurodevelopment.

      Thank you very much for your positive comments to our manuscript.

    1. Author response:

      eLife Assessment

      This descriptive manuscript builds on prior research showing that the elimination of Origin Recognition Complex (ORC) subunits does not halt DNA replication. The authors use various methods to genetically remove one or two ORC subunits from specific tissues and observe continued replication, though it may be incomplete. The replication appears to be primarily endoreduplication, indicating that ORC-independent replication may promote genome reduplication without mitosis. Despite similar findings in previous studies, the paper provides convincing genetic evidence in mice that liver cells can replicate and undergo endoreduplication even with severely depleted ORC levels. While the mechanism behind this ORC-independent replication remains unclear, the study lays the groundwork for future research to explore how cells compensate for the absence of ORC and to develop functional approaches to investigate this process. The reviewers agree that this valuable paper would be strengthened significantly if the authors could delve a bit deeper into the nature of replication initiation, potentially using an origin mapping experiment. Such an exciting contribution would help explain the nature of the proposed new type of Mcm loading, thereby increasing the impact of this study for the field at large.<br />

      We appreciate the reviewers’ suggestion. Till now we know of only one paper that mapped origins of replication in regenerating mouse liver, and that was published two months back in Cell (PMID: 39293447).  We want to adopt this method, but we do not need it to answer the question asked.  We have mapped origins of replication in ORC-deleted cancer cell lines and compared to wild-type cells in Shibata et al., BioRXiv (PMID: 39554186) (it is under review).  We report the following:  Mapping of origins in cancer cell lines that are wild type or engineered to delete three of the subunits, ORC1, ORC2 or ORC5 shows that specific origins are still used and are mostly at the same sites in the genome as in wild type cells. Of the 30,197 origins in wild type cells (with ORC), only 2,466 (8%) are not used in any of the three ORC deleted cells and 18,319 (60%) are common between the four cell types. Despite the lack of ORC, excess MCM2-7 is still loaded at comparable rates in G1 phase to license reserve origins and is also repeatedly loaded in the same S phase to permit re-replication. 

      Citation: Specific origin selection and excess functional MCM2-7 loading in ORC-deficient cells. Yoshiyuki Shibata, Mihaela Peycheva, Etsuko Shibata, Daniel Malzl, Rushad Pavri, Anindya Dutta. bioRxiv 2024.10.30.621095; doi: https://doi.org/10.1101/2024.10.30.621095 (PMID: 39554186)

      Public Reviews:

      Reviewer #1 (Public review):

      The origin recognition complex (ORC) is an essential loading factor for the replicative Mcm2-7 helicase complex. Despite ORC's critical role in DNA replication, there have been instances where the loss of specific ORC subunits has still seemingly supported DNA replication in cancer cells, endocycling hepatocytes, and Drosophila polyploid cells. Critically, all tested ORC subunits are essential for development and proliferation in normal cells. This presents a challenge, as conditional knockouts need to be generated, and a skeptic can always claim that there were limiting but sufficient ORC levels for helicase loading and replication in polyploid or transformed cells. That being said, the authors have consistently pushed the system to demonstrate replication in the absence or extreme depletion of ORC subunits.

      Here, the authors generate conditional ORC2 mutants to counter a potential argument with prior conditional ORC1 mutants that Cdc6 may substitute for ORC1 function based on homology. They also generate a double ORC1 and ORC2 mutant, which is still capable of DNA replication in polyploid hepatocytes. While this manuscript provides significantly more support for the ability of select cells to replicate in the absence or near absence of select ORC subunits, it does not shed light on a potential mechanism.

      The strengths of this manuscript are the mouse genetics and the generation of conditional alleles of ORC2 and the rigorous assessment of phenotypes resulting from limiting amounts of specific ORC subunits. It also builds on prior work with ORC1 to rule out Cdc6 complementing the loss of ORC1.

      The weakness is that it is a very hard task to resolve the fundamental question of how much ORC is enough for replication in cancer cells or hepatocytes. Clearly, there is a marked reduction in specific ORC subunits that is sufficient to impact replication during development and in fibroblasts, but the devil's advocate can always claim minimal levels of ORC remaining in these specialized cells.

      The significance of the work is that the authors keep improving their conditional alleles (and combining them), thus making it harder and harder (but not impossible) to invoke limiting but sufficient levels of ORC. This work lays the foundation for future functional screens to identify other factors that may modulate the response to the loss of ORC subunits.

      This work will be of interest to the DNA replication, polyploidy, and genome stability communities.

      Thank you.

      Reviewer #2 (Public review):

      This manuscript proposes that primary hepatocytes can replicate their DNA without the six-subunit ORC. This follows previous studies that examined mice that did not express ORC1 in the liver. In this study, the authors suppressed expression of ORC2 or ORC1 plus ORC2 in the liver.

      Comments:

      (1) I find the conclusion of the authors somewhat hard to accept. Biochemically, ORC without the ORC1 or ORC2 subunits cannot load the MCM helicase on DNA. The question arises whether the deletion in the ORC1 and ORC2 genes by Cre is not very tight, allowing some cells to replicate their DNA and allow the liver to develop, or whether the replication of DNA proceeds via non-canonical mechanisms, such as break-induced replication. The increase in the number of polyploid cells in the mice expressing Cre supports the first mechanism, because it is consistent with few cells retaining the capacity to replicate their DNA, at least for some time during development.

      In our study, we used EYFP as a marker for Cre recombinase activity. ~98% of the hepatocytes in tissue sections and cells in culture express EYFP, suggesting that the majority of hepatocytes successfully expressed the Cre protein to delete the ORC1 or ORC2 genes. To assess deletion efficiency, we employed sensitive genotyping and Western blotting techniques to confirm the deletion of ORC1 and ORC2 in hepatocytes isolated from Alb-Cre mice. Results in Fig. 2C and Fig. 6D demonstrate the near-complete absence of ORC2 and ORC1 proteins, respectively, in these hepatocytes.

      The mutant hepatocytes underwent at least 15–18 divisions during development. The inherited ORC1 or ORC2 protein present during the initial cell divisions, would be diluted to less than 1.5% of wild-type levels within six divisions, making it highly unlikely to support DNA replication, and yet we observe hepatocyte numbers that suggest there was robust cell division even after that point.

      Furthermore, the EdU incorporation data confirm DNA synthesis in the absence of ORC1 and ORC2. Specifically, immunofluorescence showed that both in vitro and in vivo, EYFP-positive hepatocytes (indicating successful ORC1 and ORC2 deletion) incorporated EdU, demonstrating that DNA synthesis can occur without ORC1 and ORC2.

      Finally, the Alb-ORC2f/f mice have 25-37.5% of the number of hepatocyte nuclei compared to WT mice (Table 2).  If that many cells had an undeleted ORC2 gene, that would have shown up in the genotyping PCR and in the Western blots.

      (2) Fig 1H shows that 5 days post infection, there is no visible expression of ORC2 in MEFs with the ORC2 flox allele. However, at 15 days post infection, some ORC2 is visible. The authors suggest that a small number of cells that retained expression of ORC2 were selected over the cells not expressing ORC2. Could a similar scenario also happen in vivo?

      This would not explain the significant incorporation of EdU in hepatocytes that do not have detectable ORC by Western blots and that are EYFP positive.  Also note that for MEFs we are delivering the Cre by AAV infection in vitro, so there is a finite probability that a cell will not receive Cre and will not delete ORC2.  However, in vivo, the Alb-Cre will be expressed in every cell that turns on albumin.  There is no escaping the expression of Cre.

      (3) Figs 2E-G shows decreased body weight, decreased liver weight and decreased liver to body weight in mice with recombination of the ORC2 flox allele. This means that DNA replication is compromised in the ALB-ORC2f/f mice.

      It is possible that DNA replication is partially compromised or may slow down in the absence of ORC2. However, it is important to emphasize that livers with ORC2 deletion remain capable of DNA replication, so much so that liver function and life span are near normal. Therefore, some kind of DNA replication has to serve as a compensatory mechanism in the absence of ORC2 to maintain liver function and support regeneration.

      (4) Figs 2I-K do not report the number of hepatocytes, but the percent of hepatocytes with different nuclear sizes. I suspect that the number of hepatocytes is lower in the ALB-ORC2f/f mice than in the ORC2f/f mice. Can the authors report the actual numbers?

      We show in Table 2 that the Alb-Orc2f/f mice have about 25-37.5% of the hepatocytes compared to the WT mice.

      (5) Figs 3B-G do not report the number of nuclei, but percentages, which are plotted separately for the ORC2-f/f and ALB-ORC2-f/f mice. Can the authors report the actual numbers?

      In all the FACS experiments in Fig. 3B-G we collect data for a total of 10,000 nuclei (or cells).  For Fig. 3E-G we divide the 10,000 nuclei into the bottom 40% on the EYFP axis (EYFP low, which is mostly EYFP negative) as the control group, and EYFP high (top 20% on the EYFP axis) test group.  We will mention this in the revision and label EYFP negative and positive as EYFP low and high.

      (6) Fig 5 shows the response of ORC2f/f and ALB-ORC2f/f mice after partial hepatectomy. The percent of EdU+ nuclei in the ORC2-f/f (aka ALB-CRE-/-) mice in Fig 5H seems low. Based on other publications in the field it should be about 20-30%. Why is it so low here? The very low nuclear density in the ALB-ORC2-f/f mice (Fig 5F) and the large nuclei (Fig 5I) could indicate that cells fire too few origins, proceed through S phase very slowly and fail to divide.

      The percentage of EdU+ nuclei in the ORC2f/f without Alb-Cre mice is 8%, while in PMID 10623657, the 10% of wild type nuclei incorporate  EdU at 42 hr post partial hepatectomy (mid-point between the 36-48 hr post hepatectomy that was used in our study).  The important result here is that in the ORC2f/f mice with Alb-Cre (+/-) we are seeing significant EdU incorporation. We will also correct the X-axis labels in 5F, 5I, 7E and 7F to reflect that those measurements were not made at 36 hr post-resection but later (as was indicated in the schematic in Fig. 5A).

      (7) Fig 6F shows that ALB-ORC1f/f-ORC2f/f mice have very severe phenotypes in terms of body weight and liver weight (about on third of wild-type!!). Fig 6H and 6I, the actual numbers should be presented, not percentages. The fact that there are EYFP negative cells, implies that CRE was not expressed in all hepatocytes.

      The liver to body weight ratio is what one has to look at, and it is 70% of the WT.  In females the liver and body weight are low (although in proportion to each other), which maybe is what the reviewer is talking about.  However, the fact that liver weight and body weight are not as low in males, suggest that this is a gender (hormone?) specific effect and not a DNA replication defect.  We have another paper also in BioRXiv (Su et al.) that suggests that ORC subunits have significant effect on gene expression, so it is possible that that is what leads to this sexual dimorphism in phenotype.

      The bottom 40% of nuclei on the EYFP axis in the FACS profiles (what was labeled EYFP negative but will now be called EYFP low) contains mostly non-hepatocytes that are genuinely EYFP negative.   Non-hepatocytes (bile duct cells, endothelial cells, Kupffer cells, blood cells) are a significant part of cells in the dissociated liver (as can be seen in the single cell sequencing results in PMID: 32690901).  Their presence does not mean that hepatocytes are not expressing Cre.  Hepatocytes mostly are EYFP positive, as can be seen in the tissue sections (where the hepatocytes take up most of visual field) and in cells in culture.  Also if there are EYFP negative hepatocyte nuclei in the FACS, that still does not rule out EYFP presence in the cytoplasm.  The important point from the FACS is that the EYFP high nuclei (which have expressed Cre for the longest period) are polyploid relative to the EYFP low nuclei.

      (8) Comparing the EdU+ cells in Fig 7G versus 5G shows very different number of EdU+ cells in the control animals. This means that one of these images is not representative. The higher fraction of EdU+ cells in the double-knockout could mean that the hepatocytes in the double-knockout take longer to complete DNA replication than the control hepatocytes. The control hepatocytes may have already completed DNA replication, which can explain why the fraction of EdU+ cells is so low in the controls. The authors may need to study mice at earlier time points after partial hepatectomy, i.e. sacrifice the mice at 30-32 hours, instead of 40-52 hours.

      The apparent difference that the reviewer comments on stems from differences in nuclear density in the images in Fig. 7G and 5G (also quantitated in Fig. 7F and 5F).  The quantitation in Fig. 7H and 5H show that the % of EdU plus cells are comparable (5-8%). 

      (9) Regarding the calculation of the number of cell divisions during development: the authors assume that all the hepatocytes in the adult liver are derived from hepatoblasts that express Alb. Is it possible to exclude the possibility that pre-hepatoblast cells that do not express Alb give rise to hepatocytes? For example the cells that give rise to hepatoblasts may proliferate more times than normal giving rise to a higher number of hepatoblasts than in wild-type mice.

      Single cell sequencing of mouse liver at e11 shows hepatoblasts expressing hepatocyte specific markers (PMID: 32690901).  All the cells annotated from the single-cell seq analysis are differentiated cells arguing against the possibility that undifferentiated endodermal cells (what the reviewer probably means by pre-hepatoblasts) exist at e11.  The following review (https://www.ncbi.nlm.nih.gov/books/NBK27068/) says: “The differentiation of bi-potential hepatoblasts into hepatocytes or BECs begins around e13 of mouse development. Initially hepatoblasts express genes associated with both adult hepatocytes (Hnf4α, Albumin) ...”  Thus, we can be certain that undifferentiated endodermal cells are unlikely to persist on e11 and that hepatoblasts at e11 express albumin.  Our calculation of number of cell divisions in Table 2 begins from e12.

      The reviewer maybe suggesting that ORC deletion leads to the immediate demise of hepatoblasts (despite having inherited ORC protein from the endodermal cells) causing undifferentiated endodermal cells to persist and proliferate much longer than in normal development.  We consider it unlikely, but if true it will be amazing new biology, both by suggesting that deletion of ORC immediately leads to the death of the hepatoblasts (despite a healthy reserve of inherited ORC protein) and by suggesting that there is a novel feedback mechanism from the death/depletion of hepatoblasts leading to the persistence and proliferation of undifferentiated endodermal cells.

      (10) My interpretation of the data is that not all hepatocytes have the ORC1 and ORC2 genes deleted (eg EYFP-negative cells) and that these cells allow some proliferation in the livers of these mice.

      Please see the reply in question #1.  Particularly relevant: “Finally, the Alb-ORC2f/f mice have 25-37.5% of the number of hepatocyte nuclei compared to WT mice (Table 2).  If that many cells had an undeleted ORC2 gene, that would have shown up in the genotyping PCR and in the Western blots.

      Reviewer #3 (Public review):

      Summary:

      The authors address the role of ORC in DNA replication and that this protein complex is not essential for DNA replication in hepatocytes. They provide evidence that ORC subunit levels are substantially reduced in cells that have been induced to delete multiple exons of the corresponding ORC gene(s) in hepatocytes. They evaluate replication both in purified isolated hepatocytes and in mice after hepatectomy. In both cases, there is clear evidence that DNA replication does not decrease at a level that corresponds with the decrease in detectable ORC subunit and that endoreduplication is the primary type of replication observed. It remains possible that small amounts of residual ORC are responsible for the replication observed, although the authors provide arguments against this possibility. The mechanisms responsible for DNA replication in the absence of ORC are not examined.

      Strengths:

      The authors clearly show that there are dramatic reductions in the amount of the targeted ORC subunits in the cells that have been targeted for deletion. They also provide clear evidence that there is replication in a subset of these cells and that it is likely due to endoreduplication. Although there is no replication in MEFs derived from cells with the deletion, there is clearly DNA replication occurring in hepatocytes (both isolated in culture and in the context of the liver). Interestingly, the cells undergoing replication exhibit enlarged cell sizes and elevated ploidy indicating endoreduplication of the genome. These findings raise the interesting possibility that endoreduplication does not require ORC while normal replication does.

      Weaknesses:

      There are two significant weaknesses in this manuscript. The first is that although there is clearly robust reduction of the targeted ORC subunit, the authors cannot confirm that it is deleted in all cells. For example, the analysis in Fig. 4B would suggest that a substantial number of cells have not lost the targeted region of ORC2. Although the western blots show stronger effects, this type of analysis is notorious for non-linear response curves and no standards are provided. The second weakness is that there is no evaluation of the molecular nature of the replication observed. Are there changes in the amount of location of Mcm2-7 loading that is usually mediated by ORC? Does an associated change in Mcm2-7 loading lead to the endoreduplication observed? After numerous papers from this lab and others claiming that ORC is not required for eukaryotic DNA replication in a subset of cells, we still have no information about an alternative pathway that could explain this observation.

      We do not see a significant deficit in MCM2-7 loading (amount and rate) in cancer cell lines where we have deleted ORC1, ORC2 or ORC5 genes separately in Shibata et al. bioRxiv 2024.10.30.621095; doi: https://doi.org/10.1101/2024.10.30.621095 (PMID: 39554186)

      The authors frequently use the presence of a Cre-dependent eYFP expression as evidence that the ORC1 or ORC2 genes have been deleted. Although likely the best visual marker for this, it is not demonstrated that the presence of eYFP ensures that ORC2 has been targeted by Cre. For example, based on the data in Fig. 4B, there seems to be a substantial percentage of ORC2 genes that have not been targeted while the authors report that 100% of the cells express eYFP.

      The PCR reactions in Fig. 4B are still contaminated by DNA from non-hepatocyte cells:  bile duct cells, endothelial, Kupfer cells and blood cells.  Under the microscope  culture we can recognize the hepatocytes unequivocally from their morphology. <2% of the hepatocyte cells in culture in Fig. 4C are EYFP-.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public reviews:

      Reviewer #1 (public review):

      (1) The link between the background in the introduction and the actual study and findings is often tenuous or not clearly explained. A re-working of the intro to better set up and link to the study questions would be beneficial.

      We have rewritten the introduction of the manuscript and clearly stated the study questions we were aiming for:

      In paragraph 1-we have stated clearly that we need to study why ADC type of cervical cancer is more aggressive. (Line 58 - 77)

      In paragraph 2- we have stated clearly that we need to find valuable biomarkers to help diagnose lymph node metastasis, which may compensate the shortage of radiological imaging tools and reduce the rate of misdiagnosis. (Line 78 - 100)

      In paragraph 3- we have stated clearly that HPV negative cases is a special group of cervical cancer and we aim to study its cellular features. (Line 101 - 108)

      In paragraph 4- we have stated clearly that we need to decode cell-to-cell interaction mode in the tumor immune microenvironment of ADC using scRNA-seq. (Line 109 - 123)

      (2) For the sequencing, which kit was used on the Novaseq6000?

      For sequencing, we used the Chromium Controller and Chromium Single Cell 3’Reagent Kits (v3 chemistry CG000183) on the Novaseq6000. We feel sorry for lacking this quite important part and have already add the information in Methods section. (Line 196- 197)

      (3) Additional details are needed for the analysis pipeline. How were batch effects identified/dealt with, what were the precise functions and settings for each step of the analysis, how was clustering performed and how were clusters validated etc. Currently, all that is given is software and sometimes function names which are entirely inadequate to be able to assess the validity of the analysis pipeline. This could alternatively be answered by providing annotated copies of the scripts used for analysis as a supplement.

      We apologize for the inadequacy of descriptions of data analysis process. We have already provided a new part of “data processing” with more details in the Methods section (Line 202 - 221). In addition, we have also provided annotated copies of scripts in the supplementary data as Supplementary Data 1.

      (4) For Cell type annotation, please provide the complete list of "selected gene markers" that were used for annotation.

      We have already added the list of marker genes for cell type annotation in the revised manuscript as Supplementary Table 3.

      (5) No statistics are given for the claims on cell proportion differences throughout the paper (for cell types early, epithelial sub-clusters later, and immune cell subsets further on). This should be a multivariate analysis to account for ADC/SCC, HPV+/- and Early/Late stage.

      We feel sorry for lacking statistics when performing analyses of comparisons. In the revision, we have already used statistic approaches to analyze the differences between each set of group comparison. As a result, the corresponding figures have been revised, accordingly.

      For examle, Fig. 1F, Fig. 2D, Fig. 4E, Fig. 5D, Fig. 6D had been re-analyzed to compare ADC/SCC;Supplementary Fig. 1A, Supplementary Fig. 2A, Supplementary Fig. 4A, Supplementary Fig. 5A, Supplementary Fig. 6A had been re-analyzed to compare HPV+/HPV-; Supplementary Fig. 1B, Supplementary Fig. 2B, Supplementary Fig. 4B, Supplementary Fig. 5B, Supplementary Fig. 6B had been re-analyzed to compare Early/Late stage. All P values have been listed in the figure legends.

      (6) The Y-axis label is missing from the proportion histograms in Figure 2D. In these same panels, the bars change widths on the right side. If these are exclusively in ADC, show it with a 0 bar for SCC, not doubling the width which visually makes them appear more important by taking up more area on the plot.

      We feel sorry for impreciseness when presenting histograms of Fig. 2D and we have also revised other figures with similar mistakes, such as Fig. 1F,  Fig. 5D. As for the width of bars, which is due to output style of data processing, we have already corrected all similar mistakes alongside the whole manuscript, for example, Fig. 2D and Supplementary Fig. 2A-B.

      (7) Throughout the manuscript, informatic predictions (differentiation potential, malignancy score, stemness, and trajectory) are presented as though they're concrete facts rather than the predictions they are. Strong conclusions are drawn on the basis of these predictions which do not have adequate data to support. These conclusions which touch on essentially all of the major claims made in the manuscript would need functional data to validate, or the claims need to be very substantially softened as they lack concrete support. Indeed, the fact that most of the genes examined that were characteristic of a given cluster did not show the expected expression patterns in IHC highlights the fact that such predictions require validation to be able to draw proper inferences.

      Thank you for your insightful comments. As you noted, several conclusions were initially based on bioinformatics predictions. Thus in the revised manuscript, we have rewritten all relevant descriptions in a more softened way, particularly in the paragraph of “epithelial cells” in Results section, as well as the conclusions derived from bioinformatics predictions in other paragraphs throughout the manuscript. We hope our revised descriptions will enhance the precision of our work.

      For example, in paragraph “The sub-clusters of epithelial cells in ADC exhibit elevated stem-like features (from Line 353)”, many over-affirmative disriptions had been re-written in Line 353, 362, 371, 375, 379, 383, 390, 392. From Line 395 to 399, the conclusion had been revised as “The observation of cluster Epi_10_CYSTM1 and its possible specificity to ADC makes us question whether or not it may be related to the aggressiveness of ADC” compared to the previous “This observation may partially indicate that high stemness cluster Epi_10_CYSTM1 is essential for ADC to present more aggressive features”. From Line 400 to 408, conclusions from GO analyses had also been rewritten.

      In paragraph “ADC-specific epithelial cluster-derived gene SLC26A3 is a potential prognostic marker for lymph node metastasis (from Line 422)”, many conclusions based on predictions had been revises, such as Line 424 - 428, Line 439 - 441, Line 451 - 453, Line 455 - 457, Line 458 - 459, Line 471 - 473, Line 478 - 481, Line 484 - 486, Line 489, etc.

      In paragraph “Tumor associated neutrophils (TANs) surrounding ADC tumor area may contribute to the formation of a malignant microenvironment (from Line 536)”, we have changed the descriptions based on bio-infomative predictions, such as Line 560, Line 561, Line 565, Line 566, Line 572, Line 576 - 577, etc.

      In paragraph “Crosstalk among tumor cells, Tregs and neutrophils establishes the immunosuppressive TIME in ADC (from Line 601)”, we have already corrected the all the affirmative descriptions, such as Line 604, Line 612, Line 614, Line 626, Line 628 - 629, Line 641, Line 654 – 655, etc.

      All the changes have also been listed in Revision Notes in detail.

      (8) The cluster Epi_10_CYSTM1 which is the basis for much of the paper is present in a single individual (with a single cell coming from another person), and heavily unconnected from the rest of the epithelial populations. If so much emphasis is placed on it, the existence of this cluster as a true subset of cells requires validation.

      We appreciate this suggestion. We agree that the majority of Epi_10_CYSTM1 cells are derived from sample S7. The fact that we have detected this cluster in only one patient may be due to sampling differences and the inherent heterogeneity of tumor specimens. However, the relatively high number of cells in this cluster from one stage III patient suggests its presence in ADC patients and highlights its potential as a diagnostic marker for clinical staging. To further investigate whether this cluster is generally existing in ADC patients, we have identified and selected candidate genes, such as SLC26A3, ORM1, and ORM2, as representative markers of this cluster, which demonstrated high specificity (as shown in Fig. 3B). We then performed IHC staining on a total of 56 tissue samples, and the results showed positive expressions of these markers in the majority of stage IIIC tumor tissues, confirming the existence of this cell cluster (as shown in Supplementary Fig. 3E). In our revised manuscript, we have included an in-depth discussion of this issue in the seventh paragraph of the Discussion section (From Line 801).

      (9) Claims based on survival analysis of TCGA for Epi_10_CYSTM1 are based on a non-significant p-value, though there is a slight trend in that direction.

      Thank you for your insightful comment. From the data of TCGA survival analysis for Epi_10, we found a not-so-slight trend of difference between groups (with a small P value). As a result, we presented this data and hoped to add more strength to the clinical significance of this cluster. However, this indeed caused controversy because the P value is non-significant. As a result, we have already deleted this data in the revised manuscript.

      (10) The claim "The identification of Epi_10_CYSTM1 as the only cell cluster found in patients with stage IIICp raises the possibility that this cluster may be a potential marker to diagnose patients with lymph node metastasis." This is incorrect according to the sample distributions which clearly show cells from the patient who has EPI_10_CYSTM1 in multiple other clusters. This is then used as justification for SLC26A3 which appears to be associated with associated with late stage, however, in the images SLC26A3 appears to be broadly expressed in later tumours rather than restricted to a minor subset as it should be if it were actually related to the EPI_10_CYSTM1 cluster.

      We feel thankful for this question. The conclusion that “The identification of Epi_10_CYSTM1 as the only cell cluster found in patients with stage IIICp raises the possibility that this cluster may be a potential marker to diagnose patients with lymph node metastasis” has indeed been written too concrete according to the sample distribution. We feel sorry for this and have already corrected the description into “As one of stage IIIC-specific cell clusters, the cluster of Epi_10_CYSTM1, with its representative marker gene SLC26A3, presents potential diagnostic value to predict lymph node metastasis” from Line 478-481.

      However, based on our results, we do think this cluster is a potential diagnostic marker and the hypothesis is right. As for SLC26A3, we have specifically added a new paragraph (from Line 801 - 822) in Discussion section to discuss the rationality and necessity of selecting this gene as our central focus, and the reasons why SLC26A3 should be the representative of cluster Epi_10_CYSTM1. As you noted, SLC26A3 appears to be broadly expressed in later tumors rather than restricted to a minor subset in the images. We apologize for any misunderstanding caused. When presenting the IHC data, we only showed the strongly positive areas of each slide to emphasize the differences. In our revision, we have included whole slide scanning images of the IHC samples, clearly showing that SLC26A3 is restricted to a part of the tumors (Supplementary Fig.9).

      (11) The authors claim that cytotoxic T cells express KRT17, and KRT19. This likely represents a mis-clustering of epithelial cells.

      We apologize for using data without noticing the contamination of T cells with few epithelial cells. We have re-performed quality control to exclude contamination and re-analyzed all data of T cells. In the reviesed manuscript, we have therefore updated completely new data for T cells in both Fig. 4 and Supplementary Fig. 4.

      (12) Multiple claims are made for specific activities based on GO term biological process analysis which while not contradictory to the data, certainly are by no means the only explanation for it, nor directly supported.

      Our initial purpose was to use GO analysis as supports for our conclusions. However, we know these are only claims but not evidence, which is also the problem of our writing techniques as in question (7). Therefore, in our revised manuscript, we have already deleted GO data and descriptions in the paragraphs of “T cell (Fig.4)”(from Line 495) and “B/plasma cell (Fig.6)” (from Line 579), because the predictions are quite irrelevant to our conclusions.

      However, in the sections of “epithelial cell (Fig.2)” (from Line 352) and “neutrophils (Fig.5)” (from Line 536), we retained the GO data and rewrote the conclusions, because these analyses have provided us with valuable information regarding the role of specific cell clusters in ADC progression. Furthermore, our subsequent analyses, such as CellChat, have further validated the accuracy of the findings from the GO analysis. We do think this logically supports the whole storyline of the study.

      Reviewer #2 (public review):

      (1) I believe that many of the proposed conclusions are over-interpretations or unwarranted generalizations of the single-cell analysis. These conclusions are often based on populations in the scRNA-seq data that are described as enriched or specific to a given group of samples (eg. ADC). This conclusion is based on the percentage of cells in that population belonging to the given group; for example, a cluster of cells that dominantly come from ADC. The data includes multiple samples for each group, but statistical approaches are never used to demonstrate the reproducibility of these claims.

      We feel sorry that many of the conclusions have been written in an over-affirmative way but lack profound supporting evidences. In our revision, we have already optimized the writing techniques and re-written all conclusions or descriptions related to only bio-informatic predictions. Moreover, we have performed statistical re-analyses on all data and rearranged the related figures.

      For example, in Line 352, we have changed the sub-title “The sub-clusters of epithelial cells exhibit elevated stem-like features to promote the aggressiveness of ADC” into “The sub-clusters of epithelial cells in ADC exhibit elevated stem-like features”. In this paragraph, many over-affirmative discriptions such as “exclusively”, “significant”, “overwhelmingly”, “remarkably” have been deleted. From Line 486-493, the conclusion of “Moreover, SLC26A3 could be employed as a marker for the Epi_10_CYSTM1 cluster, aiding in the diagnosis of lymph node metastasis to prevent post-surgical upstaging in ADC patients in the future” have been changed into “our results propose that SLC26A3 might be considered as a diagnostic marker to predict lymph node metastasis in ADC patients”. Similar over-affirmative descriptions and conclusions had also been re-written in the other paragraphs, which has been refered to question (7) above.

      (2) This leads to problematic conclusions. For example, the "ADC-specific" Epi_10_CYSTM1 cluster, which is a central focus of the paper, only contains cells from one of the 11 ADC samples and represents only a small fraction of the malignant cells from that sample (Sample 7, Figure 2A). Yet, this population is used to derive SLC26A3 as a potential biomarker. SLC26A3 transcripts were only detected in this small population of cells (none of the other ADC samples), which makes me question the specificity of the IHC staining on the validation cohort.

      We sincerely feel grateful for this question. This is a quite important question as it is also pointed out by reviewer#1 in question (8) above. In the revised manuscript, we have already optimized our descriptions and have added detailed explanation for the importance of SLC26A3 in the Discussion section  (from Line 802 - 823). We agree that the majority of Epi_10_CYSTM1 cells are derived from sample S7. The fact that we detected this cluster in only one patient may be due to sampling differences and the inherent heterogeneity of tumor specimens. However, the relatively high number of cells in this cluster from one stage III patient suggests its presence in ADC and highlights its potential as a diagnostic marker for staging ADC. To further investigate whether this cluster is generally present in ADC patients, we identified and selected candidate genes, such as SLC26A3, ORM1, and ORM2, as representative markers of this cluster, which demonstrated high specificity (as shown in Fig. 3B). We then performed IHC staining on 56 cases of tissue samples, and the results showed positive expression of these markers in the majority of stage III tumor tissues, confirming the existence of this cell cluster (as shown in Supplementary Fig. 3E). In our revised manuscript, we have included an in-depth discussion of this issue in the seventh paragraph of the Discussion section.

      (3) This is compounded by technical aspects of the analysis that hinder interpretation. For example, it is clear that the clustering does not perfectly segregate cell types. In Figures 2B and D, it is evident that C4 and C5 contain mixtures of cell type (eg. half of C4 is EPCAM+/CD3-, the other half EPCAM-/CD3+). These contaminations are carried forward into subclustering and are not addressed. Rather, it is claimed that there is a T cell population that is CD3- and EPCAM+, which does not seem likely.

      Thank you for your insightful comment. This important point is also raised by reviewer#1 above. In the revised manuscript, we have reanalyzed our scRNA-seq data and listed the canonical marker genes for cell type annotation. Most importantly, as for T cells and its sub-clustering, we have performed quality control and re-analyzed all data for T cells, with contamination excluded. In the reviesed manuscript, we have added the re-analyzed data for T cells in both Fig. 4 and Supplementary Fig. 4.

      Recommendations for the authors:

      Reviewer #1 (recommendations for the authors):

      The text would substantially benefit from an editorial revision of language usage.

      We sincerely feel grateful for this suggestion. In our revision, we have conducted language editing and carefully rewritten our manuscript. The changes have been clearly marked in the tracked version of the revised manuscript.

      Reviewer #2 (recommendations for the authors):

      (1) Use statistical approaches to claim enrichment/specificity of populations to given groups (ADC, HPV, etc). Analysis packages like Milo for differential abundance testing would be very helpful.

      We feel grateful for this suggestion. In our revision, we have performed statistical analyses for all groups of comparison data. Meanwhile, we have rearranged the figures based on these statistical results, for example, Fig. 1F, Fig. 2D, Fig. 4E, Fig. 5D, Fig. 6D, Supplementary Fig. 1A-B, Supplementary Fig. 2A-B, Supplementary Fig. 4A-B, Supplementary Fig. 5A-B, Supplementary Fig. 6A-B.

      (2) In the subclustering, consider a round of quality control to ensure that all cells are of the cell type they are claimed to be. Contaminant clusters/cells could be filtered out or reassigned. This could be supplemented with an automated annotation approach using cell-type references.

      We feel thankful for this suggestion. As a result, we have provided copies of scripts in the supplementary data to ensure the quality control of cell type annotation.

      (3) An explanation for why SLC26A3 is so rare in the scRNA-seq data, but seemingly common in the IHC staining would be helpful. I am concerned about the specificity of the stain.

      We apologize for lacking adequate explanation of SLC26A3 and cluster Epi_10_CYSTM1. This is a quite crucial question as it has been listed above in question (8) of reviewer #1 and question (2) of reviewer #2 (public review section). In the revised manuscript, we have added intenstive discussion about this question in the seventh paragraph of Disccusion section (from Line 801 - 822). In fact, because of the heterogeneity among different individuals and different tumor regions even within one sample, Epi_10_CYSTM1 seemed to be derived from only one sample. However, the relatively high number of cells in this cluster from one late-stage (stage IIIC) patient suggests its presence in ADC and highlights its potential as a diagnostic marker for staging ADC. Furthermore, we have identified SLC26A3, ORM1 and ORM2 as specific markers of this cluser and performed IHC staining. With a positive expression of these markers, the existence of this cluster has been indirectly proved (as shown in Fig. 3B).

    1. Author response:

      The following is the authors’ response to the current reviews.

      The authors agree with the reviewers that future studies are needed to dissect the mechanisms of eIF3 binding to 3'UTRs and their impact on translation, and the impact of this binding on cellular fate.


      The following is the authors’ response to the original reviews.

      eLife Assessment

      This valuable study reveals extensive binding of eukaryotic translation initiation factor 3 (eIF3) to the 3' untranslated regions (UTRs) of efficiently translated mRNAs in human pluripotent stem cell-derived neuronal progenitor cells. The authors provide solid evidence to support their conclusions, although this study may be enhanced by addressing potential biases of techniques employed to study eIF3:mRNA binding and providing additional mechanistic detail. This work will be of significant interest to researchers exploring post-transcriptional regulation of gene expression, including cellular, molecular, and developmental biologists, as well as biochemists.

      We thank the reviewers for their positive views of the results we present, along with the constructive feedback regarding the strengths and weaknesses of our manuscript, with which we generally agree. We acknowledge our results will require a deeper exploration of the molecular mechanisms behind eIF3 interactions with 3'-UTR termini and experiments to identify the molecular partners involved. Additionally, given that NPC differentiation toward mature neurons is a process that takes around 3 weeks, we recognize the importance of examining eIF3-mRNA interactions in NPCs that have undergone differentiation over longer periods than the 2-hr time point selected in this study. Finally, considering the molecular complexity of the 13subunit human eIF3, we agree that a direct comparison between Quick-irCLIP and PAR-CLIP will be highly beneficial and will determine whether different UV crosslinking wavelengths report on different eIF3 molecular interactions. Additional comments are given below to the identified weaknesses.

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      The authors perform irCLIP of neuronal progenitor cells to profile eIF3-RNA interactions upon short-term neuronal differentiation. The data shows that eIF3 mostly interacts with 3'-UTRs - specifically, the poly-A signal. There appears to be a general correlation between eIF3 binding to 3'-UTRs and ribosome occupancy, which might suggest that eIF3 binding promotes protein

      Strengths:

      The study provides a wealth of new data on eIF3-mRNA interactions and points to the potential new concept that eIF3-mRNA interactions are polyadenylation-dependent and correlate with ribosome occupancy.

      Weaknesses:

      (1) A main limitation is the correlative nature of the study. Whereas the evidence that eIF3 interacts with 3-UTRs is solid, the biological role of the interactions remains entirely unknown. Similarly, the claim that eIF3 interactions with 3'-UTR termini require polyadenylation but are independent of poly(A) binding proteins lacks support as it solely relies on the absence of observable eIF3 binding to poly-A (-) histone mRNAs and a seeming failure to detect PABP binding to eIF3 by co-immunoprecipitation and Western blotting. In contrast, LC-MS data in Supplementary File 1 show ready co-purification of eIF3 with PABP.

      We agree the molecular mechanisms underlying the crosslinking between eIF3 and the end of mRNA 3’-UTRs remains to be determined. We also agree that the lack of interaction seen between eIF3 and PABP in Westerns, even from HEK293T cells, is a puzzle. The low sequence coverage in the LC-MS data gave us pause about making a strong statement that these represent direct eIF3 interactions, given the similar background levels of some ribosomal proteins.

      (2) Another question concerns the relevance of the cellular model studied. irCLIP is performed on neuronal progenitor cells subjected to neuronal induction for 2 hours. This short-term induction leads to a very modest - perhaps 10% - and very transient 1-hour-long increase in translation, although this is not carefully quantified. The cellular phenotype also does not appear to change and calling the cells treated with differentiation media for 2 hours "differentiated NPCs" seems a bit misleading. Perhaps unsurprisingly, the minor "burst" of translation coincides with minor effects on eIF3-mRNA interactions most of which seem to be driven by mRNA levels. Based on the ~15-fold increase in ID2 mRNA coinciding with a ~5-fold increase in ribosome occupancy (RPF), ID2 TE actually goes down upon neuronal induction.

      We agree that it will be interesting to look at eIF3-mRNA interactions at longer time points after induction of NPC differentiation. However, the pattern of eIF3 crosslinking to the end of 3’-UTRs occurs in both time points reported here, which is likely to be the more general finding in what we present.

      (3) The overlap in eIF3-mRNA interactions identified here and in the authors' previous reports is minimal. Some of the discrepancies may be related to the not well-justified approach for filtering data prior to assessing overlap. Still, the fundamentally different binding patterns - eIF3 mostly interacting with 5'-UTRs in the authors' previous report and other studies versus the strong preference for 3'-UTRs shown here - are striking. In the Discussion, it is speculated that the different methods used - PAR-CLIP versus irCLIP - lead to these fundamental differences. Unfortunately, this is not supported by any data, even though it would be very important for the translation field to learn whether different CLIP methodologies assess very different aspects of eIF3-mRNA interactions.

      We agree the more interesting aspect of what we observe is the difference in location of eIF3 crosslinking, i.e. the end of 3’-UTRs rather than 5’-UTRs or the pan-mRNA pattern we observed in T cells. The reviewer is right that it will be important in the future to compare PAR-CLIP and Quick-irCLIP side-by-side to begin to unravel the differences we observe with the two approaches.

      Reviewer #2 (Public review):

      Summary:

      The paper documents the role of eIF3 in translational control during neural progenitor cell (NPC) differentiation. eIF3 predominantly binds to the 3' UTR termini of mRNAs during NPC differentiation, adjacent to the poly(A) tails, and is associated with efficiently translated mRNAs, indicating a role for eIF3 in promoting translation.

      Strengths:

      The manuscript is strong in addressing molecular mechanisms by using a combination of nextgeneration sequencing and crosslinking techniques, thus providing a comprehensive dataset that supports the authors' claims. The manuscript is methodologically sound, with clear experimental designs.

      Weaknesses:

      (1) The study could benefit from further exploration into the molecular mechanisms by which eIF3 interacts with 3' UTR termini. While the correlation between eIF3 binding and high translation levels is established, the functionality of these interactions needs validation. The authors should consider including experiments that test whether eIF3 binding sites are necessary for increased translation efficiency using reporter constructs.

      We agree with the reviewer that the molecular mechanism by which eIF3 interacts with the 3’UTR termini remains unclear, along with its biological significance, i.e. how it contributes to translation levels. We think it could be useful to try reporters in, perhaps, HEK293T cells in the future to probe the mechanism in more detail.

      (2) The authors mention that the eIF3 3' UTR termini crosslinking pattern observed in their study was not reported in previous PAR-CLIP studies performed in HEK293T cells (Lee et al., 2015) and Jurkat cells (De Silva et al., 2021). They attribute this difference to the different UV wavelengths used in Quick-irCLIP (254 nm) and PAR-CLIP (365 nm with 4-thiouridine). While the explanation is plausible, it remains a caveat that different UV crosslinking methods may capture different eIF3 modules or binding sites, depending on the chemical propensities of the amino acid-nucleotide crosslinks at each wavelength. Without addressing this caveat in more detail, the authors cannot generalize their findings, and thus, the title of the paper, which suggests a broad role for eIF3, may be misleading. Previous studies have pointed to an enrichment of eIF3 binding at the 5' UTRs, and the divergence in results between studies needs to be more explicitly acknowledged.

      We agree with the reviewer that the two methods of crosslinking will require a more detailed head-to-head comparison in the future. However, we do think the title is justified by the fact that we see crosslinking to the termini of 3’-UTRs across thousands of transcripts in each condition. Furthermore, the 3’-UTR crosslinking is enriched on mRNAs with higher ribosome protected fragment counts (RPF) in differentiated cells, Figure 3F.

      (3) While the manuscript concludes that eIF3's interaction with 3' UTR termini is independent of poly(A)-binding proteins, transient or indirect interactions should be tested using assays such as PLA (Proximity Ligation Assay), which could provide more insights.

      This is a good idea, but would require a substantial effort better suited to a future publication. We think our observations are interesting enough to the field to stimulate future experimentation that we may or may not be most capable of doing in our lab.

      Reviewer #3 (Public review):

      Summary:

      In this manuscript by Mestre-Fos and colleagues, authors have analyzed the involvement of eIF3 binding to mRNA during differentiation of neural progenitor cells (NPC). The authors bring a lot of interesting observations leading to a novel function for eIF3 at the 3'UTR.

      During the translational burst that occurs during NPC differentiation, analysis of eIF3-associated mRNA by Quick-irCLIP reveals the unexpected binding of this initiation factor at the 3'UTR of most mRNA. Further analysis of alternative polyadenylation by APAseq highlights the close proximity of the eIF3-crosslinking position and the poly(A) tail. Furthermore, this interaction is not detected in Poly(A)-less transcripts. Using Riboseq, the authors then attempted to correlate eIF3 binding with the translation efficacy of mRNA, which would suggest a common mechanism of translational control in these cells. These observations indicate that eIF3-binding at the 3'UTR of mRNA, near the poly(A) tail, may participate to the closed-loop model of mRNA translation, bridging 5' and 3', and allowing ribosomes recycling. However, authors failed to detect interactions of eIF3, with either PABP or Paip1 or 40S subunit proteins, which is quite unexpected.

      Strength:

      The well-written manuscript presents an attractive concept regarding the mechanism of eIF3 function at the 3'UTR. Most mRNA in NPC seems to have eIF3 binding at the 3'UTR and only a few at the 5'end where it's commonly thought to bind. In a previous study from the Cate lab, eIF3 was reported to bind to a small region of the 3'UTR of the TCRA and TCRB mRNA, which was responsible for their specific translational stimulation, during T cell activation. Surprisingly in this study, the eIF3 association with mRNA occurs near polyadenylation signals in NPC, independently of cell differentiation status. This compelling evidence suggests a general mechanism of translation control by eIF3 in NPC. This observation brings back the old concept of mRNA circularization with new arguments, independent of PABP and eIF4G interaction. Finally, the discussion adequately describes the potential technical limitations of the present study compared to previous ones by the same group, due to the use of Quick-irCLIP as opposed to the PAR-CLIP/thiouridine.  

      Weaknesses:

      (1) These data were obtained from an unusual cell type, limiting the generalizability of the model.

      We agree that unraveling the mechanism employed by eIF3 at the mRNA 3’-UTR termini might be better studied in a stable cell line rather than in primary cells.

      (2) This study lacks a clear explanation for the increased translation associated with NPC differentiation, as eIF3 binding is observed in both differentiated and undifferentiated NPC. For example, I find a kind of inconsistency between changes in Riboseq density (Figure 3B) and changes in protein synthesis (Figure 1D). Thus, the title overstates a modest correlation between eIF3 binding and important changes in protein synthesis.

      We thank the reviewer for this question. Riboseq data and RNASeq data are not on absolute scales when comparing across cell conditions. They are normalized internally, so increases in for example RPF in Figure 3B are relative to the bulk RPF in a given condition. By contrast, the changes in protein synthesis measured in Figure 1D is closer to an absolute measure of protein synthesis. 

      (3) This is illustrated by the candidate selection that supports this demonstration. Looking at Figure 3B, ID2, and SNAT2 mRNA are not part of the High TE transcripts (in red). In contrast, the increase in mRNA abundance could explain a proportionally increased association with eIF3 as well as with ribosomes. The example of increased protein abundance of these best candidates is overall weak and uncertain.

      We agree that using TE as the criterion for defining increased eIF3 association would not be correct. By “highly translated” we only mean to convey the extent of protein synthesis, i.e. increases in ribosome protected fragments (RPF), rather than the translational efficiency.

      (4) Despite several attempts (chemical and UV cross-linking) to identify eIF3 partners in NPC such as PABP, PAIP1, or proteins from the 40S, the authors could not provide any evidence for such a mechanism consistent with the closed-loop model. Overall, this rather descriptive study lacks mechanistic insight (eIF3 binding partners).

      We agree that it will be important to identify the molecular mechanism used by eIF3 to engage the termini of mRNA 3’-UTRs. Nevertheless, the identification of eIF3 crosslinking to that location in mRNAs is new, and we think will stimulate new experiments in the field.

      (5) Finally, the authors suspect a potential impact of technical improvement provided by QuickirCLIP, that could have been addressed rather than discussed.

      We agree a side-by-side comparison of eIF3 crosslinks captured by PAR-CLIP versus QuickirCLIP will be an important experiment to do. However, NPCs or other primary cells may not be the best system for the comparison. We think using an established cell line might be more informative, to control for effects such as 4-thiouridine toxicity.

      Recommendations for the authors:

      Reviewer #1 (Recommendations for the authors):

      (1) The Western blot signals for SLC38A2 and ID2 are close to the membrane background and little convincing. Size markers are missing.

      We agree these antibodies are not great. They are the best we could find, unfortunately. We have included originals of all western blots and gels as supplementary information. It’s important to note that the Riboseq data for ID2 and SLC38A2 are consistent with the western blots. See Figure 3C and Figure 3–figure supplement 3B.

      (2) Figure 1 - Figure Supplement 1 appears to present data from a single experiment. This is far less than ideal considering the minor differences measured.

      Thanks for the comment. This is a representative experiment showing the early time course. We have added a second experiment with two different treatments that show the same pattern in the puromycin assay, in Figure 1–figure supplement 1.

      (3) Figure 3F: One wonders what this would look like if TE was plotted instead of RPF. Figure 3 - Figure Supplement 4 seems to show something along those lines. However, the data are not mentioned in the main results section are quite unclear. Why are data separated into TE high and low? Doesn't TE high in differentiated cells equal TE low in undifferentiated cells?

      This is an interesting question. Note that in Figure 3B, n=6300 genes show no change in TE upon differentiation, compared to a total of n=2127 that show a change in TE, with most of those changes not very large. We have now replotted Figure 3F comparing irCLIP read counts in 3’-UTRs to RPF read counts, which shows a significant positive correlation, regardless of whether we look at undifferentiated or differentiated NPCs (See Figure 3F and a new Figure 3– figure supplement 4A). We also compare irCLIP reads in 3’-UTRs to TE values, which show no correlation (See Figure 3G and Figure 3–figure supplement 4B).

      Figure 3-figure supplement 4 was actually a response to a previous round of review (at PLOS Biology) to a rather technical question from a reviewer. We think this figure and associated text should be removed. Instead, we now include supplementary tables with the processed RPF and TE values, for reference (Supplemental files 4-6). We omitted these in the original submission when they should have been included. We also abandoned comparing undifferentiated and differentiated NPCs, and instead look directly at irCLIP reads vs. RPFs or TE, regardless of NPC state, as noted above (Figure 3F, G, and Figure 3–figure supplement 4).

      (4) Figure 3C: The data should be plotted on the same y-axis scale. This would make a visual assessment of the differences in mRNA and RFP levels more intuitive.

      Thanks for this suggestion. We have rescaled the plots as requested.

      Reviewer #2 (Recommendations for the authors):

      (1) The quality of the Western blots in several figures is quite poor. Notably, Figure 1C seems to be a composite gel, as each blot appears to come from a different gel. Additionally, in Supplementary Figure 1A, there is only a single data point, yet the authors indicate that this image is representative of multiple assays. The lack of error bars in this figure raises a question vis-a-vis the reproducibility of the experiments.

      Thanks for the comments. We now include all the original gels as supplementary information. As noted above, the antibodies for ID2 and SLC38A2 are not great, we agree. And as we noted above, the Riboseq data for ID2 and SLC38A2 are consistent with the western blots.

      (2) For the top 500 targets of undifferentiated and differentiated NPCs in the Quick-irCLIP assay, the manuscript does not clarify how many targets are common and how many are unique to each condition. This information is important for understanding the extent of overlap and differentiation-specific interactions of eIF3 with mRNAs. Providing this data would strengthen the interpretation of the results.

      There are 449 of the top 500 hits in common between undifferentiated and differentiated NPCs. We have now added this information to the text, to add clarity. 

      (3) The manuscript does not provide detailed percentages or numbers regarding the overlap between iCLIP and APA-Seq peaks. Clarifying this overlap, particularly in terms of how many of the APA sites are also targets of eIF3, would bolster the understanding of how these two datasets converge to support the authors' conclusions.

      This is a difficult calculation to make, due to the fact that APA-Seq reads are generally much longer than the Quick-irCLIP reads. This is why we focused instead on quantifying the percent of Quick-irCLIP peaks (which are more narrow) overlap with predicted polyadenylation sequences, in Figure 2-figure supplement 1.

      Reviewer #3 (Recommendations for the authors):

      (1) Perform Quick-irCLIP in HEK293 cells to infer technical limitations and/or to generalize the model. The authors will then compare again eIF3 binding site in Jurkat, HEK293, and NPC.

      This is an experiment we plan to do for a future publication, given that we would want to repeat both Quick-irCLIP and PAR-CLIP at the same time.

      (2) Select mRNA candidates with high or low TE changes and analyze eIF3 binding and RPF density and protein abundance along NPC differentiation to support the role of eIF3 binding in stimulating translation.

      We agree looking at time courses in more depth would be interesting. However, this would require substantial experimentation, which is better suited to a future study. Furthermore, now that we have moved away from comparing undifferentiated NPCs and differentiated NPCs when examining TE and RPF values (Figure 3 and Figure 3–figure supplement 4), we think the results now support a more general mechanism of translation reflected in the irCLIP 3’-UTR vs. RPF correlation, independent of NPC state.

      (3) Analyze the interaction of eIF3 with eIF4G and other known partners. This will really provide an improvement to the manuscript. The lack of interaction between eIF3 and the 40S is quite surprising.

      We agree more work needs to be done on the mechanistic side. These are experiments we think would be best to carry out in a stable cell line in the future, rather than primary cells.

      (4) Perform Oligo-dT pulldown (or cap column if possible) and analyze the relative association of PABP, eIF3, and eIF4F on mRNA in NPC versus HEK293. This will clarify whether this mechanism of mRNA translation is specific to NPC or not.

      Thanks for this suggestion. We are uncertain how it would be possible to deconvolute all the possible ways to interpret results from such an experiment. We agree thinking about ways to study the mechanism will keep us occupied for a while.

      (5) Citations in the text indicate the first author, whereas the references are numbered! 

      Our apologies for this oversight. This was a carryover from previous formatting, and has been fixed.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public Review):

      (1) In my opinion, the major weakness is the selection of IVs, the same IVs should be used for each exposure, especially when the outcomes (IA, SAH, and uIA) are closely related. The removal of IVs was inconsistent, for example, why was LPA rs10455872 removed for SAH but not for uIA? (significantly more IVs were used for uIA). The authors should provide more details for the justification of the removal of IVs other than only indicating "confounder" in supplementary tables. The authors should also perform additional analyses including all IVs and IVs from other PUFA GWAS.

      We apologized for our negligence. We reconducted a two-sample MR analysis following the removal of rs10455872 from the uIA, which yielded unaltered ORs and 95% confidence intervals. The P-value was once again found to be statistically insignificant. These results demonstrate the robustness of our MR analyses and indicate that this SNP does not exert an influence on the overall results. (see Figure 4)

      For SNP selection, we adhered rigorously to the established Mendelian randomization analysis process for the screening of instrumental variables. "Confounder" is mean that a current explicit influencer that is explicitly associated with the outcome variable. Following the removal of such confounding SNPs, the analysis of heterogeneity and pleiotropy is repeated on several occasions in MR analysis using radical MR, MRPRESSO, IVW-radical and Egger-radical, with each iteration involving the removal of the corresponding anomalous SNPs until all instances of pleiotropy and heterogeneity have been eliminated, it can be observed that the final single-nucleotide polymorphism (SNP) for each group is not identical. Therefore, It can be observed that the final SNPs for each group is not identical.

      (2) In addition, it seems that the SNPs in the FADS locus were driving the MR association, while FADS is a very pleiotropic locus associated with many lipid traits, removing FADS could attenuate the MR effect. The authors should perform a sensitivity analysis to remove this locus.

      Thanks for the reviewer’s suggestion. In our revised manuscript, We reconducted MR analysis of the positive results after the removal of the FADS2 and its SNPs within 500 kb of the FADS2 locus. This analysis demonstrated that there was no significant causal pathogenic association between PUFA and IA, aSAH. This result validated that SNP: rs174564 was a significant factor driving the causal association between PUFAs and CA. (See page 6, line155-157 and Figure 8)

      (3) Instead of removing multiple "confounder" IVs which I think may bias the MR results due to very closely related lipid traits, the authors should perform multivariable MR to identify independent effects of PUFAs to IA, conditioning on other PUFAs and/or other lipids.

      Thanks for the reviewer’s suggestion. In our revised manuscript, we employed MVMR through adjust for HDL cholesterol, LDL cholesterol, total cholesterol and triglycerides, to remove bias from closely related lipid traits. The application of MVMR analysis serves to reinforce the robustness of our conclusions. (See page 6, line151-153 and Figure5-7)

      (4) Colocalization was not well described, the authors should include the colocalization results for each locus in a supplementary table. They also mentioned "a large PP for H4 (PP.H4 above 0.75) strongly supports shared causal variants affecting both gene expression and phenotype". The authors should make sure that the colocalization was performed using the expression data of each gene or using the GWAS summary of each PUFA locus.

      I apologize for our negligence. We have added the detailed results of the COLOC for each locus in the supplementary table. (See supplementary table 6)

      Recommendations for the authors:

      Reviewer #1 (Recommendations For The Authors):

      (1) I suggest the authors consult Borges et al., 2022 (doi: 10.1186/s12916-022-02399-w) for PUFA IV selection, and perform sensitivity analysis based on Borges et al., 2022 IVs and another PUFA GWAS (such as J Kettunen et al., 2016, doi: 10.1038/ncomms11122).

      Thanks for the reviewer’s suggestion. In order to provide further evidence of the robustness of the results of our analyses, we conducted MVMR and a sensitivity analysis after excluding SNPs within 500 kb of the FADS2 locus, as recommended by Borges et al. (2022). (See page 6, line151-157 and Figure 5-8)

      In regard to the article by J. Kettunen et al. (2016), we found that the validation dataset from which the article was sourced was insufficient in terms of sample size and lacked the requisite statistical efficacy to be used for validation purposes.

      (2) The authors justified that colocalization is to determine if "PUFAs are mediators in the hereditary causative route of cerebral aneurysm", which I don't think is the case.

      Colocalization is to determine whether an MR estimate is not confounded by LD.

      I apologize for our incorrect description. We have made careful modification in our revised manuscript, as follows: “There is consistent evidence that PUFAs have a beneficial causal effect on cerebral aneurysm. In order to determine an MR estimate is not confounded by LD, we used COLOC to identify shared causal SNP between PUFAs and cerebral aneurysms”. (See page 7-8, line 215-217)

      (3) Supplementary tables 2-4 were a bit confusing to me, I suggest the authors provide one supplementary table for each exposure.

      Thanks for the reviewer’s suggestion. Supplementary tables 2_1-2_5 shows the exposure data for the five PUFAs associated with IA, supplementary tables 3_1-3_5 shows the exposure data for the five PUFAs associated with aSAH and supplementary tables 4_1-4_5 shows the exposure data for the five PUFAs associated with UIA. Each exposure is represented by a distinct table.

      (4) Figure 1 legend: I can't find multivariable MR in the figure/method.

      I apologize for our negligence. In our revised manuscript, we have added the MVMR methodology. We also have modified Figure 1 and Figure 1 legend. (See Figure 1, Figure 1 legend and page 6, line 151-153)

      (5) LOO analysis was mentioned in methods and results but I could not find the results for LOO.

      I apologize for our negligence. In our revised manuscript, we have described the results of the LOO, as follows: “The leave-one-out plot demonstrates that there is a potentially influential SNP (rs174564) driving the causal link between PUFA and cerebral aneurysm.” (See page 7, line 209-210)

      (6) Finally, the authors should proofread their manuscript as many sentences are difficult to read, such as:

      Line 183: "...MR methods revealed consistency", "However, there was no any causal relationship..."

      Line 200: "For achieve that..."

      I apologize for our incorrect description. We have modified these descriptions in our revised manuscript, as follows: “The results demonstrated consistency in the outcomes and directionality of the various MR methods employed” and “In order to determine an MR estimate is not confounded by LD, we used COLOC to identify shared causal SNP between PUFAs and cerebral aneurysms”. (See page 7, line 187-188 and line 215-217).

      Reviewer #2 (Recommendations For The Authors):

      (1) Are there any previous epidemiological studies on the association between PUFA and cerebral aneurysm? It will be helpful to introduce this background.

      Thanks for the reviewer’s suggestion. The epidemiology of PUFA with aneurysm in other sites, such as the abdominal aorta, are described in the Introduction section. Although there is a paucity of large-scale multicenter clinical epidemiological studies examining the relationship between PUFAs and cerebral aneurysms, we are endeavoring to infer a prior association between PUFAs and cerebral aneurysms with the aid of Mendelian randomization analysis.

      (2) The authors performed a leave-one-out analysis but did not explain much about the results. The leave-one-out analysis seems to provide some evidence that some SNP is driving the results, like rs174564 in Supplementary Figure 5-1.

      I apologize for our negligence. In our revised manuscript, we have described the results of the leave-one-out analysis, as follows: “The leave-one-out plot demonstrates that there is a potentially influential SNP (rs174564) driving the causal link between PUFA and cerebral aneurysm”. (See page 7, line209-214)”.

      (3) In the discussion (line 211), the authors mentioned omega-6 fatty acids increased the risk of IA and aSAH, omega-3 fatty acids decreased the risk for IA and aSAH, but omega-6 by omega-3 decreased the risk of IA and aSAH. This seems to be different from the figures.

      I apologize for our incorrect description. We have modified this description in our revised manuscript, as follows: “We demonstrated that the omega-3 fatty acids, DHA and, omega-3-pct causally decreased the risk for IA and aSAH. And omega-6 by omega-3 causally increased the risk of IA and aSAH”. (See page 8, line228-230)

      Minor:

      (4) Some grammar errors need to be checked, such as:

      In line 200, "For achieve that, we tested for shared causative SNPs between PUFAs and cerebral aneurysm using COLOC".

      In line 123, "Fourth, to eliminate unclear, palindromic and associated with known confounding factors (body mass index (McDowell et 125 al., 2018), blood pressure (Sun et al., 2022), type 2 diabetes (Tian et al., 2022), high-density lipoprotein (Huang et al., 2018)) SNPs."

      I apologize for our incorrect description. We have modified these descriptions in our revised manuscript, as follows: “Fourth, remove SNPs that are obscure, palindromic, and linked to recognized confounding variables (body mass index (McDowell et al., 2018), blood pressure (Sun et al., 2022), type 2 diabetes (Tian et al., 2022), high-density lipoprotein (Huang et al., 2018))” and “In order to determine an MR estimate is not confounded by LD, we used COLOC to identify shared causal SNP between PUFAs and cerebral aneurysms”. (See page 5, line 124-127 and page 7 line215-217)

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public review):

      The findings of Ziolkowska and colleagues show that a specific projection from the nucleus reuniens of the thalamus (RE) to dorsal hippocampal CA1 neurons plays an important role in fear extinction learning in male and female mice. In and of itself, this is not a particularly new finding, although the authors' identification of structural alterations from within dorsal CA1 stratum lacunosum moleculare (SLM) as a candidate mechanism for the learning-related plasticity is potentially novel and exciting. The authors use a range of anatomical and functional approaches to demonstrate structural synaptic changes in dorsal CA1 that parallel the necessary role of RE inputs in modulating extinction learning. Yet, the significance of these findings is substantially limited by several technical shortcomings in the experimental design, and the authors' central interpretation. Otherwise, there remain several strengths in the design and interpretation that offset some of these concerns.

      Given that much is already known about the role of RE and hippocampus in modulating fear learning and extinction, it remains unclear whether addressing these concerns would substantially increase the impact of this study beyond the specific area of speciality. Below, several major weaknesses will be highlighted, followed by several miscellaneous comments.

      Methodological:

      (1) One major methodological weakness in the experimental design involves the widespread misapplication of Ns used for the statistical analyses. Much of the anatomical analyses of structural synaptic changes in the RE-CA1 pathway use N = number of axons (Figs. 1, 2), N = number of dendrites (Figs. 3, 4), and N = number of sections (Fig. 7; note that there are 7 figures in total). In every instance, N = animal number should be used. It is unclear which of these results would remain significant if N = animal number were used in each or how many more animals would be required. This is problematic since these data comprise the main evidence for the authors' central conclusion that specific structural synaptic changes are associated with fear extinction learning.

      We do agree with the reviewer that N = animal number is the preferred way to present data in most of our experiments. However, in some experimental groups we observed a very low number of entries. For example, in the 5US group we found RE+/+ spines only in 3 out of 6 analyzed animals. We believe that this observation is not due to technical problems as mCherry virus transduction required to find RE+/+ spines is similar in all experimental groups and we analyzed similar volumes of tissue. While this result still allows the calculation of density of RE+/+ spines per animal it generates no entries for spine area and PSD95 mean gray value if N = animal number. Hence, we decided to use N=animals to calculate spines and boutons densities, and N=dendritic spines/boutons to calculate other spine/bouton parameters. 

      (2) There is a lack of specific information regarding what constitutes learning with respect to behavioral freezing. It is never clearly stated what specific intervals are used over which freezing is measured during acquisition, extinction, and in extinction retrieval tests. Additionally, assessment of freezing during retrieval at 5- and 30-min time points doesn't lay to rest the possibility that there were differences in the decay rate over the 30-min period (also see below).

      We added a detailed description of how learning was assessed.

      ln 125-134: “For assessment of learning we used percent of time spent by animals freezing (% freezing). Freezing behavior was defined as complete lack of movement, except respiration. To assess within-session learning (working memory) we compared pre- and post-US freezing frequency (the first 148 sec vs last 30 sec) during the CFC session (day 1). To assess formation of long-term contextual fear memory, we compared pre-US freezing (day 1) and the first 5 minutes of the Extinction session (day 2). To assess within session contextual fear extinction we ran 2-way ANOVA to assess the effect of time and manipulation on freezing frequency. Freezing data were analyzed in 5-minute bins. To assess formation of long-term contextual fear extinction memory we compared the first 5 minutes of the Extinction session (day 2) and Test session (day 3).”

      As suggested by the reviewer, we also added data for all six 5-minut bins of Extinction sessions.

      (3) A minor-to-moderate methodological weakness concerns the authors' decision to utilize saline injected groups as controls for the chemogenetics experiments (Figs. 5, 6). The correct design is to have a CNO-only group with the same viral procedure sans hM4Di. This concern is partly mitigated by the inclusion of a CNO vs. saline injection control experiment (Fig. 6).

      Figure 5 does not describe a chemogenetic experiment.

      We added new groups with control virus (CNO vs saline) to Figure 6 (now Fig. 6D and H).

      The chemogenetic experiment shown on Figure 7 has all 4 experimental groups (Control vs hM4Di and saline vs CNO).

      (4) In the electron microscopic analyses of dendritic spines (Fig. 5), comparison of only the fear acquisition versus extinction training, and the lack of inclusion of a naïve control group, makes it difficult to understand how these structural synaptic changes are occurring relative to baseline. It is noteworthy that the authors utilize the tripartite design in other anatomical analyses (Fig. 2-4).

      We added data for the Naive mice to Figure 5.

      (5) Interpretation:

      The main interpretive weakness in the study is the authors' claim that their data shows a role for the RE-CA1 pathway in memory consolidation (i.e., see Abstract). This claim is based on the premise that, although RE-CA1 pathway inactivation with CNO treatment 30 min prior to contextual fear extinction did not affect freezing at 5- and 30-min time points relative to saline controls, these rats showed greater freezing when tested on extinction retrieval 24 h thereafter. First, the data do not rule out possible differences in the decay rate of freezing during extinction training due to CNO administration. Next, the fact that CNO is given prior to training still leaves open the possibility that acquisition was affected, even if there were not any frank differences in freezing. Support for this latter possibility derives from the fact that mice tested for extinction retrieval as early as 5 min after extinction training (Fig. 6C) showed the same impairments as mice tested 24 h later (Figs. 6A). Further, all the structural synaptic changes argued to underlie consolidation were based on analysis at a time point immediately following extinction training, which is too early to allow for any long-term changes that would underlie memory consolidation, but instead would confer changes associated with the extinction training event.

      We do agree with the reviewer that our data do not allow us to conclude whether RE-CA1 pathway is involved in acquisition or consolidation of CFE memory. Therefore, we avoid those terms in the manuscript. We just conclude that RE→CA1 participates in the CFE.

      Reviewer #2 (Public review):

      Summary:

      Ziółkowska et al. characterize the synaptic mechanisms at the basis of the REdCA1 contribution to the consolidation of fear memory extinction. In particular, they describe a layer specific modulation of RE-dCA1 excitatory synapses modulation associated to contextual fear extinction which is impaired by transient chemogenetic inhibition of this pathway. These results indicate that RE activity-mediated modulation of synaptic morphology contributes to the consolidation of contextual fear extinction

      Strengths:

      The manuscript is well conceived, the statistical analysis is solid and methodology appropriate. The strength of this work is that it nicely builds up on existing literature and provides new molecular insight on a thalamo-hippocampal circuit previously known for its role in fear extinction. In addition, the quantification of pre- and post-synapses is particularly thorough.

      Weaknesses:

      The findings in this paper are well supported by the data more detailed description of the methods is needed.

      (1) In the paragraph Analysis of dCA1 synapses after contextual fear extinction (CFE), more experimental and methodological data should be given in the text:

      - how was PSD95 used for the analysis, what was the difference between RE. Even if Thy1-GFP mice were used in Fig.2, it appears they were not used for bouton size analysis. To improve clarity, I suggest moving panel 2C to Figure 3. It is not clear whether all RE axons were indiscriminately analysed in Fig. 2 or if only the ones displaying colocalization with both PSD95 and GFP were analysed. If GFP was not taken into account here, analysed boutons could reflect synapses onto inhibitory neurons and this potential scenario should be discussed.

      PSD-95 immunostaining in close apposition to boutons was used to identify RE buttons innervating CA1 (Fig 1 and 2). In these cases PSD-95 signal was not quantified. PSD-95 in close apposition to dendritic spines was used as a proxy of PSDs in CA1 (Figure 3, 4 and 7). In these cases we assessed the integrated mean gray value of PSD-95 signal per dendritic spine (Figure 3, 4) or per ROI (Figure 7). This is explained in detail in the section Confocal microscopy and image quantification (ln 149-172).

      GFP signal was not taken into account during boutons analysis. This is explained in the materials and methods section Confocal microscopy and image quantification (ln 149-172).

      We indicate that PSD-95 is a marker of excitatory synapses located both on excitatory and inhibitory neurons.

      Ln 258: RE boutons were identified in SO and SLM as axonal thickenings in close apposition to PSD-95-positive puncta (a synaptic scaffold used as a marker of excitatory synapses located both on excitatory and inhibitory neurons (Kornau et al., 1995; El-Husseini et al., 2000; Chen et al., 2011; Dharmasri et al., 2024).

      We also cite literature demonstrating that RE projects to the hippocampal formation and forms asymmetric synapses with dendritic spines and dendrites, suggesting innervation of excitatory synapses on both excitatory and aspiny inhibitory neurons (ln 673).

      As advised by the reviewer the Figure 2C panel was moved to Figure 3 (now it is Fig 3A).

      (2) in the methods: The volume of intra-hippocampal CNO injections should be indicated. The concentration of 3 uM seems pretty low in comparison with previous studies. CNO source is missing.

      This section has been rewritten to be more clear. The concentration of CNO was chosen based on the previous studies (Stachniak et al., 2014).

      ln 103: “Cannula placement. Mice were anesthetized by inhalation of 3–5% isoflurane (IsoFlo; Abbott Animal Health) in oxygen and positioned in a stereotaxic frame (51503, Stoelting, Wood Dale, IL, USA). Two holes were drilled in the skull, and a double guide cannulae (2 mm apart and 2 mm long; 26GA, Plastics One) was lowered into the holes such that the cannula tip was located over dorsal CA1 area (2 mm posterior to bregma, ±1 mm lateral, and −1.3 mm vertical). Cannulae were kept patent by using 33-gauge internal dummy cannulae (Plastics One). The animals were used in contextual fear conditioning 21 days after the cannulation. Animals received bilateral CNO (3 μM, 0.2 μl per side for 1 min; Tocris Bioscience, Cat. No. 4936) (Stachniak et al., 2014) or saline injections (0.2 μl per side) 30 minutes before Extinction session via intrahippocampal injection cannulae (33-gauge). After the infusion, the cannula was left in place for 30 seconds. The cannula placement was verified by histology, and only data from animals with correct cannula implants were included in statistical analyses.”

      (3) More details of what software/algorithm was used to score freezing should be included.

      Freezing was automatically scored with VideoFreeze™ Software (Med Associates Inc.).

      (4) Antibody dilutions for IHC should be indicated. Secondary antibody incubation time should be indicated.

      The missing information is added.

      ln 144: “Next, sections were incubated in 4°C overnight with primary antibodies directed against PSD-95 (1:500, Millipore, MAB 1598), washed three times in 0.3% Triton X-100 in PBS and incubated in room temperature for 90 minutes with a secondary antibody bound with Alexa Fluor 647 (1:500, Invitrogen, A31571).”

      (5) No statement about code and data availability is present.

      The statements are added.

      ln 785: Row data and the code used for analysis of confocal data is available at OSF (https://osf.io/bnkpx/).

      Reviewer #3 (Public review):

      Summary:

      This paper examined the role of nucleus reuniens (RE) projections to dorsal CA1 neurons in context fear extinction learning. First, they show that RE neurons send excitatory projections to the stratum oriens (SO) and the stratum lacunosum moleculare (SLM), but not the stratum radiatum (SR). After context fear conditioning, the synaptic connections between RE and dCA1 neurons in the SLM (but not the SO) are weakened (reduced bouton and spine density) after mice undergo context fear conditioning. This weakening is reversed by extinction learning, which leads to enhanced synaptic connectivity between RE inputs and dendrites in the SLM. Control experiments demonstrate that the observed changes are due to extinction and not caused by simple exposure to the context. Extinction learning also induced increases in the size (volume and surface area) of the post-synaptic density (PSD) in SLM. To establish the functional role of RE inputs to dCA1, the researchers used an inhibitory DREADD to silence this pathway during extinction learning. They observe that extinction memory (measured 2-hours or 24-hours later) is impaired by this inhibition. Control experiments show that the extinction memory deficit is not simply due to increased freezing caused by inactivation of the pathway or injections of CNO. Inhibiting the RO projection during extinction learning also reduced the levels of PSD-95 protein levels in the spines of dCA1 neurons.

      Strengths:

      Based on their results, the authors conclude that, "the RE→SLM pathway participates in the updating of fearful context value by actively regulating CFE-induced molecular and structural synaptic plasticity in the SLM.". I believe the data are generally consistent with this hypothesis, although there is an important control condition missing from the behavioral experiments.

      Weaknesses:

      (1) A defining feature of extinction learning is that it is context specific (Bouton, 2004). It is expressed where it was learned, but not in other environments. Similarly, it has been shown that internal contexts (or states) also modulate the expression of extinction (Bouton, 1990). For example, if a drug is administered during extinction learning, it can induce a specific internal state. If this state is not present during subsequent testing, the expression of extinction is impaired just as it is when the physical context is altered (Bouton, 2004). It is possible that something similar is happening in Figure 6. In these experiments, CNO is administered to inactivate the RE-dCA1 projection during extinction learning. The authors observe that this manipulation impairs the expression of extinction the next day (or 2-hours later). However, the drug is not given again during the test. Therefore, it is possible that CNO (and/or inactivation of the RE-dCA1 pathway) induces a state change during extinction that is not present during subsequent testing. Based on the literature cited above, this would be expected to disrupt fear extinction as the authors observed. To determine if this alternative explanation is correct, the researchers need to add groups that receive CNO during extinction training and subsequent extinction testing. If the deficits in extinction expression reported in Figure 6 result from a state change, then these groups should not exhibit an impairment. In contrast, if the authors' account is correct, then the expression of extinction should still be disrupted in mice that receive CNO during training and testing.

      We do agree with the reviewer that such an experiment would be interesting. However, it could be also confusing as we could not distinguish whether the possible behavioral effects are related to the state-dependent aspects of CFE or impaired recall of CFE. Importantly, previous studies showed that RE is crucial for extinction recall (Totty et al., 2023). We also show that CFE memory is impaired not only when the animals recall CFE without CNO (day 3) but also with CNO (day 4) (Figure 6C). Moreover, we do not see the effects of CNO on CFE in the control groups (Figure 6D and H). So we believe that it is unlikely that CNO results in state-dependent CFE.

      (2) In their analysis of dCA1 synapses after contextual fear extinction (CFE) (Figure 4), the authors should have compared Ctx and Ctx-Ctx animals against naïve animals (as they did in Figure 3) when comparing 5US and Ext with naïve animals. Otherwise, the authors cannot make the following conclusion; "since changes of SLM synapses were not observed in the animals exposed to the familiar context that was not associated with the USs, our data support the role of the described structural plasticity at the RE→SLM synapses in CFE, rather than in processing contextual information in general.".

      We assume that the key experimental groups to conclude about synaptic plasticity related to particular behavior are the groups that differ just by one factor/experience. For CFE that would be mice sacrificed immediately before and after CFE session (Figure 2 & 3); on the other hand to conclude about the effects of the re-exposure to the neutral context mice sacrificed before and after second exposure to the neutral context are needed (Figure 4). The naive group, as it differs by at least two manipulations from the Ext and Ctx-Ctx groups, is interesting but not crucial in both cases. This group would be necessary if we focused on the memories of FC or novel context. However, these topics are not the main focus of the current manuscript. Still, the naive group is shown on Figures 2 & 3 to check if CFE brings spine parameters to the levels observed in mice with low freezing.

      We have re-written the cited paragraph to be more precise in our conclusions.

      "Overall, our data demonstrate that synapses in all dCA1 strata undergo structural or molecular changes relevant to CFC and/or CFE. However, only in SLM CFE-induced synaptic changes are likely to be directly regulated by RE inputs as they appear on RE+ dendrites and spines. Since such changes of SLM synapses were not observed in the animals re-exposed to the neutral context, our data support the role of the described structural plasticity at the RE→SLM synapses in CFE, rather than in processing contextual information in general."

      (3) In the materials and methods section, the description of cannula placements is confusing and needs to be rewritten.

      This section has been rewritten.

      ln 103: “Cannula placement. Mice were anesthetized by inhalation of 3–5% isoflurane (IsoFlo; Abbott Animal Health) in oxygen and positioned in a stereotaxic frame (51503, Stoelting, Wood Dale, IL, USA). Two holes were drilled in the skull, and a double guide cannulae (2 mm apart and 2 mm long; 26GA, Plastics One) was lowered into the holes such that the cannula tip was located over dorsal CA1 area (2 mm posterior to bregma, ±1 mm lateral, and −1.3 mm vertical). Cannulae were kept patent by using 33-gauge internal dummy cannulae (Plastics One). The animals were used in contextual fear conditioning 21 days after the cannulation. Animals received bilateral CNO (3 μM, 0.2 μl per side for 1 min; Tocris Bioscience, Cat. No. 4936) (Stachniak et al., 2014) or saline injections (0.2 μl per side) 30 minutes before Extinction session via intrahippocampal injection cannulae (33-gauge). After the infusion, the cannula was left in place for 30 seconds. The cannula placement was verified by histology, and only data from animals with correct cannula implants were included in statistical analyses.”

      Recommendations for the authors:

      Reviewer #1 (Recommendations for the authors):

      Other/ Minor:

      In the beginning of the second paragraph on p. 21 of the Results section, it states that "RE-dCA1 has no effect on working memory," although it was not clear what data the authors were referring to support this conclusion.

      We refer there to the changes of freezing behavior within the CFE session. This is explained now.

      Reviewer #2 (Recommendations for the authors):

      No statement about code and data availability is present.

      The statements are added.

      ln 785: “Row data and the code used for analysis of confocal data is available at OSF (https://osf.io/bnkpx/).”

    1. Author response:

      The following is the authors’ response to the original reviews.

      Reviewer #1 (Public Review): 

      Summary: 

      The authors are trying to develop a microscopy system that generates data output exceeding the previous systems based on huge objectives. 

      Strengths: 

      They have accomplished building such a system, with a field of view of 1.5x1.0 cm2 and a resolution of up to 1.2 um. They have also demonstrated their system performance on samples such as organoids, brain sections, and embryos. 

      Weaknesses: 

      To be used as a volumetric imaging technique, the authors only showcase the implementation of multi-focal confocal sectioning. On the other hand, most of the real biological samples were acquired under wide-field illumination, and processed with so-called computational sectioning. Despite the claim that it improves the contrast, sometimes I felt that the images were oversharpened and the quantitative nature of these fluorescence images may be perturbed. 

      Reviewer #2 (Public Review): 

      Summary: 

      This manuscript introduced a volumetric trans-scale imaging system with an ultra-large field-of-view (FOV) that enables simultaneous observation of millions of cellular dynamics in centimeter-wide 3D tissues and embryos. In terms of technique, this paper is just a minor improvement of the authors' previous work, which is a fluorescence imaging system working at visible wavelength region (https://www.nature.com/articles/s41598-021-95930-7). 

      Strengths: 

      In this study, the authors enhanced the system's resolution and sensitivity by increasing the numerical aperture (NA) of the lens. Furthermore, they achieved volumetric imaging by integrating optical sectioning and computational sectioning. This study encompasses a broad range of biological applications, including imaging and analysis of organoids, mouse brains, and quail embryos, respectively. Overall, this method is useful and versatile. 

      Weaknesses: 

      The unique application that only can be done by this high-throughput system remains vague. Meanwhile, there are also several outstanding issues in this paper, such as the lack of technical advances, unclear method details, and nonstandardized figures. 

      Here, we address the first part of the Weaknesses concerning the unique application, and will respond to the latter part in the Reply to the Recommendations.

      We are developing 'large field of view with cellular resolution' imaging technique, aiming to apply it to the observation of multicellular systems consisting of a large number of cells. Our proposed optical system has achieved optical performance that enables simultaneous observation of more than one million cells in a single field of view. In this paper, we have succeeded in adding three-dimensional imaging capability while maintaining the size of this two-dimensional field of view. By simultaneously observing the dynamics of a large number of cells, we can reveal spatio-temporal sequences in state transitions (pattern formation, pathogenesis, embryogenesis, etc.) in multicellular systems and discover cells that serve as a starting point. These were mentioned in the 1st and 2nd paragraphs of the Introduction section (Line 48-, 58-) and discussed in the 4th paragraph of Discussion section (Line 398-) of the main text. While our previous work on two-dimensional specimens has shown its validity, the present work demonstrated that temporal changes of multicellular systems in three-dimensional specimens can be observed at the single-cell level.

      Ideally, we aim to achieve the same level of depth observation capability as the FOV size in the lateral direction. However, at present, the penetration depth for living specimens is limited to a few hundred micrometers due to non-transparency, while the lateral FOV size exceeds 1 cm. The current optical performance is well-suited for systems where development occurs within a thin volume but a large area, such as the quail embryo presented in this paper (Fig. 6 in the revised manuscript). In addition to quail embryos, this technique can also be applied to the developmental systems of highly transparent model organisms, such as zebrafish. Furthermore, for chemically cleared specimens, even those thicker than 1.5 mm, as shown in this paper (Fig. 5 in the revised manuscript), can be observed. Besides organs other than the brain, it could also be applied to imaging entire living organisms. However, for observation depths up to 10 mm, such as in the whole mouse brain, a mechanism to compensate for spherical aberration is required, which we consider the next step in our technological development.

      Recommendations for the authors: 

      Reviewer #1 (Recommendations For The Authors): 

      (1) I suggest that authors shall re-examine the quantitative nature of their image processing algorithm. Also, I wonder whether there are parameters that could be adjusted, as images in Figure 3D and 4E seem to be oversharpened with potential loss of information. 

      As the reviewer pointed out, we recognized that there was an insufficient explanation of the image processing.

      Therefore, descriptions on the quantitative nature and parameter adjustments have been added to the text (Materials and Methods, Line 552) and the Supplementary File (Fig. S4-5, Note 2), and these have been referenced in the main text. A summary is given below.

      The adjustable parameters in our method include the cutoff frequency of the smoothing filter used in the background light estimation. If the cutoff frequency is too high, the focal plane component will be included in the “background”; if it is too low, background light will remain in the focal plane. The cutoff frequency needs to be optimized within this range. In this optimization, neither the size of the cell itself nor the performance of the optical system was considered; instead, we utilized the concept of independent component analysis (ICA). This approach is taken because the size and structure of cells vary from sample to sample, and the optical properties also vary with wavelength and location, making it impractical to consider each factor for every case. ICA employs a blind separation method, which is based on the principle that individual signals deviate from the normal (Gaussian) distribution, while the superimposition of signals tends to bring the distribution closer to the Gaussian distribution. Several indices have been proposed to quantify the non-Gaussian nature of the distribution, including kurtosis, skewness, negentropy, and mutual information. Among these measures, we empirically found skewness to be the most suitable and robust, and therefore adopted it for our algorithm. The optimal parameters were selected using a subset of the data before applying the calculations of the entire dataset. The determined values were then applied to the entire dataset.

      Regarding the oversharpening, we believe that it rarely occurs in the image data shown in the manuscript. In a case where low-frequency structures and high-frequency structures are mixed in the focal plane, oversharpeninglike effect can occur because of the disappearance of low-frequency structures, which is discussed in Supplementary File (Note 2, Figs. S5D). However, in the case of a sample with nearly uniform spatial frequency, such as the nucleus observed in this study, oversharpening is unlikely to occur by setting appropriate parameters as described above. If it appears that some images are oversharpened in the figures, it is due to the contrast of the image.

      (2) On the other hand, I am curious how a wide-field fluorescence system may reliably extract information from a denselylabeled sample within axial volume of 200 um, as they showed in the mouse brain in Figure 4. Thus I am skeptical regarding the fidelity and completeness of the signals and cells recorded there. It would be ideal if the authors could benchmark their system performance with a two-photon microscope system, which serves as the ground truth. 

      The reviewer's suggestion is reasonable; however, we are unfortunately unable to observe the same sample using a two-photon microscope. Instead, we will explain these differences from a theoretical perspective. Two-photon microscopes used for brain imaging typically employ objective lenses with a numerical aperture (NA) of at least 0.5, allowing for 3D imaging with depth resolution ranging from several micrometers down to sub-micrometer levels. In contrast, our method uses a lens system with NA of 0.25, and the optical configuration (focusing NA, pinhole size) are not optimized for resolution (Note 2 in Supplementary File), thus the longitudinal resolution (FWHM) is about 14 microns (Fig. 3E in the revised manuscript). This difference is significant in the brain imaging, where our method may not fully separate all cells in close proximity along the depth axis, as shown in the bottom panels (xz-plane) of Fig. 5F of the revised manuscript. Nevertheless, we believe that cell nuclei can be accurately detected in this 3D image using appropriate cell detection methods based on deep learning. To support this claim, we conducted cell detection using the state-of-the-art cell detection platform ELEPHANT and incorporated the results into Fig. 5 (Fig. 5G-I). This figure demonstrates that even with the current spatial resolution, accurate detection of cell nuclei is achievable.

      We accordingly added one paragraph (Line 285) in the main text to explain the cell detection method and discuss the results. We also added one section into Materials and Methods for more detail of the cell detection (Line 650).

      In conjunction with the revision, the developer of ELEPHANT (K. Sugawara) has been included as a co-author.

      Reviewer #2 (Recommendations For The Authors): 

      In my opinion, the following concerns need to be addressed. 

      Major comments: 

      (1) The proposed system's crucial element involves the development of a giant lens system with a numerical aperture (NA) of 0.25. However, a comprehensive introduction and explanation of this significant giant lens system are missing from the manuscript. I strongly suggest that the authors supplement the relevant content to provide a clearer understanding of this integral component. 

      A detailed description of the giant lens system has been added to the main text (Optical Configuration and Performance, Line 83) and the Materials and Methods section (Wide -field imaging system (AMATERAS-2w) configuration, Line 446). A diagram of the lens configuration has also been included in Fig. 1A. In conjunction with these additions, two engineers from SIGMAKOKI CO. LTD., who made significant contributions to the design and manufacturing of the lens system, have been included as co-authors.

      (2) The manuscript introduces a computational sectioning technique, based on iteratively filtering technology. However, the accuracy of this algorithm is not sufficiently validated. 

      It is challenging to discuss accuracy of the processing results compared to the ground truth, because the ground truth is unknown for any of the experiments. Instead, in the Supplementary File (Notes 2, Figures S4-5), we show how the processing results for the measured and simulated data vary with the parameter (cutoff frequency), illustrating the characteristics of our method. The results suggest that by optimally pre-selecting the parameter, it is possible to successfully separate the in-focus and out-of-focus components. This discussion is related to our response to the first recommendation made by the reviewer #1. Please review our response to Reviewer #1 regarding parameter optimization and oversharpening. Here, as an addition, we describe a discussion of the conditions that must be met in order to perform the calculation correctly, as described below (also included in Note 2, Limitation of the computational sectioning).

      To apply this method, certain requirements must be met regarding cutoff spatial frequency and intensity. Regarding cutoff spatial frequency, the algorithm utilizes a low-pass filter with a single cutoff frequency, which can make it challenging to accurately extract structures in the focal plane when structures of varying sizes and shapes are mixed within the sample. This is illustrated by the simulation shown in Fig. S5 and described in Note 2. Conversely, regarding intensity, if the structure’s intensity in the focal plane is weak compared to the Gaussian fluctuations in the background intensity, it becomes difficult to extract the structure. However, intensity fluctuations can be reduced by applying a 3x3 moving average filter to the entire image as a pre-processing step before applying the baseline estimation algorithm. 

      In the experimental data presented in this paper (Figs. 4-6 in the revised manuscript), the spatial frequency issue was not significant because the target structures, which are stained nuclei, appear to be of nearly uniform size in the focal plane. The second issue, related to intensity, is also addressed in Fig. 4, as the signal intensity from the focal plane is sufficient to overcome background light in almost all regions. In the mouse brain example, the use of confocal imaging suppresses background light, allowing the structures in the focal plane to be accurately extracted.

      (3) I didn't see a detailed description of the confocal imaging in the manuscript. If it adheres to conventional confocal technology, then the question arises: what truly constitutes the novel aspect of this technique? 

      The principle of confocal imaging and optics is based on the use of a pinhole array, a system also employed commercially by CrestOptics (X-Light, Italy). Prior to the 1990s, when the configuration utilizing Yokogawa Electric's pinhole array and microlens array pairs became popular, pinhole array-only setups were the norm, and are now considered somewhat traditional. We do not claim novelty in the optical configuration itself, but rather in the design of a confocal optical system tailored for our original large-field (low-magnification) imaging system with a relatively high NA. The pinhole array disk we designed features significantly smaller pinholes and correspondingly tighter pinhole spacing than those used for high-magnification observation purposes. We believe that this unique size and arrangement provides sufficient novelty.

      We have revised the manuscript to clearly emphasize what we believe constitutes the novelty of this technique (paragraphs starting from Line 166 and Line 183). We have also added a discussion on our confocal optical configuration and its spatial resolution in the Supplementary File (Note 1, Fig. S2-3).

      (4) Light-sheet and light-field microscopy, as two emerging 3D microscopy techniques which has theoretically higher throughput than confocal, are not sufficiently introduced in this manuscript. 

      In the previous version, we briefly mentioned light-sheet and light-field microscopy, but we recognized that more detailed explanations were necessary and should be included in the manuscript. We have added several sentences to the main text (Line 159-165). A summary is provided below. 

      Light-sheet microscopy requires the illumination light to propagate over long distances within the specimen, and many applications necessitate the use of transparency-enhanced tissue. Even when the sample is highly transparent, no existing technique can form thin optical sections as long as 1 cm. Therefore, light-sheet microscopy is not an effective method for the thin, wide, three-dimensional objects that are the focus of this project. Regarding light-field microscopy, it features a trade-off where the number of pixels in the two-dimensional plane is reduced in exchange for the ability to record three-dimensional fluorescence distribution information in a single shot. In our imaging system, the pixel spacing is set to be comparable to the Nyquist Frequency to observe as many cells as possible, meaning that no more additional pixels can be sacrificed. Therefore, the light-field microscopy technique is not suitable for our imaging system.

      (5) The fluorescence images of cardiomyocytes derived from human induced pluripotent stem cells (hiPSCs) stained with Rhodamine phalloidin, as presented in Figure 1(E), exhibit suboptimal quality. This may hinder the effective use of the image for biological research. It is imperative that the authors address and explain this aspect, shedding light on the limitations and potential implications of the research findings. 

      We acknowledge the reviewer’s concern regarding the suboptimal quality of the fluorescence image. Upon further examination, we recognized that the resolution and clarity of the image could potentially limit its utility for detailed biological analysis. To address this, we have re-examined the image size and quality to enhance its presentation in Fig. 2C-E in the revised manuscript, which allows for finer structures to be recognized within the large image size.

      Regarding the effective use of the image for biological research, the results shown in the images indicated the capability of observing subcellular structures, such as myofibrils, in cell sheets with a large area, such as myocardial sheets. This would enable us to simultaneously investigate micro-level structures (orientation and density of myofibrils) and macro-level multicellular dynamics (performance of myocardial sheet). We added the above explanation in the manuscript (Line 146). We hope this revision clarifies the quality and utility of the presented image.

      (6) The imaging quality difference between the two techniques shown in Figure 1F, G is relatively small, and the signal distribution difference shown in Figure H is significant, unlike the effects expected from an improvement in resolution. 

      We acknowledge the reviewer's concern regarding the minimal apparent difference in imaging quality between the two images. Upon re-evaluation, we recognized that the original presentation may not have clearly demonstrated the improvements intended by the different techniques. Figure 1H, which showed the line profile of Figs. 1F and G, may have been impacted by the resolution and compression settings of the image file, leading to a less pronounced distinction between the two techniques. To address this, we have enlarged Figs 1F and 1G

      (renumbered as Fig. 2D and 2E in the revised manuscript) and carefully reviewed the resolution and compression ratio to ensure that the differences are more clearly visible. 

      (7) The chart in Figure 2(C) lacks axis titles and numerical labels, making it challenging for readers to comprehend. To enhance reader convenience, it is recommended that the authors incorporate axis titles and numerical labels, providing a clearer context for interpreting the chart. 

      We appreciate the reviewer’s observation regarding the lack of axis titles and numerical labels in the figure. The vertical axis represents fluorescence intensity, which we initially omitted, assuming it was self-evident. However, as the reviewer correctly pointed out, it is crucial to ensure that figures are clear and accessible to readers from diverse backgrounds. In response, we have added the vertical axis title to Fig. 2C (renumbered as Fig. 3C in the revised manuscript) to enhance clarity, while the numerical labels remain omitted as the unit is arbitrary (a.u.). We have also reviewed all other figures in the manuscript to ensure that no similar errors are present.

      (8) In Figures 2(D) and (E), where the authors present the point spread function for quantifying the lateral and axial resolution of the system, I would recommend increasing the number of fluorescent microspheres to more than 10 for statistical averaging. This adjustment would strengthen the persuasiveness of the data and contribute to a more robust analysis. 

      We appreciate the reviewer’s recommendation to increase the number of fluorescent microspheres for statistical averaging in Figs. 2D and E (renumbered as Fig. 3D-E in the revised manuscript). In response, we have revised the graphs to present the point spread function with the statistical mean and standard deviation (SD) of fluorescent images obtained from a large sample size (N = 100), and accordingly revised the main text to mention the statistics (Line 118, Line 132). We also recognized that a similar adjustment was necessary for Figs 1C and D (renumbered as Fig. 2A-B in the revised manuscript), and have accordingly made the same modifications to those figures as well. We believe these changes enhance the robustness and persuasiveness of our data.

      (9) Figure 4(C) visually represents the characteristic 3D structures of several regions. However, discerning the 3D structural information in the images poses a challenge. To address this issue, I recommend that the authors optimize the 3D visualization to improve clarity and facilitate a more effective interpretation of the depicted structures. 

      We appreciate the reviewer’s suggestion regarding the challenges in discerning the 3D structural information in Fig. 4C. To address this, we have added representative images from the xy-plane and xz-plane of the cortex, medial habenula, and choroid plexus (Fig. 5G-I) in the revised manuscript. These additions provide a clearer visualization of the 3D distribution in each region, making it easier for readers to interpret the structures. Additionally, we have overlaid the results of deep-learning based cell detection on these images, further enhancing the visibility of the cells. This adjustment also aligns with our response to Reviewer #1's second comment.

      Minor comments: 

      (1) The labelling of ROI is missing in Figure 1(e). 

      We appreciate the reviewer’s observation regarding the missing labeling of the ROI in Fig. 1E. Upon review, we confirmed that the ROI was indeed labeled with a white square in the previous manuscript; however, it was difficult to discern due to its small size and the black-and-white contrast. To improve visibility, we have recolored the square in magenta, ensuring that it stands out more clearly in the figure (Fig. 2C in the revised manuscript).

      (2) The subfigure order and labeling in Fig. 1 and Fig. 2 are not consistent.

      We appreciate the reviewer’s attention to the subfigure order and labeling in Fig. 1 and 2 (Fig. 1-3 in the revised manuscript). To accommodate subfigures of varying sizes without leaving gaps, we arranged the subfigures in a non-sequential order. However, we have ensured that the text refers to the figures in the correct order. We acknowledge the importance of consistency and will work with the editorial team to explore the best way to present the figures while maintaining clarity and alignment with standard practices.

      (3) Figure 1B reappears in Figure 2.  

      We appreciate the reviewer’s observation regarding the repetition of Figure 1B in Figure 2. While the central part of the optical system (custom lens system) is common to both figures, the illumination system, pinhole array disk, and detection optics for the confocal set up differ. To provide a complete understanding of the optical system, we opted to include the full diagram in Fig. 2B (renumbered as Fig. 3B in the revised manuscript). We considered highlighting only the different components, but we felt that doing so might complicate the reader’s comprehension of the overall system. Therefore, we chose to include the common elements twice to ensure clarity.

    1. Author response:

      We would like to extend our sincere thanks to you and reviewers at eLife for their thoughtful handling of our manuscript and their valuable feedback, which will greatly improve our study.

      We are committed to performing the additional experiments as recommended by the reviewers. However, we would like to clarify our study's focus. 

      The novelty of our study lies in the highlights of our manuscript:

      • The formation of HIV-induced CPSF6 puncta is critical for restoring HIV-1 nuclear reverse transcription (RT).

      • CPSF6 protein lacking the FG peptide cannot bind to the viral core, thereby failing to form HIVinduced CPSF6 puncta.

      • The FG peptide, rather than low-complexity regions (LCRs) or the mixed charge domains (MCDs) of the CPSF6 protein, drives the formation of HIV-induced CPSF6 puncta.

      • HIV-induced CPSF6 puncta form individually and later fuse with nuclear speckles (NS) via the intrinsically disordered region (IDR) of SRRM2.

      By focusing on these processes, we believe our study provides a critical perspective on the molecular interactions that mediate the formation of HIV-induced CPSF6 puncta and broadens the understanding of how HIV manipulates host nuclear architecture.

      Public Reviews: 

      Reviewer #1 (Public review): 

      In recent years, our understanding of the nuclear steps of the HIV-1 life cycle has made significant advances. It has emerged that HIV-1 completes reverse transcription in the nucleus and that the host factor CPSF6 forms condensates around the viral capsid. The precise function of these CPSF6 condensates is under investigation, but it is clear that the HIV-1 capsid protein is required for their formation. This study by Tomasini et al. investigates the genesis of the CPSF6 condensates induced by HIV-1 capsid, what other co-factors may be required, and their relationship with nuclear speckels (NS). The authors show that disruption of the condensates by the drug PF74, added post-nuclear entry, blocks HIV-1 infection, which supports their functional role. They generated CPSF6 KO THP-1 cell lines, in which they expressed exogenous CPSF6 constructs to map by microscopy and pull down assays of the regions critical for the formation of condensates. This approach revealed that the LCR region of CPSF6 is required for capsid binding but not for condensates whereas the FG region is essential for both. Using SON and SRRM2 as markers of NS, the authors show that CPSF6 condensates precede their merging with NS but that depletion of SRRM2, or SRRM2 lacking the IDR domain, delays the genesis of condensates, which are also smaller. 

      The study is interesting and well conducted and defines some characteristics of the CPSF6-HIV-1 condensates. Their results on the NS are valuable. The data presented are convincing. 

      I have two main concerns. Firstly, the functional outcome of the various protein mutants and KOs is not evaluated. Although Figure 1 shows that disruption of the CPSF6 puncta by PF74 impairs HIV-1 infection, it is not clear if HIV-1 infection is at all affected by expression of the mutant CPSF6 forms (and SRRM2 mutants) or KO/KD of the various host factors. The cell lines are available, so it should be possible to measure HIV-1 infection and reverse transcription. Secondly, the authors have not assessed if the effects observed on the NS impact HIV-1 gene expression, which would be interesting to know given that NS are sites of highly active gene transcription. With the reagents at hand, it should be possible to investigate this too. 

      We thank the reviewer for her/his valuable feedback on our manuscript. We are pleased to see her/his appreciation of our results, and we will do our utmost to address the highlighted points to further improve our work.

      Reviewer #2 (Public review): 

      Summary: 

      HIV-1 infection induces CPSF6 aggregates in the nucleus that contain the viral protein CA. The study of the functions and composition of these nuclear aggregates have raised considerable interest in the field, and they have emerged as sites in which reverse transcription is completed and in the proximity of which viral DNA becomes integrated. In this work, the authors have mutated several regions of the CPSF6 protein to identify the domains important for nuclear aggregation, in addition to the alreadyknown FG region; they have characterized the kinetics of fusion between CPSF6 aggregates and SC35 nuclear speckles and have determined the role of two nuclear speckle components in this process (SRRM2, SUN2). 

      Strengths: 

      The work examines systematically the domains of CPSF6 of importance for nuclear aggregate formation in an elegant manner in which these mutants complement an otherwise CPSF6-KO cell line. In addition, this work evidences a novel role for the protein SRRM2 in HIV-induced aggregate formation, overall advancing our comprehension of the components required for their formation and regulation. 

      Weaknesses: 

      Some of the results presented in this manuscript, in particular the kinetics of fusion between CPSF6aggregates and SC35 speckles have been published before (PMID: 32665593; 32997983). 

      The observations of the different effects of CPSF6 mutants, as well as SRRM2/SUN2 silencing experiments are not complemented by infection data which would have linked morphological changes in nuclear aggregates to function during viral infection. More importantly, these functional data could have helped stratify otherwise similar morphological appearances in CPSF6 aggregates. 

      Overall, the results could be presented in a more concise and ordered manner to help focus the attention of the reader on the most important issues. Most of the figures extend to 3-4 different pages and some information could be clearly either aggregated or moved to supplementary data. 

      First, we thank the reviewer for her/his appreciation of our study and to give to us the opportunity to better explain our results and to improve our manuscript. We appreciate the reviewer’s positive feedback on our study, and we will do our best to address her/his concerns. In the meantime, we would like to clarify the focus of our study. Our research does not aim to demonstrate an association between CPSF6 condensates (we use the term "condensates" rather than "aggregates," as aggregates are generally non-dynamic (Alberti & Hyman, 2021; Banani et al., 2017), and our work specifically examines the dynamic behavior of CPSF6 during infection, as shown in Scoca et al., JMCB 2022) and SC35 nuclear speckles. This association has already been established in previous studies, as noted in the manuscript.

      About the point highlighted by the reviewer: "Kinetics of fusion between CPSF6-aggregates and SC35 speckles have been published before (PMID: 32665593; 32997983)."

      Our study differs from prior work PMID 32665593 because we utilize a full-length HIV genome and we did not follow the integrase (IN) fluorescence in trans and its association with CPSF6 but we specifically assess if CPSF6 clusters form in the nucleus independently of NS factors and next to fuse with them. In the current study we evaluated the dynamics of formation of CPSF6/NS puncta, which it has not been explored before. Given this focus, we believe that our work offers a novel perspective on the molecular interactions that facilitate HIV / CPSF6-NS fusion.

      For better clarity, we would like to specify that our study focuses on the role of SON, a scaffold factor of nuclear speckles, rather than SUN2 (SUN domain-containing protein 2), which is a component of the LINC (Linker of Nucleoskeleton and Cytoskeleton) complex.

      As suggested by the reviewer, we will keep key information in the main figure and move additional details to the supplementary material.

      Reviewer #3 (Public review): 

      In this study, the authors investigate the requirements for the formation of CPSF6 puncta induced by HIV-1 under a high multiplicity of infection conditions. Not surprisingly, they observe that mutation of the Phe-Gly (FG) repeat responsible for CPSF6 binding to the incoming HIV-1 capsid abrogates CPSF6 punctum formation. Perhaps more interestingly, they show that the removal of other domains of CPSF6, including the mixed-charge domain (MCD), does not affect the formation of HIV-1-induced CPSF6 puncta. The authors also present data suggesting that CPSF6 puncta form individual before fusing with nuclear speckles (NSs) and that the fusion of CPSF6 puncta to NSs requires the intrinsically disordered region (IDR) of the NS component SRRM2. While the study presents some interesting findings, there are some technical issues that need to be addressed and the amount of new information is somewhat limited. Also, the authors' finding that deletion of the CPSF6 MCD does not affect the formation of HIV-1-induced CPSF6 puncta contradicts recent findings of Jang et al. (doi.org/10.1093/nar/gkae769). 

      We thank the reviewer for her/his thoughtful feedback and the opportunity to elaborate on why our findings provide a distinct perspective compared to those of Jang et al. (doi.org/10.1093/nar/gkae769), while aligning with the results of Rohlfes et al. (doi.org/10.1101/2024.06.20.599834).

      One potential reason for the differences between our findings and those of Jang et al. could be the choice of experimental systems. Jang et al. conducted their study in HEK293T cells with CPSF6 knockouts, as described in Sowd et al., 2016 (doi.org/10.1073/pnas.1524213113). In contrast, our work focused on macrophage-like THP-1 cells, which share closer characteristics with HIV-1’s natural target cells. 

      Our approach utilized a complete CPSF6 knockout in THP-1 cells, enabling us to reintroduce untagged versions of CPSF6, such as wild-type and deletion mutants, to avoid potential artifacts from tagging. Jang et al. employed HA-tagged CPSF6 constructs, which may lead to subtle differences in experimental outcomes due to the presence of the tag.

      Finally, our investigation into the IDR of SRRM2 relied on CRISPR-PAINT to generate targeted deletions directly in the endogenous gene (Lester et al., 2021, DOI: 10.1016/j.neuron.2021.03.026). This approach provided a native context for studying SRRM2’s role.

      We will incorporate these clarifications into the discussion section of the revised manuscript.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public Review):

      This work makes several contributions: (1) a method for the self-supervised segmentation of cells in 3D microscopy images, (2) an cell-segmented dataset comprising six volumes from a mesoSPIM sample of a mouse brain, and (3) a napari plugin to apply and train the proposed method.

      First, thanks for acknowledging our contributions of a new tool, new dataset, and new software.

      (1) Method

      This work presents itself as a generalizable method contribution with a wide scope: self-supervised 3D cell segmentation in microscopy images. My main critique is that there is almost no evidence for the proposed method to have that wide of a scope. Instead, the paper is more akin to a case report that shows that a particular self-supervised method is good enough to segment cells in two datasets with specific properties.

      First, thanks for acknowledging our contributions of a new tool, new dataset, and new software. We agree we focus on lightsheet microscopy data, therefore to narrow the scope we have changed the title to “CellSeg3D: self-supervised 3D cell segmentation for light-sheet microscopy”.

      To support the claim that their method "address[es] the inherent complexity of quantifying cells in 3D volumes", the method should be evaluated in a comprehensive study including different kinds of light and electron microscopy images, different markers, and resolutions to cover the diversity of microscopy images that both title and abstract are alluding to.

      You have selectively dropped the last part of that sentence that is key: “.... 3D volumes, often in cleared neural tissue” – which is what we tackle. The next sentence goes on to say: “We offer a new 3D mesoSPIM dataset and show that CellSeg3D can match state-of-the-art supervised methods.” Thus, we literally make it clear our claims are on MesoSPIM and cleared data.

      The main dataset used here (a mesoSPIM dataset of a whole mouse brain) features well-isolated cells that are easily distinguishable from the background. Otsu thresholding followed by a connected component analysis already segments most of those cells correctly.

      This is not the case, as all the other leading methods we fairly benchmark cannot solve the task without deep learning (i.e., no method is at an F1-Score of 1).

      The proposed method relies on an intensity-based segmentation method (a soft version of a normalized cut) and has at least five free parameters (radius, intensity, and spatial sigma for SoftNCut, as well as a morphological closing radius, and a merge threshold for touching cells in the post-processing). Given the benefit of tweaking parameters (like thresholds, morphological operation radii, and expected object sizes), it would be illuminating to know how other non-learning-based methods will compare on this dataset, especially if given the same treatment of segmentation post-processing that the proposed method receives. After inspecting the WNet3D predictions (using the napari plugin) on the used datasets I find them almost identical to the raw intensity values, casting doubt as to whether the high segmentation accuracy is really due to the self-supervised learning or instead a function of the post-processing pipeline after thresholding.

      First, thanks for testing our tool, and glad it works for you. The deep learning methods we use cannot “solve” this dataset, and we also have a F1-Score (dice) of ~0.8 with our self-supervised method. We don’t see the value in applying non-learning methods; this is unnecessary and beyond the scope of this work.

      I suggest the following baselines be included to better understand how much of the segmentation accuracy is due to parameter tweaking on the considered datasets versus a novel method contribution:

      *  comparison to thresholding (with the same post-processing as the proposed method) * comparison to a normalized cut segmentation (with the same post-processing as the proposed method)

      *  comparison to references 8 and 9.

      Ref 8 and 9 don’t have readily usable (https://github.com/LiangHann/USAR) or even shared code (https://github.com/Kaiseem/AD-GAN), so re-implementing this work is well beyond the bounds of this paper. We benchmarked Cellpose, StartDist, SegResNets, and a transformer – SwinURNet. Moreover, models in the MONAI package can be used. Note, to our knowledge the transformer results also are a new contribution that the Reviewer does not acknowledge.

      I further strongly encourage the authors to discuss the limitations of their method. From what I understand, the proposed method works only on well-separated objects (due to the semantic segmentation bottleneck), is based on contrastive FG/BG intensity values (due to the SoftNCut loss), and requires tuning of a few parameters (which might be challenging if no ground-truth is available).

      We added text on limitations. Thanks for this suggestion.

      (2) Dataset

      I commend the authors for providing ground-truth labels for more than 2500 cells. I would appreciate it if the Methods section could mention how exactly the cells were labelled. I found a good overlap between the ground truth and Otsu thresholding of the intensity images. Was the ground truth generated by proofreading an initial automatic segmentation, or entirely done by hand? If the former, which method was used to generate the initial segmentation, and are there any concerns that the ground truth might be biased towards a given segmentation method?

      In the already submitted version, we have a 5-page DataSet card that fully answers your questions. They are ALL labeled by hand, without any semi-automatic process.

      In our main text we even stated “Using whole-brain data from mice we cropped small regions and human annotated in 3D 2,632 neurons that were endogenously labeled by TPH2-tdTomato” - clearly mentioning it is human-annotated.

      (3) Napari plugin

      The plugin is well-documented and works by following the installation instructions.

      Great, thanks for the positive feedback.

      However, I was not able to recreate the segmentations reported in the paper with the default settings for the pre-trained WNet3D: segments are generally too large and there are a lot of false positives. Both the prediction and the final instance segmentation also show substantial border artifacts, possibly due to a block-wise processing scheme.

      Your review here does not match your comments above; above you said it was working well, such that you doubt the GT is real and the data is too easy as it was perfectly easy to threshold with non-learning methods.

      You would need to share more details on what you tried. We suggest following our code; namely, we provide the full experimental code and processing for every figure, as was noted in our original submission: https://github.com/C-Achard/cellseg3d-figures.

      Reviewer #2 (Public Review):

      Summary:

      The authors propose a new method for self-supervised learning of 3d semantic segmentation for fluorescence microscopy. It is based on a WNet architecture (Encoder / Decoder using a UNet for each of these components) that reconstructs the image data after binarization in the bottleneck with a soft n-cuts clustering. They annotate a new dataset for nucleus segmentation in mesoSPIM imaging and train their model on this dataset. They create a napari plugin that provides access to this model and provides additional functionality for training of own models (both supervised and self-supervised), data labeling, and instance segmentation via post-processing of the semantic model predictions. This plugin also provides access to models trained on the contributed dataset in a supervised fashion.

      Strengths:

      (1) The idea behind the self-supervised learning loss is interesting.

      (2) The paper addresses an important challenge. Data annotation is very time-consuming for 3d microscopy data, so a self-supervised method that yields similar results to supervised segmentation would provide massive benefits.

      Thank you for highlighting the strengths of our work and new contributions.

      Weaknesses:

      The experiments presented by the authors do not adequately support the claims made in the paper. There are several shortcomings in the design of the experiment, presentation of the results, and reproducibility.

      We address your concerns and misunderstandings below.

      Major weaknesses:

      (1) The main experiments are conducted on the new mesoSPIM dataset, which contains quite small nuclei, much smaller than the pretraining datasets of CellPose and StarDist. I assume that this is one of the main reasons why these well-established methods don't work for this dataset.

      StarDist is not pretrained, we trained it from scratch as we did for WNet3D. We retrained Cellpose and reported the results both with their pretrained model and our best-retrained model. This is documented in Figure 1 and Suppl. Figure 1. We also want to push back and say that they both work very well on this data. In fact, our main claim is not that we beat them, it is that we can match them with a self-supervised method.

      Limiting method comparison to only this dataset may create a misleading impression that CellSeg3D is superior for all kinds of 3D nucleus segmentation tasks, whereas this might only hold for small nuclei.

      The GT dataset we labeled has nuclei that are normal brain-cell sized. Moreover in Figure 2 we show very different samples with both dense and noisy (c-FOS) labeling.

      We also clearly do not claim this is superior for all tasks, from our text: “First, we benchmark our methods against Cellpose and StarDist, two leading supervised cell segmentation packages with user-friendly workflows, and show our methods match or outperform them in 3D instance segmentation on mesoSPIM-acquired volumes" – we explicitly do NOT claim beyond the scope of the benchmark. Moreover we state: "We found that WNet3D could be as good or better than the fully supervised models, especially in the low data regime, on this dataset at semantic and instance segmentation" – again noting on this dataset. Again, we only claimed we can be as good as these methods with an unsupervised approach, and in the low-GT data regime we can excel.

      Further, additional preprocessing of the mesoSPIM images may improve results for StarDist and CellPose (see the first point in minor weaknesses). Note: having a method that works better for small nuclei would be an important contribution. But I doubt that the claims hold for larger and or more crowded nuclei as the current version of the paper implies.

      Figure 2 benchmarks our method on larger and denser nuclei, but we do not intend to claim this is a universal tool. It was specifically designed for light-sheet (brain) data, and we have adjusted the title to be more clear. But we also show in Figure 2 it works well on more dense and noisy samples, hinting that it could be a promising approach. But we agree, as-is, it’s unlikely to be good for extremely dense samples like in electron microscopy, which we never claim it would be.

      With regards to preprocessing, we respectfully disagree. We trained StarDist (and asked the main developer of StarDist, Martin Weigert, to check our work and he is acknowledged in the paper) and it does very well. Cellpose we also retrained and optimized and we show it works as-well-as leading transformer and CNN-based approaches. Again, we only claimed we can be as good as these methods with an unsupervised approach.

      The contribution of the paper would be much stronger if a **fair** comparison with StarDist / CellPose was also done on the additional datasets from Figure 2.

      We appreciate that more datasets would be ideal, but we always feel it’s best for the authors of tools to benchmark their own tools on data. We only compared others in Figure 1 to the new dataset we provide so people get a sense of the quality of the data too; there we did extensive searches for best parameters for those tools. So while we think it would be nice, we will leave it to those authors to be most fair. We also narrowed the scope of our claims to mesoSPIM data (added light-sheet to the title), which none of the other examples in Figure 2 are.

      (2) The experimental setup for the additional datasets seems to be unrealistic. In general, the description of these experiments is quite short and so the exact strategy is unclear from the text. However, you write the following: "The channel containing the foreground was then thresholded and the Voronoi-Otsu algorithm used to generate instance labels (for Platynereis data), with hyperparameters based on the Dice metric with the ground truth." I.e., the hyperparameters for the post-processing are found based on the ground truth. From the description it is unclear whether this is done a) on the part of the data that is then also used to compute metrics or b) on a separate validation split that is not used to compute metrics. If a) this is not a valid experimental setup and amounts to training on your test set. If b) this is ok from an experimental point of view, but likely still significantly overestimates the quality of predictions that can be achieved by manual tuning of these hyperparameters by a user that is not themselves a developer of this plugin or an absolute expert in classical image analysis, see also 3.

      We apologize for this confusion; we have now expanded the methods to clarify the setup is now b; you can see what we exactly did as well in the figure notebook: https://c-achard.github.io/cellseg3d-figures/fig2-b-c-extra-datasets/self-supervised-ext ra.html#threshold-predictions.

      For clarity, we additionally link each individual notebook now in the Methods.

      (3) I cannot reproduce any of the results using the plugin. I tried to reproduce some of the results from the paper qualitatively: First I downloaded one of the volumes from the mesoSPIM dataset (c5image) and applied the WNet3D to it. The prediction looks ok, however the value range is quite close (Average BG intensity ~0.4, FG intensity 0.6-0.7). I try to apply the instance segmentation using "Convert to instance labels" from "Utilities". Using "Voronoi-Otsu" does not work due to an error in pyClesperanto ("clGetPlatformIDs failed: PLATFORM_NOT_FOUND_KHR"). Segmentation via "Connected Components" and "Watershed" requires extensive manual tuning to get a somewhat decent result, which is still far from perfect.

      We are sorry to hear of the installation issue; pyClesperanto is a dependency that would be required to reproduce the images (sounds like you had this issue; https://forum.image.sc/t/pyclesperanto-prototype-doesnt-work/45724 ) We added to our docs now explicitly the fix:https://github.com/AdaptiveMotorControlLab/CellSeg3D/pull/90. We recommend checking the reproduction notebooks (which were linked in initial submission): https://c-achard.github.io/cellseg3d-figures/intro.html.

      Then I tried to reproduce the results for the Mouse Skull Nuclei Dataset from EmbedSeg. The results look like a denoised version of the input image, not a semantic segmentation. I was skeptical from the beginning that the method would transfer without retraining, due to the very different morphology of nuclei (much larger and elongated). None of the available segmentation methods yield a good result, the best I can achieve is a strong over-segmentation with watersheds.

      We are surprised to hear this; did you follow the following notebook which directly produces the steps to create this figure? (This was linked in preprint): https://c-achard.github.io/cellseg3d-figures/fig2-c-extra-datasets/self-supervised-extra .html

      We also expanded the methods to include the exact values from the notebook into the text.

      Minor weaknesses:

      (1) CellPose can work better if images are resized so that the median object size in new images matches the training data. For CellPose the cyto2 model should do this automatically. It would be important to report if this was done, and if not would be advisable to check if this can improve results.

      We reported this value in Figure 1 and found it to work poorly, that is why we retrained Cellpose and found good performance results (also reported in Figure 1). Resizing GB to TB volumes for mesoSPIM data is otherwise not practical, so simply retraining seems the preferable option, which is what we did.

      (2) It is a bit confusing that F1-Score and Dice Score are used interchangeably to evaluate results. The dice score only evaluates semantic predictions, whereas F1-Score evaluates the actual instance segmentation results. I would advise to only use F1-Score, which is the more appropriate metric. For Figure 1f either the mean F1 score over thresholds or F1 @ 0.5 could be reported. Furthermore, I would advise adopting the recommendations on metric reporting from https://www.nature.com/articles/s41592-023-01942-8.

      We are using the common metrics in the field for instance and semantic segmentation, and report them in the methods. In Figure 2f we actually report the “Dice” as defined in StarDist (as we stated in the Methods). Note, their implementation is functionally equivalent to F1-Score of an IoU >= 0, so we simply changed this label in the figure now for clarity. We agree this clarifies for the expert readers what was done, and we expanded the methods to be more clear about metrics.

      We added a link to the paper you mention as well.

      (3) A more conceptual limitation is that the (self-supervised) method is limited to intensity-based segmentation, and so will not be able to work for cases where structures cannot be distinguished based on intensity only. It is further unclear how well it can separate crowded nuclei. While some object separation can be achieved by morphological operations this is generally limited for crowded segmentation tasks and the main motivation behind the segmentation objective used in StarDist, CellPose, and other instance segmentation methods. This limitation is only superficially acknowledged in "Note that WNet3D uses brightness to detect objects [...]" but should be discussed in more depth. Note: this limitation does not mean at all that the underlying contribution is not significant, but I think it is important to address this in more detail so that potential users know where the method is applicable and where it isn't.

      We agree, and we added a new section specifically on limitations. Thanks for raising this good point. Thus, while self-supervision comes at the saving of hundreds of manual labor, it comes at the cost of more limited regimes it can work on. Hence why we don’t claim this should replace excellent methods like Cellpose or Stardist, but rather complement them and can be used on mesoSPIM samples, as we show here.

      Recommendations for the authors:

      Reviewer #1 (Recommendations For The Authors):

      (1) One of the listed contributions is "adding the SoftNCuts loss". This is not true, reference 10 already introduced that loss.

      “Our changes include a conversion to a fully 3D architecture and adding the SoftNCuts loss” - we dropped the common and added the word “AND” to note that we added the 3D version of the SoftNCuts loss TO the 3D architecture, which 10 did not do.

      (2) "Typically, these methods use a multi-step approach" to segment 3D from 2D: this is only true for CellPose, StarDist does real 3D.

      That is why we preface with “typically” which implies not always.

      (3) "see Methods, Figure 1c, c)" is missing an opening in parentheses.

      (4) K is not introduced in equation (1) (presumably the number of classes, which seems to be 2 for all experiments considered).

      k actually was introduced just below equation 1 as the number of classes. We added the note that k was set to 2.

      (5) X is not introduced in equation (2) (presumably the spatial position of a voxel).

      Sorry for this oversight. We add that $X$ is the spatial position of the voxel.

      Reviewer #2 (Recommendations For The Authors):

      To improve the paper the weaknesses mentioned above should be addressed:

      (1) Compare to StarDist and/or CellPose on further datasets, esp. using pre-trained CellPose, to see if the claims of competitive performance with state-of-the-art approaches hold up for the case of different nucleus morphologies. The EmbedSeg datasets from Figure 2 c are well suited for this. In the current form, the claims are too broad and not supported if thorough experiments are performed on a single dataset with a very specific morphology. Note: even if the method is not fully competitive with CellPose / StarDist on these Datasets it holds merit since a segmentation method that works for small nuclei as in the mesoSPIM dataset and works self-supervised is very valuable.

      (2) Clarify how the best instance segmentation hyperparameters are found. If you indeed optimize these on the same part of the dataset used for evaluating metrics then the current experimental set-up is invalid. If this is not the case I would still rethink if this is a good way to report the results since it does not seem to reflect user experience. I found it not possible to find good hyperparameters for either of the two segmentation approaches I tried (see also next point) so I think these numbers are too optimistic.

      (3) Improve the instance segmentation part of the plugin: either provide troubleshooting for how to install pyClesperanto correctly to use the voronoi-based instance segmentation or implement it based on more standard functionality like skimage / scipy. Provide more guidance for finding good hyperparameters for the segmentation task.

      (4) Make sure image resizing is done correctly when using pre-trained CellPose models and report on this.

      (5) Report F1 Scores only (unless there is a compelling reason to also report Dice).

      (6) Address the limitations of the method in more detail.

      On a positive note: all data and code are available and easy to download/install. A minor comment: it would be very helpful to have line numbers for reviewing a revised version.

      All comments are also addressed in the public reviews.

    1. Author response:

      The following is the authors’ response to the original reviews.

      eLife Assessment

      This valuable study provides in vivo evidence for the synchronization of projection neurons in the olfactory bulb at gamma frequency in an activity-dependent manner. This study uses optogenetics in combination with single-cell recordings to selectively activate sensory input channels within the olfactory bulb. The data are thoughtfully analyzed and presented; the evidence is solid, although some of the conclusions are only partially supported.

      We deeply thank all the reviewers for their time, effort, and insightful comments. Their revision led to a significant improvement of the paper.

      The reviewers suggested toning down our claim that we found a mechanism that synchronizes all odor-evoked MTC activities, as we do not directly show that. We concur and address this in our revised version to ensure a precise interpretation of our findings. In short, we state that we revealed a synchronization mechanism between two groups of active mitral and tufted cells (MTCs) and show that this synchronization is activity-dependent and distance-independent. This mechanism can enable the synchronization of all odor-activated MTCs.

      Another issue raised is the interpretation of the results obtained under Ketamine anesthesia. Ketamine is an NMDA receptor antagonist that plays a crucial role in the  MTC-GC reciprocal synapse. To address this, we include new analyses demonstrating that optogenetic activation of granule cells (GCs) can inhibit the recorded MTCs during baseline activity but does not substantially affect odor-evoked MTC firing rates. We show that this is correct in both Ketamine-induced anesthesia and awake mice (Dalal & Haddad, 2022). This indicates that GC-MTC connections are functional even under Ketamine anesthesia, however, they do not exert substantial suppression on odor-evoked MTC responses. We added a paragraph to the discussion section on the potential influence of Ketamine anesthesia on GC-MTC synapses and its implications on our findings.

      Finally, we discuss several recent studies that are particularly relevant to our research and expand the discussion on our hypothesis that parvalbumin-positive cells in the olfactory bulb may serve as key mediators of the activity- and distance-dependent lateral inhibition observed in our findings.

      Public Reviews:

      Reviewer #1 (Public Review):

      Summary:

      Dalal and Haddad investigated how neurons in the olfactory bulb are synchronized in oscillatory rhythms at gamma frequency. Temporal coordination of action potentials fired by projection neurons can facilitate information transmission to downstream areas. In a previous paper (Dalal and Haddad 2022, https://doi.org/10.1016/j.celrep.2022.110693), the authors showed that gamma frequency synchronization of mitral/tufted cells (MTCs) in the olfactory bulb enhances the response in the piriform cortex. The present study builds on these findings and takes a closer look at how gamma synchronization is restricted to a specific subset of MTCs in the olfactory bulb. They combined odor and optogenetic stimulations in anesthetized mice with extracellular recordings.<br /> The main findings are that lateral synchronization of MTCs at gamma frequency is mediated by granule cells (GCs), independent of the spatial distance, and strongest for MTCs with firing rates close to 40 Hz. The authors conclude that this reveals a simple mechanism by which spatially distributed neurons can form a synchronized ensemble. In contrast to lateral synchronization, they found no evidence for the involvement of GCs in lateral inhibition of nearby MTCs.

      Strengths:

      Investigating the mechanisms of rhythmic synchronization in vivo is difficult because of experimental limitations for the readout and manipulation of neuronal populations at fast timescales. Using spatially patterned light stimulation of opsin-expressing neurons in combination with extracellular recordings is a nice approach. The paper provides evidence for an activity-dependent synchronization of MTCs in gamma frequency that is mediated by GCs.

      Weaknesses:

      An important weakness of the study is the lack of direct evidence for the main conclusion - the synchronization of MTCs in gamma frequency. The data shows that paired optogenetic stimulation of MTCs in different parts of the olfactory bulb increases the rhythmicity of individual MTCs (Figure 1) and that combined odor stimulation and GC stimulation increases rhythmicity and gamma phase locking of individual MTCs (Figure 4). However, a direct comparison of the firing of different MTCs is missing. This could be addressed with extracellular recordings at two different locations in the olfactory bulb. The minimum requirement to support this conclusion would be to show that the MTCs lock to the same phase of the gamma cycle. Also, showing the evoked gamma oscillations would help to interpret the data.

      We agree with the reviewer that direct evidence of mutual synchronization between multiple recorded MTCs has not been shown in our study. Our study only shows a mechanism that can enable this synchronization. We now state this clearly in the manuscript. We based this on previous studies that tested MTC spike synchronization. Specifically, Schoppa 2006, reported that electrical OSN stimulation evokes MTC spikes synchronization in the gamma range, in-vitro. Kashiwadni et al., 1999 and Doucette et al., 2011 showed that odor-evoked MTC spike times are synchronized, in-vivo. Given these studies, we asked what is the underlying mechanism that can support such a synchronization. Our study demonstrates that activating a group of MTCs can entrain another MTC in an activity-dependent and distance-independent manner. We claim this could be the underlying mechanism for the odor-evoked synchronization as demonstrated by these previous studies.

      To make sure this is clearly stated in the manuscript we changed the title to “Activity-dependent lateral inhibition enables the synchronization of active olfactory bulb projection neurons”, and rephrased a sentence in the abstract to “This lateral synchronization was particularly effective when the recorded MTC fired at the gamma rhythm”. To further clarify this point, we made several other changes throughout the results and the discussion section.

      Another weakness is that all experiments are performed under anesthesia with ketamine/medetomidine. Ketamine is an antagonist of NMDA receptors and NMDA receptors are critically involved in the interactions of MTCs and GCs at the reciprocal synapses (see for example Lage-Rupprecht et al. 2020, https://doi.org/10.7554/eLife.63737; Egger and Kuner 2021, https://doi.org/10.1007/s00441-020-03402-7). This should be considered for the interpretation of the presented data.

      This issue has been raised by reviewers #1 and #2. We think, as also reviewer #2 acknowledged, that this issue does not compromise our results. However, to address this important point we added the below section to the Discussion:

      “Our experiments were performed under Ketamine anesthesia, an NMDA receptor antagonist that affects the reciprocal dendro-dendritic synapses between MTCs and GCs (Egger and Kuner, 2021; Lage-Rupprecht et al., 2020). Consistent with that, recent studies reported lower excitability of GC activity under anesthesia (Cazakoff et al., 2014; Kato et al., 2012).  This raises the concern that our result might not be valid in the awake state. We argue that this is unlikely. First, (Fukunaga et al., 2014) reported that GCs baseline activity in anesthetized and awake mice is similar, suggesting that MTC-GC synapses are functioning. Second, we show that light activation of GCL neurons strongly inhibits the MTC baseline activity (Figure 5) and increases MTC odor-evoked spike-LFP coupling in the gamma range (Figure 4). These experiments validate that GCL neurons can exert inhibition over MTCs in our experimental setup. Third, we have shown that light-activating all accessible GCL neurons has a minor effect on the MTC odor-evoked firing rates in an awake state (Dalal and Haddad, 2022), corroborating the finding that GCL neurons are unlikely to provide strong suppression to MTCs. Fourth, and most importantly, we showed that optogenetic stimulation of MTCs entrains other MTC spike times, which is achieved via the GCL neurons. This suggests that the lack of lateral suppression following MTC or GCL neuron opto-activation is not due to MTC-GC synapse blockage. That said, we cannot exclude the unlikely possibility that NMDA receptor blockage under anesthesia impairs MTC-to-MTC suppressive interactions but not the MTC-to-MTC mediated spike entrainment.”

      Figure 1A and D from Dalal & Haddad 2022 show the effect of GCL neurons opto-activation during odor stimulation on MTC firing rates in awake and anesthetized mice.

      Furthermore, the direct effect of optogenetic stimulation on GCs activity is not shown. This is particularly important because they use Gad2-cre mice with virus injection in the olfactory bulb and expression might not be restricted to granule cells and might not target all subtypes of granule cells (Wachowiak et al., 2013, https://doi.org/10.1523/JNEUROSCI.4824-12.2013). This should be considered for the interpretation of the data, particularly for the absence of an effect of GC stimulation on lateral inhibition.

      In this study we used Gad2-cre mice, and the protocol for viral transfection of GCL neurons reported in Fukunaga et al., 2014. They reported that: ‘more than 90% of Cre-expressing neurons in the GCL also expressed fluorescently tagged ArchT’. Consistently, when Fukunaga et al. expressed ChR2 in the GCL using the same viral infection as we used, they reported that: ”Light presentation in vivo resulted in rapid and strong depolarization of, and action potential (AP) discharges in, GCs (Fig. 3b), which in

      turn consistently and strongly hyperpolarized M/TCs (9 of 9 cells showed 100% AP suppression; Fig. 3c,d)”. This study shows clearly that this infection protocol is robust. Moreover, in new panels we added to the manuscript (Figure 5a-b), we show that optogenetic activation of GCL neurons strongly suppressed MTC activity during baseline conditions but not odor-evoked responses MTCs. This is consistent with the reports by Fukunaga et al, and indicates that GCL neurons are functional as they can suppress MTC baseline activity.

      Finally, since virus injection to the granule cell layer can target other GCL neuron types, we changed the reference in the text to GCL neurons (as was done in Gschwend et al., 2015) instead of ‘GCs’ when referring to GC. We replaced the image in Figure 4A, to show the expression of ChR2 is restricted to GCL neurons. That said, it is still possible that our protocol did not infect all GC subtypes. To address this, we added this line to the Discussion: “We also note that our viral transfection protocol in Gad2-Cre mice might not transfect all subtypes of GCs”

      Several conclusions are only supported by data from example neurons. The paper would benefit from a more detailed description of the analysis and the display of some additional analysis at the population level:

      - What were the criteria based on which the spots for light-activation were chosen from the receptive field map?

      In order to make this point clearer, we extended the explanation in the Methods on the selection criteria: “Spots were selected either randomly or manually. In the manual selection case, we selected spots that caused either significant or mild but insignificant inhibitory effect on the recorded MTC (e.g., local cold spots in the receptive-field map; see example in Figure 2a of example spots that were selected manually)”. We also add a reference in the text to the Methods: “see Methods for spots selection criteria”.

      - The absence of an effect on firing rate for paired stimulations is only shown for one example (Figure 1c). A quantification of the population level would be interesting.

      - Only one example neuron is shown to support the conclusion that "two different neural circuits mediate suppression and entrainment" in Figure 3. A population analysis would provide more evidence.

      Thank you very much for these comments. We added a population analysis in Figure 3. This analysis shows a dissociation between firing rate suppression and the entrainment groups (Figure 3c-d). This suggests that two different circuits mediate suppression and entrainment.

      - Only one example neuron is shown to illustrate the effect of GC stimulation on gamma rhythmicity of MTCs in Figures 4 f,g.

      In this figure, we show that the activation of subsets of GCL neurons elevated odor-evoked spike synchronization to the gamma rhythm. We thought it would be beneficial to demonstrate the change in spike entrainment following GCL neurons optogenetic activation regardless of the ongoing OB gamma oscillations, using the method presented by Fukunaga et al., 2014. However, this analysis requires that the neuron has a relatively high firing rate. As we describe in the figure legend of this panel, this neuron is probably a tufted cell based on the findings shown in Fukunaga et al., 2014 and Burton & Urban, 2021. Most of our recorded cells had a lower firing rate, which coincides with our typical recording depth, targeting mitral cells rather than tufted cells (~400µm deep). Since this analysis is shown only over a single neuron, we moved it to Supplementary Figure 4.

      - In Figure 5 and the corresponding text, "proximal" and "distal" GC activation are not clearly defined.

      We agree. Initially, we used these terms to refer to GC columns that include the recorded MTC (proximal) and columns that are away from it (distal). We decided that instead of using a coarse division, we would show the whole range of distances. We updated the analysis in Figure 5d to show the effect of GC optogenetic activation on MTC odor-evoked responses as a function of the distance from the recorded MTC.

      Reviewer #2 (Public Review):

      Summary

      This study provides a detailed analysis and dissociation between two effects of activation of lateral inhibitory circuits in the olfactory bulb on ongoing single mitral/tufted cell (MTC) spiking activity, namely enhanced synchronization in the gamma frequency range or lateral inhibition of firing rate.

      The authors use a clever combination of single-cell recordings, optogenetics with variable spatial stimulation of MTCs and sensory stimulation in vivo, and established mathematical methods to describe changes in autocorrelation/synchronization of a single MTC's spiking activity upon activation of lateral glomerular MTC ensembles. This assay is rounded off by a gain-of-function experiment in which the authors enhance granule cell (GC) excitation to establish a causal relation between GC activation and enhanced synchronization to gamma (they had used this manipulation in their previous paper Dalal & Haddad 2022, but use a smaller illumination spot here for spatially restricted activation).

      Strengths

      This study is of high interest for olfactory processing - since it shows directly that interactions between only two selected active receptor channels are sufficient to enhance the synchronization of single neurons to gamma in one channel (and thus by inference most likely in both). These interactions are distance-independent over many 100s of µms and thus can allow for non-topographical inhibitory action across the bulb, in contrast to the center-surround lateral inhibition known from other sensory modalities.

      In my view, parallels between vision and olfaction might have been overemphasized so far, since the combinatorial encoding of olfactory stimuli across the glomerular map might require different mechanisms of lateral interaction versus vision. This result is indicative of such a major difference.

      Such enhanced local synchronization was observed in a subset of activated channel pairs; in addition, the authors report another type of lateral interaction that does involve the reduction of firing rates, drops off with distance and most likely is caused by a different circuit-mediated by PV+ neurons (PVN; the evidence for which is circumstantial).

      Weaknesses/Room for improvement

      Thus this study is an impressive proof of concept that however does not yet allow for broad generalization. Therefore the framing of results should be slightly more careful in my opinion.

      We agree with the reviewer. We copy here our response to reviewer #1, who raised the same issue.

      We agree that direct evidence of mutual synchronization between multiple recorded MTCs has not been shown in our study. Our study only shows a mechanism that can enable this synchronization. We now state this clearly in the manuscript. We relayed previous studies that tested MTC spike synchronization. Specifically, Schoppa 2006, reported that electrical OSN stimulation evokes MTC spikes synchronization in the gamma range, in-vitro. Kashiwadni et al., 1999 and Doucette et al., showed that odor-evoked MTC spike times are synchronized, in-vivo. Given these studies, we asked what is the underlying mechanism that can support such a synchronization. Our study demonstrates that activating a group of MTCs can entrain another MTC in an activity-dependent and distance-independent manner. We claim this could be the underlying mechanism for the odor-evoked synchronization as demonstrated by these previous studies.

      To make sure this is clearly stated in the manuscript we changed the title to “Activity-dependent lateral inhibition enables the synchronization of active olfactory bulb projection neurons”, and rephrased a sentence in the abstract to “This lateral synchronization was particularly effective when the recorded MTC fired at the gamma rhythm”. To further clarify this point, we made several other changes throughout the results and the discussion section.

      Along this line, the conclusions regarding two different circuits underlying lateral inhibition vs enhanced synchronization are not quite justified by the data, e.g.

      (1) The authors mention that their granule cell stimulation results in a local cold spot (l. 527 ff) - how can they then said to be not involved in the inhibition of firing rate (bullet point in Highlights)? Please elaborate further. In l.406 they also state that GCs can inhibit MTCs under certain conditions. The argument, that this stimulation is not physiological, makes sense, but still does not rule out anything. You might want to cite Aghvami et al 2022 on the very small amplitude of GC-mediated IPSPs, also McIntyre and Cleland 2015.

      We apologize for the lack of clarity. We reported that we found a local cold spot in the context of an additional experiment not presented in the manuscript and only described in the Methods section. Following the revision, we decided to add the analysis of this experiment to Figure 5. This experiment validated that optogenetic activation of GCs is potent and can affect the recorded MTC firing rates. This is particularly important as we performed all experiments under Ketamine anesthesia, which is a NMDA receptor antagonist. In this experiment, we recorded the activity of MTCs at baseline conditions (without odor presentation) under optogenetic activation of GCs. We divided the OB surface into a grid and optogenetically activated GC columns at a random order, one light spot in each trial, using light patches of size of size 330um2. We used the same light intensity as in the optogenetic GC activation during odor stimulation (reported in Figures 4-5). We show that the recorded MTC was strongly inhibited by GC light activation, mostly when activating GCs in its vicinity (within its column, i.e., local cold spot). This experiment validates that in our experimental setup, GCs can exert inhibition over MTCs at baseline conditions.

      (2) Even from the shown data, it appears that laterally increased synchronization might co-occur with lateral suppression (See also comment on Figures 1d,e and Figure S1c)

      We kindly note that the panels you referred to do not quantify the firing rate but the rhythmicity of MTC light-evoked responses. We should have explained these graphs better in the main text and not only in the Methods section. We added a panel to Supplementary Figure 1, which describes our analysis: In each of these examples, we performed a time-frequency Wavelet analysis over the average response of the neurons across trials (computed using a sliding Gaussian with a std of 2ms). The results of the Wavelet analysis allowed us to visually capture the enhanced spike alignment across trials under paired activation as a function of the stimulus duration (as, for example, in Figure 1c, middle panel). The response amplitude to light stimulation did not change in this example (shown in Figure 1c lower panel), and the spikes entrainment increased following paired activation of MTCs.

      To address the relations between lateral suppression and synchronization at the population level, we added additional analyses to Figure 3c-d.

      (3) There are no manipulations of PVN activity in this study, thus there is no direct evidence for the substrate of the second circuit.

      We completely agree with the reviewer. Using the current data, we can only claim that optogenetic activation of GCL neurons did not affect the MTC odor-evoked response. This finding is consistent with the loss-of-function experiment reported by Fukunaga et al., 2014, where GC suppression did not change odor-evoke responses in both anesthetized and awake mice. Therefore, we speculated that PVN might be a candidate OB interneuron to mediate lateral inhibition between MTCs. This hypothesis is based on their higher likelihood of interconnecting two MTCs compared with GCs (Burton, 2017). We elaborated on this in the discussion and made sure it is clearly stated as a hypothesis.

      (4) The manipulation of GC activity was performed in a transgenic line with viral transfection, which might result in a lower permeation of the population compared to the line used for optogenetic stimulation of MTCs.

      We used a previously validated protocol for optogenetic manipulation of GCs from Fukunaga et al., 2014 in order to minimize this caveat. As we cited previously from their paper, following the expression of ChR2 in the GCL, ‘Light presentation in vivo resulted in rapid and strong depolarization of, and action potential (AP) discharges in, GCs (Fig. 3b), which in turn consistently and strongly hyperpolarized M/TCs (9 of 9 cells showed 100% AP suppression; Fig. 3c,d)’. These results are consistent with the additional experiment we added to the manuscript, where optogenetic activation of GCL neurons strongly suppressed MTC activity during baseline conditions (without odor presentation). The high similarity between these two reports, in which, in the case of Fukunaga et al., GC activation was directly measured, suggests that lack of opsin expression or insufficient light intensity is unlikely to explain the lack of GCL neuron activation effect on lateral inhibition. Moreover, GCL neurons' optogenetic activation during odor stimulation increased MTC spike-LFP coupling in the gamma range. Therefore, the dissociation between the effects of GCL neurons on spike entrainment and lateral inhibition suggests that the lack of lateral inhibition following GC activation is unlikely due to low expression rates.

      In some instances, the authors tend to cite older literature - which was not yet aware of the prominent contribution of EPL neurons including PVN to recurrent and lateral inhibition of MT cells - as if roles that then were ascribed to granule cells for lack of better knowledge can still be unequivocally linked to granule cells now. For example, they should discuss Arevian et al (2006), Galan et al 2006, Giridhar et al., Yokoi et al. 1995, etc in the light of PVN action.

      Therefore it is also not quite justified to state that their result regarding the role of GCs specifically for synchronization, not suppression, is "in contrast to the field" (e.g. l.70 f.,, l.365, l. 400 ff).

      We changed several sentences in the discussion and introduction to explain that previous studies attributed lateral suppression to GC because they were not aware of the prominent contribution of EPL neurons as has been demonstrated by more recent studies (Burton 2024, Huang et al., 2016,  Kato et al., 2013, and more).

      We also toned down the statement that these findings are in contrast to the field. Instead, we state that our findings support the claim that GCs are not involved in affecting MTC odor-evoked firing rate.

      Why did the authors choose to use the term "lateral suppression", often interchangeably with lateral inhibition? If this term is intended to specifically reflect reductions of firing rates, it might be useful to clearly define it at first use (and cite earlier literature on it) and then use it consistently throughout.

      We agree and have changed the manuscript accordingly. We added the following in the introduction: “We use this phrase here to refer to a process that suppresses the firing rate of the post-synaptic neuron.”

      A discussion of anesthesia effects is missing - e.g. GC activity is known to be reportedly stronger in awake mice (Kato et al). This is not a contentious point at all since the authors themselves show that additional excitation of GCs enhances synchrony, but it should be mentioned.

      We completely agree and added a paragraph to the Discussion in this regard. Please see also the response to reviewer #1, who made a similar suggestion.

      Some citations should be added, in particular relevant recent preprints - e.g. Peace et al. BioRxiv 2024, Burton et al. BioRxiv 2024 and the direct evidence for a glutamate-dependent release of GABA from GCs (Lage-Rupprecht et al. 2020).

      We thank the reviewer for noting us these relevant recent manuscripts. We have now cited Peace et al., when discussing the spatial range of inhibition and gamma synchronization in the OB, Lage-Rupprecht et al in the context of the involvement of NMDA receptor in MTC-GC reciprocal synapse and Burton et al. when discussing PV neurons potential function.

      The introduction on the role of gamma oscillations in sensory systems (in particular vision) could be more elaborated.

      In our previous paper (Dalal & Haddad 2022) we had an elaborated introduction on the role of gamma oscillations in sensory processing, since we focused in this study in the effect of gamma synchronization on information transmission between brain regions. In the current study we looked at gamma rhythms as a mechanism that can facilitate ensemble synchronization.

      Reviewer #3 (Public Review):

      Summary:

      This study by Dalal and Haddad analyzes two facets of cooperative recruitment of M/TCs as discerned through direct, ChR2-mediated spot stimulations:

      (1) mutual inhibition and

      (2) entrainment of action potential timing within the gamma frequency range.

      This investigation is conducted by contrasting the evoked activity elicited by a "central" stimulus spot, which induces an excitatory response alone, with that elicited when paired with stimulations of surrounding areas. Additionally, the effect of Gad2-expressing granule cells is examined.

      Based on the observed distance dependence and the impact of GC stimulations, the authors infer that mutual inhibition and gamma entrainment are mediated by distinct mechanisms.

      Strengths:

      The results presented in this study offer a nice in vivo validation of the significant in vitro findings previously reported by Arevian, Kapoor, and Urban in 2008. Additionally, the distance-dependent analysis provides some mechanistic insights.

      We thank the reviewer for his comments. Indeed, the current study provides in-vivo replication of the results reported in Arevian et al., 2008 in-vitro, and adds further insights by showing that lateral inhibition is distant-dependent. However, this is not the main focus of the current study. Following the findings reported by Dalal & Haddad 2022, the motivation for this study was to test the mechanism that allows co-activated MTCs to entrain their spike timing. By light-activating pairs of MTCs at varying distances, we detected a subset of pairs in which paired light-activation evoked activity-dependent lateral inhibition, as was reported by Arevian et al., 2008. Moreover, we think it is highly important to know that a previous result in an in-vitro study is fully reproducible in-vivo.

      Weaknesses:

      The results largely reproduce previously reported findings, including those from the authors' own work, such as Dalal and Haddad (2022), where a key highlight was "Modulating GC activities dissociates MTCs odor-evoked gamma synchrony from firing rates." Some interpretations, particularly the claim regarding the distance independence of the entrainment effect, may be considered over-interpretations.

      We kindly disagree with the reviewer. We think the current study extends rather than reproduces the findings reported in Dalal & Haddad 2022. The 2022 study mainly focused on the effect of OB gamma synchronization on odor representation in the Piriform cortex. We bidirectionally modulated the level of MTC gamma synchronization and found that it had bidirectional effects on odor representation in one of their downstream targets, the anterior piriform cortex. The current study, however, focuses on the question of how spatially distributed odor-activated MTCs can synchronize their spiking activity. Our current main finding is that paired activation of MTCs can enhance the spikes entrainment of the recorded MTC in an activity-dependent and spatially independent manner. We suggest that this mechanism is mediated by GCL neurons.

      The reviewer did not explain why he\she thinks that the distance independence of the entrainment effects is an over-interpretation. However, to make our claim more precise we added the following sentence to the corresponding results section:” Furthermore, within the distance range that we were able to measure, the increased phase-locking did not significantly correlate with the distance from the MTC”

      Recommendations for the authors:

      Reviewer #1 (Recommendations For The Authors):

      Minor comments:

      (1) Line 17f: "This lateral synchronization was particularly effective when both MTCs fired at the gamma rhythm, ..."

      This sentence implies a direct comparison of the simultaneously recorded firing of MTCs but I could not find evidence for this in this manuscript. I would suggest to change this.

      We thank the reviewer. The sentence was changed to “This lateral synchronization was particularly effective when the recorded MTC fired at the gamma rhythm”.

      (2) Line 43f: A brief description of what glomeruli are could help to avoid confusion for readers less familiar with the OB. The phrasing of "activated glomeruli" and "each glomerulus innervates" are somewhat misleading given that they do not contain the cell bodies of the projection neurons.

      We edited this part of the introduction so it briefly describes what glomeruli are: ‘Olfactory processing starts with the activity of odorant-activated olfactory sensory neurons. The axons of these sensory neurons terminate in one or two anatomical structures called glomeruli located on the surface of the olfactory bulb (OB). Each glomerulus is innervated by several mitral and tufted cells (MTCs), which then project the odor information to several cortical regions. ‘

      (3) Line 78ff: The text sounds as if glomeruli are activated by the light stimulation but ChR2 is expressed in MTCs, the postsynaptic component of the glomeruli. It would be clearer to refer to the stimulation as light activation of MTCs.

      We corrected this sentence to: ‘We first mapped each recorded cell's receptive field, i.e., the set of MTCs on the dorsal OB that affect its firing rates when they are light-stimulated.’

      (4) Line 90: It would be great to mention somewhere in this paragraph that you are analyzing single-unit data sorted from extracellular recordings with tungsten electrodes.

      We added that to the description of the experimental setup: ‘To investigate how MTCs interact, we expressed the light-gated channel rhodopsin (ChR2) exclusively in MTCs by crossing the Tbet-Cre and Ai32 mouse lines (Grobman et al., 2018; Haddad et al., 2013), and extracellularly recorded the spiking activity of MTCs in anesthetized mice during optogenetic stimulation using tungsten electrodes.’

      (5) Line 97: The term "delta entrainment" could be easily confused with the entrainment of MTCs to respiration in the delta frequency band. Maybe better to use a different term or stick to "change in entrainment" also used in the text.

      We completely agree. The term was changed to “change in entrainment” throughout the manuscript and figures.

      (6) Line 121f: "Light stimulation did not affect ..." . Should this be "Paired light stimulation did not affect ..."?

      Corrected, thank you.

      (7) Supplementary Figure 1a: The example is not very convincing. It looks a bit like a rhythmic bursting neuron mildly depending on the stimulation.

      This panel serves to present our light stimulation method. The potency of the light stimulation protocol can be seen in the receptive field maps.

      (8) Supplementary Figure 1c: Why is there no confidence interval for 'Paired'?

      This panel shows the power spectrum density of the average neuron response across trials computed over the entire stimulus window (100ms). We decided to remove this panel, as panel Figure 1d shows the evolution of the entrainment in time and, therefore, provides better insight into the effect.

      (9) Line 166f: "... across any light intensities". Maybe better "... for the four light intensities tested"?

      We agree, we changed the text in accordance.

      (10) Figure 2f: It would be more intuitive to have the x-axis in the same orientation as in 2e.

      Corrected, thank you.

      (11) Figure 4a: The image in this panel is identical to Figure 1a in Dalal and Haddad 2022 in Cell reports just with a different intensity. The reuse of items and data from previous publications should be indicated somewhere but I could not find it.

      We apologize for this replication. We replaced it with a photo showing a larger portion of the OB, demonstrating the restricted viral expression within the GCL.

      (12) Line 408ff: A brief explanation for the hypothesis of EPL parvalbumin interneurons as the ones mediating lateral inhibition would be great.

      We agree. We added the following paragraph to the discussion section: “We speculate that MTC-to-MTC suppression is mediated by EPL neurons, most likely the Parvalbumin neuron (PV). This hypothesis is based on their activity and connectivity properties with MTCs(Burton, 2017; Kato et al., 2013; Miyamichi et al., 2013; Burton, 2024). More studies are required to reveal how PV neurons affect MTC activity.”

      (13) Line 425ff: You show that only activity of high firing rate neurons is suppressed by lateral inhibition, whereas "low and noise MTC responses" are not affected. Wouldn't this rather support the conclusion that lateral inhibition prevents excess activity from the OB?

      We found lateral inhibition was mainly effective when the postsynaptic neurons fired at ~30-80Hz in response to light stimulation. That is, it affects MTC firing in this “intermediate” rate, and to a lesser extent when the MTC have low and very high firing rates. To prevent excess activity, one would expect a mechanism that affects more high firing rates than medium ones. This was demonstrated in Kato 2013 for PV-MTC inhibition

      (14) Line 387: "..., only ~20% of the tested MTC pairs exhibited significant lateral inhibition." This is higher than the 16% of neurons you reported to have lateral entrainment (line 100). Why do you consider the lateral inhibition as 'sparse' but the lateral entrainment as relevant?

      We apologize for this unclear statement. The papers we cited in this regard (Fantana et al., 2008; Lehmann et al., 2016; Pressler and Strowbridge, 2017) have tested lateral inhibition when the recorded MTC was not active, which resulted in a sparse MTC-MTC inhibition. We validated and replicated these findings in our setup, by systematically projecting light spots over the dorsal OB without simultaneous activation of the recorded MTC and found similar rates of largely scarce inhibition (data not shown). In this study, using spike-triggered average light stimulation protocol and paired activation of MTCs, we found higher rates of lateral inhibition, consistent with the reports by Isaacson and Strowbridge, 1998, Urban and Sakmann, 2002. We changed this paragraph to the following:

      “We found that in only ~20% of the tested MTC pairs exhibited significant lateral suppression. This rate is consistent with previous in-vitro studies that found lateral suppression between 10-20% of heterotypic MTC pairs (Isaacson and Strowbridge, 1998; Urban and Sakmann, 2002), and is higher compared to a case where the recorded MTC is not active (Lehmann et al., 2016).”

      Reviewer #2 (Recommendations For The Authors):

      Figure-by-figure comments:

      (1) Figures 1d,e: both these examples seem to show that the firing rate is decreased in the paired condition? From maxima at 110 to 58 Hz in d and 100 to 48 Hz in e. Please explain (see also comment on Figure S1c).

      Please see the response in the Public Review section, reviewer #2, bullet (2). We also added a panel to Supplementary Figure 1 to better explain this.

      (2) Figure 1 f The means and SEMs are hard to see. Why is the SEM bar plotted horizontally? Since this is a major finding of the paper, will there be a table provided that shows the distribution of ∆ shifts across animals?

      We apologize for the mistake. The horizontal bar was the marking of the mean. Since the SEM is small, we corrected the graph for better visualization of the SEM.

      (3) Figure 1g Showing the running average of data where there is almost none or no data points (beyond 50 Hz) seems not ideal. Is the enhanced entrainment around 40Hz significant? Perhaps the moving average should be replaced by binned data with indicated n?

      We prefer to show all data points instead of binning the data so the reader can see it all. We agree that such a wide range on the x-axis is unnecessary. We shorten this graph only to include the firing rate range in which the data points ranged.

      (4) Figure 1h Impressive result!

      Thank you!

      (5) Figure S1a: since the authors show the respiratory pattern here and there obviously was no alignment of light stimulation with inspiration, was there any correlation between the respiratory phase and efficiency of light stimulation with respect to lateral interactions?

      This is an interesting idea. In Haddad et al., 2013, figure 7, the authors performed a similar analysis, and showed that optogenetic activation of MTCs had a more pronounced effect on firing rate in the respiration phases where the neuron was less firing. However, we haven’t quantified the impact of lateral interactions with respect to the respiration phase. That being said, the data will be publicly available to test this question.

      (6) Figure S1c: Here the shift towards a lower firing rate seems to be obvious (see comment in Figures 1 d and e). Please also show the plot for Figure 1e.

      This panel shows the power spectrum density of the average neuron's response across trials computed over the entire stimulus window (100ms). We decided to remove this panel, as panel Figure 1d shows the evolution of the entrainment in time and, therefore, provides better insight into the effect.

      (7) Figure 2b: show the same plot also for pair 2? Why is it stated that there is no lateral suppression for lateral stimulation alone, if the MTC did not spike spontaneously in the first place and thus inhibition cannot be demonstrated?

      We use Figure 2b to demonstrate the effect of lateral inhibition, and in Figure 2c we detail the responses under each light intensity for both pairs. We think that showing the mean and SEM for one example is enough to give a sense of the effect, as in Figure 2c we show the average response across time together with significant assessment for each pair (panels without a p-value have no significant difference between the conditions).

      However, we agree with the comment on this specific example and therefore deleted this sentence. However, at the population level we found no inhibition when activating the lateral spots, regardless of their firing rates (shown in Supplementary Figure 2a).

      (8) Figure 2d: why is there no distance-dependent color coding for the significant data points? Or, alternatively, since the distance plot is shown in 2e, perhaps drop this information altogether? Again, the moving average is problematic.

      Distance-dependent color coding is applied to all data points in this panel. Significant data points are shown in full circles and have distance-dependent color coding, which is mainly restricted to the lower part of the distance scale (cold colors).

      We used a moving average to relate to the similar result reported in Arevian 2008.In Figure 2e, the actual distance for each data point is indicated on the x-axis.

      (9) Figure 2f: the diagonal averaging method seems to neglect a lot of the data in Figure S2b, why not use radial coordinates for averaging?

      Thank you for the great suggestion. We indeed performed radial coordinates for the averaging, and the results are more robust and better summarize the entire data.

      (10) Figure 3: These are interesting observations, but are there cumulative data on such types of pairs? Please describe and show, otherwise this can only be a supplemental observation. Regarding 3b was it always the lower light intensity that resulted in suppression and the higher in sync? Since Burton et al. 2024 have just shown that PVNs require very little input to fire!

      This figure shows several examples of entrainment and inhibition properties. As suggested, we added population analysis (Figure 3c-d). This analysis compares the firing rate changes in pairs that evoked significant suppression or entrainment. First, we found only a few pairs in which paired activation evoked both spikes entrainment and suppression. Second, the mean of firing rate changes of pairs that evoked significant entrainment (N=50, shown in Figure 1f in full circles) is significantly different from the mean of the pairs that evoked significant lateral inhibition (N=51, shown in Figure 2d in full circles).

      (11) Figure 4: This Figure and the corresponding section should be entitled "Additional GC activation... ", otherwise it might be confusing for the reader. A loss of function manipulation (local GC silencing) would be also great to have! You did this in the previous paper, why not here? Raw LFP data are not shown. In Figure 4e the reported odor response firing rate ranges only up to 40Hz, but the example in g shows a much higher frequency. Is the maximum in 4e significant? (same issue as for Figure 1g).

      We changed the phrase to ‘optogenetic GCL neurons activation’. Unfortunately, we haven’t performed experiments where we suppress GC columns. In the previous paper, we suppressed the activity of all accessible GCs, which resulted in reduced spike synchronization to the OB gamma oscillations. Silencing only the GC column is, we think, unlikely to have a substantial effect, especially if the GCs have low activity (but this needs to be tested). Furthermore, we added examples of raw LFP data for odor stimulation and odor combined with GCL column activation (see Supplementary Figure 4a).

      The instantaneous firing rate is high (~80Hz), however the firing rate values we report in Figure 4e is the average within a window of 2 seconds (the odor duration is 1.5 seconds and we extend the window to account for responses with late return to baseline). The average firing rate of this example neuron in this window was 28Hz.

      (12) Fig 5: what does "proximal" mean - does this mean stimulation of the GCs below the recorded MTC, that might actually belong to the same glomerular unit?

      Yes, by “proximal” we mean the activation of the GC in the column of the recorded MTC. However, we decided that instead of coarsely dividing the data into proximal and distal optogenetic activation of GCL neurons, we will show the data continuously to show that GC had no significant effect on MTC odor-evoked firing rates regardless of their location (Figure 5d).

      A comment on the title:

      Please tone it down: "Ensemble synchronization" is a hypothesis at this point, not directly shown in the paper. Also, the paper does not show lateral interactions between odor-activated neurons.

      We agree and have rephrased it to “Activity-dependent lateral inhibition enables the synchronization of active olfactory bulb projection neurons ”

      (1) Figure 1a, 2a scale bar missing.

      Corrected, thank you.

      (2) Figure 1 c is the "rebound" in the lateral stim trace (green) real or not significant?

      The activity during this rebound is not significantly different than the baseline activity before light stimulation.

      (3) Figure 2b legend: "lateral alone" instead of lateral?

      We appreciate the suggestion. For simplicity, we will keep it as “lateral”.

      (4) Figure 2c: some of the data plots seem to be breaking off, e.g. the blue line in the bottom third one.

      This line breaking is due to the lack of spikes in this period. The PSTHs used in all analyses result from the convolution of the spike train with a Gaussian window with a standard deviation of 50ms.

      (5) Figure 2f: Why is the x axis flopped vs 2d,e?

      This panel was mistakenly plotted that way, and was corrected.

      Comments on the text:

      Abstract - we had indicated suggestions by strike-throughs and color which are lost in the online submission system, please compare with your original text:

      Information in the brain is represented by the activity of neuronal ensembles. These ensembles are adaptive and dynamic, formed and truncated based on the animal`s experience. One mechanism by which spatially distributed neurons form an ensemble is via synchronization of their spiking activity in response to a sensory event. In the olfactory bulb, odor stimulation evokes rhythmic gamma activity in spatially distributed mitral and tufted cells (MTCs). This rhythmic activity is thought to enhance the relay of odor information to the downstream olfactory targets. However, how only specifically the odor-activated MTCs are synchronized is unknown. Here, we demonstrate that light optogenetic activation of activating one set of MTCs can gamma-entrain the spiking activity of another set. This lateral synchronization was particularly effective when both MTCs fired at the gamma rhythm, facilitating the synchronization of only the odor-activated MTCs. Furthermore, we show that lateral synchronization did not depend on the distance between the MTCs and is mediated by granule cells. In contrast, lateral inhibition between MTCs that reduced their firing rates was spatially restricted to adjacent MTCs and was not mediated by granule cells. Our findings reveal lead us to propose ? a simple yet robust mechanism by which spatially distributed neurons entrain each other's spiking activity to form an ensemble.

      Thank you. We adopted most of the changes and edited the abstract to reflect the reported results better.

      "both MTCs fired at the gamma rhythm"/this is at this point unwarranted since the mutual entrainment is not shown - tone down or present as hypothesis?

      We completely agree. This sentence was changed to “This lateral synchronization was particularly effective when the recorded MTC fired at the gamma rhythm, facilitating the synchronization of the active MTC”.

      l. 28: distance-independent instead of "spatially independent"?

      Corrected

      l. 46: are there inhibitory neurons in the ONL? Or which 6 layers are you referring to here?

      Corrected to “spanning all OB layers”.

      l. 49: "is mediated" => "likely to be mediated". Schoppa's work is in vitro and did not account for PVNs, see comment in Public Review.

      Corrected. Indeed Schoppa`s work was performed in-vitro. We cite it here since it showed that the synchronized firing of two MTC pairs depends on granule cells.

      l.52: "method"? rather "mechanism"? "specifically" instread of "only"?

      Corrected.

      l.52: perhaps more precise: a recent hypothesis is that GCs enable synchronization solely between odor-activated MTCs via an activity-dependent mechanism for GABA-release (Lage Rupprecht et al. 2020 - please cite the experimental paper here). Again. Galan has no direct evidence for GCs vs PVNs, see comment in Public Review.

      Thank you, we updated this sentence here and in the discussion and added the relevant citation.

      l. 66: spike timings instead of spike's timing?

      Corrected to spike timings

      l. 67 -71: this part could be dropped.

      We appreciate the suggestion; however, we think that it is convenient to briefly read the main results before the results section.

      l. 76 mouse instead of mice.

      Corrected.

      l. 77: for clarification: " a single MTC"?

      In some cases, we recorded more than one cell simultaneously.

      l. 89: just use "hotspot".

      Corrected

      l. 97 instead of "change", "positive change" or "increase"?

      We left the word change, since we wanted to report that the change between hotspot alone and paired stimulation was significantly higher than zero.

      l. 104: the postsyn MTC's firing rate.

      Corrected to MTC instead of MTCs

      l.108: "distributed on the OB surface" sounds misleading, perhaps "across the glomerular map"?

      Corrected.

      l. 254: "which the MTCs form with each other"- perhaps "which interconnect MTCs".

      Corrected.

      l. 270 Additional GC activation.

      Corrected to ‘optogenetic activation of GCL neurons’

      l. 284 somewhat unclear - please expand.

      Corrected to ‘This measure minimizes the bias of the neuron's firing rate on the spike-LFP synchrony value’.

      l. 371: no odors in Schoppa et al.

      Corrected to ‘It has been shown that two active MTCs can synchronize their stimulus-evoked and odor-evoked spike timings’

      l. 406 ff. good point - but where is the transition? How does this observation rule out that GCs can mediate lateral suppression?

      It is an important question. We tested two setups of GCs optogenetic activation, either column activation (in this paper) or the activation of all accessible GCs of the dorsal OB (Dalal & Haddad, 2022). Although the latter manipulation results in significant firing rate suppression, the effect of MTC suppression was relatively small in anesthetized mice and even smaller in awake mice. Optogenetically activating GCs at baseline conditions resulted in a strong suppression of only the adjacent MTCs. Taken together, we think that GCs are capable of strongly inhibit MTCs, but it is not their main function in natural olfactory sensation.

      l. 422 ff: again, this is a hypothesis, please frame accordingly.

      Corrected to ‘Activity-dependent synchronization can enables the synchronization of odor-activated MTCs that are dispersed across the glomerular map’

      l. 551 typo.

      Corrected.

      l 556 ff: Figure 2 does not show odor responses.

      Corrected.

      l 582: Mix up of above/below and low/high?

      Corrected to ‘The values in the STA map that were above or below these high and low percentile thresholds’

      Reviewer #3 (Recommendations For The Authors):

      Line 76: "Ai39" should be corrected to "Ai32".

      Corrected. Thank you.

      Figure Legends: The legends should describe the results rather than interpret the data. For instance, the legends for Figures 1f, g, and h contain interpretations. The authors should review all legends and revise them accordingly.

      We appreciate the comment. However, we kindly disagree. We don’t see these opening sentences as interpretations but as guidance to the reader. For example, ‘Paired stimulation increases spikes’ temporal precision’ is not an interpretation; instead, it describes the finding presented in this panel. We think that legends that only repeat what can already be deduced from the graph are not helpful and, in many cases, obsolete. Explaining what we think this graph shows is common, and we prefer it as it helps the reader.

      For Figures 1d and e, it may be beneficial to add the spectrograms for the second stimulation alone.

      We show the stimulation of the hotspot alone and when we stimulate both.<br /> The spectrogram of the lateral alone does not show anything of importance.

      Figures 1a and 2a: Please add color bars so that readers can understand the meaning of the colors plotted.

      Color bars were added.

      Figure 3: The purpose of this figure is unclear. Why does the baseline firing rate for the paired activation differ? Is this an isolated observation, or is it observed in other units as well?

      This issue has been raised also by reviewer #2. Attached here is our response to reviewer #2

      This figure shows several examples of entrainment and inhibition properties. As suggested, we added population analysis (Figure 3c-d). This analysis compares the firing rate changes in pairs that evoked significant suppression or entrainment. First, we found only a few pairs in which paired activation evoked both spikes entrainment and suppression. Second, the mean of firing rate changes of pairs that evoked significant entrainment (N=50, shown in Figure 1f in full circles) is significantly different from the mean of the pairs that evoked significant lateral inhibition (N=51, shown in Figure 2d in full circles).

      Figures 4 and 5 data seems to come from the same dataset as in Dalal and Haddad (2022) DOI: https://doi.org/10.1016/j.celrep.2022.110693. For example, the fluorescence image looks identical. If this is the case, the authors may want to state that that the image and and some of the data and analyses are reproduced.

      The recorded data shown in these figures are not reproduced from Dalal & Haddad 2022. We collected this data, using GC-columns activation instead of light activating the entire OB dorsal surface as was done in the 2022 paper.

      However, the histology image is the same and we now replaced it with a new image, which shows that the expression is restricted to the GCL.

      Figure 4d: the authors use the data plotted here to argue that the gamma entrainment is distance-independent. But there is a clear decrease over distance (e.g., delta PPC1 over 0.01 is not seen for distance beyond 1000 m). The claim of distance independence may be an over-interpretation of the data. Peace et al. (2024) also claimed that coupling via gamma oscillations occurs over a large spatial extent.

      From a statistical point of view, we can’t state that there is a dependency on distance as the correlation is insignificant (P = 0.86). PPC1 of value 0.01 can be found at 0, 500, and 700 microns. Lower values are found at far distances, but this can result from a smaller number of points. The reduced level of synchrony observed at distances above one mm could be the result of the reduced density of lateral interactions at these distances. That said, we rephrase the sentence to a more careful statement. Please see the rephrased sentence at the Public review section.

    1. Author response:

      We appreciate Reviewer 1’s observation that our findings (i.e., separable dynamic trajectories are systematically translated in response to whether outcomes are rewarded, and this translation is accumulated across trials) are consistent with a line attractor model. We agree with this assessment and, in the revised manuscript, will reframe our findings about the dynamic trajectories to address its consistency with a line attractor.

      However, we would like to emphasize that a line attractor model does not account for the dynamic nature of reversal probability activity observed in the neural data. Line attractor, regardless of whether it is curved or straight, implies that the activity is fixed when no reward information is presented. The focus of our work is to highlight this dynamic nature of reversal probability activity and its incompatibility with the line attractor model.

      This leads to the question of how we could reconcile the line attractor-like properties and the dynamic nature of reversal probability activity. In the revised manuscript, we will provide evidence for an augmented model that has an attractor state at the beginning of each trial, followed by dynamic activity during the trial. Such a model is an example of superposition of initial attractor states with fast within-trial dynamics, as pointed out by Reviewer 1.

      We also thank Reviewer 2 and Reviewer 3 for their comments on how the manuscript could be improved. In the revised manuscript, we will provide detailed explanations to clarify the choice of network model, data analysis methods and experiment and model setups.

      In addition, we would like to take this opportunity to point out potentially misleading statements in the reviews by Reviewer 2 and Reviewer 3. Reviewer 2 stated that “no action is required to be performed by neurons in the RNN, …, no intervening behavior is thus performed by neurons”. Reviewer 3 stated that “the RNN does not have to do any explicit computation during the non-feedback parts of the trial…”. These statements convey the message that the trained RNN does not perform any computation. In fact, the RNN is trained to make a choice during non-feedback period in response to feedback. This is the (and the only) computation RNN performs. “Intervening behavior” refers to the choice the RNN makes across trials until reversing its initially preferred choice. We think that this confusion might have happened because the meaning of the term “intervening behavior” was unclear. We will clarify this point in the revised manuscript.

      Again, thank you for the insightful comments. We will provide a more detailed response to the reviews and revise the manuscript accordingly.

    1. Author response:

      Reviewer #1 (Public review):

      Summary:

      The authors use high-throughput gene editing technology in larval zebrafish to address whether microexons play important roles in the development and functional output of larval circuits. They find that individual microexon deletions rarely impact behavior, brain morphology, or activity, and raise the possibility that behavioral dysregulation occurs only with more global loss of microexon splicing regulation. Other possibilities exist: perhaps microexon splicing is more critical for later stages of brain development, perhaps microexon splicing is more critical in mammals, or perhaps the behavioral phenotypes observed when microexon splicing is lost are associated with loss of splicing in only a few genes.

      A few questions remain:

      (1) What is the behavioral consequence for loss of srrm4 and/or loss-of-function mutations in other genes encoding microexon splicing machinery in zebrafish?

      It is established that srrm4 mutants have no overt morphological phenotypes and are not visually impaired (Ciampi et al., 2022).

      We chose not to generate and characterize the behavior and brain activity of srrm4 mutants for two reasons: 1) we were aware of two other labs in the zebrafish community that had generated srrm4 mutants (Ciampi et al., 2022 and Gupta et al., 2024, https://doi.org/10.1101/2024.11.29.626094; Lopez-Blanch et al., 2024, https://doi.org/10.1101/2024.10.23.619860), and 2) we were far more interested in determining the importance of individual microexons to protein function, rather than loss of the entire splicing program. Microexon inclusion can be controlled by different splicing regulators, such as srrm3 (Ciampi et al., 2022) and possibly other unknown factors. Genetic compensation in srrm4 mutants could also result in microexons still being included through actions of other splicing regulators, complicating the analysis of these regulators. We mention srrm4 in the manuscript to point out that some selected microexons are adjacent to regulatory elements expected of this pathway. We did not, however, choose microexons to mutate based on whether they were regulated by srrm4, making the characterization of srrm4 mutants disconnected from our overarching project goal.

      We are coordinating our publication with Lopez-Blanch et al. (https://doi.org/10.1101/2024.10.23.619860), which shows that srrm4 mutants also have minimal behavioral phenotypes.

      (2) What is the consequence of loss-of-function in microexon splicing genes on splicing of the genes studied (especially those for which phenotypes were observed).

      We acknowledge that unexpected changes to the mRNA could occur following microexon removal. In particular, all regulatory elements should be removed from the region surrounding the microexon, as any remaining elements could drive the inclusion of unexpected exons that result in premature stop codons.

      First, we will clarify our generated mutant alleles by adding a figure that details the location of the gRNA cut sites in relation to the microexon, its predicted regulatory elements, and its neighboring exons.

      Second, we will experimentally determine whether the mRNA was modified as expected for a subset of mutants with phenotypes.

      Third, we will further emphasize in the manuscript that these observed phenotypes are extremely mild compared to those observed in over one hundred protein-truncating mutations we have assessed in previous and ongoing work. We currently show one mutant, tcf7l2, which we consider to have strong neural phenotypes, and we will expand this comparison in the revision. In our study of 132 genes linked to schizophrenia (Thyme et al., 2019), we established a signal cut-off for whether a mutant would be designated as having a neural phenotype, and we classify this set of microexon mutants in this context. Far stronger phenotypes are expected of loss-of-function alleles for microexon-containing genes, as we showed in Figure S1 of this manuscript in addition to our published work.

      (3) For the microexons whose loss is associated with substantial behavioral, morphological, or activity changes, are the same changes observed in loss-of-function mutants for these genes?

      We had already included two explicit comparisons of microexon loss with a standard loss-of-function allele, one with a phenotype and one without, in Figure S1 of this manuscript. We will make the conclusions and data in this figure more obvious in the main text.

      Beyond the two pairs we had included, Lopez-Blanch et al. (https://doi.org/10.1101/2024.10.23.619860) describes mild behavioral phenotypes for a microexon removal for kif1b, and we already show developmental abnormalities for the kif1b loss-of-function allele (Figure S1).

      Additionally, we can draw expected conclusions from the literature, as some genes with our microexon mutations have been studied as typical mutants in zebrafish or mice. We will modify our manuscript to include a discussion of these mutants.

      (4) Do "microexon mutations" presented here result in the precise loss of those microexons from the mRNA sequence? E.g. are there other impacts on mRNA sequence or abundance?

      See response to point 2. We will experimentally determine whether the mRNA was modified as expected for a subset of mutants with phenotypes.

      (5) Microexons with a "canonical layout" (containing TGC / UC repeats) were selected based on the likelihood that they are regulated by srrm4. Are there other parallel pathways important for regulating the inclusion of microexons? Is it possible to speculate on whether they might be more important in zebrafish or in the case of early brain development?

      The microexons were not selected based on the likelihood that they were regulated by srrm4. We will clarify the manuscript regarding this point. There are parallel pathways that can control the inclusion of microexons, such as srrm3 (Ciampi et al., 2022). It is well-known that loss of srrm3 has stronger impacts on zebrafish development than srrm4 (Ciampi et al., 2022). The goal of our work was not to investigate these splicing regulators, but instead was to determine the individual importance of these highly conserved protein changes.

      Strengths:

      (1) The authors provide a qualitative analysis of splicing plasticity for microexons during early zebrafish development.

      (2) The authors provide comprehensive phenotyping of microexon mutants, addressing the role of individual microexons in the regulation of brain morphology, activity, and behavior.

      We thank the reviewer for their support. The pErk brain activity mapping method is highly sensitive, significantly minimizing the likelihood that the field has simply not looked hard enough for a neural phenotype in these microexon mutants. In our published work (Thyme et al., 2019), we show that brain activity can be drastically impacted without manifesting in differences in those behaviors assessed in a typical larval screen (e.g., tcf4, cnnm2, and more).

      Weaknesses:

      (1) It is difficult to interpret the largely negative findings reported in this paper without knowing how the loss of srrm4 affects brain activity, morphology, and behavior in zebrafish.

      See response to point 1.

      (2) The authors do not present experiments directly testing the effects of their mutations on RNA splicing/abundance.

      See response to point 3.

      (3) A comparison between loss-of-function phenotypes and loss-of-microexon splicing phenotypes could help interpret the findings from positive hits.

      See response to point 2.

      Reviewer #2 (Public review):

      Summary:

      The manuscript from Calhoun et al. uses a well-established screening protocol to investigate the functions of microexons in zebrafish neurodevelopment. Microexons have gained prominence recently due to their enriched expression in neural tissues and misregulation in autism spectrum disease. However, screening of microexon functionality has thus far been limited in scope. The authors address this lack of knowledge by establishing zebrafish microexon CRISPR deletion lines for 45 microexons chosen in genes likely to play a role in CNS development. Using their high throughput protocol to test larval behaviour, brain activity, and brain structure, a modest group of 9 deletion lines was revealed to have neurodevelopmental functions, including 2 previously known to be functionally important.

      Strengths:

      (1) This work advances the state of knowledge in the microexon field and represents a starting point for future detailed investigations of the function of 7 microexons.

      (2) The phenotypic analysis using high-throughput approaches is sound and provides invaluable data.

      We thank the reviewer for their support.

      Weaknesses:

      (1) There is not enough information on the exact nature of the deletion for each microexon.

      To clarify the nature of our mutant alleles, we will add a figure that details the location of the gRNA cut sites in relation to the microexon, its predicted regulatory elements, and its neighboring exons.

      (2) Only one deletion is phenotypically analysed, leaving space for the phenotype observed to be due to sequence modifications independent of the microexon itself.

      We will experimentally determine whether the mRNA is impacted in unanticipated ways for a subset of mutants with mild phenotypes (see the point 2 response to reviewer 1). We also have already compared the microexon removal to a loss-of-function mutant for two lines (Figure S1), and we will make that outcome more obvious as well as increasing the discussion of the expected phenotypes from typical loss-of-function mutants (see point 3 response to reviewer 1).

      In addition, our findings for three microexon mutants (ap1g1, vav2, and vti1a) are corroborated by Lopez-Blanch et al. (https://doi.org/10.1101/2024.10.23.619860).

      Unlike protein-coding truncations, clean removal of the microexon and its regulatory elements is unlikely to yield different phenotypic outcomes if independent lines are generated (with the exception of genetic background effects). When generating a protein-truncating allele, the premature stop codon can have different locations and a varied impact on genetic compensation. In previous work (Capps et al., 2024), we have observed different amounts of nonsense-mediated decay-induced genetic compensation (El-Brolosy, et al., 2019) depending on the location of the mutation. As they lack variable premature stop codons (the expectation of a clean removal), two mutants for the same microexons should have equivalent impacts on the mRNA.

      Reviewer #3 (Public review):

      Summary:

      This paper sought to understand how microexons influence early brain function. By selectively deleting a large number of conserved microexons and then phenotyping the mutants with behavior and brain activity assays, the authors find that most microexons have minimal effects on the global brain activity and broad behaviors of the larval fish-- although a few do have phenotypes.

      Strengths:

      The work takes full advantage of the scale that is afforded in zebrafish, generating a large mutant collection that is missing microexons and systematically phenotyping them with high throughput behaviour and brain activity assays. The work lays an important foundation for future studies that seek to uncover the likely subtle roles that single microexons will play in shaping development and behavior.

      We thank the reviewer for their support.

      Weaknesses:

      The work does not make it clear enough what deleting the microexon means, i.e. is it a clean removal of the microexon only, or are large pieces of the intron being removed as well-- and if so how much? Similarly, for the microexon deletions that do yield phenotypes, it will be important to demonstrate that the full-length transcript levels are unaffected by the deletion. For example, deleting the microexon might have unexpected effects on splicing or expression levels of the rest of the transcript that are the actual cause of some of these phenotypes.

      To clarify the nature of our mutant alleles, we will add a figure that details the location of the gRNA cut sites in relation to the microexon, its predicted regulatory elements, and its neighboring exons.

      We will experimentally determine whether the mRNA is impacted in unanticipated ways for a subset of mutants with mild phenotypes (see the point 2 response to reviewer 1).

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public Review):

      Summary:

      Previous studies have shown that treatment with 17α-estradiol (a stereoisomer of the 17β-estradiol) extends lifespan in male mice but not in females. The current study by Li et al, aimed to identify cell-specific clusters and populations in the hypothalamus of aged male rats treated with 17α-estradiol (treated for 6 months). This study identifies genes and pathways affected by 17α-estradiol in the aged hypothalamus.

      Strengths:

      Using single-nucleus transcriptomic sequencing (snRNA-seq) on the hypothalamus from aged male rats treated with 17α-estradiol they show that 17α-estradiol significantly attenuated age-related increases in cellular metabolism, stress, and decreased synaptic activity in neurons.

      Thanks.

      Moreover, sc-analysis identified GnRH as one of the key mediators of 17α-estradiol's effects on energy homeostasis. Furthermore, they show that CRH neurons exhibited a senescent phenotype, suggesting a potential side effect of the 17α-estradiol. These conclusions are supported by supervised clustering by neuropeptides, hormones, and their receptors.

      Thanks.

      Weaknesses:

      However, the study has several limitations that reduce the strength of the key claims in the manuscript. In particular:

      (1) The study focused only on males and did not include comparisons with females. However, previous studies have shown that 17α-estradiol extends lifespan in a sex-specific manner in mice, affecting males but not females. Without the comparison with the female data, it's difficult to assess its relevance to the lifespan.

      This study was originally designed based on previous findings indicating that lifespan extension is only effective in males, leading to the exclusion of females from the analysis. The primary focus of our research was on the transcriptional changes and serum endocrine alterations induced by 17α-estradiol in aged males compared to untreated aged males. We believe that even in the absence of female subjects, the significant effects of 17α-estradiol on metabolism in the hypothalamus, synapses, and endocrine system remain evident, particularly regarding the expression levels of GnRH and testosterone. Notably, lower overall metabolism, increased synaptic activity, and elevated levels of GnRH and testosterone are strong indicators of health and well-being in males, supporting the validity of our primary conclusions. However, including female controls would enhance the depth of our findings. If female controls were incorporated, we propose redesigning the sample groups to include aged male control, aged female control, aged female treated, aged male treated, as well as young male control, young male treated, young female control, and young female treated. We regret that we cannot provide this data in the short term. Nevertheless, we believe this presents a valuable avenue for future research on this topic. In this study, we emphasize the role of 17α-estradiol in overall metabolism, synaptic function, GnRH, and testosterone in aged males and underscore the importance of supervised clustering of neuropeptide-secreting neurons in the hypothalamus.

      (2) It is not known whether 17α-estradiol leads to lifespan extension in male rats similar to male mice. Therefore, it is not possible to conclude that the observed effects in the hypothalamus, are linked to the lifespan extension.

      Thanks for the reminding. 17α-estradiol was reported to extend lifespan in male rats similar to male mice (PMID: 33289482). We have added the valuable reference to introduction in the new version.  

      (3) The effect of 17α-estradiol on non-neuronal cells such as microglia and astrocytes is not well-described (Figure 1). Previous studies demonstrated that 17α-estradiol reduces microgliosis and astrogliosis in the hypothalamus of aged male mice. Current data suggest that the proportion of oligo, and microglia were increased by the drug treatment, while the proportions of astrocytes were decreased. These data might suggest possible species differences, differences in the treatment regimen, or differences in drug efficiency. This has to be discussed.

      We have reviewed reports describing changes in cell numbers following 17α-estradiol treatment in the brain, using the keywords "17α-estradiol," "17alpha-estradiol," and "microglia" or "astrocyte." Only a limited amount of data was obtained. We found one article indicating that 17α-estradiol treatment in Tg (AβPP(swe)/PS1(ΔE9)) model mice resulted in a decreased microglial cell number compared to the placebo (AβPP(swe)/PS1(ΔE9) mice), but this change was not significant when compared to the non-transgenic control (PMID: 21157032). The transgenic AβPP(swe)/PS1(ΔE9) mouse model may differ from our wild-type aging rat model in this context.

      Moreover, the calculation of cell numbers was based on visual observation under a microscope across several brain tissue slices. This traditional method often yields controversial results. For example, oligodendrocytes in the corpus callosum, fornix, and spinal cord have been reported to be 20-40% more numerous in males than in females based on microscopic observations (PMID: 16452667). In contrast, another study found no significant difference in the number of oligodendrocytes between sexes when using immunohistochemistry staining (PMID: 18709647). Such discrepancies arising from traditional observational methods are inevitable.

      We believe the data presented in this article are reliable because the cell number and cell ratio data were derived from high-throughput cell counting of the entire hypothalamus using single-cell suspension and droplet wrapping (10x Genomics).

      (4) A more detailed analysis of glial cell types within the hypothalamus in response to drugs should be provided.

      We provided more enrichment analysis data of differentially expressed genes between Y, O, and O.T in microglia and astrocytes in Figure 2—figure supplement 3. In this supplemental data, we found unlike that in neurons, Micro displayed lower levels of synapse-related cellular processes in O.T. compared to O.

      (5) The conclusion that CRH neurons are going into senescence is not clearly supported by the data. A more detailed analysis of the hypothalamus such as histological examination to assess cellular senescence markers in CRH neurons, is needed to support this claim.

      We also noticed the inappropriate claim and we have changed "senescent phenotype" to "stressed phenotype" and "abnormal phenotype" in abstract and in results.

      Reviewer #2 (Public Review):

      Summary:

      Li et al. investigated the potential anti-ageing role of 17α-Estradiol on the hypothalamus of aged rats. To achieve this, they employed a very sophisticated method for single-cell genomic analysis that allowed them to analyze effects on various groups of neurons and non-neuronal cells. They were able to sub-categorize neurons according to their capacity to produce specific neurotransmitters, receptors, or hormones. They found that 17α-Estradiol treatment led to an improvement in several factors related to metabolism and synaptic transmission by bringing the expression levels of many of the genes of these pathways closer or to the same levels as those of young rats, reversing the ageing effect. Interestingly, among all neuronal groups, the proportion of Oxytocin-expressing neurons seems to be the one most significantly changing after treatment with 17α-Estradiol, suggesting an important role of these neurons in mediating its anti-ageing effects. This was also supported by an increase in circulating levels of oxytocin. It was also found that gene expression of corticotropin-releasing hormone neurons was significantly impacted by 17α-Estradiol even though it was not different between aged and young rats, suggesting that these neurons could be responsible for side effects related to this treatment. This article revealed some potential targets that should be further investigated in future studies regarding the role of 17α-Estradiol treatment in aged males.

      Strengths:

      (1) Single-nucleus mRNA sequencing is a very powerful method for gene expression analysis and clustering. The supervised clustering of neurons was very helpful in revealing otherwise invisible differences between neuronal groups and helped identify specific neuronal populations as targets.

      Thanks.

      (2) There is a variety of functions used that allow the differential analysis of a very complex type of data. This led to a better comparison between the different groups on many levels.

      Thanks.

      (3) There were some physiological parameters measured such as circulating hormone levels that helped the interpretation of the effects of the changes in hypothalamic gene expression.

      Thanks.

      Weaknesses

      (1) One main control group is missing from the study, the young males treated with 17α-Estradiol.

      Given that the treatment period lasts six months, which extends beyond the young male rats' age range, we aimed to investigate the perturbation of 17α-Estradiol on the normal aging process. Including data from young males could potentially obscure the treatment's effects in aged males due to age effects, though similar effects between young and aged animals may exist. Long-term treatment of hormone may exert more developmental effects on the young than the old. Consequently, we decided to exclude this group from our initial sample design. We apologize for this omission.

      (2) Even though the technical approach is a sophisticated one, analyzing the whole rat hypothalamus instead of specific nuclei or subregions makes the study weaker.

      The precise targets of 17α-Estradiol within the hypothalamus remain unresolved. Selecting a specific nucleus for study is challenging. The supervised clustering method described in this manuscript allows us to identify the more sensitive neuron subtypes influenced by 17α-Estradiol and aging across the entire hypothalamus, without the need to isolate specific nuclei in a disturbed hypothalamic environment.

      (3) Although the authors claim to have several findings, the data fail to support these claims. You may mean the claim as the senescent phenotype in Crh neuron induced by 17a-estradiol.

      Thanks. We have changed the "senescent phenotype" to "stressed phenotype"  or "abnormal phenotype" in the abstract and results to avoid such claim.

      (4) The study is about improving ageing but no physiological data from the study demonstrated such a claim with the exception of the testes histology which was not properly analyzed and was not even significantly different between the groups.

      The primary objective of this study is to elucidate the effects of 17α-Estradiol on the endocrine system in the aging hypothalamus; exploring anti-aging effects is not the main focus. From the characteristics of the aging hypothalamus, we know that down-regulated GnRH and testosterone levels, along with elevated mTOR signaling, are indicators of aging in these organs (PMID: 37886966, PMID: 37048056, PMID: 22884327). The contrasting signaling networks related to metabolism and synaptic processes significantly differentiate young and aging hypothalami, and 17α-Estradiol helps rebalance these networks, suggesting its potential anti-aging effects.

      (5) Overall, the study remains descriptive with no physiological data to demonstrate that any of the effects on hypothalamic gene expression are related to metabolic, synaptic, or other functions.

      The study focuses on investigating cellular responses and endocrine changes in the aging hypothalamus induced by 17α-estradiol, utilizing single-nucleus RNA sequencing (snRNA-seq) and a novel data mining methodology to analyze various neuron subtypes. It is important to note that this study does not mainly aim to explore the anti-aging effects. Consequently, we have revised the claim in the abstract from “the effects of 17α-estradiol in anti-aging in neurons” to “the effects of 17α-estradiol on aging neurons.” We observed that the lower overall metabolism and increased expression levels of cellular processes in the synapses align with findings previously reported regarding 17α-estradiol. To address the lack of physiological data and the challenges in measuring multiple endocrine factors due to their volatile nature, we employed several bidirectional Mendelian analyses of various genome-wide association study (GWAS) data related to these serum endocrine factors to identify their mutual causal effects.

      Reviewing Editor Comment:

      Based on the Public Reviews and Recommendations for Authors, the Reviewers strongly recommend that revisions include an experimental demonstration of the physiological effects of the treatment on ageing in rats as well as the CRH-senescence link. Additional analysis of the glia would greatly strengthen the study, as would inclusion of females and young male controls. The important point was also raised that the work linking 17a-estradiol was performed in mice, and the link with lifespan in rats is not known. Discussion of this point is recommended.

      We acknowledge that 17α-estradiol has been reported to extend lifespan in male rats, similar to findings in male mice (PMID: 33289482), and we have noted this in the Introduction. We apologize for not conducting further experiments to validate this point.

      Additionally, we have revised the description of the phenotype of senescent CRH neurons to “stressed phenotype” without carrying out further experiments to confirm the senescent phenotype. To provide more clarity on the performance of glial cells during treatment, we have included additional enrichment analysis data of differentially expressed genes among young (Y), old (O), and old treated (O.T) microglia and astrocytes in Figure 2—figure supplement 3. Notably, the behavior of microglia contrasts with that of total neurons concerning synapse-related cellular processes. We apologize for being unable to include female and young controls in this study.

      Reviewer #2 (Recommendations For The Authors)

      General comments:

      (1) The manuscript is very hard to read. Proofreading and editing by software or a professional seems necessary. The words "enhanced", "extensive" etc. are not always used in the right way.

      Thanks for the suggestion. We have revised the proofreading and editing. The words "enhanced" and "extensive" were also revised in most sentences.

      (2) The numbers of animals and samples are not well explained. Is it 9 rats overall or per group? If there are 8 testes samples per group, should we assume that there were 4 rats per group? The pooling of the hypothalamic how was it done? Were all the hypothalamic from each group pooled together? A small table with the animals per group and the samples would help.

      We appreciate your reminder regarding the initial mistake in our manuscript preparation. In the preliminary submission, we reported 9 rats based solely on sequencing data and data mining. The revised version (v1) now includes additional experimental data, with an effective total of 12 animals (4 per group). Unfortunately, we overlooked updating this information in the v1 submission. We have since added detailed information in the Materials and Methods sections: Animals, Treatment and Tissues, and snRNA-seq Data Processing, Batch Effect Correction, and Cell Subset Annotation.

      (3) The Clustering is wrong. There are genes in there that do not fall into any of the 3 categories: Neurotransmitters, Receptors, Hormones.

      We have changed the description to “Vast majority of these subtypes were clustered by neuropeptides, hormones, and their receptors within all the neurons”.

      (4) The coloring of groups in the graphs is inconsistent. It must be more homogeneous to make it easier to identify.

      We have changed the colors of groups in Fig. 1D to make the color of cell clusters consistent in Fig. 1A-D.

      (5) The groups c1-c4 are not well explained. How did the authors come up with these?

      We have added more descriptions of c1-c4 in materials and methods in the new version.

      (6) In most cases it's not clear if the authors are talking about cell numbers that express a certain mRNA, the level of expression of a certain mRNA, or both. They need to do a better job using more precise descriptions instead of using general terms such as "signatures", "expression profiles", "affected neurons" etc. It is very hard to understand if the number of neurons is compared between the groups or the gene expression.

      We have changed the "signatures" to "gene signatures" to make it more accurate in meaning. The "affected neurons" were also changed to "sensitive neurons". But sorry that we were not able to find better alternatives to the "expression profiles".

      (7) Sometimes there are claims made without justification or a reference. For example, the claim about the senescence of CRH neurons due to the upregulation of mitochondrial genes and downregulation of adherence junction genes (lines 326-328) should be supported by a reference or own findings.

      The "senescence" here is not appropriate. We have changed it to "stressed phenotype" or "aberrant changes" in abstract and results.

      (8) Young males treated with Estradiol as a control group is necessary and it is missing.

      Your suggestion is appreciated; however, the treatment duration for aged mice (O.T) was set at 6 months, while the young mice were only 4 months old. This disparity makes it challenging to align treatment timelines for the young animals. The primary aim of this study is to investigate the perturbation of 17α-estradiol on the aging process, and any distinct effects due to age effect observed in young males might complicate our understanding of its role in aged males, though similar endocrine effects may exist in the young animals. Long-term treatment of hormone may exert more developmental effects on the young than the old. Therefore, we made the decision to exclude the young samples in our initial study design. We apologize for any confusion this may have caused.

      Specific Comments:

      Line 28: "elevated stresses and decreased synaptic activity": Please make this clearer. Can't claim changes in synaptic activity by gene expression.

      We have changed it to "the expression level of pathways involved in synapse".

      Line 32: "increased Oxytocin": serum Oxytocin.

      We have added the “serum”.

      Line 52 - 54: Any studies from rats?

      Thanks. In rats there is also reported that 17α-estradiol has similar metabolic roles as that in mice (PMID: 33289482) and we have added it to the refences. It’s very useful for this manuscript.

      Line 62 - 65: It wasn't investigated thoroughly in this paper so why was it suggested in the introduction?

      We have deleted this sentence as being suggested.

      Line 70: "synaptic activity" Same as line 28.

      We have changed it to "pathways involved in synaptic activity".

      Line 79: Why were aged rats caged alone and young by two? Could that introduce hypothalamic gene expression effects?

      The young males were bred together in peace. But the aged males will fight and should be kept alone.

      Lines 78, 99, 109-110: It is not clear how many animals per group were used and how many samples per group were used separately and/or grouped. Please be more specific.

      We have added these information to Materials and methods/Animals, treatment and tissues and Materials and methods/snRNA-seq data processing, batch effect correction, and cell subset annotation.

      Line 205: "in O" please add "versus young.".

      We have changed accordingly.

      Line 207: replace "were" with "was" .

      We have alternatively changed the "proportion" to "proportions".

      Line 208: replace "that" with "compared to" and after "in O.T." add "compared to?"

      We have changed accordingly.

      Line 223: "O.T." compared to what? Figure?

      We have changed it accordingly.

      Line 227: Figure?

      We have added (Figure 1E) accordingly.

      Line 229: "synaptic activity" Same as line 28.

      We have revised it.

      Line 235: "synaptic activity" and "neuropeptide secretion" Same as line 28.

      We have revised it.

      Line 256:" interfered" please revise.

      We changed to "exerted".

      Line 263: "on the contrary" please revise.

      We have changed "on the contrary" to "opposite".

      Line 270: "conversed" did you mean "conserved"?

      We have changed "conversed" to "inversed".

      Line 296-298: Please explain. Why would these be side effects?

      It’s hard to explain, therefore, we deleted the words "side effects".

      Line 308: "synaptic activity" Same as line 28.

      We have changed it to "expression levels of synapse-related cellular processes".

      Line 314: "and sex hormone secretion and signaling"Isn't this expected?

      Yes, it is expected. We have added it to the sentence "and, as expected, sex hormone secretion and signaling".

      Line 325-328: Why is this senescence? Reference?

      We have added “potent” to it.

      Line 360-361: This doesn't show elevated synaptic activity.

      "elevated synaptic activity" was changed to "The elevated expression of synapse-related pathways"

      Line 363-364: "Unfortunately" is not a scientific expression and show bias.

      We have changed it to "Notably".

      Line 376: Similar as above.

      Yes, we have change it to "in contrast".

      Lines 382-385: This is speculation. Please move to discussion.

      Sorry for that. We think the causal effects derived from MR result is evidence. As such, we have not changed it.

      Line 389: Please revise "hormone expressing".

      We have changed it accordingly.

      Line 401: Isn't this effect expected due to feedback inhibition of the biochemical pathway? Please comment.

      The binding capability of 17alpha-estradiol to estrogen receptors and its role in transcriptional activation remain core questions surrounded by controversy. Earlier studies suggest that 17alpha-estradiol exhibits at least 200 times less activity than 17beta-estradiol (PMID: 2249627, PMID: 16024755). However, recent data indicate that 17alpha-estradiol shows comparable genomic binding and transcriptional activation through estrogen receptor α (Esr1) to that of 17beta-estradiol (PMID: 33289482). Additionally, there is evidence that 17alpha-estradiol has anti-estrogenic effects in rats (PMID: 16042770). These findings imply possible feedback inhibition via estrogen receptors. Furthermore, 17alpha-estradiol likely differs from 17beta-estradiol due to its unique metabolic consequences and its potential to slow aging in males, an effect not attributed to 17beta-estradiol. For instance, neurons are also targets of 17alpha-estradiol, with Esr1 not being the sole target (PMID: 38776045). Nevertheless, the precise effective targets of 17alpha-estradiol are still unresolved.

      Line 409: This conclusion cannot be made because the effect is not statistically significant. Can say "trend" etc.

      Thanks for the recommendation. We have added "potential" in front of the conclusion.

      Line 426: "suggesting" please revise.

      sorry, it’s a verb.

      Lines 426-428: This is speculation. Please move to discussion.

      The elevated GnRH levels in O.T., observed through EIA analysis, suggest a deduction regarding the direct causal effects of 17alpha-estradiol on various endocrine factors related to feeding, energy homeostasis, reproduction, osmotic regulation, stress response, and neuronal plasticity through MR analysis. Thus, we have not amended our position. We apologize for any confusion.

      Lines 431-432: improved compared to what?

      The statement have been revised as " The most striking role of 17α-estradiol treatment revealed in this study showed that HPG axis was substantially improved in the levels of serum Gnrh and testosterone".

      Line 435: " Estrogen Receptor Antagonists". Please revise.

      Thanks for the recommendation. We have changed it to "estrogen receptor antagonists".

      Line 438" "Secrete". Please revise.

      Sorry, it is "secret".

      Lines 439-449: None of this has been demonstrated. Please remove these conclusions.

      These are not conclusions but rather intriguing topics for discussion. Given the role of 17alpha-estradiol in promoting testosterone and reducing estradiol levels in males, we believe it is worthwhile to explore the potential application of 17alpha-estradiol in increasing testosterone levels in aged males, particularly those with hypogonadism.

      Lines 450-457: No females were included in this study. Why? Also, why is this discussed? It is relevant but doesn't belong in this manuscript since it was not studied here.

      Testosterone levels are crucial for male health, while estradiol levels are essential for the health and fertility of females. Previous studies have demonstrated that 17α-estradiol does not contribute to lifespan extension in females. Given the effects of 17α-estradiol on males—specifically, its role in promoting testosterone and reducing estradiol levels—we believe it is important to discuss the potential sex-biased effects of 17α-estradiol, as this could inform future investigations. Therefore, we have chosen not to make changes to this section.

      Lines 458-459: This was not demonstrated in this article. Please remove.

      We have restricted the claim to "expression level of energy metabolism in hypothalamic neurons".

      Line 464: "Promoted lifespan extension" Not demonstrated. Please remove.

      At the end of the sentence it was revised as "which may be a contributing factor in promoting lifespan extension".

      Line 466: "Showed" No.

      The whole sentence was deleted in the new version.

      Line 483: "the sex-based effects". Not studied here.

      Since the changes in testosterone levels are significant in this dataset and this hormone has a sex-biased nature, we find it worthwhile to suggest this as a topic for future investigation. We have added "which needs further verification in the future" at the end of this sentence.

    1. Author response:

      eLife Assessment<br /> This valuable study suggests that Naa10, an N-α-acetyltransferase with known mutations that disrupt neurodevelopment, acetylates Btbd3, which has been implicated in neurite outgrowth and obsessive-compulsive disorder, in a manner that regulates F-actin dynamics to facilitate neurite outgrowth. While the study provides promising insights and biochemical, co-immunoprecipitation, and proteomic data that enhance our understanding of protein N-acetylation in neuronal development, the evidence supporting larger claims is incomplete. Nonetheless, the implications of these findings are noteworthy, particularly regarding neurodevelopmental and psychiatric conditions tied to altered expression of Naa10 or Btbd3.

      Thank you very much for recognizing our study, carefully reviewing our work, and providing insightful comments and constructive criticism!

      Public Reviews:

      Reviewer #1 (Public review):

      The manuscript examines the role of Naa10 in cKO animals, in immortalized neurons, and in primary neurons. Given that Naa10 mutations in humans produce defects in nervous system function, the authors used various strategies to try to find a relevant neuronal phenotype and its potential molecular mechanism.

      This work contains valuable findings that suggest that the depletion of Naa10 from CA1 neurons in mice exacerbates anxiety-like behaviors. Using neuronal-derived cell lines authors establish a link between N-acetylase activity, Btbd3 binding to CapZb, and F-actin, ultimately impinging on neurite extension. The evidence demonstrating this is in most cases incomplete, since some key controls are missing and clearly described or simply because claims are not supported by the data. The manuscript also contains biochemical, co-immunoprecipitation, and proteomic data that will certainly be of value to our knowledge of the effects of protein N--acetylation in neuronal development and function.

      Thanks! It would be appreciated if the Reviewer could point out in the public review which experiment lacks a control group.

      Reviewer #2 (Public review):

      In this study, the authors sought to elucidate the neural mechanisms underlying the role of Naa10 in neurodevelopmental disruptions with a focus on its role in the hippocampus. The authors use an impressive array of techniques to identify a chain of events that occurs in the signaling pathway starting from Naa10 acetylating Btbd3 to regulation of F-actin dynamics that are fundamental to neurite outgrowth. They provide convincing evidence that Naa10 acetylates Btbd3, that Btbd3 facilitates CapZb binding to F-actin in a Naa10 acetylation-dependent manner, and that this CapZb binding to F-actin is key to neurite outgrowth. Besides establishing this signaling pathway, the authors contribute novel lists of Naa10 and Btbd3 interacting partners, which will be useful for future investigations into other mechanisms of action of Naa10 or Btbd3 through alternative cell signaling pathways.

      Thank you very much for recognizing our study!

      The evidence presented for an anxiety-like behavioral phenotype as a result of Naa10 dysfunction is mixed and tenuous, and assays for the primary behaviors known to be altered by Naa10 mutations in humans were not tested. As such, behavioral findings and their translational implications should be interpreted with caution.

      (1) For the anxiety-like behavioral phenotype, we provided a paragraph titled “Naa10 and stress-induced anxiety” in the Discussion section of the text: “Our investigations revealed that hippocampal CA1-KO of Naa10 did not exhibit significant differences in the open field test (Figure S1K) but led to anxiety-like behavior in mice in the elevated plus maze (EPM) test (Figure 1A). This disparity might be attributed to the specific design of the EPM test, which is tailored to elicit a conflict between an animal's inclination to explore and its fear of open spaces and elevated areas. This distinction implies that Naa10 might play a role in stress responses within the emotional regulation circuitry, particularly in navigating potentially threatening and anxiety-provoking environments.” The open field test offers a less challenging, open environment that primarily promotes exploratory behavior. We agree that additional assays, such as the light-dark box test, would be helpful in clarifying the issue.

      (2) We agree that the behavioral findings and their translational implications should be interpreted with caution. The primary neurological behaviors known to be altered by Naa10 mutations in humans include intellectual disability and autism-like syndrome with defective emotional control. These behaviors are influenced by many factors, including defects in the hippocampal CA1. Thus, we tested hippocampal CA1 Naa10-KO mice using the Y-maze, tail suspension test, open field test, and elevated plus maze (EPM). However, only the EPM results were affected, while the other tests showed no significant changes. It should be noted that our study employed a postnatal, CA1-specific Naa10 conditional knockout (cKO) model driven by Camk2a-Cre, which selectively depletes Naa10 from hippocampal CA1 neurons after birth. In contrast, Naa10 mutations in human patients involve global effects and impact multiple brain regions from the embryonic stage, leading to a broader spectrum of phenotypes. The limited disruption in our model likely explains the absence of learning and memory deficits and the incomplete recapitulation of the full range of patient phenotypes. Furthermore, Naa10 knockout may not produce the same effects as Naa10 mutations. Our current study is primarily intended to explore the physiological function of Naa10 in hippocampal function.

      (3) We will replace all instances of “anxiety behavior” with “anxiety-like behavior.”

      Finally, while not central to the main cell signaling pathway delineated, the characterization of brain region-specific and cell maturity of Naa10 expression patterns was presented in few to single animals and not quantified, and as such should also be interpreted with caution.

      We agree that we should provide additional Naa10 immunostaining data from more than three WT and hippocampal CA1 Naa10-KO mouse brains, as well as quantify data such as the silver staining and Light Sheet Fluorescence Microscopy results presented in Figures 1C and 1D, respectively. Nevertheless, the current report presents consistent results across different mice used for various assays. For example, Figures 1B-D, with three different assays, each demonstrate that Naa10-cKO reduces neurite complexity in vivo.

      On a broader level, these findings have implications for neurodevelopment and potentially, although not tested here, synaptic plasticity in adulthood, which means this novel pathway may be fundamental for brain health.

      Thank you very much again for recognizing our study!

      Summarized list of minor concerns

      (1) The early claims of the manuscript are supported by very small sample sizes (often 1-3) and/or lack of quantification, particularly in Figures S1 and 1.

      We agree that we should provide additional Naa10 immunostaining data from more than three WT and hippocampal CA1 Naa10-KO mouse brains, as well as quantify data such as the silver staining and Light Sheet Fluorescence Microscopy results presented in Figures 1C and 1D, respectively. Nevertheless, the current report presents consistent results across different mice used for various assays. For example, Figures 1B-D, with three different assays, each demonstrate that Naa10-cKO reduces neurite complexity in vivo.

      (2) Evidence is insufficient for CA1-specific knockdown of Naa10.

      The Camk2a-Cre mice used in this study were derived from Dr. Susumu Tonegawa’s laboratory. According to the referenced paper, this strain restricts Cre/loxP recombination to the forebrain, with particularly high efficiency in the hippocampal CA1. Consistently, our data show that Naa10 was almost completely absent in the CA1 but partially depleted in the DG of the Naa10-cKO mice (Figure S1F in the text). Similar results were observed in a different pair of

      (3) The relationship between the behaviors measured, which centered around mood, and Ogden syndrome, was not clear, and likely other behavioral measures would be more translationally relevant for this study. Furthermore, the evidence for an anxiety-like phenotype was mixed.

      (1) For the anxiety-like behavioral phenotype, we provided a paragraph titled “Naa10 and stress-induced anxiety” in the Discussion section of the text: “Our investigations revealed that hippocampal CA1-KO of Naa10 did not exhibit significant differences in the open field test (Figure S1K) but led to anxiety-like behavior in mice in the elevated plus maze (EPM) test (Figure 1A). This disparity might be attributed to the specific design of the EPM test, which is tailored to elicit a conflict between an animal's inclination to explore and its fear of open spaces and elevated areas. This distinction implies that Naa10 might play a role in stress responses within the emotional regulation circuitry, particularly in navigating potentially threatening and anxiety-provoking environments.” The open field test offers a less challenging, open environment that primarily promotes exploratory behavior. We agree that additional assays, such as the light-dark box test, would be helpful in clarifying the issue.

      (2) We agree that the behavioral findings and their translational implications should be interpreted with caution. The primary neurological behaviors known to be altered by Naa10 mutations in humans include intellectual disability and autism-like syndrome with defective emotional control. These behaviors are influenced by many factors, including defects in the hippocampal CA1. Thus, we tested hippocampal CA1 Naa10-KO mice using the Y-maze, tail suspension test, open field test, and elevated plus maze (EPM). However, only the EPM results were affected, while the other tests showed no significant changes. It should be noted that our study employed a postnatal, CA1-specific Naa10 conditional knockout (cKO) model driven by Camk2a-Cre, which selectively depletes Naa10 from hippocampal CA1 neurons after birth. In contrast, Naa10 mutations in human patients involve global effects and impact multiple brain regions from the embryonic stage, leading to a broader spectrum of phenotypes. The limited disruption in our model likely explains the absence of learning and memory deficits and the incomplete recapitulation of the full range of patient phenotypes. Furthermore, Naa10 knockout may not produce the same effects as Naa10 mutations. Our current study is primarily intended to explore the physiological function of Naa10 in hippocampal function.

      (3) We will replace all instances of “anxiety behavior” with “anxiety-like behavior.”

      (4) Btbd3 is characterized by the authors as an OCD risk gene, but its status as such is not well supported by the most recent, better-powered genome-wide association studies than the one that originally implicated Btbd3. However, there is evidence that Btbd3 expression, including selectively in the hippocampus, is implicated in OCD-relevant behaviors in mice.

      Thanks for clarifying the issue!

      (5) The reporting of the statistics lacks sufficient detail for the reader to deduce how experimental replicates were defined.

      We believe we have provided sufficient detail for readers to deduce how experimental replicates were defined in each corresponding figure legend. It would be appreciated if the Reviewer could point out which specific figures lack sufficient details.

    1. Author response:

      Reviewer #1:

      Summary:<br /> In this manuscript, Bisht et al address the hypothesis that protein folding chaperones may be implicated in aggregopathies and in particular Tau aggregation, as a means to identify novel therapeutic routes for these largely neurodegenerative conditions.

      The authors conducted a genetic screen in the Drosophila eye, which facilitates the identification of mutations that either enhance or suppress a visible disturbance in the nearly crystalline organization of the compound eye. They screened by RNA interference all 64 known Drosophila chaperones and revealed that mutations in 20 of them exaggerate the Tau-dependent phenotype, while 15 ameliorated it. The enhancer of the degeneration group included 2 subunits of the typically heterohexameric prefoldin complex and other co-translational chaperones.

      In a previous paper, we identified 95 Drosophila chaperones (Raut et al., 2017). We request that “all 64 known Drosophila chaperones” be replaced with “64 out of 95 known Drosophila chaperones” to make it factually correct.

      Strengths:

      Regarding this memory defect upon V377M tau expression. Kosmidis et al (2010) pmid: 20071510, demonstrated that pan-neuronal expression of TauV377M disrupts the organization of the mushroom bodies, the seat of long-term memory in odor/shock and odor/reward conditioning. If the novel memory assay the authors use depends on the adult brain structures, then the memory deficit can be explained in this manner.

      If the mushroom bodies are defective upon TauV377M expression does overexpression of Pfdn5 or 6 reverse this deficit? This would argue strongly in favor of the microtubule stabilization explanation.

      We agree that the disruptive organization of the mushroom body may cause memory deficits upon hTauV337M expression and that expression of Pfdn5 or Pfdn6 could reverse the deficits. One possible mechanism by which overexpression of Pfdn5/6 could rescue the Tau-induced memory deficits may be due to the stabilization of microtubules in the mushroom bodies.

      Proposed revision: We will assess if Tau-induced mushroom body disruption can be rescued with the overexpression of Pfdn5 or Pfdn6.

      Weakness:

      What is unclear however is how Pfdn5 loss or even overexpression affects the pathological Tau phenotypes. Does Pfdn5 (or 6) interact directly with TauV377M? Colocalization within tissues is a start, but immunoprecipitations would provide additional independent evidence that this is so.

      Our data suggests that Pfdn5 stabilizes neuronal microtubules by directly associating with it, and loss of Pfdn5 exacerbates Tau-phenotypes by destabilizing microtubules. However, as the reviewer notes, analysis of direct interaction between Pfdn5 and hTau<sup>V337M</sup> might provide further insights into the mechanism of Pfdn5 and Tau-aggregation.

      Proposed revision: We will perform colocalization analysis and coimmunoprecipitation to ask if Pfdn5 colocalizes and directly interacts with Tau.

      Does Pfdn5 loss exacerbate TauV377M phenotypes because it destabilizes microtubules, which are already at least partially destabilized by Tau expression? Rescue of the phenotypes by overexpression of Pfdn5 agrees with this notion.

      However, Cowan et al (2010) pmid: 20617325 demonstrated that wild-type Tau accumulation in larval motor neurons indeed destabilizes microtubules in a Tau phosphorylation-dependent manner. So, is TauV377M hyperphosphorylated in the larvae?? What happens to TauV377M phosphorylation when Pfdn5 is missing and presumably more Tau is soluble and subject to hyperphosphorylation as predicted by the above?

      Proposed revisions: We will overexpress Pfdn5 or Pfdn6 with hTau<sup>V337M</sup> and ask if microtubule disruption caused by hTau<sup>V337M</sup> is rescued. Further, we will analyze the phospho-Tau levels in controls and Pfdn5 mutant background.

      Expression of WT human Tau (which is associated with most common Tauopathies other than FTDP-17) as Cowan et al suggest has significant effects on microtubule stability, but such Tau-expressing larvae are largely viable. Will one mutant copy of the Pfdn5 knockout enhance the phenotype of these larvae?? Will it result in lethality? Such data will serve to generalize the effects of Pfdn5 beyond the two FDTP-17 mutations utilized.

      Proposed revision: We will incorporate data about the effect of heterozygous mutation of Pfdn5 on the lethality and synaptic phenotypes associated with the hTau<sup>WT</sup> and hTau<sup>V337M</sup> in the revised manuscript.

      Does the loss of Pfdn5 affect TauV377M (and WTTau) levels?? Could the loss of Pfdn5 simply result in increased Tau levels? And conversely, does overexpression of Pfdn5 or 6 reduce Tau levels?? This would explain the enhancement and suppression of TauV377M (and possibly WT Tau) phenotypes. It is an easily addressed, trivial explanation at the observational level, which if true begs for a distinct mechanistic approach.

      We thank the reviewer for suggesting an alternate model for the Pfdn5 function. We will perform the Western blot analysis to assess Tau<sup>WT</sup> and Tau<sup>V337M</sup> levels in the absence of Pfdn5 or animals coexpressing Tau and Pfdn5. We will incorporate these data and conclusions in the revised manuscript.

      Finally, the authors argue that TauV377M forms aggregates in the larval brain based on large puncta observed especially upon loss of Pfdn5. This may be so, but protocols are available to validate this molecularly the presence of insoluble Tau aggregates (for example, pmid: 36868851) or soluble Tau oligomers as these apparently differentially affect Tau toxicity. Does Pfdn5 loss exaggerate the toxic oligomers and overexpression promotes the more benign large aggregates??

      We will perform the Tau solubility assay in control, in the absence of Pfdn5 or animals coexpressing Tau and Pfdn5. Moreover, we will also ask if the large Tau puncta formed in the absence of Pfdn5 are soluble oligomers or stable aggregates. We have found that the coexpression of Tau and Pfdn5 does not result in the formation of  Tau aggregates. We will incorporate these and other relevant data in the revised manuscript.

      Reviewer #2 (Public review):

      Bisht et al detail a novel interaction between the chaperone, Prefoldin 5, microtubules, and tau-mediated neurodegeneration, with potential relevance for Alzheimer's disease and other tauopathies. Using Drosophila, the study shows that Pfdn5 is a microtubule-associated protein, which regulates tubulin monomer levels and can stabilize microtubule filaments in the axons of peripheral nerves. The work further suggests that Pfdn5/6 may antagonize Tau aggregation and neurotoxicity. While the overall findings may be of interest to those investigating the axonal and synaptic cytoskeleton, the detailed mechanisms for the observed phenotypes remain unresolved and the translational relevance for tauopathy pathogenesis is yet to be established. Further, a number of key controls and important experiments are missing that are needed to fully interpret the findings.The major weakness relates to the experiments and claims of interactions with Tau-mediated neurodegeneration. In particular, it is unclear whether knockdown of Pfdn5 may cause eye phenotypes independent of Tau. Further, the GMR>tau phenotype appears to have been incorrectly utilized to examine age-dependent, neurodegeneration.

      We have consistently found the progression of eye degeneration in the population of animals expressing Tau<sup>V337M</sup>, measured as the number of fused ommatidia/total number of ommatidia, with age. A few other studies have also shown age-dependent progressive degeneration in Drosophila retinal axons or lamina (Iijima-Ando et al., 2012; Sakakibara et al., 2018). We appreciate other studies that have proposed hTau-induced eye degeneration as a developmental defect (Malmanche et al., 2017; Sakakibara et al., 2023).

      Proposed revision: a) We will analyze the age-dependent neurodegeneration in the adult brain to further support our main conclusion that Pfdn5 ameliorates hTauV337M-induced progressive neurodegeneration.

      b) We have used three independent Pfdn5 RNAi lines (the RNAi's target different regions of Pfdn5) – all of which enhance the Tau phenotypes. The knockdown of any of these RNAi lines with GMR-Gal4 does not give detectable eye phenotypes. We will include these data in the revised manuscript.

      This manuscript argues that its findings may be relevant to thinking about mechanisms and therapies applicable to tauopathies; however, this is premature given that many questions remain about the interactions from Drosophila, the detailed mechanisms remain unresolved, and absent evidence that tau and Pfdn may similarly interact in the mammalian neuronal context. Therefore, this work would be strongly enhanced by experiments in human or murine neuronal culture or supportive evidence from analyses of human data.

      Proteome analysis of Alzheimer's brain tissue shows that the Pfdn5 level is reduced in patients (Askenazi et al., 2023; Tao et al., 2020). Moreover, the Pfdn5 expression level was found to be reduced in the blood samples from AD patients (Ji et al., 2022). Another study further validates the age-dependent reduction of Pfdn5 in the tauopathy transgenic murine model (Kadoyama et al., 2019). Together, these reports highlight a potential link between Pfdn5 levels and tauopathies. We will revise the manuscript to reflect these findings in more detail.

      References

      Askenazi, M., Kavanagh, T., Pires, G., Ueberheide, B., Wisniewski, T., and Drummond, E. (2023). Compilation of reported protein changes in the brain in Alzheimer's disease. Nat Commun 14, 4466. 10.1038/s41467-023-40208-x.

      Iijima-Ando, K., Sekiya, M., Maruko-Otake, A., Ohtake, Y., Suzuki, E., Lu, B., and Iijima, K.M. (2012). Loss of axonal mitochondria promotes tau-mediated neurodegeneration and Alzheimer's disease-related tau phosphorylation via PAR-1. PLoS Genet 8, e1002918. 10.1371/journal.pgen.1002918.

      Ji, W., An, K., Wang, C., and Wang, S. (2022). Bioinformatics analysis of diagnostic biomarkers for Alzheimer's disease in peripheral blood based on sex differences and support vector machine algorithm. Hereditas 159, 38. 10.1186/s41065-022-00252-x.

      Kadoyama, K., Matsuura, K., Takano, M., Maekura, K., Inoue, Y., and Matsuyama, S. (2019). Changes in the expression of prefoldin subunit 5 depending on synaptic plasticity in the mouse hippocampus. Neurosci Lett 712, 134484. 10.1016/j.neulet.2019.134484.

      Malmanche, N., Dourlen, P., Gistelinck, M., Demiautte, F., Link, N., Dupont, C., Vanden Broeck, L., Werkmeister, E., Amouyel, P., Bongiovanni, A., et al. (2017). Developmental Expression of 4-Repeat-Tau Induces Neuronal Aneuploidy in Drosophila Tauopathy Models. Sci Rep 7, 40764. 10.1038/srep40764.

      Raut, S., Mallik, B., Parichha, A., Amrutha, V., Sahi, C., and Kumar, V. (2017). RNAi-Mediated Reverse Genetic Screen Identified Drosophila Chaperones Regulating Eye and Neuromuscular Junction Morphology. G3 (Bethesda) 7, 2023-2038. 10.1534/g3.117.041632.

      Sakakibara, Y., Sekiya, M., Fujisaki, N., Quan, X., and Iijima, K.M. (2018). Knockdown of wfs1, a fly homolog of Wolfram syndrome 1, in the nervous system increases susceptibility to age- and stress-induced neuronal dysfunction and degeneration in Drosophila. PLoS Genet 14, e1007196. 10.1371/journal.pgen.1007196.

      Sakakibara, Y., Yamashiro, R., Chikamatsu, S., Hirota, Y., Tsubokawa, Y., Nishijima, R., Takei, K., Sekiya, M., and Iijima, K.M. (2023). Drosophila Toll-9 is induced by aging and neurodegeneration to modulate stress signaling and its deficiency exacerbates tau-mediated neurodegeneration. iScience 26, 105968. 10.1016/j.isci.2023.105968.

      Tao, Y., Han, Y., Yu, L., Wang, Q., Leng, S.X., and Zhang, H. (2020). The Predicted Key Molecules, Functions, and Pathways That Bridge Mild Cognitive Impairment (MCI) and Alzheimer's Disease (AD). Front Neurol 11, 233. 10.3389/fneur.2020.00233.

    1. Author response:

      We appreciate the constructive feedback from the reviewers and will work to address many of these concerns in a revised version.  Here, we provide initial responses to a few key points that the reviewers raised:

      (1) The reviewers rightly pointed out that it is very important to clearly define and explain what qualifies as metastatic potential to particular organs in our system.  We acknowledge the valuable contributions of animal models in metastatic cancer studies, but here we intentionally limited our scope to metastasis that had occurred within the human system only.  For example, we use data from cancer cells that model human organotropism from the breast to the lung, since the cells originated from infiltrative ductal carcinoma (human breast) but were collected from pleural effusions (human lung). We propose that in this case a comparison with a human lung cancer-derived cell line that was itself purified from a pleural effusion could reveal factors essential for lung metastasis, without adding the confounder of an animal microenvironment.  The MetMap Explorer contains valuable information, but the “metastatic potential of each cell line” is measured in a mouse environment.  Knowing that a particular cell line, which originated from a human lung metastasis, can further metastasize to other organs in a mouse does not necessarily mean that those cells could do so in humans.  The microenvironment responses to metastatic colonization can differ among species.  Further, the changes a cell needs to make to adapt to a new organ system in a mouse could be confounded by the changes needed to adapt to mouse conditions in general.  Finally, migration from a site of ectopic injection may not mimic migration from an initial tumor site.  We agree that the very best data would come from matched primary and metastatic tumors in the same human patient, but those data do not currently exist and generating them would require future work beyond the scope of this study.   In our revision, we will ensure that  we more clearly explain how and why we chose the cell lines we did and what the advantages and limitations of this choice are.

      (2) The reviewers are correct that our unsupervised Principal component analysis (PCA) does not precisely stratify cells according to epithelial-mesenchymal status.  In a high dimensional, complex system, it is expected than an unsupervised analysis such as this will not capture just one biological feature in the first principal component. Therefore, when we performed PCA on the compartmental organization profiles of different healthy and cancerous cell lines, instead of finding the largest variation (PC1) following exactly EMT state, it captured an ordering that includes influences from epithelial-mesenchymal state, disease condition, nuclear geometry, and other cellular properties.  However, it was striking that this completely unsupervised analysis did match previous annotations of EMT state so well (as seen in supp fig 1b).  Therefore, we conclude that the most prominent variations in A/B compartment signature strongly relate to EMT state.   In the revision, we will more clearly present the caveats of this interpretation.

      (3) Our decision to focus on A/B compartmentalization rather than TAD or loop structure in this analysis was intentional and biologically motivated, rather than solely being a reflection of data resolution.  Both compartments and topologically associated domains (TADs) are key parts of genome organization and disruption of these structures has the potential to alter downstream gene regulation, as shown by numerous studies. But, compartments have been found, more so than TADs, to be strongly associated with cell type and cell fate.  Therefore,  in this manuscript, we decided to focus only on the compartment organization changes between different healthy and cancerous cells as they are more likely to represent the stable alterations of the genome organization malignant transformations.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews

      Reviewer #1: 

      Summary:

      In this study, Avila et al. tested the hypothesis that chronic pain states are associated with changes in the excitability of the medial prefrontal cortex (mPFC). The authors used the slope of the aperiodic component of the EEG power spectrum (= the aperiodic exponent) as a novel, non-invasive proxy for the cortical excitation-inhibition ratio. They performed source localization to estimate the EEG signals generated specifically by the mPFC. By pooling resting-state EEG recordings from three existing datasets, the authors were able to compare the aperiodic exponent in the mPFC and across the whole brain (at all modeled cortical sources) between 149 chronic pain patients and 115 healthy controls. Additionally, they assessed the relationship between the aperiodic exponent and pain intensity reported by the patients. To account for heterogeneity in pain etiology, the analysis was also performed separately for two patient subgroups with different chronic pain conditions (chronic back pain and chronic widespread pain). The study found robust evidence against differences in the aperiodic exponent in the mPFC between people with chronic pain and healthy participants, and no correlation was observed between the aperiodic exponent and pain intensity. These findings were consistent across different patient subgroups and were corroborated by the whole-brain analysis.

      Strengths:

      The study is based on sound scientific reasoning and rigorously employs suitable methods to test the hypothesis. It follows a pre-registered protocol, which greatly increases the transparency and, consequently, the credibility of the reported results. In addition to the planned steps, the authors used a multiverse analysis to ensure the robustness of the results across different methodological choices. I find this particularly interesting, as the EEG aperiodic exponent has only recently been linked to network excitability, and the most appropriate methods for its extraction and analysis are still being determined. The methods are clearly and comprehensively described, making this paper very useful for researchers planning similar studies. The results are convincing, and supported by informative figures, and the lack of the expected difference in mPFC excitability between the tested groups is thoroughly and constructively discussed.

      We are grateful for the appreciation of the strengths of our study.  

      Weaknesses:

      Firstly, although I appreciate the relatively large sample size, pooling data recorded by different researchers using different experimental protocols inevitably increases sample variability and may limit the availability of certain measures, as was the case here with the reports of pain intensity in the patient group. Secondly, the analysis heavily relies on the estimation of cortical sources, an approach that offers many advantages but may yield imprecise results, especially when default conduction models, source models, and electrode coordinates are used. In my opinion, this point should be discussed as well.

      We agree that the heterogeneous sample of people with chronic pain increases variability and limits the availability of clinical measures. We further agree on the limitations of source space analysis. Therefore, we have added these limitations to the discussion section.

      Reviewer #2: 

      Summary:

      This study evaluated the aperiodic component in the medial prefrontal cortex (mPFC) using restingstate EEG recordings from 149 individuals with chronic pain and 115 healthy participants. The findings showed no significant differences in the aperiodic component of the mPFC between the two groups, nor was there any correlation between the aperiodic component and pain intensity. These results were consistent across various chronic pain subtypes and were corroborated by whole-brain analyses. The study's robustness was further reinforced by preregistration and multiverse analyses, which accounted for a wide range of methodological choices.

      Strengths:

      This study was rigorously conducted, yielding clear and conclusive results. Furthermore, it adhered to stringent open and reproducible science practices, including preregistration, blinded data analysis, and Bayesian hypothesis testing. All data and code have been made openly available, underscoring the study's commitment to transparency and reproducibility.

      We appreciate the appraisal of the strengths of our study, highlighting our efforts in open and reproducible science practices.

      Weaknesses:

      The aperiodic exponent of the EEG power spectrum is often regarded as an indicator of the excitatory/inhibitory (E/I) balance. However, this measure may not be the most accurate or optimal for quantifying E/I balance, a limitation that the authors might consider addressing in the future.

      We are grateful for this suggestion and fully agree that the aperiodic component of the power spectrum is not necessarily the most optimal and accurate measure for quantifying E/I balance. We have now included this limitation in the discussion section.

      Recommendations for the authors

      Reviewer #1: 

      (1) In the Results section, it might be helpful to provide the mean values of the aperiodic exponent (before age correction) for all tested groups and subgroups. As this measure is still not widely used, providing these values would allow readers to better understand the normal range of the aperiodic exponent.

      We have added the mean values of the aperiodic exponent and their standard deviation (before age correction) to the manuscript's results section (page 6 and 11).

      (2) When reporting the aperiodic exponent across all cortical sources (Q3), I think it would be useful to include the raw values in Figure 6 in the main text rather than in the Supplementary Materials. At a glance, these plots seem to suggest that the aperiodic exponent differs between groups in the occipital and parietal regions, even though no tests were significant after correcting for multiple comparisons. Maybe this observation also deserves a mention in the text and possibly in the Discussion..?

      We have moved the report on the aperiodic exponent across all cortical sources from the Supplementary Material to the main text. It is now Fig. 7 of the main manuscript. Moreover, we agree that the plots suggest group differences in certain brain regions. However, according to our rigorous open and reproducible science practices and pre-registration, we prefer not to speculate on these non-significant findings. 

      (3) In the Methods section, when describing the participants, the authors state that "Gender was balanced across both groups...". It might be better to avoid referring to the datasets as "balanced," considering that the sample includes almost twice as many females as males.

      We have replaced the misleading statement with the more precise statement that ”the gender ratio of both groups was similar.”

      (4) In the Methods section, when describing the source localization, I find it slightly confusing that the authors first mention the anterior cingulate cortex as a possible label included in the mPFC cortical parcels but then state that the version of the cortical atlas used did not contain such a label. It might be simpler not to mention the cingulate cortex at all.

      We have deleted the misleading sentence from the manuscript.  

      Reviewer #2: 

      (1) The aperiodic exponent of the EEG power spectrum is often considered an indicator of the excitatory/inhibitory (E/I) balance, but this measure can be susceptible to artifacts. It is important to acknowledge this limitation and consider exploring alternative measures to quantify the E/I ratio in future studies.

      We are grateful for this suggestion and fully agree that the aperiodic component of the power spectrum is not necessarily the most optimal and accurate measure for quantifying E/I balance. We have now included this limitation in the discussion section.

      (2) The study assumed a linear relationship between the E/I ratio (represented by the aperiodic exponent of the EEG power spectrum) and chronic pain. However, this assumption may not hold true in all cases, and this point could be discussed in the study.

      We fully agree that the relationship between the E/I ratio and chronic pain might not be a linear one and have added this point to the discussion section.

      (3) The aperiodic component was characterized in eyes-closed resting-state EEG recordings, although EEG data were collected in both eyes-closed and eyes-open conditions. The authors could also consider assessing the aperiodic component from EEG data with eyes open.

      We thank the reviewer for this suggestion. We have focused our analysis on eyes-closed recordings since these recordings are usually less contaminated by artifacts than eyes-open recordings. Moreover, in our current datasets, some participants were missing eyes-open recordings. We agree that performing similar analyses for the eyes-open recordings would also be interesting. However, adding these analyses would double the amount of data included in the manuscript, which would likely overload it. We have, therefore, now included a statement to the discussion that future studies should also analyze eyes-open EEG recordings.  

      (4) The EEG power spectrum was calculated from signals after source reconstruction, a crucial step for targeting specific brain regions. However, this process can introduce potential signal distortions, such as variations in source waveforms depending on different regularization parameters. To ensure the robustness of the results, the authors could perform the same analysis at the sensor level, for example, using signals recorded at Fz.

      We agree on the potential shortcomings and limitations of source space analysis and have added this limitation to the discussion section.

      (5) It would be beneficial to present the raw EEG power spectrum averaged across subjects for each condition, along with the scalp distribution of the aperiodic exponent. This would enhance readers' understanding of the study and help demonstrate the quality of the data.

      We are grateful for this suggestion and added the power spectrum for each condition and the scalp distribution of the aperiodic exponent to the Supplementary Material.

      (6) Linear regression models were used to control for the influence of age on aperiodic exponents and pain intensity ratings. However, it is unclear why other relevant variables, such as gender and medication use, were not considered.

      We agree that the aperiodic exponent might be influenced by gender and medication. As these analyses had not been included in our pre-registered analysis plan, we have not performed them. Moreover, although we agree that gender might have an impact, we have not found any evidence for this so far. Regarding medication, we fully agree that medication can influence the measure. However, medication was very heterogeneous, including drugs with fundamentally different mechanisms of action. Thus, we do not see a robust way to appropriately analyze these effects with sufficient statistical power. We have now added this important point to the discussion section.

      (7) The authors may consider addressing or discussing the impact of inter-individual variability on the negative results, particularly given that the data were derived from multiple experiments.

      We agree that the heterogeneous sample of people with chronic pain increases variability and limits the availability of clinical measures. We have added this limitation to the discussion.

    1. Author response:

      The following is the authors’ response to the original reviews.

      eLife Assessment

      This valuable work advances our understanding of the foraging behaviour of aerial insectivorous birds. Its major strength is the large volume of tracking data and the accuracy of those data. However, the evidence supporting the main claim of optimal foraging is incomplete.

      We deeply appreciate the thoughtful review provided by the reviewers, including their valuable insights and meticulous attention to detail. Each comment has been thoroughly evaluated, leading to substantial improvements in the manuscript. Your constructive critique has been instrumental in refining our research and rectifying any oversights. We are confident that the revised article will make a substantial contribution to ecological research, particularly in advancing our understanding of foraging theories and the behaviors of aerial insectivores.

      Public Reviews:

      Reviewer #1 (Public Review):

      This study tests whether Little Swifts exhibit optimal foraging, which the data seem to indicate is the case. This is unsurprising as most animals would be expected to optimize the energy income: expenditure ratio; however, it hasn't been explicitly quantified before the way it was in this manuscript.

      The major strength of this work is the sheer volume of tracking data and the accuracy of those data. The ATLAS tracking system really enhanced this study and allowed for pinpoint monitoring of the tracked birds. These data could be used to ask and answer many questions beyond just the one tested here.

      The major weakness of this work lies in the sampling of insect prey abundance at a single point on the landscape, 6.5 km from the colony. This sampling then requires the authors to work under the assumption that prey abundance is simultaneously even across the study region - an assumption that is certainly untrue. The authors recognize this problem and say that sampling in a spatially explicit way was beyond their scope, which I understand, but then at other times try to present this assumption as not being a problem, which it very much is.

      Further, it is uncertain whether other aspects of the prey data are problematic. For example, the radar only samples insects at 50 m or higher from the ground - how often do Little Swifts forage under 50 m high?

      Another example might be that the phrases "high abundance" and "low abundance" are often used in the manuscript, but never defined.

      It may be fair to say that prey populations might be correlated over space but are not equal. It is this unknown degree of spatial correlation that lends confidence to the findings in the Results. As such, the finding that Little Swifts forage optimally is indeed supported by the data, notwithstanding some of the shortcomings in the prey abundance data. The authors achieved their aims and the results support their conclusions.

      Thanks for this comment.

      The basic assumption of this paper is that the abundance of insects bioflow in the airspace is correlated in space and varies over time. This has been demonstrated by different studies, see for example Bell et al. (Bell, J. R., Aralimarad, P., Lim, K. S., & Chapman, J. W. (2013). Predicting insect migration density and speed in the daytime convective boundary layer. PloS one, 8(1), e54202) in which positive correlation in insect bioflow is demonstrated between different sites that are more than 100 km away in Southern England. Given the much closer proximity of the colony and the radar site, as well as the large foraging distance of the swifts that often forage in the vicinity of the radar and beyond it, it is reasonable to assume that the radar was able to successfully capture between-day variation in the abundance of flying insects in the airspace, which is highly relevant for the foraging swifts. This is likely because meteorological variables such as temperature and wind, which tend to vary over a synoptic-system scale of several hundred kilometers, significantly influence the abundance of aerial insects. Furthermore, the direction of insect flight that has been recorded by the radar points to an overall south-north directionality of the insects during the period of the study (Werber et al. Under Review: Werber, Y., Chapman, J. W., Reynolds, D. R. and Sapir, N. Active navigation and meteorological selectivity drive patterns of mass intercontinental insect migration through the Levant). Hence, it is reasonable to assume that since the colony is positioned approximately 6.5 km south of the radar site, the radar is able to reliable estimate the between-day variation in aerial insect abundance experienced by the foraging swifts. Importantly, this between-day variation is very high, and detailed information regarding this variation is provided in the paper.  We thank the reviewer for the comments on the wording and have corrected it accordingly so that it is explicitly stated that the spatial distribution of the flying insects is indeed not uniform, but is expected to be simultaneously affected by environmental variables creating spatially correlated bioflow of aerial insects.

      The term "high abundance" or "low abundance" is relative to the variable being examined but throughout the manuscript we did not use these terms to describe an absolute amount or a certain threshold but rather to describe the ecological circumstances experienced by the birds on different days that substantially varied in abundance of insect recorded by the radar. However, we have improved the wording of the text so that it is now clear that we refer to relative  and not to absolute values.

      At its centre, this work adds to our understanding of Little Swift foraging and extends to a greater understanding of aerial insectivores in general. While unsurprising that Little Swifts act as optimal foragers, it is good to have quantified this and show that the population declines observed in so many aerial insectivores are not necessarily a function of inflexible foraging habits. Further, the methods used in this research have great potential for other work. For example, the ATLAS system poses some real advantages and an exciting challenge to existing systems, like MOTUS. The radar that was used to quantify prey abundance also presents exciting possibilities if multiple units could be deployed to get a more spatially-explicit view.

      To improve the context of this work, it is worth noting that the authors suggest that this work is important because it has never been done before for an aerial insectivore; however, that justification is untrue as it has been assessed in several flycatcher and swallow species. A further justification is that this research is needed due to dramatic insect population declines, but the magnitude and extent of such declines are fiercely debated in the literature. Perhaps these justifications are unnecessary, and the work can more simply be couched as just a test of optimality theory.

      We appreciate the reviewer's helpful comment. A flycatcher is indeed an aerial insect eater, but its foraging strategy is very different from that of swifts. A comparison with the foraging strategy of the swallow is much more relevant. However, the methods used to quantify bird movement in the airspace in previous articles limited the ability to examine the optimal foraging theory in detail. Following the comment, we revised the text to better describe the uniqueness of our research. Further, since we studied insectivores, it is important to provide a broad context to potentially significant threats to the birds, albeit being debatable

      Reviewer #2 (Public Review):

      Summary:

      Bloch et al. investigate the relationships between aerial foragers (little swifts) tracked with an automated radio-telemetry system (Atlas) and their prey (flying insects) monitored with a small-scale vertical-looking radar device (BirdScan MR1). The aim of the study was to test whether little swifts optimise their foraging with the abundance of their prey. However, the results provided little evidence of optimal foraging behaviour.

      Strengths:

      This study addresses fundamental knowledge gaps on the prey-predator dynamics in the airspace. It describes the coincidence between the abundance of flying insects and features derived from tracking individual swifts.

      Weaknesses:

      The article uses hypotheses broadly derived from optimal foraging theory, but mixes the form of natural selection: parental energetics, parental survival (predation risks), nestling foraging, and breeding success.

      While this study explores additional behavioral theories alongside optimal foraging theory, its findings unequivocally support the latter. The highly statistically significant observed reduction in flight distance from the breeding colony in elation to increasing insect abundance (supporting predictions 1 and 2) coupled with an increased rate of colony visits (supporting prediction 5) demonstrate the Little Swifts' adeptness at optimizing their aerial foraging behavior. This behavior manifests in an enhanced frequency of visits to the breeding colony, underscoring their food provisioning maximization.

      Results are partly incoherent (e.g., "Thus, even when the birds foraged close to the colony under optimal conditions, the shorter traveling distance is not thought to not confer lower flight-related energetic expenditure because more return trips were made.", L285-287),

      Thanks for the comment. We have corrected this sentence.

      and confounding factors (e.g., brooding vs. nestling phase) are ignored.

      The breeding stage may indeed affect food provisioning properties but this factor is not confounded since insect abundance, and the consequent changes in bird foraging properties, fluctuated between sequential days while brooding and nestling phases take place over a period of several weeks, each. Further, despite the possible influence of breeding stages on bird behavior, variability in reproductive stages is expected among pairs in a breeding colony occupying dozens of pairs, despite some coordination in nesting initiation. Practically, the narrow and concealed nest openings hindered direct observation of the nests, posing challenges in determining the precise reproductive stage of each pair. Anyway, we added a short description of the dense colony structure to the Methods section.

      Some limits are clearly recognised by the authors (L329 and ff).

      See above the response about the distribution of insects in space.

      To illustrate potential confounding effects, the daily flight duration (Prediction 4) should decrease with prey abundance, but how far does the daily flight duration coincide with departure and arrival at sunrise and sunset (note that day length increases between March and May), respectively, and how much do parents vary in the duration of nest attendance during the day across chick ages?

      We added the following explanation to the Methods section:

      To standardize the effect of day length on daily foraging duration, we calculated and subtracted the day length from the total daily foraging time (Day duration - Daily foraging duration = Net foraging duration). The resulting data represent the daily foraging duration in relation to sunrise and sunset, independent of day length.

      To conclude, insufficient analyses are performed to rigorously assess whether little swifts optimize their foraging.

      We disagree. See our responses above.

      Filters applied on tracking data are necessary but may strongly influence derived features based on maximum or mean values. Providing sensitivity tests or using features less dependent on extreme values may provide more robust results.

      Thank you for highlighting the importance of considering the impact of data filtering on derived features. In our analysis, we employed rigorous filtering methods to emphasize central data tendencies while mitigating the influence of extreme values. These methods, validated through consultation with experts in tracking data analysis, follow established practices in the literature. Detailed descriptions of our filtering procedures can be found in the Methods section, with citations to relevant published studies.

      Radar insect monitoring is incomplete and strongly size-dependent. What is the favourite prey size of swifts? How does it match with BirdScan MR1 monitoring capability?

      We added an explanation to the Methods section to address this comment:

      The Radar Cross Section (RCS) quantifies the reflectivity of a target, serving as a proxy for size by representing the cross-sectional area of a sphere with identical reflectivity to water, whose diameter equals the target's body length. Recent findings indicate that the BirdScan MR1 radar can detect insects with an RCS as low as 3 mm², enabling the detection of insects with body lengths as small as 2 mm. These capabilities make the radar suitable for locating the primary prey of swifts, which typically range in size from 1 to 16 mm.

      Recommendations for the authors:

      Reviewer #1 (Recommendations For The Authors):

      Lines 53-59 - major run-on sentence

      Thanks for the comment. Done.

      Line 133 - describe better. Attached where? Were feathers clipped or removed?

      Thanks for the comment. Done.

      Line 153 - shouldn't be a new paragraph

      Done.

      Line 157 - justify choosing four 

      To ensure a robust analysis of swifts' behavior relative to food abundance across multiple individuals simultaneously, we opted to exclude data from instances where only 3 tags were active. This decision was motivated by the fact that these instances accounted for only 2.9% of the data, and their exclusion minimally impacted overall data volume while enhancing data quality. In contrast, instances with 4 tags, comprising 16.2% of the data, provided substantial insights. Omitting these instances would have resulted in significant data loss. Thus, setting a threshold of 4 simultaneous tags represents a balance between maintaining adequate data quantity and ensuring high data quality for meaningful analysis.

      It took me a long time to determine whether the average and maximum flight distance was actual or Euclidean. It was only in the Results that I grasped it was actual. Define up front in the Methods.

      Thanks for the comment. Done.

      In my public review, I mention that optimal foraging has been assessed in other aerial insectivores. Here are some of the papers I was referring to:

      • Davies (1977) Prey selection and the search strategy of the spotted flycatcher (Muscicapa striata): A field study on optimal foraging. Animal Behaviour 25: 1016-1022.

      • Lifjeld & Slagsvold (1988) Effects of energy costs on the optimal diet: an experiment with pied flycatchers Ficedula hypoleuca feeding nestlings. Ornis Scandinavica 19: 111-118.

      • Quinney & Ankney (1985) Prey size selection by tree swallows. Auk 102: 245-250.

      • Turner (1982) Optimal foraging by the swallow (Hirundo rustica, L): Prey size selection. Animal Behaviour 30:862-872.

      Lastly, in terms of the work not being spatially-explicit, I do note that in lines 323-324 you acknowledge that prey populations can be patchy, then ten lines later, you provide citations to say that patchiness is not a problem because of spatial correlations. This is a bit overly dismissive, in my view, and to suggest (lines 336-337) that "patches of high insect concentration...might not exist at all" is certainly incorrect (and misleading). I do note the valiant attempt to address the spatial shortcoming in the remainder of the paragraph - although addressing it does not make the problem go away.

      Thanks for the comment.

      We revised the text to make it more coherent.

      Reviewer #2 (Recommendations For The Authors):

      L161: typo > missing space in 'meanof'

      Corrected.

      L192-193: Did the authors use the timing of sunrise and sunset to determine daytime?

      Yes. The daytime was calculated in relation to sunrise and sunset.

      Did the authors calculate the MTR from sunrise to sunset, or averaging the hourly MTR?

      If using hourly MTR, specify the criteria to assign an hourly MTR to daytime when sunset/sunrise is happening during that hour.

      A simplified terminology for "Average daily insect MTR" might be useful, in particular for the result section (insect MTR).

      Average daily insect MTR is calculated for a fixed period from 5 am to 8 pm local time. An explanation has been added to the Methods section, and the terminology in the text has been simplified as suggested

      Note that the 'M' of MTR stands for migration, which may not be appropriate in this context, and simply using "insect traffic rate" may be a better terminology.

      Thanks for the comment. The 'M' of MTR can also stand for movement, as the insects detected by the radar move in the airspace. This is how this term has been defined in the paper (e.g. in line 23 of the Summary section). Therefore, we did not change the terminology to “insect traffic rate”, which is a term not used in other studies.

      Considering the large number of predictions (10!), it would be appropriate to list them in the results (e.g., "on the daily average flight distance from the breeding colony (Prediction 3)").

      We added prediction numbers to the Results and the Discussion.

      Note that the terminology varies; e.g., in the introduction "overall daily flight distance" (L75), in the results "average length of the daily flight route" (L236), and further confusion with "daily average flight distance from the breeding colony" (L232).

      Thanks for the comment. fixed.

      The terminology - average daily 'air/flight' distance (L74-76) - needs clarification.

      Done.

      Results: Use only a relevant and consistent number of decimals to report on the effect size and p-values.

      Done.

      The authors are citing non-peer-reviewed publications:

      21. Bloch I, Troupin D, Sapir N. Movement and parental care characteristics during the nesting season of 468 the Little Swift (Apus affinis) [Poster presentation]. 12th European Ornithologists' Union Congress. Cluj Napoca, Romania. 2019.

      62. Zaugg S, Schmid B, Liechti F. Ensemble approach for automated classification of radar echoes into functional bird sub-types. In: Radar Aeroecology. 2017. p. 1. doi:10.13140/RG.2.2.23354.80326

      It is acceptable to cite non-peer-reviewed sources if they have a significant contribution to the background of the article without a critical impact on the core of the research.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public Review):

      Summary:

      In the first half of this study, Pham et al. investigate the regulation of TEAD via ubiquitination and PARylation, identifying an E3 ubiquitin ligase, RNF146, as a negative regulator of TEAD activity through an siRNA screen of ubiquitin-related genes in MCF7 cells. The study also finds that depletion of PARP1 reduced TEAD4 ubiquitination levels, suggesting a certain relationship between TEAD4 PARylation and ubiquitination which was also explored through an interesting D70A mutation. Pham et al. subsequently tested this regulation in D. melanogaster by introducing Hpo loss-of-function mutations and rescuing the overgrowth phenotype through RNF146 overexpression.

      In the second half of this study, Pham et al. designed and assayed several potential TEAD degraders with a heterobifunctional design, which they term TEAD-CIDE. Compounds D and E were found to effectively degrade pan-TEAD, an effect which could be disrupted by treatment with TEAD lipid pocket binders, proteasome inhibitors, or E1 inhibitors, demonstrating that the TEAD-CIDEs operate in a proteasome-dependent manner. These TEAD-CIDEs could reduce cell proliferation in OVCAR-8, a YAP-deficient cell line, but not SK-N-FI, a Hippo pathway independent cell line. Finally, this study also utilizes ATAC-seq on Compound D to identify reductions in chromatin accessibility at the regions enriched for TEAD DNA binding motifs.

      Strengths:

      The study provides compelling evidence that the E3 ubiquitin ligase RNF146 is a novel negative regulator of TEAD activity. The authors convincingly delineate the mechanism through multiple techniques and approaches. The authors also describe the development of heterobifunctional pan-degraders of TEAD, which could serve as valuable reagents to more deeply study TEAD biology.

      Weaknesses:

      The scope of this study is extremely broad. The first half of the paper highlights the mechanisms underlying TEAD degradation; however, the connection to the second half of the paper on small molecule degraders of TEAD is jarring, and it seems as though two separate stories were combined into this single massive study. In my opinion, the study would be stronger if it chose to focus on only one of these topics and instead went deeper.

      We thank the reviewer for the thoughtful feedback. In our mind, the two parts of the paper are inherently related as they both focus on proteasome-mediated degradation of TEADs. We first demonstrated that TEAD can be turned over by the ubiquitin proteasome system under endogenous conditions and identified a PARylation-dependent E3 ligase RNF146 as a major regulator of TEAD stability. Intriguingly, we observed that the four TEAD paralogs show different levels of polyubiquitination with some of them being highly stable in cells. These observations raised the question of whether the activity of the ubiquitin-proteasome system could be further enhanced pharmacologically to effectively target TEADs. We then tackled this question by providing a proof-of-concept demonstration of engineered heterobifunctional protein degraders can effectively degrade TEADs in cells and can be exploited as a therapeutic strategy for treating Hippo-dependent cancers.

      Additionally, the figure clarity needs to be substantially improved, as readability and interpretation were difficult in many panels. Lastly, there are numerous typos and poor grammar throughout the text that need to be addressed.

      We appreciate the suggestions from the reviewer and have updated the figures with high resolution images. We also corrected typos and grammatical errors in the text.

      Reviewer #2 (Public Review):

      The paper is made of two parts. One deals with RNF146, the other with the development of compounds that may cause TEAD degradation. The two parts are rather unrelated to each other.

      The main limit of this work is the lack of evidence that TEAD factors are in fact regulated by the proteasome and ubiquitylation under endogenous conditions. Also lacking is the demonstration that TEADs are labile proteins to the extent that such quantitative regulation at the level of stability can impact on YAP-TAZ biology. Without these two elements, the relevance and physiological significance of all these data is lacking.

      As for the development of new inhibitors of TEAD, this is potentially very interesting but underdeveloped in this manuscript. Irrespectively, if TEAD is stable, these molecules are likely lead compounds of interest. If TEAD is unstable, as entertained in the first part of the paper, then these molecules are likely marginal.

      We thank the reviewer for evaluating our manuscript. As the reviewer pointed out, the paper aimed to address 1) whether TEAD is being regulated by the proteasome and ubiquitination under endogenous conditions, and 2) whether TEAD can be inhibited through pharmacologically-induced degradation. First, we demonstrated that TEAD is ubiquitinated in cells and mapped the lysine residues that are poly-ubiquitinated (Fig. 1). Next, we identified RNF146 as a major E3 ligase that ubiquitinates TEADs and reduces their stability. Third, we show that RNF146-mediated TEAD ubiquitination is functionally important: RNF146 suppresses TEAD activity, and RNF146 genetically interacts with Hippo pathway components in fruit flies. Furthermore, as we showed in Fig. S2H, RNF-146 does not affect TEAD1 and TEAD4 to the same extent. Across all four cell lines evaluated, TEAD1 is more stable than TEAD4, raising the question of whether more consistent degradation of different TEAD paralogues could be achieved. To this end, we demonstrated that while the TEAD family of proteins is labile under endogenous conditions, more complete degradation of the TEAD proteins could be achieved using a heterobifunctional CRBN degrader. We further characterized these TEAD degraders in a series of cellular and genomic assays to demonstrate their cellular activity, selectivity, and inhibitory effects against YAP/TAZ target genes. We believe these degrader compounds would be of great interest to the Hippo community. We have revised the main text to clarify these points.

      Here are a few other specific observations:

      (1) The effect of MG is shown in a convoluted way, by MS. What about endogenous TEAD protein stability?

      We thank the reviewer for the question. The MS experiment shown in Figure 1 is a standard KGG experiment, where we used MS to map ubiquitination sites on TEADs. The graphical representation of the process is included in Fig. 1C, and the details of the procedure are included in the Methods section. Fig. 1D shows the different KGG peptides detected with or without MG-132 treatment. Fig. 1E shows the quantified abundance of each of the peptides across the four conditions indicated at the bottom of the plot. Regarding endogenous TEAD stability, ​​we conducted cycloheximide chase experiments to assess the stability of endogenously expressed TEAD isoforms upon RNF146 knockdown (Fig. S2G and S2H). Using isoform-specific antibodies, we demonstrated that siRNF146 significantly stabilized TEAD4 in multiple cell lines, including H226, PATU-8902, Detroit-562, and OVCAR-8 (Fig. S2G, S2H, and S2I), supporting the notion that RNF146 is a negative regulator of TEAD stability. Notably, the effect of siRNF146 on TEAD1 stability was less pronounced, and TEAD1 is more stable than TEAD4 across all four cell lines. These results are consistent with the lower level of ubiquitination of TEAD1 (Fig. 1A) and are corroborated by various biochemical, molecular, and genetic characterizations (Fig. 3A-C and S3E).

      (2) The relevance of siRNF on YAP target genes of Fig.2D is not statistically significant.

      We thank the reviewer for this comment. We have now removed the statistically significant claim.

      (3) All assays are with protein overexpression and Ub-laddering

      We thank the reviewer for the comment. To examine the ubiquitination level of TEAD proteins, we adopted an in vivo ubiquitination assay as described in our Materials and Methods section. To our knowledge, this assay is very standard in the ubiquitination field. Furthermore, as mentioned above, we have included in our revised manuscript cycloheximide chase experiments to assess the stability of endogenously expressed TEAD isoforms upon RNF146 knockdown (Fig. S2G and S2H). In addition to the overexpression system, we also assessed endogenously expressed TEAD using isoform-specific antibodies. We demonstrated that siRNF146 firmly stabilized TEAD4 in multiple cell lines, including H226, PATU-8902, Detroit-562, and OVCAR-8 (Fig. S2G with quantification and t-test), supporting the notion that RNF146 is a negative regulator of TEAD stability.

      (4) An inconsistency exists on the only biological validation (only by overexpression) on the fly eye size. RNF gain in Fig4C is doing the opposite of what is expected from what is portrayed here as a YAP/TEAD inhibitor: RNF gain is shown to INCREASE eye size, phenocopying a Hippo loss of function phenotype. According to the model proposed, RNF addition should reduce eye size. The authors stated that " This is in contrast to the anti-growth effect of RNF-146 in the Hpo loss-of-function background and indicates RNF146 may regulate other genes/pathways controlling eye sizes besides its role as a negative regulator of Sd/yki activity". This raises questions on what the authors are really studying: why, according to the authors, these caveats should occur on the controls, and not when they study Hpo mutants?

      We thank the reviewer for the comment. We acknowledge the complexity of the fly phenotype compared to tumor growth. TEAD (Sd) isn’t the only substrate of RNF146 in the fly. For instance, RNF146 is known to positively regulate Wnt signaling by degrading Axin. Previous studies have shown that activation of the Wnt signaling pathway by removal of the negative regulator Axin from clones of cells results in an overgrowth phenotype (Legent and Treisman, 2008). The overgrowth phenotype that we observed with overexpressing RNF146 only, therefore, likely is due to the role of RNF146 in regulating other signaling pathways. Importantly, we showed that upon Hippo loss of function, overexpression of RNF146 can rescue the Hippo overgrowth phenotype (Fig 4B). This differential outcome of RNF146 expression in wildtype versus Hippo-deficient flies indicates that the genetic interactions between RNF146 and Hippo pathway components altered the phenotypic outcome, and the phenotype we get with RNF146 overexpression in a Hippo loss of function background is not simply due to additive effects of functional loss of either component alone.

      Complementary to these overexpression data, we showed that knockdown of RNF146 increased the eye size further (Fig. S4A, B) in Hippo loss of function background, further supporting the role of RNF146 as a negative regulator of the overall pro-growth signals induced by yki upon Hippo loss of function.

      (5) The role of TEAD inactivation on YAP function is already well known. Disappointingly, no prior literature is cited. In any case, this is a mere control.

      We thank the reviewer for the suggestion. We have cited several published reviews that touch upon this aspect of the TEAD-YAP function, including Calses et al., 2019; Dey et al., 2020; Halder and Johnson, 2011; Wang et al., 2018. We are open to your suggestions on additional citations.

      (6) The second part of the paper on the Development and Screening of pan-TEAD lipid pocket degraders is interesting but unconnected to the above. The degradation pathway it involves has nothing to do with the enzyme described in the first figures.

      We thank the reviewer for the comment. We acknowledge that our paper broadly covers two aspects. We believe that they are inherently connected as they both address ubiquitin/proteasome-mediated TEAD degradation and the functional consequences of TEAD degradation. Given the increasing interest in targeting TEAD/YAP/TAZ in cancers, we think the pharmacological approaches to enhance TEAD degradation using orthogonal E3 ligases provide an important toolbox to understand how this pathway can be regulated under both physiological and pathological conditions. While RNF146 appears to be a major E3 ligase responsible for TEAD turnover under physiological conditions, we showed that the four TEAD paralogs have different poly-ubiquitination levels (Fig. 1A), and are differentially labile in cells (Fig. S2G-I). These observations raised the question of whether the activity of the ubiquitination-proteasome system could be further enhanced to allow more complete removal of TEADs. To this end, we demonstrated that E3 ligases that do not regulate TEAD under endogenous conditions can be leveraged pharmacologically to achieve deep TEAD degradation, thus providing a proof of concept that TEADs can be targeted simultaneously using such approaches. Finally, in addition to establishing the basic biological concept linking RNF146 to TEAD degradation, the compounds we engineered will serve as valuable chemical tools for future studies of TEAD biology and the Hippo pathway in cancers and beyond.

      (7) The role of CIDE on YAP accessibility to Chromatin is superficially executed. Key controls are missing along with the connection with mechanisms and prior knowledge of TEAD, YAP, chromatin, and other TEAD inhibitors, just to mention a few.

      We used ATAC-seq to assess chromatin accessibility comparing cells treated with DMSO and two different concentrations of compound D. We acknowledge there are small molecule inhibitors of TEADs that can modulate accessibility of YAP binding sites. Potential mechanistic differences between TEAD degraders versus TEAD small molecule inhibitions will be a future area of investigation.

      (8) The physiological relevance and the mechanistic interpretation of what should be in the ATAC seq in ovcar cells is missing.

      We showed in Fig. 7A-D the dose response of OVCAR cells to the TEAD degraders. As evident from those experiments, TEAD degraders inhibit the proliferation of OVCAR cells as expected from their dependencies on the TEAD/YAP/TAZ transcription complex. In the ATAC-seq experiment, we showed that the canonical TEAD/YAP/TAZ target genes ANKRD1 and CCN1 have reduced chromatin accessibility at their promoter/enhancer regions (Fig. 8C). By unbiased motif and pathway analyses, we show that TEAD binding sites and YAP signatures are most significantly downregulated in OVCAR-8 cells (Fig. 8D-E). These results are incorporated into the results section of the manuscript.

      Reviewer #3 (Public Review):

      Summary

      Pham, Pahuja, Hagenbeek, et al. have conducted a comprehensive range of assays to biochemically and genetically determine TEAD degradation through RNF146 ubiquitination. Additionally, they designed a PROTAC protein degrader system to regulate the Hippo pathway through TEAD degradation. Overall, the data appears robust. However, the manuscript lacks detailed methodological descriptions, which should be addressed and improved before publication. For instance, the methods used to analyze the K48 ubiquitination site on TEAD and the gene expression analysis of Hippo Signaling are unclear. Furthermore, the multiple proteomics, RNA-seq, and ATAC-seq data must be made publicly available upon publication to ensure reproducibility. Most of the main figures are of low resolution, which needs addressing.

      We thank the reviewer for evaluating our manuscript. All of the data will be uploaded to public databases. We apologize for the low figure resolution and have updated the figures in the revised manuscript. We also expanded the methods section with more details.

      Strengths:

      - A broad range of assays was used to robustly determine the role of RNF146 in TEAD degradation.

      - Development of novel PROTAC for degrading TEAD.

      Weaknesses:

      - An orthogonal approach is needed (e.g., PARP1 inhibitor) to demonstrate PARP1's dependency in TEAD ubiquitination.

      We thank the reviewer for the suggestion. We had attempted to assess the effect of PARP inhibitors (including veliparib and olaparib) on TEAD ubiquitination, but the data is relatively complex to interpret. Besides inhibiting PARP1/2 catalytic activities, these PARP inhibitors also trap PARP on chromatin. Hence, these inhibitors could induce other cellular changes in addition to inhibiting the catalytic activities of PARP1/2. Given these potential pitfalls, we decided not to include these inconclusive data. Even though the experiments with PARP inhibitors were inconclusive, our study supports that TEAD2 and TEAD4 are PARylated in cells using an anti-PAR antibody (Fig. 3B). Furthermore, we show that mutation of the D70 PARsylation site to alanine greatly abolished TEAD4 ubiquitination in cells, suggesting PARylation is important for TEAD4 ubiquitination. In addition, PARP1 depletion by siRNA and CRISPR guide RNA reduced TEAD2 and TEAD4 ubiquitination levels, indicating PARP1 is one of the PARPs responsible for TEAD PARylation in cells.

      - The data from Table 2 is unclear in illustrating the association of identified K48 ubiquitination with TEAD4, especially since the experiments were presumably to be conducted on whole cell lysates with KGG enrichment. This raises the possibility that the K48 ubiquitination could originate from other proteins. Alternatively, if the authors performed immunoprecipitation on TEAD followed by mass spectrometry, this should be explicitly described in the text and materials and methods section.

      We thank the reviewer for this question. The experiment was an IP-mass spectrometry study in a TEAD4 amplified cell line model (PATU-8902) after IP with a pan-TEAD antibody. Here, we observed K48 ubiquitin and other ubiquitin linkages as shown in the Supplementary Table S2 of the original submission. Although it is possible that the IP wash steps could be more stringent, we did enrich for TEAD protein prior to mass spectrometry. While the ubiquitin linkage signals may come mainly from TEAD protein (mainly TEAD4), we recognized that some signals may come from other proteins. Given the caveat, we have now removed the table from our paper and updated the text accordingly.

      - Figure 2D: The methodology for measuring the Hippo signature is unclear, as is the case for Figures 7E and F regarding the analysis of Hippo target genes.

      We apologize for the lack of clarification. In short, we previously developed the Hippo signature using machine learning and chemogenomics as described previously (Pham et al. Cancer Discovery 2021). In the revised version of the manuscript, we added the methodology for measuring the Hippo signature and cited our previous publication where we developed the Hippo signature.

      - Figure S3F requires quantification with additional replicates for validation.

      We thank the reviewer for the suggestion. We added the quantification for the blot and indicated the replication in the figure legend. Note that Figure S3F is now S3G.

      - There is a misleading claim in the discussion stating "TEAD PARylation by PAR-family members (Figure 3)"; however, the demonstration is only for PARP1, which should be corrected.

      We apologize for the statement. We observed both PARP1 and PARP9 in our TEAD IP-mass spec (now Figure S3E), which suggest both PARP-family members could be invovled. Nonetheless, we primarily focus on PARP1, which is widely expressed aross cell line models and present in higher abundance. Thus, our study only experimentally validated PARP1's role in regulating TEAD.

      Recommendations for the authors:

      Reviewer #1 (Recommendations For The Authors):

      General comments:

      (1) Please provide a smoother transition and well-defined connection between the first and second parts of the manuscript. The manuscript reads as two papers that were combined into one, without much attempt to disguise the fact.

      We thank the reviewer for the suggestion. We have added a transition paragraph to smoothen the transition. We acknowledge that our paper broadly covers two aspects. However, they both touch upon TEAD ubiquitination and degradation. In the first part of the manuscript, we described TEAD biology and showed that TEADs are post-translationally modified and subsequently regulated through PARylation-dependent RNF146-mediated ubiquitination. In the second part, we highlighted our abilities to leverage the PROTAC system for degrading such labile oncogenic proteins like TEADs. In addition to the biological concept, the compounds we engineered will serve as valuable chemical tools for future studies of TEAD biology and the Hippo pathway in cancers and beyond.

      (2) To confirm the proteasome mechanism of action, viability assays should be conducted with a CRBN KO.

      We thank the reviewer for the comment. In Figure 6E, we measured TEAD protein levels under CRBN knockdown and observed an expected change in TEAD stability. This observation and the other data presented in Figure 6 suggest that TEAD proteins are targeted for proteasomal degradation under compound D treatment.

      (3) As a control, sgPARP1 or PARP1 inhibitors should be used to confirm TEAD PARylation reduction.

      We thank the reviewer for the suggestion. We had attempted to assess the effect of PARP inhibitors (including veliparib and olaparib) on TEAD ubiquitination, but the data is relatively complex to interpret. Besides inhibiting PARP1/2 catalytic activities, PARP inhibitors also trap PARP on chromatin. Hence, these inhibitors could induce other cellular changes in addition to inhibit the catalytic activities of PARP1/2. Given these pitfalls, we decided not to include these inconclusive data. Even though the experiments with PARP inhibitors were inconclusive, our study supports that TEAD2 and TEAD4 are PARylated in cells using an anti-PAR antibody (Fig. 3B). Furthermore, we show that mutation of the D70 PARsylation site to alanine greatly abolished TEAD4 ubiquitination in cells, suggesting PARylation is important for TEAD4 ubiquitination. In addition, PARP1 depletion by siRNA and CRISPR guide RNA reduced TEAD2 and TEAD4 ubiquitination levels, indicating PARP1 is one of the PARPs responsible for TEAD PARylation in cells.

      (4) MS data looks convincing but an FDR of 1% should be applied - this is the accepted standard in the proteomics field. Please research the data with the more stringent filter.

      We thank the reviewer for the suggestion. Our IP-MS experiment comparing siNTC versus siYAP1/WWTR1 in Patu-8902 cells did not have replicates and FDR could not be derived. Therefore, we listed the raw data in Supplemental Table 3 without showing statistics. To validate the putative interactions identified by IP-MS, we performed IP-Western experiments to confirm that TEAD4 interacts with PARP1 (Figure 3A). It is important to note that in addition to our report, the interaction between PARP1 and TEADs has been observed in other publications (Calses et al., 2023; Yang et al., 2017). We have included more details of the IP-MS experiment reported in Supplemental Table 3 in the revised manuscript and cited previous work reporting TEAD-PARP1 interaction.

      (5) Proofread the manuscript more thoroughly for typos and grammatical errors.

      We thank the reviewer for raising this issue and have addressed it in the revision.

      (6) Improve figure clarity (e.g., clearly labeling graph axes).

      We apologize for the oversight. The revised manuscript contains high resolution figures.

      Specific points:

      Generally, the manuscript could use additional proofreading for grammar and clarity. It would not be practical to list all, but some representative examples are listed below:

      Run-on: "They act through an event-driven mechanism instead of conventional occupancy-driven pharmacology, in addition, target protein degradation removes all functions of the target protein and may also lead to destabilization of entire multidomain protein complexes."

      Typo: "Compound D exhibits significant inhibition of cell proliferation and downstream signaling compared to compound A, a reversible TEAD lipid pocket binder that lack the ubiquitin ligase binding moiety."

      Typo: "Thus, we sought to deplete TEAD proteins by directly target them for ubiquitination and proteasomal degradation via pharmacologically inducing interactions between TEAD and other abundantly expressed and PARylation-independent E3 ligases."

      Typo: "Compound A is a close in analog of Compound B as described previously (Holden et al., 2020)."

      We have revised the manuscript and corrected the typos and grammatical errors listed above and beyond.

      Specific comments on the figures are listed below:

      Figure 2:

      • Figures 2B and 2C should be separated into separate panels for clarity.

      We have updated the Figures 2B and 2C as suggested.

      • Figure 2C - "To further assess the function of RNF146, we depleted RNF146 by either sgRNA or siRNA." This should say either CRISPR-Cas9 KO or siRNA-mediated knockdown.

      We thank the reviewer for the suggestion. We revised the text to address this issue.

      • Figure 2D - y-axis is not labeled well/clearly. Additionally, there are different resolutions for the p-values on the graph (the top p-value is slightly clearer than the other two, suggesting either a different font was used or the value was pasted on top of a picture of the graph at a different resolution).

      We updated the figures according to the suggestions.

      • Figure S2A - "We identified three ubiquitin ligases - RNF146, TRAF3, and PH5A - as potential negative regulators for the Hippos pathway from the primary screen using the luciferase reporter." However, the siPHF5A data appears to decrease luciferase levels whereas siRNF146 and siTRAF3 increase it.

      We thank the reviewer for catching this error. We removed PH5A from this list.

      Figure 3:

      • Figure 3A - label more clearly. Is this an endogenous TEAD4 co-IP?

      We thank the reviewer for the suggestion. The experiment was an IP-mass spectrometry study in a TEAD4 amplified cell line model (PATU-8902) with pan-TEAD antibody. We have included the details to in the figure legends. Figure 3A is now Figure S3E in the revised manuscript.

      • Figure 3C - why are the dark and light exposures not matching/corresponding? In the dark exposure, there are two particularly dark bands, the darkest of which is at the top of the gel. However, this darkest band disappears in the light exposure gel. Additionally, the last lane is marked as +TEAD2 and +TEAD4. Not sure if this is a typo, and meant to be only +TEAD4? Seems a bit strange to have a double TEAD lane.

      We thank the reviewer for this comment and apologize for the oversight. There was a typo in the label. The light exposure image was from a replicate run instead of the same run, therefore the lanes didn’t all match up. We have removed the light exposure panel to resolve the confusion. (Figure 3B).

      Figure 5:

      • Figure 5B - why is shTEAD1-4/Sucrose a much higher tumor volume than shNTC/Sucrose negative control? Additionally, should the legend say "sNTC/Sucrose" as it does or "shNTC/Sucrose"?

      The labels for shTEAD1-4/Sucrose and shNTC/Sucrose are correct. We do not understand why there is a slight increase in tumor volume for shTEAD1-4/Sucrose and suspect that is due to the considerable variation in the experiment. This slight change, however, doesn’t influence our observation of tumor regression in shTEAD1-4 under the Doxycycline treatment.

      "sNTC/Sucrose" is a typo. We apologize for the oversight and have revised the figure.

      • Figure 5E - cited in text after Figures 6 and 7.

      We have updated the text accordingly.

      Figure 6:

      • Figure 6B - it is very interesting how this clearly shows the Hook effect for Compound D, but it's a bit harder to see for compound E that the compound degrades pan-TEAD. Would it be possible to quantify the blots to reinforce claims about protein degradation here?

      We thank the reviewer for the question. There may seem to be some hook effect across the three concentrations of compound D treatment in Fig. 6B.  However, in Fig. 6C-E, we observed pretty consistent TEAD degradation levels across a variety of concentrations. In addition, these experiments have been repeated in multiple cell lines with consistent results. We respectfully argue that more detailed investigation of the hook effect is beyond the scope of our study.

      Figure 7:

      • Figure 7F - this heat map is extremely difficult to interpret. Are there any interesting clusters? What are the darker/lighter bands for Compound D compared to DMSO control?

      We thank the reviewer for the comment and apologize for the lack of information on the figure. These are genes from a Hippo signature derived from our earlier work (Pham et al. Cancer Discovery). As a result of degrading TEAD when treating the cells with Compound D, we observed an expected downregulation of most of these genes compared to compound A.

      Figure 8:

      • Figure 8B - these two pie charts are also difficult to interpret. Perhaps try to present the data in a form other than encircling pie charts?

      We thank the reviewer for the suggestion. However, this is a very descriptive pie chart, we used this format to save space.

      • Figure 8C - what is GNE-6915? Is this Compound D?

      Yes, this is compound D. The text is updated accordingly.

      Reviewer #3 (Recommendations For The Authors):

      Figure 3A would benefit from explicitly stating the conditions within the figure, rather than referring to the legend. This clarity is also needed for Figure 8C, indicating whether the treatment was with compound D or GNE-6915.

      We thank the reviewer for the suggestion. We have added the details to the figures and made the suggested edits.

      Standardize the terms "ubiquitination" and "ubiquitylation" throughout the paper for consistency.

      We now use the term “ubiquitination” throughout the manuscript.

      The statement "In this study, we show that the activity of TEAD transcription factors can be post-transcriptionally regulated via the ubiquitin/proteasome system" should be corrected to "post-translationally regulated."

      We have update the manuscript accordingly.

      There is an additional exclamation mark above Figure 5E that should be removed.

      We have revised Figure 5E.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews: 

      Reviewer #1 (Public Review): 

      Summary: 

      This manuscript explores the multiple cell types present in the wall of murine-collecting lymphatic vessels with the goal of identifying cells that initiate the autonomous action potentials and contractions needed to drive lymphatic pumping. Through the use of genetic models to delete individual genes or detect cytosolic calcium in specific cell types, the authors convincingly determine that lymphatic muscle cells are the origin of the action potential that triggers lymphatic contraction. 

      Strengths: 

      The experiments are rigorously performed, the data justify the conclusions, and the limitations of the study are appropriately discussed. 

      There is a need to identify therapeutic targets to improve lymphatic contraction and this work helps identify lymphatic muscle cells as potential cellular targets for intervention. 

      Weaknesses: 

      My only major comment would be that the manuscript provides a lot of rich information describing the cellular components of the muscular lymphatic vessel wall and that these data are not well represented by the title. The title (while currently accurate) could be tweaked to better represent all that is in this manuscript. Maybe something like

      "Characterization/Interrogation of the cellular components of murine collecting lymphatic vessels reveals that lymphatic muscle cells are the innate pacemaker cells regulating lymphatic contractions" or "Discovery/Confirmation of lymphatic muscle cells as innate pacemaker cells of lymphatic contraction through characterization of the cellular components of murine collecting lymphatic vessels". Potentially a cartoon summary figure of the components that make up the collecting lymphatic vessel wall could also be included. In my opinion, these changes will make this manuscript of more interest to a broader group of scientists. I have a few additional comments for consideration to improve the clarity and enhance the discussion of this work. 

      We agree with the reviewer that our original manuscript, and our resubmission even more so with the addition of the scRNAseq data, provides a significant amount of information regarding the composition of the lymphatic collecting vessel wall. We have changed our title to match one suggestion of the reviewer: “Characterization of the cellular components of murine collecting lymphatic vessels reveals that lymphatic muscle cells are the innate pacemaker cells regulating lymphatic contractions".

      Reviewer #2 (Public Review): 

      Summary: 

      This is a well-written manuscript describing studies directed at identifying the cell type responsible for pacemaking in murine-collecting lymphatics. Using state-of-the-art approaches, the authors identified a number of different cell types in the wall of these lymphatics and then using targeted expression of Channel Rhodopsin and GCaMP, the authors convincingly demonstrate that only activation of lymphatic muscle cells produces coordinated lymphatic contraction and that only lymphatic muscle cells display pressure-dependent Ca2+ transients as would be expected of a pacemaker in these lymphatics. 

      Strengths: 

      The use of a targeted expression of channel rhodopsin and GCaMP to test the hypothesis that lymphatic muscle cells serve as the pacemakers in musing lymphatic collecting vessels. 

      Weaknesses: 

      The only significant weakness was the lack of quantitative analysis of most of the imaging data shown in Figures 1-11. In particular, the colonization analysis should be extended to show cells not expected to demonstrate colocalization as a negative control for the colocalization analysis that the authors present. 

      We understand the reviewer’s concern regarding the lack of a control for the colocalization analysis and that the colocalization analysis was limited to just one set of cell markers. We have now provided a colocalization analysis of Myh11 and PDGFRα, to serve as a co-localization negative control based on our RT-PCR and scRNASeq findings, which is incorporated into the current Supplemental figure 1. In regard to the staining pattern of other various marker combinations, the results were often quite clear with the representative images that two separate cell populations were being stained such as the case with labeling endothelial cells with CD31, macrophage labeling with the MacGreen mice, or hematopoietic cells with CD45. 

      During our lengthy rebuttal process we completed a single cell RNA sequence analysis using our isolated and cleaned mouse inguinal axillary lymphatic collecting vessels to aid in our characterization of the vessel wall and to more thoroughly answer these questions regarding colocalization in arguably a robust manner. The generation of our scRNAseq dataset, derived from isolated and cleaned mouse inguinal axillary collecting vessels from 10 mice, 5 male and 5 females, allowed us to profile over 2200 of the adventitial fibroblast like cells (AdvCs) we had identified in our original submission. Using this dataset, we were able to confirm co-expression of Cd34 and Pdgfrα in AdvCs and assess the co-expression of other genes of interest from our RT-PCR experiments and immunofluorescence experiments. This approach will also allow other lymphatic investigators to assess their genes of interest as our dataset is uploaded to the NIH Gene Omnibus and will be uploaded to the Broad Institute Single Cell Portal upon publication.

      Here we show that the vast majority of non-muscle fibroblast like cells referred to as AdvCs were double positive for both CD34 and PDGFRα. We also show that the AdvCs that express commonly used pericyte markers Pdgfrb and Cspg4 also co-expressed Pdgfrα. Critically, this data also shows that the AdvCs that express genes linked with lymphatic contractile dysfunction (Ano1, Gjc1 or connexin 45, and Cacna1c “Cav1.2”) co-express Pdgfrα and would render these genes susceptible to Cre-mediated recombination using our Pdgfrα-CreER<sup>TM</sup> model.  

      Reviewer #3 (Public Review): 

      Summary: 

      Zawieja et al. aimed to identify the pacemaker cells in the lymphatic collecting vessels. Authors have used various Cre-based expression systems and optogenetic tools to identify these cells. Their findings suggest these cells are lymphatic muscle cells that drive the pacemaker activity in the lymphatic collecting vessels. 

      Strengths: 

      The authors have used multiple approaches to test their hypothesis. Some findings are presented as qualitative images, while some quantitative measurements are provided.   

      Weaknesses: 

      -  More quantitative measurements. 

      -  Possible mechanisms associated with the pacemaker activity. 

      -  Membrane potential measurements. 

      We thank the reviewers for their concerns and have addressed them in the following manner. 

      - We added novel single cell RNA sequencing of isolated and cleaned inguinal axillary vessels from 10 mice (5 males and 5 females). This allowed us to quantify the number of AdvCs that coexpress CD34 and Pdgfrα as well as the number of cells co-expressing Pdgfrα and other markers.

      - We have added a negative control with quantification for the co-localization analysis assessing Myh11 and Pdgfrα. We have added a negative control with quantification for the ChR2-photo stimulated contraction experiments using Myh11CreERT2-ChR2 mice that were not injected with tamoxifen. 

      - We also used Biocytin-AF488 in our intracellular Vm electrodes to map the specific cells in which we recorded action potentials and in neighboring cells since Biocytin-AF488 is under 1KDa and can pass through gap junctions. This approach independently labeled lymphatic muscle cells and their direct neighbors for 3 IALVs from 3 separate mice. 

      - We performed membrane potential recordings in isolated, pressurized (under isobaric conditions), and spontaneously contracting inguinal axillary lymphatic collecting vessels at different pressures. 

      - We also show that the pressure-frequency relationship is dependent on the slope of the diastolic depolarization as no other parameter was significantly altered in our study and the diastolic depolarization slope was highly correlated with contraction frequency. 

      We believe the addition of these novel data, controls, experiments, and quantifications have improved the manuscript in line with the reviewers’ suggestions.

      Recommendations for the authors:

      Reviewer #1 (Recommendations For The Authors): 

      Lines 149-162: The authors rule out the methylene blue staining cells in the cLV wall as pacemakers because they don't form continuous longitudinal connections to drive propagation. Is it possible for a pacemaker cell to only initiate the contraction and then have the LMCs make the axial electrical connections to propagate the electrical wave? I am not trying to suggest the methylene blue cells are pacemakers, but I am not sure the lack of longitudinal (or radial) connectivity is sufficient evidence to rule out the possibility. This comment also is relevant to the 3 criteria for a pacemaker cell listed in the Discussion (Lines 413-417). 

      We agree with the reviewer’s broader point that a pacemaker cell may not require direct contact with other ‘pacemaker’ cells within the tissue as long as they are still within the same electrical syncytium. However, we do expect a continuous presence of a pacemaker cell type throughout the vessel wall length to account for the persistence of spontaneous contractile behavior despite vessel length, and the ability for contraction initiation to shift (Akl et al 2011, Castorena et al 2018 and Castorena et al 2022) and the occurrence of spontaneous action potentials. In Dirk van Helden’s seminal work in 1993 on lymphatic pacemaking, a major finding was that “SM of small lymphangions or that of short segments, cut from lymphangions of any length, behaved similarly”. We have adjusted our phrase regarding the requirement of a contiguous network and instead suggest a continuous presence along the vessel network and integrated into the electrical syncytium. 

      Methylene blue is an alkaline stain that will stain acidic structures and historically methylene blue is noted to stain Interstitial cells of Cajal in the gastrointestinal tract which typically exist as network of cells(Huizinga et al 1993 and Berezin 1988). No such network was readily apparent in our methylene blue staining nor did the stained cells have a similar morphology to the ICCs of the gastrointestinal tract. Further, methylene blue is staining is not limited to ICCs or pacemaker cells at large as it has been used to kill cancer cells. Within the small intestine methylene blue was noted to also stain macrophage like cells (Mikkelsen et al 1988), and we too draw parallels between the macrophage morphology observed with Macgreen mice and methylene-blue stained cells. The specific structure for the ICC affinity for methylene blue is not well described and while the innate cytotoxicity of methylene blue and light has been used to kill ICCs and impair slow wave generation, the lack of specificity of this method leaves much to be desired. What is clear is that the ICC network highlighted by methylene blue in the gut is absent in lymphatic collecting vessels.

      In Figure 15/Video12, is it possible that the cells that are showing intracellular Ca2+ in diastole are the cells that reach a threshold membrane potential that then trigger the rest of the LMCs? As the authors have shown heterogeneity in the LMCs surface markers, is it possible that the cells with Ca2+ activity during diastole are identifiable by a distinct molecular phenotype? Or is the thought that these cells are randomly active in diastole? Some discussion/speculation about this seems appropriate. 

      We are in agreement with the reviewer’s conclusion that there is heterogeneity in the LMCs as it pertains to the calcium oscillations in diastole, either under normal buffer conditions or when L-type channels are inhibited with nifedipine. We also note significant heterogeneity in the gene expression noted within the four LMC subclusters (0-3), though we did not see significant differences in either in Ip3R1 or Ano1 expression. However, subcluster “0” had increased expression of Itprid2, also known as KRas-induced actin-interacting protein (KRAP) which is thought to tether, and thus immobilize, IP3 receptors to the actin cortex beneath the cell membrane. KRAP has been recently proposed to be a critical player in IP3 receptor “licensing” which allows IP3 receptors to release calcium (Vorontsova et al., 2022).  However, whether similar requirement of IP3R licensing is necessitated in all cells or specifically in LMCs is unknown it is quite clear there are specific release sites within the cell and this topic is currently under further investigation for a separate manuscript. We would like to note that there is yet to be a clear consensus on whether IP3R licensing is required as much of these studies are performed in cultured cells and this mechanism has only recently been described. 

      Healthy lymphatic collecting vessels typically have a single pacemaker driving a coordinated propagated contraction in ex vivo isobaric myograph studies (Castorena-Gonzalez et al., 2018), which is typically at either end of the cannulated vessel. We believe that this is due to the lack of a bordering cell in one direction and allows charge to accumulate and voltage to reach threshold at these sites preferentially. We have tried to image calcium at the pacemaking pole of the vessel to observe the specific Ca<sup>2+</sup> transients at these sites though invariably the act of imaging GCaMP6f results in the pacemaker activity initiating from the other pole of the vessel. It is our opinion that the fact that LMCs are heterogenous in their Ca<sup>2+</sup> transients is a feature to the system as it permits a wider range of depolarization signals, and thus allows finer control of the pacing as different physical/pressure or signaling stimuli is encountered. Likely, the cells with the higher propensity of Ca<sup>2+</sup> transients act as the contraction initiation site in vivo, though it must also be noted that the LMC density decreases around lymphatic valve sites. In fact, in guinea pig collecting vessels there are very few LMCs at the valves which can render them electrically uncoupled or poorly coupled (Van Helden, 1993). Thus, valve sites in which there is greater electrical resistance due to lower LMC-LMC coupling may allow for charge accumulation in the LMCs at the valve site, similar to the artificial condition achieved in our myograph preparations with two cut ends, and allow them to reach threshold first and drive coordination at the valve sties.

      An additional description of what the PTCL analysis is meant to represent physiologically would be helpful for readers. 

      We have better described the conversion of the calcium signals into “particles” for analysis at first mention in the methods and results section and have included the requisite reference to this specific methodology in Line 429-30. 

      A description of how DMAX is experimentally determined is needed. 

      We have adjusted our methods section to describe DMAX in line 774-775.

      “with Ca<sup>2+</sup>-free Krebs buffer (3mM EGTA) and diameter at each pressure recorded under passive conditions (DMAX).”

      I think the vessels referred to as popliteal lymphatic vessels are actually saphenous lymphatic vessels (afferent to the popliteal lymph node). Please clarify. 

      Indeed, some of the vessels used in this study are the afferents to the single popliteal node. They travel with the caudal branch of the saphenous vein, but have routinely been described as popliteal vessels, as opposed to saphenous lymphatic vessels, by the lymphatic field at large (Tilney 1971 PMCID: PMC1270981, Liao 2015 PMID: 25512945). To move away from this nomenclature would likely add to confusion although we agree that the lymphatic field may need to improve or correct the vessel naming paradigm to match the vascular pairs they follow.

      Reviewer #2 (Recommendations For The Authors): 

      Lines 214-215 - can you cite a reference for the observation that rhythmic contractions don't require the presence of valves? 

      We have added the reference. In Dr. Van Helden’s seminal work on the topic in 1993, “Vessel segments were then cut from selected small lymphangions (length 300-500 um) by cutting at the valves.” Additionally, work by Dr Anatoliy Gashev utilized sections of lymphatic vessels that lacked valves to study orthograde and retrograde shear sensitivity (Gashev et al., 2002).

      Lines 224-230 - It would have been nice to see colocalization analysis for all cell types so that "negative" results could be compared with the "positives" that you report. This would help bolster evidence of your ability to separate cell types. 

      We understand the reviewer’s sentiment and agree. We have now added a “negative control” colocalization staining and analysis for PDGFR and Myh11 which has been added to the current SuppFigure 1. We stained 3 IALVs from 3 separate mice with PDGFRα and Myh11 and performed confocal microscopy. We ran the FIJI BIOP-JACOP colocalization plugin as before and observed very little colocalization of the two signals. Additionally, we have also added a coexpression assessment for CD34 and PDGFRα and other genes using our scRNAseq dataset.  

      line 293 - Should read "Cx45 in..." 

      This has been corrected. 

      “The expression of the genes critically involved in cLV function—Cav1.2, Ano1, and Cx45—in the PdgfrαCreER<sup>TM</sup>-ROSA26mTmG purified cells and scRNAseq data prompted us to generate PdgfrαCreER<sup>TM</sup>-Ano1<sup>fl/fl</sup>, PdgfrαCreER<sup>TM</sup>-Cx45<sup>fl/fl</sup>, and PdgfrαCreER<sup>TM</sup>-Cav1.2<sup>fl/fl</sup> mice for contractile tests.”

      lines 470-473 - A reference for this statement should be cited. 

      We have added the reference. In Dr. Van Helden’s seminal work on the topic in 1993, “Vessel segments were then cut from selected small lymphangions (length 300-500 um) by cutting at the valves.” Additionally, work by Dr Anatoliy Gashev utilized sections of lymphatic vessels that lacked valves to study orthograde and retrograde shear sensitivity (Gashev et al., 2002).

      Lines 483-487 - References should be cited for these statements. 

      We have narrowed and clarified this statement and supported it with the necessary citations. 

      “Of course, mesenchymal stromal cells (Andrzejewska et al., 2019) and fibroblasts (Muhl et al., 2020; Buechler et al., 2021; Forte et al., 2022) are present, and it remains controversial to what extent telocytes are distinct from or are components/subtypes of either cell type (Clayton et al., 2022). Telocytes are not monolithic in their expression patterns, displaying both organ directed transcriptional patterns as well as intra-organ heterogeneity (Lendahl et al., 2022) as readily demonstrated by recent single cell RNA sequencing studies that provided immense detail about the subtypes and activation spectrum within these cells and their plasticity (Luo et al., 2022).”

      Lines 584-585 - Missing a reference citation. 

      Thank you for catching this error, the correct citation was for Boedtkjer et al 2013 and is now properly cited. 

      Line 638 - "these this" should read "this" 

      Thank you for catching this error. This particular sentence was removed in light of the addition of the scRNAseq data.

      Reviewer #3 (Recommendations For The Authors): 

      This manuscript from Zawieja et al. explored an interesting hypothesis about the pacemaker cells in lymphatic collecting vessels. Many aspects of lymphatic collecting vessels are still under investigation; hence this work provides timely knowledge about the lymphatic muscle cells as a pacemaker. Although it is an important topic of the investigation, the data provided do not support the overall goal of the manuscript. Many figures (Figure 1-5) provide quantitative estimation and the description provided in the results section might only be useful for a restricted audience, but not to the broader audience. Some of the figures are very condensed with multiple imaging panels and it is hard to follow the differences in qualitative analysis. Overall, this manuscript can be improved by more streamlined description/writing and figure arrangements (some of the figures/panels can be moved to the supplementary figures). 

      We disagree with the notion that the original data provided did not support the goal of the manuscript- to identify and test putative pacemaker cell types. Nonetheless we believe we have also added ample novel data to the manuscript, including membrane potential recordings and scRNAseq to highlight and to add further support to our conclusion that the pacemaker cell is an LMC. We believe the scRNAseq data will also greatly enhance the appeal of the manuscript to a broader audience and have renamed the manuscript in line with the wealth of data we have collected on the components of the vessel wall as we tested for putative pacemaker cells.

      As requested, we have moved many figures to the supplement to allow readers to focus more on the more critical experiments.

      A few other points that need to be addressed: 

      (1) Authors used immunofluorescence-based differences in various cell types in the collecting vessels. Initially, they chose ICLC, pericytes, and lymphatic muscle cells. But then they started following adventitial cells and endothelial cells. It is not clear from the description, why these other cells could be possibly involved in the pacemaker activity. It will be easier to follow if authors provide a graphical abstract or summary figure about their hypothesis and what is known from their and others' work. 

      We would like to clarify that we used the endothelial cells as controls to ensure what we observed via immunofluorescence and FACs RT-PCR were a separate cell type from either lymphatic muscle or lymphatic endothelial cells on the vessel wall. Staining for the endothelium also allowed us to assess where these PDGFRα+CD34+ cells reside in the vessel wall.  We started with a wide range of markers that are conventionally used for targeting specific cell types, but as expected those markers are not always 100% specific. Specifically, we focused on CD34, Kit, and Vimentin as those were the markers for the non-muscle cells observed in the lymphatic collecting vessel wall previously. What we found was that CD34 and PDGFRα labeled the same cell type. As there was not a CD34Cre mouse available at the time we instead utilized the inducible PDGFRαCreERTM. We are unsure how well an abstract figure will condense the conclusions from the experiments listed here but if absolutely required for publication we can attempt to highlight the representative cell populations identified on the vessel wall.

      (2) Authors used many acronyms in the manuscript without defining them (when they appeared for the first time). Please follow the convention. 

      We have checked the manuscript and made several corrections regarding the use of abbreviations.

      (3) How specific PDGFR-alpha as a marker of the pericytes? It can also label the mesenchymal cells. Why did the author choose PDGFR-alpha over beta for their Cre-based expression approach? 

      We tried to assess if there were a pericyte like cell present in or along the wall using PDGFRbeta (Pdgfrβ). Pdgfrβ is commonly used to identify pericytes (Winkler et al., 2010), while in contrast Pdgfrα is a known fibroblast marker (Lendahl et al., 2022). Pdgfrβ CreERT2 resulted in recombination in both LMCs and AdvCs, preventing it from being a discriminating marker for our study where as Myh11CreER<sup>T2</sup> and PDGFRαCreER<sup>TM</sup> were specific at least to cell type based on our FACSs-RT-PCR and staining. As you can tell from the scRNAseq data in Figure 5, there was no cell cluster that Pdgfrβ was specific for in contrast to PDGFRα and Myh11.  In Figure 6 we show the expression of another commonly used pericyte marker NG2 (Cspg4) in our scRNAseq dataset which was observed in both LMCs and AdvCs as well. Lastly, MCAM (Figure 6) can also be a marker for pericytes though we see only expression in the LMCs and LECs for this marker. Notably, almost all of the AdvCs express PDGFRα rendering the PDGFRαCreER<sup>TM</sup> a powerful tool to study this population of cells on the vessel wall including those that were PDGFRα+Cspg4+ or PDGFRα+ Pdgfrβ+.

      We were reliant on PDGFRαCreER<sup>TM</sup> as that was the only available PDGFRα Cre model at the time. Note we used PdgfrβCreER<sup>T2</sup> and Ng2Cre in our study but found that both Cre models recombined both LMCs and AdvCs.

      (4) Please include appropriate references for all the labeling markers (PDGFR-alpha, beta, and myc11 etc.) that are used in this manuscript. 

      We have added multiple references to the manuscript to support the use of these common cell “specific” markers as of course each marker is limited in some capacity to fully or specifically label a single population of cells (Muhl et al., 2020).

      (5) One of the criteria for the pacemaker cells is depolarization-induced propagated contractions. Authors have used optogenetics-induced depolarization to test this phenomenon. Please include negative controls for these experiments. 

      We have now added negative controls to this experiment which were non-induced (no tamoxifen) Myh11CreER<sup>T2</sup>-Chr2 popliteal vessels. This data has been added to the Figure 8.  

      (6) What are the resting membrane potentials of Lymphatic muscle cells? The authors should provide some details about this in the manuscript. 

      We agree with the reviewer and have added membrane potential recordings (Figure 13) at different pressures and filled our recording electrode with the cell labeling molecule BiocytinAF488 to highlight the action potential exhibiting cells, which were the LMCs. Lymphatic resting membrane potential is dynamic in pressurized vessels, which appears to be a critical difference in this approach as compared to pinned out vessels or those on wire myographs likely due to improper stretch or damage to the vessel wall. In mesenteric lymphatic vessels isolated from rats the minimum membrane potential achieved during repolarization ranges from -45 to 50mV typically while IALVs from mice are typically around -40mV, though IALVs have a notably higher contraction frequency. Critically, we have also added novel membrane potential recordings to this manuscript in IALVs at different pressures and show that the diastolic depolarization rate is the critical factor driving the pressure-dependent frequency.

      (7) In the discussion, the authors discussed SR Ca2+ cycling in Pacemaking, but the relevant data are not included in this manuscript, but a manuscript from JGP (in revision) is cross-referenced. 

      As discussed above, we have recently published our work where studied IALVs from Myh11CreERT2-Ip3R1fl/fl (Ip3r1ismKO) and Myh1CreERT2-Ip3r1fl/fl-Ip3r2fl/fl-Ip3r3fl/fl mice (Zawieja et al., 2023). Deletion of Ip3r1 from LMCs recapitulated the dramatic reduction in frequency we previously published in Myh11CreERT2-Ano1fl/fl mice and the loss of pressure dependent chronotropy. Furthermore, in this manuscript we also showed that the diastolic calcium transients are nearly completely lost in ILAVs from Myh11CreERT2-Ip3R1fl/fl knockout mice. There was no difference in the contractile function between IALVs from single Ip3r1 knockout and the triple Ip3r1-3 knockout mice suggesting that it is Ip3r1 that is required for the diastolic calcium oscillations. Further, in the presence of 1uM nifedipine there were still no calcium oscillations in the Myh11CreERT2-Ip3r1fl/fl LMCs. These findings provide further support for our interpretation that the pacemaking is of myogenic origin.

      Andrzejewska, A., B. Lukomska, and M. Janowski. 2019. Concise Review: Mesenchymal Stem Cells: From Roots to Boost. Stem Cells. 37:855-864.

      Buechler, M.B., R.N. Pradhan, A.T. Krishnamurty, C. Cox, A.K. Calviello, A.W. Wang, Y.A. Yang, L.

      Tam, R. Caothien, M. Roose-Girma, Z. Modrusan, J.R. Arron, R. Bourgon, S. Muller, and S.J. Turley. 2021. Cross-tissue organization of the fibroblast lineage. Nature. 593:575579.

      Castorena-Gonzalez, J.A., S.D. Zawieja, M. Li, R.S. Srinivasan, A.M. Simon, C. de Wit, R. de la Torre, L.A. Martinez-Lemus, G.W. Hennig, and M.J. Davis. 2018. Mechanisms of Connexin-Related Lymphedema. Circ Res. 123:964-985.

      Clayton, D.R., W.G. Ruiz, M.G. Dalghi, N. Montalbetti, M.D. Carattino, and G. Apodaca. 2022. Studies of ultrastructure, gene expression, and marker analysis reveal that mouse bladder PDGFRA(+) interstitial cells are fibroblasts. Am J Physiol Renal Physiol. 323:F299F321.

      Forte, E., M. Ramialison, H.T. Nim, M. Mara, J.Y. Li, R. Cohn, S.L. Daigle, S. Boyd, E.G. Stanley, A.G. Elefanty, J.T. Hinson, M.W. Costa, N.A. Rosenthal, and M.B. Furtado. 2022. Adult mouse fibroblasts retain organ-specific transcriptomic identity. Elife. 11.

      Gashev, A.A., M.J. Davis, and D.C. Zawieja. 2002. Inhibition of the active lymph pump by flow in rat mesenteric lymphatics and thoracic duct. J Physiol. 540:1023-1037.

      Lendahl, U., L. Muhl, and C. Betsholtz. 2022. Identification, discrimination and heterogeneity of fibroblasts. Nat Commun. 13:3409.

      Luo, H., X. Xia, L.B. Huang, H. An, M. Cao, G.D. Kim, H.N. Chen, W.H. Zhang, Y. Shu, X. Kong, Z.

      Ren, P.H. Li, Y. Liu, H. Tang, R. Sun, C. Li, B. Bai, W. Jia, Y. Liu, W. Zhang, L. Yang, Y. Peng, L. Dai, H. Hu, Y. Jiang, Y. Hu, J. Zhu, H. Jiang, Z. Li, C. Caulin, J. Park, and H. Xu. 2022. Pancancer single-cell analysis reveals the heterogeneity and plasticity of cancer-associated fibroblasts in the tumor microenvironment. Nat Commun. 13:6619.

      Muhl, L., G. Genove, S. Leptidis, J. Liu, L. He, G. Mocci, Y. Sun, S. Gustafsson, B. Buyandelger, I.V.

      Chivukula, A. Segerstolpe, E. Raschperger, E.M. Hansson, J.L.M. Bjorkegren, X.R. Peng, M. Vanlandewijck, U. Lendahl, and C. Betsholtz. 2020. Single-cell analysis uncovers fibroblast heterogeneity and criteria for fibroblast and mural cell identification and discrimination. Nat Commun. 11:3953.

      Van Helden, D.F. 1993. Pacemaker potentials in lymphatic smooth muscle of the guinea-pig mesentery. J Physiol. 471:465-479.

      Vorontsova, I., J.T. Lock, and I. Parker. 2022. KRAP is required for diffuse and punctate IP(3)mediated Ca(2+) liberation and determines the number of functional IP(3)R channels within clusters. Cell Calcium. 107:102638.

      Winkler, E.A., R.D. Bell, and B.V. Zlokovic. 2010. Pericyte-specific expression of PDGF beta receptor in mouse models with normal and deficient PDGF beta receptor signaling. Mol Neurodegener. 5:32.

      Zawieja, S.D., G.A. Pea, S.E. Broyhill, A. Patro, K.H. Bromert, M. Li, C.E. Norton, J.A. CastorenaGonzalez, E.J. Hancock, C.D. Bertram, and M.J. Davis. 2023. IP3R1 underlies diastolic ANO1 activation and pressure-dependent chronotropy in lymphatic collecting vessels. J Gen Physiol. 155.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Reviewer #1 (Public Review):

      This study presents valuable observations of white matter organisation from diffusion MRI and two types of synchrotron imaging in both monkeys and mice. Cross-modality comparisons are interesting as the different methods are able to probe anatomical structures at different length scales, from single axons in high-resolution synchrotron (ESRF) imaging, to clusters of axons in lower-resolution synchrotron (DEXY) data, to axon populations at the mm-scale in diffusion MRI. By acquiring all modalities in monkey and mouse ex vivo samples, the authors can observe principles of fibre organisation, and characterise how fibre characteristics, such as tortuosity and micro-dispersion, vary across select brain regions and in healthy tissue versus a demyelination model. The results are solid, though some statements (in the abstract/discussion) do not appear to be fully supported, and statistical tests would help confirm whether tissue characteristics are similar/different between different conditions.

      R1.1: Thank you for the kind feedback. We have included statistical tests in the paper for tissue characteristics where appropriate.

      Due to the very high number of sample points (one per voxel) within the 3D synchrotron volumes, testing for statistical significance is challenging for the structure tensor-based tissue fractional anisotropy (FA) metric. This causes any standard statistical test to have sufficient power to evaluate even minute differences between the volumes as statistically significant with high confidence. In other words, the null hypothesis (H0) will always be rejected with p = 0, regardless of the practical significance of the difference. Therefore, we have not added statistical analysis for FA results.

      For the tractography based metrics, the number of sample points (one per streamline) is not as high as that for the structure tensor FA, thus making it more reasonable to test for statistical significance. The statistical analyses performed included tests for equality of distributions (Two-sample Kolmogorov-Smirnov tests), equality of medians (Two-sided Wilcoxon rank sum tests), and equality of variance (Brown-Forsythe tests). The results are described in relation to Figure 5(B, D), Figure 8(CF), and detailed in the Methods section.

      One very interesting result is the observation of apparent laminar organisation of fibres in ex vivo monkey white matter samples. DESY data from the corpus callosum shows fibres with two dominant orientations (one L-R, one slightly inclined), clustered in laminar structures within this major fibre bundle. Thanks to the authors providing open data, I was able to look through the raw DESY volume and observe regions with different "textures" (different orientations) in the described laminar arrangement. That this organisation can be observed by eye, as well as by structure tensor, is fairly convincing. As not all readers will download the data themselves, the manuscript could benefit from additional figures/videos to demonstrate (1) the quality of the DESY data and (2) a more 3D visualisation of the laminar structures (where the coronal plane shows convincing columnar structure or stripes). Similarly in Figure 5A, though this nicely depicts two populations with different orientations, it is somewhat difficult to see the laminar structure in the current image.

      ESRF data of the centrum semiovale (CS) contributes evidence for similar laminar structures in a crossing fibre region, where primarily AP fibres are shown to cluster in 3 laminar structures. As above, further visualisations of the ESRF volume in the CS (as shown in Figure 4E) would be of value (e.g. showing consistency across the 4 volumes, 2D images showing stripey/columnar patterns along different axes, etc).

      R1.2: Conveying complex 3D geometry through 2D still images is indeed challenging, and we greatly appreciate the reviewer’s comments and suggestions. To better communicate the understanding of the 3D anatomical environments, we have taken the following actions:

      (1) To enhance insights into the tractography results in Figures 5A and 5D, we have rendered and added animations of the tractography scenes as supplemental material.

      (2) To visually support 3D insights concerning the consistency of the laminar organisation of the callosal fibres, we have replaced the 2D slice views in Figures 3A and 3B with 3D renderings similar to the one in Figure 4E.

      (3) An animation of Figure 4E was created to display the colour-coded structure tensor directions of all four stacked scans. This animation visually supports the complexity of the fibre orientation and the layered structural laminar organisation of the CS sample.

      A key limitation of this result is that, though the DESY data from the CC seems convincing, the same structures were not observed in high-resolution synchrotron (ESRF) data of the same tissue sample in the corpus callosum. This seems surprising and the manuscript does not provide a convincing explanation for this inconsistency. The authors argue that this is due to the limited FOV of the ESRF data (~200x200x800 microns). However, the observed laminar structures in DESY are ~40 microns thick, and ERSF data from the CST suggests laminar thicknesses in the range of 5-40 microns with a similar FOV. This suggests the ERSF FOV would be sufficient to capture at least a partial description of the laminar organisation. Further, the DESY data from the CC shows columnar variations along the LR axis, which we might expect to be observed along the long axis of the ESFR volume of the same sample. Additional analyses or explanations to reconcile these apparently conflicting observations would be of value. For example, the authors could consider down-sampling the ESRF data in an appropriate manner to make it more similar to the DESY data, and running the same analysis, to see if the observed differences are related to resolution (i.e. the thinner laminar structures cluster in ways that they look like a thicker laminar structure at lower resolution), or crop the DESY data to the size of the ESRF volume, to test whether the observed differences can be explained by differences in FOV. Laminar structures were not observed in mouse data, though it is unclear if this is due to anatomical differences or somewhat related to differences in data quality across species.

      R1.3: We have clarified and expanded upon the results regarding the laminar organisation observed in the monkey CC DESY data. As noted in R1.2, we replaced the 2D images in Figures 3A (DESY) and 3B (ESRF) with 3D renderings to better display the spatial outline of the laminar organisation in the volumes. The reviewer is correct that, although the smaller field of view (FOV) of the ESRF data should allow us to at least partially capture parts of the laminar organisation observed in the larger FOV of the DESY data, this is not guaranteed. It depends on how the smaller FOV is positioned relative to the structural organisation, and since we lack co-registration, we do not know this. It should now be visually evident that the ESRF FOV can be placed such that it does not cover the observed laminae, a point which is now also emphasised in the Discussion. 

      Secondly, it is important to emphasise that the voxel colouring using the primary structure tensor direction is just a visualisation technique, which has limitations when it comes to assessing laminar organisation. Mapping 3D directions to RGB colours is inherently difficult and will always have ambiguities. If we had used the standard R-G-B to LR-AP-IS colouring in Figure 3, the laminar organisation would not be evident. Additionally, the laminae will only be visible when there are clear angular differences. There can still be a layered organisation even if we don’t observe it, which is the case for the mouse. The primary direction differences of these layers could be very low (i.e., parallel layers), and consequently not visually evident. This point has been clarified in both the Results and Discussion sections.

      Finally, in response to R1.6, we have added analyses regarding the shape of the FOD, specifically estimating the Orientation Dispersion Index (ODI) and Dispersion Anisotropy (DA). This provides further context to the reviewer’s comments about the discrepancies in laminar organisation. We have reflected on the relationship between DA and the visually observed laminar organisation, and this has been integrated into the relevant parts of the Results and Discussion sections.

      The changes to manuscript reflecting the statements above are listed here: 

      The Discussion section (page 21): “In the monkey CC DESY data, which has a field of view (FOV) comparable to a dMRI voxel, a columnar laminar organisation at a macroscopic level was visually revealed from the structure tensor (ST) direction colouring. However, this laminar organisation was not visible in the higher-resolution ESRF data for the same tissue sample. Although the two samples were not co-registered, the size of a single ESRF FOV within the DESY sample is illustrated in Fig. 3A. This demonstrates the possibility of placing the ESRF sample where the observed laminar structure is absent. Consequently, knowledge of the tissue structural organisation and its orientation is important to fully benefit from the stacked FOV of the ESRF sample and when choosing appropriate minimal FOV sizes in future experiments.

      Interestingly, when characterising FODs with measures like ODI and DA as indicators of fibre organisation, rather than relying on visualisation, results from large- and small-FOV data show no discrepancies. This statistical approach discards the spatial context (visually perceived as laminae), highlighting the need to combine both methods.” 

      The Results section (page 8): “The mid-level DA values suggest some anisotropic spread of the directions, reflecting the angled laminar organisation observed in the DESY sample. Interestingly, the DA value for the ESRF sample is almost identical, despite the laminar bands being less visually apparent.”

      The Results section (page 17): “Nevertheless, visualisation of orientations did not reveal any axonal organisation in the mouse CC due to the lack of local angular contrast, unlike the clear laminar structures seen in the monkey sample (Fig. 3A). Any parallel organisation in tissue remains undetectable because our visual contrast relies on angular differences.”

      The Discussion section (page 22): “In the monkey CC (mid-body), we observed laminar organisation indicated by clear spatial angular differences in the ST directions in the sample (Fig. 3A). Quantifications of the FOD shape showed DA indices of 0.55 and 0.59 for the DESY and ESRF samples, respectively. In contrast, the mouse CC (splenium) did not visually reveal a similar angled laminar organisation (Fig. 7C), and the DA indices were lower, at 0.49 and 0.32, respectively. Two possible explanations exist. First, the within-pathway laminar organisation may not be identical across the entire CC. Consequently, more scans from other CC regions would be required to confirm. Second, the different species might account for the differences. Larger brains like the monkey might foster a different level of within-pathway axon organisation compared to the smaller mouse. Although we could not visually detect laminar organisation from the colour coding of the ST direction in the mouse, the non-zero DA values suggest some level of organisation. This is supported by our streamline tractography, which indicates a vertical layered organisation (Fig. 8A, B). It further aligns with studies using histological tracer mapping that shows a stacked parallel organisation of callosal projections in mice, between cortex regions M1 and S1 (Zhou et al. 2013). Nevertheless, we cannot rely solely on voxel-wise ST directions to fully describe axonal organisation, as this method does not contrast almost parallel fasciculi (inclination angles approaching 0 degrees). Analysing patterns in tractography streamlines would be an interesting future direction for this purpose.”

      The authors further quantify various other characteristics of the white matter, such as micro-dispersion, tortuosity, and maximum displacement. Notably, the microscopic FA calculated via structure tensor is fairly consistent across regions, though not modalities. When fibre orientations are combined across the sample, they are shown to produce similar FODs to dMRI acquired in the same tissue, which is reassuring. As noted in the text, the estimates of tortuosity and max displacement are dependent on the FOV over which they are calculated. Calculating these metrics over the same FOV, or making them otherwise invariant to FOV, could facilitate more meaningful comparisons across samples and/or modalities.

      R1.4: This raises an interesting point about the necessity of normalising the FOV to obtain invariant, tractography-based metrics of tortuosity and maximum deviation across different samples and modalities. In general, achieving this is challenging, and in this study, it is practically not possible. Between species, we encounter significant differences in brain volume ratios, which complicates the establishment of a common reference FOV due to the distinct anatomical organisation of monkey and mouse brains (see our response to R1.8). Within species, we would encounter challenges due to missing contrast—such as issues with staining—and the lack of perfect co-registration.

      The Discussion section (page 28) has been extended to reflect this: ”Within the same species, assuming perfect co-registration of samples, it would be possible to perform correlative imaging and analysis. This would allow validation of whether tractography streamlines could be reproduced at different image resolutions within the same normalised FOV. Although this was not possible with the current data and experimental setup, it would be an interesting point to pursue in future work.”

      Though the results seem solid, some statements, particularly in the abstract and discussion, do not seem to be fully supported by the data. For example, the abstract states "Our findings revealed common principles of fibre organisation in the two species; small axonal fasciculi and major bundles formed laminar structures with varying angles, according to the characteristics of major pathways.", though the results show "no strong indication within the mouse CC of the axonal laminar organisation observed in the monkey". Similarly, the introduction states: "By these means, we demonstrated a new organisational principle of white matter that persists across anatomical length scales and species, which governs the arrangement of axons and axonal fasciculi into sheet-like laminar structures." Further comments on the text are provided below.

      R1.5: We understand that it can be misunderstood that the laminar organisation is identical in monkeys and mice, which is not the case. For example, we show that in the corpus callosum, pathways are parallel in the mouse but not in the monkey. We have clarified that while the principle of layered laminar organisation of pathways is shared between monkeys and mice, species-specific differences do exist.

      We have made the following clarifying changes to the manuscript:

      The Abstract (page 2): “Our findings revealed common principles of fibre organisation that apply despite the varying patterns observed across species” 

      The Introduction (page 4-5): “Through these methods, we demonstrated organisational principles of white matter that persists across anatomical length scales and species. These principles govern the organisation of axonal fasciculi into sheet-like laminar shapes (structures with a predominant planar arrangement). Interestingly, while these principles remain consistent, they result in varied structural organisations in different species.” 

      The Discussion (page 21): “despite species differences”.

      One observation not notably discussed in the paper is that the spherical histograms of Figure 3E/H appear to have an anisotropic spread of the white points about 0,0. It would be interesting if the authors could comment on whether this could be interpreted as the FOD having asymmetric dispersion and if so, whether the axis of dispersion relates to the fibre orientations of the laminar structures.

      R1.6: That is a good point, and to address it, we have fitted spherical Bingham distributions to the FODs, allowing us to quantify their shapes. From each Bingham distribution, we derived two wellknown indices from the diffusion MRI community: the Orientation Dispersion Index (ODI) and Dispersion Anisotropy (DA) index. The ODI explains the dispersion of fibres for a single bundle FOD, whereas DA expresses the shape of the FOD on the unit sphere surface, i.e., the degree of anisotropy. We have integrated the Bingham-based analysis into the Methods, Discussion, and Results sections concerning Figures 3 and 7, but not Figure 4, which contains multiple fibre bundles that we cannot separate on a voxel level. The analysis does not impact the overall message and conclusion but adds interesting context to the discussion around laminar organisation.

      A limitation of the study is that it considers only small ex vivo tissue samples from two locations in a single postmortem monkey brain and slightly larger regions of mouse brain tissue. Consequently, further evidence from additional brain regions and subjects would be required to support more generalised statements about white matter organisation across the brain.

      R1.7: Collecting more samples from various locations in the brain would provide valuable insights into the consistency of white matter organisation across anatomical length scales, as well as the structuretensor based anisotropy and tortuosity metrics. However, being awarded beamtime at two different synchrotron facilities to scan the same sample with different imaging setups is practically challenging. At the ESRF, we have gathered additional image volumes from other white matter regions of the monkey brain that support all our findings, which will be published separately. X-ray synchrotron imaging technology is advancing rapidly, with faster acquisition times enabling more image volumes to be stitched together. This extends the FOV and allows for a more robust statistical description of the anatomy. Consequently, future studies with an extended FOV and varying image resolutions could utilise a single synchrotron facility to collect additional samples, further supporting our findings.

      The Discussion section (page 27) has been extended to reflect this: “Increasing the number of samples across both species and examining laminar organisation at various length scales in more regions would strengthen our findings. However, securing beamtime at two different synchrotron facilities to scan the same sample with varying image resolutions is a limiting factor. Beamline development for multiresolution experimental setups, along with faster acquisition methods, is a rapidly advancing field. For instance, the Hierarchical Phase-Contrast Tomography (HiP-CT) imaging beamline at ID-18 at the ESRF, enables multi-resolution imaging within a single session to address this challenge, though it is currently limited to a resolution of 2.5 μm (Walsh et al. 2021).”

      Given the monkey results, the mouse study (section 2.5 onwards) lacks some motivation. In particular, it is unclear why a demyelination model was studied and if/how this would link to the laminar structure observed in the monkey data. Further, it is unclear how comparable tortuosity/max deviation values are across species, considering the differences in data quality and relative resolution, given that the presented results show these values are very modality-dependent.

      R1.8: We have clarified the motivation for including the mouse part of the study in both the Introduction and the Results sections.

      The Introduction section (page 5): “Furthermore, using a mouse model of focal demyelination induced by cuprizone (CPZ) treatment, we investigate the inflammation-related influence on axonal organisation. This is achieved through the same structure tensor-derived micro-anisotropy and tractography streamline metrics.”

      The Results section (page 15): “Finally, we investigated the organisation of fasciculi in both healthy mouse brains and a murine model of focal demyelination induced by five weeks of cuprizone (CPZ) treatment. This allowed for the exploration of the disease-related influence on axonal organisation, particularly under inflammation-like conditions with high glial cell density at the demyelination site (He et al. 2021). The experimental setup for DESY and ESRF is similar to that described for the monkey, with the exception that we did not perform dMRI and synchrotron imaging on the same brains, and only collected MRI data for healthy mouse brains. This approach allowed us to apply the same structure tensor and tractography streamline analysis used previously, but in a healthy versus disease comparison, demonstrating the methodology’s ability to provide insights into pathological conditions.”

      Across species, the comparison of tortuosity and maximum deviation must be approached with caution. On one hand, we observe a comparable influence of the extra-axonal environment in both the monkey and mice, as discussed in the section “Sources to the non-straight trajectories of axon fasciculi.” On the other hand, the anatomical scale and relative image resolution are significant factors, as correctly pointed out. In the mouse, for instance, the measures are influenced by white matter pathway macroscopic effects, making cross-species comparison challenging to perform in a normalised way.

      The limitations section of the Discussion (page 28) has been updated to reflect this: ”A limiting consequence of having samples imaged at differing anatomical scales is that certain measures become inherently hard to compare in a normalised way. The tractography-based metrics—tortuosity and maximum deviation—serve as good examples of this resolution and FOV dependence. In the ESRF samples, the anatomical scale was at the level of individual axons, and the streamline metrics primarily reflect micro-scale effects from the extra-axonal environment, such as the influence of cells and blood vessels. In comparison, the larger anatomical scale in the DESY samples represents the level of fasciculi and above, with metrics influenced by macroscopic effects, such as the bending of the CC pathway. Both scales are interesting and can provide valuable insights in their own right, but caution is required when comparing the numbers, especially for cross-species studies where there is a significant difference in brain volume ratios.”

      The paper introduces a new method of "scale-space" parameters for structure tensors. Since, to my understanding, this is the first description of the method, some simple validation of the method would be welcomed. Further, the same scale parameters are not used across monkeys and mice, with a larger kernel used in mice (Table 2) which is surprising given their smaller brain size. Some explanation would be helpful.

      R1.9: We have expanded the description of the scale-space structure tensor approach in the Methods section. Specifically, we have elaborated on the empirical process used to select the scale-space parameters shown in Table 2 and explained why multiple scales were applied only to the monkey samples scanned at ESRF (see Table 2, sample IDs 2 and 3) but not to the other datasets. Additionally, we have added a supplementary figure to assist in illustrating the concept.

      Reviewer #2 (Public Review):

      Summary:

      In this work, the authors combine diffusion MRI and high-resolution x-ray synchrotron phase-contrast imaging in monkey and mouse brains to investigate the 3D organization of brain white matter across different scales and species. The work is at the forefront of the anatomical investigation of the human connectome and aligns with several current efforts to bridge the resolution gap between what we can see in vivo at the millimeter scale and the complexity of the human brain at the sub-micron scale. The authors compare the 3D white matter organization across modalities within 2 small regions in one monkey brain (body of the corpus callosum, centrum semiovale) and within one region (splenium of the corpus callosum) in healthy mice and in one murine model of focal demyelination. The study compares measures of tissue anisotropy and fiber orientations across modalities, performs a qualitative comparison of fasciculi trajectories across brain regions and tissue conditions using streamlined tractography based on the structure tensor, and attempts to quantify the shape of fasciculi trajectories by measuring the tortuosity index and the maximum deviation for each reconstructed streamline. Results show measures of anisotropy and fiber orientations largely agree across modalities, especially for larger FOV data. The high-resolution data allows us to explore the fiber trajectories in relation to tissue complexity and pathology. The authors claim the study reveals new common organization principles of white matter fibers across species and scales, for which axonal fasciculi arrange into sheet-like laminar structures.

      Strengths:

      The aim of the study is of central importance within present efforts to bridge the gap between macroscopic structures observable in vivo in humans using conventional diffusion MRI and the microscopic organization of white matter tissue. Results obtained from this type of study are important to interpret data obtained in vivo, inform the development of novel methodologies, and expand our knowledge of the structural and thus functional organization of brain circuits.

      Multi-scale data acquired across modalities within the same sample constitute extremely valuable data that is often hard to acquire and represent a precious resource for validation of both diffusion MRI tractography and microstructure methods.

      The inclusion of multi-species data adds value to the study, allowing the exploration of common organization principles across species.

      The addition of data from a murine cuprizone model of focal demyelination adds interesting opportunities to study the underlying biological changes that follow demyelination and how these impact tissue anisotropy and fiber trajectories. These data can inform the interpretation and development of diffusion MRI microstructure models.

      Weaknesses:

      The main claim of a newly discovered laminar organization principle that is consistent across scales and species is not supported strongly enough by the data. The main evidence in support of the claim comes from the larger FOV data obtained from the body of the corpus callosum in the monkey brain. A laminar organization principle is partially shown in the centrum semiovale in the monkey brain and it is not shown in mice data. Additionally, the methods lack details to help the correct interpretation of these findings (e.g., how were these fasciculi defined?; how well do they represent different axonal populations?; what is the effect of blood vessels on the structure tensor reconstruction?; how was laminar separation quantified?) and the discussion does not provide a biological background for this organization. The corpus callosum sample suggests axons within a bundle of fibers are organized in a sheet-like fashion, while data from the centrum semiovale suggest fibers belonging to different fiber bundles are organized in a sheet-like arrangement. While I acknowledge the challenges in acquiring such high-resolution data, additional samples from different regions in the same animals and from different animals would help strengthen this claim.

      R2.1 

      -  how were these fasciculi defined?

      In the introduction (page 3), we have clarified our definition of an axon fasciculus: “A fasciculus is a bundle of axons that travel together over short or long distances. Its size and shape can vary depending on its internal organisation and its relationship to neighbouring fasciculi.”

      Additionally, we emphasise in the Results section (page 12) that the centroid streamlines are not guaranteed to be actual fasciculi, but rather representations of them. The paragraph now states: “To ease visualisation and quantification, we used QuickBundle clustering(Garyfallidis et al. 2012) to group neighbouring streamlines with similar trajectories into a centroid streamline. This centroid streamline serves as an approximation of the actual trajectory of a fasciculus.”

      - what is the effect of blood vessels on the structure tensor reconstruction?

      Fair point, that was not clear from our description. The clarification contains two parts. First, the estimation of the structure tensor occurs in all voxels, and in that sense, the blood vessels respond very similarly to axons. Second, when it comes to sample statistics derived from the structure tensor analysis (FA histograms and the FODs), they will have an influence, albeit a small one, given the low volume percentage of the blood vessels within the FOVs. In the monkey samples, segmenting the blood vessels was achievable with little effort, allowing us to exclude their contribution from FA statistics and FODs. To make this clear, we have added a paragraph to the Methods section (page 34) titled “Structure tensor-based quantifications,” reflecting this clarification. Additionally, we have restructured the entire structure tensor methods description (starting on page 32) as part of the reviewer comments in R1.6 and R1.9.

      - how was laminar separation quantified?

      We have added a clarification in Results section (page 7): “The laminar thickness was determined by manual measurements on laminae visually identified in the 3D volume”.

      - discussion does not provide a biological background for this organization.

      A good point. Including the biological background is relevant as it supports the laminar organisation of white matter pathways observed in our findings and those of others.

      We have added a section on this background in the Discussion (page 24): “We believe our observed topological rule of white matter laminar organisation can be explained by a biological principle known from studies of nervous tissue development. The first axons to reach their destination, guided by their growth cones, are known as “pioneering” axons. “Follower” axons use the shaft of the pioneering axon for guidance to efficiently reach the target region (Breau and Trembleau 2023). Axons can form a fasciculus by fasciculating or defasciculating along their trajectory through a zippering or unzipping mechanism, controlled by chemical, mechanical, and geometrical parameters. Zippering “glues” the axons together, while unzipping allows them to defasciculate at a low angle (Šmít et al. 2017). Although speculative, the zippering mechanism may be responsible for forming the laminar topology observed across length scales. The defasciculation effect can explain our results in the corpus callosum (CC) of monkeys, with laminar structures at low angles (~35 degrees) also observed by (Innocenti et al. 2019; Caminiti et al. 2009), as well as in other major pathways (Sarubbo et al. 2019). In contrast, a fasciculation mechanism may be observed in the mouse CC (0 degrees). If the geometrical angle between two axons is high, i.e., toward 90 degrees, the zippering mechanism will not occur, and the two axons (fasciculi) will cross (Šmít et al. 2017). This supports our and other findings that crossing fasciculi or pathways occur at high angles toward 90 degrees in the fully matured brain (Wedeen et al. 2012). Once myelination begins, the zippering mechanism is lost (Šmít et al. 2017), suggesting that laminar topology is established at the earliest stages of brain maturation.”

      - additional samples from different regions in the same animals and from different animals would help strengthen this claim

      Reviewer #1 also pointed to the inclusion of additional samples, and this is now discussed as part of the study limitations on page 27 (see also R1.7).

      The main goal of the study is to bridge the organization of white matter across anatomical length scales and species. However, given the substantial difference in FOVs between the two imaging modalities used, and the absence of intermediate-resolution data, it remains difficult to effectively understand how these results can be used to inform conventional diffusion MRI. In this sense, the introduction does not do a good enough job of building a strong motivation for the scientific questions the authors are trying to answer with these experiments and for the specific methodology used.

      R2.2: Indeed, this is an essential point now emphasised in the introduction, page 3, which now states: ”Despite the limited resolution of dMRI, the water diffusion process can reveal microstructural geometrical features, such as axons and cell bodies, though these features are compounded at the voxel level. Consequently, estimating microstructural characteristics depends on biophysical modelling assumptions, which can often be simplistic due to limited knowledge of the 3D morphology of cells and axons and their intermediate-level topological organisation within a voxel. Thus, complementary highresolution imaging techniques that directly capture axon morphology and fasciculi organisation in 3D across different length scales within an MRI voxel are essential for understanding anatomy and improving the accuracy of dMRI-based models(Alexander et al. 2019).”

      Additionally, in the introduction, page 4, we have made the following changes to strengthen the link across modalities, such that it now states: “In the x-ray synchrotron data, we applied a scale-space structure tensor analysis, which allowed for the quantification of structure tensor-derived tissue anisotropy and FOD in the same anatomical regime indirectly detected by dMRI.”

      The cuprizone data represent a unique opportunity to explore the effect of demyelination on white matter tissue. However, this specific part of the study is not well motivated in the introduction and seems to represent a missed opportunity for further exploration of the qualitative and quantitative relationship between diffusion MRI and sub-micron tissue information (although unfortunately not within the same brain sample). This is especially true considering the diffusion MRI protocol for mice would allow extrapolation of advanced measures from different tissue compartments.

      R2.3: A similar point was raised by Reviewer 1 (R1.8), and we have clarified the motivation for including the healthy mice and the demyelination samples.  

      Recommendations for the authors:

      Reviewer #1 (Recommendations For The Authors):

      Many thanks to the authors for providing open data. This was very helpful when reviewing the manuscript and is a valuable resource for the community.

      R1.10: We are happy to share our data with the community. Understanding anatomy in 3D is hard to achieve through still images and animations, so the ability to explore it on your own is quite important. The link to the data repository has been added in the Methods section in the following paragraph: “Due to the size of the data selected, processed image volumes, masks and results are available at https://zenodo.org/records/10458911. Other datasets can be shared on request.“

      One confusing element of the paper is that orientations (or axes) do not seem to be consistent across samples/modalities. For example, the green tensors in Figures 3 C and D are tilted up/down in opposite directions and the streamlines in Figure 5A seem opposite (SL) from what we would expect from Figure 2A (SR). Having consistent orientations across modalities and images would help the reader. When colouring tensors (e.g. in Figure 3), the authors could consider a 3D colour scheme (similar to that used by diffusion MRI) rather than colouring by only inclination, as this would provide useful information on whether different laminae have similar orientations, as implied by the tractography in Figure 4.

      R1.11: Thank you for spotting the suboptimal consistency between Figures 2, 3, and 5. Figure 2 has been corrected and updated. The left-right direction in the coronal views was not correctly displayed. Additionally, the glyph directions have been updated in Figures 2 and 3.

      By default, we use the “standard” RGB colour scheme used in dMRI. However, for the monkey CC— essentially Figure 3—this did not effectively illustrate our findings. We decided to use a different directional colour encoding scheme, which captures the angular deviation from the L-R axis. This was to assist in the visualisation of the inclination angle between the laminars. We have used the same colour scheme for the tensors in Figure 3 to avoid confusion.

      On a general note, the standard colour scheme has uniform “colour contrast” in all directions, but when there is only a single dominant direction in the sample, it can make sense to concentrate the colour contrast in that axis.

      Results: "even higher FA anisotropy in the micro-tensor domain of 0.997, i.e., the micro (μ)FA (20, 21)." I understand these references lead to a definition of μFA that is based on multiple diffusion tensor encodings which is quite different from that suggested by Kaden. It may be preferable to reference Kaden directly (since I understand this is the method used) to avoid confusion.

      R1.12: Correctly spotted, and we now reference the method from Kaden et al. and use the other references elsewhere when relevant.

      "and scanned the mouse brain in a whole." - typo?

      R1.13: Thank you for spotting the typo. The mouse brain was kept in the skull during MRI scanning, which has been clarified in the Methods section.

      The crossing fibre region appears to be sometimes referred to as the centrum semiovale, and other times as the CST. CS seems the better description and keeping this naming consistent would avoid confusion to the reader.

      R1.14: Well spotted, thank you. We have replaced the usage of Corticospinal Tract (CST) with centrum semiovale (CS) where relevant.

      Direct comments on the text:

      Abstract: "Individual axon fasciculi exhibited tortuous paths .... in a manner independent of fibre complexity and demyelination"

      Do statistical comparisons of the various distributions support this? The data shows somewhat increased tortuosity in the CST compared to the CC, and somewhat lower tortuosity in CPZ tissue.

      R1.15: The intention of the text was not to point to the comparison of tortuosity, but rather to highlight the maximum deviation. We observe a high probability density of maximum deviations at approximately 5-10 microns in all samples, which corresponds to the size of structures in the extraaxonal environment, such as blood vessels and cells.

      Additionally, we understand that the original statement might imply an expectation of a statistical analysis demonstrating independence, which is not the case. To clarify, we have reformulated the sentence in the Abstract (page 2) to address these points: “Fasciculi exhibited non-straight paths around obstacles like blood vessels, comparable across the samples of varying fibre complexity and demyelination.”

      Abstract: "A quantitative analysis of tissue anisotropies and fibre orientation distributions gave consistent results for different anatomical length scales and modalities, while being dependent on the field-of-view."

      To my understanding, the FODs here from different modalities are calculated over different FOVs (in monkeys at least), and FODs are only presented for a single FOV for each modality, meaning it is difficult to separate the effects of modality from FOV. The microscopic anisotropy is also noticeably different across modalities (DESY < ESRF < dMRI).

      R1.16: That is a fair point. Our statement was trying to capture too much condensed content to be correctly interpretable. We have reformulated the sentence to state: “Quantifications of fibre orientation distributions were consistent across anatomical length scales and modalities, whereas tissue anisotropy had a more complex relationship, both dependent on the field-of-view”.

      While it is true that we only present the ST-derived quantifications – FOD and FA statistics – for a single FOV per modality and sample, the results shown for the ESRF monkey samples (Figures 3 and 4) are a merge of four individually processed volumes. The quantifications of each individual subFOV have now been added as a supplementary figure (Figure S3) to highlight the consistency of the methodology and the effect of shifting the FOV position. In the case of the mouse, we have two volumes from different mice, which also display similar FOD and FA statistics.

      Abstract: "Our study emphasises the need to balance field-of-view and voxel size when characterising white matter features across anatomical length scales."

      This point does not seem very well explored in the paper, rather it is an observation of the limitations of the different imaging modalities. For example, there aren't analyses to compare metrics from highresolution data at different FOVs (i.e. by taking neighbourhoods of different sizes), nor are metrics compared from data at different resolutions and the same FOV.

      R1.17: The question is related to R1.16, R1.4, and R1.8, and we have addressed this point in our responses to those comments.

      Figure 7 - Taking into account the eigenvalues can be helpful when interpreting the secondary and tertiary eigenvectors of tensors (V2 and V3). It would be interesting to know whether the eigenvalues L2 ~= L3 are approximately equal (suggesting isotropic diffusion about V1, where the definition of V2 versus V3 isn't very meaningful), or if L2 is noticeably larger than L3 (suggesting anisotropic diffusion about V1, potentially similar to the anisotropic dispersion discussed above).

      R1.18: It would be interesting to explore the eigenvalues of the structure tensor in more detail, as has been done for the diffusion tensor. However, we believe this belongs to future work, as such additional detailed methodological analysis would complicate the already complex story. As mentioned in response to R1.10, most processed data has been made publicly available, and the rest can be requested (due to the storage size of the data sets) to perform such additional analysis.

      Discussion: "Importantly, our findings revealed common principles of fibre organisation in both monkeys and mice; small axonal fasciculi and major bundles formed sheet-like laminar structures," See above regarding the lack of evidence for laminar structures in mouse data.

      R1.19: We have reformulated the text for clarification as part of R1.3. Additionally, we added FOD quantifications to support why we do not observe an apparent laminar organisation in the mouse CC— please see our response to R1.6.

      Discussion: "Interestingly, the dispersion magnitude is indicative of fasciculi that skirt around obstacles in the white matter such as cells and blood vessels, and the results are largely independent of both white matter complexity (straight vs crossing fibre region) and pathology." Again, do statistical tests of the various distributions support this?

      R1.20: As part of R1.1, we have added statistical tests of significance for the quantifications of how max deviation changes when bending around objects. Indeed, the distributions are not statistically the same, and we do not wish to convey that sentiment, but they are comparable in the object sizes that they detect. As done in the abstract, we have reformulated the sentence to avoid misunderstanding and have replaced “largely independent” with “observed across.”

      Discussion: "Tax et al. have demonstrated the calculation of a sheet probability index from diffusion MRI data, which suggested the presence of sheet-like features in the CC"

      My understanding was that this was observed in crossing fibre regions, such as where fibres projecting with the CC cross the CST, but not the main body of the CC itself. Tax defines sheet structure as "composed of two tracts that cross each other on the same surface in certain regions along their trajectories." Is this a different phenomenon to the laminar structures observed here (where we observe fibres within a single tract being locally organised into laminar structures)?

      R1.21: Thank you for pointing our attention to this. We have corrected the section in the Discussion (page 23), so it now states: “Additionally, Tax et al. have demonstrated the calculation of a gridcrossing sheet probability index from diffusion MRI data, which suggested the presence of sheet-like features in a crossing fibre region (Tax et al. 2016), which is in line with our findings in the synchrotron data. Note that the method by Tax et al. only detects sheet-like structures crossing on a grid and does not reveal laminar structures with lower inclination angles, as we observed in the monkey CC.”

      Discussion: "We found that FODs were consistent across image resolutions and modalities, but only given that the FOV is the same." See above.

      R1.22: As part of our response to R1.6, we quantified the FODs using the ODI and DA indices, which should help support our statement. Nevertheless, we have toned down the statement and reformulated the text as follows: “We found that FODs were comparable across image resolutions and modalities. The observed discrepancies can be attributed to the fact that the FOVs are not exactly matched.”

      Discussion: "microscopic FA were highly correlated across modalities."

      The data shows FA is considerably lower in DESY to ESRF; within modality FA is quite consistent irrespective of tissue region; and differences between the CC and CG shown in ESRF data in mice are not repeated in DESY. It is unclear from the current data if this would lead to a high correlation across modalities. Some evidence would be helpful.

      R1.23: This is a fair point; we have not performed a correlation analysis. However, the pattern we observe for the synchrotron samples is as follows: When the anatomical length scale increases (becomes more macroscopic), the FA distribution shifts to lower values. This reflects the scale of information captured with the ST analysis (see also R1.9). Therefore, the most interesting comparison of FA statistics occurs when the resolution and anatomical length scale are approximately the same.  The sentence in question has been reformulated to the following: ”Estimates of structure tensor derived microscopic FA show a clear pattern across modalities.”

      Discussion: "If so, the (inclination angle) information might serve to form rules for low-resolution diffusion MRI based tractography about how best to project through bottleneck regions, which is currently a source of false-positives trajectories (6)."

      This is an interesting idea but it is unclear to me how this inclination information would help track through bottlenecks where, by definition, fibres are passing through with the same orientation. Some further explanation would be helpful.

      R1.24: We have elaborated on the section in the Discussion (page 23), explaining how this can be used to improve tractography tracing through complex regions: “The reason is that standard tractography methods do not "remember" or follow anatomical organisation rules as they trace through complex regions. Our findings on pathway lamination and inclination angles—low for parallel-like trajectories and high for crossing-like trajectories—can help incorporate trajectory memory into these methods, reducing the risk of false trajectories”.

      Reviewer #2 (Recommendations For The Authors):

      Below I report comments that if addressed I believe would improve the clarity and readability of the manuscript.

      -  Figures 1 and 2 would be more meaningful if combined into one figure. This would allow for a direct visual comparison of the two modalities. If space is needed, I believe the second row of Figure 1 (coronal views of CC) does not add much information. It is often hard to navigate the different orientations of the tissue in the images; thus any effort in trying to help the reader visually clarify would improve readability.

      R2.4: We considered the reviewer’s suggestion to merge Figures 2 and 3. However, this made both the figures and the main text additionally complex, so we chose to retain the original figure layout. Secondly, Figure 3 utilises a non-standard directional colormap. Keeping the colormap consistent within each figure is a feature we wish to preserve. In response to R1.11, the figures have been updated to have more consistent orientations for the monkey samples.

      In Figure 2, the second row, showing a coronal view of the CC, is essential for comparison with human data in Figure S1. It highlights where we observed the columnar laminar organisation and their inclination angle, as also detected by DTI.

      -  Figure 4 shows synchrotron data revealing an anterior-posterior component within the centrum semiovale that is not necessarily seen in the dMRI data. Could the authors comment on this?

      R2.5: Thank you for pointing this out. We have now addressed this in the Results section (page 10), where we describe the observation in detail: “Interestingly, visual inspection of the colour-coded structure tensor directions in Fig. 4E shows the existence of voxels whose primary direction is along the A-P axis. However, this represents a small enough portion of the volume that it does not appear as a distinct peak on the FOD.“

      -  The authors claim they observed several purple axons crossing orthogonally in Figure 5c. However, that is not necessarily clear in the figure.

      R2.6: We appreciate the feedback. We have now coloured the streamlines of the crossing fasciculi in Figure 5C in red.

      -  Figure 5 would benefit from adding the color encoding scheme for Figure 5d, as sometimes this is not necessarily consistent.

      R2.7: We appreciate the feedback. We have added an indication of the standard directional colour coding to Figure 5D.

      -  Figure 5d shows interesting data from the complex region. However, it is hard to visualize and it looks like there are not many streamlines traveling entirely I-S? Maybe a different orientation of the sample would help visualization.

      R2.8: A similar point was raised by Reviewer 1 (see R1.2). We have added an animation of the scene to assist in the interpretation of the 3D organisation within this complex sample.

      -  The concept of axon fasciculi is not necessarily immediately clear. Adding an explanation for what the authors refer to when using this term would improve clarity.

      R2.9: In the introduction, we now state our conceptual definition of an axon fasciculus as a number of axons that follow each other (see also R2.1).

      -  The methods do not provide details on how structure tensor FA is measured.

      R2.10: Thank you for pointing this out. We have restructured and expanded the structure tensor description in the Methods section (see also R1.9 and R2.1), which now includes the definition of FA.

      -  Why didn't the authors select the same cc region for both mice and monkeys? It seems this would have increased the strength of the comparison.

      R2.11: We agree. The reason lies in the chronology of experiments and the fact that we cannot control where demyelination takes place. We have added a clarifying description in the Methods section (page 31): “Note that several separate beamline experiments were conducted to collect the volumes listed in Table 1. In the first two experiments, samples from the monkey brain were scanned at ESRF and DESY, respectively. The samples from the mouse brain were imaged in two subsequent experiments. Consequently, the location of the identified demyelinating lesion in the cuprizone mice, which cannot be precisely controlled, did not match the location of the CC biopsies in the monkey.”

      -  While it is mentioned in the results, the methods do not explain how vessel segmentations or cell segmentation in mice was performed and for which datasets it was performed.

      R2.12: For the small ROI shown in Figure 6, the labelling was a manual process using the software ITK-SNAP, which has now been clarified in the corresponding figure caption. The generation of ROI masks and blood vessel segmentations involved a combination of intensity thresholding, morphological operations, and manual labelling in ITK-SNAP. This has been clarified in the restructured and expanded description of structure tensor analysis in the Methods section (starting on page 32).

      -  From the methods it is hard to understand (1) how many mice were used; (2) why dMRI was done on a different sample; (3) whether the same selenium region was selected for both healthy and CPZ animals; (4) how the registration across samples was performed.

      R2.13: We appreciate the feedback and have inserted clarifying statements in the relevant parts of the Methods section. (1) The total number of mice included was three: one normal, one cuprizone, and one normal for MRI scanning. (2) The quality of the collected dMRI on the mouse was too poor to use, and it could not be redone as the brain had already been sliced and prepared for synchrotron experiments. (3) The same splenium section was selected for both healthy and cuprizone mice. (4) A paragraph on image registration has been added.

      -  Diffusion MRI method sections would benefit from additional details on the protocols used.

      R2.14: Thank you for pointing this out. We have added more details about the diffusion MRI protocols, including the b-value, gradient strength, and other relevant parameters.

    1. Author response:

      eLife Assessment

      This study provides useful findings about the effects of heterozygosity for Trio variants linked to neurodevelopmental and psychiatric disorders in mice. However, the strength of the evidence is limited and incomplete mainly because the experimental flow is difficult to follow, raising concerns about the conclusions' robustness. Clearer connections between variables, such as sex, age, behavior, brain regions, and synaptic measures, and more methodological detail on breeding strategies, test timelines, electrophysiology, and analysis, are needed to support their claims.

      We appreciate the opportunity to address the constructive feedback provided by eLife and the reviewers. Below, we respond to the overall assessment and individual reviewers' comments, clarifying our experimental approach, addressing concerns, and providing additional details where necessary.

      We thank the editors for highlighting the significance of our findings regarding the effects of Trio variant heterozygosity in mice. We acknowledge the feedback concerning the experimental flow and agree that clarity is paramount. To address these concerns:

      (1) Connections between variables: We will revise the manuscript to explicitly outline and extend explanations and the relationships between sex, age, behavior, brain regions, and synaptic measures, ensuring that the rationale for each experiment and its relevance to the overall conclusions are improved.

      (2) Methodological details: Our paper Methods section was formatted to be short with additional details provided in the Supplemental Methods section.  We will merge all into an extended section to improve clarity. We will also expand on our breeding strategies, test timelines, electrophysiological protocols, and data analysis methods in the revised Methods section. These additions aim to enhance the transparency and reproducibility of our study and to ensure full support of our conclusions.

      (3) Experimental flow: We will revise and extend our results, methods, and discussion sections to clarify the rationale and experimental design to guide readers through the experimental sequence and rationale.

      We are confident these revisions address the concerns raised and enhance the robustness and coherence of our findings.

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      This study explores how heterozygosity for specific neurodevelopmental disorder-associated Trio variants affects mouse behavior, brain structure, and synaptic function, revealing distinct impacts on motor, social, and cognitive behaviors linked to clinical phenotypes. Findings demonstrate that Trio variants yield unique changes in synaptic plasticity and glutamate release, highlighting Trio's critical role in presynaptic function and the importance of examining variant heterozygosity in vivo.

      Strengths:

      This study generated multiple mouse lines to model each Trio variant, reflecting point mutations observed in human patients with developmental disorders. The authors employed various approaches to evaluate the resulting behavioral, neuronal morphology, synaptic function, and proteomic phenotypes.

      Weaknesses:

      While the authors present extensive results, the flow of experiments is challenging to follow, raising concerns about the strength of the experimental conclusions. Additionally, the connection between sex, age, behavioral data, brain regions, synaptic transmission, and plasticity lacks clarity, making it difficult to understand the rationale behind each experiment. Clearer explanations of the purpose and connections between experiments are recommended. Furthermore, the methodology requires more detail, particularly regarding mouse breeding strategies, timelines for behavioral tests, electrophysiology conditions, and data analysis procedures.

      We appreciate the reviewer’s recognition of the novelty and comprehensiveness of our approach, particularly the generation of multiple mouse lines and our efforts to model Trio variant effects in vivo.

      Weaknesses

      (1) Experimental flow and rationale and connection between variables: We will expand on the connections between behavioral data, neuronal morphology, synaptic function, and proteomics in the Results and Discussion sections to clarify how each experiment informs the reasoning and the conclusions and to highlight the relationships between sex, age, behavior, and synaptic measures.

      (2) Methodological details: Our paper Methods section was formatted to be short to fulfill word limits on the submitted version, with additional details provided in the Supplemental Methods section. We will merge our Methods and Supplemental Methods sections and expand on our breeding strategies, test timelines, electrophysiological protocols, and data analysis methods in the revised Methods section.  These additions aim to enhance the transparency and reproducibility of our study and to ensure full support of our conclusions.

      Reviewer #2 (Public review):

      Summary:

      The authors generated three mouse lines harboring ASD, Schizophrenia, and Bipolar-associated variants in the TRIO gene. Anatomical, behavioral, physiological, and biochemical assays were deployed to compare and contrast the impact of these mutations in these animals. In this undertaking, the authors sought to identify and characterize the cellular and molecular mechanisms responsible for ASD, Schizophrenia, and Bipolar disorder development.

      Strengths:

      The establishment of TRIO dysfunction in the development of ASD, Schizophrenia, and Bipolar disorder is very recent and of great interest. Disorder-specific variants have been identified in the TRIO gene, and this study is the first to compare and contrast the impact of these variants in vivo in preclinical models. The impact of these mutations was carefully examined using an impressive host of methods. The authors achieved their goal of identifying behavioral, physiological, and molecular alterations that are disorder/variant specific. The impact of this work is extremely high given the growing appreciation of TRIO dysfunction in a large number of brain-related disorders. This work is very interesting in that it begins to identify the unique and subtle ways brain function is altered in ASD, Schizophrenia, and Bipolar disorder.

      Weaknesses:

      (1) Most assays were performed in older animals and perhaps only capture alterations that result from homeostatic changes resulting from prodromal pathology that may look very different.

      (2) Identification of upregulated (potentially compensating) genes in response to these disorder-specific Trio variants is extremely interesting. However, a functional demonstration of compensation is not provided.

      (3) There are instances where data is not shown in the manuscript. See "data not shown". All data collected should be provided even if significant differences are not observed.

      I consider weaknesses 1 and 2 minor. While they would very interesting to explore, these experiments might be more appropriate for a follow-up study. I would recommend that the missing data in 3 should be provided in the supplemental material.

      We are grateful for the reviewer’s recognition of our study’s significance and methodological rigor. The acknowledgment of Trio dysfunction as a novel and impactful area of research is deeply appreciated.

      Weaknesses: 

      We agree that focusing on older animals may limit insights into early-stage pathophysiology. However, given the goal of this study was to examine the functional impacts of Trio heterozygosity at an adolescent stage and to reveal the ultimate impact of these alleles on synaptic function, we believe the choice of animal age aligns with our objectives. We agree that future studies of earlier developmental stages will be beneficial and complement these findings.

      Functional compensation: In this study, we tested functional compensation through rescue experiments in +/K1431M brain slices using a Rac1-specific inhibitor, NSC, which prevents its activation by Trio or Tiam1. Our findings strongly suggest that increased Rac1 activity, attributed to the proposed compensation, drives the deficiency in neurotransmitter release. Furthermore, this deficiency can be normalized by direct Rac1 inhibition.

      Data not shown: We will incorporate all previously shown data into the Supplemental Materials, even when results are nonsignificant. We agree that this ensures full transparency and facilitates a more comprehensive evaluation of our findings.

    1. Author response:

      We thank the editors at eLife and the reviewers for the care with which our mansucript has been reviewed and the constructive feedback that we have received. Both reviewers viewed the manuscript positively and in particular praised the merits of the forward genetic screen that led to the discovery of a new link between the HIF-1 pathway and fatty acid desaturation.

      We agree with all points by Reviewer #1. We will modify our manuscript to clarify that two types of C18:1 fatty acids are present in our lipidomics, and that the majority is likely vaccenic acid that is not a FAT-2 substrate. The title will be modified and Fig. 1A corrected.

      All points raised by Reviewer #2 are also valid and we will try to address most of them experimentally, though not always as suggested. In particular, we plan to use FRAP to verify that membrane-fluidizing treatments are effective in the fat-2 mutant. We also plan to use qPCR to test whether the novel egl-9(lof) and hif-1(gof) alleles lead to the expected downregulation of ftn-2. We note that the pathway connecting EGL-9, HIF-1 and FTN-2 is well supported by published work and that the alleles isolated in our screen are consistent with it, with the addition that FAT-2 is likely a regulated outcome of FTN-2 inhibition/mutation. We also plan to monitor FAT-2 protein levels using Western blots and thus provide more clarity about the mechanism of action of the novel fat-2(wa17) suppressors. The manuscript will be modified to tone down interpretations not directly supported by experiments.

    1. Author response:

      We would like to thank the editors and reviewers for reviewing our work, for finding it valuable supported by convincing data, which we greatly appreciate, but also for identifying the weaknesses of the manuscript. We plan to address these weaknesses in the revised version, briefly as follows:

      (1) In the Discussion, we will elaborate more on a possible generalization of our results, while being aware of the limited space in this experimental paper and therefore intend to address this in more detail and comprehensively in a subsequent perspective article.

      (2) In the Discussion, we will more clearly address the limitations of our work, in particular the difference between the measurement of extracellular adenosine production ex vivo and the actual production in vivo, where the measurement is indeed very challenging, and also the limitations of manipulating the SAM pathway only at the Ahcy level.

      (3) We will describe in detail and complement the supplementary RNAseq data. The RNAseq data have already been described in detail in our previous paper (doi.org/10.1371/journal.pbio.3002299), but we agree with the reviewers that we should describe the necessary details again here.

      (4) We will fill in the missing data on encapsulation efficiency; we agree that it was unfortunate to omit them.

      (5) We will supplement the data with methyltransferase expressions and better describe the changes in expression of some SAM pathway genes, which, especially with methyltransferase expressions, also support stimulation of this pathway by changes in expression. Although the goal of this work was to test by 13C-labeling whether SAM pathway activity is upregulated, not to analyze how the activity is regulated, we certainly agree that an explanation of possible regulation, especially in the context of the enzyme expressions we show, should be included in our work.

    1. Author response:

      We thank the editors and reviewers for their comments on our manuscript. We found the comments of the reviewers helpful and plan to add new text, analyses, and figures to answer some of the outstanding questions.

      In response to the reviewers’ comments, we will clarify the goal of the paper in the introduction: to test the hypothesis that causal knowledge (i.e., an intuitive theory of biology) is embedded in domain-preferring semantic networks (i.e., semantic animacy network). This work links developmental psychology work on intuitive theories and cognitive neuroscience.

      As we will emphasize in the revised manuscript, the primary goal of the current paper is to test the claim that semantic networks encode causal knowledge, rather than to rule out the contribution of domain-general reasoning mechanisms to causal inference.

      In response to the reviewers’ suggestions, we will add multivariate and univariate whole-cortex analyses that provide further tests for domain-general causality responses. In particular, we will include new figures showing univariate responses to the mechanical inference condition over the non-causal control conditions as well as decoding between these conditions. The reviewers have also asked us to provide individual subject dispersion data. We appreciate this suggestion, and new figures will be added to display this information.

      We will also perform additional analysis in the precuneus (PC) to look for shared responses to illness and mechanical inferences. In accordance with our hypotheses, we have shown that the PC responds preferentially to illness inferences. To address the reviewers’ concerns about the selectivity of the PC to illness inferences, we will compare responses to i) illness inferences compared to the noncausal conditions and ii) mechanical inferences compared to the noncausal conditions in the PC to investigate the extent to which a shared response to causal inference across domains emerges in this region.

      Critically, we find that the cortical areas that distinguish between causal and non-causal conditions in a ‘domain general manner’ (i.e., for both illness and mechanical inferences) are driven by higher responses to the non-causal condition. Moreover, these responses in prefrontal cortex and elsewhere overlap an RT predictor of neural activity, suggesting that they may reflect difficulty effects.

      These results suggest that in the current task, signatures of causal inference are primarily found in domain-preferring semantic networks, rather than in domain-general fronto-parietal reasoning systems. We will provide additional discussion of the argument that the current results do not speak against the role of domain general systems across all types of causal reasoning. Instead, they suggest that the types of implicit causal inferences measured in the current study depend primarily on domain-preferring semantic networks.

      The reviewers have asked us to analyze responses to causal inferences about illness in the fusiform face area (FFA). We will perform this analysis. However, we note that univariate and multivariate whole-cortex analyses that are already included in the paper did not identify lateral ventral occipito-temporal cortex as a key region involved in causal inferences about illness. Further, we do not have FFA localizer data in the current participants; therefore, the results cannot be interpreted to reflect activity in functionally defined FFA.

      Two reviewers asked us to justify our choice of an implicit magic-detection task, which we will now do more clearly in the manuscript. This task was selected to ensure that participants were attending to the meaning of the vignettes. The goal of the current study was to investigate implicit causal inferences that routinely occur in language comprehension, e.g., when someone is reading a book. Past work has shown that explicitly judging the causality of causal and non-causal stimuli results in differences in response times across conditions (e.g., Kuperberg et al., 2006). In the current study, such judgments would also have introduced a confound between the behavioral decision and the condition of interest: the use of an explicit causal judgment task makes it impossible to know whether any observed neural differences between causal and non-causal conditions are simply due to differences in the selection of task responses. The selection of an orthogonal magic-detection task limits these confounds from complicating our interpretation of the neural data.

      One of the reviewers asked us to justify the number of catch trials that we decided to include in our paradigm. Approximately 20% of the vignettes were “magical” vignettes (the same proportion as each of the 4 experimental conditions) to encourage participants to remain attentive throughout the task. Since these catch trials are excluded from analysis, their proportion is unlikely to influence the results of the study. We will clarify this in the manuscript.

      A question was raised about the balance of trial numbers across conditions and across runs. To address this, we will include individual comparisons of each causal condition (n=36) with each non-causal condition (n=36; i.e., equal trial counts) where they are not already shown. With regard to runs, each condition is shown either 6 or 7 times per run (maximum difference of 1 trial between conditions), and the number of trials per condition is equal across the whole experiment: each condition is shown 7 times in two of the runs and 6 times four of the runs. This minor design imbalance is typical of fMRI experiments and is unlikely to impact the results. We will clarify this in the manuscript.

      We believe that our planned revisions will strengthen the paper and highlight its contributions to our understanding of the neural basis of implicit causal inference.

    1. Author response:

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      Horizontal gene transfer is the transmission of genetic material between organisms through ways other than reproduction. Frequent in prokaryotes, this mode of genetic exchange is scarcer in eukaryotes, especially in multicellular eukaryotes. Furthermore, the mechanisms involved in eukaryotic HGT are unknown. This article by Banerjee et al. claims that HGT occurs massively between cells of multicellular organisms. According to this study, the cell free chromatin particles (cfChPs) that are massively released by dying cells are incorporated in the nucleus of neighboring cells. These cfChPs are frequently rearranged and amplified to form concatemers, they are made of open chromatin, expressed, and capable of producing proteins. Furthermore, the study also suggests that cfChPs transmit transposable elements (TEs) between cells on a regular basis, and that these TEs can transpose, multiply, and invade receiving cells. These conclusions are based on a series of experiments consisting in releasing cfChPs isolated from various human sera into the culture medium of mouse cells, and using FISH and immunofluorescence to monitor the state and fate of cfChPs after several passages of the mouse cell line.

      Strengths:

      The results presented in this study are interesting because they may reveal unsuspected properties of some cell types that may be able to internalize free-circulating chromatin, leading to its chromosomal incorporation, expression, and unleashing of TEs. The authors propose that this phenomenon may have profound impacts in terms of diseases and genome evolution. They even suggest that this could occur in germ cells, leading to within-organism HGT with long-term consequences.

      Weaknesses:

      The claims of massive HGT between cells through internalization of cfChPs are not well supported because they are only based on evidence from one type of methodological approach: immunofluorescence and fluorescent in situ hybridization (FISH) using protein antibodies and DNA probes. Yet, such strong claims require validation by at least one, but preferably multiple, additional orthogonal approaches. This includes, for example, whole genome sequencing (to validate concatemerization, integration in receiving cells, transposition in receiving cells), RNA-seq (to validate expression), ChiP-seq (to validate chromatin state).

      We agree with the reviewer’s suggestions. We propose to use RNA-seq using an orthogonal platform as a solution. This will allow us to answer multiple questions viz. validation of expression of human DNA in mouse cells, obtaining a detailed insight into genes and pathways driven by human cfChPs and enable us to identify chimeric human and mouse transcripts.

      Another weakness of this study is that it is performed only in one receiving cell type (NIH3T3 mouse cells). Thus, rather than a general phenomenon occurring on a massive scale in every multicellular organism, it could merely reflect aberrant properties of a cell line that for some reason became permeable to exogenous cfChPs. This begs the question of the relevance of this study for living organisms.

      We agree with the reviewer’s suggestion. We propose to show horizontal transfer of cfChPs using four different cell-lines representing four different species.

      Should HGT through internalization of circulating chromatin occur on a massive scale, as claimed in this study, and as illustrated by the many FISH foci observed in Fig 3 for example, one would expect that the level of somatic mosaicism may be so high that it would prevent assembling a contiguous genome for a given organism. Yet, telomere-to-telomere genomes have been produced for many eukaryote species, calling into question the conclusions of this study.

      The reviewer is right in expecting that the level of somatic mosaicism may be so high that it would prevent assembling a contiguous genome. This is indeed the case, and we find that beyond ~ 250 passages the genomes of the cfChPs treated NIH3T3 cells begin to die out apparently become their genomes have become too unstable for survival. This point will be highlighted in the revised version. It is likely that cell death resulting from large scale HGT creates a vicious cycle of more cell death induced by cfChPs thereby helping to explain the massive daily turnover of cells in the body (10<sup>9</sup> – 10<sup>12</sup> cells per day).  

      Reviewer #2 (Public review):

      I must note that my comments pertain to the evolutionary interpretations rather than the study's technical results. The techniques appear to be appropriately applied and interpreted, but I do not feel sufficiently qualified to assess this aspect of the work in detail.

      I was repeatedly puzzled by the use of the term "function." Part of the issue may stem from slightly different interpretations of this word in different fields. In my understanding, "function" should denote not just what a structure does, but what it has been selected for. In this context, where it is unclear if cfChPs have been selected for in any way, the use of this term seems questionable.

      We think this is a matter of semantics. We have used the term “function” since cfChPs that enter the cell are biologically active; they transcribe, translate, synthesize, proteins and proliferate. We, therefore feel that the term function is not inappropriate.

      Similarly, the term "predatory genome," used in the title and throughout the paper, appears ambiguous and unjustified. At this stage, I am unconvinced that cfChPs provide any evolutionary advantage to the genome. It is entirely possible that these structures have no function whatsoever and could simply be byproducts of other processes. The findings presented in this study do not rule out this neutral hypothesis. Alternatively, some particular components of the genome could be driving the process and may have been selected to do so. This brings us to the hypothesis that cfChPs could serve as vehicles for transposable elements. While speculative, this idea seems to be compatible with the study's findings and merits further exploration.

      We take the reviewer’s point. We will replace the term “predatory genome” with a more neutral and factual term “supernumerary genome” in the title and throughout the manuscript in the revised version.

      I also found some elements of the discussion unclear and speculative, particularly the final section on the evolution of mammals. If the intention is simply to highlight the evolutionary impact of horizontal transfer of transposable elements (e.g., as a source of new mutations), this should be explicitly stated. In any case, this part of the discussion requires further clarification and justification.

      We propose to revise the “discussion” section taking into account the issues raised by the reviewer and highlight the potential role of cfChPs in evolution by acting as vehicles of transposable elements.  

      In summary, this study presents important new findings on the behavior of cfChPs when introduced into a foreign cellular context. However, it overextends its evolutionary interpretations, often in an unclear and speculative manner. The concept of the "predatory genome" should be better defined and justified or removed altogether. Conversely, the suggestion that cfChPs may function at the level of transposable elements (rather than the entire genome or organism) could be given more emphasis.

      Our responses to this paragraph are given in the two above sections.

    1. Author response:

      We thank the reviewers for their careful readings of our paper and their very positive assessment. Here we address the two major concerns they raised, referring to the revised version of the manuscript that will be submitted:

      (1) Important points were raised regarding the brief elongation events we reported. The time resolution and noise in our system reduce the accuracy of the burst velocity measurements. To address this, we have reached out to a colleague who is set up to repeat these measurements with microfluidics-assisted TIRF. The noise should be greatly reduced and the system is also optimal for directly visualizing labeled FHOD3, as suggested. We hope this experimental approach will provide new insights.

      In the meantime, we analyzed our data more closely. We were asked about the pauses we observe before bursts of elongation and how we know they are functionally relevant. The short answer is that we do not know. We reported them because they were so common:  in three independent experiments with wild type FHOD3L-CT we analyzed a total of 20 filaments. We detected 112 dim regions and 97 of these were pause/burst events (~87%). Among the cases lacking a pause we include instances of apparent "double bursts" with no time for capping in between (which may be a time resolution issue) and some cases where the burst was in progress when data collection started. In the latter case, we cannot determine whether or not a pause was missed. We cannot rule out that this pause reflects an interaction with the surface but might expect the frequency to be lower if it were. In fact, we did detect pauses in the profilin-actin negative control but only 4 pauses were detected across 21 filaments analyzed compared to 97 pauses observed in the presence of wild type FHOD3L across 20 filaments analyzed. We will revise the text to make our conclusions about pauses more circumspect.

      For comparison to our current data, we further analyzed the filaments in TIRF assays with no formin present. As the reviewers point out, inhomogeneities in filament intensity are normal. Thus, we examined any dim spots for pauses and/or bursts. We will report (future Figure 2G) that the velocity of growth of these dim spots was the same as the velocity of the rest of the filament. While our numbers may not be perfectly accurate due to the noise in our system, the difference of 3-4 fold increase versus no detectable change in rate is substantial and statistically different. In addition, we determined the number of dim spots per length of filament. We found a higher frequency of dim spots when FHOD3L-CT or FHOD3S-CT was present vs no formin, as will be shown in Figure 2 – figure supplement 1G and 2D.

      We are convinced that the brief dim events we observed in the presence of FHOD3L-CT do, in fact, reflect formin-mediated elongation and hope that the reviewers concur. This does not preclude our interest in the microfluidics and two-color assays, which we will pursue in the future.

      (2) The reviewers were concerned about the low protein levels in the GS-FH1 rescue experiments as reflected in the HA fluorescence intensity distributions shown in Fig. 5 – figure supplement 2A. While the scenario proposed could explain our observations with the GSFH1 rescues, it is quite complex and does not preclude the conclusion that the FH1 domain is critical. One limit of this scenario would be that the protein levels in the GS-FH1 cells reflect completely inactive protein, as opposed to FHOD3L that cannot elongate (by design). Given that the C-terminal half of the protein folds and functions and that the changes are made within an intrinsically disordered region, we do not favor this model. The reviewers suggest that the mutant protein detected in the few cells with (probably residual) sarcomeres could be stabilized, in part or entirely, by heterodimerization with residual endogenous wild type protein. We agree that heterodimerization is possible. The question becomes, how active is a heterodimer? If heterodimers have any activity, it seems far from sufficient to rescue sarcomere formation, suggesting that two functional FH1 domains are critical. To confirm this possibility, we would have to be able to determine whether the few sarcomeres present in these cases are residual and/or the new sarcomeres the low level of heterodimers could make. That said, we do not see evidence of correlation between protein levels and rescue at the level present in these cells (addressed below). Unfortunately, the proposed IP to test whether FHOD3L binds actin in vivo would only potentially report on filament side binding (both direct and indirect). It would not address whether the GS-FH1 mutant functions as a nucleator, elongator, bundler and/or capping protein in vivo.

      If we assume that the protein present is active, the critical question that we can address is whether the phenotype is due to low protein levels or if the phenotype is due to loss of elongation activity by FHOD3L. To address this question, we revisited our data.

      First, we plotted the distributions of the intensities of the cells we analyzed further, in addition to the automated readout of all the cells in the dish we originally presented (e.g. Fig. 4 – figure supplement 2A,B). These cells were selected randomly and, as should be the case, the distributions of their intensities agree well with the original distributions for the three different rescue constructs: FHOD3L, K1193L, and GS-FH1 (Fig. 6 – figure supplement 1A,B). We then asked whether there was any correlation between HA intensities with the sarcomere metrics. Consistent with in our pilot data, no correlation is evident in any of the three cases across the range of intensities we collected (400 – 2700 a.u.) (Fig. 6 – figure supplement 1C,D,E). We were originally satisfied with the GS-FH1 data, despite the low average intensity levels, because the intensities were well within the range that we established in pilot studies. These data reconfirm that the intensity levels are reasonable in a larger study.

      To more specifically address the question of whether low HA fluorescence intensity is likely to reflect sufficient protein levels to build sarcomeres, we re-examined two data sets from the FHOD3L WT rescue data. We found that, by chance, the first replicate of data from the wild type rescue has a comparable intensity distribution to that of the GSFH1 rescues (580 +/- 261 / cell vs. 548 +/- 105 / cell). In addition, we collected all of the data from cells with intensity levels <720, selected to mimic the distribution of the GS-FH1 cells (Fig. 6 – figure supplement 3A). We then compared the sarcomere metrics (sarcomere number, sarcomere length, sarcomere width) between the full data set and the two low intensity subsets using statistical tests as reported for the rest of the cell biology data set:

      · Sarcomere number is the only non-normal metric. We therefore used the Mann Whitney U test for each pairwise comparison, which shows no difference between all 3 WT distributions.

      · We compared Z-line lengths by Student’s two-sample, unpaired t-test for each pairwise comparison, again finding no significant difference for all distributions.

      · Sarcomere length shows a weakly significant difference (p=0.017 (compared to 0.033 for 3 treatment groups based on Bonferroni correction)) between the whole WT data set and bio rep 1, but no difference between the whole WT data set and the HA<720 group via Student’s two-sample, unpaired t-test.

      An alternate statistical analysis approach, one-way ANOVA and Tukey post hoc tests, gave similar results. Thus, cells expressing wild type FHOD3L at levels comparable to levels detected in GS-FH1 mutant rescues, are fully rescued. Based on these findings we conclude that the expression levels in the GS-FH1 are high enough to rescue the FHOD3 knock down, supporting our conclusion that the defect is due to loss of elongation activity. We will add this analysis and discussion to the revised manuscript.

      In future studies we will design less severe mutations to the FH1 domain. We hope to identify one with a strong effect on elongation and another with an intermediate effect. Once the best candidates are characterized in vitro, we will test them in our rescue experiments. If the strong mutant mimics the GS-FH1 rescue and the intermediate mutant is less severe, we will have strengthened our conclusion that elongation is a critical FHOD3L activity in sarcomere formation.

      Additional improvements will be made to the manuscript based on recommendations we received from the reviewers.

    1. Author response:

      The following is the authors’ response to the original reviews.

      eLife Assessment

      This is a potentially interesting study regarding the role of gasdesmin D in experimental psoriasis. The study contains useful data from murine models of skin inflammation, however the main claims (on neutrophil pyroptosis) are incompletely supported in its current form and require additional experimental support to justify the conclusions made.

      We sincerely appreciate the positive assessment regarding the significance of our study, as well as the valuable suggestions provided by the reviewers. We have included new data, further discussions and clarifications in the revised manuscript to adequately address all the concerns raised by the reviewers and better support our conclusions.

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      In this study, Liu, Jiang, Diao et.al. investigated the role of GSDMD in psoriasis-like skin inflammation in mice. The authors have used full-body GSDMD knock-out mice and Gsdm floxed mice crossed with the S100A8- Cre. In both mice, the deficiency of GSDMD ameliorated the skin phenotype induced by the imiquimod. The authors also analyzed RNA sequencing data from the psoriatic patients to show an elevated expression of GSDMD in the psoriatic skin.

      Overall, this is a potentially interesting study, however, the manuscript in its current format is not completely a novel study.

      Strengths:

      It has the potential to unravel the new role of neutrophils.

      Weaknesses:

      The main claims are only partially supported and have scope to improve

      We thank the reviewer for the positive evaluation of the interest and potential of our work. In response to reviewers’ suggestions, we have added new content, including additional data and discussions, to further demonstrate the important role of GSDMD-mediated neutrophil pyroptosis in the pathogenesis of psoriasis, thereby enhancing the completeness of our research.

      Reviewer #2 (Public review):

      Summary:

      The authors describe elevated GSDMD expression in psoriatic skin, and knock-out of GSDMD abrogates psoriasis-like inflammation.

      Strengths:

      The study is well conducted with transgenic mouse models. Using mouse-models with GSDMD knock-out showing abrogating inflammation, as well as GSDMD fl/fl mice without neutrophils having a reduced phenotype.

      I fear that some of the conclusions cannot be drawn by the suggested experiments. My major concern would be the involvement of other inflammasome and GSDMD bearing cell types, esp. Keratinocytes (KC), which could be an explanation why the experiments in Fig 4 still show inflammation.

      Weaknesses:

      The experiments do not entirely support the conclusions towards neutrophils.

      We appreciate the reviewers’ positive evaluation regarding the application of our mouse models. We also thank the reviewers for insightful comments and suggestions that can improve the quality of our work. Addressing these issues has significantly strengthened our conclusions. Our responses to the above questions are as follows.

      Specific questions/comments:

      Fig 1b: mainly in KC and Neutrophils?

      In Figure 1b, we observed that GSDMD expression is higher in the psoriasis patient tissues compared to control samples. As the role of GSDMD in keratinocytes during the pathogenesis of psoriasis has already been explored[1], we focused our study on GSDMD in neutrophils. In response to the comments, we have added co-staining results of the neutrophil marker CD66b and GSDMD in the revised manuscript (see new Figure 3b in the revised manuscript). This addition further substantiates the expression of GSDMD in neutrophils within psoriasis tissue.

      Fig 2a: PASI includes erythema, scaling, thickness and area. Guess area could be trick, esp. in an artificial induced IMQ model (WT) vs. the knock-out mice.

      In our model, to accurately assess the disease condition in mice, we standardized the drug treatment area on the dorsal side (2*3 cm). Therefore, the area was not factored into the scoring process, and we have included a detailed description of this in the revised manuscript.

      Fig 2d: interesting finding. I thought that CASP-1 is cleaving GSDMD. Why would it be downregulated?

      Regarding the downregulation of CASP in GSDMD KO mouse skin tissue, existing studies indicate that GSDMD generates a feed-forward amplification cascade via the mitochondria-STING-Caspase axis [2]. We hypothesize that the absence of GSDMD attenuates STING signaling’s activation of Caspase.

      Line 313: as mentioned before (see Fig 1b). KC also show a stron GSDMD staining positivity and are known producers of IL-1b and inflammasome activation. Guess here the relevance of KC in the whole model needs to be evaluated.

      Our research primarily focuses on the role of neutrophil pyroptosis in psoriasis, this does not conflict with existing reports indicating that KC cell pyroptosis also contributes to disease progression[1]. Both studies underscore the significant role of GSDMD-mediated pyroptotic signaling in psoriasis, and the consistent involvement of KC cells and neutrophils further emphasizes the potential therapeutic value of targeting GSDMD signaling in psoriasis treatment. We have expanded upon this discussion in the revised manuscript.

      Fig 4i - guess here the conclusion would be that neutrophils are important for the pathogenesis in the IMQ model, which is true. This experiment does not support that this is done by pyroptosis.

      To address the question, we analyzed the publicly available single-cell transcriptomic data (GSE165021) and found that, compared to the control group, neutrophils infiltrating in IMQ-induced psoriasis-like tissue display a higher expression of pyroptosis-related genes (see new Figure 3e in the revised manuscript). These results strengthen our conclusions about the role of neutrophil pyroptosis in the progression of psoriasis.

      Recommendations for the authors:

      Reviewer #1 (Recommendations for the authors):

      Specific Comments:

      • Figure 1: Micro abscesses would already be dead, which would likely reflect as non-specific staining. Authors should consider double staining (e.g., GSDMD+Ly6G).

      We thank the reviewer for the useful suggestion. We have added co-staining results of the neutrophil marker CD66b and GSDMD in the revised manuscript (see new Figure 3b in the revised manuscript). This addition further substantiates the expression of GSDMD in neutrophils within psoriasis tissue.

      • Figures 1 b, c, and d do not have the n number for representative experiments and images.

      We apologize for our oversight. We have added the relevant information in the revised manuscript and have reviewed and corrected the entire text.

      • What is the difference between psoriasis patients in Figure 1 versus Figure 3 as the staining patterns are different? It is difficult to interpret from Figure 1 that expression is limited to neutrophils. Authors should consider double staining (e.g., GSDMD+Ly6G). How many samples were stained to draw this conclusion?

      We thank the reviewer for the suggestion. In Figure 1b, we observed that GSDMD expression is higher in the psoriasis patient tissues compared to control samples. We have added co-staining results of the neutrophil marker CD66b and GSDMD in the revised manuscript (see new Figure 3b in the revised manuscript). For each staining group, we examined samples from 3-5 patients to draw the conclusion.

      • Figure 2: GSDMD deficiency mitigates psoriasis-like inflammation in mice has been shown before (PMID#37673869). The paper showed that the GSDMD was mainly expressed in keratinocytes. What is the view of the authors on it and how does this data correlate with the data presented in this manuscript by the authors?

      Consistent with previous studies[1], we observed increased expression of pyroptosis-related proteins in psoriatic lesions. However, our research focused specifically on the role of neutrophil pyroptosis in psoriasis, this does not conflict with existing reports indicating that KC cell pyroptosis also contributes to disease progression. Both studies underscore the significant role of GSDMD-mediated pyroptotic signaling in psoriasis, and the consistent involvement of KC cells and neutrophils further emphasizes the potential therapeutic value of targeting GSDMD signaling in psoriasis treatment. We have expanded upon this discussion in the revised manuscript.

      • Figure 3d: It is unclear if the IF shows an epidermal or dermal area. As shown by authors in other figures (human psoriatic skin), do authors observe more GSDMD in the micro abscess, which is localized in the epidermis? The authors should also show the staining of GSDM/Ly6G in the whole skin sample.

      The region we presented for immunofluorescence staining corresponds to the dermis of the mice, as we did not observe typical neutrophil micro abscesses similar to those in human psoriasis in the epidermis of IMQ-induced classical psoriasis vulgaris (PV) model. Therefore, we have only shown the staining in the dermal area.

      • Figure 3e: PI staining also represents necrotic cells and TUNEL staining would not represent just apoptotic cells. It is unclear how the authors conclude an ongoing pyroptosis in neutrophils. A robust dataset is needed to provide evidence supporting neutrophil pyroptosis in the IMQ-challenged mice.

      We thank the reviewer for the valuable suggestion. GSDMD is the effector protein of pyroptosis. To further confirm that cells are undergoing pyroptosis, it is necessary to morphologically stain the GSDMD N-terminal protein. Although there is currently no GSDMD N-terminal fluorescent antibody available, we detected the cleaved N-terminus of GSDMD by WB in mouse psoriasis-like skin tissue, and its increased expression suggested increased cell pyroptosis (see new Figure 1d in the revised manuscript). Moreover, we analyzed the publicly available single-cell transcriptomic data (GSE165021) and found that, compared to the control group, neutrophils infiltrating in IMQ-induced psoriasis-like tissue display a higher expression of pyroptosis-related genes (see new Figure 3e in the revised manuscript). These results strengthen our conclusions about the role of neutrophil pyroptosis in the progression of psoriasis.

      • Figure 4: The authors did not clarify the reason for choosing D4 over the usual D7 for the imiquimod experiment. S100A8-Cre is also reported in monocytes and granulocytes/monocyte progenitors. And, the authors also show the expression in macrophages and neutrophils, but in the text, only neutrophils are mentioned. The authors should state the results in the text as well to avoid misrepresentation of the data.

      We thank the reviewer for the useful suggestion. We have repeated many times of experiments in our previous studies and observed that the IMQ-induced mouse psoriasis model showed the obvious signs of self-resolution after Day 4 even with continuing topical IMQ application, thus we chose 4 days over 7 days for the imiquimod experiment, which are consistent with many other studies[3, 4].

      Many studies use S100A8-Cre mice for neutrophil-specific gene knockout[5, 6]. Moreover, we used Ly6G antibody to eliminate neutrophils in GSDMD-cKO mice and control mice. It was found that the difference in lesions between the two groups was abolished after neutrophil depletion, indicating that neutrophil pyroptosis plays an important role in the pathogenesis of imiquimod-induced psoriasis-like lesions in mice. As the database analysis results showed that macrophages have slight expression of S100a8, according to the suggestion of the reviewer, we have added a more precise description in the revised manuscript.

      • Figure S2a: Ly6G antibody reduced the ly6G positive, but also negative cells compared to PBS. If this is correct, what is the explanation, and how this observation has been considered for concluding results?

      Neutrophils play an important role in regulating inflammatory responses, and their deletion can reduce the overall inflammatory level in the body, which also results in a decrease in other non-neutrophil cells. However, this change does not affect our conclusions. Our results show that after the deletion of neutrophils, there is no difference in the pathological manifestations between the cKO group and the control group. This further that GSDMD in neutrophil plays an important role in the pathogenesis of miquimod-induced psoriasis-like lesions in mice.

      • The conclusion in Figure 4i is incorrect as Ly6G administration had an effect on the wt, so it shows neutrophils play a role, but not neutrophil pyroptosis.

      - 321 "It was found that the difference in lesions between the

      - 321 two groups was abolished after neutrophil depletion (Fig4i, S2a), indicating that

      - 322 neutrophil pyroptosis plays an important role in the pathogenesis of

      - 323 imiquimod-induced psoriasis-like lesions in mice"

      Our results show that after the deletion of neutrophils, there is no difference in the pathological manifestations between the cKO group and the control group. This further indicates that the lower disease scores observed in cKO mice, in the absence of neutrophil deletion, depend on the presence of neutrophils. In the revised manuscript, we have changed the statement to “It was found that the difference in lesions between the two groups was abolished after neutrophil depletion (Fig4i, S2a), indicating that GSDMD in neutrophil plays an important role in the pathogenesis of miquimod-induced psoriasis-like lesions in mice”

      • The effect of LyG Ab: reduced PASI in the wt, but the effect on the ko remains the same. What are the other molecular changes observed? What was the level of neutrophils in the wt and the S1A008Cre GsdmDfl/fl mice under steady state and how are they change upon imiquimod challenge? A complete profiling of the immune cells is needed for all the experiments.

      As demonstrated by the results, the deletion of neutrophils did not significantly alter the pathological phenotype of cKO mice. We believe that this outcome precisely highlights the crucial role of GSDMD in regulating neutrophil inflammatory responses.

      • Figure S2b: The authors conclude that Il-1b in the imiquimod skin is mainly expressed by neutrophils, but the analysis presented in the figure does not support this conclusion. Both neutrophils and macrophages are majorly positive for I1-b, with some expression on Langerhans and fibroblasts. No n numbers are provided for the experiment

      As we discussed in the manuscript, we speculate that neutrophil pyroptosis may release cytokines, which in turn activate other cells to secrete cytokines, forming a complex inflammatory network in psoriasis. This may suggest that neutrophil pyroptosis may be involved in the pathogenesis of psoriasis by affecting the secretion of cytokines such as IL-1B and IL-6 by neutrophils, thereby affecting the function of other immune cells such as T cells and macrophages.

      We have added the n number in the revised manuscript.

      • For clarity and transparency, a list of antibodies with the associate clone and catalogue number should be provided or integrated into the method text.

      We thank the reviewer for the useful suggestion. We have added the associate clone and catalogue number of antibodies used in the method text of revised manuscript.

      Reviewer #2 (Recommendations for the authors):

      Fig 3b: psoriasis and pustular psoriasis have a different pathophysiology (autoimmune vs. autoinflammatory). Neutrophils are centrally important for GPP for the cleavage of IL-36. Guess as not further referred to pustular psoriasis in the paper, that comparison is rather deviating from the story.

      In Figure 3b, we stained for GSDMD and CD66b in both plaque psoriasis (PV) and generalized pustular psoriasis (GPP), not to compare the expression differences between the two types of psoriasis, but rather to demonstrate that significant GSDMD expression is present in neutrophils in different types of psoriasis. Unfortunately, due to the lack of a well-established animal model for GPP, we were only able to conduct studies using the established PV animal model. We acknowledge this limitation in our research. In our revised manuscript, we have added the following explanation in the discussion section: “Although we observed significantly increased GSDMD in neutrophils in pustular psoriasis, we were constrained to studying the established PV animal model due to the current absence of a mature GPP animal model. This represents a limitation of our study.”

      In summary, we appreciate the Reviewer’s comments and suggestions. We feel that the inclusion of new data addresses the concerns in a comprehensive manner and adds further support to our original conclusions. We hope you will now consider the revised manuscript worthy of publication in eLife.

      References:

      (1) Lian, N., et al., Gasdermin D-mediated keratinocyte pyroptosis as a key step in psoriasis pathogenesis. Cell Death & Disease, 2023. 14(9): p. 595.

      (2) Han, J., et al., GSDMD (gasdermin D) mediates pathological cardiac hypertrophy and generates a feed-forward amplification cascade via mitochondria-STING (stimulator of interferon genes) axis. Hypertension, 2022. 79(11): p. 2505-2518.

      (3) Lin, H., et al., Forsythoside A alleviates imiquimod-induced psoriasis-like dermatitis in mice by regulating Th17 cells and IL-17a expression. Journal of Personalized Medicine, 2022. 12(1): p. 62.

      (4) Emami, Z., et al., Evaluation of Kynu, Defb2, Camp, and Penk Expression Levels as Psoriasis Marker in the Imiquimod‐Induced Psoriasis Model. Mediators of Inflammation, 2024. 2024(1): p. 5821996.

      (5) Stackowicz, J., et al., Neutrophil-specific gain-of-function mutations in Nlrp3 promote development of cryopyrin-associated periodic syndrome. Journal of Experimental Medicine, 2021. 218(10): p. e20201466.

      (6) Abram, C.L., et al., Distinct roles for neutrophils and dendritic cells in inflammation and autoimmunity in motheaten mice. Immunity, 2013. 38(3): p. 489-501.

    1. Author response:

      Public Reviews:

      Reviewer #1 (Public review):

      Fuchs describes a novel method of enzymatic protein-protein conjugation using the enzyme Connectase. The author is able to make this process irreversible by screening different Connectase recognition sites to find an alternative sequence that is also accepted by the enzyme. They are then able to selectively render the byproduct of the reaction inactive, preventing the reverse reaction, and add the desired conjugate with the alternative recognition sequence to achieve near-complete conversion. I agree with the authors that this novel enzymatic protein fusion method has several applications in the field of bioconjugation, ranging from biophysical assay conduction to therapeutic development. Previously the author has published on the discovery of the Connectase enzymes and has shown its utility in tagging proteins and detecting them by in-gel fluorescence. They now extend their work to include the application of Connectase in creating protein-protein fusions, antibody-protein conjugates, and cyclic/polymerized proteins. As mentioned by the author, enzymatic protein conjugation methods can provide several benefits over other non-specific and click chemistry labeling methods. Connectase specifically can provide some benefits over the more widely used Sortase, depending on the nature of the species that is desired to be conjugated. However, due to a similar lengthy sequence between conjugation partners, the method described in this paper does not provide clear benefits over the existing SpyTag-SpyCatcher conjugation system.  Additionally, specific disadvantages of the method described are not thoroughly investigated, such as difficulty in purifying and separating the desired product from the multiple proteins used. Overall, this method provides a novel, reproducible way to enzymatically create protein-protein conjugates.

      The manuscript is well-written and will be of interest to those who are specifically working on chemical protein modifications and bioconjugation.

      Reviewer #2 (Public review):

      Summary:

      Unlike previous traditional protein fusion protocols, the author claims their proposed new method is fast, simple, specific, reversible, and results in a complete 1:1 fusion. A multi-disciplinary approach from cloning and purification, biochemical analyses, and proteomic mass spec confirmation revealed fusion products were achieved.

      Strengths:

      The author provides convincing evidence that an alternative to traditional protein fusion synthesis is more efficient with 100% yields using connectase. The author optimized the protocol's efficiency with assays replacing a single amino acid and identification of a proline aminopeptidase, Bacilius coagulans (BcPAP), as a usable enzyme to use in the fusion reaction. Multiple examples including Ubiquitin, GST, and antibody fusion/conjugations reveal how this method can be applied to a diverse range of biological processes.

      Weaknesses:

      Though the ~100% ligation efficiency is an advancement, the long recognition linker may be the biggest drawback. For large native proteins that are challenging/cannot be synthesized and require multiple connectase ligation reactions to yield a complete continuous product, the multiple interruptions with long linkers will likely interfere with protein folding, resulting in non-native protein structures. This method will be a good alternative to traditional approaches as the author mentioned but limited to generating epitope/peptide/protein tagged proteins, and not for synthetic protein biology aimed at examining native/endogenous protein function in vitro.

      I would like to sincerely thank both reviewers for their insightful and constructive feedback on the manuscript. I have addressed reviewer #1’s comments below:

      (1) The benefits over the SpyTag-SpyCatcher system. Here, the conjugation partners are fused via the 12.3 kDa SpyCatcher protein, which is considerably larger than the Connectase fusion sequence (20 aa). This is briefly mentioned in the introduction (p. 1 ln 24-25). In a related technology, the SpyTag-SpyCatcher system was split into three components, SpyLigase, SpyTag and KTag  (Fierer et al., PNAS 2014). The resulting method introduces a sequence between the fusion partners (SpyTag (13aa) + KTag (10aa)), which is similar in length to the Connectase fusion sequence. I mention this method in the discussion (p. 8, ln 296 - 297), but preferred not to comment on its efficiency. It appears to require more enzyme and longer incubation times, while yielding less fusion product (Fierer et al., Figure 2).

      (2) Purification of the fusion product. The method is actually advantageous in this respect, as described in the discussion (p. 8, ln 257-263). I plan to add a figure showing an example in the revised article.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews: 

      Reviewer #1 (Public Review): 

      Summary: 

      This study presents useful insights into the in vivo dynamics of insulin-producing cells (IPCs), key cells regulating energy homeostasis across the animal kingdom. The authors provide compelling evidence using adult Drosophila melanogaster that IPCs, unlike neighboring DH44 cells, do not respond to glucose directly, but that glucose can indirectly regulate IPC activity after ingestion supporting an incretin-like mechanism in flies, similar to mammals. The authors link the decreased activity of IPCs to hyperactivity observed in starved flies, a locomotive behavior aimed at increasing food search. 

      Furthermore, there is supporting evidence in the paper that IPCs receive inhibitory inputs from Dh44 neurons, which are linked to increased locomotor activity. However, although the electrophysiological data underlying the dynamics of IPCs in vivo is compelling, the link between IPCs and other potential elements of the circuitry (e.g. octopaminergic neurons) regulating locomotive behaviors is not clear and would benefit from more rigorous approaches. 

      This paper is of interest to cell biologists and electrophysiologists, and in particular to scientists aiming to understand circuit dynamics pertaining to internal state-linked behaviors competing with the feeding state, shown here to be primarily controlled by the IPCs. 

      Strengths: 

      (1) By using whole-cell patch clamp recording, the authors convincingly showed the activity pattern of IPCs and neighboring DH44 neurons under different feeding states. 

      (2) The paper provides compelling evidence that IPCs are not directly and acutely activated by glucose, but rather through a post-ingestive incretin-like mechanism. In addition, the authors show that Dh44 neurons located adjacent to the IPCs respond to bath application of glucose contrary to the IPCs. 

      (3) The paper provides useful data on the firing pattern of 2 key cell populations regulating foodrelated brain function and behavior, IPCs and Dh44 neurons, results which are useful to understand their in vivo function. 

      Weaknesses: 

      (1) The term nutritional state generally refers to the nutrients which are beneficial to the animal. In Figure 1, the authors showed that IPCs respond to glucose but not proteins. To validate the term nutritional state the authors could test the effect of a non-nutritive sugar (e.g. D-arabinose or L-Glucose) on the post-ingestive physiological responses of the IPCs.

      We thank the referee for this insightful comment. Following their suggestion, we included two new experimental data sets, which we added to Figure 1: We show that IPCs do not respond to the non-nutritive sugar D-arabinose (Figure 1H). In order to further expand this data set and our conclusions, we additionally show that IPCs do respond to fructose – a second nutritive sugar in addition to glucose (Figure 1H). Together, these data sets permit the conclusion that IPCs are sensitive to the ingestion of nutritive sugars, and do not respond to ingestion of nonnutritive sugars or high protein diets. Thus, we validate the term nutritional state.

      (2) It is difficult to grasp the main message from the figures in the result section as some figures have several results subsections referring to different points the authors want to make. The key results of a figure will be easier to understand if they are summarized in one section of the results. Alternatively, a figure can be split into 2 figures if there are several key messages in those figures, e.g. Figures 2 and 3.  

      We appreciate this suggestion and have made several changes to our manuscript to add more clarity. Among other things, we have changed the order of data presentation in Figure 2, as suggested by the referee below, where we now start with the IPC activation data rather than the OAN activation. We also swapped the order of data presentation and split Figure S1 into Figures S1 & S2. Moreover, we re-arranged the panel order in supplementary figure S4. This significantly improved the flow of the results section. Since the figures the referee refers to contain comparative data, for example between diets (Figure 1) or neuron types (Figure 2), we prefer to keep these data sets together. However, we have carefully revised the results section to more clearly relate our statements to individual figure panels.

      (3) The prime investigation of the paper is about the physiological response and locomotive behavioral readout linked to IPCs. The authors do not show a link between OANs and IPCs in terms of functional or behavioral readouts. In Figure 2 the authors first start with stating a link between OAN neurons and locomotion changes resulting from internal feeding states. The flow of the paper would be better if the authors focused on the effect of optogenetic activation of IPCs under different feeding states and their impact on fly locomotion. If the experiments done on optogenetic activation of OANs were to validate the experimental approach the data on OAN neurons is better suited for the supplement without the need of a subsection in the result section on the OANs.  

      We agree with the reviewer’s suggestion and switched the order of the figure panels and text to aid the flow of the manuscript. We now show and discuss the IPC activation data first (Figure 2C-H) and OAN activation afterwards (Figure 2I-K). We did keep the OAN data in the main document, though, since that facilitates comparisons between the small effects of IPC activation and the large, well-established effects of OAN activation.

      (4) Figure 2F shows that optogenetic activation of IPCs in fed flies does not influence their locomotor output. In the text, the conclusion linked to Figure 2F-H states that IPC activation reduces starvation-induced hyperactivity which is a statement more suited to Figure 2I-K. 

      We edited the text accordingly.

      (5) The authors show activation of Dh44 neurons leads to hyperpolarisation of the IPCs. What is the functional link between non-PI Dh44 neurons and the IPCs? Do IPCs express DH44R or is DH44 required for this effect on IPCs? Investigating a potential synaptic or peptidergic link between DH44 neurons and IPCs and its effect on behavior would benefit the paper, as it is so far not well connected. 

      Although we have not performed any experiments dedicated to investigating the functional link between DH44Ns outside the PI and the IPCs in this study, there are two lines of evidence supporting that this connection is relatively direct. First, IPCs do express DH44R1 & R2, as we show in a parallel study in eLife (Held M, et al. ‘Aminergic and peptidergic modulation of Insulin-Producing Cells in Drosophila’. eLife. 2024;13. doi:10.7554/ELIFE.99548.1). Second, we performed functional connectivity experiments using a Leucokinin (LK) driver line in that paper. This driver line labels two pairs of non-PI DH44Ns in the VNC, which are DH44 and LK positive (Zandawala et al 2018). Activating that line leads to inhibition of IPCs, similar to the effect we observed here for DH44N activation. These two lines of evidence suggest that there could be a direct peptidergic connection between DH44+ neurons and IPCs. We have added a paragraph mentioning these experiments to our discussion:

      ‘Notably, the DH44<sup>PI</sup>Ns express the DH44 peptide, as confirmed by anti-DH44 stainings(100). This also applies to a large fraction of neurons labelled in the broad DH44 driver line(100). However, a subset of neurons labelled in the broad line did not exhibit DH44 immunoreactivity(100), and might therefore not actually express the DH44 peptide. Hence, the inhibition of IPCs could be driven by neurons in the DH44 driver line that do not express DH44. A strong candidate for the inhibition are LK and DH44-positive neurons, which are labelled by the broad line(76). In a parallel study, we showed that LK-expressing neurons strongly inhibit IPCs(30), similar to the broad DH44 line used here. Furthermore, evidence from single-nucleus transcriptomic analysis shows that IPCs express DH44-R1 and DH44-R2 receptors(30). Therefore, it is possible that DH44Ns communicate with IPCs through a direct peptidergic connection. Notably, the inhibitory effect of non-PI DH44Ns on IPCs was very strong and fast, suggesting that a connection via classical synapses is more likely. Regardless, our results show that the glucose sensing DH44<sup>PI</sup>Ns and IPCs act independently of each other.’

      Reviewer #2 (Public Review): 

      Summary: 

      In this study, Bisen et al. characterized the state-dependency of insulin-producing cells in the brain of *Drosophila melanogaster*. They successfully established that IPC activity is modulated by the nutritional state and age of the animal. Interestingly, they demonstrate that IPCs respond to the ingestion of glucose, rather than to perfusion with it, an observation reminiscent of the incretin effect in mammals. The study is well conducted and presented and the experimental data convincingly support the claims made. 

      Strengths: 

      The study makes great use of the tools available in *Drosophila* research, demonstrating the effect that starvation and subsequent refeeding have on the physiological activity of IPCs as well as on the behavior of flies to then establish causal links by making use of optogenetic tools. 

      It is particularly nice to see how the authors put their findings in context to published research and use for example TDC2 neuron activation or DH44 activity to establish baselines to relate their data to. 

      Weaknesses: 

      I find the inability of SD to rescue the IPC starvation effect in Figure 1G&H surprising, given that the fully fed flies were raised and kept on that exact diet. Did the authors try to refeed flies with SD for longer than 24 hours? I understand that at some point the age effect would also kick in and counteract potential IPC activity rescue. I think the manuscript would benefit if the authors could indicate the exact age of the SD refed flies and expand a bit on the discussion of that point.  

      We have expanded the first paragraph of our discussion to tackle these questions, in particular the potential effect of aging, as suggested by the referee. We now also indicate the exact age of the flies. Moreover, we have conducted additional experiments in which we added either glucose or arabinose to our standard diet (Figure 1H). As we would have expected based on our hypothesis that the glucose concentration in our standard diet was too low to cause an increase in IPC activity after starvation, we find that feeding standard diet plus glucose increases IPC activity to the same level as glucose only, and that adding arabinose to the standard diet does not lead to increased IPC activity after starvation (Figure 1H).

      The incretin-like effect is exciting and it will be interesting in the future to find out what might be the signal mediating this effect. It is interesting that IPCs in explants seem to be responsive to glucose. I think it would help if the authors could briefly discuss possible sources for the different findings between these in fact very different preparations. Could the the absence of the inhibitory DH44 feedback in the *ex-vivo* recordings for example play a role? 

      We thank the referee for this interesting point and expanded our discussion accordingly. We included that, in particular in brain explants without a VNC, the inhibitory connection we describe might be absent, as the referee suggested: ‘Previous ex vivo studies suggested that IPCs, like pancreatic beta cells, sense glucose cell-autonomously(23,24). Consistent with this, we observed an increase in IPC activity after the ingestion of glucose (Figure 2B). However, IPC activity did not increase during the perfusion of glucose directly over the brain. Importantly, the fly preparations were kept alive for several hours allowing the glucose-rich saline to enter circulation and reach all body parts. Several factors may explain the difference between ex vivo and in vivo preparations. First, in ex vivo studies, certain regulatory feedback mechanisms present in vivo could be absent. For example, the strong inhibitory input IPCs receive from DH44Ns we found would likely be absent in brain explants without a VNC. A lack of inhibitory feedback might allow for more direct glucose sensing by IPCs ex vivo, whereas in vivo, the IPC response could be suppressed by more complex systemic feedback. Second, we attempted to use the intracellular saline formulation employed in a previous ex vivo study44. However, we observed that IPCs depolarized quickly using this saline, leading to unstable recordings that did not meet our quality standards for in vivo experiments. Another possible explanation for the lack of an effect of glucose might have been that the dominant circulating sugar in flies is trehalose(70,71) which is derived from glucose. When we extended our experiments, we found that trehalose perfusion did not affect IPC activity either, strengthening the idea that IPCs do not directly sense changes in hemolymph sugar levels. Therefore, our findings suggest that, similar to mammals, IPC activity and hence, insulin release, is not simply modulated by hemolymph sugar concentration in Drosophila.’ 

      The incretin-like effect the authors observed seems to start only after 5h which seems longer than in mammals where, as far as I know, insulin peaks around 1h. Do the authors have ideas on how this timescale relates to ingestion and glucose dynamics in flies? 

      We have now included the following section in the discussion to explicitly address the question of different activity dynamics in flies and mammals, but also the limitations of our electrophysiological approach in this regard: ‘We observed that IPC activity increased over a timescale of hours, which is longer compared to the fast insulin response in mammals, where insulin typically peaks within an hour of feeding(97). In flies, insulin levels rise within minutes of refeeding, followed by a drop after 30 min(20). Our experimental techniques limit our ability to capture these fast initial dynamics, since the preparation for intracellular recordings requires tens of minutes, so that we typically recorded IPC activity at least 20 min after the last food ingestion. Notably, studies in fasted mammals have shown that insulin peaks within minutes of refeeding, followed by a rapid decline, with levels stabilizing as feeding continues(98,99). We speculate a similar dynamic could be present in flies, but with our approach, we capture the steady-state reached tens of minutes after food ingestion rather than a potential initial peak.’ 

      The authors mention "a decrease in the FV of IPC-activated starved flies even before the first optogenetic stimulation (Figure 2I),". Could this be addressed by running an experiment in darkness, only using the IR illumination of their behavioral assay? 

      We thank the referee for pointing out this unexpected result. We discuss this in more detail in the new version of our manuscript and expand on the reasons for not performing these optogenetic activation experiments in the dark: First, the red LED required to activate CsChrimson triggers strong startle responses in dark-adapted flies, which mask other behavioral effects, in particular subtle ones such as those observed for IPCs. The startle response is much reduced when performing experiments under low background light conditions. Second, flies, at least in our hands, do not exhibit robust foraging behavior or starvation-induced hyperactivity in the dark, which is critical for our behavioral experiments. However, we also explain in our discussion that we believe the effect of background illumination is relatively small, since flies expressing CsChrimson in OANs or DH44Ns show comparable activity levels to controls. Hence, a part of this effect is likely attributable to leak currents induced by CsChrimson expression. We would like to point out though that we are careful in our description of the IPC effect on behavior, and focus on the fact that it is considerably smaller than the effects of other modulatory neurons (DH44Ns and OANs).

      The authors show an inhibitory effect of DH44 neuron activation on IPC activity. They further demonstrate that DH44PI neurons are not the ones driving this and thus conclude that "...IPCs are inhibited by DH44Ns outside the PI.". As the authors mentioned the broad expression of the DH44-Gal4 line, can they be sure that the cells labeled outside the PI are actually DH44+? If so they should state this more clearly, if not they should adapt the discussion accordingly.   

      We have substantially added to our discussion of this point, according to the referee’s great suggestion. In short, the broad line includes neurons that are DH44 positive and neurons that are not: ‘Notably, the DH44<sup>PI</sup>Ns express the DH44 peptide, as confirmed by anti-DH44 stainings(100). This also applies to a large fraction of neurons labelled in the broad DH44 driver line(100). However, a subset of neurons labelled in the broad line did not exhibit DH44 immunoreactivity(100), and might therefore not actually express the DH44 peptide. Hence, the inhibition of IPCs could be driven by neurons in the DH44 driver line that do not express DH44.’

      Reviewer #3 (Public Review): 

      Although insulin release is essential in the control of metabolism, adjusted to nutritional state, and plays major roles in normal brain function as well as in aging and disease, our knowledge about the activity of insulin-producing (and releasing) cells (IPCs) in vivo is limited. 

      In this technically demanding study, IPC activity is studied in the Drosophila model system by fine in vivo patch clamp recordings with parallel behavioral analyses and optogenetic manipulation. 

      The data indicate that IPC activity is increased with a slow time course after feeding a high-glucose diet. By contrast, IPC activity is not directly affected by increasing blood glucose levels. This is reminiscent of the incretin effect known from vertebrates and points to a conserved mechanism in insulin production and release upon sugar feeding. 

      Moreover, the data confirm earlier studies that nutritional state strongly affects locomotion. Surprisingly, IPC activity makes only a negligible contribution to this. Instead, other modulatory neurons that are directly sensitive to blood glucose levels strongly affect modulation. Together, these data indicate a network of multiple parallel and interacting neuronal layers to orchestrate the physiological, metabolic, and behavioral responses to nutritional state. Together with the data from a previous study, this work sets the stage to dissect the architecture and function of this network. 

      Strengths: 

      State-of-the-art current clamp in situ patch clamp recordings in behaving animals are a demanding but powerful method to provide novel insight into the interplay of nutritional state, IPC activity, and locomotion. The patch clamp recordings and the parallel behavioral analyses are of high quality, as are the optogenetic manipulations. The data showing that starvation silences IPC activity in young flies (younger than 1 week) are compelling. The evidence for the claim that locomotor activity is not increased upon IPC activity but upon the activity of other blood glucose-sensitive modulatory neurons (Dh44) is strong. The study provides a great system to experimentally dissect the interplay of insulin production and release with metabolism, physiology, and behavior. 

      Weaknesses: 

      Neither the mechanisms underlying the incretin effect, nor the network to orchestrate physiological, metabolic, and behavioral responses to nutritional state have been fully uncovered. Without additional controls, some of the conclusions would require significant downtoning. Controls are required to exclude the possibility that IPCs sense other blood sugars than glucose. The claim that IPC activity is controlled by the nutritional state would require that starvation-induced IPC silencing in young animals can be recovered by feeding a normal diet. At current firing in starvation, silenced IPCs can only be induced by feeding a high-glucose diet that lacks other important ingredients and reduces vitality. Therefore, feasible controls are needed to exclude that diet-induced increases in IPC firing rate are caused by stress rather than nutritional changes in normal ranges. The finding that refeeding starved flies with a standard diet had no effect on IPC activity but a strong effect on the locomotor activity of starved flies contradicts the statement that locomotor activity is affected by the same dietary manipulations that affect IPC activity. The compelling finding that starvation induces IPC firing would benefit from determining the time course of the effect. The finding that IPCs are not active in fed animals older than 1 week is surprising and should be further validated. 

      We thank the referee for the thoughtful and constructive criticism of our experiments and conclusions. Below, we lay out how we tackled the individual points raised by the referee.

      (1) ‘Controls are required to exclude the possibility that IPCs sense other blood sugars than glucose.’  

      To address this point, we conducted experiments in which we perfused trehalose (Figure 3B), the main circulating hemolymph sugar in Drosophila and other insects. Our results clearly show that trehalose does not affect IPC activity upon perfusion, confirming our statements that IPCs do not sense key blood sugars directly.

      (2) ‘Feasible controls are needed to exclude that diet-induced increases in IPC firing rate are caused by stress rather than nutritional changes in normal ranges’. 

      We agree with the referee that this point was not completely fleshed out in our first submission. We have now performed additional experiments in which we added glucose (and fructose) to our standard diet (Figure 1H). Flies feeding on this diet received all necessary nutrients but still experienced high concentrations of sugars. The effects of high glucose in a standard diet background were indistinguishable from those of high glucose in agarose, confirming that the IPCs respond to sugar rather than stress. Another important observation in this context is that IPCs in flies kept on a high protein diet exhibited much lower spike rates than flies exhibiting the high glucose diet, even though they had a much shorter lifespan and therefore, presumably, experienced much higher stress levels (Figure 1H, Figure S1). These observations underline that stress is certainly not the primary factor here.

      (3) ‘The finding that refeeding starved flies with a standard diet had no effect on IPC activity but a strong effect on the locomotor activity of starved flies contradicts the statement that locomotor activity is affected by the same dietary manipulations that affect IPC activity.’

      We have revised the respective section of the results and discussion accordingly and are more careful and clearer in our interpretation of this behavioral dataset: ‘These results show that the locomotor activity was affected by the same dietary manipulations that had strong effects on IPC activity. However, IPC activity changes alone cannot explain the modulation of starvation-induced hyperactivity. On the one hand, high-glucose diets which drove the highest activity in IPCs were not sufficient to reduce locomotor activity back to baseline levels. On the other hand, refeeding flies with SD did not revert the effects of starvation on IPC activity (Figure 1H), but it was sufficient to reduce the locomotor activity below baseline levels (Figure 2B). This suggests that the modulation of starvation-induced hyperactivity is achieved by multiple modulatory systems acting in parallel.’

      (4) ‘The compelling finding that starvation induces IPC firing would benefit from determining the time course of the effect.’

      We followed the referee’s excellent suggestion and determined the time course of the starvation effect in three timesteps, similar to the experiments we did for refeeding (Figure 1G). In addition, we now also quantify the number of active IPCs (i.e., IPCs that fired at least one action potential during our five-minute analysis window), which further illustrates the dynamics of the starvation and refeeding effects. We find that the starvation effect is graded, and that IPC activity decreases with increasing starvation duration.

      (5) ‘The finding that IPCs are not active in fed animals older than 1 week is surprising and should be further validated.’

      To address the referee’s comment, we have added 14 new IPC recordings from flies in the 6–26-day range, such that we now have recordings from 9-14 IPCs for each age range (Figure S2B). They confirmed our previous analysis and strengthened the finding that IPC activity dramatically decreases after 8 days (on our standard diet). The total number of IPCs in this supplementary dataset was thus increased from 34 to 48.

      Recommendations for the authors:

      Reviewer #1 (Recommendations For The Authors): 

      (1) Do IPCs respond to glucose specifically after ingestion or generally to any other nutritive sugars? To tackle this question the IPC responses in starved flies can be recorded after refeeding flies with other nutritive sugars (fructose, sucrose). 

      To address this important question, we have performed additional experiments in which we refed starved flies with fructose, as a nutritive sugar, and arabinose, as a non-nutritive sugar. As expected, IPCs responded to fructose but not arabinose and hence nutritive sugars in general. We describe and discuss these key results in the new version of our manuscript.

      (2) In Figure 2, the x and y axes are not annotated on all subfigures, which might help improve clarity. 

      We have annotated the subfigures as requested.

      (3) In the discussion on page 9 ("...we observed an increase in IPC activity after the ingestion of glucose (Figure 2B)."), the authors refer to Figure 2B instead of 3C.

      We have fixed this oversight.

      Reviewer #2 (Recommendations For The Authors): 

      Introduction 

      I think it could be helpful for the reader if you would briefly state the number of IPCs and whether you are targeting all of them with Dilp2-Gal4. 

      We included the numbers according to the suggestion. 14 IPCs are labeled in the driver line, and this is the number of IPCs commonly assumed to be present in the PI.

      Figures 

      In some Figures (for example 1D & E) the authors state the number of IPCs recorded (N) but not the number of animals used (n). This should be stated as the data from within an animal are dependent and might give insights about IPC heterogeneity. 

      We have compiled tables for the supplementary material (Tables S5 & S6) in which we state the number of IPCs and DH44<sup>PI</sup>Ns recorded and the number of different flies for each figure panel. We have recorded an average of 1.4 IPCs per fly (217 IPCs from 160 flies). We therefore expect the bias introduced by individual flies to be rather small. However, in our parallel study, we specifically investigate the heterogeneity of IPCs by maximizing the number of IPCs recorded per fly (Held M, et al. ‘Aminergic and peptidergic modulation of Insulin-Producing Cells in Drosophila’. eLife. 2024;13. doi:10.7554/ELIFE.99548.1). In the case of DH44PINs, we recorded 24 neurons in 21 flies – 1.1 neurons per fly.

      - Figure 3D: There is some white visible among the cell bodies in the overlay. I assume this comes from projecting across layers rather than indicating DH44 - IPC overlap? It would help to explicitly state that. 

      We have added a statement to the results section, in which we explain that most of the white is due to overlap in the z-projection rather than overlap in the driver lines. However, there are few cases (typically one to two cells per brain), in which neurons labeled by the DH44 line also stain positive for Dilp2, indicating they express both neuropeptides. We have added this information to the manuscript:  

      Results: ‘DH44<sup>PI</sup>Ns are anatomically similar to IPCs, and their cell bodies are located directly adjacent to those of IPCs in the PI, making them an ideal positive control for our experiments (Figure 3D). A small subset of DH44<sup>PI</sup>Ns also expresses Dilp2(75), and our immunostainings confirmed colocalization of Dilp2 and DH44 in a single neuron (Figure 3D, white arrow).’

      In figure caption: ‘UAS-myr-GFP was expressed under a DH44-GAL4 driver to label DH44 neurons. GFP was enhanced with anti-GFP (green), brain neuropils were stained with anti-nc82 (cyan), and IPCs were labelled using a Dilp2 antibody (magenta). White arrow indicates Dilp2 and DH44-GAL4 positive neuron. The other white regions in the image result from an overlap in z-projections between the two channels, rather than from antibody colocalization.’

      - Figure 4I: One might get the impression that the fast onset peak of activity precedes the stimulation onset, using a thinner line width might help avoid that. 

      This effect is due to a combination of using relatively heavy lines for clear visibility of the data and a gentle smoothing step (a 2s median filter, which corresponds to less than 1% of the 300s stimulation window) in our analysis of the behavioral data. However, inspection of the raw data clearly shows increases in velocity after the onset of the optogenetic activation. We clarified this in the figure caption: ‘Average FV across all DH44N activation trials based on two independent replications of the experiment in I. Note that the peak in average FV lies within the first frame of the stimulation window.’

      - S3 panel letters do not match references in the text.

      We fixed this oversight.

      Formatting 

      - Page 10: The paragraphs on the bottom of the page got switched around.

      This has been fixed.

      - Page 14: The first paragraph after the header "Free-walking assay" seems to be coming from elsewhere. 

      We apologize for this slightly embarrassing mistake. We used our related bioRxiv preprint (Held et al.) as a template for formatting this paper, and accidentally left this part of the methods section in the manuscript. We have fixed this error in our resubmission.

      Reviewer #3 (Recommendations For The Authors): 

      Major suggestions: 

      (1) The data show convincingly that IPC activity is decreased by starvation during the first week of adult life (Figures 1C and D). However, the conclusion that IPC activity is controlled by the nutritional state requires additional care. First, refeeding starved adult animals with a normal diet does not bring back normal IPC firing rates (Figure 1H). Therefore, IPC activity does not strictly follow changes in nutritional state, but IPCs are silenced by starvation. Second, from the second week of adult life on, IPCs are silent anyway, and thus unlikely responsive to changes in the nutritional state anymore (which might be different on a different standard diet?) The only effect of feeding on IPC activity is observed upon feeding starved, young animals with high glucose for 12-24 hrs (Figure 1G). However, it is not clear whether increased IPC firing is caused by the effects of high glucose on the nutritional state in a normal range, or because of diet-induced stress (the diet also severely shortens lifespan, Figure 1S). Does high glucose also increase IPC firing rate in young, fed animals? These would have strongly increased glucose concentrations but not suffer the stress of not getting any other nutrients. Such experiments would be required to make the statement that glucose feeding increases IPC firing rate. 

      We have performed several experiments to address this criticism. First, we performed a time course analysis of the starvation effect. We show that the IPC activity reduction is graded, and that IPC activity declines already after two hours of starvation, a timepoint at which stress levels should still be relatively small (Figure 1G). Second, we refed flies with high glucose concentrations added to the standard diet (Figure 1H). This minimized any potential stress responses due to a lack in nutrients. Third, we now show that IPCs specifically respond to nutritive (glucose and fructose), but not to non-nutritive sugars (arabinose, Figure 1H). We believe that these data sets, in addition to the graded refeeding effect, make a strong case for the nutritional state dependent modulation of IPCs. 

      (2) The testing of locomotor activity is well done, nicely recapitulates starvation-induced increases in locomotion, and adds interesting novel findings on refeeding with high glucose versus high protein diet. However, the statement that locomotor activity was affected by the same dietary manipulations that had strong effects on IPC activity does not reflect the data presented. Refeeding starved flies with a standard diet had no effect on IPC activity (Figure 1H) but a strong effect on locomotor activity of starved flies (a strong reduction, even stronger than high glucose diet, Figure 2B). 

      We have revised the respective section of the results and discussion accordingly and are more careful and clearer in our interpretation of this behavioral dataset: ‘These results show that the locomotor activity was affected by the same dietary manipulations that had strong effects on IPC activity. However, IPC activity changes alone cannot explain the modulation of starvationinduced hyperactivity. On the one hand, high-glucose diets which drove the highest activity in IPCs were not sufficient to reduce locomotor activity back to baseline levels. On the other hand, refeeding flies with SD did not revert the effects of starvation on IPC activity (Figure 1H), but it was sufficient to reduce the locomotor activity below baseline levels (Figure 2B). This suggests that the modulation of starvation-induced hyperactivity is achieved by multiple modulatory systems acting in parallel.’

      Related to points 1 and 2, a key statement that the results establish that IPC activity is controlled by the nutritional state requires care. What the data convincingly show is that IPC activity is near zero upon starvation. 

      As described above, we have added several extensive data sets (fructose feeding, arabinose feeding, trehalose perfusion, starvation time course) to show that we indeed observe a nutritional state dependent modulation of IPCs and describe these new results in the results and discussion.

      (3) The time course of nutritional state-dependent changes of IPC activity is claimed to be slow, several hours to days. Unless I have missed a figure, the underlying data are not presented (only for high glucose diet). It would be great if this could also be shown for a standard diet with higher glucose concentrations than the one used so that it rescues starvation-induced IPC silencing without shortening lifespan (if this is feasible?). The data showing starvation-induced IPC silencing are convincing, but, unless I have missed it, the time course has not been determined. It would be very nice to actually show this. Have different starvation times been tested in relation to IPC firing rate, and if yes, with what time resolution? Does IPC activity change already after 0.5 or 1 or a few hours of starvation? If starvation can silence IPCs faster than assumed, the nearzero IPC activity in animals older than a week could very well be caused by longer time intervals between meals. 

      We have performed experiments to address both important points raised by the referee here. 1) We have added high glucose concentrations to our standard diet, and show that it has the same effect – a significant increase in IPC activity – as the high glucose diet (Figure 1H). 2) We have analyzed the time course of IPC activity reduction in response to starvation (Figure 1G). Indeed, we find that a few hours of starvation start reducing IPC activity. We discuss the possibility that reduced IPC activity in older flies could be due to reduced food intake: ‘One of our experiments demonstrated that IPC activity was heavily diminished in flies older than 10 days (Figure S2B). A possible explanation could be that flies feed less as they age. However, this only holds true for flies older than 14 days86. Therefore, reduced IPC activity in 10-11 day old flies is unlikely to result from reduced food intake and likely involves inhibition of insulin signaling.’

      (4) The data on the proposed incretin effect are of high importance in potentially highlighting a highly conserved link between glucose ingestion and insulin release. An important control would be to test different sugars, such as trehalose, an important blood sugar of flies. If glucose is converted into trehalose and this is what IPCs sense, then perfusion of glucose has no effect. The fact fantastic experiments show that the DH44 neurons are sensitive to glucose perfusion does rule out that IPCs sense a different sugar. This would be very different from the incretin effect that requires additional hormones. In addition, as mentioned above, controls are required to show that high glucose affects IPCs as a nutrient and not as a stressor (see point 1), for example refeeding with a standard diet that contains a higher glucose concentration but does not reduce lifespan. Another great control to solidify the exciting claim on the incretin effect would be to knock out candidate Drosophila incretin hormones and test whether a high glucose diet stops increasing the IPC firing rate (although simpler controls might also do the job). 

      We have performed the two key experiments suggested by the referee. 1) We perfused trehalose as the primary blood sugar of flies and showed that IPCs do not respond to trehalose perfusion (Figure 3B & C). This further strengthens the finding that IPC activity in flies shows an incretin-like effect. 2) We have added high concentrations of glucose to our standard diet to provide flies with a full diet that contains high glucose concentrations. IPC activity in these flies was indistinguishable from the activity in flies which consumed pure glucose diets. In contrast, IPC activity in flies kept on a high protein diet, which dramatically reduced lifespan, was very low. These results clearly show that higher IPC activity is not due to increased stress levels, but a function of nutritive sugar ingestion. We further validated this hypothesis by refeeding flies with fructose as a nutritive sugar, which increased IPC activity, and arabinose as a non-nutritive sugar, which did not affect IPC activity (Figure 1H).

      Another point that might be relevant to this discussion is that IPC activity is almost entirely shut down during flight in Drosophila (which we showed in Liessem et al. 2023, Current Biology 33 (3), 449-463. e5). Several ‘stress hormones’ are released during flight, including octopamine. The fact that IPC activity is low in flying flies, starved flies, and flies kept on a pure protein diet (which all experience high stress levels), to us, very clearly suggests that stress is not the predominant factor here. We would also like to point out that, while the lifespan was reduced in flies kept on pure glucose diets, survival rates were at 100% until day 14, and we carried out our experiments on day 2 after starvation. Hence, these flies might not (yet) experience particularly high stress levels.

      (5) The discussion relates the absence of IPC firing in animals older than 1 week to aging. However, given that the flies fed on a normal diet show the typical lifespan for Drosophila, a 10-dayold fly is still in its youth. Maybe flies at 10 days eat simply less and thus IPC spiking goes down as in starved flies, especially because the standard diet used contains low glucose. Do IPCs also become silent after a week if the animals are fed with a standard diet that contains a higher glucose concentration? Without additional controls, this part of the discussion is pretty speculative and should be revised. 

      We agree with the reviewer, that it is not clear whether reduced IPC activity is a direct result of physiological changes that occur with aging, or an indirect effect of reduced food intake, which occur during aging. In both cases, in our view, it would be an age-related effect. Since this is a minor point of our manuscript, we decided not to perform additional experiments, other than significantly increasing the sample size for the aging data set already presented to shore up our findings (Figure S2B). We have, however, revisited the discussion of this point according to the referee’s suggestion: ‘One of our experiments demonstrated that IPC activity was heavily diminished in flies older than 10 days (Figure S2B). A possible explanation could be that flies feed less as they age. However, this only holds true for flies older than 14 days(85). Therefore, reduced IPC activity in 10-11 day old flies is unlikely to result from reduced food intake and likely involves inhibition of insulin signaling.’

      Other suggestions: 

      (6) For the mixed effects of octopamine and tyramine on larval locomotion that are referred to, it might be interesting to also look at Schützler et al 2019, PNAS because it shows that starvation activates TBH so that the octopamine to tyramine ratio is increased. 

      We refer to Schützler et al. in the following paragraph of our discussion: ‘This intermittent locomotor arrest has been previously described in adult flies and is thought to be mediated by ventral unpaired median OANs, which have been suggested to suppress long-distance foraging behavior(69). Since these are not the only neurons we activate in the TDC2 line, we speculate that the stopping phenotype could also result from concerted effects of octopamine and tyramine modulating muscle contractions(65-67) and motor neuron excitability(68), as previously described in Drosophila larvae, or from OANs interfering with pattern generating networks in the ventral nerve cord (VNC) during longer activation(69).’  

      (7) The reference list requires care. For example, reference 43 is identical to 67, reference 66 gives no information on incretin-like hormones in Drosophila as stated in the text 

      We carefully double-checked our reference list and corrected the mistakes mentioned.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public Review):

      I have reviewed, with interest, the manuscript "Psychological stress disturbs bone metabolism via miR-335-3p/Fos signaling in osteoclast". The described findings are relevant and useful for daily practice in periodontology. The paper is concise, professionally written, and easy to read. In this study, Jiayao et al. revealed the role of miR-335-3p in psychological stress-induced osteoporosis. CUMS mice were constructed to observe the femur phenotype, osteoclasts were identified as the primary research object, and miRNA-seq was used to find the key miRNAs linking the brain and peripheral tissues. This study showed that the expression of miR-335-3p was simultaneously reduced in mice's NAC, serum, and bone under psychological stress. The miR-335-3p/Fos/NFATC1 signaling pathway was validated in osteoclasts to reveal the potential mechanism of enhanced osteoclast activity under psychological stress. From a new perspective of miRNAs, this study indicates a possible cause of disturbed bone metabolism due to psychological stress and may suggest a new approach to treating osteoporosis.

      We thank this reviewer for the instructive suggestions and encouragement.

      Reviewer #2 (Public Review):

      Zhang et al. established chronic unpredictable mild stress (CUMS) mouse model, which displayed osteoporosis phenotype, suggesting a potential correlation between psychological stress and bone metabolism. They found that miRNA candidate miR-335-3p is downregulated in the long bone of CUMS mice through microRNA sequencing and qRT-PCR experiments. They further demonstrated that miR-335-3p attenuates osteoclast activity via inhibiting Fos signaling, which can induce NFATC1 expression and regulate osteoclast activity.

      Strengths:

      The authors established CUMS mouse model and confirmed the osteoporosis phenotype through careful characterization of bone and analysis of osteoclast activity. They performed microRNA sequencing to identify the miRNA candidate regulating the bone loss in the CUMS mouse model. They also validated the expression of miR-335-3p and interfered with the function of miR-335-3p through an in vitro assay. Overall, the findings from this study provide important hints for the correlation between psychological stress and bone metabolism.

      We thank this reviewer for the comprehensive summary and positive comment on our work.

      Weakness:

      The data provided by the authors are preliminary, especially the mechanistic insight, which needs to be enhanced. The authors have shown that miR-335-3p expression was altered in the CUMS mouse model and the change of its expression regulated osteoclast activity. The validation should be conducted in vivo, and the mechanism behind this should be investigated further.

      We thank the reviewer’s important insight on the need for further in vivo validation of the role of miR-335-3p. Therefore, we designed and produced Antagomir-335-3p (antagonist) and Agomir-335-3p (agonist). Then, we injected them into the body through the tail vein for about 2 months and observed the bone phenotype in each group of mice. The results suggested that the decrease of miR-335-3p in vivo could lead to bone loss, which was consistent with our in vitro validation results (Figure 5H-I).

      Reviewing Editor:

      Method

      (1) Bone histomorphometric analysis following ASBMR's guidelines Bone histomorphometric analysis of bone formation and bone resorption: The authors should follow ASBMR's guidelines for bone histomorphometry (PMCID: PMC3672237 and PMID: 3455637) to perform standard analyses of histomorphometry, rather than selected areas. They should also clearly describe a software used and define the areas analyzed.

      We carefully re-analyzed bone histomorphometry according to ASBMR guidelines and combine this with our own understanding. At the same time, we improved the description of micro-CT and histological analysis in the method. If there is still any lack of standardization, we would be grateful for any constructive suggestions to improve this.

      (2) Osteoclast cultures require nuclear staining to demonstrate multinucleated Trap positive cells.

      We used the RAW264.7, a mouse macrophage-like cell line, for in vitro culture and induced its differentiation towards osteoclasts. Successfully induced osteoclasts showed enlarged cytoplasm and multinucleated fusion. Tartrate-resistant acid phosphatase (Trap) is the signature enzyme of osteoclasts. It can bind to the chromogen to exhibit a mauve color, based on the principle of azo-coupled immunohistochemistry. At the same time, small and rounded nuclei fused show a lighter color (author response image 1, yellow arrows). We attempted to stain the nuclei with hematoxylin based on this. However, it was unable to further distinguish the contours of the nuclei clearly due to the similar color to the Trap positive signals. Besides, many other scholars have assessed osteoclast activity in vitro experiments based solely on the results of Trap staining (area and number) (Cheng et al., 2022; Li et al., 2019; Ma et al., 2021; Zhong et al., 2023). Nevertheless, in the immunofluorescence staining of osteoclasts, the nuclei were labeled using a Hochest antibody to reflect the multinucleated fusion of osteoclasts (Figure 5G).  

      (3) Osteoclast pit assays should be carried out to necessarily demonstrate the change of osteoclast resorption ability caused by miR-335-3p.

      We added osteoclast pit assays to validate the role of miR-335-3p on osteoclast resorptive capacity (Figure 5D-E).

      (4) Serum ELISA assay should be done to examine the global change of bone remodeling in the CUMS mice to assess bone formation and bone resorption that will support their claim.

      We performed additional tests on serum concentrations of R-hydroxy glutamic acid protein (BGP), TRAP, Cathepsin K (CTSK), parathyroid hormone (PTH), calcium (CA), phosphate (P) in control and CUMS mice, which could better reflect the global change of bone remodeling in the CUMS mice (Figure 3— figure supplement 1).

      (5) miR-RNA-seq: A labeled volcano plot should be used to replace the present one to show significant changes in differential gene expression.

      We appreciate this great suggestion. We replaced the volcano plot that showed significant changes in differential gene expression (Figure 4B). We also uploaded the raw data to the GEO database (GSE253504), making the results clearer and more accessible.

      Discussion

      The authors should discuss previous works on the influences of hormones from the brain on chronic stress-induced bone loss and an association of these influences with their findings.

      The discussion on the relationship between the bone metabolism regulation of both hormones and miR-335-3p in psychological stress was added in the second and fifth paragraphs of the discussion. To conclude, on the one hand, brain-derived and blood-transported miR-335-3p regulate bone metabolism synergistically. On the other hand, it exerted a more direct influence on bone under psychological stress.

      Language

      The language of the MS should be improved.

      The manuscript has been carefully edited by a professional proofreader.

      Reviewer #1 (Recommendations For The Authors):

      (1) Figure 1F: The exact meaning of the Waveform Graph shown at left needs to be clarified for the not-so-experienced reader.

      We added the more detailed meaning of the Waveform Graph in figure legends (Figure legend 1F).

      (2) Is the concomitant increase in osteogenic and osteoblastic activity in this study consistent with that seen in similar disease studies? This could be added to the discussion.

      In the fifth paragraph of the discussion section, we present the alterations of osteogenic and osteoblastic activity observed in other studies that are similar to ours. We also had a detailed discussion based on these observations.

      (3) Figure 6A: Please highlight the key information to visualize the potential linkage among miR-335-3p, Fos, and osteoclast.

      We highlighted the crucial linkage among miR-335-3p, Fos, and osteoclast with red arrows (Figure 6A)

      4) Figure 6E: The specific area of the selected comparison needs to be clarified. Please add white dotted lines and lettering T (trabecular bone) and GP (growth plate) for the not-so-experienced reader. This will provide some orientation.

      We used white dotted lines as well as letters to label the tissue in immunofluorescence staining images (Figure 6E).

      (5) Line 350: "NAC derived and blood-trans, Ported miR-335-3p". There is a grammatical error. Please conduct general proofreading of the text and writing style.

      Thank you for pointing this out. We have corrected this grammatical error, and we also checked the full text to correct similar errors.

      Reviewer #2 (Recommendations For The Authors):

      (1) miR-335-3p was downregulated in the femur in the CUMS mice. The possible mechanism for this outcome should be further discussed. In Figure 4B, the Volcano plot showed that only a few miRNA were differentially expressed between the control and CUMS mice. How do the authors explain this?

      The chronic unpredictable mild stress (CUMS) model was constructed using normal mice. As the name of the model suggests, the stimulus is mild and does not cause developmental damage or teratogenic effects in mice. Conversely, CUMS has the potential to result in the chronic pathological conditions. Besides, in miRNA sequencing results from other tissues with similar models to ours, the number of differential miRNAs is also around a few dozen (Ma et al., 2019).

      (2) The authors have demonstrated that miR-335-3p inhibits osteoclast differentiation based on an in vitro assay in Figure 5; however, an in vivo experiment is required to provide more solid evidence.

      We strongly agree that in vivo experimental validation would bring more convincing results to this study. Therefore, we designed and produced Antagomir-335-3p (antagonist) and Agomir-335-3p (agonist), which were injected into mice via the tail vein every five days. Samples were collected at one and two months following the injection. We found that sustained two-month injections of antagomir could significantly lead to bone loss in mice (Figure 5H-I), which is consistent with our in vitro validation results.

      However, the Agomir-miR-335-3p group did not exhibit a notable enhancement of bone mass. This may be attributed to the fact that the 11-week-old normal mice selected for this study were in their prime and did not have strong osteoclastic activity in vivo. Therefore, the osteoclastic inhibition of Agomir-335-3p could not be demonstrated.

      In addition, no significant difference was seen one month after the injection. The main reason may be that the time is too short. On the one hand, the drug we injected was RNA preparation. They lacked stability resulting in poor delivery efficiency, which took some time to take effect. On the other hand, bone remodeling is also a time-consuming process.

      (3) FOS and NFATC1 should be expressed in the nuclei of the cells, therefore, the quality of the images needs to be improved.

      NFATC1 is a T-cell-activating nuclear factor that is activated in the nucleus to regulate the transcription of a variety of osteoclast-related genes, including ACP5, MMP9, etc. FOS could bind and interact with NFATC1, resulting in nuclear translocation and transcription activated. This could promote the differentiation and maturation of osteoclasts. They are both synthesized and processed in the cytoplasm and eventually enter the nucleus to perform their functions. Therefore, they are expressed in both the nucleus and the cytoplasm (Deng et al., 2022; Hounoki et al., 2008; Li et al., 2022).

      In Figure 5G, we labeled cell nuclei with HOCHEST antibody with blue fluorescence, and more co-localized signals of nuclei (blue), FOS (red), and NFATC1 (green) were seen in the Inhibitor-miR-335-3p group, whereas the opposite result was observed in the Mimic-miR-335-3p group. These results indicated that inhibited miR-335-3p could promote osteoclast differentiation in vitro.

      (4) The expression of FOS was elevated in CUMS group in Figure 6E; however, its mRNA level was unchanged, as shown in Figure 6 supplement; what is the explanation for this? How do the authors claim FOS is the downstream target if its mRNA expression is not impacted by CUMS?

      The results demonstrated that miR-335-3p targeted binding to the mRNA of Fos did not result in mRNA degradation. Instead, this binding interferes with the protein translation process, which ultimately leads to the reduction of FOS protein.

      (5) What would be the bone phenotype if a FOS inhibitor was injected into the control and CUMS mice? It is important to examine FOS function through an in vivo context.

      The regulatory role of FOS for osteoclasts has been validated in numerous articles, both in vivo and in vitro(Aikawa et al., 2008; Cao et al., 2023; Cheng et al., 2022). For example, Aikawa et al. designed a small-molecule inhibitor of c-Fos/activator protein-1 (AP-1) using three-dimensional (3D) pharmacophore modeling, which helped verify the effect of FOS on osteoclasts in vivo(Aikawa et al., 2008).

      We also strongly agree that in vivo injection of inhibitors of FOS, especially in CUMS mice, could further substantiate the role of miR-335-3p in osteoclasts under psychological stress. However, the study was constrained by the unavailability of commercially viable, efficacious small molecule inhibitors of FOS. In the future, we plan to design more precise therapeutic targets for psychological stress induced osteoporosis based on existing research ideas.

      Reference

      Aikawa, Y., Morimoto, K., Yamamoto, T., Chaki, H., Hashiramoto, A., Narita, H., Hirono, S., & Shiozawa, S. (2008). Treatment of arthritis with a selective inhibitor of c-Fos/activator protein-1. Nature Biotechnology, 26(7), 817-823. https://doi.org/10.1038/nbt1412

      Cao, Z., Niu, X. B., Wang, M. H., Yu, S. W., Wang, M. K., Mu, S. L., Liu, C., & Wang, Y. X. (2023, Nov). Anemoside B4 attenuates RANKL-induced osteoclastogenesis by upregulating Nrf2 and dampens ovariectomy-induced bone loss [Article]. Biomedicine & Pharmacotherapy, 167, 12, Article 115454. https://doi.org/10.1016/j.biopha.2023.115454

      Cheng, X., Yin, C., Deng, Y., & Li, Z. (2022). Exogenous adenosine activates A2A adenosine receptor to inhibit RANKL-induced osteoclastogenesis via AP-1 pathway to facilitate bone repair. Molecular Biology Reports, 49(3), 2003-2014. https://doi.org/10.1007/s11033-021-07017-1

      Deng, W., Ding, Z., Wang, Y., Zou, B., Zheng, J., Tan, Y., Yang, Q., Ke, M., Chen, Y., Wang, S., & Li, X. (2022). Dendrobine attenuates osteoclast differentiation through modulating ROS/NFATc1/ MMP9 pathway and prevents inflammatory bone destruction. Phytomedicine : International Journal of Phytotherapy and Phytopharmacology, 96, 153838. https://doi.org/10.1016/j.phymed.2021.153838

      Hounoki, H., Sugiyama, E., Mohamed, S. G.-K., Shinoda, K., Taki, H., Abdel-Aziz, H. O., Maruyama, M., Kobayashi, M., & Miyahara, T. (2008). Activation of peroxisome proliferator-activated receptor gamma inhibits TNF-alpha-mediated osteoclast differentiation in human peripheral monocytes in part via suppression of monocyte chemoattractant protein-1 expression. Bone, 42(4), 765-774. https://doi.org/10.1016/j.bone.2007.11.016

      Li, Y., Yang, C., Jia, K., Wang, J., Wang, J., Ming, R., Xu, T., Su, X., Jing, Y., Miao, Y., Liu, C., & Lin, N. (2022). Fengshi Qutong capsule ameliorates bone destruction of experimental rheumatoid arthritis by inhibiting osteoclastogenesis. Journal of Ethnopharmacology, 282, 114602. https://doi.org/10.1016/j.jep.2021.114602

      Li, Z., Huang, J., Wang, F., Li, W., Wu, X., Zhao, C., Zhao, J., Wei, H., Wu, Z., Qian, M., Sun, P., He, L., Jin, Y., Tang, J., Qiu, W., Siwko, S., Liu, M., Luo, J., & Xiao, J. (2019). Dual Targeting of Bile Acid Receptor-1 (TGR5) and Farnesoid X Receptor (FXR) Prevents Estrogen-Dependent Bone Loss in Mice. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research, 34(4), 765-776. https://doi.org/10.1002/jbmr.3652

      Ma, K., Zhang, H., Wei, G., Dong, Z., Zhao, H., Han, X., Song, X., Zhang, H., Zong, X., Baloch, Z., & Wang, S. (2019). Identification of key genes, pathways, and miRNA/mRNA regulatory networks of CUMS-induced depression in nucleus accumbens by integrated bioinformatics analysis. Neuropsychiatric Disease and Treatment, 15, 685-700. https://doi.org/10.2147/NDT.S200264

      Ma, Q., Liang, M., Wu, Y., Luo, F., Ma, Z., Dong, S., Xu, J., & Dou, C. (2021). Osteoclast-derived apoptotic bodies couple bone resorption and formation in bone remodeling. Bone Research, 9(1), 5. https://doi.org/10.1038/s41413-020-00121-1

      Zhong, L., Lu, J., Fang, J., Yao, L., Yu, W., Gui, T., Duffy, M., Holdreith, N., Bautista, C. A., Huang, X., Bandyopadhyay, S., Tan, K., Chen, C., Choi, Y., Jiang, J. X., Yang, S., Tong, W., Dyment, N., & Qin, L. (2023). Csf1 from marrow adipogenic precursors is required for osteoclast formation and hematopoiesis in bone. eLife, 12. https://doi.org/10.7554/eLife.82112

    1. Author response:

      The following is the authors’ response to the original reviews.

      Reviewer #1 (Public Review):

      Batra, Cabrera, Spence et al. present a model which integrates histone posttranslational modification (PTM) data across cell models to predict gene expression with the goal of using this model to better understand epigenetic editing. This gene expression prediction model approach is useful if a) it predicts gene expression in specific cell lines b) it predicts expression values rather than a rank or bin, c) it helps us to better understand the biology of gene expression, or d) it helps us to understand epigenome editing activity. Problematically for points a) and b) it is easier to directly measure gene expression than to measure multiple PTMs and so the real usefulness of this approach mostly relates to c) and d).

      We thank the reviewer for their comment and we agree that directly measuring gene expression (e.g., by performing RNA-seq) is easier than performing multiple PTMs in a new cell line. We designed our approach keeping in mind that the primary use case is to understand how epigenome editing would affect gene expression.

      Other approaches have been published that use histone PTM to predict expression (e.g. 27587684, 36588793). Is this model better in some way? No comparisons are made. The paper does not seem to have substantial novel insights into understanding the biology of gene expression. The approach of using this model to predict epigenetic editor activity on transcription is interesting and to my knowledge novel but I doubt given the variability of the predictions (Figures 6 and S7&8) that many people will be interested in using this in a practical sense. As the authors point out, the interpretation of the epigenetic editing data is convoluted by things like sgRNA activity scoring and to fully understand the results likely would require histone PTM profiling and maybe dCas9 ChIP-seq for each sgRNA which would be a substantial amount of work.

      We thank the reviewer for this insightful comment. We have included citations for a series of papers (PMIDs: 27587684, 30147283, 36588793) that performed gene expression prediction using histone PTM data. However, each of these methods perform classification of gene expression as opposed to predicting the actual gene expression value via regression. Additionally, the referenced studies all work with Roadmap Epigenomics read depth data as opposed to p-values obtained from the ENCODE pipelines, making it difficult to make direct comparisons.

      We outline in the Discussion section that by creating a comprehensive dataset of epigenome editing outcomes, which include quantification of histone PTMs before and after in situ perturbations, will improve our understanding of the effects of dCas9-p300 on gene expression and assist in the design of gRNAs for achieving fine-tuned control over gene expression levels. 

      Furthermore from the model evaluation of H3K9me3 it seems the model is not performing well for epigenetic or transcriptional editing- e.g. we know for the best studied transcriptional editor which is CRISPRi (dCas9-KRAB) that recruitment to a locus is associated with robust gene repression across the genome and is associated with H3K9me3 deposition by recruitment of KAP1/HP1/SETDB1 (PMID: 35688146, 31980609, 27980086, 26501517). However, it seems from Figures 2&4 that the model wouldn't be able to evaluate or predict this.

      We thank the reviewer for their comment. We have included a supplementary figure, Figure 4 – figure supplement 1, that quantifies how sensitive the trained gene expression model is to perturbations in H3K9me3. Indeed our data suggests that the model predictions are sensitive to perturbations in H3K9me3. For instance, there is a clear decrease and a gradual increase as the position where the perturbation is performed moves from upstream to downstream of the TSS. Additionally, the magnitude of the predicted fold-change is a function of how much the H3K9me3 is perturbed and hence the magnitude of change would be even higher if the perturbation magnitude is increased. However, this precise magnitude is hard to estimate In the absence of experimental perturbation data for H3K9me3.

      The model seems to predict gene expression for endogenous genes quite well although the authors sometimes use expression and sometimes use rank (e.g. Figure 6) - being clearer with how the model predicts expression rather than using rank or fold change would be very useful.

      We thank the reviewer for this important suggestion. We have added text in the revised manuscript to clarify that the model predicts gene expression values, which can be interpreted as rank or fold change, depending on the use case.

      One concern overall with this approach is that dCas9-p300 has been observed to induce sgRNA-independent off-target H3K27Ac (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8349887/ see Figure S5D) which could convolute interpretation of this type of experiment for the model.

      This is an excellent point and indeed, we and others have observed that dCas9-p300 can result in off-target H3K27ac levels (both increased and suppressed) across the genome. However, p300 is one of the few known proteins that can catalyze H3K27ac in the human genome, and H3K27ac remains a proxy for active genomic regulatory elements. Nevertheless, dCas9-p300 off target activity could certainly convolute our approach. We have included language to address this caveat in our discussion. Interestingly, even though dCas9-p300 (and other epigenome editing enzymes) can lead to off-target chromatin modifications, these effects often occur without coincident disruptions to the transcriptome. This suggests that many chromatin modifications, while “supportive” or “instructive” of/for transcription, may be insufficient (either alone or in the context of dCas9-based fusions) for transcriptional effects.

      Figure 2

      It seems this figure presents known rather than novel findings from the authors' description. Please comment on whether there are any new findings in this figure. Please comment on differences in patterns of repressive and activating histone PTMs between cell lines (e.g. H1-Esc H3K27me3 green 25-50% is more enriched than red 0-25%).

      Thank you for pointing out this issue. We have revised the text in both the Results and Discussion sections to better articulate that the goal of this figure is to validate the hypothesis that there are consistent patterns of histone PTMs with respect to gene expression across different human cell types.

      In Figure 2, which illustrates the raw histone marks data, the non-monotonic behavior of H3K27me3 in H1-hESC cells is indicative of a real biological phenomenon. This interpretation is supported by the relatively low Pearson correlation for the H3K27me3 mark observed in these cells, as documented in Figure 1b of another study: https://www.biorxiv.org/content/10.1101/2024.03.29.587323v1.

      Figure 3&4

      There are a number of approaches including DeepChrome and TransferChrome that predict endogenous gene expression from histone PTMs. I appreciate that the authors have not used the histone PTM data to predict gene expression levels of an "average cell" but rather that they are predicting expression within specific cell types or for unseen cell types. But from what is presented it isn't clear that the author's model is better or enabling beyond other approaches. The authors should show their model is better than other approaches or make clear why this is a significant advance that will be enabling for the field. For example is it that in this approach they are actually predicting expression levels whereas previous approaches have only predicted expressed or not expressed or a rank order or bin-based ranking?

      We thank the reviewer for this comment. We have added text to clarify the difference between our approach and existing approaches. There are two key differences between our model and other approaches. First, the gene expression model that we have trained here predicts gene expression values instead of gene expression levels as either high or low. Second, we have trained our models on ENCODE p-value data instead of read depths obtained from the Roadmap Epigenomics Consortium.

      Figure 5

      From the methods, it seems gene activation is measured by qpcr in hek293 transfected with individual sgRNAs and dCas9-p300. The cells aren't selected or sorted before qPCR so how are we sure that some of the variability isn't due to transfection efficiency associated with variable DNA quality or with variable transfection efficiency?

      This is a good question. All DNA preps were generated using high-quality reagents and consistent protocols. In addition, the only variable that changed with respect to transfection efficiency was the gRNA-encoding vector used in qPCR assays. We have added new data which demonstrates that transfection efficiency is shared across experiments (Figure 5 – figure supplement 1). We have also added additional experimental data as well as computational analysis analyzing a new dCas9-p300 based Perturb-seq dataset to the manuscript (Figure 6 – figure supplement 1), which use lentiviral transduction and RNA-seq as readouts and thus, are buffered against the variances mentioned by the Reviewer.

      Figure 6

      The use of rank in 6D and 6E is confusing. In 6D a higher rank is associated with higher expression while in 6E a higher rank seems to mean a lower fold change e.g. CYP17A1 has a low predicted fold-change rank and qPCR fold-change rank but in Figure 5 a very high qPCR fold change. Labeling this more clearly or explaining it in the text further would be useful.

      We thank the reviewer for their suggestion. We have made relevant changes to the caption of Figure 6 to clarify this.

      Reviewer #2 (Public Review):

      Summary:

      The authors build a gene expression model based on histone post-translational modifications and find that H3K27ac is correlated with gene expression. They proceed to perturb H3K27ac at 8 gene promoters, and measure gene expression changes to test their model.

      Strengths:

      The combination of multiple methods to model expression, along with utilizing 6 histone datasets in 13 cell types allowed the authors to build a model that correlates between 0.7-0.79 with gene expression. This group also utilized a tool they are experts in, dCas9-p300 fusions to perturb H3K27ac and monitor gene expression to test their model. Ranked correlations showed some support for the predictions after the perturbation of H3K27ac.

      Weaknesses:

      The perturbation of only 8 genes, and the only readout being qPCR-based gene expression, as opposed to including H3K27ac, weakened their validation of the computational model. Likewise, the use of six genes that were not expressed being most activated by dCas9-p300 might weaken the correlations vs. looking at a broad range of different gene expressions as the original model was trained on.

      We thank the reviewer for their comments. We have added additional experimental data as well as computational analysis analyzing a new dCas9-p300 based Perturb-seq dataset to the manuscript. We observe that the models we have developed are able to predict the fold-change rank across genes reasonably well (Figure 6 – figure supplement 1), similar to what we observe in Figure 6E.

      Reviewer #1 (Recommendations For The Authors):

      The authors should comment on how their model is different from or better than other models that use histone PTM data to predict gene expression.

      We thank the reviewer for this insightful suggestion. We have included citations for a series of papers (PMIDs: 27587684, 30147283, 36588793) that performed gene expression prediction using histone PTM data. However, each of these methods perform classification of gene expression as opposed to predicting the actual gene expression value via regression. Additionally, the referenced studies all work with Roadmap Epigenomics read depth data as opposed to p-values obtained from the ENCODE pipelines, making it difficult to make direct comparisons.

      The authors need to make clear whether their model will apply to other common epigenetic or transcriptional editors such as CRISPRi/H3K9me3 which is widely used.

      In this study, we focus on the histone changes induced by p300. However, future studies may use the framework described in our manuscript and apply it to other transcriptional editors as well.

      The authors need to be clearer about where they are predicting expression and where they are using rank. Ideally, show both.

      We thank the reviewer for this important suggestion. We have added text in the revised manuscript to clarify that the model predicts gene expression values, which can be interpreted as rank or fold change, depending on the use case.

      The authors should ideally show a case where they use the model to make a prediction of genes that can and can not be activated by dCas9-p300 or other epigenetic editors and then prove this with experiments.

      Thank you for the excellent suggestion. While it is indeed relevant, exploring this would extend beyond the scope of our current study. We consider it a valuable topic for future research.

      Reviewer #2 (Recommendations For The Authors):

      The y-axis in 5C needs to be labeled. The authors state it is "relative mRNA" but these numbers correlated with fold changes shown in Table S2.

      We have clarified the definition of the Y-axis in the caption for Figure 5C.

    1. Author response:

      Reviewer #1 (Public review):

      I did not follow the logic behind including spindle amplitude in the meta-analysis. This is not a measure of SO-spindle coupling (which is the focus of the review), unless the authors were restricting their analysis of the amplitude of coupled spindles only. It doesn't sound like this is the case though. The effect of spindle amplitude on memory consolidation has been reviewed in another recent meta-analysis (Kumral et al, 2023, Neuropsychologia). As standardization this isn't a measure of coupling, it wasn't clear why this measure was included in the present meta-analysis. You could easily make the argument that other spindle measures (e.g., density, oscillatory frequency) could also have been included, but that seems to take away from the overall goal of the paper which was to assess coupling.

      Indeed, spindle amplitude refers to all spindle events rather than only coupled spindles. This choice was made because we recognized the challenge of obtaining relevant data from each study—only 4 out of the 23 included studies performed their analyses after separating coupled and uncoupled spindles. This inconsistency strengthens the urgency and importance of this meta-analysis to standardize the methods and measures used for future analysis on SO-SP coupling and beyond. We agree that focusing on the amplitude of coupled spindles would better reveal their relations with coupling, and we will discuss this limitation in the manuscript.

      Nevertheless, we believe including spindle amplitude in our study remains valuable, as it served several purposes. First, SO-SP coupling involves the modulation between spindle amplitude and slow oscillation phase. Different studies have reported conflicting conclusions regarding how spindle amplitude was related to coupling– some found significant correlations (e.g., Baena et al., 2023), while others did not (e.g., Roebber et al., 2022). This discrepancy highlights an indirect but potentially crucial insight into the role of spindle amplitude in coupling dynamics. Second, in studies related to SO-SP coupling, spindle amplitude is one of the most frequently reported measures along with other coupling measures that significantly correlated with oversleep memory improvements (e.g. Kurz et al., 2023; Ladenbauer et al., 2021; Niknazar et al., 2015), so we believe that including this measure can more comprehensively review of the existing literature on SO-SP coupling. Third, incorporating spindle amplitude allows for a direct comparison between the measurement of coupling and individual events alone in their contribution to memory consolidation– a question that has been extensively explored in recent research. (e.g., Hahn et al., 2020; Helfrich et al., 2019; Niethard et al., 2018; Weiner et al., 2023). Finally, spindle amplitude was identified as a key moderator for memory consolidation in Kumral et al.'s (2023) meta-analysis. By including it in our analysis, we sought to replicate their findings within a broader framework and introduce conceptual overlaps with existing reviews. Therefore, although we were not able to selectively include coupled spindles, there is still a unique relation between spindle amplitude and SO-SP coupling that other spindle measures do not have. 

      Originally, we also intended to include coupling density or counts in the analysis, which seems more relevant to the coupling metrics. However, the lack of uniformity in methods used to measure coupling density posed a significant limitation. We hope that our study will encourage consistent reporting of all relevant parameters in future research, enabling future meta-analyses to incorporate these measures comprehensively. We will add this discussion to the manuscript in the revised version to further clarify these points.

      References:

      Roebber, J. K., Lewis, P. A., Crunelli, V., Navarrete, M. & Hamandi, K. Effects of anti-seizure medication on sleep spindles and slow waves in drug-resistant epilepsy. Brain Sci. 12, 1288 (2022). https://doi.org/10.3390/brainsci12101288

      All other citations were referenced in the manuscript.

      At the end of the first paragraph of section 3.1 (page 13), the authors suggest their results "... further emphasise the role of coupling compared to isolated oscillation events in memory consolidation". This had me wondering how many studies actually test this. For example, in a hierarchical regression model, would coupled spindles explain significantly more variance than uncoupled spindles? We already know that spindle activity, independent of whether they are coupled or not, predicts memory consolidation (e.g., Kumral meta-analysis). Is the variance in overnight memory consolidation fully explained by just the coupled events? If both overall spindle density and coupling measures show an equal association with consolidation, then we couldn't conclude that coupling compared to isolated events is more important.

      While primary coupling measurements, including coupling phase and strength, showed strong evidence for their associations with memory consolidation, measures of spindles, including spindle amplitude, only exhibited limited evidence (or “non-significant” effect) for their association with consolidation. These results are consistent with multiple empirical studies using different techniques (e.g., Hahn et al., 2020; Helfrich et al., 2019; Niethard et al., 2018; Weiner et al., 2023), which reported that coupling metrics are more robust predictors of consolidation and synaptic plasticity than spindle or slow oscillation metrics alone. However, we agree with the reviewer that we did not directly separate the effect between coupled and uncoupled spindles, and a more precise comparison would involve contrasting the “coupling of oscillation events” with ”individual oscillation events” rather than coupling versus isolated events.

      We recognized that Kumral and colleagues’ meta-analysis reported a moderate association between spindle measures and memory consolidation (e.g., for spindle amplitude-memory association they reported an effect size of approximately r = 0.30). However, one of the advantages of our study is that we actively cooperated with the authors to obtain a large number of unreported and insignificant data relevant to our analysis, as well as separated data that were originally reported under mixed conditions. This approach decreases the risk of false positives and selective reporting of results, making the effect size more likely to approach the true value. In contrast, we found only a weak effect size of r = 0.07 with minimal evidence for spindle amplitude-memory relation. However, we agree with the reviewer that using a more conservative term in this context would be a better choice since we did not measure all relevant spindle metrics including the density.

      To improve clarity in our manuscript, we will revise the statement to: “Together with other studies included in the review, our results suggest a crucial role of coupling but did not support the role of spindle events alone in memory consolidation,” and provide relevant references. We believe this can more accurately reflect our findings and the existing literature to address the reviewer’s concern.

      It was very interesting to see that the relationship between the fast spindle coupling phase and overnight consolidation was strongest in the frontal electrodes. Given this, I wonder why memory promoting fast spindles shows a centro-parietal topography? Surely it would be more adaptive for fast spindles to be maximally expressed in frontal sites. Would a participant who shows a more frontal topography of fast spindles have better overnight consolidation than someone with a more canonical centro-parietal topography? Similarly, slow spindles would then be perfectly suited for memory consolidation given their frontal distribution, yet they seem less important for memory.

      Regarding the topography of fast spindles and their relationship to memory consolidation, we agree this is an intriguing issue, and we have already developed significant progress in this topic in our ongoing work. We share a few relevant observations: First, there are significant discrepancies in the definition of “slow spindle” in the field. Some studies defined slow spindle from 9-12 Hz (e.g. Mölle et al., 2011; Kurz et al., 2021), while others performed the event detection within a range of 11-13/14 Hz (e.g. Barakat et al., 2011; D'Atri et al., 2018). Compounding this issue, individual differences in spindle frequency are often overlooked, leading to challenges in reliably distinguishing between slow and fast spindles. Some studies have reported difficulty in clearly separating the two types of spindles altogether (e.g., Hahn et al., 2020). Moreover, a critical factor often ignored in past research is the traveling nature of both slow oscillations and spindles across the cortex, where spindles are coupled with significantly different phases of slow oscillations (see Figure 5). We believe a better understanding of coupling in the context of the movement of these waves will help us better understand the observed frontal relationship with consolidation. We will address this in our revised manuscript.

      The authors rightly note the issues with multiple comparisons in sleep physiology and memory studies. Multiple comparison issues arise in two ways in this literature. First are comparisons across multiple electrodes (many studies now use high-density systems with 64+ channels). Second are multiple comparisons across different outcome variables (at least 3 ways to quantify coupling (phase, consistency, occurrence) x 2 spindle types (fast, slow). Can the authors make some recommendations here in terms of how to move the field forward, as this issue has been raised numerous times before (e.g., Mantua 2018, Sleep; Cox & Fell 2020, Sleep Medicine Reviews for just a couple of examples). Should researchers just be focusing on the coupling phase? Or should researchers always report all three metrics of coupling, and correct for multiple comparisons? I think the use of pre-registration would be beneficial here, and perhaps could be noted by the authors in the final paragraph of section 3.5, where they discuss open research practices.

      There are indeed multiple methods that we can discuss, including cluster-based and non-parametric methods, etc., to correct for multiple comparisons in EEG data with spatiotemporal structures. In addition, encouraging the reporting of all tested but insignificant results, at least in supplementary materials, is an important practice that helps readers understand the findings with reduced bias. We agree with the reviewer’s suggestions and will add more information in section 3.5 to advocate for a standardized “template” used to analyze and report effect size in future research.

      We advocate for the standardization of reporting all three coupling metrics– phase, consistency, and occurrence. Each coupling metric captures distinct properties of the coupling process and may interact with one another (Weiner et al., 2023). Therefore, we believe it is essential to report all three metrics to comprehensively explore their different roles in the “how, what, and where” of long-distance communication and consolidation of memory. As we advance toward a deeper understanding of the relationship between memory and sleep, we hope this work establishes a standard for the standardization, transparency, and replication of relevant studies.

      Reviewer #2 (Public review):

      Regarding the Moderator of Age: Although the authors discuss the limited studies on the analysis of children and elders regarding age as a moderator, the figure shows a significant gap between the ages of 40 and 60. Furthermore, there are only a few studies involving participants over the age of 60. Given the wide distribution of effect sizes from studies with participants younger than 40, did the authors test whether removing studies involving participants over 60 would still reveal a moderator effect?

      We agree that there is an age gap between younger and older adults, as current studies often focus on contrasting newly matured and fully aged populations to amplify the effect, while neglecting the gradual changes in memory consolidation mechanisms across the aging spectrum. We suggest that a non-linear analysis of age effects would be highly valuable, particularly when additional child and older adult data become available.

      In response to the reviewer’s suggestion, we re-tested the moderation effect of age after excluding effect sizes from older adults. The results revealed a decrease in the strength of evidence for phase-memory association due to increased variability, but were consistent for all other coupling parameters. The mean estimations also remained consistent (coupling phase-memory relation: -0.005 [-0.013, 0.004], BF10 = 5.51, the strength of evidence reduced from strong to moderate; coupling strength-memory relation: -0.005 [-0.015, 0.008], BF10 = 4.05, the strength of evidence remained moderate). These findings align with prior research, which typically observed a weak coupling-memory relationship in older adults during aging (Ladenbauer et al, 2021; Weiner et al., 2023) but not during development (Hahn et al., 2020; Kurz et al., 2021; Kurz et al., 2023). Therefore, this result is not surprising to us, and there are still observable moderate patterns in the data. We will report these additional results in the revised manuscript, and interpret “the moderator effect of age becomes less pronounced during development after excluding the older adult data”. We believe the original findings including the older adult group remain meaningful after cautious interpretation, given that the older adult data were derived from multiple studies and different groups.

      Reviewer #3 (Public review):

      First, the authors conclude that "SO-SP coupling should be considered as a general physiological mechanism for memory consolidation". However, the reported effect sizes are smaller than what is typically considered a "small effect" (0.10)

      While we acknowledge the concern about the small effect sizes reported in our study, it is important to contextualize these findings within the field of neuroscience, particularly memory research. Even in individual studies, small effect sizes are not uncommon due to the inherent complexity of the mechanisms involved and the multitude of confounding variables. This is an important factor to be considered in meta-analyses where we synthesize data from diverse populations and experimental conditions. For example, the relationship between SO-slow SP coupling and memory consolidation in older adults is expected to be insignificant.

      As Funder and Ozer (2019) concluded in their highly cited paper, an effect size of r = 0.3 in psychological and related fields should be considered large, with r = 0.4 or greater likely representing an overestimation and rarely found in a large sample or in a replication. Therefore, we believe r = 0.1 should not be considered as a lower bound of the small effect. Bakker et al. (2019) also advocate for a contextual interpretation of the effect size. This is particularly important in meta-analyses, where the results are less prone to overestimation compared to individual studies, and we cooperated with all authors to include a large number of unreported and insignificant results. In this context, small correlations may contain substantial meaningful information to interpret. Although we agree that effect sizes reported in our study are indeed small at the overall level, they reflect a rigorous analysis that incorporates robust evidence across different levels of moderators. Our moderator analyses underscore the dynamic nature of coupling-memory relationships, with certain subgroups demonstrating much stronger and more meaningful effects, especially after excluding slow spindles and older adults. For example, both the coupling phase and strength of frontal fast spindles with slow oscillations exhibited "moderate-to-large" correlations with the consolidation of different types of memory, especially in young adults, with r values ranging from 0.18 to 0.32. (see Table S9.1-9.4). We will add more discussion about the influence of moderators on the dynamics of coupling-memory associations. In addition, we will update the conclusion to be “SO-fast SP coupling should be considered as a general physiological mechanism for memory consolidation”.

      Reference:

      Funder, D. C. & Ozer, D. J. Evaluating effect size in psychological research: sense and nonsense. Adv. Methods Pract. Psychol. Sci. 2, 156–168 (2019). https://doi.org/10.1177/2515245919847202.

      Bakker, A. et al. Beyond small, medium, or large: Points of consideration when interpreting effect sizes. Educ. Stud. Math. 102, 1–8 (2019). https://doi.org/10.1007/s10649-019-09908-4

      Second, the study implements state-of-the-art Bayesian statistics. While some might see this as a strength, I would argue that it is the greatest weakness of the manuscript. A classical meta-analysis is relatively easy to understand, even for readers with only a limited background in statistics. A Bayesian analysis, on the other hand, introduces a number of subjective choices that render it much less transparent.

      This kind of analysis seems not to be made to be intelligible to the average reader. It follows a recent trend of using more and more opaque methods. Where we had to trust published results a decade ago because the data were not openly available, today we must trust the results because the methods can no longer be understood with reasonable effort.

      This becomes obvious in the forest plots. It is not immediately apparent to the reader how the distributions for each study represent the reported effect sizes (gray dots). Presumably, they depend on the Bayesian priors used for the analysis. The use of these priors makes the analyses unnecessarily opaque, eventually leading the reader to question how much of the findings depend on subjective analysis choices (which might be answered by an additional analysis in the supplementary information).

      We appreciate the reviewer for sharing this viewpoint and we value the opportunity to clarify some key points. To address the concern about clarity, we will include a sub-section in the methods section explaining how to interpret Bayesian statistics including priors, posteriors, and Bayes factors, making our results more accessible to those less familiar with this approach.

      On the use of Bayesian models, we believe there may have been a misunderstanding. Bayesian methods, far from being "opaque" or overly complex, are increasingly valued for their ability to provide nuanced, accurate, and transparent inferences (Sutton & Abrams, 2001; Hackenberger, 2020; van de Schoot et al., 2021; Smith et al., 1995; Kruschke & Liddell, 2018). It has been applied in more than 1,200 meta-analyses as of 2020 (Hackenberger, 2020). In our study, we used priors that assume no effect (mean set to 0, which aligns with the null) while allowing for a wide range of variation to account for large uncertainties. This approach reduces the risk of overestimation or false positives and demonstrates much-improved performance over traditional methods in handling variability (Williams et al., 2018; Kruschke & Liddell, 2018). Sensitivity analyses reported in the supplemental material (Table S9.1-9.4) confirmed the robustness of our choices of priors– our results did not vary by setting different priors.

      As Kruschke and Liddell (2018) described, “shrinkage (pulling extreme estimates closer to group averages) helps prevent false alarms caused by random conspiracies of rogue outlying data,” a well-known advantage of Bayesian over traditional approaches. This explains the observed differences between the distributions and grey dots in the forest plots. Unlike p-values, which can be overestimated with a large sample size and underestimated with a small sample size, Bayesian methods make assumptions explicit, enabling others to challenge or refine them– an approach aligned with open science principles (van de Schoot et al., 2021). For example, a credible interval in Bayesian model can be interpreted as “there is a 95% probability that the parameter lies within the interval.”, while a confidence interval in frequentist model means “In repeated experiments, 95% of the confidence intervals will contain the true value.” We believe the former is much more straightforward and convincing for readers to interpret. We will ensure our justification for using Bayesian models is more clearly presented in the manuscript.

      We acknowledge that even with these justifications, different researchers may still have discrepancies in their preferences for Bayesian and frequentist models. To increase the effort of transparent reporting, we have also reported the traditional frequentist meta-analysis results in Supplemental Material 10 to justify the robustness of our analysis, which suggested non-significant differences between Bayesian and frequentist models. We will include clearer references in the next version of the manuscript to direct readers to the figures that report the statistics provided by traditional models.

      References:

      Hackenberger, B.K. Bayesian meta-analysis now—let's do it. Croat. Med. J. 61, 564–568 (2020). https://doi.org/10.3325/cmj.2020.61.564

      Sutton, A.J. & Abrams, K.R. Bayesian methods in meta-analysis and evidence synthesis. Stat. Methods Med. Res. 10, 277–303 (2001). https://doi.org/10.1177/096228020101000404

      Williams, D.R., Rast, P. & Bürkner, P.C. Bayesian meta-analysis with weakly informative prior distributions. PsyArXiv (2018). https://doi.org/10.31234/osf.io/9n4zp

      van de Schoot, R., Depaoli, S., King, R. et al. Bayesian statistics and modelling. Nat Rev Methods Primers 1, 1 (2021). https://doi.org/10.1038/s43586-020-00001-2

      Smith, T.C., Spiegelhalter, D.J. & Thomas, A. Bayesian approaches to random-effects meta-analysis: a comparative study. Stat. Med. 14, 2685–2699 (1995). https://doi.org/10.1002/sim.4780142408

      Kruschke, J.K. & Liddell, T.M. The Bayesian New Statistics: Hypothesis testing, estimation, meta-analysis, and power analysis from a Bayesian perspective. Psychon. Bull. Rev. 25, 178–206 (2018). https://doi.org/10.3758/s13423-016-1221-4

      However, most of the methods are not described in sufficient detail for the reader to understand the proceedings. It might be evident for an expert in Bayesian statistics what a "prior sensitivity test" and a "posterior predictive check" are, but I suppose most readers would wish for a more detailed description. However, using a "Markov chain Monte Carlo (MCMC) method with the no-U-turn Hamiltonian Monte Carlo (HMC) sampler" and checking its convergence "through graphical posterior predictive checks, trace plots, and the Gelman and Rubin Diagnostic", which should then result in something resembling "a uniformly undulating wave with high overlap between chains" is surely something only rocket scientists understand. Whether this was done correctly in the present study cannot be ascertained because it is only mentioned in the methods and no corresponding results are provided. 

      We appreciate the reviewer’s concerns about accessibility and potential complexity in our descriptions of Bayesian methods. Our decision to provide a detailed account serves to enhance transparency and guide readers interested in replicating our study. We acknowledge that some terms may initially seem overwhelming. These steps, such as checking the MCMC chain convergence and robustness checks, are standard practices in Bayesian research and are analogous to “linearity”, “normality” and “equal variance” checks in frequentist analysis. We have provided exemplary plots in the supplemental material and will add more details to explain the interpretation of these convergence checks. We hope this will help address any concerns about methodological rigor.

      In one point the method might not be sufficiently justified. The method used to transform circular-linear r (actually, all references cited by the authors for circular statistics use r² because there can be no negative values) into "Z_r", seems partially plausible and might be correct under the H0. However, Figure 12.3 seems to show that under the alternative Hypothesis H1, the assumptions are not accurate (peak Z_r=~0.70 for r=0.65). I am therefore, based on the presented evidence, unsure whether this transformation is valid. Also, saying that Z_r=-1 represents the null hypothesis and Z_r=1 the alternative hypothesis can be misinterpreted, since Z_r=0 also represents the null hypothesis and is not half way between H0 and H1.

      First, we realized that in the title of Figures 12.2 and 12.3. “true r = 0.35” and “true r = 0.65” should be corrected as “true Z_r”. The method we used here is to first generate an underlying population that has null (0), moderate (0.35), or large (0.65) Z_r correlations, then test whether the sampling distribution drawn from these populations followed a normal distribution across varying sample sizes. Nevertheless, the reviewer correctly noticed discrepancies between the reported true Z_r and its sampling distribution peak. This discrepancy arises because, when generating large population data, achieving exact values close to a strong correlation like Z_r = 0.65 is unlikely. We loop through simulations to generate population data and ensure their Z_r values fall within a threshold. For moderate effect sizes (e.g., Z_r = 0.35), this is straightforward using a narrow range (0.345 < Z_r < 0.355). However, for larger effect sizes like Z_r = 0.65, a wider range (0.6 < Z_r < 0.7) is required. therefore sometimes the population we used to draw the sample has a Z_r slightly deviated from 0.65. This remains reasonable since the main point of this analysis is to ensure that large Z_r still has a normal sampling distribution, but not focus specifically on achieving Z_r = 0.65.

      We acknowledge that this variability of the range used was not clearly explained and it is not accurate to report “true Z_r = 0.65”. In the revised version, we will address this issue by adding vertical lines to each subplot to indicate the Z_r of the population we used to draw samples, making it easier to check if it aligns with the sampling peak. In addition, we will revise the title to “Sampling distributions of Z_r drawn from strong correlations (Z_r = 0.6-0.7)”. We confirmed that population Z_r and the peak of their sampling distribution remain consistent under both H0 and H1 in all sample sizes with n > 25, and we hope this explanation can fully resolve your concern.

      We agree with the reviewer that claiming Z_r = -1 represents the null hypothesis is not accurate. The circlin Z_r = 0 is better analogous to Pearson’s r = 0 since both represent the mean drawn from the population with the null hypothesis. In contrast, the mean effect size under null will be positive in the raw circlin r, which is one of the important reasons for the transformation. To provide a more accurate interpretation, we will update Table 6 to describe the following strength levels of evidence: no effect (r < 0), null (r = 0), small (r = 0.1), moderate (r = 0.3), and large (r = 0.5).

    1. Author response:

      The following is the authors’ response to the original reviews.

      We thank the Editors and reviewers for their candid evaluation of our work. While it was suggested that we should demonstrate the validity of our approach with maybe 10 different datasets but we felt that this would place an undue burden on our resources. Generally, it takes about 4 to 6 months for us to build a dataset and this does not include the time taken to train and test our AI models. This would mean that it would take us another 3 to 5 years to complete this research project if we chose to provide 10 different datasets. Publishing a research on one dataset is definitely not unheard of: for example, Subramanian et al. (2016) published their widely-cited benchmark dataset for just BACE1 inhibitors. However, we hoped that the additional work where we showed that we were able to improve the benchmark dataset for BACE1 inhibitors and achieve the same high level of predictive performance for this dataset would convince the readers (and reviewers) of the reproducibility of our approach. Furthermore, we also showed that our approach is robust and does not rely on a large volume of data to achieve this near-perfect accuracy. As can be seen in the Supplemental section, even our AI models trained on ONLY 250 BRAF actives and 250 inactives could achieve 96.3% accuracy! Logically, if the model is robust then we would expect the model to be reproducible. As such, we do not feel it is necessary for us to test our approach on 10 different datasets. 

      It was also suggested that we expand this study to other types of molecular representations to give a better idea of generalizability. We would like to point out that we tested, in total, 55 single fingerprints and paired combinations. Our goal was to create an approach that could give superior performance for virtual screening and we believe that we have achieved this. Based on the results of our study, we are of the opinion that molecular representations do not, in general, have an oversized effect on AI virtual screening. Although it is important to be aware that certain molecular representations may give SLIGHTLY better performance but we can see that with the exception of the 79-bit E-State fingerprint (which could still achieve an impressive 85% accuracy for the SVM model), nearly all molecular fingerprints and paired combinations that we used were able to achieve an accuracy of above 97%. Therefore, we do not share the reviewers' concern that our approach may not be useful when applied with other types of molecular representations.

      It is true that our work involved manual curation of the datasets but the goal of this paper is to lay down some  ground rules for the future development of a data-centric AI approach. Although manual curation is a routine practice in AI/ML, but it should be recognised that there is good manual curation and bad manual curation, and rules need to be established to ensure we have good manual curation. Without these rules, we would also not be able to establish and train a data-centric AI. All manual curation involves a level of subjectiveness but that subjectiveness comes from one's experience and domain knowledge of the field in which the AI is being applied. For example, in the case of this study, we relied on our knowledge and understanding of pharmacology to determine whether a compound is pharmacologically inactive or active. This may seem somewhat arbitrary to the uninitiated but it is anything but arbitrary. It is through careful thought and assessment of the chemical compounds that we choose these compounds for training the AI. Unfortunately, this sort of subjective assessment cannot be easily or completely explained but we do show where current practices have failed when building a dataset for training an AI for virtual screening.

    1. Author response:

      (1) Controls for the genetic background are incomplete, leaving open the possibility that the observed oviposition timing defects may be due to targeted knockdown of the period (per) gene but from the GAL4, Gal80, and UAS transgenes themselves. To resolve this issue the authors should determine the egg-laying rhythms of the relevant controls (GAL4/+, UAS-RNAi/+, etc); this only needs to be done for those genotypes that produced an arrhythmic egg-laying rhythm.

      We agree with this objection, and in the corrected version we plan to provide the assessment of the egg laying rhythms for the missing GAL4 controls as recommended only for Figure 3.

      (2) Reliance on a single genetic tool to generate targeted disruption of clock function leaves the study vulnerable to associated false positive and false negative effects: a) The per RNAi transgene used may only cause partial knockdown of gene function, as suggested by the persistent rhythmicity observed when per RNAi was targeted to all clock neurons. This could indicate that the results in Fig 2C-H underestimate the phenotypes of targeted disruption of clock function. b) Use of a single per RNAi transgene makes it difficult to rule out that off-target effects contributed significantly to the observed phenotypes. We suggest that the authors repeat the critical experiments using a separate UAS-RNAi line (for period or for a different clock gene), or, better yet, use the dominant negative UAS-cycle transgene produced by the Hardin lab (https://doi.org/10.1038/22566).

      We have recently acquired mutant flies with a dominant negative-cycle transgene (UAS-cycDN, Tanoue et al. 2004), and we plan to repeat our experiments with these mutants, in order to confirm our results.

      (3) The egg-laying profiles obtained show clear damping/decaying trends which necessitates careful trend removal from the data to make any sense of the rhythm. Further, the detrending approach used by the authors is not tested for artefacts introduced by the 24h moving average used.

      In the revised version we will show that the detrending approach used does not introduce any artefacts. The analysis of numerical simulations with an aperiodic stochastic signal superposed to a decaying signal shows that the detrending method used does not result in a spurious periodic signal. Furthermore, we can show that when the underlying signal is rhythmic, the correct period is obtained even when the moving average is a few hours larger or smaller than 24 h.

      (4) According to the authors the oviposition device cannot sample at a resolution finer than 4 hours, which will compel any experimenter to record egg laying for longer durations to have a suitably long time series which could be useful for circadian analyses.

      We apologize for not being clear enough. The device can in principle sample at any desired resolution. Notice, however, that the variable we are analyzing (number of eggs laid by a single female) has only a few possible values, which is one of the features that render the assessment of rhythmicity a particularly difficult task. If egg laying is sampled more often (say, at 2 h intervals) more time points will be available, but the values available for each time point will be much less. We will show an example where we compare both rates (2h and 4h). Even though the 2h sampling reveals the rhythmicity of the time series, the significance of the peaks obtained is less than when sampling at 4h intervals. We have found that a 4h sampling seems to provide the best compromise between frequency of the sampling and discreteness of the variable.

      On the other hand, it is important to stress that sampling frequency and longer durations are not very correlated (see e.g. Cohen et al. Journal of Theoretical Biology 314, pp 182 [2012]). It has been shown that the best way to make accurate predictions of the period of a rhythmic signal is to have a series spanning many cycles, irrespective of the sampling frequency. In other words, it is not true that with a 2h sampling it would be possible to analyze shorter series than with 4h sampling. Unfortunately, egg laying records are usually less than 5 cycles long, which is one of the reasons for the difficulties in the assessment of their rhythmicity.

      (5) Despite reducing the interference caused by manually measuring egg-laying, the rhythm does not improve the signal quality such that enough individual rhythmic flies could be included in the analysis methods used. The authors devise a workaround by combining both strongly and weakly rhythmic (LSpower > 0.2 but less than LSpower at p < 0.05) data series into an averaged time series, which is then tested for the presence of a 16-32h "circadian" rhythm. This approach loses valuable information about the phase and period present in the individual mated females, and instead assumes that all flies have a similar period and phase in their "signal" component while the distribution of the "noise" component varies amongst them. This assumption has not yet been tested rigorously and the evidence suggests a lot more variability in the inter-fly period for the egg-laying rhythm.

      The assumption is difficult to test rigorously, since for individual flies the records seem to be so noisy that no information can be extracted. As shown in the paper, it is even very difficult to assess the presence of rhythmicity at the individual level. We consider that the appearance of a rhythm after averaging several records shows the presence of this rhythm at the individual level. But it could be argued that the presence of rhythmicity in the average record could be due to only a few (or even a single) rhythmic individuals. In order to show that this is probably not the case, in the revised version we will show that, when the individuals that are rhythmic are left out, the average of the remaining flies still shows a rhythm (albeit a weaker one, as was to be expected).

      Regarding our assumption that all flies have the “same” period, the results on Fig. 1 F cannot really rule out this possibility, because with so few cycles, the determination of the period is not very accurate (see e.g. Cohen et al. Journal of Theoretical Biology 314, pp 182 [2012]). In our case, the error for the period is related to the width of the corresponding peak in the periodogram, which is typically 4 hs. In any case, in the revised version we will try to show, by using numerical simulations, that when the individual periods are not the same, but are distributed approximately as in Fig 1F, the average series is still rhythmic with the correct period.

      (6) This variability could also depend on the genotype being tested, as the authors themselves observe between their Canton-S and YW wild-type controls for which their egg-laying profiles show clearly different dynamics. Interestingly, the averaged records for these genotypes are not distinguishable but are reflected in the different proportions of rhythmic flies observed. Unfortunately, the authors also do not provide further data on these averaged profiles, as they did for the wild-type controls in Figure 1, when they discuss their clock circuit manipulations using perRNAi. These profiles could have been included in Supplementary figures, where they would have helped the reader decide for themselves what might have been the reason for the loss of power in the LS periodogram for some of these experimental lines.

      Even though we think that the individual records are in general too noisy to be really informative, we will provide all the individual egg profiles in the Supplementary Material of the revised version, in order to let the reader, check this for herself/himself.

      (7) By selecting 'the best egg layers' for inclusion in the oviposition analyses an inadvertent bias may be introduced and the results of the assays may not be representative of the whole population.

      We agree that this may introduce some bias in the results. But in our opinion this bias is very difficult to avoid, since for females that lay very few eggs, rhythmicity can even be difficult to define (some females can spend a whole day without laying a single egg). On the other hand, even when the results may not be representative of the whole population, they would be representative of the flies that lay most of the eggs in a population, which seems to be very relevant in ecological terms.

      (8) An approach that measures rhythmicity for groups of individual records rather than separate individual records is vulnerable to outliers in the data, such as the inclusion of a single anomalous individual record. Additionally, the number of individual records that are included in a group may become a somewhat arbitrary determinant for the observed level of rhythmicity. Therefore, the experimental data used to map the clock neurons responsible for oviposition rhythms would be more convincing if presented alongside individual fly statistics, in the same format as used for Figure 1.

      The question of possible rhythmic outliers has been addressed above, in question 5, where we discuss why we think that such outliers are not “determinant for the observed level of rhythmicity”. As also mentioned above, even though we think that they are too noisy to be informative, we plan to include all individual profiles in the Supplementary Material.

      (9) The features in the experimental periodogram data in Figures 3B and D are consistent with weakened complex rhythmicity rather than arrhythmicity. The inclusion of more individual records in the groups might have provided the added statistical power to demonstrate this. Graphs similar to those in 1G and 1I, might have better illustrated qualitative and quantitative aspects of the oviposition rhythms upon per knockdown via MB122B and Mai179; Pdf-Gal80.

      We assume that the features mentioned refer to the appearance in the periodograms of two small peaks under the significance lines. We are aware that in the studies of the rhythmicity of locomotor activity such features are usually interpreted as “complex rhythms”, i.e. as evidence of the existence of two different mechanisms producing two different rhythms in the same individual. In our case, however, at least two other possibilities should be taken into account. Since the periodograms we show assess the rhythmicity of the average time series of several individuals, the two small peaks could correspond to the periods of two different subpopulations. Another possibility could be that such peaks are simply an artifact of the method in the analysis of time series that consist of very few cycles (as explained above) and also few points per cycle. A cursory examination of the individual profiles, that will be provided in the new version, do not seem to support any of the first two possibilities mentioned. On the other hand, we will show evidence that the analysis of series that are perfectly random sometimes result in periodograms with some small peaks.

    1. Author response:

      We would like to thank the editors and reviewers for taking the time to help improve our manuscript. We appreciate the feedback and will definitely increase the level of methodological detail in a revised submission.

      Here is a brief summary of our plan to address the points raised by the reviewers. We will respond to the comments in a point-by-point manner when we resubmit a revised manuscript.

      Reviewer 1

      This reviewer raised a question about the 60 Hz frame rate for recording. We agree that increasing the number of cameras and frame rate would improve the tracking quality, but this would come at the cost of scalability. In the current study (and other concurrent studies in the lab), we recorded from 10-20 families simultaneously to try to sample the distribution of behavioral responses to stimuli observed in animals in our colony. This was only possible logistically because of the lightweight equipment design allowing us to record data from animals without large disruptions to their home-cage environment.

      One strategy for acquiring higher-resolution data is to build a small number of enclosures that are fully surrounded by cameras, and to cycle animals through these enclosures (1). However, this strategy limits throughput by reducing the number of animals per day that can be studied. If the size and cost of cameras and computers decreases in the future, then this recording strategy will be scalable to the whole-colony level. For our current study and analysis, we are limited by the resolution of our dataset. We do believe that our data (although not a perfect 3d reconstruction or an extremely high frame rate) is sufficient to label behavioral states with high accuracy. We will add a figure to more clearly show that behavioral state data can be accurately inferred from this imperfect data, which has also been recently highlighted by other groups (2).

      Additionally, with recent progress in the application of deep learning to animal pose tracking, new models can infer 3d pose dynamics from 2d data (3) and leverage spatiotemporal structure to clean up noisy data (4). We believe that other groups will be able to use these types of approaches to extract much more value from this dataset. So, in summary, we do understand the concern related to reconstruction quality and will 1) more clearly define the usefulness of our current models, 2) release our data and code so that others can build upon it or repurpose it, and 3) plan future experiments with higher camera count and frame rate as permitted by logistical constraints. 

      Reviewer 2

      This reviewer asked for an increased level of methodological detail. We will try to address this in a few ways:

      (1) Code and data sharing. We believe that many of the questions related to the methodology will be best answered by sharing the data and code directly. Because there is a large amount of code associated with this manuscript, it is impractical to list every step and every parameter in the paper. Along with our revised manuscript, we will make our data and code publicly available. That said, we will improve our description of key parameters in the paper as the reviewer suggested.

      (2) More detailed Methods section. The reviewer asked us to provide more methodological detail. We understand that this is currently a weakness of our manuscript, and we will focus on addressing it. For instance, the reviewer rightly points out that we did not describe the motion watches used to generate the data in Figure S7. We will address this.

      (3) Simplify the manuscript. The paper currently has 22 figures, and further analysis could be done based on the results shown in any of them. For instance, this reviewer asked us to add a comparison across females and males (similar to our comparison of juveniles and adults). While we plan to add that analysis, we recognize that there are several figures/panels that are not closely related to our intended goal of describing the patterns we found in our large dataset. We will simplify the manuscript by removing some excess figures/panels and focus on describing the parts of the analysis that are crucial to our conclusions in greater detail.

      (4) More careful language. This reviewer pointed out that there were some inaccuracies with our descriptive language. For instance, we used the term "natural" behavior to describe the behavior of animals in captivity, which may more accurately be described as their home-cage behavior. We will be more careful to align our language to the standard for the field. For instance, several studies refer to unrestrained behavior in a laboratory setting as "spontaneous" behavior rather than "natural" behavior (5). In our case, the data consists of both spontaneously occurring behavior and responses to a set of stimuli. We will make sure that the descriptions are more precise in the revised manuscript.

      (1) Bala, P. C. et al. Automated markerless pose estimation in freely moving macaques with OpenMonkeyStudio. Nat Commun 11, (2020).

      (2) Weinreb, C. et al. Keypoint-MoSeq: parsing behavior by linking point tracking to pose dynamics. bioRxiv (2023) doi:10.1101/2023.03.16.532307.

      (3) Gosztolai, A. et al. LiftPose3D, a deep learning-based approach for transforming two-dimensional to three-dimensional poses in laboratory animals. Nat Methods 18, 975–981 (2021).

      (4) Wu, A. et al. Deep Graph Pose: a semi-supervised deep graphical model for improved animal pose tracking. Adv Neural Inf Process Syst 33, 6040–6052 (2020).

      (5) Levy, D. R. et al. Mouse spontaneous behavior reflects individual variation rather than estrous state. Curr Biol 33, 1358-1364.e4 (2023).

    1. Author response:

      Reviewer #1 (Public review):

      This study is focused on a population of neurons in the mouse parasubthalamic nucleus (pSTN) that express Tackhykinin1 (Tac1). This gene has been used before to target pSTN for functional circuit studies because it is fairly selective for pSTN in this region, though it targets only a subset of pSTN neurons. Prior work has shown that activity in these neurons can impact motivated behaviors, including feeding and drinking behaviors, and that their activity is associated with aversion or avoidance behaviors. While not breaking much new ground, this study adds to that work by making use of a 2-way active avoidance assay, where a CS predicts a US (footshock), that the mice can escape. Using fiber photometry, the authors show convincing evidence that Tac1 neurons in pSTN increase their activity in response to a US footshock, and that after some pairings the neurons will start responding to the CS too, though to a lesser extent than the US. Their most important data shows that either ablation or optogenetic inhibition of these cells can hugely block the active avoidance (escape) behavior, suggesting these neurons are key for the performance of this task, which they interpret as key for learning the task (but see more below). They show that optogenetic stimulation is aversive in a real-time place assay, and when paired with footshock can enhance active avoidance behavior. Finally, they show that Tac1 pSTN axons in PVT recapitulate these effects while showing that axons in CEA or PBN may only recapitulate some of these effects (more below). Overall I think the data is solid and shows that the activity of Tac1 pSTN neurons in the 2 way active avoidance task is causally related to avoidance behavior in the direction that would be predicted by recent literature. However, I think the authors overstate the conclusions in the title, abstract, and text. I do not think the data make a strong case for a role for these cells in learning, at least in any classical sense, as used in the title and abstract and elsewhere. Also, the statement in the abstract that the pSTN mediates its effects 'differentially' through its downstream targets is not convincingly supported by data.

      We are very pleased that Reviewer 1 thought our data is solid.

      Major concerns:

      (1) The authors infer that the activity in the Tac1 pSTN neurons is necessary for aversive or avoidance 'learning'. But this is not well defined, what exactly does that mean and what types of evidence would support or falsify such a hypothesis? Moreover, the authors show convincingly, and in line with prior reports, that these cells are activated by aversive stimuli (here footshock), and that activation of these cells is sufficient to induce avoidance behavior. Because manipulation of these cells can serve as a primary negative reinforcer, it becomes even more challenging and important to explain how experiments that manipulate these cells while measuring behavior/performance can discriminate between changes in: (1) primary aversion, (2) motivation to avoid, (3) associative learning, or (4) memory/retrieval. The authors seem to favor #3, but they don't make a clear case for this point of view or else what they mean by 'avoidance learning'. In my opinion, the data do not well discriminate between possibilities 1 through 3. The authors should clarify their logic and temper their conclusions throughout.

      Thank you Reviewer 1 for providing us insightful suggestions. Based on our fiber photometry data that the activities of PSTN Tac1+ neurons show a significant increase in CS-evoked calcium fluorescent signals in late trials relative to those in early trials (Figure 1H-K) and our optogenetic inhibition experiments during CS (Figure 2N-Q), these results illustrate that the activities of PSTN Tac1+ neurons are modulated by learning and are required for active avoidance learning. Moreover, PSTN Tac1+ neurons are activated by footshock and activation of these cells is sufficient to induce avoidance behavior. These findings demonstrate that PSTN Tac1+ neurons encode aversive information. Together, our current data support that PSTN Tac1+ neurons encode both aversive event and its predicting cue. We will clarify our conclusions in the revised manuscript.

      (2) Abstract line 37 is not well supported. The authors focus mostly on pSTN projections to PVT and show that the measurements or manipulation of these axons recapitulates the effects seen with pSTN cell bodies. The authors do fewer studies of axons in CeA and PBN, but do find that they can recapitulate the effects with opsin inhibition, but detect no effects with opsin stimulation. However, the lack of effect with opsin stimulation in Figure S7a-e proves very little on its own. It could be technical, due to inadequate expression or functional efficacy. It is not supported by histological and functional evidence that the manipulation was effective. Overall, I can only conclude that the projections to these regions might be very similar (based on the inhibition data), or might be a little different. The data are thus inadequate to support the authors' claim that the pSTN mediates learning differentially through its downstream targets.

      In the revised version of manuscript, we will provide more histological and functional evidence for the PSTN-to-CeA and PSTN-to-PBN circuits to support our conclusion on the functional roles of these downstream targets. Similar with our anterograde experiment that the PSTN densely projects to CeA and PBN (Figure S6), optogenetic activation and inhibition experiments showed dense axonal terminals in the CeA and PBN from the PSTN and this line of data will be included in the revised manuscript. In addition, we will further examine these circuits by investigating the functional roles of CeA-projecting or PBN-Projecting PSTN neurons during 2-way active avoidance task.

      Other concerns:

      (3) Line 93 is not adequately supported by data in Figure 1b. Additional data is needed that shows expression across cases, including any spread that may be visible when zooming out from pSTN. Additional methods are needed to indicate what exclusion criteria were applied and how many mice were excluded. These data could help support the statement on line 93 that expression was largely restricted within pSTN.

      In the revised version of manuscript, we will provide larger example images containing pSTN and its adjacent areas to demonstrate that the viral expression is well restricted into this brain area. Moreover, we will provide detailed information on the exclusion criteria and the number of mice excluded in the Method section.   

      (4) From the results and methods it is not clear where the GFP signal would come from in the mice expressing Casp3 for the ablation studies. It is therefore not clear if the absence of GFP should be taken as evidence of cell loss. For example, it is not clear if multiple vectors were used, if volumes and titers were carefully matched between control groups, or if competition/occlusion between AAVs could be ruled out. It is also not clear how this was quantified, that is how many sections/subjects and how counting was done. It is not clear how long was waited between the AAV infusion, behavior, and euthanasia, perhaps especially important for the ablation done after avoidance learning occurred.

      I totally agree with Reviewer 1’s concerns. We will perform immunohistochemistry or in situ hybridization for Tachykinin-1 itself and then measure colocalization of GFP with Tachykinin-1 inside and outside of the PTSN, and the degree of absence of Tachykinin-1 in Casp mice. In addition, we will provide more detailed experimental information in the revised manuscript.

      (5) The authors should consider showing individual measurements and not just mean/sem wherever feasible, for example, to support the statement on line 141 that 'all ablated mice showed...'.

      Thank you Reviewer 1 for this suggestion. We will re-plot the data as individual measurements in the revised manuscript.

      (6) S3 is an important control for interpreting data in Figure 2d-i. Something similar is needed to support the inferences made in 2j-u. The very strong effect showing a lack of active avoidance in response to CS or the US when pSTN Tac1 neurons are inhibited during CS or during US suggests that something gross may be going on, such as a gross motor or sensory response that supersedes the effect of footshock. The authors do not comment on whether there are any gross behavioral responses to the inhibition, but an experiment as in S3 is needed, for example, to show that behavior is intact during pSTN inhibition if delivered after the mice already learned to associate CS with US.

      Thank you Reviewer 1 for this insightful suggestion. During the review process, we have performed this line of experiment as in Figure S3. We measured the behavioral responses during pSTN optogenetic inhibition after the mice already learned to associate CS with US and found most GtACR-expressing mice showed unaffected avoidance learning. This data will be included in the revised manuscript.

      (7) The authors use 100 shocks of 0.8 mA for 7 days. I think this is quite strong and in the pSTN inhibition experiments it seems to be functionally 'inescapable' and could thus produce behaviors similar to 'learned helplessness'. Can the authors consider whether this might contribute to the striking findings they observed in their opsin inhibition assays?

      I agree with the Reviewer 1’s comment on the string findings in the optogenetic inhibition results. Indeed, based on the results on days 1 and 2, optogenetic inhibition of PSTN tac1+ neurons has significantly blocked GtACR-expressing animals’ behavioral performance during 2-way active avoidance task. To examine whether the effect by optogenetic inhibition of these neurons could possibly decline with prolonged training, we conducted additional 5-day training. We will discuss and add this comment in the revised manuscript.

      (8) The description of the experiment in S5 is inadequate. What are the adjacent areas? Where do the authors see spread? The use of the word 'case' in figure S5 implies an individual case, but the legend says 5 mice were used for 'case 1' and 3 mice were used for 'case 2'. The use of the word 'off-target in the figure implies that the expression was of the intended target. But the text of results and methods implies it was intentional targeting of unnamed and unshown adjacent regions. This should be clarified.

      We will add histological images and clarify these comments in the revised manuscript. The purpose of this experiment is to illustrate that even slightly spreading ChR2 viruses into Tac1+ neurons of the adjacent areas of the PSTN did not result in behavioral changes and this will indirectly support the main behavioral function caused by the PSTN tac1+ neurons rather than its neighboring areas. Because Tac1+ neurons outside the PSTN are sparsely expressed, it is quite difficult to completely restrict the viral expression in the PSTN from the anterior to the posterior. Thus, we will provide detailed information on the exclusion criteria and the number of mice excluded in the Method section.   

      (9) The authors suggest the CPA study is divergent from Serra et al 2023. Though I think this could be due to how the conditioning was done, it would be helpful for the authors to include less processed data. This would aid in possible interpretations for any divergences across studies. Can the authors include raw data (in seconds of time spent) in each compartment for each group across baseline and test days?

      We will follow Reviewer 1’s suggestion to include raw data (in seconds of time spent) in each compartment for each group across baseline and test days in the revised manuscript.

      Reviewer #2 (Public review):

      Summary:

      The manuscript by Hu et. al presents a clearly-designed examination of the role of tachykinin1-expressing neurons in the parasubthalamic nucleus of the lateral posterior hypothalamus (PTSN) in active avoidance learning. These glutamatergic neurons have previously been implicated in responding to negative stimuli. This manuscript expands the current understanding of PTSNTac1 neurons in learned responses to threats by showing their role in encoding and mediating the active avoidance response. The authors first use bulk fiber photometry imaging to show the encoding of the active avoidance procedure, followed by cell-type specific manipulations of PTSNTac1 neurons during active avoidance. Finally, they show that encoding and mediation of active avoidance in a downstream target of PTSNTac1 neurons, the PVT/intermediodorsal nuclei of the dorsal thalamus (IMD), has the same effect as what was discovered in the cell body. This contrasts other output regions of the PTSN, such as the PBN and CeA, which were not found to promote active avoidance learning. The experiments presented were well-designed to support the conclusions of the authors, however, the manuscript is missing several key control experiments and supplemental information to support their main findings.

      Strengths:

      The manuscript provides information on a brain region and downstream target that mediates active avoidance learning. The manuscript provides valuable information via necessity and sufficiency experiments to show the role of the population of interest (PTSNTac1 neurons) in active avoidance learning. The authors also performed most behavior experiments in male and female mice, with adequate power to address potential sex differences in the control of active avoidance by PTSNTac1 neurons. Finally, the manuscript provides valuable information about the specificity of the PTSNTac1 downstream target in regulating active avoidance learning, identifying the PVT/intermediodorsal nuclei of the dorsal thalamus as the key target and ruling out the PBN and CeA.

      We highly appreciate that Reviewer 2 thought that our experiments presented were well-designed to support the conclusions and provided valuable information in several aspects.

      Weaknesses:

      However, several main conclusions of the paper must be interpreted carefully due to missing or inadequate control experiments and histological verification.

      (1) Inadequate presentation of viral localization. The authors state that expression was "largely restricted within PSTN" however there is no quantification of the amount of viral expression beyond the target region. Given that Tac1 is expressed in neighboring regions, it is critical to show the viral expression and fiber implant location data for all animals included in the figures. Furthermore, criteria for inclusion and exclusion based on mistargeting should be delineated. This should also be clearly outlined for the experiments in Figure S5, where "behavioral effects of activation of sparsely Tac1-expressing neurons in two adjacent areas of PSTN" was tested but the location of viral expression in those cases is unclear.

      Similar with questions 3 and 8 of Reviewer 1. We will provide the viral expression and fiber implant location data for all animals included in the figures and histological images in Figure S5 in the revised manuscript. Moreover, we will provide detailed information on the exclusion criteria and the number of mice excluded in the Method section.  

      2) Lack of motion artifact correction with isosbestic signal for GCamp recordings. It is appreciated that the authors included a separate EGFP-expressing group to compare to the GCamp-expressing group, however, additional explanation is required for the methods used to analyze the raw fluorescent signal. Namely, were fluorescent signals isosbestic-corrected prior to calculating ΔF/F? If no isosbestic signal was used to correct motion artifacts within a recording session, additional explanation is needed to explain how this was addressed. The lack of motion artifacts in the EGFP signal in a separate cohort is inadequate to answer this caveat as motion artifacts are within-animal.

      We will follow Reviewer 2’s suggestion and perform isosbestic-correction for fluorescent signals prior to calculating ΔF/F. We will re-plot related figures and add this information in the revised manuscript.

      (3) Missing control experiment demonstrating intact locomotor performance in caspase ablation experiments. The authors use caspase ablation of PTSNTac1 neurons prior to active avoidance learning to appraise the necessity of this cell population. However, a control experiment showing intact locomotor ability in ablated mice was not performed.

      We will follow Reviewer 2’s suggestion to perform a control experiment showing intact locomotor ability in caspase 3-ablated mice and will include this data in the revised manuscript.

      (4) Missing control experiment demonstrating [lack of] valence with PTSN silencing manipulations. The authors performed a real-time and conditioned place preference experiments for ChR2-expressing mice (Fig 3M) and found stimulation to be negatively-valenced and generate an aversive memory, respectively. Absent this control experiment with silencing, an alternative conclusion remains possible that optogenetic silencing via GtACR2 created nonspecific location preferences in the active avoidance apparatus, confounding the interpretation of those results.

      Thank you Reviewer 2 for this useful suggestion. We will examine the valence with PTSN silencing manipulations by using a RTPP test and add this data in the revised manuscript.

      (5) Incomplete analysis of sex differences. Data in female mice is conspicuously missing from inhibition experiments. The rationale for exclusion from this dataset would be useful for the interpretation of the other noted sex differences.

      Thank you Reviewer 2 for this useful suggestion. During the review process, we have performed ablation and inhibition experiments in females, demonstrating similar behavioral effects as those in males. We will add these data in the revised manuscript.

      Reviewer #3 (Public review):

      Summary:

      This study by Hu et al. examined the role of tachykinin1 (Tac1)-expressing neurons in the para subthalamic nucleus (PSTH) in active avoidance of electric shocks. Bulk recording of PSTH Tac1 neurons or axons of these neurons in PVT showed activation of a shock-predicting tone and shock itself. Ablation of these neurons or optogenetic manipulation of these neurons or their projection to PVT suggests the causality of this pathway with the learning of active avoidance.

      Strengths:

      This work found an understudied pathway potentially important for active avoidance of electric shocks. Experiments were thoroughly done and the presentation is clear. The amount of discussion and references are appropriate.

      We are very pleased to have Reviewer 3’s positive comments on the manuscript.

      Weaknesses:

      Critical control experiments are missing for most experiments, and statistical tests are not clear or not appropriate in most parts. Details are shown below.

      (1) There are some control experiments missing. Notably, optogenetic manipulation is not verified in any experiments. It is important to verify whether neural activation with optogenetic activation is at the physiological level or supra-physiological level, and whether optogenetic inhibition does not cause unwanted activity patterns such as rebound activation at the critical time window.

      Thank you Reviewer 3 for this useful suggestion. We will perform in vitro slice recording experiments to verify optogenetic manipulations and add this line of evidence in the revised manuscript.

      (2) Neural ablation with caspase was confirmed by GFP expression. However, from the present description, a different virus to express EITHER caspase or GFP was injected, and then the numbers of GFP-expressing neurons were compared. It is not clear how this can detect ablation.

      Similar with question 4 of Reviewer 1. We will perform immunohistochemistry or in situ hybridization for Tachykinin-1 itself and then measure colocalization of GFP with Tachykinin-1 inside and outside of the PTSN, and the degree of absence of Tachykinin-1 in Casp-ablated mice. In addition, we will provide more detailed experimental information in the revised manuscript.

      (3) In many places, statistical approaches are not clear from the present figures, figure legends, and Methods. It seems that most statistics were performed by pooling trials, but it is not described, or multiple "n" are described. For example, it is explicitly mentioned in Figure 4H, "n = 3 mice, n = 213 avoidance trials and n = 87 failure trials". The authors should not pool trials, but should perform across-animal tests in this and other figures, and "n" for should be clearly described in each plot.

      We have provided all statistical information in the Supplementary Table 1. In the revised manuscript, we will perform across-animal tests, re-plot new figures and provide clear statistical information.

      (4) It is also unclear how the test types were selected. For example, in Figure 1K and O with similar datasets, one is examined by a paired test and the other is by an unpaired test. Since each animal has both early vs late trials, and avoidance vs failure trials, paired tests across animals should be performed for both.

      Following Reviewer 3’s suggestion, we will perform across-animal tests. In the first version of our manuscript, for fiber photometry experiments, we pooled trial data of each animal and performed statistics tests across trials. Because avoidance and failure trials were different, we thus selected an unpaired test for this kind of dataset.

      (5) It is also strange to show violin plots for only 6 animals. They should instead show each dot for each animal, connected with a line to show consistent increases of activity in late vs early trials and avoidance vs failure trials.

      Similar with question 4 of Reviewer 3, we pooled trial data of each animal and performed statistics tests across trials. We will perform across-animal tests and re-plot figures by connecting with a line to show consistent increases of activity in late vs early trials and avoidance vs failure trials for each animal.

      (6) To tell specificity in avoidance learning, it is better to show escape in the current trials with optogenetic manipulation.

      Thank you Reviewer 3 for this useful suggestion. We will follow this suggestion and add this analysis in the revised manuscript.

      (7) For place aversion, % time decrease across days was tested. It is better to show the original number before normalization, as well.

      Similar with question 9 of Reviewer 1, we will show the original number before normalization in the revised manuscript.

      (8) For anatomical results in Figure S6, it is important to show images with lower magnification, too.

      We will follow this suggestion and provide histological images with lower magnification in the revised manuscript.

      (9) Inactivation of either pathway from PSTH to PBN or to CeA also inhibits active avoidance, but the authors conclude that these effects are "partial" compared to the inactivation of PSTH to PVT. It is not clear how the effects were compared since the effects of PSTH-CeA inactivation are quite strong, comparable to PSTH-PVT inactivation by eye. They should quantify the effects to conclude the difference.

      We will quantify the effects of different downstream targets of the PSTN to make a precise conclusion.

      (10) Supplementary table 1: as mentioned above, n for statistical tests should be clearer.

      As mentioned above, we will perform across-animal tests and provide clear statistical information in the figure legends and supplementary table 1.

    1. Author response:

      (1) General Statements

      We thank all three reviewers for their constructive comments and suggestions. We also thank reviewers #2 and #3 for considering our work to be timely and of interest to the field, not only for basic researchers, but also for translational scientists and industry. We are now providing additional results to further support our hypothesis and hope that all reviewers will find that our manuscript is now ready for publication. 

      (2) Point-by-point description of the revisions

      Reviewer #1 (Evidence, reproducibility and clarity (Required)): 

      The manuscript by Coquel et al. investigates the effects of BKC and IBC, two compounds found in Psoralea corylifolia in DNA replication and the response to DNA damage, and explores their potential use in cancer treatment. These compounds have been previously shown to affect different cellular pathways and the authors use transformed cancer cells of different origins and a non-transformed cell line to question if their combination is toxic in cancer versus non-cancer cells. They propose that BKC inhibits DNA polymerases while IBC targets CHK2. Their results show that both compounds do affect DNA replication, inducing replication stress and affecting double strand break repair. They also show that their combined use increases their toxicity in a synergistic manner. 

      However, there are some major conclusions that are still not very well supported by the data: first, the differential effect on cancer and non-transformed cells; second, the direct link of BKC to the inhibition of DNA polymerases; and third, it is unclear if CHK2 is the relevant target for IBC in this context. 

      Regarding these points the authors should address the following issues: 

      (1) Most of the experiments use BJ fibroblasts as a control cell line. In order to evaluate if these compounds are preferentially toxic for cancer cells, the use of more than one non-transformed cell line is necessary. In addition, BJ cells are fibroblasts while most of the cancer cell lines employed are of epithelial origin. The authors could use MCF10 and RPE cells (both of epithelial origin) as control cell lines to complement the results and better support this claim. 

      We have now monitored the effect of IBC and BKC on the proliferation of MCF-7, MCF-10A and RPE-1 cells using the WST-1 assay and obtained similar results as for BJ and MCF-7 cells. These results are now included in the revised manuscript as Fig. S1A and S1B.

      (2) In order to explore what are the targets of BKC and IBC Cellular Thermal Shift Assays (CETSA) could be used. Either by doing an unbiased mass spectrometry analysis of proteins stabilized by these compounds or by a direct analysis of candidate proteins by western blot (a similar approach has been used for IBC to show that it inhibits SIRT2 in Ren et al., 2024 Phytotherapy Res).

      We thank this Reviewer for suggesting the use of the CETSA assay. We have now performed  CETSA on MCF-7 cells and found that IBC stabilizes CHK2 but not CHK1, to the same extent as the commercial CHK2 inhibitor BML-277 used here as a positive control. These results are now shown in new Fig. 4G and 4H.

      (3) For BKC in vitro polymerase assays could be carried out to show the direct inhibition of the DNA polymerase delta, for instance. 

      We have used high-speed Xenopus egg extracts to replicate ssDNA in vitro (Fig. S2C). This assay differs from the in vitro replication assay using low-speed Xenopus egg extracts (Fig. 2H) in that it only monitors elongation by replicative DNA polymerases (Pol δ and ε) and not earlier steps such as origin licensing and activation. The combined use of both low-speed and highspeed extracts strongly supports the view that BKC inhibits replicative DNA polymerases. 

      To confirm this result, we have also used CETSA to monitor BKC binding to different subunits of DNA Polδ and Polε in MCF-7 cells and in Xenopus egg extracts (Fig. 3C-D Fig. S3). We found that BKC binds POLD1 and POLE, the catalytic subunits of Pol δ and ε respectively, but not the accessory subunit POLD3 nor PCNA. Together with our docking results and DNA fiber experiments, these data strongly support the view that BKC is a potent inhibitor of DNA Pol and Pol. 

      (4) In addition, the authors could analyze the integrity of replication forks by PCNA immunofluorescence analysis. The colocalization of PCNA and POLD or POLE subunits could also support the role of DNA polymerases as targets of BKC. 

      Our molecular docking results also show that BKC occupies the catalytic sites of DNA Pol δ and ε, which may not affect their subcellular localization and/or PCNA binding. Since our DNA replication assays, CETSA and DNA fiber analyses strongly support the view that BKC inhibits replicative DNA polymerases, we have not performed this additional experiment.

      (5) In the case of IBC and the inhibition of CHK2, the authors should check the effect of IBC on the phosphorylation of BRCA1 on S988. The changes in CHK2 phosphorylation in Figure 3B are not convincing. The experiment should be repeated and the average of at least three experiments needs to be quantified. 

      We now provide evidence that IBC inhibits BRCA1 phosphorylation on S988. Western blots and quantification for three biological replicates are shown in Fig. 4C and Fig. S4H. Densitometric quantification of CHK2 phosphorylation on S516 from 3 biological replicates, along with statistical analysis, is now shown in Fig. S4G.

      (6) To prove that CHK2 is the relevant target for IBC the authors could test if ATM and CHK2 knockout cells are more resistant to this compound, since it would prevent the phosphorylation of CHK2. 

      We have performed siRNA transfection targeting CHK2. The transfected cells died after 72 hours in culture, so we have been unable to determine whether CHK2-KD cells have increased resistance to IBC.  

      In addition to these experiments, I would suggest some other major improvements in the manuscript: 

      (1) The concentration of both compounds should be provided in molar units throughout the paper.

      Thanks for pointing this out, we now use molar units throughout the paper.

      (2) The authors do not clearly indicate the concentration that is employed in the different experiments, making it difficult to assess the results. For instance, Figure 2 does not include the concentration in the legend or in the text. Time and concentration need to be clearly shown for each experiment. 

      The experimental conditions and inhibitor concentrations are now clearly indicated for each experiment.

      (3) Some experiments are only repeated once (fiber assays) or twice (cell cycle analysis by flow cytometry). These experiments need to be repeated 3 times and the proper statistical analysis performed (comparison of the medians). 

      Superplots with biological replicates for all DNA fiber assays are now displayed. The number of biological replicates is now indicated in the legends and appropriate statistical analyses are used.

      Other minor points or suggestions: 

      (1) Analyzing fork asymmetry would further support the direct effect of BKC on DNA polymerases. 

      The effect of BKC on fork asymmetry is now shown in Fig. 2F. 

      (2) A dose dependent analysis of BKC on the speed of DNA replication would also support this point. 

      Superplots of DNA fiber assays showing the effect of different concentrations of BKC on fork speed from three biological replicates are now included in Fig. 2E.

      (3) Page 7: BKC reduces fork speed ...two-fold. This sentence is not very clear, it would be better to say that speed is half of the control. 

      This sentence was changed to “BKC reduced fork speed by a factor of two relative to untreated cells”.

      (4) Figure 4G and S4D show contradictory results regarding the induction of Rad51 foci by IBC treatment. This needs to be clarified. 

      Figure 4G and S4D (now Fig. 5G and S5D) do not show contradictory results. In both cases, IBC treatment impaired the induction of RAD51 foci by IR or bleomycin.  

      (5) Page 12, Figure S5C is called for but it does not exist (probably meaning Figure S5B). 

      We apologize for this error, which has now been corrected.  

      Reviewer #1 (Significance): 

      The work by Coquel et al. aims at elucidating the use of BKC and IBC as a combined therapy to induce cell death in cancer cells by targeting DNA replication and CHK2. Both BKC and IBC have been previously shown to affect the proliferation of cancer cells. BKC has been shown to induce S phase arrest in an ATR dependent manner in MCF7 cells (Li et al., 2016 Front Pharm), while IBC induces cell death in MDA-MB-231 cells (Wu et al., 2022 Molecules). In this regard, the more interesting contribution of the manuscript is the potential identification of the targets of these compounds in cancer cells. The inhibition of CHK2 by IBC is quite compelling although it needs to be further proven. In contrast, the hypothesis that BKC inhibits DNA polymerases remains highly speculative. The results offer a limited advance in the knowledge of the mechanism of action of these two compounds. Focusing on the action of IBC on CHK2 would increase the impact of the results. In this sense a very recent report has been published showing that IBC inhibits SIRT2 (Ren et al., 2024 Phyto Res), showing that IBC can affect multiple enzymes and processes. This should be taken into account for a further analysis of its mechanism of action. 

      In addition to the identification of the targets of BKC and IBC, the authors also focus on their combination for cancer treatment. This is based on the idea that blocking the DSB repair and inducing replication stress at the same time is an efficient approach to induce cancer cell death. This is not a new concept, since the loss of ATM sensitizes cancer cells to the inhibition of the replication stress response and several combination therapies have been put forward with the idea of generating replication stress and preventing the subsequent repair of the double strand breaks induced in these cells. Thus, the novelty here is limited, especially considering that the effect of BKC on DNA replication has already been described. Further, since its mechanism of action is unclear, it is difficult to ascribe the observed synergy to the speculated hypothesis. A deeper analysis of IBC as a CHK2 inhibitor would be more interesting, and the potential combination with other chemotherapy agents such as replication stress inhibitors, HU or DNA damaging agents. Also, the lack of a good control of non-transformed cells also reduces the relevance of the work. 

      In its current state, the interest of the manuscript is limited. The mechanistical advance is not strong enough and is not completely supported by the data, and the use of these compounds as a combination therapy does not provide new insights in cancer treatment. In my opinion, focusing on the inhibition of CHK2 by IBC and its potential use would broaden the impact of the results beyond the mere analysis of the action of these compounds. 

      We thank this reviewer for his/her constructive and insightful comments. We have followed his/her advice and focused our analysis on the action of IBC on CHK2. Using CETSA, we confirmed that IBC binds CHK2 to the same extent as BML-277 inhibitor, but does not bind CHK1. We also show that IBC inhibits BRCA1 phosphorylation on S988 and CHK2 phosphorylation on S516. Together with the results presented in the initial version of the manuscript, these data support the view that CHK2 is a key IBC target. We have also applied CETSA to DNA polymerases and confirmed that BKC directly targets DNA Polδ and ε. Although it is unlikely that IBC and BKC will ever be used in combination therapies, the synergistic effect that we measured on cancer cells in vivo and in vitro indicates that IBC sensitizes cancer cells to endogenous replication stress and to exogenous sources of DNA damage, which could be used to replace BKC in combination therapies. For instance, our data indicate that IBC can be used in combination with drugs such as etoposide, doxorubicin or cyclophosphamide to potentiate their effect on drug-resistant lymphoma cell lines (DLBCL). As requested by this Reviewer, we have modified the discussion section to put more emphasis on IBC and CHK2 inhibitors and we hope that he/she will now find this revised version suitable for publication.

      Reviewer #2 (Evidence, reproducibility and clarity): 

      In the manuscript by Coquel et al., the authors report their findings on the effect of 2 natural compounds from Psoralea corylofolia plant extracts on cancer cells. They show that these compounds, bakuchiol (BKC) and isobavachalcone (IBC), inhibit proliferation of cancer cells and tumor development in xenografted mice, particularly when used in combination. They further show that BKC inhibited DNA polymerases and induced replication stress, and show evidence that IBC inhibits Chk2 kinase activity and downstream double-strand break repair. Based on their findings, the authors conclude that Chk2 inhibition and DNA replication inhibition represent a potential synergistic strategy to selecting target cancer cells. 

      Major: 

      (1) The data showing IBC is a Chk2 inhibitor is weak and more rigorous investigation is needed to establish this compound as a Chk2 inhibitor. 

      As indicate in our response to Reviewer #1, we have now analyzed the binding of IBC to CHK2 using the Cellular Thermal Shift Assay (CETSA) in MCF-7 cells. Our data clearly show that IBC binds to CHK2 but not CHK1. These results are now shown in Fig. 4G and 4H.

      For one, the authors mention they screened 43 cell cycle-related kinases in vitro, but only show data for 8 kinases in their kinase activity screens. Of these 8 kinases, Chk2 is the most strongly inhibited, but there are no data shown for the other 35 kinases. 

      Data for all the protein kinases tested in the in vitro assay are now presented in Fig. S4D and S4E.  

      Additionally, the purpose of the CHK2 mutants should be discussed in the text. 

      The CHK2(I157T) mutation is linked to an increased risk of breast and colorectal cancers. CHK2(R145W) is associated with Li-Fraumeni Syndrome. Both mutations do not affect the basal kinase activity of CHK2. This information is now indicated in the legend of Fig. S4D. 

      Secondly, the western blot in Fig 3B, appears to show a very modest effect of IBC on Chk2 autophosphorylation and not that different from the effect of IBC on Akt phosphorylation in Fig S3a. Yet, the authors claim that IBC inhibits Chk2 but not Akt. To strengthen these blots, a known Chk2 inhibitor, such as the one shown in Fig 4 (BML-277) should be included as a positive control for pChk2 similarly to what was shown for Akt with MK-2206. 

      We have now replaced the western blot in Fig. 3B (now Fig. 4B) with another biological replicate. Quantifications and statistical analyses of biological replicates are shown in Fig. S4G. Overall, we observed a 50% reduction of CHK2 auto-phosphorylation in MCF7 cells treated with IBC, and a 20% reduction in AKT phosphorylation (Fig. S4A). There was no additional reduction in AKT phosphorylation when cells were treated with IBC in combination with MK-2206, compared to cells treated with MK-2206 alone. We now include the CHK2 inhibitor BML-277 as a positive control alongside with IBC to monitor CHK2 and CHK1 auto-phosphorylation in Fig. 4B, S4G, 4D and S4I, respectively.

      Western blots showing a loss of phosphorylation of additional Chk2 targets is also needed. The manuscript mentions Brca1 S988 as a Chk2 substrate important for DSB repair. Showing the effect of IBC on this phosphorylation site would strengthen the conclusions. 

      We now provide evidence that IBC inhibits BRCA1 phosphorylation at S988. Western blots and quantification for three biological replicates are shown in Fig. 4C and S4H. 

      (2) The authors claim that the combination of IBC and BKC inhibit cell growth in a synergistic manner and that the "effect is more pronounce on cancer cells than on non-cancer cells." However, only 1 non-malignant cell line was used, and it was a fibroblast line. To make this claim, the authors need to show the effect in additional non-malignant cells, preferably with epithelial cell types. 

      We have now monitored cell proliferation using the WST-1 assay in two additional non-malignant cell lines, namely MCF-10A and RPE-1 cells. Cells were treated with IBC/BKC and their growth was compared to that of MCF-7 cells. These experiments yielded similar results to those obtained with BJ fibroblasts. These new data are now included in the revised version as Fig. S1A and S1B. 

      Minor: 

      (1) Densitometry data for all western blots should be shown with mean+/- stdev of independent western blots. 

      Densitometry data for all western blots with biological replicates are now shown in supplementary figures.

      (2) In Figure 1B the statistical test used to analyze cell number was not stated. 

      The statistical test is now indicated in Fig. 1B.

      (3) In Figure 2A, the DAPI image for BKC is the merged image and should be replaced with just DAPI. 

      This error has now been corrected.

      (4) In Figure 2B, the y-axis label says "yH2AX foci (MFI)". MFI and foci are not the same thing, and for yH2AX, the signal is often not focal. MFI of yH2AX is an appropriate measurement for replication stress, it's just not appropriate to equate MFI to foci. 

      We apologize for this labeling error, which has now been corrected.

      (5) For the 53BP1 MFI and Rad51 MFI shown in Fig 4 and Fig S4, it is more appropriate to show the number of foci/cell as these are better indicators of breaks and repair sites. MFI is influenced by expression levels of the proteins and not necessarily the break/repair. 

      The numbers of 53BP1 and RAD51 foci are now shown.

      (6) The data in Figures 5B and 5C are very difficult to read. Perhaps color-coat the lines/symbols. 

      We have now colored the graph to increase its readability. 

      Reviewer #2 (Significance): 

      The findings reported in this manuscript are timely, of interest to the field, and are mostly wellsupported by the experimental data. However, there are a few concerns that need to be addressed. 

      We are grateful to Reviewer #2 for his positive assessment of our manuscript. We hope that we have adequately addressed all of his/her specific concerns and that he/she will agree with the need to put more emphasis on IBC and CHK2 inhibition as requested by Reviewer #1.

      Reviewer #3 (Evidence, reproducibility and clarity): 

      The manuscript: "Synergistic effect of inhibiting CHK2 and DNA replication on cancer cell growth" successfully demonstrates that the compounds BKC and IBC found in Psoralea corylifolia act synergistically to inhibit cancer cell proliferation, using a wide range of well-chosen methodologies. Moreover, the authors characterized the mechanisms of action of both drugs, which result in inhibition of cell proliferation. The use of multiple cell lines and the mice models makes the study robust and complete. The manuscript presents a well written study that offers new insights and contributions to the field. 

      A few suggestions to improve the study: 

      (1) Given that both compounds BKC and IBC have already been previously described in the literature, it would be helpful for the reader to have them described better at the beginning of the study. 

      Thanks for pointing this out. We have now better described BKC and IBC at the beginning of the results section, as well as in the discussion. We agree that this could be helpful to readers.

      (2) Addition of western blot quantifications over the number of experimental repeats is important specifically for Fig. 2C and Fig. 3C where partial effect of treatment on a signal level is reported. 

      The densitometry analysis of data shown in Fig. 2C and biological replicates are now shown in Fig. S2B. Quantification for Fig. 3C (now Fig. 4D) is shown in Fig. S4I.

      (3) The quantification of mean intensity for 53BP1 and RAD51 foci should be exchanged with the quantification of number of foci per cell. While the quantification of gH2AX signal intensity is a correct representation of induction of this signal upon damage, foci formed by protein recruitment to DNA damage sites should be quantified by counting the number of foci, rather than signal in the whole cell/nucleus. These proteins exist before damage and are re-located in response to the damage. 

      Quantification of 53BP1 and RAD51 foci is now expressed as the number of foci per cell. 

      (4) Materials & Methods section is missing the methods for the experiment described in Fig. 1B. In summary, after addressing our few concerns, we believe the manuscript should be accepted for publication. 

      The WST-1 assay used for cell number quantification is included in “Reagents” in Material & Methods section.

      Reviewer #3 (Significance):

      The manuscript presents a well written study that offers new insights and contributions to the field. Although the inhibitors described have been known in science, the authors present convincingly their mode of action, which is either better characterized (for BKC) or inhibiting a different than previously suggested enzyme (for IBC). Authors also nicely pinpoint and explain the narrow window of concentrations when these two compounds act synergistically rather than additively. The analyses in multiple cell lines, mouse models and in combination with other cancer treatments, makes this study of interest not only for fundamental researchers but also for translational scientists and industry.

      My field of expertise: DNA replication and replication stress across model systems. 

      We are grateful to Reviewer #3 for his/her very positive assessment of our work and we hope that he/she will find this revised version suitable for publication.

    1. Author response:

      Reviewer #1: 

      Summary:

      Ngo et. al use several computational methods to determine and characterize structures defining the three major states sampled by the human voltage-gated potassium channel hERG: the open, closed, and inactivated state. Specifically, they use AlphaFold and Rosetta to generate conformations that likely represent key features of the open, closed, and inactivated states of this channel. Molecular dynamics simulations confirm that ion conduction for structure models of the open but not the inactivated state. Moreover, drug docking in silico experiments show differential binding of drugs to the conformation of the three states; the inactivated one being preferentially bound by many of them. Docking results are then combined with a Markov model to get state-weighted binding free energies that are compared with experimentally measured ones.

      Strengths:

      The study uses state-of-the art modeling methods to provide detailed insights into the structure-function relationship of an important human potassium channel. AlphaFold modeling, MD simulations, and Markov modeling are nicely combined to investigate the impact of structural changes in the hERG channel on potassium conduction and drug binding.

      We appreciate the reviewer’s recognition of our integration of state-of-the-art computational methods, including AlphaFold2, Rosetta, MD simulations, and Markov modeling. We are pleased that the reviewer found our approach to investigating the structure-function relationship of the hERG channel insightful.

      Weaknesses:

      (1) The selection of inactivated conformations based on AlphaFold modeling seems a bit biased. The authors base their selection of the "most likely" inactivated conformation on the expected flipping of V625 and the constriction at G626 carbonyls. This follows a bit of the "Streetlight effect". It would be better to have selection criteria that are independent of what they expect to find for the inactivated state conformations. Using cues that favour sampling/modeling of the inactivated conformation, such as the deactivated conformation of the VSD used in the modeling of the closed state, would be more convincing. There may be other conformations that are more accurately representing the inactivated state. I see no objective criteria that justify the non-consideration of conformations from cluster 3 of the inactivated state modeling. I am not sure whether pLDDT is a good selection criterion. It reports on structural confidence, but that may not relate to functional relevance.

      We acknowledge the concern regarding the selection criteria for the inactivated state models. In the revised manuscript version, we plan to broaden our selection approach and explicitly include conformations from different clusters beyond those highlighted in the initial submission (e.g., from cluster 3). We will also incorporate structural metrics that do not solely depend on the known channel inactivation hallmarks or reply on the pLDDT scores to further justify our chosen representative inactivated state models.

      (2) The comparison of predicted and experimentally measured binding affinities lacks an appropriate control. Using binding data from open-state conformations only is not the best control. A much better control is the use of alternative structures predicted by AlphaFold for each state (e.g. from the outlier clusters or not considered clusters) in the docking and energy calculations. Using these docking results in the calculations would reveal whether the initially selected conformations (e.g. from cluster 2 for the inactivated state) are truly doing a better job in predicting binding affinities. Such a control would strengthen the overall findings significantly.

      We agree that a more rigorous control for our drug-binding predictions is desirable. To address this, we will include molecular docking simulations and associated drug binding affinity estimations for more hERG channel models, including alternate conformations from the initial clustering that were not chosen as the final models. This will allow us to test whether our inactivated state structure from cluster 2 indeed outperforms or differs significantly from other possible inactivated hERG channel conformations in reproducing experimental drug potencies.

      (3) Figures where multiple datapoints are compared across states generally lack assessment of the statistical significance of observed trends (e,g. Figure 3d).

      (4) Figure 3 and Figures S1-S4 compare structural differences between states. However, these differences are inferred from the initial models. The collection of conformations generated via the MD runs allow for much more robust comparisons of structural differences.

      We will incorporate statistical analyses and measures of uncertainty for key comparisons. In Figures 3 and S1-S4 the consensus structural hERG channel models for open, inactivated and closed states are being compared, i.e. one representative model for each state. We believe this is a valid comparison, and the statistical analysis of the observed trends based on those models (e.g., in the bar plot of Figure 3d) alone might not be possible. However, we agree with the reviewer that instead of relying solely on those initial static models, we will also draw on the ensemble of states sampled during the MD simulations to quantify structural differences between different putative hERG channel states. Specifically, we will present ensemble-averaged measurements and highlight how these distributions differ significantly between states.

      Reviewer #2:

      Summary:

      Ngo et al. use AlphaFold2 and Rosetta to model closed, open, and inactive states of the human ion channel hERG. Subsequent MD simulations and comparisons with experiments support the plausibility of their models.

      Strengths:

      This is thorough work studied from many different angles. It provides a self-consistent picture of how conformational changes in hERG may affect its function and binding to different targets.

      We are grateful for the reviewer’s recognition of the thoroughness and multi-faceted nature of our study.

      Weaknesses:

      Though this work claims the methodologies can be generalized to other systems, it is not obvious how. Many modeling choices seem arbitrary and also seem to have required extensive expert knowledge of the system. This limits the applicability of the modeling strategy.

      We appreciate the reviewer’s comment on the generalizability of our approach. In the revision, we will more explicitly discuss the rationale behind the modeling choices and the extent to which they reflect system-specific knowledge. We will clarify how the strategies we developed (e.g., iterative refinement with AlphaFold2 and Rosetta, followed by MD simulation validation) can be adapted to other ion channels or related proteins. We will also outline a more generalizable workflow, specifying which steps require system-specific information and which steps are broadly applicable.

      Reviewer #3:

      Summary:

      The authors use Alphafold2, Rosetta, and Molecular Dynamics to model structures of the hERG K channel in open, inactive, and closed states. Experimental CryoEM data for open hERG (Wang and Mackinnon 2017), and closed EAG (Mandala and Mackinnon, 2002) were used as the main templates for channel models presented here. Given the importance of hERG as a safety pharmacology target, the identification of a robust simulation method to assess drug block is an important addition to the field.

      Strengths

      The key findings here are new inactivated and closed hERG channel conformations and hERG channel conformations with drugs docked in the inner vestibule below the selectivity filter. Amino acid pathways and interaction networks for different states are also presented.

      The inactive state and drug block models are carefully correlated with experimental data for the inactivated state of hERG (Lau et al, 2024) and with experimental free energy data for drug binding and have overall good agreement.

      It is remarkable that using cytoplasmic domain structures of hERG as a starting point revealed inactivation state structures in the hERG selectivity filter in Figures 2,3.

      We thank the reviewer for highlighting the novelty and importance of our work, particularly regarding the identification of new inactivated and closed hERG channel conformations and the modeling of drug block. We are also pleased that the reviewer found the correlation with experimental data to be strong and the structural insights to be valuable.

      Weaknesses

      Figure 6, if each data point is for a different drug, then perhaps identify each point.

      Thank you so much for this suggestion. Please note that Table 3 contains drug-specific data plotted in Figure 6 including drug names. We will provide a reference to Table 3 in the revised Figure 6 caption. We will also revise Figure 6 (and any similar figures) to clearly identify each data point with the corresponding drug and/or include a corresponding key in the Figure legend. This will make it easier to correlate each data point’s binding prediction with the experimental datasets.

      The PAS domain was not included in the models as stated in Methods page 14 but the PAS does appear in some of the templates used as starting points for models in Figure 1 a,b,c. Perhaps mentioning that the PAS was not included in some (all?) of the final models should be moved into the main text and discussed.

      The drug block of 1b channels (which do not contain PAS) has been reported to be slightly different than that for 1a channels (which contain PAS) and for 1a/1b channels (see London et al., 1997; https://doi.org/10.1161/01.RES.81.5.870 and Abi-Gerges et. al., 2011; DOI: 10.1111/j.1476-5381.2011.01378.x) and this should be discussed since the models presented here appear to be performed in the absence of the PAS.

      It also appears that the N-linker region (between PAS and the S1) and distal C region of hERG (post CNBHD-COOH) are not included in models, please state this if correct, and discuss.

      We appreciate the reviewer’s insightful comment regarding the PAS domain and the potential influence of other regions, such as the N-linker and distal C-region, on hERG channel drug binding and state transitions.

      The PAS domain did appear in the starting templates used for initial structural modeling (as shown in Figure 1a, b, c), but it was not included in the final models used for subsequent analyses. Similarly, the N-linker and the distal C-region were also omitted from the final models. These omissions were primarily due to hardware constraints used for AlphaFold structural modeling, as including these additional protein regions would exceed the memory capacity of graphical processing unit (GPU) cards on our available intramural, external and cloud high-performance computing resources, leading to failures during the protein structure prediction step.

      The PAS domain of hERG 1a isoform, even if not serving as a direct drug-binding site, can influence the gating kinetics of hERG channels as the reviewer pointed out. By altering the probability and duration with which those ion channels occupy specific conformational states, it can indirectly affect how well drugs bind. For example, if the presence of the PAS domain shifts channel gating so that more channels enter (and remain in) the inactivated state, drugs with a higher affinity for that state would appear to bind more potently, as observed in electrophysiological experiments. It is also plausible that the PAS domain could exert allosteric effects that alter the conformational landscape of the ion channel during gating transitions, potentially impacting drug accessibility or binding stability. This is an intriguing hypothesis and an important avenue for future research.

      With access to more powerful computational resources, it would be valuable to explore the full-length hERG 1a channel, including the PAS domain and associated regions, to assess their potential contributions to drug binding and gating dynamics. We will incorporate a discussion of these points into the main text, acknowledging the limitations of our current models, citing the references provided by the reviewer, and highlighting the need for future studies to explore these protein regions in greater detail.

    1. Author response:

      Response to Reviewer 1

      We will investigate the intracellular localization of ABCA1 in both EpH4 and EpH4-Snail cells. We will also examine the changes in ACAT expression levels within these cell lines.

      Response to Reviewer 2

      We will first investigate whether the chemoresistance exhibited by EpH4-Snail cells can be abolished not only through pharmacological inhibition of ABCA1 but also by knocking out the ABCA1 gene. Regarding causality, as demonstrated in Figure 2, we have already shown that reducing cholesterol levels in EpH4-Snail cells decreases ABCA1 expression. To further explore this relationship, we will assess whether increasing sphingomyelin levels by adding ceramide to the culture medium, thereby correcting the sphingomyelin-to-cholesterol ratio, would reduce ABCA1 expression. Furthermore, we will evaluate whether lowering cholesterol levels in EpH4-Snail cells via simvastatin treatment, along with normalization of the sphingomyelin-to-cholesterol ratio, attenuates their resistance to the anticancer drug nitidine chloride. Additionally, we will incorporate quantitative analyses for several experiments, as suggested in the reviewers’ comments, to enhance the robustness of our findings.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Overall authors’ response

      We would like to thank the 3 reviewers for a thorough critique of our manuscript, and acknowledging the novelty and importance of our studies, in particular the relevance to collagenrelated pathologies such as idiopathic pulmonary fibrosis and chronic skin wound. We appreciate that there are shortcomings in these studies, as highlighted by reviewers; we have rewritten parts of our manuscript to clarify any misunderstandings, and conducted additional experiments to address concerns raised by reviewers (please see below red text within each response), which have been incorporated into our revised manuscript (modified text highlighted in yellow in revised manuscript). We believe that the revision had made our manuscript stronger in support of our original conclusions. 

      Public Reviews: 

      Reviewer #1 (Public Review): 

      Summary: 

      The authors describe that the endocytic pathway is crucial for ColI fibrillogenesis. ColI is endocytosed by fibroblasts, prior to exocytosis and formation of fibrils, which can include a mixture of endogenous/nascent ColI chains and exogenous ColI. ColI uptake and fibrillogenesis are regulated by circadian rhythm as described by the authors in 2020, thanks to the dependence of this pathway on circadian-clock-regulated protein VPS33B. Cells are capable of forming fibrils with recently endocytosed ColI when nascent chains are not available. Previously identified VPS33B is demonstrated not to have a role in endocytosis of ColI, but to play a role in fibril formation, which the authors demonstrate by showing the loss of fibril formation in VPS33B KO, and an excess of insoluble fibrils - along-side a decrease in soluble ColI secretion - in VPS33B overexpression conditions. A VPS33B binding protein VIPAS39 is also shown to be required for fibrillogenesis and to colocalise with ColI. The authors thus conclude that ColI is internalised into endosomal structures within the cell, and that ColI, VPS33B, and VIPA39 are co-trafficked to the site of fibrillogenesis, where along with ITGA11, which by mass spectrometric analysis is shown to be regulated by VPS33B levels, ColI fibrils are formed. Interestingly, in involved human skin sections from idiopathic pulmonary fibrosis (IPF) patients, ITGA11 and VPS33B expression is increased compared to healthy tissue, while in patient-derived fibroblasts, uptake of fluorescently-labelled ColI is also increased. This suggests that there may be a significant contribution of endocytosis-dependent fibrillogenesis in the formation of fibrotic and chronic wound-healing diseases in humans. 

      Strengths: 

      This is an interesting paper that contributes an exciting novel understanding of the formation of fibrotic disease, which despite its high occurrence, still has no robust therapeutic options. The precise mechanisms of fibrillogenesis are also not well understood, so a study devoted to this complex and key mechanism is well appreciated. The dependence of fibrillogenesis on VPS33B and VIPA39 is convincing and robust, while the distinction between soluble ColI secretion and insoluble fibrillar ColI is interesting and informative. 

      Weaknesses: 

      There are a number of limitations to this study in its current state. Inhibition of ColI uptake is performed using Dyngo4a, which although proposed as an inhibitor of Clathrin-dependent endocytosis is known to be quite un-specific. This may not be a problem however, as the endocytic mechanism for ColI also does not seem to be well defined in the literature, in fact, the principle mechanism described in the papers referred to by the authors is that of phagocytosis.

      We thank the reviewer for pointing this out. Macropinocytosis or phagocytosis could be modelled using high molecular weight dextran, and we have used fluorescently-labelled dextran to investigate potential co-localisation with exogenous collagen to investigate the involvement of these mechanisms in addition to endocytosis, and showed very little co-localisation (revised Figure S2B, lines 123-126). Further, we have performed a competition experiment where unlabelled collagen was added in excess at the same time as labelled collagen and showed that excess unlabelled collagen led to a retention of labelled collagen at the cell periphery (revised Figure S2C, lines 126-129). This is suggestive of collagen-I uptake utilises a different pathway to dextran (i.e. fluid-phase endocytosis) and is a receptor-mediated process.  

      It would be interesting to explore this important part of the mechanism further, especially in relation to the intracellular destination of ColI.

      We agree with the reviewer that the intracellular destination of ColI is very interesting, which is what the current Chang lab is investigating, although we believe the research findings fall out of scope for the revised manuscript here. However, we have included additional immunofluorescence data to support that collagen is indeed taken up into endosomal compartments using GFP-tagged Rab5 constructs (revised Figure 1D, Figure S6A).

      The circadian regulation does not appear as robust as the authors' last paper, however, there could be a larger lag between endocytosis of ColI and realisation of fibrils.

      The authors state that the endocytic pathway is the mechanism of trafficking and that they show ColI, VPS33B, and VIPA39 are co-trafficked. However, the only link that is put forward to the endosomes is rather tenuously through VPS33B/VIPA39.

      We would like to clarify that we meant the post-Golgi compartment. We did not mean VPS33b/VIPAS39 as an endosome marker; however as we see collagen entering the cell in intracellular compartments, which is then recycled, we take that as convention, the endosome would be involved. This is further supported that we see some colocalisation with the classic Rab5 endosome marker.

      There is no direct demonstration of ColI localisation to endosomes (ie. immunofluorescence), and this is overstated throughout the text.

      We appreciate the comment and have modified overstatements in the revised manuscript as appropriate. As stated above, we have included additional immunofluorescence data to support that collagen is indeed taken up into endosomal compartments.

      Demonstrating the intracellular trafficking and localisation of ColI, and its actual relationship to VPS33B and VIPA39, followed by ITGA11, would broaden the relevance of this paper significantly to incorporate the field of protein trafficking. Finally, the "self-formation" of ColI fibrils is discussed in relation to the literature and the concentration of fluorescently-tagged ColI, however as the key message of the paper is the fibrillogenesis from exocytosed colI, I do not feel like it is demonstrated to leave no doubt. Specific inhibition of intracellular trafficking steps, or following the progressive formation of ColI fibrils over time by immunofluorescence would demonstrate without any further doubt that ColI must be endocytosed first, to form fibrils as a secondary step, rather than externally-added ColI being incorporated directly to fibrils, independent of cellular uptake.

      We appreciate the concern raised here. This is precisely why we trypsinised and replated cells as part of the workflow, so we can make sure that there is no residual exogenous collagen which is not endocytosed being incorporated onto pre-existing fibrils. We have new data using flow imaging, which showed that cells that don’t endocytose exogenous collagen has accumulation of said collagen at the periphery of the cells, which is greatly reduced after trypsinisation. This new data is in a more detailed methodology-based study which is under preparation, which will allow future studies to further dissect the collagen intracellular trafficking process, and thus is not included in the revised manuscript. 

      Reviewer #2 (Public Review): 

      Summary: 

      In this manuscript, the authors describe a mechanism, by which fluorescently-labelled Collagen type

      I is taken up by cells via endocytosis and then incorporated into newly synthesized fibers via an ITGA11 and VPS33B-dependent mechanism. The authors claim the existence of this collagen recycling mechanism and link it to fibrotic diseases such as IPF and chronic wounds. 

      Strengths: 

      he manuscript is well-written, and experimentally contains a broad variation of assays to support their conclusions. Also, the authors added data of IPF patient-derived fibroblasts, patient-derived lung samples, and patient-derived samples of chronic wounds that highlight a potential in vivo disease correlation of their findings. 

      The authors were also analyzing the membrane topology of VPS33B and could unravel a likely 'hairpin' like conformation in the ER membrane. 

      Weaknesses: 

      Experimental evidence is missing that supports the non-degradative endocytosis of the labeled collagen.

      We thank the reviewer for raising this. We would like to clarify that we do not think that all endocytosed collagen-I is recycled, but rather sorted in the endosome which determines the fate of endocytosed collagen. Interestingly, results from Kadler’s group has shown that blocking lysosome function (through chloroqine and bafilomycin) significantly reduced endogenous collagen fibril formation (https://www.biorxiv.org/content/10.1101/2024.05.09.593302v1), suggesting a nondegradative role for lysosome in fibrillogenesis.   

      The authors show and mention in the text that the endocytosis inhibitor Dyngo®4a shows an effect on collagen secretion. It is not clear to me how specific this readout is if the inhibitor affects more than endocytosis. This issue was unfortunately not further discussed.

      We thank the reviewer for this comment and have included in discussion the specificity of Dyngo4a (revised manuscript lines 383392). The ponceau stain suggests that Dyngo4a treatment did not affect global secretion and thus the effects are specific to collagen-I (Fig 2B).

      The authors use commercial rat tail collagen, it is unclear to me which state the collagen is in when it's endocytosed. Is it fully assembled as collagen fiber or are those single heterotrimers or homotrimers?

      We apologise for the confusion and will clarify in our revision. These would be single helical trimers from acid-extracted rat tail collagen. We have performed additional light scattering and CD spectra to confirm the molecular weight and helicity, and confirm that adding fluorescent tags did not alter the readout. We have included this in the revised manuscript (revised Figure S1A-C, manuscript lines 82-86).    

      The Cy-labeled collagen is clearly incorporated into new fibers, but I'm not sure whether the collagen is needed to be endocytosed to be incorporated into the fibers or if that is happening in the extracellular space mediated by the cells.

      We appreciate the concern raised here, which is also raised by reviewer 1. As answered above, this is why we trypsinised and replated cells as part of the workflow, so we can make sure that there is no residual exogenous collagen being incorporated onto pre-existing fibrils. We also have new data using flow imaging, which shows that cells that don’t endocytose exogenous collagen has accumulation of said collagen at the periphery of the cells, which is greatly reduced after trypsinisation. This new data is in a methodology-based manuscript which is under preparation, thus will not be included in the revised manuscript.  

      In general for the collagen blots, due to the lack of molecular weight markers, what chain/form of collagen type I are you showing here?

      Apologies for the lack of molecular weight markers, it was an oversight by the authors and have been included in the revised figures.  

      Besides the VPS33B siRNA transfected cells the authors also use CRISPR/Cas9-generated KO. The KO cells do not seem to be a clean system, as there is still a lot of mRNA produced. Were the clones sequenced to verify the KO on a genomic level?

      Yes, the clones were verified and used in our previous paper on circadian control of collagen homeostasis. There are instances where despite knockout at the protein level, mRNA is still persistent; however these transcripts are likely then directed to degradation through nonsense-mediated mRNA decay. To fully understand this mechanism is beyond the scope of this paper. 

      For the siRNA transfection, a control blot for efficiency would be great to estimate the effect size. To me it is not clear where the endocytosed collagen and VPS33B eventually meet in the cells and whether they interact. Or is ITGA11 required to mediate this process, in case VPS33B is not reaching the lumen?

      This is an interesting question. We have conducted experiments with Col1-GFP11 containing conditioned media incubated with VPS33b-barrell in the revised paper, which showed that they interact within the cell and not at the cell periphery (revised Figure 6G, lines 293-296), again highlighting that VPS33b is not involved in the endocytosis step but interacts with endocytosed collagen-I intracellularly. We have attempted colocliasation studies using the split GFP approach with VPS33B and ITGA11 to investigate where they interact, but as the ITGA11 construct we used did not localise to the cell surface as expected, we are not confident that this system is appropriate for investigating how/if VPS33B interacts with ITGA11, and there are simply no good antibody for VPS33B for staining. 

      The authors show an upregulation of ITGA11 and VPS33B in IPF patients-derived fibroblasts, which can be correlated to an increased level of ColI uptake, however, it is not clear whether this increased uptake in those cells is due to the elevated levels of VPS33B and/or ITGA11.

      We would like to clarify here that we do not think collagen-I uptake is due to VPS33B and/or ITGA11, as siITGA11 and VPS33B in fibroblasts showed no consistent changes in uptake as determined by flow cytometry, which was included in the original manuscript (now revised Figure 6H, 7I). VPS33B and ITGA11 are involved in the ‘outward’ arm of recycled collagen-I, i.e. directing to fibrillogenesis route. We agree that the inclusion of additional functional studies using IPF patient-derived patient fibroblasts would add to the manuscript, and have performed siRNA against VPS33B and ITGA11 on IPF fibroblasts, and demonstrated a late of endocytic recycling events (revised Figure 8D, S6B, lines 351-353).  

      Reviewer #3 (Public Review): 

      Summary: 

      Chang et al. investigated the mechanisms governing collagen fibrillogenesis, firstly demonstrating that cells within tail tendons are able to uptake exogenous collagen and use this to synthesize new collagen-1 fibrils. Using an endocytic inhibitor, the authors next showed that endocytosis was required for collagen fibrillogenesis and that this process occurs in a circadian rhythmic manner. Using knockdown and overexpression assays, it was then demonstrated that collagen fibril formation is controlled by vacuolar protein sorting 33b (VPS33b), and this VPS33b-dependent fibrillogenesis is mediated via Integrin alpha-11 (ITGA11). Finally, the authors demonstrated increased expression of VPS33b and ITGA11 at the gene level in fibroblasts from patients with idiopathic pulmonary fibrosis (IPF), and greater expression of these proteins in both lung samples from IPF patients and in chronic skin wounds, indicating that endocytic recycling is disrupted in fibrotic diseases. 

      Strengths: 

      The authors have performed a comprehensive functional analysis of the regulators of endocytic recycling of collagen, providing compelling evidence that VPS33b and ITGA11 are crucial regulators of this process. 

      Weaknesses: 

      Throughout the study, several different cell types have been used (immortalised tail tendon fibroblasts, NIHT3T cells, and HEK293T cells). In general, it is not clear which cells have been used for a particular experiment, and the rationale for using these different cell types is not explained. In addition, some experimental details are missing from the methods.

      We thank the reviewer for pointing out the lack of clarity, and have filled in missing information in the methods. HEK293T cells were used for virus production for the VPSoe system, and we have clarified the cell types used in figure legends (predominantly iTTF). We have also provided justification when NIH3T3 cells were used (revised lines 290-291).    

      There is also a lack of functional studies in patient-derived IPF fibroblasts which means the link between endocytic recycling of collagen and the role of VPS33b and ITGA11 cannot be fully established.

      We thank the reviewer for this comment, which was also raised by reviewer 2 above. We agree that the inclusion of additional functional studies using IPF patient-derived patient fibroblasts would add to the manuscript and have performed siRNA against VPS33B and ITGA11 on IPF fibroblasts, and demonstrated a late of endocytic recycling events (revised Figure 8D, S6B, lines 351-353).  

      Recommendations for the authors:

      Reviewer #1 (Recommendations For The Authors): 

      The authors inhibit Clathrin-dependent endocytosis with dyngo4a. It is well known that this inhibitor is not highly specific for this pathway. It is also not explained why the authors only inhibit the Clathrin uptake pathway, and not pinocytosis or Clathrin-independent endocytosis too. The authors refer to papers that describe pinocytosis for collagen endocytosis.

      We thank the reviewer for raising this question. Based on the fact that inhibition of clathrin-dependent pathway does not completely abrogate endocytosis of collagen-I, we anticipate that other pathways are involved in mediating collagen-I uptake, although additional data suggested this is unlikely through fluid-phase endocytosis, and is receptor mediated (revised Figure S2B, C).  

      Where does the ColI go in the cell? Depending on the uptake pathway, it is likely to pass through endocytic carriers to endosomes, where it may be recycled to the PM or degraded. From the start, the authors describe the ColI as being in vesicular structures, however, the imaging data that this is based on is not co-labelled with anything to determine the potential structure/localisation. This is not done at any point in the paper, until IF is shown of ColI with VIPA39, however without the relevant controls, this IF is unconvincing, as the general pattern of ColI and VIPA39 as an endosomal marker are not classically recognisable. Additionally, VPS33B is described as a late endosome/lysosome marker, which would have different connotations on ColI trafficking or destination than other types of endosomes.

      We thank the reviewer for pointing out the weaknesses in our original IF. We have included new confocal images showing labelled collagen co-localisation with GFP-tagged Rab5 through transient transfection, which is a more traditional endosome marker (revised Figure 1D, Figure S6A).  

      We are currently characterising the compartments to where ColI is trafficked to, which is being prepared as part of a methodology-based manuscript. We believe that this characterisation would be too detailed to be included in a revised version of this manuscript. The Kadler lab also have data suggesting that the lysosome is involved in collagen fibrillogenesis instead of its canonical degradation function, which is in another submitted manuscript (https://www.researchsquare.com/article/rs-1336021/v1). It was not included in this manuscript due to our focus (i.e. endocytic-recycling).   

      In Figure 5H, the pattern of Cy5-ColI staining looks like it could even be ER/Golgi in the VPSKO zoom panel, but in the absence of co-labelling, we cannot conclude anything. In order for the authors to conclude that ColI is within the endosomes, co-labelled If should be performed to demonstrate ColIendosomal colocalization. Likewise for the role of VPS33B in ColI fibrillogenesis: dependence of the process is demonstrated, but the relationship is not defined. This could be clarified using IF. This would also support the authors' statements of co-trafficking between ColI, VPS33B, and VIPA39, which as the paper stands, is not demonstrated.

      We would like to clarify that our hypothesis is that the endosome controls how collagen is being deposited outside the cell, i.e. whether it’s protomeric secretion or fibrillogenesis, and that the decision of whether an endocytosed collagen is recycled or degraded lies in this compartment. The reviewer is correct that it may not be just the endosome that endocytosed collagen-I ends up in, as we have new data suggesting involvement of other intracellular compartment, although the detailed mechanism is beyond the scope of this manuscript. Nonetheless, we have included new data showing co-localisation of endocytosed collagen with Rab5 in this revised manuscript (revised Figure 1D, Figure S6A).  

      The basis of this paper is that endocytosis of ColI must occur before re-exocytosis as fibrillar ColI. The authors show this through pulse-chase experiments, with a trypsinisation step to remove any externally bound ColI. The authors also show nice time progression by flow cytometry, but it would truly demonstrate this point if they showed 0 timepoint, or low timepoint of IF to show progressive lengthening of ColI fibrils. This is used early on in Figure 1D, although the presentation here is not very clear. This is especially important as the authors address the self-seeding capabilities of Collagen in cell-free conditions in Figure 1F.

      We would like to thank the reviewer for this suggestion.  From previous endogenously tagged collagen data, we know that the appearance of collagen fibrils is rather rapid, thus it may not be a gradual lengthening as expected, but rather a depletion of endocytosed collagen in the initial seeding/growth step (please see https://www.researchsquare.com/article/rs-1336021/v1). We have included an image of replated fibroblasts after 18 hours showing no appearance of extracellular collagen, endogenous or otherwise (revised Figures S2A, line 110).  

      Finally, although the involvement of ITGA11 is interesting, it is not well described, and its role is not well demonstrated. This could likely be clarified by an additional introduction to ITGA11 and its role in collagen exocytosis/fibrillogenesis.

      We would like to thank the reviewer for pointing this out and have included additional sentences to specifically introduce ITGA11 and its role in fibrillogenesis (see lines 320, 321; 446-450).  

      Specific points: 

      Line 73: You haven't compared reuse vs production, so you can't say that reuse is central rather than production. They may be both as important or production still may be the most crucial, maybe it depends on cell/collagen type. Using the ColI KD or CHX to block nascent synthesis, you could directly compare the impact of both.

      We would like to clarify that we are not referring to reuse/recycling here. We meant that production of collagen (i.e. single hetero/homotrimer molecules within the cell) is not as crucial as the utilisation (i.e. are these being secreted as protomers, or assembled into fibrils) of these building blocks by the cells, which was supported by our finding that production (as suggested by mRNA levels) of IPF fibroblasts are similar to that in control fibroblasts (now revised Figure 8A). We have conducted ColI siRNA to block nascent synthesis in the original manuscript and showed that fibroblasts can efficiently make new fibrils by recycling exogenous collagen (Figure 3B, C), although we appreciate that siRNA may not completely inhibit endogenous production. Thus, we have also included new data using collagen-I knockout cells to support our hypothesis that without endogenous production, fibroblasts can still effectively make collagen fibrils if they can reuse what is available in the extracellular space (revised Figure 4, Figure S3C, D; lines 178-199).  

      Lines 83-87: The rationale for this experiment is not clear. Cy3-ColI is added, taken up into cells, and incorporated into fibrils coming from cells. 5FAM-ColI is added at a later stage, then at 2 days (when incorporation is demonstrated in Fig 1B), it is also incorporated into cells as expected. Why does this comment on ColI not being degraded any more than Cy3-ColI alone?

      We believe that the pulse chase experiment using the differently tagged collagen demonstrated a dimension of dynamics that is not demonstrated with Cy3-ColI alone. In this case, Cy3-ColI was initially added, and removed after 3 days; 5FAM-ColI is then added and incubated for 2 more days. Thus after 5 days since the initial pulse, the Cy3-ColI persisted and was not degraded. We would like to apologise for causing this confusion, and have clarified in the revised manuscript (lines 542-549; Figure S1D figure legend).  

      Figure 1A: I would like to see a negative control: either dark colI or no Cy3-Col, or timescale. Is B quantified from these images?

      We thank the reviewer for this comment. We have added the nocollagen control image in our revision (revised Figure S1D). 1B is not quantified from the ex vivo tendon experiments, but rather the in vitro cell culture experiments (i.e. those from 1D-1F, although they are all from independent experiments).  

      Figure 1B: in iTTF cells (immortalised tendon cells) Corrected to max: What does that mean?

      As there are variations between individual experiments (e.g. changes in the amount of collagen added due to pipetting) we have normalised to the maximum value obtained in each individual experiments so that we can display all biological repeats within the same graph.  

      Figure 1C: You can't say ColI is in vesicular structures from this, they are spots, yes, but that could also be in Golgi/ER (unlikely to be cytosolic but not impossible).

      We appreciate this comment and have change the wording accordingly and call them intracellular/punctate structures.

      Figure 1D: Not the best presentation: The cell mask has structures: what are these? It's not clear if this is a single cell, would be better with a defined marker (endocytic marker, lysosome etc). Instead of a low-resolution 3D view, it would be clearer with normal confocal XY and zooms of "vesicular structures" using appropriate markers as 3D reconstructions I think it could be removed.

      This is a single cell and the cell mask is staining plasma membrane. We didn’t use defined marker as we wanted to visualise the whole intracellular cell compartment. We appreciate that further proof is needed to verify the location of the endocytosed collagen, and have included additional confocal imaging data to support the localisation of collagen into Rab5 positive intracellular compartments (revised Figure 1D, Figure S6B).  

      Figure 1 E/F: Cy3 is only visible in extracellular structure, not also intracellular. Why? Would be useful to see the time points of incorporation at the end of the pulse, then at an early point into the chase, to demonstrate 1) Cy3-ColI uptake into cells and progressive incorporation rather than potential direct binding of ColI-Cy3 to ECM, or other non-specific factors. Showing the image at 0t would demonstrate an absence of external labelled colI and therefore its appearance later could be presumed that it had been internalised before.

      As the cells were trypsinized and replated after one hour labelled collagen feeding to ensure we are only tracking endocytosed collagen, t=0 in this case would be cells that are unattached. We have included t=18hr images post replate instead to show baseline level of collagen (revised Figures S2A, line 110).

      Figure S1A: yellow box: doesn't show only Cy3-ColI, there is red and yellow in the central cell, and large yellow blobs in the cell above. These images do not support this claim, including the Fiber Zoom box. They should also be shown in single channels to demonstrate the authors' points better.

      Apologies for the confusion – this is to show that newly added FAM5 Collagen is also co-localising with previously endocytosed Cy3-ColI, i.e. the Cy3-ColI is persisting rather than being degraded.  

      Line 92: endocytosed into distinct structures: These images are very vague, but I don't think you can call them distinct structures, all you can say from this is that they are spots.

      We have changed the wording to ‘distinct puncta’.  

      It is not clear why the authors use Cy3, Cy5, and 5FAM labelled colI. A brief explanation would be useful.

      Apologies for the confusion, we initially included our justification (to show that the fluorescence labels do not change the way collagen is internalised) but removed it in the final manuscript due to length. We have added the justification (revised line 101-102).   

      Figure 1F: It would be useful to see a quantification of the Cy3 channel here: I agree with the conclusions, and find the 0.5 ug/ml condition more convincing than 0.1 actually, although there is some feint Cy3 in cell-free samples there seems to be quite a big increase in the presence of cells, and this would look more convincing if quantified.

      We thank the reviewer for this suggestion and have included quantification in the revised manuscript (revised Figure 1G-I).  

      Figure 2B: Dyng is not an abbreviation of Dyng. Standardise Dyng/Dyngo/Dyngo4a. WB is soluble colI and represents little (if any) insoluble col. IF is more or less the other way round. How do they compare this?

      Thank you for pointing out the inconsistencies, we have corrected this in the revised manuscript. We took the conditioned media from the same experiment where cells are fixed for IF and carried out Western blot analyses. The IF showed some collagen still present, albeit significantly reduced. This is in agreement with the western blot results (i.e. Dyng4a inhibits both soluble and insoluble forms of collagen deposition).  

      Figure 2C: not an image series. Quant: no cells/independent exps and STATS?

      Apologies for the missing experimental details in figure legends, it should say ‘representative of N=3 experiments’. We are not sure what the reviewer meant by Figure 2C not being an image series, as we meant it to be an image series of the individual fluorescence channels. We have changed this terminology to avoid confusion, and have included statistical analyses in the methods section. The statistical analyses of the fibril quantification is next to the fluorescence images.  

      Figures 2D/E: The authors show that internalised ColI peaks at 20h and decreases to 60h, Fibers peak at 40h. How is this measured? ECM removed? Why would there be less in the cells, degradation? Whats the synchronisation?

      We apologise for omitting the synchronisation method in methods section, and have included in our revised manuscript (revised lines 542-544). This is through dexamethasone addition (and removal after 1hr incubation) as standard. The internalised Col-I is measured using Cy3ColI so the cells would have both nascent and external collagen. Total intracellular collagen at the different time points would likely be higher than represented as a result, but here we are demonstrating that internalisation is a rhythmic event using the external labelled collagen. Fibers are measured using standard IF and then fibril counting.  

      Please note that we are only overlaying the two graphs to form our hypothesis that endocytosis may be used for accumulation of collagen protomers that then allows for efficient fibrillogenesis. They are not directly comparable as the quantification are of different things (internalised Cy3-ColI, total collagen fibrils). We have clarified this in our discussion (revised lines 399-401).  

      Discussion: Where does the ColI go? Solubilised? Degraded? Taken up by other cells? 

      The inverse correlation is not very tight. In fact, at 38h where fiber count peaks, Cy3-ColI also peaks (esp in normalised data, Figure S2D).

      We thank the reviewer for this comment and have reworded our main text to reflect this, and included additional discussion in our revised manuscript (revised lines 401-404).  

      Line 123: What is the turnover rate of Fibrils? Don't know for how long the transcription has been done, or when this would affect the fibril number. You have the quant for Fn1, where is the quant for ColI?

      We have included the quantification of collagen-I in original Figure 2A. We appreciate that it might cause confusion in Figure 2C (as we co-stained ColI and Fn1 in the same experiment) we have removed the collagen-I panel from the revised Figure 2C. We know from previous results that the number of fibrils fluctuate over 24hour period, although the turnover of one specific fibril is unlikely going to be 24 hours (https://www.biorxiv.org/content/10.1101/331496v2)

      Line 124: no accumulation of col in extracellular space, but you don't know how much endogenous colI (or other endogenous ECM proteins) they're taking up as it isn't measured here. If the author wants to comment on this, should use either exogenous col to monitor take up and resection or block transcription/translation to show fibril formation endo/exocytosis independent of endogenous synthesis.

      This experiment has been done in the original manuscript – siCol1a1 experiment was done with two rounds of siRNA, first round is normal transfection followed by reverse transfection onto fresh coverslips (this will ensure no prior ECM is being deposited, see Figure 3). However we appreciate that there may still be low levels of endogenous collagen-I, and thus have included new data using collagen-I knock-out fibroblasts to strengthen our findings (revised Figure 4).  

      Line 142: Why is fibronectin synthesis also decreased in Col KD? This is clear in the image but no explanation/reference is given.

      Due to the dynamic and complex nature of ECM, it is unsurprising if there is a knockon effect when knocking down one matrix protein. However, we have quantified the amount of fibronectin fibril deposited by scr and siCol1a1 fibroblasts, and showed that there was in fact no significant change between the two treatments (revised Figure 3A).

      Figure 3A: Need labels for which colour/protein is shown. Needs quantifying, especially as the Fn1 decrease is not so obvious here, it is consistent between Figure 3A and 2C?

      We have provided quantification in the revision (revised Figure 3A). Figure 3A and 2C are two separate experiments (one is Dyngo treatment and one is siCol1a1), and neither showed significant changes in fibronectin fibril areas.   

      Figure 3B: Line 151: the text states that "The observation of fibrillar Cy3 signals in siCol1a1 cells showed that the cells can repurpose collagen into fibrils without the requirement for intrinsic collagen-I production (red arrow Figure 3B), however, there is clearly endogenous colI here too (along the fiber and also strongly at each end). Does the ColI antibody recognise the exogenous ColI?

      In our hands the ColI antibody does not recognise exogenous ColI, as the cell-free Cy3-ColI images were also stained with ColI antibody to ensure the two experimental conditions were treated exactly the same.

      This conclusion could only be made in the true absence of collagen: either in knock-out cells, or where collagen production/trafficking has been blocked (ie knockout of ColI chaperone or ERES block), or in a cell type that produces collagens but not ColI. Alternatively, if there are any fibrils seen that are completely negative, they should be shown in the figure and quantified (number of Cy3-ColI+-ColI+ vs Cy3-ColI+-ColI-).

      We thank the reviewer for this suggestion. We have included new data from collagen knock-out fibroblasts in this revision (revised Figure 4).  

      Figure S4A: the quality of this blot isn't very high, the result is not very clear and the high intensity (unspecific?) band below confounds the interpretation. In the author's previous paper (NCB 2020) the blots for VPS33B were much clearer, as is Fig S4D. It would be nice to include a clearer blot, maybe from the other repeats.

      This is the only blot that we used to select which knockout clones to use for our previous paper, which is why the quality is not as high. Knockout clones were all verified with additional western blots, and we do not think that endogenous VPS33b is expressed at high levels (also verified by MS analyses).  Fig S4D is overexpression of VPS33b, which is much easier to detect.  

      Figure S4D: This blot is much clearer, it would be useful to include a high gain to show the VPS33B band in CT to be able to understand the true increase.

      From the qPCR data one can see that the increase at mRNA is 20+ fold increase; we’ve always had problems trying to detect endogenous VPS33b using western blot or mass spectrometry analysis.  

      Figure 4A: The fibrils here in the CT are not obvious, and the difference between CT and KOs is not appreciable. Would this be clearer shown at a lower magnification, with zooms where needed? Or immunogold labelling/CLEM to label the ColI?

      It is not trivial to carry out immunogold labelling/CLEM. These are cell-derived matrices in culture and thus lower magnification may not show as many collagen fibrils as one would expect. We are not confident that lower magnification will provide more information as the characteristic D-banded collagen pattern will be lost.  

      Line 167/Figure 4B: It looks like there is more internal ColI in KO, but the images are not good enough to tell. This could be better shown by flow cytometry.

      We have previously seen that VPSKO leads to accumulation of collagen-I in intracellular punctas (NCB2020) which is also seen here. Flow cytometry data for internalisation of external collagen is already included in original Figure 5G (revised Figure 6H).  

      Again you mention intercellular vesicles, but based on these images, it is not possible to conclude this. These large spots could be aggregation elsewhere in the cell. Specific localisation should be shown by co-labelled IF/confocal, or it could be nicely shown by EM + fluorescent element (CLEM / Immunogold), or these statements removed from the text.

      We appreciate that the term ‘vesicles’ is very defined in the trafficking field, and have changed it to ‘intracellular compartments’.  

      Line 173-174 / Figure 4E: Why do you think the matrix mass is not increased in VPSoe by the approach shown in E when there is seemingly a huge increase by IF? E must also measure other ECM matrix proteins, which do you expect to be secreted by these cells? Could this confound the data if they too are affected by VPSoe?

      IF is showing specifically collagen-I. Hydroxyproline detects multiple collagens, and shows a trend of increase (although not significant due to one outlier). Matrix mass is a very generic measurement of total ECM deposited based on decellularized ECM weight. The reviewer is correct that VPSoe may also affect other ECM deposition, however here we are focussing specifically with its effect on collagen-I. How VPSoe changes other types of ECM deposition would be something that could be addressed in future studies and is not within scope of this manuscript.   

      Are the results in E paired?

      Individual values between control and VPSoe in each separate experiments are paired.  

      Figure 4F: Is quantification from IF shown in D? Specify which kind of microscopy it is based on.

      Quantification is based on fibril counting using standard fluorescence microscopy, as used in our previous paper. D is independent of F, as F is specifically looking at synchronised circadian effects, and D (and elsewhere) we are looking at global collagen deposition effects, irrespective of what time of day the cells are in.  

      Figure S5F: What do the yellow/red spots in the blots represent?

      We apologise for the initial unclear description of what the yellow/magenta circles depict in relation to the phosphoimages of the radiolabelled cell free translation products displayed in Supplementary Figure 5, panels F, G and I. These circles indicate non-glycosylated (yellow) and N-glycosylated (magenta) species respectively, as is now clearly descried in the revised manuscript.

      Figure 5 title: You can't conclude this from these images, need confocal and PM or cytosolic marker.

      We have changed the title to ‘VPS33B co-trafficks with collagen-I”. There is no good commercial VPS33b antibody for immunofluorescence staining, which is why we used the split GFP approach in this paper, and the images were acquired using confocal imaging (Olympus SpinSR system).  

      Figure 5E: The authors describe that ColI is in endosomes throughout most of the paper, and this is based on the involvement of VPS33B in the colI pathway. VPS33B is thought to be at the late endosome/lysosome. However, these images do not look like classic endosomes or lysosomes, or other normal organelle IF phenotypes. The fluorescent intensity looks saturated, and it is difficult to conclude anything from these images. It is unclear where in the cell the largest blob in the zoom would be localised and in which cell. I would suggest that this image is replaced and proper controls included (IgG controls and single channels) as well as using different markers for other potential intracellular structures.

      We appreciate the reviewers comment with regards to the classification of VPS33b localisation in the endosome compartment. We did not mean to use VPS33b as an endosome marker, as the focus of our studies are the function of VPS33b in directing endogenous or exogenous collagen to fibrillogenesis. With live imaging we could see endocytosed collagen moving in intracellular compartments, and have conducted additional staining to show co-localisation with Rab5 (revised Figure 1), which we take to indicate, through convention, that it is occupying an endosome compartment. We have included single channel images in the revised manuscript (revised Figure 6E).

      Line 255/ Figure 5G: no consistent change in uptake. Why are the results so varied in the KO and oe, here and in Fig 4C/E? N=4, what does that mean? 4 cells? 4 independent exps?

      In all cases, “N” represents independent biological experiments in this manuscript. Thus “N=4” in this case is 4 independent biological experiments, with at least 10,000 cells analysed per experiment. 

      We don’t know why there is a variation in response, however that is also why we concluded that it is unlikely that VPS33B is directly involved with collagen uptake. We have changed 5G (now revised Figure 5H) to a paired line graph for better representation.  

      Figure 5H shows the uptake of Cy5ColI. At this resolution, VP2ko looks like the col is ER, in one of the cells in the zoom, it looks like it is at Golgi. I think that the uptake route of ColI needs to be better defined, as there is no way to tell here where the colI goes. ColI being recycled/degraded would be most likely. But this figure looks like that might not be the case. It is also not clear where the zooms come from, they should be indicated with dashed boxes in the lower mag image

      We thank the reviewer for this comment, and agree that we need to define the uptake route of ColI. This is currently being assembled as a methodology manuscript, and how ColI is being recycled/degraded is one major research area of the Chang lab. 

      We have added dashed boxes in the lower mag images to indicate where the zooms derived from, and we would also like to thank the reviewer for pointing this out as we realised we have accidentally cropped the image to a slightly different area for the VPSko image, and have now corrected this.  

      Line 257: Based on this data, it could be trafficking through the cell as well as into the extracellular space.

      We think that VPS33B is involved in trafficking collagen through the cell to plasma membrane but not secreted, as based on our split-GFP experiment we never observed extracellular GFP signal, which suggests VPS33b is not deposited extracellularly.

      Line 259: "highlighting the role in recycling col to fibril formation sites" is an overstatement based on the data shown here, there is no data on colI trafficking or its regulation

      We respectfully disagree that we have not shown data on col-I trafficking or regulation by VPS33b – split GFP highlighted cotrafficking to the plasma membrane, and we have shown a clear relationship between VPS33b and collagen-I fibril formation, with minimal changes to collagen-I mRNA levels. We acknowledge that we have not shown specifically the location of VPS33b at fibrillogenic sites and have modified this statement in revised manuscript (revised line 302).  

      Line 262: "Having identified VPS33B as specifically driving collagen-I fibril formation" is also an overstatement.

      We refer here the data that VPS33b is not controlling collagen-I secretion (as demonstrated by the CM westerns) and specifically fibrillogenesis. We have clarified this in the revised text (revised line 304).  

      Line 286: It would be useful to have a brief intro to PLOD3.

      We have included a brief intro to PLOD3 in the introduction, as well as the results highlighted by the reviewer, in our revised manuscript (revised line 54-58).  

      Line 289/290: There could be other explanations for disruption to exo-endocytosis when disrupting col trafficking. Is VPS33B controlling exocytosis in general? Why should it be specific to col? Likewise with siITGA11 KD? Hypothesis for ITGA11 and fibrillogenesis?

      The relationship between ITGA11 and collagen fibrillogenesis is currently in a manuscript by Donald Gullberg and Cedric Zeltz, under revision at Matrix Biology (see reference 63 in revised manuscript). We do not think that VPS33b is controlling exocytosis in general, which is supported by the minimal change in ponceau stain of the western blots in the manuscript. Previously it has been shown that VPS33B co-trafficks with PLOD3, a collagen-I modifier.  

      Figure 6I: Why only quant Scr + siITGA11, not in VPSoe? It looks like there is still an increase in intracellular or fibril formation in VPSoe + siITGA11, which would be a key result to discuss.

      We would like to clarify that 6I (now revised Figure 7I) is on the endocytosis of exogenous collagen-I, not quantification of Figure 6H.  

      Line 307: Discuss fibrillogenic sites, what are they?

      As we have not shown direct evidence of VPS33B delivering endocytosed collagen at the site of fibrillogenesis, we have decided to alter the text to avoid overstatement, as suggested from previous reviewers’ comments.  

      Figure 8: What does pentachrome label?

      Pentachrome staining allows for simultaneous staining of multiple species: collagen in red, sulphated mucopolysaccharides in violet, red blood cells in yellow, muscle in orange, nuclei in green.

      Line 326: "In this study we have identified the endosome as a major protagonist in..." This is an overstatement and cant be drawn from this data.

      We have modified this statement to “In this study we have identified an endocytic recycling mechanism for type I collagen fibrillogenesis that is under circadian regulation”

      Line 330/331: "Collagen-I co-traffics with VPS33B in a VIPAS-containing endosomal compartment that directs collagen-I to sites of fibril assembly," This is also an overstatement that cannot be drawn from this data.

      We have modified this statement to “Collagen-I co-traffics with VPS33B to the plasma membrane for fibrillogenesis”.  

      Line 340: again, the demonstration of the involvement of the endocytic pathway is very limited.

      We have provided new evidence in the revised manuscript that support the involvement of classical endosomal compartments.  

      Line 366: You cant conclude this, you have not manipulated these proteins to show a functional effect or modulation of fibrillogenesis, it could still be a secondary effect.

      We have provided new evidence in the revised manuscript that supports this conclusion. 

      Line 569: "Unless otherwise stated, incubation and washes were done at room temperature." Which incubations? Specify if this is just post-fixation during the EM prep or during cell culture.

      This is specific to the EM preparation and we have clarified in the revised manuscript (revised line 663).  

      Small text alterations:

      Overall we would like to thank the reviewer for highlighting these errors and mistakes in our manuscript, and have corrected them in our revised manuscript.  

      Figure 1E: Fluoro image series? This is only one image.

      We wrote this to mean single channel images, we have corrected the terminology.  

      Line 111: Ref for Dyngo4a?

      We have included this in the revised manuscript  

      Line 121: introduction/abbreviation definition for Fn1? Instead it is on Line 140.

      Thank you for highlighting this, we have corrected this in revised manuscript.  

      Figure S2C: Alignment of labels cleaves x-axis.

      We thank the reviewer for catching this and have corrected this with our revised manuscript.  

      Figure S4F and G should be inverted to mention sequentially in the text.

      We thank the reviewer for catching this and have corrected this in our revised manuscript.  

      Line 182: Figure 4J should be G.

      We thank the reviewer for catching this and have corrected this in our revised manuscript.

      Line 209: typo: N-glycosylated.

      We have corrected this typo in our revised manuscript.

      Fig 6E: Very big as a figure element compared to others.

      We have made this smaller in the revised manuscript to fit better with rest of the figure.  

      Line 313: Figure 7E not F.

      Thank you for spotting this, we have corrected it.  

      Line 555: Typo: Scraped.

      We have corrected this typo in our revised manuscript.

      Line 562: missing )

      We have corrected this typo in our revised manuscript.

      Standardise

      We thank the reviewer for spotting the mistakes below and have corrected in our revised manuscript.  

      Legends: Include numbers of repeats and STATs throughout. 

      Terminology: Dyng etc. 

      Scale bars: some included as editable lines, some with size on top, small/large etc.

      In certain cases we have positioned the scale bars in different regions of the figures to ensure no obscuring of the images.

      VPS33b v B. 

      Reviewer #2 (Recommendations For The Authors):  

      The authors can improve the experimental part of the manuscript the following: 

      -  For all the western blots please include molecular weight markers.

      We thank the reviewer for noticing this omission and have included molecular weight markers in the revised manuscript.  

      - Performing immunofluorescence and western blot analysis of endocytosed collagen -/+ inhibitors for lysosomal degradation (BafA1 or E64d+PepstatinA) in order to exclude endocytosis for degradation.

      We thank the reviewer for this comment, another paper from the lab has identified lysosome to be involved in collagen fibrillogenesis (https://www.biorxiv.org/content/10.1101/2024.05.09.593302v1), thus  

      - Figure out how Dyngo4a is affecting Col1 secretion in the first place? Does it interfere with the secretory pathway. Alternatively, use a different model to block endocytosis (e.g. siRNA Dynamin).

      We thank the reviewer for raising this. The Dyngo CM blot for total ponceau stain (revised Figure 2B) showed minimal changes, which suggest that global secretion is not affected.  

      - Further characterization of the VPS33B / collagen vesicles by immunofluorescence containing markers for early, late, and recycling endosomes. Block endocytic recycling by depletion of either Rabs or e.g. EHD1.

      There are no good VPS33b antibody for staining. We have included images of GFP-tagged Rab5 co-localisation with labelled collagen-I (revised Figure 1D, Figure S6B).  

      - Further clarify the status of the VPS33B knockouts e.g. by sequencing. also provide a readout of the siRNA KD, besides the mRNA levels, since there the difference is not striking.

      The knockout cell lines were characterised previously in our 2020 paper, which is referred to in our revised manuscript. We have always had issues detecting endogenous VPS33b due to reagents limitations, which is why we resorted to mRNA as the key readout.  

      - Doing siRNA knockdowns and endocytosis inhibition in the IPF fibroblasts to further strengthen the link between elevated expression of VPS33B/ ITGA11 and increased collagen uptake.

      We thank the reviewer for suggesting these experiments. Due to limitations of the patient-derived fibroblasts (cell numbers and passage numbers) we had to prioritise experiments, and thus have performed siRNA against VPS33B and ITGA11 in the IPF fibroblasts. We showed that in both cases the amount of recycled labelled-collagen in collagen fibrils is significantly reduced (revised Figure 8D).  

      Reviewer #3 (Recommendations For The Authors): 

      Major points 

      (1) Choice of cells: Please provide a rationale for why each cell line was used, and make sure that it is clear throughout the manuscript which cell line was used for each particular experiment. The HEK293T cell line is also missing from the reagent table.

      We thank the reviewer for pointing out this omission, and have clarified in our revised manuscript which cell lines were used in each experiment. We used HEK293T to generate lentiviruses as described in the methods section.  

      (2) Missing information from methods. Experimental details are missing from the methods in several places, making it difficult for someone to replicate an experiment. For example, no details are given in the methods describing the explant culture of murine tail tendons (described in results lines 78100), and there are no details on how the skin samples were obtained or stained. Further, no ethical approval details are provided for the use of human skin tissue.

      We apologise for leaving the ethical approval details and skin sample collection out, this was an oversight and will be included in the revised manuscript. We have also included the method to how murine tail tendons were cultured ex vivo (revised lines 527-531, 546-553).  

      (3) Functional studies in patient-derived cells. To fully establish the role of VPS33b and ITGA11 in fibrotic diseases, functional studies including the knockdown/overexpression of these genes could be performed to establish if the same response is seen as in non-diseased cells.

      We agree that this will add much to the paper, and have performed siRNA against VPS33B and ITGA11 in the IPF fibroblasts. We showed that in both cases the amount of recycled labelled-collagen in collagen fibrils is significantly reduced (revised Figure 8D).

      Minor Points

      We thank the reviewer for pointing out these mistakes, and have corrected and included additional details in the revised manuscript.  

      (1) Lines 51-52. Wording of this sentence is unclear, please rephrase. 

      (2) Line 182. Should this be Fig 4G rather than J? 

      (3) Line 209. Correct spelling of glycosylated. 

      (4) Line 463. Incomplete brackets and details missing? 

      (5) Line 590. Correct tense - was rather than are. 

      (6) Line 593. Specify centrifugation speed. 

      (7) Line 619. Nuclei rather than nucleus. 

      (8) Ln 650. Statistical analysis - was normality tested? 

      (9) Figure 1e - Difficult to read labels for coll/DAPI.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Joint Public review:

      Summary:

      This work provides a new general tool for predicting post-ERCP pancreatitis before the procedure depending on pancreatic calcification, female sex, intraductal papillary mucinous neoplasm, a native papilla of Vater, or the use of pancreatic duct procedures. Even though it is difficult for the endoscopist to predict before the procedure which case might have post-ERCP pancreatitis, this new model score can help with the maneuver and when the patient is at high risk of pancreatitis, sometimes can be deadly), so experienced endoscopists can do the procedure from the start. This paper provides a model for stratifying patients before the ERCP procedure into low, moderate, and high risk for pancreatitis. To be validated, this score should be done in many countries and on large numbers of patients. Risk factors can also be identified and added to the score to increase rank.

      Thank you for reviewing our manuscript. We hope that this score will be validated in other countries from now on.

      Strengths

      (1) One of the severe complications of endoscopic retrograde cholangiopancreatography procedure is pancreatitis, so investigators try all the time to find a score that can predict which patients will probably have pancreatitis after the procedure. Most scores depend on the intraprocedural maneuver. Some studies discuss the preprocedural score that can predict pancreatitis before the procure. This study discusses a new preprocedural score for post-ERCP pancreatitis.

      Thank you for evaluating our manuscript and raising a strength of this manuscript.

      (2) Depending on this score that identifies low, moderate, and high-risk patients for post-pancreatitis, so from the start, experienced and well-trained endoscopists can do the procedure or can refer patients to tertiary hospitals or use interventional radiology or endoscopic retrograde cholangiopancreatography.

      Thank you for evaluating our manuscript and raising a strength of this manuscript.

      (3) The number of patients in this study is sufficient to analyze data correctly.

      Thank you for evaluating our manuscript and raising a strength of this manuscript.

      Weaknesses:

      (1) It is a single-country, retrospective study.

      Thank you for this comment. It’s exactly as you said. This is a limitation (Lines 326-327).

      (2) Many cases were excluded, so the score cannot be applied to those patients.

      Thank you for this valuable comment. The predictive PEP score is not necessary for the excluded patients. The reasons were as follows. Biliary duct cannulation was not attempted in patients for whom it was difficult to identify the Vater papilla. The biliary tract was separated from the pancreas in patients with a past history of choledochojejunostomy, pancreatojejunostomy, or pancreatogastrostomy. PEP risk was thought to be low in these patients and patients who underwent bile duct cannulation via the choledochoduodenal fistula. PEP diagnosis is difficult in patients with acute pancreatitis, whose diagnosis is currently in progress. We added these explanations (Lines 98-106).

      (3) Many other studies, e.g., https://link.springer.com/article/10.1007/s00464-021-08491-1, https://pubmed.ncbi.nlm.nih.gov/36344369/, that have been published before discussing the same issue, so what is the new with this score?

      Thank you for raising the new reference written by Archibugi et al. in 2023. The novelty of our score is that it is calculated using the factors that are investigated before ERCP procedures. The study written by Archibugi et al. involved procedure time and cannulation attempts for PEP prediction. These two factors are unknown before ERCP procedures. Therefore, a preprocedural predictive risk model for PEP was not created before our study was performed. We added the content of the past study written by Archibugi and included the report as a reference (Lines 65-67, 73-74).

      (4) The discussion section needs reformulation to express the study's aim and results.

      Thank you for this valuable comment. I have rewritten the first paragraph of the discussion. In the paragraph, we showed that the study achieved the aim on the basis of the results (Lines 245-255).

      (5) Why did the authors select these items in their scoring system and did not add more variables?

      Thank you for this valuable comment. We selected the items listed in the Japanese guidelines for acute pancreatitis and post-ERCP pancreatitis. We added this description (Lines 123-126). The original references of the guidelines were cited in the first draft version.

      Recommendations for the authors:

      Reviewer #1 (Recommendations for the authors):

      Comment1. Please revise these documents: copyright, disclaimer, ethics approval, consent to participate, consent for publication, data and material availability, competing interests, funding, authors' contributions, and acknowledgments.

      First, thank you for reviewing our manuscript. We have already described the required information in the “author information” section. The sentences containing this information were proofread in English.

      Reviewer #2 (Recommendations for the authors):

      Comment 1. It would be best if you did this study in a Prospective way for more validation.

      First, thank you for reviewing our manuscript. We have revised our manuscript according to your comments. It’s exactly as you said. These points are limitations (Lines 312-318, lines 326-327). We hope that future validation studies over wider geographic regions will prove our opinions.

      Comment 2. The model name should be Acronyum (the first letter of the five items in the risk model).

      Thank you for this valuable comment. Sorry, we could not create a memorable model name using the first letter of the five items.

      Comment 3. You say that you include the pre-procedure criteria that predict PEP. You state one of the items, pancreatic duct procedure. Do you mean it is a history?

      Thank you for this valuable comment. This means that the main purpose is the pancreatic duct. Therefore, the pancreatic duct procedure is listed as “planned pancreatic duct procedures” in Figure 2 (Lines 40-41, 231-234). When an unintended pancreatic duct procedure is performed, we can calculate the risk score by adding two points for “planned pancreatic duct procedures” (Lines 48-49, 247-250).

      Comment 4. Regarding calcification, do you mean chronic pancreatitis? It needs more clarification regarding its degree.

      Thank you for this valuable comment. We regard pancreatic calcification as a finding of chronic pancreatitis. Pancreatic calcification was defined as the degree that was confirmed by imaging, such as CT, MRI, and EUS. These definitions have been written in the first draft version (Lines 134-137).

      Comment 5. Why don't you include young age in the model? Your result found that age less than 50 is significantly associated with PEP.

      Thank you for this valuable comment. We selected the PEP risk factors listed in the Japanese guidelines for acute pancreatitis and post-ERCP pancreatitis. Age less than 50 years was listed as a PEP risk factor in the Japanese guidelines for acute pancreatitis. We added this description (Lines 123-126).

      Comment 6. There is an ancient reference, some of them in 1994,1996.

      Sorry for the old references. These references were written by Cotton et al. 1991, Freeman et al. 1996, and Loperfido et al. 1998. These are still important today. The diagnostic criteria for PEP were determined in the report written by Cotton et al., which is Cotton’s criteria. The other two references are representative reports that described risk factors for PEP, and these two reports were cited in the Japanese guidelines for pancreatitis written by Takada et al. 2022 (Lines 123-126).

      Comment 7. In the introduction, you say that the first score includes one of the items for PEP pain during the procedure. It is a little bit strange.

      Thank you for this comment. The first PEP risk score did not involve PEP pain but involved pain during the procedure (Line 68).

      Comment 8. We know that once ERCP is indicated, you justify the importance of the risk model, stating that if one or more risks are found, we can do EUS or PTD. It is not reasonable to abort the procedure in case of frequent pancreatic duct cannulation or cancel ERCP if pt has one or more risk factors.

      Thank you for this valuable comment. If ERCP is performed for high-risk patients, prophylaxes for PEP, such as procedures by experts, pancreatic stent placement, and NSAID suppository insertion, should be performed as much as possible (Lines 281-287, 308-311).

      Comment 9. Regarding ERCP pancreatitis criteria, does it include amylase 3t or lipase?

      Thank you for this comment. We used Cotton’s criteria for diagnosing PEP. Cotton’s criteria include hyperamylasemia (more than three times the normal upper limit) at least 24 hours after ERCP (114-116).

      Comment 10. It is well known that pr with functional biliary disorder has a high incidence of PEP; it doesn't need a manometer for diagnosis. It needs to be included.

      Thank you for this comment. Moreover, functional biliary disorders are difficult to diagnose before ERCP procedures (Lines 259-262). The factor that is not apparent before ERCP could not be included in the predictive PEP scoring system.

      Comment 11: What is gabexare and nafamost.

      Thank you for this comment, and sorry for our insufficient explanation. These compounds include gabexate masilate and nafamostat masilate, which are protease inhibitors. In some institutions, protease inhibitors are used as prophylaxis for PEP. We added “protease inhibitors” (Lines 138-139, Tables 1 and 2).

      Reviewer #3 (Recommendations for the authors):

      Comment 1. The sample size needs clarification.

      First, thank you for reviewing our manuscript. The sample size has been included in the “Methods” section (Lines 157-165).

      Comment 2. They need to be mentioned cause they depend on old references in discussion and background.

      Thank you for this comment. The previous references were written by Cotton et al. 1991, Freeman et al. 1996, and Loperfido et al. 1998. These are still important today. The diagnostic criteria for PEP were determined in the report written by Cotton et al., which is Cotton’s criteria. The other two references are representative reports that described risk factors for PEP, and these two reports were cited in the Japanese guidelines for pancreatitis written by Takada et al. 2022 (Lines 122-126). In the background and discussion, we added new recent references and information related to the references (Lines 65-67, 285-287, 291-295, 308-311).

      Comment 3. Case definition should be added to the methodology.

      Thank you for this comment. We added patient information. Please refer to the response against the eLife assessment, weakness, (2).

      Comment 4. Do you include all who met the inclusion criteria, or was there any random sampling technique?

      No, we did not use random sampling techniques.

      Comment 5. What is the value of comparing the development and validation groups? I do not think it adds anything new as if you want to exclude confounders. Has the comparison revealed that a confounder does exist? What was your point of view concerning that?

      Thank you for this valuable comment, and sorry for the insufficient explanation. The differences between the development cohort and the validation cohort are important because the goodness of fit for the score could be confirmed in significantly different groups. We added this explanation (Lines 197-199, 251-253).

    1. Author response:

      Public Reviews:

      Reviewer #1 (Public review):

      Summary

      The authors determine the phylogenetic relation of the roughly two dozen wtf elements of 21 S. pombe isolates and show that none of them in the original S. pombe are essential for robust mitotic growth. It would be interesting to test their meiotic function by simply crossing each deletion mutant with the parent and analyzing spores for non-Mendelian inheritance. If this has been reported already, that information should be added to the manuscript. If not, I suggest the authors do these simple experiments and add this information.

      Thanks for the great summary! Most of the wtf genes have been tested for meiotic drive phenotypes previously by Bravo Nunez et al. (2020; http://doi.org/10.1371/journal.pgen.1008350). The reference was cited in our original manuscript, and we added the details in the revised manuscript.

      Strengths:

      The most interesting data (Figure 4) show that one recombinant (wtfC4) between wtf18 and wtf23 produces in mitotic growth a poison counteracted by its own antidote but not by the parental antidotes. Again, it would be interesting to test this recombinant in a more natural setting - meiosis between it and each of the parents.

      We will test the meiotic driver phenotype of the wtfC4 we constructed in S. pombe as suggested.

      Weaknesses:

      In the opinion of this reviewer, some minor rewriting is needed.

      We did the rewriting as this reviewer suggested in the comments to authors.

      Reviewer #2 (Public review):

      Summary:

      This important study provides a mechanism that can explain the rapid diversification of poison-antidote pairs (wtf genes) in fission yeast: recombination between existing genes.

      Thanks!

      Strengths:

      The authors analyzed the diversity of wtf in S. pombe strains, and found pervasive copy number variations. They further detected signals of recurrent recombination in wtf genes. To address whether recombination can generate novel wtf genes, the authors performed artificial recombination between existing wft genes, and showed that indeed a new wtf can be generated: the poison cannot be detoxified by the antidotes encoded by parental wtf genes but can be detoxified by own antidote.

      Thanks for the great summary!

      Weaknesses:

      The study can benefit from demonstrating that the novel poison-antidote constructed by the authors can serve as a meiotic driver.

      We will test the meiotic driver phenotype of the wtfC4 we constructed in S. pombe as suggested.

      Reviewer #3 (Public review):

      Summary:

      In this manuscript, Wang and colleagues explore factors contributing to the diversification of wtf meiotic drivers. wtf genes are autonomous, single-gene poison-antidote meiotic drivers that encode both a spore-killing poison (short isoform) and an antidote to the poison (long isoform) through alternative transcriptional initiation. There are dozens of wtf drivers present in the genomes of various yeast species, yet the evolutionary forces driving their diversification remain largely unknown. This manuscript is written in a straightforward and effective manner, and the analyses and experiments are easy to follow and interpret. While I find the research question interesting and the experiments persuasive, they do not provide any deeper mechanistic understanding of this gene family.

      Thanks! Please see the following for our point-to-point response.

      Strengths:

      (1) The authors present a comprehensive compendium and analysis of the evolutionary relationships among wtf genes across 21 strains of S. pombe.

      (2) The authors found that a synthetic chimeric wtf gene, combining exons 1-5 of wtf23 and exon 6 of wtf18, behaves like a meiotic driver that could only be rescued by the chimeric antidote but neither of the parental antidotes. This is a very interesting observation that could account for their inception and diversification.

      Thanks for the great summary!

      Weaknesses:

      (1) Deletion strains

      The authors separately deleted all 25 Wtf genes in the S. pombe ference strain. Next, the authors performed a spot assay to evaluate the effect of wtf gene knockout on the yeast growth. They report no difference to the WT and conclude that the wtf genes might be largely neutral to the fitness of their carriers in the asexual life cycle at least in normal growth conditions.

      The authors could have conducted additional quantitative growth assays in yeast, such as growth curves or competition assays, which would have allowed them to detect subtle fitness effects that cannot be quantified with a spot assay. Furthermore, the authors do not rule out simpler explanations, such as genetic redundancy. This could have been addressed by crossing mutants of closely related paralogs or editing multiple wtf genes in the same genetic background.

      Another concern is the lack of detailed information about the 25 knockout strains used in the study. There is no information provided on how these strains were generated or, more importantly, validated. Many of these wtf genes have close paralogs and are flanked by repetitive regions, which could complicate the generation of such deletion strains. As currently presented, these results would be difficult to replicate in other labs due to insufficient methodological details

      We will generate growth curves for all the 25 wtf deletion strains. We will also provide detailed for wtf gene knockout. However, for 25 wtf genes, there are too many combinations for editing two genes, and it is technically challenging to knock out multiple wtf together. Nevertheless, our results suggest single wtf gene has little effect on the host fitness under normal condition.  

      (2) Lack of controls

      The authors found that a synthetic chimeric wtf gene, constructed by combining exons 1-5 of wtf23 and exon 6 of wtf18, behaves as a meiotic driver that can be rescued only by its corresponding chimeric antidote, but not by either of the parental antidotes (Figure 4F). In contrast, three other chimeric wtf genes did not display this property (Figure 4C-E). No additional experiments were conducted to explain these differences, and basic control experiments, such as verifying the expression of the chimeric constructs, were not performed to rule out trivial explanations. This should be at the very least discussed. Also, it would have been better to test additional chimeras.

      We will verify the expression of the chimeric genes, and test the phenotype of meiotic diver for wtfC4 in S. pombe.

      (3) Statistical analyses

      In line 130 the authors state that: "Given complex phylogenetic mixing observed among wtf genes (Figure 1E), we tested whether recombination occurred. We detected signals of recombination in the 25 wtf genes of the S. pombe reference genome (p = 0) and in the wtf genes of the 21 S. pombe strains (p = 0) using pairwise homoplasy index (HPI) test. ". Reporting a p-value of 0 is not appropriate. Exact P-values should be reported.

      We will report the exact p values in the revised manuscript.

    1. Author response:

      We appreciate the reviewers' thoughtful and constructive comments. In this provisional response, we aim to address what we see as the key critiques, with a detailed, point-by-point reply to be provided alongside the revised manuscript. Below, we outline how we intend to address these critiques in the revised manuscript.

      (1) We will revise sections of the manuscript to ensure that all results, particularly those concerning the effects of lesions, are described more clearly and with sufficient context. This includes providing additional visualizations and rewording any ambiguous statements.

      (2) In this study, we examined a subset of 7,396 blocks where animals quickly adapted after block switches (achieving LCriterion in 20 or fewer trials), thereby focusing on expert-level performance and avoiding periods that might be affected by low motivation. It is valid to question whether the same observations would hold if the full dataset were analyzed. To address this, we expanded our analysis to include a supplementary figure Supplementary Figure 1.1 that illustrate the same relationships based on block length (BL) instead of LRandom, both with and without the restriction on LCriterion (n = 9,156 blocks in which the block length is under 100 trials, without any LCriterion restrictions), and based on LRandom without any LCriterion restrictions and with a less stringent LCriterion restriction (with ≤ 50 Trials for the criterion). This method allowed us to include all trials in our dataset. We observed similar effects of block length on choice behavior around switches (Figure 3), confirming the consistency of our findings across different analytical conditions.

      (3) We agree that robust validation of model selection is crucial. To address this, we will generate a confusion matrix to assess whether our model selection process accurately identifies the correct model class across a range of generative parameters. Include additional model selection metrics, such as cross-validation, to complement the BIC analysis and provide a more robust comparison of models.

      (4) We acknowledge the concern regarding our comparison of the "best" and the "4th best" models. The "4th best" model was chosen because it is the most widely recognized in the literature. Our intention was to demonstrate the performance of the most commonly used model, but we understand how this may have been misleading. To address this, we will revise our comparison to focus on the "best" and the "2nd best" models, ensuring greater clarity in the manuscript. Additionally, we will include supplementary simulation results and figures to provide a more comprehensive analysis on models.

    1. Author response:

      We appreciate the expression of enthusiasm for our paper by the editors and the three reviewers and the suggestions on how to improve the study. Here we outline how we will address the reviewers’ concerns and suggestions in a planned revision of our manuscript.

      Reviewer #1 listed two primary weaknesses:

      (1) the need for discussion of the extent to which the cell line we used resembles CRH neurons and

      (2) that we did not test for the effect of blockade of the glucocorticoid receptor.

      (1) As the reviewer acknowledges, our experiments called for the use of a cell line to dissect intracellular trafficking of the α1 adrenoreceptor. We selected the N42 cell line for this purpose because it is an immortalized hypothalamic cell line (developed by Belsham and colleagues, Belsham et al., 2004) that expresses CRH. We have used this cell line successfully in the past to study transcriptional and rapid non-genomic actions of glucocorticoids, which indicated that, in addition to expressing CRH, these cells also express both the nuclear glucocorticoid receptor and a membrane-associated receptor that binds glucocorticoids (Rainville et al., 2019; Weiss et al., 2019). We believe that this hypothalamic cell line is the most closely related to native PVN CRH neurons of any cell line available. As requested, we will add to the Discussion of the manuscript to further justify our choice of cells.

      (2) We agree that this experiment should be performed. We will test the classical GR (and progesterone) antagonist RU486 (mifepristone) for its effect on the cort regulation of α1 adrenoreceptor trafficking. Our ex vivo electrophysiology studies have indicated that the rapid glucocorticoid effect in native hypothalamic CRH neurons is not blocked by RU486 and is not, therefore, dependent on activation of the classical nuclear GR (Di et al., 2003; Di et al., 2016).

      Reviewer #2 also listed two main weaknesses of the study:

      (1) that we did not test whether the adrenoreceptor desensitization by restraint stress generalizes to other stress modalities and might be more robust with a pure somatic stressor, and

      (2) the lack of identification of a target protein as a mechanism for the role of nitrosylation.

      (1) We used restraint stress as a means to elicit corticosterone release, which desensitized the HPA response to a NE-dependent somatic stressor (lipopolysaccharide injection) but not to a NEindependent psychological stressor (predator odor) (Jiang et al., 2021). We got a near-complete loss of the sensitivity of CRH neurons to NE with restraint (i.e., near ceiling effect), such that a different stressor, including a more purely somatic stressor, should not increase the Cort-induced desensitization further. For that reason, we would argue that testing other stressors would not add value to the current study. That said, we plan and have received new funding to test in the future whether the Cort desensitization of the HPA response to LPS stress generalizes to other somatic stressors. We also have future plans to test for the Cort desensitization of other Gq-coupled receptors.

      (2) We agree that finding the molecular target of nitrosylation as the mechanism for Cort desensitization of α1 adrenoreceptors would significant improve the study, but this is a potentially enormous undertaking as it will require the screening and validation of multiple proteins involved in protein trafficking to find the one(s) targeted for nitrosylation by Cort. We tested β-arrestin as a possible target in the paper, but did not find Cort to regulate β-arrestin nitrosylation. We plan to undertake a general nitrosylation screen of proteins to identify multiple possible targets, but prefer to defer this and the validation of possible targets to a future, more thorough analysis.

      Reviewer #3 also pointed out two main weaknesses of our study:

      (1) that the glucocorticoidnitrosylation link was confusing, and

      (2) that it was unclear how blocking α1 adrenoreceptors reversed the Cort-induced cytosolic accumulation of the receptor.

      We appreciate the reviewer pointing out these deficiencies in our interpretation and explanation of our findings. We plan to address them directly in the revised version of the paper. 

      References

      Belsham DD, Cai F, Cui H, Smukler SR, Salapatek AMF, Shkreta L (2004) Generation of a phenotypic array of hypothalamic neuronal cell models to study complex neuroendocrine disorders. Endocrinology 145:393–400.

      Weiss GL, Rainville JR, Zhao Q, Tasker JG (2019) Purity and stability of the membrane-limited glucocorticoid receptor agonist dexamethasone-BSA. Steroids 142:2-5. 

      Rainville JR, Weiss GL, Evanson N, Herman JP, Vasudevan N, Tasker JG (2019) Membrane-initiated nuclear trafficking of the glucocorticoid receptor in hypothalamic neurons. Steroids 142:55-64.

      Di S, Malcher-Lopes R, Halmos KCs, Tasker JG (2003) Non-genomic glucocorticoid inhibition via endocannabinoid release in the hypothalamus: a fast feedback mechanism. Journal of Neuroscience 23:4850-4857.

      Di S, Itoga CA, Fisher MO, Solomonow J, Roltsch EA, Gilpin NW, Tasker JG (2016) Acute stress suppresses inhibition and increases anxiety via endocannabinoid release in the basolateral amygdala. Journal of Neuroscience 36:8461-8470.

      Jiang Z, Chen C, Weiss GL, Fu X, Stelly CE, Sweeten BLW, Tirrell PS, Pursell I, Stevens CR, Fisher MO, Begley JC, Harrison LM, Tasker JG (2022) Stress-induced glucocorticoid desensitizes adrenoreceptors to gate the neuroendocrine response to somatic stress in male mice. Cell Reports 41(3):111509.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Reviewer #1 (Public Review):

      Summary:

      "Neural noise", here operationalized as an imbalance between excitatory and inhibitory neural activity, has been posited as a core cause of developmental dyslexia, a prevalent learning disability that impacts reading accuracy and fluency. This study is the first to systematically evaluate the neural noise hypothesis of dyslexia. Neural noise was measured using neurophysiological (electroencephalography [EEG]) and neurochemical (magnetic resonance spectroscopy [MRS]) in adolescents and young adults with and without dyslexia. The authors did not find evidence of elevated neural noise in the dyslexia group from EEG or MRS measures, and Bayes factors generally informed against including the grouping factor in the models. Although the comparisons between groups with and without dyslexia did not support the neural noise hypothesis, a mediation model that quantified phonological processing and reading abilities continuously revealed that EEG beta power in the left superior temporal sulcus was positively associated with reading ability via phonological awareness. This finding lends support for analysis of associations between neural excitatory/inhibitory factors and reading ability along a continuum, rather than as with a case/control approach, and indicates the relevance of phonological awareness as an intermediate trait that may provide a more proximal link between neurobiology and reading ability. Further research is needed across developmental stages and over a broader set of brain regions to more comprehensively assess the neural noise hypothesis of dyslexia, and alternative neurobiological mechanisms of this disorder should be explored.

      Strengths:

      The inclusion of multiple methods of assessing neural noise (neurophysiological and neurochemical) is a major advantage of this paper. MRS at 7T confers an advantage of more accurately distinguishing and quantifying glutamate, which is a primary target of this study. In addition, the subject-specific functional localization of the MRS acquisition is an innovative approach. MRS acquisition and processing details are noted in the supplementary materials according to the experts' consensus-recommended checklist (https://doi.org/10.1002/nbm.4484). Commenting on the rigor, the EEG methods is beyond my expertise as a reviewer.

      Participants recruited for this study included those with a clinical diagnosis of dyslexia, which strengthens confidence in the accuracy of the diagnosis. The assessment of reading and language abilities during the study further confirms the persistently poorer performance of the dyslexia group compared to the control group.

      The correlational analysis and mediation analysis provide complementary information to the main case-control analyses, and the examination of associations between EEG and MRS measures of neural noise is novel and interesting.

      The authors follow good practice for open science, including data and code sharing. They also apply statistical rigor, using Bayes Factors to support conclusions of null evidence rather than relying only on non-significant findings. In the discussion, they acknowledge the limitations and generalizability of the evidence and provide directions for future research on this topic.

      Weaknesses:

      Though the methods employed in the paper are generally strong, there are certain aspects that are not clearly described in the Materials & Methods section, such as a description of the statistical analyses used for hypothesis testing.

      Thank you for pointing this out. A description of the statistical models used in the analyses of EEG biomarkers has been added to the Materials and Methods:

      “First, exponent and offset values were averaged across all electrodes and analyzed using a 2x2 repeated measures ANOVA with group (dyslexic, control) as a between-subjects factor and condition (resting state, language task) as a within-subjects factor. Age was included in the analyses as a covariate due to the correlation between variables. Next, exponent and offset values were averaged across electrodes corresponding to the left (F7, FT7, FC5) and right inferior frontal gyrus (F8, FT8, FC6), and to the left (T7, TP7, TP9) and right superior temporal sulcus (T8, TP8, TP10). The electrodes were selected based on the analyses outlined by Giacometti and colleagues (2014) and Scrivener and Reader (2022). For these analyses, a 2x2x2x2 repeated measures ANOVA with age as a covariate was conducted with group (dyslexic, control) as a between-subjects factor and condition (resting state, language task), hemisphere (left, right), and region (frontal, temporal) as within-subjects factors. Results for the alpha and beta bands were calculated for the same clusters of frontal and temporal electrodes and analyzed with a similar 2x2x2x2 repeated measures ANOVA; however, for these analyses, age was not included as a covariate due to a lack of significant correlations.”

      We also expanded the description of the statistical models used in the analyses of MRS biomarkers:

      “To analyze the metabolite results, separate univariate ANCOVAs were conducted for Glu, GABA+, Glu/GABA+ ratio and Glu/GABA+ imbalance measures with group (control, dyslexic) as a between-subjects factor and voxel gray matter volume (GMV) as a covariate. Additionally, for the Glu analysis, age was included as a covariate due to a correlation between variables. Both frequentist and Bayesian statistics were calculated. Glu/GABA+ imbalance measure was calculated as the square root of the absolute residual value of a linear relationship between Glu and GABA+ (McKeon et al., 2024).”

      With regard to metabolite quantification, it is unclear why the authors chose to analyze and report metabolite values in terms of creatine ratios rather than quantification based on a water reference given that the MRS acquisition appears to support using a water reference.

      We have decided to use the ratio of Glu and GABA to total creatine (tCr), as this is still a common practice in MRS studies at 7T (e.g., Nandi et al., 2022; Smith et al., 2021). This approach normalizes the signal, reducing the impact of intensity variations across different regions and tissue compositions. Additionally, total creatine concentration is considered relatively stable across different brain regions, which is particularly important in our study, where a functional localizer was used to establish the left STS region individually. Our decision was further influenced by previous studies on dyslexia (Del Tufo et al., 2018; Pugh et al., 2014) which have reported creatine ratios and included GM volume as a covariate in their models, thus providing comparability. It is now indicated in the Results:

      “For comparability with previous studies in dyslexia (Del Tufo et al., 2018; Pugh et al., 2014) we report Glu and GABA as a ratio to total creatine (tCr).”

      and in the Method sections:

      “Glu and GABA+ concentrations were expressed as a ratio to total-creatine (tCr; Creatine + Phosphocreatine) following previous MRS studies in dyslexia (Del Tufo et al., 2018; Pugh et al., 2014).

      We did not estimate absolute concentrations using water signals as a reference, as this would require accounting for water relaxation times, which may vary across our age range. Nevertheless, our dataset has been made publicly available for future researchers to calculate and compare absolute values.

      Del Tufo, S. N., Frost, S. J., Hoeft, F., Cutting, L. E., Molfese, P. J., Mason, G. F., Rothman, D. L., Fulbright, R. K., & Pugh, K. R. (2018). Neurochemistry Predicts Convergence of Written and Spoken Language: A Proton Magnetic Resonance Spectroscopy Study of Cross-Modal Language Integration. Frontiers in Psychology, 9, 1507. https://doi.org/10.3389/fpsyg.2018.01507

      Nandi, T., Puonti, O., Clarke, W. T., Nettekoven, C., Barron, H. C., Kolasinski, J., Hanayik, T., Hinson, E. L., Berrington, A., Bachtiar, V., Johnstone, A., Winkler, A. M., Thielscher, A., Johansen-Berg, H., & Stagg, C. J. (2022). tDCS induced GABA change is associated with the simulated electric field in M1, an effect mediated by grey matter volume in the MRS voxel. Brain Stimulation, 15(5), 1153–1162. https://doi.org/10.1016/j.brs.2022.07.049

      Pugh, K. R., Frost, S. J., Rothman, D. L., Hoeft, F., Del Tufo, S. N., Mason, G. F., Molfese, P. J., Mencl, W. E., Grigorenko, E. L., Landi, N., Preston, J. L., Jacobsen, L., Seidenberg, M. S., & Fulbright, R. K. (2014). Glutamate and choline levels predict individual differences in reading ability in emergent readers. Journal of Neuroscience, 34(11), 4082–4089. https://doi.org/10.1523/JNEUROSCI.3907-13.2014

      Smith, G. S., Oeltzschner, G., Gould, N. F., Leoutsakos, J. S., Nassery, N., Joo, J. H., Kraut, M. A., Edden, R. A. E., Barker, P. B., Wijtenburg, S. A., Rowland, L. M., & Workman, C. I. (2021). Neurotransmitters and Neurometabolites in Late-Life Depression: A Preliminary Magnetic Resonance Spectroscopy Study at 7T. Journal of Affective Disorders, 279, 417–425. https://doi.org/10.1016/j.jad.2020.10.011

      GABA is typically quantified using J-editing sequences as lower field strengths (~3T), and there is some evidence that the GABA signal can be reliably measured at 7T without editing, however, the authors should discuss potential limitations, such as reliability of Glu and GABA measurements with short-TE semi-laser at 7T.

      In addition, MRS measurements of GABA are known to be influenced by macromolecules, and GABA is often denoted as GABA+ to indicate that other compounds contribute to the measured signal, especially at a short TE and in the absence of symmetric spectral editing.

      A general discussion of the strengths and limitations of unedited Glu and GABA quantification at 7T is warranted given the interest of this work to researchers who may not be experts in MRS.

      While we agree with the Reviewer that at 3T, it is recommended to use J-edited MRS to measure GABA (Mullins et al., 2014), the better spectral resolution at 7T allows for more reliable results for both metabolites using moderate echo-time, non-edited MRS (Finkelman et al., 2022). In this study, we used a short echo time (TE), which is optimal for Glu but not ideal for GABA, as it interferes with other signals. We are grateful to the Reviewer for suggesting the addition of a short paragraph to the Discussion, describing the practicalities of 3T and 7T MRS and changing the abbreviation to GABA+ to inform readers of possible macromolecule contamination:

      “We chose ultra-high-field MRS to improve data quality (Özütemiz et al., 2023), as the increased sensitivity and spectral resolution at 7T allows for better separation of overlapping metabolites compared to lower field strengths. Additionally, 7T provides a higher signal-to-noise ratio (SNR), improving the reliability of metabolite measurements and enabling the detection of small changes in Glu and GABA concentrations. Despite these theoretical advantages, several practical obstacles should be considered, such as susceptibility artifacts and inhomogeneities at higher field strengths that can impact data quality. Interestingly, actual methodological comparisons (Pradhan et al., 2015; Terpstra et al., 2016) show only a slight practical advantage of 7T single-voxel MRS compared to optimized 3T acquisition. For example, fitting quality yielded reduced estimates of variance in concentration of Glu in 7T (CRLB) and slightly improved reproducibility levels for Glu and GABA (at both fields below 5%). Choosing the appropriate MRS sequence involves a trade-off between the accuracy of Glu and GABA measurements, as different sequences are recommended for each metabolite. J-edited MRS is recommended for measuring GABA, particularly with 3T scanners (Mullins et al., 2014). However, at 7T, more reliable results can be obtained using moderate echo-time, non-edited MRS (Finkelman et al., 2022). We have opted for a short-echo-time sequence, which is optimal for measuring Glu. However, this approach results in macromolecule contamination of the GABA signal (referred to as GABA+).”

      Finkelman, T., Furman-Haran, E., Paz, R., & Tal, A. (2022). Quantifying the excitatory-inhibitory balance: A comparison of SemiLASER and MEGA-SemiLASER for simultaneously measuring GABA and glutamate at 7T. NeuroImage, 247, 118810. https://doi.org/10.1016/j.neuroimage.2021.118810

      Mullins, P. G., McGonigle, D. J., O'Gorman, R. L., Puts, N. A., Vidyasagar, R., Evans, C. J., Cardiff Symposium on MRS of GABA, & Edden, R. A. (2014). Current practice in the use of MEGA-PRESS spectroscopy for the detection of GABA. NeuroImage, 86, 43–52. https://doi.org/10.1016/j.neuroimage.2012.12.004

      Özütemiz, C., White, M., Elvendahl, W., Eryaman, Y., Marjańska, M., Metzger, G. J., Patriat, R., Kulesa, J., Harel, N., Watanabe, Y., Grant, A., Genovese, G., & Cayci, Z. (2023). Use of a Commercial 7-T MRI Scanner for Clinical Brain Imaging: Indications, Protocols, Challenges, and Solutions-A Single-Center Experience. AJR. American Journal of Roentgenology, 221(6), 788–804. https://doi.org/10.2214/AJR.23.29342

      Pradhan, S., Bonekamp, S., Gillen, J. S., Rowland, L. M., Wijtenburg, S. A., Edden, R. A., & Barker, P. B. (2015). Comparison of single voxel brain MRS AT 3T and 7T using 32-channel head coils. Magnetic Resonance Imaging, 33(8), 1013–1018. https://doi.org/10.1016/j.mri.2015.06.003

      Terpstra, M., Cheong, I., Lyu, T., Deelchand, D. K., Emir, U. E., Bednařík, P., Eberly, L. E., & Öz, G. (2016). Test-retest reproducibility of neurochemical profiles with short-echo, single-voxel MR spectroscopy at 3T and 7T. Magnetic Resonance in Medicine, 76(4), 1083–1091. https://doi.org/10.1002/mrm.26022

      Further, the single MRS voxel location is a limitation of the study as neurochemistry can vary regionally within individuals, and the putative excitatory/inhibitory imbalance in dyslexia may appear in regions outside the left temporal cortex (e.g., network-wide or in frontal regions involved in top-down executive processes). While the functional localization of the MRS voxel is a novelty and a potential advantage, it is unclear whether voxel placement based on left-lateralized reading-related neural activity may bias the experiment to be more sensitive to small, activity-related fluctuations in neurotransmitters in the CON group vs. the DYS group who may have developed an altered, compensatory reading strategy.

      We agree that including only one region of interest for the MRS measurements is a potential limitation of our study, and we have now added this information to the Discussion:

      “Moreover, since the MRS data was collected only from the left STS, it is plausible that other areas might be associated with differences in Glu or GABA concentrations in dyslexia.”

      However, differences in Glu and GABA concentrations in this region were directly predicted by the neural noise hypothesis of dyslexia. We acknowledge that this information was missing in the previous version of the manuscript. It is now included in the Results:

      “Moreover, the neural noise hypothesis of dyslexia identifies perisylvian areas as being affected by increased glutamatergic signaling, and directly predicts associations between Glu and GABA levels in the superior temporal regions and phonological skills (Hancock et al., 2017).”

      as well as in the Discussion:

      “Nevertheless, the neural noise hypothesis predicted increased glutamatergic signaling in perisylvian regions, specifically in the left superior temporal cortex (Hancock et al., 2017).”

      Figure 1 contains a lot of information, and it may be helpful to split it into 2 figures (EEG vs. MRS) so that the plots could be made larger and the reader could more easily digest the information.

      (a) I would also recommend displaying separate metabolite fit plots for each group, since the current presentation in panel F makes it appear that the MRS data is examined by testing differences between groups across the full spectrum (where the lines diverge), which really isn't the case.

      (b) The GABA peak is not visible in the spectrum, and Glutamate and GABA both have multiple peaks that should be shown on the spectrum. This may be best achieved by displaying the individual metabolite sub-spectra below the full spectrum

      Thank you for these suggestions. We have split the information into two Figures following the Reviewer’s recommendations.

      It is not clear why the 3T structural images were used for segmentation and calculation of tissue fraction if 7T structural images were also acquired (which would presumably have higher resolution).

      Generally, T1-weighted images from the 7T scanner exhibit more artifacts than those from the 3T scanner due to higher magnetic field inhomogeneity. These artifacts are especially pronounced in regions near air-tissue interfaces, such as the temporal lobes. Therefore, we chose the 3T structural images for segmentation and tissue fraction calculations and clarified this in the Method section:

      “Voxel segmentation was performed on structural images from a 3T scanner, coregistered to 7T structural images in SPM12, as the latter exhibited excessive artifacts and intensity bias in the temporal regions”.

      The basis set includes a large number of metabolites (27), including many low-concentration metabolites/compounds (e.g., bHG, bHB, Citrate, Threonine, ethanol) that are typically only included in studies targeting specific metabolites in disease/pathology. Please justify the inclusion of this maximal set of metabolites in the basis set, given that the inclusion of overlapping low-concentration metabolites may influence metabolite measurements of interest (https://doi.org/10.1002/mrm.10246).

      There is still no consensus in the MR community on which metabolites should be included in the model of human cerebral 1H-MR spectra. Typically, only major contributors such as NAA, Cr, Cho, Lac, mI, and possibly Glx are evaluated. Some studies also include additional metabolites like Ace, Ala, Asp, GABA, Glc, Gly, sI, NAAG, and Tau. In this study, as in a few others, further metabolites such as PCh, GPC, PCr, GSH, PE, and Thr were introduced and this approach seems suitable for high-field spectra (Hofmann et al., 2002).

      Hofmann, L., Slotboom, J., Jung, B., Maloca, P., Boesch, C., & Kreis, R. (2002). Quantitative 1H-magnetic resonance spectroscopy of human brain: Influence of composition and parameterization of the basis set in linear combination model-fitting. Magnetic Resonance in Medicine, 48(3), 440–453. https://doi.org/10.1002/mrm.10246

      Please provide a figure indicating the localization of the MRS voxel for a sample subject.

      A figure indicating the localization of the MRS voxel for a sample subject was added to the MRS checklist.

      It would be helpful to include Table S1 in the main article.

      Table S1 from the Supplementary Material has now been added to the main manuscript as Table 1 in the Results section.

      Please report descriptive statistics for EEG and MRS measures in Table S1.

      We have added a new Table S1 in the Supplementary Material, providing descriptive statistics for EEG and MRS E/I balance measures, presented separately for the dyslexic and control groups.

      I recommend avoiding using the terms "direct" and "indirect" to contrast MRS and EEG measures of E/I balance. Both of these measures are imperfect and it is misleading to say that MRS is a "direct" measure of neurotransmitters. There is also ambiguity in what is meant by "direct": in contrast to EEG, MRS does not measure neural activity and does not provide high-resolution temporal information, so in a sense, it is less direct.

      Thank you for this suggestion. We have replaced the terms 'direct' and 'indirect' biomarkers with 'MRS' and 'EEG' biomarkers throughout the text.

      There are many cases throughout the results in which Bayes and frequentist stats seem to contradict each other in terms of significance and what should be included in the models, especially with regard to the interaction effects (the Bayes factors appear to favor non-significant interactions). I think this is worth considering and describing to offer more clarity for the readers.

      We agree that a discussion of the divergent results between Bayesian and frequentist models was missing in the previous version of the manuscript. To provide greater clarity for the readers, we have conducted follow-up Bayesian t-tests in every case where the results indicated the inclusion of non-significant interactions with the effect of group in the model. These additional analyses have been performed for the exponent, offset, as well as for beta bandwidth in the Supplementary Material. We have also added a paragraph addressing these discrepancies in the Discussion:

      “Remarkably, in some models, results from Bayesian and frequentist statistics yielded divergent conclusions regarding the inclusion of non-significant effects. This was observed in more complex ANOVA models, whereas no such discrepancies appeared in t-tests or correlations. Given reports of high variability in Bayesian ANOVA estimates across repeated runs of the same analysis (Pfister, 2021), these results should be interpreted with caution. Therefore, following the recommendation to simplify complex models into Bayesian t-tests for more reliable estimates (Pfister, 2021), we conducted follow-up Bayesian t-tests in every case that favored the inclusion of non-significant interactions with the group factor. These analyses provided further evidence for the lack of differences between the dyslexic and control groups. Another source of discrepancy between the two methods may stem from the inclusion of interactions between covariates and within-subject effects in frequentist ANOVA, which were not included in Bayesian ANOVA to adhere to the recommendation for simpler Bayesian models (Pfister, 2021).”

      Pfister, R. (2021). Variability of Bayes factor estimates in Bayesian analysis of variance. The Quantitative Methods for Psychology, 17(1), 40-45. doi:10.20982/tqmp.17.1.p040

      It would be helpful to indicate whether participants in the DYS group had a history of reading intervention/remediation. In addition to showing that the DYS group performed lower than the CON group on reading assessments as a whole and given their age, was the performance on the reading assessments at an individual level considered for inclusion in the study? (i.e., were participants' persistent poor reading abilities confirmed with the research assessments?)

      We were unable to assess individual reading skills due to the lack of standardized diagnostic norms for adult dyslexia in Poland. Therefore, participants in the dyslexic group were recruited based on a previous clinical diagnosis of dyslexia, and reading and reading-related tasks were used for group-level comparisons only. This information has been added to the Methods section:

      “Since there are no standardized diagnostic norms for dyslexia in adults in Poland, individuals were assigned to the dyslexic group based on a past diagnosis of dyslexia.”

      Unfortunately, we did not collect information about participants' history of reading intervention or remediation. In this context, we acknowledge that including a sample of adult participants is a potential limitation of our study, however, this was already mentioned in the Discussion.

      Regarding the fMRI task, please indicate whether the participants whose threshold and/or contrast was changed for localization were from the DYS or CON group.

      This information is now added to the Method section:

      “For 6 participants (DYS n = 2, CON n = 4), the threshold was lowered to p < .05 uncorrected, while for another 6 participants (DYS n = 3, CON n = 3) the contrast from the auditory run was changed to auditory words versus fixation cross due to a lack of activation for other contrasts.”

      Reviewer #2 (Public Review):

      Summary:

      This study utilized two complementary techniques (EEG and 7T MRI/MRS) to directly test a theory of dyslexia: the neural noise hypothesis. The authors report finding no evidence to support an excitatory/inhibitory balance, as quantified by beta in EEG and Glutamate/GABA ratio in MRS. This is important work and speaks to one potential mechanism by which increased neural noise may occur in dyslexia.

      Strengths:

      This is a well-conceived study with in-depth analyses and publicly available data for independent review. The authors provide transparency with their statistics and display the raw data points along with the averages in figures for review and interpretation. The data suggest that an E/I balance issue may not underlie deficits in dyslexia and is a meaningful and needed test of a possible mechanism for increased neural noise.

      Weaknesses:

      The researchers did not include a visual print task in the EEG task, which limits analysis of reading-specific regions such as the visual word form area, which is a commonly hypoactivated region in dyslexia. This region is a common one of interest in dyslexia, yet the researchers measured the I/E balance in only one region of interest, specific to the language network.

      We agree with the Reviewer that including different tasks for the EEG biomarkers assessment would be valuable. However, this limitation was already addressed in the Discussion:

      “Importantly, our study focused on adolescents and young adults, and the EEG recordings were conducted during rest and a spoken language task. These factors may limit the generalizability of our results. Future research should include younger populations and incorporate a broader array of tasks, such as reading and phonological processing, to provide a more comprehensive evaluation of the E/I balance hypothesis.”

      Further, this work does not consider prior studies reporting neural inconsistency; a potential consequence of increased neural noise, which has been reported in several studies and linked with candidate-dyslexia gene variants (e.g., Centanni et al., 2018, 2022; Hornickel & Kraus, 2013; Neef et al., 2017). While E/I imbalance may not be a cause of increased neural noise, other potential mechanisms remain and should be discussed.

      Thank you for referring us to other works reporting neural variability in dyslexia. We agree that a broader context regarding sources of reduced neural synchronization, beyond E/I imbalance, was missing in the previous version of the manuscript. We have now included these references in the Discussion:

      “Furthermore, although our results do not support the idea of E/I balance alterations as a source of neural noise in dyslexia, they do not preclude other mechanisms leading to less synchronous neural firing posited by the hypothesis. In this context, there is evidence showing increased trial-to-trial inconsistency of neural responses in individuals with dyslexia (Centanni et al., 2022) or poor readers (Hornickel and Kraus, 2013) and its associations with specific dyslexia risk genes (Centanni et al., 2018; Neef et al., 2017). At the same time, the observed trial-to-trial inconsistency was either present only in a subset of participants (Centanni et al., 2018), limited to some experimental conditions (Centanni et al., 2022), or specific brain regions – e.g., brainstem in Hornickel and Kraus (2013), left auditory cortex in Centanni et al. (2018), or left supramarginal gyrus in Centanni et al. (2022).”

      A better description of the exponent and offset components is needed at the beginning of the results, given that the methods are presented in detail at the end. I also do not see a clear description of these components in the methods.

      A description of the aperiodic components is now included in the Results:

      “In the initial step of the analysis, we analyzed the aperiodic (exponent and offset) components of the EEG spectrum. The exponent reflects the steepness of the EEG power spectrum, with a higher exponent indicating a steeper signal; while the offset represents a uniform shift in power across frequencies, with a higher offset indicating greater power across the entire EEG spectrum (Donoghue et al., 2020).”

      as well as in the Materials and Methods:

      “Two broadband aperiodic parameters were extracted: the exponent, which quantifies the steepness of the EEG power spectrum, and the offset, which indicates signal’s power across the entire frequency spectrum.”

      Reviewer #3 (Public Review):

      Summary:

      This study by Glica and colleagues utilized EEG (i.e., Beta power, Gamma power, and aperiodic activity) and 7T MRS (i.e., MRS IE ratio, IE balance) to reevaluate the neural noise hypothesis in Dyslexia. Supported by Bayesian statistics, their results show solid 'no evidence' of EI balance differences between groups, challenging the neural noise hypothesis. The work will be of broad interest to neuroscientists, and educational and clinical psychologists.

      Strengths:

      Combining EEG and 7T MRS, this study utilized both the indirect (i.e., Beta power, Gamma power, and aperiodic activity) and direct (i.e., MRS IE ratio, IE balance) measures to reevaluate the neural noise hypothesis in Dyslexia.

      Weaknesses:

      The authors may need to provide more data to assess the quality of the MRS data.

      We have addressed the following specific recommendations of the Reviewer providing more data about the quality of the MRS data.

      The authors may need to explain how the number of subjects is determined in the MRS section.

      We have clarified the MRS sample description in the Results section:

      “Due to financial and logistical constraints, 59 out of the 120 recruited subjects, selected progressively as the study unfolded, were examined with MRS. Subjects were matched by age and sex between the dyslexic and control groups. Due to technical issues and to prevent delays and discomfort for the participants, we collected 54 complete sessions. Additionally, four datasets were excluded based on our quality control criteria, and three GABA+ estimates exceeded the selected CRLB threshold. Ultimately, we report 50 estimates for Glu (21 participants with dyslexia) and 47 for GABA+ and Glu/GABA+ ratios (20 participants with dyslexia).”

      Is there a reason why theta and gamma peaks were not observed in the majority of participants? What are the possible reasons that likely caused the discrepancy between this study and previously reported relevant studies?

      We have now added a discussion about the absence of oscillatory peaks in the theta and gamma bands to the Discussion section:

      “We could not perform analyses for the gamma oscillations since in the majority of participants the gamma peak was not detected above the aperiodic component. Due to the 1/f properties of the EEG spectrum, both aperiodic and periodic components should be disentangled to analyze ‘true’ gamma oscillations; however, this approach is not typically recognized in electrophysiology research (Hudson and Jones, 2022). Indeed, previous studies that analyzed gamma activity in dyslexia (Babiloni et al., 2012; Lasnick et al., 2023; Rufener and Zaehle, 2021) did not separate the background aperiodic activity. For the same reason, we could not analyze results for the theta band, which often does not meet the criteria for an oscillatory component manifested as a peak in the power spectrum (Klimesch, 1999). Moreover, results from a study investigating developmental changes in both periodic and aperiodic components suggest that theta oscillations in older participants are mostly observed in frontal midline electrodes (Cellier et al., 2021), which were not analyzed in the current study.”

      Hudson, M. R., & Jones, N. C. (2022). Deciphering the code: Identifying true gamma neural oscillations. Experimental Neurology357, 114205. https://doi.org/10.1016/j.expneurol.2022.114205

      Klimesch, W. (1999). EEG alpha and theta oscillations reflect cognitive and memory performance: A review and analysis. Brain Research Reviews29(2-3), 169-195. https://doi.org/10.1016/S0165-0173(98)00056-3

      Based on Figure 1F, the quality of the MRS data may be contaminated by the lipid signal, especially for the DYS group. To better evaluate the MRS data, especially the GABA measurements, the authors need to show:

      (a) the placement of the MRS voxel on the anatomical images;

      Averaged MRS voxel placement was already presented in Figure 1 (now Figure 2) in the manuscript. Now, we have also added exemplary single-subject images to the MRS checklist in the Supplement.

      (b) Glu and GABA model functions

      We have now provided more meaningful Glu and GABA indications in Figure 2.

      (c) CRLB for GABA

      We have added respective estimates to the Supplement:

      %CRLB of Glu: mean 2.96, SD = 0.79

      %CRLB of GABA: mean 10.59, SD = 2.76

      %CRLB of NAA: 1.76 SD = 0.46

      Further, the authors added voxel's gray matter volume as a covariate when performing separate ANCOVAs. The authors may need to use alpha correction or 1-fCSF correction to corroborate these results.

      We chose to use the ratio of Glu and GABA to total creatine (tCr), as this remains a common practice in MRS studies at 7T (e.g., Nandi et al., 2022; Smith et al., 2021). This decision was also influenced by previous dyslexia studies (Del Tufo et al., 2018; Pugh et al., 2014) and is now clarified in the Results and Methods sections.

      Regarding alpha correction, a recent paper (García-Pérez et al., 2023) recommends: 'In general, avoid corrections for multiple testing if statistical claims are to be made for each individual test, in the absence of an omnibus null hypothesis.' Since we report null findings, further alpha correction would not significantly impact the results.

      García-Pérez, M. A. (2023). Use and misuse of corrections for multiple testing. Methods in Psychology8, 100120. https://doi.org/10.1016/j.metip.2023.100120

    1. Author response:

      The following is the authors’ response to the original reviews.

      Reviewer #1 (Public Review): 

      Though the Norrin protein is structurally unrelated to the Wnt ligands, it can activate the Wnt/βcatenin pathway by binding to the canonical Wnt receptors Fzd4 and Lrp5/6, as well as the tetraspanin Tspan12 co-receptor. Understanding the biochemical mechanisms by which Norrin engages Tspan12 to initiate signaling is important, as this pathway plays an important role in regulating retinal angiogenesis and maintaining the blood-retina-barrier. Numerous mutations in this signaling pathway have also been found in human patients with ocular diseases. The overarching goal of the study is to define the biochemical mechanisms by which Tspan12 mediates Norrin signaling. Using purified Tspan12 reconstituted in lipid nanodiscs, the authors conducted detailed binding experiments to document the direct, high-affinity interactions between purified Tspan12 and Norrin. To further model this binding event, they used AlphaFold to dock Norrin and Tspan12 and identified four putative binding sites. They went on to validate these sites through mutagenesis experiments. Using the information obtained from the AlphaFold modeling and through additional binding competition experiments, it was further demonstrated that Tspan12 and Fzd4 can bind Norrin simultaneously, but Tspan12 binding to Norrin is competitive with other known co-receptors, such as HSPGs and Lrp5/6. Collectively, the authors proposed that the main function of Tspan12 is to capture low concentrations of Norrin at the early stage of signaling, and then "hand over" Norrin to Fzd4 and Lrp5/6 for further signal propagation. Overall, the study is comprehensive and compelling, and the conclusions are well supported by the experimental and modeling data. 

      Strengths: 

      • Biochemical reconstitution of Tspan12 and Fzd4 in lipid nanodiscs is an elegant approach for testing the direct binding interaction between Norrin and its co-receptors. The proteins used for the study seem to be of high purity and quality. 

      • The various binding experiments presented throughout the study were carried out rigorously. In particular, BLI allows accurate measurement of equilibrium binding constants as well as on and off rates. 

      • It is nice to see that the authors followed up on their AlphaFold modeling with an extensive series of mutagenesis studies to experimentally validate the potential binding sites. This adds credence to the AlphaFold models. 

      • Table S1 is a further testament to the rigor of the study. 

      • Overall, the study is comprehensive and compelling, and the conclusions are well supported by the experimental and modeling data. 

      Suggestions for improvement: 

      • It would be helpful to show Coomassie-stained gels of the key mutant Norrin and Tspan12 proteins presented in Figures 2E and 2F. 

      We have included Stain-Free SDS-PAGE gels from the purification of the Norrin and Tspan12 mutants in a new Figure S4.

      • Many Norrin and Tspan12 mutations have been identified in human patients with FEVR. It would be interesting to comment on whether any of the mutations might affect the NorrinTspan12 binding sites described in this study. 

      Thank you for this suggestion. We have inspected human mutation databases gnomAD, ClinVar, and HGMD for known mutations in the predicted Tspan12-Norrin binding interface and their occurrence in human patients with FEVR or Norrie disease.

      While a number of Tspan12 residues that we predict to interact with Norrin are impacted by rare mutations in humans (e.g., L169M, E170V, E173K, D175N, E196G, S199C, as found in the gnomAD database), these alleles are of unknown clinical significance (as found in ClinVar or HGMD databases). It is possible that mutations that slightly weaken the Norrin-Tspan12 interface may not produce a strong phenotype, especially given the avidity we expect from this system. By our examination, the missense variants of clinical significance that have been found in the Tspan12 LEL would be expected to destabilize the protein (i.e., mutations to or from cysteine or proline, or mutations to residues involved in packing interactions within the LEL fold), and therefore these mutations may produce a disease phenotype by impacting Tspan12 protein expression levels.  

      Several Norrin mutations that are associated with Norrie disease, FEVR, or other diseases of the retinal vasculature have been found in the predicted Tspan12 binding site. For example, Norrin mutations at positions L103 (L103Q, L103V), K104 (K104N, K104Q), and A105 (A105T, A105P, A105E, A105S, A105T, A105V) have been found in patients, all of which may disrupt binding to Tspan12. However, the deleterious effect of K104 mutations on Norrin-stimulated signaling could also be explained by a weakened Norrin-Fzd4 binding interface. Norrin mutations at R115 (R115L and R115Q), as well as R121 (R121L, R121G, R121Q, and R121W) have also been found in patients with various diseases of the retinal vasculature. Additionally, the Norrin mutation T119P has been found in patients with Norrie disease, but we would expect this mutation to destabilize Norrin in addition to disrupting the Tspan12 binding site. 

      While we commented briefly on mutations R115L and R121W in the original draft (page 5, paragraphs 4 and 1, respectively), we have updated the manuscript with more comments on disease-associated mutations to the predicted Tspan12 binding site on Norrin (page 5, first partial paragraph; page 9, first partial paragraph). 

      • Some of the negative conclusions (e.g. the lack of involvement of Tspan12 in the formation of the Norrin-Lrp5/6-Fzd4-Dvl signaling complex) can be difficult to interpret. There are many possible reasons as to why certain biological effects are not recapitulated in a reconstitution experiment. For instance, the recombinant proteins used in the experiment may not be presented in the correct configurations, and certain biochemical modifications, such as phosphorylation, may also be missing. 

      We agree that different Tspan12 and Fzd4 stoichiometries, lipid compositions, and posttranslational modifications could impact the results of our study, and that it is important to mention these possibilities. We have added these caveats to the discussion section (page 10, last paragraph).  

      Reviewer #2 (Public Review): 

      This is an interesting study of high quality with important and novel findings. Bruguera et al. report a biochemical and structural analysis of the Tspan12 co-receptor for norrin. Major findings are that Norrin directly binds Tspan12 with high affinity (this is consistent with a report on BioRxiv: Antibody Display of cell surface receptor Tetraspanin12 and SARS-CoV-2 spike protein) and a predicted structure of Tspan12 alone or in complex with Norrin. The

      Norrin/Tspan12 binding interface is largely verified by mutational analysis. An interaction of the Tspan12 large extracellular loop (LEL) with Fzd4 cannot be detected and interactions of fulllength Tspan12 and Fzd4 cannot be tested using nano-disc based BLI, however, Fzd4/Tspan12 heterodimers can be purified and inserted into nanodiscs when aided by split GFP tags. An analysis of a potential composite binding site of a Fzd4/Tspan12 complex is somewhat inconclusive, as no major increase in affinity is detected for the complex compared to the individual components. A caveat to this data is that affinity measurements were performed for complexes with approximately 1 molecule Tspan12 and FZD4 per nanodisc, while the composite binding site could potentially be formed only in higher order complexes, e.g., 2:2 Fzd4/Tspan12 complexes. Interestingly, the authors find that the Norrin/Tspan12 binding site and the Norrin/Lrp6 binding site partially overlap and that the Lrp6 ectodomain competes with Tspan12 for Norrin binding. This result leads the authors to propose a model according to which Tspan12 captures Norrin and then has to "hand it off" to allow for Fzd4/Lrp6 formation. By increasing the local concentration of Norrin, Tspan12 would enhance the formation of the Fzd4/Lrp5 or Fzd4/Lrp6 complex. 

      Thank you for pointing out the BioRxiv report showing Norrin-Tspan12 LEL binding. We have cited this in the introduction of our revised manuscript (page 2, paragraph 3).

      The experiments based on membrane proteins inserted into nano-discs and the structure prediction using AlphaFold yield important new insights into a protein complex that has critical roles in normal CNS vascular biology, retinal vascular disease, and is a target for therapeutic intervention. However, it remains unclear how Norrin would be "handed off" from Tspan12 or Tspan12/Fzd4 complexes to Fzd4/Lrp6 complexes, as the relatively high affinity of Norrin to Fzd4/Tspan12 dimers likely does not favor the "handing off" to Fzd4/Lrp6 complexes. 

      While the Fzd4-Tspan12 interaction is strong, our data suggest that Fzd4 and Tspan12 bind Norrin with negative cooperativity, suggesting that Fzd4 binding may enhance Norrin-Tspan12 dissociation to facilitate handoff. This model is based on 1) the dissociation of Norrin from beadbound Tspan12 in the presence of saturating Fzd4 CRD (Figure 3D), and 2) a weaker measured affinity of Norrin-Tspan12LEL in the presence of saturating Fzd4 CRD (Figure 3F). We have now added wording to emphasize this in the discussion section (page 9, end of first full paragraph).

      However, as you note, the Norrin-Tspan12 affinity that we measured in the presence of Fzd CRD (tens of nM) is still much stronger than the known Norrin-LRP6 affinity (0.5-1µM), which predicts that the efficiency of this handoff may be low. We have now commented on this in the discussion section and mentioned an alternative model in which Tspan12 presents the second Norrin protomer to LRP5/6 for signaling, instead of dissociating (page 9, paragraph 2). However, the handoff efficiency could also be impacted by other factors such as the relative abundance and surface distribution of Tspan12, Fzd4, LRP6 and HSPGs.  

      Areas that would benefit from further experiments, or a discussion, include: 

      -  The authors test a potential composite binding site of Fzd4/Tspan12 heterodimers for norrin using nanodiscs that contain on average about 1 molecule Fzd4 and 1 molecule Tspan12. The Fzd4/Tspan12 heterodimer is co-inserted into the nanodiscs supported by split-GFP tags on Fzd4 and Tspan12. The authors find no major increase in affinity, although they find changes to the Hill slope, reflecting better binding of norrin at low norrin concentrations. In 293F cells overexpressing Fzd4 and Tspan12 (which may result in a different stoichiometry) they find more pronounced effects of norrin binding to Fzd4/Tspan12. This raises the possibility that the formation of a composite binding requires Fzd4/Tspan12 complexes of higher order, for example, 2:2 Fzd4/Tspan12 complexes, where the composite binding site may involve residues of each Fzd4 and Tspan12 molecule in the complex. This could be tested in nanodiscs in which Fzd4 and Tspan12 are inserted at higher concentrations or using Fzd4 and Tspan12 that contain additional tags for oligomerization. 

      It is quite possible that Tspan12 and Fzd4 cluster into complexes with a stoichiometry greater than 1:1 in cells (this is supported by e.g., BRET experiments in (Ke et al., 2013)), and we mention in the discussion that that receptor clustering may be an additional mechanism by which Tspan12 exerts its function (page 10, paragraph 4). We would be quite interested to know the stoichiometry of Fzd4 and Tspan12 complexes in cells at endogenous expression levels, both in the presence and absence of Norrin, and to biochemically characterize these putative larger complexes in the future. We have amended the discussion to mention the caveat that our reconstitution experiments do not test higher-stoichiometry Fzd4/Tspan12 complexes (page 10, last paragraph).

      - While Tspan12 LEL does not bind to Fzd4, the successful reconstitution of GFP from Tspan12 and Fzd4 tagged with split GFP components provides evidence for Fzd4/Tspan12 complex formation. As a negative control, e.g., Fzd5, or Tspan11 with split GFP tags (Fzd5/Tspan12 or Fzd4/Tspan11) would clarify if FZD4/Tspan12 heterodimers are an artefact of the split GFP system. 

      The split-GFP system allows us to co-purify receptors that do not normally co-localize (for example, as we have shown with Fzd4 and LRP6 in the absence of ligand (Bruguera et al., 2022)) so we do not mean to claim that it provides evidence for Fzd4/Tspan12 complex formation. In fact, we were unable to co-purify co-expressed Fzd4 and Tspan12 unless they were tethered with the split GFP system, and separately-purified Fzd4 and Tspan12 did not incorporate into nanodiscs together unless they were tethered by split GFP. Based on these experiments, we expect that the purported Fzd4-Tspan12 interaction that others have found by co-IP or co-localization is easily disrupted by detergent, may require a specific lipid, and/or may not be direct.

      To clarify this point, we have noted in the results section that without the split GFP tags, Tspan12 and Fzd4 did not co-purify or co-reconstitute into nanodiscs, and that co-reconstitution was enabled by the split GFP system (page 6, first full paragraph).   

      - Fzd4/Tspan12 heterodimers stabilized by split GFP may be locked into an unfavorable orientation that does not allow for the formation of a composite binding site of FZD4 and Tspan12, this is another caveat for the interpretation that Fzd4/Tspan12 do not form a composite binding site. This is not discussed. 

      While the split GFP does enforce a Fzd4/Tspan12 dimer, the split GFP is removed by protease cleavage during the final step of the purification process, after the dimer is contained in a nanodisc. This should allow Fzd4 and Tspan12 to freely adopt any pose and to diffuse within the confines of the nanodisc lipid bilayer. However, it has been shown that the phospholipid bilayer in small nanodiscs is not as fluid as the physiological plasma membrane, and although we used the slightly larger belt protein (MSP1E3D1, 13 nm diameter nanodiscs), perhaps the receptors are indeed locked in some unfavorable state for this reason. Additionally, the nanodiscs are planar, so if the formation of a composite binding site requires membrane curvature, this would not be recapitulated in our system. We have cited these caveats in the discussion section (page 10, last paragraph).  

      - Mutations that affect the affinity of norrin/fzd4 are not used to further test if Fzd4 and Tspan12 form a composite binding site. Norrin R41E or Fzd4 M105V were previously reported to reduce norrin/frizzled4 interactions and signaling, and both interaction and signaling were restored by Tspan12 (Lai et al. 2017). Whether a Fzd4/Tspan12 heterodimer has increased affinity for Norrin R41E was not tested. Similarly, affinity of FZD4 M105V vs a Fzd4 M105V/Tspan12 heterodimer were not tested. 

      Since the high affinity of Norrin for both Fzd4 and Tspan12 may have obscured any enhancement of Norrin affinity for Fzd4/Tspan12 compared to either receptor alone, we did consider weakening Fzd-Norrin affinity to sensitize this experiment, inspired by the experiments you mention in (Lai et al., 2017). However, we suspected that the slight increase in Norrin affinity for the Fzd4/Tspan12 dimer compared to Fzd4 alone was driven mainly by increased avidity that enhanced binding of low Norrin concentrations, and this avidity effect would likely confound the interpretation of any experiment monitoring 2:2 complex formation. Additionally, on the basis that soluble Fzd4 extracellular domain and Tspan12 bind Norrin with negative cooperativity (Figures 3D and 3F), we concluded that this composite binding site was unlikely.

      - An important conclusion of the study is that Tspan12 or Lrp6 binding to Norrin is mutually exclusive. This could be corroborated by an experiment in which LRP5/6 is inserted into nanodiscs for BLI binding tests with Norrin, or Tspan12 LEL, or a combination of both. Soluble LRP6 may remove norrin from equilibrium binding/unbinding to Tspan12, therefore presenting LRP6 in a non-soluble form may yield different results. 

      We agree that testing this conclusion in an orthogonal experiment would be a valuable addition to this study. We have now performed a similar experiment to the one you described, but with Norrin immobilized on biosensors, and with LRP6 in detergent competing with Tspan12 LEL for Norrin binding (Figure S12, discussed on page 8, first full paragraph). The results of this experiment show that biosensor-immobilized Norrin will bind LRP6, and that soluble Tspan12 inhibits LRP6 binding in a concentration-dependent manner. The LRP6 construct we use (residues 20-1439) includes the transmembrane domain but has a truncated C terminus, since LRP6 constructs containing the full C terminus tend to aggregate during purification. We chose to immobilize Norrin to make the experiment as interpretable as possible, since immobilizing LRP6 and competing Norrin off with the LEL could result in an increase in signal (from the LEL binding the second available Norrin protomer) as well as a decrease (from Norrin being competed off of the immobilized LRP6). We conducted the experiment in detergent (DDM) instead of nanodiscs to be able to test higher concentrations of LRP6.

      - The authors use LRP6 instead of LRP5 for their experiments. Tspan12 is less effective in increasing the Norrin/Fzd4/Lrp6 signaling amplitude compared to Norrin/Fzd4/Lrp5 signaling, and human genetic evidence (FEVR) implicates LRP5, not LRP6, in Norrin/Frizzled4 signaling. The authors find that Norrin binding to LRP6 and Tspan12 is mutually exclusive, however this may not be the case for Lrp5. 

      This is an important point which we have now addressed in the text (page 8, end of first full paragraph). LRP5 is indeed the receptor implicated in FEVR and expressed in the relevant tissues for Tspan12/Norrin signaling. Unfortunately, LRP5 expresses poorly and we are unable to purify sufficient quantities to perform these experiments. However, LRP5 and LRP6 both transduce Tspan12-enhanced Norrin signaling in TOPFLASH assays (as you mention and as shown by (Zhou and Nathans, 2014)), bind Norrin, and are highly similar (they share 71% sequence identity overall and 73% sequence identity in the extracellular domain), so we expect their Norrin-binding sites to be conserved.

      - The biochemical data are largely not correlated with functional data. The authors suggest that the Norrin R115L FEVR mutation could be due to reduced norrin binding to tspan12, but do not test if Tspan12-mediated enhancement of the norrin signaling amplitude is reduced by the R115L mutation. Similarly, the impressive restoration of binding by charge reversal mutations in site 3 is not corroborated in signaling assays. 

      We agree that testing the impact of Norrin mutations in cell-based signaling assays would be an informative way to further test our model. However, the Norrin mutants we tested generated poor TopFlash signals in all conditions tested. This may be due to general protein instability, weakened affinity for LRP, or weaker interactions with HSPGs. Whatever the cause, the low signal made it challenging to conclusively say whether the Norrin mutations affected Tspan12mediated signaling enhancement.

      When expressed for purification, Tspan12 mutants generally expressed poorly compared to WT Tspan12, so we were concerned that differences in protein stability or trafficking would lead to lower cell-surface levels of mutant Tspan12 relative to WT in TopFlash signaling assays, which would confound interpretation of mutant Tspan’s ability to enhance Norrin signaling.

      Because of these challenges, follow-up experiments to investigate the signaling capabilities of Norrin and Tspan12 mutants were not informative and we have not included them in the revised manuscript.

      Reviewer #3 (Public Review): 

      Brugeuera et al present an impressive series of biochemical experiments that address the question of how Tspan12 acts to promote signaling by Norrin, a highly divergent TGF-beta family member that serves as a ligand for Fzd4 and Lrp5/6 to promote canonical Wnt signaling during CNS (and especially retinal) vascular development. The present study is distinguished from those of the past 15 years by its quantitative precision and its high-quality analyses of concentration dependencies, its use of well-characterized nano-disc-incorporated membrane proteins and various soluble binding partners, and its use of structure prediction (by AlphaFold) to guide experiments. The authors start by measuring the binding affinity of Norrin to Tspan12 in nanodiscs (~10 nM), and they then model this interaction with AlphaFold and test the predicted interface with various charge and size swap mutations. The test suggests that the prediction is approximately correct, but in one region (site 1) the experimental data do not support the model. [As noted by the authors, a failure of swap mutations to support a docking model is open to various interpretations. As AlphFold docking predictions come increasingly into common use, the compendium of mutational tests and their interpretations will become an important object of study.] Next, the authors show that Tspan12 and Fzd4 can simultaneously bind Norrin, with modest negative cooperativity, and that together they enhance Norrin capture by cells expressing both Tspan12 and Fzd4 compared to Fzd4 alone, an effect that is most pronounced at low Norrin concentration. Similarly, at low Norrin concentration (~1 nM), signaling is substantially enhanced by Tspan12. By contrast, the authors show that LRP6 competes with Tspan12 for Norrin binding, implying a hand-off of Norrin from a Tspan12+Fzd4+Norrin complex to a LRP5/6+Fzd4+Norrin complex. Thanks to the authors' careful dose-response analyses, they observed that Norrin-induced signaling and Tspan12 enhancement of signaling both have bell-shaped dose-response curves, with strong inhibition at higher levels of Norrin or Tspan12. The implication is that the signaling system has been built for optimal detection of low concentrations of Norrin (most likely the situation in vivo), and that excess Tspan12 can titrate Norrin at the expense of LRP5/6 binding (i.e., reduction in the formation of the LRP5/6+Fzd4+Norrin signaling complex). In the view of this reviewer, the present work represents a foundational advance in understanding Norrin signaling and the role of Tspan12. It will also serve as an important point of comparison for thinking about signaling complexes in other ligand-receptor systems. 

      Recommendations for the authors: 

      Reviewer #2 (Recommendations For The Authors):   

      - In Figure 5F high concentrations of transfected Tspan12 plasmid inhibit signaling, which the authors interpret to support the model that Tspan12/Norrin binding prevents Norrin/LRP6/FZD4 complex formation. Alternatively, the cells do not tolerate the expression of the tetraspanin at high levels, for example, due to misfolding and aggregate formation. To distinguish these possibilities: Do high levels of Tspan12 overexpression also inhibit signaling induced by Wnt3a and appropriate Frizzled receptors, even though Tspan12 has no influence on Wnt/LRP6 binding? 

      We thank the reviewer for suggesting this important control experiment. We have added the Wnt-simulated TOPFLASH values to the figure in 5F for all conditions. In repeating this experiment, we noticed that high levels of transfected Tspan12 may decrease cell viability and therefore have adjusted the range of transfected Tspan12 in the new Figure 5F (discussed on page 8, second full paragraph). Under this new protocol, both Norrin- and Wnt-stimulated signaling were inhibited by the highest amount of transfected Tspan12. However, Norrinstimulated signaling is inhibited by lower amounts of transfected Tspan12 than Wnt-stimulated signaling, and to a greater extent, supporting our proposed model that Tspan12 competes with LRP for Norrin binding.

      - Is Tspan12 with c-terminal rho-tag (the form incorporated into nanodiscs) also used for functional luciferase assays, or was untagged Tspan12 used for the luciferase assays in Fig 4D and 5F? Does the c-terminal tag interfere with Tspan12-mediated enhancement of Norrin signaling? 

      For the luciferase assays included in this manuscript, wildtype, full-length, untagged Tspan12 is used. We have clarified this in our methods section. When we tested the wildtype vs Cterminally rho1D4-tagged version of Tspan12 in TOPFLASH assays, we saw that the enhancement of Norrin signaling by Tspan12-1D4 was weaker than enhancement by untagged Tspan12. This is consistent with the finding reported in Cell Reports (Lai et al., 2017) that a chimeric Tspan12 receptor with its C-terminus replaced with that of Tspan11 was still capable of enhancing Norrin signaling, though to a lesser extent than WT Tspan12. The deficiency of signaling by our rho1D4-tagged Tspan12 could be due to a difference in receptor expression level or trafficking, but in the absence of a reliable antibody against Tspan12, we were unable to assess the expression levels or localization of the untagged Tspan12 to compare it to the rho1D4-tagged version. (For binding experiments, we reasoned that the C-terminal tag should not affect Tspan12’s ability to bind Norrin extracellularly, especially as we found that purified fulllength Tspan12 and Tspan12∆C (residues 1-252) bound Norrin equally well; we have added this comparison to table S1.)  

      Reviewer #3 (Recommendations For The Authors): 

      Minor comments. 

      Based on the Fzd4-Dvl binding experiment, the authors might state explicitly the possibility that Tspan12's relevance is entirely accounted for by extracellular ligand capture. 

      We have stated this possibility explicitly in the discussion section (page 9, last paragraph). 

      Page 4, 3rd paragraph. I suggest "To experimentally test this structural prediction..." rather than "validate". 

      Thank you for this suggestion; we have replaced this wording. 

      This next item is optional, but I hope that the authors will consider it. This manuscript provides an opportunity for the authors to be more expansive in their thinking, and to put their work into the larger context of ligand+receptor+accessory protein interactions. The authors describe the Wnt7a/7b-Gpr124-RECK system and the role of HSPs in Norrin and Wnt signaling, but perhaps they can also comment on non-Wnt ligand-receptor systems where accessory proteins are found. They might add a figure (or supplemental figure) with a schematic showing the roles of HSP and Gpr124-RECK, and some non-Wnt ligand-receptor systems. This would help to make the present work more widely influential.

      Thank you for this suggestion. We have added a figure (Figure 6, discussed on page 10, paragraphs 2 and 3) and expanded our discussion to include other co-receptor systems. We have specifically focused on co-receptors that both capture ligands and interact with their primary receptor(s), thus delivering ligands to their receptors, as we have proposed for Tspan12. Within Wnt signaling, other co-receptor systems with this mechanism are RECK/Gpr124 (for Wnt7a/b) and Glypican-3. We found it interesting that this mechanism is also shared by several growth factor pathways with cystine knot ligands (like Norrin), so we have illustrated and mentioned three of these examples.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public Review):

      Summary:

      In this study, Zhang et al., presented an electrophysiology method to identify the layers of macaque visual cortex with high density Neuropixels 1.0 electrode. They found several electrophysiology signal profiles for high-resolution laminar discrimination and described a set of signal metrics for fine cortical layer identification.

      Strengths:

      There are two major strengths. One is the use of high density electrodes. The Neuropixels 1.0 probe has 20 um spacing electrodes, which can provide high resolution for cortical laminar identification. The second strength is the analysis. They found multiple electrophysiology signal profiles which can be used for laminar discrimination. Using this new method, they could identify the most thin layer in macaque V1. The data support their conclusion.

      Weaknesses:

      While this electrophysiology strategy is much easier to perform even in awake animals compared to histological staining methods, it provides an indirect estimation of cortical layers. A parallel histological study can provide a direct matching between the electrode signal features and cortical laminar locations. However, there are technical challenges, for example the distortions in both electrode penetration and tissue preparation may prevent a precise matching between electrode locations and cortical layers. In this case, additional micro wires electrodes binding with Neuropixels probe can be used to inject current and mark the locations of different depths in cortical tissue after recording.

      While we agree that it would be helpful to adopt a more direct method for linking laminar changes observed with electrophysiology to anatomical layers observed in postmortem histology, we do not believe that the approach suggested by the reviewer would be particularly helpful. The approach suggested involves making lesions, which are known to be quite variable in size, asymmetric in shape, and do not have a predictable geometry relative to the location of the electrode tip. In contrast, our electrophysiology measures have identified clear boundaries which precisely match the known widths and relative positions of all the layers of V1, including layer 4A, which is only 50 microns thick, much smaller than the resolution of lesion methods.

      Reviewer #2 (Public Review):

      Summary:

      This paper documents an attempt to accurately determine the locations and boundaries of the anatomically and functionally defined layers in macaque primary visual cortex using voltage signals recorded from a high-density electrode array that spans the full depth of cortex with contacts at 20 um spacing. First, the authors attempt to use current source density (CSD) analysis to determine layer locations, but they report a striking failure because the results vary greatly from one electrode penetration to the next and because the spatial resolution of the underlying local field potential (LFP) signal is coarse compared to the electrical contact spacing. The authors thus turn to examining higher frequency signals related to action potentials and provide evidence that these signals reflect changes in neuronal size and packing density, response latency and visual selectivity.

      Strengths:

      There is a lot of nice data to look at in this paper that shows interesting quantities as a function of depth in V1. Bringing all of these together offers the reader a rich data set: CSD, action potential shape, response power and coherence spectrum, and post-stimulus time response traces. Furthermore, data are displayed as a function of eye (dominant or non-dominant) and for achromatic and cone-isolating stimuli.

      This paper takes a strong stand in pointing out weaknesses in the ability of CSD analysis to make consistent determinations about cortical layering in V1. Many researchers have found CSD to be problematic, and the observations here may be important to motivate other researchers to carry out rigorous comparisons and publish their results, even if they reflect negatively on the value of CSD analysis.

      The paper provides a thoughtful, practical and comprehensive recipe for assigning traditional cortical layers based on easily-computed metrics from electrophysiological recordings in V1, and this is likely to be useful for electrophysiologists who are now more frequently using high-density electrode arrays.

      Weaknesses:

      Much effort is spent pointing out features that are well known, for example, the latency difference associated with different retinogeniculate pathways, the activity level differences associated with input layers, and the action potential shape differences associated with white vs. gray matter. These have been used for decades as indicators of depth and location of recordings in visual cortex as electrodes were carefully advanced. High density electrodes allow this type of data to now be collected in parallel, but at discrete, regular sampling points. Rather than showing examples of what is already accepted, the emphasis should be placed on developing a rigorous analysis of how variable vs. reproducible are quantitative metrics of these features across penetrations, as a function of distance or functional domain, and from animal to animal. Ultimately, a more quantitative approach to the question of consistency is needed to assess the value of the methods proposed here.

      We thank the reviewer for suggesting the addition of quantitative metrics to allow more substantive comparisons between various measures within and between penetrations. We have added quantification and describe this in the context of more specific comments made by this reviewer. We have retained descriptions of metrics that are well established because they provide an important validation of our approaches and laminar assignments.

      Another important piece of information for assessing the ability to determine layers from spiking activity is to carry out post-mortem histological processing so that the layer determination made in this paper could be compared to anatomical layering.

      We are not aware of any approach that would provide such information at sufficient resolution. For example, it is well known that electrolytic lesions often do not match to the locations expected from electrophysiological changes observed with single electrodes. As noted above, our observation that the laminar changes in electrophysiology precisely match the known widths and relative positions of all the layers of V1, including layer 4A, provides confidence in our laminar assignments.

      On line 162, the text states that there is a clear lack of consistency across penetrations, but why should there be consistency: how far apart in the cortex were the penetrations? How long were the electrodes allowed to settle before recording, how much damage was done to tissue during insertion? Do you have data taken over time - how consistent is the pattern across several hours, and how long was the time between the collection of the penetrations shown here?

      Answers to most of these questions can be found within the manuscript text. We have added text describing distance between electrode penetrations (at least 1mm, typically far more) and added a figure which shows a map of the penetration locations. The Methods section describes electrode penetration methods to minimize damage and settling times of penetrations. Data are provided regarding changes in recordings over time (see Methods, Drift Correction). The stimuli used to generate the data described are presented within a total of 30 minutes or less, minimizing any changes that might occur due to electrode drift. There is a minimum of 3 hours between different penetrations from the same animal.

      The impact of the paper is lessened because it emphasizes consistency but not in a consistent manner. Some demonstrations of consistency are shown for CSDs, but not quantified. Figure 4A is used to make a point about consistency in cell density, but across animals, whereas the previous text was pointing out inconsistency across penetrations. What if you took a 40 or 60 um column of tissue and computed cell density, then you would be comparing consistency across potentially similar scales. Overall, it is not clear how all of these different metrics compare quantitatively to each other in terms of consistency.

      As noted above, we have now added quantitative comparisons of consistency between different metrics. It is unclear why the reviewer felt that we use Figure 4A to describe consistency. That figure was a photograph from a previous publication simply showing the known differences in neuron density that are used to define layers in anatomical studies. This was intended to introduce the reader to known laminar differences. At any rate, we have been unable to contact the previous publishers of that work to obtain permission to use the figure. So we have removed that figure as it is unnecessary to illustrate the known differences in cell density that are used to define layers. We have kept the citation so that interested readers can refer to the publication.

      In many places, the text makes assertions that A is a consistent indicator of B, but then there appear to be clear counterexamples in the data shown in the figures. There is some sense that the reasoning is relying too much on examples, and not enough on statistical quantities.

      Without reference to specific examples we are not able to address this point.

      Overall

      Overall, this paper makes a solid argument in favor of using action potentials and stimulus driven responses, instead of CSD measurements, to assign cortical layers to electrode contacts in V1. It is nice to look at the data in this paper and to read the authors' highly educated interpretation and speculation about how useful such measurements will be in general to make layer assignments. It is easy to agree with much of what they say, and to hope that in the future there will be reliable, quantitative methods to make meaningful segmentations of neurons in terms of their differentiated roles in cortical computation. How much this will end up corresponding to the canonical layer numbering that has been used for many decades now remains unclear.

      Reviewer #3 (Public Review):

      Summary:

      Zhang et al. explored strategies for aligning electrophysiological recordings from high-density laminar electrode arrays (Neuropixels) with the pattern of lamination across cortical depth in macaque primary visual cortex (V1), with the goal of improving the spatial resolution of layer identification based on electrophysiological signals alone. The authors compare the current commonly used standard in the field - current source density (CSD) analysis - with a new set of measures largely derived from action potential (AP) frequency band signals. Individual AP band measures provide distinct cues about different landmarks or potential laminar boundaries, and together they are used to subdivide the spatial extent of array recordings into discrete layers, including the very thin layer 4A, a level of resolution unavailable when relying on CSD analysis alone for laminar identification. The authors compare the widths of the resulting subdivisions with previously reported anatomical measurements as evidence that layers have been accurately identified. This is a bit circular, given that they also use these anatomical measurements as guidelines limiting the boundary assignments; however, the strategy is overall sensible and the electrophysiological signatures used to identify layers are generally convincing. Furthermore, by varying the pattern of visual stimulation to target chromatically sensitive inputs known to be partially segregated by layer in V1, they show localized response patterns that lend confidence to their identification of particular sublayers.

      The authors compellingly demonstrate the insufficiency of CSD analysis for precisely identifying fine laminar structure, and in some cases its limited accuracy at identifying coarse structure. CSD analysis produced inconsistent results across array penetrations and across visual stimulus conditions and was not improved in spatial resolution by sampling at high density with Neuropixels probes. Instead, in order to generate a typical, informative pattern of current sources and sinks across layers, the LFP signals from the Neuropixels arrays required spatial smoothing or subsampling to approximately match the coarser (50-100 µm) spacing of other laminar arrays. Even with smoothing, the resulting CSDs in some cases predicted laminar boundaries that were inconsistent with boundaries estimated using other measures and/or unlikely given the typical sizes of individual layers in macaque V1. This point alone provides an important insight for others seeking to link their own laminar array recordings to cortical layers.

      They next offer a set of measures based on analysis of AP band signals. These measures include analyses of the density, average signal spread, and spike waveforms of single- and multi-units identified through spike sorting, as well as analyses of AP band power spectra and local coherence profiles across recording depth. The power spectrum measures in particular yield compact peaks at particular depths, albeit with some variation across penetrations, whereas the waveform measures most convincingly identified the layer 6-white matter transition. In general, some of the new measures yield inconsistent patterns across penetrations, and some of the authors' explanations of these analyses draw intriguing but rather speculative connections to properties of anatomy and/or responsivity. However, taken as a group, the set of AP band analyses appear sufficient to determine the layer 6-white matter transition with precision and to delineate intermediate transition points likely to correspond to actual layer boundaries.

      Strengths:

      The authors convincingly demonstrate the potential to resolve putative laminar boundaries using only electrophysiological recordings from Neuropixels arrays. This is particularly useful given that histological information is often unavailable for chronic recordings. They make a clear case that CSD analysis is insufficient to resolve the lamination pattern with the desired precision and offer a thoughtful set of alternative analyses, along with an order in which to consider multiple cues in order to facilitate others' adoption of the strategy. The widths of the resulting layers bear a sensible resemblance to the expected widths identified by prior anatomical measurements, and at least in some cases there are satisfying signatures of chromatic visual sensitivity and latency differences across layers that are predicted by the known connectivity of the corresponding layers. Thus, the proposed analytical toolkit appears to work well for macaque V1 and has strong potential to generalize to use in other cortical regions, though area-targeted selection of stimuli may be required.

      Weaknesses:

      The waveform measures, and in particular the unit density distribution, are likely to be sensitive to the criteria used for spike sorting, which differ widely among experimenters/groups, and this may limit the usefulness of this particular measure for others in the community. The analysis of detected unit density yields fluctuations across cortical depth which the authors attribute to variations in neural density across layers; however, these patterns seemed particularly variable across penetrations and did not consistently yield peaks at depths that should have high neuronal density, such as layer 2. Therefore, this measure has limited interpretability.

      While we agree that our electrophysiological measure of unit density does not strictly reflect anatomical neuronal density, we would like to remind the reader that we use this measure only to roughly estimate the correspondence between changes in density and likely layer assignments. We rely on other measures (e.g. AP power, AP power changes in response to visual stimuli) that have sharp borders and more clear transitions to assign laminar boundaries. Further, as noted in the reviewer’s list of strengths, the laminar assignments made with these measures are cross validated by differences in response latencies and sensitivity to different types of stimuli that are observed at different electrode depths.

      More generally, although the sizes of identified layers comport with typical sizes identified anatomically, a more powerful confirmation would be a direct per-penetration comparison with histologically identified boundaries. Ultimately, the absence of this type of independent confirmation limits the strength of their claim that veridical laminar boundaries can be identified from electrophysiological signals alone.

      As we have noted in response to similar comments from other reviewers, we are not aware of a method that would make this possible with sufficient resolution.

      Recommendations for the authors:

      Reviewing Editor (Recommendations For The Authors):

      The reviewers have indicated that their assessment would potentially be stronger if their advice for quantitative, statistically validated comparisons was followed, for example, to demonstrate variability or consistency of certain measures that are currently only asserted. Also, if available, some histological confirmation would be beneficial. It was requested that the use and modification of the layering from Balaram & Kaas is addressed, as well as dealing with inconsistencies in the scale bars on those figures. There are two figure permission issues that need to be resolved prior to publication: Balaram & Kaas 2014 in Fig 1A, Kelly & Hawken 2017 in Fig. 4A.

      Please see detailed responses to reviewer comments below. We have added new supplemental figures to quantitatively compare variability among metrics. As noted above, the suggested addition of data linking the electrophysiology directly to anatomical observations of laminar borders from the same electrode penetration is not feasible. The figure reused in Figure 1A is from open-access (CC BY) publication (Balaram & Kaas 2014). After reexamining the figure in the original study, we found that the inferred scale bar would give an obviously inaccurate result. So, we decided to remove the scale bar in Figure 1A. We haven’t received any reply from Springer Nature for Figure 4A permission, so we decided to remove the reused figure from our article (Kelly & Hawken 2017).

      Reviewer #1 (Recommendations For The Authors):<br /> Figure 4A has a different scale to Figure 4B-4F. It is better to add dashed lines to indicate the relationship between the cortical layers or overall range from Figure 4A to the corresponding layers in 4B to 4F.

      The reused figure in Figure 4A is removed due to permission issue. See also comments above.

      Reviewer #2 (Recommendations For The Authors):

      General comments

      This paper demonstrates that voltage signals in frequency bands higher than those used for LFP/CSD analysis can be used from high-density electrical contact recording to generate a map of cortical layering in macaque V1 at a higher spatial resolution than previously attained.

      My main concern is that much of this paper seems to show that properties of voltage signals recorded by electrodes change with depth in V1. This of course is well known and has been mapped by many who have advanced a single electrode micron-by-micron through the cortex, listening and recording as they go. Figure 4 shows that spike shapes can give a clear indication of GM to WM borders, and this is certainly true and well known. Figures 5 and 6 show that activity level on electrodes can indicate layers related to LGN input, and this is known. Figure 7 shows that latencies vary with layer, and this is certainly true as we know. A main point seems to be that CSD is highly inconsistent. This is important to know if CSD is simply never going to be a good measure for layering in V1, but it would require quantification and statistics to make a fair comparison.

      We are glad to see that the reviewer understands that changes in electrical signals across layers are well known and are expected to have particular traits that change across layers. We do not claim that have discovered anything that is unexpected or unknown. Instead, we introduce quantitative measures that are sensitive to these known differences (historically, often just heard with an audio monitor e.g. “LGN axon hash”). While the primary aim of this paper is not to show that Neuropixels probes can record some voltage signal properties that cannot be recorded with a single electrode before, we would like to point out that multi-electrode arrays have a very different sampling bias and also allow comparisons of simultaneous recordings across contacts with known fixed distances between them. For example our measure of “unit spread” could not be estimated with a single electrode.

      We’ve added Figure S3 to show quantitative comparison of variation between CSD and AP metrics. These figures add support to our prior, more anecdotal descriptions showing that CSDs are inconsistent and lack the resolution needed to identify thin layers.

      Some things are not explained very clearly. Like achromatic regions, and eye dominance - these are not quantified, and we don't know if they are mutually consistent - are achromatic/chromatic the same when tested through separate eyes? How consistent are these basic definitions? How definitive are they?

      The quantitative definitions of achromatic region/COFD and eye dominance column can be found in our previous paper (Li et al., 2022) cited in this article. The main theme of this study is to develop a strategy for accurately identifying layers, the more detailed functional analysis will be described in future publications.

      Specific comments

      The abstract refers to CSD analysis and CSD signals. Can you be more precise - do you aim to say that LFP signals in certain frequency bands are already known to lack spatial localization, or are you claiming to be showing that LFP signals lack spatial resolution? A major point of the results appears to be lack of consistency of CSD, but I do not see that in the Abstract. The first sentence in the abstract appears to be questionable based on the results shown here for V1.

      We have updated the Abstract to minimize confusion and misunderstanding.

      Scale bar on Fig 1A implies that layers 2-5 are nearly 3 mm thick. Can you explain this thickness? Other figures here suggest layers 1-6 is less than 2 mm thick. Note, in a paper by the same authors (Balaram et al) the scale bar (100 um, Figure 4) on similar macaque tissue suggests that the cortex is much thinner than this. Perhaps neither is correct, but you should attempt to determine an approximately accurate scale. The text defines granular as Layer 4, but the scale bar in A implies layer 4 is 1 mm thick, but this does not match the ~0.5 mm thickness consistent with Figure 1E, F. The text states that L4A is less then 100 um thick, but the markings and scale bar in Figure 1A suggests that it could be more than 100 um thick.

      We thank the reviewer for pointing out that there are clearly errors in the scale bars used in these previously published figures from another group. In the original figure 1(Balaram & Kaas 2014), histological slices were all scaled to one of the samples (Chimpanzee) without scale bar. After reexamining the scale bar we derived based on figure 2 of the original study, we found the same problem. Since relative widths of layers are more important than absolute widths in our study, we decided to remove the scale bar that we had derived and added to the Figure 1A.

      Line 157. Fix "The most commonly visual stimulus"

      Text has been changed

      Line 161. Fix "through dominate eye"

      Text has been changed

      Line 166. Please specify if the methods established and validated below are histological, or tell something about their nature here.

      The Abstract and Introduction already described the nature of our methods

      Line 184. Text is mixing 'dominant' and 'dominate', the former is better.

      Text has been changed accordingly

      Line 188. Can you clarify "beyond the time before a new stimulus transition". Are you generally referring to the fact that neuronal responses outlast the time between changes in the stimulus?

      That is correct. We are referring to the fact that neuronal responses outlast the time between changes in the stimulus. We have edited the text for clarity.

      Line 196. Fix "dominate eye" in two places.

      Text has been changed

      Line 196. The text seems to imply it is striking to find different response patterns for the two eyes, but given the OD columns, why should this be surprising?

      Since we didn’t find systematic comparison for CSD depth profiles of dominant/non-dominant eyes, or black/white in the past studies, we just describe what we saw in our data. The rational for testing each eye is that it is known that LGN projections from two eyes remain separated in direct input layer of V1, so comparing CSDs from two eyes could potentially help identifying input layers, such as L4C. Here we provide evidence showing that CSD profiles from two eyes deviate from naive expectations. For example, CSDs from black stimulus show less variation between two eyes, whereas CSDs from white stimulus could range from similar profile to drastically different ones across eyes.

      Line 198. Text like, "The most consistent..." is stating overall conclusions drawn by the authors before pointing the reader specifically to the evidence or the quantification that supports the statement.

      We’ve adjusted the text pointing to Figure S2, where depth profiles of all penetrations are visualized, and a newly added Figure S3, where the coefficients of variation for several metric profiles were shown.

      Line 200. "white stimulus is more variable" - the text does not tell us where/how this is supported with quantitative analysis/statistics.

      We’ve adjusted the text pointing to Figure S2, S3

      The metric in 4B is not explained, the text mentions the plot but the reader is unable to make any judgement without knowledge of the method, nor any estimate of error bars.

      The figure is first mentioned in section: Unit Density, and text in this section already described the definition of neuron density and unit density.  We’ve also modified the text pointing to the method section for details.

      Line 236. The text states the peak corresponds to L4C, but does not explain how the layer lines were determined.

      As described early in the CSD section, all layer boundaries are determined following the guide which layouts the strategy for how to draw borders by combining all metrics.

      At Line 296 the spike metrics section ends without providing a clear quantification of how useful the metrics will be. It is clear that the GM to WM boundary can be identified, but that can be found with single electrodes as well, as neurophysiologists get to see/hear the change in waveform as the electrode is advanced in even finer spatial increments than the 20 um spacing of the contacts here.

      The aim of this study is to develop an approach for accurately delineating layers simultaneously. The metrics we explored are considered estimation of well-known properties, so they can provide support for the correctness we hope to achieve. Here we first demonstrate the usefulness and later show the average across penetrations (Figure 9C-F). We are less concerned in quantification of how different factors affect precision and consistency of these metrics or how useful a single metric is, but rather, as described in the guide section, whether we can delineate all layers given all metrics.

      Line 302-306. Why this statement is made here is unclear, it interrupts the flow for a reason that perhaps will be explained later.

      This statement notes the insensitivity of this measure to temporal differences, introducing the value of incorporating a measure of how AP powers changes over time in the next section of the manuscript.

      Line 311. What is the reason to speculate about no canceling because of temporal overlap? Are you assuming a very sparse multi unit firing rate such that collisions do not happen?

      Here we describe a simple theoretical model in which spike waveforms only add without cancelling, then the power would be proportional to the number of spikes. In reality, spike waveform sometimes cancels causing the theoretical relationship to deteriorate to some degree.

      Lines 327-346. There is a considerable amount of speculation and arguing based on particular examples and there is a lack of quantification. Neuron density is mentioned, but not firing rate. would responses from fewer neurons with higher firing rate not be similar to more neurons with lower firing rates?

      According to the theoretical model we described, power is proportional to numbers of spikes which then depend on both neuron density and firing rate. So fewer neurons with higher firing rate would generate similar power to more neurons with lower firing rate. We’ve expanded the explanation of the model and added Figure S4 about the depth profile of firing rate. Text has also been adjusted pointing to the Figure S2, S3 about quantitively comparisons of variability.

      Line 348 states there is a precise link between properties and cortical layers, but the manuscript has not, up to this point, shown how that link was determined or quantified it.

      Through our generative model of power and the similarity between depth profile of firing rate and depth profile of neuron density (Figure S4), depth profile of power can be used to approximate depth profile of neuron density which is known to be closely correlated to cortical layering.

      Line 350. What is meant by "stochastic variability"?

      The text essentially says distances from electrode contact to nearby cell bodies were random, so closer cells have higher spike amplitudes and in turn result in higher power on a channel.

      The figures showing the two metrics, Pf and Cf, should be shown for the same data sets. The markings indicate that Fig 5 and Fig 6 show results from non-overlapping data sets. This does not build confidence about the results in the paper.

      Here we use typical profiles to demonstrate the characteristics of the power spectrum/coherence spectrum because of the variation across penetrations. We show later, in the guide section, all metrics for one penetration (another two cases in supplemental figures) and how to combine all metrics to derive layer delineations.

      Line 375 the statement is somewhat vague, "there are nevertheless sometimes cases where they can resolve uncertainties," can you please provide some quantitative support?

      We provided 3 examples in Figure 6, and more examples are shown in Figure 8, Figure S5, S6.

      Line 379. I believe the change you want to describe here is a change associated with a transition in the visual stimulus. It would be good to clarify this in the first several sentences here. Baseline can mean different things. I got the impression that your stimuli flip between states at a rate fast enough that signals do not really have time to return to a baseline.

      We rephrased the sentence to describe the metric more precisely. A pair of uniform colors flipping in 1.5 second intervals is usually long enough for spiking activities to decay to a saturated level.

      This section (379 - 398) continues a qualitative show-and-tell feel. There appears to be a lot of variability across the examples in Figure 7. How could you try to quantify this variability versus the variability in LFP? And, in this section overall, the text and figure legend don't really describe what the baseline is.

      Text adjustments are made to briefly describe the baseline window and point to the Method section where definitions are described in detail. We’ve added Figure S3 together with Figure S2 to address the variability across penetrations, stimuli, and metrics.

      Line 405 - 415. The discussion here does not consider that layers may not have well defined boundaries, the text gives the impression that there is some ultimate ground truth to which the metrics are being compared, but that may not be accurate.

      Except for a few layers/sublayers, such as L2, L3A, L3B, most layer boundaries of neocortex are well defined (Figure 1A) and histological staining of neurons/density and correlated changes in chemical content show very sharp transitions. The best of these staining methods is cytochrome oxidase, which shows sharp borders at the top and bottom of layer 4A, top and bottom of layer 4C, and the layer 5/6 border. There is also a sharp transition in neuronal cell body size and density at the top and bottom of layer 4Cb. The definition and delineation of all possible layers are constantly being refined, especially by accumulated knowledge of genetic markers of different cell types and connection patterns. In our study, we develop metrics to estimate well known anatomical and functional properties of different layers. We have also discussed layer boundaries that have been ambiguous to date and explained the reason and criteria to resolve them.

      Line 423. The text references Figure 1A in stating that relative thickness and position is crucial, but FIgure 1A does not provide that information and does not explain how it might be determined, or how much of a consensus there is. Also, the text does not consider that the electrode may go through the cortex at oblique angles, and not the same angle in each layer, and the relative thickness may not be a dependable reference.

      There are numerous studies that describe criteria to delineate cortical layers, the referenced article (Balaram & Kaas 2014) is used here as an example. We are not aware of any publication that has systematically compared the relative thickness of layers across the V1 surface of a given animal or across animals. Nevertheless, it is clear from the literature that there is considerable similarity across animals. Accordingly, we cannot know what the source of variability in overall cortical thickness in our samples is, but we do see considerable consistency in the relative thickness of the layers we infer from our measures. We illustrate the differences that we see across penetrations and consider likely causes, such as the extent to which the coverslip pressing down on the cortex might differentially compress the cortex at different locations within the chamber.

      The angle deviation of probe from surface will not change the relative thickness of layers, and the rigid linear probe is unlikely to bend in the cortex.

      Line 433. The term "Coherence" is used, clarify is this is you Cf from Figure 6. The text states, "marked decrease at the bottom of layer 6". Please clarify this, I do not see that in Figure 6.

      Text has been adjusted.

      In Figure 6, the locations of the lines between L1 and 2 do not seem to be consistent with respect to the subtle changes in light blue shading, across all three examples, yet the text on line 436 states that there is a clear transition.

      We feel that the language used accurately reflects what is shown in the figure. While the transition is not sharp, it is clear that there is a transition. This transition is not used to define this laminar border. We have edited the text to clarify that the L1/2 border is better defined based on the change in AP power which shows a sharp transition (Figure 7). 

      The text states that the boundary is also "always clear" from metrics... and sites Figure 5, but I do not see that this boundary is clear for all three examples in Figure 5.

      Text has been adjusted.

      Line 438. The text states that "it is not unusual for unit density to fall to zero below the L1/2 border (Figure 8E)", but surprisingly, the line in Figure 8 E does not even cover the indicated boundary between L1 and L2.

      At this point, the number of statements in the text that do not clearly and precisely correlate to the data in the figures is worrisome, and I think you could lose the confidence of readers at this point.

      We do not see any inconstancy between what is stated in our text and what is noted by the reviewer. The termination of the blue line corresponds to the location where no units are detected. This is the location where “unit density falls to zero”.  In this example, no units resolved through spike sorting until ~100mm beneath the L1/L2 boundary, which is exactly zero unity density (Figure 8E). That there are electrical signals in this region is clear from the AP power change (Figure 8C) which also shows the location of the L1/L2 border.

      Line 448. Text states that the 6A/B border is defined by a sharp boundary in AP power, but Figure 8A "AP power spectrum" does not show a sharp change at the A/B line. There is a peak in this metric in the middle to upper middle of 6A, but nothing so sharp to define a boundary between distinct layers, at least for penetration A2.

      Text has been adjusted.

      In Figure 8, the layer labels are not clear, whereas they are reasonably clear in the other figures.

      This is a technical problem regarding vector graphics that were not properly converted in PDF generation. We will upload each high-quality vector graphics when we finalize the version of record.

      The text emphasizes differences in L4B and L4C with respect to average power and coherence, but the transition seems a bit gradual from layer 3B to 4C in some examples in Figure 6. And in Figure 5, A3, there doesn't appear to be any particular transition along the line between 4B and 4C.

      In this guide section, we pointed out early that some metrics are good for some boundaries and variation exists between penetrations. We’ve expanded text emphasizing the importance of timing differences in DP/P for differentiating sublayers in L4. Lastly, in case of several unresolvable boundaries given all the metrics, the prior knowledge of relative thickness should be used.

      Line 466 provides prescriptions in absolute linear distances, but this is unwise given that cortex may be crossed at oblique angles by electrodes, particularly for parts of V1 that are not on the surface of the brain. Other parts of the text have emphasized relative measurements.

      Text has been changed using relative measurements.

      Line 507. The text says 9C and 4A are a good match, but the match does not look that good (4A has substantial dips at 0.5 and 0.75, and substantial peaks), and there is no quantification of fit. The error bars on 9C do not help show the variability across penetrations, they appear to be SEM, which shows that error bars get smaller as you average more data. It would seem more important to understand what is the variance in the density from one penetration to the next compared to the variance in density across layers.

      We have replaced “good match” with “roughly corresponds”. We note that we do not use unit density as a metric for identification of laminar borders and instead show that the expected locations of layers with higher neuronal density correspond to the locations where there are similar changes in unit density. It should be noted that Figure 9C is an average across many penetrations so should not be expected to show transitions that are as sharp in individual penetrations. Because of the figure permission issue, we have removed Figure 4A, and changed the text accordingly.

      Figure 9C-F show a lot of variability in the individual curves (dim gray lines) compared to the overall average. Does this show that these metrics are not reliable indicators at the level of single penetration, but show some trends across larger averages?

      In the beginning of the guide, we emphasized that all metrics should be combined for individual penetration, because some metrics are only reliable for delineating certain layer boundaries and the quality of data for the various measures varies between penetrations. The penetration average serves the same purpose explained in the previous question as an indicator that our layer delineation was not far off.

      The discussion mentions improvements in layer identification made here. Did this work check the assignments for these penetration against assignments made based on some form of ground truth? Previous methods would advance electrodes steadily, and make lesions, and carry out histology. Is there any way to tell how this method would compare to that?

      Even electrolytic lesions do not necessarily reveal ground truth and can be quite misleading. And their resolution is limited by lesion size. Lesions are typically variable in size, asymmetric and have variable shape and position relative to the location of the electrode tip, likely affected by the quality and location of electrical grounding and variations in current flow due to locations of blood vessels. A review of the published literature with electrode lesions shows that electrophysiological transitions are likely a far more accurate indicator of recording locations than post-mortem histology from electrolytic lesions. It is extremely rare for the locations of lesions to be precisely aligned to expected laminar transitions. See for example Chatterjee et al (Nature 2004). Also see several manuscripts from the Shapley lab. The lone rare exception of which we are aware is Blasdel and Fitzpatrick1984 in which consistently small and round lesions were produced and even these would be too large (~100 microns) to accurately identify layers if it were not for the fact that the electrode penetrations were very long and tangential to the cortical layers. 

      Reviewer #3 (Recommendations For The Authors):

      - The authors say (lines 360-362) that "Assuming spikes of a neuron spread to at least two adjacent recording channels, then the coherence between the two channels would be directly proportional to number of spikes, independent of spike amplitude." Has this been demonstrated? Very large amplitude spikes should show up on more channels than small amplitude spikes. Do waveform amplitudes and unit densities from the spike waveform analyses show consistent relationships to the power and/or coherence distributions over depth across penetrations?

      This part of the manuscript is providing a theoretical rational for what might be expected to affect the measures that we have derived. That is why we begin by stating that we are making an assumption. The answers to the reviewer’s questions are not known and have not been demonstrated. By beginning with this theoretical preface, we can point to cases where the data match these expectations as well as other cases where the data differ from the theoretical expectations.

      Coherence, by definition, is a normalized metric that is insensitive to amplitude. Spike amplitude mainly depends on how close the signal source is to electrode, and spike spread mainly depends on cell body size and shape given the same distance to electrode. Therefore, a very large spike amplitude could stem from a very close small cell to electrode, but would result in a small spike spread, especially axonal spikes (Figure 4B, red spike). Spike amplitudes on average are higher in L4C which matches the expectation that higher cell density would result, on average, closer cell body to electrode (Figure S4A). Nonetheless, the high-density small cell bodies in L4C result in a small spike spread (Figure 9D).

      - I suggest clarifying what is defined as the baseline window for the ΔP/P measure - is it the entire 10-150 ms response window used for the power spectrum analysis?

      Text adjustments are made in the Methods where the time windows are defined at the beginning of the CSD section. Only temporal change metrics (ΔCSD and ΔP/P) use the baseline window ([-40, 10]ms). The other two spectrum metrics (Power and Coherence) use the response window ([10, 150]ms).

      - Firing rate differs by cell type and, on average, differs by layer in V1. Many layer 2/3 neurons, for example, have low maximum firing rates when driven with optimized achromatic grating stimuli. To the extent that the generative models explaining the sources of power and coherence signals rely on the assumption that firing rates are matched across cortical depth, these models may be inaccurate. This assumption is declared only subtly, and late in the paper, but it is relevant to earlier claims.

      Text adjustments are made to explicitly describe the possibility that uneven depth profile of firing rate could counteract the depth profile of neuron density, resulting distorted or even a flat depth profile of power/coherence that deviates far from the depth profile of neuron density. In a newly added Figure S4, we first show the average firing rate profile during a set of stimuli (uniform color, static/drifting, achromatic/chromatic gratings), then specifically the PSTHs of the same stimuli shown in this study. It can be seen that layers receiving direct LGN inputs tend to fire at a higher rate (L4C, L6A). Firing rates in the PSTHs either roughly match across layers or are much higher in the densely packed layers. Therefore, the depth profile of firing rate contributes to rather than counteracting that of neuron density, enhancing the utility of the power/coherence profile for identification of correct layer boundaries.

      - Given the acute preparation used for recordings, I wonder whether tissue is available for histological evaluation. Although the layers identified are generally appropriate in relative size, it would be particularly compelling if the authors could demonstrate that the fraction of the cortical thickness occupied by each layer corresponded to the proportion occupied by that layer along the probe trajectory in histological sections. This would lend strength to the claim that these analyses can be used to identify layers in the absence of histology. Furthermore, variations in apparent cortical thickness could arise from different degrees of deviation from surface normal approach angles, which might be apparent by evaluation of histological material. I would add that variation in thickness on the scale shown in Fig. S4 is more likely to have an explanation of this kind.

      To serve other purposes unrelated to this study (identification of CO blobs), we cut the postmortem tissue in horizontal slices, so the histological comparison suggested cannot be made. The cortical thickness measured in this study had been affected not only by the angle deviation from the surface normal but also the swelling and compression of cortex. Nevertheless, evaluating the absolute thickness of cortex is not the main purpose of this study.

      Text and figure suggestions:

      - Fig 1A has been modified from Balaram & Kaas (2014) to revert to the Brodmann nomenclature scheme they argue against using in that paper; I wonder if they would object to this modification without explanation. Related, in the main text the authors initially refer to layers using Brodmann's labels with a secondary scheme (Hassler's) in parentheses and later drop the parenthetical labels; these conventions are not described or explained. Readers less familiar with the multiple nomenclature schemes for monkey V1 layers might be confused by the multiple labels without context, and could benefit from a brief description of the convention the authors have adopted.

      Throughout our article, we only used Brodmann’s naming convention because it has historically been adopted for old world monkey which we use in our study, whereas Hassler’s naming convention is more commonly used for new world monkey. Different naming conventions do not change our result, and it is out of scope for our study to discuss which nomenclature is more appropriate.

      - References to "dominate eye" throughout the text and figure legends should be replaced with "dominant eye."

      It has been changed throughout the article.

      - It is a bit odd to duplicate the same example in Fig. 2C and 2E. Perhaps a unique example would be a better use of the space.

      Here we first demonstrate the filtering effect, then compare profiles across different penetrations. The same example bridges the transition allowing side-by-side comparison.

      - The legend for Fig. 3 might be clearer if it simply listed the stimulus transitions for each column left to right, i.e. "black to white (non-dominant eye), white to black (non-dominant eye), black to white (dominant eye), ..."

      We feel that the icons are helpful. Here we want to show the stimulus colors directly to readers.

      - The misalignment between Fig. 4A vs. 4B-F, combined with the very small font size of the layer labels in Fig. 4B-F, make the visual comparison difficult. In Figs. 7 and 8, layer labels (and most labels in general) are much too small and/or low resolution to read easily. Overall, I would recommend increasing font size of labels in figures throughout the paper.

      The reused figure in Figure 4A is removed due to permission issue. Font sizes are adjusted.

      - Line 591 "using of high-density probes" should be "using high-density probes"

      Text has been changed accordingly

    1. Author response:

      The following is the authors’ response to the original reviews.

      Response to Editor and Reviewer Comments:

      Many thanks to the editor and reviewers for the thoughtful assessment of our manuscript “Commissureless acts as a substrate adapter in a conserved Nedd4 E3 ubiquitin ligase pathway to promote axon growth across the midline.” Thank you also for the positive comments about the quality of our writing, and for deeming our study rigorous and thorough. We are very pleased that, overall, you believe our combination of genetic and biochemical approaches offers useful insight into the mechanism of Robo regulation at the Drosophila embryonic midline and effectively reconciles the contradictory findings of previous studies done in this field.

      Response to the previous Public Reviews:

      We appreciate the concerns expressed by the reviewers and the suggestions of areas in which the study and manuscript could be improved. The reviewer suggestions were very helpful as we revised our manuscript in order to strengthen our mechanistic understanding of Robo downregulation and better characterize the role Nedd4 plays in this process. We strongly agree with Reviewer 1 that our insight into the mechanism of Robo downregulation via Comm would be much stronger had we not solely relied on overexpression experiments to investigate the effects of PY motif mutations on Comm function. While it is outside the scope of this particular paper, we appreciate your suggestion to use gene editing to investigate the role of PY motif mutation on endogenous comm function and believe this would be a useful question to address in future papers. In addition to this concern, both reviewers identified additional opportunities to strengthen the paper. We have done our best to incorporate reviewer suggestions and will outline how we addressed the following four areas that were identified by both reviewers as areas where additional data could strengthen our conclusions:

      (1) Additional experiments to examine Comm and Robo1 localization in vivo: Characterizing Robo localization in vivo when co-expressed with PY-mutant Comm variants.

      (2) Testing biochemical interactions in embryonic protein extracts: Examining the biochemical interaction between Robo, Comm, and Nedd4 in a more biologically relevant context than cell culture.

      (3) Additional genetic interaction experiments: A) Investigating whether Nedd4 overexpression enhances the Comm G.O.F phenotype of enhanced ectopic crossing. B) Testing for additional genetic interactions with comm.

      (4) Editing the text of the manuscript for clarity.

      (1) Characterizing Robo localization in vivo when co-expressed with Comm variants.

      In the first version of our manuscript, we characterized the localization of wild-type and PY mutant Comm variants expressed in apterous neurons (Figure 5C), but did not examine how these variants of Comm affected localization of their cargo Robo1. To address this gap, we co-expressed 10X UAS Comm-myc (WT, 1PY, 2PY) with 10X UAS Robo-HA under the ap gal4 driver, visualized Comm and Robo by immunostaining for Myc and HA, and measured colocalization between Comm and Robo. We found that Robo colocalizes equally with all comm variants and that its expression pattern mimics that of the Comm variant with which it is expressed. We observe that Robo is restricted to cell bodies when overexpressed with WT Comm but “leaks out” into axons when co-expressed with Comm 1PY or 2PY. This finding suggests that PY motifs are not only required for effective Comm localization to the appropriate cellular areas, but also for proper routing of its cargo, Robo1. These new data are presented in a new supplemental figure: Figure S3.

      (2) Examining the biochemical interaction between Robo, Comm, and Nedd4 in vivo.

      To examine biochemical interaction between Comm, Robo, and Nedd4 in a more biologically relevant context, we performed immunoprecipitations in fly embryonic lysate prepared from the following categories: WT, elav gal4: 5X UAS Comm-myc WT, and elav gal4: 5X UAS Comm-myc WT + 10X UAS Nedd4-HA. We performed immunoprecipitation for myc (Comm), and blotted for endogenous Robo, Myc (Comm), and HA (Nedd4). Corroborating our results in cell culture (Figure 7 A-C), we were able to pull down a three-protein complex consisting of Comm, Nedd4 and Robo in embryonic fly tissue. These new data are presented in a new supplemental figure: Figure S8.

      (3) Investigating additional genetic interactions between Comm and Nedd4.

      A) In our submitted manuscript, we demonstrated that overexpression of Nedd4 enhances Comm-induced downregulation of Robo levels (Figure 7 D-G). To determine whether Nedd4 also increases ectopic crossing, which is a morphological output of Comm activity/Robo downregulation, we analyzed nerve cord phenotypes in embryos from the following categories: WT, embryos expressing WT Comm under the elav gal4, and embryos co-expressing WT Comm and Nedd4 under the elav gal4 driver. We measured nerve cord widths and sorted them into three different “bins” of phenotypic severity, with more severe phenotypes being characterized by thinner nerve cords. We find that the distribution of phenotypes in embryos expressing Comm alone differs significantly from embryos expressing Comm + Nedd4, with the latter shifted toward more severe/thinner phenotypic classes. In addition to examining nerve cord width, we investigated whether Nedd4 can enhance collapse of the nerve cord segments (defined by loss of negative space within the segment) induced by Comm overexpression. We determined percentage of collapsed nerve cord segments and divided these values into three phenotypic classes: no collapse, partial collapse, and total collapse. The distribution of phenotypes in embryos co-expressing Nedd4 and Comm differs significantly from those expressing Comm alone. In the Comm expressing population, we only observe nerve cords with no or partial collapse, but in flies co-expressing Comm and Nedd4 we observe the more severe complete collapse phenotype. These findings suggest that addition of Nedd4 enhances the Comm gain of function phenotype both by further reducing nerve cord width and increasing the occurrence of defects related to ectopic crossing. These new data are presented in a new supplemental figure: Figure S9.

      B) The reviewers also suggested additional genetic interaction experiments between Nedd4 and Comm. It was suggested that we included experiments to look at Nedd4 manipulations in Comm null mutant backgrounds. However, given the complete penetrance and expressivity of the Comm null mutation in which no axons cross the midline, these experiments would not be informative. As an alternative, we attempted to use the described hypomorphic Comm allele, but here too, the baseline commissural axon guidance defects are too strong to allow meaningful detection of enhanced phenotypes. Finally, we tested whether removing one copy of comm could reveal phenotypes in the nedd4 zygotic mutants, but we did not detect defects. This is perhaps unsurprising given that comm heterozygotes have no detectable midline crossing defects.

      (4) Text edits.

      We have made a variety of changes to decrease ambiguity in the text and create a more user-friendly experience for the reader. In the text, as opposed to just the figures, we now explicitly state whether we use 5X or 10X UAS constructs for each of our overexpression constructs. We also edited all mentions of the truncated frazzled construct (FraDc) so that they are uniform. We have also edited all mentions of MiMIC so that they are uniform. In addition, we answer a few questions the reviewers posed. First, we clarify that S2R+ cells express endogenous Comm at very low levels. In addition, we clarify about how we know expression levels are similar across the three Comm variants by explaining that transgenes incorporated into the fly genome by targeted insertion into the same location on the third chromosome.

      We hope that these changes adequately address reviewer concerns, strengthen our study, and enhance readability of the paper. We appreciate the time you took to evaluate our manuscript and the thoughtful commentary and suggestions that you provided.

    1. Author response:

      Public Reviews:

      Reviewer #1 (Public review):

      This work addresses an important question in the field of Drosophila aggression and mating- prior social isolation is known to increase aggression in males by increased lunging, which is suppressed by group housing (GH). However, it is also known that single-housed (SH) males, despite their higher attempts to court females, are less successful. Here, Gao et al., developed a modified aggression assay, to address this issue by recording aggression in Drosophila males for 2 hours, over a virgin female which is immobilized by burying its head in the food. They found that while SH males frequently lunge in this assay, GH males switch to higher intensity but very low-frequency tussling. Constitutive neuronal silencing and activation experiments implicate cVA sensing Or67d neurons promoting high-frequency lunging, similar to earlier studies, whereas Or47b neurons promote low-frequency but higher intensity tussling. Using optogenetic activation they found that three pairs of pC1 neurons- pC1SS2 increase tussling. While P1a neurons, previously implicated in promoting aggression and courtship, did not increase tussling in optogenetic activation (in the dark), they could promote aggressive tussling in thermogenetic activation carried out in the presence of visible light. It was further suggested, using a further modified aggression assay that GH males use increased tussling and are able to maintain territorial control, providing them mating advantage over SI males and this may partially overcome the effect of aging in GH males.

      Strengths:

      Using a series of clever neurogenetic and behavioral approaches, subsets of ORNs and pC1 neurons were implicated in promoting tussling behaviors. The authors devised a new paradigm to assay for territory control which appears better than earlier paradigms that used a food cup (Chen et al, 2002), as this new assay is relatively clutter-free, and can be eventually automated using computer vision approaches. The manuscript is generally well-written, and the claims made are largely supported by the data.

      Thank you for your precise summary of our study and being very positive on the novelty and significance of the study.

      Weaknesses:

      I have a few concerns regarding some of the evidence presented and claims made as well as a description of the methodology, which needs to be clarified and extended further.

      (1) Typical paradigms for assaying aggression in Drosophila males last for 20-30 minutes in the presence of nutritious food/yeast paste/females or all of these (Chen et al. 2002, Nilsen et al., 2004, Dierick et al. 2007, Dankert et al., 2009, Certel & Kravitz 2012). The paradigm described in Figure 1 A, while important and more amenable for video recording and computational analysis, seems a modification of the assay from Kravitz lab (Chen et al., 2002), which involved using a female over which males fight on a food cup. The modifications include a flat surface with a central food patch and a female with its head buried in the food, (fixed female) and much longer adaptation and recording times respectively (30 minutes, 2 hours), so in that sense, this is not a 'new' paradigm but a modification of an existing paradigm and its description as new should be appropriately toned down. It would also be important to cite these earlier studies appropriately while describing the assay.

      We will tone down the description and cite related references.

      (2) Lunging is described as a 'low intensity' aggression (line 111 and associated text), however, it is considered a mid to high-intensity aggressive behavior, as compared to other lower-intensity behaviors such as wing flicks, chase, and fencing. Lunging therefore is lower in intensity 'relative' to higher intensity tussling but not in absolute terms and it should be mentioned clearly.

      Ww will textually address this issue.

      (3) It is often difficult to distinguish faithfully between boxing and tussling and therefore, these behaviors are often clubbed together as box, tussle by Nielsen et al., 2004 in their Markov chain analysis as well as a more detailed recent study of male aggression (Simon & Heberlein, 2020). Therefore, authors can either reconsider the description of behavior as 'box, tussle' or consider providing a video representation/computational classifier to distinguish between box and tussle behaviors.

      We will textually address this issue.

      (4) Simon & Heberlein, 2020 showed that increased boxing & tussling precede the formation of a dominance hierarchy in males, and lunges are used subsequently to maintain this dominant status. This study should be cited and discussed appropriately while introducing the paradigm.

      We will cite this paper and discuss on this issue.

      (5) It would be helpful to provide more methodological details about the assay, for instance, a video can be helpful showing how the males are introduced in the assay chamber, are they simply dropped to the floor when the film is removed after 30 minutes (Figures 1-2)?

      We will provide more methodological details.

      (6) The strain of Canton-S (CS) flies used should be mentioned as different strains of CS can have varying levels of aggression, for instance, CS from Martin Heisenberg lab shows very high levels of aggressive lunges. Are the CS lines used in this study isogenized? Are various genetic lines outcrossed into this CS background? In the methods, it is not clear how the white gene levels were controlled for various aggression experiments as it is known to affect aggression (Hoyer et al. 2008).

      We will textually address this issue.

      (7) How important it is to use a fixed female for the assay to induce tussling? Do these females remain active throughout the assay period of 2.5 hours? Is it possible to use decapitated virgin females for the assay? How will that affect male behaviors?

      We will textually address this issue and provide additional videos.

      (8) Raster plots in Figure 2 suggest a complete lack of tussling in SH males in the first 60 minutes of the encounter, which is surprising given the longer duration of the assay as compared to earlier studies (Nielsen et al. 2004, Simon & Heberlein, 2020 and others), which are able to pick up tussling in a shorter duration of recording time. Also, the duration for tussling is much longer in this study as compared to shorter tussles shown by earlier studies. Is this due to differences in the paradigm used, strain of flies, or some other factor? While the bar plots in Figure 2D show some tussling in SH males, maybe an analysis of raster plots of various videos can be provided in the main text and included as a supplementary figure to address this.

      We will textually address the first question and provide more detailed analysis for the second question.

      (9) Neuronal activation experiments suggesting the involvement of pC1SS2 neurons are quite interesting. Further, the role of P1a neurons was demonstrated to be involved in increasing tussling in thermogenetic activation in the presence of light (Figure 4, Supplement 1), which is quite important as the role of vision in optogenetic activation experiments, which required to be carried out in dark, is often not mentioned. However, in the discussion (lines 309-310) it is mentioned that PC1SS2 neurons are 'necessary and sufficient' for inducing tussling. Given that P1a neurons were shown to be involved in promoting tussling, this statement should be toned down.

      We will tone down this statement.

      (10) Are Or47b neurons connected to pC1SS2 or P1a neurons?

      We conducted pathway analysis in the FlyWire electron microscopy database to investigate the connection between Or47b neurons and pC1 neurons. The results indicate that at least three intermediate neurons are required to establish a connection from Or47b neurons to pC1 neurons. Although the FlyWire database currently only contains neuronal data from female brains, they provide a reference for circuit connect in males. Using the currently available upstream and downstream tracing tools (e.g., retro-/trans-Tango), it is not possible to establish a direct connection between the two. Identifying the intermediate neurons involved in this connection is beyond this study. We will discuss on this concern in our revised manuscript.

      (11) The paradigm for territory control is quite interesting and subsequent mating advantage experiments are an important addition to the eventual outcome of the aggressive strategy deployed by the males as per their prior housing conditions. It would be important to comment on the 'fitness outcome' of these encounters. For instance, is there any fitness advantage of using tussling by GH males as compared to lunging by SH males? The authors may consider analyzing the number of eggs laid and eclosed progenies from these encounters to address this.

      We will discuss on this concern.

      Reviewer #2 (Public review):

      Summary:

      Gao et al. investigated the change of aggression strategies by the social experience and its biological significance by using Drosophila. Two modes of inter-male aggression in Drosophila are known: lunging, high-frequency but weak mode, and tussling, low-frequency but more vigorous mode. Previous studies have mainly focused on the lunging. In this paper, the authors developed a new behavioral experiment system for observing tussling behavior and found that tussling is enhanced by group rearing while lunging is suppressed. They then searched for neurons involved in the generation of tussling. Although olfactory receptors named Or67d and Or65a have previously been reported to function in the control of lunging, the authors found that these neurons do not function in the execution of tussling, and another olfactory receptor, Or47b, is required for tussling, as shown by the inhibition of neuronal activity and the gene knockdown experiments. Further optogenetic experiments identified a small number of central neurons pC1[SS2] that induce the tussling specifically. In order to further explore the ecological significance of the aggression mode change in group rearing, a new behavioral experiment was performed to examine territorial control and mating competition. Finally, the authors found that differences in the social experience (group vs. solitary rearing) are important in these biologically significant competitions. These results add a new perspective to the study of aggressive behavior in Drosophila. Furthermore, this study proposes an interesting general model in which the social experience-modified behavioral changes play a role in reproductive success.

      Strengths:

      A behavioral experiment system that allows stable observation of tussling, which could not be easily analyzed due to its low frequency, would be very useful. The experimental setup itself is relatively simple, just the addition of a female to the platform, so it should be applicable to future research. The finding about the relationship between the social experience and the aggression mode change is quite novel. Although the intensity of aggression changes with the social experience was already reported in several papers (Liu et al., 2011, etc.), the fact that the behavioral mode itself changes significantly has rarely been addressed and is extremely interesting. The identification of sensory and central neurons required for the tussling makes appropriate use of the genetic tools and the results are clear. A major strength of the neurobiology in this study is the finding that another group of neurons (Or47b-expressing olfactory neurons and pC1[SS2] neurons), distinct from the group of neurons previously thought to be involved in low-intensity aggression (i.e. lunging), function in the tussling behavior. Further investigation of the detailed circuit analysis is expected to elucidate the neural substrate of the conflict between the two aggression modes.

      Thank you for the acknowledgment of the novelty and significance of the study, and your suggestions for improving the manuscript.

      Weaknesses:

      The experimental systems examining the territory control and the reproductive competition in Figure 5 are novel and have advantages in exploring their biological significance. However, at this stage, the authors' claim is weak since they only show the effects of age and social experience on territorial and mating behaviors, but do not experimentally demonstrate the influence of aggression mode change itself. In the Abstract, the authors state that these findings reveal how social experience shapes fighting strategies to optimize reproductive success. This is the most important perspective of the present study, and it would be necessary to show directly that the change of aggression mode by social experience contributes to reproductive success.

      We will either tone down this statement or provide additional analysis.

      In addition, a detailed description of the tussling is lacking. For example, the authors state that the tussling is less frequent but more vigorous than lunging, but while experimental data are presented on the frequency, the intensity seems to be subjective. The intensity is certainly clear from the supplementary video, but it would be necessary to evaluate the intensity itself using some index. Another problem is that there is no clear explanation of how to determine the tussling. A detailed method is required for the reproducibility of the experiment.

      We will provide more detailed methods and data analysis regarding tussling behavior.

      Reviewer #3 (Public review):

      In this manuscript, Gao et al. presented a series of intriguing data that collectively suggest that tussling, a form of high-intensity fighting among male fruit flies (Drosophila melanogaster) has a unique function and is controlled by a dedicated neural circuit. Based on the results of behavioral assays, they argue that increased tussling among socially experienced males promotes access to resources. They also concluded that tussling is controlled by a class of olfactory sensory neurons and sexually dimorphic central neurons that are distinct from pathways known to control lunges, a common male-type attack behavior.

      A major strength of this work is that it is the first attempt to characterize the behavioral function and neural circuit associated with Drosophila tussling. Many animal species use both low-intensity and high-intensity tactics to resolve conflicts. High-intensity tactics are mostly reserved for escalated fights, which are relatively rare. Because of this, tussling in the flies, like high-intensity fights in other animal species, has not been systematically investigated. Previous studies on fly aggressive behavior have often used socially isolated, relatively young flies within a short observation duration. Their discovery that 1) older (14-days-old) flies tend to tussle more often than younger (2-days-old) flies, 2) group-reared flies tend to tussle more often than socially isolated flies, and 3) flies tend to tussle at a later stage (mostly ~15 minutes after the onset of fighting), are the result of their creativity to look outside of conventional experimental settings. These new findings are key for quantitatively characterizing this interesting yet under-studied behavior.

      Precisely because their initial approach was creative, it is regrettable that the authors missed the opportunity to effectively integrate preceding studies in their rationale or conclusions, which sometimes led to premature claims. Also, while each experiment contains an intriguing finding, these are poorly related to each other. This obscures the central conclusion of this work. The perceived weaknesses are discussed in detail below.

      Thank you for the precise summary of the key findings and novelty of the study, and your insightful suggestions.

      Most importantly, the authors' definition of "tussling" is unclear because they did not explain how they quantified lunges and tussling, even though the central focus of the manuscript is behavior. Supplemental movies S1 and S2 appear to include "tussling" bouts in which 2 flies lunge at each other in rapid succession, and supplemental movie S3 appears to include bouts of "holding", in which one fly holds the opponent's wings and shakes vigorously. These cases raise a concern that their behavior classification is arbitrary. Specifically, lunges and tussling should be objectively distinguished because one of their conclusions is that these two actions are controlled by separate neural circuits. It is impossible to evaluate the credibility of their behavioral data without clearly describing a criterion of each behavior.

      We will add more details in methods.

      It is also confusing that the authors completely skipped the characterization of the tussling-controlling neurons they claimed to have identified. These neurons (a subset of so-called pC1 neurons labeled by previously described split-GAL4 line pC1SS2) are central to this manuscript, but the only information the authors have provided is its gross morphology in a low-resolution image (Figure 4D, E) and a statement that "only 3 pairs of pC1SS2 neurons whose function is both necessary and sufficient for inducing tussling in males" (lines 310-311). The evidence that supports this claim isn't provided. The expression pattern of pC1SS2 neurons in males has been only briefly described in reference 46. It is possible that these neurons overlap with previously characterized dsx+ and/or fru+ neurons that are important for male aggressions (measured by lunges), such as in Koganezawa et al., Curr. Biol. 2016 and Chiu et al., Cell 2020. This adds to the concern that lunge and tussling are not as clearly separated as the authors claim.

      Reply: we will perform additional morphological and functional experiments on pC1<sup>SS2</sup> neurons, e.g., whether they are fru or dsx positive and comparing them with P1a neurons.

      While their characterizations of tussling behaviors in wild-type males (Figures 1 and 2) are intriguing, the remaining data have little link with each other, making it difficult to understand what their main conclusion is. Figure 3 suggests that one class of olfactory sensory neurons (OSN) that express Or47b is necessary for tussling behavior. While the authors acknowledged that Or47b-expressing OSNs promote male courtship toward females presumably by detecting cuticular compounds, they provided little discussion on how a class of OSN can promote two different types of innate behavior. No evidence of a functional or circuitry relationship between the Or47b pathway and the pC1SS2 neurons was provided. It is unclear how these two components are relevant to each other. Lastly, the rationale of the experiment in Figure 5 and the interpretation of the results is confusing. The authors attributed a higher mating success rate of older, socially experienced males over younger, socially isolated males to their tendency to tussle, but tussling cannot happen when one of the two flies is not engaged. If, for instance, a socially isolated 14-day-old male does not engage in tussling as indicated in Figure 2, how can they tussle with a group-housed 14-day-old male? Because aggressive interactions in Figure 5 were not quantified, it is impossible to conclude that tussling plays a role in copulation advantage among pairs as authors argue (lines 282-288).

      Regarding why Or47b-expressing OSNs regulate two types of innate behaviors, we will add a discussion in the revised manuscript to explore the possible mechanisms underlying this phenomenon.

      Regarding the relationship between Or47b-expressing OSNs and pC1<sup>SS2</sup> neurons, we conducted pathway connection analyses using the FlyWire database. Although the FlyWire database currently only contains neuronal data from female brains, these findings provide a certain degree of reference. The results indicate that at least three intermediate neurons are required to establish the connection between these two neuronal types. We hope the editor and reviewers would agree with us that identifying these intermediate neurons involved in this connection is beyond this study.

      Regarding the rationale and conclusions from the experiments in Figure 5, we acknowledge the difficulty in quantifying tussling and lunging behaviors in these experiments. In the revised manuscript, we will tone down the statements about the relationship between fighting strategies and reproductive success. Additionally, we will provide further behavioral experiments to support the association between these two factors.

      Despite these weaknesses, it is important to acknowledge the authors' courage to initiate an investigation into a less characterized, high-intensity fighting behavior. Tussling requires the simultaneous engagement of two flies. Even if there is confusion over the distinction between lunges and tussling, the authors' conclusion that socially experienced flies and socially isolated flies employ distinct fighting strategies is convincing. Questions that require more rigorous studies are 1) whether such differences are encoded by separate circuits, and 2) whether the different fighting strategies are causally responsible for gaining ethologically relevant resources among socially experienced flies. Enhanced transparency of behavioral data will help readers understand the impact of this study. Lastly, the manuscript often mentions previous works and results without citing relevant references. For readers to grasp the context of this work, it is important to provide information about methods, reagents, and other key resources.

      We will add more details in methods and cite additional references, we will also perform additional experiment on pC1<sup>SS2</sup> function.

    1. Author response:

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      This study investigates the role of macrophage lipid metabolism in the intracellular growth of Mycobacterium tuberculosis. By using a CRISPR-Cas9 gene-editing approach, the authors knocked out key genes involved in fatty acid import, lipid droplet formation, and fatty acid oxidation in macrophages. Their results show that disrupting various stages of fatty acid metabolism significantly impairs the ability of Mtb to replicate inside macrophages. The mechanisms of growth restriction included increased glycolysis, oxidative stress, pro-inflammatory cytokine production, enhanced autophagy, and nutrient limitation. The study demonstrates that targeting fatty acid homeostasis at different stages of the lipid metabolic process could offer new strategies for host-directed therapies against tuberculosis.

      The work is convincing and methodologically strong, combining genetic, metabolic, and transcriptomic analyses to provide deep insights into how host lipid metabolism affects bacterial survival.

      Strengths:

      The study uses a multifaceted approach, including CRISPR-Cas9 gene knockouts, metabolic assays, and dual RNA sequencing, to assess how various stages of macrophage lipid metabolism affect Mtb growth. The use of CRISPR-Cas9 to selectively knock out key genes involved in fatty acid metabolism enables precise investigation of how each step-lipid import, lipid droplet formation, and fatty acid oxidation affect Mtb survival. The study offers mechanistic insights into how different impairments in lipid metabolism lead to diverse antimicrobial responses, including glycolysis, oxidative stress, and autophagy. This deepens the understanding of macrophage function in immune defense.

      The use of functional assays to validate findings (e.g., metabolic flux analyses, lipid droplet formation assays, and rescue experiments with fatty acid supplementation) strengthens the reliability and applicability of the results.

      By highlighting potential targets for HDT that exploit macrophage lipid metabolism to restrict Mtb growth, the work has significant implications for developing new tuberculosis treatments.

      Weaknesses:

      The experiments were primarily conducted in vitro using CRISPR-modified macrophages. While these provide valuable insights, they may not fully replicate the complexity of the in vivo environment where multiple cell types and factors influence Mtb infection and immune responses.

      We thank the reviewer for pointing this out. We acknowledge that our in vitro system may indeed not fully replicate the complex in vivo environment in light of the heterogenous responses of macrophages to Mtb infection in whole animal models. We do believe, however, that the Hoxb8 in vitro model provides a powerful genetic tool to interrogate host-Mtb interactions using primary macrophages that represent the bone marrow-derived macrophage lineage. Reviewer #1 also made several helpful suggestions in their recommendations to authors relating to the reorganization of the data in our Figures in both the manuscript and the supplemental data.  We will incorporate these suggestions into the revised version of the manuscript upon resubmission.

      Reviewer #2 (Public review):

      Summary:

      Host-derived lipids are an important factor during Mtb infection. In this study, using CRISPR knockouts of genes involved in fatty acid uptake and metabolism, the authors claim that a compromised uptake, storage, or metabolism of fatty acid restricts Mtb growth upon infection. Further, the authors claim that the mechanism involves increased glycolysis, autophagy, oxidative stress, pro-inflammatory cytokines, and nutrient limitation. The authors also claim that impaired lipid droplet formation restricts Mtb growth. However, promoting lipid droplet biogenesis does not reverse/promote Mtb growth.

      Strengths:

      The strength of the study is the use of clean HOXB8-derived primary mouse macrophage lines for generating CRISPR knockouts.

      Weaknesses:

      There are many weaknesses of this study, they are clubbed into four categories below

      (1) Evidence and interpretations: The results shown in this study at several places do not support the interpretations made or are internally contradictory or inconsistent. There are several important observations, but none were taken forward for in-depth analysis. A

      a) The phenotypes of PLIN2-/-, FATP1-/-, and CPT-/- are comparable in terms of bacterial growth restriction; however, their phenotype in terms of lipid body formation, IL1B expression, etc., are not consistent. These are interesting observations and suggest additional mechanisms specific to specific target genes; however, clubbing them all as altered fatty acid uptake or catabolism-dependent phenotypes takes away this important point.

      We thank the reviewer for highlighting this. Our main focus was on assessing the impact of manipulating lipid homeostasis in macrophages and the consequences this has on the intracellular growth of Mtb.  It was never our intention to imply these mutants generated equivalent phenotypes, and we will modify the revised manuscript to reflect this point.  We will stress that interfering with lipid processing at different stages in macrophages results in both shared and divergent anti-microbial conditions against Mtb.

      b) Finding the FATP1 transcript in the HOXB8-derived FATP1-/- CRISPR KO line is a bit confusing. There is less than a two-fold decrease in relative transcript abundance in the KO line compared to the WT line, leaving concerns regarding the robustness of other experiments as well using FATP1<sup>-/-</sup> cells.

      CRISPR-Cas9 targeting of genes with single sgRNAs as is the case with our mutants generates insertions and deletions (INDELs) at the CRISPR cut site. These INDELs do not block mRNA transcription totally, and this is widely reported and accepted in the field.  In these cases, RT-PCR or RNA-seq methods are not used to verify CRISPR knockouts as they are not sensitive enough to identify INDELs. We provide knockout efficiencies by ICE analysis in supplemental information file 1 for all the mutants used in the study. We also demonstrate protein depletion by western blot and flow cytometry for all the mutants (Figure 1 - figure supplement 1). Only mutants with greater than >90% protein depletion were used for subsequent characterization.

      c) No gene showing differential regulation in FATP1<sup>-/-</sup> macrophages, which is very surprising.

      We assume the reviewer is referring to the Mtb transcriptome response in FATP1<sup>-/-</sup> macrophages, which we agree was unexpected.  However, we saw a significant compensatory response in the host cell (at transcriptional level) in FATP1-/- macrophages as evidenced by an upregulation of other fatty acid transporters (Figure 5 - figure supplement 1). We postulate that these compensatory responses could, in part, alleviate the stresses the bacteria experience within the cell, and these were discussed in the manuscript.

      d) ROS measurements should be done using flow cytometry and not by microscopy to nail the actual pattern.

      We thank the reviewer for the suggestion. However, confocal imaging is also widely used to measure ROS with similar quantitative power and individual cell resolution (PMID: 32636249, 35737799).

      (2) Experimental design: For a few assays, the experimental design is inappropriate

      a) For autophagy flux assay, immunoblot of LC3II alone is not sufficient to make any interpretation regarding the state of autophagy. This assay must be done with BafA1 or CQ controls to assess the true state of autophagy.

      We would like to point out that monitoring LC3I to LC3II conversion by western blot, confocal imaging of LC3 puncta and qPCR analysis of autophagy related genes are all validated assays for monitoring autophagic flux in a wide variety of cells. We refer the reviewer to the latest extensive guidelines on the subject (PMID: 33634751). Furthermore, Bafilomycin A and chloroquine are not specific inhibitors of autophagy and therefore are of limited value as controls. BafA is an inhibitor of the proton-ATPase apparatus as well impacting autophagy through activity on the Ca-P60A/SERCA pathway. Chloroquine impacts vacuole acidification, autophagosome/lysosome fusion and slows phagosome maturation. So, while BafA and chloroquine will reduce autophagy their effects are pleotropic and their impact on Mtb is unknown.

      b) Similarly, qPCR analyses of autophagy-related gene expression do not reflect anything on the state of autophagy flux.

      See our response above.

      (3) Using correlative observations as evidence:

      a) Observations based on RNAseq analyses are presented as functional readouts, which is incorrect.

      We are not entirely sure where we used our RNA-seq data sets as functional readouts. We used our transcriptome data to provide a preliminary identification of anti-microbial responses in the mutant macrophages infected with Mtb. Where applicable, we followed up and confirmed the more compelling RNA-seq data either by metabolic flux analyzes, qPCR, ROS measurements, and quantitative imaging.

      b) Claiming that the inability to generate lipid droplets in PLIN2-/- cells led to the upregulation of several pathways in the cells is purely correlative, and the causal relationship does not exist in the data presented.

      Again, it was not our intention to infer causality. Throughout the manuscript, we endeavor to present our data with a specific focus on describing the consequences of interfering with either fatty acid import, lipid droplet biogenesis and fatty acid oxidation on macrophage responses to Mtb.  We will revisit the revised manuscript to remove any sections that imply causality.

      (4) Novelty: A few main observations described in this study were previously reported. That includes Mtb growth restriction in PLIN2 and FATP1 deficient cells. Similarly, the impact of Metformin and TMZ on intracellular Mtb growth is well-reported. While that validates these observations in this study, it takes away any novelty from the study.

      To the best of our knowledge, Mtb growth restrictions in PLIN2 and FATP1 deficient macrophages have not been reported elsewhere. To the contrary, PLIN2 knockout macrophages obtained from PLIN2 deficient mice have been reported to robustly support Mtb replication (PMID: 29370315), quite the opposite to our data. We extensively discuss these discrepancies in the manuscript. We also discuss and cite appropriate references where Mtb growth restriction for similar macrophage mutants have been reported (CD36<sup>-/-</sup> and CPT2<sup>-/-</sup>). Our aim was to carry out a systematic myeloid specific genetic interference of fatty acid import, storage and catabolism to assess the effect on Mtb growth at all stages of lipid handling instead of focusing on one target. In the chemical approach, we used TMZ and Metformin deliberately because they had already been reported as being active against intracellular Mtb and we wished to place our data in the context of existing literature.  These studies were referenced extensively in the text.

      (5) Manuscript organisation: It will be very helpful to rearrange figures and supplementary figures.

      We will re-organize the figures in the manuscript revision as per the reviewer’s recommendation, and the recommendations of reviewer #1.

      We will address the other concerns raised by reviewer #2 in the recommendations to authors during revision of the manuscript. 

      Reviewer #3 (Public review):

      Summary:

      This study provides significant insights into how host metabolism, specifically lipids, influences the pathogenesis of Mycobacterium tuberculosis (Mtb). It builds on existing knowledge about Mtb's reliance on host lipids and emphasizes the potential of targeting fatty acid metabolism for therapeutic intervention.

      Strengths:

      To generate the data, the authors use CRISPR technology to precisely disrupt the genes involved in lipid import (CD36, FATP1), lipid droplet formation (PLIN2), and fatty acid oxidation (CPT1A, CPT2) in mouse primary macrophages. The Mtb Erdman strain is used to infect the macrophage mutants. The study, reveals specific roles of different lipid-related genes. Importantly, results challenge previous assumptions about lipid droplet formation and show that macrophage responses to lipid metabolism impairments are complex and multifaceted. The experiments are well-controlled and the data is convincing.

      Overall, this well-written paper makes a meaningful contribution to the field of tuberculosis research, particularly in the context of host-directed therapies (HDTs). It suggests that manipulating macrophage metabolism could be an effective strategy to limit Mtb growth.

      Weaknesses:

      None noted. The manuscript provides important new knowledge that will lead mpvel to host-directed therapies to control Mtb infections.

    1. Author response:

      Reviewer #1 (Public review):

      Summary:

      This study investigates what happens to the stimulus-driven responses of V4 neurons when an item is held in working memory. Monkeys are trained to perform memory-guided saccades: they must remember the location of a visual cue and then, after a delay, make an eye movement to the remembered location. In addition, a background stimulus (a grating) is presented that varies in contrast and orientation across trials. This stimulus serves to probe the V4 responses, is present throughout the trial, and is task-irrelevant. Using this design, the authors report memory-driven changes in the LFP power spectrum, changes in synchronization between the V4 spikes and the ongoing LFP, and no significant changes in firing rate.

      Strengths:

      (1) The logic of the experiment is nicely laid out.

      (2) The presentation is clear and concise.

      (3) The analyses are thorough, careful, and yield unambiguous results.

      (4) Together, the recording and inactivation data demonstrate quite convincingly that the signal stored in FEF is communicated to V4 and that, under the current experimental conditions, the impact from FEF manifests as variations in the timing of the stimulus-evoked V4 spikes and not in the intensity of the evoked activity (i.e., firing rate).

      Weaknesses:

      I think there are two limitations of the study that are important for evaluating the potential functional implications of the data. If these were acknowledged and discussed, it would be easier to situate these results in the broader context of the topic, and their importance would be conveyed more fairly and transparently.

      (1) While it may be true that no firing rate modulations were observed in this case, this may have been because the probe stimuli in the task were behaviorally irrelevant; if anything, they might have served as distracters to the monkey's actual task (the MGS). From this perspective, the lack of rate modulation could simply mean that the monkeys were successful in attending the relevant cue and shielding their performance from the potentially distracting effect of the background gratings. Had the visual probes been in some way behaviorally relevant and/or spatially localized (instead of full field), the data might have looked very different.

      Any task design involves tradeoffs; if the visual stimulus was behaviorally relevant, then any observed neurophysiological changes would be more confounded by possible attentional effects. We cannot exclude the possibility that a different task or different stimuli would produce different results; we ourselves have reported firing rate enhancements for other types of visual probes during an MGS task (Merrikhi et al. 2017). We have added an acknowledgement of these limitations in the discussion section (lines 311-319). At minimum, our results show a dissociation between the top-down modulation of phase coding, which is enhanced during WM even for these task-irrelevant stimuli, and rate coding. Establishing whether and how this phase coding is related to perception and behavior will be an important direction for future work.

      With this in mind, it would be prudent to dial down the tone of the conclusions, which stretch well beyond the current experimental conditions (see recommendations).

      We have edited the title (removing the word ‘primarily’) and key sentences throughout to tone down the conclusions, generally to state that the importance of a phase code in WM modulations is *possible* given the observed results, rather than certain (see abstract line 27, introduction lines 58-60, results line 215, conclusion lines 294-295).

      (2) Another point worth discussing is that although the FEF delay-period activity corresponds to a remembered location, it can also be interpreted as an attended location, or as a motor plan for the upcoming eye movement. These are overlapping constructs that are difficult to disentangle, but it would be important to mention them given prior studies of attentional or saccade-related modulation in V4. The firing rate modulations reported in some of those cases provide a stark contrast with the findings here, and I again suspect that the differences may be due at least in part to the differing experimental conditions, rather than a drastically different encoding mode or functional linkage between FEF and V4.

      We have added a paragraph to the discussion section addressing links to attention and motor planning (lines 301-322), and specifically acknowledging the inherent difficulties of fully dissociating these effects when interpreting our results (lines 311-319).

      Reviewer #2 (Public review):

      Summary:

      It is generally believed that higher-order areas in the prefrontal cortex guide selection during working memory and attention through signals that selectively recruit neuronal populations in sensory areas that encode the relevant feature. In this work, Parto-Dezfouli and colleagues tested how these prefrontal signals influence activity in visual area V4 using a spatial working memory task. They recorded neuronal activity from visual area V4 and found that information about visual features at the behaviorally relevant part of space during the memory period is carried in a spatially selective manner in the timing of spikes relative to a beta oscillation (phase coding) rather than in the average firing rate (rate code). The authors further tested whether there is a causal link between prefrontal input and the phase encoding of visual information during the memory period. They found that indeed inactivation of the frontal eye fields, a prefrontal area known to send spatial signals to V4, decreased beta oscillatory activity in V4 and information about the visual features. The authors went one step further to develop a neural model that replicated the experimental findings and suggested that changes in the average firing rate of individual neurons might be a result of small changes in the exact beta oscillation frequency within V4. These data provide important new insights into the possible mechanisms through which top-down signals can influence activity in hierarchically lower sensory areas and can therefore have a significant impact on the Systems, Cognitive, and Computational Neuroscience fields.

      Strengths:

      This is a well-written paper with a well-thought-out experimental design. The authors used a smart variation of the memory-guided saccade task to assess how information about the visual features of stimuli is encoded during the memory period. By using a grating of various contrasts and orientations as the background the authors ensured that bottom-up visual input would drive responses in visual area V4 in the delay period, something that is not commonly done in experimental settings in the same task. Moreover, one of the major strengths of the study is the use of different approaches including analysis of electrophysiological data using advanced computational methods of analysis, manipulation of activity through inactivation of the prefrontal cortex to establish causality of top-down signals on local activity signatures (beta oscillations, spike locking and information carried) as well as computational neuronal modeling. This has helped extend an observation into a possible mechanism well supported by the results.

      Weaknesses:

      Although the authors provide support for their conclusions from different approaches, I found that the selection of some of the analyses and statistical assessments made it harder for the reader to follow the comparison between a rate code and a phase code. Specifically, the authors wish to assess whether stimulus information is carried selectively for the relevant position through a firing rate or a phase code. Results for the rate code are shown in Figures 1B-G and for the phase code are shown in Figure 2. Whereas an F-statistic is shown over time in Figure 1F (and Figure S1) no such analysis is shown for LFP power. Similarly, following FEF inactivation there is no data on how that influences V4 firing rates and information carried by firing rates in the two conditions (for positions inside and outside the V4 RF). In the same vein, no data are shown on how the inactivation affects beta phase coding in the OUT condition.

      We plan to incorporate statistical analysis of this point in the revised version.

      Moreover, some of the statistical assessments could be carried out differently including all conditions to provide more insight into mechanisms. For example, a two-way ANOVA followed by post hoc tests could be employed to include comparisons across both spatial (IN, OUT) and visual feature conditions (see results in Figures 2D, S4, etc.). Figure 2D suggests that the absence of selectivity in the OUT condition (no significant difference between high and low contrast stimuli) is mainly due to an increase in slope in the OUT condition for the low contrast stimulus compared to that for the same stimulus in the IN condition. If this turns out to be true it would provide important information that the authors should address.

      We plan to incorporate statistical analysis of this point in the revised version.

      There are also a few conceptual gaps that leave the reader wondering whether the results and conclusion are general enough. Specifically,

      (1) the authors used microstimulation in the FEF to determine RFs. It is thus possible that the FEF sites that were inactivated were largely more motor-related. Given that beta oscillations and motor preparatory activity have been found to be correlated and motor sites show increased beta oscillatory activity in the delay period, it is possible that the effect of FEF inactivation on V4 beta oscillations is due to inactivation of the main source of beta activity. Had the authors inactivated sites with a preponderance of visual neurons in the FEF would the results be different?

      We do not believe this to be likely based on what is known anatomically and functionally about this circuitry. Anatomically, the projections from FEF to V4 arise primarily from the supragranular layers, not layers which contain the highest proportion of motor activity (Barone et al. 2000, Pouget et al. 2009, Markov et al. 2013). Functionally, based on electrical identification of V4-projecting FEF neurons, we know that FEF to V4 projections are predominantly characterized by delay rather than motor activity (Merrikhi et al. 2017). We have now tried to emphasize these points when we introduce the inactivation experiments (lines 180-182).

      Experimentally, the spread of the pharmacological effect with our infusion system is quite large relative to any clustering of visual vs. motor neurons within the FEF, with behavioral consequences of inactivation spreading to cover a substantial portion of the visual hemifield (e.g., Noudoost et al. 2014, Clark et al. 2014), and so our manipulation lacks the spatial resolution to selectively target motor vs. other FEF neurons.

      (2) Somewhat related to this point and given the prominence of low-frequency activity in deeper layers of the visual cortex according to some previous studies, it is not clear where the authors' V4 recordings were located. The authors report that they do have data from linear arrays, so it should be possible to address this.

      Unfortunately our chamber placement for V4 has produced linear array penetration angles which do not reliably allow identification of cortical layers. We are aware of previous results showing layer-specific effects of attention in V4 (e.g., Pettine et al. 2019, Buffalo et al. 2011), and it would indeed be interesting to determine whether our observed WM-driven changes follow similar patterns. We may be able to analyze a subset of the data with current source density analysis to look for layer-specific effects in the future, but are not able to provide any information at this time.

      (3) The authors suggest that a change in the exact frequency of oscillation underlies the increase in firing rate for different stimulus features. However, the shift in frequency is prominent for contrast but not for orientation, something that raises questions about the general applicability of this observation for different visual features.

      We plan to incorporate statistical analysis of this point in the revised version.

      (4) One of the major points of the study is the primacy of the phase code over the rate code during the delay period. Specifically, here it is shown that information about the visual features of a stimulus carried by the rate code is similar for relevant and irrelevant locations during the delay period. This contrasts with what several studies have shown for attention in which case information carried in firing rates about stimuli in the attended location is enhanced relative to that for stimuli in the unattended location. If we are to understand how top-down signals work in cognitive functions it is inevitable to compare working memory with attention. The possible source of this difference is not clear and is not discussed. The reader is left wondering whether perhaps a different measure or analysis (e.g. a percent explained variance analysis) might reveal differences during the delay period for different visual features across the two spatial conditions.

      We have added discussion regarding the relationship of these results to previous findings during attention in the discussion section (lines 301-322).

      The use of the memory-guided saccade task has certain disadvantages in the context of this study. Although delay activity is interpreted as memory activity by the authors, it is in principle possible that it reflects preparation for the upcoming saccade, spatial attention (particularly since there is a stimulus in the RF), etc. This could potentially change the conclusion and perspective.

      We have added a new discussion paragraph addressing the relationship to attention and motor planning (lines 301-322). We have also moderated the language used to describe our conclusions throughout the manuscript in light of this ambiguity.

      For the position outside the V4 RF, there is a decrease in both beta oscillations and the clustering of spikes at a specific phase. It is therefore possible that the decrease in information about the stimuli features is a byproduct of the decrease in beta power and phase locking. Decreased oscillatory activity and phase locking can result in less reliable estimates of phase, which could decrease the mutual information estimates.

      We plan to incorporate statistical analysis of this point in the revised version.

      The authors propose that coherent oscillations could be the mechanism through which the prefrontal cortex influences beta activity in V4. I assume they mean coherent oscillations between the prefrontal cortex and V4. Given that they do have simultaneous recordings from the two areas they could test this hypothesis on their own data, however, they do not provide any results on that.

      This paper only includes inactivation data. We are working on analyzing the simultaneous recording data for a future publication.

      The authors make a strong point about the relevance of changes in the oscillation frequency and how this may result in an increase in firing rate although it could also be the reverse - an increase in firing rate leading to an increase in the frequency peak. It is not clear at all how these changes in frequency could come about. A more nuanced discussion based on both experimental and modeling data is necessary to appreciate the source and role (if any) of this observation.

      As the reviewer notes, it is difficult to determine whether the frequency changes drive the rate changes, vice versa, or whether both are generated in parallel by a common source. We have adjusted our language to reflect this (lines 277-278). Future modeling work may be able to shed more light on the causal relationships between various neural signatures.

      Reviewer #3 (Public review):

      Summary:

      In this report, the authors test the necessity of prefrontal cortex (specifically, FEF) activity in driving changes in oscillatory power, spike rate, and spike timing of extrastriate visual cortex neurons during a visual-spatial working memory (WM) task. The authors recorded LFP and spikes in V4 while macaques remembered a single spatial location over a delay period during which task-irrelevant background gratings were displayed on the screen with varying orientation and contrast. V4 oscillations (in the beta range) scaled with WM maintenance, and the information encoded by spike timing relative to beta band LFP about the task-irrelevant background orientation depended on remembered location. They also compared recorded signals in V4 with and without muscimol inactivation of FEF, demonstrating the importance of FEF input for WM-induced changes in oscillatory amplitude, phase coding, and information encoded about background orientations. Finally, they built a network model that can account for some of these results. Together, these results show that FEF provides meaningful input to the visual cortex that is used to alter neural activity and that these signals can impact information coding of task-irrelevant information during a WM delay.

      Strengths:

      (1) Elegant and robust experiment that allows for clear tests for the necessity of FEF activity in WM-induced changes in V4 activity.

      (2) Comprehensive and broad analyses of interactions between LFP and spike timing provide compelling evidence for FEF-modulated phase coding of task-irrelevant stimuli at remembered location.

      (3) Convincing modeling efforts.

      Weaknesses:

      (1) 0% contrast background data (standard memory-guided saccade task) are not reported in the manuscript. While these data cannot be used to consider information content of spike rate/time about task-irrelevant background stimuli, this condition is still informative as a 'baseline' (and a more typical example of a WM task).

      We plan to incorporate statistical analysis of this point in the revised version.

      (2) Throughout the manuscript, the primary measurements of neural coding pertain to task-irrelevant stimuli (the orientation/contrast of the background, which is unrelated to the animal's task to remember a spatial location). The remembered location impacts the coding of these stimulus variables, but it's unclear how this relates to WM representations themselves.

      Indeed, here we have focused on how maintaining spatial WM impacts visual processing of incoming sensory information, rather than on how the spatial WM signal itself is represented and maintained. Behaviorally, this impact on visual signals could be related to the effects of the content of WM on perception and reaction times (e.g., Soto et al. 2008, Awh et al. 1998, Teng et al. 2019), but no such link to behavior is shown in our data.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public reviews

      Reviewer #1 (Public Review): 

      Summary: 

      In this study, Masroor Ahmad Paddar and his/her colleagues explore the noncanonical roles of ATG5 and membrane atg8ylation in regulating retromer assembly and function. They begin by examining the interactomes of ATG5 and expand the scope of these effects to include homeostatic responses to membrane stress and damage. 

      Strengths: 

      This study provides novel insights into the noncanonical function of ATG8ylation in endosomal cargo sorting process. 

      Weaknesses: 

      The direct mechanism by which ATG8ylation regulates the retromer remains unsolved. 

      We agree with the reviewer.  We do however show how at least one aspect of atg8ylation contributes to the proper retromer function, which occurs via lysosomal membrane maintenance and repair. Understanding the more direct effects on retromer will require a separate study. We now emphasize this in the revised manuscript (p. 18) and point out the limitations of the present work (p. 18): “One of the limitations of our study is that beyond effects of membrane atg8ylation on quality of lysosomal membrane and its homeostasis there could be more direct effects of membrane modification with mATG8s that still need to be understood”.

      Reviewer #2 (Public Review): 

      Summary:

      Padder et al. demonstrate that ATG5 mediates lysosomal repair via the recruitment of the retromer components during LLOMe-induced lysosomal damage and that mAtg8-ylation contributes to retromer-dependent cargo sorting of GLUT1. Although previous studies have suggested that during glucose withdrawal, classical autophagy contributes to retromer-dependent GLUT1 surface trafficking via interactions between LC3A and TBC1D5, the experiments here demonstrate that during basal conditions or lysosomal damage, ATGs that are not involved in mATG8ylation, such as FIP200, are not functionally required for retromer-dependent sorting of GLUT1. Overall, these studies suggest a unique role for ATG5 in the control of retromer function, and that conjugation of ATG8 to single membranes (CASM) is a partial contributor to these phenotypes. 

      Strengths: 

      (1) Overall, these studies suggest a unique non-autophagic role for ATG5 in the control of retromer function. They also demonstrate that conjugation of ATG8 to single membranes (CASM) is a partial contributor to these phenotypes. Overall, these data point to a new role for ATG5 and CASM-dependent mATG8ylation in lysosomal membrane repair and trafficking. 

      (2) Although the studies are overall supportive of the proposed model that the retromer is controlled by CASM-dependent mATG8-ylaytion, it is noteworthy that previous studies of GLUT1 trafficking during glucose withdrawal (Roy et al. Mol Cell, PMID: 28602638) were predominantly conducted in cells lacking ATG5 or ATG7, which would not be able to discriminate between a CASM-dependent vs. canonical autophagy-dependent pathway in the control of GLUT1 sorting. Is the lack of GLUT1 mis-sorting to lysosomes observed in FIP200 and ATG13KO cells also observed during glucose withdrawal? Notably, deficiencies in glycolysis and glucose-dependent growth have been reported in FIP200 deficient fibroblasts (Wei et al. G&D, PMID: 21764854) so there may be differences in regulation dependent on the stress imposed on a cell. 

      We thank the reviewer for the overall assessment of the strengths of the study.  We have discussed in the manuscript the elegant study by Roy et al., PMID 28602683. To accommodate reviewer’s comment, we have additionally emphasized in the text that our study is focused on basal conditions and conditions that perturb endolysosomal compartments. We agree with the reviewer that under metabolic stress conditions (such as glucose limitation) more complex pathways may be engaged and have acknowledged that in the discussion. We have now included this in the limitations of the study (p. 18): “Another limitation of our study is that we have focused on basal conditions or conditions causing lysosomal damage, whereas metabolic stress including glucose excess or limitation with its multitude of metabolic effects have not been addressed”.

      Weaknesses: 

      (1) Additional controls are needed to clarify the role of CASM in the control of retromer function. Because the manuscript proposes both CASM-dependent and independent pathways in the ATG5 mediated regulation of the retromer, it is important to provide robust evidence that CASM is required for retromer-dependent GLUT1 sorting to the plasma membrane vs. lysosome. The experiments with monensin in Fig. 7C-E are consistent with but not unequivocally corroborative of a role for CASM. 

      We fully agree with the reviewer. In fact, our data with bafilomycin A1 treatment causing GLUT1 miss-sorting show that it is the perturbance of lysosomes  and not CASM per se that leads to mis-sorting of GLUT1 (Fig. 7D,E). Note that it has been shown (PMIDs: 28296541, 25484071 and 37796195) that although bafilomycin A1 deacidifies lysosomes it does not induce but instead inhibits CASM. This is because bafilomycin A1 causes dissociation of V1 and V0 sectors of V-ATPase, unlike other CASM-inducing agents which promote V1 V0 association. Complementing this, our data with ATG2AB DKO and ESCRT VPS37A KO (Fig. 8A-F) indicate that the repair of lysosomes is important to keep the retromer machinery functional (as illustrated in Fig. 8G). This may be one of the effector mechanisms downstream of membrane atg8ylation in general and hence also downstream of CASM. We have revised Fig. 7 title to read “Lysosomal perturbations cause GLUT1 mis-sorting” and have explained these relationships in the text (p. 12-13): “Since bafilomycin A1 does not induce CASM but disturbs luminal pH, we conclude that it is the less acidic luminal pH of the endolysosomal organelles, and not CASM, that is sufficient to interfere with the proper sorting of GLUT1.”

      Based on the results shown with ATG16KO in Fig 4A-D, rescue experiments of these 16KO cells with WT vs. C-terminal WD40 mutant versions of ATG16 will specifically assess the requirement for CASM and potentially provide more rigorous support for the conclusions drawn. 

      We have carried out complementation with ATG16L1 WT and its E230 mutant (devoid of WD40 repeats but still capable of canonical autophagy) and placed these data in Fig. 7 (panels I and J) as recommended by the reviewer. This is now described on p. 13 (To additionally test this notion, we compared ATG16L1 full length (ATG16L1FL) and ATG16L1E230 (Rai et al., PMID 30403914) for complementation of the GLUT1 sorting defect in ATG16L1 KO cells (Fig. 7I,J). ATG16L1E230 [Rai, 2019, 30403914] lacks the key domain to carry out CASM via binding to VATPase 29,30 31-33 but retains capacity to carry out atg8ylation.  Both ATG16L1FL and ATG16L1E230 complemented mis-sorting of GLUT1 (Fig. 7I,J). Collectively, these data indicate that it is not absence of CASM/VAIL but absence of membrane atg8ylation in general that promotes GLUT1 mis-sorting.).

      (2) Also, the role of TBC1D5 should be further clarified. In Fig S7, are there any changes in the interactions between TBC1D5 and VPS35 in response to LLOMe or other agents utilized to induce CASM? 

      We thank the reviewer for pointing this out. We do have data with VPS35 in co-IPs shown in Fig. S7.  There is no change in the amounts of VPS35 or TBC1D5 in GFP-LC3A co-IPs. We now include in Fig. S7 (new panel D) a graph with quantification in the revised manuscript and emphasize this point (p. 12): “However, under CASM-inducing conditions, no changes were detected (Fig. S7B-D) in interactions between TBC1D5 and LC3A or in levels of VPS35 in LC3A co-IP, a proxy for LC3A-TBC1D5-VPS29/retromer association. This suggests that CASM-inducing treatments and additionally bafilomycin A1 do not affect the status of the TBC1D5-Rab7 system”.        

      Does TBC1D5 loss-of-function modulate the numbers of GLUT1 and Gal3 puncta observed in ATG5 deficient cells in response to LLOMe? 

      We agree that TBC1D5 is an interesting aspect. However, because TBC1D5 does not change its interactions in the experiments in our study, we consider this topic (i.e. whether TBC1D5 phenocopies VPS35 and ATG5 KOs in its effects on Gal3) to be beyond the scope of the present work. We underscore that LLOMe (lysosomal damage) mis-sorts GLUT1 even without any genetic intervention (e.g., in WT cells in the absence of ATG5 KO; Fig. 7). Thus, in our opinion the effects of TBC1D5 inactivation may be a moot point.  

      (3) Finally, the studies here are motivated by experiments in Fig. S1 (as well as other studies from the Deretic and Stallings labs) suggesting unique autophagy-independent functions for ATG5 in myeloid cells and neutrophils in susceptibility to Mycobacterium tuberculosis infection. However, it is curious that no attempt is made to relate the mechanistic data regarding the retromer or GLUT1 receptor mis-sorting back to the infectious models. Do myeloid cells or neutrophils lacking ATG5 have deficiencies in glucose uptake or GLUT1 cell surface levels? 

      Reviewer’s point is well taken. Glucose uptake, its metabolism, and diabetes underly resurgence in TB in certain populations and are important factors in a range of other diseases. This was alluded to in our discussion (lines 461-469). However, these are complex topics for future studies. We have now expanded this section of the discussion (p. 18): “In the context of tuberculosis, diabetes, which includes glucose dysregulation, is associated with increased incidence of active disease and adverse outcomes” (Dheda et al., ,PMID: 26377143; Dooley, et al., PMID:19926034).

      Reviewer #3 (Public Review): 

      In this manuscript, Padder et al. used APEX2 proximity labeling to find an interaction between ATG5 and the core components of the Retromer complex, VPS26, VPS29, and VPS35. Further studies revealed that ATG5 KO inhibited the trafficking of GLUT1 to the plasma membrane. They also found that other autophagy genes involved in membrane atg8ylation affected GLUT1 sorting. However, knocking out other essential autophagy genes such as ATG13 and FIP200 did not affect GLUT1 sorting. These findings suggest that ATG5 participates in the function of the Retromer in a noncanonical autophagy manner. Overall, the methods and techniques employed by the authors largely support their conclusions. These findings are intriguing and significant, enriching our understanding of the non-autophagic functions of autophagy proteins and the sorting of GLUT1.

      Nevertheless, there are several issues that the authors need to address to further clarify their conclusions. 

      (1) The authors confirmed the interaction between Atg5 and the Retromer complex through Co-IP experiments. Is the interaction between Atg5 and the Retromer direct? If it is direct, which Retromer complex protein regulates the interaction with Atg5? Additionally, does ATG5 K130R mutant enhance its interaction with the Retromer? 

      AlphaFold modeling in the initial submission of our study to eLife (absent from the current version) suggested the possibility of a direct interaction between ATG5 and VPS35 with ATG12—ATG5 complex facing outwards, in which case K130R would not matter. However, mutational experiments in putative contact residues did not alter association in co-IPs. So either ATG5 interacts with other retromer subunits or more likely is in a larger protein complex containing retromer. It will take a separate study to dissect associations and find direct interaction partners. 

      (2) To more directly elucidate how ATG5 regulates Retromer function by interacting with the Retromer and participates in the trafficking of GLUT1 to the plasma membrane, the authors should identify which region or crucial amino acid residues of ATG5 regulate its interaction with the Retromer. Additionally, they should test whether mutations in ATG5 that disrupt its interaction with the Retromer affect Retromer function (such as participating in the trafficking of GLUT1 to the plasma membrane) and whether they affect Atg8ylation. They also need to assess whether these mutations influence canonical autophagy and lysosomal sensitivity to damage. 

      Please see the response to point 1.

      Recommendations for the authors.

      Reviewer #1 (Recommendations For The Authors): 

      While most data are solid and convincing, the following questions need to be addressed before publication: 

      Major Concerns: 

      (1) Examining only one cargo (GLUT1) is insufficient to reflect the retromer's function comprehensively. At least two additional cargoes should be analyzed to observe the phenotypes more accurately. 

      We agree that having another retromer cargo (in addition to GLUT1) would be of interest. We point out that our data also show mis-sorting of SNX27 to lysosomes (Fig. 3H, quantifications in Fig. 3I).  SNX27 in turn sorts nearly 80 ion channels, signaling receptors, and other nutrient transporters. Which of the 80 cargos to prioritize and check (the expectation is that all 80 might be missorted given that they need SNX27)?  We have instead tested MPR, a SNX27-independent cargo. We now include data on effects of ATG5 knockout on CI-MPR (Fig. S9A-F). This is described in the text (p. 14; “Effect of ATG5 knockout on MPR sorting

      We tested whether ATG5 affects cation-independent mannose 6-phosphate receptor (CI-MPR). For this, we employed the previously developed methods (Fig. S9A) of monitoring retrograde trafficking of CI-MPR from the plasma membrane to the TGN 70,118-121. In the majority of such studies, CI-MPR antibody is allowed to bind to the extracellular domain of CI-MPR at the plasma membrane and its localization dynamics following endocytosis serves as a proxy for trafficking of CI-MPR. We used ATG5 KOs in HeLa and Huh7 cells and quantified by HCM retrograde trafficking to TGN of antibody-labeled CI-MPR at the cell surface, after being taken up by endocytosis and allowed to undergo intracellular sorting, followed by fixation and staining with TGN46 antibody. There was a minor but statistically significant reduction in CIMPR overlap with TGN46 in HeLaATG5-KO that was comparable to the reduction in HeLa cells when

      VPS35 was depleted by CRISPR (HeLaVPS35-KO) (Fig. S9B,C). Morphologically, endocytosed Ab-CI-

      MPR appeared dispersed in both HeLaATG5-KO and HeLaVPS35-KO cells relative to HeLaWT cells (Fig. S9D). Similar HCM results were obtained with Huh7 cells (WT vs. ATG5KO; Fig. S9E,F). We interpret these data as evidence of indirect action of ATG5 KO on CI-MPR sorting via membrane homeostasis, although we cannot exclude a direct sorting role via retromer. We favor the former interpretation based on the strength of the effect and the controversial nature of retromer engagement in sorting of CI-MPR (57,70,75,98,120).”)

      (2) The evidence from Alphafold predictions is weak. The direct interaction of ATG5 with retromer subunits should be tested. 

      Please see the above response to Reviewer 3.

      In addition, does retromer also interact with ATG16L1 similarly to the phenomenon in VAIL? 

      We fully agree with the reviewer that finding the direct interacting partners between retromer and membrane atg8ylation machinery is an important direction as in our opinion it would expand the repertoire of E3 ligases and its adaptors. However, given the complexity and variety of possibilities, we believe that this is a topic for a future study.  

      (3) In Line 166, Figures 2C and 2D, the Gal3 phenotype does not seem to be well complemented by VPS35. 

      We have adjusted the text to acknowledge incomplete complementation (p.7). 

      (4) In Figures 3 and 4, the authors show that KO of membrane atg8ylation machineries and ATG8-Hexa KO affects the localization of retromer cargo GLUT1 and SNX27. However, the mechanism by which membrane ATG8ylation affects retromer remains unresolved.

      Additionally, are other retromer subunits' locations are also affected, if so, how are they impacted? At least a speculative explanation should be provided. 

      Following reviewers request, we now state on p. 19 that “one of the limitations of our study is that beyond effects of membrane atg8ylation on quality of lysosomal membrane and its homeostasis there could be more direct effects of membrane modification with mATG8s on retromer that still need to be understood”.

      (5) In Figure 3, endogenous IP results are required to examine the interaction of ATG5 with retromer if suitable retromer antibodies for IP are available. 

      Endogenous IPs are given in Fig. 1. We have modified text on p. 8 to clarify this.

      (6) In Figure 4, ATG8 Hexa KO, and triple KO of LC3s or GABARAPs all increase the localization of GLUT1 on lysosomes. It seems redundant for ATG8 family proteins here.

      Can any individual member of the ATG8 family rescue this phenotype? 

      If the intent of such complementation analysis is to identify a specific mATG8 responsible for the observed effects, this is already pre-empted by the fact that TKOs also have a similar effect as HEXA mutants (i.e. loss of at least two of mATG8s is enough to cause the phenotype). We now discuss this in the text (p. 10): “Thus, at least two mATG8s, each one from two different mATG8 subclasses (LC3s and GABARAPs) or the entire membrane atg8ylation machinery was engaged in and required for proper GLUT-1 sorting”.  

      (7) In Figure 5, knockdown of ATG5 in FIP200 KO cells inhibited GLUT1 sorting from endosomes, leading to its trafficking to lysosomes. However, it is known that very little remnant ATG5 in ATG5 KD cells is enough to support ATG8 lipidation. Therefore, it is essential to repeat this experiment using ATG5/FIP200 double KO or ATG5 KO combined with an autophagy inhibitor. 

      We point out to this limitation in the text (p. 11): “….we knocked down ATG5 in FIP200 KO cells (Fig. S5D) and found that GLUT1 puncta and GLUT1+LAMP2+ profiles increased even in the FIP200 KO background with the effects nearing those of VPS35 knockout (Figs. 5D-F and S5C), with the difference between VPS35 KO and ATG5 KD attributable to any residual ATG5 levels in cells subjected to siRNA knockdowns”.

      (8) In Figure 7, the authors show that the induction of CASM inhibited GLUT1 sorting from endosomes. However, ATG5 KO, which abolishes membrane ATG8ylation, also inhibits GLUT1 sorting. This seems paradoxical and requires a reasonable explanation or discussion. 

      We understand reviewer’s comment. The answer to this paradox is that it is actually the lysosomal damage that causes GLUT1 mis-sorting and not CASM. Membrane atg8ylation, such as CASM and probably other processes given that involvement of both ATG2 and ESCRTs (Fig. 8) counteracts the damage and works in the direction of restoring/maintaining proper retromer-dependent sorting. This is now explained better in the text, and have revised the title of Fig. 7 to read “Lysosomal damage causes GLUT1 mis-sorting”. Our data with bafilomycin A1 show that it is the perturbance of lysosomes (not CASM per se) that leads to mis-sorting of GLUT1 (Fig. 7D,E), and our data with ATG2AB DKO and ESCRT (VPS37A) KO (Fig. 8A-F) indicate that repair of lysosomes is important to keep the retromer working machinery functional (as illustrated in Fig. 8G), which may be one of the effector mechanisms downstream of membrane atg8ylation  in general (and hence also of CASM).  

      (9) The immuno-staining results for Figures 7F and 7G are lacking. 

      We now provide the requested images.

      (10) In Figure 8D, the quality of the image for VPS37 KO cells treated with LLOME is not sufficient to show increased colocalization between GLUT1 and LAMP2. 

      We now provide a different example image. We note that these are epiflorescent HCM images  

      Minor Concerns: 

      (1) It would be better to distinguish the function of the membrane ATG8ylation machinery (i.e., ATG5) from the function of membrane ATG8ylation in the description. No ATG8ylation-deficient mutants were used in this study. 

      We have used atg8ylation mutants (e.g. KOs in ATG3, ATG5, ATG7, and ATG16L1). We now emphasize this better in the text (p. 10). 

      (2) In Figure 2D, a green box appears there by incident. 

      This has been fixed.

      (3) In Figure 3A, the conjugate for ATG5-ATG12 is absent in the gel for IB: ATG5.

      The ATG5 antibody used in Fig. 3A recognizes primarily the conjugated form of ATG5. This is now clarified in the figure legend. 

      (4) Figure 5G is missing in the manuscript. 

      Fig 5G is now mentioned in the text. Thank you.

      (5) The gRNA sequence information for FIP200 KO is missing in the Methods section. 

      Reference(s) to the already published gRNA sequence are in the manuscript. 

      (6) Suggest moving the last paragraph in Result section to Discussion section. 

      We kept this single-paragraph section in Results as it contains actual data.

      Reviewer #2 (Recommendations For The Authors): 

      (1) It is unclear why the rescue of VPS35KO cells in Fig 1C-D is so modest. 

      Complementation data depend on transfection efficiency and some variability is to be expected.

      Reviewer #3 (Recommendations For The Authors): 

      (1) Figures 2A, 2C, 2E, and 2G lack scale bars. Figure 2D has a small square above the y axis. 

      Relative scale bars are now included. 

      (2) Figures S3B, S3D, and S3F lack scale bars. 

      Relative scale bars are now included.

    1. Author response:

      We thank the Editor and Reviewers for their work on our manuscript, and are happy to receive their positive comments, as well as their questions and suggestions. We are currently revising the manuscript and are planning to de-emphasize Brownian recovery as a simple yet biologically irrelevant benchmark and include comparisons with other biologically inspired strategies suggested by the reviewers. As for sharing the code and data: we completely agree: dataset 1 is already public and we will share the other dataset as well as the code. In a nutshell, we will be addressing the referee’s suggestions as follows:

      (1)   As Referee 1 points out, even if the algorithm does not require a map of space, the agent is still required to tell apart North, East, South and West relative to the wind direction which is implicitly assumed known. We will better clarify the spatial encoding required to implement these strategies.

      (2)   Referee 1 remarks that the learned recovery strategy works best and suggests to give it a more prominent role and better characterize it. We agree that what is done in the void state is definitely key and more work is needed to understand it. In the revised manuscript, we are planning to further substantiate the statistics of the learned recovery by repeating training several times and comparing several trajectories. Note that this strategy is much more flexible than the others and could potentially mix aspects of recovery to aspects of exploitation: we defer a more in-depth analysis that disentangles these two aspects elsewhere.

      (3)   Referee 1 asks whether an optimal, minimal representation of the olfactory states exists. Q learning defines the olfactory states prior to training and does not allow to systematically optimize odor representation for the task. Given the odor features, we can however discretize them in more or less olfactory states. We expect that decreasing the number of olfactory states provides less positional information and potentially degrades performance, although loss in performance may be overshadowed by noise or by efficient recovery. We are planning to re-train our model with a smaller numer of non-void states and will provide the comparison. The number of void states does not need further testing: we chose 50 void states because it matches the time agents typically remain in the void and indeed achieves very high performance (less than 50 void states results in no convergence and more than 50 introduces states that are rarely visited)

      (4)   Both reviewers correctly remark that Brownian motion is not biologically relevant. We will make sure to further clarify that this is a rather simple --but biologically irrelevant-- benchmark. We are planning to include results with both circling and zigzaging as biologically inspired recovery strategies.

      (5)   We agree with reviewer 2 that animal locomotion does not look like a series of discrete displacements on a checkerboard. However, to overcome this limitation, one has to first focus on a specific system to define actions in a way that best adheres to a species’ motor controls. Second, these actions are likely continuous, which makes reinforcement learning notoriously more complex. While we agree that more realistic models are definitely needed for a comparison with real systems, this remains outside the scope of the current work.

      (6)   We agree with the referees and editor that it is important to publish the code and data alongside with the manuscript. It was already planned and we will make sure to share the links within the revised version of the manuscript.

    1. Author response:

      The following is the authors’ response to the current reviews.

      Reviewer #1 (Public review):

      Summary:

      The study by Nelson et al. is focused on formation of the Drosophila Posterior Signaling Center (PSC) which ultimately acts as a niche to support hematopoietic stem cells of the lymph gland (LG). Using a combination of genetics and live imaging, the authors show that PSC cells migrate as a tight collective and associate with multiple tissues during a trajectory that positions them at the posterior of the LG.

      This is an important study that identifies Slit-Robo signaling as a regulator of PSC morphogenesis, and highlights the complex relationship of interacting cell types - PSC, visceral mesoderm (VM) and cardioblasts (CBs) - in coordinated development of these three tissues during organ development. However, one point requiring clarification is the idea that PSC cells exhibit a collective cell migration; it is not clear that the cells are migrating rather than being pushed to a more dorsal position through dorsal closure and/or other similar large scale embryo movement. This does not detract from the very interesting analysis of PSC morphogenesis as presented.

      This Public Review by Reviewer #1 is identical to their original Public Review, thus we are unsure whether Reviewer #1 assessed the revised version of our manuscript, and whether they read our responses to their original Public Review. Below we summarize our original responses to the weaknesses listed for the first version of our manuscript.

      Strengths:

      • Using expression of Hid or Grim to ablate associated tissues, they find evidence that the VM and CB of the dorsal vessel affect PSC migration/morphology whereas the alary muscles do not. Slit is expressed by both VM and CBs, and therefore Slit-Robo signaling was investigated as PSCs express Robo.

      • Using a combination of approaches, the authors convincingly demonstrate that Slit expression in the CBs and VM acts to support PSC positioning. A strength is the ability to knockdown slit levels in particular tissue types using the Gal4 system and RNAi.

      • Although in the analysis of robo mutants, the PSC positioning phenotype is weaker in the individual mutants (robo1 and robo2) with only the double mutant (robo1,robo2) exhibiting a phenotype comparable to the slit RNAi. The authors make a reasonable argument that Slit-Robo signaling has an intrinsic effect, likely acting within PSCs, because PSCs show a phenotype even when CBs do not (Fig 4G).

      • New insight into dorsal vessel formation by VM is presented in Fig 4A,B, as loss of the VM can affect dorsal vessel morphogenesis. This result additionally points to the VM as important.

      Weaknesses:

      • The authors are cautioned to temper the result that Slit-Robo signaling is intrinsic to PSC since loss of robo may affect other cell types (besides CBs and PSCs) to indirectly affect PSC migration/morphogenesis. In fact, in the robo2, robo1 mutant, the VM appears to be incorrectly positioned (Fig. 4G).

      We maintain our conclusion, and, we point out that the Reviewer stated, “The authors make a reasonable argument that Slit-Robo signaling has an intrinsic effect, likely acting within PSCs”. We already added a statement to the Discussion reminding the reader of the possibility of secondary defects (“Finally, it is possible that PSC cells do not intrinsically require Robo activation, but rather CB-independent PSC mis-positioning in sli or robo mutants could be a secondary defect caused by compromised Slit-Robo signaling in some other tissue.”).

      • If possible, the authors should use RNAi to knockdown Robo1 and Robo2 levels specifically in the PSCs if a Gal4 is available; might Antp.Gal4 (Fig 1K) be useful? Even if knockdown is achieved in PSCs+CBs, this would be a better/complementary experiment to support the approach outlined in Fig 4D.

      As described in our first response, use of Antp-GAL4 with RNAi would be no better than a whole animal double Robo mutant.

      • Movies are hard to interpret, as it seems unclear that the PSCs actively migrate rather than being pushed/moved indirectly due to association with VM and CBs/dorsal vessel.

      Vm does not directly contact the PSC, so the Vm cannot be physically pushing the PSC. In their original review, Reviewer #3 expressed similar concerns (Weaknesses #1 and #2), and upon their review of our revised manuscript they determined we addressed these concerns.

      Reviewer #2 (Public review):

      The paper by Nelson KA, et al. explored the collective migration, coalescence and positioning of the posterior signaling center (PSC) cells in Drosophila embryo. With live imaging, the authors observed the dynamic progress of PSC migration. Throughout this process, visceral mesoderm (VM), alary muscles (Ams) and cardioblasts (CBs) are in proximity of PSC. Genetic ablation of these tissues reveals the requirement for VM and CBs, but not AMs in this process. Genetic manipulations further demonstrated that Slit-Robo signaling was critical during PSC migration and positioning. While the genetic mechanisms of positioning the PSC were explored in much detail, including using live imaging, the functional consequence of mispositioning or (partial) absence of PSC cells has not been addressed, but would much increase the relevance of their findings. A few additional issues need to be addressed as well in this otherwise well-done study.

      Previous major points:

      (1) The only readout in their experiments is the relative correctness of PSC positioning. Importantly, what is the functional consequence if PSC is not properly positioned? This would be particularly important with robo-sli manipulations, where the PSC is present but some cells are misplaced. What is the consequence? Are the LGs affected, like specification of their cell types, structure and function? To address this for at least the robo-slit requirement in the PSC, it may be important to manipulate them directly in the PSC with a split Gal4 system, using Antp and Odd promoters.

      We state in our original response that exploring the functional consequences of PSC mis-positioning was outside the scope of this study. Given that the necessary cis-regulatory modules have not been identified at Antp or Odd, creating a split-GAL4 with ‘Antp and Odd promoters’ cannot be accomplished in a reasonable time frame, as we previously detailed in our original response.

      (2) The densely, parallel aligned fibers in the lower part of Figure 1J seemed to be visceral mesoderm, but further up (dorsally) that may be epidermis. It is possible that the PSC migrate together with the epidermis? This should be addressed.

      This was directly addressed by the additional data included in our revision. When epidermal closure is stalled, the PSC is able to migrate past the stalled leading edge, closer to the midline.

      (3) Although the authors described the standards of assessing PSC positioning as "normal" or "abnormal", it is rather subtle at times and variable in the mutant or KD/OE examples. The criteria should be more clearly delineated and analyzed double-blind, also since this is the only readout. Further examples of abnormal positioning in supplementary figures would also help.

      We addressed this comment in detail in our original response. Briefly, double-blinding was oftentimes not possible due to the obviousness of the genotype in the image. The criteria we outline for normal PSC positioning is as comprehensive as possible given the subtlety variability of mis-positioning phenotypes. Two of the authors independently analyzed the relatively large sets of samples and arrived at the same conclusions.

      (4) Discussion is very lengthy and should shortened.

      We shortened the Discussion in the revised version.

      Comments on revised version:

      Although the authors have responded to my concerns as they deemed suitable, these concerns still stand for the revised version.

      Given our responses above and the lack of detail in this comment, we are unsure why the Reviewer is still concerned.

      Reviewer #3 (Public review):

      Summary:

      This work is a detailed and thorough analysis of the morphogenesis of the posterior signaling center (PSC), a hematopoietic niche in the Drosophila larva. Live imaging is performed from the stage of PSC determination until the appearance of a compact lymph gland and PSC in the stage 16 embryo. This analysis is combined with genetic studies that clarify the involvement of adjacent tissue, including the visceral mesoderm, alary muscle, and cardioblasts/dorsal vessel. Lastly, the Slit/Robo signaling system is clearly implicated in the normal formation of the PSC.

      Strengths:

      The data are clearly presented and well documented, and fully support the conclusions drawn from the different experiments.

      The authors have addressed all of my previous comments, in particular concerning the role of epidermal cell rearrangements during dorsal closure as a possible force acting on the movement of PSC cells. The authors have clarified their definition of "collective migration" as it applies to the movement of PSC. The revised paper will make an important contribution to our understanding of the mechanisms driving morphogenesis.

      We are appreciative of the time spent by the Reviewer reading our responses and assessing the revision.

      ---------

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public Review):

      Summary:

      The study by Nelson et al. is focused on the formation of the Drosophila Posterior Signaling Center (PSC) which ultimately acts as a niche to support hematopoietic stem cells of the lymph gland (LG). Using a combination of genetics and live imaging, the authors show that PSC cells migrate as a tight collective and associate with multiple tissues during a trajectory that positions them at the posterior of the LG.

      This is an important study that identifies Slit-Robo signaling as a regulator of PSC morphogenesis, and highlights the complex relationship of interacting cell types - PSC, visceral mesoderm (VM), and cardioblasts (CBs) - in the coordinated development of these three tissues during organ development. However, one point requiring clarification is the idea that PSC cells exhibit a collective cell migration; it is not clear that the cells are migrating rather than being pushed to a more dorsal position through dorsal closure and/or other similar large-scale embryo movement. This does not detract from the very interesting analysis of PSC morphogenesis as presented.

      Since each referee asked for clarification concerning collective cell migration, we present a combined response further below, placed after the comments from Reviewer #3.

      Strengths:

      (1) Using the expression of Hid or Grim to ablate associated tissues, they find evidence that the VM and CB of the dorsal vessel affect PSC migration/morphology whereas the alary muscles do not. Slit is expressed by both VM and CBs, and therefore Slit-Robo signaling was investigated as PSCs express Robo.

      (2) Using a combination of approaches, the authors convincingly demonstrate that Slit expression in the CBs and VM acts to support PSC positioning. A strength is the ability to knockdown slit levels in particular tissue types using the Gal4 system and RNAi.

      (3) Although in the analysis of robo mutants, the PSC positioning phenotype is weaker in the individual mutants (robo1 and robo2) with only the double mutant (robo1,robo2) exhibiting a phenotype comparable to the slit RNAi. The authors make a reasonable argument that Slit-Robo signaling has an intrinsic effect, likely acting within PSCs because PSCs show a phenotype even when CBs do not (Figure 4G).

      (4) New insight into dorsal vessel formation by VM is presented in Figure 4A, B, as loss of the VM can affect dorsal vessel morphogenesis. This result additionally points to the VM as important.

      Weaknesses:

      (1) The authors are cautioned to temper the result that Slit-Robo signaling is intrinsic to PSC since the loss of robo may affect other cell types (besides CBs and PSCs) to indirectly affect PSC migration/morphogenesis. In fact, in the robo2, robo1 mutant, the VM appears to be incorrectly positioned (Figure 4G).

      We have reexamined our wording in the relevant Results section and, given that this referee agrees that we, “make a reasonable argument that Slit-Robo signaling has an intrinsic effect, likely acting within PSCs because PSCs show a phenotype even when CBs do not (Figure 4G)”, it was not clear how we might temper our conclusions more. Given that PSC cells express Robo1 and Robo2, and that the Vm does not contact the PSC, our ‘reasonable argument’ appears fair and parsimonious. Since we agree with the referee that a reader should be made as aware as possible of alternatives, we will add a comment to the Discussion, reminding the reader of the possibility of a secondary defect.

      (2) If possible, the authors should use RNAi to knockdown Robo1 and Robo2 levels specifically in the PSCs if a Gal4 is available; might Antp.Gal4 (Fig 1K) be useful? Even if knockdown is achieved in PSCs+CBs, this would be a better/complementary experiment to support the approach outlined in Figure 4D.

      While we agree that PSC-specific knockdown of Robo1 and Robo2 simultaneously would be ideal, this is not possible. First, the most-effective UAS-RNAi transgenes (that is, those in a Valium 20 backbone) are both integrated at the same chromosomal position; these cannot be simultaneously crossed with a GAL4 transgenic line to attempt double knock down. Additionally, as with all RNAi approaches that must rely on efficient knockdown over the rapid embryonic period, even having facile access to the above does not ensure the RNAi approach will cause as effective depletion as the genetic null condition that we use. Second, as the referee concedes, there is no embryonic PSC-specific GAL4. The proposed use of Antp-GAL4 would cause knockdown in many tissues (PSC, CB, Vm, epidermis and amnioserosa). This would lead to a reservation similar to that caused by our use of the straight genetic double mutant, as regards potential indirect requirement for Robo function.

      (3) Movies are hard to interpret, as it seems unclear that the PSCs actively migrate rather than being pushed/moved indirectly due to association with VM and CBs/dorsal vessel.

      First, the Vm does not directly contact the PSC, so it cannot be pushing the PSC dorsally. We will re-examine our text to be certain to make this clear. Second, in our analysis of bin mutants, which lack Vm, LGs and PSCs are able to reach the dorsal midline region in the absence of Vm. Finally, please see our response to Reviewer #3, point 2, for why we maintain that PSC cells are “migrating” even though some PSC cells are attached to CBs.

      Reviewer #2 (Public Review):

      The paper by Nelson KA, et al. explored the collective migration, coalescence, and positioning of the posterior signaling center (PSC) cells in Drosophila embryo. With live imaging, the authors observed the dynamic progress of PSC migration. Throughout this process, visceral mesoderm (VM), alary muscles (Ams), and cardioblasts (CBs) are in proximity to PSC. Genetic ablation of these tissues reveals the requirement for VM and CBs, but not AMs in this process. Genetic manipulations further demonstrated that Slit-Robo signaling was critical during PSC migration and positioning. While the genetic mechanisms of positioning the PSC were explored in much detail, including using live imaging, the functional consequence of mispositioning or (partial) absence of PSC cells has not been addressed, but would much increase the relevance of their findings. A few additional issues need to be addressed as well in this otherwise well-done study.

      Major points:

      (1) The only readout in their experiments is the relative correctness of PSC positioning. Importantly, what is the functional consequence if PSC is not properly positioned? This would be particularly important with robo-sli manipulations, where the PSC is present but some cells are misplaced. What is the consequence? Are the LGs affected, like the specification of their cell types, structure, and function? To address this for at least the robo-slit requirement in the PSC, it may be important to manipulate them directly in the PSC with a split Gal4 system, using Antp and Odd promoters.

      We agree that the functional consequence of PSC mis-positioning is important and a relevant question to eventually address. However, virtually all markers and reagents used to assess the effect of the PSC on progenitor cells and their differentiated descendants are restricted to analyses carried out on the third larval instar - some three days after the experiments reported here. Most of the manipulated conditions in our work are no longer viable at this phase and, thus, addressing the functional consequences of a malformed PSC will require the field to develop new tools. 

      As we noted in the Introduction, the consistency with which the wildtype PSC forms as a coalesced collective at the posterior of the LG strongly suggests importance of its specific positioning and shape, as has now been found for other niches (citations in manuscript). Additionally, in the Discussion we mention the existence of a gap junction-dependent calcium signaling network in the PSC that is important for progenitor maintenance. Without continuity of this network amongst all PSC cells (under conditions of PSC mis-positioning), we strongly anticipate that the balance of progenitors to differentiated hemocytes will be mis-managed, either constitutively, and / or under immune challenge conditions. 

      Finally, to our knowledge, the tools do not exist to build a “split Gal4 system using Antp and Odd promoters”. The expression pattern observed using the genomic Antp-GAL4 line must be driven by endogenous enhancers–none of which have been defined by the field, and thus cannot be used in constructing second order drivers. Similarly, for odd skipped, in the embryo the extant Odd-GAL4 driver expresses only in the epidermis, with no expression in the embryonic LG. Thus, the cis regulatory element controlling Odd expression in the embryonic LG is unknown. In the future, the discovery of an embryonic PSC-specific driver will aid in addressing the specific functional consequences of PSC mis-positioning.

      (2) The densely, parallel aligned fibers in the part of Figure 1J seemed to be visceral mesoderm, but further up (dorsally) that may be epidermis. It is possible that the PSC migrate together with the epidermis? This should be addressed.

      See response to Reviewer #3.

      (3) Although the authors described the standards of assessing PSC positioning as "normal" or "abnormal", it is rather subtle at times and variable in the mutant or KD/OE examples. The criteria should be more clearly delineated and analyzed double-blind, also since this is the only readout. Further examples of abnormal positioning in supplementary figures would also help.

      We appreciate the Reviewer’s concern and acknowledge that the phenotypes we observed were indeed variable, and, at times subtle. As we show and discuss in the paper, our results revealed that the signaling requirements for proper PSC positioning are complex; this was favorably commented upon by Reviewer #1 (“...highlights the complex relationship of interacting cell types - PSC, visceral mesoderm (VM), and cardioblasts (CBs) - in the coordinated development of these three tissues during organ development.…”). We suspect the phenotypic variability is attributable to any number of biological differences such as heterogeneity of PSC cells and an accompanying difference in the timing of their competence to receive and respond to Slit-Robo signaling, the timing of release of Slit from CBs and Vm, number of cells in a given PSC, which PSC cells in the cluster respond to too little or too much signaling, and/or typical variability between organisms. Furthermore, PSC positioning analyses were conducted by two of the authors, who independently came to the same conclusions. For many of the manipulations double blinding was not possible since the genotype of the embryo was discernible due to the obvious phenotype of the manipulated tissue.

      (4) The Discussion is very lengthy and should shortened.

      We will re-examine the prose and emphasize more conciseness, while maintaining clarity for the reader.

      Reviewer #3 (Public Review):

      Summary:

      This work is a detailed and thorough analysis of the morphogenesis of the posterior signaling center (PSC), a hematopoietic niche in the Drosophila larva. Live imaging is performed from the stage of PSC determination until the appearance of a compact lymph gland and PSC in the stage 16 embryo. This analysis is combined with genetic studies that clarify the involvement of adjacent tissue, including the visceral mesoderm, alary muscle, and cardioblasts/dorsal vessels. Lastly, the Slit/Robo signaling system is clearly implicated in the normal formation of the PSC.

      Strengths:

      The data are clearly presented, well documented, and fully support the conclusions drawn from the different experiments. The manuscript differs in character from the mainstay of "big data" papers (for example, no sets of single-cell RNAseq data of, for instance, PSC cells with more or less Slit input, are offered), but what it lacks in this regard, it makes up in carefully planned and executed visualizations and genetic manipulations.

      Weaknesses:

      A few suggestions concerning improvement of the way the story is told and contextualized.

      (1) The minute cluster of PSC progenitors (5 or so cells per side) is embedded (as known before and shown nicely in this study) in other "migrating" cell pools, like the cardioblasts, pericardial cells, lymph gland progenitors, alary muscle progenitors. These all appear to move more or less synchronously. What should also be mentioned is another tissue, the dorsal epidermis, which also "moves" (better: stretches?) towards the dorsal midline during dorsal closure. Would it be reasonable to speculate (based on previously published data) that without the force of dorsal closure, operating in the epidermis, at least the lateral>medial component of the "migration" of the PSC (and neighboring tissues) would be missing? If dorsal closure is blocked, do essential components of PSC and lymph gland morphogenesis (except for the coming-together of the left and right halves) still occur? Are there any published data on this?

      Each of the Reviewers is interested in our response to this very relevant question, and, thus, we will address the issue en bloc here. First, we will add a Supplementary Figure showing that LG and CBs are still able to progress medially towards the dorsal midline when dorsal closure stalls.  This rules out any major effect for the most prominent “large-scale embryo cell sheet movement” in positioning the PSC. Second, published work by Haack et. al. and Balaghi et. al. shows that CBs and leading edge epidermal cells are independently migratory, and we will add this context to the manuscript for the reader.

      (2) Along similar lines: the process of PSC formation is characterized as "migration". To be fair: the authors bring up the possibility that some of the phenotypes they observe could be "passive"/secondary: "Thus, it became important to test whether all PSC phenotypes might be 'passive', explained by PSC attachment to a malforming dorsal vessel. Alternatively, the PSC defects could reflect a requirement for Robo activation directly in PSC cells." And the issue is resolved satisfactorily. But more generally, "cell migration" implies active displacement (by cytoskeletal forces) of cells relative to a substrate or to their neighbors (like for example migration of hemocytes). This to me doesn't seem really clearly to happen here for the dorsal mesodermal structures. Couldn't one rather characterize the assembly of PSC, lymph gland, pericardial cells, and dorsal vessel in terms of differential adhesion, on top of a more general adhesion of cells to each other and the epidermis, and then dorsal closure as a driving force for cell displacement? The authors should bring in the published literature to provide a background that does (or does not) justify the term "migration".

      Before addressing this specifically, we remind readers of our response above that states the rationale ruling out large, embryo-scale movements, such as epidermal dorsal closure, in driving PSC positioning. So, how are PSC cells arriving at their reproducible position? This manuscript reports the first live-imaging of the PSC as it comes to be positioned in the embryo. We interpret these movies to suggest strongly that these cells are a ‘collective’ that migrates. Neither the data, nor we, are asserting that each PSC cell is ‘individually’ migrating to its final position. Rather, our data suggest that the PSC migrates as a collective. The most paradigmatic example of directed, collective cell migration, is of Drosophila ovarian border cells. That cell cluster is surrounded at all times by other cells (nurse cells, in that case), and for the collective to traverse through the tissue, the process requires constant remodeling of associations amongst the migrating cells in the collective (the border cells), as well as between cells in the collective and those outside of it (the nurse cells). In fact, the nurse cells are considered the substrate upon which border cells migrate. Note also that in collective border cell migration cells within the collective can switch neighbors, suggesting dynamic changes to cell associations and adhesions. 

      In our analysis, the PSC cells exhibit qualities reminiscent of the border cells, and thus we infer that the PSC constitutes a migratory cell collective.  We also show in Figure 1H that PSC cells exhibit cellular extensions, and thus have a very active, intrinsic actin-based cytoskeleton. In fact, in Figure 1I, we point out that PSC cells shift position within the collective, which is not only a direct feature of migration, but also occurs within the border cell collective as that collective migrates. Additionally, the fact that the lateral-most PSC cells shift position in the collective while remaining a part of the collective–and they do this while executing net directional movement–makes a strong argument that the PSC is migratory, as no cell types other than PSCs are contacting the surfaces of those shifting PSC cells. Lastly, the Reviewer’s supposition that, rather than migration, dorsal mesoderm structures form via “differential adhesion, on top of a more general adhesion of cells to each other” is, actually, precisely an inherent aspect of collective cell migration as summarized above for the ovarian border collective.

      In our resubmission we will adjust text citing the existing literature to better put into context the reasoning for why PSC formation based on our data is an example of collective cell migration.

      (3) That brings up the mechanistic centerpiece of this story, the Slit/Robo system. First: I suggest adding more detailed data from the study by Morin-Poulard et al 2016, in the Introduction, since these authors had already implicated Slit-Robo in PSC function and offered a concrete molecular mechanism: "vascular cells produce Slit that activates Robo receptors in the PSC. Robo activation controls proliferation and clustering of PSC cells by regulating Myc, and small GTPase and DE-cadherin activity, respectively". As stated in the Discussion: the mechanism of Slit/Robo action on the PSC in the embryo is likely different, since DE-cadherin is not expressed in the embryonic PSC; however, it maybe not be THAT different: it could also act on adhesion between PSC cells themselves and their neighbors. What are other adhesion proteins that appear in the late lateral mesodermal structures?

      Could DN-cadherin or Fasciclins be involved?

      We agree with the Reviewer that Slit-Robo signaling likely acts in part on the PSC by affecting PSC cell adhesion to each other and/or to CBs (lines 428-435). As stated in the Discussion, we do not observe Fasciclin III expression in the PSC until late stages when the PSC has already been positioned, suggesting that Fasciclin III is not an active player in PSC formation. Assessing whether the PSC expresses any other of the suite of potential cell adhesion molecules such as DN-Cadherin or other Fasciclins, and then study their potential involvement in the Slit-Robo pathway in PSC cells, would be part of a follow-up study.  

      Recommendations for the authors:

      Reviewing Editor Comments:

      The authors are encouraged to address several key issues and provide more explicit clarification when interpreting the behavior of the PSC cells as "migration." It is recommended that the authors engage with all reviewers' comments and refine the text based on the feedback they find valuable.

      Reviewer #1 (Recommendations For The Authors):

      Major concerns:

      (1) Is it possible to assay robo1 and/or robo1 RNAi in a tissue-specific manner to further explore an intrinsic role in the PSC? Might the VM indirectly affect PSCs in a CB-independent manner? How does this affect the interpretation of results in Figure 4.

      See also our response to Reviewer #1, Public review weaknesses #2.

      Though we agree with the Reviewer that this is the better experiment to test for an intrinsic role for Robo in the PSC, this experiment is not possible at this time. As we noted in the manuscript, we do not yet have an embryonic PSC-specific GAL4, though we have been putting efforts towards identifying/developing such a tool. The Antp-GAL4 driver we used in this study will drive not only in both PSCs and CBs, but also in Vm, epidermis, and amnioserosa, as well as other tissues. The other available embryonic PSC drivers are not specific to the PSC and will drive expression in CBs and Vm, at minimum. This, combined with the reality that RNAi can be ineffective in embryonic tissues, resulted in our use of whole organism mutants to best address this question. 

      We acknowledge that it is possible the Vm indirectly effects the PSC in a CB-independent manner in the double Robo mutant, and we added a statement to the Discussion reiterating this point. However, because the PSC expresses Robo1 and Robo2, we maintain that the simplest interpretation of the results in Figure 4 is that PSC cells require intrinsic Robo signaling. And, as we state in the manuscript, it is possible that Slit signals directly from Vm to Robo on the PSC.

      (2) As this is the first study to be presenting PSC formation as involving collective cell migration, can the authors provide experimental evidence and rationale for this categorization?

      We have added our rationale to the Results section in the revision.

      See also our response to Reviewer #3, Public review weakness #2.

      (3) The Slit staining presented in Fig 3 W', Z' should be quantified. Furthermore, what is the VM phenotype when Robo1 is overexpressed? Is there a VM-specific phenotype and could this indirect effect cause the PSC to misform/mismigrate?

      We didn’t quantify Slit levels in the Vm-specific Robo overexpression condition because there was a visually striking difference compared to controls (increased intensity and specific localization to Vm membranes), and the manipulation resulted in a PSC phenotype. Thus, the evidence we show appears sufficient to strongly suggest that our genetic manipulation resulted in successful trapping of Slit on the Vm.

      As to a Vm phenotype when Robo1 is overexpressed Vm-specifically: we know Vm is present, but we haven’t performed an in-depth phenotypic analysis. In the manuscript we show that this manipulation at least affects organization of PSC-adjacent CBs, which we go on to show is correlated with mis-positioned PSCs. Thus, the PSC phenotype in this condition is not solely due to a Vm-specific phenotype.

      Minor concerns/suggestions:

      (1) I might have missed it but where are the Movies referenced in the text? Are legends provided for the videos? It is important that this is included in the final version (or more clearly presented if I missed it).

      We thank you the Reviewer for pointing this out; we now direct the reader to the movies at appropriate places within the text.

      (2) In Figure 5, it might be helpful to add a third column to A in which the PSCs are pseudo-colored and thus highlighted because it is difficult to discern the white (not pink) PSCs...

      We appreciate the suggestion and now include these panels as Figure 5A’’ in the revision.

      (3) If I am following correctly, the lost PSC cells in Figure 5 don't move. Doesn't this suggest that what is critical is that the PSCs attach to the VM and/or CBs, and not necessarily that they are an actively migrating cell type? They "move" but might be passively carried.

      See also the response to Reviewer #3, Public reviews weaknesses #2.

      The Reviewer is correct that the PSC cells in Fig. 5 don’t move very much, but we interpret this differently from the Reviewer. After detachment of the cells in question they undergo dramatic shape changes, indicating active cytoskeletal remodeling, so the molecular machinery needed for migration appears to remain intact. Thus, we suggest that this observation actually emphasizes our finding that collectivity is needed for the migration. Given the consistency of PSC coalescence/collectivity and the intricate regulation that controls it, we believe it to be an integral part of PSC identity. When PSC cells become detached, they likely lose an aspect of their identity. In various manipulations we’ve noted instances of severely dispersed PSC cells expressing very low levels of identity markers Antp or Odd. Cells in such cases are likely compromised for their function, and this can include, for example, whether they can properly sense cues for migration.

      Reviewer #2 (Recommendations For The Authors):

      Minor points:

      (1) The expression pattern of Antp-Gal4 > myrGFP in the whole embryo should be shown to better demonstrate the overlap with Odd. How does it compare with Antp-Gal4 > CD8::GFP?

      We do not understand the question posed. We are not suggesting that Antp and Odd overlap in all cells, nor even many cells. It has been demonstrated by the field that co-expression among mesodermal cells, in the position where LG cells are specified, is a marker for the PSC. We have not thoroughly investigated all reporter lines for the GAL4 drivers used by the field.

      (2) Does Tincdelta4-Gal4 not at all express in the PSC? This should be verified.

      This question appears to refer to depletion of Slit by RNAi or cell killing driven by tinCΔ4-GAL4. TinCΔ4-GAL4 is expressed in CBs and in precisely 1 embryonic PSC cell. First, Slit isn’t expressed by any PSC cells to our eye, so any PSC mis-positioning observed upon tinCΔ4>Sli RNAi implicates CB involvement in PSC positioning. In designing tests for CB involvement, we were unable to identify any mutant known to lack CBs (or have fewer CBs) that didn’t also affect specification of the LG/PSC. The cell killing approach seemed best.  It is possible that, in this scenario, perhaps ablation of a single, key PSC cell could affect final positioning of the other PSCs, but we think that less likely than a role for CBs. We also retain our original conclusion due to the fact that we often find mis-positioned PSC cells adjacent to mis-positioned CBs, including in the panel representing the CB ablation experiment, Figure 2S.  

      (3) Line 212: The data provide evidence that Vm is necessary, but clearly not sufficient, as CBs are also necessary.

      We see how this wording was misleading and have adjusted the text accordingly.

      (4) The CBs are not visible in Figure 3B.

      We are unsure what the Reviewer is referring to, as we are certain that the signal between the blue outlines is indeed Slit expression in CBs.

      Reviewer #3 (Recommendations For The Authors):

      One minor mistake (I believe): in line 229 it should say "3C and 3D"

      We have corrected this error.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews

      Reviewer #1 (Public Review): 

      (1) Although the theory is based on memory, it also is based on spatially-selective cells.

      Not all cells in the hippocampus fulfill the criteria of place/HD/border/grid cells, and place a role in memory. E.g., Tonegawa, Buszaki labs' work does not focus on only those cells, and there are certainly a lot of non-pure spatial cells in monkeys (Martinez-Trujillo) and humans (iEEG). Does the author mainly focus on saying that "spatial cells" are memory, but do not account for non-spatial memory cells? This seems to be an incomplete account of memory - which is fine, but the way the model is set up suggests that *all* memory is, place (what/where), and non-spatial attributes ("grid") - but cells that don't fulfil these criteria in MTL (Diehl et al., 2017, Neuron; non-grid cells; Schaeffer et al., 2022, ICML; Luo et al., 2024, bioRxiv) certainly contribute to memory, and even navigation. This is also related to the question of whether these cell definitions matter at all (Luo et al., 2024). The authors note "However, this memory conjunction view of the MTL must be reconciled with the rodent electrophysiology finding that most cells in MTL appear to have receptive fields related to some aspect of spatial navigation (Boccara et al., 2010; Grieves & Jeffery, 2017). The paucity of non-spatial cells in MTL could be explained if grid cells have been mischaracterized as spatial." Is the author mainly talking about rodent work?

      There is a new section in the introduction that deals with these issues, titled ‘Why Model the Rodent Navigation Literature with a Memory Model?’ That section reads:

      “Spatial navigation is inherently a memory problem – learning the spatial arrangement of a new enclosure requires memory for the conjunction of what and where. This has long been realized and in the introduction to ‘Hippocampus as a Cognitive Map’, O’Keefe and Nadel (1978) wrote “We shall argue that the hippocampus is the core of a neural memory system providing an objective spatial framework within which the items and events of an organism's experience are located and interrelated” (emphasis added). Furthermore, in the last chapter of their book, they extended cognitive map theory to human memory for non-spatial characteristics. However, in the decades since the development of cognitive map theory, the rodent spatial navigation and human memory literatures have progressed somewhat independently.

      The ideas proposed in this model are an attempt to reunify these literatures by returning to the original claim that spatial navigation is inherently a memory problem. The goal of the current study is to explain the rodent spatial navigation literature using a memory model that has the potential to also explain the human memory literature. In contrast, most grid cell models (Bellmund et al., 2016; Bush et al., 2015; Castro & Aguiar, 2014; Hasselmo, 2009; Mhatre et al., 2012; Solstad et al., 2006; Sorscher et al., 2023; Stepanyuk, 2015; Widloski & Fiete, 2014) are domain specific models of spatial navigation and as such, they do not lend themselves to explanations of human memory. Thus, the reason to prefer this model is parsimony. Rather than needing to develop a theory of memory that is separate from a theory of spatial navigation, it might be possible to address both literatures with a unified account.

      This study does not attempt to falsify other theories of grid cells. Instead, this model reaches a radically different interpretation regarding the function of grid cells; an interpretation that emerges from viewing spatial navigation as a memory problem. All other grid cell models assume that an entorhinal grid cell displaying a spatially arranged grid of firing fields serves the function of spatial coding (i.e., spatial grid cells exist to support a spatial metric). In contrast, the proposed memory model of grid cells assumes that the hexagonal tiling reflects the need to keep memories separate from each other to minimize confusion and confabulation – the grid pattern is the byproduct of pattern separation between memories rather than the basis of a spatial code. 

      It is now understood that grid-like firing fields can occur for non-spatial twodimensional spaces. For instance, human entorhinal cortex exhibits grid-like responses to video morph trajectories in a two-dimensional bird neck-length versus bird leg-length space (Constantinescu et al., 2016). As a general theory of learning and memory, the proposed memory model of grid cells is easily extended to explain these results (e.g., relabeling the border cell inputs in the model as neck-length and leg-length inputs). However, there are other grid cell models that can explain both spatial grid cells as well as non-spatial grid-like responses (Mok & Love, 2019; Rodríguez-Domínguez & Caplan, 2019; Stachenfeld et al., 2017; Wei et al., 2015). Similar to this memory model of grid cells, these models are also positioned to explain both the rodent spatial navigation and human memory literatures. Nevertheless, there is a key difference between this model and other grid cell models that generalize to non-spatial representations. Specifically, these other models assume that grid cells exhibiting spatial receptive fields serve the function of identifying positions in the environment (i.e., their function is spatial). As such, these models do not explain why most of the input to rodent hippocampus appears to be spatial (Boccara et al., 2010; Diehl et al., 2017; Grieves & Jeffery, 2017). This memory model of grid cells provides an answer to the apparent paucity of nonspatial cell types in rodent MTL by proposing that grid cells with spatial receptive fields have been misclassified as spatial (they are what cells rather than where cells) and that place cells are fundamentally memory cells that conjoin what and where.”

      (2) Related to the last point, how about non-grid multi-field mEC cells? In theory, these also should be the same; but the author only presents perfect-look grid cells. In empirical work, clearly, this is not the case, and many mEC cells are multi-field non-grid cells (Diehl et al., 2017). Does the model find these cells? Do they play a different role? As noted by the author "Because the non-spatial attributes are constant throughout the two-dimensional surface, this results in an array of discrete memory locations that are approximately hexagonal (as explained in the Model Methods, an "online" memory consolidation process employing pattern separation rapidly turns an approximately hexagonal array into one that is precisely hexagonal). " If they are indeed all precisely hexagonal, does that mean the model doesn't have non-grid spatial cells? 

      Grid cells with irregular firing fields are now considered in the discussion with the following paragraphs

      “According to this model, hexagonally arranged grid cells should be the exception rather than the rule when considering more naturalistic environments. In a more ecologically valid situation, such as with landmarks, varied sounds, food sources, threats, and interactions with conspecifics, there may still be remembered locations were events occurred or remembered properties can be found, but because the non-spatial properties are non-uniform in the environment, the arrangement of memory feedback will be irregular, reflecting the varied nature of the environment. This may explain the finding that even in a situation where there are regular hexagonal grid cells, there are often irregular non-grid cells that have a reliable multi-location firing field, but the arrangement of the firing fields is irregular (Diehl et al., 2017). For instance, even when navigating in an enclosure that has uniform properties as dictated by experimental procedures, they may be other properties that were not well-controlled (e.g., a view of exterior lighting in some locations but not others), and these uncontrolled properties may produce an irregular grid (i.e., because the uncontrolled properties are reliably associated with some locations but not others, hippocampal memory feedback triggers retrieval of those properties in the associations locations).

      In this memory model, there are other situations in which an irregular but reliable multilocation grid may occur, even when everything is well controlled. In the reported simulations, when the hippocampal place cells were based on variation in X/Y (as defined by Border cells), nothing else changed as a function of location, and the model rapidly produced a precise hexagonal arrangement of hippocampal place cell memories. When head direction was included (i.e., real-world variation in X, Y, and head direction), the model still produced a hexagonal arrangement as per face-centered cubic packing of memories, but this precise arrangement was slower to emerge, with place cells continuing to shift their positions until the borders of the enclosure were sufficiently well learned from multiple viewpoints. If there is real-world variation in four or more dimensions, as is likely the case in a more ecologically valid situation, it will be even harder for place cell memories to settle on a precise regular lattice. Furthermore, in the case of four dimensions, mathematicians studying the “sphere packing problem” recently concluded that densest packing is irregular (Campos et al., 2023). This may explain why the multifield grid cells for freely flying bats have a systematic minimum distance between firing fields, but their arrangement is globally irregular (Ginosar et al., 2021). Assuming that the memories encoded by a bat include not just the three real-world dimensions of variation, but also head direction, the grid will likely be irregular even under optimal conditions of laboratory control.”

      (3) Theoretical reasons for why the model is put together this way, and why grid cells must be coding a non-spatial attribute: Is this account more data-driven (fits the data so formulated this way), or is it theoretical - there is a reason why place, border, grid cells are formulated to be like this. For example, is it an efficient way to code these variables? It can be both, like how the BVC model makes theoretical sense that you can use boundaries to determine a specific location (and so place cell), but also works (creates realistic place cells). 

      The motivation for this model is now articulated in the new section, quoted above, titled ‘Why Model the Rodent Navigation Literature with a Memory Model?’ Regarding the assumption that border cells provide a spatial metric, this assumption is made for the same reasons as in the BVC model. Regarding this, the text said: “These assumptions regarding border cells are based on the boundary vector cell (BVC) model of Barry et al. (2006). As in the BVC model, combinations of border cells encode where each memory occurred in the realworld X/Y plane.”. A new sentence is added to model methods, stating: “This assumption is made because border cells provide an efficient representation of Euclidean space (e.g., if the animal knows how far it is from different walls of the enclosure, this already available information can be used to calculate location).”

      But in this case, the purpose of grid cell coding a non-spatial attribute, and having some kind of system where it doesn't fire at all locations seems a little arbitrary. If it's not encoding a spatial attribute, it doesn't have to have a spatial field. For example, it could fire in the whole arena - which some cells do (and don't pass the criteria of spatial cells as they are not spatially "selective" to another location, related to above).  

      Some cells have a constant high firing rate, but they are the exception rather than the rule. More typically, cells habituate in the presence of ongoing excitatory drive and by doing so become sensitive to fluctuations in excitatory drive. Habituation is advantageous both in terms of metabolic cost and in terms of function (i.e., sensitivity to change). This is now explained in the following paragraph:

      “In theory, a cell representing a non-spatial attribute found at all locations of an enclosure (aka, a grid cell in the context of this model), could fire constantly within the enclosure. However, in practice, cells habituate and rapidly reduce their firing rate by an order of magnitude when their preferred stimulus is presented without cessation (Abbott et al., 1997; Tsodyks & Markram, 1997). After habituation, the firing rate of the cell fluctuates with minor variation in the strength of the excitatory drive. In other words, habituation allows the cell to become sensitive to changes in the excitatory drive (Huber & O’Reilly, 2003). Thus, if there is stronger top-down memory feedback in some locations as compared to others, the cell will fire at a higher rate in those remembered locations rather than in all locations even though the attribute is found at all locations. In brief when faced with constant excitatory drive, the cell accommodates, and becomes sensitive to change in the magnitude of the excitatory drive. In the model simulation, this dynamic adaptation is captured by supposing that cells fire 5% of the time on-average across the simulation, regardless of their excitatory inputs.”

      (4) Why are grid cells given such a large role for encoding non-spatial attributes? If anything, shouldn't it be lateral EC or perirhinal cortex? Of course, they both could, but there is less reason to think this, at least for rodent mEC.  

      This is a good point and the following paragraph has been added to the introduction to explain that lateral EC is likely part of the explanation. But even when including lateral EC, it still appears that most of the input to hippocampus is spatial.

      “One possible answer to the apparent lack of non-spatial cells in MTL is to highlight the role of the lateral entorhinal cortex (LEC) as the source of non-spatial what information for memory encoding (Deshmukh & Knierim, 2011). LEC can be contrasted with mEC, which appears to only provide where information (Boccara et al., 2010a; Diehl et al., 2017). Although it is generally true that LEC is involved in non-spatial processing, there is evidence that LEC provides some forms of spatial information (Knierim et al., 2014). The kind of non-spatial information provided by LEC appears to be in relation to objects (Connor & Knierim, 2017; Wilson et al., 2013). However, in a typical rodent spatial navigation study there are no objects within the enclosure. Thus, although the distinction between mEC and LEC is likely part of the explanation, it is still the case that rodent entorhinal input to hippocampus appears to heavily favor spatial information.”

      (5) Clarification: why do place cells and grid cells differ in terms of stability in the model? Place cells are not stable initially but grid cells come out immediately. They seem directly connected so a bit unclear why; especially if place cell feedback leads to grid cell fields. There is an explanation in the text - based on grid cells coding the on-average memories, but these should be based on place cell inputs as well. So how is it that place fields are unstable then grid fields do not move at all? I wonder if a set of images or videos (gifs) showing the differences in spatial learning would be nice and clarify this point.  

      In this revision, I provide a new video focused on learning of place cell memories that include head direction. This second video is in relation to the results reported in Figure 9. The short answer is that the grid fields for the non-spatial cell are based on the average across several view-dependent memories (i.e., across several place cells that have head direction sensitivity) and the average is reliable even if the place cells are unstable. The text of this explanation now reads:

      “Why was the grid immediately apparent for the non-spatial attribute cell whereas the grid took considerable prior experience for the head direction cells? The answer relates to memory consolidation and the shifting nature of the hippocampal place cells. Head direction cells only produced a reliable grid once the hippocampal place cells (aka, memory cells) assumed stable locations. During the first few sessions, the hippocampal place cells were shifting their positions owing to pattern separation and consolidation. But once the place cells stabilized, they provided reliable top-down memory feedback to the head direction cells in some places but not others, thus producing a reliable grid arrangement to the firing maps of the head direction cells. In other words, for the head direction cells, the grid only appeared once the place cells stabilized. This slow stabilization of place fields is a known property (Bostock et al., 1991; Frank et al., 2004).

      In the simulation, the place cells did not stabilize until a sufficient number of place cells were created (Figure 9C). Specifically, these additional memories were located immediately outside the enclosure, around all borders (Figure 9D). These “outside the box” memories served to constrain the interior place cells, locking them in position despite ongoing consolidation. This dynamic can be seen in a movie showing a representative simulation. The movie shows the positions of the head direction sensitive place cells during initial learning, and then during additional sessions of prior experience as the movie speeds up (see link in Figure 9 capture).

      Why did the non-spatial grid cell (k) produce a grid immediately, before the place cells stabilized? As discussed in relation to Figure 8, the non-spatial grid cell is the projection through the 3D volume of real-world coordinates that includes X, Y, and head direction. Each grid field of a non-spatial grid cell reflects feedback from several place cells that each have a different head direction sensitivity (see for instance the allocentric pairs of memories illustrated in Figure 8C and 8D). Thus, each grid field is the average across several memories that entail different viewpoints and this averaging across memories provides stability even if the individual memories are not yet stable. This average of unstable memories produces a blurry sort of grid pattern without any prior experience.

      A final piece of the puzzle relies on the same mechanism that caused the grid pattern to align with the borders as reported in the results of Figures 6 and 7. Specifically, there are some “sticky” locations with ongoing consolidation because the connection weights are bounded. Because weights cannot go below their minimum or above their maximum, it is slightly more difficult for consolidation to push or pull connection weights over the peak value or under the minimum value of the tuning curve. Thus, the place cells tend to linger in locations that correspond to the peak or trough of a border cell. There are multiple peak and trough locations but for the parameter values in this simulation, the grid pattern seen in Figure 9C shows the set of peak/trough locations that satisfy the desired spacing between memories. Thus, the average across memories shows a reliable grid field at these locations even though the memories are unstable.”

      (6) Other predictions. Clearly, the model makes many interesting (and quite specific!) predictions. But does it make some known simple predictions? 

      • More place cells at rewarded (or more visited) locations. Some empirical researchers seem to think this is not as obvious as it seems (e.g., Duvellle et al., 2019; JoN; Nyberg et al., 2021, Neuron Review).  

      • Grid cell field moves toward reward (Butler et al., 2019; Boccera et al., 2019).  

      • Grid cells deform in trapezoid (Krupic et al., 2015) and change in environments like mazes (Derikman et al., 2014).  

      Thank you for these suggestions and I have added the following paragraph to the discussion:

      “In terms of the animal’s internal state, all locations in the enclosure may be viewed as equally aversive and unrewarding, which is a memorable characteristic of the enclosure. Reward, or lack thereof, is arguably one of the most important nonspatial characteristics and application of this model to reward might explain the existence of goal-related activity in place cells (Hok et al., 2007; although see Duvelle et al., 2019), reflecting the need to remember rewarding locations for goal directed behavior. Furthermore, if place cell memories for a rewarding location activate entorhinal grid cells, this may explain the finding that grid cells remap in an enclosure with a rewarded location such that firing fields are attracted to that location (Boccara et al., 2019; Butler et al., 2019). Studies that introduce reward into the enclosure are an important first step in terms of examining what happens to grid cells when the animal is placed in a more varied environment.”

      Regarding the changes in shape of the environment, this was discussed in the section of the paper that reads “As seen in Figure 12, because all but one of the place cells was exterior when the simulated animal was constrained to a narrow passage, the hippocampal place cell memories were no longer arranged in a hexagonal grid. This disruption of the grid array for narrow passages might explain the finding that the grid pattern (of grid cells) is disrupted in the thin corner of a trapezoid (Krupic et al., 2015) and disrupted when a previously open enclosure is converted to a hairpin maze by insertion of additional walls within the enclosure (Derdikman et al., 2009).” This particular section of the paper now appears in the Appendix and Figure 12 is now Appendix Figure 2.

      Reviewer #2 (Public Review): 

      The manuscript describes a new framework for thinking about the place and grid cell system in the hippocampus and entorhinal cortex in which these cells are fundamentally involved in supporting non-spatial information coding. If this framework were shown to be correct, it could have high impact because it would suggest a completely new way of thinking about the mammalian memory system in which this system is non-spatial. Although this idea is intriguing and thought-provoking, a very significant caveat is that the paper does not provide evidence that specifically supports its framework and rules out the alternate interpretations. Thus, although the work provides interesting new ideas, it leaves the reader with more questions than answers because it does not rule out any earlier ideas. 

      Basically, the strongest claim in the paper, that grid cells are inherently non-spatial, cannot be specifically evaluated versus existing frameworks on the basis of the evidence that is shown here. If, for example, the author had provided behavioral experiments showing that human memory encoding/retrieval performance shifts in relation to the predictions of the model following changes in the environment, it would have been potentially exciting because it could potentially support the author's reconceptualization of this system. But in its current form, the paper merely shows that a new type of model is capable of explaining the existing findings. There is not adequate data or results to show that the new model is a significantly better fit to the data compared to earlier models, which limits the impact of the work. In fact, there are some key data points in which the earlier models seem to better fit the data.  

      Overall, I would be more convinced that the findings from the paper are impactful if the author showed specific animal memory behavioral results that were only supported by their memory model but not by a purely spatial model. Perhaps the author could run new experiments to show that there are specific patterns of human or animal behavior that are only explained by their memory model and not by earlier models. But in its current form, I cannot rule out the existing frameworks and I believe some of the claims in this regard are overstated. 

      As previously detailed in Box 1 and as explained in the text in several places, the model provides an explanation of several findings that remain unexplained by other theories (see “Results Uniquely Explained by the Memory Model”). But more generally this is a good point, and the initial draft failed to fully articulate why a researcher might choose this model to guide future empirical investigations. A new section in the introduction that deals with these issues, titled ‘Why Model the Rodent Navigation Literature with a Memory Model?’ That section reads:

      “Spatial navigation is inherently a memory problem – learning the spatial arrangement of a new enclosure requires memory for the conjunction of what and where. This has long been realized and in the introduction to ‘Hippocampus as a Cognitive Map’, O’Keefe and Nadel (1978) wrote “We shall argue that the hippocampus is the core of a neural memory system providing an objective spatial framework within which the items and events of an organism's experience are located and interrelated” (emphasis added). Furthermore, in the last chapter of their book, they extended cognitive map theory to human memory for non-spatial characteristics. However, in the decades since the development of cognitive map theory, the rodent spatial navigation and human memory literatures have progressed somewhat independently.

      The ideas proposed in this model are an attempt to reunify these literatures by returning to the original claim that spatial navigation is inherently a memory problem. The goal of the current study is to explain the rodent spatial navigation literature using a memory model that has the potential to also explain the human memory literature. In contrast, most grid cell models (Bellmund et al., 2016; Bush et al., 2015; Castro & Aguiar, 2014; Hasselmo, 2009; Mhatre et al., 2012; Solstad et al., 2006; Sorscher et al., 2023; Stepanyuk, 2015; Widloski & Fiete, 2014) are domain specific models of spatial navigation and as such, they do not lend themselves to explanations of human memory. Thus, the reason to prefer this model is parsimony. Rather than needing to develop a theory of memory that is separate from a theory of spatial navigation, it might be possible to address both literatures with a unified account.

      This study does not attempt to falsify other theories of grid cells. Instead, this model reaches a radically different interpretation regarding the function of grid cells; an interpretation that emerges from viewing spatial navigation as a memory problem. All other grid cell models assume that an entorhinal grid cell displaying a spatially arranged grid of firing fields serves the function of spatial coding (i.e., spatial grid cells exist to support a spatial metric). In contrast, the proposed memory model of grid cells assumes that the hexagonal tiling reflects the need to keep memories separate from each other to minimize confusion and confabulation – the grid pattern is the byproduct of pattern separation between memories rather than the basis of a spatial code. 

      It is now understood that grid-like firing fields can occur for non-spatial twodimensional spaces. For instance, human entorhinal cortex exhibits grid-like responses to video morph trajectories in a two-dimensional bird neck-length versus bird leg-length space (Constantinescu et al., 2016). As a general theory of learning and memory, the proposed memory model of grid cells is easily extended to explain these results (e.g., relabeling the border cell inputs in the model as neck-length and leg-length inputs). However, there are other grid cell models that can explain both spatial grid cells as well as non-spatial grid-like responses (Mok & Love, 2019; Rodríguez-Domínguez & Caplan, 2019; Stachenfeld et al., 2017; Wei et al., 2015). Similar to this memory model of grid cells, these models are also positioned to explain both the rodent spatial navigation and human memory literatures. Nevertheless, there is a key difference between this model and other grid cell models that generalize to non-spatial representations. Specifically, these other models assume that grid cells exhibiting spatial receptive fields serve the function of identifying positions in the environment (i.e., their function is spatial). As such, these models do not explain why most of the input to rodent hippocampus appears to be spatial (Boccara et al., 2010; Diehl et al., 2017; Grieves & Jeffery, 2017). This memory model of grid cells provides an answer to the apparent paucity of nonspatial cell types in rodent MTL by proposing that grid cells with spatial receptive fields have been misclassified as spatial (they are what cells rather than where cells) and that place cells are fundamentally memory cells that conjoin what and where.”

      - The paper does not fully take into account all the findings regarding grid cells, some of which very clearly show spatial processing in this system. For example, findings on grid-bydirection cells (e.g., Sargolini et al. 2006) would seem to suggest that the entorhinal grid system is very specifically spatial and related to path integration. Why would grid-bydirection cells be present and intertwined with grid cells in the author's memory-related reconceptualization? It seems to me that the existence of grid-by-direction cells is strong evidence that at least part of this network is specifically spatial.

      Head by direction grid cells were a key part of the reported results. These grid cells naturally arise in the model as the animal forms memories (aka, hippocampal place cells) that conjoin location (as defined by border cells), head direction at the time of memory formation, and one or more non-spatial properties found at that location. In this revision, I have attempted to better explain how including head direction in hippocampal memories naturally gives rise to these cell types. The introduction to the head direction module simulations now reads:

      “According to this memory model of spatial navigation, place cells are the conjunction of location, as defined by border cells, and one or more properties that are remembered to exist at that location. Such memories could, for instance, allow an animal to remember the location of a food cache (Payne et al., 2021). The next set of simulations investigates behavior of the model when one of the to-be-remembered properties is head direction at the time when the memory was formed (e.g., the direction of a pathway leading to a food cache). Indicating that head direction is an important part of place cell representations, early work on place cells in mazes found strong sensitivity to head direction, such that the place field is found in one direction of travel but not the other (McNaughton et al., 1983; Muller et al., 1994). Place cells can exhibit a less extreme version of head direction sensitivity in open field recordings (Rubin et al., 2014), but the nature of the sensitivity is more complicated, depending on location of the animal relative to the place field center (Jercog et al., 2019).

      It is possible that some place cell memories do not receive head direction input, as was the case for the simulations reported in Figures 6/7 – in those simulations, place cells were entirely insensitive to head direction, owing to a lack of input from head direction cells. However, removal of head direction input to hippocampus affects place cell responses (Calton et al., 2003) and grid cell responses (Winter et al., 2015), suggesting that head direction is a key component of the circuit. Furthermore, if place cells represent episodic memories, it seems natural that they should include head direction (i.e., viewpoint at the time of memory formation).

      In the simulations reported next, head direction is simply another property that is conjoined in a hippocampal place cell memory. In this case, a head direction cell should become a head direction conjunctive grid cell (i.e., a grid cell, but only when the animal is heading in a particular direction), owing to memory feedback from the hexagonal array of hippocampal place cell memories. When including head direction, the real-world dimensions of variation are across three dimensions (X, Y, and head direction) rather than two, and consolidation will cause the place cells to arrange in a three-dimensional volume. The simulation reported below demonstrates that this situation provides a “grid module”.”

      - I am also concerned that the paper does not do enough to address findings regarding how the elliptical shape of grid fields shifts when boundaries of an environment compress in one direction or change shape/angles (Lever et al., & Krupic et al). Those studies show compression in grid fields based on boundary position, and I don't see how the authors' model would explain these findings.  

      This finding was covered in the original submission: “For instance, perhaps one egocentric/allocentric pair of mEC grid modules is based on head direction (viewpoint) in remembered positions relative to the enclosure borders whereas a different egocentric/allocentric pair is based on head direction in remembered positions relative to landmarks exterior to the enclosure. This might explain why a deformation of the enclosure (moving in one of the walls to form a rectangle rather than a square) caused some of the grid modules but not others to undergo a deformation of the grid pattern in response to the deformation of the enclosure wall (see also Barry et al., 2007). More specifically, if there is one set of non-orthogonal dimensions for enclosure borders and the movement of one wall is too modest as to cause avoid global remapping, this would deform the grid modules based the enclosure border cells. At the same time, if other grid modules are based on exterior properties (e.g., perhaps border cells in relation to the experimental room rather than the enclosure), then those grid modules would be unperturbed by moving the enclosure wall.”

      I apologize for being unclear in describing how the model might explain this result. The paragraph has been rewritten and now reads:

      “Consider the possibility that one mEC grid modules is based on head direction (viewpoint) in remembered positions relative to the enclosure borders (e.g., learning the properties of the enclosure, such as the metal surface) while a different grid module is based on head direction in remembered positions relative to landmarks exterior to the enclosure (e.g., learning the properties of the experimental room, such as the sound of electronics that the animal is subject to at all locations). This might explain why a deformation of the enclosure (moving one of the walls to form a rectangle rather than a square) caused some of the grid modules but not others to undergo a deformation of the grid pattern in response to the deformation of the enclosure wall (see also Barry et al., 2007). More specifically, suppose that the movement of one wall is modest and after moving the wall, the animal views the enclosure as being the same enclosure, albeit slightly modified (e.g., when a home is partially renovated, it is still considered the same home). In this case, the set of non-orthogonal dimensions associated with enclosure borders would still be associated with the now-changed borders and any memories in reference to this border-determined space would adjust their positions accordingly in real-world coordinates (i.e., the place cells would subtly shift their positions owing to this deformation of the borders, producing a corresponding deformation of the grid). At the same time, there may be other sets of memories that are in relation to dimensions exterior to the enclosure. Because these exterior properties are unchanged, any place cells and grid cells associated with the exterior-oriented memories would be unchanged by moving the enclosure wall.”

      - Are findings regarding speed modulation of grid cells problematic for the paper's memory results? 

      - A further issue is that the paper does not seem to adequately address developmental findings related to the timecourses of the emergence of different cell types. In their simulation, researchers demonstrate the immediate emergence of grid fields in a novel environment, while noting that the stabilization of place cell positions takes time. However, these simulation findings contradict previous empirical developmental studies (Langston et al., 2010). Those studies showed that head direction cells show the earliest development of spatial response, followed by the appearance of place cells at a similar developmental stage. In contrast, grid cells emerge later in this developmental sequence. The gradual improvement in spatial stability in firing patterns likely plays a crucial role in the developmental trajectory of grid cells. Contrary to the model simulation, grid cells emerge later than place cells and head direction cells, yet they also hold significance in spatial mapping. 

      - The model simulations suggest that certain grid patterns are acquired more gradually than others. For instance, egocentric grid cells require the stabilization of place cell memories amidst ongoing consolidation, while allocentric grid cells tend to reflect average place field positions. However, these findings seemingly conflict with empirical studies, particularly those on the conjunctive representation of distance and direction in the earliest grid cells. Previous studies show no significant differences were found in grid cells and grid cells with directional correlates across these age groups, relative to adults (Wills et al., 2012). This indicates that the combined representation of distance and direction in single mEC cells is present from the earliest ages at which grid cells emerge. 

      These are good points and they have been addressed in a new section of the introduction titled ‘The Scope of the Proposed Model’. That section reads:

      “The reported simulations explain why most mEC cell types in the rodent literature appear to be spatial (Boccara et al., 2010; Diehl et al., 2017; Grieves & Jeffery, 2017). Assuming that rodents can form non-spatial memories, rodent hippocampus must receive non-spatial input from entorhinal cortex. These simulations suggest that characterization of the rodent mEC cortex as primarily spatial might be incorrect if most grid cells (except perhaps head direction conjunctive grid cells) have been mischaracterized as spatial. Other literatures with other species find non-spatial representations in MTL (Gulli et al., 2020; Quiroga et al., 2005; Wixted et al., 2014) and non-spatial hippocampal memory encoding has been found in rodents (Liu et al., 2012; McEchron & Disterhoft, 1999). The proposed memory model is compatible with these results – the ideas contained in this model could be applied to nonspatial memory representations. However, surveys of cell types in rodent entorhinal cortex seem to indicate that most cells are spatial (Boccara et al., 2010; Diehl et al., 2017; Grieves & Jeffery, 2017). How can the rodent hippocampus encode nonspatial memories if most of its input is spatial? The goal of the reported simulations is to explain the apparent paucity of non-spatial cells in rodent entorhinal cortex by proposing that grid cells have been misclassified as spatial (see also Luo et al., 2024).

      Given the simplicity of the proposed model, there are important findings that the model cannot address -- it is not that the model makes the wrong predictions but rather that it makes no predictions. The role of running speed (Kraus et al., 2015) is one such variable for which the model makes no predictions. Similarly, because the model is a rate-coded model rather than a model of oscillating spiking neurons, it makes no predictions regarding theta oscillations (Buzsáki & Moser, 2013). The model is an account of learning and memory for an adult animal, and it makes no predictions regarding the developmental (Langston et al., 2010; Muessig et al., 2015; Wills et al., 2012) or evolutionary (Rodrıguez et al., 2002) time course of different cell types. This model contains several purely spatial representations such as border cells, head direction cells, and head direction conjunctive grid cells and it may be that these purely spatial cell types emerged first, followed by the evolution and/or development of non-spatial cell types. However, this does not invalidate the model. Instead, this is a model for an adult animal that has both episodic memory capabilities and spatial navigation capabilities, irrespective of the order in which these capabilities emerged.

      This model has the potential to explain context effects in memory (Godden & Baddeley, 1975; Gulli et al., 2020; Howard et al., 2005). According to this model, different grid cells represent different non-spatial characteristics and place cells represent the combination of these “context” factors and location. In the simulation, just one grid cell is simulated but the same results would emerge when simulating hundreds of different non-spatial inputs provided that all of the simulated non-spatial inputs exist throughout the recording session. However, there is evidence that hippocampus can explicitly represent the passage of time (Eichenbaum, 2014), and time is assuredly an important factor in defining episodic memory (Bright et al., 2020). Thus, although the current model addresses unique combinations of what and where, it is left to future work to incorporate representations of when in the memory model.”

      Reviewer #3 (Public Review): 

      A crucial assumption of the model is that the content of experience must be constant in space. It's difficult to imagine a real-world example that satisfies this assumption. Odors and sounds are used as examples. While they are often more spatially diffuse than an objects on the ground, odors and sounds have sources that are readily detectable. Animals can easily navigate to a food source or to a vocalizing conspecific. This assumption is especially problematic because it predicts that all grid cells should become silent when their preferred non-spatial attribute (e.g. a specific odor) is missing. I'm not aware of any experimental data showing that grid cells become silent. On the contrary, grid cells are known to remain active across all contexts that have been tested, including across sleep/wake states. Unlike place cells, grid cells do not seem to turn off. Since grid cells are active in all contexts, their preferred attribute must also be present in all contexts, and therefore they would not convey any information about the specific content of an experience.  

      These are good points and in this revision I have attempted to explain that there is a great deal of contextual similarity across all recording sessions. One paragraph in the discussion now reads

      “In a typical rodent spatial navigation study, the non-spatial attributes are wellcontrolled, existing at all locations regardless of the enclosure used during testing (hence, a grid cell in one enclosure will be a grid cell in a different enclosure). Because labs adopt standard procedures, the surfaces, odors (e.g., from cleaning), external lighting, time of day, human handler, electronic apparatus, hunger/thirst state, etc. might be the same for all recording sessions. Additionally, the animal is not allowed to interact with other animals during recording and this isolation may be an unusual and highly salient property of all recording sessions. Notably, the animal is always attached to wires during recording. The internal state of the animal (fear, aloneness, the noise of electronics, etc.) is likely similar across all recording situations and attributes of this internal state are likely represented in the hippocampus and entorhinal input to hippocampus. According to this model, hippocampal place cells are “marking” all locations in the enclosure as places where these things tend to happen.”

      The proposed novelty of this theory is that other models all assume that grid cells encode space. This isn't quite true of models based on continuous attractor networks, the discussion of which is notably absent. More specifically, these models focus on the importance of intrinsic dynamics within the entorhinal cortex in generating the grid pattern. While this firing pattern is aligned to space during navigation and therefore can be used as a representation of that space, the neural dynamics are preserved even during sleep. Similarly, it is because the grid pattern does not strictly encode physical space that gridlike signals are also observed in relation to other two-dimensional continuous variables. 

      These models were briefly discussed in the general discussion section and in this revision they are further discussed in the introduction in a new section, titled ‘Why Model the Rodent Navigation Literature with a Memory Model?’ That section reads:

      “Spatial navigation is inherently a memory problem – learning the spatial arrangement of a new enclosure requires memory for the conjunction of what and where. This has long been realized and in the introduction to ‘Hippocampus as a Cognitive Map’, O’Keefe and Nadel (1978) wrote “We shall argue that the hippocampus is the core of a neural memory system providing an objective spatial framework within which the items and events of an organism's experience are located and interrelated” (emphasis added). Furthermore, in the last chapter of their book, they extended cognitive map theory to human memory for non-spatial characteristics. However, in the decades since the development of cognitive map theory, the rodent spatial navigation and human memory literatures have progressed somewhat independently.

      The ideas proposed in this model are an attempt to reunify these literatures by returning to the original claim that spatial navigation is inherently a memory problem. The goal of the current study is to explain the rodent spatial navigation literature using a memory model that has the potential to also explain the human memory literature. In contrast, most grid cell models (Bellmund et al., 2016; Bush et al., 2015; Castro & Aguiar, 2014; Hasselmo, 2009; Mhatre et al., 2012; Solstad et al., 2006; Sorscher et al., 2023; Stepanyuk, 2015; Widloski & Fiete, 2014) are domain specific models of spatial navigation and as such, they do not lend themselves to explanations of human memory. Thus, the reason to prefer this model is parsimony. Rather than needing to develop a theory of memory that is separate from a theory of spatial navigation, it might be possible to address both literatures with a unified account.

      This study does not attempt to falsify other theories of grid cells. Instead, this model reaches a radically different interpretation regarding the function of grid cells; an interpretation that emerges from viewing spatial navigation as a memory problem. All other grid cell models assume that an entorhinal grid cell displaying a spatially arranged grid of firing fields serves the function of spatial coding (i.e., spatial grid cells exist to support a spatial metric). In contrast, the proposed memory model of grid cells assumes that the hexagonal tiling reflects the need to keep memories separate from each other to minimize confusion and confabulation – the grid pattern is the byproduct of pattern separation between memories rather than the basis of a spatial code. 

      It is now understood that grid-like firing fields can occur for non-spatial two dimensional spaces. For instance, human entorhinal cortex exhibits grid-like responses to video morph trajectories in a two-dimensional bird neck-length versus bird leg-length space (Constantinescu et al., 2016). As a general theory of learning and memory, the proposed memory model of grid cells is easily extended to explain these results (e.g., relabeling the border cell inputs in the model as neck-length and leg-length inputs). However, there are other grid cell models that can explain both spatial grid cells as well as non-spatial grid-like responses (Mok & Love, 2019; Rodríguez-Domínguez & Caplan, 2019; Stachenfeld et al., 2017; Wei et al., 2015). Similar to this memory model of grid cells, these models are also positioned to explain both the rodent spatial navigation and human memory literatures. Nevertheless, there is a key difference between this model and other grid cell models that generalize to non-spatial representations. Specifically, these other models assume that grid cells exhibiting spatial receptive fields serve the function of identifying positions in the environment (i.e., their function is spatial). As such, these models do not explain why most of the input to rodent hippocampus appears to be spatial (Boccara et al., 2010; Diehl et al., 2017; Grieves & Jeffery, 2017). This memory model of grid cells provides an answer to the apparent paucity of nonspatial cell types in rodent MTL by proposing that grid cells with spatial receptive fields have been misclassified as spatial (they are what cells rather than where cells) and that place cells are fundamentally memory cells that conjoin what and where.”

      The use of border cells or boundary vector cells as the main (or only) source of spatial information in the hippocampus is not well supported by experimental data. Border cells in the entorhinal cortex are not active in the center of an environment. Boundary-vector cells can fire farther away from the walls but are not found in the entorhinal cortex. They are located in the subiculum, a major output of the hippocampus. While the entorhinalhippocampal circuit is a loop, the route from boundary-vector cells to place cells is much less clear than from grid cells. Moreover, both border cells and boundary-vector cells (which are conflated in this paper) comprise a small population of neurons compared to grid cells.

      AUTHOR RESPONSE: The model can be built without assuming between-border cells (early simulations with the model did not make this assumption). Regarding this issue, the text reads “Unlike the BVC model, the boundary cell representation is sparsely populated using a basis set of three cells for each of the three dimensions (i.e., 9 cells in total), such that for each of the three non-orthogonal orientations, one cell captures one border, another the opposite border, and the third cell captures positions between the opposing borders (Solstad et al., 2008). However, this is not a core assumption, and it is possible to configure the model with border cell configurations that contain two opponent border cells per dimension, without needing to assume that any cells prefer positions between the borders (with the current parameters, the model predicts there will be two border cells for each between-border cell). Similarly, it is possible to configure the model with more than 3 cells for each dimension (i.e., multiple cells representing positions between the borders).” The Solstad paper found a few cells that responded in positions between borders, but perhaps not as many as 1 out of 3 cells, such as this particular model simulation predicts. If the paucity of between-border cells is a crucial data point, the model can be reconfigured with opponent-border cells without any between border cells. The reason that 3 border cells were used rather than 2 opponent border cells was for simplicity. Because 3 head direction cells were used to capture the face-centered cubic packing of memories, the simulation also used 3 border cells per dimensions to allow a common linear sum metric when conjoining dimensions to form memories. If the border dimensions used 2 cells while head direction used 3 cells, a dimensional weighting scheme would be needed to allow this mixing of “apples and oranges” in terms of distances in the 3D space that includes head direction.

      Recommendations for the authors:

      Reviewer #1 (Recommendations For The Authors): 

      Specific questions/clarifications:  

      (1) Assumption of population-based vs single unit link to biological cells: At the start, the author assumes that each unit here can be associated with a population: "the simulated activation values can be thought of as proportional to the average firing rate of an ensemble of neurons with similar inputs and outputs (O'Reilly & Munakata, 2000)." But is a 'grid cell' found here a single cell or an average of many cells? Does this mean the model assumes many cells that have different fields that are averaged, which become a grid-like unit in the model? But in biology, these are single cells? Or does it mean a grid response is an average of the place cell inputs? 

      I apologize for being unclear about this. The grid cells in the model are equivalent to real single cells except that the simulation uses a ratecoded cell rather than a spiking cell. The averaging that was mentioned in the paper is across identically behaving spiking cells rather than across cells with different grid field arrangements. To better explain this, I have added the following text:

      “For instance, consider a set of several thousand spiking grid cells that are identical in terms of their firing fields. At any moment, some of these identically-behaving cells will produce an action potential while others do not (i.e., the cells are not perfectly synchronized), but a snapshot of their behavior can be extracted by calculating average firing rate across the ensemble. The simulated cells in the model represent this average firing rate of identically-behaving ensembles of spiking neurons.” 

      This is a mathematical short-cut to avoid simulating many spiking neurons. Because this model was compared to real spike rate maps, this real-valued average firing rate is down-sampled to produce spikes by finding the locations that produced the top 5% of real-valued activation values across the simulation.

      (2) It is not clear to me why they are circular border cells/basis sets.  

      In the initial submission, there was a brief paragraph describing this assumption. In this revision, that paragraph has been expanded and modified for greater clarity. It now reads:

      “Because head direction is necessarily a circular dimension, it was assumed that all dimensions are circular (a circular dimension is approximately linear for nearby locations). This assumption of circular dimensions was made to keep the model relatively simple, making it easier to combine dimensions and allowing application of the same processes for all dimensions. For instance, the model requires a weight normalization process to ensure that the pattern of weights for each dimension corresponds to a possible input value along that dimension. However, the normalization for a linear dimension is necessarily different than for a circular dimension. Because the neural tuning functions were assumed to be sine waves, normalization requires that the sum of squared weights add up to a constant value. For a linear dimension, this sum of squares rule only applies to the subset of cells that are relevant to a particular value along the dimension whereas for a circular dimension, this sum of squares rule is over the entire set of cells that represent the dimension (i.e., weight normalization is easier to implement with circular dimensions). Although all dimensions were assumed to be circular for reasons of mathematical convenience and parsimony, circular dimensions may relate to the finding that human observers have difficultly re-orienting themselves in a room depending on the degree of rotational symmetry of the room (Kelly et al., 2008). In addition, this simplifying assumption allows the model to capture the finding that the population of grid cells lies on a torus (Gardner et al., 2022), although I note that the model was developed before this result was known.”

      (3) Why is it 3 components? I realise that the number doesn't matter too much, but I believe more is better, so is it just for simplicity? 

      In this revision, additional text has been added to explain this assumption: “To keep the model simple, the same number of cells was assumed for all dimensions and all dimensions were assumed to be circular (head direction is necessarily circular and because one dimension needed to be circular, all dimensions were assumed to be circular). Three cells per dimensions was chosen because this provides a sparse population code of each dimension, with few border cells responding between borders, with few border cells responding between borders, while allowing three separate phases of grid cells within a grid cell module (in the model, a grid cell module arises from combination of a third dimension, such as head direction, with the real-world X/Y dimensions defined by border cells).”

      As a reminder, the text explaining the sparse coding of border cells reads: “However, this is not a core assumption, and it is possible to configure the model with border cell configurations that contain two opponent border cells per dimension, without needing to assume that any cells prefer positions between the borders (with the current parameters, the model predicts there will be two border cells for each between-border cell). Similarly, it is possible to configure the model with more than 3 cells for each dimension (i.e., multiple cells representing positions between the borders).”

      The model can work with just two opponent cells or with more than three cells per basis set. In different simulations, I have explored these possibilities. Three was chosen because it is a convenient way to highlight the face-centered cubic packing of memories that tends to occur (FCP produces 3 alternating layers of hexagonally arranged firing fields). Thus, each of the three head direction cells captures a different layer of the FCP arrangement. A more realistic simulation might combine 6 different head direction cells tiling the head direction dimension with opponent border cells (just 2 cells for each border dimensions). Such a combination would produce responses at borders, but no responses between borders and, at the same time, the head direction cells would still reveal the FCP arrangement. However, it is not easy to find the right parameters for such a mix-and-match simulation in which different dimensions have different numbers of tuning functions (e.g., some dimensions having 2 cells while others have 3 or 6 and some dimensions being linear while others are circular). When all of the dimensions are of the same type, the simple sum that arises from multiplying the input by the weight values gives rise to Euclidean distance (see Figure 3B). With a mix-and-match model of different dimension-types, it should be possible to adjust the sum to nevertheless produce a monotonic function with Euclidean distance although I leave this to future work. To keep things simple, I assumed that all dimensions are of the same type (circular, with 3 cells per dimension).  

      (4) Confusion due to the border cells/box was unclear to me. "If the period of the circular border cells was the same as the width of the box, then a memory pushed outside the box on one side would appear on the opposite side of the box, in which case the partial grid field on one side should match up with its remainder on the other side. This would entail complete confusion between opposite sides of the box, and the representation of the box would be a torus (donut-shaped) rather than a flat two-dimensional surface. To reduce confusion ..." Is this confusion of the model? Of the animal?  

      This would be confusion of the animal (e.g., a memory field overlapping with one border would also appear at the opposite border in the corresponding location). At one point in model development, I made the assumption that one side of the box wraps to the other side, and I asked Trygve Solstad to run some analyses of real data to see if cells actually wrap around in this manner. He did not find any evidence of this, and so I decided to include outsidethe-box representational area which, as it turned out, allowed the model to capture other behaviors as detailed in the paper.

      This section of the paper now reads:

      “The cosine tuning curves of the simulated border cells represent distance from the border on both sides of the border (i.e., firing rate increases as the animal approaches the border from either the inside or the outside of the enclosure). Experimental procedures do not allow the animal to experience locations immediately outside the enclosure, but these locations remain an important part of the hypothetic representation, particularly when considering the modification of memories through consolidation (i.e., a memory created inside the enclosure might be moved to a location outside the enclosure). This symmetry about the border cell’s preferred location is needed to maintain an unbiased representation, with a constant sum of squares for the border cell inputs (see methods section). Rather than using linear dimensions, all dimensions were assumed to be circular to keep the model relatively simple. This assumption was made because head direction is necessarily a circular dimension and by having all dimensions be circular, it is easy to combine dimensions in a consistent manner to produce multidimensional hippocampal place cell memories. Thus, the border cells define a torus (or more accurately a three-torus) of possible locations. This provides a hypothetical space of locations that could be represented.

      In light of the assumption to represent border cells with a circular dimension, when a memory is pushed outside the East wall of the enclosure, it would necessarily be moved to the West wall of the enclosure if the period of the circular dimension was equal to the width of the enclosure. If this were true, then the partial grid field on one side of the enclosure would match up with its remainder on the other side. Such a situation would cause the animal to become completely confused regarding opposite sides of the enclosure (a location on the West wall would be indistinguishable from the corresponding location on the East wall). To reduce confusion between opposite sides of the enclosure, the width of the enclosure in which the animal navigated (Figure 5) was assumed to be half as wide as the full period of the border cells. In other words, although the space of possible representations was a three-torus, it was assumed that the real-world twodimensional enclosure encompassed a section of the torus (e.g., a square piece of tape stuck onto the surface of a donut). The torus is better thought of as “playing field” in which different sizes and shapes of enclosure can be represented (i.e., different sizes and shapes of tape placed on the donut). Furthermore, this assumption provides representational space that is outside the box without such locations wrapping around to the opposite side of the box.”

      (5) Figure 3 - This result seems to be related to whether you use Euclidean or city-block distance. If you use Euclidean distances in two dimensions wouldn't this work out fine?  

      Euclidean distance was the metric used in the analysis of the two-dimensional simulation, but this did not work out. To make this clear, I have changed the label on the x-axes to read “Euclidean distance” for both the two- and three-dimensional simulations. The two-dimensional simulation produced city block behavior rather than Euclidean behavior because memory retrieval is the sum of the two dimensions, as is standard in neural networks, rather than the Euclidian distance formula, which would require that memory retrieval be the square root of the sum of squares of the two dimensions. One way to address this problem with the two-dimensional simulation would be to use a specific Euclidean-mimicking activation function rather than a simple sum of dimensions. The very first model I developed used such an activation function as applied to opponent border cells with just two dimensions (so 4 cells in total – left/right and top/down). This produced Euclidean behavior, but the activation function was implausible and did not generalize to simulations that also included head direction. In contrast, with three non-orthogonal dimensions, the simple sum of dimensions is approximately Euclidean.

      (6) Final sentence of the Discussion: "However, unlike the present model, these models still assume that entorhinal grid cells represent space rather than a non-spatial attribute." I am not sure if the authors of the cited papers will agree with this. They consider the spatial cases, but most argue they can treat non-spatial features as well. What the author might mean is that they assume non-spatial features are in some metric space that, in a way, is spatial. However, I am not sure if the author would argue that non-spatial features cannot be encoded metrically (e.g., Euclidean distance based on the similarity of odours). 

      In this section, when referring to “entorhinal grid cells” I was specifically referring to traditional grid cells in a rodent spatial navigation experiment. I did not mean to imply that these other theories cannot explain nonspatial grid fields, such as in the two-dimensional bird space grid cells found with humans. The way in which the proposed memory model and these other models differ is in terms of what they assume regarding the function of grid cells that exhibit spatial grid fields. In this revision, I have changed this text to read:

      “These models can capture some of the grid cell results presented in the current simulations, including extension to non-spatial grid-like responses (e.g., grid field that cover a two-dimensional neck/leg length bird space). Furthermore, these models may be able to explain memory phenomena similar to the model proposed in this study. However, unlike the proposed model, these models assume that the function of entorhinal grid cells that exhibit spatial X/Y grid fields during navigation is to represent space. In contrast, the memory model proposed in this study assume that the function of spatial X/Y grid cells is to represent a non-spatial attribute; the only reason they exhibit a spatial X/Y grid is because memories of that non-spatial attribute are arranged in a hexagonal grid owing to the uncluttered/unvarying nature of the enclosure. Thus, these model do not explain why most of the input to rodent hippocampus appears to be spatial (Boccara et al., 2010b; Diehl et al., 2017; Grieves & Jeffery, 2017) whereas the proposed model can explain this situation as reflecting the miss-classification of grid cells with a spatial arrangement as providing spatial input to hippocampus.”

      (7) It would be interesting to see videos/gifs of the model learning, and an idea of how many steps of trials it takes (is it capturing real-time rodent cell firing whilst foraging, or is it more abstracted, taking more trials). 

      The short answer is “yes”, the model is capturing real-time rodent cell firing while foraging. This is particularly true when simulating place cell memories in the absence of head direction information, as was shown in a video provided in the initial submission in relation to Figure 4. In this revision, I have provided a second video of learning when simulating place cell memories that include head direction. This second video is in relation to the results reported in Figure 9. This shows that even when learning a three-dimensional real-world space (X, Y, and head direction), the model rapidly produces an on-average hexagonal arrangement of place cells memories owing to the slight tendency of the place cell memories to linger in some locations as compared to others during consolidation. More specifically, they are more likely to linger in the locations that are the intersections of the peaks and/or troughs of the border cells and it is this tendency that supports the immediate appearance of grid cells. However, because the place cell memories are still shifting, head direction conjunctive grid cells are slower to emerge (the head direction conjunctive grid cells require stabilization of the place cells). The video then speeds up the learning process to so how place cells eventually stabilize after sufficient learning of the borders of the enclosure from different head/view directions.

      (8) One question is whether all the results have to be presented in the main text. It was difficult to see which key predictions fit the data and do so better than a spatial/navigation account. 

      Thank you for this suggestion. To make the paper more readable and easier for different readers with different interests to choose different aspects of the results to read, the second half of the results have been put in an appendix. More specifically, the second half of the results concerned place cells rather than grid cells. Thus, in this revision, the main text concerns grid cell results and the appendix concerns place cell results.

      Reviewer #3 (Recommendations For The Authors):  

      The title could usefully be shortened to focus on the main argument that observed firing patterns could be consistent with mapping memories instead of space. It's a stretch to argue that memory is the primary role when no such data is presented (i.e., there is no comparison of competing models). 

      This is a good point (I do not present evidence that conclusively indicates the function of MTL). This original title was chosen to make clear how this account is a radical departure from other accounts of grid cells. The revised title highlights that: 1) a memory model can also explain rodent single cell recording data during navigation; and 2) grid cell may not be non-spatial. The revised title is: “A Memory Model of Rodent Spatial Navigation: Place Cells are Memories Arranged in a Grid and Grid Cells are Non-spatial”

      When arguing that the main role of the hippocampus is memory, I strongly suggest engaging with the work of people like Howard Eichenbaum who spent the better part of their career arguing the same (e.g. DOI:10.1152/jn.00005.2017.)  

      Thank you for pointing out this important oversight. Early in introduction, I now write: “The proposal that hippocampus represents the multimodal conjunctions that define an episode is not new (Marr et al., 1991; Sutherland & Rudy, 1989) and neither is the proposal that hippocampal memory supports spatial/navigation ability (Eichenbaum, 2017). This view of the hippocampus is consistent with “feature in place” results (O’Keefe & Krupic, 2021) in which hippocampal cells respond to the conjunction of a non-spatial attribute affixed to a specific location, rather than responding more generically to any instance of a non-spatial attribute. In other words, the what/where conjunction is unique. Furthermore, the uniqueness of the what/where conjunction may be the fundamental building block of spatial memory and navigation. In reviewing the hippocampal literature, Howard Eichenbaum (2017) concludes that ‘the hippocampal system is not dedicated to spatial cognition and navigation, but organizes experiences in memory, for which spatial mapping and navigation are both a metaphor for and a prominent application of relational memory organization.’”

      With a focus on episodic memory, there should be a mention of the temporal component of memory. While it may rightfully be beyond the scope of this model, it's confusing to omit time completely from the discussion. 

      This issue and several others are now addressed in a new section in the introduction titled ‘The Scope of the Proposed Model’. That section reads:

      “The reported simulations explain why most mEC cell types in the rodent literature appear to be spatial (Boccara et al., 2010; Diehl et al., 2017; Grieves & Jeffery, 2017). Assuming that rodents can form non-spatial memories, rodent hippocampus must receive non-spatial input from entorhinal cortex. These simulations suggest that characterization of the rodent mEC cortex as primarily spatial might be incorrect if most grid cells (except perhaps head direction conjunctive grid cells) have been mischaracterized as spatial. Other literatures with other species find non-spatial representations in MTL (Gulli et al., 2020; Quiroga et al., 2005; Wixted et al., 2014) and non-spatial hippocampal memory encoding has been found in rodents (Liu et al., 2012; McEchron & Disterhoft, 1999). The proposed memory model is compatible with these results – the ideas contained in this model could be applied to nonspatial memory representations. However, surveys of cell types in rodent entorhinal cortex seem to indicate that most cells are spatial (Boccara et al., 2010; Diehl et al., 2017; Grieves & Jeffery, 2017). How can the rodent hippocampus encode nonspatial memories if most of its input is spatial? The goal of the reported simulations is to explain the apparent paucity of non-spatial cells in rodent entorhinal cortex by proposing that grid cells have been misclassified as spatial (see also Luo et al., 2024).

      Given the simplicity of the proposed model, there are important findings that the model cannot address -- it is not that the model makes the wrong predictions but rather that it makes no predictions. The role of running speed (Kraus et al., 2015) is one such variable for which the model makes no predictions. Similarly, because the model is a rate-coded model rather than a model of oscillating spiking neurons, it makes no predictions regarding theta oscillations (Buzsáki & Moser, 2013). The model is an account of learning and memory for an adult animal, and it makes no predictions regarding the developmental (Langston et al., 2010; Muessig et al., 2015; Wills et al., 2012) or evolutionary (Rodrıguez et al., 2002) time course of different cell types. This model contains several purely spatial representations such as border cells, head direction cells, and head direction conjunctive grid cells and it may be that these purely spatial cell types emerged first, followed by the evolution and/or development of non-spatial cell types. However, this does not invalidate the model. Instead, this is a model for an adult animal that has both episodic memory capabilities and spatial navigation capabilities, irrespective of the order in which these capabilities emerged.

      This model has the potential to explain context effects in memory (Godden & Baddeley, 1975; Gulli et al., 2020; Howard et al., 2005). According to this model, different grid cells represent different non-spatial characteristics and place cells represent the combination of these “context” factors and location. In the simulation, just one grid cell is simulated but the same results would emerge when simulating hundreds of different non-spatial inputs provided that all of the simulated non-spatial inputs exist throughout the recording session. However, there is evidence that hippocampus can explicitly represent the passage of time (Eichenbaum, 2014), and time is assuredly an important factor in defining episodic memory (Bright et al., 2020). Thus, although the current model addresses unique combinations of what and where, it is left to future work to incorporate representations of when in the memory model.”

      I recommend explaining the motivation of the theory in more detail in the introduction. It reads as "what if it's like this?" It would be helpful to instead highlight the limitations of current theories and argue why this theory is either a better fit for the data or is logically simpler. 

      This issue and several others are now addressed in the new section in the introduction titled ‘Why Model the Rodent Navigation Literature with a Memory Model?’, which I quoted above in response to the public reviews.

      It's worth considering shortening the results section to include only those that most convincingly support the main claim. The manuscript is quite long and appears to lack focus at times. 

      Thank you for this suggestion. To make the paper more readable and easier for different readers with different interests to choose different aspects of the results to read, the second half of the results have been put in an appendix. More specifically, the second half of the results concerned place cells rather than grid cells. Thus, in this revision, the main text concerns grid cell results and the appendix concerns place cell results.

      The discussion of path dependence on the formation of the grid pattern is important but only briefly discussed. It may be useful to add simulations testing whether different paths (not random walks) produce distorted grid patterns. 

      The short answer is that the path doesn’t affect things in general. The consolidation rule ensures equally spaced memories even if, for instance, one side of the enclosure is explored much more than the other side. As just one example, I have run simulations with a radial arm maze and even though the animal is constrained to only run on the maze arms. The memories still arrange hexagonally as memories become pushed outside the arms. Rather than adding additional simulations to study, I now briefly describe this in the model methods:

      “Of note, the ability of the model to produce grid cell responses does not depend on this decision to simulate an animal taking a random walk – the same results emerge if the animal is more systematic in its path. All that matters for producing grid cell responses is that the animal visits all locations and that the animal takes on different head directions for the same location in the case of simulations that also include head direction as an input to hippocampal place cells.”

      I struggle to understand in Figure 3 why retrieval strength ought to scale monotonically with Euclidean distance, and why that justifies a more complex model (three non-orthogonal dimensions). 

      The introduction to this section now reads: “Animals can plan novel straight line paths to reach a known position and evidence suggests they do so by learning Euclidean representations of space (Cheng & Gallistel, 2014; Normand & Boesch, 2009; Wilkie, 1989). Thus, it was assumed that hippocampal place cells represent positions in Euclidean space (as opposed to non-Euclidean space, such a occurs with a city-block metric).”

      p.17 "although the representational space is a torus (or more specifically a three-torus), it is assumed that the real-world two-dimensional surface is only a section of the torus (e.g., a square piece of tape stuck onto the surface of a donut)." I fail to understand how the realworld surface is only a part of the torus. In the existing theoretical and experimental work on toroidal topology of grid cell activity, the torus represents a very small fraction of the real world, and repeating activity on the toroidal manifold is a crucial feature of how it maps 2D space in a regular manner. Why then here do you want the torus to be larger than the realworld? 

      This section has been rewritten to better explain these assumptions. The relevant paragraphs now read:

      “The cosine tuning curves of the simulated border cells represent distance from the border on both sides of the border (i.e., firing rate increases as the animal approaches the border from either the inside or the outside of the enclosure). Experimental procedures do not allow the animal to experience locations immediately outside the enclosure, but these locations remain an important part of the hypothetic representation, particularly when considering the modification of memories through consolidation (i.e., a memory created inside the enclosure might be moved to a location outside the enclosure). This symmetry about the border cell’s preferred location is needed to maintain an unbiased representation, with a constant sum of squares for the border cell inputs (see methods section). Rather than using linear dimensions, all dimensions were assumed to be circular to keep the model relatively simple. This assumption was made because head direction is necessarily a circular dimension and by having all dimensions be circular, it is easy to combine dimensions in a consistent manner to produce multidimensional hippocampal place cell memories. Thus, the border cells define a torus (or more accurately a three-torus) of possible locations. This provides a hypothetical space of locations that could be represented.

      In light of the assumption to represent border cells with a circular dimension, when a memory is pushed outside the East wall of the enclosure, it would necessarily be moved to the West wall of the enclosure if the period of the circular dimension was equal to the width of the enclosure. If this were true, then the partial grid field on one side of the enclosure would match up with its remainder on the other side. Such a situation would cause the animal to become completely confused regarding opposite sides of the enclosure (a location on the West wall would be indistinguishable from the corresponding location on the East wall). To reduce confusion between opposite sides of the enclosure, the width of the enclosure in which the animal navigated (Figure 5) was assumed to be half as wide as the full period of the border cells. In other words, although the space of possible representations was a three-torus, it was assumed that the real-world twodimensional enclosure encompassed a section of the torus (e.g., a square piece of tape stuck onto the surface of a donut). The torus is better thought of as “playing field” in which different sizes and shapes of enclosure can be represented (i.e., different sizes and shapes of tape placed on the donut). Furthermore, this assumption provides representational space that is outside the box without such locations wrapping around to the opposite side of the box.”

      p.28 "More specifically, egocentric grid cells (e.g., head direction conjunctive grid cells) require stabilization of the place cell memories in the face of ongoing consolidation whereas allocentric grid cells reflect on-average place field positions." and p.32 "if place cells represent episodic memories, it seems natural that they should include head direction (an egocentric viewpoint)." But the head direction signal is not egocentric, it is allocentric. I'm unsure whether this is a typo or a potentially more serious conceptual misunderstanding. 

      Any reference to egocentric has been removed in this revision. In the initial submission, when I used egocentric, I was referring to memories that depended on the head direction of the animal at the time of memory formation. I was using “egocentric” in relation to whether the memory was related to the animal’s personal bodily experience at the time of memory formation. But I concede that this is confusing since the ego/allo distinction is typically used to differentiate angular directions that are relative to the person (left/right) versus earth (East/West). Instead, throughout the manuscript I now refer to these as view-dependent memories since head direction would entail having a different view of the environment at the time of memory formation. I still refer to the stacking of multiple view-dependent memories on the same X/Y location as being the development of an allocentric representation however, since this can be thought of as one way to learn a cognitive map of the enclosure that is view independent.

      p.37 "But if the border cells had changed their alignment with the new enclosure (e.g., if the E border dimension aligned with the North-South borders), then the place cells would have appeared to undergo global remapping as their positions rotated by 90 degrees and the grid pattern would have also rotated." But this would not be interpreted as global remapping by standard analyses of place and grid cell responses. A coherent rotation of firing patterns is not interpreted as remapping. 

      This sentence now reads: “But if the border cells had changed their alignment with the new enclosure (e.g., if the E border dimension aligned with the North-South borders), then the place cells would remain in their same positions relative to the now-rotated borders (i.e., no remapping relative to the enclosure) and the corresponding grid cells would also retain their same alignment relative to the enclosure.”

      p.37 "this is more accurately described as partial remapping (nearly all place fields were unaffected)." If nearly all place fields were unaffected, this should be interpreted as a stable map. Partial remapping is a mix of stability, rate remapping, and global remapping within a population of place cells. 

      This sentence has been removed.

      p.40 "The dependence of grid cell responses on memory may help explain why grid cells have been found for bats crawling on a two-dimensional surface (Yartsev et al., 2011), but three-dimensional grid cells have never been observed for flying bats." This is not true. Ginosar et al. (2021) observed 3D grid cells in flying bats.  

      Thank you for highlighting this issue. In the initial submission I was using “grid cell” to mean a cell that produced a precise hexagonal grid, which is not the case for the 3D grid cells in bats. In this revision, I now discuss grid cell that produce irregular grid fields, writing:

      “According to this model, hexagonally arranged grid cells should be the exception rather than the rule when considering more naturalistic environments. In a more ecologically valid situation, such as with landmarks, varied sounds, food sources, threats, and interactions with conspecifics, there may still be remembered locations were events occurred or remembered properties can be found, but because the non-spatial properties are non-uniform in the environment, the arrangement of memory feedback will be irregular, reflecting the varied nature of the environment. This may explain the finding that even in a situation where there are regular hexagonal grid cells, there are often irregular non-grid cells that have a reliable multi-location firing field, but the arrangement of the firing fields is irregular (Diehl et al., 2017). For instance, even when navigating in an enclosure that has uniform properties as dictated by experimental procedures, they may be other properties that were not well-controlled (e.g., a view of exterior lighting in some locations but not others), and these uncontrolled properties may produce an irregular grid (i.e., because the uncontrolled properties are reliably associated with some locations but not others, hippocampal memory feedback triggers retrieval of those properties in the associations locations).

      In this memory model, there are other situations in which an irregular but reliable multi-location grid may occur, even when everything is well controlled. In the reported simulations, when the hippocampal place cells were based on variation in X/Y (as defined by Border cells), nothing else changed as a function of location, and the model rapidly produced a precise hexagonal arrangement of hippocampal place cell memories. When head direction was included (i.e., real-world variation in X, Y, and head direction), the model still produced a hexagonal arrangement as per face centered cubic packing of memories, but this precise arrangement was slower to emerge, with place cells continuing to shift their positions until the borders of the enclosure were sufficiently well learned from multiple viewpoints. If there is realworld variation in four or more dimensions, as is likely the case in a more ecologically valid situation, it will be even harder for place cell memories to settle on a precise regular lattice. Furthermore, in the case of four dimensions, mathematicians studying the “sphere packing problem” recently concluded that densest packing is irregular (Campos et al., 2023). This may explain why the multifield grid cells for freely flying bats have a systematic minimum distance between firing fields, but their arrangement is globally irregular (Ginosar et al., 2021). Assuming that the memories encoded by a bat include not just the three realworld dimensions of variation, but also head direction, the grid will likely be irregular even under optimal conditions of laboratory control.”

      Multiple typos are found on page 25, end of paragraph 3: "More specifically, if there is one set of non-orthogonal dimensions for enclosure borders and the movement of one wall is too modest as to cause avoid global remapping, this would deform the grid modules based the enclosure border cells."

      As detailed above in the response the public reviews, this paragraph has been rewritten.

    1. Author Response:

      Reviewer #1 (Public Review):

      Summary:

      The study by Gupta et al. investigates the role of mast cells (MCs) in tuberculosis (TB) by examining their accumulation in the lungs of M. tuberculosis-infected individuals, non-human primates, and mice. The authors suggest that MCs expressing chymase and tryptase contribute to the pathology of TB and influence bacterial burden, with MC-deficient mice showing reduced lung bacterial load and pathology.

      Strengths:

      (1) The study addresses an important and novel topic, exploring the potential role of mast cells in TB pathology.

      (2) It incorporates data from multiple models, including human, non-human primates, and mice, providing a broad perspective on MC involvement in TB.

      (3) The finding that MC-deficient mice exhibit reduced lung bacterial burden is an interesting and potentially significant observation.

      Weaknesses:

      (1) The evidence is inconsistent across models, leading to divergent conclusions that weaken the overall impact of the study.

      The strength of the study is the use of multiple models including mouse, non-human primate as well as human samples. The conclusions have now been refined to reflect the complexity of the disease and the use of multiple models.

      (2) Key claims, such as MC-mediated cytokine responses and conversion of MC subtypes in granulomas, are not well-supported by the data presented.

      To address the reviewer’s comments, we will carry out further experimentation to strengthen the link between MC subtypes and cytokine responses.

      (3) Several figures are either contradictory or lack clarity, and important discrepancies, such as the differences between mouse and human data, are not adequately discussed.

      We will further clarify the figures and streamline the discussions between the different models used in the study.

      (4) Certain data and conclusions require further clarification or supporting evidence to be fully convincing.

      We will either provide clarification or supporting evidence for some of the key conclusions in the paper.

      Reviewer #2 (Public review):

      Summary:

      The submitted manuscript aims to characterize the role of mast cells in TB granuloma. The manuscript reports heterogeneity in mast cell populations present within the granulomas of tuberculosis patients. With the help of previously published scRNAseq data, the authors identify transcriptional signatures associated with distinct subpopulations.

      Strengths:

      (1) The authors have carried out a sufficient literature review to establish the background and significance of their study.

      (2) The manuscript utilizes a mast cell-deficient mouse model, which demonstrates improved lung pathology during Mtb infection, suggesting mast cells as a potential novel target for developing host-directed therapies (HDT) against tuberculosis.

      Weaknesses:

      (1) The manuscript requires significant improvement, particularly in the clarity of the experimental design, as well as in the interpretation and discussion of the results. Enhanced focus on these areas will provide better coherence and understanding for the readers.

      The strength of the study is the use of multiple models including mouse, non-human primate as well as human samples. The conclusions have now been refined to reflect the complexity of the disease and the use of multiple models.

      (2) Throughout the manuscript, the authors have mislabelled the legends for WT B6 mice and mast cell-deficient mice. As a result, the discussion and claims made in relation to the data do not align with the corresponding graphs (Figure 1B, 3, 4, and S2). This discrepancy undermines the accuracy of the conclusions drawn from the results.

      We apologize for the discrepancy which will be corrected in the revised manuscript

      (3) The results discussed in the paper do not add a significant novel aspect to the field of tuberculosis, as the majority of the results discussed in Figure 1-2 are already known and are a re-validation of previous literature.

      This is the first study which has used mouse, NHP and human TB samples from Mtb infection to characterize and validate the role of MC in TB. We believe the current study provides significant novel insights into the role of MC in TB.

      (4) The claims made in the manuscript are only partially supported by the presented data. Additional extensive experiments are necessary to strengthen the findings and enhance the overall scientific contribution of the work.

      We will either provide clarification or supporting evidence for some of the key conclusions in the paper.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public Review):

      Summary:

      In this manuscript, BOUTRY et al examined a cnidarian Hydra model system where spontaneous tumors manifest in laboratory settings, and lineages featuring vertically transmitted neoplastic cells (via host budding) have been sustained for over 15 years. They observed that hydras harboring long-term transmissible tumors exhibit an unexpected augmentation in tentacle count. In addition, the presence of extra tentacles, enhancing the host's foraging efficiency, correlated with an elevated budding rate, thereby promoting tumor transmission vertically. This study provided evidence that tumors, akin to parasitic entities, can also exert control over their hosts.<br /> Strengths:

      The manuscript is well-written, and the phenotype is intriguing.

      Weaknesses:

      The quality of this manuscript could be improved if more evidence were to be provided regarding the beneficial versus detrimental effects of the tumors.

      We thank the reviewer for taking the time to examine our work carefully and for their highly relevant comments and precise suggestions. We have incorporated these suggestions, which greatly improved the clarity of our manuscript concerning the beneficial and detrimental effects of tumors. Specifically, we have added a new analysis and rephrased the results section, as well as the corresponding sentences in the discussion, to enhance clarity.

      Additionally, regarding the impact of tumor size on the development of supernumerary tentacles, we have included as suggested a new analysis that was previously only available in the supplementary materials of the earlier version. This addresses the reviewer's question and significantly enhances the quality of our paper.

      We have thanked the two referees in the Acknowledgements section of our article.

      Reviewer #2 (Public Review):

      Background and Summary:

      This study addresses the intriguing question of whether and how tumors can develop in the freshwater polyp hydra and how they influence the fitness of the animals. Hydra is notable for its significant morphogenetic plasticity and nearly unlimited capacity for regeneration. While its growth through asexual reproduction (budding) and the associated processes of pattern formation have been extensively studied at the cellular level, the occurrence of tumors was only recently described in two strains of Hydra oligactis (Domazet-Lošo et al, 2014). In that research, an arrest in the differentiation of female germ cells led to an accumulation of germline cells that failed to develop into eggs. In hydra, fertile egg cells typically incorporate nurse cells, which originate from large interstitial stem cells (ISCs) restricted to the germline, through apoptosis. However, this increase in apoptosis activity is absent in "germline tumors," and germline ISCs instead form slowly growing patches that do not compromise tissue integrity. Despite the upregulation of certain genes associated with mammalian neoplasms (such as tpt1 and p23) in this tissue, determining whether this differentiation arrest and the resulting egg patches truly constitute neoplasms remains a challenge.

      The authors have recently published two papers on the ecological and evolutionary aspects of hydra tumor formation (Boutry et al 2022, 2023), which is also the focus of this manuscript. They transplanted tissues derived from animals with germline tumors to wildtype animals and analyzed their growth patterns, specifically the number of tentacles in the host tissue. They observed that such tissues induced the growth of additional tentacles compared to tissues without germline tumors. The authors conclude that this growth pattern (increased number of tentacles) is correlated with "reducing the burden on the host by (over-)compensating for the reproductive costs of tumors" and claim that "transmissible tumors in hydra have evolved strategies to manipulate the phenotype of their host". While it might be stimulating to add a fresh view from other disciplines (here, ecological and evolutionary aspects), the authors completely ignore the current knowledge of the underlying cell biology of the processes they analyze.

      Strengths:

      The study focuses on intriguing questions. Whether and how tumors can develop in the freshwater polyp hydra, and how they influence the fitness of the animals?

      Weaknesses:

      Concept of germline tumors.

      The conceptual foundation of their experiments on germline tumors was the study of Domazet-Lošo et al (2014) introducing the concept of germline tumors in hydra (see above). While this is an intriguing hypothesis, there has been little advancement in comprehending the molecular mechanisms underlying tumor formation in hydra beyond this initial investigation. Germline tumors in hydra do not fully meet the typical criteria for neoplasms observed in mammalian tissues. More importantly, a similar phenotype was already reported by the work of Paul Brien and described as "crise gametique" (Brien, 1966, Biologie de la reproduction animale - Blastogenèse, Gamétogenèse, Sexualisation, ed. Masson & Cie, Paris). This phenomenon of gametic crisis is unique to Hydra oligactis, a stenotherm, cold-adapted cosmopolitan species. In this species, gametogenesis severely impacts the vitality of the polyps, often leading to complete exhaustion and death (Tardent, 1974). Animals can only be rescued during the initial phase of the cold-induced sexual period (see also the research of Littlefield (1984, 1985, 1986, 1991). The observed arrest in differentiation arrest in germline tumors might represent an epigenetically established consequence of surviving gametogenesis. Regrettably, this important work was not mentioned by the authors or by Domazet-Lošo et al. (2014), highlighting a notable gap in the recognition of basic research in this area that might challenge the hydra tumor hypothesis.

      "Super-nummary" tentacles in graft experiments.

      The authors describe that after grafting tissue from animals with germline tumors to wild-type animals, the number of tentacles in the host tissue increased when the donor tissue had germline tumors. A maximum effect of four additional tentacles was found with donor strain H. oligactis robusta and three additional tentacles with donor strain H.oligactis St Petersburg. In general, H.oligactis wild-type host strains had fewer tentacles than H.oligactis St Petersburg strains. This is consistent with the results of Domazet-Lošo et al (2014) who showed that the number of tentacles increased in the strains with germline tumors. What conclusions can be drawn from these experiments? 

      The authors might want to conclude that transmissible tumors in Hydra have developed strategies to manipulate the phenotype of their host. But there is no evidence for this, as essential controls are missing. It is known that the size of hydra polyps is proportion-regulated, i.e. the number of tentacles varies with the size and number of (epithelial) cells. Such controls are missing in the experiments. There is also a lack of controls from wild-type animals in gametogenesis: it is very likely that grafts with wild-type animals with egg spots of comparable size as the germline tumors (see above) will result in similar numbers of tentacles in host tissue.

      We thank the reviewer for their thoughtful comments. While we appreciate the concerns raised, we maintain that the evidence provided by Domazet-Lošo et al. (2014, Nature Communications) supports the relevance of this model, including the suggested comparisons with the expression profiles of individuals undergoing induced sexual reproduction. Our study focuses primarily on the impact of these tumors on the host phenotype rather than their origin. Tumors are defined as accumulations of abnormally proliferating cells. This includes the definition provided by the referee, which describes “apoptosis activity as absent in 'germline tumors,' with germline ISCs forming slowly growing patches.” Compromise of tissue integrity is not a criterion for defining neoplasms, and many benign neoplasms do not meet this criterion. We are interested in continuing this discussion with the referee to better understand the expected evidence and agree that histological nomenclature could be improved. While further investigation into the cell biology of these tumors would be valuable, this is currently beyond the scope of our article but is being pursued in separate research.

      We also appreciate the points raised regarding the definition of germline tumors and the reference to the pioneering work of Paul Brien. However, in that publication, the concept of gametic crisis in H. oligactis describes reproductive exhaustion leading to death, rather than abnormal cell proliferation indicative of a tumor-like phenotype. This distinction likely explains why this specific paper was not cited previously.

      Our study builds on prior research using the same model (e.g., Domazet-Lošo et al. 2014; Boutry et al. 2023) and describes observations across different hydra strains from various locations worldwide (not just two), all conducted under stable warm temperatures that are not conducive to sexual development. These investigations reveal a phenomenon distinct from the senescence observed post-reproduction in H. oligactis. The phenotype we describe, characterized by an accumulation of cells in the ectoderm, aligns with studies referenced by the reviewer from leading groups in hydra research, known for their expertise in hydra cellular biology. We have relied on these studies after carefully reviewing their results and receiving training from these experts. Furthermore, our team is focused on eco-evolutionary topics and does not aim to specialize in cellular biology, as other teams are already dedicated to that field.

      We also thank the reviewer for their comments on the relevance of our findings and the missing controls. However, we have noted that the reviewer may have misunderstood our experimental design and results.

      Firstly, it appears that the reviewer based their critique mainly on the initial sentences of our Results section (illustrated in Figure 2), which outline the donor groups used in our study rather than presenting the results of the grafting experiments. This description alone is insufficient for drawing conclusions, which is why we conducted further analyses using these donor groups grafted onto different recipients. The maximum effects mentioned by the reviewer (+10 tentacles with St. Petersburg tumoral tissue and +8 tentacles with Robusta tumoral tissue, Results Section 2) represent only a part of our study. We encourage the reviewer to focus on the model analyses presented in Results Section 2, which directly relate to the grafting experiments and provide a more comprehensive evaluation of our results and conclusions. These analyses include comparisons between transmissible tumors and spontaneous tumors, offering deeper insights into their effects on tentacle development.

      In our methods (as depicted in Figure 3), we explicitly compared different types of tumorous tissue from various donors, distinguishing between spontaneous and transmissible tumors. Although we avoid labeling spontaneous tumors as "controls" to prevent confusion with healthy tissue controls, they serve as controls to the “treatment” that involves transmissible tumors, and thus are appropriate comparisons for assessing the size effect suggested by the reviewer. Spontaneous and transmissible tumors share similar size and cellular characteristics but differ significantly in the number of tentacles their hosts possess. Furthermore, we refer the reviewer to a relevant study (Ngo et al. 2021) that found no increase in tentacle numbers with larger polyps of healthy tissue. This reference has been included in the revised discussion (line 309 to 312), which now also addresses the potential effect of body size with additional explanations.

      Regarding the suggestion to include controls from animals undergoing gametogenesis, we did not find evidence in the literature indicating an increase in tentacle numbers during this process in hydra. If such studies exist, we kindly request the complete references so we can include them in our discussion. Additionally, as noted in Brien's work, Hydra oligactis undergoing gametogenesis are known to either die or experience significant degeneration afterward. Transplanting tissue from dead or dying (and reproducing) hydras poses technical challenges and raises questions about whether any observed effects result from incomplete gametogenesis, the onset of senescence, or both. While these questions are intriguing, they fall outside the scope of our article.

      In conclusion, we appreciate the opportunity to address these points and reaffirm that our study offers valuable insights into the evolutionary dynamics of interactions between transmissible tumor tissues and host phenotypes in hydra. We remain open to further discussion and welcome any additional feedback to enhance the clarity and robustness of our manuscript.

      Recommendations for the authors:

      Reviewer #1 (Recommendations For The Authors):

      (1) If the fitness of hydra is altered in those with spontaneous tumors is the increased number of tentacles associated with those with transmitted tumors able to rescue this phenotype?

      We thank the reviewer for reformulating our results. Indeed, fitness can be restored and even improved in tumorous polyps harboring supernumerary tentacles. This phenomenon, which we referred to as compensation and over-compensation in Section 3 and Figure 4, was initially discussed only in the discussion section. To improve the clarity of our manuscript, we have now specified this in the Conclusion (lines 345 to 347 and some minor rewording in the same paragraph) in the Results section (lines 284 to 286).

      (2) Does the size of the tumor predict the number of tentacles formed?

      We agree that this would be a valuable complementary analysis. We have conducted an analysis considering the qualitative size of the tumors (based on visual categories) and the number of tentacles, which is now included in our paper (lines 160-161; lines 193 to 198; lines 253 to 259; lines 314 - 322).

      (3) Considering the mentioned association of body size with tentacle numbers for hydra, is a change in size a phenotype associated with transmitted tumors, and is such a phenotype transmittable. 

      All tumorous individuals, regardless of their tumor type, exhibit a swollen body. We have added a sentence in the introduction to clarify this point (line 62).

      (4) Is there anything unique about the Rob population that would explain their mass mortality following transplantation? For instance, their resistance to spontaneous tumor formation? Similarly, is there a difference in transplantation success based on the type of tissue transplanted? The authors could address this point in the discussion.

      It is a very old lineage described nearly 80 years ago. It is unknown whether natural populations of Robusta exist, and no reports of any male individuals have been documented. We have added a sentence in the Materials and Methods section to clarify this information (lines 98 to 102).

      (5) What downsides are known about the transmittable tumors in hydra and how present are they in the grafted individuals? Are other physiological aspects such as mobility, regeneration, or sexual reproduction hindered?

      Transmissible tumors have been associated with increased vulnerability to predation and alterations in life history traits, including a higher budding rate and decreased sexual reproduction. While we were unable to measure behavioral traits in this study of our grafted individuals, this is an intriguing avenue for further research. We have included this perspective in the discussion section as a concluding remark (lines 375 to 382). Thanks a lot for the suggestion of this conclusion.

      (6) It is important to explore the mechanisms behind the phenotypic variation conferred by the types of tumors, whether of different lineage or transmissibility. For this purpose, RNA-Seq on the recipients seems like a good starting point.

      Thanks for this suggestion, we've reworded the sentence about this perspective in our discussion to be more precise (line 320).

      Boutry, Justine, Marie Buysse, Sophie Tissot, Chantal Cazevielle, Rodrigo Hamede, Antoine M. Dujon, Beata Ujvari, et al. 2023. « Spontaneously Occurring Tumors in Different Wild-Derived Strains of Hydra ». Scientific Reports 13 (1): 7449. https://doi.org/10.1038/s41598-023-34656-0.

      Domazet-Lošo, Tomislav, Alexander Klimovich, Boris Anokhin, Friederike Anton-Erxleben, Mailin J. Hamm, Christina Lange, et Thomas C. G. Bosch. 2014. « Naturally occurring tumours in the basal metazoan {Hydra} ». Nat Commun 5 (1): 4222. https://doi.org/10.1038/ncomms5222.

      Ngo, Kha Sach, Berta R-Almási, Zoltán Barta, et Jácint Tökölyi. 2021. « Experimental Manipulation of Body Size Alters Life History in Hydra ». Ecology Letters 24 (4): 728‑38. https://doi.org/10.1111/ele.13698.

    1. Author response:

      The following is the authors’ response to the previous reviews.

      This important study provides proof of principle that C. elegans models can be used to accelerate the discovery of candidate treatments for human Mendelian diseases by detailed high-throughput phenotyping of strains harboring mutations in orthologs of human disease genes. The data are compelling and support an approach that enables the potential rapid repurposing of FDA-approved drugs to treat rare diseases for which there are currently no effective treatments. The authors should provide a clearer explanation of how the statistical analyses were performed, as well as a link to a GitHub repository to clarify how figures and tables in the manuscript were generated from the phenotypic data.

      We have amended our description of the statistical analysis in the materials and methods section of the manuscript. We have also updated the GitHub repository link to a dedicated repository for this study, this contains all of the code needed to generated all the figures made from the phenotypic data provided. Additionally, we have updated the Zenodo repository to contain both the code and datasets within the same file.

      We have also updated the GitHub repository link to a dedicated repository for this manuscript, that contains all of the code needed to generate all figures from the phenotypic data provided. Additionally, we have updated the Zenodo repository link to contain both the code and datasets within the same folder structure. 

      Recommendations for the authors:

      Reviewer #1 (Recommendations for the authors):

      The authors have responded to previous review to improve the presentation of the work. The paper more than meets publication standards.

      No response required.

      Reviewer #2 (Recommendations for the authors):

      The authors have addressed all of my questions and concerns. I'm happy to see this updated paper of record.

      No response required.

      Reviewer #3 (Recommendations for the authors):

      Regarding the interactive heatmap

      The html version and the panel in Figure 2C appear not to coincide visually. Maybe the features are ordered in a different way?

      The html version of Figure 2C is for the entire feature set extract per strain and not the condensed Tierpsy256 set shown in the panel figure. We have now remade this figure to show this reduced feature set (aligning with what is shown in Figure 2C) and included both versions of the interactive heatmaps as static html files within the same repository.

      Regarding data accessibility overall

      More generally, the html file does not address my initial concern about the accessibility of the data to non-experts. Making the full dataset available was a necessary first step, but the hermetic nature of its format and the lack of a simple way to query the data remains an issue for me that limits the usefulness of this data to the broadest audience.

      We agree, but unfortunately do not currently have the resources to build a public-facing database to facilitate this.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public Review):

      Summary:

      The work by Chuong et al. provides important new insights into the contribution of different molecular mechanisms in the dynamics of CNV formation. It will be of interest to anyone curious about genome architecture and evolution from yeast biologists to cancer researchers studying genome rearrangements.

      Thank you for recognizing the broad significance of our study.

      Strengths:

      Their results are especially striking in that the "simplest" mechanism of GAP1 amplification-non-allelic homologous recombination between the flanking Ty-LTR elements is not the most common route taken by the cells, emphasizing the importance of experimentally testing what might seem on the surface to be obvious answers. One of the important developments of their work is the use of their neural network simulation-based inference (nnSBI) model to derive rates of amplicon formation and their fitness effects.

      We agree with this assessment as the results of our study challenge our intuition that the simplest path to structural variation is the most likely and reveals the great diversity in mechanisms that can lead to large scale changes in the genome.

      Weaknesses:

      The manuscript reads as though two different people wrote two different sections of the manuscript - an experimental evolutionist and a computational scientist. If the goal is to reach both groups of readers, there needs to be more explanation of both types of work. I found the computational sections to be particularly dense but even the experimental sections need clearer explanations and more specific examples of the rearrangements found. I will point out these areas in the detailed remarks to the authors. While I have no reason to question their conclusions, I couldn't independently verify the results that ODIRA was the majority mechanism since the sequence of amplified clones was not made available during the review. I've encouraged the authors to include specific, detailed sequence information for both ODIRA events as well as the specific clones where GAP1 was amplified but the flanking gene GFP was not.

      We have revised the manuscript to expand explanations of both the experimental and computational aspects of our study and to provide additional information for the reader. In doing so, we have edited the text to improve readability. We have made all raw data publicly available through the NCBI short read archive (SRA) and are hosting all sequence data for easy visualization in JBrowse using a public server.

      Reviewer #2 (Public Review):

      Summary:

      This study examines how local DNA features around the amino acid permease gene GAP1 influence adaptation to glutamine-limited conditions through changes in GAP1 Copy Number Variation (CNV). The study is well motivated by the observation of numerous CNVs documented in many organisms, but difficulty in distinguishing the mechanisms by which they are formed, and whether or how local genomic elements influence their formation. The main finding is convincing and is that a nearby Autonomous Replicating Sequence (ARS) influences the formation of GAP1 CNVs and this is consistent with a predominate mechanism of Origin Dependent Inverted Repeat Amplification (ODIRA). These results along with finding and characterizing other mechanisms of GAP1 CNV formation will be of general interest to those studying CNVs in natural systems, experimental evolution, and in tumor evolution. While the results are limited to a single CNV of interest (GAP1), the carefully controlled experimental design and quantification of CNV formation will provide a useful guide to studying other CNVs and CNVs in other organisms.

      Thank you for this positive assessment of our study.

      Strengths:

      The study was designed to examine the effects of two flanking genomic features next to GAP1 on CNV formation and adaptation during experimental evolution. This was accomplished by removing two Long Terminal Repeats (LTRs), removing a downstream ARS, and removing both LTRs and the ARS. Although there was some heterogeneity among replicates, later shown to include the size and breakpoints of the CNV and the presence of an unmarked CNV, both marker-assisted tracking of CNV formation and modeling of CNV rate and fitness effects showed that deletion of the ARS caused a clear difference compared to the control and the LTR deletion.

      The consequence of deletion of local features (LTR and ARS) was quantified by genome sequencing of adaptive clones to identify the CNV size, copy number and infer the mechanism of CNV formation. This greatly added value to the study as it showed that i) ODIRA was the most common mechanism but ODIRA is enhanced by a local ARS, ii) non-allelic homologous recombination (NAHR) is also used but depends on LTRs, and iii) de novo insertion of transposable elements mediate NAHR in strains with both ARS and LTR deletions. Together, these results show how local features influence the mechanism of CNV formation, but also how alternative mechanisms can substitute when primary ones are unavailable.

      We agree with this assessment.

      Weaknesses:

      The CNV mutation rate and its effect on fitness are hard to disentangle. The frequency of the amplified GFP provides information about mutation rate differences as well as fitness differences. The data and analysis show that each evolved population has multiple GAP1 CNV lineages within it, with some being unmarked by GFP. Thus, estimates of CNV fitness are more of a composite view of all CNV amplifications increasing in frequency during adaptation. Another unknown but potential complication is whether the local (ARS, LTR) deletions influence GAP1 expression and thus the fitness gain of GAP1 CNVs. The neural network simulation-based inference does a good job at estimating both mutation rates and fitness effects, while also accounting for unmarked CNVs. However, the model does not account for the population heterogeneity of CNVs and their fitness effects. Despite these limitations of distinguishing mutation rate and fitness differences, the authors' conclusions are well supported in that the LTR and ARS deletions have a clear impact on the CNV-mediated evolutionary outcome and the mechanism of CNV formation.

      While it is true that the inferred mutation rate and fitness effect are negatively correlated, as in other studies (Gitschlag et al., 2023; Caspi et al., 2023; Avecilla et al., 2022), our modeling approach does generate an estimate of each parameter that is best explained by the data. By reporting the confidence intervals (i.e. the 95% HDI) we define the set of parameter values that are consistent with the data. It is true that our model doesn't explicitly account for population heterogeneity; rather, following Hegreness et al. (2006), we employ a single effective fitness effect and mutation rate for all GAP1 CNVs. It is interesting to consider whether the ARS and LTR affect GAP1 expression; however, we have no evidence that this is the case.

      Reviewer #3 (Public Review):

      Summary:

      The authors represent an elegant and detailed investigation into the role of cis-elements, and therefore the underlying mechanisms, in gene dosage increase. Their most significant finding is that in their system copy number increase frequently occurs by what they call replication errors that result from the origin of replication firing.

      The authors somewhat quantitatively determine the effect of the presence of a proximal origin of replication or LTR on the different CNV scenarios.

      Strengths:

      (1) A clever and elegant experimental design.

      (2) A quantitative determination of the effect of a proximal origin of replication or LTR on the different CNV scenarios. Measuring directly the contribution of two competing elements.

      (3) ODIRA can occur by firing of a distal ARS element.

      (4) Re-insertion of Ty elements is interesting.

      We agree that these are interesting and novel findings from our study.

      Weaknesses:

      (1) Overall, the research does not considerably advance the current knowledge. The research does not investigate what the maximum distance between ARS for ODIRA is to occur. This is an important point since ODIRA was previously described. A considerable contribution to the field would be to understand under what conditions ODIRA wins NAHR.

      We agree that these are important questions and they are ones that we are pursuing in future studies.

      (2) The title and some sentences in the abstract give a wrong impression of the generality and the novelty of the observations presented. Below are some examples of much earlier work that dealt with mechanisms of CNV and got different conclusions. The Lobachev lab (Cell 2006) published a different scenario years ago, with a very different mechanism (hair-pin capped breaks). The Argueso lab found something different (NAHR) (Genetics 2013).

      In fact, the CUP1 system presents a good example of this point. The Houseley group showed a complex replication transcription-based mechanism (NAR 2022, cited), the Argueso group showed Ty-based amplification and the Resnick group showed aneuploidy-based amplification. While aneuploidy is a minor factor here the numerous works in Candida albicans, Cryptococcus neoformans, and Yeast suggest otherwise (Selmecki et al Science 2006, Yona et al PNAS 2013, Yang et al Microbiology Spectrum 2021).

      As the reviewer points out there have been several important published studies investigating mechanisms by which structural variation is generated. It is important to note that we are explicitly looking at CNVs in the context of adaptive evolution and the role of genomic features that enable different mechanisms of CNV formation. To emphasize this point, we have changed the title of our manuscript to “Template switching during DNA replication is a prevalent source of adaptive gene amplification”. Aneuploidy is indeed a mechanism of adaptive gene amplification in our current and previously reported studies. We have expanded our discussion to place our study in the context of previous studies reporting mechanisms of gene amplification.

      (3) The authors added a mathematical model to their experimental data. For me, it was very difficult to understand the contribution of the model to the research. I anticipated, for example, that the model would make predictions that would be tested experimentally. For example, " ARSΔ and ALLΔ are predicted to be almost eliminated by generation 116, as the average predicted WT proportion is 0.998 and 0.999" But to my understanding without testing the model.

      In our previous publication (Avecilla et al. 2022, PLoS Biology) we experimentally validated the use of nnSBI to infer evolutionary parameters. In this study, we have extended our modeling framework to quantify differences between genotypes, which was not previously possible. Our results reveal that the local ARS has a key role in the overall supply rate of CNVs at this locus.

      Recommendations for the authors:

      We have addressed all public reviews and recommendations.

      Reviewer #1 (Recommendations For The Authors):

      Specific comments about the work are covered in the order of appearance in the text or Figures. I apologize in advance for the number of comments. They are made out of curiosity, enthusiasm for the research, and a desire to help highlight the most interesting aspects of this work.

      We are grateful for the thoughtful comments that have helped us to significantly improve our manuscript.

      (1) I would appreciate the inclusion of several references to the work on the ODIRA model.

      a) Page 3 last paragraph: "(2) DNA replication-based mechanisms (Harel et al., 2015; Hastings, Lupski, et al., 2009; Malhotra & Sebat, 2012; Pös et al., 2021; Zhang, Gu, et al., 2009; Brewer et al., 2011)" (Addition of Brewer et al., 2011).

      We have added all suggested references.

      b) Page 4 top: (Brewer et al., 2011; Brewer et al., 2015; Martin et al., 2024). (Addition of Brewer et al., 2011).

      We have added all suggested references.

      c) Page 14 top: "Recent work has proposed that ODIRA CNVs are a major mechanism of CNVs in human genomes (Brewer et al., 2015; Martin et al., 2024; Brewer et al., 2024)." Brewer et al., 2024 focuses specifically on ODIRA and human CNVs. (Addition of Brewer et al., 2024).

      We have added all suggested references.

      (2) Page 6, third paragraph: I was surprised that a single inoculating strain was used to establish the replicate chemostats because of the possibility of non-independence of the resulting GAP1 CNVs. A nnSBI model was used to correct for this possibility later in the paper. It seems like it could have been avoided by a simple change in protocol to inoculate each chemostat with an independent inoculum. Was there a reason that the replicate chemostats were not conducted as independent events? Establishing the presence of 'founder' GAP1 CNVs without GFP seems rather secondary to the point of the paper (examining the CNVs that arise during evolution) and I would recommend it being moved to the supplement.

      As is typical in microbial experimental evolution studies, we aimed to start with genetically identical homogenous populations and observe the emergence and selection of de novo variation. Therefore, we founded independent populations from a single inoculum. However, this study, and our prior work using lineage tracking barcodes, has clearly demonstrated that during the initial growth of the culture used for the inoculum CNVs are generated that contribute to the adaptation dynamics on all derived populations. This unanticipated result now suggests that the reviewer’s suggestion is a valid one - independent populations should be derived from independent inocula and this will be our standard practice in future studies.

      We believe that our results, presented in Figure 2, establishing the presence of pre-existing GAP1 CNVs without the GFP are important as it highlights a limitation of the use of CNV reporters of gene copy number that was not previously known. However, we subsequently show that this class of variant - CNVs that are not detected by the reporter system - can be incorporated into our modeling framework enabling estimation of evolutionary parameters, which we believe is an important finding warranting inclusion in the main text.

      (3) Page 7 first full paragraph: "Finally, we also observe a significant delay (ANOVA, p = 0.00833) in the generation at which the CNV frequency reaches equilibrium in ARS∆ (~generation 112) compared to WT (pairwise t-test, adjusted p = 0.05) . . .". Is the delay in reaching a plateau in Figure 1E just a consequence of the later appearance of CNVs or do the authors believe there are two separate events responsible for this delay? E.g. if the authors think that the delay in reaching a plateau is related to lower selection coefficients of the CNVs that do arise compared to the CNVs of other strains, then this should be explicitly discussed.

      We believe that the delay in reaching equilibrium is a consequence of both a lower CNV formation and reduced selection coefficients. Lower values for the fitness coefficient and formation rate in ARS∆ explain both the delay in CNV appearance and CNV equilibrium as shown by the predicted dynamics (Figure S3B). We have added an explicit discussion of the effect of the ARS on CNV dynamics in paragraph 2 of the Discussion section paragraph 2 starting at line 456.

      (4) Page 7: Incorporating pre-existing CNVs into an evolutionary model: The rationale for how you are able to discount the formation rate of GFP-free CNVs (C-) in your model isn't clear to me. How are you able to assume that these C- events don't form after timepoint 0? Why do you assume a starting population of C- events but not a starting population of C+ events?

      We explored the possibility of modeling C- (amplifications of GAP1 without amplification of the reporter) during the evolution experiment. However, because the rate at which C- events occurs is slower than the rate at which C+ events occur (GAP1 amplifications with amplification of the reporter) we found that the effect was negligible. Importantly, the simple model is sufficient to describe the observed dynamics and thus we do not include these possible rare events.

      (5) Figure 1:

      (a) Panel B: Please put the tRNAs on the line diagrams of the four strains. I first interpreted ALLΔ as missing the tRNAs, too.

      Thank you for this suggestion. We added tRNAs to all diagrams to provide additional detail about the structure of the GAP1 locus.

      (b) Panels C, D, and E: the dark shade of the colored boxplots obscures the individual points. I recommend reducing the opacity of the box or choosing a lighter shade so that the individual points are visible on top of the box. Is the percent increase in CNVs per generation (Panel D) based on the slopes of the curves in panel B? By eye the slopes of ARS∆ and ALL∆ appear at least as steep as those of wild type and LTR∆.

      Thank you for this suggestion. We have now made the individual points visible on top of the boxplots in Figures 1C, 1D, and 1E. The lines in Figure 1B show the median value across populations per time point whereas each point in Figure 1D is the slope from linear regression using values from individual populations (data from individual populations are shown in Figure 3C).

      (6) Figure 2:

      (a) Panel A: Please remind the readers what FSC-A is measuring and label the different groups of cells in each sample. Are we supposed to assume the upper scatter in generation 8 is the pre-existing CNV variants? Are the three species at generation 50 due to 1, 2, and 3 copies of GFP? Is the new species in generation 137 further amplification of the locus? And if so, how many copies does it represent? I find it fascinating that what I assume is the 2-copy CNV (presumably a direct oriented amplicon produced by NAHR) at 50 generations is lost (out-competed by a potential inverted triplication) at later times, but I didn't find any mention of this phenomenon in the text. What do the different mutant strains look like over the same time course? Please supply supplemental figures with the flow cytometry gating and vertically aligned histograms of the GFP signal so that the peaks are more easily compared. And provide this information for each of the altered strains in supplementary materials.

      Thank you for these useful suggestions. We have added a gating legend to the figure to clearly indicate the copy-number for each subpopulation. We have edited the caption and main text to explain forward scatter (FSC-A). Raw flow cytometry plots are now provided as Supplementary figure 2 and distributions of cell-size normalized GFP signal are provided in Supplementary figure 3. Although our primary objective with Figure 2A was to show the persistence of the 1-copy GFP population the reviewer is correct that we did not highlight interesting aspects of the CNV dynamics. We have added additional text starting at line 251 to point out these features of the data.

      (b) Panel B: It would help to label the different colored boxes inside cells in Figure 2B - it took me a while to identify the white box as an unrelated adaptive mutation elsewhere in the genome. The linear arrangement of these small colored blocks seems to indicate their structural arrangement. Is that the case? And are they inverted or direct amplicons? Perhaps the authors are being agnostic at this point but it would be better if each of the blocks were separate. If there are other mutations that can explain these GFP-non-amplified survivors, were they identified in your whole genome sequencing?

      We have now included a complete legend for Figure 2B indicating that the white box reflects other beneficial mutations. We have separated this class of beneficial mutation from the GAP1 and reporter elements to reflect that they are not linked. We did not identify additional beneficial mutations but plan to pursue this question in a future project.

      (c) Panel C: Are the two sets of lines mislabeled? One would expect the "reported" CNV proportions to be lower than the total CNV proportions, not the other way around. Maybe the labels "total CNVs" and "reported CNVs" are unclear to me and I am misunderstanding what "reported" refers to. Please clarify.

      Thank you for identifying this mistake. The lines were mislabeled and have now been corrected in the revised version.

      (7) Figure 3:

      (a) A fuller discussion of panels A and B is needed. The results of panel A in particular seem like an excellent opportunity for connecting the computation to the biology. Can the authors speculate on why the ALL∆ strain has a higher CNV formation rate (𝛿c) than the ARS∆ strain? I would think that taking away one means of amplification would decrease CNV formation. Likewise, could the authors discuss why the selection coefficient (sc) for the LTR∆ strain would be the same as for the wild type? Overall, I would like to see more discussion about what these differences in formation rates and selection coefficients could mean for the types of amplicons arising in the chemostats. (In panel B I don't see the shaded area referred to in the figure legend.) A side-by-side comparison of the data in Panel A with the data shown in Supplemental Figure S3A would be instructive..

      Thank you for raising these points. We have added substantial text to the manuscript to address these findings. Starting at line 456 we state:

      “The lower CNV formation rate in the LTR∆ could be a closer approximation of ODIRA formation rates at this locus as ODIRA CNVs are the predominant CNV mechanism in the LTR∆ strain (Figure 4F). Furthermore, the low formation rates in the LTR∆ relative to WT might suggest that the presence of the flanking long terminal repeats may increase the rate of ODIRA formation through an otherwise unknown combinatorial effect of DNA replication across these flanking LTRs and template switching at the GAP1 locus. ARS∆ has the lowest CNV formation rate and it could be an approximation of the rates of NAHR between flanking LTRs and ODIRA at distal origins. We find that the ALL∆ has a higher CNV formation rate than the ARS∆, even though three elements are deleted instead of one. One explanation for this is that the deletion of the flanking LTRs in ALL∆ gives opportunity for novel transposon insertions and subsequent LTR NAHR. Indeed we find an enrichment of novel transposon-insertions in the ALL∆ (Figure 4F) and subsequent CNV formation through recombination of the Ty1-associated repeats (Figure 4H, ALL∆). Both events, transposon insertion followed by LTR NAHR, would have to occur quickly at a rate that explains our estimated CNV rate in ALL∆. While remarkable, increased transposon activity has been associated with nutrient stress (Curcio & Garfinkel, 1999; Lesage & Todeschini, 2005; Todeschini et al., 2005) and therefore feasible explanation for the CNV rate estimated in the ALL∆. Additionally, ARS∆ clones rely more on LTR NAHR to form CNVs (Figure 4F). The prevalence of ODIRA in ARS∆ and ALL∆ are similar. LTR NAHR usually occurs after double strand breaks at the long terminal repeats to give rise to CNVs (Argueso et al., 2008). Because we use haploid cells, such double strand break and homology-mediated repair would have to occur during S-phase after DNA replication with a sister chromatid repair template to form tandem duplications. Therefore the dependency on LTR NAHR to form CNVs and the spatial (breaks at LTR sequences) and temporal (S-phase) constraints could explain the lower formation rate in ARS∆.”

      In addition, we added a discussion of the different selection coefficients estimated and how the simulated competitions help us understand the decreased selection coefficients in the architecture mutants. In newly added text starting at line 479 we state:

      “The genomic elements have clear effects on the evolutionary dynamics in simulated competitive fitness experiments. The similar selection coefficients in WT and LTR∆ suggest that CNV clones formed in these background strains are similar. Indeed, the predominant CNV mechanism in both is ODIRA followed by LTR NAHR (Figure 4F). While LTR NAHR is abolished in the LTR∆, it seems that CNVs formed by ODIRA allow adaptation to glutamine-limitation similar to WT. The lower selection coefficients in ARS∆ and ALL∆ suggest that GAP1 CNVs formed in these strains have some cost. In a competition, they would get outcompeted by CNV alleles in the WT and LTR∆ background.”

      (b) The data shown in panel C seems redundant to what is shown more clearly in Supplemental Figure S3B. It seems to me the more important comparison to make in panel C would be the overlay of the predicted data to the median proportion of cells obtained from the experimental data (Figure 1B). Also, overlays of the cultures from each strain could be added to S3A. It is difficult to see the variation within each strain when the data from all four strains are superimposed as they are in Figure 3C.

      We agree and have edited Figure 3C to incorporate these suggestions and more clearly convey the intra- and interstrain variation.

      (8) Figure 4:

      (a) Panels A, B, and C are nice summaries and certainly helpful for understanding panel E, but it would be instructive to see some actual rearrangements of the ODIRA events, the NAHR, and the transposon-mediated rearrangements. It isn't clear to me what these last events look like. A figure that shows the specific architecture of example clones for each category would be helpful. I am also having a hard time reconciling ODIRA events with a copy number of 2. Are these rearrangements free isochromosomes with amplification to the telomere or are they secondary rearrangements like those described in Brewer et al., 2024? And what about the non-aneuploid rearrangement that includes the centromere? Is it a dicentric?

      We have now added more detailed depictions of CNVs in Figure 4A and provide links to visualize the alignment files. We have added additional discussion starting at line 397 of the non-canonical ODIRA events and putative neochromosome amplicons with reference to Brewer et al 2024. Starting at line 397 we state:

      “Surprisingly, we found CNVs with breakpoints consistent with ODIRA that contained only 2 copies of the amplified region, whereas ODIRA typically generates a triplication. In the absence of additional data, we cannot rule out inaccuracy in our read-depth estimates of copy numbers for these clones (ie. they have 3 copies). An alternate explanation is a secondary rearrangement of an original inverted triplication resulting in a duplication (Brewer et al., 2024); however, we did not detect evidence for secondary rearrangements in the sequencing data. A third alternate explanation is that a duplication was formed by hairpin capped double-strand break repair (Narayanan et al., 2006). Notably, we found 3 additional ODIRA clones that end in native telomeres, each of which had amplified 3 copies. In these clones the other breakpoint contains the centromere, indicating the entire right arm of chromosome XI was amplified 3 times via ODIRA, each generating supernumerary chromosomes. Thus,ODIRA can result in amplifications of large genomics regions from segmental amplifications to supernumerary chromosomes.”

      (b) In Panel B the violin plots appear to indicate that there are two size categories for amplicons in the ARS∆ strain. Do clones from these different sub-populations share a common CNV architecture?

      Thank you for making this point. (Please note that the violin plots are now Figure 4E) We added a short discussion and Supplementary Figure 14. In line 432, we state:

      “In ARS∆, we find two CNV length groups (Figure 4E) that correspond with two different CNV mechanisms (Supplementary Figure 14). 100% of smaller CNVs (6-8kb) (Supplementary Figure 14) correspond with a mechanism of NAHR between LTRs flanking the GAP1 gene (Figure 4H, ARS∆, bottom left green points). Larger CNVs (8kb-200kb) (Supplementary Figure 14) correspond with other mechanisms that tend to produce larger CNVs, including ODIRA and NAHR between one local and one distal LTR element (Figure 4H).”

      (c) Panels D and E: There is great information in these two panels but I find the color keys confusing. There doesn't seem to be any reason for the strain color key in panel E. I am assuming that the key should go with Panel D. Is there some way to indicate in Panel D which events are in which CNV category? It is cumbersome to find that information from Panel E. Perhaps the color-coding from Panel E could be applied to the row labels in Panel D. Being able to link amplicon to the mechanism of CNV formation is especially important for seeing which ODIRA events contain an origin.

      Thank you for this suggestions. We now indicate the mechanism of CNV formation using a consistent color coding in panels G and H (previously panels D and E).

      (d) Panel E: I don't understand the two axes in Panel E. If both axes are log scales, why is the origin 0 for the X-axis and 1 for the Y-axis? And why are the focal amplicons (most of which are recombination events between the two LTRs) scattered in both X and Y coordinates? Shouldn't they form a single point? The same for the recombinants with distal LTRs. Also, orange and red (ODIRA and complex CNVs, respectively) are very hard to distinguish. All of these data need to be presented in a spreadsheet identifying each clone's strain ID, chemostat number, GAP1 and GFP copy numbers, sequence across the junction, and their coordinates. The SRA project (PRJNA1016460) for the sequence data was not found in SRA. Will this data be available to easily look at read depth across chromosome XI for all of the sequenced strains - perhaps as .bam files?

      Thank you for calling these issues with data visualization to our attention. Indeed, the focal amplifications do form around a single point. We originally had jittered the data to show each individual focal amplification but agree that this is confusing. We now overlay the individual points and have altered opacity to enable visualization of individual values. The suggested table of clone data is provided in Supplementary File 2 and the SRA project is now publicly available. Moreover, we are providing all alignment (.bam) files, split, and discordant read depth profiles for each CNV strain and their corresponding ancestor aligned to our custom reference genomes in a public jbrowse server at:

      https://jbrowse.bio.nyu.edu/gresham/?data=data/ee_gap1_arch_muts for WT strains, https://jbrowse.bio.nyu.edu/gresham/LTRKO_clones for LTR∆ strains, https://jbrowse.bio.nyu.edu/gresham/ARSKO_clones for ARS∆ strains, https://jbrowse.bio.nyu.edu/gresham/ALLKO_clones for ALL∆ strains.

      (e) Supplementary Table 1 and Supplementary Figure S2: Please indicate which rearrangements (of the 8 reported in Figure S2A) were identified in each of the clones described in the table. If each of the 8 amplicons is identified by a letter, then this information could be added as a column in the table. I am assuming that each of the eight rearrangements was found in more than one chemostat. Showing these data is crucial for establishing the possibility that they were preexisting at the time of chemostat inoculation. The other possibility is that the clones with amplified GAP1 but a single copy of GFP could have been created by a secondary rearrangement in the outgrowth of the clones that originally had amplified both genes to the same extent. What is the structure of these amplicons? Is there a common junction between GAP1 and GFP? I couldn't find these data in the paper. A suggestion for Supplemental Figure S2A - include a zoomed-in inset for the GAP1 GFP region for each of the 8 read-depth plots. It is hard to see the exact location of GFP and GAP1 across all 8 tracks without getting out a ruler. Were these sequences aligned to your custom reference genome or the reference genome without GFP? If they were aligned to the custom reference that includes the GFP reporter, the reader could visually confirm the absence of GFP amplification.

      Thank you for these suggestions. We edited Supplementary Table 1 and Supplementary Figure 1A as requested. We now provide the precise CNV breakpoints in the GFP-GAP1 region (supplemental figure 1B) displaying both genome read depth and split read depth tracks. These sequences were aligned to the custom reference containing the GFP reporter, which is now clearer in the figure and caption text in line 1226.

      The clones in this figure were sampled from the five different chemostats and we have clarified this in the edited table and text at line 210. We did not detect the same CNV allele in different chemostats and therefore we do not have evidence to support GAP1 amplification without the GFP reporter pre-existing at time of inoculation. We are not able to definitively distinguish whether the amplicons were pre-existing at the time of inoculation or occurred after as we do not have barcoded lineages. We isolated clones carrying this class of amplification from the 1-GFP-copy subfraction late in the experimental evolution (generation 165-182). Given that the alleles appear to differ between populations we think the most parsimonious explanation is that these amplifications occurred after chemostat inoculation but early in the evolution experiment. We explicitly state this in the text starting in line 219.

      (9) Page 8-9: I am sorry to say that I can't evaluate the "HDI of posterior distributions". It is out of my competency range. So I am not sure what this analysis is adding to the paper. The same goes for the rest of the supplementary figures.

      HDI is a measure of certainty in an estimate, similar to confidence interval. We state this in the text in line 276. With the editing of the text we hope the modeling and its supplementary figures are more clear now.

      (10) Page 9 top: Deletion of the ARS appears to lower the fitness of the amplified GAP1 variants. Can the authors speculate on why the ARS deletion would reduce fitness? Did they consult published replication profiles to determine the size of the origin-free gap that could result from the deletion of this mid-S phase origin? Could it explain the delay in the appearance of GAP1 amplicons in the ARS-deletion strains and be responsible for their reduced selection coefficients? Did you examine the growth properties of the starting strain or any of the amplified GAP1 derivatives? Perhaps this consideration could contribute to the discussion. Could there be a bit fuller discussion on the interaction between CNV length differences as shown in Figure 4A and differences in selection coefficient as determined by the nnSBI?

      Thank you for raising this point. We have now added text to our discussion of the reduced fitness in ARS∆ in relation to DNA replication starting on line 359:

      “ARS1116 is a major origin (McGuffee et al., 2013) and ODIRA CNVs found around this origin corroborate its activity. GAP1 is highly transcribed in glutamine-limited chemostats (Airoldi et al., 2016). Head-on transcription-replication collisions at this locus may be contributing to the higher CNV formation rate in wild type and LTR∆. Elimination of the local ARS could result in less transcription-replication collisions and the slower CNV formation rates estimated. Once formed they get outcompeted by faster-forming CNVs and thus in theory are less fit than CNVs in other strain backgrounds. These simulated competitions further suggest that the ARS is a more important contributor to adaptive evolution mediated by GAP1 CNVs.”

      We examined replication profiles in McGuffee et al. Mol Cell. 2013 but could not determine the size of the origin-free gap. ARS1116 and its neighboring ARSs, ARS1118 downstream and ARS1115 upstream are efficient firing origins (Supplement 1 of McGuffee et al. 2013) and therefore the gap is likely to be minimal. The dynamics of the distal firing ARS elements involved in creating ODIRA CNVs might explain the reduced fitness, but further experiments would be required to address this. Regarding growth properties, the growth rate at steady-state in the chemostat is the same as the dilution rate regardless of strain background. Because we had the same dilution rate for each chemostat, the ARS∆ populations would have the same replication rate as the other three strains even if there may be replication rate differences in bulk culture growth. Finally, we found no significant interaction between CNV length and selection coefficients and we state this in line 359.

      (11) Page 10: WT competition simulations: It may help to explicitly state that the competition modeling approach was experimentally validated in Avecilla 2022 as opposed to just citing the paper. I found the results much more convincing after reading Avecilla 2022, but I imagine many readers may skip that.

      We added a sentence to state that the nnSBI method was experimentally validated in Avecilla et 2022 at line 249.

      Reviewer #2 (Recommendations For The Authors):

      (1) Figure 2: says reported CNV proportions (dashed). This may be a typo since I think the GFP reported should be solid, not dashed. Also, (C) isn't bold.

      Thank you for identifying these mistakes. We have corrected the figure’s caption in line 1157.

      (2) "compared to 898/345 clones" Does this refer to transposition/clone? Seems more natural to compare clones with transpositions to a total number of clones. This could be clarified.

      We rephrased the sentence (lines 519-520) to clarify that in their study Hays et al. 2023 found 898 novel Ty insertions across 345 nitrogen-evolved clones. As a result of this high rate of transposition, some clones are expected to have multiple Ty insertions.

      (3) The methods state that Kan replaces the Nat cassette that was used to make the deletions. It should be made more clear whether Kan is present and where Kan is with respect to GFP and GAP1.

      Thank you for pointing this out. To clarify we added the following sentence to the methods starting in line 567:

      “The CNV reporter is 3.1 kb and located 1117 nucleotides upstream of the GAP1 coding sequence. It consists of, in the following order, an ACT1 promoter, mCitrine (GFP) coding sequence, ADH1 terminator, and kanamycin cassette under control of a TEF promoter and terminator.”

      Additionally in line 571 we clarify the drug resistance of the genomic architecture ∆ strains that are kanamycin(+) and nourseothricin(-).

      Reviewer #3 (Recommendations For The Authors):

      (1) The major advancement of the manuscript is stated in the title "DNA replication errors are a major source of adaptive gene amplification" First, in my humble opinion the term replication errors is not quite right; the term template switching is more accurate. In that regard, recently a paper was published just on this topic (Martin et al Plos Genetics, 2024).

      We have changed the title to “Template-switching during DNA replication is a prevalent source of adaptive gene amplification”. We cite Martin et al Plos Genetics 2024 throughout the main text in lines 93, 126, 159, 502, 555.

      (2) I find the statement "We find that 49% of all GAP1 CNVs are mediated by the DNA replication-based mechanism Origin Dependent Inverted Repeat Amplification (ODIRA) regardless of background strain." Somewhat misleading, there were considerable differences between the strains. If I am not mistaken the range was 20-80%.

      Thank you for pointing this out. Indeed, the range was 26-80% across the four strains. We updated this sentence in the abstract at line 40, and in the main text at line 141 to clearly state the range.

      (3) In their attempt to fill the gap of knowledge regarding the fitness effect of the adaptive CNV the authors use a mathematical model. As an experimental biologist, I found the description lacking. It is hard for me to evaluate the contribution of the model to understanding the results and I think the authors could improve this part.

      We have edited the text regarding the modeling and associated results and hope that it is now more clear. The mathematical model describes the experiment in a simplified manner. We use it to predict the outcomes of additional experiments without additional experimental work. For example, we used it to simulate a competition between two strains, predict the total proportion of GAP1 CNVs, and predict the relative genetic diversity.

      (4) Experiments the authors may want to consider to increase the novelty of their work:

      a) Place the GAP1 gene right in the middle of the two most distant ARS elements and test the mechanism of CNV.

      Thank you for this proposed experiment. It is beyond the scope of this paper and will be pursued in future studies.

      b) The finding of de-novo Ty element insertion is interesting. What happens if the overdose strain of Jef Boeke is used (Retrotransposon overdose and genome integrity, PNAS 2009) or in contrast, a reverse transcriptase deficient strain?

      We agree. Our study has revealed a critical role for novel Ty insertion in mediating CNVs. The suggested experiments as well as using strains that lack Ty sequences will be very interesting to explore in followup studies.

      c) The genomic analyses were based on single colony isolates. To my understanding, the CNV events are identified at least partly by split reads. Therefore, each event may have a "signature" that is unique and can be concluded from single reads and not necessarily from the assembled genome. If true, a distinction between the scenarios could be achieved if bulk cultures are sequenced with enough depth. Thus, a truly dynamic and quantitative determination of the different events, rate of appearance, and disappearance can be made.

      Thank you for this suggestion, which is a good idea but not currently feasible for several reasons. First, although split reads are a powerful way to detect CNV breakpoints, we have found that even at high coverage (21-153X, median 78.5X), in clonal samples that are rare with only 3-30 split reads (median 14) detected. These observations are from a total of 23 breakpoints across 16 sequenced clones. Thus, when sequencing heterogeneous cultures, in which different CNVs only comprise a fraction of the population, our ability to detect single CNV alleles by split reads and quantify their frequency is limited. Given our observations, with a median of 14 split reads when sequencing to 78.5X genome-wide read coverage it is possible we may be able to detect an individual CNV allele once it makes up (14/78.5) 17% of the population. However, our previous study has shown that there are tens to hundreds of unique CNV alleles initially and thus this would only be feasible at very late timepoints. Second, recurrent CNVs may occur independently at the same exact location, such as LTR NAHR. Thus, unique signatures may not be obtained even if they are independent events. Third, it would be not appropriate to pursue this analysis with our current dataset, as we lack lineage tracking barcodes to validate the results.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Reviewer #1 (Public Review):

      The authors sometimes seem to equivocate on to what extent they view their model as a neural (as opposed to merely behavioral) description. For example, they introduce their paper by citing work that views heterogeneity in strategy as the result of "relatively independent, separable circuits that are conceptualized as supporting distinct strategies, each potentially competing for control." The HMM, of course, also relates to internal states of the animal. Therefore, the reader might come away with the impression that the MoA-HMM is literally trying to model dynamic, competing controllers in the brain (e.g. basal ganglia vs. frontal cortex), as opposed to giving a descriptive account of their emergent behavior. If the former is really the intended interpretation, the authors should say more about how they think the weighting/arbitration mechanism between alternative strategies is implemented, and how it can be modulated over time. If not, they should make this clearer.

      The MoA-HMM is meant to be descriptive in identifying behaviorally distinct strategies. Our intention in connecting it with a “mixture-of-strategies” view of the brain is that the results of the MoA-HMM could be indicative of an underlying arbitration process, but not modeling that process per se, that can be used to test neural hypotheses driven by this idea. We’ve added additional clarification in the discussion to highlight this point.

      Explicitly, we added the following sentence in the discussion: “For example, while the MoA-HMM itself is a descriptive model of behavior and is not explicitly modeling an underlying arbitration of controllers in the brain, the resulting behavioral states may be indicative of underlying neural processes and help identify times when different neural controllers are prevailing”

      Second, while the authors demonstrate that model recovery recapitulates the weight dynamics and action values (Fig. 3), the actual parameters that are recovered are less precise (Fig. 3 Supplement 1). The authors should comment on how this might affect their later inferences from behavioral data. Furthermore, it would be better to quantify using the R^2 score between simulated and recovered, rather than the Pearson correlation (r), which doesn't enforce unity slope and zero intercept (i.e. the line that is plotted), and so will tend to exaggerate the strength of parameter recovery.

      In the methods section, we noted that the interaction between parameters can cause the recovery of randomly drawn parameter sets to fail, as seen in Figure 3 Supplement 1. This is because there are parameter regimes (specifically when a softmax temperature is near zero) which causes choices to be random, and therefore other parameters no longer matter. To address this, we included a second supplemental figure, Figure 3 Supplement 2, where we recovered model parameters from data simulated solely from models inferred from the behavioral data. Recovery of these models is much more precise, which credits our later inferences from the behavioral data.

      To make this point clearer, we changed the reference to Figure 3 Supplements 1 & 2 to: “(Figure 3 – figure supplement 1 for recovery of randomized parameters with noted limitations, and figure supplement 2 for recovery of models fit to real data)” We additionally added the following to the Figure 3 Supplement 1 caption: “Due to the interaction between different model parameters (e.g. a small 𝛽 weight will affect the recoverability of the agent’s learning rate 𝛼), a number of “failures” can be seen.”

      Furthermore, we added an R^2 score that enforces unity slope and zero intercept alongside the Pearson correlation coefficient for more comprehensive metrics of recovery. The R^2 scores are plotted on both Figure 3 Supplements 1 & 2 as “R2”, and the following text was added in both captions: “"r" is the Pearson's correlation coefficient between the simulated and recovered parameters, and "R2" is the coefficient of determination, R2, calculating how well the simulated parameters predict the recovered parameters.”

      Finally, the authors are very aware of the difficulties associated with long-timescale (minutes) correlations with neural activity, including both satiety and electrode drift, so they do attempt to control for this using a third-order polynomial as a time regressor as well as interaction terms (Fig. 7 Supplement 1). However, on net there does not appear to be any significant difference between the permutation-corrected CPDs computed for states 2 and 3 across all neurons (Fig. 7D). This stands in contrast to the claim that "the modulation of the reward effect can also be seen between states 2 and 3 - state 2, on average, sees a higher modulation to reward that lasts significantly longer than modulation in state 3," which might be true for the neuron in Fig. 7C, but is never quantified. Thus, while I am convinced state modulation exists for model-based (MBr) outcome value (Fig. 7A-B), I'm not convinced that these more gradual shifts can be isolated by the MoA-HMM model, which is important to keep in mind for anyone looking to apply this model to their own data.

      We agree with the reviewers that our initial test of CPD significance was not sufficient to support the claims we made about state differences, especially for Figure 7D. To address this, we updated the significance test and indicators in Figure 7B,D to instead signify when there is a significant difference between state CPDs. This updated test supports a small, but significant difference in early post-outcome reward modulation between states 2 and 3.

      We clarified and updated the significance test in the methods with the following text:

      “A CPD (for a particular predictor in a particular state in a particular time bin) was considered significant if that CPD computed using the true dataset was greater than 95% of corresponding CPDs (same predictor, same state, same time bin) computed using these permuted sessions. For display, we subtract the average permuted session CPD from the true CPD in order to allow meaningful comparison to 0.

      To test whether neural coding of a particular predictor in a particular time bin significantly differed according to HMM state, we used a similar test. For each CPD that was significant according to the above test, we computed the difference between that CPD and the CPD for the same predictor and time bin in the other HMM states. We compare this difference to the corresponding differences in the circularly permuted sessions (same predictor, time bin, and pair of HMM states). We consider this difference to be significant if the difference in the true dataset is greater than 95% of the CPD differences computed from the permuted sessions.”

      We updated the significance indicators above the panels in Figure 7B,D (colored points) to refer to significant differences between states, with additional text to the left of each row of points to specify the tested state and which states it is significantly greater than. We updated the figure caption for both B and D to reflect these changes.

      We also changed text in the results to focus on significant differences between states. Specifically, we replaced the sentence “Looking at the CPD of expected outcome value split by state (Figure 7B) reveals that the trend from the example neuron is consistent across the population of OFC units, where state 2 shows the greatest CPD.” with the sentence “Looking at the CPD of expected outcome value split by state (Figure 7B) reveals that the trend from the example neuron is consistent across the population of OFC units, where state 2 has a significantly greater CPD than states 1 and 3.”

      We also replaced the sentence “Suggestively, the modulation of the reward effect can also be seen between states 2 and 3 – state 2, on average, sees a higher modulation to reward that lasts significantly longer than modulation in state 3.” with the sentence “Additionally, the modulation of the reward effect can also be seen between states 2 and 3 — immediately after outcome, we see a small but significantly higher modulation to reward during state 2 than during state 3.”

      Reviewer #2 (Public Review):

      There were a lot of typos and some figures were mis-referenced in the text and figure legends.

      We apologize for the numerous typos and errors in the text and are grateful for the assistance in identifying many of them. We have taken another thorough pass through the manuscript to address those identified by the reviewer as well as fix additional errors. To reduce redundancy, we’ll address all typoand error-related suggestions from both reviewers here.

      ● We fixed all Figure 1 references. We additionally reversed the introduction order of the agents in Figure 1 and in the results section “Reinforcement learning in the rat two-step task”, where we introduce both model-free agents before both model-based agents. This is to make the model-based choice agent description (which references the model-free choice agent in the statement “That is, like MFc, this agent tends to repeat or switch choices regardless of reward”) come after introducing the model-free choice agent.

      ● We fixed all Figure 4 references.

      ● We fixed all Figure 6 references and fixed the panel references in the figure caption to match the figure labeling: Starting with panel B, the reference to (i) was removed, and the reference to (ii) was updated to C. The previous reference to C was updated to D.

      ● All line-numbered suggestions were addressed.

      ● The text “(move to supplement?)” was removed from the methods heading, and the mistaken reference to Q_MBr was fixed.

      ● We removed all “SR” acronyms from the statistics as it was an artifact from an earlier draft.

      ● We homogenized notation in Figure 2, replacing all “c” variable references with “y”, as well as homogenized notation of β

      ● We replaced many uses of the word “action” with the word “choice” for consistency throughout the manuscript.

      ● We addressed many additional minor errors

      Reviewer #1 (Recommendations For The Authors):

      (1) Could the authors comment on why the cross-validated accuracy continues to increase, albeit non-significantly, after four states, as opposed to decreasing (as I would naively expect would be the result due to overfitting)?

      Due to the large amounts of trials and sessions obtained from each rat (often >100 sessions with >200 trials per session) and the limited number of training iterations (capped at 300 iterations), it is not guaranteed that the cross-validated accuracy would decrease over the range of states we included in Figure 4, especially given that the number of total parameters in the largest model shown (7-states, 95 parameters) is greatly less than the number of observations. Since we’re mainly interested in using this tool to identify interpretable, consistent structure across animals, we did not focus on interpreting the regime of larger models.

      (2) It seems like the model was refit multiple times with different priors ("Estimation of Population Prior"), each derived from the previous step of fitting. I'm not very familiar with fitting these kinds of models. Is this standard practice? It gives off the feeling of double-dipping. It would be helpful if the authors could cite some relevant literature here or further justify their choices.

      We adopted a “one-step” hierarchical approach, where we estimate the population prior a single time on (nearly) unconstrained model fits, and use it for a second, final round of model fits which were used for analysis. Since the prior is only estimated once, in practice there isn’t risk of converging on an overly constrained prior. This is a somewhat simplified approach motivated by analogy to the first step of EM fit in a hierarchical model, in which population- and subject-level parameters are iteratively re-estimated in terms of one another until convergence (Huys et al., 2012; Daw 2010). We have clarified this approach in the methods with citations by adding the following paragraph:

      “Hierarchical modeling gives a better estimate of how model parameters can vary within a population by additionally inferring the population distribution over which individuals are likely drawn (Daw, 2011). This type of modeling, however, is notoriously difficult in HMMs; therefore, as a compromise, we adopt a “one-step” hierarchical model, where we estimate population parameters from “unconstrained” fits on the data, which are then used as a prior to regularize the final model fits. This approach is motivated by analogy to the first step of EM fit in a hierarchical model, in which population- and subject-level parameters are iteratively re-estimated in terms of one another until convergence (Daw, 2011; Huys et al., 2012). It is important to emphasize, since we aren’t inferring the population distributions directly, that we only estimate the population prior a single time on the “unconstrained” fits as follows.”

      Reviewer #2 (Recommendations For The Authors):

      Figure 3a.iii: Did the model capture the transition probabilities correctly as well?

      We have updated Figure 3E to include additional panels (iii) and (iv) to show the recovered initial state probabilities and transition matrix.

      For Figure 6, panel B makes it look like there is a larger influence of state on ITI rate after omission, in both the top and bottom plots. However, the violin plots in panel C show a different pattern, where state has a greater effect on ITIs following rewarded trials. Is it that the example in panel B is not representative of the population, or am I misinterpreting?

      We thank the reviewer for catching this issue, as the colors were erroneously flipped in panel C. We have fixed this figure by ensuring that the colors appropriately matched the trial type (reward or omission). Additionally, we updated the colors in B and C that correspond to reward (previously gray, now blue) and omission (previously gold, now red) trials to match the color scheme used in Figure 1. We also inverted the corresponding line styles (reward changed to solid, omission changed to dashed) to match the convention used in Figure 7. To differentiate from the reward/omission color changed, we additionally changed the colors in Figure 6D and Figure 7 Supplement 1, where the color for “time” was changed from blue to gray, and the color for “state” was changed from red to gold.

      For figure 4B right, I am confused. The legend says that this is the change in model performance relative to a model with one fewer state. But the y-axis says it's the change from the single-state model. Please clarify.

      The plot is showing the increase in performance from the single-state model, while the significance tests were done between consecutive numbered states. We updated the significance indicators on the plot to more clearly identify that adjacent models are being compared (with the exception of the 2-state model, which is being compared to 0). We updated the Figure 4B caption text for the left panel to state: “Change in normalized, cross-validated likelihood when adding additional hidden states into the MoA-HMM, relative to the single-state model. Significant changes are computed with respect to models with one fewer states (e.g. 2-state vs 1-state, 3-state vs 2-state)”

    1. Author response:

      Thank you for reviewing our manuscript and providing constructive feedback. We are grateful that you recognize the importance of our work and find the evidences presented compelling. We will revise our manuscripts in accordance with reviewers’ recommendations. Below is our plan.

      (1) As recommended by Reviewer 1, we will improve the image resolution and presentation in the figures, by adjusting dark colors into brighter ones, including single-channel images, and incorporating schematic illustrations to dipict morphological changes.

      (2) Following the suggestions of reviewer 2, we will provide explanations and speculative insights into potential non-tissue autonomous effects.

      (3) As suggested by reviewer 2, we will perform principal component analyses on our RNA-seq and Cut&Tag data. 

      (2) Once we have addressed all the major and minor points raised by the reviewers, we will provide a detailed point-to-point response and submit the revised version of the manuscript.

    1. Author response:

      We would like to express our sincere gratitude to both of you, and the reviewers, for the time and effort you have invested in reviewing our manuscript. We greatly appreciate the constructive feedback provided and are committed to addressing the suggested revisions.

      In response to the public reviews, we would like to outline the following plan of action:

      (1) Addressing Weaknesses in the Manuscript: We have carefully considered the comments regarding the weaknesses identified in the manuscript. Specifically, we will:

      - Provide further clarification on the mechanism of IVM resistance in our study.

      - Expand our discussion of the limitations and future directions of the research, addressing the concerns related to the potential translation of our findings to parasitic nematodes.

      (2) Additional Experiments: We are currently conducting additional experiments to address the reviewers' suggestions, which include:

      - Testing whether the overexpression of a relevant GluCl, such as AVR-15, can restore Ivermectin sensitivity in ubr-1 mutants.

      - Examining the impact of Ceftriaxone treatment on the Ivermectin resistance in worms lacking key GluCls, such as avr-15, avr-14, and glc-1.

      - Incorporating an analysis of major human parasitic nematodes in the phylogeny and discussing the conservation of relevant mechanisms across species.

      - Double-checking the Dye filling (Dyf) phenotype in ubr-1 mutants, as suggested.

      (3) Point-by-Point response: We will respond to both sets of comments (public reviews and editorial recommendations) in a comprehensive point-by-point manner in the revised manuscript.

      (4) Timely Revisions: We aim to complete all revisions within a single round, ensuring that we address all comments thoroughly while maintaining the integrity of the data.

    1. Author response:

      Reviewer #1 (Public review):

      Summary:

      IPF is a disease lacking regressive therapies which has a poor prognosis, and so new therapies are needed. This ambitious phase 1 study builds on the authors' 2024 experience in Sci Tran Med with positive results with autologous transplantation of P63 progenitor cells in patients with COPD. The current study suggests that P63+ progenitor cell therapy is safe in patients with ILD. The authors attribute this to the acquisition of cells from a healthy upper lobe site, removed from the lung fibrosis. There are currently no cell-based therapies for ILD and in this regard the study is novel with important potential for clinical impact if validated in Phase 2 and 3 clinical trials.

      Strengths:

      This study addresses the need for an effective therapy for interstitial lung disease. It offers good evidence that the cells used for therapy are safe. In so doing it addresses a concern that some P63+ progenitor cells may be proinflammatory and harmful, as has been raised in the literature (articles which suggested some P63+ cells can promote honeycombing fibrosis; references 26 &35). The authors attribute the safety they observed (without proof) to the high HOPX expression of administered cells (a marker found in normal Type 1 AECs. The totality of the RNASeq suggests the cloned cells are not fibrogenic. They also offer exploratory data suggesting a relationship between clone roundness and PFT parameters (and a negative association between patient age and clone roundness).

      We thank the reviewer for the important comments.

      Weaknesses:

      The authors can conclude they can isolate, clone, expand, and administer P63+ progenitor cells safely; but with the small sample size and lack of a placebo group, no efficacy should be implied.

      We thank the reviewer for the suggestion and agree that we should be more cautious to discuss the efficacy of current study.

      Specific points:

      (1) The authors acknowledge most study weaknesses including the lack of a placebo group and the concurrent COVID-19 in half the subjects (the high-dose subjects). They indicate a phase 2 trial is underway to address these issues.

      N/A

      (2) The authors suggest an efficacy signal on pages 18 (improvement in 2 subjects' CT scans) and 21 (improvement in DLCO) but with such a small phase 1 study and such small increases in DLCO (+5.4%) the authors should refrain from this temptation (understandable as it is).

      We believe that exploring potential efficacy signal is also one important aim of this study in addition to safety evaluation. All these efficacy endpoint analyses had been planned in prior to the start of clinical trials (as registered in ClinicalTrial.gov) and the results anyhow need be analyzed and reported in the manuscript. And we will cautiously discuss the significance of the efficacy signal and avoid over-interpretation.

      (3) Likewise most CT scans were unchanged and those that improved were in the mid-dose group (albeit DLCO improved in the 2 patients whose CT scans improved).

      Yes, it is.

      (4) The authors note an impressive 58m increase in 6MWTD in the high-dose group but again there is no placebo group, and the low-dose group has no net change in 6MWTD at 24 weeks.

      Yes.

      (5) I also raise the question of the enrollment criteria in which 5 patients had essentially normal DLCO/VA values. In addition there is no discussion as to whether the transplanted stem cells are retained or exert benefit by a paracrine mechanism (which is the norm for cell-based therapies).

      Thank you for your detailed feedback.  The enrollment criteria are based on DLCO instead of DLCO/VA. And we would like to further discuss the possible benefit by paracrine mechanism in the revised manuscript.

      Reviewer #2 (Public review):

      Summary:

      This manuscript describes a first-in-human clinical trial of autologous stem cells to address IPF. The significance of this study is underscored by the limited efficacy of standard-of-care anti-fibrotic therapies and increasing knowledge of the role p63+ stem cells in lung regeneration in ARDS. While models of acute lung injury and p63+ stem cells have benefited from widespread and dynamic DAD and immune cell remodeling of damaged tissue, a key question in chronic lung disease is whether such cells could contribute to the remodeling of lung tissue that may be devoid of acute and dynamic injury. A second question is whether normal regions of the lung in an otherwise diseased organ can be identified as a source of "normal" p63+ stem cells, and how to assess these stem cells given recently identified p63+ stem cell variants emerging in chronic lung diseases including IPF. Lastly, questions of feasibility, safety, and efficacy need to be explored to set the foundation for autologous transplants to meet the huge need in chronic lung disease. The authors have addressed each of these questions to different extents in this initial study, which has yielded important if incomplete information for many of them.

      Strengths:

      As with a previous study from this group regarding autologous stem cell transplants for COPD (Ref. 24), they have shown that the stem cells they propagate do not form colonies in soft agar or cancers in these patients. While a full assessment of adverse events was confounded by a wave of Covid19 infections in the study participants, aside from brief fevers it appears these transplants are tolerated by these patients.

      We thank the reviewer for the important comments.

      Weaknesses:

      The source of stem cells for these autologous transplants is generally bronchoscopic biopsies/brushings from 5th-generation bronchi. Although stem cells have been cloned and characterized from nasal, tracheal, and distal airway biopsies, the systematic cloning and analysis of p63+ stem cells across the bronchial generations is less clear. For instance, p63+ stem cells from the nasal and tracheal mucosa appear committed to upper airway epithelia marked by 90% ciliated cells and 10% goblet cells (Kumar et al., 2011. Ref. 14). In contrast, p63+ stem cells from distal lung differentiate to epithelia replete with Club, AT2, and AT1 markers. The spectrum of p63+ stem cells in the normal bronchi of any generation is less studied. In the present study, cells are obtained by bronchoscopy from 3-5 generation bronchi and expanded by in vitro propagation. Single-cell RNAseq identifies three clusters they refer to as C1, C2, and C3, with the major C1 cluster said to have characteristics of airway basal cells and C2 possibly the same cells in states of proliferation. Perhaps the most immediate question raised by these data is the nature of the C1/C2 cells. Whereas they are clearly p63/Krt5+ cells as are other stem cells of the airways, do they display differentiation character of "upper airway" marked by ciliated/goblet cell differentiation or those of the lung marked by AT2 and AT1 fates? This could be readily determined by 3-D differentiation in so-called air-liquid interface cultures pioneered by cystic fibrosis investigators and should be done as it would directly address the validity of the sourcing protocol for autologous cells for these transplants. This would more clearly link the present study with a previous study from the same investigators (Shi et al., 2019, Ref. 9) whereby distal airway stem cells mitigated fibrosis in the murine bleomycin model. The authors should also provide methods by which the autologous cells are propagated in vitro as these could impact the quality and fate of the progenitor cells prior to transplantation.

      We totally agree that the sub-population of the progenitor cells should be further analyzed. We would try this in the revised manuscript. And the methods to expand P63+ lung progenitor cells have been described in full details by Frank McKeon/Wa Xian group (Rao, et.al., STAR Protocols, 2020), which is adapted to pharmaceutical-grade technology patented by Regend Therapeutics, Ltd.

      The authors should also make a more concerted effort to compare Clusters 1, 2, and 3 with the variant stem cell identified in IPF (Wang et al., 2023, Ref. 27). While some of the markers are consistent with this variant stem cell population, others are not. A more detailed informatics analysis of normal stem cells of the airways and any variants reported could clarify whether the bronchial source of autologous stem cells is the best route to these transplants. 

      We thank for reviewer for the good suggestion and would like to make more detailed comparison in the revised manuscript.

      Other than these issues the authors should be commended for these first-in-human trials for this important condition.

      Thank you so much for the kind compliment.

    1. Author response:

      Public Review:

      In this work, the authors develop a new computational tool, DeepTX, for studying transcriptional bursting through the analysis of single-cell RNA sequencing (scRNA-seq) data using deep learning techniques. This tool aims to describe and predict the transcriptional bursting mechanism, including key model parameters and the steady-state distribution associated with the predicted parameters. By leveraging scRNA-seq data, DeepTX provides high-resolution transcriptional information at the single-cell level, despite the presence of noise that can cause gene expression variation. The authors apply DeepTX to DNA damage experiments, revealing distinct cellular responses based on transcriptional burst kinetics. Specifically, IdU treatment in mouse stem cells increases burst size, promoting differentiation, while 5FU affects burst frequency in human cancer cells, leading to apoptosis or, depending on the dose, to survival and potential drug resistance. These findings underscore the fundamental role of transcriptional burst regulation in cellular responses to DNA damage, including cell differentiation, apoptosis, and survival. Although the insights provided by this tool are mostly well supported by the authors' methods, certain aspects would benefit from further clarification.

      The strengths of this paper lie in its methodological advancements and potential broad applicability. By employing the DeepTXSolver neural network, the authors efficiently approximate stationary distributions of mRNA count through a mixture of negative binomial distributions, establishing a simple yet accurate mapping between the kinetic parameters of the mechanistic model and the resulting steady-state distributions. This innovative use of neural networks allows for efficient inference of kinetic parameters with DeepTXInferrer, reducing computational costs significantly for complex, multi-gene models. The approach advances parameter estimation for high-dimensional datasets, leveraging the power of deep learning to overcome the computational expense typically associated with stochastic mechanistic models. Beyond its current application to DNA damage responses, the tool can be adapted to explore transcriptional changes due to various biological factors, making it valuable to the systems biology, bioinformatics, and mechanistic modelling communities. Additionally, this work contributes to the integration of mechanistic modelling and -omics data, a vital area in achieving deeper insights into biological systems at the cellular and molecular levels.

      We thank the reviewers for their positive opinion on our manuscript. As reflected in our detailed responses to the reviewers’ comments, we will make significant changes to address their concerns comprehensively.

      This work also presents some weaknesses, particularly concerning specific technical aspects. The tool was validated using synthetic data, and while it can predict parameters and steady-state distributions that explain gene expression behaviour across many genes, it requires substantial data for training. The authors account for measurement noise in the parameter inference process, which is commendable, yet they do not specify the exact number of samples required to achieve reliable predictions. Moreover, the tool has limitations arising from assumptions made in its design, such as assuming that gene expression counts for the same cell type follow a consistent distribution. This assumption may not hold in cases where RNA measurement timing introduces variability in expression profiles.

      Thank you for your detailed and constructive feedback on our work. We will address the key concerns raised from the following points:

      (1) Clarification on the required sample size: We tested the robustness of our inference method on simulated datasets by varying the number of single-cell samples. Our results indicated that the predictions of burst kinetics parameters become accurate when the number of cells reaches 500 (Supplementary Figure S3d, e). This sample size is smaller than the data typically obtained with current single-cell RNA sequencing (scRNA-seq) technologies, such as 10x Genomics and Smart-seq3 (Zheng GX et al., 2017; Hagemann-Jensen M et al., 2020). Therefore, we believed that our algorithm is well-suited for inferring burst kinetics from existing scRNA-seq datasets, where the sample size is sufficient for reliable predictions. We will clarify this point in the main text to make it easier for readers to use the tool.

      (2) Assumption-related limitations: One of the fundamental assumptions in our study is that the expression counts of each gene are independently and identically distributed (i.i.d.) among cells, which is a commonly adopted assumption in many related works (Larsson AJM et al., 2019; Ochiai H et al., 2020; Luo S et al., 2023). However, we acknowledged the limitations of this assumption. The expression counts of the same gene in each cell may follow distinct distributions even from the same cell type, and dependencies between genes could exist in realistic biological processes. We recognized this and will deeply discuss these limitations from assumptions and prospect as an important direction for future research.

      The authors present a deep learning pipeline to predict the steady-state distribution, model parameters, and statistical measures solely from scRNA-seq data. Results across three datasets appear robust, indicating that the tool successfully identifies genes associated with expression variability and generates consistent distributions based on its parameters. However, it remains unclear whether these results are sufficient to fully characterize the transcriptional bursting parameter space. The parameters identified by the tool pertain only to the steady-state distribution of the observed data, without ensuring that this distribution specifically originates from transcriptional bursting dynamics.

      We appreciate your insightful comments and the opportunity to clarify our study’s contributions and limitations. Although we agree that assessing whether the results from these three realistic datasets can represent the characterize transcriptional burst parameter space is challenging, as it depends on data property and conditions in biology, we firmly believe that DeepTX has the capacity to characterize the full parameter space. This believes stems from the extensive parameters and samples we input during model training and inference across a sufficiently large parameter range (Method 1.3). Furthermore, the training of the model is both flexible and scalable, allowing for the expansion of the transcriptional burst parameter space as needed. We will clarify this in the text to enable readers to use DeepTX more flexibly.

      On the other hand, we agree that parameter identification is based on the steady-state distribution of the observed data (static data), which loses information about the fine dynamic process of the burst kinetics. In principle, tracking the gene expression of living cells can provide the most complete information about real-time transcriptional dynamics across various timescales (Rodriguez J et al., 2019). However, it is typically limited to only a small number of genes and cells, which could not investigate general principles of transcriptional burst kinetics on a genome-wide scale. Therefore, leveraging the both steady-state distribution of scRNA-seq data and mathematical dynamic modelling to infer genome-wide transcriptional bursting dynamics represents a critical and emerging frontier in this field. For example, the statistical inference framework based on the Markovian telegraph model, as demonstrated in (Larsson AJM et al., 2019), offers a valuable paradigm for understanding underlying transcriptional bursting mechanisms. Building on this, our study considered a more generalized non-Mordovian model that better captures transcriptional kinetics by employing deep learning method under conditions such as DNA damage. This provided a powerful framework for comparative analyses of how DNA damage induces alterations in transcriptional bursting kinetics across the genome. We will highlight the limitations of current inference using steady-state distributions in the text and look ahead to future research directions for inference using time series data across the genome.

      A primary concern with the TXmodel is its reliance on four independent parameters to describe gene state-switching dynamics. Although this general model can capture specific cases, such as the refractory and telegraph models, accurately estimating the parameters of the refractory model using only steady-state distributions and typical cell counts proves challenging in the absence of time-dependent data.

      We thank you for highlighting this critical concern regarding the TXmodel's reliance on four independent parameters to describe gene state-switching dynamics. We acknowledge that estimating the parameters of the TXmodel using only steady-state distributions and typical single-cell RNA sequencing (scRNA-seq) data poses significant challenges, particularly in the absence of time-resolved measurements.

      As described in the response of last point, while time-resolved data can provide richer information than static scRNA-seq data, it is currently limited to a small number of genes and cells, whereas static scRNA-seq data typically capture genome-wide expression. Our framework leverages deep learning methods to link mechanistic models with static scRNA-seq data, enabling the inference of genome-wide dynamic behaviors of genes. This provides a potential pathway for comparative analyses of transcriptional bursting kinetics across the entire genome.

      Nonetheless, the refractory model and telegraphic model are important models for studying transcription bursts. We will discuss and compare them in terms of the accuracy of inferred parameters. Certainly, we agree that inferring the molecular mechanisms underlying transcriptional burst kinetics using time-resolved data remains a critical future direction. We will include a brief discussion on the role and importance of time-resolved data in addressing these challenges in the discussion section of the revised manuscript.

      The claim that the GO analysis pertains specifically to DNA damage response signal transduction and cell cycle G2/M phase transition is not fully accurate. In reality, the GO analysis yielded stronger p-values for pathways related to the mitotic cell cycle checkpoint signalling. As presented, the GO analysis serves more as a preliminary starting point for further bioinformatics investigation that could substantiate these conclusions. Additionally, while GSEA analysis was performed following the GO analysis, the involvement of the cardiac muscle cell differentiation pathway remains unclear, as it was not among the GO terms identified in the initial GO analysis.

      We thank the reviewer for this valuable feedback and for pointing out the need for clarification regarding the GO and GSEA analyses. We agree that the connection between the cardiac muscle cell differentiation pathway identified in the GSEA analysis and the GO terms from the initial analysis requires further clarification. This discrepancy arises because GSEA examines broader sets of pathways and may capture biological processes not highlighted by GO analysis due to differences in the statistical methods and pathway definitions used. We will revise the manuscript to address this point, explicitly discussing the distinct yet complementary nature of GO and GSEA analyses and providing a clearer interpretation of the results.

      As the advancement is primarily methodological, it lacks a comprehensive comparison with traditional methods that serve similar functions. Consequently, the overall evaluation of the method, including aspects such as inference accuracy, computational efficiency, and memory cost, remains unclear. The paper would benefit from being contextualised alongside other computational tools aimed at integrating mechanistic modelling with single-cell RNA sequencing data. Additional context regarding the advantages of deep learning methods, the challenges of analysing large, high-dimensional datasets, and the complexities of parameter estimation for intricate models would strengthen the work.

      We greatly appreciate your insightful feedback, which highlights important considerations for evaluating and contextualizing our methodological advancements. Below, we emphasize our advantages from both the modeling perspective and the inference perspective compared with previous model. As our work is rooted in a model-based approach to describe the transcriptional bursting process underlying gene expression, the classic telegraph model (Markovian) and non-Markovian models which are commonly employed are suitable for this purpose:

      Classic telegraph model: The classic telegraph model allows for the derivation of approximate analytical solutions through numerical integration, enabling efficient parameter point estimation via maximum likelihood methods, e.g., as explored in (Larsson AJM et al., 2019). Although exact analytical solutions for the telegraph model are not available, certain moments of its distribution can be explicitly derived. This allows for an alternative approach to parameter inference using moment-based estimation methods, e.g., as explored in (Ochiai H et al., 2020). However, it is important to note that higher-order sample moments can be unstable, potentially leading to significant estimation bias.

      Non-Markovian Models: For non-Markovian models, analytical or approximate analytical solutions remain elusive. Previous work has employed pseudo-likelihood approaches, leveraging statistical properties of the model’s solutions to estimate parameters, e.g., as explored in (Luo S et al., 2023). However, the method may suffer from low inference efficiency.

      In our current work, we leverage deep learning to estimate parameters of TXmodel, which is non-Markovian model. First, we represent the model's solution as a mixture of negative binomial distributions, which is obtained by the deep learning method. Second, through integration with the deep learning architecture, the model parameters can be optimized using automatic differentiation, significantly improving inference efficiency. Furthermore, by employing a Bayesian framework, our method provides posterior distributions for the estimated dynamic parameters, offering a comprehensive characterization of uncertainty. Compared to traditional methods such as moment-based estimation or pseudo-likelihood approaches, we believe our approach not only achieves higher inference efficiency but also delivers posterior distributions for kinetics parameters, enhancing the interpretability and robustness of the results. We will present and emphasize the computational efficiency and memory cost of our methods the revised version.

      Reference

      Zheng, G.X., Terry, J.M., Belgrader, P., Ryvkin, P., Bent, Z.W., Wilson, R., Ziraldo, S.B., Wheeler, T.D., McDermott, G.P., Zhu, J., Gregory, M.T., Shuga, J., Montesclaros, L., Underwood, J.G., Masquelier, D.A., Nishimura, S.Y., Schnall-Levin, M., Wyatt, P.W., Hindson, C.M., Bharadwaj, R., Wong, A., Ness, K.D., Beppu, L.W., Deeg, H.J., McFarland, C., Loeb, K.R., Valente, W.J., Ericson, N.G., Stevens, E.A., Radich, J.P., Mikkelsen, T.S., Hindson, B.J., Bielas, J.H. 2017. Massively parallel digital transcriptional profiling of single cells. Nature Communications 8: 14049. DOI: https://dx.doi.org/10.1038/ncomms14049, PMID: 28091601

      Hagemann-Jensen, M., Ziegenhain, C., Chen, P., Ramsköld, D., Hendriks, G.J., Larsson, A.J.M., Faridani, O.R., Sandberg, R. 2020. Single-cell RNA counting at allele and isoform resolution using Smart-seq3. Nat Biotechnol 38: 708-714. DOI: https://dx.doi.org/10.1038/s41587-020-0497-0, PMID: 32518404

      Larsson, A.J.M., Johnsson, P., Hagemann-Jensen, M., Hartmanis, L., Faridani, O.R., Reinius, B., Segerstolpe, A., Rivera, C.M., Ren, B., Sandberg, R. 2019. Genomic encoding of transcriptional burst kinetics. Nature 565: 251-254. DOI: https://dx.doi.org/10.1038/s41586-018-0836-1, PMID: 30602787

      Ochiai, H., Hayashi, T., Umeda, M., Yoshimura, M., Harada, A., Shimizu, Y., Nakano, K., Saitoh, N., Liu, Z., Yamamoto, T., Okamura, T., Ohkawa, Y., Kimura, H., Nikaido, I. 2020. Genome-wide kinetic properties of transcriptional bursting in mouse embryonic stem cells. Science Adavances 6: eaaz6699. DOI: https://dx.doi.org/10.1126/sciadv.aaz6699, PMID: 32596448

      Luo, S., Wang, Z., Zhang, Z., Zhou, T., Zhang, J. 2023. Genome-wide inference reveals that feedback regulations constrain promoter-dependent transcriptional burst kinetics. Nucleic Acids Research 51: 68-83. DOI: https://dx.doi.org/10.1093/nar/gkac1204, PMID: 36583343

      Rodriguez, J., Ren, G., Day, C.R., Zhao, K., Chow, C.C., Larson, D.R. 2019. Intrinsic dynamics of a human gene reveal the basis of expression heterogeneity. Cell 176: 213-226.e218. DOI: https://dx.doi.org/10.1016/j.cell.2018.11.026, PMID: 30554876

      Luo, S., Zhang, Z., Wang, Z., Yang, X., Chen, X., Zhou, T., Zhang, J. 2023. Inferring transcriptional bursting kinetics from single-cell snapshot data using a generalized telegraph model. Royal Society Open Science 10: 221057. DOI: https://dx.doi.org/10.1098/rsos.221057, PMID: 37035293

    1. Author response:

      The following is the authors’ response to the original reviews.

      Reviewer #1 (Recommendations For The Authors):

      (1) Gap of knowledge:

      From the introduction, I got the impression that the manuscript tries to answer the question of whether homeostatic structural plasticity is functionally redundant to synaptic scaling. However, the importance of this question needs to be worked out better. Also, I think it is hard to tackle this question with the shown experiments as one would have to block all other redundant mechanisms and see whether HSP functionally replaces them.

      We appreciate the reviewer’s valuable feedback regarding the relationship between homeostatic structural plasticity (HSP) and synaptic scaling. The main objective of our study is indeed to investigate whether structural plasticity is homeostatically regulated, and if so, whether it acts as a redundant or heterogeneous mechanism in relation to synaptic scaling, which is widely recognized as a primary homeostatic process.

      In our revised introduction, we have clarified this central question and its significance. Specifically, we explored why experimentally observed changes in spine density, a measure of structural plasticity, do not exhibit the same homeostatic characteristics as changes in spine head size, which reflects synaptic scaling, particularly under conditions of activity blockade.

      We hypothesized two key points:

      (1) Structural plasticity may not follow a monotonically activity-dependent rule as strictly as synaptic scaling.

      (2) The observed changes in spine density may be influenced by the simultaneous modulation of spine size, suggesting that structural plasticity and synaptic scaling interact within the same biological system.

      Both hypotheses were tested through a combination of experimental observations and systematic computer simulations. Our conclusions demonstrate that spine-number-based structural plasticity follows a biphasic activity-dependent rule. While it largely overlaps with synaptic scaling under typical conditions, it exhibits heterogeneity under extreme conditions, such as activity silencing. Furthermore, our simulations revealed that both mechanisms can compete and complement each other within neural networks.

      We believe that these results offer a nuanced understanding of the interaction between structural plasticity and synaptic scaling, highlighting their redundancy under most conditions but also their heterogeneity under specific circumstances. Blocking all other redundant mechanisms, as suggested, would provide a more reductionist view, which may not capture the complexity and interplay of these processes in a physiological setting. Our approach reflects this complexity, providing insight into how these mechanisms operate together in a naturalistic context.

      We have revised the introduction to better convey these points and emphasize the significance of this question for understanding the dynamics of homeostatic regulation in neural networks.

      Similarly, the simulations do not really tackle redundancy as, e.g. network growth cannot be achieved by scaling alone.

      We appreciate the reviewer’s comment regarding synaptic scaling's limitations in achieving network growth. We would like to clarify that we did not intend to suggest that structural plasticity and synaptic scaling are fully redundant. In fact, it is well established in the literature that structural plasticity plays a dominant role during development, particularly in network growth, which synaptic scaling alone cannot achieve.

      The primary objective of our study was to investigate the interaction between structural plasticity and synaptic scaling under conditions of activity perturbation, rather than during network growth or development. To avoid any confusion regarding developmental processes, we chose to grow the network using only structural plasticity in our simulations. Synaptic scaling was then introduced (or not) during the phase of activity deprivation to specifically examine its role in regulating homeostasis under these conditions.

      We have revised the corresponding sections of the manuscript to clarify this distinction, and we have ensured that the simulations reflect our focus on activity perturbation rather than network development. This distinction should help readers avoid conflating developmental processes with the specific goals of our study.

      Instead, the section on "Integral feedback mechanisms" (L112-129) contains a much better description of the actual goals of the paper than is given in the introduction. Moreover, this section does not seem to include any new results (at least the Ca-dependent structural plasticity and synaptic scaling rules seem to be very common for me). I, therefore, suggest fusing this paragraph in the introduction to obtain a clearer and better understandable gap of knowledge, which is addressed by the paper.

      We agree that the "Integral feedback control" section provides key information relevant to both the Introduction and Methodology. It outlines the theoretical framework and serves as a basis for the experimental design.

      To better reflect this, we have revised the Introduction to include the gap in knowledge. However, we opted to retain the section in the Results, slightly modified, to set the context for the first experiment.

      Along this line, as it seems a central point of the manuscript to distinguish the controller dependencies on Calcium, the different dependencies (working models) should be described in more detail. Also, the description of the inconsistencies of the previous results on HSP can be moved from the discussion (l419-l441) to the introduction.

      We have revised the manuscript to place less emphasis on the controller models while retaining the core principles of control theory. The description of the HSP model has been moved to the Introduction, as suggested, while the detailed history remains in the Discussion to maintain the manuscript's consistency.

      Systematic text revision: Regarding comment (1), we thank the reviewer for suggesting the text reorganization. We have adjusted several parts in the introduction, M&M section, and results section to increase clarity.

      (2) Pharmacological Choice:

      It should be discussed why NBQX is used to induce the homeostatic effect instead of TTX. As there are studies showing that it might block homeostatic rewiring (doi.org/10.1073/pnas.0501881102) as well as synaptic scaling (10.1523/JNEUROSCI.3753-08.2009), it seems unclear whether the observed effects are actually corresponding to those in other publications.

      The rationale for using NBQX in our experiments, rather than TTX, is detailed in the public response. We selected NBQX based on specific experimental motivations relevant to our study’s objectives, while acknowledging the potential differences in effects compared to other studies.

      Local text revision: We added one paragraph in the discussion section to explain the idea better.

      (3) Model-Experiment Connection:

      The paper combines simulations with experimental work, which is very good. However, in my opinion, the only connection between the two parts is that the experiments suggest a non-monotonic dependency between firing rate and synapse density (i.e. the biphasic dependency). The rest of the experimental results seem to be neglected in the modeling part. It is not even shown that the model reproduces the experiments. Instead, the model is tested in different situations and paradigms (blocking AMPARs in the whole culture vs network growth or silencing a sub-population). I think it would make the paper stronger and more consequential when a reproduction of the experiment by the model is demonstrated (with analogue analyses).

      The experimental results serve three main purposes. First, as the reviewer noted, the spine analysis was conducted to inform the biphasic rule. Second, spine size analysis was performed to replicate published findings and confirm our modeling results, showing that activity deprivation leads to fewer synapses with larger sizes or higher weights. Third, the correlation analysis of spine density and size across dendritic segments suggested a hybrid combination of two types of plasticity across different neurons.

      While we addressed these aspects in the Results and Discussion sections, the collective presentation in Fig. 2 may have caused some confusion. To improve clarity, we have now split the experimental results, presenting them alongside the relevant modeling data in Fig. 2, Fig. 8, and Fig. 9.

      Also, there are a few more mismatches between the experiment and the model that you will want to discuss:

      • The size-dependent homeostatic effect (l154ff, Fig2F) is not reflected by the used scaling model.

      We revised Fig 8 and the corresponding text to explain how the scaling model reflects such an effect.

      • The model assumes reduced Ca levels. Yet, the experimental protocol blocks AMPARs, which are to my knowledge not the primary source of Ca influx, but rather the NMDARs.

      The model is based on neural activity, with calcium concentration serving as an internal integral signal of the firing rate, allowing for integral control. While calcium plays a critical role in homeostasis, we caution against drawing a strict correspondence between the model's calcium dynamics and the experimental protocol, as calcium can be sourced from multiple pathways in neurons beyond AMPARs, such as NMDARs, voltage gated calcium channels, and intracellular stores. Also, our recent work demonstrated that under baseline conditions, the majority of AMPARs are not Ca2+ permeable, i.e., GluA2-lacking (Kleidonas et al., 2023)

      Improving the calcium dynamics, including secondary calcium release and calcium stores, is part of our future plan to refine the HSP model and address experimental findings that are not fully explained by the current model.

      • The model further assumes silencing by input removal, whereas the recurrent connections stay intact. Wouldn't this rather correspond to a deafferentation experiment, where connections to another brain area are cut?

      Thank you for pointing at this. The modeling section was not intended to directly replicate the tissue culture experiments but rather to provide insights into a broader range of scenarios, including pharmacological treatments, deafferentation, lesions, and even monocular deprivation.

      Systematic text revision: Regarding comment (3), the goal of our modeling work was more than reproducing. To better serve the purposes of experimental results used in the present study, to inform, confirm, and inspire, we have systematically adjusted the layout of experimental and modeling results to link them better.

      (4) Is the recurrent component too weak?

      Your results show that HSP does not restore activity after silencing (deafferentation), whereas you discuss that earlier models did achieve this by active neighbors in a spatially organized network. However, the silenced neurons in your simulations also receive inputs through the "recurrent" connections from their neighbors (at least shortly after silencing). Therefore, given the recurrent input is strong enough, they should be able to recover in a similar way as the spatially organized ones. As a consequence, I obtained the impression that, in your model networks, activity is strongly driven by external stimulation and less by recurrent connections. I understand that this is important to achieve silencing through removing the Poisson stimulation. Yet, this fact may be responsible for the failure to restore activity such that presented effects are only applicable for networks that are strongly driven by external inputs, but not for strongly recurrent networks, which would severely limit the generality of the results. As a consequence, the paper would benefit from a systematic analysis of the trade-off between recurrent strength and input strength. Maybe, different constant negative currents could be injected in all neurons, such that HSP creates more recurrent synapses in the network.

      We appreciate this insight. However, increasing recurrent input strength is beyond the scope of the current study, as it would fundamentally alter the predefined network dynamics of the Brunel network used. As noted in the manuscript, complete isolation or cell death is not always the outcome after input deprivation, lesion, or stroke, which cannot be fully explained by the Gaussian HSP rule alone. Butz and colleagues offered a solution using growth rules that maximized recurrent input, and we recognize the importance of their work.

      That said, we approached the issue from a different angle, emphasizing the role of synaptic scaling in recurrence rather than relying solely on recurrent input strength. In biological networks, external inputs may vary, recurrency can be weak or strong, and synaptic scaling can dominate. Our model offers a complementary hypothesis, suggesting that these factors, in combination, contribute to the diverse and sometimes contradictory results found in the literature, rather than posing a strict constraint on network topology.

      Local text revision: We emphasized these points in the Discussion section again.

      (5) Missing conclusions / experimental predictions

      As already described, the modelling work is not reproducing the presented or previous experimental data. Hence, the goal of modelling should be to derive a more general understanding and make experimental predictions. Yet, the conclusions in the discussion stay superficial and vague and there are no specific experimental predictions derived from the model results.

      For example, the authors report that the recovery of activity in silenced cultures is observed in a previously spatially structured model but not in theirs -- at least with slow or no scaling. Yet it is left to the reader to think about whether the current model is an improvement to the previous one, how they could be experimentally distinguished, or to which experimental findings they relate or compare, which I would expect at this point. I would advise reworking the discussion and thoroughly working out which new insights the modelling part of the study has generated (not to be confused with the assumptions of the model aka the biphasic plasticity rule) and relating them to experimental pre- and postdiction.

      We recognize the reviewer’s concern, which is closely related to comment (4). We have addressed these points by reorganizing the text to better clarify the purpose of our experimental work and its connection to the modeling results.

      Specifically, we have reworked the discussion to highlight the new insights gained from the modeling, and how these can inform experimental predictions and interpretations. This includes distinguishing our model from previous ones and providing clearer connections to experimental findings.

      Systematic text revision: Most of the comments on combining experiments and modeling results and on developing the story based on our expectations raised here are sincere and may also reflect the expectations and concerns of a broader readership, so we have accordingly adjusted the text in the Results and Discussion sections to make our points clear.

      Suggestions for minor changes:

      Fig 1I: Please check the graph and make it more self-explaining. For example, mark the "setpoint" activity (in my opinion, both curves should be at baseline there. In that case, however, I do not see the biphasic behavior anymore). Maybe the table and the graph can be aligned along the activity axis? Also: synaptic inhibition should be increased and not decreased, right?

      Local text and figure revision: I guess the reviewer meant for Fig. 2I? We have improved the visualization to avoid confusion.

      L74-81: I would reverse the order of associative and homeostatic plasticity in this paragraph.

      Local text and figure revision: We have fine-tuned the order in the first and second paragraphs to match the readers' expectations.

      L74-75: Provide references for such theories.

      Local text and figure revision: fixed.

      L84-86: Please provide a reference for the claim that negative feedback, redundancy, and heterogeneity contribute to robustness.

      Local text and figure revision: fixed.

      L 95-97: I think the heterogeneity aspect needs to be worked out a bit better. Do you mean that the described mechanisms contribute to firing rate homeostasis in a different mixture for each neuron (as shown assumed in the last figure)?

      Local text and figure revision: The term heterogeneity is used in the manuscript for two major different settings: (1) heterogeneity in terms of control theory and (2) different combinations of HSP and SS rules. We have named the second condition as diversity to avoid confusion.

      L 132: The question of linearity has not been posed so far. Also, I think "monotonous" would be a much better term than linear (as a test for linearity would require more than 2 datapoints).

      Local text and figure revision: We agreed linear is not a good term. We replaced it with ‘monotonic’ throughout the manuscript.

      Fig2 Bii: The data for 50um is clearly not Gaussian.

      We did not imply that the 50 µM condition is Gaussian. Instead, we noted that the non-linearity observed in both the 200 nM and 50 µM data suggests a non-monotonic growth rule rather than a linear one. We applied the Gaussian rule because it has been extensively studied in previous simulations, allowing us to benchmark our findings against those results.

      Fig2 D, E inset: The point at time 0 does not convey any information and could be left out.

      The time zero data is included to demonstrate that the three groups have a similar baseline, ensuring that any observed differences are due to the treatment and not pre-existing biases in the grouping.

      L 178: As the Gaussian rule drops below zero above the upper set-point again, it is rather tri-phasic than bi-phasic.

      We intended to convey that inhibition results in either spine growth or deletion, reflecting a bi-phasic response rather than a true tri-phasic one.

      Fig 6A: You may want to mark the eta variables in the curves.

      Local text and figure revision: fixed.

      Fig 6E: The curve of the S population extending to the next panel looks a bit messy.

      We retained the curve extension to visually convey the impression of excessive network activity.

      L272: It needs to be better described/motivated how protocol 1 and 2 are supposed to study the role of recurrent connection as well as what kind of biological situation this may be.

      Local text and figure revision: The corresponding text has been adjusted to avoid confusion.

      L 272: It is not clear how faster simulation leads to less recurrent connectivity, when the stimulation protocol and the rates stay the same and the algorithm compensates for the timestep properly. Maybe you rather want to say that you silence 10x longer and stimulate 10x longer?

      Local text revision: The corresponding text has been adjusted to avoid confusion.

      L. 302: "reactivate"?

      Local text revision: fixed.

      L 322f: I would suggest showing the connectivity matrix for a time-point with restored activity as well.

      Local text and figure revision: fixed.

      Fig 8A: The use of the morphological reconstructions is a bit misleading as the model uses point neuron.

      Local text revision: Now after reorganization, it is in Fig.9. We kept the reconstruction figure for motivational purposes, suggesting how to understand the meaning of the combinations in more biologically realistic scenarios. The corresponding text has been adjusted to avoid confusion.

      Fig 8E-F: the y axis should be in the same orientation as in panel D.

      Local text and figure revision: Good idea and fixed in the new Fig. 9.

      Fig. 8F: The results here look a little bit random. Maybe more runs with the same parameters would smooth out the contours or reveal a phase transition.

      Local text and figure revision: Thank you for the suggestion. We conducted an additional ten random trials to average the traces and heatmaps, improving the clarity of the results now presented in Fig. 9.

      L411: Note that there are earlier HSP models by Damasch and van Ooyen & van Pelt, that might be worth discussing here.

      Local text revision: fixed.

      L416 "beyond synaptic scaling" reference needed.

      Local text revision: fixed.

      L419: The biphasic rule was suggested by Butz already.

      Local text revision: We adjusted the text to emphasize our contribution in suggesting/confirming the biphasic rule based on direct experimental observations.

      L 419-44: Most of this is actually state-of-the art and may be better placed in the introduction to justify the use of NBQX as a competititve blocker.

      Local text revision: We adjusted the text in the introduction and Discussion sections to cover the raised points.

      L487: In my opinion, although scaling adapts the weights quickly, the information about deviating firing rate is still stored in the calcium signal such that it will also give rise to structural changes (although they may be small when the rate is low). Thus, I think that fast scaling does not abolish structural changes.

      Local text revision: We adjusted the text to account for other factors that could lead to the same or opposite conclusions.

      L502f: Sentence unclear. Do you mean Ca is an integrated (low-pass filtered) version of the firing rate?

      Yes.

      L504: What is the cumulative temporal effect of error in estimating firing rates?

      We were referring to the potential instability in numeric simulations if the firing rate is not tracked by an integral signal (calcium concentration) but is instead estimated through average spike counts over time. In our model, calcium serves as a proxy for the firing rate to guide homeostatic structural plasticity. The intake and decay constants are set to minimize the accumulation of errors over time, making long-term error accumulation unlikely. In any case, this is not intended to be a precise measure of the firing rate but rather a smooth guide for homeostatic control.

      Local text revision: We rewrote the section so as not to cause extra concerns.

      L505: Which two rules are meant here? Ca- and firing rate based or HSP and scaling?

      Local text revision: The two rules are the HSP rule and the HSS rule. We have adjusted the text to improve clarity.

      L505ff: I did not really understand the control theoretic view here and Supp Fig 5 is not self-explaining enough to help. In my view, scaling is a proportional controller for the calcium level (the setpoint is defined for calcium and not firing rate). Also, all of the HSP rules do neither contain an integral nor a differential of the error and are thus nonlinear but proportional controllers in first approximation. If this part is supposed to stay in the manuscript, the supporting information should contain a more detailed mathematical explanation. Relevant previous work on homeostatic control by synaptic scaling and homeostatic rewiring, e.g. doi: 10.23919/ECC54610.2021.9655157 should be discussed

      Local text revision: We have updated the last paragraph to increase clarity. The HSP and HSS rules are proportional and integral for neural activity, as neural firing rate homeostasis is the meaningful goal. However, it is also correct that the integral component is gone if we view calcium concentration as the goal or setpoint. This paper is discussed and cited in a paragraph above this one.

      Reviewer #2 (Recommendations For The Authors):

      I have some additional suggestions and questions for the authors, which I am presenting following the order of the figures.

      Fig 1A: I'm a little bit puzzled by the timescales between Hebbian and homeostatic plasticity; a wealth of data suggests that Hebbian plasticity acts on a faster timescale than homeostatic plasticity, while Aii-Aiii implies the opposite. In lesion-induced degeneration, for instance, which is mentioned later by the authors, spine loss has been suggested to be Hebbian (LTD) while the subsequent recovery is homeostatic. Additionally, it will not be clear to the reader if the same stimulus could induce Hebbian and homeostatic plasticity, or why; the rest of the manuscript seems to imply that any stimulus could and would trigger homeostatic plasticity, which is not the case. Finally, there should be a mention somewhere that Hebbian structural plasticity also exists.

      Local text and figure revision: We thank the reviewer for pointing out the time scale issue, which was not explicitly considered here and is now updated.

      Fig. 2Bii: There is no significant difference at 200nm NBQX for sEPSC amplitude, contrary to what is stated in the text (line 136). Which one is it?

      Local text revision: We thank the reviewer for pointing out the mistake. We have inspected the original statistical file and corrected the text.

      Fig. 2F: The description of Fig. 2F in the text confused me for the longest time. I am still unsure why 200nm NBQX is described as leading to a general size increase when it follows the control line so closely, crosses 0 at the same point, and is even below the control line for the largest spine sizes. Similarly, 50um NBQX neatly overlaps with the control condition except for the smallest and largest spines, so the "shrinkage of middle-sized spines" doesn't seem different from the control condition. I also couldn't find any data supporting the statement that 50um NBQX increased only the size of "a small subset of large spines". Maybe the authors could clarify this section? I would also suggest adding statistics between the treatments at each spine size bin to support the claims, as they are central to the rest of the paper.

      Importantly, there is no description of the normalization nor the quantification of the difference between days in the methods; I am assuming post-pre for the difference and (post-pre)/pre for the normalization, but this should be much more detailed in the methodology. I was happy to see the baseline raw spine sizes in Supplementary Fig. 1, and would also suggest adding the raw spine sizes after treatment for comparison.

      Local text and figure revision: We have adjusted the text and figure to improve clarity.

      Fig. 2G/S2A: a scale for the label sizes would be helpful. I would also like to have the same correlation for 50um NBQX treatment and the control condition (at least in the supplementary figures).

      Local text and figure revision: We have adjusted the text and figure to improve clarity.

      Fig. 2I: I might be missing something, but why is the activity line flat when there are changes in spine density and size?

      Local text and figure revision: We have adjusted the text and figure to improve clarity.

      Fig. 3C-D: they are referenced in the text as Fig. 1C-D (lines 188-194).

      Local text revision: fixed.

      Fig. 5: it is interesting that the biphasic model captures both spine loss and recovery, fitting well with lesion-induced degeneration and recovery. Does this mean that the model captures other types of plasticity, or does it suggest to the authors that both steps are homeostatic?

      Indeed, the biphasic HSP rule captures two types of activity dependence. The pioneering work by Gallinaro and Rotter (2018) also demonstrated that the HSP rule, even in its monotonic/linear form, exhibits associative properties, which are typically associated with Hebbian plasticity.

      Fig. 6A: This figure requires a more detailed legend - what are the various insets? Does the top right graph only have one curve because they are overlapping and the growth rules are the same for axons and dendrites?

      Local text revision: fixed.

      Fig. 6E: There is usually an overshoot when a stimulus is removed, in this case at the end of the silencing period (as shown in Fig. 1Aiii). Is there a reason why this is not recapitulated here? It shouldn't be as extreme as in the right panel so there should be no degeneration.

      We agree that removing the stimulus would typically trigger an opposite homeostatic process. However, in this protocol, we aimed to emphasize the role of recurrency by presenting extreme cases to illustrate potential scenarios for the readers.

      Local text revision: We revised this paragraph to walk the readers through the rationale better.

      Fig. 6: the authors mention distance-dependent connectivity (line 268), but I couldn't find any data related to that statement. I was particularly curious about that aspect, so I would like to know what this statement is based on, especially as they touch again on the role of morphology in Fig. 8, and distance-dependent connectivity is more prominent in the discussion. On a similar note, would the authors have data from other layers of CA1 that would show similar or other rules? Please note that I am not asking to include these data in the present paper - I am just curious if these data exist (or if the experiments are considered).

      Such an extensive dataset is included and thoroughly investigated in another study that has just been published in Lenz et al., 2023. We updated the reference in the revised text.

      Fig. 7E top: the scalebar is missing.

      Local text revision: fixed.

      Fig. 8A: do the colors have meaning? If yes, please state them. Also indicate that the left two neurons are pyramidal cells from CA1 and the right neurons are granule cells from the dentate gyrus.

      Local text revision: fixed.

      Line 302: "reactive" should be "reactivate".

      Local text revision: fixed.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      Aging reduces tissue regeneration capacity, posing challenges for an aging population. In this study, the authors investigate impaired bone healing in aging, focusing on calvarial bones, and introduce a two-part rejuvenation strategy. Aging depletes osteoprogenitor cells and reduces their function, which hinders bone repair. Simply increasing the number of these cells does not restore their regenerative capacity in aged mice, highlighting intrinsic cellular deficits. The authors' strategy combines Wnt-mediated osteoprogenitor expansion with intermittent fasting, which remarkably restores bone healing. Intermittent fasting enhances osteoprogenitor function by targeting NAD+ pathways and gut microbiota, addressing mitochondrial dysfunction - an essential factor in aging. This approach shows promise for rejuvenating tissue repair, not only in bones but potentially across other tissues.

      Strengths:

      This study is exciting, impressive, and novel. The data presented is robust and supports the findings well.

      Weaknesses:

      As mentioned above the data is robust and supports the findings well. I have minor comments only.

      We thank the reviewer for their enthusiastic and positive assessment of our study. We appreciate the recognition of the novelty and robustness of our data and findings. We have carefully considered the reviewer's comments and have revised the manuscript accordingly. We believe these revisions further strengthen the clarity and impact of our work.

      Reviewer #2 (Public review):

      Summary:

      Reeves et al explore a model of bone healing in the context of aging. They show that intermittent fasting can improve bone healing, even in aged animals. Their study combines a 'bone bandage' which delivers a canonical Wnt signal with intermittent fasting and shows impacts on the CD90 progenitor cell population and the healing of a critical-sized defect in the calvarium. They also explore potential regulators of this process and identify mitochondrial dysfunction in the age-related decline of stem cells. In this context, by modulating NAD+ pathways or the gut microbiota, they can also enhance healing, hinting at an effect mediated by complex impacts on multiple pathways associated with cellular metabolism.

      Strengths:

      The study shows a remarkable finding: that age-related decreases in bone healing can be restored by intermittent fasting. There is ample evidence that intermittent fasting can delay aging, but here the authors provide evidence that in an already-aged animal, intermittent fasting can restore healing to levels seen in younger animals. This is an important finding as it may hint at the potential benefits of intermittent fasting in tissue repair.

      Weaknesses:

      The authors explore potential mechanisms by which the intermittent fasting protocol might impact bone healing. However, they do not identify a magic bullet here that controls this effect. Indeed, the fact that their results with intermittent fasting can be replicated by changing the gut microbiota or modulating fundamental pathways associated with NAD, suggests that there is no single mechanism that drives this effect, but rather an overall complex impact on metabolic processes, which may be very difficult to untangle.

      We thank the reviewer for their positive assessment of our study and for highlighting the significant finding that intermittent fasting can restore age-related declines in bone healing. We appreciate the observation that our results suggest a complex interplay of metabolic processes rather than a single "magic bullet" mechanism. Indeed, the ability of gut microbiota modulation or NAD+ pathway targeting to replicate intermittent fasting's benefits underscores this complexity. While we recognize the challenges of disentangling these interconnected pathways, we believe our findings offer valuable insights into the multifaceted nature of intermittent fasting's impact on aged tissue repair. We hope this study serves as a foundation for future research aimed at identifying the individual contributions of these pathways and developing targeted therapeutic strategies.

      Reviewer #3 (Public review):

      Summary:

      This study aims to address the significant challenge of age-related decline in bone healing by developing a dual therapeutic strategy that rejuvenates osteogenic function in aged calvarial bone tissue. Specifically, the authors investigate the efficacy of combining local Wnt3a-mediated osteoprogenitor stimulation with systemic intermittent fasting (IF) to restore bone repair capacity in aged mice. The highlights are:

      (1) Novel Approach with Aged Models:

      This pioneering study is among the first to demonstrate the rejuvenation of osteoblasts in significantly aged animals through intermitted fasting, showcasing a new avenue for regenerative therapies.

      (2) Rejuvenation Potential in Aged Tissues:

      The findings reveal that even aged tissues retain the capacity for rejuvenation, highlighting the potential for targeted interventions to restore youthful cellular function.

      (3) Enhanced Vascular Health:

      The study also shows that vascular structure and function can be significantly improved in aged tissues, further supporting tissue regeneration and overall health.<br /> Through this innovative approach, the authors seek to overcome intrinsic cellular deficits and environmental changes within aged osteogenic compartments, ultimately achieving bone healing levels comparable to those seen in young mice.

      Strengths:

      The study is a strong example of translational research, employing robust methodologies across molecular, cellular, and tissue-level analyses. The authors leverage a clinically relevant, immunocompetent mouse model and apply advanced histological, transcriptomic, and functional assays to characterise age-related changes in bone structure and function. Major strengths include the use of single-cell RNA sequencing (scRNA-seq) to profile osteoprogenitor populations within the calvarial periosteum and suture mesenchyme, as well as quantitative assessments of mitochondrial health, vascular density, and osteogenic function. Another important point is the use of very old animals (up to 88 weeks, almost 2 years) modelling the human bone aging that usually starts >65 yo. This comprehensive approach enables the authors to identify critical age-related deficits in osteoprogenitor number, function, and microenvironment, thereby justifying the combined Wnt3a and IF intervention.

      Weaknesses:

      One limitation is the use of female subjects only and the limited exploration of immune cell involvement in bone healing. Given the known role of the immune system in tissue repair, future studies including a deeper examination of immune cell dynamics within aged osteogenic compartments could provide further insights into the mechanisms of action of IF.

      We thank the reviewer for their thorough summary and positive assessment of our study, particularly highlighting its translational nature, the robust methodologies employed, and the relevance of our aged animal model. We appreciate the insightful suggestion to include male subjects and to explore immune cell dynamics in future investigations.

      We acknowledge the limitation of using only female mice in the current study and agree that future studies incorporating both sexes and investigating immune cell contributions within aged osteogenic compartments would offer valuable insights into the mechanisms underlying intermittent fasting and its impact on bone healing.

      Our focus on female mice was informed by their distinct characteristics, including delayed healing and higher fracture risk (PMID: 37508423, PMID: 34434120). Importantly, female mice present a more challenging case for bone repair, making them a stringent test for evaluating the effectiveness of our rejuvenation approaches. Moreover, our research protocol, approved under animal license, adhered to ethical principles and the 3Rs, allowing us to reduce the number of animals required by focusing on a single sex.

      Recommendations for the authors:

      Reviewer #1 (Recommendations for the authors):

      (1) The authors should provide a justification for the use of female mice in this study. Additionally, the section on animal methods should be expanded to align with ARRIVE guidelines.

      We thank the reviewer for their valuable feedback. In response to the comment regarding the use of female mice, we have included a justification in the updated manuscript. As noted, female mice were selected for this study due to their distinct characteristics, such as delayed healing and higher fracture risk (PMID: 37508423, PMID: 34434120), which provide a more challenging model for evaluating bone repair strategies. We believe this made our study a stringent test of the efficacy of the rejuvenation approaches being investigated.

      Additionally, we have revised the animal methods section to ensure it aligns with the ARRIVE guidelines.

      (2) Intermittent fasting can influence circadian rhythms in various ways. In the RNA-seq data, do the authors observe any changes related to circadian rhythm pathways?

      The reviewer raises an important point regarding the influence of intermittent fasting (IF) on circadian rhythms. Our RNA-seq data revealed significant alterations in circadian rhythm pathways, particularly within the aged periosteal CD90+ cell population during IF. Specifically, the PAR bZip family transcription factors Dbp, Hlf, and Tef (q < 0.05) were significantly upregulated, consistent with their established roles as circadian rhythm regulators (PMID: 16814730, PMID: 31428688).

      In suture CD90+ cells from the Aged + IF group, Dbp expression was significantly elevated compared to the Aged AL control group. Moreover, several other circadian-controlled genes, including Sirt1, Kat2b, Csnk1e, Ezh2, Fbxw11, and Ucp2 (p < 0.05), were also upregulated (Fig. 4b), suggesting enrichment of Clock/Per2/Arntl transcriptional targets, essential components of the circadian clock.

      The observed upregulation of circadian rhythm effectors like Dbp, Hlf, and Tef further suggests a potential role for circadian transcription in CD90+ cell rejuvenation and bone repair in aged mice. While previous studies have primarily focused on the role of circadian rhythms in osteoblasts in vitro (PMID: 34579752, PMID: 30290183), our findings provide compelling evidence for their involvement in bone regeneration in vivo, providing compelling evidence for future investigation into this mechanism.

      Chip-SEQ studies have shown D-box sites near promoters in Wnt/β-catenin components (e.g. Lrp6, Lrp5, Wnt8a, Fzd4) in pro-osteogenic transcription factor Zbtb16 (and see Fig 5), and in 11 of the 44 mouse collagen genes (PMID: 31428688). These components are known to regulate osteogenesis, and their proximity to circadian-controlled transcription factors suggests a possible overlap between circadian regulation and Wnt signaling in promoting bone repair.  Additionally, circadian rhythmicity, stem cell function, and Wnt signaling are interlinked (PMID: 29277155, PMID: 25414671). Food intake is a powerful regulator of the circadian rhythm in several organs (PMID: 11114885, PMID: 32363197), but little is known about the diet-circadian interaction in bone repair. The possibility that circadian transcription can be harnessed to target Aged stem cell function towards bone repair is a promising prospect.

      We have incorporated this information in Figure 2 - figure supplement 3G-H, the results section as well as in the discussion.

      Reviewer #2 (Recommendations for the authors):

      (1) The authors refer to 'altered cellular mechanobiology', 'age-related changes in mechanobiology', etc. Here, they are using this terminology to refer to changes in F-actin intensity and nuclear shape. While I agree that these measures are indicators of a cellular response to mechanical cues, calling this 'changes in mechanobiology' doesn't sound quite correct to me. 'Mechanobiology' to me, is a field of study. Perhaps the authors should consider changing their terminology.

      We appreciate the reviewer’s insightful comment on the terminology used in our manuscript. We agree that the term "mechanobiology" is a broad field of study and using it in the context of changes in F-actin intensity and nuclear shape may be misleading. We have revised the text to better reflect the specific cellular responses to mechanical cues, such as changes in the cytoskeleton and nuclear morphology, rather than referring to them as "altered mechanobiology." The updated terminology more accurately conveys the observed cellular alterations in response to mechanical forces. We have made these adjustments throughout the manuscript for clarity and precision.

      (2) Three of the measures the authors use to highlight age-related changes (and rejuvenation) in their animal model are F-actin intensity, nuclear shape, and vascularisation. However, they never really explain what they believe these readouts mean practically/functionally. Indeed, it makes sense that less vascularisation would be associated with an aged phenotype and preclude healing, but this is only mentioned somewhat cursorily in the discussion. While vascularisation is discussed in the context of aging in the discussion, it is not discussed in the context of healing (which would seem relevant in the context of vascularisation being used as a readout in the healing models in response to Akk and IF treatment). Similarly, the changes in F-actin intensity and nuclear shape might suggest changes in the stiffness of the periosteum (as mentioned in the discussion), which could indeed be an indicator of an aged phenotype; however, their role in healing (in response to Akk and IF) are not clearly articulated.

      We appreciate the reviewer’s insightful comments and have made revisions to clarify the implications of age-related changes in vascularization, F-actin intensity, and nuclear shape, as well as the functional significance of these observations in the context of healing and rejuvenation.

      Vascularization:

      Vascularization and modulation of blood flow are critical for calvarial bone repair, as supported by multiple studies (e.g., PMID: 38032405, PMID: 21156316, PMID: 25640220). Early in the calvarial repair process, blood vessels grow independently of osteoprogenitor cells, establishing a supportive environment that promotes osteoprogenitor migration and subsequent ossification (PMID: 38834586). Furthermore, angiogenic vessels from the periosteum at defect edges contribute to creating a specialized microenvironment essential for bone healing (PMID: 38834586, PMID: 38032405). Compromised vascularization significantly impairs the healing of critical-sized calvarial defects (PMID: 29702250).

      Our data reveal a decline in periosteal vascularization with age, potentially compromising this microenvironment and impairing repair in aged animals. Importantly, our findings indicate that intermittent fasting (IF) reverses this phenotype by restoring periosteal vascularization. This rejuvenation of the vascular microenvironment aligns with improved bone repair outcomes in aged mice subjected to IF. We have revised the manuscript to emphasize the importance of vascularization in healing and to highlight the role of IF in restoring this critical aspect of the bone healing microenvironment.

      F-actin intensity and nuclear shape:

      Age-related changes in F-actin intensity and nuclear shape are associated with increased tissue stiffness, a hallmark of aging. Tissue stiffness has been shown to impair progenitor cell function and hinder repair in various systems, including neuroprogenitors (PMID: 31413369). Softening the extra cellular matrix in aged tissues has been demonstrated to partially restore progenitor function and improve repair outcomes, as seen in the case of neuroprogenitors (PMID: 31413369). In our study, IF reversed age-associated changes in F-actin expression and nuclear shape, restoring these parameters to a phenotype resembling that of younger animals. This suggests that IF mitigates the mechanical changes associated with aging, reducing tissue stiffness and rejuvenating the periosteum to facilitate improved bone healing, similar to the outcomes observed in younger models.

      Following the reviewer’s advice, we have revised the text to clearly articulate the correlations and interpretations of our data regarding tissue mechanics and bone repair. Thank you for highlighting these critical aspects.

      (3) In relation to my point 2) on nuclear shape, there are reports that aging is linked to changes in Lamin B1. Have the authors considered this? It might provide a clearer link between their data and the tissue-level phenotypes they observe.

      Thank you for your comment regarding the potential link between aging and changes in Lamin B1. Following your suggestion, we performed Lamin B1 immunostaining on samples from Young, Adult, Aged, and Aged + IF groups. However, no significant differences in Lamin B1 levels were observed across these groups. These findings indicate that changes in Lamin B1 in osteoprogenitors are not apparent during aging, suggesting that Lamin B1 alterations in the context of aging may be tissue- and cell-type-specific.

      The new data was added in Figure 1 - figure supplement 2i-j.

      (4) In the data associated with Figure 2, the authors find that in the aged mice, MMP9 expression is increased, but MMP2 expression is decreased. They associate the decrease in MMP2 expression with decreased migration, but the canonical function of MMP9 should be similar to that of MMP2. Are there tissue-specific differences in the activity of MMP2/9 that could account for this?

      Thank you for the thoughtful comment. While both MMP-2 and MMP-9 are involved in ECM remodeling and share some overlapping canonical functions, their roles are context-dependent and exhibit tissue-specific differences that could explain the observed changes in aged mice. MMP-2 has been shown to play a critical role in maintaining the structural and functional integrity of flat bones, such as those in the craniofacial skeleton, by supporting bone remodeling (PMID: 17400654, PMID: 17440987, PMID: 16959767). The decreased expression of MMP-2 in aged mice may impair these local processes, leading to reduced migratory capacity of osteoprogenitors and contributing to aging-related changes in flat bone structure and function.

      In contrast, MMP-9 is more prominently involved in long bone remodeling, particularly at the growth plate where it regulates hypertrophic chondrocyte turnover, vascularization, and ossification during endochondral bone formation (PMID: 21611966, PMID: 9590175, PMID: 23782745, PMID: 16169742 ). Additionally, MMP-2 and MMP-9 differ in their regulation of specific ECM substrates and their interactions with bone-resident cells, which may further drive divergent outcomes in distinct bone types. For example, MMP-9’s role in osteoclastogenesis and its regulation of ECM proteins like type I collagen could be more critical in long bones, while MMP-2’s involvement in fine-tuning ECM microarchitecture may hold greater importance in flat bones.

      The increased expression of MMP-9 in aged calvarial osteoprogenitors may reflect a compensatory mechanism in response to the reduced MMP-2 activity, possibly in response to increased ECM turnover demands. Further studies examining the precise molecular pathways driving these changes in osteoprogenitors will help clarify the underlying mechanisms and their contributions to age-related alterations in flat bone structure and function.

      (5) In lines 391-2, the authors conclude that the data from Figure 4 shows that "during IF, CD90 cells, despite being aged, are more capable of ECM modulation and migration". The authors certainly present evidence that this is true, but the RNAseq showed that the enriched GO terms were predominantly associated with immune responses ('response to cytokine') and the proliferation phenotype seems very strong. Therefore, I would suggest that this overarching statement regarding the findings be less focussed on this one aspect of the finding, which doesn't look to be the dominant phenotype of the cellular response. And indeed, the authors move on from here to explore a mechanism associated with metabolism, not specifically with ECM remodelling.

      We greatly appreciate the reviewer insight regarding the interpretation of our findings, particularly the conclusion drawn from Figure 4.

      In response, we have revised the conclusion to more accurately reflect these findings.

      The revised text in the conclusion now reads: " Together, these findings suggest that IF rejuvenates aged CD90+ cells, in part, by enhancing proliferation, immune response, ECM remodeling, Wnt/β-catenin pathway, and metabolism, including increased ATP levels and decreased AMPK levels.”

      We hope that this adjustment better aligns with your suggestion and provides a more accurate summary of the key findings.

      (6) Fasting blood glucose levels are often cited as an indicator of metabolic health. Did the authors look at this in their animals who underwent the IF protocol? Could this have had an impact on the healing response?

      We thank the reviewer for this insightful comment. Throughout our study, we have withdrawn blood from the animals for various analyses that were not included in this manuscript in order to maintain focus on the osteoprogenitors.

      Our analysis included the assessment of the metabolic health of the animals using fasting blood glucose levels and the area under the curve (AUC) of the intraperitoneal glucose tolerance test (IPGTT).

      Fasting blood glucose levels reflect the animals' ability to maintain stable glucose levels after fasting, while the AUC from the IPGTT measures how efficiently glucose is cleared from the bloodstream following a glucose challenge. Typically, lower fasting blood glucose levels and reduced AUC indicate improved insulin sensitivity, better glucose metabolism, and enhanced metabolic control (PMID: 18812462, PMID: 19638507).

      Our findings show that intermittent fasting (IF) significantly reduced both the fasting blood glucose levels and the AUC in the IPGTT. This indicates that IF enhances metabolic flexibility, likely through improved insulin sensitivity and better glucose homeostasis. By lowering fasting blood glucose, IF reduces the reliance on excessive gluconeogenesis during fasting, while a reduced AUC indicates more efficient postprandial glucose clearance, consistent with enhanced insulin action and reduced fluctuations in blood glucose levels. The new data has been incorporated in Figure 3 - figure supplement 1d-g.

      Methods:

      “Blood glucose level measurement

      Fasting blood glucose levels were measured (Accu-Check tests strips) from 6h fasting mice by blood sampling the tail vein. For intraperitoneal glucose tolerance test (IPGTT), glucose was injected intraperitoneally (2 g/kg), and the blood glucose levels were measured after 15, 30, 60 and 120 minutes.”

      Improved metabolic health through lower fasting glucose and reduced AUC can have profound implications for tissue repair (PMID: 32809434). Stable glucose levels ensure a consistent energy supply for key cellular processes, such as cell proliferation, migration, and differentiation, which are essential for regeneration. Enhanced insulin sensitivity supports nutrient delivery to cells and reduces inflammation, creating an environment conducive to tissue healing. Additionally, intermittent fasting's ability to optimize glucose metabolism and regulate insulin secretion may enhance the function of stem and progenitor cells, further improving the tissue repair process (PMID: 28843700). Together, these findings suggest a mechanistic link between improved metabolic health and the enhanced healing observed in animals subjected to intermittent fasting.

      (7) In Supplementary Figure 10, the authors look at bone remodelling by assessing TRAP staining, as an indicator of osteoclast activity. I'm not sure if these data add all that much to the study. The authors have looked at bone formation at a tissue level using microCT. Here, they look at bone resorption at a cellular level with the TRAP assay. Overall, this probably suggests more bone remodelling, but the TRAP assay on its own at the cellular level could also be interpreted as an osteoporosis-like phenotype. This is clearly not the case because the authors show robust bone healing by microCT. In short, as an isolated measure of osteoclast activity at the cellular level without cellular-level assays of osteoblast activity, the interpretation of these data is not that clear. The microCT speaks far more of the phenotype and is, in my opinion, sufficient to make this point.

      We thank the reviewer for their comments regarding the interpretation of the TRAP staining data and its context within the study. We appreciate the concern that, without direct assays of osteoblast activity, the TRAP assay could lead to ambiguity.

      We have shown that intermittent fasting significantly increases the number and function of osteoprogenitor cells, the precursors to osteoblasts. While we acknowledge that these data do not directly measure osteoblast numbers or activity, they strongly suggest an increased capacity for osteoblast differentiation and bone formation. This aligns with the microCT findings of robust bone structure and healing.

      After careful consideration and given that the microCT and histology findings  already provide robust and comprehensive evidence for bone structure and healing, we have decided to remove the TRAP staining data from the manuscript. We believe this change simplifies the manuscript and strengthens its focus on the most impactful data.

      (8) In the discussion, the authors make a number of links between aging and IF. However, one of the exciting conclusions of this manuscript is that IF aids in healing in aged animals. In this context, IF has not impacted the aging process itself because the animals have not experienced an IF protocol across their lifespan, but rather only after injury. In this context, perhaps the authors should also be focussing their discussion on evidence of the short-term response to IF rather than its effects on aging, which are longer-term.

      We appreciate the reviewer's comment and agree that emphasizing the short-term effects of intermittent fasting is crucial. Our study is the first to examine this protocol in Aged animals.

      To address this, we have revised the discussion and highlighted how short-term IF enhances metabolic health, promotes osteoprogenitor functionality, and supports bone remodeling, as observed in our study.

      Reviewer #3 (Recommendations for the authors):

      (1) The authors should clarify details on intermittent fasting protocols, especially regarding caloric intake differences between fasting and non-fasting days, to aid reproducibility.

      We appreciate the reviewer's suggestions and have incorporated them by clarifying the relevant details. The new data are presented in Figure 3 - figure supplement 1a-c.

      Methods:

      “Caloric intake calculation

      To assess the caloric intake of mice, the food was weighted when made available to the mice (Win), and when removed (Wout). The daily consumed food was calculated based on the weight difference (Win - Wout), then converted to kcal (1 g = 3.02 kcal, LabDiet, 5053), and expressed as kcal/mouse/day for each cage (n cage ³ 3 with 1 to 5 mice/cage).”

      (2) Did the authors evaluate the effect of their intermittent fasting protocol on fasting blood glucose levels?

      Following the reviewer comment we included two measurements: 1) Fasting blood glucose, which reflects the ability to maintain glucose homeostasis during fasting, and 2) fasting blood glucose levels and the area under the curve (AUC) of the intraperitoneal glucose tolerance test (IPGTT), which measures glucose clearance efficiency after a glucose challenge. Lower values for both typically indicate improved insulin sensitivity, glucose metabolism, and metabolic control.

      Our findings demonstrate that intermittent fasting significantly reduced both fasting blood glucose and IPGTT AUC, suggesting enhanced metabolic flexibility, likely through improved insulin sensitivity and glucose homeostasis. Lower fasting blood glucose with IF indicates reduced reliance on gluconeogenesis during fasting, while a reduced AUC suggests more efficient postprandial glucose clearance, consistent with enhanced insulin action and reduced blood glucose fluctuations. This new data is included in Figure 3 - figure supplement 1.

      Generally, the improved metabolic environment supports tissue repair by ensuring adequate energy for cell proliferation and migration, reducing inflammation, and promoting the function of stem cells involved in tissue regeneration. Thus, this outcome of intermittent fasting may create a more favorable environment for tissue repair, potentially accelerating the healing of damaged tissues and improving overall regenerative capacity.

      (3) In Figure 1E-F, the nuclei have an interesting shape and the authors quantified F-actin. Given the role of lamin B in nuclear integrity, an analysis of lamin B expression and its structural integrity in aged osteoprogenitors could provide valuable insights into cellular aging mechanisms and their potential reversal with intermittent fasting.

      In response to the reviewer's comment, we performed Lamin B1 immunostaining on samples from Young, Adult, Aged, and Aged + IF groups. We observed no significant differences in Lamin B1 levels across these groups. This suggests that age-related changes in Lamin B1 are not evident in osteoprogenitors and may be tissue- or cell-type specific. The new data was added in Figure 1 - figure supplement 2i-j.

      (4) The authors should explain, in the main text or the methods section, why are they only using females in this study.

      We appreciate the reviewer's comment regarding the use of female mice. Female mice were chosen for this study due to their delayed healing and higher fracture risk (PMID: 37508423, PMID: 34434120), presenting a more challenging model for evaluating bone repair strategies and providing a stringent test of our rejuvenation approaches. This justification has been added to the revised manuscript. The animal methods section has also been updated to comply with ARRIVE guidelines.

      (5) This story stands alone and has an incredible amount of data. However, for a follow-up study, I would like to suggest consideration of including a broader analysis of immune cell involvement within the osteogenic compartments to strengthen the mechanistic understanding of IF's impact.

      We thank the reviewer for this insightful suggestion. We agree that investigating the role of immune cells within the osteogenic compartments could provide valuable mechanistic insights into how intermittent fasting influences tissue regeneration. Immune cells are key mediators of inflammation and repair, and their interactions with osteoprogenitors and other cells in the bone healing environment likely contribute to IF's effects.

      While our study focuses on IF's impact on osteoprogenitor function and tissue repair, we acknowledge the importance of future research exploring immune cell involvement. Techniques like single-cell RNA sequencing or flow cytometry could characterize immune cell populations and their functional states within osteogenic niches, allowing for a deeper understanding of immune-skeletal interactions during IF-mediated bone healing. We appreciate the reviewer highlighting this promising avenue for future research.

      Minor corrections to the text and figures:

      (1) References formatting should be revised (eg. line 41).

      The reference formatting was corrected.

      (2) Line 144 - what do the authors mean by p2 in the references?

      Thank you for your comment, we corrected the error and removed p2 from the reference.

    1. Author response:

      Reviewer #1 (Public review):

      The significance of the target molecule and mechanisms may help in understanding the molecular mechanisms of metformin.

      We greatly appreciate the reviewer’s insightful comment regarding the significance of the target molecule and its mechanisms in understanding the molecular actions of metformin. ATP5I is responsible for the dimerization of the F<sub>1</sub>F<sub>0</sub>-ATPase(1-3). Hence, we propose conducting BN-PAGE followed by a western blot using the β-subunit of the F1 domain of F1F0-ATP synthase to investigate whether metformin affects its dimerization. This will provide a more direct evidence of the on target action of metformin on ATP5I. Due to the high abundance of F<sub>1</sub>F<sub>0</sub>-ATP synthase in cells and the slow ability of metformin to enter mitochondria, we plan to perform long-term treatments (3 and 6 days) with high concentrations of metformin (10 mM) to enhance the likelihood of detecting subtle yet biologically relevant shifts in the monomer and dimer populations. Prolonged exposure is expected to reveal the cumulative effects of metformin on F<sub>1</sub>F<sub>0</sub>-ATP synthase dimers/monomers ratio. We do not expect that metformin will totally mimic the cumulative effect of the dimerization as in ATP5I KO cells but we think it will be important to report to what extent this ratio is affected.

      Reviewer #2 (Public review):

      (1) The interpretation of the cellular co-localization of the biotin-biguanide conjugate with TOMM20 (Figure 1-D) as mitochondrial "accumulation" of the conjugate is overstated because it cannot exclude binding of the conjugate to the mitochondrial membrane. It would have been more convincing if additional incubations with the biotin-biguanide conjugate in combination with metformin had shown that metformin is competitive with the biotin-conjugate.

      We appreciate the reviewer’s insightful comment and agree that the resolution provided by fluorescence microscopy makes it challenging to pinpoint the specific mitochondrial compartment where the biotin-biguanide conjugate localizes, even with additional markers such as TOMM20 antibodies for the inner mitochondrial membrane. While it remains a possibility that the conjugate binds to the mitochondrial surface, another plausible explanation is that the biotin moiety may facilitate entry into mitochondria through a biotin-specific transporter, adding further mechanistic intricacies. Furthermore, while a competition assay with metformin might help investigate interactions with mitochondrial targets and transporters (OCT family), it would not compete for biotin-mediated transport. Thus, while we acknowledge the reviewer’s suggestion, we believe such an experiment may not provide conclusive evidence regarding the conjugate’s mitochondrial localization or mechanism of entry. Instead, we will revise the manuscript to more accurately describe the findings as "mitochondrial association" rather than "mitochondrial accumulation," ensuring that our interpretation remains consistent with the resolution and limitations of the data presented.

      (2) The manuscript reports the identification of 69 proteins by mass spectrometry of the pull-down assay of which 31 proteins were eluted by metformin. However, no Mass Spectrometry data is presented of the peptides identified. The methodology does not state the minimum number of peptides (1, 2?) that were used for the identification of the 31/69 proteins.

      Concerning the mass spectrometry results, our intention was to provide a comprehensive table summarizing these findings in a separate data sheet, as part of the data availability section. To address the reviewer’s comment and ensure full transparency, we will include this table as supplementary material in the revised manuscript. Additionally, we will update the methodology section to explicitly state these criteria and ensure clarity regarding the identification process.

      (3) The validation of ATP5I was based on the use of recombinant protein (which was 90% pure) for the SPR and the use of a single antibody to ATP5I. The validity of the immunoblotting rests on the assumption that there is no "non-specific" immunoactivity in the relevant mol wt range. Information on the validation of the antibody would be helpful.

      Regarding the recombinant protein used for SPR, its purity was evaluated using a Coomassie-stained gel. For the antibody used in immunoblotting, its specificity was validated through knockout cell lines, ensuring minimal concerns about non-specific immunoactivity within the relevant molecular weight range. Unfortunately, the KO data comes in the paper after the first immunoblots are presented. In the revised manuscript, we will clearly outline these validation steps in the methods section and additional manufacturer documentation for the antibody we used.

      (4) Knock-out of ATP5I markedly compromised the NAD/NADH ratio (Fig.3A) and cell proliferation (Figure 3D). These effects may be associated with decreased mitochondrial membrane potential which could explain the low efficacy of metformin (and most of the data in Figures 3-5). This possibility should be discussed. Effects of [metformin] on the NAD/NADH ratio in control cells and ATP5I-KO would have been helpful because the metformin data on cell growth is normalized as fold change relative to control, whereas the NAD/NADH ratio would represent a direct absolute measurement enabling comparison of the absolute effect in control cells with ATP5I KO.

      The mitochondrial membrane potential depends on a functional electron transport chain which drives proton pumping from the matrix to the intermembrane space. Metformin can decrease the mitochondrial membrane potential and this usually explained as a consequence of complex I inhibition(4). It has been published the metformin requires this membrane potential to accumulate in mitochondria so the actions of metformin are self-limiting due to this requirement. The reviewer is right that ATP5I KO cells could be resistant to metformin because they may have a lower membrane potential. We do not believe this to be the case because the response to phenformin, another biguanide that can enter mitochondria through the membrane without the need of the OCT transporters(5), is also affected in ATP5IKO cells. Of note, compensatory mechanisms such as enhanced glycolysis, as observed in ATP5I-KO cells (elevated ECAR and increased sensitivity to 2-D-deoxyglucose), and the ATPase activity of F<sub>1</sub>F<sub>0</sub>-ATP synthase could potentially help maintain membrane potential suggesting that this might not be an issue in the ATP5I KO cells. We will discuss these possibilities in the revised manuscript.

      Nevertheless, to experimentally address this point, we propose measuring mitochondrial membrane potential using tetramethylrhodamine methyl ester (TMRE) and ATP levels using luciferase-based assays (CellTiter-Glo) in ATP5I-KO cells.

      Regarding the NAD+/NADH in both control and KO cells may not be very helpful because this ratio can be corrected by LDH which is induced as part of the glycolytic adaptation that occurs after inhibition of respiration. Since our KO cells have been propagated already for several passages, the extent of this adaptation is likely different from metformin-treated cells. As we mentioned in answering Reviewer 1, we will provide a more direct measurement of metformin acting on ATP5I: the levels of F1F0-ATPase dimers and monomers.

      (5) Figure-6 CRISPR/Cas9 KO at 16mM metformin in comparison with 70nM rotenone and 2 micromolar oligomycin (in serum-containing medium). The rationale for the use of such a high concentration of metformin has not been explained. In liver cells metformin concentrations above 1mM cause severe ATP depletion, whereas therapeutic (micromolar) concentrations have minimal effects on cellular ATP status. The 16mM concentration is ~2 orders of magnitude higher than therapeutic concentrations and likely linked to compromised energy status. The stronger inhibition of cell proliferation by 16mM metformin compared with rotenone or oligomycin raises the issue of whether the changes in gene expression may be linked to the greater inhibition of mitochondrial metabolism. Validation of the cellular ATP status and NAD/NADH with metformin as compared with the two inhibitors could help the interpretation of this data.

      To address the reviewer’s final comment, we would like to clarify the rationale behind our experimental approach. NALM-6 cells are very glycolytic, have low respiration rates, and weak dependence on ATP5I (DepMap score: -0.47)(6). The concentration of 16 mM metformin was chosen based on the IC50 for this cell line. This approach aligns with our focus on the anticancer mechanism of action rather than the antidiabetic effects of metformin. Both ATP status and NAD+/NADH ratios will depend on the extent of the compensatory glycolysis. On the other hand, our genetic screening evaluates cell proliferation as an integration of all metabolic activities required for the process. This unbiased screening revealed a common pathway affected by metformin and oligomycin different that the pathway affected by rotenone, which is consistent with the finding that metformin acts of the F<sub>1</sub>F<sub>0</sub>ATPase.

      Reviewer #3 (Public review):

      (1) Most of the data are based on measurements of the oxygen consumption rate (OCR) and extracellular acidification rate (ECAR) measured by the Seahorse analyser in control and ATP5l KO cells. However, these measurements are conducted by a single injection of a biguanide, followed over time and presented as fold change. By doing so, the individual information on the effect of metformin and derivate on control and KO cells are lost. In addition, the usual measurement of OCR is coupled with certain inhibitors and uncouplers, such as oligomycin, FCCP, and Antimycin A/rotenone, to understand the contribution of individual complexes to respiration. Since biguanides and ATP5l KO affect protein levels of components of complex I and IV, it would be informative to measure their individual contributions/effects in the Seahorse. To further strengthen the data, it would be helpful to obtain measurements of actual ATP levels in these cells, as this would explain the activation of AMPK.

      We appreciate the reviewer’s observations regarding the Seahorse measurements and acknowledge the potential limitations of presenting the data as fold change. Due to experimental challenges in maintaining KP-4 and ATP5I-KO cells with sufficient nutrients, caused by their rapid glucose uptake and subsequent lactate production, it was more practical to present the Seahorse results in this format. Using inhibitors at each time point during the Seahorse experiment was not feasible, as the delay between inhibitor injections and the corresponding changes in oxygen consumption rate (OCR) and extracellular acidification rate (ECAR) would introduce variability and complicate the interpretation of dynamic responses. Nevertheless, we recognize the importance of understanding the contributions of specific respiratory complexes to OCR and ECAR. To address this, we will include a representative figure showcasing a typical Seahorse analysis, highlighting ATP turnover and proton leak after oligomycin addition, maximal respiration with FCCP, and disruption with rotenone and antimycin A. While these experiments are inherently complex due to the metabolic demands of ATP5I-KO cells, this approach will provide a clearer breakdown of mitochondrial activity. Furthermore, as mentioned in our response to Reviewer 2, we will measure ATP levels using a luciferase-based assay (CellTiter-Glo) in both control and ATP5I-KO cells to better explain AMPK activation. This will provide additional context to strengthen the interpretation of mitochondrial function and metabolic compensation mechanisms in these cells.

      (2) The authors report on alterations in mitochondrial morphology upon ATP5l KO, which is measured by subjective quantifications of filamentous versus puncta structures. Fiji offers great tools to quantify the mitochondrial network unbiasedly and with more accuracy using deconvolution and skeletonization of the mitochondria, providing the opportunity to measure length, shape, and number quantitatively. This will help to understand better, whether mitochondria are really fragmented upon ATP5l KO and rescued by its re-introduction.

      Concerning the analysis of mitochondrial morphology, we acknowledge the potential benefits of using Fiji and additional plugins such as MiNA for more accurate and unbiased quantification. Indeed, this approach could provide stronger evidence for mitochondrial fragmentation upon ATP5I-KO and its potential rescue by ATP5I reintroduction. We will consider integrating this methodology into our analysis to enhance the precision and robustness of our findings.

      (3) Finally, the authors report in the last part of the paper a genetic CRISPR/Cas9 KO screen in NALM-6 cells cultured with high amounts of metformin to identify potential new mediators of metformin action. It is difficult to connect that to the rest of the paper because a) different concentrations of metformin are used and b) the metabolic effects on energy consumption are not defined. They argue about the molecular function of the obtained hits based on literature and on a comparison of the pattern of genetic alterations based on treatments with known inhibitors such as oligomycin and rotenone. However, a direct connection is not provided, thus the interpretation at the end of the results that "the OMA1-DEL1-HRI pathway mediates the antiproliferative activity of both biguanides and the F1ATPase inhibitor oligomycin" while increasing glycolysis, needs to be toned down. This is an interesting observation, but no causality is provided. In general, this part stands alone and needs to be better connected to the rest of the paper.

      NALM-6 are very glycolytic, have low respiration rates, and weak dependence on ATP5I(6), forcing us to use higher concentrations of metformin to inhibit their growth. Recent results show that metformin targets PEN2 in the cytosol to increase AMPK activity, controlling both the glucose lowering and the life span extension abilities of metformin 7. This work raises the question whether the antiproliferative and anticancer effects of metformin are due to a mitochondrial activity or are controlled by this new pathway of AMPK activation. Hence, the genetic screening was performed to unbiasedly find how metformin works. The results provide compelling evidence for mitochondria and in particular the ATP synthase as potential targets of metformin and a foundation for future studies. We will revise the text and abstract to better reflect the exploratory nature of this finding and ensure clarity.

      (1) Paumard, P. et al. Two ATP synthases can be linked through subunits i in the inner mitochondrial membrane of Saccharomyces cerevisiae. Biochemistry 41, 10390-10396 (2002). https://doi.org/10.1021/bi025923g

      (2) Paumard, P. et al. The ATP synthase is involved in generating mitochondrial cristae morphology. EMBO J 21, 221-230 (2002). https://doi.org/10.1093/emboj/21.3.221

      (3) Habersetzer, J. et al. ATP synthase oligomerization: from the enzyme models to the mitochondrial morphology. Int J Biochem Cell Biol 45, 99-105 (2013). https://doi.org/10.1016/j.biocel.2012.05.017

      (4) Xian, H. et al. Metformin inhibition of mitochondrial ATP and DNA synthesis abrogates NLRP3 inflammasome activation and pulmonary inflammation. Immunity 54, 1463-1477 e1411 (2021). https://doi.org/10.1016/j.immuni.2021.05.004

      (5) Hawley, S. A. et al. Use of cells expressing gamma subunit variants to identify diverse mechanisms of AMPK activation. Cell metabolism 11, 554-565 (2010). https://doi.org/10.1016/j.cmet.2010.04.001

      (6) Hlozkova, K. et al. Metabolic profile of leukemia cells influences treatment efficacy of L-asparaginase. BMC Cancer 20, 526 (2020). https://doi.org/10.1186/s12885-020-07020-y

      (7) Ma, T. et al. Low-dose metformin targets the lysosomal AMPK pathway through PEN2. Nature 603, 159-165 (2022). https://doi.org/10.1038/s41586-022-04431-8

    1. Author response:

      We thank the reviewers for taking the time to read and critically assess our manuscript.

      We agree with the main points and they will be addressed in both writing and in additional experiments in a revised version of the paper.

      The shared and major point of criticism are non-conclusive metabolomic data that indicate the bc1-complex in T. gondii as a MMV1028806 target tachyzoites and bradyzoites. Regarding the former, our conclusion was mainly based on both metabolite abundance changes that are observed after treatment with one bona-fide bc1-complex inhibitor atovaquone and also steady-state stable isotope incorporation patterns. While it is true that secondary effects of metabolic inhibition occur and are often dominant, isotope labelling equilibria take more time to establish and may reflect more accurately blocked metabolic reactions i.e. the primary target.

      Regardless, we will follow the excellent suggestions to functionally assay particular mitochondrial electron transfer reactions to corroborate or revise our conclusions regarding the primary MMV1028806 target.

      For more details please refer the full author responses that will accompany the revised manuscript.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Reviewer #1 (Public review):

      Summary:

      Sun et al. are interested in how experience can shape the brain and specifically investigate the plasticity of the Toll-6 receptor-expressing dopaminergic neurons (DANs). To learn more about the role of Toll-6 in the DANs, the authors examine the expression of the Toll-6 receptor ligand, DNT-2. They show that DNT-2 expressing cells connect with DANs and that loss of function of DNT-2 in these cells reduces the number of PAM DANs, while overexpression causes alterations in dendrite complexity. Finally, the authors show that alterations in the levels of DNT-2 and Toll-6 can impact DAN-driven behaviors such as climbing, arena locomotion, and learning and long-term memory.

      Strengths:

      The authors methodically test which neurotransmitters are expressed by the 4 prominent DNT-2 expressing neurons and show that they are glutamatergic. They also use Trans-Tango and Bac-TRACE to examine the connectivity of the DNT-2 neurons to the dopaminergic circuit and show that DNT-2 neurons receive dopaminergic inputs and output to a variety of neurons including MB Kenyon cells, DAL neurons, and possibly DANS.

      We are very pleased that Reviewer 1 found our connectivity analysis a strength.

      Weaknesses:

      (1) To identify the DNT-2 neurons, the authors use CRISPR to generate a new DN2-GAL4.

      They note that they identified at least 12 DNT-2 plus neurons. In Supplementary Figure 1A, the DNT-2-GAL4 driver was used to express a UAS-histoneYFP nuclear marker. From these figures, it looks like DNT-2-GAL4 is labeling more than 12 neurons. Is there glial expression?

      Indeed, we claimed that DNT-2 is expressed in at least 12 neurons (see line 141, page 6 of original manuscript), which means more than 12 could be found. The membrane tethered reporters we used – UAS-FlyBow1.1, UASmcD8-RFP, UAS-MCFO, as well as UAS-DenMark:UASsyd-1GFP – gave a consistent and reproducible pattern. However, with DNT-2GAL4>UAS-Histone-YFP more nuclei were detected that were not revealed by the other reporters. We have found also with other GAL4 lines that the patterns produced by different reporters can vary. This could be due to the signal strength (eg His-YFP is very strong) and perdurance of the reporter (e.g. the turnover of His-YFP may be slower than that of the other fusion proteins).

      We did not test for glial expression, as it was not directly related to the question addressed in this work.

      (2) In Figure 2C the authors show that DNT-2 upregulation leads to an increase in TH levels using q-RT-PCR from whole heads. However, in Figure 3H they also show that DNT-2 overexpression also causes an increase in the number of TH neurons. It is unclear whether TH RNA increases due to expression/cell or the number of TH neurons in the head.

      Figure 3H shows that over-expression of DNT-2 FL increased the number of Dcp1+ apoptotic cells in the brain, but not significantly (p=0.0939). The ability of full-length neurotrophins to induce apoptosis and cleaved neurotrophins promote cell survival is well documented in mammals. We had previously shown that DNT-2 is naturally cleaved, and that over-expression of DNT-2 does not induce apoptosis in the various contexts tested before (McIlroy et al 2013 Nature Neuroscience; Foldi et al 2017 J Cell Biol; Ulian-Benitez et al 2017 PLoS Genetics). Similarly, throughout this work we did not find DNT-2FL to induce apoptosis.

      Instead, in Figure 3G we show that over-expression of DNT-2FL causes a statistically significant increase in the number of TH+ cells. This is an important finding that supports the plastic regulation of PAM cell number. We thank the Reviewer for highlighting this point, as we had forgotten to add the significance star in the graph. In this context, we cannot rule out the possibility that the increase in TH mRNA observed when we over-express DNT-2FL could not be due to an increase in cell number instead. Unfortunately, it is not possible for us to separate these two processes at this time. Either way, the result would still be the same: an increase in dopamine production when DNT-2 levels rise.

      We have now edited the abstract lines 38-39 adding that “By contrast, over-expressed DNT-2 increased DAN cell number,…”, within the main text in Results page 10 lines 259-265 and in the Discussion section page 15 lines 391, 393-396.

      (3) DNT-2 is also known as Spz5 and has been shown to activate Toll-6 receptors in glia (McLaughlin et al., 2019), resulting in the phagocytosis of apoptotic neurons. In addition, the knockdown of DNT-2/Spz5 throughout development causes an increase in apoptotic debris in the brain, which can lead to neurodegeneration. Indeed Figure 3H shows that an adult specific knockdown of DNT-2 using DNT2-GAL4 causes an increase in Dcp1 signal in many neurons and not just TH neurons.

      Indeed, we did find Dcp1+ TH-negative cells too (although not widely throughout the brain), although this is not shown in the images of Figure 3H where we showed only TH+ Dcp+ cells.

      That is not surprising, as DNT-2 neurons have large arborisations that can reach a wide range of targets; DNT-2 is secreted, and could reach beyond its immediate targets; Toll-6 is expressed in a vast number of cells in the brain; DNT-2 can bind promiscuously at least also Toll-7 and other Keks, which are also expressed in the adult brain (Foldi et al 2017 J Cell Biology; Ulian-Benitez et al 2017 PLoS Genetics; Li et al 2020 eLife). Together with the findings by McLaughlin et al 2019, our findings further support the notion that DNT-2 is a neuroprotective factor in the adult brain. It will be interesting to find out what other neuron types DNT-2 maintains.

      We have made some edits on these points in page 10 lines 259-265.

      We would like to thank Reviewer 1 for their positive comments on our work and their interesting and valuable feedback.

      Reviewer #2 (Public review):

      This paper examines how structural plasticity in neural circuits, particularly in dopaminergic systems, is regulated by Drosophila neurotrophin-2 (DNT-2) and its receptors, Toll-6 and Kek-6. The authors show that these molecules are critical for modulating circuit structure and dopaminergic neuron survival, synaptogenesis, and connectivity. They show that loss of DNT-2 or Toll-6 function leads to loss of dopaminergic neurons, dendritic arborization, and synaptic impairment, whereas overexpression of DNT-2 increases dendritic complexity and synaptogenesis. In addition, DNT-2 and Toll-6 modulate dopamine-dependent behaviors, including locomotion and long-term memory, suggesting a link between DNT-2 signaling, structural plasticity, and behavior.

      A major strength of this study is the impressive cellular resolution achieved. By focusing on specific dopaminergic neurons, such as the PAM and PPL1 clusters, and using a range of molecular markers, the authors were able to clearly visualize intricate details of synapse formation, dendritic complexity, and axonal targeting within defined circuits. Given the critical role of dopaminergic pathways in learning and memory, this approach provides a good opportunity to explore the role of DNT-2, Toll-6, and Kek-6 in experience-dependent structural plasticity. However, despite the promise in the abstract and introduction of the paper, the study falls short of establishing a direct causal link between neurotrophin signaling and experience-induced plasticity.

      Simply put, this study does not provide strong evidence that experience-induced structural plasticity requires DNT-2 signaling. To support this idea, it would be necessary to observe experience-induced structural changes and demonstrate that downregulation of DNT-2 signaling prevents these changes. The closest attempt to address this in this study was the artificial activation of DNT-2 neurons using TrpA1, which resulted in overgrowth of axonal arbors and an increase in synaptic sites in both DNT-2 and PAM neurons. However, this activation method is quite artificial, and the authors did not test whether the observed structural changes were dependent on DNT-2 signaling. Although they also showed that overexpression of DNT-2FL in DNT-2 neurons promotes synaptogenesis, this phenotype was not fully consistent with the TrpA1 activation results (Figures 5C and D).

      In conclusion, this study demonstrates that DNT-2 and its receptors play a role in regulating the structure of dopaminergic circuits in the adult fly brain. However, it does not provide convincing evidence for a causal link between DNT-2 signaling and experience-dependent structural plasticity within these circuits.

      We would like to thank Reviewer 2 for their very positive assessment of our approach to investigate structural circuit plasticity. We are delighted that this Reviewer found our cellular resolution impressive. We are also very pleased that Reviewer 2 found that our work demonstrates that DNT-2 and its receptors regulate the structure of dopaminergic circuits in the adult fly brain. This is already a very important finding that contributes to demonstrating that, rather than being hardwired, the adult fly brain is plastic, like the mammalian brain. Furthermore, it is remarkable that this involves a neurotrophin functioning via Toll and kinase-less Trks, opening an opportunity to explore whether such a mechanism could also operate in the human brain.

      We are very pleased that this Reviewer acknowledges that this work provides a good opportunity to explore the role of DNT-2, Toll-6, and Kek-6 in experience-dependent structural plasticity. We provide a molecular mechanism and proof of principle, and we demonstrate a direct link between the function of DNT-2 and its receptors in circuit plasticity. We also showed a link of DNT-2 to neuronal activity, as neuronal activity increased the production of DNT-2GFP, induced the cleavage of DNT-2 and a feedback loop between DNT-2 and dopamine, and both neuronal activity and increased DNT-2 levels promoted synaptogenesis.

      As the Reviewer acknowledges this approach provides a good opportunity to explore the role of DNT-2, Toll-6, and Kek-6 in experience-dependent structural plasticity. Finding out the direct link in response to lived experience is a big task, beyond the scope of this manuscript, and we will be testing this with future projects. Nevertheless, it is important to place our findings within this context together with the link to mammalian neurotrophins (as explained in the discussion), as it is here where the findings have deep and impactful implications.

      To accommodate the criticism of this Reviewer, we have now toned down our narrative. This does not diminish the importance of the findings, it makes the argument more stringent. Please see edits in: Abstract page 2 lines 42-44; and Discussion page 22 line 586 – which were the only points were a direct claim had been made.

      We would like to thank Reviewer 2 for the positive and thoughtful evaluation of our work, and for their feedback.

      Reviewer #3 (Public review):

      Summary:

      The authors used the model organism Drosophila melanogaster to show that the neurotrophin Toll-6 and its ligands, DNT-2 and kek-6, play a role in maintaining the number of dopaminergic neurons and modulating their synaptic connectivity. This supports previous findings on the structural plasticity of dopaminergic neurons and suggests a molecular mechanism underlying this plasticity.

      Strengths:

      The experiments are overall very well designed and conclusive. Methods are in general state-of-the-art, the sample sizes are sufficient, the statistical analyses are sound, and all necessary controls are in place. The data interpretation is straightforward, and the relevant literature is taken into consideration. Overall, the manuscript is solid and presents novel, interesting, and important findings.

      We are delighted that Reviewer 3 found our work solid, novel, interesting and with important findings. We are also very pleased that this Reviewer found that all necessary controls have been carried out.

      Weaknesses:

      There are three technical weaknesses that could perhaps be improved.

      First, the model of reciprocal, inhibitory feedback loops (Figure 2F) is speculative. On the one hand, glutamate can act in flies as an excitatory or inhibitory transmitter (line 157), and either situation can be the case here. On the other hand, it is not clear how an increase or decrease in cAMP level translates into transmitter release. One can only conclude that two types of neurons potentially influence each other.

      Thank you for pointing out that glutamate can be inhibitory. In response, we have removed the word ‘excitatory’ from the only point it had been used in the text: page 7 line 167.

      In mammals, the neurotrophin BDNF has an important function in glutamatergic synapses, thus we were intrigued by a potential evolutionary conservation. Our evidence that DNT-2A neurons could be excitatory is indirect, yet supportive: exciting DNT-2 neurons with optogenetics resulted in an increase in GCaMP in PAMs (data not shown); over-expression of DNT-2 in DNT-2 neurons increased TH mRNA levels; optogenetic activation of DNT-2 neurons results in the Dop2R-dependent downregulation of cAMP levels in DNT-2 neurons. Dop2R signals in response to dopamine, which would be released only if dopaminergic neurons had been excited. Accordingly, glutamate released from DNT-2 neurons would have been rather unlikely to inhibit DANs.

      cAMP is a second messenger that enables the activation of PKA. PKA phosphorylates many target proteins, amongst which are various channels. This includes the voltage gated calcium channels located at the synapse, whose phosphorylation increases their opening probability. Other targets regulate synaptic vesicle release. Thus, a rise in cAMP could facilitate neurotransmitter release, and a downregulation would have the opposite effect. Other targets of PKA include CREB, leading to changes in gene expression. Conceivably, a decrease in PKA activity could result in the downregulation of DNT-2 expression in DNT-2 neurons. This negative feedback loop would restore the homeostatic relationship between DNT-2 and dopamine levels.

      We agree with this Reviewer that whereas our qRT-PCR data show that over-expression of DNT-2 increases TH mRNA levels, this does not demonstrate that originates from PAM neurons. Similarly, although our EPAC data imply that dopamine must be released from DANs and received by DNT-2 neurons to explain those data, the evidence did not include direct visualisation of dopamine release in response to DNT-2 neuron activation. To accommodate these criticisms, we have edited the summary Figure 2E adding question marks to indicate inference points and page 9 line 221.

      Our data indeed demonstrate that DNT-2 and PAM neurons influence each other, not potentially, but really. We have provided data that: DNT-2 and PAMs are connected through circuitry; that the DNT-2 receptors Toll-6 and kek-6 are expressed in DANs, including in PAMs; that alterations in the levels of DNT-2 (both loss and gain of function) and loss of function for the DNT-2 receptors Toll-6 and Kek-6 alter PAM cell number, alter PAM dendritic complexity and alter synaptogenesis in PAMs; alterations in the levels of DNT-2, Toll-6 and kek-6 in adult flies alters dopamine dependent behaviours of climbing, locomotion in an arena and learning and long-term memory. These data firmly demonstrate that the two neuron types DNT-2 and PAMs influence each other.

      We have also shown that over-expression of DNT-2 in DNT-2 neurons increases TH mRNA levels, whereas activation of DNT-2 neurons decreases cAMP levels in DNT-2 neurons in a dopamine/Dop2R-dependent manner. These data show a functional interaction between DNT-2 and PAM neurons.

      Second, the quantification of bouton volumes (no y-axis label in Figure 5 C and D!) and dendrite complexity are not convincingly laid out. Here, the reader expects fine-grained anatomical characterizations of the structures under investigation, and a method to precisely quantify the lengths and branching patterns of individual dendritic arborizations as well as the volume of individual axonal boutons.

      Figure 5C, D do contain Y-axis labels, all our graphs in main manuscript and in supplementary files contain Y-axis labels.

      In fact, we did use a method to precisely quantify the lengths and branching patterns of individual dendritic arborisations, volume of individual boutons and bouton counting. These analyses were carried out using Imaris software. For dendritic branching patterns, the “Filament Autodetect” function was used. Here, dendrites were analysed by tracing semi-automatically each dendrite branch (ie manual correction of segmentation errors) to reconstruct the segmented dendrite in volume. From this segmented dendrite, Imaris provides measurements of total dendrite volume, number and length of dendrite branches, terminal points, etc. For bouton size and number, we used the Imaris “Spot” function. Here, a threshold is set to exclude small dots (eg of background) that do not correspond to synapses/boutons. All samples and genotypes are treated with the same threshold, thus the analysis is objective and large sample sizes can be analysed effectively. We had already provided a description of the use of Imaris in the methods section.

      We have now exapanded the protocol on how we use Imaris to analyse dendrites and synapses, in: Materials and Methods section, page 28 lines 756-768 and page 29 lines 778-799.

      Third, Figure 1C shows two neurons with the goal of demonstrating between-neuron variability. It is not convincingly demonstrated that the two neurons are actually of the very same type of neuron in different flies or two completely different neurons.

      We thank Reviewer 3 for raising this interesting point. It is not possible to prove which of the four DNT-2A neurons per hemibrain, which we visualised with DNT-2>MCFO, were the same neurons in every individual brain we looked at. This is because in every brain we have looked at, the soma of the neurons were not located in exactly the same location. Furthermore, the arborisation patterns are also different and unique, for each individual brain. Thus, there is natural variability in the position of the soma and in the arborisation patterns. Such variability presumably results from the combination of developmental and activity-dependent plasticity. Importantly, for every staining we carried out using DNT-2GAL4 and various membrane reporters and MCFO clones, we never found two identical DNT-2 neuron profiles.

      To increase the evidence in support of this point, we have now expanded Figure 1, adding one more image of DNT-2>FlyBow (Figure 1A) and two more images of DNT-2>MCFO (Figure 1D). In total, seven images in Figure 1 and two further images in Figure 5A demonstrate the variability of DNT-2 neurons.

      We would like to thank Reviewer 3 for the very positive evaluation of our work and the interesting and valuable feedback.

      Recommendations for the authors:

      Reviewer #1 (Recommendations for the authors): 

      In the fly list, several fly lines are missing references and sources. 

      Apologies for this over-sight, this has now been corrected.

      We thank Reviewer 1 for their effort and time to scrutinise our work, and for their very positive and helpful feedback.

      Reviewer #2 (Recommendations for the authors):

      (1) Here I provide some more specific comments that I hope will help the authors further improve the study.

      (2) L148: "single neuron clones revealed variability in the DNT-2A". How do the authors know that they are labeling the same subtype of DNT-2A neurons? 

      There are four anterior DNT-2A cells per hemibrain, that project from the SOG area to the SMP. It is not possible to verify that every time we look at exactly the same neuron, because the exact position of the somas and the arborisation patterns vary from brain to brain. We know this from two sources of data: (1) when using DNT-2GAL4 to visualise the expression of membrane reporters (e.g. UAS-FlyBow, UAS-mCD8-GFP, UAS-CD8-RFP) no brain ever showed a pattern identical to that of another brain, neither in the exact position of the somas nor in the exact arborisation patterns. (2) When we generated DNT-2>MCFO clones to visualise 1-2 cells at a time, no single neuron or 2-neuron clones ever showed an identical pattern. The most parsimonious interpretation is that the exact location of the somas and the exact arborisation patterns vary across individual flies. Developmental variability in neuronal patterns has also been reporter by Linneweber et al (2020) Science.

      To make our evidence more compelling, and in response to this Reviewer’s query, we have now added further images. Please find in revised Figure 1 A,B three examples of three different brains expressing DNT-2>FlyBow1.1. In Figure 1D, two more examples (altogether 4) of DNT-2>MCFO clones. Here it is clear to see that no neuron shape is identical to that of others, demonstrating variability in individual fly brains. We now show four images in Figure 1 and two more in Figure 5A that demonstrate the variability of DNT-2A neurons.

      (3) Figure 1E: Are all DNT-2A neurons positive for vGlut and Dop2R? This figure shows only two DNT-2A neurons. 

      Yes, all four DNT-2A neurons per hemibrain are vGlut positive and we have now added more images to Supplementary Figure S1A (right), also showing that presynaptic DNT-2A endings at SMP also coincide with a vGlut+ domain (Figure S1A left).

      Yes, all all four DNT-2A neurons per hemibrain are Dop2R positive and we have now added more images to Supplementary Figure S1B.

      (4) L156: Glutamate is generally considered to be inhibitory in the adult fly brain. More evidence is needed before the authors can claim that "DNT-2A neurons are excitatory glutamatergic neurons". 

      Thank you for pointing this out. Although our data do not conclusively demonstrate it, they are consistent with DNT-2A neurons being excitatory. BDNF is most commonly released from glutamatergic neurons in mammals, its release is activity-dependent and leads to formation and stabilisation of synapses.  The phenotypes we have observed are consistent with this and reveal functional evolutionarily conservation: (1) exciting DNT-2 neurons with TrpA1 results in increased production and cleavage of DNT-2GFP and de novo synaptogenesis; (2) over-expression of DNT-2 in the adult induces de novo synaptogenesis; (3) down-regulation or loss of DNT-2 and its receptors Toll-6 and Kek-6 impair synaptogenesis. Furthermore, we show that DNT-2 dependent synaptogenesis is between DNT-2 and dopaminergic neurons, which are involved in the control of locomotion, reward learning and long-term memory, and dopamine itself is required for such behaviour. Consistently with this we found that: (1) over-expression of DNT-2 increases TH mRNA levels, which would lead to the up-regulation of dopamine production; (2) exciting DNT-2 neurons increases locomotion speed in an arena; (3) knock-down of DNT-2 and its receptors decreases locomotion, whereas over-expression of DNT-2 increases locomotion; (4) over-expression of DNT-2 increases learning and long-term memory. Finally, in a previous version in bioRxiv, we also showed using optogenetics and calcium imaging that exciting DNT-2 neurons induced GCaMP signalling in their output PAM neurons, and in this version we show that exciting DNT-2 neurons regulates cAMP in DNT-2 neurons via dopamine-release dependent feedback. Altogether, the most parsimonious interpretation of these data is that vGlut+ DNT-2 neurons are excitatory.

      In any case, to address this reviewer’s point, we have now removed the word ‘excitatory’ from page 7 line 167.

      (5) Figure 1H, I: A more detailed description of the Toll-6 and Kek-6 expressing neurons will be helpful. Are they expressed in specific types of PAM and PPL1 DANs? The legend in Figure S2 mentions labeling in γ2α′1 zones, but it seems to be more than that.

      This information had been already provided, presumable this Reviewer overlooked this. This was already described in great detail by comparing our microscopy data with the single cell RNA-seq data available through Fly Cell Atlas (https://flycellatlas.org) and Scope (https://scope.aertslab.org/#/b77838f4-af3c-4c37-8dd9-cf7a41e4b034/*/welcome).

      Please see our previously submitted Table S1 “Expression of Tolls, keks and Toll downstream adaptors in cells related to DNT-2A neurons”.

      (6) Figure S3 should be controls for Figure 2A. It is incorrectly labeled as controls for Figure 3A. 

      Thank you for pointing out this typo, this has now been corrected.

      (7) L197: The authors state, "This showed that DNT-2 could stimulate dopamine production in neighboring DANs". However, the results do not fully support this conclusion because the experiments measure overall TH levels in the brain, not specifically in neighboring DANs. The observed effect could be indirect via other neurons. 

      Indeed, we have now edited the text to: “This showed that DNT-2 could stimulate dopamine production”: page 8 line 208.

      (8) Figure 3: If Toll-6 is expressed in specific subtypes of PAM DANs, are they the dying cells when Toll-6 was knocked down? I think the paper will be significantly improved if the authors provide a more in-depth analysis of the phenotype. Also, permissive temperature controls are missing for the experiments in (E)-(H). Permissive controls are essential to confirm that the observed effects are due to adult-specific RNAi knockdown.

      Current tools do not enable us to visualise Toll-6+ neurons at the same time as manipulating DNT-2 neurons and at the same time as monitoring Dcp1. Stainings with Dcp1 in the adult brain are not trivial. Thus, we cannot guarantee this. However, Toll-6 is the preferential receptor for DNT-2, and given that apoptosis increases when we knock-down DNT-2, the most parsimonious interpretation is that the dying cells bear the DNT-2 receptor Toll-6. Even if DNT-2 can promiscuously bind other Toll receptors, the simplest way to interpret these data remains that DNT-2 promotes cell survival by signalling via its receptors, as no other possible route is known to date. This would be consistent with all other data in this figure.

      We thank this Reviewer for the feedback on the controls. Unfortunately, these are not trivial experiments, they require considerable time, effort, dedication and skill. This manuscript has already taken 5 years of daily hard work. We no longer have the staff (ie the first author left the lab) nor resources to dedicate to address this point.

      (9) Figure 4B: This phenotype in DNT-2 mutants is very striking. Did the neurons still survive and did their axonal innervation in the lobes remain intact?

      Homozygous DNT-2 mutants are viable and have impair climbing, as we had already shown in Figure 7C.

      (10) L261: The authors mention that "PAM-β2β′2 neurons express Toll-6 (Table S1)". However, I cannot find this information in Table S1. 

      Unfortunately, I cannot identify the source of that statement at present and the first authors has left the lab. In any case, although the fact that knocking down Toll-6 in these neurons causes a phenotype means they must, it does not directly prove it. We have now corrected this to: “PAM-b2b'2 neuron dendrites overlap axonal DNT2 projections”, page 11 line 280.

      (11) Figure 4C, D: What about their synaptogenesis? Do they agree with the result in Figure 4B? 

      This was not tested at the time. Unfortunately, these are not trivial experiments and require considerable time, effort, dedication and skill. Addressing this point experimentally is not possible for us at this point. In any case, given the evidence we already provide, it is highly unlikely they would alter the interpretation of our findings and the value of the discoveries already provided.

      (12) L270: The authors state: "To ask whether DNT-2 might affect axonal terminals, we tested PPL1 axons." However, it is unclear why the focus was shifted to PPL1 neurons when similar analyses could have been performed on PAM DANs for consistency. In addition, it would be beneficial to assess dendritic arbor complexity and synaptogenesis in PPL1-γ1-pedc neurons to provide a more comprehensive comparison between PPL1 and PAM DANs. Performing parallel analyses on both neuron types would strengthen the study by providing insight into the generality and specificity of DNT-2 in different dopaminergic circuits. 

      The question we addressed with Figure 4 was whether the DNT-2 and its receptors could modify axons, dendrites and synapses, ie all features of neuronal plasticity. The reason we used PPL1-g1-pedc to analyse axonal terminals was because of their morphology, which offered a clearer opportunity to visualise axonal endings than PAMs did. An exhaustive analysis of PPL1-g1-pedc is beyond the scope of this work and not the central focus.

      (13) Figure 4G lacks a permissive temperature control, which is essential to confirm that the observed effects are due to adult-specific RNAi knockdown. 

      We thank this Reviewer for this feedback, which we will bear in mind for future projects.

      (14) Figure 5A requires quantification and statistical comparison.

      We thank this Reviewer for this feedback. We did consider this, but the data are too variable to quantify and we decided it was best to present it simply as an observation, interesting nonetheless. This is consistent as well with the data in Figure 1, which we have now expanded with this revision, which show the natural variability in DNT-2 neurons.

      (15) Figure 5B: Many green signals in the control image are not labeled as PSDs, raising concerns about the accuracy of the image analysis methods used for synapse identification. While I trust that the authors have validated their analysis approach, it would strengthen the study if they provided a clearer description or evidence of the validation process. 

      This was done using the Imaris “Spot function”, in volume. A threshold is set to exclude spots due to GFP background and select only synaptic spots. The selection of spots and quantification are done automatically by Imaris. All spots below the threshold are excluded, regardless of genotype and experimental conditions, rendering the analysis objective. We have now provided a detailed description of the protocol in the Materials and Methods section: page 29 lines 778-799.

      (16) Figure 5C lacks genotype controls (i.e., DNT2-GAL4-only and UAS-TrpA1-only). These controls are essential because elevated temperatures alone, without activation of DNT2 neurons, could potentially increase Syt-GCaMP production, leading to an increase in the number of Syt+ synapses. Including these controls would help ensure that the observed effects are truly due to the activation of DNT2 neurons and not temperature-related artifacts. 

      We thank this Reviewer for this feedback, which we will bear in mind for future projects.

      (17) L314-316: The authors state, "Here, the coincidence of... revealed that newly formed synapses were stable." I think this statement needs to be toned down because there is no evidence that these pre- and post-synaptic sites are functionally connected. 

      The Reviewer is correct that our data did not visualise together, in the same preparation and specimen, both pre- and post-synaptic sites. Still, given that PAMs have already been proved by others to be required for locomotion, learning and long-term memory, our data strongly suggest that synapses between them at the SMP are functionally connected.

      Nevertheless, as we do not provide direct cellular evidence, we have now edited the text to tone down this claim: “Here, the coincidence of increased pre-synaptic Syt-GFP from PAMs and post-synaptic Homer-GFP from DNT-2 neurons at SMP suggests that newly formed synapses could be stable”, page 13 line 351.

      (18) Figure 5D lacks permissive temperature controls. Also, the DNT-2FL overexpression phenotypes are different from the TpA1 activation phenotypes. The authors may want to discuss this discrepancy. 

      Regarding the controls, these are not appropriate for this data set. These data were all taken at a constant temperature of 25°C, there were no shifts, and therefore do not require a permissive temperature control. We thank this Reviewer for drawing our attention to the fact that we made a mistake drawing the diagram, which we have now corrected in Figure 5D.

      Regarding the discrepancy, this had already been discussed in the Discussion section of the previously submitted version, page 19 Line 509-526. Presumably this Reviewer missed this before.

      (19) Figure 6A, B lack permissive temperature controls. These controls are important if the authors want to claim that the behavioral defects are due to adult-specific manipulations. In addition, there is no statistical difference between the PAM-GAL4 control and the RNAi knockdown group. The authors should be careful when stating that climbing was reduced in the RNAi knockdown flies (L341-342). 

      We thank this Reviewer for this feedback, which we will bear in mind for future projects.

      Point taken, but climbing of the tubGAL80ts, PAM>Toll-6RNAi flies was significantly different from that of the UAS-Toll-6RNAi/+ control.

      (20) Figure 6C: It seems that the DAN-GAL4 only control (the second group) also rescued the climbing defect. The authors may want to clarify this point. 

      The phenotype for this genotype was very variable, but certainly very distinct from that of flies over-expressing Toll-6[CY].

      We thank Reviewer 2 for their very thorough analysis of our paper that has helped improve the work.

      Reviewer #3 (Recommendations for the authors): 

      Overall, the manuscript reports highly interesting and mostly very convincing experiments. 

      We are very grateful to this Reviewer for their very positive evaluation of our work.

      Based on my comments under the heading "public review", I would like to suggest three possible improvements. 

      First, the quantification of structural plasticity at the sub-cellular level should be explained in more detail and potentially improved. For example, 3D reconstructions of individual neurons and quantification of the structure of boutons and dendrites could be undertaken. At present, it is not clear how bouton volumes are actually recorded accurately. 

      Thank you for the feedback. The analyses of dendrites and synapses were carried out in 3D-volumes using Imaris “Filament” module and “Spot function”, respectively. Dendrites are analysed semi-automatically, ie correcting potential branching errors of Imaris, and synapses are counted automatically, after setting appropriate thresholds. Details have now been expanded in the Materials and Sections section: page 28 lines 756-768 and page 29 lines 780-799.

      We would also like to thank Imaris for enabling and facilitating our remote working using their software during the Covid-19 pandemic, post-pandemic lockdowns and lab restrictions that spanned for over a year.

      Second, the variability between DNT-2A-positive neurons with increasing sample size compared to a control (DNT-2A-negative neurons) should be demonstrated. Figure 2C does currently not present convincing evidence of increased structural variability. 

      It is unclear what data the Reviewer refers to. Figure 2C shows qRT-PCR data, and it does not show structural variability, which instead is shown with microscopy. If it is the BacTrace data in Figure 2B, the controls had been provided and the data were unambiguous. If Reviewer means Figure 1C, it is unclear why DNT-2GAL4-negative flies are needed when the aim was to visualise normal (not genetically manipulated) DNT-2 neurons. Thus, unfortunately we do not understand what the point is here.

      The observation that DNT-2 neurons are very variable, naturally, is highly interesting, and presumably this is what drew the attention of Reviewer 3. We agree that showing further data in support of this is interesting and valuable. Thus, in response to this Reviewer’s comment we have now increased the number of images that demonstrate variability of DNT-2 neurons:

      (1) We have added an extra image, altogether providing three images in new Figure 1A showing three different individual brains stained with DNT-2GAL4>UAS-FlyBow1.1. These show common morphology and features, but different location of the somas and distinct detailed arborisation patterns. Two more images using DNT-2GAL4 are provided in Figure 5A.

      (2) We have now added two further MCFO images, altogether showing four examples where the somas are not always in the same location and the axons arborise consistently at the SMP, but the detailed projections are not identical: new Figure 1D.

      These data compellingly show natural variability in DNT-2 neuron morphology.

      Third, I propose to simplify the feedback model (Figure 2F) to be less speculative. 

      Indeed, some details in Figure 2F are speculative as we did not measure real dopamine levels. Accordingly, we have now edited this diagram, adding question marks to indicate speculative inference, to distinguish from the arrows that are grounded on the data we provide.

      Accordingly, we have also edited the text in:

      - page 9, lines 221: “Altogether, this shows that DNT-2 up-regulated TH levels (Figure 2E), and presumably via dopamine release, this inhibited cAMP in DNT-2A neurons (Figure 2F)”.

      - page 20, lines 515: “Importantly, we showed that activating DNT-2 neurons increased the levels and cleavage of DNT-2, up-regulated DNT-2 increased TH expression, and this initial amplification resulted in the inhibition of cAMP signalling via the dopamine receptor Dop2R in DNT-2 neurons.”

      As minor points: 

      (1) Appetitive olfactory learning is based on Tempel et al., (1983); Proc Natl Acad Sci U S A. 1983 Mar;80(5):1482-6. doi: 10.1073/pnas.80.5.1482. This paper should perhaps be cited. 

      Thank you for bringing this to our attention, we have now added this reference to page 14 line 394.

      (2) Line 34: I would add ..."ligand for Toll-6 AND KEK-6,". 

      Indeed, thank you, now corrected.

      (3) Line 39: DNT-2-POSITIVE NEURONS. 

      Now corrected, thank you.

      (4) The levels of TH mRNA were quantified. Why not TH or dopamine directly using antibodies, ELISA, or HPLC? After all, later it is explicitly written that DNT modulates dopamine levels (line 481)! 

      We thank this Reviewer for this suggestion. We did try with HPLC once, but the results were inconclusive and optimising this would have required unaffordable effort by us and our collaborators. Part of this work spanned over the pandemic and subsequent lockdowns and lab restrictions to 30% then 50% lab capacity that continued for one year, making experimental work extremely challenging. Although we were unable to carry out all the ideal experiments, the DNT-2-dependent increase in TH mRNA coupled with the EPAC-Dop2R data provided solid evidence of a DNT-2-dopamine link.

      (5) Line 271: The PPL1-g1-pedc neuron has mainly (but not excusively) a function in short-term memory! 

      They do, but others have also shown that PPL1-g1-pedc neurons have a gating function in long-term memory (Placais et al 2012; Placais et al 2017; Huang et al 2024) and are required for long-term memory (Adel and Griffith 2020; Boto et al 2020).

      (6) Line 401: Reward learning requires PAM neurons. PPL1 neurons are required for aversive learning. 

      Indeed, PPL1 neurons are required for aversive learning, but they also have a gating function in long-term memory common for both reward and aversive learning (Adel and Griffith, 2020 Neurosci Bull; Placais et al, 2012 Nature Neuroscience; Placais et al 2017 Nature Communications; Huang et al 2024 Nature).

      Overall, the manuscript presents extremely interesting, novel results, and I congratulate the authors on their findings. 

      We would like to thank this Reviewer for taking the time to scrutinise our work, their helpful feedback that has helped us improve the work and for their interest and positive and kind works.

    1. Author response:

      The following is the authors’ response to the original reviews.

      eLife Assessment

      The work is important and of potential value to areas other than the bone field because it supports a role and mechanism for beta-catenin that is novel and unusual. The findings are significant in that they support the presence of another anabolic pathway in bone that can be productively targeted for therapeutic goals. The data for the most part are convincing. The work could be strengthened by better characterizing the osteoclast KO of Malat1 related to the Lys cre model and by including biochemical markers of bone turnover from the mice.

      We thank the editors and reviewers for their time and their positive and insightful comments. We are pleased that the editors and reviewers were very enthusiastic, as stated in their Strength comments. We have performed experiments and addressed all of the points raised by the reviewers. We have revised the manuscript accordingly and the reviewers’ points are specifically addressed below. 

      Public Reviews:

      Reviewer #1 (Public Review):

      Summary

      The authors were trying to discover a novel bone remodeling network system. They found that an IncRNA Malat1 plays a central role in the remodeling by binding to β-catenin and functioning through the β-catenin-OPG/Jagged1 pathway in osteoblasts and chondrocytes. In addition, Malat1 significantly promotes bone regeneration in fracture healing in vivo. Their findings suggest a new concept of Malat1 function in the skeletal system. One significantly different finding between this manuscript and the competing paper pertains to the role of Malat1 in osteoclast lineage, specifically, whether Malat1 functions intrinsically in osteoclast lineage or not.

      Strengths:

      This study provides strong genetic evidence demonstrating that Malat1 acts intrinsically in osteoblasts while suppressing osteoclastogenesis in a non-autonomous manner, whereas the other group did not utilize relevant conditional knockout mice. As shown in the results, Malat1 knockout mouse exhibited abnormal bone remodeling and turnover. Furthermore, they elucidated molecular function of Malat1, which is sufficient to understand the phenotype in vivo.

      We are grateful to the reviewer for highlighting the novelty, strengths and significance of our work.

      Weaknesses:

      Discussing differences between previous paper and their status would be highly informative and beneficial for the field, as it would elucidate the solid underlying mechanisms.

      These points have been fully addressed in the point-to-point response below.

      Reviewer #2 (Public Review):

      Summary:

      The authors investigated the roles of IncRNA Malat1 in bone homeostasis which was initially believed to be non-functional for physiology. They found that both Malat1 KO and conditional KO in osteoblast lineage exhibit significant osteoporosis due to decreased osteoblast bone formation and increased osteoclast resorption. More interestingly they found that deletion of Malat1 in osteoclast lineage cells does not affect osteoclast differentiation and function. Mechanistically, they found that Malat1 acts as a co-activator of b-Catenin directly regulating osteoblast activity and indirectly regulating osteoclast activity via mediating OPG, but not RANKL expression in osteoblast and chondrocyte. Their discoveries establish a previously unrecognized paradigm model of Malat1 function in the skeletal system, providing novel mechanistic insights into how a lncRNA integrates cellular crosstalk and molecular networks to fine-tune tissue homeostasis, and remodeling.

      Strengths:

      The authors generated global and conditional KO mice in osteoblast and osteoclast lineage cells and carefully analyzed the role of Matat1 with both in vivo and in vitro systems. The conclusion of this paper is mostly well supported by data.

      We are grateful to the reviewer for highlighting the novelty, strengths and significance of our work.

      Weaknesses:

      More objective biological and biochemical analyses are required.

      These points have been fully addressed in the point-to-point response below.

      Reviewer #3 (Public Review):

      Summary:

      In this manuscript, Qin and colleagues study the role of Malat1 in bone biology. This topic is interesting given the role of lncRNAs in multiple physiologic processes. A previous study (PMID 38493144) suggested a role for Malat1 in osteoclast maturation. However, the role of this lncRNA in osteoblast biology was previously not explored. Here, the authors note osteopenia with increased bone resorption in mice lacking Malat1 globally and in osteoblast lineage cells. At the mechanistic level, the authors suggest that Malat1 controls beta-catenin activity. These results advance the field regarding the role of this lncRNA in bone biology.

      Strengths:

      The manuscript is well-written and data are presented in a clear and easily understandable manner. The bone phenotype of osteoblast-specific Malat1 knockout mice is of high interest. The role of Malat1 in controlling beta-catenin activity and OPG expression is interesting and novel.

      We are grateful to the reviewer for highlighting the novelty, strengths and significance of our work.

      Weaknesses:

      The lack of a bone phenotype when Malat1 is deleted with LysM-Cre is of interest given the previous report suggesting a role for this lncRNA in osteoclasts. However, to interpret the findings here, the authors should investigate the deletion efficiency of Malat1 in osteoclast lineage cells in their model. The data in the fracture model in Figure 8 seems incomplete in the absence of a more complete characterization of callus histology and a thorough time course. The role of Malat1 and OPG in chondrocytes is unclear since the osteocalcin-Cre mice (which should retain normal Malat1 levels in chondrocytes) have similar bone loss as the global mutants.

      These points have been fully addressed in the point-to-point response below.

      Recommendations for the authors:

      Reviewing Editor (Recommendations For The Authors):

      There are several suggestions for improving the manuscript, and we hope that you will review the recommendations carefully and make changes to the paper to address the concerns raised. Suggestions have been made to better characterize the osteoclast KO of Malat1 related to the Lys cre model as well as suggestions to include biochemical markers of bone turnover from your mice.

      These points have been fully addressed in the point-to-point response below.

      Reviewer #1 (Recommendations For The Authors):

      (1) Replicate numbers in Figure 3 should be noted.

      We thank the reviewer for this point. The experiments in Fig. 3 have been replicated three times, which is now noted in the figure legend.

      (2) It is novel to identify OPG expression in chondrocytes. More discussion is expected.

      Yes, a paragraph regarding this point has been added to the Discussion section.  

      Reviewer #2 (Recommendations For The Authors):

      (1) It is better to show serum osteoblast bone formation marker and osteoclast resorption marker, such as P1NP and CTx, in both Malat1 KO and osteoblast conditional KO mice.

      We thank the reviewer for this important point. Since CTx values are often influenced by food intake, we measured serum TRAP levels, which also reflect changes in osteoclastic bone resorption. We have observed that the serum osteoblastic bone formation marker P1NP was decreased, while osteoclastic bone resorption marker TRAP was increased, in both Malat1<sup>-/-</sup> and Malat1<sup>ΔOcn</sup> mice. These changes in serum biochemical markers of bone turnover are consistent with the bone phenotype caused by Malat1 deficiency. The new data are shown in Fig.1i, Fig. 2e, and Fig.5b.    

      (2) in vitro osteoblast differentiation assay is required to further confirm Malat1 regulates osteoblast differentiation.

      We thank the reviewer for this suggestion. As recommended, we have performed in vitro osteoblast differentiation multiple times using calvarial cells, a commonly used system in the field. However, we observed big variability in the culture results across different experimental batches, whether conducted by different scientists or the same individual. This variability is likely due to differences in the purity of the cultured cells, as literature shows that the current culture system in the field contains a mixture of tissue cells, including not only osteoblasts but also other cells, such as stromal and hematopoietic lineage cells (DOI: 10.1002/jbmr.4052). We hope to test osteoblast differentiation using a purer culture system once it becomes available in the field. In contrast, our in vivo data, indicated by multiple parameters, show consistent osteoblast and bone formation phenotypes across a large number of mice. Therefore, the in vivo results in our study strongly support our conclusion regarding Malat1's role in osteoblastic bone formation.

      (3) The authors found that Matat1 regulates osteoclast activity through OPG expression not only in osteoblasts, but also in chondrocytes and concluded that chondrocyte is involved in the crosstalk with osteoclast lineage cells in marrow. This is a very novel finding. Do the authors have any in vivo data to support this point, such as deleting Malat1 in chondrocyte lineage cells with chondrocyte-specific Cre?

      We appreciate the reviewer for highlighting our novel findings and providing valuable suggestions. Given the considerable time required to generate chondrocyte-specific conditional KO mice, we plan to thoroughly investigate the crosstalk between chondrocytes and osteoclasts via Malat1 in vivo in our next project.

      Reviewer #3 (Recommendations For The Authors):

      (1) Ideally would show male and female data side by side in the main text figures

      We thank the reviewer for this suggestion. The male and female data are now displayed side by side in Fig. 1b. 

      (2) The sample size for the in vivo datasets is quite large. A power calculation should be provided to better understand how the authors decided to analyze so many mice.

      Due to staff turnover during the pandemic, the first authors and several co-authors were involved in breeding the mice and collecting and analyzing bone samples. To avoid bias in sample selection, we pooled all the samples, resulting in a highly consistent phenotype across mice. This robust approach further strengthens our conclusion. 

      (3) The candidate gene approach to look at beta-catenin is a bit random, it would be ideal to assess Malat1 binding proteins in osteoblasts in an unbiased way. Also, does Malat1 bind bcatenin in other cell types? The importance of this point is further underscored by ref 47 which indicates that Malat binds TEAD3.

      As β-catenin is a key regulator in osteoblasts, we believe that studying the interaction between β-catenin and Malat1 is not random. Instead, this approach is well-founded and based on established knowledge in the field (as discussed below). In parallel, we are investigating genome-wide Malat1-bound targets beyond β-catenin, which will be reported in future studies. 

      More detailed points have been discussed in the manuscript: 

      Given that we identified Malat1 as a critical regulator in osteoblasts, we sought to investigate the mechanisms underlying the regulation of osteoblastic bone formation by Malat1. β-catenin is a central transcriptional factor in canonical Wnt signaling pathway, and plays an important role in positively regulating osteoblast differentiation and function (28-33). Upon stimulation, most notably from canonical Wnt ligands, β-catenin is stabilized and translocates into the nucleus, where it interacts with coactivators to activate target gene transcription. Previous reports observed a link between Malat1 and β-catenin signaling pathway in cancers (34,35), but the underlying molecular mechanisms in terms of how Malat1 interacts with β-catenin and regulates its nuclear retention and transcriptional activity are unclear. 

      Ref47 tested Malat1 binding to Tead3 in osteoclasts. However, a key difference between our findings and those of Ref47 is that both our in vitro and in vivo data, using myeloid osteoclastspecific conditional Malat1 KO mice, do not support an intrinsically significant role for Malat1 in osteoclasts. 

      (4) The statement on page 6 concluding that Malat acts as a scaffold to tether β-catenin in the nucleus is not supported by data in Fig 3d demonstrating that b-catenin nucleus translocation in response to Wnt3a is similar in control and Malat-deficient cells.

      The experiment in Fig. 3d is not designed to demonstrate Malat1 and β-catenin binding, but it is essential as the result rules out the possibility that Malat1 may affect β-catenin nuclear translocation. Moreover, we have utilized two robust approaches, CHIRP and RIP, to demonstrate that Malat1 acts as a scaffold to tether β-catenin in the nucleus (Fig. 3a, b, c, Supplementary Fig. 3). 

      (5) Figure 4e: can the authors show Malat deletion efficiency in the LysM-Cre model? This is important in light of the negative data in this figure and ref 47 which claims an osteoclast intrinsic role for Malat

      We thank the reviewer for this suggestion. The deletion efficiency of Malat1 in the LysM-Cre mice is very high (>90%). This data is now presented in Fig. 4e. 

      (6) Figure 5: since the magnitude of the effects on osteoclasts at the histology level are mild, it would be nice to also look at serum markers of bone resorption (CTX)

      The magnitude of osteoclast changes at the histological level in Fig. 5 is not mild in our view, as we observe 25-30% changes with statistical significance in the osteoclast parameters of Malat1ΔOcn mice. Since CTx values are often influenced by food intake, we measured serum TRAP levels, which reflect changes in osteoclastic bone resorption. As shown in Fig.5b, serum TRAP levels are significantly elevated in Malat1<sup>ΔOcn</sup> mice compared to control mice.

      (7) Data showing chondrocytic expression of OPG is not as novel as the authors claim. Should think about growth plate versus articular sources of OPG. Growth plate chondrocytes express OPG to regulate osteoclasts in the primary spongiosa which resorb mineralized cartilage.

      In the present study, we do not focus on comparing the sources of OPG from the chondrocytes in the growth plate versus articular cartilage. The novelty of our work lies in the discovery that Malat1 links chondrocyte and osteoclast activities through the β-catenin-OPG/Jagged1 axis. This Malat1-β-catenin-OPG/Jagged1 axis represents a novel mechanism regulating the crosstalk between chondrocytes and osteoclasts. 

      (8) The relevance of the chondrocyte role of Malat is unclear since the bone phenotype in global and osteocalcin-Cre mice is similar.

      Bone mass was decreased by 20% in Malat1<sup>ΔOcn</sup> mice, while a 30% reduction was observed in global KO (Malat1<sup>-/-</sup>) mice. This difference indicates potential contributions from other cell types, such as chondrocytes, and our results in Fig. 6 further support the impact of chondrocytes in Malat1's regulation of bone mass. We plan to thoroughly investigate the crosstalk between chondrocytes and osteoclasts via Malat1 in vivo in our next project.

      (9) Fracture data in Figure 8 seems incomplete, it would be ideal to support micro CT with histology and look at multiple time points.

      We thank the reviewer for this suggestion. We have performed histological analysis of our samples, and found that Malat1 promotes bone healing in the fracture model (Fig. 8f), which is consistent with our μCT data.

    1. Author response:

      The following is the authors’ response to the previous reviews.

      Reviewer #1 (Public Review):

      In this revision, the authors significantly improved the manuscript. They now address some of my concerns. Specifically, they show the contribution of end-effects on spreading the inputs between dendrites. This analysis reveals greater applicability of their findings to cortical cells, with long, unbranching dendrites than other neuronal types, such as Purkinje cells in the cerebellum.

      They now explain better the interactions between calcium and voltage signals, which I believe improve the take-away message of their manuscript. They modified and added new figures that helped to provide more information about their simulations.

      However, some of my points remain valid. Figure 6 shows depolarization of ~5mV from -75. This weak depolarization would not effectively recruit nonlinear activation of NMDARs. In their paper, Branco and Hausser (2010) showed depolarizations of ~10-15mV.

      More importantly, the signature of NMDAR activation is the prolonged plateau potential and activation at more depolarized resting membrane potentials (their Figure 4). Thus, despite including NMDARs in the simulation, the authors do not model functional recruitment of these channels. Their simulation is thus equivalent to AMPA only drive, which can indeed summate somewhat nonlinearly.

      In the current study, we used short sequences of 5 inputs, since the convergence of longer sequences is extremely unlikely in the network configurations we have examined. This resulted in smaller EPSP amplitudes of ~5mV (Figure 6 - Supplement 2A, B). Longer sequences containing 9 inputs resulted in larger somatic depolarizations of ~10mV (Figure 6 - Supplement 2E, F). Although we had modified the (Branco, Clark, and Häusser 2010) model to remove the jitter in the timing of arrival of inputs and made slight modifications to the location of stimulus delivery on the dendrite, we saw similar amplitudes when we tested a 9-length sequence using (Branco, Clark, and Häusser 2010)’s published code (Figure 6 - Supplement 2I, J). In all the cases we tested (5 input sequence, 9 input sequence, 9 input sequence with (Branco, Clark, and Häusser 2010) code repository), removal of NMDA synapses lowered both the somatic EPSPs (Figure 6 - Supplement 2C,D,G,H,K,L) as well as the selectivity (measured as the difference between the EPSPs generated for inward and outward stimulus delivery) (Figure 6 Supplement 2M,N,O). Further, monitoring the voltage along the dendrite for a sequence of 5 inputs showed dendritic EPSPs in the range of 20-45 mV (Figure 6 - Supplement 2P, Q), which came down notably (10-25mV) when NMDA synapses were abolished (Figure 6 - Supplement 2R, S). Thus, even sequences containing as few as 5 inputs were capable of engaging the NMDA-mediated nonlinearity to show sequence selectivity, although the selectivity was not as strong as in the case of 9 inputs.

      Reviewer #1 (Recommendations for the authors):

      Minor points:

      Figure 8, what does the scale in A represent? I assume it is voltage, but there are no units. Figure 8, C, E, G, these are unconventional units for synaptic weights, usually, these are given in nS / per input.

      We have corrected these. The scalebar in 8A represents membrane potential in mV. The units of 8C,E,G are now in nS.

      Reviewer #2 (Public Review):

      Summary:

      If synaptic input is functionally clustered on dendrites, nonlinear integration could increase the computational power of neural networks. But this requires the right synapses to be located in the right places. This paper aims to address the question of whether such synaptic arrangements could arise by chance (i.e. without special rules for axon guidance or structural plasticity), and could therefore be exploited even in randomly connected networks. This is important, particularly for the dendrites and biological computation communities, where there is a pressing need to integrate decades of work at the single-neuron level with contemporary ideas about network function.

      Using an abstract model where ensembles of neurons project randomly to a postsynaptic population, back-of-envelope calculations are presented that predict the probability of finding clustered synapses and spatiotemporal sequences. Using data-constrained parameters, the authors conclude that clustering and sequences are indeed likely to occur by chance (for large enough ensembles), but require strong dendritic nonlinearities and low background noise to be useful.

      Strengths:

      (1) The back-of-envelope reasoning presented can provide fast and valuable intuition. The authors have also made the effort to connect the model parameters with measured values. Even an approximate understanding of cluster probability can direct theory and experiments towards promising directions, or away from lost causes.

      (2) I found the general approach to be refreshingly transparent and objective. Assumptions are stated clearly about the model and statistics of different circuits. Along with some positive results, many of the computed cluster probabilities are vanishingly small, and noise is found to be quite detrimental in several cases. This is important to know, and I was happy to see the authors take a balanced look at conditions that help/hinder clustering, rather than to just focus on a particular regime that works.

      (3) This paper is also a timely reminder that synaptic clusters and sequences can exist on multiple spatial and temporal scales. The authors present results pertaining to the standard `electrical' regime (~50-100 µm, <50 ms), as well as two modes of chemical signaling (~10 µm, 100-1000 ms). The senior author is indeed an authority on the latter, and the simulations in Figure 5, extending those from Bhalla (2017), are unique in this area. In my view, the role of chemical signaling in neural computation is understudied theoretically, but research will be increasingly important as experimental technologies continue to develop.

      Weaknesses:

      (1) The paper is mostly let down by the presentation. In the current form, some patience is needed to grasp the main questions and results, and it is hard to keep track of the many abbreviations and definitions. A paper like this can be impactful, but the writing needs to be crisp, and the logic of the derivation accessible to non-experts. See, for instance, Stepanyants, Hof & Chklovskii (2002) for a relevant example.

      It would be good to see a restructure that communicates the main points clearly and concisely, perhaps leaving other observations to an optional appendix. For the interested but time-pressed reader, I recommend starting with the last paragraph of the introduction, working through the main derivation on page 7, and writing out the full expression with key parameters exposed. Next, look at Table 1 and Figure 2J to see where different circuits and mechanisms fit in this scheme. Beyond this, the sequence derivation on page 15 and biophysical simulations in Figures 5 and 6 are also highlights.

      We appreciate the reviewers' suggestions. We have tightened the flow of the introduction. We understand that the abbreviations and definitions are challenging and have therefore provided intuitions and summaries of the equations discussed in the main text.

      Clusters calculations

      Our approach is to ask how likely it is that a given set of inputs lands on a short segment of dendrite, and then scale it up to all segments on the entire dendritic length of the cell.

      Thus, the probability of occurrence of groups that receive connections from each of the M ensembles (PcFMG) is a function of the connection probability (p) between the two layers, the number of neurons in an ensemble (N), the relative zone-length with respect to the total dendritic arbor (Z/L) and the number of ensembles (M).

      Sequence calculations

      Here we estimate the likelihood of the first ensemble input arriving anywhere on the dendrite, and ask how likely it is that succeeding inputs of the sequence would arrive within a set spacing.

      Thus, the probability of occurrence of sequences that receive sequential connections (PcPOSS) from each of the M ensembles is a function of the connection probability (p) between the two layers, the number of neurons in an ensemble (N), the relative window size with respect to the total dendritic arbor (Δ/L) and the number of ensembles (M).

      (2) I wonder if the authors are being overly conservative at times. The result highlighted in the abstract is that 10/100000 postsynaptic neurons are expected to exhibit synaptic clustering. This seems like a very small number, especially if circuits are to rely on such a mechanism. However, this figure assumes the convergence of 3-5 distinct ensembles. Convergence of inputs from just 2 ense mbles would be much more prevalent, but still advantageous computationally. There has been excitement in the field about experiments showing the clustering of synapses encoding even a single feature.

      We agree that short clusters of two inputs would be far more likely. We focused our analysis on clusters with three of more ensembles because of the following reasons:

      (1) The signal to noise in these clusters was very poor as the likelihood of noise clusters is high.

      (2) It is difficult to trigger nonlinearities with very few synaptic inputs.

      (3) At the ensemble sizes we considered (100 for clusters, 1000 for sequences), clusters arising from just two ensembles would result in high probability of occurrence on all neurons in a network (~50% in cortex, see p_CMFG in figures below.). These dense neural representations make it difficult for downstream networks to decode (Foldiak 2003).

      However, in the presence of ensembles containing fewer neurons or when the connection probability between the layers is low, short clusters can result in sparse representations (Figure 2 - Supplement 2). Arguments 1 and 2 hold for short sequences as well.

      (3) The analysis supporting the claim that strong nonlinearities are needed for cluster/sequence detection is unconvincing. In the analysis, different synapse distributions on a single long dendrite are convolved with a sigmoid function and then the sum is taken to reflect the somatic response. In reality, dendritic nonlinearities influence the soma in a complex and dynamic manner. It may be that the abstract approach the authors use captures some of this, but it needs to be validated with simulations to be trusted (in line with previous work, e.g. Poirazi, Brannon & Mel, (2003)).

      We agree that multiple factors might affect the influence of nonlinearities on the soma. The key goal of our study was to understand the role played by random connectivity in giving rise to clustered computation. Since simulating a wide range of connectivity and activity patterns in a detailed biophysical model was computationally expensive, we analyzed the exemplar detailed models for nonlinearity separately (Figures 5, 6, and new figure 8), and then used our abstract models as a proxy for understanding population dynamics. A complete analysis of the role played by morphology, channel kinetics and the effect of branching requires an in-depth study of its own, and some of these questions have already been tackled by (Poirazi, Brannon, and Mel 2003; Branco, Clark, and Häusser 2010; Bhalla 2017). However, in the revision, we have implemented a single model which incorporates the range of ion-channel, synaptic and biochemical signaling nonlinearities which we discuss in the paper (Figure 8, and Figure 8 Supplement 1, 2,3). We use this to demonstrate all three forms of sequence and grouped computation we use in the study, where the only difference is in the stimulus pattern and the separation of time-scales inherent in the stimuli.

      (4) It is unclear whether some of the conclusions would hold in the presence of learning. In the signal-to-noise analysis, all synaptic strengths are assumed equal. But if synapses involved in salient clusters or sequences were potentiated, presumably detection would become easier? Similarly, if presynaptic tuning and/or timing were reorganized through learning, the conditions for synaptic arrangements to be useful could be relaxed. Answering these questions is beyond the scope of the study, but there is a caveat there nonetheless.

      We agree with the reviewer. If synapses receiving connectivity from ensembles had stronger weights, this would make detection easier. Dendritic spikes arising from clustered inputs have been implicated in local cooperative plasticity (Golding, Staff, and Spruston 2002; Losonczy, Makara, and Magee 2008). Further, plasticity related proteins synthesized at a synapse undergoing L-LTP can diffuse to neighboring weakly co-active synapses, and thereby mediate cooperative plasticity (Harvey et al. 2008; Govindarajan, Kelleher, and Tonegawa 2006; Govindarajan et al. 2011). Thus if clusters of synapses were likely to be co-active, they could further engage these local plasticity mechanisms which could potentiate them while not potentiating synapses that are activated by background activity. This would depend on the activity correlation between synapses receiving ensemble inputs within a cluster vs those activated by background activity. We have mentioned some of these ideas in a published opinion paper (Pulikkottil, Somashekar, and Bhalla 2021). In the current study, we wanted to understand whether even in the absence of specialized connection rules, interesting computations could still emerge. Thus, we focused on asking whether clustered or sequential convergence could arise even in a purely randomly connected network, with the most basic set of assumptions. We agree that an analysis of how selectivity evolves with learning would be an interesting topic for further work.

      References

      • Bhalla, Upinder S. 2017. “Synaptic Input Sequence Discrimination on Behavioral Timescales Mediated by Reaction-Diffusion Chemistry in Dendrites.” Edited by Frances K Skinner. eLife 6 (April):e25827. https://doi.org/10.7554/eLife.25827.

      • Branco, Tiago, Beverley A. Clark, and Michael Häusser. 2010. “Dendritic Discrimination of Temporal Input Sequences in Cortical Neurons.” Science (New York, N.Y.) 329 (5999): 1671–75. https://doi.org/10.1126/science.1189664.

      • Foldiak, Peter. 2003. “Sparse Coding in the Primate Cortex.” The Handbook of Brain Theory and Neural Networks. https://research-repository.st-andrews.ac.uk/bitstream/handle/10023/2994/FoldiakSparse HBTNN2e02.pdf?sequence=1.

      • Golding, Nace L., Nathan P. Staff, and Nelson Spruston. 2002. “Dendritic Spikes as a Mechanism for Cooperative Long-Term Potentiation.” Nature 418 (6895): 326–31. https://doi.org/10.1038/nature00854.

      • Govindarajan, Arvind, Inbal Israely, Shu-Ying Huang, and Susumu Tonegawa. 2011. “The Dendritic Branch Is the Preferred Integrative Unit for Protein Synthesis-Dependent LTP.” Neuron 69 (1): 132–46. https://doi.org/10.1016/j.neuron.2010.12.008.

      • Govindarajan, Arvind, Raymond J. Kelleher, and Susumu Tonegawa. 2006. “A Clustered Plasticity Model of Long-Term Memory Engrams.” Nature Reviews Neuroscience 7 (7): 575–83. https://doi.org/10.1038/nrn1937.

      • Harvey, Christopher D., Ryohei Yasuda, Haining Zhong, and Karel Svoboda. 2008. “The Spread of Ras Activity Triggered by Activation of a Single Dendritic Spine.” Science (New York, N.Y.) 321 (5885): 136–40. https://doi.org/10.1126/science.1159675.

      • Losonczy, Attila, Judit K. Makara, and Jeffrey C. Magee. 2008. “Compartmentalized Dendritic Plasticity and Input Feature Storage in Neurons.” Nature 452 (7186): 436–41. https://doi.org/10.1038/nature06725.

      • Poirazi, Panayiota, Terrence Brannon, and Bartlett W. Mel. 2003. “Pyramidal Neuron as Two-Layer Neural Network.” Neuron 37 (6): 989–99. https://doi.org/10.1016/S0896-6273(03)00149-1.

      • Pulikkottil, Vinu Varghese, Bhanu Priya Somashekar, and Upinder S. Bhalla. 2021. “Computation, Wiring, and Plasticity in Synaptic Clusters.” Current Opinion in Neurobiology, Computational Neuroscience, 70 (October):101–12. https://doi.org/10.1016/j.conb.2021.08.001.

    2. Author response:

      The following is the authors’ response to the previous reviews.

      Reviewer #1 (Public Review):

      In this revision, the authors significantly improved the manuscript. They now address some of my concerns. Specifically, they show the contribution of end-effects on spreading the inputs between dendrites. This analysis reveals greater applicability of their findings to cortical cells, with long, unbranching dendrites than other neuronal types, such as Purkinje cells in the cerebellum.

      They now explain better the interactions between calcium and voltage signals, which I believe improve the take-away message of their manuscript. They modified and added new figures that helped to provide more information about their simulations.

      However, some of my points remain valid. Figure 6 shows depolarization of ~5mV from -75. This weak depolarization would not effectively recruit nonlinear activation of NMDARs. In their paper, Branco and Hausser (2010) showed depolarizations of ~10-15mV.

      More importantly, the signature of NMDAR activation is the prolonged plateau potential and activation at more depolarized resting membrane potentials (their Figure 4). Thus, despite including NMDARs in the simulation, the authors do not model functional recruitment of these channels. Their simulation is thus equivalent to AMPA only drive, which can indeed summate somewhat nonlinearly.

      In the current study, we used short sequences of 5 inputs, since the convergence of longer sequences is extremely unlikely in the network configurations we have examined. This resulted in smaller EPSP amplitudes of ~5mV (Figure 6 - Supplement 2A, B). Longer sequences containing 9 inputs resulted in larger somatic depolarizations of ~10mV (Figure 6 - Supplement 2E, F). Although we had modified the (Branco, Clark, and Häusser 2010) model to remove the jitter in the timing of arrival of inputs and made slight modifications to the location of stimulus delivery on the dendrite, we saw similar amplitudes when we tested a 9-length sequence using (Branco, Clark, and Häusser 2010)’s published code (Figure 6 - Supplement 2I, J). In all the cases we tested (5 input sequence, 9 input sequence, 9 input sequence with (Branco, Clark, and Häusser 2010) code repository), removal of NMDA synapses lowered both the somatic EPSPs (Figure 6 - Supplement 2C,D,G,H,K,L) as well as the selectivity (measured as the difference between the EPSPs generated for inward and outward stimulus delivery) (Figure 6 Supplement 2M,N,O). Further, monitoring the voltage along the dendrite for a sequence of 5 inputs showed dendritic EPSPs in the range of 20-45 mV (Figure 6 - Supplement 2P, Q), which came down notably (10-25mV) when NMDA synapses were abolished (Figure 6 - Supplement 2R, S). Thus, even sequences containing as few as 5 inputs were capable of engaging the NMDA-mediated nonlinearity to show sequence selectivity, although the selectivity was not as strong as in the case of 9 inputs.

      Reviewer #1 (Recommendations for the authors):

      Minor points:

      Figure 8, what does the scale in A represent? I assume it is voltage, but there are no units. Figure 8, C, E, G, these are unconventional units for synaptic weights, usually, these are given in nS / per input.

      We have corrected these. The scalebar in 8A represents membrane potential in mV. The units of 8C,E,G are now in nS.

      Reviewer #2 (Public Review):

      Summary:

      If synaptic input is functionally clustered on dendrites, nonlinear integration could increase the computational power of neural networks. But this requires the right synapses to be located in the right places. This paper aims to address the question of whether such synaptic arrangements could arise by chance (i.e. without special rules for axon guidance or structural plasticity), and could therefore be exploited even in randomly connected networks. This is important, particularly for the dendrites and biological computation communities, where there is a pressing need to integrate decades of work at the single-neuron level with contemporary ideas about network function.

      Using an abstract model where ensembles of neurons project randomly to a postsynaptic population, back-of-envelope calculations are presented that predict the probability of finding clustered synapses and spatiotemporal sequences. Using data-constrained parameters, the authors conclude that clustering and sequences are indeed likely to occur by chance (for large enough ensembles), but require strong dendritic nonlinearities and low background noise to be useful.

      Strengths:

      (1) The back-of-envelope reasoning presented can provide fast and valuable intuition. The authors have also made the effort to connect the model parameters with measured values. Even an approximate understanding of cluster probability can direct theory and experiments towards promising directions, or away from lost causes.

      (2) I found the general approach to be refreshingly transparent and objective. Assumptions are stated clearly about the model and statistics of different circuits. Along with some positive results, many of the computed cluster probabilities are vanishingly small, and noise is found to be quite detrimental in several cases. This is important to know, and I was happy to see the authors take a balanced look at conditions that help/hinder clustering, rather than to just focus on a particular regime that works.

      (3) This paper is also a timely reminder that synaptic clusters and sequences can exist on multiple spatial and temporal scales. The authors present results pertaining to the standard `electrical' regime (~50-100 µm, <50 ms), as well as two modes of chemical signaling (~10 µm, 100-1000 ms). The senior author is indeed an authority on the latter, and the simulations in Figure 5, extending those from Bhalla (2017), are unique in this area. In my view, the role of chemical signaling in neural computation is understudied theoretically, but research will be increasingly important as experimental technologies continue to develop.

      Weaknesses:

      (1) The paper is mostly let down by the presentation. In the current form, some patience is needed to grasp the main questions and results, and it is hard to keep track of the many abbreviations and definitions. A paper like this can be impactful, but the writing needs to be crisp, and the logic of the derivation accessible to non-experts. See, for instance, Stepanyants, Hof & Chklovskii (2002) for a relevant example.

      It would be good to see a restructure that communicates the main points clearly and concisely, perhaps leaving other observations to an optional appendix. For the interested but time-pressed reader, I recommend starting with the last paragraph of the introduction, working through the main derivation on page 7, and writing out the full expression with key parameters exposed. Next, look at Table 1 and Figure 2J to see where different circuits and mechanisms fit in this scheme. Beyond this, the sequence derivation on page 15 and biophysical simulations in Figures 5 and 6 are also highlights.

      We appreciate the reviewers' suggestions. We have tightened the flow of the introduction. We understand that the abbreviations and definitions are challenging and have therefore provided intuitions and summaries of the equations discussed in the main text.

      Clusters calculations

      Our approach is to ask how likely it is that a given set of inputs lands on a short segment of dendrite, and then scale it up to all segments on the entire dendritic length of the cell.

      Thus, the probability of occurrence of groups that receive connections from each of the M ensembles (PcFMG) is a function of the connection probability (p) between the two layers, the number of neurons in an ensemble (N), the relative zone-length with respect to the total dendritic arbor (Z/L) and the number of ensembles (M).

      Sequence calculations

      Here we estimate the likelihood of the first ensemble input arriving anywhere on the dendrite, and ask how likely it is that succeeding inputs of the sequence would arrive within a set spacing.

      Thus, the probability of occurrence of sequences that receive sequential connections (PcPOSS) from each of the M ensembles is a function of the connection probability (p) between the two layers, the number of neurons in an ensemble (N), the relative window size with respect to the total dendritic arbor (Δ/L) and the number of ensembles (M).

      (2) I wonder if the authors are being overly conservative at times. The result highlighted in the abstract is that 10/100000 postsynaptic neurons are expected to exhibit synaptic clustering. This seems like a very small number, especially if circuits are to rely on such a mechanism. However, this figure assumes the convergence of 3-5 distinct ensembles. Convergence of inputs from just 2 ense mbles would be much more prevalent, but still advantageous computationally. There has been excitement in the field about experiments showing the clustering of synapses encoding even a single feature.

      We agree that short clusters of two inputs would be far more likely. We focused our analysis on clusters with three of more ensembles because of the following reasons:

      (1) The signal to noise in these clusters was very poor as the likelihood of noise clusters is high.

      (2) It is difficult to trigger nonlinearities with very few synaptic inputs.

      (3) At the ensemble sizes we considered (100 for clusters, 1000 for sequences), clusters arising from just two ensembles would result in high probability of occurrence on all neurons in a network (~50% in cortex, see p_CMFG in figures below.). These dense neural representations make it difficult for downstream networks to decode (Foldiak 2003).

      However, in the presence of ensembles containing fewer neurons or when the connection probability between the layers is low, short clusters can result in sparse representations (Figure 2 - Supplement 2). Arguments 1 and 2 hold for short sequences as well.

      (3) The analysis supporting the claim that strong nonlinearities are needed for cluster/sequence detection is unconvincing. In the analysis, different synapse distributions on a single long dendrite are convolved with a sigmoid function and then the sum is taken to reflect the somatic response. In reality, dendritic nonlinearities influence the soma in a complex and dynamic manner. It may be that the abstract approach the authors use captures some of this, but it needs to be validated with simulations to be trusted (in line with previous work, e.g. Poirazi, Brannon & Mel, (2003)).

      We agree that multiple factors might affect the influence of nonlinearities on the soma. The key goal of our study was to understand the role played by random connectivity in giving rise to clustered computation. Since simulating a wide range of connectivity and activity patterns in a detailed biophysical model was computationally expensive, we analyzed the exemplar detailed models for nonlinearity separately (Figures 5, 6, and new figure 8), and then used our abstract models as a proxy for understanding population dynamics. A complete analysis of the role played by morphology, channel kinetics and the effect of branching requires an in-depth study of its own, and some of these questions have already been tackled by (Poirazi, Brannon, and Mel 2003; Branco, Clark, and Häusser 2010; Bhalla 2017). However, in the revision, we have implemented a single model which incorporates the range of ion-channel, synaptic and biochemical signaling nonlinearities which we discuss in the paper (Figure 8, and Figure 8 Supplement 1, 2,3). We use this to demonstrate all three forms of sequence and grouped computation we use in the study, where the only difference is in the stimulus pattern and the separation of time-scales inherent in the stimuli.

      (4) It is unclear whether some of the conclusions would hold in the presence of learning. In the signal-to-noise analysis, all synaptic strengths are assumed equal. But if synapses involved in salient clusters or sequences were potentiated, presumably detection would become easier? Similarly, if presynaptic tuning and/or timing were reorganized through learning, the conditions for synaptic arrangements to be useful could be relaxed. Answering these questions is beyond the scope of the study, but there is a caveat there nonetheless.

      We agree with the reviewer. If synapses receiving connectivity from ensembles had stronger weights, this would make detection easier. Dendritic spikes arising from clustered inputs have been implicated in local cooperative plasticity (Golding, Staff, and Spruston 2002; Losonczy, Makara, and Magee 2008). Further, plasticity related proteins synthesized at a synapse undergoing L-LTP can diffuse to neighboring weakly co-active synapses, and thereby mediate cooperative plasticity (Harvey et al. 2008; Govindarajan, Kelleher, and Tonegawa 2006; Govindarajan et al. 2011). Thus if clusters of synapses were likely to be co-active, they could further engage these local plasticity mechanisms which could potentiate them while not potentiating synapses that are activated by background activity. This would depend on the activity correlation between synapses receiving ensemble inputs within a cluster vs those activated by background activity. We have mentioned some of these ideas in a published opinion paper (Pulikkottil, Somashekar, and Bhalla 2021). In the current study, we wanted to understand whether even in the absence of specialized connection rules, interesting computations could still emerge. Thus, we focused on asking whether clustered or sequential convergence could arise even in a purely randomly connected network, with the most basic set of assumptions. We agree that an analysis of how selectivity evolves with learning would be an interesting topic for further work.

      References

      Bhalla, Upinder S. 2017. “Synaptic Input Sequence Discrimination on Behavioral Timescales Mediated by Reaction-Diffusion Chemistry in Dendrites.” Edited by Frances K Skinner. eLife 6 (April):e25827. https://doi.org/10.7554/eLife.25827.

      Branco, Tiago, Beverley A. Clark, and Michael Häusser. 2010. “Dendritic Discrimination of Temporal Input Sequences in Cortical Neurons.” Science (New York, N.Y.) 329 (5999): 1671–75. https://doi.org/10.1126/science.1189664.

      Foldiak, Peter. 2003. “Sparse Coding in the Primate Cortex.” The Handbook of Brain Theory and Neural Networks. https://research-repository.st-andrews.ac.uk/bitstream/handle/10023/2994/FoldiakSparse HBTNN2e02.pdf?sequence=1.

      Golding, Nace L., Nathan P. Staff, and Nelson Spruston. 2002. “Dendritic Spikes as a Mechanism for Cooperative Long-Term Potentiation.” Nature 418 (6895): 326–31. https://doi.org/10.1038/nature00854.

      Govindarajan, Arvind, Inbal Israely, Shu-Ying Huang, and Susumu Tonegawa. 2011. “The Dendritic Branch Is the Preferred Integrative Unit for Protein Synthesis-Dependent LTP.” Neuron 69 (1): 132–46. https://doi.org/10.1016/j.neuron.2010.12.008.

      Govindarajan, Arvind, Raymond J. Kelleher, and Susumu Tonegawa. 2006. “A Clustered Plasticity Model of Long-Term Memory Engrams.” Nature Reviews Neuroscience 7 (7): 575–83. https://doi.org/10.1038/nrn1937.

      Harvey, Christopher D., Ryohei Yasuda, Haining Zhong, and Karel Svoboda. 2008. “The Spread of Ras Activity Triggered by Activation of a Single Dendritic Spine.” Science (New York, N.Y.) 321 (5885): 136–40. https://doi.org/10.1126/science.1159675.

      Losonczy, Attila, Judit K. Makara, and Jeffrey C. Magee. 2008. “Compartmentalized Dendritic Plasticity and Input Feature Storage in Neurons.” Nature 452 (7186): 436–41. https://doi.org/10.1038/nature06725.

      Poirazi, Panayiota, Terrence Brannon, and Bartlett W. Mel. 2003. “Pyramidal Neuron as Two-Layer Neural Network.” Neuron 37 (6): 989–99. https://doi.org/10.1016/S0896-6273(03)00149-1.

      Pulikkottil, Vinu Varghese, Bhanu Priya Somashekar, and Upinder S. Bhalla. 2021. “Computation, Wiring, and Plasticity in Synaptic Clusters.” Current Opinion in Neurobiology, Computational Neuroscience, 70 (October):101–12. https://doi.org/10.1016/j.conb.2021.08.001.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Reviewer #1:

      Reviewer #1 was very appreciative of our results and commented “This is a novel result in ferredoxin and a significant contribution to the field”. We are very honored and pleased.

      Reviewer #2:

      (1) Changing the nomenclature of the models investigated to include the oxidation state being discussed. As they are now (CM, CMNA, etc), multiple re-reads were required to ascertain which redox state was being discussed for a particular model in a given section of the text. Appending "Ox" or "Red" for oxidized or reduced would be sufficient. 

      As you indicated there are several nomenclatures to distinguish the model systems in the text. On the other hand, the main issue discussed in the text is the ionization potential (IP), which is calculated by the difference in energies between oxidized and reduced states for each model. In other words, a discussion of the IP value on each model includes both the “Ox” and “Red” energies. In order to clarify the relationship between the nomenclature of models and redox states, we added sentences below.

      “Note that the IP value is obtained for each model by calculating both the Ox and Red state energies of the model.” (lines 195-196).

      On the other hand, we must specify the charge state when the geometry optimization is performed for CM and CMH models. Therefore, we revised the sentence as follows.

      “The decrease in |IP| value indicates that the relative stability of the Red state is suppressed compared with the CMH but is significantly larger than the CM, suggesting the importance of the protonation of Asp64 (Fig. S2B). 

      To consider the effect of the structural change caused by the redox on the IP, geometrical optimization of the 4Fe-4S core was performed for the CM (Red) and CMH (Red) models using the same level of theory to the single-point calculations. The optimized Cartesian coordinates are summarized in Table S3. As illustrated in Fig. S2A, the IP values of CM and CMH change from –3.27 to –2.38 eV (|DIP| = 0.89 eV), and from –1.06 to –0.19 eV (|DIP| = 0.87 eV), respectively, before and after the geometrical optimization.” (lines 224-232)

      (2) In addition to the very thorough DFT investigation of the different spin and charge combinations, did the authors try a broken-symmetry calculation to obtain the ground state description of the FeS cluster? Given the ubiquity of this approach in other FeS cluster studies, it was surprising that this approach was not taken here. Granted, the DFT investigation of each possible combination is sufficiently thorough and need not be redone. 

      Thank you for your comments. A term “spin-unrestricted method”, which is used in the manuscript in the text is synonym of “broken-symmetry method”. In order to emphasize this, we revised the manuscript as follows. 

      “All calculations were performed by using the spin-unrestricted (broken-symmetry) hybrid DFT method with the B3LYP functional set. As the basis set, 6-31G* and 6-31+G* were used for [Fe, C, N, O, H] and [S] atoms, respectively, for the IP calculations.” (Line 451)

      (3) Line 161 "an" to "a" 

      We corrected the mistake. Thank you so much. (Line 161)

      (4) Figure 4A seems a bit odd. Why do the traces eclipse the y-axis? And the traces between 330 and 370 nm are much noisier and appear thicker than the rest of the plot. Is this an issue with the monochromator grating used in wavelength selection? Reducing the thickness of the individual traces may help the data presentation in this figure. Also, the arrows on the plot have an opaque white background. Can this be removed so that the arrows do not eclipse the traces in the plot? 

      The spectrum in the Fig.4A seemed to be odd. The spectral figure has been revised to improve its appearance. (We have also corrected E53A in Figure 5B.) This reviewer also pointed out that “the traces between 330 and 370 nm are much noisier”. We are struggling with the noise caused by the grating (or the motor malfunction) of the monochromator as you pointed out. Once the monochromator is repaired and a smooth spectrum is obtained, we will upload further revisions.

      (5) Figure S9 is a very nice schematic illustrating the general findings of the study. Can this be moved to the main text?

      Thank you for your helpful comment. Accordingly, the Fig.9S and its legend are moved to the main text. (Lines 675-680)

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public Review):

      This manuscript by Bai et al concerns the expression of Scleraxis (Scx) by muscle satellite cells (SCs) and the role of that gene in regenerative myogenesis. The authors report the expression of this gene associated with tendon development in satellite cells. Genetic deletion of Scx in SCs impairs muscle regeneration, and the authors provide evidence that SCs deficient in Scx are impaired in terms of population growth and cellular differentiation. Overall, this report provides evidence of the role of this gene, unexpectedly, in SC function and adult regenerative myogenesis.

      We appreciate the comments and thank her/him for the support.

      There are a few minor points of concern.

      (1) From the data in Figure 1, it appears that all of the SCs, assessed both in vitro and in vivo, express Scx. The authors refer to a scRNA-seq dataset from their lab and one report from mdx mouse muscle that also reveals this unexpected gene expression pattern. Has this been observed in many other scRNA-seq datasets? If not, it would be important to discuss potential explanations as to why this has not been reported previously.

      Thanks for this question regarding data in Fig.1. We did initially use immunofluorescence staining of Pax7 and GFP on muscle sections and primary myoblast cultures prepared from Tg-ScxGFP mice to conclude that Scx was expressed in satellite cells (SCs). In addition to the cited mdx RNA-seq data, we have included a re-analysis of a published scRNA-seq data set in Fig.2E (Dell'Orso et al., Development, 2019), and our own scRNA-seq data (Fig.S5D, F). We have now re-examined an additional scRNA-seq data set of TA muscles at various regeneration time points (De Micheli et al., Cell Rep. 2020), in which Scx expression was detected in MuSC progenitors and mature muscle cells. We have added the De Micheli et al. reference and the re-analysis of that scRNA-seq data set for Scx expression as an additional panel in Fig. 2E, with accompanying text (p. 7, ln. 4-6). Thus, our immunostaining results are consistent with scRNA-seq data from our and two other independent scRNA-seq data sets.

      We think that Scx expression in the adult myogenic lineage was not previously reported mainly because its expression level was low, and might be dismissed as spurious detection. Additionally, detecting such low expression levels requires sophisticated detection methods with high capture efficiency. Previous studies have noted limitations in transcript capture or transcription factor dropout in 10x Genomics-based datasets (Lambert et al., Cell, 2018; Pokhilko et al., Genome Res., 2021). The most likely and straightforward reason is that Scx was simply not a focus in prior studies amid so many other genes of interest. We have now added this last explanation in the text (p.7, ln. 8-9), following the re-analyses of Scx expression in published scRNA-seq data sets.

      (2) A major point of the paper, as illustrated in Fig. 3, is that Scx-neg SCs fail to produce normal myofibers and renewed SCs following injury/regeneration. They mention in the text that there was no increased PCD by Caspase staining at 5 DPI. A failure of cell survival during the process of SC activation, proliferation, and cell fate determination (differentiation versus self-renewal) would explain most of the in vivo data. As such, this conclusion would seem to warrant a more detailed analysis in terms of at least one or two other time points and an independent method for detecting dead/dying cells (the in vitro data in Fig. 4F is also based on an assessment of activated Caspase to assess cell death). The in vitro data presented later in Fig. S4G, H do suggest an increase in cell loss during proliferative expansion of Scx-neg SCs. To what extent does cell loss (by whatever mechanism of cell death) explain both the in vivo findings of impaired regeneration and even the in vitro studies showing slower population expansion in the absence of Scx?

      We appreciate these constructive suggestions. Based on the number of available control and cKO animals, we were limited to one additional time point at 3 dpi to assess PCD by TUNEL in vivo. We were disappointed again to find no appreciable levels of PCD at 3 dpi by TUNEL (new Fig.S4I), thus no quantifications were included. We also re-did the in vitro experiment using purified SCs and monitored PCD by staining for cleaved Caspase-3 using a validated tube of antibodies (positive staining after 6 h of treatment by 1 mM staurosporine of control and ScxcKO cells; included as new Fig. S4J and legend). We were pleased to find an increase of cleaved Caspase3 stained cells, i.e. PCD, of Scx-cKO SCs at day 4 in culture, compared to that of the control. We have now replaced the old Fig. 4F with new Fig.4F and 4G to document PCD. We also provided new text/legend for these new data (p.10. ln. 2-10; new legend for Fig. 4F and 4G).

      (3) I'm not sure I understand the description of the data or the conclusions in the section titled "Basement membrane-myofiber interaction in control and Scx cKO mice". Is there something specific to the regeneration from Scx-neg myogenic progenitors, or would these findings be expected in any experimental condition in which myogenesis was significantly delayed, with much smaller fibers in the experimental group at 5 DPI?

      We very much appreciate this comment. We agree that there is unlikely anything specific about the regeneration from Scx-negative myogenic progenitors. Unfilled or empty ghost fibers (basement membrane remnant) are expected due to small fiber and poor regeneration in the ScxcKO mice at 5 dpi. We have removed the subtitle and changed the content to an expected consequence rather than something special (p. 8, ln. 19-22).

      (4) The data presented in Fig. 4B showing differences in the purity of SC populations isolated by FACS depending on the reporter used are interesting and important for the field. The authors offer the explanation of exosomal transfer of Tdt from SCs to non-SCs. The data are consistent with this explanation, but no data are presented to support this. Are there any other explanations that the authors have considered and that could be readily tested?

      Thanks for highlighting this phenomenon. We struggled with the SC purity issue for a long time. The project started with using the R26RtdT reporter for tdT’s paraformaldehyde  resistant strong fluorescence (fixation) to aid visualization in vivo. Later, when we used the tdT signal to purify SCs by FACS, we found that only 80% sorted tdT+ cells are Pax7+. We then switched to the R26RYFP reporter, from which we achieved much higher purity (95%) of SCs (Pax7+) by FACS. As such, we also repeated and confirmed many in vivo experimental results using the R26RYFP reporter (included in the manuscript). Due to the low purity of tdT+SCs by FACS, we discontinued that mouse colony after we confirmed the superior utility of the R26RYFP reporter for SC isolation.

      We sincerely apologize for not being able to conduct further testable experiments on this intriguing phenomenon. However, this issue has since been addressed and published by Murach et al., iScience, (2021). Like our experience, they found non-satellite mononuclear cells with tdT fluorescence after TMX treatment when SCs were isolated via FACS. To determine this was not due to off-target recombination or a technical artifact from tissue processing, they conducted extensive analyses. They found that the tdT+ mononuclear cells included fibrogenic cells (fibroblasts and FAPs), immune cells/macrophages, and endothelial cells. Additionally, they confirmed the significant potential of extracellular vesicle (EV)-mediated cargo transfer, which facilitates the transfer of full-length tdT transcript from lineage-marked Pax7+ cells to those mononuclear cells. We have modified the text to emphasize and acknowledge their contribution to this important point, and explained the difference between YFP and tdT reporter alleles in more detail (p.9, ln. 11-17).

      (5) The Cut&Run data of Fig. 6 certainly provide evidence of direct Scx targets, especially since the authors used a novel knock-in strain for analyses. The enrichment of E-box motifs provides support for the 207 intersecting genes (scRNA-seq and Cut&Run) being direct targets. However, the rationale elaborated in the final paragraph of the Results section proposing how 4 of these genes account for the phenotypes on the Scx-neg cells and tissues is just speculation, however reasonable. These are not data, and these considerations would be more appropriate in the Discussion in the absence of any validation studies.

      We agree with this comment and have moved speculations into the Discussion (p. 15, ln. 4-15, and from p. 18, ln. 4 to p. 19, ln. 4).

      Reviewer #2 (Public Review):

      Summary:

      Scx is a well-established marker for tenocytes, but the expression in myogenic-lineage cells was unexplored. In this study, the authors performed lineage-trace and scRNA-seq analyses and demonstrated that Scx is expressed in activated SCs. Further, the authors showed that Scx is essential for muscle regeneration using conditional KO mice and identified the target genes of Scx in myogenic cells, which differ from those of tendons.

      Strengths:

      Sometimes, lineage-trace experiments cause mis-expression and do not reflect the endogenous expression of the target gene. In this study, the authors carefully analyzed the unexpected expression of Scx in myogenic cells using some mouse lines and scRNA-seq data.

      We appreciate the comments and thank her/him for noting the strengths of our manuscript.

      Weaknesses:

      Scx protein expression has not been verified.

      We are aware of this weakness. We had previously used Western blotting (WB) using cultured SCs from control and ScxcKO mice, but did not detect endogenous Scx protein even in the control. In response to this comment, we have re-done several WB experiments using new lysates from control and ScxcKO SCs and two commercial antibodies: anti-Scx antibody 1 from Abcam (ab58655) and anti-Scx antibody 2 from Invitrogen (PA5-23943). These antibodies have been reported to detect endogenous Scx protein in tendon cells in Spang et al., BMC Musculoskelet Disord (2016) and  Bochon et al., Int J Stem Cells (2021). Despite our best efforts, we were not able to detect a reliable Scx band. We have also conducted immunofluorescence using these two antibodies. Still, we failed to detect a difference of staining signals between control and cKO SCs using these antibodies. Lastly, we conducted immunofluorescence using the ScxTy1 myoblasts and we did not find the staining signal coinciding with the Ty1 signal (by double staining). We have been very frustrated by not knowing what caused this technical difficulty in our hands. Given that these were negative data, we did not include them. However, we do hope that the combined data from scRNA-seq, ScxCreERT2 lineage-tracing, Tg-ScxGFP expression, and ScxTy1 knock-in together are deemed sufficient to make up for the deficiency of data for endogenous Scx protein in regenerative myogenic cells.

      Response to Recommendations for the Authors:

      Reviewer #1 (Recommendations For The Authors):

      p. 8: The text refers to Fig. 3I, but this should be Fig. 3H.

      We apologize for the confusion. Please note that by keeping all 14 dpi data in the same row, we placed Fig.3I at an unconventional/unexpected position, i.e., next to 3D &3E, and above 3F-H. We were aware that this unconventional placement could cause confusion, and it did. With that said, we have now re-arranged the subfigures (same data content) so that the updated Fig.3 contains subfigures in the expected and proper spatial order. We double-checked the figure referral in the text (p. 8, ln. 16-17) and the text is correct – just that the original Fig.3I should have been at the original Fig.3H position and that is now corrected.

      Reviewer #2 (Recommendations For The Authors):

      (1) Given that Scx binds to the E-box and regulates gene expression, it is of interest to know the relevance between MyoD and Scx. If possible, the reviewer recommends to include some discussions.

      Thanks for the comment. MyoD1 is a well-known transcript factor regulating myogenesis, whereas Scx is primarily studied in tenocytes and other connective tissues. We agree that our new findings deserve a discussion regarding the relevance between MyoD1 and Scx.  We have added a description of their differences in the discussion and two new references (p.19, ln. 7-17).

      (2) Considering that Scx is a transcriptional factor, it is interesting that Scx-GFP was not detected in the nuclei of regenerated myofibers. Could the subcellular localization of Scx-GFP provide some insights into the function of Scx as a transcription factor during muscle regeneration?

      Tg-ScxGFP is a transgenic line generated by random insertion into the genome (Pryce et al., 2007; cited). The plasmid used for transgenesis was constructed by replacing most of Scx’s first exon with GFP, and including ~ 9Kb flanking regulatory sequences. As such, the ScxGFP is not a fusion gene, but rather that the GFP expression is regulated by Scx promoter and enhancer(s). This GFP reporter lacks a nuclear localization signal (NLS), hence it is mainly detected in the cytoplasm; some nuclear signal is detected, presumably due to GFP’s small size permitting passive diffusion into the nucleus. Thus, the GFP signal is used as a reporter for Scx expression, but GFP subcellular localization does not provide insight into Scx function per se. Conversely, ScxTy1/Ty1 is a knock-in allele created by fusing a triple-Ty1 tag (3XTy1) to the C-terminus of Scx, and we observed that Ty1 is located in the nucleus by the immunofluorescent staining. We used the Ty1 epitope to carry out CUT&RUN experiments to gain insight to the function of Scx as a transcription factor.

      (3) Fig1D The number of arrows in the Merge image is not matched with others. In addition, the star mark in the Pax7 image is likely an error.

      Apologies. We have now corrected these errors in the revised Fig.1D.

      (4) FigS1A Is there only one myofiber shown in the dashed line in this image? It is unclear why only this myofiber is surrounded by the dashed line.

      The dashed line encircles a single fiber because it was not visible in the provided image. However, there are 3 fibers in this image. Because we did not immuno-stain for myofibers here, we circled one fiber for illustration. For clarity, we brightened the background (of the entire original images) so the background signals from myofiber boundaries are discernable without outlines.

      (5) FigS1B There was no overlapped DAPI staining in the Myogenin+ cell. DAPI-staining should be present in Myogenin+ cells because myogenin is located in the nucleus.

      Fig.S1B is immuno-staining for MyoD , and we marked one MyoD+DAPI+GFP+ cell/nucleus. Fig.S1C is immune-staining for Myogenin, and we also marked one (cell/nucleus) that is triple positive.

      (6) The position of the asterisk for the ScxGFP in FigS1D is misaligned. In addition, the position is not matched with Fig1C. Because all myofibers are Scx-positive, it is strange that only one myofiber has an asterisk. The reviewer suggests removing the mark.

      Thank you for pointing out these errors. We have now corrected the misalignment and removed the unnecessary asterisk.

    1. Author response:

      The following is the authors’ response to the original reviews.

      eLife Assessment 

      This study presents valuable experimental and numerical results on the motility of a magnetotactic bacterium living in sedimentary environments, particularly in environments of varying magnetic field strengths. The evidence supporting the claims of the authors is solid, although the statistical significance comparing experiments with the numerical work is weak. The study will be of interest to biophysicists interested in bacterial motility. 

      We thank the reviewers and editors for their careful reading and the constructive comments. With respect to the statement about weak statistical significance, we think that this statement mixes two separate issues, the significance of the difference between experiments at 0 and 50µT and the comparison of experiments with simulations. We have amended our manuscript to address both points as described below. The difference between the experiments at 0 and 50µT is indeed significant, and the discrepancy between experiments and simulations can be explained by unavoidable differences in the way we quantify bacterial throughput.

      Public Reviews: 

      Reviewer #1 (Public Review): 

      Summary: 

      The authors present experimental and numerical results on the motility Magnetospirillum gryphiswaldense MSR-1, a magnetotactic bacterium living in sedimentary environments. The authors manufactured microfluidic chips containing three-dimensional obstacles of irregular shape, that match the statistical features of the grains observed in the sediment via microcomputer tomography. The bacteria are furthermore subject to an external magnetic field, whose intensity can be varied. The key quantity measured in the experiments is the throughput ratio, defined as the ratio between the number of bacteria that reach the end of the microfluidic channel and the number of bacteria entering it. The main result is that the throughput ratio is non-monotonic and exhibits a maximum at magnetic field strength comparable with Earth's magnetic field. The authors rationalize the throughput suppression at large magnetic fields by quantifying the number of bacteria trapped in corners between grains. 

      Strengths: 

      While magnetotactic bacteria's general motility in bulk has been characterized, we know much less about their dynamics in a realistic setting, such as a disordered porous material. The micro-computer tomography of sediments and their artificial reconstruction in a microfluidic channel is a powerful method that establishes the rigorous methodology of this work. This technique can give access to further characterization of microbial motility. The coupling of experiments and computer simulations lends considerable strength to the claims of the authors, because the model parameters (with one exception) are directly measured in the experiments. 

      Weaknesses: 

      The main weakness of the manuscript pertains to the discussion of the statistical significance of the experimental throughput ratio. Especially when comparing results at zero and 50 micro Tesla. The simulations seem to predict a stronger effect than seen in the experiments. The authors do not address this discrepancy. 

      We thank the reviewer for their positive assessment and the detailed constructive remarks. 

      The increase in bacterial throughput between 0 and 50 µT is indeed more pronounced in the simulations than in the experiments, partly due to the fact that there is considerably more variability in the experimental data. We did two things to address this issue: (1) We performed additional statistical test addressing the difference between the experimental results at 0 and 50 µT. Indeed, the difference is only weakly significant (in contrast to the difference of either to 500µT). The increase is however consistent with the observation in the absence of obstacles in the channel, where we see a monotonous increase from 0 to 500 µT (Supp. Figure S5). We have added the test results in the caption of Fig. 3. (2) To address the difference between simulations and experiments, we added a section in Methods on how we determine the throughput and a short discussion in the Results section. The key points are that the initial condition is different in simulations and experiments and that the throughput is therefore quantified differently. This difference is due to experimental limitations: we cannot track bacteria through the whole channel and we wanted to avoid pushing them into the channel with fluid flow to avoid effects of flow on the results. As a consequence, bacteria continue to enter the IN region of the channel from the inlet during the experiment, while in the simulation, they all start at the beginning of the channel simultaneously. We expect this to mostly affect the case with diffusive transport (B=0).

      Reviewer #2 (Public Review): 

      Summary: 

      simulation study of magnetotactic bacteria in microfluidic channels containing sediment-mimicking obstacles. The obstacles were produced based on micro-computer tomography reconstructions of bacteria-rich sediment samples. The swimming of bacteria through these channels is found experimentally to display the highest throughput for physiological magnetic fields. Computer simulations of active Brownian particles, parameterized based on experimental trajectories are used to quantify the swimming throughput in detail. Similar behavior as in experiments is obtained, but also considerable variability between different channel geometries. Swimming at strong field is impeded by the trapping of bacteria in corners, while at weak fields the direction of motion is almost random. The trapping effect is confirmed in the experiments, as well as the escape of bacteria with reducing field strength. 

      Strengths: 

      This is a very careful and detailed study, which draws its main strength from the fruitful combination of the construction of novel microfluidic devices, their use in motility experiments, and simulations of active Brownian particles adapted to the experiment. Based on their results, the authors hypothesize that magnetotactic bacteria may have evolved to produce magnetic properties that are adapted to the geomagnetic field in order to balance movement and orientation in such crowded environments. They provide strong arguments in favor of such a hypothesis. 

      Weaknesses: 

      Some of the issues touched upon here have been studied also in other articles. It would be good to extend the list of references accordingly and discuss the relation briefly in the text. 

      We thank the reviewer for the constructive comments. We answer to the point concerning previous literature in the response to the recommendations below.

      Recommendations for the authors:

      Reviewer #1 (Recommendations For The Authors): 

      Here follows a list of points the authors should address. 

      (1) Are additional experiments feasible to decrease the statistical noise present in Fig. 3c? At the very least, the authors should discuss the statistical significance of the results at 50 muT vis-a-vis 0 T. 

      See our response to Strengths/Weaknesses above

      (2) The experimental setup is not immediately clear. I think that adding a panel from Fig. S1 (or a sketch thereof) would help clarify, especially in relation to the entry zone and end zone. 

      We are not sure what you mean. Fig. 3A already contains exactly such a panel. We have however added another supplementary figure that shows an additional detailed view of the setup (Fig. S3). In addition, we revised several figures: We have replaced Fig. S1 with a better version and exchanged the schematic view of the obstacle channel in Fig 1, removing the additional inlets that were not used in this study (also in Fig 3A), Instead we added a comment in Methods explaining their presence. Hopefully this makes the setup clear.

      (3) It should be also stated that there is no external flow imposed on the channel. 

      We have added such a statement in the description of the experiment (in section 2.2 Swimming of magnetotactic bacteria through sediment-mimicking obstacle channels.  

      (4) Fig. 3c and Fig. 6c are seemingly showing the same quantity (or closely related ones). The authors should use the same symbol and give an explicit mathematical definition. 

      The two quantities are not exactly the same, as we cannot directly quantify the flux of bacteria through the channel in our experiments. On the one hand, we cannot track bacteria through the whole channel, on the other hand, the initial conditions are not exactly the same as in the simulations. In the simulations all bacteria start at the same time at the entrance to the channel. In the experiments, they enter from the inlet and do so at different times (pushing them in with fluid flow would be possible, but carries the risk of perturbing the results due to induced flow through the channel). We have added a new section in the Methods section that explains this difference and describes the procedure used to obtain the throughput from the experiments in detail. We have also added a corresponding comment in the Result section, where the simulations are compared with the experiments. 

      Minor issues: 

      - Figures have different styles that should be unified. For example, the panel labels sometimes have round brackets and sometimes they don't.

      See above

      - Page 6, (muCT) should have the Greek letter mu 

      Thanks, corrected.

      - Fig. 3a is not very clear; see my point 2 above. 

      See above

      Reviewer #2 (Recommendations For The Authors): 

      I have only a few comments and questions, which the authors should address: 

      (1) The observed exponential dependence of decay time on the "well" depth could be related to the exponential density distribution of active particles in a gravitational field, which has been derived previously. Might be interesting to discuss such a possible connection. 

      Thank you for the suggestion, the two cases are indeed somewhat analogous with behaviors reminiscent of thermal processes with an effective temperature. Such a description is however not generally possible (even for sedimentation, only some features are described). We plan to address in future work whether it can be made more quantitative in our case of escape from the corner traps. We have included a short discussion of the analogy in the section on trapping and escape. 

      (2) The authors should consider the following relevant references, and discuss them briefly in their manuscript:

      - Sedimentation, trapping, and rectification of dilute bacteria J Tailleur, ME Cates EPL 86, 60002 (2009) 

      - Human spermatozoa migration in microchannels reveals boundary-following navigation P Denissenko, V Kantsler, DJ Smith, J Kirkman-Brown Proc. Natl. Acad. Sci. USA 109, 8007-8010 (2012) 

      - Wall accumulation of self-propelled spheres J Elgeti, G Gompper Europhysics Letters 101, 48003 (2013) 

      - Wall entrapment of peritrichous bacteria: a mesoscale hydrodynamics simulation study SM Mousavi, G Gompper, RG Winkler Son Maber 16 (20), 4866-4875 (2020) 

      - A Geometric Criterion for the Optimal Spreading of Active Polymers in Porous Media C Kurzthaler, S Mandal, T Bhabacharjee, H Löwen, SS Daba, HA Stone Nat. Commun. 12, 7088 (2021) 

      - Run-to-Tumble Variability Controls the Surface Residence Times of E. coli Bacteria G Junot, T Darnige, A Lindner, VA Martinez, J Arlt, A Dawson, WCK Poon, H Auradou, E Clement Phys. Rev. Leb. 128, 248101 (2022) 

      - Dynamics and phase separation of active Brownian particles on curved surfaces and in porous media P Iyer, RG Winkler, DA Fedosov, G Gompper Phys. Rev. Research 5, 033054 (2023) 

      We agree that there is a lot of literature on these aspects, specifically interaction of self-propelled objects with walls and motion of swimmers through porous media. We have slightly extended our overview of previous literature in the introduction and included most of these references.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Reviewer #1: 

      (1) Their results with human macrophages suggest that there are differences between murine and human macrophages in inflammasome-mediated restriction of STm growth. For example, Thurston et al. showed that in murine macrophages that inflammasome activation controls the replication of mutant STm that aberrantly invades the cytosol, but only slightly limits replication of WT STm. In contrast, here the authors found that primed human macrophages rely on caspase-1, gasdermin D and ninjurin-1 to restrict WT STm. I wonder if the priming of the human macrophages in this study could account for the differences in these studies. Along those lines, do the authors see the same results presented in this study in the absence of priming the macrophages with Pam3CSK4. I think that determining whether the control of intracellular STm replication is dependent on priming is very important.

      We thank the Reviewer for their careful attention to our manuscript and for their thoughtful comments. We have addressed this question about the impact of priming by repeating the bacterial intracellular burden assays in unprimed WT and CASP1-/- THP-1 cells. We have added additional figures to the manuscript to address this: Figure 1 – Figure Supplement 3. Under unprimed conditions, CASP1-/- cells still harbored significantly higher bacterial burdens at 6 hpi and a significant fold-increase in bacterial CFUs compared to WT cells. These results suggest that the caspase-1-mediated restriction of intracellular Salmonella replication in human macrophages is independent of priming. 

      (2) Another difference with the Thurston et al. paper is the way that the STm inoculum was prepared - stationary phase bacteria that were opsonized. Could this also account for differences between the two studies rather than differences between murine and human macrophages in inflammasome-dependent control of STm?

      We thank the Reviewer for this excellent suggestion. To address this possibility, we repeated the bacterial intracellular burden assays in WT and CASP1-/- THP-1 cells using stationary phase bacteria. We infected WT and CASP1-/- THP-1 cells with stationary phase Salmonella, and we subsequently assayed for intracellular bacterial burdens. These data have now been added to the manuscript in Figure 1 – Figure Supplement 4. Interestingly, we did not observe any fold-change in the bacterial colony forming units in both the WT and CASP1-/- THP-1 cells for the stationary phase Salmonella. These data indicate that by 6 hours postinfection, Salmonella do not replicate efficiently in human macrophages unless grown under SPI-1-inducing conditions. Furthermore, these results suggest that differences in how the Salmonella inoculum is prepared may contribute to the discrepancies between our study and previous studies, as noted by the Reviewer. 

      (3) The authors show that the pore-forming proteins GSDMD and Ninj1 contribute to control of STm replication in human macrophages. Is it possible that leakage of gentamicin from the media contributes to this control?

      Response: We thank the Reviewer for their insightful comment. We have addressed this question on the impact of gentamicin by repeating the bacterial intracellular burden assays using a lower concentration of gentamicin in combination with extensively washing the cells with RPMI media to remove the gentamicin. WT and CASP1-/- THP-1 cells were infected with WT Salmonella. Then, at 30 minutes post-infection, cells were treated with 25 μg/ml of gentamicin to kill any extracellular bacteria. At 1 hour post-infection (hpi), the cells were washed for a total of five times with fresh RPMI to remove the gentamicin, and then the media was replaced with fresh media containing no gentamicin. In parallel, we also treated cells with 100 μg/ml of gentamicin at 30 minutes post-infection, washed the cells five times with fresh RPMI at 1 hpi to remove the gentamicin, and then replaced the media with fresh media containing 10 μg/ml of gentamicin. This data has now been included in the manuscript as Figure 1 – Figure Supplement 5. We observed similar levels in the intracellular bacterial burdens at 1 hpi and 6 hpi and a fold-increase in bacterial colony forming units in CASP1-/- cells compared to WT cells across both gentamicin conditions, suggesting that gentamicin appears to not contribute to the intracellular control of Salmonella replication in human macrophages. Of note, we also tried repeating the bacterial intracellular burden assays without gentamicin, using only washes to remove extracellular at 1 hpi; however, under these experimental conditions, we observed high levels of extracellular Salmonella. Therefore, we relied on using a lower concentration of gentamicin to kill extracellular Salmonella in conjunction with extensive washing to remove the gentamicin for the remainder of the infection. 

      (4) One major question that remains to be answered is whether casp-1 plays a direct role in the intracellular localization of STm. If the authors quantify the percentage of vacuolar vs. cytosolic bacteria at early time points in WT and casp-1 KO macrophages, would that be the same in the presence and absence of casp-1? If so, then this would suggest that there is a basal level of bacterial-dependent lysis of the SCV and in WT macrophages the presence of cytosolic PAMPS trigger cell death and bacteria can't replicate in the cytosol. However, in the inflammasome KO macrophages, the host cell remains alive and bacteria can replicate in the cytosol.

      We thank this Reviewer for raising this important point. We have addressed this experimentally by quantifying the percentage of vacuolar vs. cytosolic Salmonella at 2 hpi in WT, NAIP-/-, and CASP1-/- THP-1 cells using a chloroquine (CHQ) resistance assay. This data has now been included in the manuscript in the new Figure 5A. The original subfigures of Figure 5 have consequently been rearranged. We did not observe any significant differences in vacuolar and cytosolic bacterial burdens at this early time point in WT, NAIP-/-, and CASP1-/- THP-1 cells. As noted by the Reviewer, these results suggest that the basal level of bacterialdependent lysis of the SCV in human macrophages is not dependent on caspase-1 or NAIP. 

      Reviewer #3: 

      (1) The main weaknesses of the study are the inherent limitations of tissue culture models. For example, to study interaction of Salmonella with host cells in vitro, it is necessary to kill extracellular bacteria using gentamicin. However, since Salmonella-induced macrophage cell death damages the cytosolic membrane, gentamicin can reach intracellular bacteria and contribute to changes in CFU observed in tissue culture models (major point 1). This can result in tissue culture "artefacts" (i.e., observations/conclusions that cannot be recapitulated in vivo). For example, intracellular replication of Salmonella in murine macrophages requires T3SS-2 in vitro, but T3SS-2 is dispensable for replication in macrophages of the spleen in vivo (Grant et al., 2012).  

      We thank the Reviewer for their helpful comments and insightful suggestions. We have addressed some of the concerns about gentamicin in our response to Reviewer #1 above. To address the Reviewer’s concerns further, we have included language to acknowledge the limitations of our study based on the artefacts of tissue culture models in our Discussion section: “In this study, we utilized tissue culture models to examine intracellular Salmonella replication in human macrophages. These in vitro systems allow for precise control of experimental conditions and, therefore, serve as powerful tools to interrogate the molecular mechanisms underlying inflammasome responses and Salmonella replication in both immortalized and primary human cells. Still, there are limitations of tissue culture models, as they lack the inherent complexity of tissues and organs in vivo. To assess whether our findings reflect Salmonella dynamics in the mammalian host, it will be important to complement our studies and extend the implications of our work using approaches that model more complex systems, such as organoids or organ explant models co-cultured with immune cells, and in vivo techniques, such as humanized mouse models.”

      (2) In Figure 1: are increased CFU in WT vs CASP1-deficient THP-1 cells due to Caspase 1 restricting intracellular replication or due to Caspase-1 causing pore formation to allow gentamicin to enter the cytosol thereby restricting bacterial replication? The same question arises about Caspase-4 in Figure 2, where differences in CFU are observed only at 24h when differences in cell death also become apparent. The idea that gentamicin entering the cytosol through pores is responsible for controlling intracellular Salmonella replication is also consistent with the finding that GSDMD-mediated pore formation is required for restricting intracellular Salmonella replication (Figure 3). Similarly, the finding that inflammasome responses primarily control Salmonella replication in the cytosol could be explained by an intact SCV membrane protecting Salmonella from gentamicin (Figure 5). 

      We thank the Reviewer for highlighting this important point regarding gentamicin.

      We have addressed this question in our response above to Review #1 and in Figure 1 – Figure Supplement 5. We observed caspase-1-mediated restriction of Salmonella in human macrophages even when cells were treated with a lower concentration of gentamicin (25 μg/ml) for 30 minutes and then extensively washed with RPMI media to remove any gentamicin for the remainder of the infection. These data suggest that gentamicin is likely not responsible for controlling intracellular Salmonella in human macrophages.

    1. Author response:

      We thank all three reviewers and the editors for their detailed comments on our manuscript.  The two main themes of this feedback concern the paper’s generality and its presentation.  Reviewers #2 and #3 raise questions about how the discrepancies in fitness statistics we report will be realized across organisms, environments, and in models with interactions beyond resource competition (e.g., toxicity or cross-feeding).  All reviewers and the editors have also expressed the need for the presentation to be improved, including a broader introduction to the concept of fitness (Reviewer #1), a clearer explanation of our model (Reviewer #1), better explanations of how quantifying fitness answers key biological questions (Reviewer #3), and improvements to the most technical sections to ensure accessibility to experimentalists (Reviewer #3).

      In light of these comments, we wish to clarify that the goal of this paper is to provide a proof-of-principle for how different choices in quantifying fitness can lead to different analysis outcomes.  Since the focus of this paper is on the theoretical concepts, we focus on a few example data sets and a simple model to demonstrate the existence of these discrepancies.  While other organisms and environments, especially with more complex growth dynamics and interactions, could certainly have additional or different discrepancies in fitness statistics, we believe the simplicity of our approach is valuable because it demonstrates that even basic features of microbial growth (common across systems) with realistic parameter values are sufficient to cause significant differences in fitness depending on these quantification choices.  We agree with the reviewers that a systematic documentation of how these fitness discrepancies are empirically realized is important, but we believe that question is best explored in separate future works that can focus fully on this empirical rather than theoretical question.

      We plan to revise the manuscript in several ways, following the suggestions of the three reviewers and the editor.  First, we will better articulate the main goal and conclusions of this manuscript, especially its generality and limitations.  Second, we will work to streamline and clarify several points in the main text identified by the reviewers to make it more accessible and useful to a broader audience, especially experimentalists who routinely measure fitness in their work.  We are grateful to the reviewers and the editor for their time and effort in assessing the manuscript, and we look forward to providing an updated version that addresses these concerns.

    1. Author response:

      Reviewer #1 (Public review):

      Li et al. investigate Ca2+ signaling in T. gondii and argue that Ca2+ tunnels through the ER to other organelles to fuel multiple aspects of T. gondii biology. They focus in particular on TgSERCA as the presumed primary mechanism for ER Ca2+ filling. Although, when TgSERCA was knocked out there was still a Ca2+ release in response to TG present.

      Note that we did not knockout SERCA as it is an essential gene so it would not be possible to isolate parasites that do not express SERCA. We created conditional mutants that downregulate the expression of SERCA and some activity is present in the mutant after 24 h of ATc treatment.

      Overall the Ca2+ signaling data do not support the conclusion of Ca2+ tunneling through the ER to other organelles in fact they argue for direct Ca2+ uptake from the cytosol.

      The authors show EM membrane contact sites between the ER and other organelles, so Ca2+ released by the ER could presumably be taken up by other organelles but that is not ER Ca2+ tunneling.

      They clearly show that SERCA is required for T. gondii function.

      Overall, the data presented to not fully support the conclusions reached

      We agree that the data does not support Ca2+ tunneling as defined and characterized in mammalian cells. In response to this comment, we modified the title and the text accordingly.

      However, we think that the study shows far more than just the role of SERCA in T. gondii functions. We argue that the study shows that the ER (through the activity of the SERCA pump) sequesters and re-distributes calcium to other organelles following influx through the PM. The experiments show that the ER is able to take calcium from the cytosol as it enters the parasite through SERCA activity, and this activity is important for the transition of the parasite between various extracellular calcium exposures. We believe that the role of the ER in redistributing calcium following exposure to physiological levels of extracellular calcium is demonstrated in the experiments shown in Figs 1H-I, 4G-H and 5G,H, I, J, K . There are no previous T. gondii studies that address the question of how intracellular stores are filled with calcium, which are essential for the continuation of the lytic cycle, meaning they are essential for the parasitism of T. gondii.

      Data argue for direct Ca2+ uptake from the cytosol

      The ER most likely takes up calcium from the cytosol following its entry through the PM and redistributes it to the other organelles. We will delete the word “tunneling” and replace it with transfer and re-distribution as they represent our results.

      What we think is re-distribution is shown in Figure 1H and I in which the calcium released after GPN and nigericin are enhanced after TG addition. Of note is that there is no experimental evidence that supports the regulation of calcium entry by store depletion (PMID: 24867952), and we do not think that the enhanced response is due to calcium entry.

      Figure 4G and H show that knocking down SERCA reduces significantly the response to GPN. Fig 5I shows that the mitochondrial calcium uptake is reduced after the addition of GPN in the knockdown mutant. Fig 2B shows that SERCA can take up calcium at 55 nM calcium while mitochondrial uptake needs higher concentrations (Fig 5B-C). However, higher calcium concentrations could be reached at the microdomains formed around MCS between the ER and mitochondrion. Figure 5E shows that the mitochondrion is not responsive to an increase of cytosolic calcium. This is also shown for the apicoplast in Fig. 7 E and F of the Li et al, Nat Commun 2021 paper.

      Reviewer #2 (Public review):

      The role of the endoplasmic reticulum (ER) calcium pump TgSERCA in sequestering and redistributing calcium to other intracellular organelles following influx at the plasma membrane.

      T. gondii transitions through life cycle stages within and exterior to the host cells, with very different exposures to calcium, adds significance to the current investigation of the role of the ER in redistributing calcium following exposure to physiological levels of extracellular calcium.

      They also use a conditional knockout of TgSERCA to investigate its role in ER calcium store-filling and the ability of other subcellular organelles to sequester and release calcium. These knockout experiments provide important evidence that ER calcium uptake plays a significant role in maintaining the filling state of other intracellular compartments.

      We thank the reviewer.

      While it is clearly demonstrated, and not surprising, that the addition of 1.8 mM extracellular CaCl2 to intact T. gondii parasites preincubated with EGTA leads to an increase in cytosolic calcium and subsequent enhanced loading of the ER and other intracellular compartments, there is a caveat to the quantitation of these increases in calcium loading. The authors rely on the amplitude of cytosolic free calcium increases in response to thapsigargin, GPN, nigericin, and CCCP, all measured with fura2. This likely overestimates the changes in calcium pool sizes because the buffering of free calcium in the cytosol is nonlinear, and fura2 (with a Kd of 100-200 nM) is a substantial, if not predominant, cytosolic calcium buffer. Indeed, the increases in signal noise at higher cytosolic calcium levels (e.g. peak calcium in Figure 1C) are indicative of fura2 ratio calculations approaching saturation of the indicator dye.

      We agree about the limitations of using Fura2 but according to the literature (PMID:3838314, fig. 3) Fura2 is suitable for measurements between 100 nM and 1 mM calcium.  The responses in our experiments were within its linear range and the experiments with the SERCA mutant and mitochondrial GCaMPs supports the conclusions of our work.

      We agree that the experiment shown in Fig 1C shows a response close to the limit of the linear range of Fura2 and we can provide a more representative trace in the final article. We can include new quantifications and comparisons.

      Another caveat, not addressed, is that loading of fura2/AM can result in compartmentalized fura2, which might modify free calcium levels and calcium storage capacity in intracellular organelles.

      We are aware of this issue and because of that we have modified our protocol to minimize compartmentalization. We load cells for 26 min at room temperature and keep cells in ice and do not use them for longer that 2-3 hours because we do see evidence of compartmentalization. One evidence of compartmentalization is the increase in the resting calcium concentration.

      The finding that the SERCA inhibitor cyclopiazonic acid (CPA) only mobilizes a fraction of the thapsigargin-sensitive calcium stores in T. gondii coincides with previously published work in another apicomplexan parasite, P. falciparum, showing that thapsigargin mobilizes calcium from both CPA-sensitive and CPA-insensitive calcium pools (Borges-Pereira et al., 2020, DOI: 10.1074/jbc.RA120.014906). It would be valuable to determine whether this reflects the off-target effects of thapsigargin or the differential sensitivity of TgSERCA to the two inhibitors.

      This is an interesting observation, and we will discuss the result considering the Plasmodium study and include the citation. We will add inhibition curves using the MagFluo protocol and compare CPA and TG.

      Figure S1 suggests differential sensitivity, and it shows that thapsigargin mobilizes calcium from both CPA-sensitive and CPA-insensitive calcium pools in T. gondii. Also important is that we used 1 µM TG as we are aware that TG has shown off-target effects at higher concentrations. 

      The authors interpret the residual calcium mobilization response to Zaprinast observed after ATc knockdown of TgSERCA (Figures 4E, 4F) as indicative of a target calcium pool in addition to the ER. While this may well be correct, it appears from the description of this experiment that it was carried out using the same conditions as Figure 4A where TgSERCA activity was only reduced by about 50%.

      We partially agree as pointed by the reviewer knock down of TgSERCA by only 50% means that the ER still could be targeted by zaprinast and no evidence of another target calcium pool. From the MagFLuo4 experiment (although we are aware that the fluorescence of mag Fluo4 is not linear to calcium), there is SERCA activity after 24 hr of ATc treatment.  However, when adding Zaprinast after TG we see a significant release of calcium which is true for both wild type and conditional knockdowns. Because of this result we proposed that there could be another large neutral calcium pool than the one mobilized by TG. We will address these possibilities in the discussion and interpretation of the result.

      The data in Figures 4A vs 4G and Figures 4B vs 4H indicate that the size of the response to GPN is similar to that with thapsigargin in both the presence and absence of extracellular calcium. This raises the question of whether GPN is only releasing calcium from acidic compartments or whether it acts on the ER calcium stores, as previously suggested by Atakpa et al. 2019 DOI: 10.1242/jcs.223883. Nonetheless, Figure 1H shows that there is a robust calcium response to GPN after the addition of thapsigargin.

      The results of the experiments did not exclude the possibility that GPN can also mobilize some calcium from the ER besides acidic organelles. We don’t have any evidence to support that GPN can mobilize calcium from the ER either. Based on our unpublished work, we think GPN mainly release calcium from the PLVAC. We will include the mentioned citation and discuss the result considering the possibility that GPN may be acting on the ER.

      An important advance in the current work is the use of state-of-the-art approaches with targeted genetically encoded calcium indicators (GECIs) to monitor calcium in important subcellular compartments. The authors have previously done this with the apicoplast, but now add the mitochondria to their repertoire. Despite the absence of a canonical mitochondrial calcium uniporter (MCU) in the Toxoplasma genome, the authors demonstrate the ability of T. gondii mitochondrial to accumulate calcium, albeit at high calcium concentrations. Although the calcium concentrations here are higher than needed for mammalian mitochondrial calcium uptake, there too calcium uptake requires calcium levels higher than those typically attained in the bulk cytosolic compartment. And just like in mammalian mitochondria, the current work shows that ER calcium release can elicit mitochondrial calcium loading even when other sources of elevated cytosolic calcium are ineffective, suggesting a role for ER-mitochondrial membrane contact sites. With these new tools in hand, it will be of great value to elucidate the bioenergetics and transport pathways associated with mitochondrial calcium accumulation in T. gondii.

      We thank this reviewer for his/her positive comment. Studies of bioenergetics and transport pathways associated with mitochondrial calcium accumulation is part of our future plans.

      The current studies of calcium pools and their interactions with the ER and dependence on SERCA activity in T. gondi are complemented by super-resolution microscopy and electron microscopy that do indeed demonstrate the presence of close appositions between the ER and other organelles (see also videos). Thus, the work presented provides good evidence for the ER acting as the orchestrating organelle delivering calcium to other subcellular compartments through contact sites in T. gondi, as has become increasingly clear from work in other organisms.

      Thank you

      Reviewer #3 (Public review):

      This manuscript describes an investigation of how intracellular calcium stores are regulated and provides evidence that is in line with the role of the SERCA-Ca2+-ATPase in this important homeostasis pathway. Calcium uptake by mitochondria is further investigated and the authors suggest that ER-mitochondria membrane contact sites may be involved in mediating this, as demonstrated in other organisms.

      The significance of the findings is in shedding light on key elements within the mechanism of calcium storage and regulation/homeostasis in the medically important parasite Toxoplasma gondii whose ability to infect and cause disease critically relies on calcium signalling. An important strength is that despite its importance, calcium homeostasis in Toxoplasma is understudied and not well understood.

      We agree with the reviewer. Thank you

      A difficulty in the field, and a weakness of the work, is that following calcium in the cell is technically challenging and thus requires reliance on artificial conditions. In this context, the main weakness of the manuscript is the extrapolation of data. The language used could be more careful, especially considering that the way to measure the ER calcium is highly artificial - for example utilising permeabilization and over-loading the experiment with calcium. Measures are also indirect - for example, when the response to ionomycin treatment was not fully in line with the suggested model the authors hypothesise that the result is likely affected by other storage, but there is no direct support for that.

      The MagFluo protocol has been amply used in mammalian cells, DT40 cells and other cells for the characterization of the IP3 receptor response to IP3. We will include and discuss more citations in the revised article. The scheme at the top of the figure shows the protocol used. There is no overloading with calcium because the cells are permeabilized and the concentrations of calcium used are physiological and all experiments were performed at 220 nm calcium which is within the cytosolic levels tolerated by cells. The experiment was done with permeabilized cells because permeabilization allows the indicator to become diluted, the substrate MgATP to reach the membrane of the ER and in addition allows for the exposure to precise concentrations of calcium. MagFluo4 loading is intended for its compartmentalization to all intracellular compartments and the uptake stimulated by MgATP exclusively occurs in the compartment occupied by SERCA. IO is an ionophore that causes calcium release from other stores in addition to the ER and it is expected that will result in a larger release. We must clarify that the experiment shown in Fig. 2 was done to characterize the activity of SERCA and was not aimed at the characterization of the role of SERCA in the parasite. We will explain this result better in the revised version of the article.

      Below we provide some suggestions to improve controls, however, even with those included, we would still be in favour of revising the language and trying to avoid making strong and definitive conclusions. For example, in the discussion perhaps replace "showed" with "provide evidence that are consistent with..."; replace or remove words like "efficiently" and "impressive"; revise the definitive language used in the last few lines of the abstract (lines 13-17); etc. Importantly we recommend reconsidering whether the data is sufficiently direct and unambiguous to justify the model proposed in Figure 7 (we are in favour of removing this figure at this early point of our understanding of the calcium dynamic between organelles in Toxoplasma).

      We thank the reviewer for the suggestions and will modify the language as suggested.

      Fig 7 is only a model and as all models could be incorrect. However, considering this reviewer’s criticism we will replace the model for a simpler one that is less speculative.

      Another important weakness is poor referencing of previous work in the field. Lines 248-250 read almost as if the authors originally hypothesised the idea that calcium is shuttled between ER and mitochondria via membrane contact sites (MCS) - but there is extensive literature on other eukaryotes which should be first cited and discussed in this context. Likewise, the discussion of MCS in Toxoplasma does not include the body of work already published on this parasite by several groups. It is informative to discuss observations in light of what is already known.

      We added a citation following the sentence mentioned by the reviewer in lines 248-250 (corrected preprint) and will include more in the revised article. We cite several pertinent articles that describe MCS in Toxoplasma (lines 378-380, very few actually). We will make sure not to miss any new articles that could have been recently published. Note that our work is not about describing the presence of MCSs. We are showing transfer of calcium between the ER and mitochondria and we present evidence that supports that it happens through MCSs.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Reviewer #1:

      - Summary: 

      Recordings were made from the dentate nucleus of two monkeys during a decision-making task. Correlates of stimulus position and stimulus information were found to varying degrees in the neuronal activities. 

      We agree with this summary.

      - Strengths: 

      A difficult decision-making task was examined in two monkeys.

      We agree with this statement.

      - Weaknesses: 

      One of the monkeys did not fully learn the task. The manuscript lacked a coherent hypothesis to be tested, and no attempt was made to consider the possibility that this part of the brain may have little to do with the task that was being studied. 

      We understand the reviewers concern. It is correct that one of the monkeys (Mi) did not perform at a high level, but it should be noted that both monkeys learned significantly above chance level. Therefore, we would argue that both monkeys in fact did learn the task but Mi’s performance was suboptimal. This difference in the performance levels gave us a rare opportunity to dive deeper into the reasons why some animals perform better than the others and we show that Mi (the lower performing monkey) paid more attention to the outcome of the previous trial – this is evident from our behavioural and decoding models.

      We tested the overall hypothesis that neurons of the nucleus dentate can dynamically modulate their activity during a visual attention task, comprising not only sensorimotor but also cognitive attentional components. Many neurons in the dentate are multimodal (Figure 3C-D) which was something that was theorized. One of the specific hypotheses that we tested is that the dentate cells can be direction-selective for both the sensorimotor and cognitive component. Given that many of the recorded cells showed direction-selectivity in their firing rate modulation for gap directions and/or stimulus directions, we provide strong evidence that this hypothesis is correct. We have now spelled out this hypothesis more explicitly in the introduction of the revised version. We now also explain better why we tested this specific hypothesis. Indeed, earlier studies in primates such as those by Herzfeld and colleagues (2018, Nat. Neuro.) and van Es and colleagues (2019, Current Biol) have indicated that direction-selectivity of cerebellar activity may occur in various sensorimotor domains.

      We also appreciate the comment of this Reviewer that in our original submission we did not show our attempt to consider the possibility that this part of the brain may have little to do with the task that was being studied. We in fact did consider this possibility in that we successfully injected 3 ml of muscimol (5 μg/ml, Sigma Aldrich) into the dentate nucleus in vivo in one of the monkeys (Mo). This application resulted in a reduction of more than 10% in correct responses of the covert attention task after 45 minutes, whereas the performance remained the same following saline injections. Unfortunately, due to the timing of the experiments and Covid19-related laboratory restrictions we were unable to perform these experiments in the other monkey or repeat them in Mo. We aim to replicate this in future experiments and publish it when we have full datasets of at least two monkeys available. For this paper we have prioritized our tracing experiments, highlighting the connections of the dentate nucleus with attention related areas in brainstem and cortex in both monkeys, following perfusion.

      - Perhaps the large differences in performance between the two subjects can be used as a way to interpret the neural data's relationship to behavior, as it provided a source of variance. This is what we would hypothesize if we believed that this area of the brain is playing a significant role in the task. If one animal learns much more poorly, and this region of the brain is important for that behavior, then shouldn't there be clear, interpretable differences in the neural data? 

      We thank the Reviewer for this comment. We have added a new Supplementary Figure 2, in which we present the data for both monkeys separately in the revised manuscript. Comparing the two datasets however, we see more commonalities related to the significant learning in both monkeys than differences that might be related to their different levels of learning. We have therefore decided to show the different datasets transparently in the new Supplementary Figure 2, but to stay on the conservative side in our interpretations.

      - How should we look for these differences? A number of recent papers in mice have uncovered a large body of data showing that during the deliberation period, when the animal is interpreting a sensory stimulus (often using the whisker system), there is ramping activity in a principal component space among neurons that contribute to the decision. This ramping activity is present (in the PCA space) in the motor areas of the cortex, as well as in the medial and lateral cerebellar nuclei. Perhaps a similar computational approach would benefit the current manuscript. 

      We also appreciate this point. We have done the principal component analysis accordingly, and we indeed do find the ramping activity in several components of the dentate activity of both monkeys (Mi and Mo). We have now added a new Supplementary Figure 3 with the first three components of both correct and incorrect trials for Mi and Mo, highlighting their potential contribution.

      - What is the hypothesis that is being tested? That is, what do you think might be the function of this region of the cerebellum in this task? It seems to me that we are not entirely in the dark, as previous literature on mice decision-making tasks has produced a reasonable framework: the deliberation period coincides with ramping activity in many regions of the frontal lobe and the cerebellum. Indeed, the ramp in the cerebellum appears to be a necessary condition for the ramp to be present in the frontal lobe. Thus, we should see such ramping activity in this task in the dentate. When the monkey makes the wrong choice, the ramp should predict it. If you don't see the ramping activity, then it is possible that the hypothesis is wrong, or that you are not recording from the right place. 

      It is indeed one of our specific hypotheses that the dentate cells can be direction-selective for the preparing cognitive component and/or sensorimotor response. We provide evidence that this hypothesis may be correct when we analyze the regular time response curves (see Figure 2 and the new Supplementary Figure 2 where the data of both monkeys are now presented separately). Moreover, we have now verified this by analysing the ramping curves of PCA space (new Supplementary Figure 3) and firing frequency of DN neurons that modulated upon presentation of the C-stimulus (new Supplementary Figure 4). These figures and findings are now referred to in the main text.

      - As this is a difficult task that depends on the ability of the animals to understand the meaning of the cues, it is quite concerning that one of the monkeys performed poorly, particularly in the early sessions. Notably, the disparity between the two subjects is rather large: one monkey at the start of the recordings achieved a performance that was much better than the second monkey did at the end of the recording sessions. You highlighted the differences in performance in Figure 1D and mentioned that you started recording once the animals reached 60% performance. However, this did not make sense to me as the performance of Mi even after the final day of recording did not reach the performance of Mo on the first day of recording. Thus, in contrast to Mo, Mi appeared to be not ready for the task when the recording began.

      We understand this point. However, please note that the learning performance of the monkeys concerned retraining sessions after they had had several weeks of vacation. So, even though it is correct that one of the two monkeys had a very good consolidation and started already at a relatively high level on the first retraining session, the other one also started and ended at a level above chance level (the y-axis starts at 0.5). We now highlight this point better in the Results section.

      - One objective of having two monkeys is to illustrate that what is true in one animal is also true in the other. In some figures, you show that the neural data are significantly different, while in others you combine them into one. Thus, are you confident that the neural data across the animals should be combined, as you have done in Figure 2? Perhaps you can use the large differences in performance as a source of variance to find meaning in the neural data. 

      This is a valid question; as highlighted above, we have now addressed this point in the new Supplementary Figure 2, where the data for both monkeys are presented separately. Given the sample sizes and level of variances, it is in general difficult to draw conclusions about the potential differences and contributions, but the data are sufficiently transparent to observe common trends. With regard to linking differences in the neural data to the differences in performance level, please also consider Figure 4, the new Supplementary Figure 3 (with the ramping PCA component) and new Supplementary Figure 4 (with the additional analysis of the ramping activity of DN neurons that modulated upon presentation of the C-stimulus), which suggests that the ramping stage of Mo starts before that of Mi. This difference highlights the possibility that injecting accelerations of the simple spike modulations of Purkinje cells in the cerebellar hemispheres into the complex of cerebellar nuclei may be instrumental in improving the performance of responses to covert attention, akin to what has been shown for the impact of Purkinje cells of the vestibulocerebellum on eye movement responses to vestibular stimulation (De Zeeuw et al. 1995, J Neurophysiol). This possibility is now also raised in the Discussion.

      - How do we know that these neurons, or even this region of the brain, contribute to this task? When a new task is introduced, the contributions of the region of the brain that is being studied are usually established via some form of manipulation. This question is particularly relevant here because the two subjects differed markedly in their performance, yet in Figure 3 you find that a similar percentage of neurons are responding to the various elements of the task.

      We appreciate this question. As highlighted above, we are refraining from showing our muscimol manipulation (3 ml of 5 μg/ml muscimol, Sigma Aldrich), as it only concerns 1 successful dataset and 1 control experiment. We hope to replicate this reversible lesion experiment in the future and publish it when we have full new datasets of at least two monkeys available. As explained above, for this paper we have sacrificed both monkeys following a timed perfusion, so as to have similar survival times for the transport of the neuro-anatomical tracer involved.  

      - Behavior in both animals was better when the gap direction was up/down vs. left/right. Is this difference in behavior encoded during the time that the animal is making a decision? Are the dentate neurons better at differentiating the direction of the cue when the gap direction is up/right vs. left/right? 

      These data have now been included in the new Supplementary Figure 2; we did not observe any significant differences in this respect.

      Reviewer #2:

      - The authors trained monkeys to discriminate peripheral visual cues and associate them with planning future saccades of an indicated direction. At the same time, the authors recorded single-unit neural activity in the cerebellar dentate nucleus. They demonstrated that substantial fractions of DN cells exhibited sustained modulation of spike rates spanning task epochs and carrying information about stimulus, response, and trial outcome. Finally, tracer injections demonstrated this region of the DN projects to a large number of targets including several known to interconnect the visual attention network. The data compellingly demonstrate the authors' central claims, and the analyses are well-suited to support the conclusions. Importantly, the study demonstrates that DN cells convey many motor and nonmotor variables related to task execution, event sequencing, visual attention, and arguably decision-making/working memory. 

      We thank the Reviewer for this positive and constructive feedback.

      - The study is solid and I do not have major concerns, but only points for possible improvement. 

      We thank the Reviewer for this positive feedback.

      - A key feature of this data is the extended changes/ramps in DN output across epochs (Figure 2). Crudely, this presents a challenge for the view that DN output mainly drives motor effectors, as the saccade itself lasts only a tiny fraction of the overall task. Some discussion of this dichotomy in thinking about the function(s) of the cerebellum, vis a vis the multifarious DN targets the authors demonstrate here, etc., would be helpful. 

      We agree with the Reviewer and we have expanded our Discussion on this point, also now highlighting the outcome of the new PCA analysis recommended by Reviewer 1 (see the new Supplementary figure Figure 3).

      - A high-level suggestion on the data: the presentation of the data focuses (sensibly) on the representation of the stimulus and response epochs (Figures 2-3). Yet, the authors then show that from decoding, it is, in fact, a trial outcome that is best represented in the population (Figure 4). While there is nothing 'wrong' with this, it reads slightly incongruously, and the reader does a bit of a "double take" back to the previous figures to see if they missed examples of the trial-outcome signals, but the previous presentations only show correct trials. Consider adding somewhere in the first 3 main figures some neural data showing comparisons with incorrect trials. This way, the reader develops prior expectations for the outcome decoding result and frame of reference for interpreting it. On a related note, the text contains an earlier introduction of this issue (p24 last sentence) and p25 paragraph 1 cites Figure 3D and 3E for signals "related to the absence of reward" - but the caption says this includes only correct trials? 

      We thank the Reviewer for bringing up these points. We have addressed the textual suggestions. Moreover, we have done the PCA analysis suggested by Reviewer 1 for both the correct and incorrect trials (see Supplementary material).

      - P29: The discrepancy in retrograde labeling between monkeys (2 orders of magnitude): I realize the authors can't really do anything about this, but the difference is large enough to warrant concerns in the interpretation (how did the tracer spread over the drastically larger area? Isotropically? Could it cross more "hard boundaries" and incorporate qualitatively different inputs/outputs?). A small discussion of possible caveats in interpreting the outcomes would be helpful. 

      We fully agree with this comment. As highlighted in the text, in both monkeys we first identified the optimal points for injection in the dentate nucleus electrophysiologically and we used the same pump with the same settings to carry out the injections, but even so the differences are substantial. We suspect that the larger injection might have been caused by an air bubble trapped in the syringe or a deviation in the stock solution, but we can never be sure of that. We have added a potential explanation for the caveat that might have played a role.

      - And a list of quick points: 

      We have addressed all points listed below; we want to thank the Reviewer for bringing them up.

      P3 paragraph 2 needs comma "in daily life,". 

      P4 paragraph 2 "C-gap" terminology not previously defined. 

      P4 paragraph 2 "animals employed different behavioral strategies". Grammatically, you should probably say "each animal employed a different behavioral strategy," but also scientifically the paragraph doesn't connect this claim to anything about the DN (whereas, e.g., the abstract does make this connection clear). 

      P5 paragraph 1 "theca" should be "the". 

      P6 paragraph 1 problem with ignashenkova citation insert. 

      P10 paragraph 1 I think the spike rate "difference between highest and lowest" is not exactly the same as "variance," you might want to change the terminology. 

      P10 paragraph 1 should probably say "To determine if a cell preferentially modulated". 

      P10 paragraph 1 last sentence the last clause could be clearer. 

      P17 paragraph 2 should be something like "as well as those by Carpenter and..."? 

      P20 caption: consider "...directionality in the task: only one C-stim...". 

      P20 caption: consider "to the left and right in the [L/R] task...to the top/bottom in the [U/D] task". 

      Fig1E and S1 - is there a physical meaning of the "weight" unit, and if none, can this be transformed into a more meaningful unit? 

      P21 paragraph 1 consider "activity was recorded for 304 DN neurons...". 

      P21 paragraph 1 "correlations with the temporal windows" it's not clear how activity can "correlate" with a time window, consider rephrasing (activity levels changed during these time epochs, depending on stimulus identity). 

      P21 paragraph 1 should be "by comparing the number of spikes in a bin...". 

      P22 paragraph 2 "when we aligned the neurons to the time of maximum change" needs clarification. The maximum change of what? And per neuron? Across the population? 

      P22 paragraph 2 "than that of the facilitating" should be "than did the facilitating units". 

      P24 paragraph 1 needs a comma and rewording "Within each direction, trials are sorted by the time of saccade onset". 

      P24 paragraph 1 should probably say "Same as in G, but for suppressed cells". 

      P24 paragraph 2 should say "more than one task event" not "events". 

      P24 paragraph 2 needs a comma "To fully characterize the neural responses, we fitted". 

      P25 paragraph 1 should probably say "we sampled from similar populations of DN". 

      P34 paragraph 3 consider rephrasing the sentence that contains both "dissociation" and "dissociate". 

      P37 last line: consider "coordination of cerebellum and cerebral cortex *in* higher order mental..."? 

      P38 paragraph 1 citation needed for "kinematics of goal-directed hand actions of others"? 

      P38 paragraph 1 commas probably not needed "map visual input, from high-level visual regions, onto..." 

      References

      - Herzfeld D.J., Kojima Y, Soetedjo R, Shadmehr R (2018) Encoding of error and learning to correct that error by the Purkinje cells of the cerebellum. Nat Neurosci 21:736–743.

      - van Es, D.M., van der Zwaag W., and Knapen T. (2019) Topographic Maps of Visual Space in the Human Cerebellum. Current Biol Volume 29, Issue 10p1689-1694.e3May 20.

      - De Zeeuw CI, Wylie DR, Stahl JS, Simpson JI. (1995) Phase relations of Purkinje cells in the rabbit flocculus during compensatory eye movements. J Neurophysiol. Nov;74(5):2051-64. doi: 10.1152/jn.1995.74.5.2051.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Reviewer #1 (Public Review):

      Summary:

      The pituitary gonadotropins, FSH and LH, are critical regulators of reproduction. In mammals, synthesis and secretion of FSH and LH by gonadotrope cells are controlled by the hypothalamic peptide, GnRH. As FSH and LH are made in the same cells in mammals, variation in the nature of GnRH secretion is thought to contribute to the differential regulation of the two hormones. In contrast, in fish, FSH and LH are produced in distinct gonadotrope populations and may be less (or differently) dependent on GnRH than in mammals. In the present manuscript, the authors endeavored to determine whether FSH may be independently controlled by a distinct peptide, cholecystokinin (CCK), in zebrafish.

      Strengths:

      The authors demonstrated that the CCK receptor is enriched in FSH-producing relative to LH-producing gonadotropes, and that genetic deletion of the receptor leads to dramatic decreases in gonadotropin production and gonadal development in zebrafish. Also, using innovative in vivo and ex vivo calcium imaging approaches, they show that LH- and FSH-producing gonadotropes preferentially respond to GnRH and CCK, respectively. Exogenous CCK also preferentially stimulated FSH secretion ex vivo and in vivo.

      Weaknesses:

      The concept that there may be a distinct FSH-releasing hormone (FSHRH) has been debated for decades. As the authors suggest that CCK is the long-sought FSHRH (at least in fish), they must provide data that convincingly leads to such a conclusion. In my estimation, they have not yet met this burden. In particular, they show that CCK is sufficient to activate FSH-producing cells, but have not yet demonstrated its necessity. Their one attempt to do so was using fish in which they inactivated the CCK receptor using CRISPR-Cas9. While this manipulation led to a reduction in FSH, LH was affected to a similar extent. As a result, they have not shown that CCK is a selective regulator of FSH.

      Our conclusion regarding the necessity of CCK signaling for FSH secretion is based on the following evidence:

      (1) CCK-like receptors are expressed in the pituitary gland predominantly on FSH cells.

      (2) Application of CCK to pituitaries elicits FSH cell activation and to a much lesser degree activation of LH cells.  (calcium imaging assays)

      (3) Application of CCK to pituitaries and by injections in-vivo significantly increased only FSH release.

      (4) Mutating the FSH-specific CCK receptor in a different species of fish (medaka) also causes a complete shutdown of FSH production and phenocopies a fsh-mutant phenotype (Uehara, Nishiike et al. 2023).

      Taken together, we believe that this data strongly supports the conclusion that CCK is necessary for FSH production and release from the fish pituitary. Admittedly, the overlapping effects of CCK on both FSH and LH cells in zebrafish (evident in both our calcium imaging experiments and especially in the KO phenotype) complicates the interpretation of the phenotype. We speculate that the effect of CCK on LH cells in zebrafish can be caused either by paracrine signaling within the gland or by the effects of CCK on GnRH neurons that were shown to express CCK receptors .

      In the current version, we emphasize that CCK also induces LH secretion. Although it does not affect LH to the same extent as FSH, an overlap does exist. This is mentioned in the abstract and discussion.

      Moreover, they do not yet demonstrate that the effects observed reflect the loss of the receptor's function in gonadotropes, as opposed to other cell types.

      Although there is evidence for the expression of CCK receptor in other tissues, we do show a direct decrease of FSH and LH expression in the gonadotrophs of the pituitary of the mutant fish; taken together with its significant expression in FSH cells compared to the rest of the cells of the pituitary in the cell specific transcriptomic, it is the most reasonable explanation for the mutant phenotype.

      Unfortunately, unlike in mice, technologies for conditional knockout of genes in specific cell types are not yet available for our model and cell types. Additional tissue distribution of the three receptors types of CCK was added in supplementary figure 1, from this tissue distribution it can be appreciated how in the pituitary only CCKBRA (our identified CCK receptor) is expressed, while in other tissues it is either not expressed or expressed with the additional CCK receptors that can compensate its activity.

      It also is not clear whether the phenotypes of the fish reflect perturbations in pituitary development vs. a loss of CCK receptor function in the pituitary later in life. Ideally, the authors would attempt to block CCK signaling in adult fish that develop normally. For example, if CCK receptor antagonists are available, they could be used to treat fish and see whether and how this affects FSH vs. LH secretion.

      While the observed gonadal phenotype of the KO (sex inversed fish) should have a developmental origin since it requires a long time to manifest, the effect of the KO on FSH and LH cells is probably more acute. Unfortunately a specific antagonist that affect only CCKRBA and not the other CCK receptors wasn’t identified yet.

      In the Discussion, the authors suggest that CCK, as a satiety factor, may provide a link between metabolism and reproduction. This is an interesting idea, but it is not supported by the data presented. That is, none of the results shown link metabolic state to CCK regulation of FSH and fertility. Absent such data, the lengthy Discussion of the link is speculative and not fully merited.

      In the revised manuscript, we provided data to link cck with metabolic status in supplementary figure 1 and modified the discussion to tone down the link between metabolic status to and reproductive state.

      Also in the Discussion, the authors argue that "CCK directly controls FSH cells by innervating the pituitary gland and binding to specific receptors that are particularly abundant in FSH gonadotrophs." However, their imaging does not demonstrate innervation of FSH cells by CCK terminals (e.g., at the EM level).

      Innervation of the fish pituitary does not imply a synaptic-like connection between axon terminals and endocrine cells. In fact, such connections are extremely rare, and their functionality is unclear. Instead, the mode of regulation between hypothalamic terminals and endocrine cells in the fish pituitary is more similar to "volume transmission" in the CNS, i.e. peptides are released into the tissue and carried to their endocrine cell targets by the circulation or via diffusion. A short explanation was added in lines 395-398 in the discussion

      Moreover, they have not demonstrated the binding of CCK to these cells. Indeed, no CCK receptor protein data are shown.

      Our revised manuscript  includes detailed experiments showing the activation of the receptor by its homologous ligand, supplementary Figure 1 includes a transactivation  assay of CCK to its receptor and the effect of the different mutants on the activation of the receptor. Unfortunately, no antibody is available against this fish specific receptor (one of the caveats of working with fish models); therefore, we cannot present receptor protein data.

      The calcium responses of FSH cells to exogenous CCK certainly suggest the presence of functional CCK receptors therein; but, the nature of the preparations (with all pituitary cell types present) does not demonstrate that CCK is acting directly in these cells.

      We agree with the reviewer that there are some disadvantages in choosing to work with a whole-tissue preparation. However, we believe that the advantages of working in a more physiological context far outweigh the drawbacks as it reflects the natural dynamics more precisely. Since our transcriptome data, as well as our ISH staining, show that the CCK receptor is exclusively expressed in FSH cells, it is improbable that the observed calcium response is mediated via a different pituitary cell type.

      Indeed, the asynchrony in responses of individual FSH cells to CCK (Figure 4) suggests that not all cells may be activated in the same way. Contrast the response of LH cells to GnRH, where the onset of calcium signaling is similar across cells (Figure 3).

      The difference between the synchronization levels of LH and FSH cells activity stems from the gap-junction mediated coupling between LH cells that does not exist between FSH cells(Golan, Martin et al. 2016). Therefore, the onset of calcium response in FSH cells is dependent on the irregular diffusion rate of the peptide within the preparation, whereas the tight homotypic coupling between LH cells generates a strong and synchronized calcium rise that propagates quickly throughout the entire population

      The differences in connectivity between LH and FSH cells is mentioned in lines 194-195

      Finally, as the authors note in the Discussion, the data presented do not enable them to conclude that the endogenous CCK regulating FSH (assuming it does) is from the brain as opposed to other sources (e.g., the gut).

      We agree with the reviewer that, for now, we are unable to determine whether hypothalamic or peripheral CCK are the main drivers of FSH cells. While the strong innervation of the gland by CCK-secreting hypothalamic neurons strengthens the notion of a hypothalamic-releasing hormone and also fits with the dogma of the neural control of the pituitary gland in fish (Ball 1981), more experiments are required to resolve this question.

      Reviewer #2 (Public Review):

      Summary:

      This manuscript builds on previous work suggesting that the CCK peptide is the releasing hormone for FSH in fishes, which is different than that observed in mammals where both LH and FSH release are under the control of GnRH. Based on data using calcium imaging as a readout for stimulation of the gonadotrophs, the researchers present data supporting the hypothesis that CCK stimulates FSH-containing cells in the pituitary. In contrast, LH-containing cells show a weak and variable response to CCK but are highly responsive to GnRH. Data are presented that support the role of CCK in the release of FSH. Researchers also state that functional overlap exists in the potency of GnRH to activate FSH cells, thus the two signalling pathways are not separate. The results are of interest to the field because for many years the assumption has been that fishes use the same signalling mechanism. These data present an intriguing variation where a hormone involved in satiation acts in the control of reproduction.

      Strengths:

      The strengths of the manuscript are that researchers have shed light on different pathways controlling reproduction in fishes.

      Weaknesses:

      Weaknesses are that it is not clear if multiple ligand/receptors are involved (more than one CCK and more than one receptor?). The imaging of the CCK terminals and CCK receptors needs to be reinforced.

      Reviewer consultation summary: 

      The data presented establish sufficiency, but not necessity of CCK in FSH regulation. The paper did not show that CCK endogenously regulates FSH in fish. This has not been established yet.

      This is a very important comment, also raised by reviewer 1. To avoid repetition, please see our detailed response to the comment above.

      The paper presents the pharmacological effects of CCK on ex vivo preparations but does not establish the in vivo physiological function of the peptide. The current evidence for a novel physiological regulatory mechanism is incomplete and would require further physiological experiments. These could include the use of a CCK receptor antagonist in adult fish to see the effects on FSH and LH release, the generation of a CCK knockout, or cell-specific genetic manipulations.

      As detailed in the responses to the first reviewer, we cannot conduct conditional, cellspecific gene knockout in our model. However we did conducted KO and show the direct effect on FSH and LH secretion together with physiological characterisation of the mutant.

      Zebrafish have two CCK ligands: ccka, cckb and also multiple receptors: cckar, cckbra and cckbrb. There is ambiguity about which CCK receptor and ligand are expressed and which gene was knocked out.

      In the revised manuscript, we clarified which of the receptors are expressed (CCKRBA) and which receptor is targeted. We also provided data showing the specificity of the receptors (both WT and mutant) to the ligands. Supplementary 1 shows receptor cross-activation. The method also specifies the exact NCBI ID numbers of the targeted receptor and the antibody used for the immunostaining.

      Blocking CCK action in fish (with receptor KO) affects FSH and LH. Therefore, the work did not demonstrate a selective role for CCK in FSH regulation in vivo and any claims to have discovered FSHRH need to be more conservative.

      We agree with the reviewer that the overlap in the effect of CCK measured in the calcium activation of cells and in the KO model does not allow us to conclude selectivity. In this context, it is crucial to highlight that CCKRBA exhibits high expression on FSH cells but not on LH cells. Therefore, the effect of CCK on LH cells is likely paracrine or through GnRH neurons that were shown to express CCK receptors. In the current version, we emphasize that CCK also induces LH secretion. Although it does not affect LH to the same extent as FSH, an overlap does exist. This is mentioned in the abstract and discussion.

      The labelling of the terminals with anti-CCK looks a lot like the background and the authors did not show a specificity control (e.g. anti-CCK antibody pre-absorbed with the peptide or anti-CCK in morphant/KO animals).

      Figures colours had been updated to better visualise the specific staining of the antibody. Also, The same antibody had been previously used to mark CCK-positive cells in the gut of the red drum fish(Webb, Khan et al. 2010) , where a control (pre-absorbed with the peptide) experiment had been conducted.

      Recommendations for the authors:

      Reviewer #1 (Recommendations For The Authors):

      Abstract:

      The authors have not yet established that CCK is the primary regulator of FSH in vivo.

      In the new version, we highlight the leading effect of CCK on the reproductive axis, which includes FSH and LH.

      Introduction:

      The authors need to make clear earlier in the Introduction that fish have two types of gonadotropes. This information comes too late (last paragraph) currently.

      Added in line 42

      They should discuss relevant data on the differential regulation of FSH and LH in fish, as a rationale for looking for different releasing factors.

      This has been discussed in the first paragraph of the introduction

      In the last sentence of the penultimate paragraph, the authors assume that it must be a hypothalamic factor that regulates FSH. Why is this necessarily the case? Are there data indicating that a hypothalamic factor is required for FSH production in fish?

      This has been mentioned in the discussion, we do not deny that circulating CCK or CCK from other brain areas might affect FSH secretion in the pituitary (line 402-404). However, as the hypothalamus serves as the main gateway from the brain to the pituitary and contains hypophysiotropic CCK neurons it is the most reasonable assumption.

      Results:

      In the first paragraph, the authors reference three types of CCK receptors, only one of which is expressed in the pituitary. The specific receptor should be named here.

      The receptor name and NCBI id had been added in this paragraph.

      Figure 1: What specificity controls were used for the ISH in Figure 1?

      HCR- The method used to identify RNA expression and developed by Molecular Instruments (https://www.molecularinstruments.com/hcr-rnafish-protocols), do not require specific control as had been previously done with older ISH methods. The use of multiple short probes assure the specificity to the RNA.More over the expression is specific to the targeted cells.

      In Figure 1D, the red square is missing in the KO fish (at low magnification).

      This was fixed in the updated version.

      In Figure 1G, the number of dots does not correspond to the number of animals described in the figure legend. Does each point represent an animal?

      Each dot represent a fish. The order of the numbers in the legend didn’t match the order in the graph, this had been fixed in the last version

      Figure 2A: It is not clear that all FSH (GFP) cells are double-labeled. Should all double-labeled cells appear white? Many appear as green. Some quantification of the proportion of co-labeling is needed. Also, the scale bars are too small to read. Perhaps add the size of the scale bars to the legend.

      They are all double-labeled, as can be seen by the single-color images, since GFP fluorescence is stronger than RCaMP fluorescence, the double-labelling might be seen a green cells; a scale bar was added.

      Figure 2C: Is the synchronous activity of LH cells here dependent on endogenous GnRH? Can these events be blocked with a GnRH receptor antagonist?

      We currently do not have enough data to support this hypothesis and the in vivo 2 photon system is not optimal to answer these questions since these are spontaneous events which are difficult to predict. This is the main reason we moved to an ex vivo system. The similar response we receive when applying GnRH in the ex vivo system support it is GnRH activation.

      Figure 4C: As some LH cells respond to CCK, can the authors really claim that CCK is a selective regulator of FSH? What explains the heterogeneity in the response of LH cells to CCK?

      In this version, we highlight that CCK directly activates FSH but it is also affecting LH to some extent. However it is clear that the effect on FSH cells is more significant.

      Figures 5A and B: With larger Ns, some of the trends might be significant (e.g., GnRH stimulated FSH release and CCK stimulated LH release).

      Though there is a trend, the values in the Y axis reveal that the trend of response of FSH to GnRH and LH to CCK is lower then the distribution of the basal response (the before) in all of the graphs. Hence we do not believe a larger N will affect those results. We added the range of the secreted hormones concentrations in the result description to emphasize the difference in values,

      Figures 5C and D: What explains the lack of an increase in LH secretion following GnRH treatment?

      We did not measure LH Secretion in the plasma as we didn’t have enough blood, we do see an increase in LH transcription (see supplementary figure 5 – figure supplement 1)

      Also, as mRNA levels were measured (in C), reference should be made to expression rather than transcription. Not all changes in mRNA levels reflect changes in transcription.Also, remove transcription from the legend. Reference to supplementary Figure 4 in the legend should be supplementary Figure 6. Finally, in C and D, distinguish males from females (as in 5A and B).

      Modifications had been done according to the reviewer suggestions.

      Figure legends:

      The figure legends are very long. One way to shorten them is to remove descriptions of the results. The legends should indicate what is in each figure, not the results of the experiments.

      Modifications had been done according to the reviewer suggestions.

      Sample sizes should be spelled out in the legends, as they are not in the M&M.

      We made sure all sample sizes are mentioned in the legend

      Materials and Methods:

      Section 1.1 can be removed as it repeats content presented elsewhere.

      This section was removed

      Section 1.5: It is unclear what this means: "blinding was not applied to ensure tractability" Please clarify.

      This section was removed

      Reviewer #2 (Recommendations For The Authors):

      It appears that zebrafish have two ligands: ccka, cckb. Also multiple receptors: cckar, cckbra and cckbrb. Authors need to discuss this and clearly state which ligand and which receptor they are referring to in the manuscript.

      We discussed the receptor type in the first paragraph of the results, the exact synthetic peptide used is described in the methods. The 8 amino acids of the mature CCK peptide are the same between CCKa and CCKb. A sentence regarding the specificity of the antibody to the mature CCK peptide was added in line 101.

      "to GnRH puff application (300 μl of 30 μg/μl)"; (250 μl of 30 μg/ml CCK)

      Please give the final concentration to make it easy on the readers of the data.

      The molarity of the final concentration was added.

      (2.4) Differential calcium response underlies differential hormone. This section is a bit confusing to read, for example:

      "For that, we collected the medium perfused through our ex vivo system (Fig. 2a) and measured LH and FSH levels using a specific ELISA validated for zebrafish [31] while monitoring the calcium activity of the cells."

      So the authors did the ELISA while monitoring the activity (?). This sentence does not make sense: please rewrite it.

      We modified this sentence  in line 308-311

      To functionally validate the importance of CCK signalling we used CRISPR-cas9 to generate loss-of-function (LOF) mutations in the pituitary- CCK receptor gene.

      The authors need to clearly state WHICH gene they inactivated: Zebrafish have three CCK-receptors, so "the pituitary receptor gene" needs to be defined.

      Was added again in line 107, and is mentioned in the methods

      Figure 3 is a crucial figure!

      Figure 3B: The data are not very convincing. Please state how thick the sections are in the figure legend (assuming these are adult pituitaries),

      Added in the legend (figure 1C in the new version), slice thickness and adult fish.

      Please show at least the merged image a high magnification view of the co-localization of the receptor with the cells.

      This is figure 1 in the new revision, a magnified figure was added

      Please give the scale bar size for 3B.

      Scales for all images were added

      Figure 3C: the co-localization of the terminals of the CCK and FSH cells shows very few cells expressing close to terminals.

      Important: Because the labelling of the terminals with anti-CCK looks a lot like the background, it is very important to show the control (anti-CCK antibody pre-absorbed with the peptide). The authors should have these data. The photo needs to have been taken at the same gain (contrast) and the photo showing the terminals.

      This is  a commercial antibody that had been previously validated for CCK in fish. The co-localization pattern resembles GnRH innervation in the pituitary. In fish when hypothalamic neurons innervate the pituitary they do not innervate all the cells, as this is an endocrine system, the peptide can travel to neighbouring cells via diffusion or aided blood flow (Golan, Zelinger et al. 2015) ).  The images reveal the direct innervation of CCK in the pituitary and its proximity to FSH cells.

      Figure 4c, on right. The text seems to be stretched as if the photo was adjusted without locking the aspect ratio. Please check the original images.

      This has been fixed

      Can the authors use different pseudo colours? Differentiating a double label of white versus yellow is very difficult, and thus the photo is not very convincing.

      This had been changed to green and magenta

      What is meant by "CCK-AB" antibody? Perhaps anti-CCK would be a better label

      This has been fixed

      Figure 5A: increase the magnification of the insets; the structure of the gonads is very difficult to see with clarity in these low mag images. The most obvious way to improve this figure is to reduce or eliminate the pie graph (not really necessary) and show a high magnification (and larger) image of the gonadal structure.

      This is figure 1 in the new version, with magnification of the gonad next to each body section.

      Discussion:

      " Moreover, in the zebrafish, as well as in other species, the functional overlap in gonadotropin signalling pathways is not limited to the pituitary but is also present in the gonad, through the promiscuity of the two gonadotropin receptors"<br /> The reasoning of this sentence is not clear: zebrafish do not use GnRH to control reproduction: they lack GnRH1 through genomic rearrangement (see Whitlock, Postlethwait and Ewer 2019) and KO of GnRH2/GnRH3 does not affect reproduction.

      While GnRH KO model indicate a redundancy of GnRH in this axis in zebrafish, there is also ample evidence for its importance in regulating reproduction such as its effect on gonadotropin (Golan, Martin et al. 2016) and its use in spawning inductions in fish (Mizrahi and Levavi-Sivan 2023). We believe it is currently too soon to conclude that GnRH signalling is completely non relevant to reproduction in cyprinids.  

      Reviewing Editor (Recommendations For The Authors):

      It would be interesting to see calcium imaging experiments in the CCKR receptor mutants to establish a more direct connection between peptide action and activity.

      We added a receptor assay that reflect the non-activation of the mutated receptors by CCK (supplementary figure 1) , and compared it to the wild type that is activated. This show that: 1) CCK directly activate our identified receptor in FSH cells. 2) the mutated receptors are non-active.

      "all homozygous fish (CCKR+12/+7/-1/ CCKR+12/+7/-1, n=12)"

      It may be better to write the genotype of fish separately as CCKR+12/+12, CCKR+7/+7 and CCKR-1/-1, n=12) otherwise it seems as if all alleles occurred together in the same fish.

      Modified according to the reviewer request

      In Figure 1 scale bar legends are very small. 

      Description of the scale bars were added to the all the legends

      Figure 1 legend "On the top right of each panel is the gender distribution" - fish have no gender but sex.

      Modified according to the reviewer request

      The authors should endeavour to improve the presentation of the figures. They should use a sans-serif font and check that text is not cut at the edge of figure panels, that scale bars are uniform and clearly labelled and fonts are of similar size and clearly legible. E.g. labels of the fish brain of Fig3A are very small.

      We modified all the figures to adapt the font and the scales, we increased the size of the image in Figure 3a to make the labels clearer.

      Please use the elife format to name supplementary figures, as Figure X - Figure Supplement Y (each supplement associated with one of the main figures).

      Fixed

      Peptide concentrations in the ex vivo experiments should also be given as molar concentrations not only as '250 μl of 30 μg/ml CCK'.

      Fixed

      "In contrast, FSH cells responded with a very low calcium rise in hormonal secretion in response to GnRH" - a very low rise in hormonal secretion

      Fixed

      Please clarify why you used a GnRH synthetic agonist and not the native peptide.

      It is commonly used for spawning induction in fish (line 245); it has also been shown to directly affect the secretion of LH and FSH (Biran, Golan et al. 2014, Biran, Golan et al. 2014, Mizrahi, Gilon et al. 2019) , added to line 245.

      References

      Ball, J. (1981). "Hypothalamic control of the pars distalis in fishes, amphibians, and reptiles." General and comparative endocrinology 44(2): 135-170.

      Biran, J., M. Golan, N. Mizrahi, S. Ogawa, I. S. Parhar and B. Levavi-Sivan (2014). "Direct regulation of gonadotropin release by neurokinin B in tilapia (Oreochromis niloticus)." Endocrinology 155(12): 4831-4842.

      Biran, J., M. Golan, N. Mizrahi, S. Ogawa, I. S. Parhar and B. Levavi-Sivan (2014). "LPXRFa, the Piscine Ortholog of GnIH, and LPXRF Receptor Positively Regulate Gonadotropin Secretion in Tilapia (Oreochromis niloticus)." Endocrinology 155(11): 4391-4401.

      Golan, M., A. O. Martin, P. Mollard and B. Levavi-Sivan (2016). "Anatomical and functional gonadotrope networks in the teleost pituitary." Scientific Reports 6: 23777.

      Golan, M., E. Zelinger, Y. Zohar and B. Levavi-Sivan (2015). "Architecture of GnRH-Gonadotrope-Vasculature Reveals a Dual Mode of Gonadotropin Regulation in Fish." Endocrinology 156(11): 4163-4173.

      Mizrahi, N., C. Gilon, I. Atre, S. Ogawa, I. S. Parhar and B. Levavi-Sivan (2019). "Deciphering Direct and Indirect Effects of Neurokinin B and GnRH in the Brain-Pituitary Axis of Tilapia." Front Endocrinol (Lausanne) 10: 469.

      Mizrahi, N. and B. Levavi-Sivan (2023). "A novel agent for induced spawning using a combination of GnRH analog and an FDA-approved dopamine receptor antagonist." Aquaculture 565: 739095.

      Uehara, S. K., Y. Nishiike, K. Maeda, T. Karigo, S. Kuraku, K. Okubo and S. Kanda (2023). "Cholecystokinin is the follicle-stimulating hormone (FSH)-releasing hormone." bioRxiv: 2023.2005.2026.542428.

      Webb, K. A., Jr., I. A. Khan, B. S. Nunez, I. Rønnestad and G. J. Holt (2010). "Cholecystokinin: molecular cloning and immunohistochemical localization in the gastrointestinal tract of larval red drum, Sciaenops ocellatus (L.)." Gen Comp Endocrinol 166(1): 152-159.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews: 

      Reviewer #1 (Public Review):

      The authors introduce a computational model that simulates the dendrites of developing neurons in a 2D plane, subject to constraints inspired by known biological mechanisms such as diffusing trophic factors, trafficked resources, and an activity-dependent pruning rule. The resulting arbors are analyzed in terms of their structure, dynamics, and responses to certain manipulations. The authors conclude that 1) their model recapitulates a stereotyped timecourse of neuronal development: outgrowth, overshoot, and pruning 2) Neurons achieve near-optimal wiring lengths, and Such models can be useful to test proposed biological mechanisms- for example, to ask whether a given set of growth rules can explain a given observed phenomenon - as developmental neuroscientists are working to understand the factors that give rise to the intricate structures and functions of the many cell types of our nervous system. 

      Overall, my reaction to this work is that this is just one instantiation of many models that the author could have built, given their stated goals. Would other models behave similarly? This question is not well explored, and as a result, claims about interpreting these models and using them to make experimental predictions should be taken warily. I give more detailed and specific comments below.  

      We thank the reviewer for the summary of the work. But the criticism “that this is one instantiation of many models [we] could have built” is unfair as it can apply to any model. We chose one of the most minimalistic models which implements known biological mechanisms including activity-independent and -dependent phases of dendritic growth, and constrained parameters based on experimental data. We compare the proposed model to other alternatives in the Discussion section. In the revised manuscript, we additionally investigate the sensitivity of model output to variations of specific parameters, as explained below.

      Point 1.1. Line 109. After reading the rest of the manuscript, I worry about the conclusion voiced here, which implies that the model will extrapolate well to manipulations of all the model components. How were the values of model parameters selected? The text implies that these were selected to be biologically plausible, but many seem far off. The density of potential synapses, for example, seems very low in the simulations compared to the density of axons/boutons in the cortex; what constitutes a potential synapse? The perfect correlations between synapses in the activity groups is flawed, even for synapses belonging to the same presynaptic cell. The density of postsynaptic cells is also orders of magnitude of, etc. Ideally, every claim made about the model's output should be supported by a parameter sensitivity study. The authors performed few explorations of parameter sensitivity and many of the choices made seem ad hoc.  

      We have performed detailed sensitivity analysis on the model parameters mentioned by the reviewer, including (I) the density of postsynaptic cells (somatas), (II) the density of potential synapses, and (III) the level of correlations between synapses. 

      (I) While the density of postsynaptic cells in our baseline model seems a bit low, at least when compared to densities observed in adulthood (Keller et al., 2018), we explored how altering this value affects the model dynamics. We found that the postsynaptic cell density does not affect the timing of dendritic outgrowth, overshoot and synaptic pruning. It only changes the final size of the dendritic arbor and the resulting number of connected synapses. This analysis is now included in Supplementary Figure 3-2.

      (II) The density of potential synapses and the density of connected synapses that we used in the manuscript are already in the range of densities that can be found in the literature (Leighton et al., 2024; Ultanir et al., 2007; Glynn et al., 2011; Yang et al., 2014), some of which we already cited in the original submission.

      A potential concern might be that the rapid slowing down of growth in the model could be due to a depletion of potential synapses. To illustrate that this is not the case, we showed that the number of available potential synapses over the time course of the simulations remains high (Figure 3, new panel e). Therefore, the initial density of potential synapses is sufficient and does not affect the final density of connected synapses.

      To further illustrate the robustness of our model dynamics to longer simulation times, we added a new supplementary figure (Supplementary Figure 3-1).

      These new figure additions (Figure 3e, Supplementary Figure 3-1, and Supplementary Figure 3-2) and their implications for the model dynamics are discussed in the Results section of the revised paper:

      p.9 line 198, “After the initial overshoot and pruning, dendritic branches in the model stay stable, with mainly small subbranches continuing to be refined (Figure 3-Figure Supplement 1). This stability in the model is achieved despite the number of potential synaptic partners remaining high (Figure 3e), indicating a balance between activity-independent and activitydependent mechanisms. The dendritic growth and synaptic refinement dynamics are independent of the postsynaptic somata densities used in our simulations (Figure 3-Figure Supplement 2). Only the final arbor size and the number of connected synapses decrease with an increase in the density of the somata, while the timing of synaptic growth, overshoot and pruning remains the same (Figure 3-Figure Supplement 2).”

      We also added more details to the description of our model in the Methods section:

      p.24 line 615, “For all simulations in this study, we distributed nine postsynaptic somata at regular distances in a grid formation on a 2-dimensional 185 × 185 pixel area, representing a cortical sheet (where 1 pixel = 1 micron, Figure 4). This yields a density of around 300 neurons per 𝑚𝑚2 (translating to around 5,000 per 𝑚𝑚3, where for 25 neurons in Figure 3Figure Supplement 2 this would be around 750 neurons per 𝑚𝑚2 or 20,000 per 𝑚𝑚3). The explored densities are a bit lower than compared to neuron densities observed in adulthood (Keller et al., 2018). In the same grid, we randomly distributed 1,500 potential synapses, yielding an initial density of 0.044 potential synapses per 𝜇𝑚2 (Figure 3e). At the end of the simulation time, around 1,000 potential synapses remain, showing that the density of potential synapses is sufficient and does not significantly affect the final density of connected synapses. Thus, the rapid slowing down of growth in our model is not due to a depletion of potential synaptic partners. The resulting density of stably connected synapses is approximately 0.015 synapses per 𝜇𝑚2 (around 60 synapses stabilized per dendritic tree, Figure 3b). This density compares well to experimental findings, where, especially during early development, synaptic densities are described to be within a range similar to the one observed in our model (Leighton et al., 2024; Ultanir et al., 2007; Glynn et al., 2011; Yang et al., 2014; Koshimizu et al., 2009; Tyler and Pozzo-Miller, 2001).”

      (III) Lastly, we investigated how the correlation between synapses of the same activity group might affect our conclusions. As correlations in our model mainly arise from patterns of spontaneous activity which are abundant in early postnatal development (retinal waves (Ackman et al., 2012) or endogenous activity in the form of highly synchronized events involving a large fraction of the cells (Siegel et al., 2012), we explored varying the correlations within each activity group, across activity groups and combinations of both. While this analysis supported our previously described intuition on how competition between synaptic activities should drive activity-dependent refinement, recently a study found direct evidence for such subcellular refinement of synaptic inputs specifically dependent on spontaneous activity between retinal ganglion cell axons and retinal waves in the superior colliculus (Matsumoto et al., 2024). The new analysis confirmed our earlier results that the competition between activity groups leads to activity-dependent refinement and yielded further insight into how the studied activity correlations can affect the competition. Those results are presented in a completely new figure (new Figure 5, supported by the Supplementary Figure 5-1 and 5-2) and discussed in the Results section:

      p.11 line 249, “Group activity correlations shape synaptic overshoot and selectivity competition across synaptic groups.

      Since correlations between synapses emerge from correlated patterns of spontaneous activity abundant during postnatal development (Ackman et al., 2012; Siegel et al., 2012), we explored a wide range of within-group correlations in our model (Figure 5a). Although a change in correlations within the group has only a minor effect on the resulting dendritic lengths (Figure 5b) and overall dynamics, it can change the density of connected synapses and thus also affect the number of connected synapses to which each dendrite converges throughout the simulations (Figure 5c,e). This is due to the change in specific selectivity of each dendrite which is a result of the change in within-group correlations (Figure 5d). While it is easier for perfectly correlated activity groups to coexist within one dendrite (Figure 5-Figure Supplement 1a, 100%), decreasing within-group correlations increases the competition between groups, producing dendrites that are selective for one specific activity group (60%, Figure 5d, Figure 5-Figure Supplement 1a). This selectivity for a particular activity group is maximized at intermediate (approximately 60%) within-group correlations, while the contribution of the second most abundant group generally remains just above random chance levels (Figure 5-Figure Supplement 1a). Further reducing within-group correlations (20%, Figure 5a) causes dendrites to lose their selectivity for specific activity groups due to the increased noise in the activity patterns (20%, Figure 5a). Overall, reducing within-group correlations increases synapse pruning (Figure 5f, bottom), also found experimentally (Matsumoto et al., 2024) as dendrites require an extended period to fine-tune connections aligned with their selectivity biases. This phenomenon accounts for the observed reduction in both the density and number of synapses connected to each dendrite.

      In addition to the within-group correlations, developmental spontaneous activity patterns can also change correlations between groups as for example retinal waves propagated in different domains (Feller et al., 1997) (Figure 5-Figure Supplement 2). An increase in between-group correlations in our model intuitively decreases competition between the groups since fully correlated global events synchronize the activity of all groups (Figure 5-Figure Supplement 2). The reduction in competition reduces pruning in the model, which can be recovered by combining cross-group correlations with decreased within-group correlations (Figure 5-Figure Supplement 2). Our simulations show that altering the correlations within activity groups increases competition (by lowering the within-group correlations) or decreases competition (by raising the across-group correlations). Hence, in our model, competition between activity groups due to non-trivially structured correlations is necessary to generate realistic dynamics between activity-independent growth and activity-dependent refinement or pruning.

      In sum, our simulations demonstrate that our model can operate under various correlations in the spike trains. We find that the level of competition between synaptic groups is crucial for the activity-dependent mechanisms to either potentiate or depress synapses and is fully consistent with recent experimental evidence showing that the correlation between spontaneous activity in retinal ganglion cells axons and retinal waves in the superior colliculus governs branch addition vs. elimination (Matsumoto et al., 2024)."

      Precise details on the implementation of the changed activity correlations were added to the Methods section:

      p. 25 line 638, “Within-group and across-group activity correlations. For the decreased withingroup correlations, we generated parent spike trains for each individual group with the firing rate 𝑟𝑖𝑛 = 𝑟𝑡𝑜𝑡𝑎𝑙 ∗ 𝑃𝑖𝑛 (e.g., 𝑃𝑖𝑛 = 100%; 60%; 20%, Figure 5). All the synapses of the same group share the same parent spike train and the remaining spikes for each synapse are uniquely generated with the firing rate 𝑟𝑟𝑒𝑠𝑡 = 𝑟𝑡𝑜𝑡𝑎𝑙 ∗ (1 − 𝑃𝑖𝑛) (e.g., (1 − 𝑃𝑖𝑛) = 0%; 40%; 80%), resulting in the desired firing rate 𝑟𝑡𝑜𝑡𝑎𝑙 (see Table 1). For the increase in across-group correlations, we generated one master spike train with the firing rate 𝑟𝑐𝑟𝑜𝑠𝑠 = 𝑟𝑡𝑜𝑡𝑎𝑙 ∗ 𝑃𝑐𝑟𝑜𝑠𝑠 for all the synapses of all groups (e.g., 𝑃𝑐𝑟𝑜𝑠𝑠 = 5%; 10%; 20%, Figure 5-Figure Supplement 2). This master spike train is shared across all groups and then filled up according to the within-group correlation (if not specified differently 𝑃𝑖𝑛 = 1 − 𝑃𝑐𝑟𝑜𝑠𝑠 to maintain the rate 𝑟𝑡𝑜𝑡𝑎𝑙). In all the cases, also in those where the change in across-group correlations is combined with the change in within-group correlations, the remaining spikes for each synapse are generated with a firing rate 𝑟𝑟𝑒𝑠𝑡 = 𝑟𝑡𝑜𝑡𝑎𝑙 ∗ (1 − 𝑃𝑖𝑛 − 𝑃𝑐𝑟𝑜𝑠𝑠) to obtain an overall desired firing rate of 𝑟𝑡𝑜𝑡𝑎𝑙.”

      Point 1.2. Many potentially important phenomena seem to be excluded. I realize that no model can be complete, but the choice of which phenomena to include or exclude from this model could bias studies that make use of it and is worth serious discussion. The development of axons is concurrent with dendrite outgrowth, is highly dynamic, and perhaps better understood mechanistically. In this model, the inputs are essentially static. Growing dendrites acquire and lose growth cones that are associated with rapid extension, but these do not seem to be modeled. Postsynaptic firing does not appear to be modeled, which may be critical to activity-dependent plasticity. For example, changes in firing are a potential explanation for the global changes in dendritic pruning that occur following the outgrowth phase.  

      Thanks to the reviewer for bringing up these important considerations. We do indeed write in the Introduction (e.g. lines 36-76) which phenomena we include in the model and why. The Discussion also compares our model to others (lines 433-490), pointing out that most models either focus on activity-independent or activity-dependent phases. We include both, combining the influence of both molecular gradients and growth factors as well as activity-dependent connectivity refinements instructed by spontaneous activity. We consider our model a tractable, minimalist mechanistic model which includes both activity-independent and activity-dependent aspects. 

      Regarding postsynaptic firing, this is indeed super relevant and an important point to consider. In one of our recent publications (Kirchner and Gjorgjieva, 2021), we studied only an activity-dependent model for the organization of synaptic inputs on non-growing dendrites which have a fixed length. There, we considered the effect of postsynaptic firing (via a back-propagating action potential) and demonstrated that it plays an important role in establishing a global organization of synapses on the entire dendritic tree of the neuron. For example, we showed that it could lead to the emergence of retinotopic maps on the dendritic tree which have been found experimentally (Iacaruso et al., 2017). Since we use the same activity-dependent plasticity model in this paper, we expect that the somatic firing will have the same effect on establishing synaptic distributions on the entire dendritic tree. This is now also discussed in the Discussion section of the revised manuscript:

      p. 21 line 491, “Although we did not explicitly model postsynaptic firing, our previous work with static dendrites has shown that it can play an important role in establishing a global organization of synapses on the entire dendritic tree of the neuron (Kirchner and Gjorgjieva, 2021). For example, we showed that it could lead to the emergence of retinotopic maps on the dendritic tree which have been found experimentally (Iacaruso et al., 2017). Since we use the same activity-dependent plasticity model in this paper, we expect that the somatic firing will have the same effect on establishing synaptic distributions on the entire dendritic tree.”

      Including the concurrent development of axons in the model is indeed very interesting. In fact, a recent tour-de-force techniques paper found similar to what we assume. Hebbian activity-dependent dynamics of axonal branches of retinal ganglion cells experiencing spontaneous activity in relation to retinal waves in the superior colliculus (Matsumoto et al., 2024). New branches tend to be added at the locations where spontaneous activity of individual branches is more correlated with retinal waves, whereas asynchronous activity is associated with branch elimination. We suspect the same Hebbian activity-dependent dynamics to apply also to dendritic growth. 

      To address simultaneous dynamic axons to our growing dendrites, in the revised version of the manuscript, we included a simplified form of axonal dynamics by allowing changes in the lifetime and location of potential synapses, which come from axons of presynaptic partners. We explored different median lifetimes of synapses in combination with several distances with which a synapse can move in the simulated space (new Supplementary Figure 3-3). Our results show that dynamically moving synapses only affect the dynamics and stability of our model when the rate of moving synapses combined with the distance of moving synapses is faster than the dendritic growth. In scenarios in which synapses can move across large distances, dendrites get further destabilized due to synapses transferring from one dendrite to another, perturbing the attractor fields of the potential synapses even in late phases of the simulations. Besides such non-biological scenarios, dynamically moving synapses do not affect the model dynamics too much. Thus, they mostly add additional noise and variability to the growth and pruning without changing the timing and amplitude of the dynamics. These results are discussed in the results section of the revised manuscript:

      p.9 line 207, “The development of axons is concurrent with dendritic growth and highly dynamic Matsumoto et al. (2024). To address the impact of simultaneously growing axons, we implemented a simple form of axonal dynamics by allowing changes in the lifetime and location of potential synapses, originating from the axons of presynaptic partners (Figure 3-Figure Supplement 3). When potential synapses can move rapidly (median lifetime of 1.8 hours), the model dynamics are perturbed quite substantially, making it difficult for the dendrites to stabilize completely (Figure 3–Figure Supplement 3c). However, slowly moving potential synapses (median lifetime of 18 hours) still yield comparable results (Figure 3-Figure Supplement 3). The distance of movement significantly influenced results only when potential synaptic lifetimes were short. For extended lifetimes, the moving distance had a minor impact on the dynamics, predominantly affecting the time required for dendrites to stabilize. This was the result of synapses being able to transfer from one dendrite to another, potentially forming new long-lasting connections even at advanced stages of synaptic refinement. In sum, our results show that potential axonal dynamics only affect the stability of our model when these dynamics are much faster than dendritic growth.”

      Precise details on the implementation of the dynamically moving synapses and their synaptic lifetimes are now in the Methods section:

      p. 25 line 650, “Dynamically moving synapses. For the moving synapses we introduced lifetimes for each synapse, randomly sampled from a log-normal distribution with median 1.8h (for when they move frequently), 4.5h or 18h (for when they move rarely) and variance equal to 1 (Figure 3-Figure Supplement 3b). The lifetime of a synapse decreases only when the synapse is not connected to any of the dendrites (i.e., is a potential synapse). When the lifetime of a synapse expires, the synapse moves to a new location with a new lifetime sampled from the same log-normal distribution. This enables synapses to move multiple times throughout a simulation. The exact locations and distances to which each synapse can move are determined by a binary matrix (dimensions: 𝑝𝑖𝑥𝑒𝑙𝑑𝑖𝑠𝑡𝑎𝑛𝑐𝑒 × 𝑝𝑖𝑥𝑒𝑙𝑑𝑖𝑠𝑡𝑎𝑛𝑐𝑒) representing a ring (annulus) with the inner radius 𝑑/4 and outer radius 𝑑/2 , where the synapse location is at the center of the matrix. All the locations of the matrix within the ring boundaries (between the inner radius and outer radius) are potential locations to which the synapse can move. The synapse then moves randomly to one of the possible locations where no other synapse or dendrite is located. For the movement distances, we chose the ring dimensions 3 × 3, 25 × 25 and 101 × 101, yielding the moving distances (radii) of 1 pixel per movement, 12 pixels per movement and 50 pixels per movement (𝑟 = (𝑑−1)/2). These pixel distances represent small movements, as much as a dendrite can grow in one step (1 micron), and larger movements which are far enough so that the synapse will not attract the same branches again (12 microns) or far enough so that it might attract a completely different dendrite (50 microns, Figure 3-Figure Supplement 3a).”

      Point 1.3. Line 167. There are many ways to include activity -independent and -dependent components into a model and not every such model shows stability. A key feature seems to be that larger arbors result in reduced growth and/or increased retraction, but this could be achieved in many ways (whether activity dependent or not). It's not clear that this result is due to the combination of activity-dependent and independent components in the model, or conceptually why that should be the case.

      We never argued for model uniqueness. There are always going to be many different models (at different spatial and temporal scales, at different levels of abstraction). We can never study all of them and like any modeling study in systems neuroscience we have chosen one model approach and investigated this approach. We do compare the current model to others in the Discussion. If the reviewers have a specific implementation that we should compare our model to as an alternative, we could try, but not if this means doing a completely separate project.

      Point 1.4. Line 183. The explanation of overshoot in terms of the different timescales of synaptic additions versus activity-dependent retractions was not something I had previously encountered and is an interesting proposal. Have these timescales been measured experimentally? To what extent is this a result of fine-tuning of simulation parameters?  

      We found that varying the amount of BDNF controls the timescale of the activity-dependent plasticity (see our Figure 6c). Hence, changing the balance between synaptic additions vs. retractions is already explored in Figure 6e and f. Here we show that the overshoot and retraction does not have to be fine-tuned but may be abolished if there is too much activity-dependent plasticity. 

      Regarding the relative timescales of synaptic additions vs. retractions: since the first is mainly due to activity-independent factors, and the second due to activity-dependent plasticity, the questions is really about the timescales of the latter two. As we write in the Introduction (lines 61-63), manipulating activity-dependent synaptic transmission has been found to not affect morphology but rather the density and specificity of synaptic connections (Ultanir et al. 2007), supporting the sequential model we have (although we do not impose the sequence, as both activity-independent and activitydependent mechanisms are always “on”; but note that activity-dependent plasticity can only operate on synapses that have already formed).

      The described results are robust to parameter variations (performed on the postsynaptic density, potential synapse density, and within- and across-group correlations) as described in the reply to reviewer #1 point 1.1.

      Point 1.5. Line 203. This result seems at odds with results that show only a very weak bias in the tuning distribution of inputs to strongly tuned cortical neurons (e.g. work by Arthur Konnerth's group). This discrepancy should be discussed.  

      First, we note that the correlated activity experienced by our modeled synapses (and resulting synaptic organization) does not necessarily correspond to visual orientation, or any stimulus feature, for that matter, but is rather a property of correlated spontaneous activity. 

      Nonetheless, there is some variability in what the experimental data show. Many studies have shown that synapses on dendrites are organized into functional synaptic clusters: across brain regions, developmental ages and diverse species from rodent to primate (Kleindienst et al., 2011; Takahashi et al., 2012; Winnubst et al., 2015; Gökçe et al., 2016; Wilson et al., 2016; Iacaruso et al., 2017; Scholl et al., 2017; Niculescu et al., 2018; Kerlin et al., 2019; Ju et al., 2020, Hedrick et al., 2022, Hedrick et al., 2024). Interestingly, some in vivo studies have reported lack of fine-scale synaptic organization (Varga et al., 2011; X. Chen et al., 2011; T.-W. Chen et al., 2013; Jia et al., 2010; Jia et al., 2014), while others reported clustering for different stimulus features in different species. For example, dendritic branches in the ferret visual cortex exhibit local clustering of orientation selectivity but do not exhibit global organization of inputs according to spatial location and receptive field properties (Wilson et al. 2016; Scholl et al., 2017). In contrast, synaptic inputs in mouse visual cortex do not cluster locally by orientation, but only by receptive field overlap, and exhibit a global retinotopic organization along the proximal-distal axis (Iacaruso et al., 2017). We proposed a theoretical framework to reconcile these data: combining activity-dependent plasticity similar to the BDNF-proBDNF model that we used in the current work, and a receptive field model for the different species (Kirchner and Gjorgjieva, 2021). This is now also discussed in the Discussion section of the revised manuscript:

      p. 20 line 471, “The correlated activity experienced by our modeled synapses (and resulting synaptic organization) does not necessarily correspond to visual orientation, or any stimulus feature, for that matter, but is rather a property of spontaneous activity. Nonetheless, there is some variability in what the experimental data show. Many have shown that synapses on dendrites are organized into functional synaptic clusters: across brain regions, developmental ages and diverse species from rodent to primate (Kleindienst et al., 2011; Winnubst et al., 2015; Iacaruso et al., 2017; Scholl et al., 2017; Niculescu et al., 2018; Takahashi et al., 2012; Gökçe et al., 2016; Wilson et al., 2016; Kerlin et al., 2019; Ju et al., 2020; Hedrick et al., 2022, 2024). Other studies have reported lack of fine-scale synaptic organization (Chen et al., 2013; Varga et al., 2011; Chen et al., 2011; Jia et al., 2010, 2014). Interestingly, some of these discrepancies might be explained by different species showing clustering with respect to different stimulus features (orientation or receptive field overlap) (Scholl et al., 2017; Wilson et al., 2016; Iacaruso et al., 2017). Our prior work proposed a theoretical framework to reconcile these data: combining activity-dependent plasticity as we used in the current work, and a receptive field model for the different species (Kirchner and Gjorgjieva, 2021).”

      Point 1.6. Line 268. How does the large variability in the size of the simulated arbors relate to the relatively consistent size of arbors of cortical cells of a given cell type? This variability suggests to me that these simulations could be sensitive to small changes in parameters (e.g. to the density or layout of presynapses).  

      We again thank the reviewer for the detailed explanation and feedback on parameters that should be tested in more detail. We have explored several of the suggested model parameters and believe that we have managed to explain and illustrate their effects on the model's dynamics clearly. The precise changes are explained in the reply to point 1.1 and are now available in the revised version of the manuscript.

      Point 1.7. The modeling of dendrites as two-dimensional will likely limit the usefulness of this model. Many phenomena- such as diffusion, random walks, topological properties, etc - fundamentally differ between two and three dimensions.  

      Indeed, there are many differences between two and three dimensions. We have ongoing work that extends the current model to 3D but is beyond the scope of the current paper. In systems neuroscience, people have found very interesting results making such simplified geometric assumptions about networks, for instance the one-dimensional ring model has been used to uncover fundamental insights about computations even though highly simplified and abstracted. We are convinced that our model, especially with the new sensitivity analysis, makes interesting and novel contributions and predictions.

      Point 1.8. The description of wiring lengths as 'approximately optimal' in this text is problematic. The plotted data show that the wiring lengths are several deviations away from optimal, and the random model is not a valid instantiation of the 2D non-overlapping constraints the authors imposed. A more appropriate null should be considered.  

      We appreciate the reviewer’s feedback regarding the use of the term “approximately optimal” in describing wiring lengths. We acknowledge that our initial terminology was imprecise and could be misleading. We had previously referred to the minimal wiring length as the optimal wiring length, which does not fully capture the nuances of neuronal wiring optimization. As noted in prior literature, such as the work by Hermann Cuntz (Cuntz et al., 2010 & 2012), neurons can optimize their wiring beyond simply minimizing dendritic length.

      To address this issue, to better capture the balance between wiring minimization and functional constraints, such as conduction delays, we have developed a new modeling approach based on minimum spanning trees with a balancing factor (Cuntz et al., 2010 & 2012). This factor modulates the trade-off between minimizing wiring length and accounting for conduction delays from synapses to the soma. Specifically, the model assumes a balance between minimizing the total dendritic length and minimizing the tree distance between synapses and the site of input integration, typically the soma. This balance is illustrated in Figure 8 (Figure 7 in the original manuscript), where we demonstrate that the deviation from the theoretical minimum length arises because direct paths to synapses often require longer dendrites in our models.

      Together with the new result, which we added as the new panels f, g and h to Figure 8 (originally Figure 7), we also adjusted panel a of Figure 8, to now illustrate the difference between random wiring, minimal wiring and minimal conductance delay. The updated Figure 8 and its new findings are discussed in the results section of the revised manuscript:

      p.17 line 387, “This deviation is expected given that real dendrites need to balance their growth processes between minimizing wire while reducing conduction delays. The interplay between these two factors emerges from the need to reduce conduction delays, which requires a direct path length from a given synapse to the soma, consequently increasing the total length of the dendritic cable. (Cuntz et al., 2010, 2012; Ferreira Castro et al., 2020).

      To investigate this further, we compared the scaling relations of the final morphologies of our models with other synthetic dendritic morphologies generated using a previously described minimum spanning tree (MST) based model. The MST model balances the minimization of total dendritic length and the minimization of conduction delays between synapses and the soma. This balance results in deviations from the theoretical minimum length because direct paths to synapses often require longer dendrites (Cuntz et al., 2008, 2010). The balance in the model is modulated by a balancing factor (𝑏𝑓 ). If 𝑏𝑓 is zero, dendritic trees minimize the cable only, and if 𝑏𝑓 is one, they will try to minimize the conduction delays as much as possible. It is important to note that the MST model does not simulate the developmental process of dendritic growth; it is a phenomenological model designed to generate static morphologies that resemble real cells.

      To facilitate the comparison of total lengths between our simulated and MST morphologies, we generated MST models under the same initial conditions (synaptic spatial distribution) as our models and simulated them to match several morphometrics (total length, number of terminals, and surface area) of our grown morphologies. This allowed us to create a corresponding MST tree for each of our synthetic trees. Consequently, we could evaluate whether the branching structures of our models were accurately predicted by minimum spanning trees based on optimal wiring constraints. We found that the best match occurred with a trade-off parameter 𝑏𝑓 = 0.9250 (Figure 8f). Using the morphologies generated by the MST model with the specified trade-off parameter (𝑏𝑓 ), we showed that the square root of the synapse count and the total length (𝐿) in both our model generated trees and the MST trees exhibit a linear scaling relationship (Figure 8g; 𝑅2 = 0.65). The same linear relationship can be observed for the square root of the surface area and the total length 𝐿 of our model trees and the MST trees (Figure 8h; 𝑅2 = 0.73). Overall, these results indicate that our model generate trees are wellfitted by the MST model and follow wire optimization constraints.

      We acknowledge that the value of the balancing factor 𝑏𝑓 in our model is higher than the range of balancing factors that is typically observed in the biological dendritic counterparts, which generally ranges between 0.2 and 0.4 (Cuntz et al., 2012; Ferreira Castro et al., 2020; Baltruschat et al., 2020). However, it is still remarkable that our model, which does not explicitly address these two conservation laws, achieves approximately optimal wiring. Why do we observe such a high 𝑏𝑓 value? We reason that two factors may contribute to this. First, in our models, local branches grow directly to the nearest potential synapse, potentially taking longer routes instead of optimally branching to minimize wiring length (Wen and Chklovskii, 2008). Second, the growth process in our models does not explicitly address the tortuosity of the branches, which can increase the total length of the branches used to connect synapses. In the future, it will be interesting to add constraints that take these factors into account. Taken together, combining activity-independent and -dependent dendrite growth produces morphologies that approximate optimal wiring.”

      Further details on the fitted MST model and the corresponding analysis were added to the methods section:

      p.26 line 669, “Comparison with wiring optimization MST models. To evaluate the wire minimization properties of our model morphologies (n=288), we examined whether the number of connected synapses (N), total length (L), and surface area of the spanning field (S) conformed to the scaling law 𝐿 ≈ 𝜋−1/2 ⋅ 𝑆1/2 ⋅ 𝑁1/2 (Cuntz et al., 2012). Furthermore, to validate that our model dendritic morphologies scale according to optimal wiring principles, we created simplified models of dendritic trees using the MST algorithm with a balancing factor (bf). This balancing factor adjusts between minimizing the total dendritic length and minimizing the tree distance between synapses and the soma (Cost = 𝐿 + 𝑏𝑓 ⋅ 𝑃 𝐿) (MST_tree; best bf = 0.925) (Cuntz et al., 2010); TREES Toolbox http://www.treestoolbox.org).

      Initially, we generated MSTs to connect the same distributed synapses as our models. We performed MST simulations that vary the balancing factor between 𝑏𝑓 = 0 and 𝑏𝑓 = 1 in steps of 0.025 while calculating the morphometric agreement by computing the error (Euclidean distance) between the morphologies of our models and those generated by the MST models. The morphometrics used were total length, number of terminals, and surface area occupied by the synthetic morphologies.”

      Point 1.9. It's not clear to me what the authors are trying to convey by repeatedly labeling this model as 'mechanistic'. The mechanisms implemented in the model are inspired by biological phenomena, but the implementations have little resemblance to the underlying biophysical mechanisms. Overall my impression is that this is a phenomenological model intended to show under what conditions particular patterns are possible. Line 363, describing another model as computational but not mechanistic, was especially unclear to me in this context.  

      What we mean by mechanistic is that we implement equations that model specific mechanisms i.e. we have a set of equations that implement the activity-independent attraction to potential synapses (with parameters such as the density of synapses, their spatial influence, etc) and the activitydependent refinement of synapses (with parameters such as the ratio of BDNF and proBDNF to induce potentiation vs depression, the activity-dependent conversion of one factor to the other, etc). This is a bottom-up approach where we combine multiple elements together to get to neuronal growth and synaptic organization. This approach is in stark contrast to the so-called top-down or normative approaches where the method would involve defining an objective function (e.g. minimal dendritic length) which depends on a set of parameters and then applying a gradient descent or other mathematical optimization technique to get at the parameters that optimize the objective function. This latter approach we would not call mechanistic because it involves an abstract objective function (who could say what a neuron or a circuit should be trying to optimize?) and a mathematical technique for how to optimize the function (we don’t know if neurons can compute gradients of abstract objective functions). 

      Hence our model is mechanistic, but it does operate at a particular level of abstraction/simplification. We don’t model individual ion channels, or biophysics of synaptic plasticity (opening and closing of NMDA channels, accumulation of proteins at synapses, protein synthesis). We do, however, provide a biophysical implementation of the plasticity mechanism through the BDNF/proBDNF model which is more than most models of plasticity achieve, because they typically model a phenomenological STDP or Hebbian rule that just uses activity patterns to potentiate or depress synaptic weights, disregarding how it could be implemented. To the best of our understanding, this is what is normally considered mechanistic in the field (in contrast to, for example, biophysical).

      Reviewer #2 (Public Review): 

      This work combines a model of two-dimensional dendritic growth with attraction and stabilisation by synaptic activity. The authors find that constraining growth models with competition for synaptic inputs produces artificial dendrites that match some key features of real neurons both over development and in terms of final structure. In particular, incorporating distance-dependent competition between synapses of the same dendrite naturally produces distinct phases of dendritic growth (overshoot, pruning, and stabilisation) that are observed biologically and leads to local synaptic organisation with functional relevance. The approach is elegant and well-explained, but makes some significant modelling assumptions that might impact the biological relevance of the results. 

      Strengths: 

      The main strength of the work is the general concept of combining morphological models of growth with synaptic plasticity and stabilisation. This is an interesting way to bridge two distinct areas of neuroscience in a manner that leads to findings that could be significant for both. The modelling of both dendritic growth and distance-dependent synaptic competition is carefully done, constrained by reasonable biological mechanisms, and well-described in the text. The paper also links its findings, for example in terms of phases of dendritic growth or final morphological structure, to known data well. 

      Weaknesses: 

      The major weaknesses of the paper are the simplifying modelling assumptions that are likely to have an impact on the results. These assumptions are not discussed in enough detail in the current version of the paper. 

      (1) Axonal dynamics. 

      A major, and lightly acknowledged, assumption of this paper is that potential synapses, which must come from axons, are fixed in space. This is not realistic for many neural systems, as multiple undifferentiated neurites typically grow from the soma before an axon is specified (Polleux & Snider, 2010). Further, axons are also dynamic structures in early development and, at least in some systems, undergo activity-dependent morphological changes too (O'Leary, 1987; Hall 2000). This paper does not consider the implications of joint pre- and post-synaptic growth and stabilisation.  

      We thank the reviewer for the summary of the strengths and weaknesses of the work. While we feel that including a full model of axonal dynamics is beyond the scope of the current manuscript, some aspects of axonal dynamics can be included and are now implemented and tested in the revised manuscript. Since this feedback covers similar aspects of the model that were also pointed out by reviewer #1, we refer here to our detailed reply to their comments 1.1 and 1.2, where we list and discuss all the analyses performed to address the raised issues.

      (2) Activity correlations 

      On a related note, the synapses in the manuscript display correlated activity, but there is no relationship between the distance between synapses and their correlation. In reality, nearby synapses are far more likely to share the same axon and so display correlated activity. If the input activity is spatially correlated and synaptic plasticity displays distance-dependent competition in the dendrites, there is likely to be a non-trivial interaction between these two features with a major impact on the organisation of synaptic contacts onto each neuron.  

      We have explored the amount of correlation (between and within correlated groups) in the revised manuscript (see also our reply to reviewer comment 1.1).

      However, previous experimental work, (e.g. Kleindienst et al., 2011) has provided anatomical and functional analyses that it is unlikely that the functional synaptic clustering on dendritic branches is the result of individual axons making more than one synapse (see pg. 1019).

      (3) BDNF dynamics 

      The models are quite sensitive to the ratio of BDNF to proBDNF (eg Figure 5c). This ratio is also activity-dependent as synaptic activation converts proBDNF into BDNF. The models assume a fixed ratio that is not affected by synaptic activity. There should at least be more justification for this assumption, as there is likely to be a positive feedback relationship between levels of BDNF and synaptic activation.  

      The reviewer is correct. We used the BDNF-proBDNF model for synaptic plasticity based on our previous work (Kirchner and Gjorgjieva, 2021).  

      There, we explored only the emergence of functionally clustered synapses on static dendrites which do not grow. In the Methods section (Parameters and data fitting) we justify the choice of the ratio of BDNF to proBDNF from published experimental work. We also performed sensitivity analysis (Supplementary Fig. 1) and perturbation simulations (Supplementary Fig. 3), which showed that the ratio is crucial in regulating the overall amount of potentiation and depression of synaptic efficacy, and therefore has a strong impact on the emergence and maintenance of synaptic organization. Since we already performed all this analysis, we expect that the same results will also apply to the current model which includes dendritic growth, as it involves the same activity-dependent mechanism.

      A further weakness is in the discussion of how the final morphologies conform to principles of optimal wiring, which is quite imprecise. 'Optimal wiring' in the sense of dendrites and axons (Cajal, 1895; Chklovskii, 2004; Cuntz et al, 2007, Budd et al, 2010) is not usually synonymous with 'shortest wiring' as implied here. Instead, there is assumed to be a balance between minimising total dendritic length and minimising the tree distance (ie Figure 4c here) between synapses and the site of input integration, typically the soma. The level of this balance gives the deviation from the theoretical minimum length as direct paths to synapses typically require longer dendrites. In the model this is generated by the guidance of dendritic growth directly towards the synaptic targets. The interpretation of the deviation in this results section discussing optimal wiring, with hampered diffusion of signalling molecules, does not seem to be correct. 

      We agree with this comment. We had wrongly used the term “optimal wiring” as neurons can optimize their wiring not only by minimizing their dendritic length but other factors as noted by the reviewer. In the revised manuscript we replaced the term “optimal wiring” with “minimal wiring” wherever it was incorrectly used. On top of that, we performed further analysis and discussed these differences, as pointed out in the reply to reviewer #1 point 1.8.

      To summarize, we want to again thank the reviewer for their in-depth review and all the suggestions that helped us improve the analysis and implementation of our model.

      Reviewer #3 (Public Review): 

      The authors propose a mechanistic model of how the interplay between activity-independent growth and an activity-dependent synaptic strengthening/weaken model influences the dendrite shape, complexity and distribution of synapses. The authors focus on a model for stellate cells, which have multiple dendrites emerging from a soma. The activity independent component is provided by a random pool of presynaptic sites that represent potential synapses and that release a diffusible signal that promotes dendritic growth. Then a spontaneous activity pattern with some correlation structure is imposed at those presynaptic sites. The strength of these synapses follow a learning rule previously proposed by the lab: synapses strengthen when there is correlated firing across multiple sites, and synapses weaken if there is uncorrelated firing with the relative strength of these processes controlled by available levels of BDNF/proBDNF. Once a synapse is weakened below a threshold, the dendrite branch at that site retracts and loses its sensitivity to the growth signal 

      The authors run the simulation and map out how dendrites and synapses evolve and stabilize. They show that dendritic trees growing rapidly and then stabilize by balancing growth and retraction (Figure 2). They also that there is an initial bout of synaptogenesis followed by loss of synapses, reflecting the longer amount of time it takes to weaken a synapse (Figure 3). They analyze how this evolution of dendrites and synapses depends on the correlated firing of synapses (i.e. defined as being in the same "activity group"). They show that in the stabilized phase, synapses that remain connected to a given dendritic branch are likely to be from same activity group (Figure 4). The authors systemically alter the learning rule by changing the available concentration of BDNF, which alters the relative amount of synaptic strengthening, which in turn affects stabilization, density of synapses and interestingly how selective for an activity group one dendrite is (Figure 5). In addition the authors look at how altering the activity-independent factors influences outgrowth (Figure 6). Finally, one of the interesting outcomes is that the resulting dendritic trees represent "optimal wiring" solutions in the sense that dendrites use the shortest distance given the distribution of synapses. They compare this distribute to one published data to see how the model compared to what has been observed experimentally.  

      There are many strengths to this study. The consequence of adding the activity-dependent contribution to models of synapto- and dendritogenesis is novel. There is some exploration of parameters space with the motivation of keeping the parameters as well as the generated outcomes close to anatomical data of real dendrites. The paper is also scholarly in its comparison of this approach to previous generative models. This work represented an important advance to our understanding of how learning rules can contribute to dendrite morphogenesis.

      We thank the reviewer for the positive evaluation of the work and the suggestions below.

      To improve the clarity of the manuscript, we adjusted and fixed some figures and corresponding paragraphs as follows:

      (1) We increased the number of ticks and their corresponding numbers in all the figures to make them easier to read and interpret.

      (2) In Figure 3 panel d, showing the evolution of synaptic weight, we corrected the upper limit at the yaxis to 1 (from previously 2).

      (3) Due to a typo in the implementation of the BDNF concentration, we had to correct the used BDNF concentrations from 49%, 45% and 40%, to 49%, 46.5% and 43% respectively.

      (4) The y-axis labels of Figure 6 (old Figure 5) panel e and f were changed to make the plots clearer (e: “morphology change explained (%)” to "effect on morphology (%)", and f: “synapse connection explained (%)” to "effect on connected synapses (%)").

      (5) The values for the eta and tau-w in the supplementary Table were corrected. Previously tau-w was falsely 6000 time steps which was corrected to 3000 time steps, and eta was 45% and is now 46.5%.

      We believe that all the changes to the manuscript will address the reviewer’s concerns and enhance the clarity and accuracy of the findings described in the manuscript.

    1. Author response:

      We thank the reviewers for their thoughtful comments. We are working to revise our manuscript and address each of the reviewers comments. A summary of our planned revisions and responses to some of the reviewers’ major concerns are included below.

      Cultivation Density: Reviewers #1 and #2 suggested that additional studies testing the effects of varying bacterial density during animal development (cultivation) would strengthen our findings. While we agree with the reviewers that this is a very interesting experiment, it is not feasible. Indeed, we attempted this experiment but found it nontrivial to maintain stable bacterial density conditions over long timescales as this requires matching the rate of bacterial growth with the rate of bacterial consumption. Despite our best efforts, we have not been able to identify conditions that satisfy these requirements. We will focus our revised manuscript to include only assertions about the effects of recent experiences.

      Transfer Method: Reviewers #1 and #2 expressed concern that the stress of transferring animals to a new plate may have resulted in an increased arousal state and thus a greater probability of rejecting patches. We thank the reviewers for this thoughtful remark and plan to conduct additional analyses to address this hypothesis. We did, however, anticipate this possibility and, to mitigate the stress of moving, we used an agar plug method where animals were transferred using the flat surface of small cylinders of agar. Importantly, the use of agar as a medium to transfer animals provides minimal disruption to their environment as all physical properties (e.g. temperature, humidity, surface tension) are maintained. Qualitatively, we observe no marked change in behavior from before to after transfer with the agar plug method, especially as compared to the often drastic changes observed when using a metal or eyelash pick.

      Time Parameter: Related to the transfer method, Reviewer #1 expressed concern that the simplest time parameter (time since start of the assay) might better predict animal behavior. We thank the reviewer for pointing out the need to specifically test whether the time-dependent change in explore-exploit decision-making corresponds better with satiety (time off patch) or arousal (time since transfer/start of assay) state. We will conduct additional analyses to address these alternative hypotheses.

      Parameter Initialization: Reviewer #1 pointed out an oversight in our methods section regarding the model parameter values used for the first encounter. We plan to clarify the initialization of parameters in the manuscript. In short, for the first patch encounter where k = 1:

      ρk is the relative density of the first patch.

      τs is the duration of time spent off food since the beginning of the recorded experiment. For the first patch, this is equivalent to the total time elapsed.

      ρh is the approximated relative density of the bacterial patch on the acclimation plates (see Assay preparation and recording in Methods). Acclimation plates contained one large 200 µL patch seeded with OD600 = 1 and grown for a total of ~48 hours. As with all patches, the relative density was estimated from experiments using fluorescent bacteria OP50-GFP as described in Bacterial patch density estimation in Methods.

      ρe is equivalent to ρh.

      Sensing vs. non-sensing: Reviewer #3 suggested that the term “non-sensing” may not be ethologically accurate. We thank the reviewer for their comment and agree that we do not know for certain whether the animals sensed these patches or were merely non-responsive to them. We are, however, confident that these encounters lack evidence of sensing. Specifically, we note that our analyses used to classify events as sensing or non-sensing examined whether an animal’s slow-down upon patch entry could be distinguished from either that of events where animals exploited or that of encounters with patches lacking bacteria. We found that  “non-sensing” encounters are indeed indistinguishable from encounters with bacteria-free patches where there are no bacteria to be sensed (see Figure 2 - Supplement 7C-D and Patch encounter classification as sensing or non-sensing in Methods). Regardless, we agree with the reviewer that all that can be asserted for certain about these events is that animals do not respond to the bacterial patch in any way that we measured. Therefore, we will replace the term “non-sensing” with “non-responding” to better indicate the ethological interpretation of these events.

      Time-dependent changes in sensing vs. non-sensing: Reviewer #1 remarked that the sensation of dilute patches increases with time. We agree with the reviewer that we observe increased responsiveness to dilute patches with time. Although this is interesting, our primary focus was on what decision an animal made given that they clearly sensed the presence of the bacterial patch. Nonetheless, we will add this observation to the discussion as an area of future work to investigate the sensory mechanisms behind this effect.

      Classification of sensing vs. non-sensing: Reviewers #2 and #3 expressed concerns about the validity of the two clusters identified using the semi-supervised QDA approach described. We are grateful to the reviewers for pointing out the difficulty in visualizing the clusters and the need for additional clarity in explaining the supervised labeling. We will use additional visualizations and methods to validate the clusters we have discovered. Specifically, we aim to provide additional evidence that the sensing vs. nonsensing data is bi-modal (i.e. a two-cluster classification method fits best). Further, it seems that there may be some confusion as to how we arrived at 3 encounter types (i.e. search, sample, exploit) that we plan to clarify in the manuscript. Specifically, it’s important to note that two methods were used on two different (albeit related) sets of parameters. We first used a two-cluster GMM to classify encounters as explore or exploit. We then used a two-cluster semi-supervised QDA to classify encounters as sensing or non-sensing (to be changed to “non-responding”, see above response) using a different set of parameters. We thus separated the explore cluster into two (sensing and non-sensing exploratory events) resulting in three total encounter types: exploit, sample (explore/sensing), and search (explore/non-sensing). We will clarify this in the text. Additionally, we will clarify the labelling used for “supervising” QDA. Specifically, we made two simple assumptions: 1) animals must have sensed the patch if they exploited it and 2) animals must not have sensed the patch if there were no bacteria to sense. Thus, we labeled encounters as sensing if they were found to be exploitatory as we assume that sensation is prerequisite to exploitation; and we labeled encounters as non-sensing for events where animals encountered patches lacking bacteria (OD600 = 0). All other points were non-labeled prior to learning the model. In this way, our labels were based on the experimental design and results of the GMM, an unsupervised method; rather than any expectations we had about what sensing should look like. The semi-supervised QDA method then used these initial labels to iteratively fit a paraboloid that best separated these clusters, by minimizing the posterior variance of classification.

      Accept-reject vs. stay-switch: Reviewers #1 and #2 ask for additional discussion on how the accept-reject decision-making framework differs from the stay-switch framework. We thank the reviewers for alerting us to this gap in our discussion. We intend to clarify that these frameworks ask two different types of questions (i.e. “Do you want to eat it?” versus “If so, how long do you want to eat it for?”). These concepts are well described in canonical foraging theory literature (see Pyke, Pulliam & Charnov 1977 for a review on the subject) and are easily distinguishable for animals that forage using the following framework: 1) search for prey, 2) encounter prey from a distance, 3) identify prey type, 4) decide to pursue (accept-reject decision), 5) pursue and capture the prey, 6) exploit prey, and 7) decide to stop exploiting and start searching again (stay-switch decision). In this case, it is easy to see the distinction between accept-reject and stay-switch decisions. However, in some scenarios, animals must physically encounter prey prior to identification and then must make an accept-reject decision. In these cases where pursuit and capture are not visualized, it is harder to distinguish between accept-reject and stay-switch decisions. In our experiments, we find significant bimodality in encounter duration (see Figure 2H) where short duration (exploratory) encounters appear to represent a lower bound where animals spend the minimum amount of time possible on a patch (less than 2 minutes), which we interpret as a rejection of the patch. On the other hand, exploitatory encounters span a large range of durations from 2 to 60+ minutes which we interpret as an initial acceptance of the patch followed by a series of stay-switch decisions which determine the overall duration of the encounter. While one could certainly model our data using only stay-switch decision-making, we ascertain that an encounter of minimal duration is better interpreted ethologically as a rejection than as an immediate switch decision. We will revise the text to further extrapolate upon our point of view on this somewhat philosophical distinction and what it predicts about C. elegans behavior.

      Sensory mutant behavior: Reviewers #1 and #3 ask for further speculation on the observed behavior of osm-6 and mec-4 animals. We will further elaborate on our findings, how they relate to previous studies, and what they suggest about the mechanisms behind these foraging decisions.

      Model design: Reviewer #3 suggested several alterations to the behavioral model. While the proposed model seems entirely reasonable and could aid in elucidating the time component of how prior experience affects decision-making, we chose the present model based on our experience with model selection using these data. Indeed, as the reviewer suggested, we did a great number of analyses involving model selection including model selection criteria (AIC, BIC) and optimization with regularization techniques (LASSO and elastic nets). We found that the problem of model selection was compounded by the enormous array of highly correlated variables we had to choose from. Additionally, we found that both interaction terms and non-linear terms of our task variables could be predictive of accept-reject decisions but that the precise set of terms selected depended sensitively on which model selection technique was used and generally made rather small contributions to prediction. The diverse array of results and combinatorial number of predictors to possibly include failed to add anything of interpretable value. We therefore chose to take a different approach to this problem. Rather than trying to determine what the “best” model was we instead asked whether a minimal model could be used to answer a set of core questions. Indeed, our goal was not maximal predictive performance but rather to distinguish between the effects of different influences enough to determine if encounter history had a significant, independent effect on decision making. We thus chose to only include task variables that spanned the most basic components of behavioral mechanisms to ask very specific questions. For example, we selected a time variable that we thought best encapsulated satiety. While we could have included many additional terms, or made different choices about which terms to include, based on our analyses these choices would not have qualitatively changed our results. Further, we sought to validate the parameters we chose with additional studies (i.e. food-deprived and sensory mutant animals). We regard our study as an initial foray into demonstrating accept-reject decision-making in nematodes. The exact mechanisms and, consequently, the best model design is therefore beyond the scope of this study. Lastly, Reviewer #3 criticized the use of only sensed patches in the model. While we acknowledge that we are not certain as to whether the “non-sensing” encounters are truly not sensed, we find qualitatively similar results when including all exploratory patches in our analyses. In fact, when all encounters are used, we find stronger correlations between our task variables and the accept-reject decision. However, we take the position that sensation is necessary for decision-making and thus believe that while our model’s predictive performance may be better using all encounters, the interpretation of our findings is stronger when we only include sensing events.

    1. Author response:

      First of all, I'd like to express my heartfelt thanks to you for your meticulous and professional review comments. Your feedback is very important to our work. It not only helps us identify the shortcomings in the paper, but also provides valuable guidance for improving the quality of the paper.

      We carefully read every suggestion you made and were deeply inspired. Please rest assured that we will carefully consider and revise each opinion to ensure that our research work is more rigorous and clear. We promise to revise the manuscript accordingly to meet the standards of the journal and enhance the credibility and influence of the research.

      The main modifications include the experiment of A Mid1 supplementation experiment in Mid1 knockout micesupplementing Mid1 in Mid1 knockout mice; Detection of kinases such as CaMKII, PKA and ERK1/2; Supplementary references; Supplement the behavioral experiment of new object recognition; Electrophysiological measurement experiment of supplementing LTP; Supplementary neuron-specific immunohistochemical staining experiment; Supplementing the information of knockout mice used in the study; Modify the language expression of the article and the problem of too few pictures.

      Thank you again for your valuable time and professional advice. We look forward to submitting the revised manuscript to you for further review.

    1. Author response:

      Reviewer #1 (Public review):

      Summary:

      Cesar, Santos & Cogni use a meta-analysis to report on the direction and magnitude of three fundamental fitness components in defensive symbioses. Specifically, the work focuses on interactions between three arthropod host families (Aphididae, Culicidae, Drosophilidae, and others) and common bacterial endosymbionts (Wolbachia, Serratia, Hamiltonella, Spiroplasma, Rickettsia, Regiella X-type and Arsenophonus). The results of the overall analysis confirm common assumptions and previous work on such fitness components, showing that defensive symbionts provide strong protection to hosts and cause detectable costs to both hosts and the enemy. The analysis provides insight into the extent of the cost/benefit tradeoff for hosts, reporting that the cost is six times lower than the protective effect. The confirmation that natural enemies attacking hosts infected with symbionts have a reduction in their fitness is also an interesting one, as this shows that the majority of defensive symbionts provide protection by resisting enemy infection, as opposed to tolerating it. This finding has important consequences for evolutionary counter-responses in the enemy species. Of course, this result has less relevance for certain types of enemies (such as parasitoids) where successful infection is dependent upon host killing.

      Interesting results also emerge from the subgroup analysis. For the full dataset, both natural and introduced symbionts were similarly effective in positively influencing the fitness of hosts. However, in the Wolbachia-specific analysis, the artificially introduced symbionts caused costs to the hosts where the natural strain did not. These findings have potentially important ramifications for schemes that use endosymbionts for biocontrol or vector competence, suggesting that (in some cases) natural strains may be the more stable choice for deploying (as they are associated with lower costs).

      The analysis draws from an impressively large dataset, but the interpretation of the full impact of the results would be helped by greater detail on the species/strain level systems included, the data extraction approach, and inclusion criteria. Accounting for phylogenetic nonindependence and alternative coding of one of the moderator variables could also strengthen the biological relevance of the models. Suggestions and thoughts are outlined below.

      We sincerely thank Reviewer #1 for the time and effort dedicated to reviewing our manuscript. The suggestions provided are highly constructive and will greatly assist us in improving both our analyses and the manuscript overall.

      Strengths & Potential Improvements:

      An impressively large number of effect sizes (3000) from only 226 studies is collected, robustly confirming common assumptions on the magnitude of fundamental fitness components. However the paper would benefit from a clear breakdown in the main text of the specificities of each system included (e.g. a table at the host species/symbiont strain level, where it is possible). Currently, there is not enough detail for those who want a deep dive to understand what data was extracted for the analysis from these 226 studies, or those who want to understand the underlying diversity in the dataset.

      We thank the reviewer for the suggestion, and we will add this information to our revised manuscript.

      Currently, when the 'natural enemy group' is tested as a moderator it is coded broadly by type of organism (e.g. virus, bacterium, fungi, parasitoid). But this doesn't adequately capture the mode of killing/fitness reduction by the enemy, which would be the much more biologically relevant categorisation for your questions. For example, parasitoid infection is dependent upon host death (thus host fecundity is not relevant, because the host either survived or did not). Among bacterial and viral pathogens antagonists there is scope for both fecundity and survival to be affected. This in turn may be a very influential factor for the outcome. You could consider recoding this enemy moderator.

      We agree, and we will implement this in the analysis to our revised manuscript.

      The analysis is restricted to arthropod hosts and defensive symbionts that are also classed as endosymbionts. This focus should be made clear early on in the paper, as there are many systems (that are classed by many as defensive symbioses) that are not part of the analysis.

      We agree, and we will implement this to our revised manuscript.

      There is fairly minimalistic testing of moderators/sub-groups (which probably has its statistical strengths) but perhaps there are also some missed opportunities for testing other ecological contributors to variance, including coinfection (although perhaps limited by power) and other approaches to coding enemy group (as detail above).

      We agree, and we will implement this in the analysis to our revised manuscript.

      Looking at the overview of systems included, there's likely a high degree of phylogenetic non-independence in the dataset. Where it is possible, using phylogenetically controlled models could strengthen this analysis.

      We thank the reviewer for the suggestion. We will explore the possibility of using phylogenetically controlled models in our analyses, although we recognize the challenges associated with their implementation, particularly in the case of the natural enemies, given the great diversity of distant related groups included in our study - viruses, bacteria, fungi, protozoans, nematodes and parasitoids wasps.

      Looking at your included systems (Table S5), you might be able to test the effect of coinfection on the 3 variables of interest. For example, it would be particularly important to see if the effects of two symbionts are additive or not.

      We agree, and we will implement this in the analysis to our revised manuscript.

      No code for the analysis is provided for review at this stage and full details of the dataset are also not available. This slightly limits the ability to assess the full scope and robustness of the study. It would be helpful to have an extensive table in the supplementary detailing (minimum) the reference, study, experiment, host species, symbiont strain, and a description of the exact data extraction source (e.g.table/figure/in text), and method of extraction.

      The code for the analysis and the full raw data with the suggested information are available at https://github.com/cassiasqr/MetaSymbiont (The link is available at the end of the manuscript).

      Reviewer #2 (Public review):

      Summary:

      In this exciting study, Cesar and co-authors perform a meta-analysis on the influence of arthropod symbionts on the fitness of their hosts when they are exposed or not to natural enemies. These so-called defensive symbionts are increasingly recognized as key elements in arthropod survival against natural enemies, with effects that ripple through entire terrestrial ecosystems. The topic is timely, the approach is sound, and the manuscript is well-written. I believe this manuscript will attract the attention of entomologists and of microbiologists interested in symbiosis. This study builds on a previous meta-analysis that I was involved in, which was based on phloem-feeding insects. This novel data set is much larger and includes flies (including the model system Drosophila) and mosquitoes (a group of high medical interest). While the previous metaanalysis considered only parasitoids as natural enemies, this study also includes fungi, bacteria, and viruses.

      Strengths:

      The authors compile a very large dataset and provide a broad quantitative overview of the effects of defensive symbionts in insects. By measuring symbiont effects in the presence and absence of natural enemies, the authors are able to infer whether a trade-off between defense and the costs of mutualism in the absence of enemy pressure exists. Defensive symbioses are an important research topic that had its initial "momentum" a decade ago, so the timing for such a systematic review is very appropriate.

      We sincerely thank Reviewer #2 for dedicating their time and effort to reviewing our manuscript. The suggestions are very insightful and will significantly contribute to improving our manuscript.

      Weaknesses:

      I think the manuscript could be improved by clarifying several sections, particularly the introduction and methods. The introduction section is too specific and heavily reliant on particular examples. In my view, the theoretical background of the study could be made clearer, and the knowledge gap identified more explicitly. A focus on how widespread defensive symbioses are, along with a brief, up-to-date review of the groups possessing such symbionts, would help. This lack of focus is also observed in the methods section, where more details are needed in many instances to better understand how data was collected and analyzed. Regarding the analyses, the multi-level analysis contains many moderators, but it's unclear why these moderators were included. While this may seem a minor issue, it highlights a disconnection between the analyses, the conceptual background, and the hypotheses tested. 

      We thank the reviewer for the suggestions, and we will try to make the introduction and the methods section clearer. 

      Another important weakness is that the analyses are too general, and much-hidden information is not immediately apparent. For instance, readers cannot easily identify which species of symbionts are studied (and the effects they have), or which natural enemies are involved. Although this information is found in the supplementary material, including it in the main body would significantly improve the manuscript.

      We agree, and we will implement this to our   revised manuscript.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public review):

      (1) The technology requires a halo-tagged derivation of the active compound, and the linked position will have a huge impact on the potential "target hits" of the molecules. Given the fact that most of the active molecules lack of structure-activity relationship information, it is very challenging to identify the optimal position of the halo tag linkage.

      We appreciate your insightful comment. While finding the optimal position to attach a chemical linker to a small molecule of interest is indeed a challenging but necessary step, this is a common difficulty across all target-ID methods, except for those that are modification-free, as we described in Discussion. However, modification-free approaches such as DARTS, CETSA, and TPP have their own limitations, such as low sensitivity and a high false-positive rate. Additionally, DARTS and SPROX are limited to use with cell lysates. Please refer to the introduction in our manuscript for more details on these approaches. On the other hand, synthesizing HTL derivatives is relatively straightforward compared to other modifications, and we provide helpful guidelines for chemical linker design, provided the optimal chemical moiety has been identified, which is crucial for target identification. We selected dasatinib and HCQ/CQ as model compounds because previous studies offered insights into their derivative synthesis. Our data also show that DH5 retains strong kinase inhibitory activity (Figure 4—figure supplement 2), and DC661-H1 demonstrates potent inhibition of autophagy (Figure 6—figure supplement 1). For novel compounds, conducting a thorough structure-activity relationship (SAR) study is essential to determine the optimal position for HTL derivative synthesis.

      (2) Although POST-IT works in zebrafish embryos, there is still a long way to go for the broad application of the technology in other animal models.

      Thank you for your constructive comment. Yes, there is still a long way to go in developing the POST-IT system for broader applications in other animal models, especially in mice. However, we hope that our study provides valuable insights and inspiration to scientists and experts for applying the POST-IT system in various models. We are also committed to further improving its applicability.

      (3) The authors identified SEPHS2 as a new potential target of dasatinib and further validated the direct binding of dasatinib with this protein. However, considering the super strong activity of dasatinib against c-Src (sub nanomolar IC50 value), it is hard to conclude the contribution of SEPHS2 binding (micromolar potency) to its antitumor activity.

      Thank you for your insightful comment. We agree that the anticancer activity of dasatinib primarily results from inhibiting tyrosine kinases such as SRC and ABL. However, SEPHS2 contains an “opal" termination codon, UGA, at the 60th amino acid residue, which codes for selenocysteine. Due to the technical challenge of expressing selenoproteins in E. coli, we mutated it to cysteine for expression in E. coli to avoid premature translation termination, as described in the Materials and Methods section. Although the purified recombinant SEPHS2 shows a Kd of about 10 µM for dasatinib, the binding affinity to endogenous SEPHS2 may be higher since selenocysteine is larger and more electronegative than cysteine. This presents an interesting area for future investigation. Furthermore, our study of dasatinib’s binding to SEPHS2 could help facilitate the development of new SEPHS2 inhibitors, potentially targeting the active site of SEPHS2.

      Reviewer #3 (Public review):

      (1) Target Specificity: It is crucial for the authors to differentiate between the primary targets of the POST-IT system and those identified as side effects. This distinction is essential for assessing the specificity and utility of the technology.

      Thank you for your insightful comment. Drugs inevitably bind to various proteins with differing affinities, which can contribute to both side effects and beneficial outcomes. Typically, the primary targets exhibit high affinities. In this manuscript, we ranked the identified protein targets of DH5 based on affinity from mass spectrometry and p-values (Fig. 5A), and for DC661-H1, we used the SILAC ratio (Fig. 6A). We also individually assessed many drug-protein binding affinities using the MST assay, as well as in vitro and in cellulo assays, demonstrating their specificity. Moreover, we believe it is essential to identify as many protein targets as possible at physiological drug concentrations to better understand the drug’s side effects. Of course, further investigation is required to assess the roles and effects of these target proteins.

      (2) In Vivo Target Identification: The manuscript lacks detailed clarity on which specific targets were successfully identified in the in vivo experiments. Expanding on this information would provide a clearer view of the system's effectiveness and scope in complex biological settings.

      Thank you for your insightful comment regarding in vivo target identification. In this manuscript, we utilized a cell line as the primary method for in vivo target identification and validation after optimizing our system in test tubes. We successfully validated many of the targets identified using our POST-IT system (Figure 6—figure supplement 3). To demonstrate the proof of principle for in vivo application, we employed zebrafish embryos as an in vivo model, showing that endogenous SRC can be effectively pulled down by DH5 treatment (Fig. 7). While we could have explored the entire proteome to identify endogenous target proteins in zebrafish that bind to DH5 or dasatinib, we felt this would extend beyond our original scope, given that we have already demonstrated POST-IT’s ability to identify target proteins for dasatinib. Specific target identification and validation are crucial when using zebrafish for drug discovery. Additionally, we acknowledge that drugs likely interact with a range of protein targets in living organisms and may undergo metabolism and interactions within the circulatory system, which we address in our discussion.

      (3) Reproducibility and Scalability: Discussion on the reproducibility of the POST-IT system across various experimental setups and biological models, as well as its scalability for larger-scale drug discovery programs, would be beneficial.

      Thank you for the suggestion. While our system has shown  high reproducibility in our experiments, further improving both reproducibility and scalability would be advantageous. One potential approach to address this is through the generation of stable-expressing cell lines and transgenic zebrafish lines, which we have discussed in the revised manuscript. Establishing stable cell lines with robust POST-IT expression could enhance scalability for drug discovery applications.

      (4) Quantitative Analysis: A more detailed quantitative analysis of the protein interactions identified by POST-IT, including statistical significance and comparative data against other technologies, would enhance the manuscript.

      Thank you for your suggestion. In our assessment of drug-protein affinity, we included Kd values as quantitative measures using MST assays. The protein targets of dasatinib identified through mass spectrometry are also accompanied by p-values for quantitative analysis (Fig. 5A), and the detailed procedures are described in the Material and methods section. While it is challenging to provide direct comparative data against other technologies, our system successfully identified many known target proteins for dasatinib, as well as SEPHS2 and VPS37C as new targets for dasatinib and for HCQ/CQ, respectively, which were not detected by other methods.

      (5) Technological Limitations: The authors should discuss any limitations or potential pitfalls of the POST-IT system, which would be crucial for future users and for guiding subsequent improvements.

      Thank you for your insightful suggestion We agree that clearly defining the technological limitations is important. Therefore, we have expanded our original discussion on the limitations of our POST-IT system (Discussion section, paragraph 6).

      (6) Long-Term Stability and Activity: Information on the long-term stability and activity of the POST-IT components in different biological environments would ensure the reliability of the system in prolonged experiments.

      Yes, this is an important question. We did not notice any stability or toxicity issues with Halo-PafA and Pup substrates in HEK293T cells or zebrafish, which is an important factor for stable cell lines and transgenic zebrafish lines. However, HTL derivatives of the drug could be toxic or unstable due to the nature of the drug or its metabolism, which needs to be taken into account when designing experiments, and we have included this in the Discussion.

      (7) Comparison with Existing Technologies: A detailed comparison with existing proximity tagging and target identification technologies would help position POST-IT within the current landscape, highlighting its unique advantages and potential drawbacks.

      We appreciate your valuable feedback and agree that such comparisons are crucial. We have included a detailed overview and comparison of existing proximity-tagging systems and their related target identification technologies in the Introduction (lines 78-100) and Discussion (lines 391-412), highlighting their respective pros and cons. Additionally, we have expanded the discussion to further compare these technologies with our POST-IT system, addressing its advantages and limitations (lines 378-390, lines 448-467). We hope this provides sufficient context and information to effectively position POST-IT among the landscape of proximity-tagging target identification technologies.

      (8) Concerns Regarding Overexposed Bands: Several figures in the manuscript, specifically Figure 3A, 3B, 3C, 3F, 3G, Figure 4D, and the second panels in Figure 7C as well as some figures in the supplementary file, exhibit overexposed bands.

      We appreciate your astute observation regarding the overexposed bands and apologize for any confusion. The “overexposed” bands represent the unpupylated proteins, while the bands above them correspond to the pupylated proteins. We intended to clearly show both pupylated and unpupylated bands, although the latter are generally much weaker. We are currently working on further improving our POST-IT system to enhance pupylation efficiency.

      (9) Innovation Concern: There is a previous paper describing a similar approach: Liu Q, Zheng J, Sun W, Huo Y, Zhang L, Hao P, Wang H, Zhuang M. A proximity-tagging system to identify membrane protein-protein interactions. Nat Methods. 2018 Sep;15(9):715-722. doi: 10.1038/s41592-018-0100-5. Epub 2018 Aug 13. PMID: 30104635. It is crucial to explicitly address the novel aspects of POST-IT in contrast to this earlier work.

      Thank you for bringing this to our attention. Proximity-tagging systems like BioID, TurboID, NEDDylator, and PafA (Lui Q et al., Nat Methods 2018) were initially developed to study protein-protein interactions or identify protein interactomes, as these applications are of broader interest and generally easier to implement. However, applying proximity-tagging systems for small molecule target identification requires significant optimization. As described in the introduction (lines 78-100), target protein identification systems have since been developed using TurboID and NEDDylator (Tao AJ et al., Nat Commun 2023; Hill ZB et al., J Am Chem Soc 2016). It is conceivable that a PafA-based proximity-tagging system could also be adapted for target-ID, and other groups may pursue this approach in the future. Although the PafA-Pup system shows great promise for target-ID applications, extensive optimization was needed to enable its use for this purpose. Finally, we demonstrate that POST-IT offers distinct advantages over other proximity-tagging-based target-ID systems. For more details, please refer to the introduction and discussion sections.

      Recommendations for the authors:

      Reviewer #2 (Recommendations for the authors):

      (1) Figure 1- Figure Supplement 1A: The Pup substrate "HB-Pup" is mentioned, but the main text or figure legend provides no introduction or description.

      We appreciate your astute observation. We have added a description in the main text and figure legend as follows: “…and used HB-Pup as a control, which contains 6´His and BCCP at the N terminus of Pup” in the main text (line 142) and “HB, TS, and SBP refer to 6´His and BCCP, twin-STII (Strep-tag II), and streptavidin binding peptide, respectively.” in the Figure 1-figure supplement 1A.

      (2) Figure 1 - Figure Supplement 3B: The authors used TS-sPupK61R as a substrate but did not explain why. The main text mentions that mutating sPup alone did not affect polypupylation, raising the question of why TS-sPupK61R was used in this figure. Furthermore, while the authors state that polypupylation becomes evident after 1 hour of incubation (more pronounced after 2 or 3 hours), the reactions here were conducted for only 30 minutes.

      Thank you for your question. Figure 1 - Figure Supplement 3B was conducted to test self-pupylation levels in the different Halo-PafA derivatives. For this purpose, we could use any Pup substrate such as SBP-sPup and SBPK4R-sPupK61R, instead of Ts-sPup and TS-sPupK61R, as they do not show any differences in pupylation activity. We chose Ts-sPup and TS-sPupK61R simply because any Pup substrates could be used for this purpose. Similarly, we did not need to incubate the reaction for a longer time to detect polypupylation, as our intention was to test “self-pupylation”. We demonstrated in Figure 1 – figure supplement 2 that polypupylation is dependent on the number or position of lysine residues in Pup substrate or tags. The results clearly showed that self-pupylation was almost completely abolished by the Halo8KR mutation. To clarify this, we added the following description in lines 168-169: “Ts-sPup and TS-sPupK61R were chosen as sPup substrates for this experiment, although any Pup substrates could have been used. The levels of self-pupylation were assessed.”

      (3) Line 156: The statement that "the TS-tag completely abolished polypupylation in TS-sPup" is inaccurate. Using TSK8R-sPupK61R as the substrate, several bands appear, which likely represent Halo-PafA with varying degrees of polypupylation. Some bands also appear to correspond to those seen when using TS-sPup as a substrate. The authors should clarify how they distinguish between multipupylation and polypupylation in this case.

      We sincerely appreciate your insight into clarifying the distinction between multipupylation and polypupylation. Polypupylation refers to the addition of a new Pup onto a previously linked Pup on the target protein, akin to polyubiquitination. In contrast, multipupylation involves multiple single pupylations at different positions on the target proteins. Since pupylation occurs exclusively at lysine residues in tag-Pup substrates, mutating all lysine residues to arginine, as in TSK48R-sPupK61R, prevents the mutant tag-Pup from linking to another Pup. This means that only single pupylation can proceed with this type of mutant Pup substrate. If multiple pupylated bands are observed with this mutant substrate, it indicates “multipupylation” rather than “polypupylation”, as shown in Figure 1-figure supplement 2D. The same applies to the pupylation bands in Figure 1-figure supplement 2E and F, as sSBP-sPupK61R and SBPK4R-sPupK61R lack lysine residues. By comparing these multipupylation bands, it is also possible to distinguish them from polypupylation bands, which are marked by yellow arrows. However, after 2-3 pupylation bands, higher-order bands become increasingly difficult to distinguish.

      To clarify the mutation in the TS-tag, we revised the sentence in line 156 from “However, further mutations within the TS-tag completely abolished polypupylation in TS-sPup” to “However, further mutations of two lysine residues within the TS-tag, creating TSK8R-sPupK61R, completely abolished polypupylation in TS-sPup”. Additionally, we have inserted sentences in line 152 to define polypupylation and multipupylation, as described here.

      (4) Line 160: Similar to the above concern about line 156, the claim that SBPK4R and sSBP completely prevented polypupylation is unconvincing and requires more supporting evidence.

      Thank you for raising this concern. As mentioned above, both SBPK4R and sSBP lack lysine residues required for pupylation. As a result, these mutants can only undergo multiple single pupylations on the lysine residues of the target protein, which leads to “multipupylation”. In Figure 1-figure supplement 2E and F, pupylation bands by sSBP-sPupK61R or SBPK4R-sPupK61R do not display doublet bands (one from multipupylation and the other from polypupylation), as seen with SBP-sPup, marked by yellow arrows. Notably, Halo-PafA containing polypupylated branches migrates more slowly than one with an equal number of multipupylation events. To clarify this point, we have added the phrase “as shown in sSBP-sPupK61R and SBP4KR-sPupK61R” at the end of the sentence in line 160.

      (5) Lines 176-177: The authors claim that PafAS126A exhibited reduced polypupylation compared to PafA, but given that PafAS126A may reduce depupylase activity, how could it reduce polypupylation levels? Moreover, it is hard to find any data supporting this conclusion in Figure 1 - Figure Supplement 3B.

      We appreciate your insightful comment. At this point, we do not fully understand how the mutation that reduces depupylase activity also decreases polypupylation. It is possible that PafAS126A has a lower preference for pupylated Pup as a prey, which is required for polypupylation, since depupylase activity depends on recognizing pupylated Pup as a prey to remove it. Nonetheless, Halo-PafAS126A shows reduced levels of higher molecular weight bands compared to Halo-PafA, as shown in Figure 1-figure supplement 3B, while exhibiting increased pupylation in lower molecular weight bands, which represent either multipupylation or low-degree polypupylation. Since higher molecular weight bands (> 150 kD) are likely due to polypupylation, this result suggests reduced polypupylation and increased multipupylation in Halo-PafAS126A. To clarify this in the main text, we have added the following description in line 177: “as evidenced by the decreased levels of high molecular weight bands and an increase in low molecular weight bands”

      (6) POST-IT system in cellulo validation: The system was developed using the Halo-tag, yet the in-cell validation uses FRB and FKBP instead, without explaining this switch. This inconsistency makes the logic of the experiment unclear.

      We appreciate your insightful comment. The interaction between rapamycin and FRB or FKBP is known to be highly specific and robust, making this system useful in various biological contexts. Due to this property, rapamycin can induce interaction between two proteins when one is fused with FRB and the other with FKBP. Before testing or optimizing the POST-IT system in cells, we hypothesized that using the rapamycin-induced interaction between FRB and FKBP could introduce pupylation of the target protein, provided that PafA is fused with FRB or FKBP and the target protein is fused with the other. The results demonstrate that PafA can introduce pupylation of the target protein in a proximity-dependent manner via this chemically induced interaction. To further clarify this in the main text, we modified the original sentence in lines 214-216 as follows: “To mimic drug-target interaction-induced pupylation in live cells and assess the potential of PafA as a proximity-tagging system for target-ID, we incorporated the rapamycin-induced interaction between FRB and FKBP into our PL system, as this interaction between a small molecule and a protein is known to be highly specific and robust (Figure 3—figure supplement 1A).”

      (7) Line 209: The authors decided to use the SBP-tag for further studies due to better performance, but in Figure 3 - Figure supplement 1, they still used the unintroduced HB-Pup as the substrate, which is confusing and lacks explanation.

      Thank you for raising your question. The SBP-tag is not superior to the TS-tag in terms of pupylation activity. However, the TSK8R mutant cannot bind to Strep-Tactin beads, while the SBP mutants, SBPK4R and sSBP, can bind to streptavidin. Therefore, we chose the SBP-tag instead of the TS-tag for further studies as a Pup substrate in POST-IT system, as we needed to pull down the target proteins. HB-Pup is consistently used as a control throughout various experiments, as it is the original Pup substrate. In Figure 3-figure supplement 1B and C, HB-Pup was used to test chemically induced pupylation by PafA. In these cases, it was not so critical which Pup substrate was chosen. Furthermore, we compared HB-Pup and different SBP-sPup substrates in Figure 3-figure supplement 1D, where HB-Pup was used as a control or for comparison. Although pupylation bands with HB-Pup appear more robust, this substrate contains multiple lysine residues, leading to high levels of polypupylation. To make it clear, we modified the sentence in line 209 to “Therefore, we decided to use the SBP-tag as a Pup substrate in the POST-IT system for further studies.”.

      (8) Line 220: Both SBP-sPup and SBPK4R-sPupK61R are described as exhibiting efficient pupylation, but the data show mostly self-pupylation and little to no pupylation of the target protein.

      Thank you for your concern. However, pupylation of the target protein is actually quite substantial, as the intensities of the free form and pupylated proteins are relatively similar, as shown in the upper panel of Figure 3-figure supplement 1D. Self-pupylation is always much higher than target pupylation, because PafA constantly pupylates itself, whereas pupylation of the target protein occurs only through interaction. Furthermore, V5-FRB-mKate2-PafA contains many lysine residues, which increases the levels of self-pupylation.

      (9) Lines 222-224: The authors chose SBPK4R-sPupK61R to avoid polypupylation, although SBP-sPup did not cause detectable polypupylation. Neither substrate caused pupylation of the target protein, so the rationale behind this choice is unclear.

      Thank you for raising your question. Similar to the above comment (#8), please refer to the pupylation bands of the target protein, as shown in the upper panel of Figure 3-figure supplement 1D. The pupylation band of the target protein is quite remarkable, as the intensities of the free form and pupylated proteins are comparable. Additionally, there are no multiple pupylation bands in either case, except for one additional weak multipupylation band, indicating no polypupylation by SBP-sPup, which does not have K-to-R mutations. Of course, SBPK4R-sPupK61R can only undergo single pupylation, as it does not contain lysine residues. Although we did not observe polypupylation by SBP-sPup in this experimental condition, it is possible that SBP-sPup may cause polypupylation under different experimental conditions or with other target proteins. Since SBPK4R-sPupK61R exhibits comparable pupylation of the target protein at least in this experiment setting as SBP-sPup, we selected SBPK4R-sPupK61R as the Pup substrate for POST-IT system to avoid any potential polypupylation that could be caused by SBP-sPup in other cases. We believe that polypupylation can introduce bias into the analysis and hinder the comprehensive discovery of additional target proteins for small molecules.

      (10) Line 224: The authors conclude that rapamycin greatly reduced self-pupylation, but the supporting data are unclear.

      Thank you for your constructive comments on our manuscript. Please refer to the lower panel of Figure 3-figure supplement 1D. When using either SBPK4R-sPupK61R or SBP-sPup, rapamycin treatment results in reduced levels of self-pupylation compared to the no-treatment control. However, we did not observe this reduction with HB-Pup and do not know the reason. To clarify this in the main text, we added the following description to the end of the sentence: “when using either SBPK4R-sPupK61R or SBP-sPup, as shown in the lower panel of Figure 3—figure supplement 1D”

      (11) Line 234: The authors selected an 18-amino acid linker, but given that linkers longer than 10 amino acids enhance labeling, this choice should be explained.

      Thank you for raising your question. In fact, a linker of 10 amino acids (aa) or longer is likely to behave similarly. We chose an 18 aa linker instead of a 40 aa linker primarily for the convenience of cloning and to reduce the potential for DNA sequence recombination associated with longer repeats. Additionally, a longer, flexible linker may behave like an intrinsically disordered protein (Harmon et al., 2017), which can lead to unwanted protein-protein interactions or phase separation. To elaborate on this, we added the following sentences after the sentence in line 233-235: “We chose the 18-amino acid linker instead of the 40-amino acid linker for easier cloning and to lower the risk of DNA recombination from longer repeats. Additionally, a longer, flexible linker may behave like an intrinsically disordered protein (Harmon et al., 2017), an unwanted feature for target-ID.”

      (12) S126A and K172R mutations: The authors claim that these mutations additively enhanced pupylation under cellular conditions, but in Figure 3B, the band intensities appear similar for the wild-type and mutant versions.

      Thank you for raising your concern. Although a single pupylation band appears similar among the three different Halo-PafA proteins, multipupylation bands are slightly but noticeably increased by the S126A and K172R mutations compared to Halo8KR-PafA. Since we used SBPK4R-sPupK61R as a Pup substrate, all higher molecular weight bands result from multipupylation rather than polypupylation. This illustrates why it is preferable to use SBPK4R-sPupK61R over SBP-sPup, as the pupylation bands with SBP-sPup are mixtures of poly- and multipupylation, making it difficult to assess levels of target labeling. To clarify this in the main text, we added the following description after the sentence in line 236: “as the higher molecular weight multipupylation bands are slightly but noticeably increased with these mutations compared to Halo8KR-PafA”

      (13) Line 263: The authors selected DH5 for further experiments due to its efficiency, but the data suggest that the performance of DH1 to DH5 is similar.

      We appreciate your question about the different dasatinib HTL derivatives. However, our data clearly show that DH2-5 derivatives bind significantly more effectively to Halo-PafA in vitro and in live cells compared to DH1 (Figure 4A and B). Additionally, the DH2-5 derivatives result in dramatically increased pupylation of the target protein in vitro and noticeable enhancement in live cells (Figure 4C and D). Among DH2 to DH5, there is no obvious difference in binding to Halo-PafA or pupylation of the target protein. Therefore, we chose DH5, as we believe that the longer linker in DH5 may facilitate the binding of a more diverse range of target proteins to dasatinib, enabling the discovery of additional target proteins.

      (14) Line 309: The authors introduce HCQ and CQ as important drugs but then investigate the mechanism using DC661 without introducing or justifying the choice of this compound.

      Thank you for your point. We explained the reason to choose DC661, a dimer form of CQ, instead of CQ for the synthesis of an HTL derivative in line 310. “assuming that a dimer would enhance binding affinity as previously described.” As the dimer forms of a drug or a small molecule such as testosterone dimers, estrogen dimers, and numerous anticancer drug dimers have been often developed to enhance drug effects (Paquin A et., Molecules 2021). Similarly, dimer forms of HCQ/CQ have been introduced and shown to be more potent (Hrycyna CA et al., ACS Chem Biol 2014; Rebecca VW et al., Cancer Discovery 2019). We expected that using a dimer form might offer higher probability to identify target proteins for HCQ/CQ.

      (15) The authors suggest that multipupylation levels were enhanced but do not explain whether this might benefit the system or introduce other issues. Clarifying this point would provide valuable insight for potential users of this system.

      Thank you for your thoughtful suggestion. Polypupylation likely leads to biased enrichment of a limited set of target proteins, and its levels may not correlate with the binding affinity of target proteins to the small molecule of interest, features that can negatively impact target-ID. In contrast, multipupylation may be correlated with binding affinity or interaction frequency, as we observed increased levels of multipupylation with higher Pup concentrations and longer incubation times. This suggests that target proteins with multiple lysines in proximity to PafA can be sequentially pupylated, starting with the most accessible lysine. However, if a target protein has only one accessible lysine, pupylation will occur only once, regardless of the protein’s affinity to the small molecule. In summary, while polypupylation may be a drawback for target-ID, multipupylation could be useful for both target-ID and understanding binding mode. To elaborate on this, we added the following additional explanation after the sentence in line 152: “, whereas multipupylation is more likely correlated with binding affinity or interaction frequency.”

      (16) The author should address whether the Halotag ligand modification of the drug alters the binding properties between the drug and targets. That may be causing artifact binding of the drug and other proteins.

      Thank you for your insightful comment. Yes, it is true that chemical modifications of the small molecule of interest, such as linker derivatization (e.g., HTL) or photo-affinity labeling, generally lead to reduced activity or affinity compared to the original molecule. Synthesizing a derivative is a common challenge across all target-ID methods, except for modification-free approaches, as we mentioned in the Discussion. However, modification-free methods like DARTS, CETSA, and TPP have their own limitations, including low sensitivity or high false positive rates. Identifying the optimal position for chemical modification on the small molecule of interest is critical. We chose dasatinib and HCQ/CQ as model compounds, because previous studies provided insights into their derivative synthesis. In addition, our data show that DH5 retains robust kinase inhibitory activity (Figure 4-figure supplement 2), and DC661-H1 exhibits potent autophagy inhibition (Figure 6-figure supplement 1). For novel compounds, a thorough structure-activity relationship study is essential to identify the optimal position for HTL derivative synthesis.

      (17) The author stated there is no observable toxicity in zebrafish without providing a detailed analysis or enough data. Further analysis of the expression of Halo-PafA and its substrate sPup influence on toxicity or side effects to the living cells or animals would be needed. It is important for in vivo applications.

      Thank you for your constructive suggestion. We have now included additional experimental data in Figure 7-figure supplement 1, showing no toxicity in zebrafish embryos expressing the POST-IT system. We assessed toxicity in two ways: by injecting the POST-IT DNA plasmid into one-cell-stage embryos for acute expression, and by using embryos from transgenic zebrafish expressing POST-IT under a heat-shock inducible promoter. Neither the injection nor the heat-shock activation of POST-IT expression resulted in any noticeable toxicity.

    1. Author response:

      The following is the authors’ response to the previous reviews.

      eLife Assessment

      This important work presents two studies on predictive processes in subjects with and without tinnitus. The evidence supporting the authors' claims is compelling, as their second study serves as an independent replication of the first. Rigorous matching between study groups was performed, especially in the second study, increasing the probability that the identified differences in predictive processing can truly be attributed to the presence of tinnitus. This work will be of interest to researchers, especially neuroscientists, in the tinnitus field.

      We thank the editors at elife very much for their favorable assessment of our manuscript. Based upon the comments of the reviewer, we aimed to further improve our manuscript to be a valuable addition to the tinnitus research field.

      Public Reviews:

      Reviewer #2 (Public review):

      Summary:

      This study aimed to test experimentally a theoretical framework that aims to explain the perception of tinnitus, i.e., the perception of a phantom sound in the absence of external stimuli, through differences in auditory predictive coding patterns. To this aim, the researchers compared the neural activity preceding and following the perception of a sound using MEG in two different studies. The sounds could be highly predictable or random, depending on the experimental condition. They revealed that individuals with tinnitus and controls had different anticipatory predictions. This finding is a major step in characterizing the top-down mechanisms underlying sound perception in individuals with tinnitus.

      Strengths:

      This article uses an elegant, well-constructed paradigm to assess the neural dynamics underlying auditory prediction. The findings presented in the first experiment were partially replicated in the second experiment, which included 80 participants. This large number of participants for an MEG study ensures very good statistical power and a strong level of evidence. The authors used advanced analysis techniques - Multivariate Pattern Analysis (MVPA) and classifier weights projection - to determine the neural patterns underlying the anticipation and perception of a sound for individuals with or without tinnitus. The authors evidenced different auditory prediction patterns associated with tinnitus. Overall, the conclusions of this paper are well supported, and the limitations of the study are clearly addressed and discussed.

      Weaknesses:

      Even though the authors took care of matching the participants in age and sex, the control could be more precise. Tinnitus is associated with various comorbidities, such as hearing loss, anxiety, depression, or sleep disorders. The authors assessed individuals' hearing thresholds with a pure tone audiogram, but they did not take into account the high frequencies (6 kHz to 16 kHz) in the patient/control matching. Moreover, other hearing dysfunctions, such as speech-in-noise deficits or hyperacusis, could have been taken into account to reinforce their claim that the observed predictive pattern was not linked to hearing deficits. Mental health and sleep disorders could also have been considered more precisely, as they were accounted for only indirectly with the score of the 10-item mini-TQ questionnaire evaluating tinnitus distress. Lastly, testing the links between the individuals' scores in auditory prediction and tinnitus characteristics, such as pitch, loudness, duration, and occurrence (how often it is perceived during the day), would have been highly informative.

      Thank you very much for your careful evaluation of our manuscript. We agree with you that our study design has some limitations such as the assessment of higher frequencies, comorbidities, and tinnitus characteristics. In our discussion, we aimed to acknowledge these issues for future research to improve this study design and gain more insights into neural tinnitus processes.

      See e.g.:

      Line 946-949:

      “Additionally, we rigorously controlled for hearing loss in Study 2, however, pure-tone audiometric testing was solely performed up to 8kHz and we were therefore not able to draw conclusions regarding hearing impairments in higher frequencies and their influence on the effects.”

      Line 949-954:

      “Moreover, we did not screen our participants for hyperacusis. This hypersensitivity to mild sounds is widely correlated with the sensation of tinnitus and underlying neural mechanisms are potentially intertwined with tinnitus processes (Schilling et al., 2023; Yukhnovich et al., 2023; Zheng, 2020). Screening for hyperacusis in future work can therefore reveal more details on participant characteristics influencing predictive processing.”

      Line 955-958:

      “In both studies, tinnitus distress was not correlated with the reported prediction effects. Nevertheless, tinnitus can also be characterized by other features such as its loudness, pitch or duration which were not included in the experimental assessment.”

      Line 958-963:

      “Additionally, we solely used a short version of the Mini-TQ (Goebel and Hiller, 1992) in Study 2, which did not allow us to relate prediction scores to subscales like sleep disturbances which potentially influence cognitive functioning and thus predictive processing. Next to sleeping disorders and distress, tinnitus is often also accompanied by psychological comorbidities such as depression or anxiety (Langguth, 2011) which are potential confounds of the results.”

      Comments on revisions:

      Thank you for your responses. There are a few remaining points that, if addressed, could further enhance the manuscript:

      - While the manuscript acknowledges the limitation of not matching groups on hearing thresholds in Study 1, a deeper analysis of participants' hearing abilities and their impact on MEG results, similar to that conducted in Study 2, would be valuable. Specifically, including a linear model that considers all frequencies, group membership, and their interactions could highlight differences across groups. Additionally, examining the effect of high-frequency hearing loss on prediction scores, as performed in Study 2, would strengthen the analysis, particularly given the trend noted (line 719). Such an addition could make a significant contribution to the literature by exploring how hearing abilities may influence prediction patterns.

      We appreciate your feedback and agree with you that it is a crucial question how hearing abilities influence prediction patterns in tinnitus. However, as hearing status was not assessed in the control group in study 1, we are unfortunately not able to include linear models to investigate differences across groups in this sample. This led us to the implementation of study 2 with a comprehensive hearing assessment to investigate group differences. We highlighted this issue in our methods section.

      Line 170-172:

      “As pure-tone audiometric testing was not included for the control subjects, group comparisons between hearing thresholds were not feasible.”

      - The connection with the hippocampal regions (line 864) remains somewhat unclear. While the inclusion of the Paquette reference appropriately links temporal region activity with tinnitus, it does not fully support the statement: "An increased focus on hippocampal regions, e.g., in fMRI, patient, or animal studies, could be a worthwhile complement to our MEG work, given the outstanding relevance of medial temporal areas in the formation of associations in statistical learning paradigms"

      Thank you for your constructive input. This section is purely speculative, and we do not aim to provide strong claims or expected results but solely point out potential future research directions.

      - Authors should add a comparison of participants mini-TQ scores on both studies

      We appreciate your input and added a comparison of mini TQ-scores between samples. For study 1, all subscales were included, however, we computed the comparison solely based on the items of the mini-TQ to increase comparability. The results were not significant, i.e., tinnitus distress values did not differ between studies.

      Line 629-632:

      “We additionally compared tinnitus distress values assessed by the mini-TQ (Goebel and Hiller, 1992) between study 1 and study 2 to detect potential differences between the samples, however, results of the Welch’s t-test were not significant with t(30.7)=1.27, p\=.214.”

      - Authors should add significant level on Fig 6.B as in Fig 3.C, and a n.s on Fig 6.D

      Thank you very much for your input, we added significance levels and a n.s. to the Figures 6B and 6D.

    1. Author response:

      The following is the authors’ response to the previous reviews.

      Public Reviews:

      Reviewer #1 (Public Review):

      Summary:

      This article identifies ADGR3 as a candidate GPCR for mediating beige fat development. The authors use human expression data from Human Protein Atlas and Gtex databases and combine this with experiments performed in mice and a murine cell line. They refer to a GPCR bioactivity screening tool PRESTO-Salsa, with which it was found that Hesperetin activates ADGR3. From their experiments, authors conclude that Hesperetin activates ADGR3, inducing a Gs-PKA-CREB axis resulting in adipose thermogenesis.

      Strengths:

      The authors analyze human data from public databases and perform functional studies in mouse models. They identify a new GPCR with a role in thermogenic activation of adipocytes.

      Considerations:

      Selection of ADGRA3 as a candidate GPCR relevant for mediating beiging in humans:

      The authors identify GPCRs that are expressed more highly in murine iBAT compared to iWAT in response to cold and assess which of these GPCRs are expressed in human subcutaneous or visceral adipocytes. Although this strategy will identify GPCRs that are expressed at higher levels in brown fat compared to beige and thus possibly more active in thermogenic function, the relevance in choosing GPCRs that also are expressed in unstimulated human white adipocytes should be considered. Thermogenic activity is not normally present in human white adipocytes. It would have strengthened the GPCR selection if the authors instead had assessed the intersection with human brown adipocytes that were activated with norepinephrine.

      We appreciate your constructive feedback and believe that by adopting this refined strategy, we will strengthen our selection of GPCRs related to adipose thermogenesis in other ongoing studies. We look forward to continuing our research in this area and contributing to the understanding of adipose thermogenesis and its potential therapeutic applications. Thank you once again for your valuable input. 

      Strategy to investigate the role of ADGRA3 in WAT beiging:

      Having identified ADGRA3 as their candidate receptor, the authors investigated the receptor in mouse models, the murine inguinal adipocyte cell line 3T3 and in human subcutaneous adipose progenitors (HAdsc) differentiated in vitro. Calling the human cells "beige" is a stretch as these cells are derived from a white adipose depot. The authors do observe regulation in UCP1 and abundance of mitochondria following modification of ADGRA3 in the cells. However, in future studies, it should be considered if the receptor rather plays a role in differentiation per se, and perhaps not specifically in thermogenic differentiation/activity.

      Regarding the reviewer's suggestion to consider whether ADGRA3 plays a role in differentiation per se, rather than specifically in thermogenic differentiation/activity, we acknowledge that this is an important consideration. Our current studies have focused on the role of ADGRA3 in regulating UCP1 expression and mitochondrial abundance, which are hallmarks of adipose thermogenic activity. However, we recognize that ADGRA3 may also have broader roles in adipocyte differentiation and function that are not limited to thermogenesis.

      To address this point, in future studies, we plan to conduct additional experiments to investigate the potential role of ADGRA3 in adipocyte differentiation, including its effects on the expression of markers of adipocyte differentiation and its impact on adipocyte metabolism and function. These studies will provide further insights into the mechanisms by which ADGRA3 regulates adipocyte biology.

      According to the Human Protein Atlas and Gtex databases, ADGRA3 is not only expressed in adipocytes, but also in other tissues and cell types. The authors address this by measuring the expression in a panel of these tissues, demonstrating a knockdown not only in the adipose tissue, but also in the liver and less pronounced in the muscle (Figure S2). It should thus be emphasized that the decreased TG levels in serum and liver in the mice might in fact depend on Adgra3 overexpression in the liver. Even though this might not have been the purpose of the experiment, it is important to highlight this as it could serve as hypothesis building for future studies of the function of this receptor.

      Thank you for your thoughtful comments and feedback. We appreciate the insight provided by the Human Protein Atlas and Gtex databases regarding the tissue distribution of ADGRA3. We fully acknowledge that the decreased TG levels observed in both the serum and liver of the mice might be linked to the overexpression of Adgra3 in the liver.

      Although this was not the primary objective of our experiment, we agree that this observation is worth highlighting as it could serve as a basis for future hypothesis-driven research on the functional role of ADGRA3 in different tissues. In light of your comments, we emphasized this potential link between Adgra3 overexpression in the liver and reduced TG levels in discussion, as follows.

      “…the precise mechanisms underlying the influence of on adipose thermogenesis. Furthermore, it is crucial to highlight that the observed decrease in TG levels in both serum and liver (Figure 4-figure supplement 2C-D) might be attributed to the significant increase in Adgra3 expression in the liver, which is a consequence of the nanoparticle-mediated overexpression of Adgra3. While the exact mechanism remains to be fully elucidated, this correlation suggests a potential link between Adgra3 overexpression in the liver and reduced TG levels in the serum. We will employ more sophisticated models in subsequent studies to further…”

      Reviewer #3 (Public Review):

      Summary:

      The manuscript by Zhao et al. explored the function of adhesion G protein-coupled receptor A3 (ADGRA3) in thermogenic fat biology.

      Strengths:

      Through both in vivo and in vitro studies, the authors found that the gain function of ADGRA3 leads to browning of white fat and ameliorates insulin resistance.

      Weaknesses:

      There are several lines of weak methodologies such as using 3T3-L1 adipocytes and intraperitoneal(i.p.) injection of virus. Moreover, as the authors stated that ADGRA3 is constitutively active, how could the authors then identify a chemical ligand?

      Comments on revised version:

      The revised manuscript by Zhao et al. has limited improvement. The authors refused to perform revised experiments using primary cultures even though two reviewers pointed out the same weakness (3T3-L1 adipocytes are unsuitable). Using infrared thermography to measure body temperature is also problematic.

      Thanks for your comments. We regret that human adipocytes induced from human adipose-derived stem cells (hADSCs) were not recognized as primary cultures by multiple reviewers. Therefore, we have included relevant experimental results of mouse primary adipocytes induced from stromal vascular fraction (SVF) in Figure 8E-H as a supplement. The thermal imaging device was used to measure the temperature of BAT, while the body temperature was measured at 9:00 using a rectal probe connected to a digital thermometer.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Reviewer #1 (Public review):

      Summary:

      This paper presents a data processing pipeline to discover causal interactions from time-lapse imaging data, and convicingly illustrates it on a challenging application for the analysis of tumor-on-chip ecosystem data. The core of the discovery module is the original tMIIC method of the authors, which is shown in supplementary material to compare favourably to two state-of-the-art methods on synthetic temporal data on a 15 nodes network.

      Strengths:

      This paper tackles the problem of learning causal interactions from temporal data which is an open problem in presence of latent variables. The core of the method tMIIC of the authors is nicely presented in connection to Granger- Schreiber causality and to the novel graphical conditions used to infer latent variables and based on a theorem about transfer entropy. tMIIC compares favourably to PC and PCMCI+ methods using different kernels on synthetic datasets generated from a network of 15 nodes. A full application to tumor-onchip cellular ecosystems data including cancer cells, immune cells, cancer-associated fibroblasts, endothelial cells and anti cancer drugs, with convincing inference results with respect to both known and novel effects between those components and their contact.

      The code and dataset are available online for the reproducibility of the results.

      We thank Reviewer #1 for highlighting the main results and strengths of our paper, as well as, for his/her recommendations below to further improve the manuscript.

      Weaknesses:

      The references to ”state-of-the-art methods” concerning the inference of causal networks should be more precise by giving citations in the main text, and better discussed in general terms, both in the first section and in the section of presentation of CausalXtract. It is only in the legend of the figures of the supplementary material that we get information. Of course, comparison on our own synthetic datasets can always be criticized but this is rather due to the absence of common benchmark and I would recommend the authors to explicitly propose their datasets as benchmark to the community.

      Following Reviewer #1’s suggestion, we now compare tMIIC’s performance to other state-of-the-art causal discovery methods for time series data in the main text and in a new Figure 2. This Figure 2 also highlights the relation between graph-based causal discovery methods for time series data and Granger-Schreiber temporal causality, as discussed in more details in Methods (Theorem 1).

      We also agree about the importance of sharing benchmark datasets with the community. This is the reason why we provide the dynamical equations of the 15-node benchmarks in Supplementary Tables 1 & 2, so that anyone can generate equivalent time series datasets of any desired length.

      Reviewer #2 (Public review):

      Summary:

      The authors propose a methodology to perform causal (temporal) discovery. The approach appears to be robust and is tested in the different scenarios: one related with live-cell imaging data, and another one using synthetic (mathematically defined) time series data. They compare the performance of their findings against another well-know method by using metrics like F-score, precision and recall,

      Strengths:

      Performance, robustness, the text is clear and concise, The authors provide the code to review.

      We thank Reviewer #2 for his/her positive assessment of our work and the suggestions below to improve the manuscript.

      Weaknesses:

      One concern could be the applicability of the method in other areas like climate, economy. For those areas, public data are available and might be interesting to test how the method performs with this kind of data.

      While our main expertise concerns the analysis of biological and biomedical data, we agree that tMIIC (which is included in MIIC R package) could in principle be applied to other areas, like climate, economy.

      We have not included benchmarks on such diverse types of datasets in the present manuscript, which focuses on CausalXtract’s pipeline for the analysis and causal interpretation of live-cell time-lapse imaging data from complex cellular systems.

    1. Author response:

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      The authors aim to elucidate the diversity and gene expression patterns of marine plankton using innovative collection and sequencing methodologies. Their work investigates the taxonomic and functional profiles of planktonic communities, providing insights into their ecological roles and responses to environmental changes.

      Strengths:

      The methodology utilized in this study, particularly the combination of single-cell sequencing and advanced bioinformatics techniques, represents a significant advancement in the field of plankton research. The application of the Smart-seq2 protocol for cDNA synthesis, followed by rigorous quality control measures, ensures high-quality data generation. This comprehensive approach not only enhances the resolution of the obtained genetic information but also allows for a more detailed exploration of the diversity and functional potential of the phytoplankton community.

      One of the major strengths of this study is the rigorous methodological approach, including precise sampling techniques and robust data analysis protocols, which enhance the reliability of the results. The use of advanced sequencing technologies allows for a comprehensive assessment of gene expression, significantly contributing to our understanding of plankton diversity and its implications for marine ecosystems.

      Weaknesses:

      While the evidence presented is solid, there are areas where the analysis could be expanded. The authors could further explore the ecological interactions within plankton communities, which would provide a more holistic view of their functional roles. Additionally, a broader discussion of the implications of their findings for marine conservation efforts could enhance the manuscript's impact.

      The choice of both the plankton net and filter pore size during the plankton collection process is critical, as these factors directly impact the types of phytoplankton collected. The use of a 25 μm filter paper, in particular, may result in the omission of many eukaryotic phytoplankton species. This limitation, combined with the characteristics of the plankton net, could affect the comprehensiveness and accuracy of the results, potentially influencing the study's conclusions regarding phytoplankton diversity.

      The timing of fixation is crucial, as it directly affects whether the measured transcriptome accurately represents the organisms' actual transcriptional state in their native water environment. If fixation occurred a significant time after sample collection, the transcriptomic data may not reflect their true in situ transcriptional activity, which greatly reduces the relevance of this method.

      Thank you for your time, effort, and expertise.

      We agree that additional analyses could improve our understanding of the plankton communities sampled. We have conducted an array of alternative analyses that were not included in the current manuscript and plan to perform new analyses over the next few months as part of a deeper revision of the manuscript. We are especially interested in “providing a more holistic view of the functions” of individual plankton within the community.

      As for the protocol details, the pore size of the filter paper was chosen to focus on ~100 micron-sized organisms as a starting point: they are likely to contain more RNA than smaller organisms, making them well suited for an initial proof of concept of the methodology. That choice, however, is not particularly tightly constrained, therefore smaller plankton could be captured. This is supported by the lack of correlation, in our data, between organismal size and number of detected sequencing reads.

      Timing to cell death/fixation is a common question we receive not just in this manuscript but any RNA-Seq from primary samples. In this case, plankton were seen swimming until picking, and after picking each organism was deposited within two seconds into a lysis buffer for fixation. Therefore, we do not have reason to believe that the transcriptional activity sampled in the sequencing reads differs in any major way from the one in living plankton. Nonetheless, a study specifically testing the effect of time between ocean sampling and reverse transcription would provide more quantitative information on this point.

      Reviewer #2 (Public review):

      Summary:

      The paper introduces Ukiyo-e-Seq, a novel method integrating microscopy with single-cell transcriptomics to study individual, uncultured eukaryotic plankton cells. By combining microscopic imaging with transcriptomic analysis, the approach links plankton morphology to gene expression, enabling taxonomic identification and functional protein exploration. Ukiyo-e-Seq was tested on 66 microbial eukaryotic cells, revealing taxonomic diversity across four superkingdoms and allowing analysis of protein complexes and developmental genes in individual species. According to the authors, this method has the potential to advance single-cell marine biodiversity studies by addressing limitations in traditional taxonomy and metatranscriptomics, especially for rare or uncultured organisms.

      However, the study's conclusions are often weakly supported by data, particularly given that this is not the first study to combine microscopy and single-cell transcriptomics of eukaryotic plankton using Smart-seq2.

      Strengths:

      A notable strength is the authors' generation of several single-cell transcriptomes for the diatom Chaetoceros, which could benefit from greater focus rather than broadly addressing eukaryotic single cells.

      Weaknesses:

      The study lacks comparison with other single-cell transcriptomics studies and it was presented as the first study that combines imaging and single-cell transcriptomics (smart-seq2) of eukaryotic plankton while in fact it is not. The sampling methodology is not replicable as the authors used a tea strainer instead of standard plankton collection equipment to filter larger cells. Terminology throughout the paper is unconventional, such as "public and private contigs," "single-organism genomics," "highly expressed contigs," and "optical methods." Additionally, the authors did not specify which database was used for taxonomic assignments. These issues may stem from the authors' limited background in microbial ecology. Overall, the study has many drawbacks and it could benefit from complete rewriting and focusing mainly on single-cell transcriptomics of diatoms.

      Thank you for your time, effort, and expertise.

      There might be a bit of confusion between single-cell and single-organism sequencing, likely due to lack of clarity in our initial submission. In particular, in this manuscript no effort was spent trying to dissociate oligocellular plankton into individual cells before sequencing. While probably feasible, we expect that to be technically much harder than single-organism sequencing as performed here. The reviewer does not reference a published paper where combined imaging and RNA-Seq of individual uncultured plankton has been achieved, and we were unable to find one in the scientific literature. As stated in the manuscript, others have already performed some work on cultured plankton and single-organism sequencing (without matching images) of uncultured environmental microorganisms.

      The suggestion to focus on a smaller biological niche such as diatoms and adopt language more familiar to that specific community is well received. Indeed, given that organisms as diverse as fish larvae and diatoms could be profiled with Ukiyo-e-Seq, future studies could use the same method to address specific questions with a deeper and more narrow scope. However, this manuscript is demonstrating the feasibility of Ukiyo-e-Seq and its ability to produce usable data for a broad spectrum of organisms: part of the scientific audience might not have a specific interest in diatoms.

      The tea strainer was used for coarse pre-filtering: the exact pore size, geometry and factory tolerance on those measurements are inconsequential because each organism is later chosen (or not) based on a high-resolution microscopy image (or multiple, if fluorescence is considered). This really is a strength of Ukiyo-e-Seq over FACS or droplet-based sorters, which can only collect coarse optical information from each organism for (typically) less than 1 millisecond. In Ukiyo-q-Seq, while the actual decision to pick an individual is currently manual (by the operator of the picker), it can be automated in principle. For instance, one could build a machine learning model of plankton taxonomy based on a large collection of labelled images and use predictions from such a model to automatically drive the picker (e.g. focussing on diatoms), increasing throughput. Even in that case, however, the initial filtering stages using tea strainers, plankton nets, filter paper etc. would not be critical for the final selection of individuals as long as they are not too restrictive.

      The database used for taxonomic assignment was the NCBI non-redundant nucleotide database, accessed through the reference library provided by Kraken2 (nt).

      Reviewer #3 (Public review):

      Gatt et al. present a novel take on single-cell RNA-sequencing from complex planktonic samples, introducing an approach they aptly named Ukiyo-e-Seq. This work combines environmental sampling with cell picking, microscopic imaging, and Smart-seq2 single-cell RNA sequencing to profile uncultured eukaryotic plankton. Developing single-cell approaches for such ecosystems is critical, given the poor representation of many planktonic species in cultures and reference databases. This work could help bridge existing technological gaps between morphological and molecular studies of aquatic microeukaryotes

      The authors argue that microscopy does not provide information on the biochemistry of species under consideration. At best, it provides taxonomic labeling of species within a sample, yet imaging fails to assess their metabolic state or to disentangle cryptic species. In a standard metatranscriptomic setup, the sequence pool is described by aligning assembled contigs with reference databases to obtain functional and taxonomic information. This complex community-level data is impossible to parse at the single-organism level. Moreover, by relying on reference datasets, a lot of potential information can be missed. The aim of the approach is to combine the strengths of both methods, generating single-cell transcriptomic data linked to individual plankton images.

      Strengths:

      Ukiyo-e-Seq generated a valuable dataset by combining imaging and transcriptomics for individual planktonic organisms from environmental samples. This multimodal approach has the potential to improve taxonomic predictions and functional insights at the single-organism level. This manuscript demonstrates the technical feasibility of such an approach. Data of this type is rare and thus represents a valuable resource to further advance single-cell sequencing of planktonic species from environmental samples.

      Weaknesses:

      (1) The merge-split strategy, where single-cell reads are pooled prior to assembly, is counterintuitive. Pooling obscures the single-organism resolution that single-cell methods aim to achieve. The approach might be useful for assembling low-coverage contigs, but risks masking unique expression profiles for transcripts unique to a given well. As an alternative, the authors could assemble each well independently to obtain well-specific transcriptomic bins. Assemblies could then be clustered based on sequence similarity, thereby imposing strict clustering parameters to maintain resolution, to create a common reference for downstream analysis if needed. In my opinion, better results would be obtained by implementing a per-well assembly and read mapping.

      (2) The focus on the top five most expressed contigs throughout the manuscripts' data analysis is a limiting choice, as it excludes most contigs. In the preprint, we are presented with a very narrow view of the data. Visualising the entire range of assembled contigs would provide a better picture of the transcriptomic composition and diversity per well. It would be interesting to assess if the full information could be used to preliminary bin transcriptomic sequences from individual wells, for example, by gathering all 'private' contigs with high read coverage in a single well. Does such a set represent a single complete eukaryotic transcriptome?

      (3) I missed a verification with (broad-scale) taxonomic assessments based on the associated microscopic images. In their goals, the authors state that a joint approach has the potential to discover new taxonomic biodiversity. I agree, and to me, this is what is exciting about the preprint, yet I miss an example or the right bioinformatic implementation to drive home this claim. Are there organisms in wells where poor taxonomic annotations, based on alignment to a reference database or the LCA approach implemented in Kraken2, would usually result in ignoring the species in classic metatranscriptomics? Can you advance the taxonomic annotation by referring back to the organisms' picture? Can manual assessment of taxonomy advance the results from the LCA approach?

      (4) The current use of AlphaFold to predict protein structures does not convincingly add to the study's core objectives.

      Overall, Ukiyo-e-Seq presents a promising method for studying single-cell diversity in environmental samples, though the bioinformatic pipeline requires refinement to support some of the claims made by the authors. Additionally, the manuscript would benefit from clarity and additional details in its methods and a more consistent approach to presenting results and summary statistics across all assembled contigs and all sampled wells, rather than focusing on selected wells.

      Thank you for your time and effort, and for your expertise on the matter.

      The suggestions to conduct additional bioinformatic analyses to explore more fully the criticality and potential of various design choices (e.g. meta-assembly) are well received. We have tried some of those ideas already (e.g. assembling individual wells) and we have considered but not yet conducted or polished others (e.g. a more thorough taxonomic verification). We will endeavour to carry out as many of those analyses as possible during the deeper revision process in the coming months.

      AlphaFold 3’s use was designed to demonstrate the ability to investigate protein-protein interactions from individual species. When two peptide sequences are detected within the same well, they are more likely to be potential interacting partners than in a metatranscriptomic study, because the compartmentalisation of reads into tens or hundreds of wells greatly reduces the search space of potential interaction partners (which has a baseline runtime complexity of n squared, where n is the number of peptide sequences identified).

      ----------

    1. Author response:

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      In this manuscript, Liu et al. present CROWN-seq, a technique that simultaneously identifies transcription-start nucleotides and quantifies N6,2'-O-dimethyladenosine (m6Am) stoichiometry. This method is derived from ReCappable-seq and GLORI, a chemical deamination approach that differentiates A and N6-methylated A. Using ReCappable-seq and CROWN-seq, the authors found that genes frequently utilize multiple transcription start sites, and isoforms beginning with an Am are almost always N6-methylated. These findings are consistently observed across nine cell lines. Unlike prior reports that associated m6Am with mRNA stability and expression, the authors suggest here that m6Am may increase transcription when combined with specific promoter sequences and initiation mechanisms. Additionally, they report intriguing insights on m6Am in snRNA and snoRNA and its regulation by FTO. Overall, the manuscript presents a strong body of work that will significantly advance m6Am research.

      Strengths:

      The technology development part of the work is exceptionally strong, with thoughtful controls and well-supported conclusions.

      We appreciate the reviewer for the very positive assessment of the study. We have addressed the concerns below.

      Weaknesses:

      Given the high stoichiometry of m6Am, further association with upstream and downstream sequences (or promoter sequences) does not appear to yield strong signals. As such, transcription initiation regulation by m6Am, suggested by the current work, warrants further investigation.

      We thank the reviewer for the insightful comments. We have softened the language related to m6Am and transcription regulation. We totally agree with the reviewer that future investigation is required to determine the molecular mechanism behind m6Am and transcription regulation.

      Reviewer #2 (Public review):

      Summary:

      In the manuscript "Decoding m6Am by simultaneous transcription-start mapping and methylation quantification" Liu and co-workers describe the development and application of CROWN-Seq, a new specialized library preparation and sequencing technique designed to detect the presence of cap-adjacent N6,2'-O-dimethyladenosine (m6Am) with single nucleotide resolution. Such a technique was a key need in the field since prior attempts to get accurate positional or quantitative measurements of m6Am positioning yielded starkly different results and failed to generate a consistent set of targets. As noted in the strengths section below the authors have developed a robust assay that moves the field forward.

      Furthermore, their results show that most mRNAs whose transcription start nucleotide (TSN) is an 'A' are in fact m6Am (85%+ for most cell lines). They also show that snRNAs and snoRNAs have a substantially lower prevalence of m6Am TSNs.

      Strengths:

      Critically, the authors spent substantial time and effort to validate and benchmark the new technique with spike-in standards during development, cross-comparison with prior techniques, and validation of the technique's performance using a genetic PCIF1 knockout. Finally, they assayed nine different cell lines to cross-validate their results. The outcome of their work (a reliable and accurate method to catalog cap-adjacent m6Am) is a particularly notable achievement and is a needed advance for the field.

      Weaknesses:

      No major concerns were identified by this reviewer.

      We thank the reviewer for the positive assessment of the method and dataset. We have addressed the concerns below.

      Mid-level Concerns:

      (1) In Lines 625 and 626, the authors state that “our data suggest that mRNAs initate (mis-spelled by authors) with either Gm, Cm, Um, or m6Am.” This reviewer took those words to mean that for A-initiated mRNAs, m6Am was the ‘default’ TSN. This contradicts their later premise that promoter sequences play a role in whether m6Am is deposited.

      We thank the reviewer for the comment. We have changed this sentence into “Instead, our data suggest that mRNAs initiate with either Gm, Cm, Um, or Am, where Am are mostly m6Am modified.” The revised sentence separates the processes of transcription initiation and m6Am deposition, which will not confuse the reader.

      (2) Further, the following paragraph (lines 633-641) uses fairly definitive language that is unsupported by their data. For example in lines 637 and 638 they state “We found that these differences are often due to the specific TSS motif.” Simply, using ‘due to’ implies a causative relationship between the promoter sequences and m6Am has been demonstrated. The authors do not show causation, rather they demonstrate a correlation between the promoter sequences and an m6Am TSN. Finally, despite claiming a causal relationship, the authors do not put forth any conceptual framework or possible mechanism to explain the link between the promoter sequences and transcripts initiating with an m6Am.

      (3) The authors need to soften the language concerning these data and their interpretation to reflect the correlative nature of the data presented to link m6Am and transcription initiation.

      For (2) and (3). We have softened the language in the revised manuscript. Specifically, for lines 633-641 in the original manuscript, we have changed “are often due to” into “are often related to” in the revised manuscript, which claims a correlation rather than a causation.

      Reviewer #3 (Public review):

      Summary:

      m6Am is an abundant mRNA modification present on the TSN. Unlike the structurally similar and abundant internal mRNA modification m6A, m6Am’s function has been controversial. One way to resolve controversies surrounding mRNA modification functions has been to develop new ways to better profile said mRNA modification. Here, Liu et al. developed a new method (based on GLORI-seq for m6A-sequencing), for antibody-independent sequencing of m6Am (CROWN-seq). Using appropriate spike-in controls and knockout cell lines, Liu et al. clearly demonstrated CROWN-seq’s precision and quantitative accuracy for profiling transcriptome-wide m6Am. Subsequently, the authors used CROWN-seq to greatly expand the number of known m6Am sites in various cell lines and also determine m6Am stoichiometry to generally be high for most genes. CROWN-seq identified gene promoter motifs that correlate best with high stoichiometry m6Am sites, thereby identifying new determinants of m6Am stoichiometry. CROWN-seq also helped reveal that m6Am does not regulate mRNA stability or translation (as opposed to past reported functions). Rather, m6Am stoichiometry correlates well with transcription levels. Finally, Liu et al. reaffirmed that FTO mainly demethylates m6Am, not of mRNA but of snRNAs and snoRNAs.

      Strengths:

      This is a well-written manuscript that describes and validates a new m6Am-sequencing method: CROWN-seq as the first m6Am-sequencing method that can both quantify m6Am stoichiometry and profile m6Am at single-base resolution. These advantages facilitated Liu et al. to uncover new potential findings related to m6Am regulation and function. I am confident that CROWN-seq will likely be the gold standard for m6Am-sequencing henceforth.

      Weaknesses:

      Though the authors have uncovered a potentially new function for m6Am, they need to be clear that without identifying a mechanism, their data might only be demonstrating a correlation between the presence of m6Am and transcriptional regulation rather than causality.

      We thank the reviewer for the very positive assessment of the CROWN-seq method. We have softened the language which is related to the correlation between m6Am and transcription regulation.

    1. Author response:

      Reviewer 1 (Public Review)

      (1) The proposed design is not sufficient to answer the research question. The rationale of the study proposed in the introduction is that auditory stimulation may explain the analgesic effects of RPMS. To answer this question, the authors should have used a factorial design using 4 groups (active RPMS + sound; active RPMS + no sound; sham RPMS + sound; sham RPMS + no sound). Using this design, it would have been possible to determine if the sound, the afferent stimulation, or both are necessary to produce analgesia. Rather, they tested two types of RPMS (iTBS, cTBS) without real rationale, one electrical stimulation and a placebo.

      We will clarify that the study design employed was originally designed to determine whether iTBS or cTBS would be more effective to reduce pain. We included TENS as a positive control, and sham as a negative control. We were indeed surprised by the findings, and present them herein. Future RCTs should be performed to reproduce these findings.

      (2) There are multiple ways that the current design could have introduced biases. The study was not randomized but pseudo-randomised. What does that mean? Was their allocation concealment? Was the assessor and data analyst blinded to group allocation? Did an intention to treat analyses were performed? Did the participants were adequately blinded (was it measured)?

      This study was not designed as an RCT, but rather as experimental study. The study was pseudo-randomized to ensure that the groups had equal allocation and distribution of sexes.

      The groups were blinded to the other stimulations (they were not informed of the various arms of the study, through different consent forms).

      It was not possible to blind the experimenter as the iTBS and cTBS protocols are very different: iTBS has multiple bursts separated by brief intervals, whereas cTBS is continuous). The data were masked for analysis, and only unblinded at the final stage. We will update the manuscript to reflect these changes.

      (3) The TENS parameters used were not optimal and are not those commonly used in clinical practice. This could have explained the lack of TENS effects. The lack of TENS effects has not been discussed and it is concerning. If TENS had been effective (as expected), the story about the auditory effects would not have been presented as the primary mechanisms underlying the current results.

      We acknowledge that this is a limitation of the study. A future study should address this. However, we will not remove the arm for transparency.

      (4) No primary outcome has been identified. It is important to mention that the interpretation of results is based on the presence of only one statistically significant result. Pain intensity and pain unpleasantness are not affected. This was not properly addressed in the Discussion. What does that mean that secondary hyperalgesia is affected but not pain?

      We reiterate that this study was not designed as an RCT, but rather an experimental study with The primary outcomes measures that capture change in  were measures of pain sensitivity (pain intensity NRS, pain unpleasantness NRS, and secondary hyperalgesia). We will clarify this in the revised manuscript.

      We will now include discussion of the effects being solely on secondary hyperalgesia, and not on pain intensity and unpleasantness.

      (5a) The use of secondary hyperalgesia variable is concerning. How is it possible to measure secondary hyperalgesia if there is no lesioned tissue?

      Secondary hyperalgesia refers to hyperalgesia assessed in an area adjacent to or remote of the site of stimulation. In general, it is not required to lesion a tissue to activate the nociceptive system or to induce pain. We have cited other studies that have employed secondary hyperalgesia as a pain outcome measure without inducing a lesion.

      Hyperalgesia reflects increased pain on suprathreshold stimulation. Then, one measures the subjective response to a painful (i.e. suprathreshold) stimulation, then applies a conditioning stimulation (e.g. heat), and measures the subjective response to the same original stimulus. If the response after conditioning is higher than the baseline measure, hyperalgesia has been induced. Secondary hyperalgesia just refers to hyperalgesia assessed in an area adjacent to or remote of the site of stimulation. In general, it is not required to lesion a tissue to activate the nociceptive system or to induce pain.

      (5b) If heat creates secondary hyperalgesia without lesion, what does that mean physiologically?

      Secondary hyperalgesia is normally interpreted as a perceptual correlate of central sensitization.

      (5c) Is it a valid and reliable "pain" variable?

      Yes and yes. A noxious heat stimulus can reliably elicit secondary hyperalgesia (see section 3.2 from Quesada et al. 2021). We also cite several studies that have used secondary hyperalgesia as an outcome measure of central sensitization in pain.

      (6) The follow-up study has been designed to cover the RPMS sound using pink noise. However, the pink noise was also present during the PHP measurement. How can we determine whether the absence of change is due to the pink noise during the RPMS or the presence of pink noise during PHP? I don't think this is possible to discriminate.

      We will add a third study that performs the control analysis with the sound of the rPMS masked, but no pink noise otherwise. The study will be performed in two groups: one with pink noise, and one without pink noise.

      Appraisal

      (7) Despite all these potential issues, authors interpret their data with high confidence and with several overstatements in the Title, Abstract, and Discussion. The results do not support their conclusions. The fact that auditory stimulation may produce an analgesic effect is a hypothesis, but the current study cannot ascertain it.

      We believe that the chief concern with the interpretation lies with concerns with the second study. The proposed third experiment will address these concerns.

      Reviewer 2 (Public Review):

      (1) My biggest concern in this paper is that the stimulation protocols are not applied after pain was induced in the subjects, but before. This is not bad in itself, but as the paper presents the stimulations as potential "treatments" it generates a severe mismatch between the objective, context (introduction), and impact (discussion) presented for the experiments, and how they are actually designed. This adds to the fact that healthy volunteers are used here to generate a study with low translational capability, that aims to be translational and provide an indication for clinics (maybe this is why the reduction in pain intensity caused by PMS when applied in patients, reported in references [29, 35 and 39], is not observed here).

      We will reframe these as prophylaxis, rather than treatment. This study was an experimental study originally designed to determine which stimulation parameters (cTBS or iTBS) would be better suited to modulate pain. We performed the study in healthy individuals undergoing acute pain, akin to a person undergoing painful procedure, which could lead to central sensitization and pain persistence (e.g., post-surgical pain). However, before testing this in individuals undergoing actual procedures, it is essential to determine efficacy in people before translation.

      Khan et al [29] is a case study with neuropathic pain, whereas our study uses a nociceptive pain model. Lim et al [35] employed 10 sessions of rPMS stimulation in patients with acute low back pain. Similar to our study, the change in VAS driven by rPMS was no different than the sham stimulation. We notice that there is no reference 39, and will correct this.

      (2) TENS treatment duration is simply too short (90s) to be considered a therapeutic TENS intervention. I get that this duration was chosen to match the one of PMS, but TENS is never applied like this in the clinics, in which the duration varies from 10 minutes to an hour (or more). This specific study comparing different durations recommends 40 minutes for knee osteoarthritis pain relief (PMID: 12691335). Under these conditions, this stimulation is more similar to a sham TENS than to a real TENS treatment: I would suggest interpreting it as such. As the paper is right now, it could give the impression that PMS could produce clinical effects not observed in TENS, but while the PMS application resembles a clinical one, the TENS application does not (due to its extremely short duration). As an example, giving paracetamol at a dose 10 times below its effective dose is a placebo, not a paracetamol treatment.

      We acknowledge that this is a limitation, and will address this in the Discussion of the revised manuscript.

      (3) This study measured pain, not central sensitization. Specifically, the effects refer to the area of secondary hyperalgesia. The IASP definition for central sensitization is "Increased responsiveness of nociceptive neurons in the central nervous system to their normal or subthreshold afferent input." (PMID: 32694387). No neuronal results are reported in this article. Therefore, central sensitization is not measured here, and we do not know if it is reduced by sound. This frontally clashes with the title of the article and with many interpretations of the results. For a deep review on this topic, I recommend PMID: 39278607 and the short article PMID: 30416715.

      It is widely accepted that central sensitization is the neurophysiological basis of secondary hyperalgesia (see PMID: 11313449; PMID: 10581220).

      The reviewer is conflating secondary hyperalgesia due to central sensitization and chronic pain. Whether chronic pain is driven or maintained by central sensitization is not the goal of our study. However, there is ample evidence that nociceptive drive can induce plasticity in the CNS, which alters pain sensitivity, and that these changes facilitate pain.

      (4a) There is no mention of blinding/masking/concealing in this manuscript. Was the therapist blind to whether they applied one protocol, another, or a placebo? Were the evaluators blind, as this can heavily influence their measurements? And the volunteers? Was allocation concealed? Was this blinding measured afterwards? Blinding is, together with randomization, the most important methodological feature for those interventional studies. For example, not introducing blinding and concealing directly makes a study lose 4 out of 10 points in the PEDro scale, failing to fulfill criteria 3, 5, 6, and 7 (https://pedro.org.au/english/resources/pedro-scale/).

      This study was not designed as an RCT, but rather as experimental study. The study was pseudo-randomized to ensure that the groups had equal allocation and distribution of sexes.

      The groups were blinded to the other stimulations (they were not informed of the various arms of the study, through different consent forms). However, blinding was not measured afterwards (again, this was not meant to be an RCT).

      It was not possible to blind the experimenter as the iTBS and cTBS protocols are very different: iTBS has multiple bursts separated by brief intervals, whereas cTBS is continuous). The data were masked for analysis, and only unblinded at the final stage. We will update the manuscript to reflect these changes.

      (4b) Continuing with methodological considerations, the dropout percentage is high (18% for the first and 25% for the second study), both above the 15% cutoff for criterion 8 of the PEDro, losing another point.

      In the study, only 2 withdrew after feeling the heat, 2 were lost to follow up, and 2 had incomplete data. That totals 6/123 in Study 1. In study 2, none of the participants that met inclusion/exclusion criteria, and who were ‘allocated’ to the study were included (0% dropout/data loss).

      We are unsure how to address this point, as we had clear inclusion/exclusion criteria, and these could only be measured after consenting. As this is an experimental study performed on healthy individuals in a university setting, we are not able to collect any study related data prior to consent.

      We openly reported individuals who did not meet the criteria, and thus were excluded. These criteria are a combination of what is required to collect good quality data, and what we are ethically permitted to do. We understand that in an interventional trial where >15% drop out due to intolerance, or adverse events would indeed be concerning.

      (5) Data reporting and statistical treatment can be improved, as only differences are reported and regression to the mean is not accounted for in this study. Moreover, baseline levels for the dependent variables (control session) are not accessible for evaluation and they are not compared statistically, making it impossible to know if the groups were similar at baseline. This will imply failing criterion 3 of the PEDro, for a total of 2/10 points.

      This only concerns study 1, as study 2 is a within subject study design. Study 1 provides the raw data in Figure 4. We will provide the raw data for each of the primary outcome measures in a supplemental table in the revision.

    1. Author response:

      In this initial response to the public review, we outline our plan to address the major concerns raised. Below, we provide a general categorization of the suggestions and our corresponding responses

      Weakness #1: Statistical Concerns - using the number of seizures (rather than the number of animals) may identify small effects that could be insignificant. Effect size should be taken into consideration.

      Reviewer 1:

      “While the data generally supports the authors' conclusions, a weakness of this manuscript lies in their analytical approach where EEG feature-space comparisons used the number of spontaneous or evoked seizures as their replicates as opposed to the number of IHK mice; these large data sets tend to identify relatively small effects of uncertain biological significance as being highly statistically significant.”

      Reviewer 2:

      “In several sections of the paper, the authors argue that two different groups are similar on the basis that no statistical difference was found between the two groups (i.e., p > 0.05); however, the failure to find a statistically significant difference, particularly with relatively small sample sizes, is not rigorous evidence that the two groups are actually similar - they are just "not significantly different.”

      Reviewer 3:

      “(3) The utility of increasing the number of seizures for enhancing statistical power is limited unless the sample size under evaluation is the number of seizures. However, the standard practice is for the sample size to be the number of mice.”

      Reviewer 3:

      “(1) Evaluation of seizure similarity using the SVM modeling and clustering is not sufficiently explained to show if there are meaningful differences between induced and spontaneous seizures. SVM modeling did not include analysis to assess the overfitting of each classifier since mice were modeled individually for classification.”

      We understand the reviewers’ concerns. In this work, we used linear mixed effect model to address two levels of variability –between animals and within animals. The interactive linear mixed effect model shows that most (~90%) of the variability in our data comes from within animals (Residual), the random effect that the model accounts for, rather than between animals. Since variability between animals are low, the model identifies common changes in seizure propagation across animals, while accounting for the variability in seizures within each animal. Therefore, the results we find are of changes that happen across animals, not of individual seizures. We will make text edits to enhance understanding of the linear mixed effect model.

      To address the point raised about similarity, we will explain how the SVM classifier was trained. The purpose of the SVM is not to identify meaningful differences between induced and spontaneous seizures. Rather, it is to classify EEG sections as “seizures” or non-seizures, demonstrating the gross similarity between induced and spontaneous seizures despite minor differences. We will make text clarifications for the SVM model.

      Weakness #2: Clinical and biological significance is unclear.

      Reviewer 1:

      “Furthermore, the clinical relevance of similarly small differences in EEG feature space measurements between seizure-naïve and epileptic mice is also uncertain.”

      Reviewer 2:

      “While the paper may be relevant for the ETSP and contract research organizations (CROs), the paper was not written to attract the interest of biological scientists, even those in this specific area of epilepsy research. It may be of low interest to other neuroscientists… The key issue the authors aim to address is the 30-40% of patients with DRE, but the real problem with DRE patients is not that these people have seizures with no effect of the ASDs; rather, although ASD may reduce seizure burden, these patients continue to have some remaining seizures even after high doses of ASDs, which often leads to adverse effects from the particular ASDs… It remains unclear that the optogenetically induced seizures in this model are better than similarly induced seizures in a naïve animal, and there is no evidence that the model will be useful for finding new ASDs to treat DRE.”

      Reviewer 3:

      “(6) Human epilepsy is extensively heterogeneous in both etiology and individual phenotype, and it may be hard to generalize the approach.”

      Reviewer 2:

      “The authors state that this approach should be used to test for and discover new ASDs for DRE, and also used for various open/closed loop protocols with deep-brain stimulation; however, the paper does not actually discuss rigorously or critically the background literature on other published studies in these areas or how this approach will improve future research for a broader audience than the ETSP and CROs. Thus, it is not clear whether the utility will apply more widely and how extensive a readership will be attracted to this work.”

      We appreciate the reviewer’s concerns. We will revise the manuscript to better emphasize the potential significance of our approach. The on-demand seizure model can be applied to address biologically and clinically relevant questions beyond its utility in drug screening. For example, crossing the Thy1-ChR2 mouse line with genetic epilepsy models, such as Scn1a mutants, could reveal how optogenetic stimulation differentially induces seizures in mutant versus non-mutant mice, providing insights into seizure generation and propagation in Dravet Syndrome. Due to the cellular specificity of optogenetics, we also envision this approach being used to study circuit-specific mechanisms of seizure generation and propagation. Regarding drug-resistant epilepsy (DRE) and anti-seizure drug (ASD) screening, we agree with the reviewer that probing new classes of ASDs for DRE represents the critical goal. However, we believe a full exploration of additional ASD classes and/or modeling DRE lies outside the scope of this manuscript.

      Weakness #3: Definition of Seizure is unclear

      Reviewer 2:

      “Although the figures provide excellent examples of individual electrographic seizures and compare induced seizures in epileptic and naïve animals, it is unclear which criteria were used to identify an actual seizure induced by the optogenetic stimulus, versus a hippocampal paroxysmal discharge (HPD), an "afterdischarge", an "electrophysiological epileptiform event" (EEE, Ref #36, D'Ambrosio et al., 2010 Epilepsy Currents), or a so-called "spike-wave-discharge" (SWD). Were HPDs or these other non-seizure events ever induced using stimulation in animals with IH-KA? A critical issue is that these other electrical events are not actual seizures, and it is unclear whether they were included in the column showing data on "electrographic afterdischarges" in Figure 5 for the studies on ASDs”

      Reviewer 3:

      “(2) The difference between seizures and epileptiform discharges or trains of spikes (which are not seizures) is not made clear.”

      Reviewer 2:

      “The differences between the optogenetically evoked seizures in IH-KA vs naïve mice are interpreted to be due to the "epileptogenesis" that had occurred, but the lesion from the KA-induced injury would be expected to cause differences in the electrically and behaviorally recorded seizures - even if epileptogenesis had not occurred. This is not adequately addressed.”

      Thank you for pointing out the unclear definition of the seizures analyzed. We agree and will revise the text to clarify this issue. In this manuscript, we focused on tonic-clonic seizures. We analyzed animal behavior during evoked events, and a high percentage of induced electrographic events were accompanied by behavioral seizures with a Racine scale of three or above. Regarding epileptogenesis, our model is based on the IHK model, in which spontaneous tonic-clonic seizures occur a few to several days after KA injection. These mice are, by definition, epileptogenic. We will further clarify this methodology in the text.

      Weakness #4: Similarity/Difference with Kindling Not Clear

      Reviewer 2:

      “The authors did not test whether an apparent "kindling" effect, apparently seen in naïve controls, also occurred in animals micro-injected with kainic acid (KA). This effect could cause model instability that might result in variability in response to ASDs. It is not clear whether the number of optogenetically induced seizures in epileptic animals would affect the response to drugs. It is also unclear how much of an improvement the animal model in the present work is over other similar models of TLE, where electrically triggered seizures could simply be applied to one of them.”

      Reviewer 3:

      “(5) It is unlikely that long-term adaptation to CA1-stimulated seizure induction is absent in these mice. A duration of evaluation longer than 16 days is warranted in light of the downward slope at days 13-16 for induced seizures in Figure 4C.”

      We appreciate the reviewer’s comments regarding the “kindling effect” as well as its similarity to the kindling model. We will carefully assess the data and address this in the revised manuscript. In electrical kindling, the activated cellular population is non-specific, including both excitatory and inhibitory neurons. In our model, we specifically activate predominantly excitatory neurons (Thy1-positive neurons), which we observed to participate in convulsant-induced seizures (as demonstrated in Thy1-GCaMP experiments). We consider this specificity an improvement over the kindling model, making our approach more biologically relevant.

      Weakness #5: Time needed to generate model is significant. Unclear if animals were pre-selected

      Reviewer 1:

      “Finally, the multiple surgeries and long timetable to generate these mice may limit the value compared to existing models in drug-testing paradigms.

      Reviewer 2:

      “The authors offer little mention of other research using animal models of TLE to screen ASDs, of which there are many published studies - many of them with other strengths and/or weaknesses. For example, although Grabenstatter and Dudek (2019, Epilepsia) used a version of the systemic KA model to obtain dose-response data on the effects of carbamazepine on spontaneous seizures, that work required use of KA-treated rats selected to have very high rates of spontaneous seizures, which requires careful and tedious selection of animals. The ETSP has published studies with an intra-amygdala kainic acid (IA-KA) model (West et al., 2022, Exp Neurol), where the authors claim that they can use spontaneous seizures to identify ASDs for DRE; however, their lack of a drug effect of carbamazepine may have been a false negative secondary to low seizure rates. The approach described in this paper may help with confounds caused by low or variable seizure rates. These types of issues should be discussed, along with others.”

      We appreciate the reviewer’s insights. In an existing model investigating spontaneous tonic-clonic seizures (such as the intra-amygdala kainate injection model), the time investment is back-loaded, requiring two to three weeks per condition while counting spontaneous seizures, which may occur only once a day. In contrast, our model requires a front-loaded time investment. Once the animals are set up, we can test multiple drugs within a few weeks, providing significant time savings. Additionally, we did not pre-screen animals in our study. Existing models often pre-select mice with high rates of spontaneous seizures, whereas in our model, seizures can be induced even in animals with few spontaneous seizures. We believe that bypassing the need for pre-screening is a key advantage of our induced seizure model.

      Reviewer 3:

      “(7) No mention or assessment of mouse sex as a biological variable.”

      Thank you for pointing this out. Both female and male animals were included in this study: Epileptic cohort: 7 males, 3 females; Naïve cohort: 3 males, 4 females

    1. Author response:

      The following is the authors’ response to the original reviews.

      Reviewer #1 (Public Review):

      Summary:

      Wilson's Disease (WD) is an inherited rare pathological condition due to a mutation in ATP7B that alters mitochondrial structure and dysfunction. Additionally, WD results in dysregulated copper metabolism in patients. These metabolic abnormalities affect the functions of the liver and can result in cholecystitis. Understanding the immune component and its contribution to WD and cholecystitis has been challenging. In this work, the authors have performed single-cell RNA sequencing of mesenchymal tissue from three WD patients and three liver hemangioma patients.

      Strengths:

      The authors describe the transcriptomic alterations in myeloid and lymphoid compartments.

      Weaknesses:

      In brief, this manuscript lacks a clear focus, and the writing needs vast improvement. Figures lack details (or are misrepresented), the results section only catalogs observations, and the discussion needs to focus on their findings' mechanistic and functional relevance. The major weakness of this manuscript is that the authors do not provide a mechanistic link between the absence of ATP7B and NK cells' impaired/altered functions. While the work is of high clinical relevance, there are various areas that could be improved.

      In this study, we reported for the first time that ATP7B mutation and the resulting metabolic abnormalities in hepatocytes cause functional alteration of immune cells in WD patients. We dissected the transcriptional profiles of liver mesenchymal cells and delineated the functional differences of main immune cells in WD patients through scRNA-seq. The NK cell exhaustion and its clinical significance were further demonstrated.

      The mechanism study is of our concern. Given that the ATP7B mutation is hepatocyte-specific, its effect on immune cells is most probably through intercellular communication rather than through the direct action of ATP7B protein. How ATP7B mutation disturbs the metabolic homeostasis in hepatocyte, how metabolic pathways regulate the release of signal substances, and how signal substances act on the NK cells need to be explained. These contents, together with this manuscript, are beyond the scope of a single article, so we put the novelty in this manuscript.

      We sincerely appreciate the comments. We have improved the manuscript based on your valuable suggestions. The mechanism study is our subsequent research topic. We are actively promoting it and have found that ATP7B mutation rewires a certain metabolism pathway in hepatocyte, and that a critical metabolite functions as the mediator causing NK cell exhaustion.

      Reviewer #2 (Public Review):

      Summary:

      Wilson's disease is a rare genetic disorder caused by mutations in the ATP7B gene. Previous studies have documented that ATP7B mutations can disrupt copper metabolism, affecting brain and liver function. In this paper, the authors performed a retrospective clinical study and found that Wilson's disease has a high incidence of cholecystitis. Single-cell RNA-seq analysis revealed changes in the immune microenvironment, including the activation of immune responses and the exhaustion of natural killer cells.

      Strengths:

      A key finding of this study is that the predominant ATP7B gene mutation in the Chinese population is the 2333G>T (p. R778L) mutation. The authors reported associations between Wilson's disease and cholecystitis, as well as the exhaustion of natural killer cells.

      Weaknesses:

      The underlying mechanisms linking ATP7B mutations to cholecystitis and natural killer cell exhaustion remain unclear. Specifically, it is not yet determined whether copper metabolism alterations directly cause cholecystitis and natural killer cell exhaustion, or if these effects are secondary to liver dysfunction.

      In this study, we reported for the first time that ATP7B mutation and the resulting metabolic abnormalities in hepatocytes cause functional alteration of immune cells in WD patients. We dissected the transcriptional profiles of liver mesenchymal cells and delineated the functional differences of main immune cells in WD patients through scRNA-seq, focusing on the NK cell exhaustion and its clinical significance.

      The mechanism study is of our concern. Given that the ATP7B mutation is hepatocyte-specific, its effect on immune cells is most probably through intercellular communication, so we prioritize the studying of this aspect. How ATP7B mutation disturbs the metabolic homeostasis in hepatocyte, how metabolic pathways regulate the release of signal substances, and how signal substances act on the NK cells need to be explained. These contents, together with this manuscript, are beyond the scope of a single article, so we put the novelty in this manuscript.

      We sincerely appreciate the comments. The mechanism study is the topic of our follow-up study. We are actively promoting the research and we have found that ATP7B mutation rewires a certain metabolism pathway in hepatocyte, and that a critical metabolite functions as the mediator causing NK cell exhaustion.

      Reviewer #1 (Recommendations For The Authors):

      Major:

      (1) Abstract. A major portion of this manuscript focuses on non-NK cells. Data that describes NK cell exhaustion is only minimal. Therefore, the authors should modify the abstract.

      Thank you for your valuable suggestion. We have supplemented the description of functional changes in other immune cells, and have modified the abstract (line 31-35).

      (2) Introduction. There are three paragraphs. The first paragraph discusses cholecystitis. However, there are too many repetitions, and the information is unclear. In the second part, the authors discuss NK cells and their exhaustion. The authors do not establish a clear rationale or logic linking NK cells to WD or cholecystitis. In the last paragraph, the authors describe their findings. Their correlation between NK cell exhaustion and the poor healing process of cholecystitis has no direct experimental proof.

      Thank you for your comments. We have deleted the repetitions and rephrased some sentences (line 72-74). Briefly, in the first paragraph, we proposed the significant prognostic value of immune cell dysfunction for cholecystitis. In the second paragraph, we introduced NK cell exhaustion and its potential to predict prognosis of certain diseases. In the third paragraph, we introduced that the liver is a central organ involved in metabolism and immunity, holding a large number of NK cells. Liver pathologies commonly impact the development and outcome of inflammation-associated diseases such as cholecystitis. WD was selected as a research model. In the last paragraph, we introduced our findings from clinical study, scRNA-seq, clinical samples, and bioinformatics analysis, and concluded at the end.

      (3) Results. Overall, the results section lacks clarity and a clear focus. Figure legends need to be significantly detailed. The authors make too many broad statements without any support. The authors also make too many overstatements.

      Thank you for your valuable suggestion. We have improved the inaccurate statements and made detailed refinement of figure legends. All the changes are marked in the manuscript, and related responses are described below.

      Figure 1: No information is provided about the functional impairment of ATP7B protein due to the mutation found in the cohort of Chinese patients. What does 'immune abnormalities' (line 127) mean? What is the relevance of showing liver fibrosis and copper accumulation in the eye in Figure 1c and d, respectively? Total cholesterol concentrations are still within the range in the plasma of WD patients, but the authors call it higher. ECAR has not changed in WD patients, but the authors claim it has (line 117).

      (1) All these gene mutations in WD disable the protein function and cause the same outcome. (2) We have deleted the inappropriate statement. (3) In clinical observation, we found that WD not only causes copper accumulation in hepatocytes, but also leads to a variety of diseases, including liver fibrosis, Kayser-Fleischer Ring, and lower risk of hyperglycemia. We showed these together with the data of cholecystitis incidence. We think these might suggest the significance of intercellular communication between hepatocytes and other cells in microenvironment. (4) We have deleted the inappropriate statement (line 108-110, 112-113).

      Figure 2: Did the authors use the liver mesenchymal tissue or mesenchymal cells? Figure 2 states that they used mesenchymal cells, different from liver mesenchymal tissue. Numbers within Figure 2b UMAP are not visible. Were the initial T and NK cells annotated as indicated in Figure S2 (CD3D, CD#E, CD3G)? If so, that does not include NK cells.

      (1) The liver mesenchymal cells were used for scRNA-seq. (2) It is possible that the image resolution was reduced due to the compression of files by the submission system during merging process. We confirm that the image resolution of all figures meets publishing requirements, and that all characters on the figures are visible. You can download figure files to view details. (3) It was our negligence that the incomplete cell markers were shown in Figure S2. We have updated the markers (CD3D, CD3E, NKG7), references (Ref #53, #55, and #56), and related figures (Figure 2e, and Figure S2c).

      Figure 3: The authors should change 'Case' to 'WD patients' both in the text and figures. DEGs in Figure 3C indicate a transcriptomic alteration in the B cell compartment, which the authors do not delineate. Also, the rationale and explanation for the CellChat analyses are minimal. Concluding that a change occurred within the TME with minimal data and explanations is unfair.

      Thank you for your comments. (1) We apologize for the confusion caused by the use of nomenclatures and abbreviations in the text and figures. In all scRNA-seq data analysis, presentation, and description, we used specific terms (CASE and CON) to refer to the group of WD patients and controls, as well as their cell population. We have now unified the use of nomenclature in full text and defined them when first appeared (line 126-127), avoiding using lowercase form to prevent confusion. (2) We have now compared the expression of key genes of B cell between the two group in the next section “The dysfunction of main immune cells in WD patients” (line 230-235, Figure 4e, Figure S4e). (3) We have described the results of cellular communication in more detail (line 188-194). (4) We have modified the conclusion and all the related statement in full text (line 29-31, 82-84, 149, 194-195).

      Figure 4: This section deals with multiple cell types with minimal explanations. This section discusses various cell types, but it lacks focus. In particular, the T cell section should be separated and elaborated more in detail.

      (1) In this section, we intended to show the comparison in function of main immune cells that account for a considerable proportion, instead of just showing differently expressed genes that provide minimal information. The evaluation of functional signature, based on the integration of multiple gene expression, allows a direct understanding of the final outcome owing to transcriptional changes. (2) Given that the main functions of T cells did not change significantly and there were more significant changes in innate immunity, the T cell section is relatively short and unsuitable as a separated part.

      Figure 5: What are the distinct subsets of NK cells authors have found in the WD patients and controls? How do these subsets differ between the two groups in numbers and their transcriptomes? The presentation and labeling of Figure 5 and Supplementary Figure 5 need to be vastly improved. The pseudotime presentation in Figure 5b should be presented separately for the patients and the controls. Are the changes in gene expression presented in Figure 5a due to the change in the subset compositions? Figure 5c immuno-staining is not at all visible. A clear explanation should be given for the differences between Figure 5c and Figure 5e, where NKG2A expressions are shown. A better explanation for Figure 5d is required. Did the authors use all the antibodies with the same fluorochrome? If so, what color is that? Can the authors include the individual samples in the bar diagram in Figure 5e? Again, the data in Figure 5 is insufficient to conclude that NK cells are exhausted in WD patients. While the role of changes in the expression of T-BET and EOMES can be related to dysfunction and cellular exhaustion of NK cells, the statement made by the authors needs to be toned down as they do not test with independent experiments.

      (1) The subsets of NK cell were clustered by gene expression profile and labeled by the characteristically expressed gene, using certain algorithm in the routine procedure. They cannot be distinguished in clinical samples by one or several genes or other sorting methods. Thus, we were not able to analyze these subsets in clinical samples. (2) We have supplemented the comparison of numbers and transcriptomes of three NK subtypes between the two groups (line 268-273). (3) We have checked the figures and confirmed that all characters on the figures are visible. (4) We have separately presented the plot in Figure S5d. (5) We compared the expression level of genes presented in Figure 5a between the two groups in three NK subtypes and supplemented this part (line 264-268). The results were very consistent across the three subtypes, suggesting that the results in total NK population were contributed by all three subtypes and not affected by a single composition. (6) KLRC1 is also known as NKG2A. We are sorry for not making a clear explanation, and now we use KLRC1 only in all text to avoid confusion. We have made a more clear and detailed description for Figure 5c, 5d, and 5e (now labeled as Figure 5b, 5c, and 5d), and have included the fluorochrome in Figure 5d (now labeled as Figure 5c) and the individual value in Figure 5e (now labeled as Figure 5d) (line 293-299). (7) In this section, we found the upregulated expression of inhibitory receptors, downregulated expression of effector molecules, and the impaired NK cell-mediated cytotoxicity in NK cell of WD patients from scRNA-seq. Then we validated the findings in clinical liver section samples and clinical blood samples by mIHC and flow cytometry, respectively. According to the recent articles, exhausted NK cells are characterized by decreased production of effector cytokines (e.g., IFNγ), as well as by impaired cytolytic activity, and downregulate expression of certain activating receptors and upregulate expression of inhibitory receptors (e.g., 10.3389/fimmu.2017.00760, 10.1038/s41590-018-0132-0, 10.1038/s41467-019-09212-y, 10.1080/2162402X.2016.1264562). Therefore, we concluded NK cell exhaustion in WD patients. (8) In the part about transcription factors, we kept the description of objective data and deleted the statement of the contribution of transcription factors to NK exhaustion.

      Figure 6: Data presented in Figure 6 and the conclusion made in this manuscript are predictive. There is no direct testing of ATP7B in NK cells to show the functions of this gene. Extension of this to patient survival is purely speculative. As long as authors state these facts clearly in their text, it can be acceptable. However, they do not extend their conclusions to similar liver diseases.

      ATP7B mutation is hepatocyte-specific, and it does not occur in any immune cells. The function of ATP7B in NK cell was not studied. We found the NK exhaustion and poor prognosis of cholecystitis in WD patients. Given that there were researches demonstrating that NK exhaustion is correlated with poor liver cancer prognosis, we hypothesized that NK exhaustion contributes to the poor prognosis of cholecystitis. Bioinformatics studies confirmed our hypothesis and supported the extension of this result to other inflammatory diseases. We had no experimental data, but this result was reliable in bioinformatics method.

      (4) Discussion: While the authors analyzed multiple cell types, the discussion is primarily focused on NK cells. There is no clear link between copper utilization, NK cell function, and exhaustion that the authors articulate.

      Thank you for your comments. The focus of our study is NK cell exhaustion, which is experimentally proven, so we discussed this aspect. We prioritize the effect of intercellular communication and metabolic alteration on the NK cell exhaustion in our follow-up study. Excess copper is released into the circulation in some circumstances in WD patients, but generally they receive long-term de-coppering therapy to maintain intracellular copper at a non-lethal level. Thus, we do not tend to consider copper as a critical factor in this study. In original manuscript, we mentioned the cuproptosis and its potential as a novel target. It is likely to lead to ambiguity and misunderstanding, so we deleted this part to put our point of view clearly.

      (5) Supplementary Figures: The presentation and labeling of these figures need to be changed.

      Thank you for your suggestions. We have modified the figures and confirmed that all characters on the figures are visible.

      Reviewer #2 (Recommendations For The Authors):

      It is better to test whether ATP7B mutation can directly affect immune functions.

      Thank you for your suggestions. Given that the ATP7B mutation is hepatocyte-specific, its effect on immune cells is most probably through intercellular communication. Thus, we prioritize the effect of intercellular communication on the NK cell exhaustion and we are actively promoting the research.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public reviews:

      Reviewer 1

      We would like to express our gratitude to Reviewer 1 for providing a thorough summary of our work and highlighting its strengths. With regards to the weaknesses, we are committed to improve the manuscript by performing the necessary changes. First, we will specify the exact p-value in all cases.

      Regarding the discussion section, we acknowledge the feedback regarding its potential confusion. In line with the reviewer's suggestion, we will reduce the literature review and highlight our findings.

      Finally, for the preprint we did not include cofounders such as HIV infection and ethnicity as our study population did not exhibit viral infections and comprised only Hispanic individuals. We will make a more thorough description of the population of study and address these characteristics explicitly in both the methods section and the initial part of the results.

      Reviewer 2

      We appreciate and thank reviewer 2 for the commentaries. Although it is true that several papers have described the role of microbiome in COVID-19 severity, we firmly believe that our current work stands out. There is not much information related to this association in Mediterranean countries, especially in the south of Spain. In addition, most of the studies only describe microbiota composition in stool or nasopharyngeal samples separately, without investigating any potential relationships between them as we do.

      (1) We agree with the reviewer idea of a limited sample size. We faced the challenge of collecting the samples during the peak of COVID-19 pandemia. Thus, doctors and nurses were overwhelmed and not always available for carrying out patient recruitment following the inclusion criteria. Despite these constraints, we ensured that all included samples met our specified inclusion criteria and were from subjects with confirmed symptomatology.

      In addition, our main goal was to identify whether severity of the disease could be assessed through microbiota composition. Therefore we did not include a healthy group. Despite not having a large N, our results should be reproducible as they are supported by statistical analysis.

      (2) We thank reviewer commentary, and since our original sentence may have lacked clarity, we intend to modify it to ensure it conveys the intended meaning more effectively.

      Nonetheless, we remain confident in the significance of our findings. Not only have we found correlation between microbiota and COVID severity, but we have also described how specific bacteria from each condition is associated with key biochemical parameters of clinical COVID infection.

      (3) We appreciate the feedback provided by the reviewer. In this case, we have performed 16S analysis due to its cost-effectiveness compared to metagenomic approaches. Furthermore, 16S analysis has undergone refinements that ensure comprehensive coverage and depth, along with standardized analysis protocols. Unlike 16S, metagenomic approaches lack software tools such as QIIME that facilitate standardization of analysis and, thus, reduce reproducibility of results.

      (4) We sincerely appreciate this insightful suggestion. simply listing associations between both microbiomes and COVID-19 severity could not be enough, we intend to discuss how microbiota composition may be linked to the mechanisms underlying COVID-19 pathogenesis in our discussion.

      (5) We are grateful for the constructive criticism and intend to rewrite our abstract to enhance clarity. Additionally, we will thoroughly review all figures and their descriptions to ensure accuracy and comprehensibility.

      Reviewer 3

      We acknowledge the annotations made by reviewer 3 and are committed to addressing all identified weaknesses to enhance the quality of our work. Our idea is to modify the methods section and figures to make them easier to understand.

      Specifically, in the case of Figure 1, we recognize an error in the description of the Bray-Curtis test. We appreciate the commentary and we will make the necessary changes. Moreover, there is another observation related to Figure 1 description. We are going to modify it in order to gain accuracy.

      For figure 2 we are planning to add a supplementary table showing the abundance of detected genus. Nevermind, we will also update the manuscript text to provide clarification on how we obtained this result.

      Regarding the clarification about "1% abundance," we want to emphasize that we are referring to relative abundance, where 1 represents 100%. To avoid confusion, we will explicitly state this in both the methods section and figure descriptions. Besides, it is true that the statistical test employed for the analysis is not mentioned in the figure description and we recognize that the image may be difficult to interpret. Therefore, we will modify the text and a supplementary table displaying the abundance and p values is going to be added.

      Furthermore, we agree with the reviewer's suggestion to investigate whether the bacteria identified as potential biomarkers for each condition are specific to their respective severity index or if there is a threshold. Thus, we will reanalyze the data and include a supplementary table with the abundance of each biomarker for each condition. We will also place greater emphasis on these results in our discussion.

      Finally, in response to the reviewer's suggestion, we are going to go through the nasopharyngeal-fecal axis part in the discussion. It is well described that COVID-19 induces a dysbiosis in both microbiomes. Consequently, we understand that the ratio we have described could be an interesting tool for assessing COVID severity development as it considers alterations in both environments. However, we acknowledge that there may be room for improvement in clarifying the significance of this intriguing finding and its implications.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public review):

      This manuscript from Schwintek and coworkers describes a system in which gas flow across a small channel (10^-4-10^-3 m scale) enables the accumulation of reactants and convective flow. The authors go on to show that this can be used to perform PCR as a model of prebiotic replication.

      Strengths:

      The manuscript nicely extends the authors' prior work in thermophoresis and convection to gas flows. The demonstration of nucleic acid replication is an exciting one, and an enzyme-catalyzed proof-of-concept is a great first step towards a novel geochemical scenario for prebiotic replication reactions and other prebiotic chemistry.

      The manuscript nicely combines theory and experiment, which generally agree well with one another, and it convincingly shows that accumulation can be achieved with gas flows and that it can also be utilized in the same system for what one hopes is a precursor to a model prebiotic reaction. This continues efforts from Braun and Mast over the last 10-15 years extending a phenomenon that was appreciated by physicists and perhaps underappreciated in prebiotic chemistry to increasingly chemically relevant systems and, here, a pilot experiment with a simple biochemical system as a prebiotic model.

      I think this is exciting work and will be of broad interest to the prebiotic chemistry community.

      Weaknesses:

      The manuscript states: "The micro scale gas-water evaporation interface consisted of a 1.5 mm wide and 250 µm thick channel that carried an upward pure water flow of 4 nl/s ≈ 10 µm/s perpendicular to an air flow of about 250 ml/min ≈ 10 m/s." This was a bit confusing on first read because Figure 2 appears to show a larger channel - based on the scale bar, it appears to be about 2 mm across on the short axis and 5 mm across on the long axis. From reading the methods, one understands the thickness is associated with the Teflon, but the 1.5 mm dimension is still a bit confusing (and what is the dimension in the long axis?) It is a little hard to tell which portion (perhaps all?) of the image is the channel. This is because discontinuities are present on the left and right sides of the experimental panels (consistent with the image showing material beyond the channel), but not the simulated panels. Based on the authors' description of the apparatus (sapphire/CNC machined Teflon/sapphire) it sounds like the geometry is well-known to them. Clarifying what is going on here (and perhaps supplying the source images for the machined Teflon) would be helpful.

      We understand. We will update the figures to better show dimensions of the experimental chamber. We will also add a more complete Figure in the supplementary information. Part of the complexity of the chamber however stems from the fact that the same chamber design has also been used to create defined temperature gradients which are not necessary and thus the chamber is much more complex than necessary.

      We added the scheme of the whole PTFE Chip to Figure 2 in the top left corner, indicating the ROI shown in the fluorescence micrographs. Additionally, the channel walls are now clearly indicated by white dotted lines. The dimensions of the setup are now shown clearer, by showing the total width of the channel as well as its height until the gas flux channel, as well as its depth. Changed caption of the figure accordingly and it now reads: “[…] The PTFE chip cutout in the top left corner shows the ROI used for the micrographs. The color scale is equal for both simulation and experiment and Channel dimensions are 4 x 1.5 x 0.25 mm as indicated. Dotted lines visualize the location of the channel walls. […]“

      The data shown in Figure 2d nicely shows nonrandom residuals (for experimental values vs. simulated) that are most pronounced at t~12 m and t~40-60m. It seems like this is (1) because some symmetry-breaking occurs that isn't accounted for by the model, and perhaps (2) because of the fact that these data are n=1. I think discussing what's going on with (1) would greatly improve the paper, and performing additional replicates to address (2) would be very informative and enhance the paper. Perhaps the negative and positive residuals would change sign in some, but not all, additional replicates?

      To address this, we will show two more replicates of the experiment and include them in Figure 2.

      We are seeing two effects when we compare fluorescence measurements of the experiments.

      Firstly, degassing of water causes the formation of air-bubbles, which are then transported upwards to the interface, disrupting fluorescence measurements. This, however, mostly occurs in experiments with elevated temperatures for PCR reactions, such as displayed in Figure 4.

      Secondly, due to the high surface tension of water, the interface is quite flexible. As the inflow and evaporation work to balance each other, the shape of the interface adjusts, leading to alterations in the circular flow fields below.

      Thus the conditions, while overall being in steady state, show some fluctuations. The strong dependence on interface shape is also seen in the simulation. However, modeling a dynamic interface shape is not so easy to accomplish, so we had to stick to one geometry setting. Again here, the added movies of two more experiments should clarify this issue.

      We performed three more replicates of the experiment and included the averaged data points together with their respective standard deviation as error bars in Figure 2d. Additionally, the videos of each individual repeat are now added to the supplementary files for the reader to better understand where the strong fluctuations around half an hour come from. The Figure caption was adjusted to “ […] The maximum relative concentration of DNA increased within an hour to ~30 X the initial concentration, with the trend following the simulation. Error bars are the standard deviation from four independent measurements. […].

      The main text was also changed to better explain how the fluctuations impact the measurements: […] Water continuously evaporated at the interface, but nucleic acids remained in the aqueous phase accumulating near the interface. They could only escape downward either by diffusion or by the vortex induced by the gas flowing across the interface, pushing the molecules back deeper into the bulk (See the flow lines in Fig2(b) taken from the simulation).  As the gas flow continuously removed excess vapor, the evaporation rate remained constant. Thus, except for fluctuations, a stable interface shape should be expected. However, due to the high surface tension of water, the interface is very flexible. As the inflow and evaporation work to balance each other, the shape of the interface adjusts, likely in response to small fluctuations in gas pressure and spatial variations in water surface tension. This is leading to alterations in the circular flow fields below (Supplementary Movie 2).

      As these fluctuations are difficult to simulate, we decided to stick with one interface shape, matching evaporation and inflow speeds. The evaporation rate at the interface was therefore set to be proportional to the vapor concentration gradient and varied spatially along the interface between 5 and 10.5 µm/s (See Suppl. Fig. VI.1(d)). Using the known diffusion coefficient of 95 µm²/s for the 63mer[9]}, the simulation closely matched the experimental results. In both cases, DNA accumulated in regions with circular flow patterns driven by the gas flux (Fig.2(b), right panel).

      5 minutes after starting the experiment, the maximum DNA accumulation was 3-fold, while after one hour of evaporation, around 30-fold accumulation was observed. Due to molecules residing in very shallow volumes when directly at the interface, the fluorescence signal can vary drastically compared to measurements deeper in the bulk. This can be seen in the fluctuations between independent measurements (See Supplementary Movies 2b,2b,2c), especially around 0.5~h shown in Figure 2(d). The simulated maximum accumulation followed the experimental results and starts saturating after about one hour (Fig.2(d)). […]”

      The authors will most likely be familiar with the work of Victor Ugaz and colleagues, in which they demonstrated Rayleigh-Bénard-driven PCR in convection cells (10.1126/science.298.5594.793, 10.1002/anie.200700306). Not including some discussion of this work is an unfortunate oversight, and addressing it would significantly improve the manuscript and provide some valuable context to readers. Something of particular interest would be their observation that wide circular cells gave chaotic temperature profiles relative to narrow ones and that these improved PCR amplification (10.1002/anie.201004217). I think contextualizing the results shown here in light of this paper would be helpful.

      Thanks for pointing this out and reminding us. We apologize. We agree that the chaotic trajectories within Rayleigh-Bénard convection cells lead to temperature oscillations similar to the salt variations in our gas-flux system. Although the convection-driven PCR in Rayleigh-Bénard is not isothermal like our system, it provides a useful point of comparison and context for understanding environments that can support full replication cycles. We will add a section comparing approaches and giving some comparison into the history of convective PCR and how these relate to the new isothermal implementation.

      We added a main text paragraph after the last paragraph in section “Strand Separation Dynamics”: “[…]Rayleigh-Bénard convection cells generate similar patterns to those seen in Fig. 3(c) The oscillations in salt concentration resemble the temperature fluctuations observed in convection-based PCR reactions from earlier studies [32,33], which showed that chaotic temperature variations, compared to periodic ones, enhanced the efficiency of the PCR reaction.[…]

      Again, it appears n=1 is shown for Figure 4a-c - the source of the title claim of the paper - and showing some replicates and perhaps discussing them in the context of prior work would enhance the manuscript.

      We appreciate the reviewer for bringing this to our attention. We will now include the two additional repeats for the data shown in Figure 4c, while the repeats of the PAGE measurements are already displayed in Supplementary Fig. IX.2. Initially, we chose not to show the repeats in Figure 4c due to the dynamic and variable nature of the system. These variations are primarily caused by differences at the water-air interface, attributed to the high surface tension of water. Additionally, the stochastic formation of air bubbles in the inflow—despite our best efforts to avoid them—led to fluctuations in the fluorescence measurements across experiments. These bubbles cause a significant drop in fluorescence in a region of interest (ROI) until the area is refilled with the sample.

      Unlike our RNA-focused experiments, PCR requires high temperatures and degassing a PCR master mix effectively is challenging in this context. While we believe our chamber design is sufficiently gas-tight to prevent air from diffusing in, the high surface-to-volume ratio in microfluidics makes degassing highly effective, particularly at elevated temperatures. We anticipate that switching to RNA experiments at lower temperatures will mitigate this issue, which is also relevant in a prebiotic context.

      The reviewer’s comments are valid and prompt us to fully display these aspects of the system. We will now include these repeats in Figure 4c to give readers a deeper understanding of the experiment's dynamics. Additionally, we will provide videos of all three repeats, allowing readers to better grasp the nature of the fluctuations in SYBR Green fluorescence depicted in Figure 4c.

      The data from the triplicates are now added to Figure 4c, showing how air bubbles, forming through degassing at the high temperatures required for Taq polymerase, disrupt the measurement, as they momentarily dry off the channel and stop the reaction until the channel fills again. Figure caption has been adapted and now reads: “[…] Dotted lines show the data from independent repeats. Air bubbles formed through degassing can momentarily disrupt the reaction. […]”

      We additionally changed the main text to explain the reader the experimental difficulties: “[…] In other repetitions of the reaction, this increase was sometimes even observed earlier, around the one-hour mark (dotted lines). However, air bubbles nucleated by degassing events rise and temporarily dry out the channel, interrupting the reaction until the liquid refills the channel (Supplementary Movies 4,4b,4c\&5). Despite our best efforts, we were unable to fully prevent this, especially given the high temperatures required for Taq polymerase activity. In an identical setting when the gas- and water flux were switched off, no fluorescence increase was found (See Fig. 4(c) red lines). Fluorescence variations are additionally caused by fluctuations in the position of the gas-water interface, as discussed earlier. […]”

      I think some caution is warranted in interpreting the PCR results because a primer-dimer would be of essentially the same length as the product. It appears as though the experiment has worked as described, but it's very difficult to be certain of this given this limitation. Doing the PCR with a significantly longer amplicon would be ideal, or alternately discussing this possible limitation would be helpful to the readers in managing expectations.

      This is a good point and should be discussed more in the manuscript. Our gel electrophoresis is capable of distinguishing between replicate and primer dimers. We know this since we were optimizing the primers and template sequences to minimize primer dimers, making it distinguishable from the desired 61mer product. That said, all of the experiments performed without a template strand added did not show any band in the vicinity of the product band after 4h of reaction, in contrast to the experiments with template, presenting a strong argument against the presence of primer dimers.

      We added a main text section explaining this to the reader: “[…]Suppl. Fig. IX.2 shows all independent repeats of the corresponding experiments. No product was detected in any of these cases, ruling out reaction limitations such as primer dimer formation. Primer dimers would form even in the absence of a template strand and would be identifiable through gel electrophoresis. As Taq polymerase requires a significant overlap between the two dimers to bind, this would result in a shorter product compared to the 61mer used here.  […]”

      Reviewer #2 (Public review):

      Schwintek et al. investigated whether a geological setting of a rock pore with water inflow on one end and gas passing over the opening of the pore on the other end could create a non-equilibrium system that sustains nucleic acid reactions under mild conditions. The evaporation of water as the gas passes over it concentrates the solutes at the boundary of evaporation, while the gas flux induces momentum transfer that creates currents in the water that push the concentrated molecules back into the bulk solution. This leads to the creation of steady-state regions of differential salt and macromolecule concentrations that can be used to manipulate nucleic acids. First, the authors showed that fluorescent bead behavior in this system closely matched their fluid dynamic simulations. With that validation in hand, the authors next showed that fluorescently labeled DNA behaved according to their theory as well. Using these insights, the authors performed a FRET experiment that clearly demonstrated the hybridization of two DNA strands as they passed through the high Mg++ concentration zone, and, conversely, the dissociation of the strands as they passed through the low Mg++ concentration zone. This isothermal hybridization and dissociation of DNA strands allowed the authors to perform an isothermal DNA amplification using a DNA polymerase enzyme. Crucially, the isothermal DNA amplification required the presence of the gas flux and could not be recapitulated using a system that was at equilibrium. These experiments advance our understanding of the geological settings that could support nucleic acid reactions that were key to the origin of life.

      The presented data compellingly supports the conclusions made by the authors. To increase the relevance of the work for the origin of life field, the following experiments are suggested:

      (1) While the central premise of this work is that RNA degradation presents a risk for strand separation strategies relying on elevated temperatures, all of the work is performed using DNA as the nucleic acid model. I understand the convenience of using DNA, especially in the latter replication experiment, but I think that at least the FRET experiments could be performed using RNA instead of DNA.

      We understand the request only partially. The modification brought about by the two dye molecules in the FRET probe to be able to probe salt concentrations by melting is of course much larger than the change of the backbone from RNA to DNA. This was the reason why we rather used the much more stable DNA construct which is also manufactured at a lower cost and in much higher purity also with the modifications. But we think the melting temperature characteristics of RNA and DNA in this range is enough known that we can use DNA instead of RNA for probing the salt concentration in our flow cycling.

      Only at extreme conditions of pH and salt, RNA degradation through transesterification, especially under alkaline conditions is at least several orders of magnitude faster than spontaneous degradative mechanisms acting upon DNA [Li, Y., & Breaker, R. R. (1999). Kinetics of RNA degradation by specific base catalysis of transesterification involving the 2 ‘-hydroxyl group. Journal of the American Chemical Society, 121(23), 5364-5372.]. The work presented in this article is however focussed on hybridization dynamics of nucleic acids. Here, RNA and DNA share similar properties regarding the formation of double strands and their respective melting temperatures. While RNA has been shown to form more stable duplex structures exhibiting higher melting temperatures compared to DNA [Dimitrov, R. A., & Zuker, M. (2004). Prediction of hybridization and melting for double-stranded nucleic acids. Biophysical Journal, 87(1), 215-226.], the general impact of changes in salt, temperature and pH [Mariani, A., Bonfio, C., Johnson, C. M., & Sutherland, J. D. (2018). pH-Driven RNA strand separation under prebiotically plausible conditions. Biochemistry, 57(45), 6382-6386.] on respective melting temperatures follows the same trend for both nucleic acid types. Also the diffusive properties of RNA and DNA are very similar [Baaske, P., Weinert, F. M., Duhr, S., Lemke, K. H., Russell, M. J., & Braun, D. (2007). Extreme accumulation of nucleotides in simulated hydrothermal pore systems. Proceedings of the National Academy of Sciences, 104(22), 9346-9351.].

      Since this work is a proof of principle for the discussed environment being able to host nucleic acid replication, we aimed to avoid second order effects such as degradation by hydrolysis by using DNA as a proxy polymer. This enabled us to focus on the physical effects of the environment on local salt and nucleic acid concentration. The experiments performed with FRET are used to visualize local salt concentration changes and their impact on the melting temperature of dissolved nucleic acids.  While performing these experiments with RNA would without doubt cover a broader application within the field of origin of life, we aimed at a step-by-step / proof of principle approach, especially since the environmental phenomena studied here have not been previously investigated in the OOL context. Incorporating RNA-related complexity into this system should however be addressed in future studies. This will likely require modifications to the experimental boundary conditions, such as adjusting pH, temperature, and salt concentration, to account for the greater duplex stability of RNA. For instance, lowering the pH would reduce the RNA melting temperature [Ianeselli, A., Atienza, M., Kudella, P. W., Gerland, U., Mast, C. B., & Braun, D. (2022). Water cycles in a Hadean CO2 atmosphere drive the evolution of long DNA. Nature Physics, 18(5), 579-585.].

      (2) Additionally, showing that RNA does not degrade under the conditions employed by the authors (I am particularly worried about the high Mg++ zones created by the flux) would further strengthen the already very strong and compelling work.

      Based on literature values for hydrolysis rates of RNA [Li, Y., & Breaker, R. R. (1999). Kinetics of RNA degradation by specific base catalysis of transesterification involving the 2 ‘-hydroxyl group. Journal of the American Chemical Society, 121(23), 5364-5372.], we estimate RNA to have a half-life of multiple months under the deployed conditions in the FRET experiment (High concentration zones contain <1mM of Mg2+). Additionally, dsRNA is multiple orders of magnitude more stable than ssRNA with regards to degradation through hydrolysis [Zhang, K., Hodge, J., Chatterjee, A., Moon, T. S., & Parker, K. M. (2021). Duplex structure of double-stranded RNA provides stability against hydrolysis relative to single-stranded RNA. Environmental Science & Technology, 55(12), 8045-8053.], improving RNA stability especially in zones of high FRET signal. Furthermore, at the neutral pH deployed in this work, RNA does not readily degrade. In previous work from our lab [Salditt, A., Karr, L., Salibi, E., Le Vay, K., Braun, D., & Mutschler, H. (2023). Ribozyme-mediated RNA synthesis and replication in a model Hadean microenvironment. Nature Communications, 14(1), 1495.], we showed that the lifetime of RNA under conditions reaching 40mM Mg2+ at the air-water interface at 45°C was sufficient to support ribozymatically mediated ligation reactions in experiments lasting multiple hours.

      With that in mind, gaining insight into the median Mg2+ concentration across multiple averaged nucleic acid trajectories in our system (see Fig. 3c&d) and numerically convoluting this with hydrolysis dynamics from literature would be highly valuable. We anticipate that longer residence times in trajectories distant from the interface will improve RNA stability compared to a system with uniformly high Mg2+ concentrations.

      Added a new Supplementary section for this. We used the trace from Figure 3(c) and calculated the hydrolysis rate for each timestep by using literature values from RNA [Li, Y., & Breaker, R. R. (1999). Kinetics of RNA degradation by specific base catalysis of transesterification involving the 2 ‘-hydroxyl group. Journal of the American Chemical Society, 121(23), 5364-5372.]. We conclude that the conditions deployed for the experiment are not harsh on RNA, with hydrolysis rates in the E-6 1/min regime. The figure below (also now in the supplementary information) shows the hydrolysis of RNA deployed under the conditions of the experiment in Figure 3. RNA is not expected to hydrolyze under these conditions and timescales, in which a replication reaction would occur. With a half life of around 83 days, even a prebiotically plausible – very slow – replication reaction would not be constrained by hydrolysis boundary conditions in this scenario.

      Referenced to this section in the supplementary information in the maintext: […] In the experimental conditions used here, RNA would also not readily degrade, even if the strand enters the high salt regimes (See Suppl. Sec. IX). Using literature values for hydrolysis rates under the deployed conditions, we estimate dissolved RNA to have a half life of around 83 days. […]

      (3) Finally, I am curious whether the authors have considered designing a simulation or experiment that uses the imidazole- or 2′,3′-cyclic phosphate-activated ribonucleotides. For instance, a fully paired RNA duplex and a fluorescently-labeled primer could be incubated in the presence of activated ribonucleotides +/- flux and subsequently analyzed by gel electrophoresis to determine how much primer extension has occurred. The reason for this suggestion is that, due to the slow kinetics of chemical primer extension, the reannealing of the fully complementary strands as they pass through the high Mg++ zone, which is required for primer extension, may outcompete the primer extension reaction. In the case of the DNA polymerase, the enzymatic catalysis likely outcompetes the reannealing, but this may not recapitulate the uncatalyzed chemical reaction.

      This is certainly on our to-do list for future experiments in this setting. Our current focus is on templated ligation rather than templated polymerization and we are working hard to implement RNA-only enzyme-free ligation chain reaction, based on more optimized parameters for the templated ligation from 2’3’-cyclic phosphate activation that was just published [High-Fidelity RNA Copying via 2′,3′-Cyclic Phosphate Ligation, Adriana C. Serrão, Sreekar Wunnava, Avinash V. Dass, Lennard Ufer, Philipp Schwintek, Christof B. Mast, and Dieter Braun, JACS doi.org/10.1021/jacs.3c10813 (2024)]. But we first would try this at an air-water interface which was shown to work with RNA in a temperature gradient [Ribozyme-mediated RNA synthesis and replication in a model Hadean microenvironment, Annalena Salditt, Leonie Karr, Elia Salibi, Kristian Le Vay, Dieter Braun & Hannes Mutschler, Nature Communications doi.org/10.1038/s41467-023-37206-4 (2023)] before making the jump to the isothermal setting we describe here. So we can understand the question, but it was good practice also in the past to first get to know the setting with PCR, then jump to RNA.

      Recommendations for the authors:

      Reviewer #2 (Recommendations for the authors):

      (1) Could the authors comment on the likelihood of the geological environments where the water inflow velocity equals the evaporation velocity?

      This is an important point to mention in the manuscript, thank you for pointing that out. To produce a defined experiment, we were pushing the water out with a syringe pump, but regulated in a way that the evaporation was matching our flow rate. We imagine that a real system will self-regulate the inflow of the water column on the one hand side by a more complex geometry of the gas flow, matching the evaporation with the reflow of water automatically. The interface would either recede or move closer to the gas flux, depending on whether the inflow exceeds or falls short of the evaporation rate. As the interface moves closer, evaporation speeds up, while moving away slows it down. This dynamic process stabilizes the system, with surface tension ultimately fixing the interface in place.

      We have seen a bit of this dynamic already in the experiments, could however so far not yet find a good geometry within our 2-dimensional constant thickness geometry to make it work for a longer time. Very likely having a 3-dimensional reservoir of water with less frictional forces would be able to do this, but this would require a full redesign of a multi-thickness microfluidics. The more we think about it, the more we envisage to make the next implementation of the experiment with a real porous volcanic rock inside a humidity chamber that simulates a full 6h prebiotic day. But then we would lose the whole reproducibility of the experiment, but likely gain a way that recondensation of water by dew in a cold morning is refilling the water reservoirs in the rocks again. Sorry that I am regressing towards experiments in the future.

      We added a paragraph after the second paragraph in Results and Discussion.

      It now reads: […] For a real early Earth environment we envision a system that self-regulates the water column's inflow by automatically balancing evaporation with capillary flows. The interface adjusts its position relative to the gas flux, moving closer if the inflow is less than the evaporation rate, or receding if it exceeds it. When the interface nears the gas flux, evaporation accelerates, while moving it away slows evaporation. This dynamic process stabilizes the system, with surface tension ultimately fixing the interface's position. […]

      (2) Could the authors speculate on using gases other than ambient air to provide the flux and possibly even chemical energy? For example, using carbonyl sulfide or vaporized methyl isocyanide could drive amino acid and nucleotide activation, respectively, at the gas-water interface.

      This is an interesting prospect for future work with this system. We thought also about introducing ammonia for pH control and possible reactions. We were amazed in the past that having CO2 instead of air had a profound impact on the replication and the strand separation [Water cycles in a Hadean CO2 atmosphere drive the evolution of long DNA, Alan Ianeselli, Miguel Atienza, Patrick Kudella, Ulrich Gerland, Christof Mast & Dieter Braun, Nature Physics doi.org/10.1038/s41567-022-01516-z (2022)]. So going more in this direction absolutely makes sense and as it acts mostly on the length-selectively accumulated molecules at the interface, only the selected molecules will be affected, which adds to the selection pressure of early evolutionary scenarios.

      Of course, in the manuscript, we use ambient air as a proxy for any gas, focusing primarily on the energy introduced through momentum transfer and evaporation. We speculate that soluble gasses could establish chemical gradients, such as pH or redox potential, from the bulk solution to the interface, similar to the Mg2+ accumulation shown in Figure 3c. The nature of these gradients would depend on each gas's solubility and diffusivity. We have already observed such effects in thermal gradients [Keil, L. M., Möller, F. M., Kieß, M., Kudella, P. W., & Mast, C. B. (2017). Proton gradients and pH oscillations emerge from heat flow at the microscale. Nature communications, 8(1), 1897.] and finding similar behavior in an isothermal environment would be a significant discovery.

      Added a paragraph in the Conclusion to showcase this: [… ] Furthermore we expect that other gases, such as CO2, could establish chemical gradients in this environment. Such gradients have been observed in thermal gradients before [23] and finding similar behaviour in an isothermal environment would be a significant discovery.[…]

      (3) Line 162: Instead of "risk," I suggest using "rate".

      Thanks for pointing this out! Will be changed.

      Fixed.

      (4) Using FRET of a DNA duplex as an indicator of salt concentration is a decent proxy, but a more direct measurement of salt concentration would provide further merit to the explicit statement that it is the salt concentration that is changing in the system and not another hidden parameter.

      Directly observing salt concentration using microscopy is a difficult task. While there are dyes that change their fluorescence depending on the local Na+ or Mg2+ concentration, they are not operating differentially, i.e. by making a ratio between two color channels. Only then we are not running into artifacts from the dye molecules being accumulated by the non-equilibrium settings. We were able to do this for pH in the past, but did not find comparable optical salt sensors. This is the reason we ended up with a FRET pair, with the advantage that we actually probe the strand separation that we are interested in anyhow. Using such a dye in future work would however without a doubt enhance the understanding of not only this system, but also our thermal gradient environments.

      (5) Figure 3a: Could the authors add information on "Dried DNA" to the caption? I am assuming this is the DNA that dried off on the sides of the vessel but cannot be sure.

      Thanks to the reviewer for pointing this out. This is correct and we will describe this better in the revised manuscript.

      Added a sentence in the caption to address this: […] Fluctuations in interface position can dry and redissolve DNA repeatedly (see “Dried DNA” in right panel). […]

      (6) Figure 4b and c: How reproducible is this data? Have the authors performed this reaction multiple independent times? If so, this data should be added to the manuscript.

      The data from the gel electrophoresis was performed in triplicates and is shown in full in supplementary information. The data in c is hard to reproduce, as the interface is not static and thus ROI measurements are difficult to perform as an average of repeats. Including the data from the independent repeats will however give the reader insight into some of the experimental difficulties, such as air bubbles, which form from degassing as the liquid heats up, that travel upwards to the interface, disrupting the ongoing fluorescence measurements.

      This was also pointed out by reviewer 1 and addressed there.

      (7) Line 256: "shielding from harmful UV" statement only applies to RNA oligomers as UV light may actually be beneficial for earlier steps during ribonucleoside synthesis. I suggest rephrasing to "shielding nucleic acid oligomers from UV damage.".

      Will be adjusted as mentioned.

      Fixed.

      (8) The final paragraph in the Results and Discussion section would flow better if placed in the Conclusion section.

      This is a good point and we will merge results and discussion closer together.

      Fixed.

      (9) Line 262, "...of early Life" is slightly overstating the conclusions of the study. I suggest rephrasing to "...of nucleic acids that could have supported early life."

      This is a fair comment. We thank the reviewer for his detailed analysis of the manuscript!

      Changed the phrase to: […]In this work we investigated a prebiotically plausible and abundant geological environment to support the replication of nucleic acids. […]

      (10) In references, some of the journal names are in sentence case while others are in title case (see references 23 and 26 for example).

      Thanks - this will be fixed.

      Fixed.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Reviewer #1 (Public Review):

      This study provides compelling evidence that RAR, rather than its obligate dimerization partner RXR, is functionally limiting for chromatin binding. This manuscript provides a paradigm for how to dissect the complicated regulatory networks formed by dimerizing transcription factor families.

      Dahal and colleagues use advanced SMT techniques to revisit the role of RXR in DNA-binding of the type-2 nuclear receptor (T2NR) RAR. The dominant consensus model for regulated DNA binding of T2NRs posits that they compete for a limited pool of RXR to form an obligate T2NR-RXR dimer. Using advanced SMT and proximity-assisted photoactivation technologies, Dahal et al. now test the effect of manipulating the endogenous pool size of RAR and RXR on heterodimerization and DNA-binding in live U2OS cells. Surprisingly, it turns out that RAR, rather than RXR, is functionally limiting for heterodimerization and chromatin binding. By inference, the relative pool size of various T2NRs expressed in a given cell, rather than RXR, is likely to determine chromatin binding and transcriptional output.

      The conclusions of this study are well supported by the experimental results and provide unexpected novel insights into the functioning of the clinically important class of T2NR TFs. Moreover, the presented results show how the use of novel technologies can put long-standing theories on how transcription factors work upside down. This manuscript provides a paradigm for how to further dissect the complicated regulatory networks formed by T2NRs or other dimerizing TFs. I found this to be a complete story that does not require additional experimental work. However, I do have some suggestions for the authors to consider.

      Reviewer #1 (Recommendations For The Authors):

      (1) Does the increased chromatin binding measured when the RAR levels are increased reflect a higher occupancy of a similar set of loci, or are additional loci bound? The authors could discuss this issue in the context of the published literature. Obviously, this could be addressed experimentally by ChIP-seq or a similar analysis, but this would extend beyond the main topic of this manuscript.

      We attempted to explore this experimentally using ChIP-seq with multiple RAR- and RXR-specific antibodies. Unfortunately, our results were inconclusive, as the antibody enrichment relative to the IgG control was insufficient for reliable interpretation. Specifically, our ChIP-seq enrichment levels were only around 1.5fold, while the accepted standard for meaningful ChIP enrichment is typically at least 2-fold. Due to these technical limitations, we decided to defer these experiments for now.

      However, we agree with the reviewer that understanding whether the increased chromatin binding of RAR reflects higher occupancy at the same set of loci or binding to additional loci is a key question. In similar experiments involving the transcription factor TFEB (Esbin et al., 2024, Genes Dev, doi: 10.1101/gad.351633.124) where an increase in the SMT bound fraction occurred, both scenarios—higher occupancy at known loci and binding to additional loci in ChIP-seq was observed. So, addressing this intriguing possibility in future studies focused on RAR and RXR would be interesting.

      (2) The results presented suggest convincingly that endogenous RXR is normally in excess to its binding partners (in U2OS cells). This point could be strengthened further by reducing RXR levels, e.g., by knocking out 1 allele or the use of shRNAs (although the latter method might be too hard to control). Overexpression of another T2NR might also help determine the buffer capacity of RXR.

      We appreciate the reviewers’ acknowledgment that our results convincingly demonstrate that endogenous RXR is typically in excess relative to its binding partners in U2OS cells. We agree that this conclusion could be further reinforced by experiments such as overexpression of another T2NR to test RXR's buffering capacity. We are actively pursuing follow-up experiments involving overexpression of additional T2NRs to address this question in more detail. These studies are ongoing, and we plan to explore the buffer capacity of RXR more extensively in a future manuscript.

      (3) The ~10% difference in fbound of RAR and RXR (in Figs 1 and 2), while they should be 1:1 dimers, is explained by invoking the expression of RXR isoforms. Can the authors be more specific concerning the nature of these isoforms?

      We have provided detailed information about different T2NRs expressed in U2OS cells according to the Expression Atlas and the Human Protein Atlas Database in Supplementary Table S1. Table S1 specifically shows that both isoforms of RXRα and RXRβ are expressed in U2OS cells. Additionally, the caption of Table S1 explicitly notes the presence of isoform RXRβ in U2OS cells. In the main text, we reference Table S1 when discussing the 10% difference in fbound between RARα and RXRα, and we have now suggested that the expression of RXRβ likely accounts for the observed discrepancy.

      Reviewer #2 (Public Review):

      Summary:

      In the manuscript "Surprising Features of Nuclear Receptor Interaction Networks Revealed by Live Cell Single Molecule Imaging", Dahal et al combine fast single molecule tracking (SMT) with proximity-assisted photoactivation (PAPA) to study the interaction between RARa and RXRa. The prevalent model in the nuclear receptor field suggests that type II nuclear receptors compete for a limiting pool of their partner RXRa. Contrary to this, the authors find that over-expression of RARa but not RXRa increases the fraction of RXRa molecules bound to chromatin, which leads them to conclude that the limiting factor is the abundance of RARa and not RXRa. The authors also perform experiments with a known RARa agonist, all trans retinoic acid (atRA) which has little effect on the bound fraction. Using PAPA, they show that chromatin binding increases upon dimerization of RARa and RXRa.

      Strengths:

      In my view, the biggest strength of this study is the use of endogenously tagged RARa and RXRa cell lines. As the authors point out, most previous studies used either in vitro assays or over-expression. I commend the authors on the generation of single-cell clones of knock-in RARa-Halo and Halo-RXRa. The authors then carefully measure the abundance of each protein using FACS, which is very helpful when comparing across conditions. The manuscript is generally well written and figures are easy to follow. The consistent color-scheme used throughout the manuscript is very helpful.

      Weaknesses:

      (1) Agonist treatment:

      The authors test the effect of all trans retinoic acid (atRA) on the bound fraction of RARa and RXRa and find that "These results are consistent with the classic model in which dimerization and chromatin binding of T2NRs are ligand independent." However, all the agonist treatments are done in media containing FBS. FBS is not chemically defined and has been found to have between 10 and 50 nM atRA (see references in PMID 32359651 for example). The addition of 1 nM or 100 nM atRA is unlikely to result in a strong effect since the medium already contains comparable or higher levels of agonist. To test their hypothesis of ligand-independent dimerization, the authors should deplete the media of atRA by growing the cells in a medium containing charcoal-stripped FBS for at least 24 hours before adding agonist.

      We acknowledge the reviewer's concern regarding the presence of atRA in FBS and agree that it may introduce baseline levels of agonist. However, in our experiments, both the 1 nM and 100 nM atRA treatments resulted in observable changes in RAR expression levels (Figure S3C). Additionally, the luciferase assays demonstrated that 100 nM atRA significantly increased retinoic acid-responsive promoter activity (Figure S1C). Given these clear responses to atRA, we believe the observed lack of effect on the chromatin-bound fraction cannot be attributed to the presence of comparable or higher levels of atRA in the FBS, as the reviewer suggests. Moreover, since our results align with the established literature and do not impact the core findings of our study, we decided not to pursue the suggested experiments with charcoal-stripped FBS in this manuscript.  

      (2) Photobleaching and its effect on bound fraction measurements:

      The authors discard the first 500 to 1000 frames due to the high localization density in the initial frames. This will preferentially discard bound molecules that will bleach in the initial frames of the movie and lead to an over-estimation of the unbound fraction.

      For experiments with over-expression of RAR-Halo and Halo-RXR, the authors state that the cells were pre-bleached and that these frames were used to calculate the mean intensity of the nuclei. When pre-bleaching, bound molecules will preferentially bleach before the diffusing population. This will again lead to an over-representation of the unbound fraction since this is the population that will remain relatively unaffected by the pre-bleaching. Indeed, the bound fraction for over-expressed RARa and RXRa is significantly lower than that for the corresponding knock in lines. To confirm whether this is a biological result, I suggest that the authors either reduce the amount of dye they use so that this pre-bleaching is not necessary or use the direct reactivation strategy they use for their PAPA experiments to eliminate the pre-bleaching step.

      As for the measurement of the nuclear intensity, since the authors have access to multiple HaloTag dyes, they can saturate the HaloTagged proteins with a high concentration of JF646 or JFX650 to measure the mean intensity of the protein while still using the PA-JFX549 for SMT. Together, these will eliminate the need to prebleach or discard any frames.

      The Janelia Fluor dyes used in our experiments are known for their high photostability (Grimm et al., 2021, JACS Au, doi: 10.1021/jacsau.1c00006). During the initial 80 ms imaging to calculate the mean nuclear intensity, the laser power was kept at very low intensity (~3%) for a brief duration (~10 seconds), in contrast to the high-intensity (~100%) used during the tracking experiments, which span around 3 minutes. This low-power illumination does not induce significant photobleaching but merely puts the dyes in a temporary dark state. Therefore, this pre-bleaching step closely resembles the direct reactivation strategy employed in our PAPA experiments.

      To further address the reviewer's concern, we performed a frame cut-off analysis for our SMT movies of endogenous RARα-Halo and over-expressed RARα-Halo (Figure S9B). The analysis shows no significant change in the bound fraction of either endogenous or over-expressed RARα-Halo when discarding the initial 1000 frames. Based on these results, we conclude that the pre-bleaching does not lead to an overestimation of the unbound fraction, and that our experimental approach is robust.

      (3) Heterogeneous expression of the SNAP fusion proteins:

      The cell lines expressing SNAP tagged transgenes shown in Fig S6 have very heterogeneous expression of the SNAP proteins. While the bulk measurements done by Western blotting are useful, while doing single-cell experiments (especially with small numbers - ~20 - of cells), it is important to control for expression levels. Since these transgenic stable lines were not FACS sorted, it would be helpful for the reader to know the spread in the distribution of mean intensities of the SNAP proteins for the cells that the SMT data are presented for. This step is crucial while claiming the absence of an effect upon over-expression and can easily be done with a SNAPTag ligand such as SF650 using the procedure outlined for the over-expressed HaloTag proteins.

      We agree with the reviewer that there is heterogeneity in SNAP protein expression across the transgenic lines. In response to the reviewer’s suggestion, we performed the proposed experiment to assess the distribution of mean intensities for two key experimental conditions: Halo-RXRα with overexpressed RARα-SNAP and HaloRXRα with overexpressed RARαRR-SNAP. These results again confirm that the increase in chromatin-bound fraction of Halo-RXRα is observed only in the presence of RARα capable of heterodimerizing with RXRα, supporting our main conclusion (Figure S9).

      For these experiments, we followed the same labelling procedure described in the methods section for tracking endogenous Halo-tagged proteins alongside transgenic SNAP proteins. As shown in Figure S9, for ~ 70 cell nuclei, the distribution of mean intensities is similar for both conditions, with the bound fraction of Halo-RXRα significantly increasing in the presence of RARα-SNAP compared to RARαRR-SNAP. This analysis underscores that the observed effects are indeed due to the functional differences between the two RARα variants rather than variability in expression levels.

      (4) Definition of bound molecules:

      The authors state that molecules with a diffusion coefficient less than 0.15 um2/s are considered bound and those between 1-15 um2/s are considered unbound. Clarification is needed on how this threshold was determined. In previous publications using saSPT, the authors have used a cutoff of 0.1 um2/s (for example, PMID 36066004, 36322456). Do the results rely on a specific cutoff? A diffusion coefficient by itself is only a useful measure of normal diffusion. Bound molecules are unlikely to be undergoing Brownian motion, but the state array method implemented here does not seem to account for non-normal diffusive modes. How valid is this assumption here?

      We acknowledge the inconsistency in the diffusion coefficient thresholds for defining the chromatin-bound fraction used across our group’s publications. The choice of threshold or cutoff (0.1 µm²/s vs 0.15 µm²/s) is largely arbitrary and does not significantly impact the results. To validate this, we tested the effect of different cutoffs on fbound (%) for endogenously expressed Halo-tagged RARα and RXRα (Figure S10). As shown in Figure S10, there was no substantial difference in fbound (%) calculated using a 0.1 µm²/s versus 0.15 µm²/s cutoff (e.g., RARα clone c156: 47±1% vs 49±1%; RXRα clone D6: 34±1% vs 35±1%). 

      Since we have consistently applied the 0.15 µm²/s cutoff throughout this manuscript across all experimental conditions, the comparative analysis of fbound (%) remains valid. While we agree that a Brownian diffusion model may not fully capture the motion of bound molecules, our state array model accounts for localization error, which likely incorporates some of the chromatin motion features. Moreover, the distinction between bound (<0.15 µm²/s) and unbound (1-15 µm²/s) populations is sufficiently large that using a normal diffusion model is reasonable for our analysis.

      (5) Movies:

      Since this is an imaging manuscript, I request the authors to provide representative movies for all the presented conditions. This is an essential component for a reader to evaluate the data and for them to benchmark their own images if they are to try to reproduce these findings.

      We have now included representative movies for all the SMT experimental conditions presented in the manuscript. Please see data availability section of the manuscript.

      (6) Definition of an ROI:

      The authors state that "ROI of random size but with maximum possible area was selected to fit into the interior of the nuclei" while imaging. However, the readout speed of the Andor iXon Ultra 897 depends on the size of the defined ROI. If the ROI was variable for every movie, how do the authors ensure the same sampling rate?

      We used the frame transfer mode on the Andor iXon Ultra 897 camera for our acquisitions, which allows for fast frame rate measurements without altering the exposure time between frames. Additionally, we verified the metadata of all our movies to ensure a consistent frame interval of 7.4 ms across all conditions. This confirms that the sampling rate was maintained uniformly, despite the variability in ROI size. 

      Reviewer #2 (Recommendations For The Authors):

      (1) 'Hoechst' is mis-spelled.

      We have now corrected this typo in the manuscript.

      (2) Cos7 appears in several places throughout the text. I assume this is a typo. If so, please correct it. If not, please explain if some experiments were done in Cos7 cells and kindly provide a justification for that.

      The use of Cos7 cells is intentional and not a typo. Cos7 cells have been previously utilized in studies investigating the interaction between T2NRs (Kliewer et al., 1992, Nature, doi: 10.1038/355446a0). In our study, due to technical issues with antibodies for coIP in U2OS cells, we initially used Cos7 cells for control experiments to verify that Halo-tagging of RARα and RXRα did not disrupt their interaction, by transiently expressing the constructs in Cos7 cells. Following these control experiments, we confirmed the direct interaction of endogenously expressed RAR and RXR in U2OS cells with their respective binding partners using the SMT-PAPA assay. Since these results confirmed that Halo-tagging did not interfere with RAR-RXR interactions, we chose not to repeat the coIP experiments in U2OS cells.

      Reviewer #3 (Public Review):

      Summary:

      This study aims to investigate the stoichiometric effect between core factors and partners forming the heterodimeric transcription factor network in living cells at endogenous expression levels. Using state-of-the-art single-molecule analysis techniques, the authors tracked individual RARα and RXRα molecules labeled by HALO-tag knock-in. They discovered an asymmetric response to the overexpression of counter-partners. Specifically, the fact that an increase in RARα did not lead to an increase in RXRα chromatin binding is incompatible with the previous competitive core model. Furthermore, by using a technique that visualizes only molecules proximal to partners, they directly linked transcription factor heterodimerization to chromatin binding.

      Strengths:

      The carefully designed experiments, from knock-in cell constructions to singlemolecule imaging analysis, strengthen the evidence of the stoichiometric perturbation response of endogenous proteins. The novel finding that RXR, previously thought to be a target of competition among partners, is in excess provides new insight into key factors in dimerization network regulation. By combining the cutting-edge single-molecule imaging analysis with the technique for detecting interactions developed by the authors' group, they have directly illustrated the relationship between the physical interactions of dimeric transcription factors and chromatin binding. This has enabled interaction analysis in live cells that was challenging in single-molecule imaging, proving it is a powerful tool for studying endogenous proteins.

      Weaknesses:

      As the authors have mentioned, they have not investigated the effects of other T2NRs or RXR isoforms. These invisible factors leave room for interpretation regarding the origin of chromatin binding of endogenous proteins (Recommendations 4). In the PAPA experiments, overexpressed factors are visualized, but changes in chromatin binding of endogenous proteins due to interactions with the overexpressed proteins have not been investigated. This might be tested by reversing the fluorescent ligands for the Sender and Receiver. Additionally, the PAPA experiments are likely to be strengthened by control experiments (Recommendations 5).

      We agree that this would be an interesting experiment. However, there are three technical challenges that complicate its implementation: First, as demonstrated in our original PAPA paper, dark state formation is less efficient when dyes are conjugated to Halo compared to SNAPf, making the reverse configuration less optimal. Second, SNAPf-tagged proteins have slower labeling kinetics than Halotagged proteins, often resulting in under-labeling of SNAPf. Third, our SNAPf transgenes were integrated polyclonally. Since background PAPA scales with the concentration of the sender-labeled protein, variable concentrations of the senderlabeled SNAPf proteins would introduce significant variability, complicating the interpretation of the background PAPA signal. Due to these concerns, we believe that performing reciprocal measurements with reversed fluorescent ligands may not yield reliable results. 

      Reviewer #3 (Recommendations For The Authors):

      (1) The term "Surprising features" in the title is ambiguous and may force readers to search for what it specifically refers to. Including a word that evokes specific features might be helpful.

      Our findings contradict previous work, which suggested that chromatin binding of T2NRs is regulated by competition for a limited pool of RXR. In contrast, we found that RAR expression can limit RXR chromatin binding, but not the other way around, which challenges the existing model. This unexpected result is what we refer to as a "surprising feature" in our title, and we believe it accurately reflects the novel insights our study provides. We also think that this is clearly conveyed in our manuscript abstract, supporting the use of "Surprising features" in the title. 

      (2) p.3, line 11 - The threshold of 0.15 μm2s-1 seems to be a crucial value directly linked to the value of fbound. What is the rationale for choosing this specific value? If consistent conclusions can be obtained using threshold values that are similar but different, it would strengthen the robustness of the results.

      Please refer to our response to Reviewer #2’s Public Review point 4. The threshold choice is arbitrary and doesn’t affect the overall conclusions. To test this, we compared fbound (%) values calculated using both 0.1 μm²s-1 and 0.15 μm²s-1 cutoffs. For example, with endogenously expressed Halo-tagged RARα (clone c156), we observed fbound values of 47±1% vs 49±1%, and for RXRα (clone D6), 34±1% vs 35±1%, respectively (Figure S10). Since we have consistently applied the 0.15 μm²s-1 cutoff across all experimental conditions in this manuscript, the comparisons of fbound (%) between different conditions are robust and valid.

      (3) p.4, line 13 - "the fbound of endogenous RARα-Halo (47{plus minus}1%) was largely unchanged upon expression of SNAP (47{plus minus}1%)" part of the sentence is not surprising. It would make more sense if it were expressed as "the fbound of endogenous RARα-Halo (47{plus minus}1%) was largely unchanged upon expression of RXRα-SNAP (49{plus minus}1%), consistent with the control SNAP (47{plus minus}1%).".

      We understand how the original phrasing may be confusing to the readers and have restructured the sentence as suggested by the reviewer for clarity.

      (4) p.6, line 26 - The discussion that "most chromatin binding of endogenous RXRα in U2OS cells depends on heterodimerization partners other than RARα" seems to contradict the top right figure in Figure 4. If that's the case, the binding partner for the bound red molecule might be yellow rather than blue. Given a decrease in the number of RARα molecules with an unchanged binding ratio, the total number of binding molecules has decreased. Could it be interpreted that the potential reduction in RXRα chromatin binding, accompanying the decrease in binding RARα, is compensated for by other partners?

      We agree with the reviewer that both the yellow and blue molecules in Figure 4 represent T2NRs that can heterodimerize with RXR. For simplicity, we chose to omit the depiction of RXR dimerization with other T2NRs (represented in yellow) in Figure 4. We have now included a note in the figure caption to clarify this. We plan to follow up on the buffer capacity of RXR with other T2NRs in a separate manuscript and will discuss this aspect in more detail once we have data from those experiments.

      (5) Fig. 3 - I expected that DR localizations always appear more frequently than PAPA localizations by the difference in the number of distal molecules. Why does the linear line for SNAP-RXRα in Fig. 3 B have a slope exceeding 1? Also, although the sublinearity is attributed to binding saturation, is there any possibility that this sublinearity originates from the PAPA system like the saturation of PAPA reactivation? Control samples like Halo-SNAPf-3xNLS might address these concerns.

      The number of DR and PAPA localizations depends on the arbitrarily chosen intensity and duration of green and violet light pulses. For any given protein pair, different experimental settings can result in PAPA localizations being greater than, less than, or equal to the number of DR localizations. Therefore, the informative metric is not the absolute number of DR and PAPA localizations, but rather how the ratio of PAPA to DR localizations changes between different conditions—such as between interacting pairs and non-interacting controls.

      Regarding the sublinearity, we agree that it is essential to consider whether the observed sublinearity might stem from saturation of the PAPA signal. We know of two ways in which this could occur:

      First, PAPA can be saturated as the duration of the green light pulse increases and dark-state complexes are depleted. However, this cannot explain the nonlinearity that we observe, because the duration of the green light pulse is constant, and thus the probability that a given complex is reactivated by PAPA is also constant. Likewise, holding the violet pulse duration constant yields a constant probability that a given molecule is reactivated by DR. PAPA localizations are expected to scale linearly with the number of complexes, while DR localizations are expected to scale linearly with the total number of molecules. Sublinear scaling of PAPA localizations with DR localizations thus implies that the number of complexes scales sublinearly with the total concentration of the protein.

      Second, saturation could occur if PAPA localizations are undercounted compared to DR localizations. While this is a valid concern, we consider it unlikely in this case because 1) our localization density is below the level at which our tracking algorithm typically undercounts localizations, and 2) we observe sublinearity for RXR → RAR PAPA even though the number of PAPA localizations is lower than the DR localizations; undercounting due to excessive localization density would be expected to introduce the opposite bias in this case.

      (6) Fig. 4 - The differences between A, B, and C on the right side of the model are subtle, making it difficult to discern where to see. Emphasizing the difference in molecule numbers or grouping free molecules at the top might help clarify these distinctions.

      We appreciate the reviewer’s feedback. In response, we have revised Figure 4 by grouping the free molecules on the top right side for panels A, B and C, as suggested.

      (7) While the main results are obtained through single-molecule imaging, no singlemolecule fluorescence images or trajectory plots are provided. Even just for representative conditions, these could serve as a guide for readers trying to reproduce the experiments with different custom-build microscope setups. Also, considering data availability, depositing the source data might be necessary, at least for the diffusion spectra.

      We have now included representative movies for all the presented SMT conditions as source data. Please see data availability section of the manuscript.

      (8) Tick lines are not visible on many of the graph axes. 

      We have revised the figures to ensure that the tick lines are now clearly visible on all graph axes.

      (9) Inconsistencies in the formatting are present in the methods, such as "hrs" vs. "hours", spacing between numbers and units, and "MgCl2". "u" should be "μ" and "x" should be "×". 

      We have corrected the formatting errors.

      (10) Table S4, rows 16 and 17 - Are "RAR"s typos for "RXR"s? 

      We have corrected this in the manuscript.

      (11) p.10~12 - Are three "Hoestch"s typos for "Hoechst"s? 

      This is now corrected in the manuscript.

      (12) p.11, line 17 - According to the referenced paper, the abbreviation should be "HILO" in all capital letters, not "HiLO". 

      This is now corrected in the manuscript.

      (13) "%" on p.3, line 18, and "." on p.6, line 27 are missing. 

      This missing “%”  and “.” are now added.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Reviewer #1 (Public review):

      Summary:

      The manuscript by Yao S. and colleagues aims to monitor the potential autosomal regulatory role of the master regulator of X chromosome inactivation, the Xist long non-coding RNA. It has recently become apparent that in the human system, Xist RNA can not only spread in cis on the future inactive X chromosome but also reach some autosomal regions where it recruits transcriptional repression and Polycomb marking. Previous work has also reported that Xist RNA can show a diffused signal in some biological contexts in FISH experiments.

      In this study, the authors investigate whether Xist represses autosomal loci in differentiating female mouse embryonic stem cells (ESCs) and somatic mouse embryonic fibroblasts (MEFs). They perform a time course of ESC differentiation followed by Capture Hybridization of Associated RNA Targets (CHART) on both female and male ESCs, as well as pulldowns with sense oligos for Xist. The authors also examine transcriptional activity through RNA-seq and integrate this data with prior ChIP-seq experiments. Additional experiments were conducted in MEFs and Xist-ΔB repeat mutants, the latter fails to recruit Polycomb repressors.

      Based on this experimental design, the authors make several bold claims:

      (1) Xist binds to about a hundred specific autosomal regions.

      (2) This binding is specific to promoter regions rather than broad spreading.

      (3) Xist autosomal signal is inversely correlated with PRC1/2 marks but positively correlated with transcription.

      (4) Xist targeting results in the attenuation of transcription at autosomal regions.

      (5) The B-repeat region is important for autosomal Xist binding and gene repression.

      (6) Xist binding to autosomal regions also occurs in somatic cells but does not lead to gene repression.

      Together, these claims suggest that Xist might play a role in modulating the expression of autosomal genes in specific developmental and cellular contexts in mice.

      Strengths:

      This paper deals with an interesting hypothesis that Xist ncRNA can also function at autosomal loci.

      Weaknesses: The claims reported in this paper are largely unsubstantiated by the data, with multiple misinterpretations, lacking controls, and inadequate statistics. Fundamental flaws in the experimental design/analysis preclude the validity of the findings. Major concerns are listed below: (1) The entire paper is based on the CHART observation that Xist is specifically targeted to autosomal promoters. Overall, the data analysis is flawed and does not support such conclusions. Importantly the sense WT and the 0h controls are not used, nor are the biological replicates. 

      We respectfully disagree with Rev1 but nevertheless thank the reviewer for making some suggestions that helped to strengthen our manuscript.  We have provided new experiments and analyses in the revised manuscript. Please see responses below.

      Rev1 seems to have missed or misunderstood some key experiments. In fact, the sense WT and 0h controls were shown. Furthermore, we included at least two biological replicates for each experiment.

      We used both male ES cells (which do not express Xist) and sense probes as key negative controls, as outlined in Figure S1. Crucially, we only analyzed peaks that were reproducible between biological replicates. The Xist CHART peaks in differentiating female ES cells were significantly enriched above the “background” defined by the sense probe and male controls. Specifically, in comparison to undifferentiated female ES cells (day 0) where both X chromosomes are active and Xist is not induced, Xist CHART robustly pulled down the X chromosome during cell differentiation (day 4, day 7, and day 14). In contrast, male ES cells showed no significant pull-down of the X chromosome, and the sense group also exhibited markedly reduced binding (new Figure S1B). Furthermore, Principal Component Analysis (PCA) of CHART-seq reads (day 4 as an example) include Xist, sense, and input in WT and ΔRepB female, further confirmed that the sense probe CHART was clearly distinguishable from Xist CHART signals. Please see revised Figure S1C. Together, these findings underscore the specificity and robustness of our CHART results.

      Data is typically visualized without quantification, and when quantified, control loci/gene sets are erroneously selected. Firstly, CHART validation on the X in FigS1 is misleading and not based on any quantifications (e.g., see the scale on Kdm6a (0-190) compared to Cdkl5 (0-40)). If scaled appropriately, there is Xist signal on the escapee. 

      Rev1 may have misread the presented data. In the example raised by Rev1, Fig. S1 is inherently quantitative: e.g., a ratio is a number in Fig. S1A (now Fig. S1B) and all gene tracks in Fig. 1B-E are shown with scales. We showed X-linked genes in Fig. S1 (now Fig. S2) as a control to demonstrate that the CHART worked and that Xist accumulated over time from day 0 to day 14. Our new Figure 1B demonstrates the Xist accumulation in graph format. 

      Our paper focuses on Xist autosomal binding sites. Thus, the X-linked examples were placed in the supplement. Escapee genes do in fact accumulate Xist at their promoter regions and this finding is consistent with data published by Simon et al. (2013, Nature). It was therefore not desirable in this paper to reanalyze X-linked genes, including escapees. Nevertheless, to address the reviewer’s concerns, we present new data in new Figure S3A. Here we analyzed the density of Xist binding across X-linked genes, including both active and inactive genes, as well as escapee genes. From this quantitative analysis, it should be clear that escapees do bind Xist. However, from the metagene plots in Figure S3B, we confirm the previous conclusion that escapees bind Xist at high levels just upstream of the promoter and that there is a depletion of Xist in the escapee gene body, consistent with a barrier preventing Xist from moving into the active gene. 

      All X-linked loci should have been quantified and classified based on escape status; sense control should also be quantified, and biological replicates should be shown separately. 

      Please see above response.

      Additionally, in the revised manuscript, we have examined the Irreproducible Discovery Rate (IDR) to validate the reproducibility of peaks between the two replicates in the revised version, and we included a representative example from female WT ES cells at day 4 (revised Figure S4A). The results showed a strong correlation between the replicates, with an IDR threshold of 0.05 (red point > 0.05). As described in the Methods section, to ensure reliable and robust peak identification, we performed peak calling (MACS2) separately on each replicate, and then used bedtools intersect to identify peaks that overlapped between the two replicates. This stringent process, including strict q-value settings in MACS2, ensures the reliability and reproducibility of the peaks presented in this study.

      Secondly, and most importantly, Figure 1 does not convincingly show specific Xist autosomal binding. Panel A quantification is on extremely variable y-scales and actually shows that Xist is recruited globally to nearly all autosomal genes, likely indicating an unspecific signal. Again, the sense and 0h controls should have been quantified along with biological replicates. 

      Figure 1 shows heatmaps and corresponding metagenes for d0, d4, d7, and d14 female ES cells. Two biological replicates are analyzed. In our revised manuscript, we have used Pearson and Spearman correlation coefficients to measure the strength and direction of a relationship between two biological replicates and shown that the two replicates have high reproducibility (new Figure S1A). On d0, the Xist coverage on autosomes and X chromosome is low, but there is a clear increase on d4, d7, and d14, particularly at the TSS of autosomal genes, as shown by the metagene plots on in Figure 1A-B and the CHART density maps in new Figure 1E-F. We also show relative depletion of Xist signals in the male and sense negative controls.

      Upon inspecting genome browser tracks of all regions reported in the manuscript (Rbm14, Srp9, Brf1, Cand2, Thra, Kmt2c, Kmt2e, Stau2, and Bcl7b), the signal is unspecific on all sites with the possible exception of Kmt2e. On all other loci, there is either a strong signal in the 0h ESC controls or more signal in some of the sense controls. This implies that peak calling is picking up false positive regions. How many peaks would have been picked up if the sense or the 0h controls were used for peak calling? It is likely that there would be a lot since there are also possible "peaks" (e.g., Fzd9) in control tracks. 

      The analysis cannot be performed by visual inspection. A statistical analysis must be performed to call signal above noise. This is why we performed peak-calling on two biological replicates and identified overlapping peaks using bedtools intersect to improve reliability. Significant peaks are noted as black bars under each track. As mentioned above, for our analysis, we focused on the top 100 peaks based on peak scores to ensure robustness. Xist has significantly higher signal compared to the sense probe in the Xist-autosomal peak regions (revised Figure 1E-F). Additionally, we conducted peak calling on undifferentiated ES cells (d0) and detected a significantly higher number of peaks (~600) compared to the differentiated states (d4 or d7) (~100).

      Single-cell sequencing studies have shown that about 2% of undifferentiated mESCs express detectable Xist (Pacini et al., Nat Commun, 2021). The Xist peaks in “day 0” cells may be due to the differentiating population.

      Further inspection of the data was not possible as the authors did not provide access to the raw fastq files. When inspecting results from past published experiments {Engreitz, 2013 #1839} reported regions were not bound by Xist. 

      On the contrary, we deposited the raw data files to GEO prior to the submission of the paper and included the reviewer link to access them. As of August 24, 2024, GEO publicly released these files, allowing for full inspection of the data. 

      Regarding the Engreitz publication, it is not recommended to compare our current study to their analysis for the crucial reason that the Engreitz study was not conducted under physiological conditions. The authors overexpressed the Xist gene in male ES cells. Because Xist RNA can silence genes in male cells as well, this ectopic overexpression normally leads to cell death — thus forcing examination of effects in a narrow time window before Xist can fully spread and act across the genome. Comparing our experiments (endogenous Xist expression in female ES cells) to the ectopic overexpression in male ES cells of Engreitz et al. should therefore not be undertaken.

      Thirdly, contrary to the authors' claim, deleting the B repeat does not lead to a loss of autosomal signal. Indeed, comparing Fig1A and Fig2B side by side clearly shows no difference in the autosomal signal, likely because the autosomal signal is CHART background. Properly quantifying the signal with separate replicates as well as the sense and 0h controls is vital. Overall current data together with published results indicate that CHART peak calling on autosomes is due to technical noise or artefacts.

      In our revised manuscript, we have included the quantitative results as mentioned above in the main and supplementary figure (new Figure 1E-F, Figure 2E-F, and S3A). The data clearly show an enrichment in the Xist CHART samples in differentiating female ES cells.

      We believe the reviewer may be comparing the original Figure 1A and Figure 2A (not Figure 2B). As mentioned above, the analysis cannot be performed by visual inspection. Please see new Figure 2E and 2F. From these data, it should be clear that deleting RepB causes a decrease in Xist targeting to autosomal loci.

      (2) The RNA-seq analysis is also flawed and precludes strong statements. Firstly, the analysis frequently lacks statistical analysis (Fig3B, FigS2B-C) and is often based on visualizations (Fig 3D-G) without quantifications. Day 4 B-repeat deletion does not lead to a significant change in the expression of genes close to Xist signal (Fig3H, d14 does not fully show). 

      Please see new revised Figure 3B and Figures S2B-C (now revised as Figures S6A and S6B). 

      Secondly, for all transcriptional analysis, it is important to show autosomal non-target genes, which is not always done. 

      In the revised manuscript, we included non-target genes for each analysis (new Figure 4E-F, 5D and 5F, 7C and 7E, S7F, S8).

      Indeed, both males and B repeat deletion will lead to transcriptional changes on autosomes as a secondary effect from different X inactivation status. The control set, if used, is inappropriate as it compares one randomly selected set of ~100 genes. This introduces sampling error and compares different classes of genes. Since Xist signal targets more active genes, it is important to always compare autosomal target genes to all other autosomal genes with similar basal expression patterns.

      Please see new Figure S8. We included 100 randomly selected non-target sites on autosomes for this comparative analysis. For consistency, we applied the same flanking regions (10 kb) in the analysis of both target and non-target genes. We believe that this selection method for nontargets is appropriate for two reasons: first, it allows us to control for Xist binding and non-binding; second, it ensures a similar number of genes in both groups, providing a robust foundation for statistical analysis. 

      (3) The ChIP-seq analysis also has some problems. The authors claim that there is no positive correlation between genes close to Xist autosomal binding (10kb) compared to those 50kb away (Fig 3C, S2D); however, this analysis is based entirely on metagene visualization. Signal within the Xist binding sites should be quantified (not genes close by) and compared to other types of genomic loci and promoters. Focusing on the 50kb group only as controls is misleading.

      We believe the reviewer may have misunderstood our conclusions. As stated in the paper, we observed lower coverage of the histone marks H3K27me3 and H2AK119ub, associated with PRC2 and PRC1, respectively. Our conclusions regarding PRC1/2 support the RNA-seq results, indicating that Xist tends to bind to actively expressed genes. In other words, these genes exhibit lower levels of PRC-mediated silencing signals. This observation underscores the relationship between Xist binding and gene activity, highlighting that Xist preferentially associates with regions that are less subject to silencing by polycomb repressive complexes.

      Secondly, the authors only look at PRC mark signal upon differentiation; what about the 0h timepoint, i.e., is there pre-marking? 

      Day 0 is not an appropriate timepoint for this analysis because Xist is not yet induced. There is also a small fraction of cells (<5%) that spontaneously differentiate and start to undergo XCI. Because of these reasons, the day 0 timepoint is considered somewhat heterogeneous and it would be difficult to make conclusions regarding Xist peaks in these samples.

      Most worryingly, the data analysis is not consistent between figures (see Fig3C vs 5H-I). In Fig5, the group of Xist targets was chosen as those within 100kb of Xist binding, which would encompass all the control regions from Fig3C. In this analysis, the authors report that there is Xist-dependent H3K27me3 deposition, and in fact, here the Xist autosomal targets have more of it than the controls. Overall, all of this analysis is misleading, and clear conclusions cannot be made.

      We believe that the reviewer may have also misunderstood the analysis in Figure 5. Figure 5 shows the effect of the Xist inhibitor, X1, on H3K27me3 and gene expression. X1 blocks reduces PRC2 targeting and gene silencing — consistent with X1’s effect on RepA as published in Aguilar et al. 2022. 

      All in all, because the fundamental observation is not robust (see point 1), all subsequent analyses are also affected. There are also multiple other inconsistencies within the analysis; however, they have not been included here for brevity.

      We again respectfully disagree with Rev1 but thank the reviewer for making suggestions that helped to strengthen our manuscript.  We believe that the revised manuscript with new analyses is improved in part because of the reviewer’s critical comments.

      Reviewer #2 (Public review):

      Summary:

      To follow-up on recent reports of Xist-autosome interaction the authors examine female (and male transgenic) mESCs and MEFs by CHARTseq. Upon finding that only 10% of reads map to X, they sought to identify reproducible alternative sites of Xist-binding, and identify ~100 autosomal Xistbinding sites and show a transient impact on expression.

      Strengths:

      The authors address a topical and interesting question with a series of models including developmental timepoints and utilize unbiased approaches (CHARTseq, RNAseq). For the CHARTseq they have controls of both sense probes and male cells; and indeed do detect considerable background with their controls. The use of deletions emphasizes that intact functional Xist is involved. The use of 'metagene' plots provides a visual summation of genic impact.

      Reviewer 2 has made some excellent suggestions. We have revised the manuscript accordingly and are grateful to the reviewer for the recommendations.

      Weaknesses:

      Overall, the result presentation has many 'sample' gene presentations (in contrast to the stronger 'metagene' summation of all genes). The manuscript often relies on discussion of prior X chromosomal studies, while the data generated would allow assessment of the X within this study to confirm concordance with prior results using the current methodology/cell lines. 

      Many of the 'follow-up' analyses are in fact reprocessing and comparison of published datasets. The figure legends are limited, and sample size and/or source of control is not always clear. While similar numbers of autosomal Xist-binding sites were often observed, the presented data did not clarify how many were consistent across time-points/cell types. While there were multiple time points/lines assessed, only 2 replicates were generally done.

      We apologize for the deficiencies in the legend.  The revised manuscript has corrected them.

      We generated many new datasets with deep sequencing, with at least two biological replicates for each. Such experiments are extremely expensive by nature. Thus, two biological replicates are typically considered acceptable.

      Additionally, we performed reanalysis of published datasets to test whether — in the hands of other investigators — cell lines expressing Xist also supported autosomal targeting. Figure 4 is a case in point. Here we examined Tg1 and Tg2, which respond to doxycycline to overexpress Xist from an ectopic site. Transcriptomic analysis showed significant downregulation of autosomal Xist targets, as exemplified by Rbm14 and Bcl7b (new Figure 4C, S9B). In contrast, non-targets of Xist such as Stau1 did not demonstrate significant changes in gene expression (new Figure 4E and 4G). Looking across all autosomal target genes, we observed a significant decrease in mean expression in the Xist overexpressing cell lines (new Figure 4D). The fact that the autosomal changes were also observed in datasets generated by other investigators greatly strengthen our conclusions. 

      Aim achievement:

      The authors do identify autosomal sites with enrichment of chromatin marks and evidence of silencing. More details regarding sample size and controls (both treatment, and most importantly choice of 'non-targets' - discussed in comments to authors) are required to determine if the results support the conclusions.

      Specific scenarios for which I am concerned about the strength of evidence underlying the conclusion:

      I found the conclusion "Thus, RepB is required not only for Xist to localize to the X- chromosome but also for its localization to the ~100 autosomal genes " (p5) in constrast to the statement 2 lines prior: "A similar number of Xist peaks across autosomes in ΔRepB cells was observed and the autosomal targets remained similar". Some quantitative statistics would assist in determining impact, both on autosomes and also X; perhaps similar to the quintile analysis done for expression.

      We have added the Xist coverage panel for day 4 and 7 in the identified Xist-autosomal peak regions (new Figure 1E-F, Figure 2E-F), as mentioned above. The results clearly demonstrate that the deletion of RepB decreases Xist binding to autosomes. Also, we showed that ΔRepB increased X-linked genes expression in our revised Figure 3D. 

      It is stated that there is a significant suppression of X-linked genes with the autosomal transgenes; however, only an example is shown in Figure 4B. To support this statement, a full X chromosomal geneset should be shown in panels F and G, which should also list the number of replicates. 

      Please see new Figure 4B.

      As these are hybrid cells, perhaps allelic suppression could be monitored? Is Med14 usually subject to X inactivation in the Ctrl cells, and is the expression reduced from both X chromosomes or preferentially the active (or inactive) X chromosome?

      If Rev2 is referring to Figure 4, the dataset used in Figure 4 comes from another research group and was previously published (Loda, A. et al. Nat Commun, 2017).

      If Rev2 is referring to our ES cells, they are N2 cell lines.  The X chromosomes are fully hybridized (Cas/Mus), but the autosomes are not fully hybridized (Ogawa et al., Science, 2008). Med14 is subject to XCI and is expressed from the Xa, silenced on the Xi. 

      The expression change for autosomes after transgene induction is barely significant; and it was not clear what was used as the Ctrl? This is a critical comparator as doxycycline alone can change expression patterns.

      We agree that there was a modest change in expression after transgene induction, but it is a significant change. Again, the dataset is from a published study where the authors generated doxycycline-responsive Xist transgenes (see above). The control in this case is Dox-treated wildtype cells. We now clarify these points.

      In the discussion there is the statement. "Genetic analysis coupled to transcriptomic analysis showed that Xist down-regulates the target autosomal genes without silencing them. This effect leads to clear sex difference - where female cells express the ~100 or so autosomal genes at a lower level than male cells (Figure 7H)." This sweeping statement fails to include that in MEFs there is no significant expression difference, in transgenics only borderline significance, and at d14 no significant expression difference. The down-regulation overall seems to be transient during development while targeting is ongoing?

      Indeed, the Xist effects on autosomes seem to occur during cell differentiation in ES cells. While there is no apparent effect in MEFs, we cannot exclude effects on other somatic cells. Regardless of whether the effects are in early development or throughout life, the sex differences may have life-long effects in mammals. The study conducted in human cells by the Plath lab also concluded that the differences primarily affect stem cells.

      Finally, I would have liked to see discussion of the consistency of the identified genes to support the conclusion that the autosomal sites are not merely the results of Xist diffusion.

      We address this in the third paragraph of the Discussion. Our main argument is that if autosomal binding were caused by diffusion, then RepB deletion or X1 treatment would have led to increased binding at autosomal sites, as Xist would bind less to the X chromosome. However, as demonstrated in our study, both treatments resulted in reduced Xist binding on both the X chromosome and autosomes. This finding suggests that the binding is specific and reliant on Xist's RepA and RepB domains, rather than being a passive diffusion process.

      To examine overlap between the conditions (days of differentiation and WT/RepB cells), we generated Venn Diagrams as now shown in Figure S4E.

      The impact of Xist on autosomes is important for consideration of impact of changes in Xist expression with disease (notably cancers). Knowing the targets (if consistent) would enable assessment of such impact.

      We thank Rev2 for the very helpful review and for the forward-looking experiments. Indeed, the physiological changes brought on by autosomal targeting will be of future interest.

      Reviewer #3 (Public review):

      Summary:

      Yao et al use CHART to identify chromatin associated with Xist in female mouse ESCs, and, as control, male ESCs at various timepoints of differentiation. Besides binding of Xist to X chromosome regions they found significant binding to autosomes, concentrating mostly on promoter regions of around 100 autosomal genes, as elucidated by MACS. The authors went on to show that the RepB repeat is mostly responsible for these autosomal interactions using a female ESC line in which RepB is deleted. Evidence is provided that Xist interacts with active autosomal genes containing lower coverage of repressive marks H3K27me3 and H2AK119ub and that RepB dependent Xist binding leads to dampening of expression, but not silencing of autosomal genes. These results were confirmed by overexpression studies using transgenic ESCs with doxycycline-inducible Xist as well as via a small molecule inhibitor of Xist (X1), inducing/inhibiting the dampening of autosomal genes, respectively. Finally, using MEFs and Xist mutants RepB or RepE the authors provide evidence that Xist is bound to autosomal genes in cells after the XCI process but appears not to affect gene expression. The data presented appear generally clear and consistent and indicate some differences between human and mouse autosomal regulation by Xist. Thus, these results are timely and should be published.

      We thank Rev3 for the positive remarks and great suggestions.  We have amended the manuscript per below. 

      Strengths:

      Regulation of autosomal gene expression by Xist is a "big deal" as misregulation of this lncRNA causes developmental defects and human disease. Moreover, this finding may explain sexspecific developmental differences between the sexes. The results in this manuscript identify specific mouse autosomal genes bound by Xist and decipher critical Xist regions that mediate this binding and gene dampening. The methods used in this study are appropriate, and the overall data presented appear convincing and are consistent, indicating some differences between human and mouse autosomal regulation by Xist.

      Weaknesses:

      (1) The figure legends and/or descriptions of data are often very short lacking detail, and this unnecessarily impedes the reading of the manuscript, in particular the figures would benefit not only from more detailed descriptions/explanations of what has been done but also what is shown. 

      We have included more detailed descriptions in the figure legends and throughout the manuscript.

      This will facilitate the reading and overall comprehension by the reader. One out of many examples: In Fig S1B in the CHART data at d4 and d7 there is not only signal in female WT Xist antisense but also in female sense control. For a reader that is not an expert in XCI it would be helpful to point out in the legend that this signal corresponds to the lncRNA Tsix (I suppose), that is transcribed on the other strand.

      We thank the reviewer for this excellent point.  We have amended the Results section accordingly.

      (2) Different scales are used in the lower panels of Figures 1A and 2A, which makes it difficult to directly compare signals between the different differentiation stages.

      We have included a figure combining all timepoints — d0, d4, d7, and d14 WT female Xist CHART signals  — on the X chromosome and autosomes to support our thesis. Please see new Figure 1B.

      (3) In this study some of the findings on mouse cells contrast previously published results in human ESCs: 1) Xist binding occurs preferentially to promoters in mice, not in human. 2) Binding of Xist is mostly detected in polycomb-depleted regions in mice but there is a positive correlation between Xist RNA and PRC2 marks in human ESCs. These differences are surprising but may be very interesting and relevant. While I am aware that this might be a difficult task, it would be helpful to experimentally address this issue in order to distinguish whether species specific and/or methodological differences between the studies are responsible for these differences.

      Indeed, our findings in mouse cells contrast with those observed in humans. As discussed in the manuscript, this discrepancy may be attributed to factors such as cell type, differentiation methods, and the Xist pull-down technique employed (our CHART method utilizes a 20 nt oligo library, whereas RAP uses long oligos). We agree that future work should investigate the underlying causes of these differences between mouse and human systems.

      Recommendations for the authors:

      Reviewer #2 (Recommendations for the authors):

      For Figure 2: labelling ∆B on the panel A timeline (e.g. d0-∆B) would make the results clearer for the audience. Panel B makes most sense beside panel E of Figure 1, so combine here and skip in Figure 1?

      We have modified Figure 2A and thank Rev2 for this suggestion. As for the embedded tables: since we performed peak calling for WT and ∆B separately, we believe that showing both the peak numbers and their corresponding peak patterns provides a clearer representation of the data.

      I agree that at day 7 there appears to be a difference in X; but by day 14 this looks much more minimal - is it just time-shifted rather than altered? Perhaps this could be discussed. Autosomal binding sites show no change in number.

      Day 7 exhibits the strongest Xist binding on the X chromosome, consistent with the de novo establishment phase of XCI when Xist is expressed at the highest levels (300 copies/cell during de novo XCI versus ~100 copies/cell during maintenance [Sunwoo et al., 2015 as cited]. Per our RNA-seq analysis here, we also observed highest Xist expression on day 7 and reduced levels on day 14 (Fig. S5A). This expression difference explains the reduced Xist CHART levels on day 14 compared to day 7. 

      While the X has previously been examined, it would seem beneficial to conduct the same expression analyses (Figure 3) for the X (perhaps supplemental), as the authors have the data 'in hand'. I feel comparison to X in the main figure for panels A and B would fit, while a similar analysis for the X for panel C could be supplemental, presumably supporting the published data to which this data is currently compared. 

      This is a good suggestion. Please find the new data in Figures 2E-F and 3D, which demonstrate that the RepB deletion inhibits Xist binding on the X chromosome, resulting in increased X-linked gene expression, as previously mentioned. Since Xist binds across the X chromosome, we did not perform peak calling as we did for the autosomes. Therefore, applying a similar analysis as in Figures 3A-B may not be appropriate in this case.

      Such a direct comparison to X-data from the same study would be important. For panel H: How many replicates (2)? This should be in the legend. What is the change in median expression? Again, a supplemental figure showing impact on X-linked targets would be useful. Do male and female ESCs show an expression difference prior to differentiation (ie d0)? The data underlying this Figure should be in one of the supplementary tables, showing the full statistical tests and average change. The supplementary tables 8-12 list the WT target genes, not expression differences with the deletion. Again, given that the difference appears transient, might the ∆B cells be altered in rate of differentiation?

      Panel H (revised Figure 3G) includes two replicates, and this has been added to the legends. We have provided a supplementary figure demonstrating that RepB increases the expression levels of X-linked genes on days 4, 7, and 14 (revised Figure 3D). Male and female ESCs show differences in the expression of X-linked genes, as both X chromosomes are active in females at this stage prior to differentiation (revised Figure S5C). 

      A supplementary table with statistical tests and average change information has been included in our revised version (Table S11).

      On the other hand, these Xist-autosomal target genes displayed no significant differences between WT male, female, or ∆B female cells on day 0 — prior to onset of XCI and Xist expression. Please see new Figure 3H. 

      As for whether ∆B cells are altered in their rate of differentiation, the analysis by Colognori et al. 2019 indicates that ∆B cells differentiate similarly to WT cells. (In Figure 6 of Colognori et al. 2019, autosomal genes expressed similarly in WT and ∆B cells, whereas XCI is affected only in ∆B cells)

      We have also modified the legends for our supplementary tables.

      Why were the transgene lines examined upon neuronal differentiation rather than the same approach as in Figures 1-3? I would have thought neuronal differentiation might be more similar to d14, where limited changes remain? Could the authors clarify and discuss?

      We apologize for the confusion. The Tg lines in Figure 4 came from a previously published study. We performed reanalysis of published datasets because we wanted to test whether — in the hands of other investigators — cell lines expressing Xist also supported autosomal targeting. Here we examined Tg1 and Tg2, which respond to doxycycline to overexpress Xist from an ectopic site. Transcriptomic analysis showed significant downregulation of autosomal Xist targets, as exemplified by Bcl7b and Rbm14 (Figure 4C and S9B). In contrast, non-targets of Xist such as Stau1 did not demonstrate significant changes in gene expression (Figure 4E and 4F). Looking across all autosomal target genes, we observed a significant decrease in mean expression in the Xist overexpressing cell lines (Figure 4D). The fact that the autosomal changes were also observed in datasets generated by other investigators greatly strengthen our conclusions. We have clarified this in the Results section.

      Figure 5 - the legend should specify the number of replicates and clarify the blue/green (intuitive, but not specified). Are the 'target' / 'non-target' genes from d4 Chart (but the RNA from d5)? How are 'non-targets' defined - do they match the 'targets' in certain criteria (expression level, chromatin features, GC content)? Do they change per differentiation protocol?

      We have modified the legends to clarify that the 'target' and 'non-target' genes are derived from the day 4 CHART-seq data, while the RNA data is from day 5, as that study sequenced day 5 and not day 4. Non-targets were randomly chosen based on (i) the absence of Xist binding and (ii) similar expression levels. Please see revised Figure S8.

      It would be helpful to compare Xist expression levels across the various models, and the MEF model could be better described - are they polyploid as often happens?

      We have included the Xist expression levels of ES cells and MEF cells in the revised version (revised Figure S5A, 6D). The transformed MEFs are indeed tetraploid, as is typical.

      For 6A to be informative, one needs to know % mapping to X in ES timeline, which is in supplemental, so perhaps 6A should also be supplemental?

      We have moved 6A to the supplemental figure.

      It is odd that ∆B seems to have had more impact in MEFs, and I would like more discussion - but I also think I am missing something: "We observed that Xist signals were more substantially reduced on both the Xi and autosomal regions in ΔRepE MEFs compared to ΔRepB cells", yet in lower panel 6 G it looks like ∆B is LOWER than ∆E? Am I misinterpreting?

      We apologize for the confusing writing.  The revised text now reads:  “To investigate, we utilized a deletion of Xist’s Repeat E (∆RepE), which was previously demonstrated to severely abrogate localization of Xist to the Xi 41,42. We reasoned that the severe loss of Xist binding might unmask a transcriptomic difference. As expected, we observed that Xist signals were somewhat more reduced on the Xi in ΔRepE MEFs compared to ΔRepB cells (Figure 6E-6F). Despite this reduction, peak coverages in autosomal target genes did not increase in ΔRepE MEFs (Figure 6E-6F). However, there was an overall decrease in the number of significant autosomal peaks in ∆RepE MEFs relative to WT cells (Figure 6A). Regardless, we observed no significant transcriptomic differences in ∆RepE MEFs relative to WT MEFs (Figure 7A-7E). Additionally, further examination of RNA sequencing data from male and female MEF cells in two published studies 43,44 corroborated that the expression levels of these autosomal Xist targets did not exhibit significant changes (Figure 7F and 7G). Altogether, the analysis in MEFs demonstrates that Xist continues to bind autosomal genes in post-XCI somatic cells. However, autosomal binding of Xist in post-XCI cells does not overtly impact expression of the associated autosomal genes. Nonetheless, we cannot exclude more subtle changes that do not meet the significance cut-off.”

      Overall, I would like to see how consistent these autosomal peaks are - I shudder to suggest Venn diagrams, but something to show whether there are day/lineage specific peaks and/or ∆repeat B/E resistant peaks. 

      We now present Venn diagrams comparing MEF, ES_d4, and ES_d7, showing approximately 50% overlap between MEF and ES cells (revised Figure S10B). This may be expected, as each timepoint is a different developmental stage of XCI, with expected gene expression differences.

      Very minor comments:

      It would be easier if the supplemental tables were tabs in 1 file!

      We will defer to the editor on how best to format the supplemental tables.

      Similar to the text, could gene names be included in the supplemental?

      We have provided gene names in the supplemental files.

      Figure 3 legend: should 'representing' be representative?

      We have modified it.

      "Xist patterns identified in human cells" p 5; it is challenging to follow human versus mouse, so specify or ensure correct use of XIST/Xist Indeed, we edited the manuscript accordingly.

      Gene names should be italicized.

      We have italicized gene names in our manuscript.

      Ref. 38 lacks details (...).

      We have updated the reference.

      Peak-like characters - perhaps characteristics? P8

      We have modified this.

      Reviewer #3 (Recommendations for the authors):

      On page 6, the 6th sentence in the first paragraph needs correction. "Consistent with Xist's behavior on the X chromosome."

      We have modified the sentence. Thank you.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public Review):

      The study by Longhurst et al. investigates the mechanisms of chemoresistance and chemosensitivity towards three compounds that inhibit cell cycle progression: camptothecin, colchicine, and palbociclib. Genome-wide genetic screens were conducted using the HAP1 Cas9 cell line, revealing compound-specific and shared pathways of resistance and sensitivity. The researchers then focused on novel mechanisms that confer resistance to palbociclib, identifying PRC2.1. Genetic and pharmacological disruption of PRC2.1 function, but not related PRC2.2, leads to resistance to palbociclib. The researchers then show that disruption of PRC2.1 function (for example, by MTF2 deletion), results in locus-specific changes in H3K27 methylation and increases in D-type cyclin expression. It is suggested that increased expression of D-type cyclins results in palbociclib resistance.

      Strengths:

      The results of this study are interesting and contribute insights into the molecular mechanisms of CDK4/6 inhibitors. Importantly, while CDK4/6 inhibitors are effective in the clinic, tumour recurrence is very high due to acquired resistance.

      Weaknesses:

      A key resistance mechanism is Rb loss, so it is important to understand if resistance conferred by PRC2.1 loss is mediated by Rb, and whether restoration of PRC2.1 function in Rb-deplete cells results in renewed palbociclib sensitivity. It is also important to understand the clinical implications of the results presented. The inclusion of these data would significantly improve the paper. However, besides some presentation issues and typos as described below, it is my opinion that the results are robust and of broad interest.

      Major questions:

      (1) Is the resistance to CDK4/6 inhibition conferred by mutation of MTF2 mediated by Rb?

      (2) Are mutations in PRC2.1 found in genetic analyses of tumour samples in patients with acquired resistance?

      We thank the reviewer for their editing and experimental suggestions, and have integrated their responses into our re-submitted manuscript.

      We also agree that understanding the role of RB1 in mediating palbociclib resistance to the proposed resistance mechanism is of particular interest. However, as there are three RB proteins expressed in human cells, this is a technically difficult question to probe genetically. Despite this technical challenge, we have provided multiple lines of evidence in our resubmitted manuscript that the resistance to palbociclib observed in our PRC2.1-deficent cells is mediated through the canonical CDK4/6-RB1 pathway. First, disruption of RB1 in HAP1 cells results in palbociclib resistance to a level comparable level to PRC2.1 disruption (Fig. 4E). Second, inactivation of SUZ12 or MTF2 increases the number of cells entering S-phase in palbociclib treatment (Fig. 4G) with no increase in basal rates of apoptosis (Fig. S2D), suggesting that any proliferation advantage observed in PRC2.1-defective cells is due to resistance to  palbociclib-induced cell cycle arrest. Third, we show that over expression of CCND1 and CCND2 is sufficient to drive resistance to palbociclib in wild-type HAP1 cells (Fig. S5F).  And finally, increased levels of CCND1 and CCND2 observed in cells lacking PRC2.1 activity results in higher CDK4/6 activity as measured by RB1 phosphorylation, despite palbociclib blockade (Fig. 6F). All these lines of evidence strongly suggest that MTF2-containing PRC2.1 regulates G1 progression in through the canonical CDK4/6RB1 pathway by repressing CCND1 and CCND2 expression. 

      Whether or not MTF2 deletion leads to palbociclib resistance in clinical samples is also of a question of particular interest. Currently, we are unaware of any reports that specifically mention MTF2 deletion as leading to palbociclib resistance, and we were unable to find another example in our own cancer database review. However, we have included references to other examples of MTF2 mutation resulting in chemotherapeutic resistance in our discussion. Additionally, although MTF2 is rarely observed to be mutated in cancers (Ngubo et al. 2023), it is highly differentially expressed and investigating decreased MTF2 transcription in palbociclib resistant tumors, though challenging, might prove fruitful.  However, as mechanisms of palbociclib resistance is an area of active investigation, we speculate that future studies might uncover additional examples of MTF2 mediating resistance to this clinically important chemotherapeutic.  

      Reviewer #2 (Public Review):

      Summary:

      Longhurst et al. assessed cell cycle regulators using a chemogenetic CRISPR-Cas9 screen in haploid human cell line HAP1. Besides known cell cycle regulators they identified the PRC2.1 subcomplex to be specifically involved in G1 progression, given that the absence of members of the complex makes the cells resistant to Palbociclib. They further showed that in HAP1 cells the PRC2.1, but not the PRC2.2 complex is important to repress the cyclins CCND1 and CCND2. This can explain the enhanced resistance to Palbociclib, a CDK4/6Inhibitor, after PRC2.1 deletion.

      Strengths:

      The initial CRISPR screen is very interesting because it uses three distinct chemicals that disturb the cell cycle at various stages. This screen mostly identified known cell cycle regulators, which demonstrates the validity of the approach. The results can be used as a resource for future research.

      The most interesting outcome of the experiment is the finding that knockouts of the PRC2.1 complex make the cell resistant to Palbociclib. In a further experiment, the authors focused on MTF2 and JARID2 as the main components of PRC2.1 and PRC2.2, respectively. Via extensive analyses, including genome-wide experiments, they confirmed that MTF2 is particularly important to repress the cyclins CCND1 and CCND2. The absence of MTF2 therefore leads to increased expression of these genes, sufficient to make the cell resistant to palociclib. This result will likely be of wide interest to the community.

      Weaknesses:

      The main weakness of the manuscript is that the experiments were performed in only one cell line. To draw more general conclusions, it would be essential to confirm some of the results in other cell lines.

      In addition, some of the findings, such as the results from the CRISPR screen as well as the stronger impact of the MTF2 KO on H3K27me3 and gene expression (compared to JARID2 KO), are not unexpected, given that similar results were already obtained before by other labs.

      We thank the reviewer for their suggestions and we believe that we have addressed their main concern about the generality of the MTF2 regulation of D-type cyclin expression in our resubmitted manuscript. We have now shown through shRNA knockdown that MTF2 represses CCND1 in two additional cell lines, the breast cancer MDA-MB-231 and immortalized monkey COS7 cell line (Fig. 6E). However, it is important to note that MTF2 did not control CCND1 expression in every cell line tested (Fig. 6D), underscoring the context-dependent nature of this regulation. Future studies will illuminate what cell or tumor types in which this regulation is observed.

      Additionally, while MTF2 has previously been shown to exert a greater effect on H3K27me3 levels in some circumstances (Loh et al. 2021, Rothberg et al. 2018), a number of notable reports in ES cell lines have concluded that PRC2 localization and H3K27me3 at the majority of genomic sites are dependent on both PRC2.1 and PRC2.2 activity (Healy et al. 2019, Højfeldt et al. 2019, Perino et al. 2020, Oksuz et al. 2018). Therefore, we think it is important to highlight the greater dependence on MTF2 for promoter proximal H3K27me3 levels in our transformed cell line context.  

      Reviewer #3 (Public Review):

      This study begins with a chemogenetic screen to discover previously unrecognized regulators of the cell cycle. Using a CRISPR-Cas9 library in HAP1 cells and an assay that scores cell fitness, the authors identify genes that sensitize or desensitize cells to the presence of palbociclib, colchicine, and camptothecin. These three drugs inhibit proliferation through different mechanisms, and with each treatment, expected and unexpected pathways were found to affect drug sensitivity. The authors focus the rest of the experiments and analysis on the polycomb complex PRC2, as the deletion of several of its subunits in the screen conferred palbociclib resistance. The authors find that PRC2, specifically a complex dependent on the MTF2 subunit, methylates histone 3 lysine 27 (H3K27) in promoters of genes associated with various processes including cell-cycle control. Further experiments demonstrate that Cyclin D expression increases upon loss of PRC2 subunits, providing a potential mechanism for palbociclib resistance.

      The strengths of the paper are the design and execution of the chemogenetic screen, which provides a wealth of potentially useful information. The data convincingly demonstrate in the HAP1 cell line that the MTF2-PRC2 complex sustains the effects of palbociclib (Figure 4), methylates H3K27 in CpG-rich promoters (Figure 5), and represses Cyclin D expression (Figure 6). These results could be of great interest to those studying cell-cycle control, resistance mechanisms to therapeutic cell-cycle inhibitors, and chromatin regulation and gene expression.

      There are several weaknesses that limit the overall quality and potential impact of the study. First, none of the results from the colchicine and camptothecin screens (Figures 1 and 2) are experimentally validated, which lessens the rigor of those data and conclusions. Second, all experiments validating and further exploring results from the palbociclib screen are restricted to the Hap1 cell line, so the reproducibility and generality of the results are not established. While it is reasonable to perform the initial screen to generate hypotheses in the Hap1 line, other cancer and non-transformed lines should be used to test further the validity of conclusions from data in Figures 4-6. Third, conclusions drawn from data in Figures 3D and 4D are not fully supported by the experimental design or results. Finally, there have been other similar chemogenetic screens performed with palbociclib, most notably the study described by Chaikovsky et al. (PMID: 33854239). Results here should be compared and contrasted to other similar studies.

      We thank the reviewer for their suggestions regarding our manuscript. While the genes recovered as mediating cellular responses to camptothecin and colchicine was never confirmed following our chemogenetic screens, we felt our primary findings were in the area of palbociclib resistance and decided focus our follow-up investigations on genes. We included the results camptothecin and colchicine chemogenetic screens as confirmation of the specificity of PRC2 mutation resulting in resistance to palbociclib (Fig. 4C) and for others in the community to use as a resource for future investigations. We have also clarified our results for Figure 3D and 4D in our revised manuscript, as well as included additional plots of these results (Fig. S1DS1F). And, with our resubmitted manuscript, we believe we have addressed their concern of the generality of our results by demonstrating our primary finding that MTF2 regulates D-type cyclins in additional cell lines other than HAP1. We feel these results indicate that while not “general”, there are additional cellular contexts that our main result holds true. In line with this, and to address how our chemogenetic screens fits into the landscape of previous studies, including Chaikosvsky et al., we have included the following lines to our discussion:  “Additionally, other chemogenetic screens utilizing palbociclib and have not identified that inactivation of PRC2 components as either enhancing or reducing palbociclib-induced proliferation defects, suggesting that PRC2 mutation is neutral in the cell lines studied. These observations not only underscore the context-dependent ramifications of mutation of these PRC2 complex members, but also may help inform the context in which CDK4/6 inhibitors are most efficacious.”

      Recommendations for the authors:

      Reviewer #1 (Recommendations For The Authors):

      (1) "We found that only thirteen and twenty genes resulted in sensitivity or resistance, respectively, in every conditions tested and were deemed non-specific and excluded from any further analysis (see Table S2)." It's unclear to me why these genes were deemed 'nonspecific'. Are these genes functionally important for the general exclusion of xenobiotic molecules?

      By this, we simply meant that these effects were not specific to one condition. Such genes could affect drug half-life or a general stress response, but are less likely to have functions directly tied to the pathway targeted by a drug than are genes whose loss affects only one condition.  

      (2) "Given that increased CCND1 levels is sufficient to drive increased CDK4/6 kinase activity, upregulation of these D-type cyclins is likely to be a significant contributor to the palbociclib resistance in MTF2∆ cells." It's unclear to me what is the basis for this statement. This is only true if there is free CDK4/6. If CDK4/6 is already fully occupied by D-type cyclins, then increased CCND1 levels would not be expected to have an effect. 

      While we anticipated that increased levels of CCND1 would result in more CDK4/6-Dtype association, we now demonstrate in the new Figure S5F that there is more CCND1 in complex with CDK6 in both SUZ12∆ and MTF2∆ cell lines. Furthermore, we able to show in Figure S5G that overexpression of D-type cyclins results in resistant to palbociclib-induced proliferation defects in HAP1 cells.

      (3) The description of the results is very confusing in places, especially regarding "resistance" versus "sensitivity" genes. For example: "CCNE1, CDK6, CDK2, CCND2 and CCND1, all of which are integral to promoting the G1/S phase transition, ranked as the 2nd, 24th, 27th, 29th and 46th most important genes for palbociclib resistance, respectively (Figures 1F and 1G). CCND1 and CCND2 bind either CDK4 or CDK6, the molecular targets of palbociclib, whereas CDK2 and CCNE1 form a related CDK kinase that promotes the G1/S transition.

      Similarly, cells with sgRNAs targeting RB1, whose phosphorylation by CDK4/6 is a critical step in G1 progression, displayed substantial resistance to palbociclib." My reading of this paragraph suggests that disruption of the CDK6 locus is associated with palbociclib resistance - surely this is a typo and instead should have been sensitivity? Please explain.

      We thank the reviewer for pointing this out and have corrected this typo  

      (4) Sensitivity to palbociclib was enhanced in cells expressing sgRNAs targeting H4 acetylation, positive regulators of Pol II transcription, and regulators of the DNA Damage Response pathway (Figures 3A and 3B), although this sensitivity was much weaker than that seen with DNA damaging agents. This observation is consistent with long-term treatment with palbociclib inducing DNA damage, as has been suggested by a number of recent publications 65,66." This is also consistent with recent work on Cdk7 inhibitors (Wilson et al. Mol Cell 2023), as Cdk7 inhibition is expected to affect both CDK1/2/4/6 activities and Pol II transcription.

      We thank the reviewer for bringing this observation to our attention and we have added this citation to this passage in our manuscript.

      (5) Figure 3D - would it not make sense to plot the data such that palbo concentration is on the x-axis? It is also difficult to interpret since the data are normalized to starting "% proliferation" at the indicated palbo treatment, when it is likely that % proliferation changes significantly with palbo concentration. Indeed, this is the graphing format used for a later figure (Figure 4D). The data with rotenone suggests palbo antagonizes rotenone-mediated reduction in proliferation. But it's unclear to me whether the graph shows the converse - that rotenone treatment modulates palbo-induced cell cycle arrest.

      This reviewer is correct about the fact that increasing doses of palbociclib in the absence of oxidative phosphorylation do indeed have an effect on proliferation. However, it is helpful to normalize proliferation values to each initial dose of palbociclib and then compare this to the different oxidative phosphorylation inhibitors treatment combinations. To illustrate that the oxidative phosphorylation inhibitors do indeed antagonize palbociclib-induced proliferation defects, we have now included the data graphed as each oxidative phosphorylation inhibitor vs palbociclib as Supplemental Figures S1D-S1F.

      • The highest concentration of GSK126 tested (5µM) does not appear to confer resistance, but perhaps this is due to off-target effects or cytotoxicity?

      We agree with the reviewer that at the highest doses of dose of GSK126, low doses of palbociclib do not confer resistance to palbociclib. However, higher doses do appear to have this effect. We have included a statement in our results section to address this reviewer’s observations. 

      • Disruption of Emi1 leads to resistance (Figure 1F, FZR1), yet overexpression induces resistance (Mouery et al. bioRxiv 2023). Explain.

      We do not understand why EMI1 responds in this way, and therefore we cannot comment on this in the text. 

      Typos/stylistic comments:

      • Typo "However, the net result of these opposing effects on cell cycle progression, and the contribution of the individual subcomplexes to this regulation, rained unclear."

      We thank the reviewer for pointing this out, and we have corrected it.  

      • Use of the word "growth" - I think the authors should be more precise. Is "proliferation" meant here?

      We thank the reviewer for pointing this out, and we have corrected it.

      • n Figure 4G, two of the panels have 8.42%. Is this correct, or may it be a copy/paste error?

      This was an error, but is no longer relevant as we have reconducted and reanalyzed this experiment.

      Reviewer #2 (Recommendations For The Authors):

      Major Points

      (1) Some of the conclusions should be confirmed in additional cell lines. I would suggest testing the resistance to Palbociclib in several additional cell lines, where MTF2 and JARID2 are deleted. If the conclusion can be generalized, one would expect that the differential role of MTF2 versus JARID2 can be confirmed in more cell lines.

      While the PRC2.1-dependent repression of D-type cyclins does not appear to be general, we have now demonstrated in Figures 5SE and 6F that there are multiple different cellular contexts in which our observations are consistent. Specifically, we demonstrate that GSK126 causes upregulation of CCND1 in both immortalized nontumor cells (COS7 cells) and in the breast cancer cell line MDA-MB-231. Moreover, in both cases we showed that this effect is PRC2.1-dependent, as shRNA knockdown of MTF2 increases expression of CCND1.

      (2) In addition, it may be attractive to make use of publicly available RNA-seq data of MTF2 and JARID2 knockout/down cells, to investigate the generality of the finding that PRC2.1 regulates CCND1 and CCND2.

      While it would be useful to address this issue, Figure S5E demonstrates that the repression of D-type cyclin expression by PRC2.1 is context dependent. Furthermore, prior to identifying the lines shown in Figure 6F and 5SE, we were not aware of which lines to focus our investigations on. However, we have now demonstrated a few cellular contexts in which either chemical inhibition of PRC2 or knockdown of MTF2 results in de-repression of CCND1 expression.

      (3) At a bare minimum the authors should strongly discuss the limitations of the study, and tone down the conclusions.

      We would agree with this based upon the data in the original submitted manuscript, however, now that we have shown that this effect is more general, this is less critical. That said, we do not see this effect in all cell lines, and we have made this apparent in the final version of the manuscript.

      Minor point

      (1) In my view, Figures 1-3 should be shortened to the most essential points, and some data/figures should be moved to the supplementary figures. Especially the STING genenetwork graphs are in my view not particularly meaningful.

      While we understand the opinion of this reviewer, we feel that these data will be of significant interest to some readers.  

      (2) Figure 6E and 6F/G appear to be largely redundant. This can perhaps be made more concise.

      This has been addressed in the new version of Figure 6

      (3) Figure 5D should be enlarged. 

      We thank the reviewer for this suggestion and have enlarged the image.

      Reviewer #3 (Recommendations For The Authors):

      The manuscript could be edited to improve clarity. In several places, the scientific logic motivating an experiment is confusing, and there are several hypotheses and conclusions that seem opposite from what the data are suggesting. Some aspects of the figures were also unclear. Specific examples include the following:

      (1) Last sentence of abstract : "Our results demonstrate a role for PRC2.1, but not PRC2.2, in promoting G1 progression." Data show that knockout of PRC2.1 components promotes G1 progression through upregulation of CycD, so the conclusion here is the opposite.

      We thank the reviewer for catching this error. We have now changed this to “in antagonizing G1 progression”.

      (2) In the second paragraph of the results, CCNE1, CDK2, etc are described as scoring high for palbociclib resistance, but those genes scored as sensitizing. Also, in that paragraph, it is described that a drug is sensitizing cells to loss of a gene, which seems like incorrect logic. It should be clarified that knock-out of a gene either sensitizes or desensitizes cells to the drug.

      We thank the reviewer for catching this error. We have now corrected it.  

      (3) In the motivation for the experiment in Figure 3D, it is written: "we asked whether chemical inhibition of oxidative phosphorylation could rescue sensitivity to palbociclib". Considering that knock-out of genes that mediate oxidative phosphorylation confer resistance to palbociclib, it is confusing why it was expected that chemical inhibitors would restore sensitivity.

      We are sorry if the original wording was confusing. We have now changed this to “combined inhibition of oxidative phosphorylation and CDK4/6 activity mutually rescue the proliferation defect imposed by agents targeting the other process”.  

      (4) If the intention of Figure 3D is to test the hypothesis that chemical inhibition of oxidative phosphorylation modulates sensitivity to palbociclib, the clarity of Figure 3D would be improved if data were shown such that palbociclib concentration is on the x-axis and the different curves are different drug concentrations.

      It appears that there is some mutual suppression, which inhibition of each process rescues cells partly from inhibition of the other. In fact, with these drugs the stronger of the two is seen as the rescue of mitochondrial poisons by palbociclib. We have now discussed this in the text.  

      (5) The authors should check the units on the x-axis in Figure 4D, should they be log[uM Palbo] or log [nM Palbo]?

      We thank the reviewer for catching this error. We have now corrected it

      (6) It should be clarified which data are summarized in the graph to the right in Figure 4G, are these experiments with palbociclib?

      This is currently included in the figure legends.

      (7) The text suggests that the control CCNE1 knockout is shown in Figure 4E, but those data are missing.

      This has been corrected in Figure 4E.

      Several conclusions are not well supported by the data and should be revised or more data and analysis should be added.

      (1) The titular conclusion that the "PRC2.1 Subcomplex Opposes G1 Progression through Regulation of CCND1 and CCND2" has only been demonstrated in the context of a Cdk4/6 inhibitor in HAP1 cells. There is little evidence supporting this claim that is broadly applicable. For example, data in Figure 4G show small and not demonstrable significant differences in G1 and S phase populations in the mock experiments. Also, experiments in other cells are needed to support the rigor and generality of the conclusion.

      Our chemogenetic screen and competitive proliferation assay data in Figure 4A, 4C and 4E support the conclusion that PRC2.1 and PRC2.2 play opposing roles in G1 progression. Furthermore, we have repeated the initial BrdU incorporation experiments shown in Figure 4G and have been able to demonstrate that JARID2∆ cells do indeed display a significant decrease of cells entering into S-phase when treated with palbociclib. Most importantly, in the Figures 6D and 6E we show additional cell lines where this is the case.  Therefore, we feel that this title is valid in the current version of the manuscript, where we have shown it to be the case in multiple tumor-derived human cell lines as well as immortalized non-human primate cells.  

      (2) It is unclear how the data in Figure 3D support the conclusion that the administered inhibitors of oxidative phosphorylation influence response to palbociclib.

      As noted in the response to point 4, we have now discussed this mutual rescue more thoroughly in the text.  

      (3) In Figure 4D, the IC50 values should be calculated and statistical significance based on biological replicates should be determined. Also, the conclusion that "increasing doses of GSK126 withstood palbociclib-induced growth suppression" is overstated, as ultimately all drug conditions succumb to palbocilib suppression of proliferation, although there may be differences in sensitivity.

      We have now  included a statical analysis of each data point in Figure 4D.  

      Editorial comments:

      (1) The title does not seem to optimally capture the content of the paper. Please consider changing it, e.g. focusing on palbociclib resistance. 

      While we used this particular drug to make the original observation, we feel it is more general to discuss the underlying biology (cyclin gene control) than the pharmacological methodology. Moreover, we have now extended our findings about the regulation of D-type cyclins by PRC2.1 to several cell lines, derived from both cancers and primary cells, re-enforcing the fact that this effect is observed more broadly.   

      (2) Please indicate the biological system (haploid human HAP1 cells) in either title or abstract.

      The abstract now indicates that we have observed this in CML, breast cancer and immortalized primary cells.

    1. Author response:

      Reviewer #1 (Public review):

      Summary:

      The authors aim to investigate the relationship between low estrogen levels, postmenopausal hypertension, and the potential role of the molecule L-AABA as a biomarker for hypertension. By employing metabolomic analysis and various statistical methods, the study seeks to understand how estrogen deficiency affects blood pressure and identify key metabolites involved in this process, with a particular focus on L-AABA.

      Strengths:

      The study addresses a relevant and understudied area: the role of estrogen and metabolites in postmenopausal hypertension. It presents a novel hypothesis that L-AABA may serve as a protective factor against hypertension, which could have significant clinical implications if proven.

      We appreciate the acknowledgment of our study’s focus on an important and understudied area. Our hypothesis regarding L-AABA’s role as a possible protective factor against hypertension indeed holds promise for advancing clinical implications.

      Weaknesses:

      The evidence linking L-AABA to hypertension is largely correlative, lacking experimental validation or mechanistic proof. Key limitations, such as the inadequacy of the ovariectomy model in replicating human menopause, are acknowledged but not addressed with alternative approaches. In summary, while the study offers an intriguing hypothesis, its conclusions are premature and require further experimental validation and human data to substantiate the claims.

      We recognize the limitations regarding the correlative nature of our findings and the inadequacy of the OVX model in replicating human menopause. Future research will prioritize experimental validation and incorporate human studies to solidify our conclusions.

      Reviewer #2 (Public review):

      Summary:

      In this manuscript, Dr. Yao Li et al. documented the metabolomic profile of the aorta from OVX rats and that from OVX plus E2. These conditions mimic post-menopause hypertension and hormonal replacement therapy.

      Strengths:

      The authors state that this is probably the first study to examine the metabolic changes in the aorta of post-menopause hypertension.

      As pointed out by the reviewer, our study may be the first to investigate changes in aortic metabolism in postmenopausal hypertension. As an exploratory study, our goal is to depict the overall characteristics and explore possible research directions.

      Weaknesses:

      There are several weaknesses, and a few of them are quite serious.

      (1) The aorta is not a resistant artery and has little to do with hypertension. The authors should have used resistant arteries for this study. The expression of several adrenergic receptors and cholinergic receptors in the aorta and resistant arteries are different. It is unknown whether the aorta metabolomic profile has any relevance to BP and whether they are similar to that of the resistant arteries. I understand the logistics issue of obtaining enough tissues from resistant arteries. At least, once some leads are discovered in the aorta, the authors should validate it in resistant arteries. This should be feasible.

      We acknowledge the limitation of using the aorta and will aim to include studies on resistant arteries to validate our metabolomic findings.

      (2) The aorta and all the arteries have three layers. It is critically important to know whether the metabolic changes occur in the intima or in the media, while the adventitia probably has little to do with vasoconstriction and hypertension. If the authors want to use the aorta to conduct the preliminary study, they should completely remove the adventitia and then use samples with and without their endothelium stripped and then assess their metabolomic profiles. After the leads are obtained from this preliminary profiling, they should be validated in endothelium and smooth muscles of the resistant artery. The current experiments are not appropriately designed.

      Future studies will involve detailed profiling of specific arterial layers, focusing on the intima and media to enhance the relevance of our findings related to hypertension.

      (3) The tail-cuff BP measurement is a technique of the last century. The current gold standard of BP measurement is by telemetry. The tail-cuff method is particularly problematic in this study because the 1-2 h restraining of the rats for more than 10 times BP measurement will cause significant stress in the animal, and their stress hormone secretion might cause biased metabolomic profiles in the OVX versus shames operated mice. The problem can be totally avoided by using telemetry.

      We appreciate the suggestion and will consider telemetry for more accurate blood pressure measurements in future experiments to minimize stress-related bias.

      (4) Although the L-AABA showed a high p-value (10^-4) of a decrease in the OVX rats, the fold change is small (2-3 folds). Such a small change should be validated using a different method to be convincing.

      We plan to employ additional methods to validate the observed changes in L-AABA levels in the following research, ensuring robustness of our findings.

      (5) The authors claim (or hypothesize) that the reduced AABA level in OVX can cause vascular remodeling. This can be easily validated by the histology of the OVX-resistant artery, and they should do that during the revision. The authors should also examine the M1 macrophage function from the OVX mice to validate their claimed link of AABA to M1.

      We intend to conduct histological analyses and examine M1 macrophage function in OVX-resistant arteries to validate our hypothesis in the following research.

      (6) As mentioned above, the authors need to pinpoint the changes of AABA to target cells, i.e., endothelial cells, SMC, or M1, and then use in vitro or in vivo cell biology approaches to assess whether these cells in the OVX rat indeed have an abnormality in function and, indeed, such functional changes are responsible for the BP phenotype.

      Addressing these points, we aim to pinpoint specific cell types affected by AABA variations and conduct in vitro and in vivo studies to examine their physiological impacts in the following research.

      (7) The results of the current study can be condensed into 1 or 2 figures that can serve as a base or a starting point for a deeper scientific study.

      Thank you for your suggestion. As a omics research, our research approach may differ from traditional mechanism studies.

      Summary

      The experimental design of this manuscript is inappropriate, and the methods are not up to the current standards. The whole study is descriptive and rudimentary. It lacks validation and mechanism. The data from this manuscript might be of some value and can serve as the first step for more investigation of the mechanism of post-menopause hypertension.

      Reviewer #3 (Public review):

      Summary:

      The decrease in estrogen levels is strongly associated with postmenopausal hypertension. Dr. Yao Li and colleagues aimed to investigate the metabolomic mechanisms of underlying postmenopausal hypertension using OVX and OVX+E2 rat models. They successfully established a correlation between reduced estrogen levels and the development of hypertension in rats. They identified L-alpha-aminobutyric acid (AABA) as a potential marker for postmenopausal hypertension. The research explored the metabolic alterations in aortic tissues and proposed several potential mechanisms contributing to postmenopausal hypertension.

      Strengths:

      The group performed a comprehensive enrichment analysis and various statistical analyses of the metabolomics data.

      As summarized by the reviewer, our current study conducted a comprehensive analysis of metabolomics data. It is also a reliable foundation for further mechanism research.

      Weaknesses:

      (1) The manuscript is descriptive in nature, although they mentioned their primary objective is to explore the potential mechanisms linking low estrogen levels with postmenopausal hypertension. No mechanism insights have been interrogated in this study, which has been mentioned by the authors in the discussion. The connection between E2, AABA, and macrophage needs to be validated in endothelial cells, vascular smooth muscle cells, and other aortic tissue cells. Without such verification, the manuscript predominantly raises hypotheses only based on metabolomic data.

      We have proposed research hypotheses based on detailed omics data. Further research on the mechanisms involving endothelial and vascular smooth muscle cells to validate the pathway connections between E2, AABA, and macrophages is undoubtedly the future direction of this study.

      (2) The serum contains three forms of estrogen: Estradiol, Estrone, and Estriol. The authors used the Rat E2 ELISA kit. Ideally, all three forms of estrogen should be measured.

      Future assays will aim to measure Estradiol, Estrone, and Estriol to capture a more comprehensive picture of estrogen’s role in postmenopausal hypertension.

    1. Author response:

      The following is the authors’ response to the original reviews.

      eLife Assessment

      This useful study reports on the discovery of an antimicrobial agent that kills Neisseria gonorrhoeae. Sensitivity is attributed to a combination of DedA assisted uptake of oxydifficidin into the cytoplasm and the presence of a oxydifficidin-sensitive RplL ribosomal protein. Due to the narrow scope, the broader antibacterial spectrum remains unclear and therefore the evidence supporting the conclusions is incomplete with key methods and data lacking. This work will be of interest to microbiologists and synthetic biologists.

      General comment about narrow scope: The broader antibacterial spectrum of oxydifficidin has been reported previously (S B Zimmerman et al., 1987). The main focus of this study is on its previously unreported potent anti-gonococcal activity and mode of action. While it is true that broad-spectrum antibiotics have historically played a role in effectively controlling a wide range of infections, we and others believe that narrow-spectrum antibiotics have an overlooked importance in addressing bacterial infections. Their advantage lies in their ability to target specific pathogens without markedly disrupting the human microbiota.

      Public Reviews:

      Reviewer #1 (Public Review):

      Summary:

      Kan et al. report the serendipitous discovery of a Bacillus amyloliquefaciens strain that kills N. gonorrhoeae. They use TnSeq to identify that the anti-gonococcal agent is oxydifficidin and show that it acts at the ribosome and that one of the dedA gene products in N. gonorrhoeae MS11 is important for moving the oxydifficidin across the membrane.

      Strengths:

      This is an impressive amount of work, moving from a serendipitous observation through TnSeq to characterize the mechanism by which Oxydifficidin works.

      Weaknesses:

      (1) There are important gaps in the manuscript's methods.

      The requested additions to the method describing bacterial sequencing and anti-gonococcal activity screening will be made. However, we do not think the absence of these generic methods reduces the significance of our findings.

      (2) The work should evaluate antibiotics relevant to N. gonorrhoeae.

      (1) It is not clear to us why reevaluating the activity of well characterized antibiotics against known gonorrhoeae clinical strains would add value to this manuscript. The activity of clinically relevant antibiotics against antibiotic-resistant N. gonorrhoeae clinical isolates is well described in the literature. Our use of antibiotics in this study was intended to aid in the identification of oxydifficidin’s mode of action. This is true for both Tables 1 and 2.

      (2) If the reviewer insists, we would be happy to include MIC data for the following clinically relevant antibiotics: ceftriaxone (cephalosporin/beta-lactam), gentamicin (aminoglycoside), azithromycin (macrolide), and ciprofloxacin (fluoroquinolone).

      (3) The genetic diversity of dedA and rplL in N. gonorrhoeae is not clear, neither is it clear whether oxydifficidin is active against more relevant strains and species than tested so far.

      (1) We thank the reviewer for this suggestion. We aligned the DedA sequence from strain MS11 with DedA proteins from 220 N. gonorrhoeae strains that have high-quality assemblies in NCBI. The result showed that there are no amino acid changes in this protein. Using the same method, we observed several single amino acid changes in RplL. This included changes at A64, G25 and S82 in 4 strains with one change per strain. These sites differ from R76 and K84, where we identified changes that provide resistance to oxydifficidin. Notably, in a similar search of representative Escherichia, Chlamydia, Vibrio, and Pseudomonas NCBI deposited genomes, we did not identify changes in RplL at position R76 or K84.

      (2) While the usefulness of screening more clinically relevant antibiotics against clinical isolates as suggested in comment 2 was not clear to us, we agree that screening these strains for oxydifficidin activity would be beneficial. We have ordered Neisseria gonorrhoeae strain AR1280, AR1281 (CDC), and Neisseria meningitidis ATCC 13090. They will be tested when they arrive.

      Reviewer #2 (Public Review):

      Summary:

      Kan et al. present the discovery of oxydifficidin as a potential antimicrobial against N. gonorrhoeae, including multi-drug resistant strains. The authors show the role of DedA flippase-assisted uptake and the specificity of RplL in the mechanism of action for oxydifficidin. This novel mode of action could potentially offer a new therapeutic avenue, providing a critical addition to the limited arsenal of antibiotics effective against gonorrhea.

      Strengths:

      This study underscores the potential of revisiting natural products for antibiotic discovery of modern-day-concerning pathogens and highlights a new target mechanism that could inform future drug development. Indeed there is a recent growing body of research utilizing AI and predictive computational informatics to revisit potential antimicrobial agents and metabolites from cultured bacterial species. The discovery of oxydifficidin interaction with RplL and its DedA-assisted uptake mechanism opens new research directions in understanding and combating antibiotic-resistant N. gonorrhoeae. Methodologically, the study is rigorous employing various experimental techniques such as genome sequencing, bioassay-guided fractionation, LCMS, NMR, and Tn-mutagenesis.

      Weaknesses:

      The scope is somewhat narrow, focusing primarily on N. gonorrhoeae. This limits the generalizability of the findings and leaves questions about its broader antibacterial spectrum. Moreover, while the study demonstrates the in vitro effectiveness of oxydifficidin, there is a lack of in vivo validation (i.e., animal models) for assessing pre-clinical potential of oxydifficidin. Potential SNPs within dedA or RplL raise concerns about how quickly resistance could emerge in clinical settings.

      (1) Spectrum/narrow scope: The broader antibacterial spectrum of oxydifficidin has been reported previously (S B Zimmerman et al., 1987). The focus of this study is on its previously unreported potent anti-gonococcal activity and its mode of action. While it is true that broad-spectrum antibiotics have historically played a role in effectively controlling a wide range of infections, we and others believe that narrow-spectrum antibiotics have an overlooked importance in addressing bacterial infections. Their advantage lies in their ability to target specific pathogens without markedly disrupting the human microbiota.

      (2) Animal models: We acknowledge the reviewer’s insight regarding the importance of in vivo validation to enhance oxydifficidin’s pre-clinical potential. However, due to the labor-intensive process needed to isolate oxydifficidin, obtaining a sufficient quantity for animal studies is beyond the scope of this study. Our future work will focus on optimizing the yield of oxydifficidin and developing a topical mouse model for subsequent investigations.

      (3) Potential SNPs: Please see our response to Reviewer #1’s comment 3. We acknowledge that potential SNPs within dedA and rplL raise concerns regarding clinical resistance, which is a common issue for protein-targeting antibiotics. Yet, as pointed out in the manuscript, obtaining mutants in the lab was a very low yield endeavor.

      Reviewer #3 (Public Review):

      Summary:

      The authors have shown that oxydifficidin is a potent inhibitor of Neisseria gonorrhoeae. They were able to identify the target of action to rplL and showed that resistance could occur via mutation in the DedA flippase and RplL.

      Strengths:

      This was a very thorough and clearly argued set of experiments that supported their conclusions.

      Weaknesses:

      There was no obvious weakness in the experimental design. Although it is promising that the DedA mutations resulted in attenuation of fitness, it remains an open question whether secondary rounds of mutation could overcome this selective disadvantage which was untried in this study.

      We thank the reviewer for the positive comment. We agree that investigating factors that could compensate for the fitness attenuation caused by DedA mutation would enhance our understanding of the role of DedA.

      Recommendations for the authors:

      Reviewer #1 (Recommendations For The Authors):

      (1) The use of the term "N. gonorrhoeae wildtype" should not be used. It is uninformative, as the species contains a large amount of diversity. Instead, please name the strain. From Figure 1, it looks like the authors used MS11. Since MS11 is a longstanding lab strain and likely does not reflect circulating N. gonorrhoeae, and since H041 is no longer in circulation, the authors should ideally test the compound against more representative strains of N. gonorrhoeae. This includes panels of isolates available through the CDC, for example (https://www.cdc.gov/drugresistance/resistance-bank/index.html). I encourage the authors to include FC428 or another recently identified isolate with the penA 60 allele to demonstrate oxydifficidin's activity against contemporary concerning isolates/lineages.

      (1) “N. gonorrhoeae MS11” is now used instead of “N. gonorrhoeae WT” in this manuscript.

      (2) In our revised manuscript, we have added MIC data for recently identified Neisseria gonorrhoeae isolates AR#1280 and AR#1281 which contain the penA 60 allele (Table 1). The data shows oxydifficidin maintains its potent activity against these multidrug-resistant strains. We also added a description of this data to the results section as shown below.

      Original text: “Oxydifficidin was more potent against N. gonorrhoeae MS11 than almost all other antibiotics we tested. In fact, it was only slightly less active than the highly optimized third-generation cephalosporin, ceftazidime.([18]) However, unlike third-generation cephalosporins, oxydifficidin retained activity against the multidrug resistant H041 clinical isolate (Table 1).([4]) H041 is resistant to the “standard of care” cephalosporin ceftriaxone (2 µg/mL) as well as a number of other antibiotics that are normally active against N. gonorrhoeae (penicillin G, 4 µg/mL; cefixime, 8 µg/mL; levofloxacin, 32 µg/mL).”

      Changed to: “Oxydifficidin was more potent against N. gonorrhoeae MS11 than most other antibiotics we tested. Notably, unlike clinically used antibiotics such as ceftriaxone, azithromycin, and ciprofloxacin, oxydifficidin retained activity against all multidrug-resistant clinical isolates we examined (Table 1).” (Line 77-79)

      (2) Does oxydifficidin have activity against N. meningitidis? It is the species most closely related to N. gonorrhoeae and the other pathogenic Neisseria.

      Oxydifficidin has potent activity against N. meningitidis ATCC 13090. In our revised manuscript, we have included its MIC data in Figure 1c.

      (3) Given claims that oxydifficidin activity in N. gonorrhoeae as compared to other Neisseria reflects N. gonorrhoeae's dedA and sensitive rplL, it would be good to assess the allelic diversity of these genes in N. gonorrhoeae. There are over 20,000 genomes from clinical isolates of N. gonorrhoeae in databases. It should be straightforward to check whether dedA and rplL allelic variants already exist in the population. Should variants be observed, oxydifficidin should be tested against the associated strains of N. gonorrhoeae.

      Response: We thank the reviewer for this suggestion. We aligned the DedA sequence from strain MS11 with DedA proteins from 220 N. gonorrhoeae strains that have high-quality assemblies in NCBI. The result showed that there are no amino acid changes in this protein. Using the same method, we observed several single amino acid changes in RplL. This included changes at A64, G25 and S82 in 4 strains with one change per strain. These sites differ from R76 and K84, where we identified changes that provide resistance to oxydifficidin. Notably, in a similar search of representative Escherichia, Chlamydia, Vibrio, and Pseudomonas NCBI deposited genomes, we did not identify changes in RplL at position R76 or K84.

      New text: “A survey of 220 N. gonorrhoeae strains with high-quality assemblies in NCBI found no mutations in the DedA protein.” (Line 104-105)

      “These two mutations were not found in the survey of the same collection of N. gonorrhoeae strains used to look for DedA mutations.” (Line 143-144)

      (4) Clinically relevant antibiotics for N. gonorrhoeae are penicillin, tetracycline, spectinomycin, gentamicin, ciprofloxacin, azithromycin, ceftriaxone; moreover, zoliflodacin and gepotidacin have reportedly successfully completed phase 3 trials. The authors should redo their MIC testing with these antibiotics (e.g., for Figures 1 and 2 and Tables 1 and 2), both because this will enable direct comparison with the many clinical isolates that have undergone testing and because these are the drugs most pertinent to clinical practice. Ampicillin, ceftazidime, chloramphenicol, bacitracin, and daptomycin are not relevant. Could the authors explain why they tested vancomycin, polymyxin B, irgasan, melittin, avilamycin, and thiostrepton?

      Our use of antibiotics with diverse modes of action (e.g. vancomycin, polymyxin B, irgasan, melittin, avilamycin, and thiostrepton) in this study was intended to aid in the identification of oxydifficidin’s mode of action. This is true for both Tables 1 and 2.

      To address the reviewer’s concern, in our revised manuscript, we have added MIC data for the following clinically relevant antibiotics: ceftriaxone (cephalosporin/beta-lactam), gentamicin (aminoglycoside), azithromycin (macrolide), and ciprofloxacin (fluoroquinolone) to Table 1.

      (5) Please describe the characteristics of the transposon library (finding four transposons in a single strain does seem unexpected, given how most transposon libraries aim for one transposon insertion per strain).

      We understand that one transposon insertion per strain is ideal for transposon libraries. This Bacillus strain proved to be recalcitrant to genetic manipulation. In the rare cases where we obtained resistance colonies upon electroporation with the transposon, all colonies contained multiple (≥ 4) transposon insertions. This made it impractical to build a library with one transposon insertion per library member.

      We assumed that the anti-N. gonorrhoeae activity most likely originated from a natural product BGC, which typically range from 10-100 kb in size.

      Based on the average of 50 kb per BGC, ~80 transposon insertions would be required to fully search the 4.2 Mb genome of Bacillus amyloliquefaciens BK for a BGC. At 4 mutations per transformant, 1x coverage of the genome would require only 20 library members.

      After extensive electroporation of transposon into Bacillus amyloliquefaciens BK, we were able to obtain a library of 50 members, including one mutant (Tn5-3) that lacked anti-N. gonorrhoeae activity.

      New text added to the methods section:

      “A library containing 50 transposon mutants was obtained. In the mutants examined, each strain contained ≥4 transposon insertions” (Line 337-339)

      (6) Please describe in the methods how you sequenced and annotated the genome of Bacillus amyloliquefaciens BK.

      The sequencing method is now described in “Genomic Sequencing and annotation of Bacillus amyloliquefaciens” section. The genome of Bacillus amyloliquefaciens BK was not fully annotated. Mutations were identified as described in the updated methods section below.

      New text:

      “Genomic Sequencing and annotation of Bacillus amyloliquefaciens

      Genomic DNA from Bacillus amyloliquefaciens BK WT and transposon mutant Tn5-3 was isolated using PureLink Microbiome DNA purification kit (Invitrogen) according to the manufacturer’s instructions.

      The Bacillus amyloliquefaciens BK WT genome was assembled by mapping its sequencing data onto the annotated genome of Bacillus amyloliquefaciens FZB42 using Geneious Prime. Differences in the mutant strain Tn5-3 were identified by mapping its sequencing data onto the assembled Bacillus amyloliquefaciens BK WT genome. The mutated genes were then annotated using NCBI BLAST. The oxydifficidin BGC was annotated using the antiSMASH online server.” (Line 253-260)

      (7) Please describe in the methods how you screened the library for strains that lacked anti-gonococcal activity.

      The method is added to our revised manuscript as section “Screening of Bacillus Strains Lacking Anti-N. gonorrhoeae Activity”.

      New text:

      “Screening of Bacillus Strains Lacking Anti-N. gonorrhoeae Activity

      The transposon mutants of Bacillus amyloliquefaciens BK were grown overnight in LB medium at 30 °C. Each overnight culture was then diluted 1:5000, and 1 μl of the diluted culture was spotted onto a GCB agar plate swabbed with N. gonorrhoeae cells. The plate was then incubated overnight at 37 °C with 5% CO2. The mutant strain (Tn5-3) lacking anti-N. gonorrhoeae activity was identified due to its failure to produce a zone of growth inhibition in the resulting N. gonorrhoeae lawn.” (Line 341-346)

      (8) Was only one strain found that was a 'non-producer' of anti-N. gonorrhoeae activity? Line 68 suggests that this was only one of multiple non-producers. Is that correct? If so, did you work up the others, and did they also have disruptions in the same biosynthetic gene cluster?

      Only one strain was identified as a “non-producer” of anti-N. gonorrhoeae activity. We have modified the text to clarify this point.

      Original text: “The sequencing of one non-producer strain revealed that it surprisingly contained four transposon insertions and one frame shift mutation.”

      Changed to: “The sequencing of the non-producer strain revealed that it surprisingly contained four transposon insertions and one frame shift mutation.” (Line 53-54 )

      (9) All sequences (including Bacillus amyloliquefaciens BK) must be deposited in a public database (e.g., NCBI) and the accession numbers reported in the manuscript.

      Genomic sequence data of Bacillus amyloliquefaciens BK has been deposited in GenBank, and its accession number (GCA_019093835.1) now appears in figure legend of Figure S1a.

      Figure S1a legend:

      “Genome-based phylogenetic tree containing Bacillus amyloliquefaciens BK and closely related Bacillus spp. The tree was built by Genome Clustering of MicroScope using neighbor-joining method. The NCBI accession numbers of Bacillus strains used in the tree are GCA_000196735.1, GCA_000204275.1, GCA_000015785.2, GCA_019093835.1, GCA_000009045.1, GCA_000011645.1, GCA_000172815.1, GCA_000008005.1, and GCA_000007845.1 (from top to bottom).”

      Minor

      (10) Statements in the article would benefit from fact-checking. For example:

      - gonorrhea is not the second most prevalent sexually transmitted infection worldwide; it is the second most reported bacterial sexually transmitted infection.

      - Treatment is ceftriaxone 500mg IM x1 in the US, but 1g IM x1 in the UK and Europe. The UK guidelines also permit ciprofloxacin, should sequencing indicate gyrA 91S. I suggest reviewing / specifying which treatment guidelines you're referring to.

      We appreciate the reviewer’s corrections. The word “prevalent” is now changed to “reported”.

      Original text: “Gonorrhea, which is caused by Neisseria gonorrhoeae, is the second most prevalent sexually transmitted infection worldwide.”

      Changed to: “Gonorrhea, which is caused by Neisseria gonorrhoeae, is the second most reported sexually transmitted infection worldwide.” (Line 2-3)

      Original text: “Gonorrhea is the second most prevalent sexually transmitted infection worldwide, its causative agent is the bacterium Neisseria gonorrhoeae.”

      Changed to: “Gonorrhea is the second most reported sexually transmitted infection worldwide, its causative agent is the bacterium Neisseria gonorrhoeae.” (Line 18-19)

      “In the USA” is now added to the sentence stating gonorrhea treatment.

      Original text: “The high dose (500 mg) of the cephalosporin ceftriaxone is currently the only recommended therapy for treating gonorrhea infections.”

      Changed to: “The high dose (500 mg) of the cephalosporin ceftriaxone is currently the only recommended therapy for treating gonorrhea infections in the USA.” (Line 20-22)

      (11) Please make sure all results are in the results section. The report of cell morphology, for example, should be in the results, not the discussion.

      In our revised manuscript, we have included the cell morphology data in the results section with the text changes below.

      Original text: “Interestingly, not only was dedA deficient N. gonorrhoeae less susceptible to oxydifficidin, oxydifficidin also kills this mutant more slowly (Figure 2b) than WT N. gonorrhoeae MS11.”

      Changed to: “Interestingly, not only was dedA deficient N. gonorrhoeae less susceptible to oxydifficidin, oxydifficidin also kills this mutant more slowly (Figure 2b) than WT N. gonorrhoeae MS11. The dedA deletion mutant also showed an altered cell morphology with reduced membrane integrity and lower formation of micro-colonies (Figure S4). (Line 100-104)

      Original text: “The dedA deletion mutant also showed an altered cell morphology with reduced membrane integrity and lower formation of micro-colonies (Figure S4), indicating that it should show reduced pathogenesis and fitness, and, as a result, not accumulate in a clinical setting, which adds to the therapeutic appeal of oxydifficidin.”

      Changed to: “The dedA deletion mutant exhibited altered cell morphology, characterized by diminished membrane integrity and reduced micro-colony formation, indicating that it should show reduced pathogenesis and fitness, and, as a result, not accumulate in a clinical setting, which adds to the therapeutic appeal of oxydifficidin” (Line 206-210)

      (12) Tables 1 and 2 should be combined and should address the most relevant antibiotics

      The MIC data of additional relevant antibiotics are now included in Table 1. However, we still believe that keeping Tables 1 and 2 separate enhances the clarity of the manuscript. Table 2 specifically focuses on diverse ribosomal targeting antibiotics, which highlights the unique binding site of oxydifficidin.

      (13) Supplemental Figure 1a. The tree could be better resolved, and there are four entries with the identical listing of "Bacillus amyloliquefaciens subsp. plantarum" on different branches. In the methods or the legend, please indicate the accession numbers for these genomes. Also please specify how this tree was made-is it a maximum likelihood tree? Something else?

      The tree is now better resolved and includes new entries. The requested information regarding accession numbers and tree construction method has been included in the figure legend.

      New supplemental Figure 1a legend:

      “a. Genome-based phylogenetic tree containing Bacillus amyloliquefaciens BK and closely related Bacillus spp. The tree was built by Genome Clustering of MicroScope using neighbor-joining method. The NCBI accession numbers of Bacillus strains used in the tree are GCA_000196735.1, GCA_000204275.1, GCA_000015785.2, GCA_019093835.1, GCA_000009045.1, GCA_000011645.1, GCA_000172815.1, GCA_000008005.1, and GCA_000007845.1 (from top to bottom).”

      Reviewer #2 (Recommendations For The Authors):

      The conclusions drawn in the manuscript are well-supported by the experimental data presented.

      I have the below minor comments:

      (1) "serendipitously identified" - I feel this wording should be avoided throughout the manuscript. The point of a research paper is to communicate methodology and experimental detail, and this language portrays the opposite.

      While we agree that methodology and experimental procedures are paramount in scientific reporting, we believe it is equally important to convey, particularly to younger generations, that a part of the scientific process is often unplanned and can benefit from chance observations. Therefore, we would like to keep this wording.

      (2) The introduction should include the biological roles/function of DedA proteins in bacteria.

      DedA proteins perform a wide array of biological roles and functions in bacteria. In the results section (Line 107-116), we have described the most well-established of these functions, particularly the flippase activity, which appears to be directly related to oxydifficidin sensitivity. We believe that introducing this information in the results section enhances the manuscript’s clarity and flow.

      (3) "When we screened this contaminant for antibacterial activity against lawns of other Gram-negative bacteria it did not produce a zone of growth of inhibition against any of the bacteria we tested (e.g., Escherichia coli, Vibrio cholerae, Caulobacter crescentus)." Can these data Figures be included in the Supplements?

      This result was recorded in the lead author’s notebook, but no image was saved.

      (4) Line 52: Was any base analyses performed on the Tn-mutants i.e., how many insertion-sites? Depth of mutants? Was a library constructed in this study or previously? Why were only BGC assessed?

      Please see our response to Reviewer #1’s comment (5). We focused on BGCs because we believed the anti-N. gonorrhoeae activity most likely resulted from a molecule encoded by a natural product BGC.

      (5) Line 98: Do the other 2 predicted DedA-like proteins also have a role in uptake of oxydifficidin? Is there some redundancy in uptake?

      We generated knockout mutants for two other predicted DedA-like proteins in N. gonorrhoeae MS11, and the MIC of oxydifficidin for these mutants remained the same as for the N. gonorrhoeae MS11 wild type strain. Therefore, we believe that the DedA protein discussed in this manuscript is the primary transporter of oxydifficidin. However, we cannot completely rule out the possibility of redundancy in oxydifficidin uptake by other DedA-like proteins.

      New text: “We also generated deletion mutants for two other predicted dedA-like genes, and the MIC of oxydifficidin for these mutants remained the same as for the N. gonorrhoeae MS11 wild type strain.” (Line 98-100)

      Reviewer #3 (Recommendations For The Authors):

      This is a well presented manuscript and I could not immediately see any issues with it.

      We appreciate the reviewer’s positive feedback.

    1. Author response:

      We are submitting a revised manuscript with major additions that address the main concerns in the initial reviews. At the highest level, this revision provides i) orthogonal biochemical measurements that yield concrete evidence of lysosomal protein aggregates, and ii) a plausible mechanism linking lysosomal lipid handling and protein aggregation through disruption of ESCRT function. We believe these additions significantly improve the completeness of this study and the conclusions that can be drawn from the data.

      Below are more specific highlights on the addition in this revision:

      -       We included orthogonal techniques (thioflavin-T staining and Lyso-IP followed by differential extraction) and confirmed the accumulation of RIPA-insoluble protein aggregates at the lysosomes in cells under lipid perturbation (Figure 3).

      -       We performed TMT-Proteomics and identified accumulation of insoluble ESCRT components at the lysosomes under lipid perturbation (Figure 4). Two new authors involved in this effort are added onto the manuscript.

      -       The ESCRT result prompted us to revisit lysosomal membrane integrity. With improved imaging conditions and analysis we were able to see increased membrane permeabilization under lipid perturbation. VPS4A overexpression partially rescued this phenotype, suggesting that lipid accumulation impairs ESCRT disassembly (Figure 5).

      -       Together, the results suggest that lipid perturbation impairs ESCRT function, compromising both lysosomal membrane repair and microautophagy, resulting in the accumulation of endogenous protein aggregates at the lysosomes (Graphical Abstract).

      Reviewer #1 (Recommendations For The Authors):

      (1) Perhaps the most prominent limitation of this work is the unilateral focus on native cells (i.e. cells under no endogenous or exogenous stress) as the model for protein aggregate formation. Furthermore, although the ProteoStat stain has been utilized by many investigators before, the sole reliance on this stain as the read-out for their assays is concerning. To compound the concern, the ProteoStat-positive puncta co-localize with lysosmal markers which was surprising even to the authors. All in all, it behooves the authors to test proteostasis in multiple parallel ways to actually define what they are studying. How is it possible that protein aggregates under native conditions are only co-localized with lysosomes? Are we really studying protein aggregates which should predominantly be cytoplasmic insoluble aggregates?

      (a) They need to get away from a simple stain like ProteoStat and conduct co-stainings with other markers such as poly-ubiquitin antibodies and other chaperones to define what and where else exactly are these aggregates.

      Co-staining with poly-ubiquitin was included in the original manuscript. We added orthogonal staining with another widely used amyloid dye, Thioflavin-T, and provided fine-grained quantification of lysosomal vs cytosolic localization of various signals (Figures S4A-C & 3A-B).

      (b) They need to do Immunoblots with and without triton insolubility to see if these aggregates are insoluble as most would predict. They can do lysosomal isolation vs cytoplasmic to see if the insoluble aggregates are really lysosomal.

      We performed Lyso-IP followed by differential detergent extraction to confirm the accumulation of insoluble proteins at the lysosomes (Figure 3C). Proteomic analysis identified some of these insoluble proteins as ESCRT subunits (Figure 4).

      (c) They should compare aggregate formation in the native state versus cells with lysosomal inhibition via Bafilomycin or chloroquine versus cells with proteosomal inhibition. The lysosomal inhibition experiments are particularly informative given the lysosomal relevance they have uncovered.

      We included other small molecule inhibitors and at different time points to compare the effect of different modes of proteostasis challenge (Figure S4A-D). Together with the ESCRT finding, our results suggest the role of microautophagy in our system, and provide a model of how ProteoStat- and/or ubiquitin- positive substrates become partitioned between the cytoplasm and lysosomes under different perturbations.

      (d) Many protein aggregates which are too bulky for proteosome degradation will traditionally be dealt with by aggrephagy. Why is this not observed?

      Knockdown of core macroautophagy components did not impact Proteostat intensity in our CRISPRi screen, suggesting that basal macroautophagy plays a negligible role in clearing endogenous amyloid-like structures in our experimental system. We provide an alternative model that these aggregates instead arrive at the lysosomes via microautophagy.

      (2) After addressing #1, they can validate if the genes they identified by CRISPR screens are also important in modulation of protein aggregate burden in other systems. For example, if they inhibit lysosomes by Bafilo or Chloroquine to obtain protein aggregates and then Knockdown the identified genes in the CRISPR screens, will they get the same results?

      We addressed the effect of different modes of proteostasis challenge as recommended above. Deacidifying the lysosomes alone causes intense protein aggregation (Figure S4A-D) and eventually cell death, and was thus not combined with other perturbations.

      (3) They identify lysosomal lipid metabolism genes/pathways as the culprit for inducing proteostasis. In particular sphingolipid and cholesteryl ester species appear to be operational here. However, there are no specific lipids species or specific lipid metabolism gene that is causative. Rather, you have to knockdown entire processes to have an effect. This suggests that the focus on lysosome health (i.e. permeability, proteolysis, etc) is rudimentary. When you have to knockdown entire classes of lipids, this would indicate more broad effects on cellular lipids (including membrane lipids beyond the lysosome) and related cellular health?

      We included data on the effect of knocking down MYLIP, PSAP, and as a comparison PSMD2 on the growth rate of K562 cells (Figure S5A). MYLIP and PSAP KDs, which cause predominantly an accumulation of lipids, do not impede cell growth. Increasing lipid uptake by MYLIP KD increases cell proliferation under our culture conditions, suggesting a general negative impact on cell health was not required for the association between lipid levels and protein aggregates.

      (a) They conduct a superficial methyl-beta-cyclodextrin experiment with equivocal results. The use of MBCD for different time-courses to deplete various membrane cholesterol pools including the plasma membrane pool is important to ascertain what aspect of the cellular cholesterol is affecting proteostasis. MBCD +/- cholesterol reintroduction time-courses for rescue will also be key to determine the culprit cellular cholesterol pool.

      The MBCD / Filipin experiment helped us determine that ProteoStat doesn’t directly stain cholesterol, nor any major plasma membrane components. Free cholesterol was implicated in neither the screen nor the lipidomics and was not the subject of targeted experiments.

      (b) The same concept can be applied to sphingolipids. There are sphingolipids in abundance in multiple membrane compartments. Which ones are causal here? More nuanced evaluation of this with sphingolipid staining/tracking can be conducted.

      We attempted experiments where sphingolipids were added back to cells grown in FBS-depleted media. Nevertheless, we were not able to consistently deliver these lipid species and doing so while ensuring the correct subcellular localization at physiologically relevant level would require substantial methods development.

      (c) As part of this, are lipid rafts and/or caveolae being affected by the perturbations in cholesterol and sphingolipids? Lipid rafts are highly enriched in these 2 lipids which could link to their preteostasis observation.

      Indeed, ceramides released from SM hydrolysis are proposed to self-assembled into microdomains with negative curvature that can promote the formation of intralumenal vesicles (Alonso and Goni, 2018; Niekamp et al 2022). We propose that SM accumulation may hinder this process by counteracting the negative membrane curvature and impede microautophagy.

      (d) How about ER membrane lipids? The UPR and subsequent effects on proteostasis are intricately involved with ER lipid bilayer composition.

      We did not perform lipidomics on ER membranes in this study, though we note that at steady state, sphingolipids and cholesterol esters are not expected to be enriched at the ER (Ikonen and Zhou, 2021). We checked whether lipid-related genetic perturbations induced the UPR in published perturb-seq data in K562 cells. Neither MYLIP nor PSAP knockdown induced a UPR.

      In conclusion, the manuscript is interesting but the excitement over a link between lysosome-related lipid metabolism and proteostasis needs to be tamped until a more robust experimental approach is employed to generate supportive and corroborating results.

      Reviewer #2 (Recommendations For The Authors):

      - The paper has a number of grammatically awkward sentences. Editing these would enhance clarity.

      - It is important to show the co-localization of aggregates with the lysosome. This is shown in supplements but should be in a main figure. Here the authors cite previous work indicating that ProteoStat puncta co-localize with ubiquitinated proteins and state that they do not see this, then essentially just move on. Is there an explanation for this discrepancy and can it be resolved? What do they think is really going on? What happens to levels of ubiquitinated proteins when lipid metabolism is perturbed as in these experiments?

      We have included the lipid-induced lysosomal protein aggregation data in the main text (Figure 3A-B), and provided fine-grained quantification of the cytosolic-vs-lysosomal ProteoStat / Ub / ThT signals under different aggregate-inducing conditions (Figure S4A-D). We discuss these results in the main text and propose a model involving ESCRT-mediated microautophagy in the main text. This is supported further by the LysoIP-proteomics and LMP analysis.

      - Please add an indicator of amino acid numbers to Fig. 3C.

      These annotations are now included (now Figure S3C).

      - The legend for 3D is mislabelled.

      We have corrected the legend (now Figure S3D).

      Reviewer #3 (Recommendations For The Authors):

      Protein homeostasis and lipid homeostasis are both are important for maintaining cellular functions. However, the crosstalk remains largely unknown. The manuscript entitled as "Impairment of lipid homoeostasis causes accumulation of protein aggregates in the lysosome" deals with this interesting topic. An important link between lysosomal protein aggregation and sphingolipids/cholesterol esters metabolism were discovered. The topic belonging to the Cell Biology domain also falls into the aims and scope of eLife. Here are the revisions I recommend:

      (1) From lipidomics analysis, a remarkable correlation between levels of sphingomyelin and cholesterol ester and ProteoStat staining was found. Could the authors explain how sphingomyelin and cholesterol ester are quantified? The two lipids are not included as internal standards from the lipidomics experiment.

      Sphingomyelin and cholesterol ester internal standards are included in the Avanti 330707 SPLASH® LIPIDOMIX® Mass Spec Standard, which was supplied at 3% v/v to the MeOH/H2O cell lysis buffer. We have amended the Methods section to clarify this.

      (2) Could the authors perhaps delete Figure 1B and show it on Figure 2A only? There is no need to show the same figure two times. The threshold of both False Discovery Rate and Median Enrichment needs to be added. From Figure 2A, the Lysosomal hydrolases (GBA, LIPA, GALC) seems located in statistically insignificant region. Based on previous studies, the GBA could have an effect on sphingolipid levels, then how to explain that sphingomyelin was highly correlated with ProteoSate staining?

      We have combined the two volcano plots into a single figure (now Figure 1D), and added a line to help visualize the gene effects while considering the combined contribution of FDR and enrichment. Individual lysosomal hydrolases indeed have insignificant effects on ProteoStat and this is discussed in the main text as having relatively constrained impacts on the general lipidome. For example, while GBA and GALC KDs can lead to accumulation of their immediate substrates (glucosylceramide and galactosylceramide, respectively), they do not directly impinge on sphingomyelin.

      (3) The authors show the corelation between ProteoState staining and different lipids/lipid classes in Figure 3B and Figure S3A. It is not necessary to show the corelation with individual lipids (such as sphingomyelin(d18:1/24:0) and cholesterol ester(18:2). The corelation with full collection of lipid classes would be more representative, which is only list in Figure 3B and Figure S3A. It is suggested to add the information of how many individual lipids in each chass are used for the correlation analysis. Replace Figure 3A to Figure S3A, and put Figure 3A as supplementary figure are suggested.

      We decided to retain the correlation of two individual lipids (a sphingomyelin and a cholesterol ester species) with ProteoStat as examples to illustrate with clarity how we obtained the class-wide comparison. The number of individual lipids included in each class for correlation analysis is now included in Figures 2F and S3A.

      (4) The authors state that lipid uptake and metabolism modulate proteostasis. However, only cholesterol and LDL were tested. It would be more precise to state as cholesterol uptake and metabolism modulate proteostasis. In addition, sphingolipids and cholesterol esters accumulate with increased lysosomal protein aggregation. It would be interesting to see the effects of sphingolipids uptake, since sphingolipids are correlated with proteostasis better than cholesterol.

      We attempted to add back specific sphingolipids to assess sufficiency. However, we found it challenging to ensure that these lipids were distributed to the correct subcellular locations at physiologically relevant levels. Without this crucial information, it was difficult to draw any conclusions about the sufficiency of the sphingolipids we tested to impair proteostasis.

      Alonso A, Goñi FM. 2018. The Physical Properties of Ceramides in Membranes. Annu Rev Biophys 47:633–654. doi:10.1146/annurev-biophys-070317-033309

      Ikonen E, Zhou X. 2021. Cholesterol transport between cellular membranes: A balancing act between interconnected lipid fluxes. Dev Cell 56:1430–1436. doi:10.1016/j.devcel.2021.04.025

      Niekamp P, Scharte F, Sokoya T, Vittadello L, Kim Y, Deng Y, Südhoff E, Hilderink A, Imlau M, Clarke CJ, Hensel M, Burd CG, Holthuis JCM. 2022. Ca2+-activated sphingomyelin scrambling and turnover mediate ESCRT-independent lysosomal repair. Nat Commun 13:1875. doi:10.1038/s41467-022-29481-4

    1. Author response:

      We thank the editors and reviewers for their thorough evaluation of our manuscript. We appreciate the constructive feedback and insights provided. 

      We acknowledge that some of our conclusions would benefit from more measured statements and additional computational controls. We will revise the manuscript to better reflect the scope and limitations of our analytical approach. While we cannot add new experimental validations at this stage, we will strengthen our computational analyses and clarify our methodology.

      Below, we outline our planned revisions to address the major points raised in the public reviews:

      Clarification of Terms and Definitions:

      (1) We will make it clearer in our manuscript to emphasize that we reuse the same raw datasets from our previous study as described in Calendrilli et al, 2023, and there is no modification to the experimental methods or data. 

      (2) We will provide clear definitions for:

      - "Non-differentially expressed" genes

      - "Ctrl specific" RNA sets

      - The composition of control populations in different analyses

      (3) We will revise the use of "non-diffusive RNA-chromatin interactome" and “RNase-resistant” terminology to better reflect our actual findings.

      (4) We will also improve clarity regarding:

      - The rationale for focusing on specific genomic regions

      - The interpretation of evolutionary conservation data

      (5) We will provide additional rationale on the exclusion of short-range interactions.

      Figure Revisions:

      (1) Figure 3a: We will correct any discrepancy between text references and figure content.

      (2) Figure 4: We will standardize the color scheme between control and RNase-treated samples.

      (3) We will follow the reviewer's suggestion to move figure 1g to the supplementary file. 

      Additional Computational Analyses:

      (1) We will consider adding controls for RNA length effects and integrate any existing knowledge on the protection extent variation across different RBP.

      Discussions:

      (1) We will carefully rephrase our conclusions to more accurately reflect the scope and limitations of our computational findings, ensuring we do not overstate the implications.

      (2) We will expand the discussion of limitations, including:

      - The focus on RNase-resistant interactions only

      - The cell-type specificity of our findings

      - The lack of functional validation

      - The limited ability to discern and study the transient or weak RNA-chromatin interactions using the current dataset

      (3) Regarding the recent papers from Jenner and Davidovich groups about RNase treatment effects on chromatin solubility:

      - We will discuss these findings in our revised manuscript

      - We will address potential limitations this may impose on our interpretations

    1. Author response:

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      This work examines the binding of several phosphonate compounds to a membrane-bound pyrophosphatase using several different approaches, including crystallography, electron paramagnetic resonance spectroscopy, and functional measurements of ion pumping and pyrophosphatase activity. The work attempts to synthesize these different approaches into a model of inhibition by phosphonates in which the two subunits of the functional dimer interact differently with the phosphonate.

      Strengths:

      This study integrates a variety of approaches, including structural biology, spectroscopic measurements of protein dynamics, and functional measurements. Overall, data analysis was thoughtful, with careful analysis of the substrate binding sites (for example calculation of POLDOR omit maps).

      Weaknesses:

      Unfortunately, the protein did not crystallize with the more potent phosphonate inhibitors. Instead, structures were solved with two compounds with weak inhibitory constants >200 micromolar, which limits the molecular insight into compounds that could possibly be developed into small molecule inhibitors. Likewise, the authors choose to focus the spectroscopy experiments on these weaker binders, missing an opportunity to provide insight into the interaction between more potent binders and the protein.

      We acknowledge the reviewer concern regarding the choice of weaker inhibitors. We attempted co-crystallization with all available inhibitors, including those with higher potency. However, despite numerous efforts, these potent inhibitors yielded low-resolution crystals, making them unsuitable for detailed structural analysis. Therefore, we chose to focus on the weaker binders, as we were able to obtain high-quality crystal structures for these compounds. This allowed us to perform DEER spectroscopy with the added advantage of accurately analyzing the data against structural models derived from X-ray crystallography. Using these weaker inhibitors enabled a more precise interpretation of the DEER data, thus providing reliable insights into the conformational dynamics and inhibition mechanism. However, as suggested by the reviewer, in the revised version, we will perform DEER analysis on the more potent inhibitors to provide additional insight into their interactions.

      In general, the manuscript falls short of providing any major new insight into membrane-bound pyrophosphatases, which are a very well-studied system. Subtle changes in the structures and ensemble distance distributions suggest that the molecular conformations might change a little bit under different conditions, but this isn't a very surprising outcome. It's not clear whether these changes are functionally important, or just part of the normal experimental/protein ensemble variation.

      We respectfully disagree with the reviewer. The scale of motions seen in this study correspond to those seen in the full panoply of crystal structures of mPPases. Some proteins undergo very large conformational changes during catalysis – such as the rotary ATPase. This one doesn’t, meaning that the precise motions we describe are likely to be relevant. Conformational changes in the ensemble, whether large or small, represent essential protein motions which underlie key mPPase catalytic function. Our DEER spectroscopy data demonstrate the sensitivity and resolution necessary to monitor these subtle changes in equilibria, even if these are only a few Angstroms. For several of the conditions we investigated by DEER in solution, corresponding x-ray structures have been solved, with the derived distances agreeing well with the DEER distributions. This further validates the biological relevance of the structures, including serial time-resolved ones that indicate asymmetry.

      The ZLD-bound crystal structure doesn't predict the DEER distances, and the conformation of Na+ binding site sidechains in the ZLD structure doesn't predict whether sodium currents occur. This might suggest that the ZLD structure captures a conformation that does not recapitulate what is happening in solution/ a membrane.

      We agree with the reviewer that the ZLD-bound crystal structure does not predict the DEER distances. However, we believe this discrepancy arises from the effect of the bulkiness of ZLD inhibitor, which prevents the closure of the hydrolytic centre. Additionally, the absence of Na+ at the ion gate in the ZLD-bound structure suggests that Na+ transport does not occur, a conclusion further supported by our electrometric measurements. We agree with the reviewer, that the distances observed in the DEER experiments might represent a potential new conformation in solution, which may not be captured by the static X-ray structure, thereby offering insights into the dynamic nature of the protein under physiological conditions. Finally, the static x-ray structures have not captured the asymmetric conformations that must exist to explain half-of-the-sites reactivity.

      Reviewer #2 (Public review):

      Summary:

      Crystallographic analysis revealed the asymmetric conformation of the dimer in the inhibitor-bound state. Based on this result, which is consistent with previous time-resolved analysis, authors verified the dynamics and distance between spin introduced label by DEER spectroscopy in solution and predicted possible patterns of asymmetric dimer.

      Strengths:

      Crystal structures with inhibitor bound provide detailed coordination in the binding pocket thus useful information for the PPase field and maybe for drug development.

      Weaknesses:

      The distance information measured by DEER is advantageous for verifying the dynamics and structure of membrane protein in solution. However, regarding T211 data, which, as the authors themselves stated, lacks measurement precision, it is unclear for readers how confident one can judge the conclusion leading from these data for the cytoplasmic side.

      We thank the reviewer for acknowledging the advantageous use of the DEER methodology for identifying dynamic states of membrane proteins in solution. We used two sites in our analysis: S525 (periplasm) and T211 (cytoplasm). As we clearly stated in the original manuscript, S525R1 yielded high-quality DEER data, while T211R1 yielded weak (or no) visual oscillations, leading to broad, though different distributions for the several conditions tested. Our main conclusions are based on the S525R1 data. We included the T211R1 data because, although it does not provide definitive evidence, it is consistent with our proposed model and offers additional insights into biologically relevant conditions. Furthermore, the shifts in the centre of mass (Fig EV8D) of the broad T211R1 distributions show a trend that is consistent with our model; although not proving it, it does not exclude it either. Lastly, these data do indeed confirm an important structural feature of mPPase in solution conditions which is the intrinsically high dynamic state of the loop5-6 where T211 is located, and consistent with our previous (Kellosalo et al., Science,  2012; Li et al., Nat. Commun, 2016; Vidilaseris et al., Sci. Adv., 2019; Strauss et al., EMBO Rep., 2024) and current x-ray crystallography data.

      The distance information for the luminal site, which the authors claim is more accurate, does not indicate either the possibility or the basis for why it is the ensemble of two components and not simply a structure with a shorter distance than the crystal structure.

      We thank the reviewer for pointing out this possibility and alternative interpretation of our DEER data. In the revised version, we will show that our DEER data are consistent with (and do not exclude) asymmetry and rephrase to be inclusive of other possibilities. Importantly, this additional possibility does not affect the current interpretation of the data in our manuscript.

      Reviewer #3 (Public review):

      Summary:

      Membrane-bound pyrophosphatases (mPPases) are homodimeric proteins that hydrolyze pyrophosphate and pump H+/Na+ across membranes. They are attractive drug targets against protist pathogens. Non-hydrolysable PPi analogue bisphosphonates such as risedronate (RSD) and pamidronate (PMD) serve as primary drugs currently used. Bisphosphonates have a P-C-P bond, with its central carbon can accommodate up to two substituents, allowing a large compound variability. Here the authors solved two TmPPase structures in complex with the bisphosphonates etidronate (ETD) and zoledronate (ZLD) and monitored their conformational ensemble using DEER spectroscopy in solution. These results reveal the inhibition mechanism of these compounds, which is crucial for developing future small molecule inhibitors.

      Strengths:

      The authors show that seven different bisphosphonates can inhibit TmPPase with IC50 values in the micromolar range. Branched aliphatic and aromatic modifications showed weaker inhibition.

      High-resolution structures for TmPPase with ETD (3.2 Å) and ZLD (3.3 Å) are determined. These structures reveal the binding mode and shed light on the inhibition mechanism. The nature of modification on the bisphosphonate alters the conformation of the binding pocket.

      The conformational heterogeneity is further investigated using DEER spectroscopy under several conditions.

      Weaknesses:

      The authors observed asymmetry in the TmPPase-ELD structure above the hydrolytic center. The structural asymmetry arises due to differences in the orientation of ETD within each monomer at the active site. As a result, loop5-6 of the two monomers is oriented differently, resulting in the observed asymmetry. The authors attempt to further establish this asymmetry using DEER spectroscopy experiments. However, the (over)interpretation of these data leads to more confusion than any further understanding. DEER data suggest that the asymmetry observed in the TmPPase-ELD structure in this region might be funneled from the broad conformational space under the crystallization conditions.

      See also the response below - We respectfully disagree with the reviewer. The asymmetry was previously established using serial time crystallography (Strauss et al., EMBO Rep, 2024) and biochemical assays (e.g. Malinen et al., Prot. Sci., 2022; Artukka et al., Biochem J, 2018; Luoto et al., PNAS, 2013) and also partially seen in one static structure (Vidilaseris et al., Sci Adv 2019). DEER data only show that the previously proposed asymmetry could also be present within the conformational ensemble in solution conditions. Indeed, our data do not (and cannot) exclude this possibility.

      DEER data for position T211R1 at the enzyme entrance reveal a highly flexible conformation of loop5-6 (and do not provide any direct evidence for asymmetry, Figure EV8).

      Please see relevant response above. We acknowledge that T211 is indeed situated on a highly dynamic loop, which is important for gating and our DEER data confirm its high flexibility. Given we have not observed oscillations of this site, leading to broad distributions, we have stated in the original manuscript that we will not establish the presence of any asymmetry in solution on the basis of T211, rather relying on the S525 site, for which we have acquired high-quality DEER data, as was also pointed out and have been commented on by all reviewers.

      Similarly, data for position S521R1 near the exit channel do not directly support the proposed asymmetry for ETD.

      The reviewer appears to suggest that we hold the S525R1 DEER data as direct proof of asymmetry; this is combative on the grounds that to directly prove asymmetry would require time-resolved DEER measurements, far beyond the scope of this work. Rather, we have applied DEER measurements to explore whether asymmetry (observed previously via time-resolved X-ray crystallography) is also present (or indeed a possibility) in solution. We simply state that the DEER data are consistent with asymmetry (i.e., that the mean distance increases in the presence of ETD compared to the apo-state). This is a restrained interpretation of the data.

      Despite the high quality of the data, they reveal a very similar distance distribution. The reported changes in distances are very small (+/- 0.3 nm), which can be accommodated by a change of spin label rotamer distribution alone. Further, these spin labels are located on a flexible loop, thereby making it difficult to directly relate any distance changes to the global conformation

      We thank the reviewer for recognising the high quality of our DEER data for the S525R1, where visual oscillations in the raw traces, as in our case, reportedly lead to highly accurate and reliable distributions, able to separate (in fortuitous cases) helical movements of only a few Angstroms. The ability of DEER/PELDOR offering near Angstrom resolution was previously demonstrated by the acquisition and solution of high resolution multi-subunit spin-labelled membrane protein structures (Pliotas at al., PNAS, 2012; Pliotas et al., Nat Struct Mol Biol, 2015; Pliotas, Methods Enzymol, 2017) as well as it ability in detecting small (and of similar to mPPase magnitude) conformational changes in different integral membrane proteins systems (Kapsalis et al., Nature Comms, 2019; Kubatova et al., PNAS, 2023; Schmidt et al., JACS, 2024; Lane et al., Structure, 2024; Hett et al., JACS, 2021; Zhao et al., Nature, 2024), occurring under different conditions and/or stimuli in solution and/or lipid environment. The changes here are not very small (e.g. ~ 7 Angstroms between the two mean distance extremes (Ca vs IDP)) for DEER’s proven detection sensitivity, and with all other conditions showing changes between those extremes.

      These changes are relatively small, but they are expected for membrane ion pumps. Indeed, none of the mPPase structures show helical movements of greater than a half a turn, and that only in helices 6 and 12. There appear to be larger-scale loop closing motions of the 5-6 loop that includes T211, due to the presence of E217 which binds to one of the Mg2+ ions that coordinate the leaving group phosphate. (This is, inter alia, the reason that this loop is so flexible: it can not order before substrate is bound.) Here we have the resolution to detect such subtle differences by DEER, given there are clear shifts in our time domain data and these are reflected in the mean distances in the distributions. Therefore, our study demonstrates the sensitivity and resolution DEER offers in detecting subtle conformational transitions, key in membrane proteins pathways. To further belabour this point, we do not quantify the DEER data (for instance through parametric fitting) to extract populations of different conformational states and we appreciate that to do so would be highly prone to error; however we do (and can, we feel without overinterpretation) assert that the mean distances shift.

      The interpretations listed below are not supported by the data presented:

      (1) 'In the presence of Ca2+, the distance distribution shifts towards shorter distances, suggesting that the two monomers come closer at the periplasmic side, and consistent with the predicted distances derived from the TmPPase:Ca structure.' Problem: This is a far-stretched interpretation of a tiny change, which is not reliable for the reasons described in the paragraph above.

      While the authors overall agree with the reviewer assessment that ±0.3 nm is a small (not a minor) change, there are literature examples quantifying (or using for quantification) distribution peaks separated by similar Δr. (Kubatova et al., PNAS, 2023; Schmidt et al., JACS, 2024; Hett et al., JACS, 2021; Zhao et al., Nature, 2024). In particular, none of the mPPase structures show helical movements of greater than a half a turn (in helices 6 and 12 in particular). There appear to be larger-scale loop closing motions of the 5-6 loop that includes T211, due to the presence of E217 which binds to one of the Mg2+ ions that coordinate the leaving group phosphate. (This is, inter alia, the reason that this loop is so flexible: it can not order before substrate is bound.)

      Importantly, we have fitted Gaussians to the experimental distance distributions of 525R1 output by the Comparative Deer Analyzer 2.0 and observed a change in the distribution width in presence of Ca2+, implying the rotameric freedom of the spin label is restricted. However, the CW-EPR for 525R1 indicate that the rotational correlation time of the spin label is highly consistent between conditions (the spectra are almost identical); this cannot be explained simply by rotameric preference of the spin label (as asserted by the reviewer 3), as there is no (further) immobilisation observed from the CW-EPR of apo-state (Figure EV9) to that in presence of Ca2+. Furthermore, in the absence of conformational changes, it is reasonable to assume (and demonstrable from the CW-EPR data) that the rotamer cloud should not significantly change between conditions. However, Gaussian fits of the two extreme cases yielding the longest (i.e., in presence of IDP) and shortest (in presence of ZTD) mean distances for the 525R1 DEER data indicated significant (i.e., above the noise floor after Tikhonov validation) probability density for the IDP condition at 50 Å (P(r) = 0.18). This occurs at four standard deviations above the mean of the ZTD condition, which by random chance should occur with <0.007% probability. Indeed, one can say that to observe 18% probability density at four standard deviations above the mean by random chance would occur on the order of one in 4 x 10^6.

      As in previous response the method can detect changes of such magnitude which are not small, but physiologically relevant and expected for integral membrane proteins, such as mPPases. Indeed, even in equal (or more) complex systems such as heptameric mechanosensitive channel proteins DEER provided sub-Angstrom accuracy, when a spin labelled high resolution XRC structure was solved (Pliotas et al., PNAS, 2012; Pliotas et al., Nat Struct Mol Biol, 2015). Despite this is ideal case where DEER accuracy was experimentally validated another high resolution structural method on modified membrane protein and is not very common it demonstrates the power of the method , especially when strong oscillations are present in the raw DEER data (as here for mPPase 525R1), even when multiple distances are present, Angstrom resolution is achievable in such challenging protein classes.

      (2) 'Based on the DEER data on the IDP-bound TmPPase, we observed significant deviations between the experimental and the in silico distances derived from the TmPPase:IDP X-ray structure for both cytoplasmic- (T211R1) and periplasmic-end (S525R1) sites (Figure 4D and Figure EV8D). This deviation could be explained by the dimer adopting an asymmetric conformation under the physiological conditions used for DEER, with one monomer in a closed state and the other in an open state.'

      Problem: The authors are trying to establish asymmetry using the DEER data. Unfortunately, no significant difference is observed (between simulation and experiment) for position 525 as the authors claim (Figure 4D bottom panel). The observed difference for position 112 must be accounted for by the flexibility and the data provide no direct evidence for any asymmetry.

      Reviewer 3 is wrong in suggesting that we are trying to prove asymmetry through the DEER data. That is a well-known fact in the literature (eg Vidilaseris et al, Sci Adv 2019 where we show (1) that the exit channel inhibitor ATC (i.e., close to 525) binds better in solution to the TmPPase:PPi complex than the TmPPase:PPi2 complex, and (2) that ATC binds in an asymmetric fashion to the TmPPase:IDP2 complex with just one ATC dimer on one of the exit channels. We merely use the DEER data to support this well-established fact.

      However, we agree that the DEER data in presence of IDP does not provide direct proof for asymmetry; particularly mutant T211R1 yields in silico distributions too short for measurement by DEER. It is possible that the deviations observed (and particularly likely for T211R1) arise from conformational heterogeneity in solution. We will rephrase this paragraph accordingly: “Owing to the broad nature of the T211R1 (cytoplasmic site) distance distributions, we refrain from interpreting shifts in this data. For the 525R1 (periplasmic site) for which we obtained data of high quality (as also pointed out by both reviewers 2 and 3) we observed deviations between the experimental and the in-silico distances derived from the TmPPase:IDP X-ray structure. While this deviation is less pronounced than for the +ZTD condition, the deviation is consistent with an asymmetric conformation in solution.”

      (3) 'Our new structures, together with DEER distance measurements that monitor the conformational ensemble equilibrium of TmPPase in solution, provide further solid experimental evidence of asymmetry in gating and transitional changes upon substrate/inhibitor binding.'

      Problem: See above. The DEER data do not support any asymmetry.

      We feel that the reviewer comments here are somewhat unfounded. The DEER data (and we will limit discussion only to the 525R1 mutant in this regard) satisfy relevant criteria of the white paper (Schiemann et al., 2021, JACS) from the EPR community (signal-to-noise ratio w.r.t modulation depth of > 20 in all cases; replicates have been performed and will be added into the main-text or supplementary; near quantitative labelling efficiency (evidenced by lack of free spin label signal in the CW-EPR spectra); analysed using the CDA (now Figure EV10, this data we will promote to the main-text) to avoid confirmation bias).

      While the DEER data do not prove asymmetry, we do not claim proof of asymmetry in the above sentence. We concede to rephrase the offending sentence above as: “Our new structures, together with DEER distance measurements that monitor the conformational ensemble of TmPPase in solution, do not exclude asymmetry in gating and transitional changes upon substrate/inhibitor binding and are consistent with our proposed model.” We feel that this reframed conjecture of asymmetry is well founded; indeed, comparing the experimental apo-state 525R1 distance distribution with in-silico modelling performed on the hybridised asymmetric structure (i.e., comprised of one monomer bound to Ca2+ and another bound to IDP) yields an overlap coefficient (Islam and Roux, JPC B, 2015) of >0.97. This implies the envelope of the modelled distance distribution is quantitatively inside the envelope of the experimental distance distribution. Thus, the DEER data do not exclude asymmetry (previously observed by time-resolved XRC) in solution. While we appreciate that ideally one would measure time-resolved DEER to directly correlate kinetics of conformational changes within the ensemble to the catalytic cycle of mPPase,(and this is something we aim to do in the future), it is beyond the the scope of this study.

      Indeed, half-of-the-sites reactivity has been demonstrated in at least the following papers (Vidilaseris et al, Sci Acv. ,2019, Strauss et al, EMBO Rep. 2024, Malinen et al Prot Sci, 2022, Artukka et al Biochem J, 2018; Luoto et al, PNAS, 2013). Half-of-the sites activity requires asymmetry in the mechanism, and therefore asymmetric motions in the active site (viz 211) and exit channel (viz 525). As mentioned above, we have demonstrated this for other inhibitors (Vidilaseris et al 2019) and as part of a time-resolved experiment (Strauss et al 2024). In fact, given the wealth of evidence showing that the symmetrical crystal structures sample a non- or less-productive conformation of the protein, it would be quixotic to propose the DEER experiments - in solution - do not generate asymmetric conformations. It certainly doesn’t obey Occam’s razor of choosing the simplest possible explanation that covers the data.

      (4) Based on these observations, and the DEER data for +IDP, which is consistent with an asymmetric conformation of TmPPase being present in solution, we propose five distinct models of TmPPase (Figure 7).

      Problem: Again, the DEER data do not support any asymmetry and the authors may revisit the proposed models.

      We respectfully disagree with the reviewer. Please see our detailed response above. However, in the revised version, we will clarify that the proposed models are not solely based on the DEER data but are grounded in both current and previously solved structures, with the DEER data providing additional consistency with these models.

      (5) 'In model 2 (Figure 7), one active site is semi-closed, while the other remains open. This is supported by the distance distributions for S525R1 and T211R1 for +Ca/ETD informed by DEER, which agrees with the in silico distance predictions generated by the asymmetric TmPPase:ETD X-ray structure'

      Problem: Neither convincing nor supported by the data

      We respectfully disagree with the reviewer. However, owing to the conformational heterogeneity of T211R1, in the revised version, we will exclude it in the above sentence, to the effect: Please see our detailed response above.

    1. Author Response:

      Thank you for your interest in our paper. We would also like to thank the anonymous reviewers for their critical and constructive comments. Although the reviewers found our work interesting, they raised several important concerns about our study. To address these concerns, mostly we will perform new experiments as following.

      1. Examine whether antioxidant-NAC can block SFN-induced TFEB-nuclear translocation in NPC cells;

      2. Examine whether calcineurin inhibitor (FK506+CsA) or Ca 2+ inhibitor (Bapta-AM) can block SFN-induced TFEB-nuclear translocation in NPC cells.

      3. Investigate whether cholesterol was cleared by activation of TFEB by SFN in vivo tissues.

      4. Investigate whether SFN-evoked the lysosomal exocytosis is TFEB-dependent by using TFEB-KO cells.

      5. Examine the effect of NPC1 deficiency on dextran trafficking by studying the localization of CF- dex and Lamp1.

      6. Perform cytotoxicity experiments to examine whether SFN used in this study is cytotoxic in various cell lines

      In addition, according to the reviewers’ suggestions, we will make clarifications and corrections wherever appropriate in the manuscript. Below please find our point-by-point responses and plans to the reviewers’ comments.

      Reviewer #1 (Public review):

      Summary:

      The authors are trying to determine if SFN treatment results in dephosphorylation of TFEB, subsequent activation of autophagy-related genes, exocytosis of lysosomes, and reduction in lysosomal cholesterol levels in models of NPC disease.

      Strengths:

      (1) Clear evidence that SFN results in translocation of TFEB to the nucleus.

      (2) In vivo data demonstrating that SFN can rescue Purkinje neuron number and weight in NPC1-/- animals.

      Thank you for the support!

      Weaknesses:

      (1) Lack of molecular details regarding how SFN results in dephosphorylation of TFEB leading to activation of the aforementioned pathways. Currently, datasets represent correlations.

      Thank you for this constructive comment. The reviewer is right that in this manuscript the molecular mechanism of SFN-activated TFEB has not been discussed in details. Because previously we have shown that SFN induces TFEB nuclear translocation via a Ca 2+ - dependent but MTOR (mechanistic target of rapamycin kinase)-independent mechanism through a moderate increase in reactive oxygen species (ROS). And calcineurin-mediated TFEB dephosphorylation underlies SFN-induced TFEB activation. These data have been published in 2021 autophagy (Li, Shao et al. 2021) . Therefore, in this study we did not mention this part. We will add the molecular mechanism of TFEB activation by SFN in the discussion part. And to further confirm this mechanism in NPC cells, we will also perform experiments including: 1) examine whether antioxidant-NAC can block SFN-induced TFEB-nuclear translocation in NPC cells; 2) examine whether calcineurin inhibitor (FK506+CsA) can block SFN-induced TFEB-nuclear translocation in NPC cells.

      (2) Based on the manuscript narrative, discussion, and data it is unclear exactly how steady-state cholesterol would change in models of NPC disease following SFN treatment. Yes, there is good evidence that lysosomal flux to (and presumably across) the plasma membrane increases with SFN. However, lysosomal biogenesis genes also seem to be increasing. Given that NPC inhibition, NPC1 knockout, or NPC1 disease mutations are constitutively present and the cell models of NPC disease contain lysosomes (even with SFN) how could a simple increase in lysosomal flux decrease cholesterol levels? It would seem important to quantify the number of lysosomes per cell in each condition to begin to disentangle differences in steady state number of lysosomes, number of new lysosomes, and number of lysosomes being exocytosed.

      Thank you for the suggestion. It is important to define the three states 1) original number of lysosomes, 2) number of new lysosomes, and 3) number of lysosomes being exocytosis. However, we have checked literature, so far it seems that there is no good method that could clearly differentiate the three states of lysosomes.

      (3) Lack of evidence supporting the authors' premise that "SFN could be a good therapeutic candidate for neuropathology in NPC disease".

      Suggestion was taken! We will investigate whether cholesterol was reduced by activation of TFEB by SFN in vivo to strength the point that SFN could be a potential therapeutic compound for NPC treatment. And to avoid confusion, we have removed this sentence.

      Reviewer #2 (Public review):

      Summary:

      This study presents a valuable finding that the activation of TFEB by sulforaphane (SFN) could promote lysosomal exocytosis and biogenesis in NPC, suggesting a potential mechanism by SFN for the removal of cholesterol accumulation, which may contribute to the development of new therapeutic approaches for NPC treatment.

      Strengths:

      The cell-based assays are convincing, utilizing appropriate and validated methodologies to support the conclusion that SFN facilitates the removal of lysosomal cholesterol via TFEB activation.

      Weaknesses:

      (1) The in vivo experiments demonstrate the therapeutic potential of SFN for NPC. A clear dose-response analysis would further strengthen the proposed therapeutic mechanism of SFN. Additional data supporting the activation of TFEB by SFN for cholesterol clearance in vivo would strengthen the overall impact of the study

      We understand the reviewer’s point. We examined two doses of SFN-30 and 50mg/kg. As shown in Fig.6, SFN (50mg/kg), but not 30mg/kg prevents a degree of Purkinje cell loss in the lobule IV/V of cerebellum, suggesting a dose-correlated preventive effect of SFN. In vivo experiments with higher concentrations of SFN and optimized dosage form of SFN were planned in the future study, but will not be included in this study.

      We will investigate whether cholesterol was cleared by activation of TFEB by SFN in vivo.

      (2) In Figure 4, the authors demonstrate increased lysosomal exocytosis and biogenesis by SFN in NPC cells. Including a TFEB-KO/KD in this assay would provide additional validation of whether these effects are TFEB-dependent.

      Thank you for this valuable suggestion. We will investigate whether SFN-evoked the lysosomal exocytosis is TFEB-dependent by using TFEB-KO cells.

      (3) For lysosomal pH measurement, the combination of pHrodo-dex and CF-dex enables ratiometric pH measurement. However, the pKa of pHrodo red-dex (according to Invitrogen) is ~6.8, while lysosomal pH is typically around 4.7. This discrepancy may account for the lack of observed lysosomal pH changes between WT and U18666A-treated cells. Notably, previous studies (PMID: 28742019) have reported an increase in lysosomal pH in U18666A-treated cells.

      We understand the reviewer’s point. But we used pHrodo™ Green-Dextran (P35368, Invitrogen), but not pHrodo red-dex to measure the lysosomal luminal acidity. According to the product information from Invitrogen, pHrodo Green-dex conjugates are non-fluorescent at neural pH, but fluorescence bright green at acidic pH ranges 4-9, such as those in endosomes and lysosomes. Therefore, pHrodo Green-dex can be used to monitor the acidity of lysosome (Hu, Li et al. 2022) . We also used LysoTracker Red DND-99 (Thermo Scientific, L7528) to measure lysosomal pH (Fig. 4G, H), which is consistent with results of pHrodo Green/CF measurement. Overall, in our hands, we have not detected pH change of lysosomes in U18666A-treated NPC1 cell models.

      (4) The authors are also encouraged to perform colocalization studies between CF-dex and a lysosomal marker, as some researchers may be concerned that NPC1 deficiency could reduce or block the trafficking of dextran along endocytosis.

      Suggestion was taken! We will examine the effect of NPC1 deficiency on dextran trafficking by studying the localization of CF-dex and Lamp1.

      (5) In vivo data supporting the activation of TFEB by SFN for cholesterol clearance would significantly enhance the impact of the study. For example, measuring whole-animal or brain cholesterol levels would provide stronger evidence of SFN's therapeutic potential.

      We really appreciate the reviewer’s suggestions. We will investigate whether cholesterol was cleared by activation of TFEB by SFN in vivo.

      Reviewer #3 (Public review):

      Summary:

      The authors demonstrate that activation of TFEB facilitates cholesterol clearance in cell models of Niemann-Pick type C (NPC). This is done through a variety of approaches including activation of TFEB by sulforaphane (SFN), a naturally occurring small-molecule TFEB agonist. SFN induces TFEB nuclear translocation and promotes lysosomal exocytosis. In an NPC mouse model, SFN dephosphorylates/activates TFEB in the brain and rescues the loss of Purkinje cells.

      Strengths:

      NPC is a severe disease and there is little in the way of treatment. The manuscript points towards some treatment options. However, the title, the title "Small-molecule activation of TFEB Alleviates Niemann-Pick Disease..." is far too strong and should be changed.

      Weaknesses:

      (1) The manuscript is extremely hard to read due to the writing; it needs careful editing for grammar and English.

      We will thoroughly check grammar to improve the manuscript.

      (2) There are a number of important technical issues that need to be addressed.

      We will address the technical issues mentioned in the following.

      (3) The TFEB influence on filipin staining in Figure 1A is somewhat subtle. In the mCherry alone panels there is a transfected cell with no filipin staining and the mCherry-TFEBS211A cells still show some filipin staining.

      We understand the reviewer’s point. We will investigate whether cholesterol is cleared by activation of TFEB by SFN in vivo.

      (4) Figure 1C is impressive for the upregulation of filipin with U18666A treatment. However, SFN is used at 15 microM. This must be hitting multiple pathways. Vauzour et al (PMID: 20166144) use SFN at 10 nM to 1microM. Other manuscripts use it in the low microM range. The authors should repeat at least some key experiments using SFN at a range of concentrations from perhaps 100 nM to 5 microM. The use of 15 microM throughout is an overall concern.

      We understand the reviewer’s point. See RESPONSE #1, previously we have shown that SFN (10–15 μM, 2–9 h) induces robust TFEB nuclear translocation in a dose- and time-dependent manner in HeLa GFP-TFEB stable cells as well as in other human cell lines without cytotoxicity (Li, Shao et al. 2021) . According to previous results, in this study, we chose SFN (15 μM) to examine its effect on cholesterol clearance. We will add the information in the discussion part. In this study, we will perform dose-response TFEB nuclear translocation in NPC model cells as well as cytotoxicity experiments to examine whether the concentrations of SFN used in various cell lines are toxic.

      References:

      Hu, M. Q., P. Li, C. Wang, X. H. Feng, Q. Geng, W. Chen, M. Marthi, W. L. Zhang, C. L. Gao, W. Reid, J. Swanson, W. L. Du, R. Hume and H. X. Xu (2022). "Parkinson's disease-risk protein TMEM175 is a proton-activated proton channel in lysosomes.” Cell 185(13): 2292-+.

      Li, D., R. Shao, N. Wang, N. Zhou, K. Du, J. Shi, Y. Wang, Z. Zhao, X. Ye, X. Zhang and H. Xu (2021). “Sulforaphane Activates a lysosome-dependent transcriptional program to mitigate oxidative stress.” Autophagy 17(4): 872-887.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public Review):

      Summary:

      The work from Petazzi et al. aimed at identifying novel factors supporting the differentiation of human hematopoietic progenitors from induced pluripotent stem cells (iPSCs). The authors developed an inducible CRISPR-mediated activation strategy (iCRISPRa) to test the impact of newly identified candidate factors on the generation of hematopoietic progenitors in vitro. They first compared previously published transcriptomic data of iPSCderived hemato-endothelial populations with cells isolated ex vivo from the aorta-gonadmesonephros (AGM) region of the human embryo and they identified 9 transcription factors expressed in the aortic hemogenic endothelium that were poorly expressed in the in vitro differentiated cells. They then tested the activation of these candidate factors in an iPSCbased culture system supporting the differentiation of hematopoietic progenitors in vitro. They found that the IGF binding protein 2 (IGFBP2) was the most upregulated gene in arterial endothelium after activation and they demonstrated that IGFBP2 promotes the generation of functional hematopoietic progenitors in vitro.

      Strengths:

      The authors developed an extremely useful doxycycline-inducible system to activate the expression of specific candidate genes in human iPSC. This approach allows us to simultaneously test the impact of 9 different transcription factors on in vitro differentiation of hematopoietic cells, and the system appears to be very versatile and applicable to a broad variety of studies.

      The system was extensively validated for the expression of 1 transcription factor (RUNX1) in both HeLa cells and human iPSC, and a detailed characterization of this test experiment was provided.

      The authors exhaustively demonstrated the role of IGFBP2 in promoting the generation of functional hematopoietic progenitors in vitro from iPSCs. Even though the use of IGFBP2interacting proteins IGF1 and IGF2 have been previously reported in human iPSC-derived hematopoietic differentiation in vitro (Ditadi and Sturgeon, Methods 2016; Ng et al., Nature Biotechnology 2016), and IGFBP-2 itself has been shown to promote adult HSC expansion ex vivo (Zhang et al., Blood 2008), its role on supporting in vitro hematopoiesis was demonstrated here for the first time.

      Weaknesses:

      Although the authors performed a very thorough characterization of the system in proof-ofprinciple experiments activating a single transcription factor, the data provided when 9 independent factors were used is not sufficient to fully validate the experimental strategy. Indeed, in the current version of the manuscript, it is not clear whether the results presented in both the scRNAseq analysis and the functional assays are the consequence of the simultaneous activation of all 9 TF or just a subset of them. This is essential to establish whether all the proposed factors play a role during embryonic hematopoiesis, and a more complete analysis of the scRNAseq dataset could help clarify this aspect.

      Similarly, the data presented in the manuscript are not sufficient to clarify at what stage of the endothelial-to-hematopoietic transition (EHT) the TF activation has an impact. Indeed, even though the overall increase of functional hematopoietic progenitors is fully demonstrated, the assays proposed in the manuscript do not clarify whether this is due to a specific effect at the endothelial level or to an increased proliferation rate of the generated hematopoietic progenitors. Similar conclusions can be applied to the functional validation of IGFBP2 in vitro.

      The overall conclusions are sometimes vague and not always supported by the data. For instance, the authors state that the CRISPR activation strategy resulted in transcriptional remodeling and a steer in cell identity, but they do not specify which cell types are involved and at what level of the EHT process this is happening. In the discussion, the authors also claim that they provided evidence to support that RUNX1T1 could regulate IGFBP2 expression. However, this is exclusively based on the enrichment of RUNX1T1 gRNA in cells expressing higher levels of IGFBP2 and it does not demonstrate any direct or indirect association of the two factors.

      We thank the reviewer for the positive comments about the importance of our work and have now addressed the points raised as weaknesses by performing additional analysis and experiments, adding a new schematic of the mechanism, and rewording our claims.

      We have clarified the different effects mediated by the activation and the IGFBP2 addition in a summary section at the end of the results and added Figure 6, showing this in visual form. We have also clearly stated the limitations related to the correlation between RUNX1T1 and IGFBP2 in the discussion and toned down our claims regarding this throughout the entire paper. We have also reworded the text to clarify the specific cell types identified in the sequencing data that we refer to.

      Reviewer #2 (Public Review):

      To enable robust production of hematopoietic progenitors in-vitro, Petazzi et al examined the role of transcription factors in the arterial hemogenic endothelium. They use IGFBP2 as a candidate gene to increase the directed differentiation of iPSCs into hematopoietic progenitors. They have established a novel induced-CRISPR mediated activation strategy to drive the expression of multiple endogenous transcription factors and show enhanced production of hematopoietic progenitors through expansion of the arterial endothelial cells. Further, upregulation of IGFBP2 in the arterial cells facilitates the metabolic switch from glycolysis to oxidative phosphorylation, inducing hematopoietic differentiation. While the overall study and resources generated are good, assertions in the manuscript are not entirely supported by the experimental data and some claims need further experimental validation.

      We thank the reviewer for the positive comments, and we have provided new data and analysis to make sure that all our assertations are clearly supported and also reworded those where limitations were identified by the reviewers.

      Recommendations for the authors:

      Reviewing Editor (Recommendations For The Authors):

      The assessment could change from "incomplete" to "solid" if the authors: i) improve data analysis (for both scRNAseq and functional assays) by providing additional information that could strengthen their conclusions, as suggested in the specific comments by both reviewers; ii) either provide new functional evidence supporting their mechanistic conclusion or alternatively tone down the claims that are not fully supported by data and acknowledge the limitations raised by reviewers in the discussion; (iii) the issue of paracrine signaling to expand only hematopoietic progenitors needs to be addressed.

      We have now improved the data analysis and provided additional functional tests to strengthen our conclusions and toned down those that were identified by the reviewers as not supported enough and included a discussion on these limitations. We have also reworded the section about the paracrine signaling throughout the paper.

      Reviewer #1 (Recommendations For The Authors):

      Figure 1 contains exclusively published data. It might be more appropriate to use it as a supplementary figure or as part of a more exhaustive figure (maybe combining Figures 1 and 2 together?).

      Figure 1 contained novel bioinformatic analyses that represent the base of our research and it has a different content and focus to figure 2, which is already a large figure. We therefore believe it is better to keep it as a separate figure, containing a new panel now too. 

      It seems there is an issue with Figure S3 labelling:

      • In line 112, Figure S2A-B does not display genomic PCR and sequencing results;

      • In line 123, Figure S3D-E does not show viability and proliferation data;

      • In line 127, Figure S3G does not show mCherry expression in response to DOX;

      We apologies for the confusion with the numbers, we have now correctly labelled the figures.

      It would be more informative to include gates and frequency on flow cytometry plots in Figure S3, to be able to evaluate the extent of the reduction in mCherry expression.

      We have now included the gating and frequency of mCherry-expressing cells in Supplementary Figure 3D.

      It is not clear from the text and figures whether the SB treatment was maintained throughout the hematopoietic differentiation protocol (line 122):

      • If so, it would be important to confirm that HDAC treatment does not affect EHT cultures

      • If not, can the authors provide some evidence that transgene silencing is not occurring during hematopoietic differentiation?

      We have clarified that we decided to treat the cells with SB exclusively in maintenance condihons because HDACs have been shown to be essenhal for the EHT (lines 138-142). We have now also included addihonal data showing the high expression of the mCherry tag reporhng the iSAM expression on day 8 (Supplementary Figure 4F).

      Can the authors provide a simple diagram summarizing the experimental strategy for each differentiation experiment in the respective supplementary figure? For instance, at what stage of the protocol was DOX added in Figure 3? Or at what stage IGFBP2 was added in Figure 5? It would be a very useful addition to the interpretation of the results.

      We have now included three schemahcs for all the experiments in the manuscript in supplementary figure 4 A-C.

      In Figure 3, the authors should provide more detailed information about the data filtering of the scRNAseq experiment, and more specifically:

      • How many cells were included in the analysis for each library after QC and filtering?

      • How "cells in which the gRNAs expression was detected" were selected? Do they include only cells showing expression of gRNAs for all 9 TF?

      This informahon is now included in the method sechon lines 773-781; the detailed code is available on the GitHub link provided in the same sechon. We have filtered the cells expressing one gRNA for the non-targehng gRNA (iSAM_NT) control and more than one for the iSAM_AGM sample. 

      In Figure 3A, it is not clear whether the expression of the 9 factors is consistently detected in all cells or just a subset of them, and the heatmap in Figure 3A does not provide this information. It would be more accurate to provide expression on a per-cell basis, for instance, as a violin plot displaying single dots representing each cell. 

      We have now included this violin plot in Supplementary Figure 4G as requested. However, this visualisation is difficult to interpret because some of the target genes’ expression seems variable in both experimental and control conditions. We had envisaged that this could have been the case and so this is why we had included the three different controls.  For this reason we chose to show the normalised expression which takes all the different variables into account (Figure 3A). 

      In Figure 3B-C, it seems that clusters EHT1 and EHT2 do not express endothelial markers anymore. Are these fully differentiated hematopoietic cells rather than cells undergoing EHT? In general, it would be quite important to provide evidence of expressed marker genes characterizing each cluster (eg. heatmap summarizing top DEG in the supplementary figure?). 

      We have now provided a spreadsheet containing the clusters’ markers that we used in

      Supplementary Table 1) a heatmap in Figure 3E. Furthermor,e we have now edited Figure 3C to include Pan Endothelial markers (PECAM1 and CDH5). These data show that the EHT1 and EHT2 cluster both express endothelial markers but are progressively downregulated as expected during endothelial to hematopoietic transition. We have also included and discussed this in the manuscript lines 192-195 and a schematic for the mechanism in Figure 6.

      In Figure 3E, displaying the proportion of clusters within each sample/library would be a more accurate way of comparing the cell types present in each library (removing potential bias introduced by loading different numbers of cells in each sample).

      We have now included the requested data in Supplementary Figure 4I and it confirms again the expansion of arterial cells in the activated cells.    

      In Figure 3G, by plating 20,000 total CD34+, the assay does not account for potential differences in sample composition. It is then hard to discriminate between the increased number of progenitors in the input or an enhanced ability of HE to undergo EHT. This is an important aspect to consider to precisely identify at what level the activation of the 9 factors is acting. A proper quantification of flow cytometry data summarizing the % of progenitors, arterial cells, etc. would be useful to interpret these results.

      Lines 204-205 reworded. We are very much aware of the fact that the CD34+ cell population consists of a range of cells across the EHT process and this is precisely why we carried out this single cell sequencing analyses.  We purposely tested the effect of the observed changes in composition by colony assays

      In Figure 3G, it seems that NT cells w/o DOX have very little CFU potential (if any). Can the authors provide an explanation for this?

      We think that the limited CFU potential is due to the extensive genetic manipulation and selection that the cells underwent for the derivation of all the iSAM lines but this did not impede us from observing an effect of gene activation on CFU numbers. This is one of the primary reasons that we then validated our overall findings using the parental iPSC line in control condition and with the addition of IGFBP2. We show that the parental iPSC line gives rise to hematopoietic progenitor, both immunophenotypically (Figure 4D) and functionally, at expected levels (Figure 4B left column).

      Figure 4A shows an upregulation of IGFBP2 in arterial cells as a result of TF activation. However, from the data presented here, it is not possible to evaluate whether this is specific to the arterial cluster, or it is a common effect shared by all cell types regardless of their identity. 

      Data has now been included in Supplementary Figure 4H, which shows that all the cells show an increase in IGFBP2, but arterial cells show the highest increase. We have now edited the text to reflect this, in lines 228-230.

      In Figure 5A-B only a minority of arterial cells express RUNX1 in response to IGFBP2 treatment. Is this sufficient to explain the very significant increase in the generation of functional hematopoietic progenitors described in Figure 4? Quantification and statistical analysis of RUNX1 upregulation would strengthen this conclusion.

      We have now provided the statistical analysis showing significant upregulation of RUNX1 upon IGFBP2 addition. The p values are now provided in the figure 5 legend.

      In Figure 5 the authors conclude that IGFBP2 remodels the metabolic profile of endothelial cells. However, it is not clear which cell types and clusters were included in the analysis of Figure 5C-G. Is the switch from Glycolysis to Oxidative Phosphorylation specific to endothelial cells? Or it is a more general effect on the entire culture, including hematopoietic cells? 

      We based this conclusion on the fact that the single-cell RNAseq allows to verify that the metabolic differences are obtained in the endothelial cells. Given that we sorted the adherent cells, the majority of these are endothelial cells as shown in Figure 5A. The Seahorse pipeline includes a number of washing steps resulting in the analyses being performed on the adherent compartment which we know consists primarily of endothelial cells. We cannot exclude some contamination from non-endothelial cells but we highlight to this reviewer that the initial observation of the metabolic changes was identified in endothelial cells in the single cell sequencing data. Taken together, we believe that this implies that metabolic changes are specific to this population. We have clarified this in the line 317.

      In the discussion, the authors conclude that they "provide evidence to support the hypothesis that RUNX1T1 could regulate IGFBP2 expression". To further support this conclusion, the authors could provide a correlation analysis of the expression of the two genes in the cell type of interest. 

      Following the observation of the IGFBP2 high expression across clusters, we have now reworded this sentence in lines 382-385  We have tried to perform the correlation analysis but we believe this not to be appropriate due to the detection level of the gRNA, we have now included this as a limitation point in the discussion lines 416-427, and also toned down the conclusion we did draw about RUNX1T1 throughout the whole manuscript.

      As mentioned by the authors, IGFBP2 binds IGF1 and IGF2 modulating their function. Both IGF1 (http://dx.doi.org/10.1016/j.ymeth.2015.10.001) and IGF2 (doi:10.1038/nbt.3702) have been used in iPSC differentiation into definitive hematopoietic cells. It would be relevant to discuss/reference this in the discussion.

      We have now included the suggested reference in the section where we discuss the role of IGFBP2 in binding IGF1 and IGF2.

      Reviewer #2 (Recommendations For The Authors):

      (1) Figure 1 compares the transcriptome of human AGM and in-vitro derived hemogenic endothelial cells (HECs). It is not clear why only the genes downregulated in the latter were chosen. Are there any significantly upregulated genes, knockdown/knockout which could also serve a similar purpose? Single-cell transcriptome database analysis is very preliminary. A detailed panel with differences in cluster properties of HECs between the two systems should be provided. A heatmap of all differentially expressed genes between the two samples must be generated, along with a logical explanation for choosing the given set of genes. 

      We have now included another panel in figure 1 to better clarify the logic behind the strategy used to identify our target genes (Figure 1A).

      (2) Figure 2 - a panel describing the workflow of gRNA design and targeting for the 9 candidate genes, along with lentiviral packaging and transduction would make it easier to follow. 

      We have now included three schematics for all the experiments in the manuscript in supplementary figure 4 A-C. 

      (3) Figure 3- to assess the effect of arterial cell expansion on the emergence of hematopoietic progenitors, CD34+ Dll4+ cells should be sorted for OP9 co-culture assay.

      Using only CD34+ cells does not answer the question raised. Also, the CFU assay performed does not fully support the claim of enhanced hematopoietic differentiation since only CFU-E and CFU-GM colonies are increased in Dox-treated samples, with no effect on other colony types. OP9 co-culture assay with these cells would be required to strengthen this claim. 

      We wanted to clarify that the effect on the methylcellulose coming from the activated cells was not limited to CFU-E, as the reviewer reported; instead, it also affected CFU-GM and CFU-M. 

      We have now performed additional experiments where we sorted the CD34+ compartment into DLL4- and DLL4+ in Supplementary Figure 5D-E, which we discussed in lines 250-258. 

      (4) In Figure 3F, there appears to be a lot of variation in the DLL4% fold change values for

      DOX treated iSAM_AGM sample, which weakens the claim of increased arterial expansion.

      Can the authors explain the probable reason? It is suggested that the two other controls (iSAM_+DOX and iSAM_-DOX) should be included in this analysis. It is imperative to also show % populations rather than just fold change to gain confidence.

      We agree that there is a lot of variability. That is because differentiation happens in 3D in embryoid bodies, which contain many different cell types that differentiate in different proportions across independent experiments. We have now included the raw data in Supplementary Figure 4 D, with additional statistical analysis to show the expansion of arterial cells including also the suggested additional controls.

      (5) How does activation of these target genes cause increased arterialization? Is the emergence of non-HE populations suppressed? Or is it specific to the HE? The data on this should be clarified and also discussed. ANTO/Lesley text

      We have provided additional data clarifying the connection between increased arterialisation and hemogenic potential. We showed that the activation induces increased arterialisation and that IGFBP2 acts by supporting the acquisition of hemogenic potential. We have discussed this in lines 326-348 and provided a new figure to explain this in detail (figure 6)

      (6) Considering that IGFBP2 was chosen from the activated target gene(s) cluster, can the authors explain why the reduced CFU-M phenomenon observed in Figure 3G does not appear in the MethoCult assay for IGFBP2 treated cells (Figure 4B)?

      The difference could be explained by the fact that in Figure 3G, the cells underwent activation of multiple genes, while in Figure 4B, they were only exposed to IGFBP2. Our results show that IGFBP2 could at least partially explain the phenotype that we see with the activation, but we believe that during the activation experiments, there might be other signals available that might not be induced by IGFBP2 alone. We have also added a summary section and a figure to clarify the different mechanisms of action of the gene activation and IGFBP2.

      (7) Figure 4- while the experiments conducted support the role of IGFBP2 in increasing hematopoietic output, there is no experimental evidence to prove its function through paracrine signalling in HECs. The authors need to provide some evidence of how IGFBP2 supplementation specifically expands only the hematopoietic progenitors. Experimental strategies involving specifically targeting IGFBP2 in hemogenic/arterial endothelial cells are required to prove its cell type specific function. Additionally, assessing the in vivo functional potential of the hematopoietic cells generated in the presence of IGFBP2, by bone-marrow transplantation of CD34+ CD43+ cells, is essential. 

      The role of IGFBP2 in the context of HSC production and expansion was not the topic of our research, and we have not claimed that IGFBP2  affects the long-term repopulating capacity of HSPCs. Therefore, we believe that the requested experiments are not required to support the specific claims that we do make. We have now provided more experiments and bioinformatic analysis that support the role of IGFBP2 in inducing the progression of EHT from arterial cells to hemogenic endothelium, and to avoid misunderstandings, we have toned down our claims by editing the text regarding its paracrine effect s. 

      (8) Figure 4C-D -It is recommended to plot % populations along with fold change value. As this is a key finding, it is important to perform flow cytometry for additional hematopoietic markers- CD144, CD235a and CD41a to demonstrate whether this strategy can also expand erythroid-megakaryocyte progenitors. Telma

      Figure 4C already shows the percentage values; we have now added the percentage for Figure 4D in SF5C. We have also performed additional analysis as requested and added the data obtained to Supplementary Figure 5D.

      (9) In Figure 5, analysis showing the frequency of cells constituting different clusters, between untreated and IGFBP2-treated samples in the single-cell transcriptome analysis is essential. Additional experiments are required to validate the function of IGFBP2 through modulation of metabolic activity. Inhibition of oxidative phosphorylation in the IGFBP2treated cells should reduce the hematopoietic output. Authors should consider doing these experiments to provide a stronger mechanistic insight into IGFBP2-mediated regulation of hematopoietic emergence.

      We have now included the requested cluster composition in Supplementary Figure 5F. We decided not to include further tests on the metabolic profile of IGFBP2 as we already discussed in other papers that showed, using selective inhibitors, that the EHT coincides with a glycol to OxPhos switch. 

      (10) It is very striking to see that IGFBP2 supplementation changes the transcriptional profile of developing hematopoietic cells by increasing transcription of OXPHOS-related genes with concomitant reduction of glycolytic signatures, particularly at Day 13. However, the mitochondrial ATP rate measurements do not seem convincing. The bioenergetic profiles show that when mitochondrial inhibitors are added, both groups exhibit decreased OCR values and, on the other hand, higher ECAR. This indicates that both groups have the capability to utilize OXPHOS or glycolysis and may only differ in their basal respiration rates.

      Differences in proliferation rate can cause basal respiration to change. There is no information on how the bioenergetic profile was normalized (cell no./protein amount). Given that IGFBP2 has been shown to increase proliferation, it is very likely that the cells treated with IGFBP2 proliferated faster and therefore have higher OCR. The data needs to be normalized appropriately to negate this possibility.

      We have previously tested whether IGFBP2 causes an increase in proliferation by analysing the cell cycle of cells treated with it, as we initially thought this could be a mechanism of action. We have now provided the quantification of the cell cycle in the cells treated with IGFBP2, showing no effect was observed in cell cycle Supplementary Figure 4E. Following this analysis, we decided to plate the same number of cells and test their density under the microscope before running the experiment; each experiment was done in triplicate for each condition. We have now added this info to the method sections lines 806-813.  We did not comment on the basal difference, which we agree might be due to several factors, but we only compared the difference in response to the inhibitors, which isn’t affected by the basal level but exclusively by their D values. We have also included the formulas used to calculate the ATP production rate.

      Overall, it appears that IGFBP2 does not seem to primarily cause metabolic changes, but simply accelerates the metabolic dependency on OXPHOS. Hence, the term 'metabolic remodelling' must be avoided unless IGFBP2 depletion/loss of function analysis is shown.

      We thank the reviewer for suggesting how to interpret the data about the dependency on OXPHOS. We have now changed the conclusions and claims about the effect of IGFBP2. We have also included a cell cycle analysis of the hematopoietic cells derived upon IGFBP2 addition to show that they don’t show differences in proliferation that could cause the increase in colony formation we observed. Regarding the assay, we have plated the same number of cells for each group to make sure we were comparing the same number of cells, which we also assessed in the microscope before the test, and we eliminated the suspension cells during the washes that preceded the measurement. The review is correct in indicating that there is a basal difference in the value of OCR and ECAR where the IGFBP2 is lower at the start and not higher, which would not conceal higher proliferation. Finally, the ATP production rate is calculated on the variation of OCR and ECAR upon the addition of inhibitors, which normalizes for the basal differences.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Reviewer #1 (Recommendations For The Authors):

      Summary:

      In this manuscript, the molecular mechanism of interaction of daptomycin (DAP) with bacterial membrane phospholipids has been explored by fluorescence and CD spectroscopy, mass spectrometry, and RP-HPLC. The mechanism of binding was found to be a two-step process. A fast reversible step of binding to the surface and a slow irreversible step of membrane insertion. Fluorescence-based titrations were performed and analysed to infer that daptomycin bound simultaneously two molecules of PG with nanomolar affinity in the presence of calcium. Conformational change but not membrane insertion was observed for DAP in the presence of cardiolipin and calcium.

      Strengths:

      The strength of the study is skillful execution of biophysical experiments, especially stoppedflow kinetics that capture the first surface binding event, and careful delineation of the stoichiometry.

      Weaknesses:

      The weakness of the study is that it does not add substantially to the previously known information and fails to provide additional molecular details. The current study provides incremental information on DAP-PG-calcium association but fails to capture the complex in mass spectrometry. The ITC and NMR studies with G3P are inconclusive. There are no structural models presented. Another aspect missing from the study is the reconciliation between PG in the monomer, micellar, and membrane forms.

      Besides the two-stage process, another important finding in the current work is the stable complex that plays a critical role in the drug uptake both in vitro and in B. subtilis. This complex has been shown to be a stable species in HPLC and its binding stoichiometry and affinity have been quantitatively characterized. The complex may not be stable enough in gas phase to be detected in the MS analysis, which was designed to detect the phospholipid and Dap components, not the complex itself. The structural model of this complex is clearly proposed and presented in Figure 6. 

      The NMR and ITC studies have a very clear conclusion that Dap has a weak interaction with the PG headgroup alone, which is unable to account for the Dap-PG interaction observed in the fluorescence studies. Thus, the whole PG molecule has to be involved in the interaction, leading to the discovery of the stable complex.  

      Reviewer #2 (Recommendations For The Authors):

      (1) I appreciate and agree with the comment that there are stages of daptomycin insertion, and these might involve the formation of different complexes with different binding partners (e.g. pre-insertion vs quaternary vs bactericidal). However, it seems like lipid II is an apparent participant in daptomycin membrane dynamics (Grein et al. Nature Communications 2020). It's not clear why this was excluded from analysis by the authors, or what basis there is for the discussion statement that the quaternary complex can shift into the bactericidal complex by exchanging 1 PG for lipid II. 

      We agree that lipid II and other isoprenyl lipids may be involved in the uptake and insertion of daptomycin into membrane according to the results of the Nat. Comm. paper. However, these isoprenyl lipids are very small components of the membrane in comparison to PG and their contribution to the drug uptake is thus expected to be much less significant. Nonetheless, we included farnesyl pyrophosphate (FPP) as an analog of bactoprenol pyrophosphate (C55PP), which was reported to have the same promoting effect as lipid II in the previous study, in our study but found no promoting effect in the fluorescence assay (Fig. 2B). In addition, no complex was formed when FPP replaced PG in our preparation and analysis of the drug-lipid complex. In consideration of these negative results and the expected small contribution, other isoprenyl lipids or their analogs were not included in the study.

      The statement of forming the proposed bactericidal complex from the identified complex is a speculation that is possible only when lipid II has a higher affinity for Dap than a PG ligand. To avoid confusion, we deleted the sentence’ in the revision. 

      (2) The detailed examination of daptomycin dynamics, particularly on the millisecond scale, in this paper is ideal for characterizing the effect of lipid II on daptomycin insertion. It would be helpful to either include lipid II in some analyses (micelle binding, fluorescence shifts, CD) or at least address why it was excluded from the scope of this work.

      As mentioned in the response to the first comment, we did not exclude isoprenyl lipids in our study but used some of their analogs in the fluorescence assay. Besides FPP mentioned above, we also tested geranyl pyrophosphate and geranyl monophosphate but obtained the same negative results. Lipid II was not directly used because it is one of the three isoprenyl lipids reported to have the same promoting effects in the Nat. Comm. paper and also because its preparation is not easy. Even if lipid II were different from other isoprenyl lipids in promoting membrane binding, its contribution is likely negligible at the reversible stage compared to the phospholipids because of its minuscule content in bacterial membrane. This is the main reason we did not use the isoprenyl lipids in the fast kinetic study (this stage only involves reversible binding, not insertion). 

      (3) Grein et al. 2020 saw that PG did not have a strong effect on daptomycin interaction with membranes. I believe this discrepancy is more likely due to the complex physical parameters of supported bilayers versus micelles/vesicles or some other methodological variable, but if the authors have more insight on this, it would be valuable commentary in the discussion.

      We totally agree that the discrepancy is likely due to the different conditions in the assays. It is hard to tell exactly what causes the difference. Thus, we did not attempt to comment on the cause of this difference in the discussion.

      (4) Isolation of the daptomycin complex from B. subtilis cells clearly had different traces from the in vitro complex; is it possible that lipid II is present in the B. subtilis complex? If not, a time-course extraction could be useful to support the model that different complexes have different activities. Isolates from early-stage incubation with daptomycin may lack lipid II but isolates from longer incubations may have lipid II present as the complex shifts from insertion to bactericidal.

      From the day we isolated the complex from B. subtilis, we have been looking for evidence for the previously proposed lipid complexes containing lipid II or other isoprenyl lipids but have not been successful. We did not see any sign of lipid II or other isoprenyl lipids in the MALDI or ESI mass spectroscopic data. The minute peaks in the HPLC traces are not the expected complexes in separate LC-MS analysis. However, this does not mean that such complexes are not present in the isolated PG-containing complex because: (1) the amount of such complexes may be too small to be detected due to the low content of the isoprenyl lipids; (2) the isoprenyl lipids, particularly lipid II, are not easily ionizable due to their size and unique structure for detection in mass spectrometry. 

      We don’t think the drug treatment time is the reason for the failure in detecting lipid II or other isoprenyl lipids. In our reported experiment, the cells were treated with a very high dose of Dap for 2 hours before extraction. In a separate experiment done recently, we treated B. subtilis at 1/3 of the used dose under the same condition and found all treated cells were dead after 1 hour in a titration assay, consistent with the results from reported time-killing assays in the literature. From this result, the proposed bactericidal lipid-containing complex should have been formed in the treated cells used in our extraction and isolated along with the PG-containing complex. It was not detected likely due to the reasons discussed above. To avoid the interference of the PG-containing complex, a large amount of bacterial cells might have to be treated at a low dose to isolate enough amount of the lipid II-containing complex for identification. However, isolation or identification of the lipid II-containing complex is outside the scope of the current investigation and is therefore not pursued. 

      (5) Part of the daptomycin mechanism of interacting with bacterial membranes involves the flipping of daptomycin from one leaflet to another. There was some mentioned work on the consistency of results between micelles and vesicles, but the dynamics or existence of a flipping complex in the bilayer system wasn't addressed at all in this paper.

      The current investigation makes no attempt to solve all problems in the daptomycin mode of action and is limited to the uptake of the drug, up to the point when Dap is inserted into the membrane. Within this scope, flipping of the complex is not yet involved and is thus irrelevant to the study. How the complex is flipped and used to kill the bacteria is what should be investigated next.  

      (6) The authors mention data with phosphatidylethanolamine in the text, but I could not find the data in the main or supplemental figures. I recommend including it in at least one of the figures.

      It is much appreciated that this error is identified. The POPE data was lost when the graphic (Fig. 2B) was assembled in Adobe to create Figure 2. We re-draw the graphic and reassemble the figure to solve this problem. Fig. 2B has also been modified to use micromolar for the concentration of the lipids.

      (7) Readability point: I'd suggest some consistency in the concentrations mentioned. Making the concentrations either all molar-based or all percentage-based would make comparison across figures easier.

      As suggested, we have changed the % into micromolar concentrations in Fig. 2B and also in Fig. 3A. 

      (8) The model figure is quite difficult to interpret, particularly the final stage of the tail unfolding. I recommend the authors use a zoomed-in inset for this stage, or at least simplify the diagram by removing the non-participating lipid structures. The figure legend for the model figure should also have a brief description of the events and what the arrows mean, particularly the POPS PG arrow in the final panel of the figure. I am assuming here the authors are implying that daptomycin can transiently interact with one lipid species and move to another, but the arrow here suggests that daptomycin is moving through the lipid headgroup space.

      We really appreciate the suggestions. As suggested, we put an inset to show the preinsertion complex more clearly. In addition, we have removed the green arrows originally intended to show the re-organization/movement of the phospholipids. Moreover, the legend is changed to ‘Proposed mechanism for the two-phased uptake of Dap into bacterial membrane. In the first phase, Dap reversibly binds to negative phospholipids with a hidden tail in the headgroup region, where it combines with two PG molecules to form a pre-insertion complex. In the second phase, the hidden tail unfolds and irreversibly inserts into the membrane. The inset shows the headgroup of the pre-insertion complex with the broad arrow showing the direction for the unfolding of the hidden tail. The red dots denote Ca2+.’  

      (9) The authors listed the Kd for daptomycin and 2 PG as 7.2 x 10-15 M2. Is this correct? This is an affinity in the femtomolar range.

      Please note that this Kd is for the simultaneous binding of two PG molecules, not for the binding of a single ligand that we usually refer to. Assuming that each PG contributes equally to this interaction, the binding affinity for each ligand is then the squared root of 7.2 x 10-15 M2, which equals to 8.5 x 10-8 M. This is equivalent to a nanomolar affinity for PG and is a reasonably high affinity.

      Reviewer #3 (Recommendations For The Authors):

      (1) The authors reported an increase in daptomycin intensity with the increasing amount of negatively charged DMPG. A similar observation has been reported for GUVs, however, the authors did not refer to this paper in their manuscript: E. Krok, M. Stephan, R. Dimova, L. Piatkowski, Tunable biomimetic bacterial membranes from binary and ternary lipid mixtures and their application in antimicrobial testing, Biochim. Biophys. Acta - Biomembr. 1865 (2023) [1]. This paper is also consistent with the authors' observation that there is negligible fluorescence detected for the membranes composed of PC lipids upon exposure to the Dap treatment.

      As suggested, this paper is cited as ref. 29 in the revision by adding the following sentence at the end of the section ‘Dependence of Dap uptake on phosphatidylglycerol.’: ‘PG-dependent increase of the steady-state fluorescence was also observed in giant unilamellar vesicles (GUVs).29’. The numbering is changed accordingly for the remaining references.  

      (2) Please include the plot of the steady-state Kyn fluorescence vs the content of POPA (Figure 2C shows traces for DMPG, CL, and POPS). Both POPA and POPS lipids are negatively charged, however, POPS seems to interact with Dap, while POPA does not. In my opinion, this observation is really interesting and might deserve a more thorough discussion. The authors might want to describe what could be the mechanism behind this lipid-specific mode of binding.

      As suggested, a plot is now added for POPA in Fig. 2C, which is basically a flat line without significant increase for the Kyn fluorescence. Indeed, the different effect of the negative phospholipids is very interesting, indicating that the reversible binding of Dap to the lipid surface is dependent not only on the Ca2+-mediated ionic interaction but also the structure of the headgroup. In other words, Dap recognizes the phospholipids at the surface binding stage. Considering this headgroup specificity, the last sentence in the second paragraph in “Discussion’ is changed from ‘In addition, due to the low lipid specificity, this reversible binding likely involves Ca2+-mediated ionic interaction between Dap and the phosphoryl moiety of the headgroups.’ to ‘In addition, due to the specificity for negative phospholipids (Fig. 2B and 2C), this reversible binding of Dap likely involves both a nonspecific Ca2+-mediated ionic interaction and a specific interaction with the remaining part of the headgroups.’

      (3) The authors write that they propose a novel mechanism for the Ca2+-dependent insertion of Dap to the bacterial membrane, however, they rather ignored the already published findings and hypotheses regarding this process. In fact the role of Ca2+, as well as the proposed conformational changes of Dap, which allow its deeper insertion into the membrane are well known:

      The role of Ca2+ ions in the mechanism of binding is actually three-fold: (i) neutralization of daptomycin charge [2], (iii) creating the connection between lipids and daptomycin and (iii) inducing two daptomycin conformational changes. It should be noted that the interactions between calcium ions and daptomycin are 2-3 orders of magnitude stronger than between daptomycin and PG lipids [3,4]. Thus, upon the addition of CaCl2 to the solution, the divalent cations of calcium bind preferentially to the daptomycin, rather than to the negatively charged PG lipids, which results in the decrease of daptomycin net negative charge but also leads to its first conformational change [4]. Upon binding between calcium ions and two aspartate residues, the area of the hydrophobic surface increases, which allows the daptomycin to interact with the negatively charged membrane. In the next step, Ca2+ acts as a bridge connecting daptomycin with the anionic lipids. This event leads to the second conformational change, which enables deeper insertion of daptomycin into the lipid membrane and enables its fluorescence [4]. The overall mechanism has a sequential character, where the binding of daptomycin-Ca2+ complex to the negatively charged PG (or CA) occurs at the end.

      The authors should focus on emphasizing the novelty of their manuscript, keeping in mind the already published paper.

      We agree with the comments on the three general roles of calcium ion in the Dap interaction with membrane. The current investigation does not ignore the previous findings, which involve many more works than mentioned above, but takes these findings as common knowledge. Actually, the role of calcium ion is not the focus of current work. Instead, the current work focuses on how the drug is taken up and inserted into the membrane in the presence of the ion and how its structure changes in this process. With the known roles of calcium ion in mind, we propose an uptake mechanism (Fig. 6) that shows no conflict with the common knowledge.

      We would like to point out that the ‘deeper insertion into the membrane’ in the comment is different from the membrane insertion referred to in our manuscript. This ‘deeper insertion’ still remains in the reversible stage of binding to the membrane surface because all negative phospholipids can do this (causing a conformational change and fluorescence increase, as quantified in Fig.2C) but now we know that only PG can enable irreversible membrane insertion because of our work. In addition, the comment that calcium binding to daptomycin causes first conformational change is not supported by our finding that no conformational change is found for Dap in the presence of calcium in a lipid-free environment (Fig. 3B). One important aspect of novelty and contribution of our work is to clear up some of these ambiguities in the literature. Another contribution of our work is to demonstrate the formation of a stable complex between Dap and PG with a defined stoichiometry and its crucial role in the drug uptake. 

      (4) One paragraph in the section "Ca2+- dependent interaction between Dap and DMPG" is devoted to a discussion of the formation of precipitate upon extraction of DMPG-containing micelles, exposed to Dap in the calcium-rich environment. Contrary, in the absence of Dap, no precipitate was detected. The authors did not provide any visual proof for their statement. Please include proper photographs in the supplementary information.

      The precipitate formed upon extraction of the DMPG-containing micelles was too little to be visually identifiable but could be collected by centrifugation and detected by fluorescence or HPLC after dissolving in DMSO. For visualization, we show below the precipitate formed using higher amount of Dap and DMPG. The Dap-DMPG-Ca2+ complex (left tube) was formed by mixing 1 mM Dap, 2 mM DMPG and 1 mM Ca2+ and the control (right tube) was a mixture of 2 mM DMPG and 1 mM Ca2+. This is now added as Fig. S7 in the supplementary information (the index is modified accordingly) and cited in the main text.

      (5) The authors wrote that it is not clear how many calcium ions are bound to Dap-2PG complex (page 11, Discussion section). There are already reports discussing this issue. I recommend citing the paper discussing that exactly two Ca2+ ions bind to a single Dap molecule: R. Taylor, K. Butt, B. Scott, T. Zhang, J.K. Muraih, E. Mintzer, S. Taylor, M. Palmer, Two successive calcium-dependent transitions mediate membrane binding and oligomerization of daptomycin and the related antibiotic A54145, Biochim. Biophys. Acta - Biomembr. 1858, (2016) 1999-2005 [5]

      We were aware of the cited work that shows binding of two Ca2+ but also noted that there are more works showing one Ca2+ in the binding, such as the paper in [Ho, S. W., Jung, D., Calhoun, J. R., Lear, J. D., Okon, M., Scott, W. R. P., Hancock, R. E. W., & Straus, S. K. (2008), Effect of divalent cations on the structure of the antibiotic daptomycin. European Biophysics Journal, 37(4), 421–433.]. That was the reason we said ‘it is not clear how many calcium ions are bound to Dap-2PG complex’. Now, both papers are cited (as Ref. #33, 34) to support this statement.

      (6) The authors wrote two contradictory statements:

      -  PG cannot be found in mammalian cell membranes:

      "Moreover, the complete dependence of the membrane insertion on PG also explains why Dap selectively attacks Gram-positive bacteria without affecting mammalian cells, because PG is present only in bacterial membrane but not in mammalian membrane. " (Page 10, Discussion section, last sentence of the first paragraph)

      "However, Dap absorbed on bacterial surface is continuously inserted into the acyl layer via formation of complex with PG in a time scale of minutes, whereas no irreversible insertion of Dap occurs on mammalian membrane due to the absence of PG while the bound Dap is continuously released to the circulation as the drug is depleted by the bacteria." (Page 13, Discussion section)

      -  PG in trace amounts is present in mammalian membranes:

      "The proposed requirement of the pre-insertion quaternary complex increases the threshold of PG content for the membrane insertion to happen and thus makes it impossible on the surface of mammalian cells even if their plasma membrane contains a trace amount of PG." (Page 13, Discussion section).

      In fact, phosphatidylglycerol comprises 1-2 mol% of the mammalian cell membranes. Please, correct this information, which in this form is misleading to the readers.

      We appreciate the comments about the PG content in mammalian cells. Changes are made as listed below:

      (1) p10, the sentence is changed to ‘Moreover, the complete dependence of the membrane insertion on PG also explains why Dap selectively attacks Gram-positive bacteria without affecting mammalian cells, because PG is a major phospholipid in bacterial membrane but is a minor component in mammalian membrane.’ 

      (2) p13, the sentence is changed to ‘However, Dap absorbed on bacterial surface is continuously inserted into the acyl layer via formation of complex with PG in a time scale of minutes, whereas little irreversible insertion of Dap occurs on mammalian membrane due to the low content of PG while the bound Dap is continuously released to the circulation as the drug is depleted by the bacteria.’

      (3) p13, another sentence is modified to ‘The proposed requirement of the pre-insertion quaternary complex increases the threshold of PG content for the membrane insertion to happen and thus makes it less likely on the surface of mammalian cells that contain PG at a low level in the membrane.’ 

      (7) Please include information that Dap is effective only against Gram-positive bacteria and does not show antimicrobial properties against Gram-negative strains. The authors focused on emphasizing that Dap does not affect mammalian membranes, most likely due to the low PG content, however even membranes of Gram-negative bacteria are not susceptible to the Dap, despite the relatively high content of negatively charged PG in the inner membrane (e.g. inner cell membrane of E. coli has ~20% PG).

      The requested information is already included in ‘Introduction’. In this part, Dap is introduced to be only active against Gram-positive bacteria, implicating that it is not active against Gram-negative bacteria. The reason Dap is inactive against E. coli or other Gramnegative bacteria is because the outer membrane prevents the antibiotic from accessing the PG in the inner membrane to cause any harm. When the outer membrane is removed, Dap will also attack the plasma membrane of Gram-negative bacteria. 

      Literature cited in the comments:

      (1) E. Krok, M. Stephan, R. Dimova, L. Piatkowski, Tunable biomimetic bacterial membranes from binary and ternary lipid mixtures and their application in antimicrobial testing, Biochim. Biophys. Acta - Biomembr. 1865 (2023). https://doi.org/10.1101/2023.02.12.528174.

      (2) S.W. Ho, D. Jung, J.R. Calhoun, J.D. Lear, M. Okon, W.R.P. Scott, R.E.W. Hancock, S.K. Straus, Effect of divalent cations on the structure of the antibiotic daptomycin, Eur. Biophys. J. 37 (2008) 421-433. https://doi.org/10.1007/S00249-007-0227-2/METRICS.

      (3) A. Pokorny, P.F. Almeida, The Antibiotic Peptide Daptomycin Functions by Reorganizing the Membrane, J. Membr. Biol. 254 (2021) 97-108. https://doi.org/10.1007/s00232-02100175-0.

      (4) L. Robbel, M.A. Marahiel, Daptomycin, a bacterial lipopeptide synthesized by a nonribosomal machinery, J. Biol. Chem. 285 (2010) 2750127508. https://doi.org/10.1074/JBC.R110.128181.

      (5) R. Taylor, K. Butt, B. Scott, T. Zhang, J.K. Muraih, E. Mintzer, S. Taylor, M. Palmer, Two successive calcium-dependent transitions mediate membrane binding and oligomerization of daptomycin and the related antibiotic A54145, Biochim. Biophys. Acta - Biomembr. 1858 (2016) 1999-2005. https://doi.org/10.1016/J.BBAMEM.2016.05.020.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      This work used a comprehensive dataset to compare the effects of species diversity and genetic diversity within each trophic level and across three trophic levels. The results showed that species diversity had negative effects on ecosystem functions, while genetic diversity had positive effects. These effects were observed only within each trophic level and not across the three trophic levels studied. Although the effects of biodiversity, especially genetic diversity across multi-trophic levels, have been shown to be important, there are still very few empirical studies on this topic due to the complex relationships and difficulty in obtaining data. This study collected an excellent dataset to address this question, enhancing our understanding of genetic diversity effects in aquatic ecosystems.

      Strengths:

      The study collected an extensive dataset that includes species diversity of primary producers (riparian trees), primary consumers (macroinvertebrate shredders), and secondary consumers (fish). It also includes the genetic diversity of the dominant species at each trophic level, biomass production, decomposition rates, and environmental data.

      The conclusions of this paper are mostly well supported by the data and the writing is logical and easy to follow.

      Weaknesses:

      (1) While the dataset is impressive, the authors conducted analyses more akin to a "meta-analysis," leaving out important basic information about the raw data in the manuscript. Given the complexity of the relationships between different trophic levels and ecosystem functions, it would be beneficial for the authors to show the results of each SEM (structural equation model).

      We understand the point raised by the reviewer. We now provide individual SEMs (Figure 3), although we limit causal relationships to those for which the p-value was below 0.2 for the sake of graphical clarity. We also provide the percentage of explained variance for each ecosystem function. We detail the graph in the Results section (see l. 317-328) and discuss them (see l. 387-398). Note that we do not detail each function separately as this would (in our opinion) result in a long descriptive paragraph from which it might be difficult to get some key information. Rather, we summarize the percentage of explained variance for each function and discuss the strength of environmental vs biodiversity effects for some examples. In the Discussion, we explain why environmental effects (on functions and biodiversity) are relatively weak. We mainly attribute this to the sampling scheme that follows an East-West gradient (weak altitudinal range) rather than an upstream-downstream gradient as it is traditionally done in rivers. The reasoning behind this sampling scheme is explained in our companion paper (Fargeot et al. Oikos 2023) to which we now refer more explicitly in the MS. Briefly, using an upstream-downstream gradient would have certainly push up the effects of the environment, but this would have made extremely complex the inference of biodiversity effects due to strong collinearity among environmental and biodiversity parameters.

      (2) The main results presented in the manuscript are derived from a "metadata" analysis of effect sizes. However, the methods used to obtain these effect sizes are not sufficiently clarified. By analyzing the effect sizes of species diversity and genetic diversity on these ecosystem functions, the results showed that species diversity had negative effects, while genetic diversity had positive effects on ecosystem functions. The negative effects of species diversity contradict many studies conducted in biodiversity experiments. The authors argue that their study is more relevant because it is based on a natural system, which is closer to reality, but they also acknowledge that natural systems make it harder to detect underlying mechanisms. Providing more results based on the raw data and offering more explanations of the possible mechanisms in the introduction and discussion might help readers understand why and in what context species diversity could have negative effects.

      (We now provide more details. However, we are unfortunately not sure that this helped reaching some stronger explanation regarding underlying mechanisms. To be frank, we did not succeed in improving mechanistic inferences based on the outputs of the SEM models. We explored visually some additional relationships (e.g. relationships between the biomass of the focal species and that of other species in the assemblage) that we now discuss a bit more, but again, this did not really help in better understanding processes. We realize this is a limitation of our study and that this can be frustrating for readers. Nonetheless, as said in the Discussion, field-based study must be taken for what they are; observational studies forming the basis for future mechanistic studies. Although we failed to explain mechanisms, we still think that we provide important field-base evidence for the importance of biodiversity (as a whole) for ecosystem functions.

      3) Environmental variation was included in the analyses to test if the environment would modulate the effects of biodiversity on ecosystem functions. However, the main results and conclusions did not sufficiently address this aspect.

      This is now addressed, see our response to your first comment. We now explain (result section) and discuss environmental effects. As explained in the MS, environmental effects are similar in strength to those of biodiversity and are not that high, which is partly explained by the sampling scheme (see Fargeot et al. 2023). This is a choice we’ve made at the onset of the experiment, as we wanted to focus on biodiversity effects and avoid strong collinearity as it is generally the case in rivers (which impedes any proper and strong statistical inferences).

      Reviewer #2 (Public review):

      Summary:

      Fargeot et al. investigated the relative importance of genetic and species diversity on ecosystem function and examined whether this relationship varies within or between trophic-level responses. To do so, they conducted a well-designed field survey measuring species diversity at 3 trophic levels (primary producers [trees], primary consumers [macroinvertebrate shredders], and secondary consumers [fishes]), genetic diversity in a dominant species within each of these 3 trophic levels and 7 ecosystem functions across 52 riverine sites in southern France. They show that the effect of genetic and species diversity on ecosystem functions are similar in magnitude, but when examining within-trophic level responses, operate in different directions: genetic diversity having a positive effect and species diversity a negative one. This data adds to growing evidence from manipulated experiments that both species and genetic diversity can impact ecosystem function and builds upon this by showing these effects can be observed in nature.

      Strengths:

      The study design has resulted in a robust dataset to ask questions about the relative importance of genetic and species diversity of ecosystem function across and within trophic levels.

      Overall, their data supports their conclusions - at least within the system that they are studying - but as mentioned below, it is unclear from this study how general these conclusions would be.

      Weaknesses:

      (4) While a robust dataset, the authors only show the data output from the SEM (i.e., effect size for each individual diversity type per trophic level (6) on each ecosystem function (7)), instead of showing much of the individual data. Although the summary SEM results are interesting and informative, I find that a weakness of this approach is that it is unclear how environmental factors (which were included but not discussed in the results) nor levels of diversity were correlated across sites. As species and genetic diversity are often correlated but also can have reciprocal feedbacks on each other (e.g., Vellend 2005), there may be constraints that underpin why the authors observed positive effects of one type of diversity (genetic) when negative effects of the other (species). It may have also been informative to run SEM with links between levels of diversity. By focusing only on the summary of SEM data, the authors may be reducing the strength of their field dataset and ability to draw inferences from multiple questions and understand specific study-system responses.

      We have addressed this remark and we ask the reviewers and the readers to refer to our response to comment 1 from reviewer 1. Regarding co-variation among biodiversity estimates (SGDCs according to Vellend’s framework), we have addressed these issues in a companion paper that we now cite and expand further in the MS (Fargeot et al. Oikos, 2023). Given the size of the dataset and its complexity (and associated analyses), we have decided to focus on patterns of species and genetic biodiversity in a first paper (Oikos paper) and then on the link between biodiversity and functions (this paper). As it can be read in the Oikos’s paper, there are no co-variation in term of biodiversity estimates; species diversity is not correlated to genetic diversity, and within facet, there are not co-variation among species. In addition, environmental predictors are highly estimate-specific (i.e. environmental predictors sustaining species and genetic estimates are idiosyncratic). As a result (see the new Figure 3), environmental effects are relatively weak (the same intensity that those of biodiversity) and collinearity among parameters is relatively weak. The second point is important, as this permit to better infer parameters from models, and this allows to discuss direct relationships (as observed in Figure 3, indirect environmental effects are relatively rare). We provide in the Discussion a bit more explanation about the absence of co-variation among biodiversity estimates (see l. 433-440).

      (5) My understanding of SEM is it gives outputs of the strength/significance of each pathway/relationship and if so, it isn't clear why this wasn't used and instead, confidence intervals of Z scores to determine which individual BEFs were significant. In addition, an inclusion of the 7 SEM pathway outputs would have been useful to include in an appendix.

      We now provide p-values (Table S2) and the seven models (Figure 3).

      (6) I don't fully agree with the authors calling this a meta-analysis as it is this a single study of multiple sites within a single region and a specific time point, and not a collection of multiple studies or ecosystems conducted by multiple authors. Moreso, the authors are using meta-analysis summary metrics to evaluate their data. The authors tend to focus on these patterns as general trends, but as the data is all from this riverine system this study could have benefited from focusing on what was going on in this system to underpin these patterns. I'd argue more data is needed to know whether across sites and ecosystems, species diversity and genetic diversity have opposite effects on ecosystem function within trophic levels.

      We agree. “Meta-regression” would perhaps be more adequate than “meta-analyses”. We changed the formulation.

      Reviewer #3 (Public review):

      The manuscript by Fargeot and colleagues assesses the relative effects of species and genetic diversity on ecosystem functioning. This study is very well written and examines the interesting question of whether within-species or among-species diversity correlates with ecosystem functioning, and whether these effects are consistent across trophic levels. The main findings are that genetic diversity appears to have a stronger positive effect on function than species diversity (which appears negative). These results are interesting and have value.

      However, I do have some concerns that could influence the interpretation.

      (7) Scale: the different measures of diversity and function for the different trophic levels are measured over very different spatial scales, for example, trees along 200 m transects and 15 cm traps. It is not clear whether trees 200 m away are having an effect on small-scale function.

      Trees identification and invertebrate (and fish) sampling are done on the same scale. Trees are spread along the river so that their leaves fall directly in the river. Traps have been installed all along the same transect in various micro-habitats. Diversity have been measured at the exact same scale for all organisms. We have modified the MS to make this clear.

      (8) Size of diversity gradients: More information is needed on the actual diversity gradients. One of the issues with surveys of natural systems is that they are of species that have already gone through selection filters from a regional pool, and theoretically, if the environments are similar, you should get similar sets of species, without monocultures. So, if the species diversity gradients range from say, 6 to 8 species, but genetic diversity gradients span an order of magnitude more, you can explain much more variance with genetic diversity. Related to this, species diversity effects on function are often asymptotic at high diversity and so if you are only sampling at the high diversity range, we should expect a strong effect.

      Fish species number varies from 1 to 11, invertebrate family number varies from 15 to 42 and the tree species number varies from 7 to 20 (see Fargeot et al. 2023 for details). We have added this information in the M&M. The gradients are hence relatively large and do not cover a restricted set of values. There is a variance in species number among sites, even if sites are collected along a relatively weak altitudinal gradient. This is obviously complex to compare to SNP (genomic) diversity. Genetic and species effects are similar in effect sizes (percentage of explained variance), so it does not seem we have biased one of the two gradients of biodiversity.

      (9) Ecosystem functions: The functions are largely biomass estimates (expect decomposition), and I fail to see how the biomass of a single species can be construed as an ecosystem function. Aren't you just estimating a selection effect in this case?

      The biomass estimated for a certain area represents an estimate of productivity, whatever the number of species being considered. Obviously, productivity of a species can be due to environmental constraints; the biomass is expected to be lower at the niche margin (selection effect). But if these environmental effects are taken into account (which is the case in the SEMs), then the residual variation can be explained by biodiversity effects. We provide an explanation (l. 217-219).

      (10) Note that the article claims to be one of the only studies to look at function across trophic levels, but there are several others out there, for example:

      Thanks, we now cite some of these studies (Li et al 2020, Moi et al. 2021, Seibold et al. 2018).

      Recommendations for the authors:

      Reviewer #1 (Recommendations for the authors):

      Introduction:

      The introduction of the manuscript is generally well-structured, and the scientific questions are clearly presented. However, in each paragraph where specific aspects are introduced, the authors do not focus sufficiently on the given points. The current introduction discusses the weaknesses of previous studies extensively but lacks detailed explanations of mechanisms and a clear anticipation of this study's contributions.

      For example:

      L72-77: The authors mention that "genetic diversity may functionally compensate for a species loss," but this point is not highly relevant to the main analyses of this study, which focus on comparing the relative effects of species diversity and genetic diversity.

      Yes true, we understand the point made by the reviewers. We deleted this part of the sentence.

      L87-95: As previously noted, "whether environmental variation decreases or enhances the relative influence of genetic and species diversity on ecosystem functions" was not addressed in this study. Additionally, the last sentence seems unnecessary here, as it does not relate to "environmental variation." The phrase "generate insightful knowledge for future mechanistic models" is vague. It would be helpful to specify what kind of knowledge and what types of future mechanistic models are being referred to.

      We modified these two sentences. We now posit the prediction that what has been observed under controlled conditions (that genetic and species have effects of similar magnitude) might not be the norm under fluctuating environments (because it has been shown that environmental variation modulates the strength of interspecific BEFS and create huge variance).

      L96-116: The use of "for instance" three times in this paragraph makes the structure seem scattered, as only examples are provided. Improving the transition words can help the text focus better on the main point.

      We have modified some parts of this section to better reflect predictions

      L115-116: Again, it would be beneficial to specify what kind of insightful information can be provided.

      We have modified this sentence by making more explicit some of the information that may be gained.

      L117-134: Stating clear expectations can help the introduction focus on the mechanisms and assist readers in following the results.

      We now provide some predictions. We were reluctant to make predictions in the first version of the MS as we have the feeling that predictions can go on very different direction depending on how we set the scene. We therefore stick to predictions that we think are the most logical (the simplest ones). This illustrates the lack of theoretical papers on these issues.

      Methods:

      L287-293: The method for estimating the standard effect size is unclear. I assume it was derived from the SEM models? This needs further clarification.

      Yes, it is derived from the standardized estimate from each pSEM. This is now explained in the MS.

      Results:

      As mentioned in the public review, it is very important to show the results of analyzing raw data.

      Done, see Figure 3 and Results section.

      Table 1: The font and format of the PCA table are different from other tables and appear vague, resembling a picture rather than a table.

      Changed.

      Table 2 (and supplementary table): "D.f." is not explained in the table legend. Is 1 the numerator df and 30 the denominator df? Is the denominator the residual? Additionally, the table legend mentions "magnitude and direction." ANOVA only tests if the biodiversity effects are significantly different between species or genetic diversity, but not the magnitude. For example, -0.5 and 0.5 are very different, but their effect magnitudes are the same.

      This is a mistake; sorry the format of the Table was from a previous version of the MS in which we used linear models rather that linear mixed models (both lead to the same results). The ANOVA used to test the significance of fixed terms in linear mixed model are based on Wald chi-sqare tests, and it should have been read “Chi-value” rather than “F-value” in both tables and the only degree of freedom in this test is the one at the numerator. This has been changed. We have changed the caption of the Table (“ANOVA table for the linear mixed model testing whether the relationships between biodiversity and ecosystem functions measured in a riverine trophic chain differ between the biodiversity facets (species or genetic diversity) and the types of BEF (within- or between-trophic levels)”)

      Minor:

      There should always be a space between a number and a unit. In the manuscript, spaces are inconsistently used between numbers and units.

      Corrected

      Reviewer #2 (Recommendations for the authors):

      (1) In the introduction, the authors could focus more and build out what they predicted/hypothesized as well as what has been found in the manipulated experiments that examined the role of species and genetic diversity. That would enhance the background information for a more general audience, and highlight expected results and why.

      We modified the Introduction according to comments made by reviewer 1 and clarified the predictions as best as we can.

      (2) Similarly, the discussion is fairly big picture, but this dataset focused exclusively on this 3-trophic interaction in a riverine system. It could be beneficial to dig into the ecology to find out why the opposite effects of species and genetic diversity are seen within trophic levels in this system.

      We have added some explanations based on the specific pSEM (see our responses to the public reviews for details). But as said in the responses to the public reviews, even with mode detailed models, it is hard to tease apart mechanisms. One important point is that genetic and species diversity do not correlate one to each other (they do not co-vary over space), which means the effect of one facet is independent from the other. However, apart from that, we can’t really tell more without more mechanistic approaches. We understand this is frustrating, but this is the nature of field-based data. This does not mean they are useless. On the contrary, they confirm and expand patterns found under controlled conditions (which for ecologists is quite important as nature is our playground), but they are limited in inferences of mechanisms.

      (3) It would also be informative if the authors specified what positive and negative Z scores mean. It seems counterintuitive in Figure 3. For example, in the upper left, it's denoted as a larger intraspecific effect - which I'd assume is higher genetic (within species) diversity - but is this not where species diversity effects are higher? In theory this figure could be similar to Figure 1 from Des Roches et al. 2018 - where showing the 1:1 line of where species and genetic diversity effects are similar and then how some are more impacted by SD or GD as that links to the overall question, right?

      For example: Figure 3 makes it seem that GD effects are stronger (more positive) for within trophic responses (which is reflected in the text), but in that quadrant, it states that the interspecific effect is larger?

      yes, you’re true Figure 3 (now Figure 4) is not ideal. We added an explicit explanation for interpreting Zr in the main text. In addition, we modified the text in the quadrat as this was not correct. Note that it cannot be directly be compared to that of DesRoches et al. In DesRoches et al., there is a single effect size (ES) per situation (which is roughly expressed as “ES = effect of species - effect of genotypes”). Here, there are two ES per situation, one for the species effect, the other for the genetic effect, which makes the biplot more complex (as species and genetic can be similar in magnitude, but opposite in direction, e.g., 0.5 and -0.5). We may have done as DesRoches et al. (“ES = effect of species - effect of genotypes”), but as we don’t have absolute ES (as in DesRoches) the resulting signs of the ES are non sensical…Not easy for us to find a clever solution (or said differently, we were not clever enough to find an easy solution).  Nonetheless, we tried another visualization by including “sub-quadrats” into the four main quadrats. We hope this will be clearer

      (4) It's unclear why authors included both a simplified linear mixed model with diversity type and biodiversity facet as fixed factors, and then a second linear model that included trophic level (with those other 2 factors and interactions), but only showed results of trophic level from that more complex model. It is unclear why they include two models when the more complex one would have evaluated all aspects of their research question and shown the same patterns.

      You’re true, the more complex model evaluates both aspects. Nonetheless, as the hypotheses were strictly separated, we thought it is simpler to associate one model to one hypothesis. We agree that this duplicates information, but we would like to keep the two models to make the text more gradual.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Reviewer 1:

      - The manuscript needs comprehensive proofreading for language and formatting. In many instances, spaces are missing or not required.

      Thank you for your comments. The manuscript has been thoroughly proofread for errors in language and formatting.

      - Could the authors explore correlation network analyses to get additional insights into the structure of different clusters? 

      We have added a co-occurrence analysis (at species taxonomic level) based on SparCC to the manuscript (Figure 2).

      This is described on Page 9 line 141-148

      - The GitHub link is not correct. 

      The github repository has now been made public.

      - It is not possible to access the dataset on ENA. 

      We have changed the ENA study PRJEB57401 status to open.

      - Add the graphs obtained with decontam analysis as a supplementary figure. 

      We have added the outputs of decontam (.csv files with feature lists of ASVs that were filtered based on the prevalence and frequency tests) to the github repository.

      - There is nothing about the RPL group in the results section, while the authors discuss this issue in the introduction. What about the controls with proven fertility? 

      Thank you. We have amended the manuscript to compare characteristics between the RPL, unexplained subfertility and controls groups.

      Line 1279-130 page 8:  

      “The study group represented 85% of samples with high sperm DNA fragmentation, 85% of samples with elevated ROS and 79% of samples with oligospermia. Rates of abnormal seminal parameters including low sperm concentration, reduced progressive motility and ROS concentrations were found to be highest in the MFI group (Supplementary Figure 1). Baseline characteristics between the RPL, unexplained subfertility and controls groups were similar.

      Line 150-154 Page 9: 

      “Bacterial richness, diversity and load were similar between all patient groups examined in the study (Supplementary Figure 4).

      - While correctly stated in the title, the term microbiota should be used throughout the manuscript instead of "microbiome" 

      Thank you. This misnomer has been amended throughout the manuscript.

      Minor corrections:

      Line 25: provoke is not a good term here. 

      Thank you. The term ‘provoke’ has been removed

      Line 26: why does semen culture have a limited scope? 

      Thank you. Line 40-41 Page 3 has been amended:

      “It is therefore plausible that asymptomatic seminal infections may be associated with impaired reproductive function in some men. Since semen culture has a limited scope for studying the seminal microbiota due to its inability to identify all present microbiota next generation sequencing (NGS) approaches have been reported recently by a growing number of investigators (13, 14, 15, 16, 17, 18, 19)”.

      Line 68: write μl correctly

      Thank you. This has been corrected

      Line 131: several organisms at the genus level. 

      Thank you. This has been corrected

      Line 136: what are the relative abundances of these genera? Is this relevant? 

      The mean relative abundances for the key taxa mention in each cluster are all above 20%. This information has been added to the manuscript text on page 9, line 153.

      Line 173: Molina et al. 

      Thank you. This has been corrected

      Line 173: the contaminations are referred to the low biomass nature of testicular samples. If present, bacteria of accessory gland secretions are an integral part of the seminal microbiota itself. Please review these sentences. 

      Thank you. This had been reworked to highlight the important of urethral contamination, which you later allude to as a limitation of our study is the failure to provide paired urine and semen samples.

      Page 11 line 194-196

      “Molina et al report that 50%-70% of detected bacterial reads may be environmental contaminants in a sample from extracted testicular spermatozoa (35); with the addition of passage along the urethra it is likely that contamination of ejaculated semen would be much higher.”

      Table 1: remove results interpretation from table caption. 

      Thank you this has been acted upon.

      Table 1: why in some cases, like in DNA fragmentation index, the total is not equal to n=223? 

      This is due to missing data/ analysis not possible for some men due to the requirement of a minimum number of sperm in the ejaculate to perform DNA fragmentation testing.

      Table 1: "frag" is not defined. 

      Thank you, this has been amended

      Tables 2, 3 & 4: bacterial genera in italics. 

      Thank you, this has been amended

      Figure 1A: add the fertility status information above the cluster colors. 

      Thank you, this has been amended in Figure 1.

      Figure 1C: the color code is confusing. Use different colors for each cluster. 

      Figure 1 legend: bacterial genera in italics. 

      Figures 1 & 2: the authors should use similar chart formatting in the two tables. 

      Thank you, this has been amended

      Reviewer 2:

      (1) The patient groups have different diagnoses and should be handled as different groups, and not fused into one 'patient' group in analyses. <br /> Why are the data in tables presented as controls and cases? I would consider men from couples with recurrent pregnancy loss, unexplained infertility, and male factor infertility to have different seminal parameters (not to fuse them into one group). This means, that the statistical analyses should be performed considering each group separately, and not to fuse 3 different infertility diagnoses into one patient group. 

      We have conducted detailed analyses, requested by the reviewer, comparing seminal DNA, ROS and microbiota characteristics between each individual patient groups (Supplimental figures 1 and 4). No specific taxa (at either genera or species-level) were found to differ in relative abundance between the diagnostic groups. However, we expect associations between parameters such as reactive oxygen species, or DNA fragmentation, and relative abundance of bacterial species, to be general and not restricted to or specific to each diagnostic group. Therefore, we also conducted further analyses aggregating data from all patient groups to investigate relationships common to these different forms of male reproductive dysfunction.

      (2) Were any covariables included in the statistical analyses, e.g. age, BMI, smoking, time of sexual abstinence, etc? 

      Covariates were not included in the statistical analyses. This has been added in the manuscript to the limitations.

      Page 14 line 267-268

      “Additionally, we did not have other covariables such as smoking status with which to include in further analyses”.

      (3) Furthermore, it is known that 16S rRNA gene analysis does not provide sensitive enough detection of bacteria on the species level. How much do the authors trust their results on the species level? 

      The limitations of taxonomic assignment using 16S rRNA gene metataxonomics are well documented. However, the capacity to assign sequence amplicons at species level depends on the sequence variability of the 16S rRNA gene for each of the taxa reported and the specific gene region chosen. In this study, amplification of the V1-V2 region was performed using a mixed 28f primer set (see methods for details) that enables resolution and assignment of several bacterial species highly relevant to the reproductive tract including Lactobacillus spp., such as L. crispatus and L. iners, (e.g. https://doi.org/10.3389/fcell.2021.641921, https://doi.org/10.1128/msystems.01039-23, https://doi.org/10.1186/s12915-023-01702-2). In this study, we report the presence of L. iners, but not L. crispatus in semen samples, and we have also identified a specific association/co-occurrence between Gardnerella vaginalis and Lactobacillus iners, similar to that observed in vaginal bacterial communities.

      (4) Were the analyses of bacterial genera and species abundances with seminal quality parameters controlled for diagnosis and other confounders? 

      As stated in point 2, no adjustment was made for co-variates. No differences in microbiome composition were observed among the three diagnostic groups, so no adjustments were made to our analysis.

      (5) The authors stress that their study is the biggest on the microbiome in semen. However, when considering that the study consists of 4 groups (with n=46-63), it does not stand out from previous studies. 

      Our study is overall the largest investigating interactions between the seminal microbiome and male reproductive dysfunction. Other studies have included greater numbers of men with infertility.

      (6) Weaknesses: There is a lack of paired seminal/urinal samples. 

      Thank you. This limitation has been added.

      Page 14 line 266-267

      “A further limitation of this study, and others, is the lack of reciprocal genital tract microbiota testing of the female partners, or paired seminal and urinary samples from male participants”.

      Recommendation for authors to consider:

      Including previous classical reviews in the introduction: DOI:10.1097/MOU.0000000000000742 <br /> DOI: 10.1038/s41585-019-0250-y 

      Thank you. This has been added.

      Mentioning in the M&M section that there is a supplementary text with a more detailed M&M part. 

      Thank you. This has been added. Further methodological detail can be found in supplementary text.

      Revising the use of 'microbiota' and 'microbiome', they are not synonyms. When talking of 16S rRNA gene analysis, we consider 'microbiome' analysis. 

      Thank you. This misnomer has been amended throughout the manuscript.

      Revising the text, there are several erratas (e.g. verb missing, etc). 

      Thank you for your comments. The manuscript has been thoroughly proofread for errors in language and formatting.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews: 

      Reviewer #1 (Public Review):

      Summary: 

      In the manuscript entitled "Magnesium modulates phospholipid metabolism to promote bacterial phenotypic resistance to antibiotics", Li et al demonstrated the role of magnesium in promoting phenotypic resistance in V. alginolyticus. Using standard microbiological and metabolomic techniques, the authors have shown the significance of fatty acid biosynthesis pathway behind the resistance mechanism. This study is significant as it sheds light on the role of an exogenous factor in altering membrane composition, polarization, and fluidity which ultimately leads to antimicrobial resistance. 

      Strengths: 

      (1) The experiments were carried out methodically and logically. 

      (2) An adequate number of replicates were used for the experiments. 

      Weaknesses: 

      (1) The introduction section needs to be more informative and to the point.  

      Thank you so much for your suggestion. We have revised the introduction to make it more informative and to the point as following:

      “Non-inheritable antibiotic or phenotypic resistance represents a serious challenge for treating bacterial infections. Phenotypic resistance does not involve genetic mutations Phenotypic resistance does not involve genetic mutations and is transient, allowing bacteria to resume normal growth. Biofilm and bacterial persisters are two phenotypic resistance types that have been extensively studied (Brandis et al., 2023; Corona & Martinez, 2013). Biofilms have complex structures, containing elements that impede antibiotic diffusion, sequestering and inhibiting their activity (Ciofu et al., 2022). Biofilm-forming bacteria and persisters also have distinct metabolic states that significantly reduce their antibiotic susceptibility (Yan & Bassler, 2019). These two types of phenotypic resistance share the common feature in their retarded or even cease of growth in the presence of antibiotics (Corona & Martinez, 2013). However, specific factors that promote phenotypic resistance and allow bacteria to proliferate in the presence of antibiotics remain poorly defined.

      Metal ions have a diverse impact on the chemical, physical, and physiological processes of antibiotic resistance  (Booth et al, 2011; Lu et al, 2020; Poole, 2017). This includes genetic elements that confer resistance to metals and antibiotics (Poole, 2017) and metal cations that directly hinder (or enhance) the activity of specific antibiotic drugs (Zhang et al., 2014). The metabolic environment can also impact the sensitivity of bacteria to antibiotics (Jiang et al., 2023; Lee & Collins, 2012; Peng et al., 2015; Zhang et al., 2020; Zhao et al., 2021). Light metal ions, such as magnesium, sodium, and potassium, can behave as cofactors for different enzymes (Du et al., 2016) and influence drug efficacy. Heavy metal ions, including Cu2+ and Zn2+, confer resistance to antibiotics (Yazdankhah et al., 2014; Zhang et al., 2018). Recent reports suggest that sodium negatively regulates redox states to promote the antibiotic resistance of Vibrio alginolyticus (Yang et al., 2018), while actively growing Bacillus subtilis cope with ribosome-targeting antibiotics by modulating ion flux (Lee et al, 2019). In Gram-negative bacteria, by contrast, zinc enhances antibiotic efficacy by potentiating carbapenem, fluoroquinolone, and β-lactam-mediated killing (Isaei et al., 2016; Zhang et al., 2014). Magnesium influences bacterial structure, cell motility, enzyme function, cell signaling, and pathogenesis (Wang et al., 2019). This mineral also modulates microbiota to harvest energy from the diet (Garcia-Legorreta et al., 2020), allowing Bacillus subtilis to cope with ribosome-targeting antibiotics by modulating ion flux (Lee et al., 2019). However, the role of magnesium in promoting phenotypic resistance is less well understood.

      Vibrios inhabit seawater, estuaries, bays, and coastal waters, regions full of metal ions such as magnesium (Kumarage et al., 2022). Magnesium is the second most dissolved element in seawater after sodium. At a salinity of 3.5% seawater, the magnesium concentration is about 54 mM (Potis, 1968), and in deep seawater, can be as high as 2,500 mM (Wang et al., 2024). Vibrio parahaemolyticus and V. alginilyticus are two representative Vibrio pathogens that infect humans and aquatic animals, resulting in illness and economic loss, respectively (Grimes, 2020). (Fluoro)quinolones such as balofloxacin are used to treat Vibrio infection, however, resistance has emerged due to overuse (Suyamud et al., 2024). Indeed, (fluoro)quinolones are one of China's two primary residual chemicals associated with aquaculture (Liu et al., 2017). Vibrio can develop quinolone resistance through mutations in the DNA gyrase gene or through plasmid-mediated mechanisms (Dutta et al., 2021). Thus, the use of V. parahaemolyticus and V. alginilyticus as bacterial representatives, and balofloxacin as a quinolone-based antibacterial representative, can help to define novel magnesiumdependent phenotypic resistance mechanisms of pathogenic Vibrio species. 

      The current study evaluated whether magnesium induces phenotypic resistance in Vibrio species and defined the molecular/genetic basis for this resistance. Genetic approaches, GC-MS analysis of metabolite and membrane remodeling upon antibiotic exposure, membrane physiology, and extensive antimicrobial susceptibility testing were used for the evaluations.”

      (2) The weakest point of this paper is in the logistics through the results section. The way authors represented the figures and interpreted them in the results section (or the figure legends) does not match. The figures are difficult to interpret and are not at all self-explanatory. 

      Thank you so much for your suggestion. We have followed your suggestion to check the match between result and figures. They are now revised. 

      (3) There are too many mislabeling of the figure panels in the main text which makes it difficult to find out which figures the authors are explaining. There should be more explanation on why and how they did the experiments and how the results were interpreted. 

      Thank you so much for your suggestion. We have checked the figures and main text to ensure that we make every figure clearly stated.  

      Reviewer #2 (Public Review): 

      Summary: 

      In this study, the authors aimed to identify if and how magnesium affects the ability of two particular bacteria species to resist the action of antibiotics. In my view, the authors succeeded in their goals and presented a compelling study that will have important implications for the antibiotic resistance research community. Since metals like magnesium are present in all lab media compositions and are present in the host, the data presented in this study certainly will inspire additional research by the community. These could include research into whether other types of metals also induce multi-drug resistance, whether this phenomenon can be observed in other bacterial species, especially pathogenic species that cause clinical disease, and whether the underlying molecular determinants (i.e. enzymes) of metal-induced phenotypic resistance could be new antimicrobial drug targets themselves. 

      Strengths: 

      This study's strengths include that the authors used a variety of methodologies, all of which point to a clear effect of exogenous Mg2+ on drug resistance in the targeted species. I also commend the authors for carrying out a comprehensive study, spanning evaluation of whole cell phenotypes, metabolic pathways, genetic manipulation, to enzyme activity level evaluation. The fact that the authors uncovered a molecular mechanism underlying Mg2+-induced phenotypic resistance is particularly important as the key proteins should be studied further.

      Weaknesses: 

      I believe there are weaknesses in the manuscript, however. The authors take for granted that the reader is familiar with all the assays utilized, and do not properly explain some experiments, and thus I highly suggest that the authors add a brief statement in each situation describing the rationale for each selected methodology (more details are in the private review to the authors). The Results section is also quite long and bogs down at times, and I suggest that the authors reduce its length by 10 to 20%. In contrast, the Introduction is sparse and lacks key aspects, for example, there should be mention of the study's main purpose and approaches, plus an introduction to the authors' choice of species and their known drug resistance properties, as well as the drug of choice (balofloxacin). Another notable weakness is that the authors evaluated Mg2+-induced phenotypic resistance only against two closely related species, and thus the generalizability of this mechanism of drug resistance is not known. The paper would be strengthened if the authors could demonstrate this type of phenotypic resistance in at least one more Gram-negative species and at least one Gram-positive species (antimicrobial susceptibility evaluations would suffice), each of which should be pathogenic to humans. Demonstrating magnesium-induced phenotypic drug resistance in the WHO Priority Bacterial Pathogens would be particularly important. 

      In general, the conclusions drawn by the authors are justified by the data, except for the interpretation of some experiments. Importantly, this paper has discovered new antimicrobial resistance mechanisms and has also pointed to potential new targets for antimicrobials. 

      Thank you so much for your suggestion! We followed your idea the revise the manuscript as following:

      (1) We added a brief statement in the situation to explain the result and methodology according to your suggestion in the private review.

      (2) To make the streamline of the story more logic, we moved the whole second result to supplementary text and supplementary figure. 

      (3) We revised the introduction part by adding additional information to make it informative and to the point as following:

      “Non-inheritable antibiotic or phenotypic resistance represents a serious challenge for treating bacterial infections. Phenotypic resistance does not involve genetic mutations Phenotypic resistance does not involve genetic mutations and is transient, allowing bacteria to resume normal growth. Biofilm and bacterial persisters are two phenotypic resistance types that have been extensively studied (Brandis et al., 2023; Corona & Martinez, 2013). Biofilms have complex structures, containing elements that impede antibiotic diffusion, sequestering and inhibiting their activity (Ciofu et al., 2022). Biofilm-forming bacteria and persisters also have distinct metabolic states that significantly reduce their antibiotic susceptibility (Yan & Bassler, 2019). These two types of phenotypic resistance share the common feature in their retarded or even cease of growth in the presence of antibiotics (Corona & Martinez, 2013). However, specific factors that promote phenotypic resistance and allow bacteria to proliferate in the presence of antibiotics remain poorly defined.

      Metal ions have a diverse impact on the chemical, physical, and physiological processes of antibiotic resistance  (Booth et al, 2011; Lu et al, 2020; Poole, 2017). This includes genetic elements that confer resistance to metals and antibiotics (Poole, 2017) and metal cations that directly hinder (or enhance) the activity of specific antibiotic drugs (Zhang et al., 2014). The metabolic environment can also impact the sensitivity of bacteria to antibiotics (Jiang et al., 2023; Lee & Collins, 2012; Peng et al., 2015; Zhang et al., 2020; Zhao et al., 2021). Light metal ions, such as magnesium, sodium, and potassium, can behave as cofactors for different enzymes (Du et al., 2016) and influence drug efficacy. Heavy metal ions, including Cu2+ and Zn2+, confer resistance to antibiotics (Yazdankhah et al., 2014; Zhang et al., 2018). Recent reports suggest that sodium negatively regulates redox states to promote the antibiotic resistance of Vibrio alginolyticus (Yang et al., 2018), while actively growing Bacillus subtilis cope with ribosome-targeting antibiotics by modulating ion flux (Lee et al, 2019). In Gram-negative bacteria, by contrast, zinc enhances antibiotic efficacy by potentiating carbapenem, fluoroquinolone, and β-lactam-mediated killing (Isaei et al., 2016; Zhang et al., 2014). Magnesium influences bacterial structure, cell motility, enzyme function, cell signaling, and pathogenesis (Wang et al., 2019). This mineral also modulates microbiota to harvest energy from the diet (Garcia-Legorreta et al., 2020), allowing Bacillus subtilis to cope with ribosome-targeting antibiotics by modulating ion flux (Lee et al., 2019). However, the role of magnesium in promoting phenotypic resistance is less well understood.

      Vibrios inhabit seawater, estuaries, bays, and coastal waters, regions full of metal ions such as magnesium (Kumarage et al., 2022). Magnesium is the second most dissolved element in seawater after sodium. At a salinity of 3.5% seawater, the magnesium concentration is about 54 mM (Potis, 1968), and in deep seawater, can be as high as 2,500 mM (Wang et al., 2024). Vibrio parahaemolyticus and V. alginilyticus are two representative Vibrio pathogens that infect humans and aquatic animals, resulting in illness and economic loss, respectively (Grimes, 2020). (Fluoro)quinolones such as balofloxacin are used to treat Vibrio infection, however, resistance has emerged due to overuse (Suyamud et al., 2024). Indeed, (fluoro)quinolones are one of China's two primary residual chemicals associated with aquaculture (Liu et al., 2017). Vibrio can develop quinolone resistance through mutations in the DNA gyrase gene or through plasmid-mediated mechanisms (Dutta et al., 2021). Thus, the use of V. parahaemolyticus and V. alginilyticus as bacterial representatives, and balofloxacin as a quinolone-based antibacterial representative, can help to define novel magnesiumdependent phenotypic resistance mechanisms of pathogenic Vibrio species. 

      The current study evaluated whether magnesium induces phenotypic resistance in Vibrio species and defined the molecular/genetic basis for this resistance. Genetic approaches, GC-MS analysis of metabolite and membrane remodeling upon antibiotic exposure, membrane physiology, and extensive antimicrobial susceptibility testing were used for the evaluations.”

      (4) We examined the effect of magnesium in WHO listed priority strains, which confirmed the results as following:

      “Importantly, exogenous MgCl2 also increased MICs of clinic isolates, carbapenemresistant Escherichia coli, carbapenem-resistant Klebsiella pneumoniae, carbapenemresistant Pseudomonas aeruginosa and carbapenem-resistant Acinetobacter baumannii to balofloxacin (Fig 1G).”

      Recommendations for the authors:

      Reviewer #1 (Recommendations For The Authors): 

      (1) There are many grammatical mistakes to point out. The manuscript needs proofreading and editing.

      We appreciate this comment! The manuscript has been revised by a native speaker.

      (2) The introduction could be more informative. A little more description of magnesium - such as what it does to antibiotics and how it's known to affect the microbiome - might be helpful for the general readers. The question remains why out of all the metal ions that might affect antibiotic resistance (many of them are less explored), authors particularly decided to work on the effect of magnesium. The introduction should cover the rationale of their hypothesis. Also, the authors might want to briefly talk about the model organisms (V. algonolyticus and V. parahemolyticus) describing how threatening they are and how they are becoming resistant to antibiotics. 

      We appreciate this comment! We revise the introduction by providing additional information as following:

      “In Gram-negative bacteria, by contrast, zinc enhances antibiotic efficacy by potentiating carbapenem, fluoroquinolone, and β-lactam-mediated killing (Isaei et al., 2016; Zhang et al., 2014). Magnesium influences bacterial structure, cell motility, enzyme function, cell signaling, and pathogenesis (Wang et al., 2019). This mineral also modulates microbiota to harvest energy from the diet (Garcia-Legorreta et al., 2020), allowing Bacillus subtilis to cope with ribosome-targeting antibiotics by modulating ion flux (Lee et al., 2019). However, the role of magnesium in promoting phenotypic resistance is less well understood.

      Vibrios inhabit seawater, estuaries, bays, and coastal waters, regions full of metal ions such as magnesium (Kumarage et al., 2022). Magnesium is the second most dissolved element in seawater after sodium. At a salinity of 3.5% seawater, the magnesium concentration is about 54 mM (Potis, 1968), and in deep seawater, can be as high as 2,500 mM (Wang et al., 2024). Vibrio parahaemolyticus and V. alginilyticus are two representative Vibrio pathogens that infect humans and aquatic animals, resulting in illness and economic loss, respectively (Grimes, 2020). (Fluoro)quinolones such as balofloxacin are used to treat Vibrio infection, however, resistance has emerged due to overuse (Suyamud et al., 2024). Indeed, (fluoro)quinolones are one of China's two primary residual chemicals associated with aquaculture (Liu et al., 2017). Vibrio can develop quinolone resistance through mutations in the DNA gyrase gene or through plasmid-mediated mechanisms (Dutta et al., 2021). Thus, the use of V. parahaemolyticus and V. alginilyticus as bacterial representatives, and balofloxacin as a quinolone-based antibacterial representative, can help to define novel magnesiumdependent phenotypic resistance mechanisms of pathogenic Vibrio species. 

      The current study evaluated whether magnesium induces phenotypic resistance in Vibrio species and defined the molecular/genetic basis for this resistance. Genetic approaches, GC-MS analysis of metabolite and membrane remodeling upon antibiotic exposure, membrane physiology, and extensive antimicrobial susceptibility testing were used for the evaluations. ”

      (3) Figure 1C is mislabeled as 1B (line 100). Line 101: The sentence is not clear and very confusing. What is meant by 15.6mM - 62.4 mM? Are they talking about the concentration of BLFX (though in the figure the concentration was shown in µg)? Please rewrite the sentence in a simplified way. Also, the zone of inhibition was decreased with increasing MgCl2, not increased. 

      We appreciate this comment! These have been revised, including that Fig 1B is now corrected as Fig. 1C. Line 101, which is now Line 122. The sentence was revised as following:

      “At balofloxacin doses of 1.56, 3.125, 6.25, and 12.5 µg, the zone of inhibition decreased with increasing MgCl2 (Fig 1D)”

      (4) In the western blot images, it would be nice to indicate the MW of the protein bands shown. The loading control used for the experiments should be clearly mentioned in the figure legends. 

      We appreciate this comment! The MWs are indicated in the western-blot image throughout the manuscript. 

      The loading control is clearly stated in the figure legend as following:

      “Whole cell lysates resolved by SDS-PAGE gel was stained with Coomassie brilliant blue as loading control.”. 

      (5) Figures 2 B and C: the figure legend does not explain what the authors wanted to show. It's not clear how they plotted the inhibitory curve, or the binding efficacy. These panels need an explanation of how the analysis was done.

      We appreciate this comment! The figure 2 is now removed to Suppl. Fig 2, and the description of figure 2 is moved to Suppl. Text. We revise the description of the result as following, which is in Suppl. Text:

      “Prior studies suggest that the chelation of antibiotics by magnesium ions inhibits antibiotic uptake (Deitchman et al., 2018; Lunestad and Goksøyr, 1990). To investigate whether magnesium binds to balofloxacin, balofloxacin was pre-incubated with magnesium, and zone of inhibition (ZOI) analysis was conducted. Six different concentrations of balofloxacin were separately incubated with six different concentrations of MgCl2, and then spotted on filter paper so that a defined amount of balofloxacin could be used for ZOI. While lower concentrations of MgCl2, (0.78, 3.125, or 12.5 mM) did not alter the ZOI, higher concentrations, including 50 and 200 mM MgCl2, decreased the ZOI (Suppl. Fig 2A), suggesting that even high doses of magnesium had only a partial effect on balofloxacin through direct binding. For example, at 200 mM MgCl2 and 5 or 10 μg/mL balofloxacin, the balofloxacin ZOI was 53.2 and 70.3% of the ZOI at 0 mM MgCl2, suggesting that  50% of the antibiotics were still functional. Intracellular BLFX also decreased with increasing MgCl2 (Suppl. Fig 2B), while exogenous Mg2+ increased intracellular Mg2+ levels in a dose-dependent manner. For example, exogenous 50 and 200 mM MgCl2 increased intracellular Mg2+ levels to 1.21 and 1.31 mM, respectively (Suppl. Fig 2C). The relationship between TolC, an efflux pump that transports quinolones from bacterial cells, and Mg2+ was also assessed (Kobylka et al., 2020; Song et al., 2020). The expression of TolC/tolC was unaffected by Mg2+ (Suppl. Fig 2D). Magnesium is critical for LPS stability. LPS levels increased at 200 mM Mg2+ (Suppl. Fig 2E), however, the loss of waaF, lpxA, and lpxC, three key genes involved in LPS biosynthesis, did not influence balofloxacin sensitivity/resistance in the presence of Mg2+ (Suppl. Fig 2F). These findings suggest that magnesium-induced LPS biosynthesis does not contribute directly to BLFX resistance and demonstrate that Mg2+ influx is involved in balofloxacin resistance.”

      (6) For the metabolomics results, it will help immensely if the authors provide a volcano plot of the identified metabolites and plot the heat map according to the -log2 metabolite intensities. In Figure 3A, it's not clear what information is conveyed through Euclidean distance calculations of the heat map. In Figure 3 B, the authors mentioned that the OPLS-DA test was conducted, although the figure shows a PCA plot, so it's not clear how these two are connected. Figure 3 E: the figure legend says scattered plot, but the panel represents color-coded numerical values, not a scattered plot. Also, it's not clear how they got those values. 

      We appreciate this comment! We quite agree with you that if the differential metabolites could be shown as volcano plot. However, we didn’t adopt volcano plot in this study because this is a magnesium concentration-dependent metabolomes that includes 6 groups in parallel. Volcano plots may give a complex view of the comparison among different groups. We also tried to plot the heat map according to the -log2 metabolite intensities. Although this analysis cluster 200 mM and 50 mM groups better, the data of low magnesium concentrations was not consistent, which may be due to the minor metabolic change of low concentrations magnesium. Thank you for your understanding. 

      For Euclidean distance calculations, we explain in the figure legend as following:

      “Euclidean distance calculations were used to generate a heatmap that shows clustering of the biological and technical replicates of each treatment.” 

      In Figure 2B, which was Figure 3B in previous version, it has been replaced with OPLS-DA analysis in the revised version. 

      In Figure 2E, which was Figure 3E in previous version, it is revised as following:

      “E. Areas of the peaks of palmitic acid and stearic acid generated by GC-MS analysis.” 

      (7) In Figure 4, the figure legends (as well as the in the text) are not properly referred to. Please make sure to refer to the correct panel. 

      We appreciate this comment! The figure legends have been corrected to match the panel and text. 

      Figure 4F: how was the synergy analysis done? In the methods section, the authors described the antibiotic bactericidal assay protocol, but there was no clear indication of how they generated the isobologram. 

      We appreciate this comment! We provide additional information in the Figure 3F legend, which was Figure 4F in previous version,  as following: 

      “Synergy analysis for BFLX with palmitic acid for V. alginolyticus. Synergy was performed by comparing the dose needed for 50% inhibition of the synergistic agents (white) and non-synergistic (i.e., additive) agents (purple).”

      (8) Figure 5 A: the scatter plot is plotted according to the area along the Y axis: which "area" is represented here? There is absolutely no explanation, neither in the results nor in the figure legends. Using box plots might be a better option than using a scattered plot.

      We appreciate this comment! “Area” has been noted in the revised manuscript as following:

      “The area indicates the area of the peak of the metabolite in total ion chromatography of GC-MS.” 

      (9) In Figure 6 A, the heat map is plotted according to the column Z scores. What is meant by "column Z score"? The corresponding figure legend says, "heat map showing differential abundance of lipid". Z scores do not represent an abundance of a variable, so the conclusion might not be appropriate here. 

      We appreciate this comment! In Figure 5A, which was Figure 6A in previous version, column Z score shows the abundance of metabolites analyzed, which is automatically generated in the heat map analysis to give a sign of these metabolites tested. The legend has been revised as following: 

      “Heatmap showing changes in differential lipid levels at the indicated concentration of MgCl2.”  

      (10) Line 313-314: it should be Figure EV6C.  

      We appreciate this comment! The citation has been corrected.

      (11) The authors have shown that Mg+2 does not alter the LPS transport system, however, there was some significant increase in LPS expression at 200mM MgCl2. It would be interesting if the authors could also check if Mg+2 has any effect on the outer membrane protein (OMP) integrity (by checking OMP components BamA and LptD).  

      We appreciate this comment!  We have carefully examined the membrane permeability in Figure 7. We thus didn’t perform additional experiment here to see the change of BamA and LptD. Thank you very much for your understanding.

      (12) I wonder if the authors could check the effect of extracellular Mg+2 during the co-treatment of palmitic acid, linoleic acid, and balofloxacin. Will there still be the antagonistic effect or the presence of Mg+2 could change the phenotype? 

      We appreciate this comment! Additional experiments is performed as following:

      “Furthermore, magnesium had a minimal effect on the antagonistic effect of palmitic acid, linolenic acid, and balofloxacin (Fig 4G), suggesting that this mineral functions through lipid metabolism.” 

      Reviewer #2 (Recommendations For The Authors)

      (1) As mentioned in the Public Review, I strongly believe that the impact of this study will be more significant if magnesium-induced phenotypic drug resistance could be demonstrated in at least one other Gram-negative and one other Grampositive species, both of which should be human pathogens. The full suite of experiments would not be necessary for this suggestion; evaluation of the effect of Mg concentration in growth media on the drug resistance of other species, testing the different antibiotic types used in this study, would be sufficient. 

      We appreciate this comment! Additional experiments have performed to test this idea. Mg2+ has the similar effect on carbapenem-resistant Escherichia coli, carbapenem-resistant Klebsiella pneumoniae, carbapenem-resistant Pseudomonas aeruginosa and carbapenem-resistant Acinetobacter baumannii as the similar as on the Vibrio species in shown in Figure 1G. These have been described following as

      “Importantly, exogenous MgCl2 also increased MICs of clinic isolates, carbapenemresistant Escherichia coli, carbapenem-resistant Klebsiella pneumoniae, carbapenemresistant Pseudomonas aeruginosa and carbapenem-resistant Acinetobacter baumannii to balofloxacin (Fig 1G).”

      (2) I recommend that the Introduction section be expanded. I recommend one or two sentences introducing the two Vibrio species selected for study. I.e. why did the authors choose these two species? What is known about their phenotypic drug resistance in the literature? Why did the authors select balofloxacin for their studies, is it a common antimicrobial used vs Vibrios? As well, the end of the Introduction section ends abruptly with no transition to the present study itself. The end of the introduction should include one or two sentences introducing the main purpose of the study, its approach, and the techniques undertaken. For example, "In this study, we evaluated whether magnesium induces phenotypic resistance in Vibrio species and the molecular/genetic basis for such resistance. We used genetic approaches, GC-MS analysis of metabolite and membrane remodeling upon antibiotic exposure, membrane physiology, and extensive antimicrobial susceptibility evaluations." 

      We appreciate this comment! We revise the introduction by providing additional information as following:

      “In Gram-negative bacteria, by contrast, zinc enhances antibiotic efficacy by potentiating carbapenem, fluoroquinolone, and β-lactam-mediated killing (Isaei et al., 2016; Zhang et al., 2014). Magnesium influences bacterial structure, cell motility, enzyme function, cell signaling, and pathogenesis (Wang et al., 2019). This mineral also modulates microbiota to harvest energy from the diet (Garcia-Legorreta et al., 2020), allowing Bacillus subtilis to cope with ribosome-targeting antibiotics by modulating ion flux (Lee et al., 2019). However, the role of magnesium in promoting phenotypic resistance is less well understood.

      Vibrios inhabit seawater, estuaries, bays, and coastal waters, regions full of metal ions such as magnesium (Kumarage et al., 2022). Magnesium is the second most dissolved element in seawater after sodium. At a salinity of 3.5% seawater, the magnesium concentration is about 54 mM (Potis, 1968), and in deep seawater, can be as high as 2,500 mM (Wang et al., 2024). Vibrio parahaemolyticus and V. alginilyticus are two representative Vibrio pathogens that infect humans and aquatic animals, resulting in illness and economic loss, respectively (Grimes, 2020). (Fluoro)quinolones such as balofloxacin are used to treat Vibrio infection, however, resistance has emerged due to overuse (Suyamud et al., 2024). Indeed, (fluoro)quinolones are one of China's two primary residual chemicals associated with aquaculture (Liu et al., 2017). Vibrio can develop quinolone resistance through mutations in the DNA gyrase gene or through plasmid-mediated mechanisms (Dutta et al., 2021). Thus, the use of V. parahaemolyticus and V. alginilyticus as bacterial representatives, and balofloxacin as a quinolone-based antibacterial representative, can help to define novel magnesiumdependent phenotypic resistance mechanisms of pathogenic Vibrio species. 

      The current study evaluated whether magnesium induces phenotypic resistance in Vibrio species and defined the molecular/genetic basis for this resistance. Genetic approaches, GC-MS analysis of metabolite and membrane remodeling upon antibiotic exposure, membrane physiology, and extensive antimicrobial susceptibility testing were used for the evaluations. ”

      (3) The authors introduce the acronym AWST but never use it again in the paper, instead they use SWT. The authors should introduce SWT only for consistency. 

      We appreciate this comment! We have corrected all the “SWT” to “ASWT”

      (4) Line 76 is not clear: what is meant by "some of which could influence drug efficacy" - the enzymes that utilize light metal ions are co-factors? Or the metals directly?  

      We appreciate this comment! The information we wanted to deliver is that light metal ions can serve as cofactors to catalyze biochemical reaction. Such chemical reaction would alter the drug efficacy, e.g. the Fe-S cluster are metallocofactor for proteins which regulates redox chemistry including antibioticinduced redox change. However, this information is not appropriate for this manuscript, so we delete this sentence. 

      (5) Line 90: add a reference corroborating that this chemical composition is a mimic of marine water. The NaCl concentration used in particular looks quite low. 

      We appreciate this comment! It was a typo error. The NaCl concentration was 210 mM as shown in Suppl. Table 1. We also provide details of the chemical composition of the marine water as following:

      “Marine environments and agriculture, where antibiotics are commonly used, are rich in magnesium. To investigate whether this mineral impacts antibiotic activity, the minimal inhibitory concentration (MIC) of V. alginolyticus ATCC33787 and V. parahaemolyticus VP01, which we referred as ATCC33787 and VP01 afterwards, isolated from marine aquaculture, to balofloxacin (BLFX) in Luria-Bertani medium

      (LB medium) plus 3% NaCl as LBS medium and “artificial seawater” (ASWT) medium that included the major ion species in marine water (Wilson, 1975) (LB medium plus 210 mM NaCl, 35 mM Mg2SO4, 7 mM KCl, and 7 mM CaCl2) were assessed”

      (6) Line 98 and Figure 1B. M9 is indicated in the text but does not appear in the figure, the figure only shows SWT. This should be checked. Line 99: based on Figure 1C, the authors are adding MgCl2 to SWT, SWT should be mentioned in this line. Line 100: I believe this is referring to Figure 1C, which should be checked. 

      We appreciate this comment! 

      Line 98, which is now Line 118: We have corrected M9 to ASWT as following:

      “However, the MIC for BLFX was higher in ASWT medium supplemented with Mg2SO4 or MgCl2 than in LB medium (Fig 1B).”

      Line 99, which is now Line 133: the sentence is corrected as following:

      “The MIC for BLFX increased at higher concentrations of MgCl2 in ASWT”

      Line 100, which is now Line 135: we have corrected Fig 1B to Fig. 1C.

      (7) Line 101: text and Figure 1D are not consistent, as Figure 1D does not show this level of precision in added MgCl2 as indicated in the text (15.6 - 62.4 mM).  

      We appreciate this comment! The sentence has been corrected as following: “At balofloxacin doses of 1.56, 3.125, 6.25, and 12.5 µg, the zone of inhibition decreased with increasing MgCl2 (Fig 1D)””.  

      (8) MgCl2 clearly induces increasing levels of BLFX resistance, and to high levels, but not for every antibiotic. For example, the level of increased resistance to blactams is low (ceftriaxone) and plateaus (ceftazidime). As well, resistance to gentamicin plateaus at a lower level than the other aminoglycosides. These observations do not take away from the conclusion that Mg induces multi-drug resistance, but since the behaviour of the MICs for these drugs is different than the other drugs, they should be mentioned. Also, Figure 1F - tetracyclines (plural) is used for vertical axis label - does this refer to the tetracycline itself or the class itself, and if the class, which one was tested? 

      We appreciate this comment! We revise the description as following: “Notably, magnesium had a reduced effect on ceftriaxone and gentamicin than other antibiotics.”

      The tetracyclines is labeled as “Oxytetracycline” in the revised manuscript. 

      - The magnesium chelation experiments presented in Figure 2 are not clear. The authors should briefly mention how this was done around line 128, and what data underlies the values in Figure 2C. Figure 2B is also not clear to me at all. Similarly, how the authors measured intracellular balofloxacin and Mg2+ is not clear and should be mentioned briefly around lines 130-132. 

      We appreciate this comment! These have been rewritten following as  “To investigate whether magnesium binds to balofloxacin, balofloxacin was preincubated with magnesium, and zone of inhibition (ZOI) analysis was conducted. Six different concentrations of balofloxacin were separately incubated with six different concentrations of MgCl2, and then spotted on filter paper so that a defined amount of balofloxacin could be used for ZOI. While lower concentrations of MgCl2, (0.78, 3.125, or 12.5 mM) did not alter the ZOI, higher concentrations, including 50 and 200 mM MgCl2, decreased the ZOI (Suppl. Fig 2A), suggesting that even high doses of magnesium had only a partial effect on balofloxacin through direct binding. For example, at 200 mM MgCl2 and 5 or 10 μg/mL balofloxacin, the balofloxacin ZOI was 53.2 and 70.3% of the ZOI at 0 mM MgCl2, suggesting that  50% of the antibiotics were still functional. Intracellular BLFX also decreased with increasing MgCl2 (Suppl. Fig 2B), while exogenous Mg2+ increased intracellular Mg2+ levels in a dose-dependent manner. For example, exogenous 50 and 200 mM MgCl2 increased intracellular Mg2+ levels to 1.21 and 1.31 mM, respectively (Suppl. Fig 2C). The relationship between TolC, an efflux pump that transports quinolones from bacterial cells, and Mg2+ was also assessed (Kobylka et al., 2020; Song et al., 2020). The expression of TolC/tolC was unaffected by Mg2+ (Suppl. Fig 2D). Magnesium is critical for LPS stability. LPS levels increased at 200 mM Mg2+ (Suppl. Fig 2E), however, the loss of waaF, lpxA, and lpxC, three key genes involved in LPS biosynthesis, did not influence balofloxacin sensitivity/resistance in the presence of Mg2+ (Suppl. Fig 2F). These findings suggest that magnesium-induced LPS biosynthesis does not contribute directly to BLFX resistance and demonstrate that Mg2+ influx is involved in balofloxacin resistance.”

      - Line 135: LPS cannot be "expressed", as the authors word it here. This should be corrected. Also, the inspection of Figure 2G actually shows the levels of LPS increase with increased Mg2+. The authors should re-evaluate these results and change their description around this area of the Results. 

      We appreciate this comment! We have removed the whole Figure 2 to Supplementary Text and Supplementary Figure 2. We rewrite this part as following: “The relationship between TolC, an efflux pump that transports quinolones from bacterial cells, and Mg2+ was also assessed (Kobylka et al., 2020; Song et al., 2020). The expression of TolC/tolC was unaffected by Mg2+ (Suppl. Fig 2D). Magnesium is critical for LPS stability. LPS levels increased at 200 mM Mg2+ (Suppl. Fig 2E), however, the loss of waaF, lpxA, and lpxC, three key genes involved in LPS biosynthesis, did not influence balofloxacin sensitivity/resistance in the presence of Mg2+ (Suppl. Fig 2F). These findings suggest that magnesium-induced LPS biosynthesis does not contribute directly to BLFX resistance and demonstrate that Mg2+ influx is involved in balofloxacin resistance.”

      - Section: MgCl2 affects bacterial metabolism. Authors switched to M9 medium - why? This contrasts with other sections using SWT and should be explained. Also, I cannot evaluate whether the statistical analysis of the data here was performed correctly and was appropriate for this type of experiment. I advise the authors to move the details in lines 166-169 to the Materials and Methods and replace this section instead with a more accessible description of the statistical analysis that a non-expert would be able to appreciate. Furthermore, analysis of Figure 3A indicates that the levels of asparagine, 4-hydroxybutyric acid, uracil, cystathionine, fumaric acid, and aminoethanol have significantly changed at high MgCl2, but these are not mentioned in the text. I suggest the authors mention these if they are relevant to the 12 enriched pathways, especially the biosynthesis of fatty acids. 

      We appreciate this comment! 

      We indicate the reason we use M9 medium as following:

      “To better understand how magnesium affects bacterial metabolism” for explaining why the M9 medium was used.”

      The information lines 166-169 indicated has been removed to M &M. 

      We have carefully examined the abundance of the metabolites and the enriched pathway. Among the listed metabolites, only fumarate is within the enriched pathways. We mention this point in our revised manuscript as following:

      “The increase in fatty acid biosynthesis could be partially explained by an imbalanced pyruvate cycle/TCA cycle, in which fumarate levels increased at higher Mg2+ while succinate levels increased at lower Mg2+ (Suppl. Fig 5B). These findings indicated that glycolysis fluxes into fatty acid biosynthesis rather than the pyruvate cycle/TCA cycle. The relevance of fatty acids and BLFX was demonstrated by the observation that exogenous palmitic acid increased bacterial resistance to balofloxacin (Fig 2F). These results suggest that fatty acid metabolism may be critical to magnesium-based phenotypic resistance.”

      - Line 211 appears to refer to Figure 4F and should be checked. Similarly in line 216 - appears this should be Figure 4H, and line 218 should be Figure 4H. Line 226: add a reference to Fig 4I (after arcA was decreased). Line 227: what are genes N646_1004 and N646_1885? Based on Fig 4J these are crp - authors should add to line 227. Line 228 appears to refer to Figure 4J, not Figure 4I. Line 229 - should be Figure 4K, not Figure 4I. Line 231 - should be 4L, not 4K. Line 239 - should be 4M.

      We appreciate this comment! The text and figure is now matched. 

      - Line 312: the descriptions of "11 lipids, 32 lipids, and 53", and then "26 lipids, 52 lipids, and 107 lipids" are not clear at all and should be corrected. 

      We appreciate this comment! The sentence is revised as following:

      “The abundance of 11, 32, and 53 lipids was increased in 3.125, 50, and 200 mM MgCl2-treated bacteria, respectively, while the abundance of 26, 52, and 107 lipids was decreased in 3.125, 50, and 200 mM MgCl2-treated bacteria, respectively (Suppl. Fig 7C)”

      - Line 340. What is the assay the authors are using to measure the levels of the PGS and PSS enzymes? This is not mentioned or clear in this part of the Results.  

      We appreciate this comment!  We provide the information in the manuscript as following:

      “Levels of PGS and PSS were quantified by ELISA kits according to manufacture’s instruction (Shanghai Fusheng Industrial Co., Ltd., China)”

      - Line 372: What is the assay for measuring membrane depolarization? This is not mentioned and I suggest it should be. Line 374: Figure 7B does not show time dependence, only dose dependence, this should be corrected, it is assumed the authors are referring to Fig 7C for the time dependence data. 

      We appreciate this comment! We provide the information in the result as following:  

      “The voltage-sensitive dye, DiBAC4(3) showed that 12.5–200 mM MgCl2 promoted membrane depolarization in a dose-dependent manner (Fig 6A)”

      We also explain how DiBAC4(3) can be used to measure membrane depolarization in the Materials and Methods section as following:

      “DiBAC4(3) is a s voltage-sensitive probe that penetrates depolarized cells, binding intracellular proteins or membranes exhibiting enhanced fluorescence and red spectral shift.”

      To make it clear the specific figure, we revise the sentence as following:

      “Meanwhile, MgCl2 had a dose-dependent (Fig 6B) and time-dependent (Fig 6C) effect on proton motive force (PMF).”

      - Line 384: mention how FM5-95 measures membrane permeability. The authors should also clarify how this reagent is used to measure membrane fluidity, and it is not clear if the data for this is presented in Figure 7 - please clarify. Regarding SYTO9 dye experiment: the authors should briefly explain the experimental design - how SYTO9 dye operates and why FACS was chosen. What is labeled with FITC?  

      We appreciate this comment! We clarify the reason we use FM5-95 in the Methods and Materials section as following:

      “Measurement of fluidity by fluorescence microscopy

      Measurement of membrane fluidity is performed as previously described (Wen et al., 2022). Briefly, ATCC33787 were cultured in medium with indicated concentrations of MgCl2, collected and then adjusted to OD 0.6. Aliquot of 100 μL bacteria cells of each sample were diluted to 1 mL and 10 μL (10 mg/mL) FM5-95 (Thermo Fisher

      Scientific, USA) was added. FM5-95 is a lipophilic styryl dye that insert into the outer leaflet of bacterial membrane and become fluorescence. This dye preferentially bind to the microdomains with high membrane fluidity(Wen et al., 2022). After incubated for 20 min at 30 ℃ at vibration without light, the sample was centrifuged for 10 min at 12,000 rpm. The pellets were resuspended with 20 μL of 3% NaCI. Aliquot of 2 μL sample was dropped on the agarose slide, and take photos under the inverted fluorescence microscope.”

      This data is presented as micrographs in Fig. 6D, which shows the decreased FM5-95 staining with increasing concentrations of MgCl2. We make this description clear with the following revision:

      “FM5-95 staining decreased with increasing concentrations of Mg2+, and no staining was observed in the presence of 200 mM Mg2+ (Fig 6D).”

      We explain the reason why we use SYTO9 as following:

      “SYTO9, a green fluorescent dye that binds to nucleic acid, enters and stains bacteria cells when there is an increase in membrane permeability (Lehtinen et al., 2004; McGoverin et al., 2020). Staining decreased with increasing MgCl2, indicating that bacterial membrane permeability declined in an Mg2+ dose-dependent manner (Fig 6E).”

      We didn’t use FACS in this study, while we only analyze the fluorescence distribution with the equipment. To make it clear, we revise the sentence as following:

      “After incubated for 15 min at 30 ℃ at vibration without light, the mixtures were filtered and measured by flow cytometry (BD FACSCalibur, USA).”

      - Lines 391-397. The statement that palmitic acid shifts the peaks in Figure 7F is not supported by the data. There is essential no change in the major peak position within each MgCl2 concentration set with increasing palmitic acid. For the linolenic acid data, it is clear that linolenic acid increases permeability only at 50 mM MgCl2-this should be mentioned in the text. 

      We appreciate this comment! We revise the sentence as following:

      “Exogenous palmitic acid also shifted the fluorescence signal peaks to the left in an MgCl2-dependent manner while palmitic acid only slightly shifted the peaks (Fig 6F). In contrast, exogenous linolenic acid shifted the peak to the right in a dose-dependent manner at 50 mM MgCl2 (Fig 6G).” 

      - Line 404-405 - as mentioned earlier, the assay for the update of BLFX should be mentioned (if it is done so earlier in the text, then it does not need to be here).  

      We appreciate this comment! It has been mentioned in the introduction.  

      - Discussion: CpxA/R-OmprF pathway is mentioned here for the first time. Is this one of the pathways modified by MgCl2 as determined during the course of the study? If so, this should be reworded to mention that. If not, the relevance of this particular pathway as it relates to light metals and phenotypic resistance should be discussed.

      We appreciate this comment! Since it is not relevant to the discussion of Mg2+ and fatty acid biosynthesis, we delete this sentence in the revised manuscript.  

      -The following grammatical errors should be corrected:

      -line 55 change to: "genetic mutations; instead, this type of resistance is transient, and bacteria resume normal growth"

      -line 57: change to "resistance types are biofilm" 

      -line 61: change to "states that significantly" 

      -line 63: change to "resistance share the common feature in they retard or even cease in the presence" 

      -line 65: change to "resistance that allow bacteria to proliferate" 

      -line 81: change "But whether" to "Whether" 

      -line 178: change to "may be critical to the Mg-based phenotypic resistance"

      -line 86: change to "Marine environments and agriculture are rich in magnesium, where..." 

      -line 93: change in to vs

      -line 154: insert space after metabolism 

      -line 158: change 'identified" to "focused on the levels of" 

      -line 160: change "The levels of forty-one metabolites" 

      -line 198: change shared to share 

      -line 310: increased is duplicated, delete one 

      -line 451: add "the" before ratio 

      -line 453: gram should be capitalized 

      -line 462: "the regulation" should be reworded to "More importantly, the effect of exogenous MgCl targets the..." 

      -line 469: add dash between Mg2+ and limited

      -line 478: change "the crucial" to "a crucial" 

      -there are numerous locations in the manuscript where the word "magnetism" is used when clearly the word is supposed to be magnesium - this should be corrected

      We appreciate this comment! These have been corrected or revised. 

      Editors comments:

      Page 2 line 27; Page 25 line number 426; page 27 line number 481: In the abstract and discussion, only Vibrio alginolyticus was mentioned, even though two Vibrio species were used in the study. It would be helpful to understand the rationale behind the focus on this particular species.

      We appreciate this comment! We have revised the introduction to provide additional information as following:

      “Vibrios inhabit seawater, estuaries, bays, and coastal waters, regions full of metal ions such as magnesium (Kumarage et al., 2022). Magnesium is the second most dissolved element in seawater after sodium. At a salinity of 3.5% seawater, the magnesium concentration is about 54 mM (Potis, 1968), and in deep seawater, can be as high as 2,500 mM (Wang et al., 2024). Vibrio parahaemolyticus and V. alginilyticus are two representative Vibrio pathogens that infect humans and aquatic animals, resulting in illness and economic loss, respectively (Grimes, 2020). (Fluoro)quinolones such as balofloxacin are used to treat Vibrio infection, however, resistance has emerged due to overuse (Suyamud et al., 2024). Indeed, (fluoro)quinolones are one of China's two primary residual chemicals associated with aquaculture (Liu et al., 2017). Vibrio can develop quinolone resistance through mutations in the DNA gyrase gene or through plasmid-mediated mechanisms (Dutta et al., 2021). Thus, the use of V. parahaemolyticus and V. alginilyticus as bacterial representatives, and balofloxacin as a quinolone-based antibacterial representative, can help to define novel magnesium-dependent phenotypic resistance mechanisms of pathogenic Vibrio species.”

      On Page 2, line 34: The abstract contains some undefined abbreviations, such as 'PE' and 'PG', which should be explained. 

      We appreciate this comment! We explain the PE and PG in the revised abstract as following:

      “phosphatidylethanolamine (PE) biosynthesis is reduced and phosphatidylglycerol (PG)”

      On Page 2, line 31-32: For the statement "Exogenous supplementation of fatty acids confirm the role of fatty acids in antibiotic resistance…" it would be beneficial to specify whether the fatty acids were saturated or unsaturated. 

      Response, We appreciate this comment! We revise the sentence as following:

      “Exogenous supplementation of unsaturated and saturated fatty acids increased and decreased bacterial susceptibility to antibiotics, respectively, confirming the role of fatty acids in antibiotic resistance.”

      The potential effects of the specific ions (SO4 and Cl2) present in the Mg2SO4 and MgCl2 compounds used in the study were not discussed. It would be useful to understand if these ions had any influence on the observed outcomes.

      We appreciate this comment! We revise the sentence as following:

      “However, the MIC for BLFX was higher in ASWT medium supplemented with Mg2SO4 or MgCl2 than in LB medium (Fig 1B). And Mg2SO4 or MgCl2 had no

      difference on MIC, suggesting it is Mg2+ not other ions contribute to the MIC change.”

      On Page 8, line 141: The heading of Figure 2, "Mg2+ elevates intracellular Mg2+," seems redundant and could be revised for clarity or modified. 

      We appreciate this comment! Figure 2 is now moved to supplementary figure as Suppl. Fig 2. The title is revised as following:

      “Figure 2. Mg2+ decreases balofloxacin uptake.”

      On Page 4, line 91: some terms/abbreviations, such as 'LB' and 'M9,' require expansion or definition to ensure the reader's understanding.

      We appreciate this comment! We include the expansion for LB and M9 in the  revised manuscript as following:

      “Luria-Bertani medium (LB medium)” and “M9 minimal medium (M9 medium)”

      Page 4, line 92: The real seawater composition used in the experiments should be supported by a reference.

      We appreciate this comment! We provide the reference in the revised manuscript as following:

      ““artificial seawater” (ASWT) medium that included the major ion species in marine water (Wilson, 1975) (LB medium plus 210 mM NaCl, 35 mM Mg2SO4, 7 mM KCl, and 7 mM CaCl2)”

      Page 4 line, number 93: the he full names of the bacterial strains (e.g., ATCC33787 and VP01) should be provided instead of just the strain numbers.

      We appreciate this comment! We revised the sentence as following:

      “To investigate whether this mineral impacts antibiotic activity, the minimal inhibitory concentration (MIC) of V. alginolyticus ATCC33787 and V. parahaemolyticus VP01, which we referred as ATCC33787 and VP01 afterwards,”

      Finally, there appears to be a potential contradiction between the statements on page 12, lines 211-212 and 214-216, regarding the effects of Mg2+ on the synthesis of unsaturated fatty acids. Further explanation may be needed to reconcile these seemingly contradictory points.

      We appreciate this comment! For line 221-226, which was previously line 211-212, is about the gene expression for fatty acid biosynthesis. While, Line 228 and 233, which was previously line 214-216 is about the gene expression for fatty acid degradation. We agree that the previous description is a little bit confuse. We revise the sentence to emphasize that we focus on fatty acid degradation so that the readers can tell them apart. 

      In the text, we revised it as following:

      “In addition, we also quantified gene expression during fatty acid degradation to determine whether Mg2+ affects this process”  In the figure legend, we also indicate that 

      “H. qRT-PCR for the expression of genes encoding fatty acid degradation in the absence or presence of the indicated concentrations of MgCl2”

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      In this paper Homan et al used mouse models of Metabolic Dysfunction-Associated Steatotic Liver Disease and different specific target deletions in cells to rule out the role of Complement 3a Receptor 1 in the pathogenesis of disease. They provided limited evidence and only descriptive results that despite C3aR being relevant in different contexts of inflammation, however, these tenets did not hold true.

      Weaknesses:

      (1) The results are based on readouts showing that C3aR is not involved in the pathogenesis of liver metabolic disease.

      (2) The description of the mouse models they used to validate their findings is not clear. Lysm-cre mice - which are claimed to delete C3aR in (?) macrophages are not specific for these cells, and the genetic strategy to delete C3aR in Kupffer cells is not clear.

      (3) Taking this into account, it is very challenging to determine the validity of these data, also considering that they are merely descriptive and correlative.

      We generated 2 different cohorts of mice using LysM-Cre (Jackson Strain #004781) to drive deletion in all macrophages and Clec4f-Cre (Jackson Strain #033296) to specifically ablate C3ar1 in Kupffer cells. These experimental models have been clearly defined in the revised manuscript on pages 5 and 7 and in the methods section (page 10). The reviewer’s point is well taken that the LysM-Cre transgene can also be active in granulocytes and some dendritic cells. Even so, despite deletion of C3ar1 in macrophages and other granulocytes, we do not see a major effect on hepatic steatosis and fibrosis in this GAN diet induced model of MASLD/MASH. This was a somewhat surprising finding. We do not agree that our findings are correlative. We specifically ablated C3aR1 in macrophages or Kupffer cells and found no significant differences in the major readouts of steatosis and fibrosis for MASLD/MASH between control and knockout mice. It is possible that in other models of liver injury that we did not test (e.g., short-term treatment with a hepatotoxin such as carbon tetrachloride), there may be differences in liver injury in mice lacking C3ar1 in macrophages, but the GAN diet model has been shown to better parallel the gene expression changes in human MAFLD/MASH. This has been added to the discussion (page 9).

      Reviewer #2 (Public review):

      Summary:

      Homan et al. examined the effect of macrophage- or Kupffer cell-specific C3aR1 KO on MASLD/MASH-related metabolic or liver phenotypes.

      Strengths:

      Established macrophage- or Kupffer cell-specific C3aR1 KO mice.

      Weaknesses:

      Lack of in-depth study; flaws in comparisons between KC-specific C3aR1KO and WT in the context of MASLD/MASH, because MASLD/MASH WT mice likely have a low abundance of C3aR1 on KCs.

      Homan et al. reported a set of observation data from macrophage or Kupffer cell-specific C3aR1KO mice. Several questions and concerns as follows could challenge the conclusions of this study:

      (1) As C3aR1 is robustly repressed in MASLD or MASH liver, GAN feeding likely reduced C3aR1 abundance in the liver of WT mice. Thus, it is not surprising that there were no significant differences in liver phenotypes between WT vs. C3aR1KO mice after prolonged GAN diet feeding. It would give more significance to the study if restoring C3aR1 abundance in KCs in the context of MASLD/MASH.

      GAN diet feeding resulted in higher liver C3ar1 compared to regular diet (Figure 1H). This thus became an impetus for studying the effects of C3ar1 deletion in macrophages or Kupffer cells, which are responsible for the majority of liver C3ar1 expression, in MASLD/MASH (Figures 2B and 3H). This point has been added to the text on page 5.

      (2) Would C3aR1KO mice develop liver abnormalities after a short period of GAN diet feeding?

      We did not assess if short term GAN diet feeding resulted in significant differences in liver abnormalities in the C3ar1 macrophage or Kupffer cell knockout mice. Perhaps the reviewer’s point is that perhaps with shorter periods of GAN diet feeding there may be a phenotype in the KO mice. We agree that this is entirely possible, though with shorter feeding timeframes what is typically seen is hepatic steatosis without fibrosis. Nevertheless, the most important element in our opinion for a disease preventing or modifying model lies with the longer-term GAN diet feeding. With long term GAN diet feeding that has been previously shown to model human MASLD/MASH, we did not observe significant differences in liver abnormalities with the KO mice. This has been added to the discussion (page 8).

      (3) What would be the liver macrophage phenotypes in WT vs C3aR1KO mice after GAN feeding?

      Similar to the above point, given the lack of a major MASLD/MASH phenotype in hepatic steatosis and fibrosis, we did not further profile the liver macrophage profiles of the macrophage or Kupffer cell C3ar1 KO mice with GAN feeding.

      (4) In Fig 1D, >25wks GAN feeding had minimal effects on female body weight gain. These GAN-fed female mice also develop NASLD/MASH liver abnormalities?

      We thank the reviewer for this question. In general, female GAN-fed mice develop milder MASLD/MASH abnormalities. We have included additional data in the revised manuscript in Figure S4. These results show no to minimal development of a MASLD/MASH gene signature.

      (5) Would C3aR1KO result in differences in liver phenotypes, including macrophage population/activation, liver inflammation, lipogenesis, in lean mice?

      We have provided additional data further characterizing liver inflammation, lipogenesis and macrophages in macrophage C3ar1 KO mice under lean/regular diet conditions in Figure 2K. These results show a potential trend but no substantial development of a MASLD/MASH gene signature.

      (6) The authors should provide more information regarding the generation of KC-specific C3aR1KO. Which Cre mice were used to breed with C3aR1 flox mice?

      Clec4f-Cre transgenic mice were used to generate Kupffer cell specific KO of C3ar1. This has been clarified and explicitly stated in the revised manuscript on page 7 and in the methods section.

      Recommendations for the authors:

      Reviewer #1 (Recommendations for the authors):

      These data should be repeated using a more established model of Kupffer cell target deletion via Clec4-F mice.

      Our data with Kupffer cell C3ar1 deletion is indeed done with Clec4f-Cre transgenic mice. This has been clarified in the revised manuscript on page 7 and in the methods section.

      Reviewer #2 (Recommendations for the authors):

      (1) Typo: "iver" in the abstract

      (2) Line 97, "GAN diet I" should be "GAN diet"?

      These points have been corrected in the revised manuscript.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public Review): 

      Summary: 

      Recent years have seen spectacular and controversial claims that loss of function of the RNA splicing factor Ptbp1 can efficiently reprogram astrocytes into functional neurons that can rescue motor defects seen in 6-hydroxydopamine (6-OHDA)-induced mouse models of Parkinson's disease (PD). This latest study is one of a series that fails to reproduce these observations, but remarkably also reports that neuronal-specific loss of function of Ptbp1 both induces expression of dopaminergic neuronal markers in striatal neurons and rescues motor defects seen in 6-OHDA-treated mice. The claims, if replicated, are remarkable and identify a straightforward and potentially translationally relevant mechanism for treating motor defects seen in PD models. However, while the reported behavioral effects are strong and were collected without sample exclusion, other claims made here are less convincing. In particular, no evidence that Ptbp1 loss of function actually occurs in striatal neurons is provided, and the immunostaining data used to claim that dopaminergic markers are induced in striatal neurons is not convincing. Furthermore, no characterization of the molecular identity of Ptbp1-deficient striatal neurons is provided using single-cell RNA-Seq or spatial transcriptomics, making it difficult to conclude that these cells are indeed adopting a dopaminergic phenotype. 

      Overall, while the claims of behavioral rescue of 6-OHDA-treated mice appear compelling, it is essential that these be independently replicated as soon as possible before further studies on this topic are carried out. Insights into the molecular mechanisms by which neuronalspecific loss of function of Ptbp1 induces behavioral rescue are lacking, however. Moreover, the claims of induction of neuronal identity in striatal neurons by Ptbp1 require considerable additional work to be convincing.

      We thank the reviewer for the detailed analysis of our study. Please find our answers to the points raised by the reviewer below in blue.

      Strengths of the study: 

      (1) The effect size of the behavioral rescue in the stepping and cylinder tests is strong and significant, essentially restoring 6-OHDA-lesioned mice to control levels.

      (2) Since the neurotoxic effects of 6-OHDA treatment are highly variable, the fact that all behavioral data was collected blinded and that no samples were excluded from analysis increases confidence in the accuracy of the results reported here. 

      We appreciate the reviewer’s feedback and acknowledgement of the strengths of our study. We undertook several optimization steps in the surgery, post-operative care, and handling of the animals for behavior experiments to ensure high reproducibility of our experiments.

      Weaknesses of the study:  

      (1) Neurons express relatively little Ptbp1. Indeed, cellular expression levels as measured by scRNA-Seq are substantially below those of astrocytes and other non-neuronal cell types, and Ptbp1 immunoreactivity has not been observed in either striatal or midbrain neurons (e.g. Hoang, et al. Nature 2023). This raises the question of whether any recovery of Th expression is indeed mediated by the loss of function of Ptbp1 rather than by off-target effects. AAVmediated rescue of Ptbp1 expression could help clarify this.

      In the original manuscript, we delivered control vectors that only express the ABE to 6-OHDAlesioned mice (labeled as AAV-ctrl) and did not detect TH positive cells in the midbrain or striatum of control mice or rescue of spontaneous motor skills. We can therefore exclude that the delivery procedure, AAV-PHP.eB capsid, or ABE expression caused adverse effects leading to induction of TH expression and functional rescue of spontaneous motor behaviors in PD mice. To further exclude that these effects were caused by off-target editing, we experimentally determined off-target binding sites of our sgRNA (sgRNA-ex3) using GUIDEseq and subsequently analyzed these sites in treated animals by NGS (Figure 3 – supplement 3). While two off-target sites were identified, it is unlikely that base editing at these sites caused the observed phenotypes. One off-target site was identified in the myopalladin (Mypn) gene, which encodes for a muscle-specific protein that plays a role in regulating the structure and growth of skeletal and cardiac muscle (Filomena et al., 2021, 2020).  The other site is not located in a coding region, but in an intron of the ankyrin-1 (Ank1) gene, encoding for an adaptor protein linking membrane proteins to the underlying cytoskeleton (Cunha and Mohler, 2009). Even though this gene is also expressed in neurons, base editing within this intronic region did not lead to changes in transcript levels (Figure 3 – supplement 3). Thus, the induction of TH expression upon adenine base editing with sgRNA-ex3 is likely a direct consequence of PTBP1 downregulation.

      Further supporting this conclusion, in the revised manuscript we additionally show PTBP1 downregulation at the RNA and protein level in the SNc and striatum after base editor treatment (Figure 2 – figure supplement 5; figure 3 – supplement 2).

      (2) It is not clear why dopaminergic neurons, which are not normally found in the striatum, are observed following Ptbp1 knockout. This is very similar to the now-debunked claims made in Zhou, et al. Cell 2020, but here performed using the hSyn rather than GFAP mini promoter to control AAV expression. While this is the most dramatic and potentially translationally relevant claim of the study, this claim is extremely surprising and lacks any clear mechanistic explanation for why it might happen in the first place.  

      We agree with the reviewer that our study does not provide mechanistic insights into how Ptbp1 downregulation in neurons leads to the induction of dopaminergic markers in the striatum. As we believe that this is not within the scope of a revision, we discuss potential follow-up experiments in the discussion section of the revised manuscript.

      This observation is even more surprising in light of reports that antisense oligonucleotidemediated knockdown of Ptbp1, which should have affected both neuronal and glial Ptbp1 expression, failed to induce expression of dopaminergic neuronal markers in the striatum (Chen, et al. eLife 2022). Selective loss of function of Ptbp1 in striatal and midbrain astrocytes likewise results in only modest changes in gene expression. 

      Using 6-OHDA lesioned Aldh1l1-CreERT2;Rpl22lsl-HA mice, the Chen et al. study (eLife 2022) assessed potential astrocyte to neuron conversion by quantifying the presence of HA-labeled neurons after ASO-mediated knockdown of Ptbp1. Even though they did not detect HApositive neurons in the SNc, suggesting absence of astrocyte to neuron conversion, the images in Figure 4D reveal TH positive cells in the lesioned hemisphere, similar to our observations in Figure 2B-D. While it cannot be excluded that these TH positive cells are remnants from an incomplete 6-OHDA lesion, they could also be endogenous neurons with induced expression of dopaminergic markers after ASO-mediated knockdown of Ptbp1. Furthermore, Chen et al. performed the apomorphine test to assess changes in motor skills, which did not reveal an improvement in our study either.

      It is critically important that this claim be independently replicated, and that additional data be provided to conclusively show that striatal neurons are indeed expressing dopaminergic markers.

      Our behavior and immunofluorescence experiments involving mice injected into the striatum were performed with two independently generated cohorts of 6-OHDA mice. In detail, the 6OHDA mice were generated by two independent surgeons from different labs (>6 months between experiments of these cohorts), leading to comparable behavioral outcomes before and after treatment. Subsequent behavior and immunofluorescence experiments with each cohort were performed and analyzed by two independent and blinded researchers, showing comparable results.

      (3) More generally, since multiple spectacular and irreproducible claims of single-step glial-toneuron reprogramming have appeared in high-profile journals in recent years, a consensus has emerged that it is essential to comprehensively characterize the identity of "transformed" cells using either single-cell RNA-Seq or spatial transcriptomics (e.g. Qian, et al. FEBS J 2021; Wang and Zhang, Dev Neurobiol 2022). These concerns apply equally to claims of neuronal subtype conversion such as those advanced here, and it is essential to provide these same datasets. 

      In the revised version, we have analyzed the expression of additional neuronal markers in TH positive cells of the striatum using 4i imaging. Briefly, our results showed that the vast majority of TH-expressing cells also expressed the markers DAT and NEUN, further corroborating the neuronal and dopaminergic identity of these cells. Additional analysis revealed that this TH/DAT/NEUN expressing cell population expressed markers of GABAergic neurons, either of medium spiny neurons (~50%) and various types of interneurons (~50%). While our 4i analysis has allowed us to broadly classify these TH-expressing populations, we agree that detailed transcriptional analysis at the single cell level is required to understand the molecular mechanisms underlying the generation of TH positive cells. These analyses are, however, not within the scope of a revision and would require a thorough dedicated study. We have added these results and discussion points to the revised manuscript.

      (4) Low-power images are generally lacking for immunohistochemical data shown in Figures 3 and 4, which makes interpretation difficult. DAPI images in Figure 3C do not appear nuclear. Immunostaining for Th, DAT, and Dcx in Figure 4 shows a high background and is difficult to interpret. 

      We thank the reviewer for closely evaluating these images and suggestions for improvement. In the revised manuscript, we provide low power images and higher magnification insets as requested to allow for easier interpretation.

      (5) Insights into the mechanism by which neuronal-specific loss of Ptbp1 function induces either functional recovery, or dopaminergic markers in striatal neurons, is lacking.

      In the revised manuscript, we provide a more detailed discussion of mechanisms that could potentially be involved in the functional recovery or expression of dopaminergic markers. However, deciphering the exact molecular mechanisms underlying these observations requires thorough transcriptional analysis at the single cell level, which is out of scope of this revision.

      Reviewer #2 (Public Review):

      Summary: 

      The manuscript by Bock and colleagues describes the generation of an AAV-delivered adenine base editing strategy to knockdown PTBP1 and the behavioral and neurorestorative effects of specifically knocking down striatal or nigral PTBP1 in astrocytes or neurons in a mouse model of Parkinson's disease. The authors found that knocking down PTBP1 in neurons, but not astrocytes, and in striatum, but not nigra, results in the phenotypic reorganization of neurons to TH+ cells sufficient to rescue motor phenotypes, though insufficient to normalize responses to dopaminomimetic drugs.

      Strengths: 

      The manuscript is generally well-written and adds to the growing literature challenging previous findings by Qian et al., 2020 and Zhou et al., 2020 indicating that astrocytic downregulation of PTBP1 can induce conversion to dopaminergic neurons in the midbrain and improve parkinsonian symptoms. The base editing approach is interesting and potentially more therapeutically relevant than previous approaches.

      Weaknesses: 

      The manuscript has several weaknesses in approach and interpretation. In terms of approach, the animal model utilized, the 6-OHDA model, though useful to examine dopaminergic cell loss, exhibits accelerated neurodegeneration and none of the typical pathological hallmarks (synucleinopathy, Lewy bodies, etc.) compared to the typical etiology of Parkinson's disease, limiting its translational interpretation. 

      We thank the reviewer for the detailed assessment of our study and pinpointing its current weaknesses. Please find our answers to all comments below in blue.

      We agree with the reviewer that the 6-OHDA model lacks the typical pathological hallmarks of PD. Nevertheless, we chose this model for two reasons:

      i) The 6-OHDA model was used by both Qian et al. (2020) and Zhou et al. (2020). To allow comparison of our results to these studies, it was crucial to use the same model. Notably, the 6-OHDA model was also used by Chen et al. (2022) and Hoang et al. (2023) for comparison to the two studies from 2020.

      ii) The 6-OHDA model is straightforward to generate and displays robust motor impairments for evaluation of potential therapeutic effects of neuroregeneration treatment approaches. We therefore believe that the model is well-suited to analyze the cellular and behavioral effects (specifically motor skills) of PTBP1 downregulation. 

      In future studies, it would be critical to include models that also display typical pathological hallmarks of the disease to further evaluate the therapeutic effect of this base editing approach. These experiments are, however, not within the scope of this study, which was aimed to focus on the cellular and behavioral effects of PTBP1 downregulation. 

      In addition, there is no confirmation of a neuronal or astrocytic knockdown of PTBP1 in vivo; all base editing validation experiments were completed in cell lines. 

      In the revised manuscript, we assess in vivo base editing efficiencies at the Ptbp1 target site in the SNc (AAV-hsyn, 15.6%) and striatum (AAV-hysn, 21.1%). Furthermore, we assessed in vivo Ptbp1 downregulation at the RNA and protein level to complement our in vitro data (Figure 2 – figure supplement 5; figure 3 – supplement 2).

      Finally, it is unclear why the base editing approach was used to induce loss-of-function rather than a cell-type specific knockout, if the goal is to assess the effects of PTBP1 loss in specific neurons. 

      We expressed base editors under cell-type specific promoter to induce a reliable loss-offunction mutation at the Ptbp1 exon-intron junction in neurons or astrocytes. Performing these mutations with Cas9 nucleases instead would have had potential limitations and risks, including i) indel mutations do not always lead to a frameshift and loss-of-function despite high indel formation at the targeted site, ii) nucleases induce DNA double strand breaks, which can have serious side effects (e.g. chromosomal rearrangements or translocations), and iii) ‘mosaicisms’ as edited cells contain different indel mutations, which may result in different effects and thus complicate analysis of the downstream effects. We discuss these points in the revised manuscript.  

      In terms of interpretation, the conclusion by the authors that PTBP1 knockdown has little likelihood to be therapeutically relevant seems overstated, particularly since they did observe a beneficial effect on motor behavior. We know that in PD, patients often display negligible symptoms until 50-70% of dopaminergic input to the striatum is lost, due to compensatory activity of remaining dopaminergic cells. Presumably, a small recovery of dopaminergic neurons would have an outsized effect on motor ability and may improve the efficacy of dopaminergic drugs, particularly levodopa, at lower doses, averting many problematic side effects. Since striatal dopamine was assessed by whole-tissue analysis, which is not necessarily reflective of synaptic dopamine availability, it is difficult to assess whether the ~10% increase in TH+ cells in the striatum was sufficient to improve dopamine function. However, the improvement in motor activity suggests that it was.

      As pointed out by the reviewer, it is difficult to estimate the therapeutic effect and importance of a ~10% increase in TH+ cells for PD patient. Guided by the reviewer’s suggestion, we have included a more in-depth discussion of our results and its potential therapeutic value as well as outstanding questions for future studies in the revised manuscript.

      Reviewer #3 (Public Review):

      This study explores the use of an adenine base editing strategy to knock down PTBP1 in astrocytes and neurons of a Parkinson's disease mouse model, as a potential AAV-BE therapy. The results indicate that editing Ptbp1 in neurons, but not astrocytes, leads to the formation of tyrosine hydroxylase (TH)+ cells, rescuing some motor symptoms.

      Several aspects of the manuscript stand out positively. Firstly, the clarity of the presentation. The authors communicate their ideas and findings in a clear and understandable manner, making it easier for readers to follow. 

      The Materials and methods section is well-elaborated, providing sufficient detail for reproducibility. 

      The logical flow of the manuscript makes sense, with each section building upon the previous one coherently.

      The ABE strategy employed by the authors appears sound, and the manuscript presents a coherent and well-supported argument.

      Positively, some of the data in this study effectively counteracts previous work in line with more recent publications, demonstrating the authors' ability to contribute to the ongoing conversation in the field.

      We thank the reviewer for appreciating the effort we have put into this study. Please find below a point-by-point reply to the weaknesses raised by the reviewer. 

      However, while the in vitro data yields promising results, it may have been overly optimistic to assume that the efficiencies observed in dividing cells will directly translate to in vivo conditions. This consideration is important given the added complexities of vector optimization, different cell types targeted in vitro versus in vivo, as well as unknown intrinsic limitations of the base editing technology. 

      We agree with the reviewer that in vitro base editing efficiencies might not directly translate to in vivo editing outcomes. We therefore assessed in vivo base editing efficiencies at the Ptbp1 locus and PTBP1 downregulation in the striatum and midbrain. Our data revealed that in vivo base editing activity was lower than in our in vitro setting (in vitro: Figure 1; figure 1 – figure supplement 2; in vivo: figure 2 – figure supplement 5; figure 3 – supplement 2). However, we believe that these rates are slightly underestimated since we sequenced DNA isolated from the whole tissue (striatum or SNc) and not from purified astrocytes or neurons. Moreover, we could demonstrate that editing led to a reduction of Ptbp1 transcript and PTBP1 protein level (Figure 2 – figure supplement 5; figure 3 – supplement 2).

      In addition, certain aspects of the manuscript would benefit from a more in-depth and comprehensive discussion rather than being only briefly touched upon. Such a discussion would enhance the relevance of the obtained results and provide the foundation for improvement when using similar approaches.

      Following the reviewer’s suggestion, we included a more in-depth discussion of our results in the revised manuscript.

      Recommendations for the authors:

      Reviewing Editor (Recommendations for the Authors):

      A summary of key recommendations that might improve the eLife assessment in a subsequent submission are provided below, as a guide to help the authors focus on changes that might enhance the strength of evidence (e.g., from "incomplete" to "solid").

      (1) Provide further explanation of the mechanistic relationship between the downregulation of Ptbp1 and TH+ dopaminergic neuron reprogramming. Additional discussion of this topic should also be included.

      (2) Demonstrate proof of editing in the intended targeted cells in vitro and/or in vivo.

      (3) Show evidence of successful Base Editor delivery in vivo.

      (4) Perform a deeper characterization of TH+ cells in vivo and provide a more thorough discussion of the identity of the targeted cells. This may include an exploration of whether TH+ cells detected are TH+ interneurons and/or establish their identity based on transcriptomics or a similar approach.

      (5) Provide better-quality representative images supporting the quantitative data.

      (6) Please include full statistical reporting including exact p-values wherever possible alongside the summary statistics (test statistic and df) and 95% confidence intervals. These should be reported for all key questions and not only when the p-value is less than 0.05 in the main manuscript.

      In the revised manuscript, we provided 1) suggestions of the mechanistic relationship between Ptbp1 knockdown, dopamine synthesis, and the functional rescue of spontaneous behaviors, 2) proof of in vivo base editing and successful base editor delivery, 3) deeper characterization of TH-expressing cells in vivo using 4i imaging, 4) better quality images, and 5) full statistical reporting.  

      Individual Reviewer recommendations for the authors are included below.

      Reviewer #1 (Recommendations For The Authors):

      Confirm loss of Ptbp1 function in infected striatal neurons. Single-cell RNA-Seq or spatial transcriptomic analysis must be performed to characterize the identity of the edited striatal neurons. The quality of the immunostaining in Figures 3 and 4 needs to be improved, and lowpower images provided. Were eLife a conventional journal, I would have insisted on all these being included prior to publication. Please also arrange for independent replication of the behavioral rescue and induction of dopaminergic marker gene expression in the striatum. 

      In the revised manuscript, we confirmed Ptbp1 downregulation at the tissue level in the SNc and striatum by RT-qPCR and western blot and included low-power images for easier interpretation. Additionally, we assessed expression of additional neuronal markers on striatal sections using 4i imaging and found that TH/DAT/NEUN positive populations either expressed markers of medium spiny neurons or interneurons. We have included these results in the revised manuscript.

      Our behavioral and imaging experiments involving mice injected into the striatum were in fact performed with two independently generated cohorts of 6-OHDA mice. In detail, the 6OHDA mice were generated by two independent surgeons from different labs (>6 months between experiments of these two cohorts), leading to comparable behavioral outcomes before and after treatment. The experiments with each cohort were performed and analyzed by two independent and blinded researchers, yielding comparable results. 

      Reviewer #2 (Recommendations For The Authors):

      (1) In the introduction, lines 43-45: This statement is inaccurate. Current treatment strategies do not focus on slowing or halting disease progression. There is currently no accepted therapy that does this. Dopaminergic therapies and deep brain stimulation can compensate for circuitry dysfunction as a result of dopamine cell loss but do not slow the disease. The referenced paper used is older and does not refer to new treatments for PD and is a summary article for a special issue of the Disease Models and Mechanisms journal. Please ensure that all references used are appropriate for the statement they are attached to.

      We thank the reviewer for pointing this out. We have rephrased this statement accordingly and provided an appropriate reference describing current treatment strategies.

      (2) The number of TH+ cells in the intact nigra seems low compared to published data. Suggest a stereological approach may be better than the Abercrombie method.

      Following the reviewer’s suggestion, we re-quantified the number of TH positive cells using a stereological approach (Nv:Vref method). We have included these results in the revised manuscript. 

      (3) Have the authors considered that the striatal TH+ cells could be TH+ striatal interneurons? 

      In the revised manuscript, we performed additional 4i imaging experiments to further analyze the identity of the TH positive cells in the striatum. Briefly, we found that TH/DAT/NEUN positive populations either expressed markers of GABAergic medium spiny neurons or interneurons. We have added these results to the revised manuscript (Figure 4). 

      (4) The Western blot shown in Figure 1 C for C8-D1A has some abnormalities and makes it difficult to judge the bands. Also, for 1B, the legends are difficult to see.

      In the revised manuscript, we have repeated the respective western blot to make interpretation of the bands easier, and adapted the legends in Figure 1B for better visibility.

      (5) Figure 2: Please show representative images for the GFAP-targeted editing.

      Representative images of the GFAP-targeted groups can be found in Figure 2 – figure supplement 3.

      (6) Figure 2, Supplement 3: Please include quantification.

      The quantifications for these images can be found in Figure 2D and 2F. 

      (7) Figure 1, Supplement 2: The gene name in A is misspelled.

      Thank you for point this out. In the revised manuscript, we added the correct gene name.

      (8) Line 267-276: As previously indicated, the statement here is overstated based on the data provided. In addition, the citation provided to justify this claim (Kannari et al., 2000) is an odd choice as the dosage of L-DOPA utilized was not therapeutically relevant (50 mg/kg). A better indication of efficacy would be the return to basal, unaffected levels rather than the fold increase in dopamine levels. A better comparison would be Lindgren et al., 2010 who showed that L-DOPA-treated animals with a physiologically relevant dose (6 mg/kg) that did not induce dyskinesia, showed a return to basal, non-lesioned dopamine levels in the striatum after LDOPA by microdialysis. To really support this claim, the authors would need to use an approach that could measure synaptic dopamine availability, rather than whole-tissue dopamine levels, such as microdialysis, fiber photometry, or an equivalent.

      Following the reviewer’s suggestions, we replaced this reference with Lindgren et al. (2010) and provide a more detailed interpretation of our results and remaining questions for future studies.  

      Reviewer #3 (Recommendations For The Authors):

      Major and minor issues are discussed below by section.

      INTRODUCTION and AIM - Lines 36-73

      - The authors effectively contextualize the aim of their study by providing comprehensive background information on previous research regarding cell 'reprogramming' into dopaminergic neurons in the SNc. However, the introduction lacks contextualization of TH+ cells and PD. For readers who may not be well-versed in the Parkinson's field, understanding the importance of TH (Tyrosine Hydroxylase) may be challenging, since the term "TH+ cells" is mentioned only once by the end of the introduction (line 71), to then become a key element in the entire study.

      - Providing a brief explanation of the role of Tyrosine Hydroxylase in the synthesis of L-DOPA would facilitate the reader's comprehension of why the presence of TH+ cells following Base Editing treatment is relevant.

      - Further elaboration on the relationship between the downregulation of the general RNA binding protein, PTBP1, and the specific dopaminergic-related readout, TH, would improve coherence and strengthen the linkage between the introductory section and the results.

      We thank the reviewer for the constructive suggestions. In the introduction of the revised manuscript, we describe the meaning and importance of TH in the context of dopamine synthesis and PD. Likewise, we briefly outlined the importance of the PTBP1/nPTBP regulatory loops during neuronal differentiation and maturation. 

      RESULTS 

      Result Section 1 - Line 75-109

      - Thorough screening of sgRNAs targeting splice junctions across the Ptbp1 gene in HEPA cells, shows the achievement of high levels of editing (80-90%) with sgRNA-ex3 and sgRNAex7. 

      - The data also indicates that editing translates into significant reductions in ptbp1 expression, along with an increase in the expression of genes repressed by PTBP1.

      - Despite obtaining lower percentages of editing events in N2a neuroblastoma cells and the C8-D1A astroglial cell line, the differential expression levels of ptbp1 and the readout genes remain significant. However, the gRNA screening assay is performed in immortalized, dividing cells. 

      - Providing proof that Adenosine Base Editing of Ptbp1 is successful in non-dividing cells (such as SNc and/or striatal primary neurons) would strengthen the case for the potential therapy in the intended cell type.

      Following the reviewer’s comment, we show in vivo base editing rates in the SNc and striatum of treated PD mice in the revised manuscript (Figure 2 – figure supplement 5; figure 3 – supplement 2).

      - Moreover, assessing the expression levels of tyrosine hydroxylase by qPCR after Ptbp1 base editing in vitro could help contextualize the use of TH+ detection as an in vivo readout and may help explain why the total number of TH+ cells is low after ABE treatment in vivo - as shown in following sections.

      In the revised manuscript, we now provide quantifications of in vivo base editing efficiencies in the SNc (~15%) and striatum (~20%). As expected from these lower in vivo base editing rates, downregulation of Ptbp1 at the transcript and protein level was less pronounced compared to our in vitro experiments. It seems likely that higher base editing efficiency and more pronounced downregulation of Ptbp1 could lead to a larger population of TH expressing cells. We have added these results and interpretations to the revised manuscript.

      - Furthermore, although ABEs are less prone to generating bystander and other nucleotide changes compared to CBEs, it is still possible. Figures 1 (line 811) and 1-supplement 2 (line 842) only show a brief window of the Sanger sequencing trace. Updating these figures to display a wider view of the sequencing trace would enhance transparency. If unwanted edits are detected, while they may not significantly alter the relevance, impact, or structure of the paper, they may become an important aspect of the discussion. 

      Indeed, ABEs can induce bystander edits and we also detected such edits at the Ptbp1 target site. However, since our base editing strategy was designed to yield a loss of Ptbp1 function, bystander editing at the splice site was not a primary focus in our analysis. Nevertheless, we included CRISPResso output images showing the specific editing outcomes in a wider analysis window in the revised manuscript (Figure 3 – figure supplement 2). 

      Result Section 2 - Lines 110-159

      A split intein system is used in vivo with sgRNA-ex3, after updating the promoter to make it cell-specific: hSyn to restrict expression to neurons and GFAP to restrict expression to astrocytes. 

      However, no other assay is performed to assess whether a) the promoter change and/or b) splitting Cas9 may affect the editing efficiency compared to their initial in vitro approach.

      In the revised manuscript, we assessed the performance of the in vivo AAV vectors encoding the split intein ABE with sgRNA-ex3 in vitro in N2a and C8-D1A cells. Our results show that all vectors are functional and result in base editing at the target locus.

      -  Addressing whether this is the case may explain the low number of TH+ cells observed in vivo. 

      - The authors could also consider staining for Cas9 to address whether the low number of TH+cells could be attributed to a poor Cas9 delivery.

      To confirm successful in vivo base editor delivery, we quantified in vivo base editing efficiencies in the SNc and striatum of PD mice. Our analysis revealed in vivo base editing efficiencies at both tissue sites, confirming that base editors were successfully delivered. Editing efficiencies were, however, substantially lower (Figure 2 – figure supplement 5; figure 3 – supplement 2).  than in our in vitro cell line setting (Figure 1; figure 1 – figure supplement 2). Even though tissue editing rates likely underestimate the cell type-specific editing rates in astrocytes or neurons, higher base editing rates would have likely resulted in a higher number of TH positive cells. We have added these results and their implications to the revised manuscript. 

      -  Moreover, despite the presence of TH, in Figure 2 E,F authors examine the striatal innervation from newly generated TH+ cells in the SNc by Fluorescence Intensity (FI) to conclude that the edited cells do not form projections towards the striatum. Considering the low levels of TH+ positive cells obtained, the accumulation of gross FI might not be the most accurate way to assess the presence or absence of cell projections.

      - Using another marker that stains the projections rather than the cell soma, and that is a marker of dopaminergic neurons, might be a better way to address this.

      To address the reviewer’s comment, we analyzed the presence of potential dopaminergic fibers in the mfb, where projections are more concentrated (around the injection coordinates of 6-OHDA), using the dopaminergic marker DAT. In line with our previous observations in the striatum, we did not detect an increase in DAT fluorescence intensity upon treatment on the lesioned hemisphere (Figure 2 – figure supplement 4).  

      Result Section 3 - Line 160-182

      Minor issue

      - The same dual split intein system is used in the striatum. However, in Figure 3 - Figure Supplement 1 - line 958 and in Figure 3 - Figure Supplement 4 - line 1000authors show the injection of 2x the viral genomes indicated along the manuscript. In previous experiments the SNc 2x108vg/animal was used whereas this figure shows 4x108vg/animal injected in the striatum. 

      - The authors should clarify if the vg injected in the striatum was different from what they previously indicated.

      Compared to injection in the SNc, the volume of vector injected in the striatum was doubled since the region is significantly larger. We clarified that the injected vector genomes were different between striatum and SNc in the revised manuscript.

      Result Section 4- Line 183-220

      In this section, the authors thoroughly examine the neuronal nature of TH+ cells through NeuN co-staining and iterative immunofluorescence imaging (4i). BrdU experiments are conducted to determine the origin of these cells, leading to the conclusion that TH+ cells derive from nondividing cells and express the neuronal marker DAT, characteristic of dopamine-producing neurons (DANs). Cell shape of the TH+ cells in the striatum and SNc is also evaluated measuring their Feret's diameter and their cell surface. Authors conclude there's heterogeneity in the TH+ cell population due to the presence of TH+/Neun- as well as differences in cell shape. 

      However, their explanation of this heterogeneity is solely attributed to differences in the microenvironment and lacks further elaboration. Similarly, their observation that almost half the number of TH+ striatal cells after treatment express CTIP2 (Line 213 and Figure 4B), a marker for GABAergic medium spiny neurons, which they state as "interesting" (line 213) is not developed further. Delving deeper into these topics could strengthen the discussion.

      In the revised manuscript, we provided a more in-depth discussion of the 4i imaging results and potential therapeutic implications. Additionally, we suggest follow-up experiments to analyze the identity, function, and molecular mechanisms underlying the expression of TH upon PTBP1 downregulation in future studies. 

      Result Section 5- Line 221-243

      Two drug-free and two drug-induced behavioral tests are conducted in control and treated animals to evaluate the restoration of motor functions following treatment. Consistent with their previous findings, only the treatment targeted to neurons resulted in the restoration of motor functions in drug-free behavioral tests. The rationale behind each test and its evaluation is clearly explained.

      DISCUSSION 

      - In the discussion section, the authors effectively re-examine their results contextualizing their data with previous studies in the field. However, it would be helpful at this point in the manuscript to reconsider the use of the term 'cell reprogramming,' as this study does not involve actual cell reprogramming. The concept "reprograming" entails the process of transforming adult cells into a stem cell-like state, to then differentiate them into a different cell type. As proven in section 4 by a BrdU proliferation assay, the targeted cells are differentiated neurons. Considering BrdU is administered 5 days after ABE treatment, if true cell reprogramming was taking place, there should be evidence of BrdU incorporation. Cell reprogramming or reprograming is mentioned 4 times in the manuscript (line 34, line 54, line 265, line 277). Therefore, using another terminology would be more accurate.

      Following the reviewer’s suggestion, we removed the term “cell reprograming” from the manuscript and rather describe it as induction of TH expression in endogenous neurons.

      - As noted in the comments of section 4, a more thorough discussion about the various possibilities for heterogeneity would enhance the manuscript's contribution to the PD field.

      In the revised manuscript, we provided a more in-depth discussion of the 4i imaging results and potential therapeutic implications. 

      - Despite observing low numbers of TH+ cells, no significant rescue of drug-induced behaviors, and low levels of released dopamine, the authors merely state that these results make the therapy non-viable, but there is no further exploration or discussion. Whether the limitations lie in the ABE strategy itself, such as its efficiency in targeting and editing of differentiated neurons; or if the issues lie on the injection and delivery, is never discussed. A deeper argumentation on the possible underlying reasons for these challenges would greatly enhance the manuscript and contribute to the advancement of ABE therapies in the brain.

      We believe that the efficacy of our base editing approach could be significantly enhanced by optimizing the delivery. Currently, we are using a dual AAV approach to deliver intein-split ABEs. Since this approach relies on the delivery of higher AAV doses to achieve cotransduction of a cell by two different AAVs, the efficiency could be significantly enhanced by using smaller Cas9 orthologues that can be delivered as a single AAV. Furthermore, in this study we performed a single injection into the dorsal striatum to deliver ABE-expressing AAVs. Performing multiple injections into the rostral, medial, and caudal regions of the striatum might allow us to transduce more cells and induce TH expression in a larger population of striatal neurons. We have included these points in the revised manuscript.

      - While drug-induced behaviors are not recovered, the data demonstrates a rescue of spontaneous behaviors. Further discussion on the potential differences in circuitry underlying these variations in behavioral rescue would also enrich the manuscript's discussion.

      In the revised manuscript, we provide suggestions for potential mechanisms involved in the rescue of spontaneous behavior vs. absence of rescue of drug-induced behaviors. 

      FIGURES AND FIGURE SUPPLEMENTS

      General minor issue - low magnification images in the following figures, make it difficult to visualize positive cells in tissue sections: Figure 2; Figure 2- supplement 1; Figure 2 - supplement 3, Figure 3- supplement 1. Adding a higher magnification imaging of positive cells in tissue sections of SNc and striatum might help with the visualization. 

      As suggested by the reviewer, we included higher magnification images in the corresponding figures to improve interpretation of our results.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public Review): 

      In the presented manuscript, the authors investigate how neural networks can learn to replay presented sequences of activity. Their focus lies on the stochastic replay according to learned transition probabilities. They show that based on error-based excitatory and balance-based inhibitory plasticity networks can selforganize towards this goal. Finally, they demonstrate that these learning rules can recover experimental observations from song-bird song learning experiments. 

      Overall, the study appears well-executed and coherent, and the presentation is very clear and helpful. However, it remains somewhat vague regarding the novelty. The authors could elaborate on the experimental and theoretical impact of the study, and also discuss how their results relate to those of Kappel et al, and others (e.g., Kappel et al (doi.org/10.1371/journal.pcbi.1003511))). 

      We agree with the reviewer that our previous manuscript lacked comparison with previously published similar works. While Kappel et al. demonstrated that STDP in winner-take-all circuits can approximate online learning of hidden Markov models (HMMs), a key distinction from our model is that their neural representations acquire deterministic sequential activations, rather than exhibiting stochastic transitions governing Markovian dynamics. Specifically, in their model, the neural representation of state B would be different in the sequences ABC and CBA, resulting in distinct deterministic representations like ABC and C'B'A', where ‘A’ and ‘A'’ are represented by different neural states (e.g., activations of different cell assemblies). In contrast, our network learns to generate stochastically transitioning cell assemblies which replay Markovian trajectories of spontaneous activity obeying the learned transition probabilities between neural representations of states. For example, starting from reactivation from assembly ‘A’, there may be an 80% probability to transition to assembly ‘B’ and 20% to ‘C’. Although Kappel et al.'s model successfully solves HMMs, their neural representations do not themselves stochastically transition between states according to the learned model. Similar to the Kappel et al.'s model, while the models proposed in Barber (2002) and Barber and Agakov (2002) learn the Markovian statistics, these models learned a static spatiotemporal input patterns only and how assemblies of neurons show stochastic transition in spontaneous activity has been still unclear. In contrast with these models, our model captures the probabilistic neural state trajectories, allowing spontaneous replay of experienced sequences with stochastic dynamics matching the learned environmental statistics.

      We have included new sentences for explain these in ll. 509-533 in the revised manuscript.

      Overall, the work could benefit if there was either (A) a formal analysis or derivation of the plasticity rules involved and a formal justification of the usefulness of the resulting (learned) neural dynamics; 

      We have included a derivation of our plasticity rules in ll. 630-670 in the revised manuscript. Consistent with our claim that excitatory plasticity updates the excitatory synapse to predict output firing rates, we have shown that the corresponding cost function measures the discrepancy between the recurrent prediction and the output firing rate. Similarly, for inhibitory plasticity, we defined the cost function that evaluates the difference between the excitatory and inhibitory potential within each neuron. We showed that the resulting inhibitory plasticity rule updates the inhibitory synapses to maintain the excitation-inhibition balance.

      and/or (B) a clear connection of the employed plasticity rules to biological plasticity and clear testable experimental predictions. Thus, overall, this is a good work with some room for improvement. 

      Our proposed plasticity mechanism could be implemented through somatodendritic interactions. Analogous to previous computational works (Urbanczik and Senn., 2014; Asabuki and Fukai., 2020; Asabuki et al., 2022), our model suggests that somatic responses may encode the stimulus-evoked neural activity states, while dendrites encode predictions based on recurrent dynamics that aim to minimize the discrepancy between somatic and dendritic activity. To directly test this hypothesis, future experimental studies could simultaneously record from both somatic and dendritic compartments to investigate how they encode evoked responses and predictive signals during learning (Francioni et al., 2022).

      We have included new sentences for explain these in ll. 476-484 in the revised manuscript.

      Reviewer #2 (Public Review): 

      Summary: 

      This work proposes a synaptic plasticity rule that explains the generation of learned stochastic dynamics during spontaneous activity. The proposed plasticity rule assumes that excitatory synapses seek to minimize the difference between the internal predicted activity and stimulus-evoked activity, and inhibitory synapses try to maintain the E-I balance by matching the excitatory activity. By implementing this plasticity rule in a spiking recurrent neural network, the authors show that the state-transition statistics of spontaneous excitatory activity agree with that of the learned stimulus patterns, which are reflected in the learned excitatory synaptic weights. The authors further demonstrate that inhibitory connections contribute to well-defined state transitions matching the transition patterns evoked by the stimulus. Finally, they show that this mechanism can be expanded to more complex state-transition structures including songbird neural data. 

      Strengths: 

      This study makes an important contribution to computational neuroscience, by proposing a possible synaptic plasticity mechanism underlying spontaneous generations of learned stochastic state-switching dynamics that are experimentally observed in the visual cortex and hippocampus. This work is also very clearly presented and well-written, and the authors conducted comprehensive simulations testing multiple hypotheses. Overall, I believe this is a well-conducted study providing interesting and novel aspects of the capacity of recurrent spiking neural networks with local synaptic plasticity. 

      Weaknesses: 

      This study is very well-thought-out and theoretically valuable to the neuroscience community, and I think the main weaknesses are in regard to how much biological realism is taken into account. For example, the proposed model assumes that only synapses targeting excitatory neurons are plastic, and uses an equal number of excitatory and inhibitory neurons. 

      We agree with the reviewer. The network shown in the previous manuscript consists of an equal number of excitatory and inhibitory neurons, which seems to lack biological plausibility. Therefore, we first tested whether a biologically plausible scenario would affect learning performance by setting the ratio of excitatory to inhibitory neurons to 80% and 20% (Supplementary Figure 7a; left). Even in such a scenario, the network still showed structured spontaneous activity (Supplementary Figure 7a; center), with transition statistics of replayed events matching the true transition probabilities (Supplementary Figure 7a; right). We then asked whether the model with our plasticity rule applied to all synapses would reproduce the corresponding stochastic transitions. We found that the network can learn transition statistics but only under certain conditions. The network showed only weak replay and failed to reproduce the appropriate transition (Supplementary Fig. 7b) if the inhibitory neurons were no longer driven by the synaptic currents reflecting the stimulus, due to a tight balance of excitatory and inhibitory currents on the inhibitory neurons. We then tested whether the network with all synapses plastic can learn transition statistics if the external inputs project to the inhibitory neurons as well. We found that, when each stimulus pattern activates a non-overlapping subset of neurons, the network does not exhibit the correct stochastic transition of assembly reactivation (Supplementary Fig. 7c). Interestingly, when each neuron's activity is triggered by multiple stimuli and has mixed selectivity, the reactivation reproduced the appropriate stochastic transitions (Supplementary Fig. 7d).

      We have included these new results as new Supplementary Figure 7 and they are explained in ll.215-230 in the revised manuscript.

      The model also assumes Markovian state dynamics while biological systems can depend more on history. This limitation, however, is acknowledged in the Discussion. 

      We have included the following sentence to provide a possible solution to this limitation: “Therefore, to learn higher-order stochastic transitions, recurrent neural networks like ours may need to integrate higher-order inputs with longer time scales.” in ll.557-559 in the revised manuscript. 

      Finally, to simulate spontaneous activity, the authors use a constant input of 0.3 throughout the study. Different amplitudes of constant input may correspond to different internal states, so it will be more convincing if the authors test the model with varying amplitudes of constant inputs. 

      We thank the reviewer for pointing this out. In the revised manuscript, we have tested constant input with three different strengths. If the strength is moderate, the network showed accurate encoding of transition statistics in the spontaneous activity as we have seen in Fig.2. We have additionally shown that the weaker background input causes spontaneous activity with lower replay rate, which in turn leads to high variance of encoded transition, while stronger inputs make assembly replay transitions more uniform. We have included these new results as new Supplementary Figure 6 and they are explained in ll.211214 in the revised manuscript.

      Reviewer #3 (Public Review): 

      Summary: 

      Asabuki and Clopath study stochastic sequence learning in recurrent networks of Poisson spiking neurons that obey Dale's law. Inspired by previous modeling studies, they introduce two distinct learning rules, to adapt excitatory-to-excitatory and inhibitory-to-excitatory synaptic connections. Through a series of computer experiments, the authors demonstrate that their networks can learn to generate stochastic sequential patterns, where states correspond to non-overlapping sets of neurons (cell assemblies) and the state-transition conditional probabilities are first-order Markov, i.e., the transition to a given next state only depends on the current state. Finally, the authors use their model to reproduce certain experimental songbird data involving highly-predictable and highly-uncertain transitions between song syllables. 

      Strengths: 

      This is an easy-to-follow, well-written paper, whose results are likely easy to reproduce. The experiments are clear and well-explained. The study of songbird experimental data is a good feature of this paper; finches are classical model animals for understanding sequence learning in the brain. I also liked the study of rapid task-switching, it's a good-to-know type of result that is not very common in sequence learning papers. 

      Weaknesses: 

      While the general subject of this paper is very interesting, I missed a clear main result. The paper focuses on a simple family of sequence learning problems that are well-understood, namely first-order Markov sequences and fully visible (nohidden-neuron) networks, studied extensively in prior work, including with spiking neurons. Thus, because the main results can be roughly summarized as examples of success, it is not entirely clear what the main point of the authors is. 

      We apologize the reviewer that our main claim was not clear. While various computational studies have suggested possible plasticity mechanisms for embedding evoked activity patterns or their probability structures into spontaneous activity (Litwin-Kumar et al., Nat. Commun. 2014, Asabuki and Fukai., Biorxiv 2023), how transition statistics of the environment are learned in spontaneous activity is still elusive and poorly understood. Furthermore, while several network models have been proposed to learn Markovian dynamics via synaptic plasticity (Brea, et al. (2013); Pfister et al. (2004); Kappel et al. (2014)), they have been limited in a sense that the learned network does not show stochastic transition in a neural state space. For instance, while Kappel et al. demonstrated that STDP in winner-take-all circuits can approximate online learning of hidden Markov models (HMMs), a key distinction from our model is that their neural representations acquire deterministic sequential activations, rather than exhibiting stochastic transitions governing Markovian dynamics. Specifically, in their model, the neural representation of state B would be different in the sequences ABC and CBA, resulting in distinct deterministic representations like ABC and C'B'A', where ‘A’ and ‘A'’ are represented by different neural states (e.g., activations of different cell assemblies). In contrast, our network learns to generate stochastically transitioning cell assemblies that replay Markovian trajectories of spontaneous activity obeying the learned transition probabilities between neural representations of states. For example, starting from reactivation from assembly ‘A’, there may be an 80% probability to transition to assembly ‘B’ and 20% to ‘C’. Although Kappel et al.'s model successfully solves HMMs, their neural representations do not themselves stochastically transition between states according to the learned model. Similar to the Kappel et al.'s model, while the models proposed in Barber (2002) and Barber and Agakov (2002) learn the Markovian statistics, these models learned a static spatiotemporal input patterns only and how assemblies of neurons show stochastic transition in spontaneous activity has been still unclear. In contrast with these models, our model captures the probabilistic neural state trajectories, allowing spontaneous replay of experienced sequences with stochastic dynamics matching the learned environmental statistics.

      We have explained this point in ll.509-533 in the revised manuscript.

      Going into more detail, the first major weakness I see in this paper is the heuristic choice of learning rules. The paper studies Poisson spiking neurons (I return to this point below), for which learning rules can be derived from a statistical objective, typically maximum likelihood. For fully-visible networks, these rules take a simple form, similar in many ways to the E-to-E rule introduced by the authors. This more principled route provides quite a lot of additional understanding on what is to be expected from the learning process. 

      We thank the reviewer for pointing this out. To better demonstrate the function of our plasticity rules, we have included the derivation of the rules of synaptic plasticity in ll. 630-670 in the revised manuscript. Consistent with our claim that excitatory plasticity updates the excitatory synapse to predict output firing rates, we have shown that the corresponding cost function measures the discrepancy between the recurrent prediction and the output firing rate. Similarly, for inhibitory plasticity, we defined the cost function that evaluates the difference between the excitatory and inhibitory potential within each neuron. We showed that the resulting inhibitory plasticity rule updates the inhibitory synapses to maintain the excitation-inhibition balance.

      For instance, should maximum likelihood learning succeed, it is not surprising that the statistics of the training sequence distribution are reproduced. Moreover, given that the networks are fully visible, I think that the maximum likelihood objective is a convex function of the weights, which then gives hope that the learning rule does succeed. And so on. This sort of learning rule has been studied in a series of papers by David Barber and colleagues [refs. 1, 2 below], who applied them to essentially the same problem of reproducing sequence statistics in recurrent fully-visible nets. It seems to me that one key difference is that the authors consider separate E and I populations, and find the need to introduce a balancing I-to-E learning rule. 

      The reviewer’s understanding that inhibitory plasticity to maintain EI balance is one of a critical difference from previous works is correct. However, we believe that the most striking point of our study is that we have shown numerically that predictive plasticity rules enable recurrent networks to learn and replay the assembly activations whose transition statistics match those of the evoked activity. Please see our reply above.

      Because the rules here are heuristic, a number of questions come to mind. Why these rules and not others - especially, as the authors do not discuss in detail how they could be implemented through biophysical mechanisms? When does learning succeed or fail? What is the main point being conveyed, and what is the contribution on top of the work of e.g. Barber, Brea, et al. (2013), or Pfister et al. (2004)? 

      Our proposed plasticity mechanism could be implemented through somatodendritic interactions. Analogous to previous computational works (Senn, Asabuki), our model suggests that somatic responses may encode the stimulusevoked neural activity states, while dendrites encode predictions based on recurrent dynamics that aim to minimize the discrepancy between somatic and dendritic activity. To directly test this hypothesis, future experimental studies could simultaneously record from both somatic and dendritic compartments to investigate how they encode evoked responses and predictive signals during learning.

      To address the point of the reviewer, we conducted addionnal simulations to test where the model fails. We found that the model with our plasticity rule applied to all synapses only showed faint replays and failed to replay the appropriate transition (Supplementary Fig. 7b). This result is reasonable because the inhibitory neurons were no longer driven by the synaptic currents reflecting the stimulus, due to a tight balance of excitatory and inhibitory currents on the inhibitory neurons. Our model predicts that mixed selectivity in the inhibitory population is crucial to learn an appropriate transition statistics (Supplementary Fig. 7d). Future work should clarify the role of synaptic plasticity on inhibitory neurons, especially plasticity at I to I synapses. We have explained this result as new supplementary Figure7 in the revised manuscript.

      The use of a Poisson spiking neuron model is the second major weakness of the study. A chief challenge in much of the cited work is to generate stochastic transitions from recurrent networks of deterministic neurons. The task the authors set out to do is much easier with stochastic neurons; it is reasonable that the network succeeds in reproducing Markovian sequences, given an appropriate learning rule. I believe that the main point comes from mapping abstract Markov states to assemblies of neurons. If I am right, I missed more analyses on this point, for instance on the impact that varying cell assembly size would have on the findings reported by the authors.

      The reviewer’s understanding is correct. Our main point comes from mapping Markov statistics to replays of cell assemblies. In the revised manuscript, we performed additional simulations to ask whether varying the size of the cell assemblies would affect learning. We ran simulations with two different configurations in the task shown in Figure 2. The first configuration used three assemblies with a size ratio of 1:1.5:2. After training, these assemblies exhibited transition statistics that closely matched those of the evoked activity (Supplementary Fig.4a,b). In contrast, the second configuration, which used a size ratio of 1:2:3, showed worse performance compared to the 1:1.5:2 case (Supplementary Fig.4c,d). These results suggest that the model can learn appropriate transition statistics as long as the size ratio of the assemblies is not drastically varied.

      Finally, it was not entirely clear to me what the main fundamental point in the HVC data section was. Can the findings be roughly explained as follows: if we map syllables to cell assemblies, for high-uncertainty syllable-to-syllable transitions, it becomes harder to predict future neural activity? In other words, is the main point that the HVC encodes syllables by cell assemblies? 

      The reviewer's understanding is correct. We wanted to show that if the HVC learns transition statistics as a replay of cell assemblies, a high-uncertainty syllable-to-syllable transition would make predicting future reactivations more difficult, since trial-averaged activities (i.e., poststimulus activities; PSAs) marginalized all possible transitions in the transition diagram.

      (1) Learning in Spiking Neural Assemblies, David Barber, 2002. URL: https://proceedings.neurips.cc/paper/2002/file/619205da514e83f869515c782a328d3c-Paper.pdf  

      (2) Correlated sequence learning in a network of spiking neurons usingmaximum likelihood, David Barber, Felix Agakov, 2002. URL: http://web4.cs.ucl.ac.uk/staff/D.Barber/publications/barber-agakovTR0149.pdf  

      Recommendations for the authors:

      Reviewer #1 (Recommendations For The Authors): 

      In more detail: 

      A) Theoretical analysis 

      The plasticity rules in the study are introduced with a vague reference to previous theoretical studies of others. Doing this, one does not provide any formal insight as to why these plasticity rules should enable one to learn to solve the intended task, and whether they are optimal in some respect. This becomes noticeable, especially in the discussion of the importance of inhibitory balance, which does not go into any detail, but rather only states that its required, both in the results and discussion sections. Another unclarity appears when error-based learning is discussed and compared to Hebbian plasticity, which, as you state, "alone is insufficient to learn transition probabilities". It is not evident how this claim is warranted, nor why error-based plasticity in comparison should be able to perform this (other than referring to the simulation results). Please either clarify formally (or at least intuitively) how plasticity rules result in the mentioned behavior, or alternatively acknowledge explicitly the (current) lack of intuition. 

      The lack of formal discussion is a relevant shortcoming compared to previous research that showed very similar results with formally more rigorous and principled approaches. In particular, Kappel et al derived explicitly how neural networks can learn to sample from HMMs using STDP and winner-take-all dynamics. Even though this study has limitations, the relation with respect to that work should be made very clear; potentially the claims of novelty of some results (sampling) should be adjusted accordingly. See also Yanping Huang, Rajesh PN Rao (NIPS 2014), and possibly other publications. While it might be difficult to formally justify the learning rules post-hoc, it would be very helpful to the field if you very clearly related your work to that of others, where learning rules have been formally justified, and elaborate on the intuition of how the employed rules operate and interact (especially for inhibition). 

      Lastly, while the importance of sampling learned transition probabilities is discussed, the discussion again remains on a vague level, characterized by the lack of references in the relevant paragraphs. Ideally, there should be a proof of concept or a formal understanding of how the learned behaviour enables to solve a problem that is not solved by deterministic networks. Please incorporate also the relation to the literature on neural sampling/planning/RL etc. and substantiate the claims with citations. 

      We have included sentences in ll. 691-696 in the revised manuscript to explain that for Poisson spiking neurons, the derived learning rule is equivalent to the one that minimizes the Kullback-Leibler divergence between the distributions of output firing and the dendritic prediction, in our case, the recurrent prediction (Asabuki and Fukai; 2020). Thus, the rule suggests that the recurrent prediction learns the statistical model of the evoked activity, which in turn allows the network to reproduce the learned transition statistics.

      We have also added a paragraph to discuss the differences between previously published similar models (e.g., Kappel et al.). Please see our response above.

      B) Connection to biology 

      The plasticity rules in the study are introduced with a vague reference to previous theoretical studies of others. Please discuss in more detail if these rules (especially the error-based learning rule) could be implemented biologically and how this could be achieved. Are there connections to biologically observed plasticity? E.g. for error-based plasticity has been discussed in the original publication by Urbanzcik and Senn, or more recently by Mikulasch et al (TINS 2023). The biological plausibility of inhibitory balance has been discussed many times before, e.g. by Vogels and others, and a citation would acknowledge that earlier work. This also leaves the question of how neurons in the songbird experiment could adapt and if the model does capture this well (i.e., do they exhibit E-I balance? etc), which might be discussed as well. 

      Last, please provide some testable experimental predictions. By proposing an interesting experimental prediction, the model could become considerably more relevant to experimentalists. Also, are there potentially alternative models of stochastic sequence learning (e.g., Kappel et al)? How could they be distinguished? (especially, again, why not Hebbian/STDP learning?) 

      We have cited the Vogels paper to acknowledge the earlier work. We have also included additional paragraphs to discuss a possible biologically plausible implementation of our model and how our model differs from similar models proposed previously (e.g., Kappel et al.). Please see our response above.

      Other comments 

      As mentioned, a derivation of recurrent plasticity rules is missing, and parameters are chosen ad-hoc. This leaves the question of how much the results rely on the specific choice of parameters, and how robust they are to perturbations. As a robustness check, please clarify how the duration of the Markov states influences performance. It can be expected that this interacts with the timescale of recurrent connections, so having longer or shorter Markov states, as it would be in reality, should make a difference in learning that should be tested and discussed.

      We thank the reviewer for pointing this out. To address this point, we performed new simulations and asked to what extent the duration of Markov states affect performance. Interestingly, even when the network was trained with input states of half the duration, the distributions of the durations of assembly reactivations remain almost identical to those in the original case (Supplementary Figure 3a). Furthermore, the transition probabilities in the replay were still consistent with the true transition probabilities (Supplementary Figure 3b). We have also included the derivation of our plasticity rule in ll. 630-670 in the revised manuscript. 

      Similarly, inhibitory plasticity operates with the same plasticity timescale parameter as excitatory plasticity, but, as the authors discuss, lags behind excitatory plasticity in simulation as in experiment. Is this required or was the parameter chosen such that this behaviour emerges? Please clarify this in the methods section; moreover, it would be good to test if the same results appear with fast inhibitory plasticity. 

      We have performed a new simulation and showed that even when the learning rate of inhibitory plasticity was larger than that of excitatory plasticity, inhibitory plasticity still occurred on a slower timescale than excitatory plasticity. We have included this result in a new Supplementary Figure 2 in the revised manuscript.

      What is the justification (biologically and theoretically) for the memory trace h and its impact on neural spiking? Is it required for the results or can it be left away? Since this seems to be an important and unconventional component of the model, please discuss it in more detail. 

      In the model, it is assumed that each stimulus presentation drives a specific subset of network neurons with a fixed input strength, which avoids convergence to trivial solutions. Nevertheless, we choose to add this dynamic sigmoid function to facilitate stable replay by regulating neuron activity to prevent saturation. We have explained this point in ll.605-611 in the revised manuscript.

      Reviewer #2 (Recommendations For The Authors): 

      I noticed a couple of minor typos: 

      Page 3 "underly"->"underlie" 

      Page 7 "assemblies decreased settled"->"assemblies decreased and settled"

      We have modified the text. We thank the reviewer for their careful review.

      I think Figure 1C is rather confusing and not intuitive. 

      We apologize that the Figure 1C was confusing. In the revised figure, we have emphasized the flow of excitatory and inhibitory error for updating synapses.

      Reviewer #3 (Recommendations For The Authors): 

      One possible path to improve the paper would be to establish a relationship between the proposed learning rules and e.g. the ones derived by Barber. 

      When reading the paper, I was left with a number of more detailed questions I omitted from the public review: 

      (1) The authors introduce a dynamic sigmoidal function for excitatory neurons, Eq. 3. This point requires more discussion and analysis. How does this impact the results? 

      In the model, it is assumed that each stimulus presentation drives a specific subset of network neurons with a fixed input strength, which avoids convergence to trivial solutions. Nevertheless, we choose to add this dynamic sigmoid function to facilitate stable replay by regulating neuron activity to prevent saturation. We have explained this point in ll.605-611 in the revised manuscript.

      (2) For Poisson spiking neurons, it would be great to understand what cell assemblies bring (apart from biological realism, i.e., reproducing data where assemblies can be found), compared to self-connected single neurons. For example, how do the results shown in Figure 2 depend on assembly size? 

      We have changed the cell assembly size ratio and how it affects learning performance in a new Supplementary Figure 4. Please see our reply above.

      (3) The authors focus on modeling spontaneous transitions, corresponding to a highly stochastic generative model (with most transition probabilities far from 1). A complementary question is that of learning to produce a set of stereotypical sequences, with probabilities close to 1. I wondered whether the learning rules and architecture of the model (in particular under the I-to-E rule) would also work in such a scenario. 

      We thank the reviewer for pointing this out. In fact, we had the same question, so we considered a situation in which the setting in Figure 2 includes both cases where the transition matrix is very stochastic (prob=0.5) and near deterministic (prob=0.9).

      (4) An analysis of what controls the time so that the network stays in a certain state would be welcome. 

      We trained the network model in two cases, one with a fast speed of plasticity and one with a slow speed of plasticity. As a result, we found that the duration of assembly becomes longer in the slow learning case than in the fast case. We have included these results as Supplementary Figure 5 in the revised manuscript.

      Regarding the presentation, given that this is a computational modeling paper, I wonder whether *all* the formulas belong in the Methods section. I found myself skipping back and forth to understand what the main text meant, mainly because I missed a few key equations. I understand that this is a style issue that is very much community-dependent, but I think readability would improve drastically if the main model and learning rule equations could be introduced in the main text, as they start being discussed. 

      We thank the reviewer for the suggestion. To cater to a wider audience, we try to explain the principle of the paper without using mathematical formulas as much as possible in the main text.

    1. Author response:

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      The authors aimed to quantify feral pig interactions in eastern Australia to inform disease transmission networks. They used GPS tracking data from 146 feral pigs across multiple locations to construct proximity-based social networks and analyze contact rates within and between pig social units.

      Strengths:

      (1) Addresses a critical knowledge gap in feral pig social dynamics in Australia.

      (2) Uses robust methodology combining GPS tracking and network analysis.

      (3) Provides valuable insights into sex-based and seasonal variations in contact rates.

      (4) Effectively contextualizes findings for disease transmission modeling and management.

      (5) Includes comprehensive ethical approval for animal research.

      (6) Utilizes data from multiple locations across eastern Australia, enhancing generalizability.

      Weaknesses:

      (1) Limited discussion of potential biases from varying sample sizes across populations

      This is a really good comment, and we will address this in the discussion as one of the limitations of the study.

      (2) Some key figures are in supplementary materials rather than the main text.

      We will move some of our supplementary material to the main text as suggested.

      (3) Economic impact figures are from the US rather than Australia-specific data.

      We included the impact figures that are available for Australia (for FDM), and we will include the estimated impact of ASF in Australia in the introduction.

      (4) Rationale for spatial and temporal thresholds for defining contacts could be clearer.

      We will improve the explanation of why we chose the spatial and temporal thresholds based on literature, the size of animals and GPS errors.

      (5) Limited discussion of ethical considerations beyond basic animal ethics approval.

      This research was conducted under an ethics committee's approval for collaring the feral pigs. This research is part of an ongoing pest management activity, and all the ethics approvals have been highlighted in the main manuscript.

      The authors largely achieved their aims, with the results supporting their conclusions about the importance of sex and seasonality in feral pig contact networks. This work is likely to have a significant impact on feral pig management and disease control strategies in Australia, providing crucial data for refining disease transmission models.

      Reviewer #2 (Public review):

      Summary:

      The paper attempts to elucidate how feral (wild) pigs cause distortion of the environment in over 54 countries of the world, particularly Australia.

      The paper displays proof that over $120 billion worth of facilities were destroyed annually in the United States of America.

      The authors have tried to infer that the findings of their work were important and possess a convincing strength of evidence.

      Strengths:

      (1) Clearly stating feral (wild) pigs as a problem in the environment.

      (2) Stating how 54 countries were affected by the feral pigs.

      (3) Mentioning how $120 billion was lost in the US, annually, as a result of the activities of the feral pigs.

      (4) Amplifying the fact that 14 species of animals were being driven into extinction by the feral pigs.

      (5) Feral pigs possessing zoonotic abilities.

      (6) Feral pigs acting as reservoirs for endemic diseases like brucellosis and leptospirosis.

      (7) Understanding disease patterns by the social dynamics of feral pig interactions.

      (8) The use of 146 GPS-monitored feral pigs to establish their social interaction among themselves.

      Weaknesses:

      (1) Unclear explanation of the association of either the female or male feral pigs with each other, seasonally.

      This will be better explain in the methods.

      (2) The "abstract paragraph" was not justified.

      We have justified the abstract paragraph as requested by the reviewer.

      (3) Typographical errors in the abstract.

      Typographical errors have been corrected in the Abstract.

      Reviewer #3 (Public review):

      Summary:

      The authors sought to understand social interactions both within and between groups of feral pigs, with the intent of applying their findings to models of disease transmission. The authors analyzed GPS tracking data from across various populations to determine patterns of contact that could support the transmission of a range of zoonotic and livestock diseases. The analysis then focused on the effects of sex, group dynamics, and seasonal changes on contact rates that could be used to base targeted disease control strategies that would prioritize the removal of adult males for reducing intergroup disease transmission.

      Strengths:

      It utilized GPS tracking data from 146 feral pigs over several years, effectively capturing seasonal and spatial variation in the social behaviors of interest. Using proximity-based social network analysis, this work provides a highly resolved snapshot of contact rates and interactions both within and between groups, substantially improving research in wildlife disease transmission. Results were highly useful and provided practical guidance for disease management, showing that control targeted at adult males could reduce intergroup disease transmission, hence providing an approach for the control of zoonotic and livestock diseases.

      Weaknesses:

      Despite their reliability, populations can be skewed by small sample sizes and limited generalizability due to specific environmental and demographic characteristics. Further validation is needed to account for additional environmental factors influencing social dynamics and contact rates

      This is a good point, and we thank the reviewer for pointing out this issue. We will discuss the potential biases due to sample size in our discussion. We agree that environmental factors need to be incorporated and tested for their influence on social dynamics, and this will be added to the discussion as we have plans to expand this research and conduct, the analysis to determine if environmental factors are influencing social dynamics.

    1. Author response:

      Reviewer #1:

      (1) This concern is addressed in the ESM6, and partly in the ESM1. Indeed, many of the concerns raised by the reviewer later are already addressed on the multiple supplementary materials provided, so we kindly ask the reviewer to read them before moving forward into the discussion.

      (2) This concern is reasonable, but its solution is not "extremely easy", as the reviewer states. The reviewer indicates the use of captive-based versus non-captive-based sources, remarking maximum lifespan, the main variable that is clearly expected to be systematically biased by the source of the data. Nevertheless, except for the ZIMS database, which includes only captive individuals, and some sources, as CNRS databases and EURING, which exclusively includes wild populations, the remaining databases, which are indeed where the vast majority of the data was collected from (i.e. Amniotes database, Birds of the World and AnAge) do not make any distinction. This means that they include just the maximum lifespan from the species as known by the authors of such databases' entries, regardless of provenance, which is also not usually made explicit by the database. Therefore, correcting for this would imply checking all the primary sources. Considering that these databases sometimes do not cite the primary source, but a secondary one, and that on several occasions such source is a specialized book that is not easily accessible, and still these referenced datasets may not indicate the source of the data, tracing all of this information becomes an arduous task, that would even render the usage of databases themselves useless. We will include some details about the concerns of database usage in the discussion to address this.

      Furthermore, it remains relevant to indicate that what we discuss later about the possible effects of captivity is about our usage of animals that come from both sources, not about the provenance of the literature-extracted data used (i.e. captive or wild maximum lifespan, for example), which is an independent matter. We can test for the first for next submission, but very difficultly could we test for the second (as the reviewer seems to be pointing to). In any case, as we do not have in any case the same species from both a captive and a wild source, it would be difficult to determine if the effect tested comes from captivity or from species-specific differences.

      (3) We will add data on the replicability of the glycation measurement in the next manuscript version. The CV for several individuals of different species measured repeated times is quite low (always below 2%).

      (4) The reviewer remarks reported here are already addressed on the supplementary material (ESM6), given the lack of space in the main manuscript. We therefore kindly ask the reviewer to read the supplementary material added to the submission. If the editors agree, all or a considerable part of this could be transferred to the main text for clarity, but this would severely extend the length of a text that the reviewer already considered very long.

      Reviewer #2:

      Thanks for spotting this issue with the coefficient, as it is actually a redaction mistake. It is a remnant of a previous version of the manuscript in which a log-log relation was performed instead. Previous reviewers raised concerns about the usage of log transformation for glycation, this variable being (theoretically) a proportion variable (to which we argue that it does not behave as such), which they considered not to be transformed with a logarithm. After this, we still finally took the decision of not to transform this variable. In this line, the transformations of variables were decided generally by preliminary data exploration. In this particular case, both approaches lead to the same conclusion of higher glycation resistance in the species with higher glucose. Nevertheless, we will consider exploring the comparison of different versions for the resubmission.

      About the issue related to handling time, this variable is not available, for the reasons already exposed in the answer to the other reviewer. Moreover, Kruskal-Wallis test, by its nature, does not determine differences in medians between groups per se, as the reviewer claims, but just differences in ranks-sums. It can be equivalently used for that purpose when the groups' distributions are similar, but not when they differ, as we see here with a difference in variance. What a significant outcome in a Kruskal-Wallis test tells us, thus, is just that the groups differ (in their ranks-sums), which here is plausibly caused by the higher variance in the stressed individuals. Even if we conclude that the average is higher in those groups, mere comparisons of averages for groups with very different variances render different interpretations than when homoscedasticity is met, particularly more so when the distribution of groups overlaps. For example, in a case like this, where the data is left censored (glucose levels cannot be lower than 0), most of this higher variance is related to many values in the stressed groups lying above all the baseline values. This, of course, would increase the average, but such a parameter would not mean the same as if the distributions did not overlap.

      Regarding the GVIFs, why the values are above 1.6 is not well known, but we do not consider this a major concern, as the values are never above 2.2, level usually considered more worrying. We will include a brief explanation of this in the results section. Also, we explicitly calculated life history variables adjusted for body mass, which should eliminate their otherwise strong correlation. There exist other biological and interpretational reasons justified in the ESM6 for using the residuals on the models, instead of the raw values, despite previously raised concerns.

      Given the asseveration by the reviewer that credible intervals are not to be used for the post hoc comparisons, as this is what the whiskers shown in Figure 4B represent, the affirmation of this graph suggesting any difference between groups remains doubtful. New comparisons have now been made with the function HPDinterval() applied to the differences between each diet category calculated from the posterior values of each group, confirming no significant differences exist.

      We do not understand the suggestion made in relation to the model shown in Table 2. Removing glucose from the model could have two results, as the reviewer indicates: 1. Maximum lifespan (ML) relates with glycation, potentially spuriously through the effect of glucose (in this case not included) on both; 2. ML does not relate to glycation, and therefore "high glycation levels do not preclude the evolution of long lifespans", which is what we are already showing with the current model, which also controls for glucose, in an attempt to determine if not just raw glycation values, but glycation resistance, relates to longevity. This is intended to asses if long-lived species may show mechanisms that avoid glycation, by showing levels lower than expected for a non-enzymatic reaction.

    1. Author response:

      In this manuscript, we have addressed one of the possible modes of recruitment of Swi6 to the putative heterochromatin loci.

      Our investigation was guided by earlier work showing ability of HP1 a to bind to a class of RNAs and the role of this binding in recruitment of HP1a to heterochromatin loci in mouse cells (Muchardt et al). While there has been no clarity about the mechanism of Swi6 recruitment given the multiple pathways being involved, the issue is compounded by the overall lack of understanding as to how Swi6 recruitment occurs only at the repeat regions. At the same time, various observations suggested a causal role of RNAi in Swi6 recruitment.

      Thus, guided by the work of Muchardt et al we developed a heuristic approach to explore a possibly direct link between Swi6 and heterochromatin through RNAi pathway. Interestingly, we found that the lysine triplet found in the hinge domain in HP1, which influences its recruitment to heterochromatin in mouse cells, is also present in the hinge domain of Swi6, although we were cautious, keeping in mind the findings of Keller et al showing another role of Swi6 in binding to RNAs and channeling them to the exosome pathway. 

      Accordingly, we envisaged that a mode of recruitment of Swi6 through binding to siRNAs to cognate sites in the dg-dh repeats shared among mating type, centromere and telomere loci could explain specific recruitment as well as inheritance following DNA replication. In accordance we framed the main questions as follows: i) Whether Swi6 binds specifically and with high affinity to the siRNAs and the cognate siRNA-DNA hybrids and whether the Swi63K-3A mutant is defective in this binding, ii) whether this lack of binding of Swi63K-3A affects its localization to heterochromatin, iii) whether the this specificity is validated by binding of Swi6 but not Swi63K-3A  to siRNAs and siRNA-DNA hybrids in vivo and iv) whether the binding mode was qualitatively and quantitatively different from that of Cen100 RNA or random RNAs, like GFP RNA.

      We think that our data provides answers to these lines of inquiry to support a model wherein the Swi6-siRNA mediated recruitment can explain a cis-controlled nucleation of heterochromatin at the cognate sites in the genome. We have also partially addressed the points raised by the study by Keller et al by invoking a dynamic balance between different modes of binding of Swi6 to different classes of RNA to exercise heterochromatin formation by Swi6 under normal conditions and RNA degradation under other conditions.

      While we aver about our hypothesis, we do acknowledge the need for more detailed investigation both to buttress our hypothesis and address the dynamics of siRNA binding and recruitment of Swi6  and how Swi6 functions fit in the context of other components of heterochromatin assembly, like the HDACs and Clr4 on one hand and exosome pathway on the other. Our future studies will attempt to address these issues.

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      This manuscript explores the RNA binding activities of the fission yeast Swi6 (HP1) protein and proposes a new role for Swi6 in RNAi-mediated heterochromatin establishment. The authors claim that Swi6 has a specific and high affinity for short interfering RNAs (siRNAs) and recruits the Clr4 (Suv39h) H3K9 methyltransferases to siRNA-DNA hybrids to initiate heterochromatin formation. These claims are not in any way supported by the incomplete and preliminary RNA binding or the in vivo experiments that the authors present. The proposed model also lacks any mechanistic basis as it remains unclear (and unexplored) how Swi6 might bind to specific small RNA sequences or RNA-DNA hybrids. Work by several other groups in the field has led to a model in which siRNAs produced by the RNAi pathway load onto the Ago1-containing RITS complex, which then binds to nascent transcripts at pericentromeric DNA repeats and recruits Clr4 to initiate heterochromatin formation. Swi6 facilitates this process by promoting the recruitment of the RNA-dependent RNA polymerase leading to siRNA amplification.

      Weaknesses:

      (1) a) The claims that Swi6 binds to specific small RNAs or to RNA-DNA hybrids are not supported by the evidence that the authors present. Their experiments do not rule out non-specific charged-based interactions.

      We disagree. We have used synthetic siRNAs of 20-22 nt length to do EMSA assay, as mentioned in the manuscript. Further, we have sequenced the small RNAs obtained after RIP experiments to validate the enrichment of siRNA in Swi6 bound fraction as compared to the mutant Swi6-bound fraction. These results are internally consistent regardless of the mode of binding. In any case the binding occurs primarily through the chromodomain although it is influenced by the hinge domain (see below).

      Furthermore, we have carried out EMSA experiments using Swi6 mutants carrying all three possible double mutations of the K residues in the KKK triplet and found that there was no difference in the binding pattern as compared to the wt Swi6: only the triple mutant “3K-3A” showed the effect. These results suggest that that the bdining is not completely dependent on the basic residues. These results will be included in the revised version.

      We also have some preliminary data from SAXS study showing that the CD of wt Swi6 shows a change in its structure upon binding to the siRNA, while the “3K-3A” mutant of Swi6 has a compact, folded structure that occludes the binding site of Swi6 in the chromodomain.” We propose to mention this preliminary finding in the revised version as unpublished data.

      b) Claims about different affinities of Swi6 for RNAs of different sizes are based on a comparison of KD values derived by the authors for a handful of S. pombe siRNAs with previous studies from the Buhler lab on Swi6 RNA binding. The authors need to compare binding affinities under identical conditions in their assays.

      Thus, the EMSA data do suggest sequence specificity in binding of Swi6 to specific siRNA sequences (Figure S5) and implies specific residues in Swi6 being responsible for that. Thus, Identification of the residues in Swi6 involved in siRNA binding in the CD would definitely be interesting, as also the experimental confirmation of the consensus siRNA sequence. It may however be noted that as against the binding of Swi6 to siRNAs occurs through CD, that of Cen100 or GFP RNA was shown be through the hinge domain by Keller et al.

      The estimation of Kd by the Buhler group was based on NMR study, which we are not in a position to perform in the near future. Nonetheless, we did carry out EMSA study using the ‘Cen100’ RNA, same as the one used by the Keller et al study. Surprisingly, in contrast with the result of EMSA in agarose gel showing binding of Swi6 to “Cen100” RNA as reported by Keller et al, we fail to observe any binding in EMSA done in acrylamide gel. (The same is true of the RevCen 100). While this raises issues of why the Keller et al chose to do EMSA in agarose gel instead of the conventional approach of using acrylamide gel, it does lend support to our claim of stronger binding of Swi6 to siRNAs. Another relevant observation of binding of Swi6 to the “RevCen” RNA precursor RNAs but a detectable binding to siRNAs denoted as VI-IX (as measured by competition experiments, that are derived from RevCen RNA; Figure S4 and S7), which are derived by Dcr1 cleavage of the ‘’RevCen’’ RNA.

      We also disagree that we carried out EMSA with a small bunch of siRNAs. As indicated in Figure 1 and S1, we synthesized nearly 12 siRNAs representing the dg-dh repeats at Cen, mat and tel loci and measured their specificity of binding to Swi6 using EMSA assay by labeling the ones labelled “D”, “E” and “V” directly and those of the remaining ones by the latter’s ability to compete against the binding (Figure 1, S4). These results point to presence of a consensus sequence in siRNAs that shows highly specific and strong binding to Swi6 in the low micromolar range.

      Further, our claim of binding of Swi6 and not Swi63K>3A to siRNA in vivo is validated by RIP experiments, as shown in Fig 2 and S9.

      c) The regions of Swi6 that bind to siRNAs need to be identified and evidence must be provided that Swi6 binds to RNAs of a specific length, 20-22 mers, to support the claim that Swi6 binds to siRNAs. This is critical for all the subsequent experiments and claims in the study.

      We have provided both in vitro data, which is va;idiated in vivo by RIP experiments, as mentioned above. However, we agree that it wpuld be very interesting to identify the residues in Swi6 chromdomain responsible for binding to siRNA. However, such an investigation is beyond the scope of the present study.

      (2) a) The in vivo results do not validate Swi6 binding to specific RNAs, as stated by the authors. Swi6 pulldowns have been shown to be enriched for all heterochromatic proteins including the RITS complex. The sRNA binding observed by the authors is therefore likely to be mediated by Ago1/RITS.

      We disagree with the first comment. Our RIP experiments do validate the in vitro results (Fig 1, 2, S4 and S9), as argued above. The observation alluded to by the reviewer “Swi6 pulldowns have been shown to be enriched for all heterochromatic proteins including the RITS complex” is not inconsistent with our observation; it is possible that the siRNA may be released from the RITS complex and transferred to Swi6, possibly due to its higher affinity.

      Thus, we would like to suggest that the role of Swi6 is likely to be coincidental or subsequent to that of Ago1/RITS (see below). We think that the binding by Swi6 to the siRNA and siRNA-DNA hybrid and could be also carried out in cis at the level of siRNA-DNA hybrids.

      This point needs to be addressed in future studies.

      b) Most of the binding in Figure S8C seems to be non-specific.

      We would like to point out that the result in Figure S8C needs to be examined together with the Figure S8B, which shows RNA bound by Swi6 but not Swi63K-3A to hybridize with dg, dh and dh-k probes.

      c) In Figure S8D, the authors' data shows that Swi6 deletion does not derepress the rev dh transcript while dcr1 delete cells do, which is consistent with previous reports but does not relate to the authors' conclusions.

      The purpose of results shown in Figure S8D is just to compare the results of Swi6 with that of Swi63K-3A.

      d) Previous results have shown that swi6 delete cells have 20-fold fewer dg and dh siRNAs than swi6+ cells due to decreased RNA-dependent RNA polymerase complex recruitment and reduced siRNA amplification.

      This result is consistent with our results invoking a role of Swi6 in binding to, protecting and recruiting siRNAs to homologous sites.

      To find if the overall production of siRNA is compromised in swi6 3K->3A mutant, we i) calculated the RIP-Seq read counts for swi6 3K->3A , swi6+ and vector control in 200 bp genomic bins , ii) divided the Swi6 3K->3A and swi6+ signals by that of control, iii) removed the background using the criteria of signal value < 25% of max signal, and iv) counted the total reads (in excess to control) in all peak regions in both samples.  This revealed a total count of 10878 and 8994 respectively for Swi6 3K->3A  and swi6+ samples, possibly implying that the overall siRNA production is not compromised in the Swi6 3K->3A mutant.

      (3) a) The RIP-seq data are difficult to interpret as presented. The size distribution of bound small RNAs, and where they map along the genome should be shown as for example presented in previous Ago1 sRNA-seq experiments.

      Please see the response to 2(d).

      b) It is also unclear whether the defects in sRNA binding observed by the authors represent direct sRNA binding to Swi6 or co-precipitation of Ago1-bound sRNAs.

      The correspondence between our in vivo and in vitro results suggests that the binding to Swi6 would be direct. We do not observe a complete correspondence between the Swi6- and Ago-bound siRNAs. We think Swi6 binding may be coincident with or following RITS complex formation.

      This point will be discussed in the Revision.

      The authors should also sequence total sRNAs to test whether Swi6-3A affects sRNA synthesis, as is the case in swi6 delete cells.

      Please see response to 2(d) above.

      (4) The authors examine the effects of Swi6-3A mutant by overexpression from the strong nmt1 promoter. Heterochromatin formation is sensitive to the dosage of Swi6. These experiments should be performed by introducing the 3A mutations at the endogenous Swi6 locus and effects on Swi6 protein levels should be tested.

      Although we agree, we think that the heterochromatin formation is occurring in presence of nmt1-driven Swi6 but not Swi63K>3A, as indicated by the phenotype and Swi6 enrichment at otr1R::ade6, imr1::ura4 and his3-telo (Figure 3) and mating type (Fig. S10). Furthermore, the both GFP-Swi6 and GFPSwi63K>3A are expressed at similar level (Fig. S8A).

      (5) The authors' data indicate an impairment of silencing in Swi6-3A mutant cells but whether this is due to a general lower affinity for nucleosomes, DNA, RNA, or as claimed by the authors, siRNAs is unclear. These experiments are consistent with previous findings suggesting an important role for basic residues in the HP1 hinge region in gene silencing but do not reveal how the hinge region enhances silencing.

      Our study aims to correlate the binding of Swi6 but not Swi63K-3A to siRNA with its localization to heterochromatin. A similar difference in binding of Swi6 but not Swi63K-3A to siRNA-DNA hybrid, together with sensitivity of silencing and Swi6 localization to heterochromatin to RNaseH support the above correlations as being causally connected.

      In terms of mechanism of binding, we need to clarify that the primary mode of binding is through the CD and not the hinge domain, although the hinge domain does influence this binding. This result is different from those of Keller et al.

      We have some structural data based on preliminary SAXS experiment supporting binding of siRNA to the CD and influence of the hinge domain on this binding. However, this line of investigation need to be extended and will be subject of future investigations.

      (6) RNase H1 overexpression may affect Swi6 localization and silencing indirectly as it would lead to a general reduction in R loops and RNA-DNA hybrids across the genome. RNaseH1 OE may also release chromatin-bound RNAs that act as scaffolds for siRNA-Ag1/RITS complexes that recruit Clr4 and ultimately Swi6.

      These are formal possibilities. However, the correlation between swi6 binding to siRNA-DNA hybrid and delocalization upon RNase H1 treatment argues for a more direct link.

      (7) Examples of inaccurate presentation of the literature.

      a) The authors state that "RNA binding by the murine HP1 through its hinge domains is required for heterochromatin assembly (Muchardt et al, 2002). The cited reference provides no evidence that HP1 RNA binding is required for heterochromatin assembly. Only the hinge region of bacterially produced HP1 contributes to its localization to DAPI-stained heterochromatic regions in fixed NIH 3T3 cells.

      Noted. Statement will be corrected.

      b) "... This scenario is consistent with the loss of heterochromatin recruitment of Swi6 as well as siRNA generation in rnai mutants (Volpe et al, 2002)." Volpe et al. did not examine changes in siRNA levels in swi6 mutant cells. In fact, no siRNA analysis of any kind was reported in Volpe et al., 2002.

      Correct.  We only say that Swi6 recruitment is reduced in rnai mutants and correlate it with ability of SWi6 to bind to siRNA generated by RNAi and subsequently to siRNA-DNA hybrid.

      Reviewer #2 (Public review):

      The aim of this study is to investigate the role of Swi6 binding to RNA in heterochromatin assembly in fission yeast. Using in vitro protein-RNA binding assays (EMSA) they showed that Swi6/HP1 binds centromere-derived siRNA (identified by Reinhardt and Bartel in 2002) via the chromodomain and hinge domains. They demonstrate that this binding is regulated by a lysine triplet in the conserved region of the Swi6 hinge domain and that wild-type Swi6 favours binding to DNA-RNA hybrids and siRNA, which then facilitates, rather than competes with, binding to H3K9me2 and to a lesser extent H3K9me3.

      However, the majority of the experiments are carried out in swi6 null cells overexpressing wild-type Swi6 or Swi63K-3A mutant from a very strong promoter (nmt1). Both swi6 null cells and overexpression of Swi6 are well known to exhibit phenotypes, some of which interfere with heterochromatin assembly. This is not made clear in the text.

      We think that the argument is not valid as we show that swi6 but not Swi63K-3A could restore silencing at imr1::ura4, otr1::ade6 and his3-telo (Fig 3) and mating type (Fig. S10), when transformed into a swi6D strain.

      Whilst the RNA binding experiments show that Swi6 can indeed bind RNA and that binding is decreased by Swi63K-3A mutation in vitro (confusingly, they only much later in the text explained that these 3 bands represent differential binding and that II is likely an isotherm). The gels showing these data are of poor quality and it is unclear which bands are used to calculate the Kd.

      We disagree with the comment about the quality of EMSA data. We think it is of similar quality or better than that of Keller et al, except in some cases, like Fig 1D, a shorter exposure shown to distinguish the slowest shifted band has caused the remaining bands to look fainter.

      RNA-seq data shows that overall fewer siRNAs are produced from regions of heterochromatin in the Swi63K-3A mutant so it is unsurprising that analysis of siRNA-associated motifs also shows lower enrichment (or indeed that they share some similarities, given that they originate from repeat regions).

      Please see response to comment 2(d) of the first reviewer above.

      It is not clear which bands are being alluded to. However, we‘ll rectify any gaps in information in the revision.

      The experiments are seemingly linked yet fail to substantiate their overall conclusions. For instance, the authors show that the Swi63K-3A mutant displays reduced siRNA binding in vitro (Figure 1D) and that H3K9me2 levels at heterochromatin loci are reduced in vivo (Figure 3C-D). They conclude that Swi6 siRNA binding is important for Swi6 heterochromatin localization, whilst it remains entirely possible that heterochromatin integrity is impaired by the Swi63K-3A mutation and hence fewer siRNAs are produced and available to bind. Their interpretation of the data is really confusing.

      Our argument is that the lack of binding by Swi63K>3A to siRNA can explain the loss of recruitment to heterochromatin loci and thus affect the integrity of heterochroamtin; the recruitment of Swi6 can occur possibly by binding initially to siRNA and thereafter as siRNA-DNA hybrid. However, the overall level of siRNAs is not affected, as in 2(D) above. This interpretation is supported by results of ChIP assay and confocal experiments, as also by the effect of RNaseH1 in the recruitment of Swi6.

      The authors go on to show that Swi63K-3A cells have impaired silencing at all regions tested and the mutant protein itself has less association with regions of heterochromatin. They perform DNA-RNA hybrid IPs and show that Swi63K-3A cells which also overexpress RNAseH/rnh1 have reduced levels of dh DNA-RNA hybrids than wild-type Swi6 cells. They interpret this to mean that Swi6 binds and protects DNA-RNA hybrids, presumably to facilitate binding to H3K9me2. The final piece of data is an EMSA assay showing that "high-affinity binding of Swi6 to a dg-dh specific RNA/DNA hybrid facilitates the binding to Me2-K9-H3 rather than competing against it." This EMSA gel shown is of very poor quality, and this casts doubt on their overall conclusion.

      We do agree with the reviewer about the quality of EMSA (Fig. 5B). However, as may be noticed in the EMSA for siRNA-DNA hybrid binding  (Fig 4A), the bands of Swi6-bound siRNA-DNA hybrid are extremely retarded. Hence the EMSA for subsequent binding by H3-K9-Me peptides required a longer electrophoretic run, which led to reduction in the sharpness of the bands. Nevertheless, the data does indicate binding efficiency in the order H3K9-Me2> H3-K9-Me3 > H3-K9-Me0. Having said that, we plan to repeat the EMSA or address the question by other methods, like SPR.

      Unfortunately, the manuscript is generally poorly written and difficult to comprehend. The experimental setups and interpretations of the data are not fully explained, or, are explained in the wrong order leading to a lack of clarity. An example of this is the reasoning behind the use of the cid14 mutant which is not explained until the discussion of Figure 5C, but it is utilised at the outset in Figure 5A.

      We tend to agree somewhat and will attempt to submit a revised version with greater clarity, as also the explanation of experiment with cid14D strain.

      Another example of this lack of clarity/confusion is that the abstract states "Here we provide evidence in support of RNAi-independent recruitment of Swi6". Yet it then states "We show that...Swi6/HP1 displays a hierarchy of increasing binding affinity through its chromodomain to the siRNAs corresponding to specific dg-dh repeats, and even stronger binding to the cognate siRNA-DNA hybrids than to the siRNA precursors or general RNAs." RNAi is required to produce siRNAs, so their message is very unclear. Moreover, an entire section is titled "Heterochromatin recruitment of Swi6-HP1 depends on siRNA generation" so what is the author's message?

      The reviewer has correctly pointed out the error. Indeed, our results actually indicate an RNAi-dependent rather than independent mode of recruitment. Rather, we would like to suggest an H3-K9-Me2-indpendnet recruitment of Swi6. We will rectify this error in our revised manuscript.

      The data presented, whilst sound in some parts is generally overinterpreted and does not fully support the author's confusing conclusions. The authors essentially characterise an overexpressed Swi6 mutant protein with a few other experiments on the side, that do not entirely support their conclusions. They make the point several times that the KD for their binding experiments is far higher than that previously reported (Keller et al Mol Cell 2012) but unfortunately the data provided here are of an inferior quality and thus their conclusions are neither fully supported nor convincing.

      We have used the method of Heffler et al (2012) to compute the Kd from EMSA data.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Joint Public Review:

      (1) This work investigates numerically the propagation of subthreshold waves in a model neural network that is derived from the C. elegans connectome. Using a scattering formalism and tight-binding description of the network -- approximations which are commonplace in condensed matter physics -- this work attempts to show the relevance of interference phenomena, such as wavenumber-dependent propagation, for the dynamics of subthreshold waves propagating in a network of electrical synapses.

      (2) The primary strength of the work is in trying to use theoretical tools from a far-away corner of fundamental physics to shed light on the properties of a real neural system. While a system composed of neurons and synapses is classical in nature, there are occasions in which interference or localization effects are useful for understanding wave propagation in complex media [review, van Rossum & Nieuwenhuizen, 1999]. However, it is expected that localization effects only have an impact in some parameter regimes and with low phase dissipation. The authors should have addressed the existence of this validity regime in detail prior to assuming that interference effects are important.

      The theoretical concept and tool used in this study are not situated in a far-away corner of fundamental physics but hold one of the central positions in condensed matter physics and statistical physics. In fact, the non-scientific statement about where the theoretical concept and tool employed by the researchers are positioned within the realm of fundamental physics is irrelevant. The fundamental physics governs the foundations of all natural phenomena, and thus it provides indispensable principles for interpreting not only neural systems but also all life phenomena. One such principle explored in our study is the interference and localization of waves.

      Specifically, in the third paragraph of the Introduction, we introduced that the interference effect of subthreshold oscillating waves, beyond being a theoretical possibility, is a phenomenon actually observed in neural tissue (Chiang and Durand, 2023; Gupta et al., 2016). Moreover, according to Devor and Yarom (2002), the propagation of subthreshold oscillations observed in the inferior olivary nucleus extended beyond a distance of 0.2 mm. Therefore, considering the propagation of subthreshold waves and the resulting interference in the connectome of C. elegans, which has a total body length of less than 1 mm, a diameter of about 0.08 mm, and most neurons distributed in the ring structure near its neck, provides sufficient validity for the initiation of theoretical and computational studies.

      The primary objective of our study is to investigate which regimes of signal transmission/localization and interference phenomena are valid within the network of electrical synapses in C. elegans, the only system for which the neural connectome structure is perfectly known. As the Reviewer rightly pointed out in the question, this is exactly the issue that the Reviewer is curious about. Therefore, the existence of this validity regime cannot be addressed prior to conducting the study but can only be identified as a result of performing the research. And we have conducted such a study.

      (3) An additional approximation that was made without adequate justification is the use of a tight-binding Hamiltonian. This can be a reasonable approximation, even for classical waves, in particular in the presence of high-quality-factor resonators, where most of the wave amplitude is concentrated on the nodes of the network, and nodes are coupled evanescently with each other. Neither of these conditions were verified for this study.

      The tight-binding Anderson Hamiltonian we used in this study originally consisted of the on-site energy at each node and the hopping matrix between nodes. When the on-site energy is relatively much more stable (i.e., has a large negative value) compared to the hopping matrix, most of the wave amplitude becomes concentrated on the nodes as the Reviewer mentioned. However, as is well-known from reference papers (Anderson, 1958; Chang et al., 1995; Meir et al., 1989; Shapir et al., 1982; Thomas and Nakanishi, 2016), in this study, we also removed the on-site energy to prevent the waves from being concentrated on the nodes. Therefore, the tight-binding Hamiltonian we used in this study ensures that waves propagate through edges in the network where the values of the hopping matrix exist.

      To assist the Reviewer in better understanding the model used in this study, we provide additional explanations as follows. In the manuscript, we have already provided detailed descriptions of the setup using the tight-binding Anderson Hamiltonian in the Method section under “Construction of our circuit model” and the explanation of Figure 1. In the model we used, the edges represented by solid lines are perfect conductors, while the dotted lines representing gap junctions act as potential barriers (Fig. 1B). Therefore, when electric signals propagate, we are dealing with the phenomenon where signals transmitted through the edges encounter potential barriers, causing scattering or attenuation. The model described by the Reviewer is indeed a commonly used model in condensed matter physics, but we did not use the exact model mentioned by the Reviewer. Instead, as is common in well-known reference papers, we modified it to suit our purposes. We hope this explanation helps the Reviewer gain a better understanding.

      (4) The motivation for this work is to understand the basic mechanisms underlying subthreshold intrinsic oscillations in the inferior olive, but detailed connectivity patterns in this brain area are not available. The connectome is known for C elegans, but sub-threshold oscillations have not been observed there, and the implications of this work for C elegans neuroscience remain unclear. The authors should also give more evidence for the claim that their study may give a mechanism for synchronized rhythmic activity in the mammalian inferior olive nucleus, or refrain from making this conclusion.

      We agree with the Reviewer's point. In this study, we do not provide additional analysis on the mammalian inferior olive nucleus beyond what is already known from previous research. What we intended to discuss in the Discussion section was to suggest that within our model, there is a “possibility” that a group of cells exchanging wave signals of a specific wavenumber with high transmittance may show synchronized rhythmic activity. Therefore, to avoid any misunderstanding for the reader, we have revised the corresponding sentence in the Discussion as follows.

      In the Discussion, “The plausible possibility according to our model study is that the constructive interference of subthreshold membrane potential waves with a specific wavenumber may generate the synchronized rhythmic activation.

      (5) In the same vein, since the work emphasizes the dependence on the wavenumber for the propagation of subthreshold oscillations, they should make an attempt at estimating the wavenumber of subthreshold oscillations in C elegans if they were to exist and be observed. Next, the presence of two "mobility edges" in the transmission coefficient calculated in this work is unmistakably due to the discrete nature of the system, coming from the tight-binding approximation, and it is unclear if this approximation is justified in the current system.

      In this study, we modeled the propagation of subthreshold waves on the electrical synapse network of C. elegans, but we did not explain the generation of subthreshold oscillations themselves. Here, we simply injected wave signals with various wavenumber values into the network using a hypothetical device called an "Injector." As the Reviewer pointed out, estimating the wavenumbers of subthreshold oscillations that may exist or be observed in C. elegans would require a comprehensive investigation of the membrane potential dynamics occurring in the membranes of individual neurons. However, this is beyond the scope of this study and would require considerable effort to accomplish.

      As for the use of the tight-binding Hamiltonian, we have addressed that in our response to the third paragraph in the Joint Public Review above.

      (6) Similarly, it is possible that the wavenumber-dependent transmission observed depends strongly on the addition of a large number of virtual nodes (VNs) in the network, which the authors give little to no motivation for. As these nodes are not present in the C elegans connectome, the authors should explain the motivation for their inclusion in the model and should discuss their consequences on the transmission properties of the network.

      As mentioned in our response to the third paragraph in the Joint Public Review above, in our model, a node is simply a pathway for waves to pass through. Therefore, inserting virtual nodes between two neurons that are connected in the C. elegans connectome does not alter the actual connection structure. In other words, virtual nodes do not create new connections between cells that didn’t exist in the connectome. The virtual nodes we introduced are merely a way to divide the sections—axon, gap junction, dendrite—through which the wave passes when it is transmitted between two neurons. As we have already explained in Fig. 1B, the edge connected by two virtual nodes, represented by a dotted line, is motivated to depict the gap junction acting as a potential barrier. We hope this explanation helps the Reviewer better understand the model used in this study.

      (7) As it stands, the work would only have a very limited impact on the understanding of subthreshold oscillations in the rat or in C elegans. Indeed, the preprint falls short of relating its numerical results to any phenomena which could be observed in the lab.

      In this study, we proposed a minimalistic model built using the currently available but limited C. elegans connectome information. Specifically, our model is not a phenomenological one that adjusts parameters to accurately predict experimental measurements, but rather an attempt at a novel conceptual approach to theoretically possible scenarios. While the model may not be satisfactory enough to explain experimental phenomena at present, it is a theoretical/computational study that someone needs to undertake. We believe this is the path of scientific progress. Therefore, as the Reviewer has expressed concern, it is entirely understandable that reproducing the numerical results measured in actual experiments is difficult in this study. Nevertheless, we believe that this study makes a basic contribution to the conceptual understanding of subthreshold signal propagation in C. elegans’ electric synapses.

      Rather than offering a stretched opinion, we maintain a positive hope that future researchers in this field will improve the model by incorporating more detailed and extensive biological data through follow-up studies, allowing us to get closer to describing real phenomena.

      Recommendations for the authors:

      Reviewer #1 (Recommendations for the authors):

      The word "Sensory" was misspelled in Figures 2, 4 and 5.

      We appreciate the feedback from Reviewer #1. We have corrected the mentioned typos in Figures 2, 4, and 5 of the revised manuscript.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Reviewer #1 (Public Review):

      What neurophysiological changes support the learning of new sensorimotor transformations is a key question in neuroscience. Many studies have attempted to answer this question at the neuronal population level - with varying degrees of success - but few, if any, have studied the change in activity of the apical dendrites of layer 5 cortical neurons. Neurons in layer 5 of the sensory cortex appear to play a key role in sensorimotor transformations, showing important decision and reward-related signals, and being the main source of cortical and subcortical projections from the cortex. In particular, pyramidal track (PT) neurons project directly to subcortical regions related to motor activity, such as the striatum and brainstem, and could initiate rapid motor action in response to given sensory inputs. Additionally, layer 5 cortical neurons have large apical dendrites that extend to layer 1 where different neuromodulatory and long-range inputs converge, providing motor and contextual information that could be used to modulate layer 5 neurons output and/or to establish the synaptic plasticity required for learning a new association. 

      In this study, the authors aimed to test whether the learning of a new sensorimotor transformation could be supported by a change in the evoked response of the apical dendrites of layer 5 neurons in the mouse whisker primary somatosensory cortex. To do this, they performed longitudinal functional calcium imaging of the apical dendrites of layer 5 neurons while mice learned to discriminate between two multi-whisker stimuli. The authors used a simple conditioning task in which one whisker stimulus (upward or backward air pu , CS+) is associated with a reward after a short delay, while the other whisker stimulus (CS-) is not. They found that task learning (measured by the probability of anticipatory licking just after the CS+) was not associated with a significant change in the average population response evoked by the CS+ or the CS-, nor a change in the average population selectivity. However, when considering individual dendritic tufts, they found interesting changes in selectivity, with approximately equal numbers of dendrites becoming more selective for CS+ and dendrites becoming more selective for CS-. 

      One of the major challenges when assessing changes in neural representation during the learning of such Go/NoGo tasks is that the movements and rewards themselves may elicit strong neural responses that may be a confounding factor, that is, inexperienced mice do not lick in response to the CS+, while trained mice do. In this study, the authors addressed this issue in three ways: first, they carefully monitored the orofacial movements of mice and showed that task learning is not associated with changes in evoked whisker movements. Second, they show that whisking or licking evokes very little activity in the dendritic tufts compared to whisker stimuli (CS+ and CS-). Finally, the authors introduced into the design of their task a post-conditioning session after the last conditioning session during which the CS+ and the CS- are presented but no reward is delivered. During this post-session, the mice gradually stopped licking in response to the CS+. A better design might have been to perform the pre-conditioning and post-conditioning sessions in nonwater-restricted, unmotivated mice to completely exclude any lick response, but the fact that the change in selectivity persists after the mice stopped licking in the last blocks of the post-conditioning session (in mice relying only on their whiskers to perform the task) is convincing. 

      The clever task design and careful data analysis provide compelling evidence that learning this whisker discrimination task does not result in a massive change in sensory representation in the apical dendritic tufts of layer 5 neurons in the primary somatosensory cortex on average. Nevertheless, individual dendritic tufts do increase their selectivity for one or the other sensory stimulus, likely enhancing the ability of S1 neurons to accurately discriminate the two stimuli and trigger the appropriate motor response (to lick or not to lick). 

      One limitation of the present study is the lack of evidence for the necessity of the primary somatosensory cortex in the learning and execution of the task. As the authors have strongly emphasized in their previous publications, the primary somatosensory cortex may not be necessary for the learning and execution of simple whisker detection tasks, especially when the stimulus is very salient. Although this new task requires the discrimination between two whisker stimuli, the simplicity and salience of the whisker stimuli used could make this task cortex-independent. Especially when considering that some mice seem to not rely entirely on their whiskers to execute the task. 

      Nevertheless, this is an important result that shows for the first time changes in the selectivity to sensory stimuli at the level of individual apical dendritic tufts in correlation with the learning of a discrimination task. This study sheds new light on the cortical cellular substrates of reward-based learning and opens interesting perspectives for future research in this area. In future studies, it will be important to determine whether the change in selectivity of dendritic calcium spikes is causally involved in the learning of the task or whether it simply correlates with learning, as a consequence of changes in synaptic inputs caused by reward. The dendritic calcium spikes may be involved in the establishment of synaptic plasticity required for learning and impact the output of layer 5 pyramidal neurons to trigger the appropriate motor response. It would be important also to study the changes in selectivity in the apical dendrite of the identified projection neurons.  

      Reviewer #2 (Public Review):

      Summary: 

      The authors did not find an increased representation of CS+ throughout reinforcement learning in the tuft dendrites of Rbp4-positive neurons from layer 5B of the barrel cortex, as previously reported for soma from layer 2/3 of the visual cortex. 

      Alternatively, the authors observed an increased selectivity to both stimuli (CS+ and CS-) during reinforcement learning. This feature: 

      (1) was not present in repeated exposures (without reinforcement), 

      (2) was not explained by the animal's behaviour (choice, licking, and whisking), and 

      (3) was long-lasting, being present even when the mice disengaged from the task. 

      Importantly, increased selectivity was correlated with learning (% correct choices), and neural discriminability between stimuli increased with learning. 

      In conclusion, the authors show that tuft dendrites from layer 5B of the barrel cortex increase the representation of conditioned (CS+) and unconditioned stimuli (CS-) applied to the whiskers, during reinforcement learning. 

      Strengths: 

      The results presented are very consistent throughout the entire study, and therefore very convincing: 

      (1) The results observed are very similar using two different imaging techniques (2-photon planar imaging- and SCAPE-volumetric imaging). Figure 3 and Figure 4 respectively. 

      (2) The results are similar using "different groups" of tuft dendrites for the analysis (e.g.

      initially unresponsive and responsive pre- and post-learning). Figure 5. 

      (3) The results are similar from a specific set of trials (with the same sensory input, but di erent choices). Figure 7. 

      (4) Additionally, the selectivity of tuft dendrites from layer 5B of the barrel cortex was higher in the mice that exclusively used the whisker to respond to the stimuli (CS+ and CS-).  The results presented are controlled against a group of mice that received the same stimuli presentation, except for the reinforcement (reward). 

      Additionally, the behaviour outputs, such as choice, whisking, and licking could not account for the results observed. 

      Although there are no causal experiments, the correlation between selectivity and learning (percentage of correct choices), as well as the increased neural discriminability with learning, but not in repeated exposure, are very convincing. 

      Weaknesses: 

      The biggest weakness is the absence of causality experiments. Although inhibiting specifically tuft dendritic activity in layer 1 from layer 5 pyramidal neurons is very challenging, tuft dendritic activity in layer 1 could be silenced through optogenetic experiments as in Abs et al. 2018. By manipulating NDNF-positive neurons the authors could specifically modify tuft dendritic activity in the barrel cortex during CS presentations, and test if silencing tuft dendritic activity in layer 1 would lead to the lack of selectivity and an impairment of reinforcement learning. Additionally, this experiment will test if the selectivity observed during reinforcement learning is due to changes in the local network, namely changes in local synaptic connectivity, or solely due to changes in the long-range inputs.    

      We agree that such causal manipulations are a logical next step. Such manipulations are unfortunately not specific to layer 5 apicals, so the results would be difficult to interpret. We now discuss the challenge of such manipulations in the Discussion section.

      Recommendations for the authors:

      Reviewer #1 (Recommendations For The Authors): 

      Overall, the study is solid and the article is well and clearly written. I have no suggestion for other experiments that would fall within the scope of this article. I would like only to suggest some additional analyses and clarifications in the writing. 

      Additional analyses: 

      Obviously, the main confounding factor in this type of data comes from the acquired motor response which follows - with a short latency - the sensory stimulus. This is particularly problematic for functional calcium imaging which has very low temporal resolution. The authors have addressed this question to some extent by showing that motor-evoked activity does not account for the change in selectivity acquired with learning and through the use of a post-conditioning session during which no reward was delivered. Figures 8C-D show that mice gradually stop licking in response to CS+ in this session and that the distribution of the selectivity index remains similar in these last blocks. Perhaps a more convincing analysis would be to simply select Miss and Correct rejection trials in which mice did not lick in response to the CS+ and CS-, respectively. Ideally, if the number of trials is sufficient, one could even select trials devoid of any evoked movement (no licking and no whisking).  

      We agree it would be interesting to compare Miss and Correct rejection trials to further rule out effects of a motor response, but there were never enough Miss trials to conduct such an analysis. Even in very early learning, there are few Miss trials (see Figure 1, session 2). We found that in early learning, animals would lick in most trials. Then, over the course of conditioning, they would learn to withhold licks during CS- presentation. Thus, we were able to examine Hits, Correct rejections, and False alarms (Figure 7), but not Miss trials. We have added text suggesting a future experiment in which the stimulus strengths are substantially reduced to drastically increase the error rates.

      The fact that changes in selectivity occur in both directions overall is really interesting. However, in the way the data are presented currently, one may wonder about mice/field of view vs single cell effect. i.e., do di erent dendritic tufts in the same field of view show opposite changes in selectivity? If we were to replot Figure 3A for a single mouse, would we obtain the same picture?  

      We appreciate this very good suggestion and have added scatter plots and selectivity index histograms for individual conditioned animals in Supplementary figure 2. These data demonstrate that different dendritic tufts in the same field of view exhibit opposite changes in selectivity.

      The authors point out that they observed no change in the mean response or selectivity during learning, but did find changes in selectivity at the level of individual dendritic tufts. This suggests that, at the population level, the ability to discriminate between the two stimuli should improve. A possible complementary analysis would be to show that the ability to decode stimulus identity from dendritic tuft population activity increases with learning.  

      Given the substantial change in individual tuft selectivity and that the tuft events occur are not rare, the population result is guaranteed. If individual tufts increase selectivity, the population will also increase its selectivity on a trial-by-trial basis. We have nevertheless included a new supplementary figure with a population analysis using SVMs to demonstrate this.

      Clarification: 

      The authors should make it clear from the beginning that mice are still water-restricted during the post-conditioning session and actually do keep licking for many CS+ trials. Therefore, this session is not devoid of motor response. 

      We have clarified this in the text.

      Did mice in the repeated exposure condition receive any reward during the recording sessions? If so when were rewards delivered? 

      We previously described in the Methods that these mice received water in their home cage, but we now additionally clarify this in the Results section.

      Minor: 

      Figure 2Aii, the labels of the Alpha and Betta barrels should be swapped. 

      Fixed

      Line 218: I believe this sentence should read "Using SCAPE microscopy, ...". 

      Corrected.

      Line 665: 'Reconstruction from 50' does that refer to the single cell reconstruction on the left panel? 

      Yes – Clarified in legend

      Reviewer #2 (Recommendations For The Authors): 

      Minor suggestions: 

      The 'summary' should mention from which brain area the results were acquired. Otherwise, it is misleading, giving the idea that the results described a generic feature, which is still unknown.  

      Added to the text.

      Please correct sentence 219: "SCAPE microscopy, we image tuft activity of additional mice..." 

      Added to the text.

      In the same sentence (219) it would be good to provide the number of additional mice imaged (2). 

      Added to the text.

      Regarding Supplementary Figure 1, it would be interesting to correlate the second peak after reward and learning rate, to provide further support to the sentences 109 to 113. 

      We agree this would be interesting to examine, but only four animals exhibited this second peak, which is too small of a sample to observe a meaningful correlation. We now clarify this in the text.

      In Figure 3, why not present the correlation between 'neural discriminability' and % of correct choices? 

      We appreciate the suggestion and have added this plot to Figure 3.

      The 'results' section will benefit tremendously if the authors consistently indicate the figures to which the results are being described, or 'data not shown' if it is the case. To give a few examples: 

      Sentence 108 - "averaged 28% ΔF/F" - From which figure is this result coming from?  Sentence 123 - "(p = 0.62, 0.64, respectively)" - comparison not shown, but see Figures 2E and D respectively? 

      Sentence 125 - "(CS+ responsive (...) across all sessions)" - From which figure is this result coming from? 

      Sentence 130 - "during pre-conditioning (p=0.66) or post-conditioning sessions (p=0.44) - From which figure? 

      Sentence 154 - "(Pre: p=0.20; last rewarded: p=0.43; Post: p=0.64, sign-rank test)" - From which figure? 

      Sentence 175 - "(-0.049, -0.001, and 0.003" - From which figure? Please show the graph that shows that the mean SI is not different. It can be supplementary. The distribution of SI will be strengthened by it.  

      We added this plot to supplementary figure 2.

      Sentence 244 - "(conditioned: 458/603; repeated exposure: 334/457) - From Figure 5E. 

      Sentence 256 - "(p=0.04, 2-sample t-test comparison mice) - From Figure 5B.  Sentence 258 - "(p=0.03, paired t-test) - from Figure 5B  Sentences 370 to 378 - No reference to the figure. 

      The 'discussion' section (sentences 459 to 494) refers to the differences between the current and previous studies (references 1,3,5), namely soma vs. dendrites and layer 2/3 vs. layer 5. However, it should also mention the difference between the nature of the stimuli and the brain area recorded (visual cortex vs. barrel cortex).

      We have addressed these issues in the text.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Reviewer 1:

      Authors reject the substance of Reviewer 1’s feedback primarily due to clear lack of understanding of typical parameterization practices used to avoid overfitting. To ensure the Spearman-rank correlation accuracy, 70% of all data was withheld from the optimization process and used solely for testing to yield figure 6. Data was withheld prior to model parameterization and therefore avoids Reviewer 1’s charge of “artificially forcing the correlation”. Authors did appreciate the request for clarification of additional definitions and minor reorganization suggestions. Below we provide specific responses to each numbered point (note: multiple responses are provided for some of the reviewer points).

      Point 1: Clarify Metrics Definition and Evaluation

      Authors clarified the description of biodiversity metrics. The metrics associated with manual methods are detailed in the third paragraph of the Materials and Methods: Data Analysis section, while the sensor-based metric is described in the second paragraph, and summarized in its last sentence.

      Text Additions:

      Authors added clarification to the introduction’s first paragraph defining biodiversity metrics, including species richness.

      Authors added detailed definitions of community metrics and their significance in community ecology in the Materials and Methods section (3rd paragraph of “Data Analysis” section). The discussion was updated to include a reference to community ecology and the benefits of big data, specifically highlighting the potential of autonomous optical sensors in entomology.

      Methods Reorganization

      We have reorganized the Methods section for clarity. Updated section clarifies metrics studied, location, dates, a description and methods around optical sensors, Malaise traps, and sweep netting.

      Text Additions:

      An overview paragraph was added to “Data analysis” (3rd paragraph) detailing key metrics used, specifying metrics such as abundance, richness, Shannon index, and Simpson index.

      Visualization methods for sensor data to deliver analogous metrics of abundance, richness, and diversity indices was added to “Data analysis” section.

      Supplementary Table 1 and the first paragraph of the Materials and Methods section cover location, dates, and other general information.

      Detailed descriptions and methods for optical sensors, Malaise traps, and sweeping are provided.

      Integration of Metrics

      Authors integrated two paragraphs explaining the fundamental differences between conventional methods in the 3rd paragraph of the discussion and the presented method of biodiversity measurement.

      Point 2: Body-to-Wing Ratio Calculation

      The backscattered optical cross-section is now clearly defined as the value measured at the maximum point of the event. Specifically, we have added the word ‘maximum’ to our methods section for clarity.

      Point 3: Ecosystem Services Paragraph

      We have shortened and edited this paragraph for clarity. The revised text is now more straightforward and comprehensible.

      Point 4: Results Section Structure

      We believe restructuring the results section around each metric would result in redundancy. The value of our analysis is in the comparison of different methods; therefore, instead of talking about methods in isolation, we provide an integrated discussion and comparison of all three methods across all metrics. Instead, we have maintained our current structure but ensured that the metrics are consistently described and analyzed.

      Point 5: Abundance Correlation

      We agree that the lack of a correlation between methods for abundance remains an open question. However, we maintain that fitting a linear model would be inappropriate and potentially misleading in the absence of significant correlation. We have clarified this in our manuscript.

      Point 6: Richness and Diversity Evaluations

      The authors disagree with Reviewer 1's feedback, citing a clear misunderstanding of standard parameterization practices used to prevent overfitting. Specifically, authors implemented a 30/70 Training/Testing split. Therefore only 30% of the data was used to fit the model and 70% of the dataset was reserved for testing to ensure the validity and reliability of our clustering results. By validating with a 70% testing dataset, we ensure that the clustering model can accurately group new data points and is robust against overfitting. This process helps verify that the identified clusters are meaningful and consistent across different subsets of the data.  Spearman's rho converts the data values into ranks and does not assume a linear relationship between the variables or require the data to follow a normal distribution. Spearman's rank correlation offers robustness against non-linearity and outliers by focusing on ranks. This approach is explained in the 4th paragraph of the “Data Analysis” section.

      Point 7: Clustering Method Credibility

      Authors acknowledge the variability in optical sensor features. However, the Law of Large Numbers supports increased insect measurement accuracy and stability occurs from optical insect sensors due to the increased number of observations made by the optical sensors compared to conventional methods. The manuscript now includes a detailed discussion of these aspects in the 3rd paragraph of discussion, emphasizing the correlation observed despite variability.

      Reviewer 2:

      Authors appreciate Reviewer 2’s feedback especially regarding contextualization. While authors disagree with the need for more specific experimental questions in a methods paper and the suggested need for more complex analysis, we agree with the essence of the review and added additional text regarding potential questions, method applications, and ecosystem processes for contextualization.

      Point 1: Larger Question Framing

      We present this article as a methodological paper rather than asking a specific experimental question. This approach is justified by the generalizable nature of methods papers, akin to those describing ImageJ or mass spectrometers. The method is widely applicable to a range of scientific questions. 

      We provided a discussion on how this technology could be applied in community ecology, conservation, and managed ecological systems like agriculture.

      In the Conclusion section we provided elaboration on the potential research questions and applications.

      Point 2: Complex Analyses

      While complex analyses like NMDS are useful for specific questions, this paper aims to establish the method. Once established, this method can be applied to various research questions in future studies. Therefore, as we are not directly asking an experimental question, more complex analysis is unnecessary.

      Point 3: Ecosystem Process (Granivory) Assay

      We have improved the contextualization and explanation of the ecosystem process assay throughout the manuscript, ensuring it is well-integrated and clear to readers.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Reviewer #1 (Public Review):

      Summary:

      This paper explores how diverse forms of inhibition impact firing rates in models for cortical circuits. In particular, the paper studies how the network operating point affects the balance of direct inhibition from SOM inhibitory neurons to pyramidal cells, and disinhibition from SOM inhibitory input to PV inhibitory neurons. This is an important issue as these two inhibitory pathways have largely been studies in isolation. Support for the main conclusions is generally solid, but could be strengthened by additional analyses.

      Strengths:

      A major strength of the paper is the systematic exploration of how circuit architecture effects the impact of inhibition. This includes scans across parameter space to determine how firing rates and stability depend on effective connectivity. This is done through linearization of the circuit about an effective operating point, and then the study of how perturbations in input effect this linear approximation.

      Weaknesses:

      The linearization approach means that the conclusions of the paper are valid only on the linear regime of network behavior. The paper would be substantially strengthened with a test of whether the conclusions from the linearized circuit hold over a large range of network activity. Is it possible to simulate the full network and do some targeted tests of the conclusions from linearization? Those tests could be guided by the linearization to focus on specific parameter ranges of interest.

      We agree with the reviewer that it would be interesting to test if our results hold in a nonlinear regime of network behaviour (i.e. the chaotic regime, see also comment 1 by reviewer 2). As mentioned above, this requires a different type of model (either rate-based or spiking model with multiple neurons instead of modelling the mean population rate dynamics) which, in our opinion, exceeds the scope of this manuscript. Furthermore, the core measures of our study, network gain, and stability require linearization. In a chaotic regime where the linearization approach is impossible, we would need to consider/define new measures to characterize network response/activity. Therefore, while certainly being an interesting question to study, the broad scope of the studying networks in a nonlinear regime is better tackled in a separate study. We now acknowledge in the discussion of our manuscript that the linearization approach is a limitation in our study and that it would be an interesting future direction to investigate chaotic dynamics.

      The results illustrated in the figures are generally well described but there is very little intuition provided for them. Are there simplified examples or explanations that could be given to help the results make sense? Here are some places such intuition would be particularly helpful:

      page 6, paragraph starting ”In sum ...”

      Page 8, last paragraph

      Page 10, paragraph starting ”In summary ...”

      Page 11, sentence starting ”In sum ...”

      We agree with the reviewer that we didn’t provide enough intuition to our results. We now extended the paragraphs listed by the reviewer with additional information, providing a more intuitive understanding of the results presented in the respective chapter.

      Reviewer #2 (Public Review):

      Summary:

      Bos and colleagues address the important question of how two major inhibitory interneuron classes in the neocortex differentially affect cortical dynamics. They address this question by studying Wilson-Cowan-type mathematical models. Using a linearized fixed point approach, they provide convincing evidence that the existence of multiple interneuron classes can explain the counterintuitive finding that inhibitory modulation can increase the gain of the excitatory cell population while also increasing the stability of the circuit’s state to minor perturbations. This effect depends on the connection strengths within their circuit model, providing valuable guidance as to when and why it arises.

      Overall, I find this study to have substantial merit. I have some suggestions on how to improve the clarity and completeness of the paper.

      Strengths:

      (1) The thorough investigation of how changes in the connectivity structure affect the gain-stability relationship is a major strength of this work. It provides an opportunity to understand when and why gain and stability will or will not both increase together. It also provides a nice bridge to the experimental literature, where different gain-stability relationships are reported from different studies.

      (2) The simplified and abstracted mathematical model has the benefit of facilitating our understanding of this puzzling phenomenon. (I have some suggestions for how the authors could push this understanding further.) It is not easy to find the right balance between biologically detailed models vs simple but mathematically tractable ones, and I think the authors struck an excellent balance in this study.

      Weaknesses:

      (1) The fixed-point analysis has potentially substantial limitations for understanding cortical computations away from the steady-state. I think the authors should have emphasized this limitation more strongly and possibly included some additional analyses to show that their conclusions extend to the chaotic dynamical regimes in which cortical circuits often live.

      We agree with the reviewer that it would be interesting to test if our results hold in a chaotic regime of network behaviour (see also comment by reviewer 1). As mentioned above, this requires a different type of model (either rate-based or spiking model with multiple neurons instead of modelling the mean population rate dynamics) which, in our opinion, exceeds the scope of this manuscript. Furthermore, the core measures of our study, network gain, and stability require linearization. In a chaotic regime where the linearization approach is impossible, we would need to consider/define new measures to characterize network response/activity. Therefore, while certainly being an interesting question to study, the broad scope of the studying networks in a nonlinear regime is better tackled in a separate study. We now acknowledge in the discussion of our manuscript that the linearization approach is a limitation in our study and that it would be an interesting future direction to investigate chaotic dynamics.

      (2) The authors could have discussed – even somewhat speculatively – how SST interneurons fit into this picture. Their absence from this modelling framework stands out as a missed opportunity.

      We believe that the reviewer wanted us to speculate about VIP interneurons (and not SST interneurons, which we already do extensively in the manuscript). Previous models have included VIP neurons in the circuit (e.g. del Molino et al., 2017; Palmigiano et al., 2023; Waitzmann et al., 2024). While we do not model VIP cells explicitly, we implicitly assume that a possible source of modulation of SOM neurons comes from VIP cells. We have now added a short discussion on VIP cells in the last paragraph in our discussion section.

      (3) The analysis is limited to paths within this simple E,PV,SOM circuit. This misses more extended paths (like thalamocortical loops) that involve interactions between multiple brain areas. Including those paths in the expansion in Eqs. 11-14 (Fig. 1C) may be an important consideration.

      We agree with the reviewer that our framework can be extended to study many other different paths, like thalamocortical loops, cortical layer-specific connectivity motifs, or circuits with VIP or L1 inhibitory neurons. Studying these questions, however, are beyond the scope of our work. In our discussion, we now mention the possibility of using our framework to study those questions.

      Reviewer #3 (Public Review):

      Summary:

      Bos et al study a computational model of cortical circuits with excitatory (E) and two subtypes of inhibition parvalbumin (PV) and somatostatin (SOM) expressing interneurons. They perform stability and gain analysis of simplified models with nonlinear transfer functions when SOM neurons are perturbed. Their analysis suggests that in a specific setup of connectivity, instability and gain can be untangled, such that SOM modulation leads to both increases in stability and gain. This is in contrast with the typical direction in neuronal networks where increased gain results in decreased stability.

      Strengths:

      - Analysis of the canonical circuit in response to SOM perturbations. Through numerical simulations and mathematical analysis, the authors have provided a rather comprehensive picture of how SOM modulation may affect response changes.

      - Shedding light on two opposing circuit motifs involved in the canonical E-PV-SOM circuitry - namely, direct inhibition (SOM → E) vs disinhibition (SOM → PV → E). These two pathways can lead to opposing effects, and it is often difficult to predict which one results from modulating SOM neurons. In simplified circuits, the authors show how these two motifs can emerge and depend on parameters like connection weights.

      - Suggesting potentially interesting consequences for cortical computation. The authors suggest that certain regimes of connectivity may lead to untangling of stability and gain, such that increases in network gain are not compromised by decreasing stability. They also link SOM modulation in different connectivity regimes to versatile computations in visual processing in simple models.

      Weaknesses:

      The computational analysis is not novel per se, and the link to biology is not direct/clear.

      Computationally, the analysis is solid, but it’s very similar to previous studies (del Molino et al, 2017). Many studies in the past few years have done the perturbation analysis of a similar circuitry with or without nonlinear transfer functions (some of them listed in the references). This study applies the same framework to SOM perturbations, which is a useful and interesting computational exercise, in view of the complexity of the high-dimensional parameter space. But the mathematical framework is not novel per se, undermining the claim of providing a new framework (or ”circuit theory”).

      In the introduction we acknowledge that our analysis method is not novel but is rather based on previous studies (del Molino et al., 2017; Kuchibhotla et al., 2017; Kumar et al., 2023, Litwin-Kumar et al., 2016; Mahrach et al., 2020; Palmigiano et al., 2023; Veit et al., 2023; Waitzmann et al., 2024). We now rewrote parts of the introduction to make sure that it does not sound like the computational analysis has been developed by us, but that we rather use those previously developed frameworks to dissect stability and gain via SOM modulation.

      Link to biology: the most interesting result of the paper with regard to biology is the suggestion of a regime in which gain and stability can be modulated in an unconventional way - however, it is difficult to link the results to biological networks: - A general weakness of the paper is a lack of direct comparison to biological parameters or experiments. How different experiments can be reconciled by the results obtained here, and what new circuit mechanisms can be revealed? In its current form, the paper reads as a general suggestion that different combinations of gain modulation and stability can be achieved in a circuit model equipped with many parameters (12 parameters). This is potentially interesting but not surprising, given the high dimensional space of possible dynamical properties. A more interesting result would have been to relate this to biology, by providing reasoning why it might be relevant to certain circuits (and not others), or to provide some predictions or postdictions, which are currently missing in the manuscript.

      - For instance, a nice motivation for the paper at the beginning of the Results section is the different results of SOM modulation in different experiments - especially between L23 (inhibition) and L4 (disinhibition). But no further explanation is provided for why such a difference should exist, in view of their results and the insights obtained from their suggested circuit mechanisms. How the parameters identified for the two regimes correspond to different properties of different layers?

      As pointed out by the reviewer, the main goal of our manuscript is to provide a general understanding of how gain and stability depend on different circuit motifs (ie different connectivity parameters), and how circuit modulations via SOM neurons affect those measures. However, we agree with the reviewer that it would be useful to provide some concrete predictions or postdictions following from our study.

      An interesting example of a postdiction of our model is that the firing rate change of excitatory neurons in response to a change in the stimulus (which we define as network gain, Eq. 2) depends on firing rates of the excitatory, PV, and SOM neurons at the moment of stimulus presentation (Fig. 3ii; Fig. 4Aii,Bii,Cii; Fig. 5Aii, Bii, Cii). Hence any change in input to the circuit can affect the response gain to a stimulus presentation, in line with experimental evidence which suggests that changes in inhibitory firing rates and changes in the behavioral state of the animal lead to gain modifications (Ferguson and Cardin 2020).

      Another recent concrete example is the study of Tobin et al., 2023, in which the authors show that optogenetically activating SOM cells in the mouse primary auditory cortex (A1) decreases the excitatory responses to auditory stimuli. In our framework, this corresponds to the case of decreases in network gain (gE) for positive SOM modulation, as seen in the circuit with PV to SOM feedback connectivity (Suppl. Fig. S1).

      Another example is the study by Phillips and Hasenstaub 2016, in which the authors study the effect of optogenetic perturbations of SOM (and PV) cells on tuning curves of pyramidal cells in mouse A1. While they find large heterogeneity in additive/subtractive or multiplicative/divisive tuning curve changes following SOM inactivation, most cells have a purely multiplicative or purely additive component (and none of the cells have a divisive component). In our study, we see that large multiplicative responses of the excitatory population follow from circuits with strong E to SOM feedback connectivity.

      We note that in future computational studies, it would be useful to apply our framework with a focus on a specific brain region and add all relevant cell types (at a minimum E, PV, SOM, and VIP) plus a dendritic compartment, in order to formulate much more precise experimental predictions.

      We have now added additional information to the discussion section.

      - Another caveat is the range of parameters needed to obtain the unintuitive untangling as a result of SOM modulation. From Figure 4, it appears that the ”interesting” regime (with increases in both gain and stability) is only feasible for a very narrow range of SOM firing rates (before 3 Hz). This can be a problem for the computational models if the sweet spot is a very narrow region (this analysis is by the way missing, so making it difficult to know how robust the result is in terms of parameter regions). In terms of biology, it is difficult to reconcile this with the realistic firing rates in the cortex: in the mouse cortex, for instance, we know that SOM neurons can be quite active (comparable to E neurons), especially in response to stimuli. It is therefore not clear if we should expect this mechanism to be a relevant one for cortical activity regimes.

      We agree with the reviewer that it’s important to test the robustness of our results. As suggested by the reviewer, we now include a new supplementary figure (Suppl. Fig. S2) which measures the percentage of data points in the respective quadrant Q1-Q4 when changing the SOM firing rates (as done in Fig. 5). We see that the quadrants in which the network gain and stability change in the same direction (Q2 and Q3) remain high in the case for E to SOM feedback (Suppl. Fig. S2A) over SOM rates ranging over 0-10 Hz (and likely beyond).

      - One of the key assumptions of the model is nonlinear transfer functions for all neuron types. In terms of modelling and computational analysis, a thorough analysis of how and when this is necessary is missing (an analysis similar to what has been attempted at in Figure 6 for synaptic weights, but for cellular gains). In terms of biology, the nonlinear transfer function has experimentally been reported for excitatory neurons, so it’s not clear to what extent this may hold for different inhibitory subtypes. A discussion of this, along with the former analysis to know which nonlinearities would be necessary for the results, is needed, but currently missing from the study. The nonlinearity is assumed for all subtypes because it seems to be needed to obtain the results, but it’s not clear how the model would behave in the presence or absence of them, and whether they are relevant to biological networks with inhibitory transfer functions.

      It is true that the nonlinear transfer function is a key component in our model. We chose identical transfer functions for E, PV, and SOM (; Eq. 4) to simplify our analysis. If the transfer function of one of the neuron types would be linear (β \= 1), then the corresponding b terms (the slope of the nonlinearity at the steady state; b \= dfX/dqX; Fig. 1B; Eq. 4) would be equal to α. Therefore, if neurons had a linear transfer function in our model, there would not be a dependence of network gain on E and PV firing rate as studied in Fig. 3-5. This is because the relationship between PV rates and their gain would be constant (bP \= α) in Fig. 1B (bottom).

      If all the transfer functions were linear, changes in firing rates would not have an impact on network gain or stability. Changing the nonlinear transfer function by changing the α or β terms in Eq. 4 would only scale the way a change in the rates affects the b terms and hence the results presented in Fig. 3-5. More interesting would be to study how different types of nonlinearities, like sigmoidal functions or sublinear nonlinearities (i.e. saturating nonlinearities), would change our results. However, we think that such an investigation is out of scope for this study. We now added a comment to the Methods section.

      Experimentally, F-I curves have been measured also for PV and SOM neurons. For example, Romero-Sosa et al., 2021 measure the F-I curve of pyramidal, PV and SOM neurons in mouse cortical slices. They find that similar to pyramidal neurons, PV and SOM neurons show a nonlinear F-I curve. We now added the citation of Romero-Sosa et al., 2021 to our manuscript.

      - Tuning curves are simulated for an individual orientation (same for all), not considering the heterogeneity of neuronal networks with multiple orientation selectivity (and other visual features) - making the model too simplistic.

      The reviewer is correct that we only study changes in tuning curves in a simplistic model. In our model, the excitatory and PV populations are tuned to a single orientation (in the case of Fig. 7 to θ \= 90). While this is certainly an oversimplification, it allows us to understand how additive/subtractive and multiplicative/divisive changes in the tuning curves come about in networks with different connectivity motifs. To model heterogeneity of tuning responses within a network, it requires more complex models. A natural choice would be to extend a classical ring attractor model (Rubin et al., 2015) by splitting the inhibitory population into PV and SOM neurons, or study the tuning curve heterogeneity that occurs in balanced networks (Hansel and van Vreeswijk 2012). However, this model has many more parameters, like the spatial connectivity profiles from and onto PV and SOM neurons. While highly valuable, we believe that studying such models exceeds the scope of our current manuscript. We now added a paragraph in the discussion section, mentioning this as an interesting future direction.

      Reviewer #1 (Recommendations For The Authors):

      The last sentence of the abstract is hard to interpret before reading the rest of the paper - suggest replacing or rephrasing.

      We rephrased the sentence to make more clear what we mean.

      Page 3, last full paragraph: I think this assumes that phi is positive. What is the justification for that assumption? More generally, I think you could say a bit more about phi in the main text since it is a fairly complicated term.

      The reviewer is correct, for a stable system phi is always positive. We now clarify this and explain phi in more detail in the main text.

      Fig 1D: It would be helpful to identify when the stimulus comes on and be clearer about what the stimulus is. I assume it’s a step increase in S input at 0.05 s or so - but that should be immediately apparent looking at the figure.

      We agree with the reviewer and we added a dashed line at the time of stimulus onset in Fig. 1D.

      Page 5: ”To motivate our analysis we compare ... (Fig. 2A)” - Figure 2A does not show responses without modulation, so this sentence is confusing.

      The dashed lines in Fig. 2A (and Fig. 2C) actually represents the rate change without modulation.

      Page 6: sentence “The central goal of our study ...” seems out of place since this is pretty far into the results, and that goal should already be clear.

      We agree with the reviewer, hence we updated the sentence.

      Page 10, top: the green curve in panel Aii always has a negative slope - so I am confused by the statement that increasing wSE decreases both gain and stability.

      We thank the reviewer for pointing out this mistake. We now fixed it in the text.

      Figure 6: in general it is hard to see what is going on in this figure (the green and blue in particular are hard to distinguish). Some additional labels would be helpful, but I would also see if the color scheme can be improved.

      We added a zoom-in to the panels which were hard to distinguish.

      Reviewer #2 (Recommendations For The Authors):

      Major recommendations:

      (1) The authors should explain early on in the results section what the key factor(s) is that differentiates SOM from PV cells in their model. E.g., in Fig. 1A, the only obvious difference is that SOM cells don’t inhibit themselves. However, later on in the paper, the difference in external stimulus drive to these interneuron classes is more heavily emphasized. Given the importance of that difference (in external stim drive), I think this should be highlighted early on.

      We now mention the key factors that differentiate PV and SOM neurons already when describing Fig. 1A.

      (2) The result in Figs. 5,6 demonstrate that recurrent SOM connectivity is important for achieving increases in both gain and stability. This observation could benefit from some intuitive explanation. Perhaps the authors could find this explanation by looking at their series expansion (Eqs. 11-14, Fig. 1C) and determining which term(s) are most important for this effect. The corresponding paths through the circuit – the most important ones – could then be highlighted for the reader.

      We agree with the reviewer that our results benefit from more intuitive explanations. This has also been pointed out by reviewer 1 in their public review. We now extended the concluding paragraphs in the context of Fig. 4-6 with additional information, providing a more intuitive understanding of the results presented in the respective chapter. While it is possible to gain an intuitive understanding of how the network gain depends on rate and weight parameters (Eq. 2), this understanding is unfortunately missing in the case of stability. The maximum eigenvalue of the system have a complex relationship with all the parameters, and often have nonlinear dependencies on changes of a parameter (e.g. as we show in Fig. 3iv or one can see in Fig. 6). We now discuss this difficulty at the end of the section “Influence of weight strength on network gain vs stability”.

      (3) I think the authors should consider including some analyses that do not rely on the system being at or near a fixed point. I admit that such analysis could be difficult, and this could of course be done in a future study. Nevertheless, I want to reiterate that this addition could add a lot of value to this body of work.

      As outlined above, we decided to not include additional analysis on network behaviour in nonlinear regimes but we now acknowledge in the discussion of our manuscript that the linearization approach is a limitation in our study and that it would be an interesting future direction to investigate chaotic dynamics.

      Minor recommendations:

      (1) At the top of P. 6, when the authors first discuss the stability criterion involving eigenvalues, they should address the question ”eigenvalues of what?”. I suggest introducing the idea of the Jacobian matrix, and explaining that the largest eigenvalue of that matrix determines how rapidly the system will return to the fixed point after a small perturbation.

      We included an additional sentence in the respective paragraph explaining the link between stability and negative eigenvalues, and we also added a sentence in the Methods section stating the the largest real eigenvalue dominates the behavior of the dynamical system.

      (2) The panel labelling in Fig. 3 is unnecessarily confusing. It would be simpler (and thus better) to simply label the panels A,B,C,D, or i,ii,iii,iv, instead of the current labelling: Ai, Aii, Aiii, Aiv. (There are currently no panels ”B” in Fig. 3).

      We updated the figure accordingly.

      Reviewer #3 (Recommendations For The Authors):

      • Suggestions for improved or additional experiments, data or analyses.

      Analysis of the effect of different nonlinear transfer functions is necessary.

      Please see our detailed answer to the reviewer’s comment in the public review above.

      Analysis of gain modulation in models with more realistic tuning properties.

      Please see our detailed answer to the reviewer’s comment in the public review above.

      Mathematical analysis of the conditions to obtain ”untangled” gain and stability:

      One of the promises of the paper is that it is offering a computational framework or circuit theory for understanding the effect of SOM perturbation. However, the main result, namely the untangling of gain and stability, has only been reported in numerical simulations (e.g. Fig. 6). Different parameters have been changed and the results of simulations have been reported for different conditions. Given the simplified model, which allows for rigorous mathematical analysis, isn’t it possible to treat this phenomenon more analytically? What would be the conditions for the emergence of the untangled regime? This is currently missing from the analyses and results.

      We agree with the reviewer that our results benefit from more intuitive explanations. This has also been pointed out by reviewer 1 in their public review. We now extended the concluding paragraphs in the context of Fig. 4-6 with additional information, providing a more intuitive understanding of the results presented in the respective chapter. While it is possible understand analytically of how the network gain depends on rate and weight parameters (Eq. 2), this understanding is unfortunately missing in the case of stability. The maximum eigenvalue of the system have a complex relationship with all the parameters, and often have nonlinear dependencies on changes of a parameter (e.g. as we show in Fig. 3iv or one can see in Fig. 6). This doesn’t allow for a a deep analytical understanding of the entangling of gain and stability. We now discuss this difficulty at the end of the section “Influence of weight strength on network gain vs stability”.

      • Recommendations for improving the writing and presentation. The Results section is well written overall, but other parts, especially the Introduction and Discussion, would benefit from proof reading - there are many typos and problems with sentence structures and wording (some mentioned below).

      We have gone through the manuscript again and improved the writing.

      The presentation of the dependence on weight in Figure 6 can be improved. For instance, the authors talk about the optimal range of PV connectivity, but this is difficult to appreciate in the current illustration and with the current colour scheme.

      We added a zoom in to the panels which were hard to distinguish.

      • Minor corrections to the text and figures. Text:

      We thank the reviewer for their thorough reading of our manuscript. We fixed all the issues from below in the manuscript.

      Some examples of bad structure or wording:

      From the Abstract:

      ”We show when E - PV networks recurrently connect with SOM neurons then an SOM mediated modulation that leads to increased neuronal gain can also yield increased network stability.” From Introduction:

      Sentence starting with ”This new circuit reality ...”

      ”Inhibition is been long identified as a physiological or circuit basis for how cortical activity changes depending upon processing or cognitive needs ...”

      Sentence starting with ”Cortical models with both ...”

      ”... allowing SOM neurons the freedom to ..”

      From Results:

      ”... affects of SOM neurons on E ..”

      ”seem in opposition to one another, with SOM neuron activity providing either a source or a relief of E neuron suppression”. The sentence after is also difficult to read and needs to be simplified.

      P. 7: ”We first remark that ...”

      Difficult to read/understand - long and badly structured sentence.

      P. 8: ”adding a recurrent connection onto SOM neurons from the E-PV subcircuit” It’s from E (and not PV) to be more precise (Fig. 5).

      Discussion:

      ”Firstly, E neurons and PV neurons experience very similar synaptic environments.” What does it mean?

      ”Fortunately, PV neurons target both the cell bodies and proximal dendrites” Fortunately for whom or what? ”in line with arge heterogeneity”

      Methods:

      Matrix B is never defined - the diagonal matrix of b (power law exponents) I assume.

      Some of the other notations too, e.g. bs, etc (it’s implicit, but should be explained).

      Structure of sentence:

      ”Network gain is defined as ...” (p. 17)

      Figure:

      The schematics in Figure 4 can be tweaked to highlight the effect of input (rather than other components of the network, which are the same and repetitive), to highlight the main difference for the reader.

    1. Author response:

      Reviewer #1:

      We thank the reviewer for recognizing the impact of our work on the pivotal roles of N-glycan-dependent ERQC in cellular fitness and pathogenicity and providing valuable comments to be considered to improve the manuscript. As suggested, we will rearrange data, reduce text volume, and discuss the possibility of how ERQC mutation decreases EV secretion without significant defect in conventional secretion. Regarding the proteomics data, we have already initiated a comparative analysis of total intracellular and EV-associated proteins to determine whether the reduced cargo loading in the Ugg1 mutant is specific to EV-associated proteins. Additionally, we may extend the analysis to include total secretion, enabling a clearer comparison between classical secretion and EV-mediated secretion to better evaluate the extent of classical secretion defects in the Ugg1 mutant.

      Reviewer #2:

      We sincerely thank the reviewer for the positive evaluation of our work. As recommended, we will reduce the text and reorganize the data to enhance the manuscript's readability.

      Reviewer #3:

      We sincerely thank the reviewer for the high appreciation of our work. As recommended, we will provide a more detailed explanation of the results with improved interpretation, strongly grounded on the obtained data.

    1. Author response:

      Reviewer #1 (Public review):

      Weaknesses:

      (1) The assertion that membrane trafficking is impaired by this variant could be bolstered by additional data.

      We agree with this comment and will perform additional analysis and experiments to support the assertion that membrane trafficking is impaired. As noted by the Reviewers, standard biochemical approaches to obtain such data may be challenging due to the fact that Kv3.1 is expressed in only a subset of cells and that we do not have a Kv3.1-A421V specific antibody.

      (2) In some experiments details such as the age of the mice or cortical layer are emphasized, but in others, these details are omitted.

      We appreciate that the Reviewer has noted this omission. We will include such details in the resubmission.

      (3) The impairments in PV neuron AP firing are quite large. This could be expected to lead to changes in PV neuron activity outside of the hypersynchronous discharges that could be detected in the 2-photon imaging experiments, however, a lack of an effect on PV neuron activity is only loosely alluded to in the text. A more formal analysis is lacking. An important question in trying to understand mechanisms underlying channelopathies like KCNC1 is how changes in membrane excitability recorded at the whole cell level manifest during ongoing activity in vivo. Thus, the significance of this work would be greatly improved if it could address this question.

      Yes, the impairments in neocortical PV-IN excitability are more marked than any other PV interneuronopathy that we have studied. We will include a more extensive analysis of the 2-photon imaging data in the resubmission. However, there are limitations to the inferences that can be made as to firing patterns based on 2-photon calcium imaging data, particularly for interneurons.

      (4) Myoclonic jerks and other types of more subtle epileptiform activity have been observed in control mice, but there is no mention of littermate control analyzed by EEG.

      We did not observe myoclonic jerks in control mice. This data will be included in the resubmission.

      Reviewer #2 (Public review):

      Weaknesses:

      In some experiments, the age of the animal in each experiment is not clearly stated. For example, the experiments in Figure 2 demonstrate impaired K+ conductance and membrane localization, but it is not clear whether they correlated with the excitability and synaptic defects shown in subsequent figures. Similarly, it is unclear how old mice the authors conducted EEG recordings, and whether non-epileptic mice are younger than those with seizures.

      We will include explicit information as to the age of the animals used for each experiment in the resubmission.

      The trafficking defect of mutant Kv3.1 proposed in this study is based only on the fluorescence density analysis which showed a minor change in membrane/cytosol ratio. It is not very clear how the membrane component was determined (any control staining?). In addition to fluorescence imaging, an addition of biochemical analysis will make the conclusion more convincing (while it might be challenging if the Kv3.1 is expressed only in PV+ cells).

      We will include additional information in the Methods section as to how the membrane component was determined in a revised version of the manuscript. We agree with Reviewer #2 regarding the limitations in the ability to further evaluate this.

      While the study focused on the superficial layer because Kv3.1 is the major channel subunit, the PV+ cells in the deeper cortical layer also express Kv3.1 (Chow et al., 1999) and they may also contribute to the hyperexcitable phenotype via negative effect on Kv3.2; the mutant Kv3.1 may also block membrane trafficking of Kv3.1/Kv3.2 heteromers in the deeper layer PV cells and reduce their excitability. Such an additional effect on Kv3.2, if present, may explain why the heterozygous A421V KI mouse shows a more severe phenotype than the Kv3.1 KO mouse (and why they are more similar to Kv3.2 KO). Analyzing the membrane excitability differences in the deep-layer PV cells may address this possibility.

      We will include recordings from PV-INs in deeper layers of the neocortex in the revised version of the manuscript, as requested.

      In Table 1, the A421V PV+ cells show a depolarized resting membrane potential than WT by ~5 mV which seems a robust change and would influence the circuit excitability. The authors measured firing frequency after adjusting the membrane voltage to -65mV, but are the excitability differences less significant if the resting potential is not adjusted? It is also interesting that such a membrane potential difference is not detected in young adult mice (Table 2). This loss of potential compensation may be important for developmental changes in the circuit excitability. These issues can be more explicitly discussed.

      We will include a more thorough discussion of this finding in the revised version of the manuscript. However, we do not completely understand this finding. It could be compensatory, as suggested by the Reviewer; however, it is transient and seems to be an isolated finding (i.e., there does not appear to be parallel “compensation” in other properties). Alternatively, it could be that impaired excitability of the Kcnc1-A421V/+ PV-INs may reflect impaired/delayed development, which itself is known to be activity-dependent.

      Reviewer #3 (Public review):

      Weaknesses:

      The manuscript identifies a partial mechanism of disease that leaves several aspects unresolved including the possible role of the observed impairments in thalamic neurons in the seizure mechanism. Similarly, while the authors identify a reduction in potassium currents and a reduction in PV cell surface expression of Kv3.1 it is not clear why these impairments would lead to a more severe disease phenotype than other loss-of-function mutations which have been characterized previously. Lastly, additional analysis of video-EEG data would be helpful for interpreting the extent of the seizure burden and the nature of the seizure types caused by the mutation.

      We agree with this comment. We studied neurons in the reticular thalamus as these cells are known to express Kv3.1 and are linked to epilepty pathogenesis. Yet, we focused on neocortical PV-INs over other Kv3.1-expressing neurons such as neurons of the reticular thalamus because we evaluated the impairments of intrinsic excitability to be more profound in neocortical PV-INs. Cross of Kcnc1-Flox(A421V)/+ mice to a cerebral cortex interneuron-specific driver that would avoid recombination in thalamus – such as Ppp1r2-Cre (RRID:IMSR_JAX:012686) – could assist in determining the relative contribution of thalamic reticular nucleus dysfunction to the overall phenotype, as performed by Makinson et al (2017) to address a similar question. There are of course other Kv3.1-expressing neurons in the brain, including in GABAergic interneurons in hippocampus and amygdala. We will include additional discussion in a revised version of the manuscript as to why we think there is more severe impairment in our Kcnc1-Flox(A421V)/+ mice relative to Kv3.1 and Kv3.2 knockout mice. We will include additional data on the epilepsy phenotype in the revised version of the manuscript, as requested.

    1. Author response:

      We thank the Dr. Ealand and Reviewers for their thoughtful comments on our submitted manuscript. We are in the process of revising our manuscript in light of the comments received, outlined below.

      In addition to the requested revisions, we have new data with M. tuberculosis strain H37Rv +/- gidB deletion (and complementation), confirming that deletion of gidB sensitizes the strain to rifampicin, and extending our findings to pathogenic tuberculosis. This will also be incorporated into the revised manuscript.

      Reviewer #1:

      (1) The structural work at the end feels like both an afterthought in terms of the science and the writing. I would suggest re-writing that section to be clearer about what the figure says and does not say. For example, the caption of Figure 6 appears to be more informative than the text and refers to concepts not present in the main text. In general, I found this section to be the most difficult to understand.

      We are rewriting this section to make it more coherent with the rest of the manuscript.

      (2) "delta-gidB" is written out in the caption of Figure 6. Line 234: gidB not italics.

      Thank you, these changes will be incorporated in the revised manuscript.

      Reviewer #2:

      (1) It would be essential to provide information regarding the growth rate and, ideally, translation rates in the gidB KO and the isogenic WT. As translation balances accuracy and speed, only characterising the speed is not sufficient to understand the phenomenon.

      We are performing these assays and will incorporate them in the revised manuscript.

      (2) Cryo-EM analysis of vacant 70S ribosomes is not sufficient for understanding the mechanisms underlying the accuracy defects in the gidB KO. One should assemble and solve structurally near-cognate and non-cognate complexes. I believe the authors are over-interpreting the scant structural data they have. Furthermore, current representation makes it impossible to assess the resolution of the structure, especially in the areas of interest.

      While we agree with the Reviewer that structures of translating ribosomes will be most informative in elucidating the molecular mechanism(s) by which methylation (or not) by GidB contributes to mistranslation, those experiments are ongoing and beyond the scope of the current study. Unlike E. coli ribosomes, for which there are a plethora of structures for mutants available, there are very structures of mycobacterial ribosomes beyond wild-type apo ribosomes. Therefore we feel that the structures of apo mycobacterial ribosomes +/- GidB-mediated methylation are still of value, and a necessary “first step” for the mechanistic work alluded to above. Secondly, the apo ribosome structures still hint at potential mechanisms by which mistranslation and 16S rRNA methylation may impact on each other – as in the comments to R#1 above, we are revising the text to increase clarity and coherence of this section.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public Review):

      Summary:

      In this manuscript, the authors follow up on their published observation that providing a lower glucose parental nutrition (PN) reduces sepsis from a common pathogen [Staphylococcus epidermitis (SE)] in preterm piglets. Here they found that a higher dose of glucose could thread the needle and get the protective effects of low glucose without incurring significant hypoglycemia. They then investigate whether the change in low glucose PN impacts metabolism to confer this benefit. The finding that lower glucose reduces sepsis is important as sepsis is a major cause of morbidity and mortality in preterm infants, and adjusting PN composition is a feasible intervention.

      Strengths:

      (1) They address a highly significant problem of neonatal sepsis in preterm infants using a preterm piglet model.

      (2) They have compelling data in this paper (and in a previous publication, ref 27) that low glucose PN confers a survival advantage. A downside of the low glucose PN is hypoglycemia which they mitigate in this paper by using a slightly high amount of glucose in the PN.

      (3) The experiment where they change PN from high to low glucose after infection is very important to determine if this approach might be used clinically. Unfortunately, this did not show an ability to reduce sepsis risk with this approach. Perhaps this is due to the much lower mortality in the high glucose group (~20% vs 87% in the first figure).

      (4) They produce an impressive multiomics data set from this model of preterm piglet sepsis which is likely to provide additional insights into the pathogenesis of preterm neonatal sepsis.

      Weaknesses:

      (1) The high glucose control gives very high blood glucose levels (Figure 1C). Is this the best control for typical PN and glucose control in preterm neonates? Is the finding that low glucose is protective or high glucose is a risk factor for sepsis?

      This work is a follow-up from our previous work where we explored different PN glucose regimens. Taken together our experiments heavily imply that glucose provision is associated to severity in a seemingly linear manner. In the clinical setting, there is no fixed glucose provision, but guidelines specify ranges that are acceptable. However, these guidelines do not take possible infections into account and are designed to optimize growth outcomes. Increased provision of glucose to preterm neonates may therefore increase their infection risk, but parenteral glucose cannot be entirely avoided as it would lead to hypoglycaemia and associated brain damage. In the present paper the reduced glucose PN reflects the lowest end of the recommended PN glucose intake. More work is needed to figure out the best glucose provision to infected preterm newborns, balancing positive and negative factors.

      (2) In Figure 1B, preterm piglets provided the high glucose PN have 13% survival while preterm piglets on the same nutrition in Figure 6B have ~80% survival. Were the conditions indeed the same? If so, this indicates a large amount of variation in the outcome of this model from experiment to experiment.

      In the follow-up experiment outlined in Figure 6 we reduced the follow-up time to 12 hours in an effort to minimize the suffering of the animals. We did this because we could detect relevant differences in the immune response between High and low glucose infected pigs as 12 hours. If we had extended the follow-up experiment to 22 hours we would likely have seen a much increased mortality.

      (3) Piglets on the low glucose PN had consistently lower density of SE (~1 log) across all time points. This may be due to changes in immune response leading to better clearance or it could be due to slower growth in a lower glucose environment.

      We agree with this assessment and have adjusted our result section to reflect this.

      (4) Many differences in the different omics (transcriptomics, metabolomics, proteomics) were identified in the SE-LOW vs SE-HIGH comparison. Since the bacterial load is very different between these conditions, could the changes be due to bacterial load rather than metabolic reprogramming from the low glucose PN?

      We analyzed the relationship between bacterial burdens and mortality and found that it did not correlate within each of the treatment groups. We have now added this data to the results section as supplemental and report this fact in the section called “Reduced glucose supply increases hepatic OXPHOS and gluconeogenesis and attenuates inflammatory pathways”. This finding inspired us to further explore the relationship between bacterial burdens and infection responses in our model which has resulted in our recent preprint: Wu et at. Regulation of host metabolism and defense strategies to survive neonatal infection. BioRxiv 2024.02.23.581534; doi: https://doi.org/10.1101/2024.02.23.581534

      Reviewer #2 (Public Review):

      Summary:

      The authors demonstrate that a low parenteral glucose regimen can lead to improved bacterial clearance and survival from Staph epi sepsis in newborn pigs without inducing hypoglycemia, as compared to a high glucose regimen. Using RNA-seq, metabolomic, and proteomic data, the authors conclude that this is primarily mediated by altered hepatic metabolism.

      Strengths:

      Well-defined controls for every time point, with multiple time points and biological replicates. The authors used different experimental strategies to arrive at the same conclusion, which lends credibility to their findings. The authors have published the negative findings associated with their study, including the inability to reverse sepsis-related mortality after switching from SE-high to SE-low at 3h or 6h and after administration of hIAIP.

      Weaknesses:

      (1) The authors mention, and it is well-known, that Staph epi is primarily involved in late-onset sepsis. The model of S. epi sepsis used in this study clearly replicates early-onset sepsis, but S. epi is extremely rare in this time period. How do the authors justify the clinical relevance of this model?

      The distinction between early and late onset sepsis makes sense clinically because they are likely to be caused by different organisms and therefore require different empirical antibiotic regimes. Early onset sepsis is caused by organisms transferred perinatally often following chorioamnionitis or uro-gential maternal infections (Strep. agalacticae/E. coli) whereas Late onset sepsis is likely caused by organisms from indwelling catheters or mucosal surfaces, most often coagulase negative staphylococci. Timing of an infection after birth of course plays a role, but the virulence factors of the pathogen probably plays a large role in shaping the immune response. Therefore, even though the infection in our model is initiated on the first day after birth, the organism that we use, Staph epidermidids, makes it a better model for pathogenesis of late onset sepsis. However, it is also important to acknowledge that the pathophysiology of “sepsis” may be similar despite timing and pathogen and depends on the degree of immune activation and downstream effects on organs.

      (2) The authors find that the neutrophil subset of the leukocyte population is diminished significantly in the SE-low and SE-high populations. However, they conclude on page 10 that "modulations of hepatic, but not circulating immune cell metabolism, by reduced glucose supply..." and this is possible because the authors have looked at the entire leukocyte transcriptome. I am curious about why the authors did not sequence the neutrophil-specific transcriptome.

      We collected the whole blood transcript during the experiments, which reflect the transcription profile of all the circulating leucocytes. Since we did not do single cell RNA sequencing during the experiment there is no possibility of isolating the neutrophil transcriptome at this time. Your point however is valid and we will reconsider incorporating single cell transcriptomics in future experiments.

      (3) The authors use high (30g/k/d) and low (7.2g/k/d) glucose regimens. These translate into a GIR of 21 and 5 mg/k/min respectively. A normal GIR for a preterm infant is usually 5-8, and sometimes up to 10. Do the authors have a "safe GIR" or a threshold they think we cannot cross? Maybe a point where the metabolism switch takes place? They do not comment on this, especially as GIR and glucose levels are continuous variables and not categorical.

      Our reduced glucose PN was chosen as it corresponded with the low end of recommended guidelines for PN glucose intake. There likely is not a “safe GIR” as the clinical responses to glucose intake during infections do not seem binary but increase with glucose intake. It is also important to remember that the reduced glucose intervention still resulted in significant morbidity and a 25% mortality within 22 hours. There is therefore still vast room for improvement, but even though further reduction in PN glucose would probably provide further protection it would entail dangerous hypoglycaemia (as described in our previous paper). The findings in this current paper has prompted us to explore several strategies to replace parenteral glucose with alternative macronutrients. Thus, the optimal PN for infected newborns would probably differ from standard PN in all macronutrients and will require much more pre- and clinical research.

      (4) In Figures 2B and C the authors show that SE-high and SE-low animals have differences in the oxphos, TCA, and glycolytic pathways. The authors themselves comment in the Supplementary Table S1B, E-F that these same metabolic pathways are also different in the Con-Low and Con-high animals, it is just the inflammatory pathways that are not different in the non-infected animals. How can they then justify that it is these metabolic pathways specifically which lead to altered inflammatory pathways, and not just the presence of infection along with some other unfound mechanism?

      It is to be expected that the inflammatory pathways do not differ between the Con-Low and Con-High groups as there is no infection to induce these pathways. The identified metabolic pathways that differ between SE-High and SE-Low animals seem to us the best explanation of the differences in clinical phenotype.

      (5) The authors mention in Figure 1F that SE-low animals had lower bacterial burdens than SE-high animals, but then go on to infer that the inflammatory cytokine differences are attributed to a rewiring of the immune response. However, they have not normalized the cytokine levels to the bacterial loads, as the differences in the cytokines might be attributed purely to a difference in bacterial proliferation/clearing.

      Please see our response to reviewer #1

      (6) The authors mention that switching from SE-high to SE-low at 3 or 6 h time points does not reduce mortality. Have the authors considered the reverse? Does hyperglycemia after euglycemia initially, worsen mortality? That would really conclude that there is some metabolic reprogramming happening at the very onset of sepsis and it is a lost battle after that.

      A very good point that we have not explored yet, we have added this consideration to the discussion and slightly amended our conclusions of this follow-up experiment.

      Reviewer #3 (Public Review):

      Summary:

      Baek and colleagues present important follow-up work on the role of serum glucose in the management of neonatal sepsis. The authors previously showed high glucose administration exacerbated neonatal sepsis, while strict glucose control improved outcomes but caused hypoglycemia. In the current report they examined the effect of a more tailored glucose management approach on outcomes and examined hepatic gene expression, plasma metabolome/proteome, blood transcriptome, as well as the the therapeutic impact of hIAIP. The authors leverage multiple powerful approaches to provide robust descriptive accounts of the physiologic changes that occur with this model of sepsis in these various conditions. Strengths:

      (1) Use of preterm piglet model.

      (2) Robust, multi-pronged approach to address both hepatic and systemic implications of sepsis and glucose management.

      (3) Trial of therapeutic intervention - glucose management (Figure 6), hIAIP (Figure 7).

      Weaknesses:

      (1) The translational role of the model is in question. CONS is rarely if ever a cause of EOS in preterm neonates. The model. uses preterm pigs exposed at 2 hours of age. This model most likely replicates EOS.

      Please see our response to Reviewer #2

      (2) Throughout the manuscript it is difficult to tell from which animals the data are derived. Given the ~90% mortality in the experimental CONS group, and 25% mortality in the intervention group, how are the data from animals "at euthanasia" considered? Meaning - are data from survivors and those euthanized grouped together? This should be clarified as biologically these may be very different populations (ie, natural survivor vs death).

      This is a very valid point. For all endpoints that are analyzed “at euthanasia” the age of the animal will vary. Some will have been euthanized early due to clinical deterioration and some will have survived all the way to the end of the experiment. This needs to be kept in mind when interpreting the results. We have further highlighted this point in the discussion and made it clear to the reader at what time-point each analysis was performed.

      (3) With limited time points (at euthanasia ) for hepatic transcriptomics (Figure 2), plasma metabolite (Figure 3) blood transcriptome (Figure 4), and plasma proteome (Figure 5) it is difficult to make conclusions regarding mechanisms preceding euthanasia. Per methods, animals were euthanized with acidosis or clinical decompensation. Are the reported findings demonstrative of end-organ failure and deterioration leading to death, or reflective of events prior?

      Yes, all organ specific endpoints are snapshots of the state of the animals at the time of euthanasia, pooling together animals that succumbed to sepsis and those that survived to 22 hours post infection. These results therefore reflect the end-state of the infection we cannot be sure when the differences between groups manifested themselves. However, given the stark differences in plasma lactate at 12 hours post infection it is likely that changes to metabolism occurred before most of animals succumbed to sepsis.

      We agree this is a weakness in our model, but we have since published a pre-print where we have further explored how metabolic adaptations shape the fate of similarly infected preterm pigs: BioRxiv 2024.02.23.581534; doi: https://doi.org/10.1101/2024.02.23.581534

      (4) Data are descriptive without corresponding "omics" from interventions (glucose management and/or hIAIP) or at least targeted assessment of key differences.

      We only did in-depth analysis of the glucose intervention as this showed the most promising clinical effects that warranted further in-depth investigation. It is possible that further insights could be gained from in-depth analysis of the other interventions but given that there were no obvious clinical befits we refrained from that.

      Recommendations for the authors:

      Reviewer #1 (Recommendations For The Authors):

      I am intrigued that mortality was not correlated to bacterial burden. Please provide the "data not shown" as this would help the reader understand better whether the difference in bacterial burden is driving the phenotypes and findings of the low glucose group.

      We have added this data to supplementary figure 1.  

      Reviewer #2 (Recommendations For The Authors):

      (1) I would urge the authors to consider a neutrophil-specific transcriptomic analysis. I understand that this would add significantly to the resubmission process. If the authors wish to include that as a future direction instead, they need to specifically mention the limitations of whole blood transcriptomics and how different immune cell types react differently to bacterial antigens.

      We agree with your considerations but we cannot include that data using the whole blood method applied in the experiment. We have added your consideration to the discussions.

      (2) I urge the authors to remove any impression that this is a model of late-onset sepsis, which is implied from the introduction, lines 3 and 4.

      Our intention was not to directly suggest that our model is a perfect reflection of late-onset sepsis but rather to highlight the relevance of using a pathogen commonly associated with LOS. We believe our model primarily captures the effects of intense pro-inflammatory immune activation, which may have parallels with various forms of sepsis, including LOS.

      Reviewer #3 (Recommendations For The Authors):

      Drawing on the robust nature of your "omics", identify key measures and test whether they are altered earlier in the development of clinical sepsis. Test whether these are altered by the intervention.

      A very valid point, at the moment it is not possible for us to explore this within the confines of these experiments. But, building upon these findings and the ones in our recent preprint we are confident that shifts in hepatic ratio of Oxidative phosphorylation and gluconeogenesis vs glycolysis shape the immune response to infections in neonates. In our upcoming experiments we are planning to incorporate plasma metabolomics at earlier timepoints to monitor when shifts in metabolism occur. However, given the heterogeneity of pigs, as opposed to inbred rodent models, sacrificing animals at fixed timepoints to gauge their organ function will be hard to interpret as it is impossible to know what the end state of the particular animal would have been. Therefore longitudinal sampling of liver tissue, during the course of infection would be challenging.

    1. Author response:

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      In "Drift in Individual Behavioral Phenotype as a Strategy for Unpredictable Worlds," Maloy et al. (2024) investigate changes in individual responses over time, referred to as behavioral drift within the lifespan of an animal. Drift, as defined in the paper, complements stable behavioral variation (animal individuality/personality within a lifetime) over shorter timeframes, which the authors associate with an underlying bet-hedging strategy. The third timeframe of behavioral variability that the authors discuss occurs within seasons (across several generations of some insects), termed "adaptive tracking." This division of "adaptive" behavioral variability over different timeframes is intuitively logical and adds valuable depth to the theoretical framework concerning the ecological role of individual behavioral differences in animals.

      Strengths:

      While the theoretical foundations of the study are strong, the connection between the experimental data (Figure 1) and the modeling work (Figure 2-4) is less convincing.

      Weaknesses:

      In the experimental data (Figure 1), the authors describe the changes in behavioral preferences over time. While generally plausible, I identify three significant issues with the experiments:

      (1) All of the subsequent theoretical/simulation data is based on changing environments, yet all the experiments are conducted in unchanging environments. While this may suffice to demonstrate the phenomenon of behavioral instability (drift) over time, it does not properly link to the theory-driven work in changing environments. An experiment conducted in a changing environment and its effects on behavioral drift would improve the manuscript's internal consistency and clarify some points related to (3) below.

      In our framework, we posit that the amount of drift has been shaped by evolution to maximize fitness in the environments that the population has experienced, and this drift is observed independent of environment. While we agree that exploring the role of changing environments on the measure of drift would be interesting, we would anticipate the effects may be nuanced and beyond the scope of the current paper (and the scope of our theoretical work, which assumes that the individual phenotype is unaffected by change of environment except as mediated by death due to fitness effects). For example, it would be difficult to differentiate drift from idiosyncratic differences in learning (Smith et al., 2022), and non-adaptive plasticity to unrelated cues has been posited as a method of producing diverse phenotypes (Maxwell and Magwene, 2017), so “learning” to uncorrelated stimuli could conceivably be a mechanism for drift. Given the scope of the current study, we prioritized eliminating potential confounds for measuring drift, but remain interested in the interaction between learning and drift.

      (2) The temporal aspect of behavioral instability. While the analysis demonstrates behavioral instability, the temporal dynamics remain unclear. It would be helpful for the authors to clarify (based on graphs and text) whether the behavioral changes occur randomly over time or follow a pattern (e.g., initially more right turns, then more left turns). A proper temporal analysis and clearer explanations are currently missing from the manuscript.

      We agree it would be helpful to have more description of the dynamics over time aside from the power spectrum and autoregressive model fits. We hope to address this in more detail to provide more description of the changes over time in a revision.

      (3) The temporal dimension leads directly into the third issue: distinguishing between drift and learning (e.g., line 56). In the neutral stimuli used in the experimental data, changes should either occur randomly (drift) or purposefully, as in a neutral environment, previous strategies do not yield a favorable outcome. For instance, the animal might initially employ strategy A, but if no improvement in the food situation occurs, it later adopts strategy B (learning). In changing environments, this distinction between drift and learning should be even more pronounced (e.g., if bananas are available, I prefer bananas; once they are gone, I either change my preference or face negative consequences). Alternatively, is my random choice of grapes the substrate for the learning process towards grapes in a changing environment? Further clarification is needed to resolve these potential conflicts.

      As in our response to point 1, we believe this is a crucial distinction, and we intend to further highlight it in the discussion in the revision and further expand our discussion of how the two strategies may interact.

      Reviewer #2 (Public review):

      Summary:

      This is an inspired study that merges the concept of individuality with evolutionary processes to uncover a new strategy that diversifies individual behavior that is also potentially evolutionarily adaptive.

      The authors use a time-resolved measurement of spontaneous, innate behavior, namely handedness or turn bias in individual, isogenic flies, across several genetic backgrounds.

      They find that an individual's behavior changes over time, or drifts. This has been observed before, but what is interesting here is that by looking at multiple genotypes, the authors find the amount of drift is consistent within genotype i.e., genetically regulated, and thus not entirely stochastic. This is not in line with what is known about innate, spontaneous behaviors. Normally, fluctuations in behavior would be ascribed to a response to environmental noise. However, here, the authors go on to find what is the pattern or rule that determines the rate of change of the behavior over time within individuals. Using modeling of behavior and environment in the context of evolutionarily important timeframes such as lifespan or reproductive age, they could show when drift is favored over bet-hedging and that there is an evolutionary purpose to behavioral drift. Namely, drift diversifies behaviors across individuals of the same genotype within the timescale of lifespan, so that the genotype's chance for expressing beneficial behavior is optimally matched with potential variation of environment experienced prior to reproduction. This ultimately increases the fitness of the genotype. Because they find that behavioral drift is genetically variable, they argue it can also evolve.

      Strengths:

      Unlike most studies of individuality, in this study, the authors consider the impact of individuality on evolution. This is enabled by the use of multiple natural genetic backgrounds and an appropriately large number of individuals to come to the conclusions presented in the study. I thought it was really creative to study how individual behavior evolves over multiple timescales. And indeed this approach yielded interesting and important insight into individuality. Unlike most studies so far, this one highlights that behavioral individuality is not a static property of an individual, but it dynamically changes. Also, placing these findings in the evolutionary context was beneficial. The conclusion that individual drift and bet-hedging are differently favored over different timescales is, I think, a significant and exciting finding.

      Overall, I think this study highlights how little we know about the fundamental, general concepts behind individuality and why behavioral individuality is an important trait. They also show that with simple but elegant behavioral experiments and appropriate modeling, we could uncover fundamental rules underlying the emergence of individual behavior. These rules may not at all be apparent using classical approaches to studying individuality, using individual variation within a single genotype or within a single timeframe.

      Weaknesses:

      I am unconvinced by the claim that serotonin neuron circuits regulate behavioral drift, especially because of its bidirectional effect and lack of relative results for other neuromodulators. Without testing other neuromodulators, it will remain unclear if serotonin intervention increases behavioral noise within individuals, or if any other pharmacological or genetic intervention would do the same. Another issue is that the amount of drugs that the individuals ingested was not tracked. Variable amounts can result in variable changes in behavior that are more consistent with the interpretation of environmental plasticity, rather than behavioral drift. With the current evidence presented, individual behavior may change upon serotonin perturbation, but this does not necessarily mean that it changes or regulates drift.

      However, I think for the scope of this study, finding out whether serotonin regulates drift or not is less important. I understand that today there is a strong push to find molecular and circuit mechanisms of any behavior, and other peers may have asked for such experiments, perhaps even simply out of habit. Fortunately, the main conclusions derived from behavioral data across multiple genetic backgrounds and the modeling are anyway novel, interesting, and in fact more fundamental than showing if it is serotonin that does it or not.

      We agree that our data do not support a strong conclusion that serotonin plays a privileged role in regulating drift. Based on previous literature (e.g. Kain et al., 2014, where identical pharmacological manipulations had an effect on variability while dopaminergic and octopaminergic manipulations did not), we think it likely that large global perturbations in serotonin that we observe are likely to influence plasticity that might be involved in drift (and thus find the results we observe not particularly surprising). Nonetheless, we agree that the mechanism by which serotonin may affect drift could be indirect, and it is similarly plausible that many global perturbations could lead to some shift in the amount of drift. We intend to further discuss these issues in the revision.

      To this point, one thing that was unclear from the methods section is whether genotypes that were tested were raised in replicate vials and how was replication accounted for in the analyses. This is a crucial point - the conclusion that genotypes have different amounts of behavioral drift cannot be drawn without showing that the difference in behavioral drift does not stem from differences in developmental environment.

      While a cursory inspection suggests that batch effects between different replicates was small, we intend to clarify this and more explicitly address the effects of replicates in revision.

      Reviewer #3 (Public review):

      Summary:

      The paper begins by analyzing the drift in individual behavior over time. Specifically, it quantifies the circling direction of freely walking flies in an arena. The main takeaway from this dataset is that while flies exhibit an individual turning bias (when averaged over time), their preferences fluctuate over slow timescales.

      To understand whether genetic or neuromodulatory mechanisms influence the drift in individual preference, the authors test different fly strains concluding that both genetic background and the neuromodulator serotonin contribute to the degree of drift.

      Finally, the authors use theoretical approaches to identify the range of environmental conditions under which drift in individual bias supports population growth.

      Strengths:

      The model provides a clear prediction of the environmental fluctuations under which a drift in bias should be beneficial for population growth.

      The approach attempts to identify genetic and neurophysiological mechanisms underlying drift in bias.

      Weaknesses:

      Different behavioral assays are used and are differently analysed, with little discussion on how these behaviors and analyses compare to each other.

      We intend to address this in a revision of the discussion.

      Some of the model assumptions should be made more explicit to better understand which aspects of the behaviors are covered.

      We will further clarify the assumptions of the model in revision.

  3. Nov 2024
    1. Author response:

      Reviewer #1 (Public review):

      Summary:

      Urination requires precise coordination between the bladder and external urethral sphincter (EUS), while the neural substrates controlling this coordination remain poorly understood. In this study, Li et al. identify estrogen receptor 1-expressing neurons (ESR1+) in Barrington's nucleus as key regulators that faithfully initiate or suspend urination. Results from peripheral nerve lesions suggest that BarEsr1 neurons play independent roles in controlling bladder contraction and relaxation of the EUS. Finally, the authors performed region-specific retrograde tracing, claiming that distinct populations of BarEsr1 neurons target specific spinal nuclei involved in regulating the bladder and EUS, respectively.

      Strength:

      Overall, the work is of high quality. The authors integrate several cutting-edge technologies and sophisticated, thorough analyses, including opto-tagged single unit recordings, combined optogenetics, and urodynamics, particularly those following distinct peripheral nerve lesions.

      Weakness:

      (1) My major concern is the novelty of this study. Keller et al. 2018 have shown that BarEsr1 neurons are active during urination and play an essential role in relaxing the external urethral sphincter (EUS). Minimally, substantial content that merely confirms previous findings (e.g. Figures 1A-E; Figures 3A-E) should be move to the supplementary datasets.

      Indeed, we are aware of and have carefully studied the literature of Keller et al. Our manuscript here presents novel experiments beyond the scopes of that paper. Thanks to this comment, we will substantially revise our manuscript to enhance the visibility of novel data while keeping the agreeing data in the supplementary.

      (2) I also have concerns regarding the results showing that the inactivation of BarEsr1 neurons led to the cessation of EUS muscle firing (Figures 2G and S5C). As shown in the cartoon illustration of Figure 8, spinal projections of BarEsr1 neurons contact interneurons (presumably inhibitory) that innervate motor neurons, which in turn excite the EUS. I would therefore expect that the inactivation of BarEsr1 should shift the EUS firing pattern from phasic (as relaxation) to tonic (removal of relaxation), rather than stopping their firing entirely. Could the authors comment on this and provide potential reasons or mechanisms for this finding?

      We agree with this point. We meant that the EUS’ phasic bursting pattern was rapidly stopped upon BarEsr1 photoinhibition, but not all the firing stopped instantaneously. According to the previous studies (Chang et al., 2007, de Groat, 2009, de Groat and Yoshimura, 2015, Kadekawa et al., 2016), the voiding physiology of rodents is probably different from that of humans, such that for rodents the urine is step-wise pumped out in the gap time between multiple consecutive EUS phasic bursting epochs, and for humans the urine is continuously pumped out once the EUS firing is almost fully inhibition during a period of time. Namely, for mice, the EUS display sustained tonic activity following phasic bursting, while, in contrast, for humans the EUS keeps tonic firing until the moment of voiding onset (complete inhibition, muscle relaxed). Despite the prominent differences in the basic physiological properties, our assumption is that the logic of circuits from the brainstem to the urethra in this pathway is evolutionally conserved for both species; thus the logic of brainstem coordination of voiding could also be the same for both species, which is the main interest of our study (of using an animal model to address concerns of human health). Thus, to interpret our data for a broader audience we made a simplified and inaccurate expression. We apologize for the inaccuracy and we will correct our previous inaccurate description in the revised manuscript.

      (3) Current evidence is insufficient to support the claim that the majority of BarEsr1 neurons innervate the SPN but not DGC. The current spinal images are uninformative, as the fluorescence reflects the distribution of Esr1- or Crh-expressing neurons in the spinal cord, along with descending BarEsr1 or BarCrh axons. Given the close anatomical proximity of these two nuclei, a more thorough histological analysis is required to demonstrate that the spinal injections were accurately confined to either the SPN or the DGC.

      We agree that current evidence is insufficient to support the current claim. To address this concern and strengthen our claim, we will repeat the retrograde viral tracing experiments, combined with CTB647 injections to label the injection site, to validate specific targeting of SPN or DGC populations. We will also add higher-magnification imaging to distinguish BarESR1 axonal projections targeting SPN versus DGC. Results from these ongoing experiments will be incorporated into the revised manuscript.

      Reviewer #2 (Public review):

      Summary:

      The authors have performed a rigorous study to assess the role of ESR1+ neurons in the PMC to control the coordination of bladder and sphincter muscles during urination. This is an important extension of previous work defining the role of these brainstem neurons, and convincingly adds to the understanding of their role as master regulators of urination. This is a thorough, well-done study that clarifies how the Pontine micturition center coordinates different muscle groups for efficient urination, but there are some questions and considerations that remain.

      Strengths:

      These data are thorough and convincing in showing that ESR1+PMC neurons exert coordinated control over both the bladder and sphincter activity, which is essential for efficient urination. The anatomical distinctions in pelvic versus pudendal control are clear, and it's an advance to understand how this coordination occurs. This work offers a clearer picture of how micturition is driven.

      Weaknesses:

      The dynamics of how this population of ESR1+ neurons is engaged in natural urination events remains unclear. Not all ESR1+neurons are always engaged, and it is not measured whether this is simply variation in population activity, or if more neurons are engaged during more intense starting bladder pressures, for instance. In particular, the response dynamics of single and doubly-projecting neurons are not defined. Additionally, the model for how these neurons coordinate with CRH+ neuron activity in the PMC is not addressed, although these cell types seem to be engaged at the same time. Lastly, it would be interesting to know how sensory input can likely modulate the activity of these neurons, but this is perhaps a future direction.

      In response to the reviewer’s comments, we will attempt perform the following revisions for this round:

      (1) Engagement of ESR1+ neurons in natural urination events:

      We agree that probably not all ESR1+ neurons are consistently engaged during urination. To address this, we will perform a detailed analysis of the opto-tagged single unit recordings data.

      (2) Response dynamics of single- and doubly-projecting neurons:

      (a) We will use retrograde labelling combined with Ca2+ photometry recordings to differentiate the response dynamics of SPN- and DGC-projecting neurons during urination.

      (b) We will perform functional validations to assess the specific roles of single- and doubly-projecting neurons in coordinating bladder and EUS activity.

      (3) Coordination with CRH+ neurons in the PMC:<br /> We appreciate the suggestion to include CRH+ neurons in our model. We will expand our model to incorporate CRH+ neurons and their potential interactions with ESR1+ neurons.

      (4) Sensory modulation of ESR1+ neurons:<br /> The reviewer raises an excellent point regarding sensory input modulation of ESR1+ neuron activity. Although this is beyond the scope of our current study, we recognize its importance and propose to include this as a future direction.

      Reviewer #3 (Public review):

      Summary:

      The paper by Li et al explored the role of Estrogen receptor 1 (Esr1) expressing neurons in the pontine micturition center (PMC), a brainstem region also known as Barrington's nucleus (Hou et al 2016, Keller et al 2018). First, the author conducted bulk Ca2+ imaging/unit recording from PMCESR1 to investigate the correlations of PMCESR1 neural activity to voiding behavior in conscious mice and bladder pressure/external urethral muscle activity in urethane anesthetized mice. Next, the authors conducted optogenetics inactivation/activation of PMCESR1 to confirm the contribution to the voiding behavior also conducted peripheral nerve transection together with optogenetics activation to confirm the independent control of bladder pressure and urethral sphincter muscle.

      Weaknesses:

      (1) The study demonstrates that pelvic nerve transection reduces urinary volume triggered by PMCESR1+ cell photoactivation in freely moving mice. Could the role of pudendal nerve transection also be examined in awake mice to provide a more comprehensive understanding of neural involvement?

      Thank you for the suggestion, the pudendal nerve transection in awake mice is indeed a challenging experiment that has been missed. We will try it for the revision.

      (2) While the paper primarily focuses on PMCESR1+ cells in bladder-sphincter coordination, the analysis of PMCESR1+-DGC/SPN neural circuits - given their distinct anatomical projections in the sacral spinal cord - feels underexplored. How do these circuits influence bladder and sphincter function when activated or inhibited? Also, do you have any tracing data to confirm whether bladder-sphincter innervation comes from distinct spinal nuclei?

      Thank you for this great comment. The projection-specific neuronal function analysis is, as also suggested by Reviewer 2 in a similar comment (#8), missing in our first submission. These are so challenging experiments that we have missed in the first round of tests, but we decide to pursuit this goal again. Namely, we will perform photometry recordings of PMC neurons projecting to the DGC/SPN during measuring bladder pressure and urethral sphincter EMG activity. Additionally, while our study does not include direct tracing data to confirm distinct spinal nuclei for bladder and sphincter innervation, this has been well-documented in classic literature (Yao et al., 2018, Karnup and De Groat, 2020, Karnup, 2021). Specifically, anatomical studies have shown that SPN primarily innervates the bladder, while the DGC is associated with the innervation of the urethral sphincter. We will cite these references to provide context and support for our interpretations.

      (3) Although the paper successfully identifies the physiological role of PMCESR1+ cells in bladder-sphincter coordination, the study falls short in examining the electrophysiological properties of PMCESR1+-DGC/SPN cells. A deeper investigation here would strengthen the findings.

      While our study primarily focuses on the functional role of PMCESR1+ neurons in bladder-sphincter coordination, we acknowledge that understanding their intrinsic electrophysiological characteristics could further strengthen our findings. However, this aspect falls beyond the scope of the current study. Nevertheless, we recognize the significance of this direction and are excited to pursue it in future research. We appreciate the reviewer’s suggestion, as it highlights an important avenue for expanding upon our current findings.

      (4) The parameters for photoactivation (blue light pulses delivered at 25 Hz for 15 ms, every 30 s) and photoinhibition (pulses at 50 Hz for 20 ms) vary. What drove the selection of these specific parameters? Moreover, for photoactivation experiments, the change in pressure (ΔP = P5 sec - P0 sec) is calculated differently from photoinhibition (Δpressure = Ppeak - Pmin). Can you clarify the reasoning behind these differing approaches?

      We sincerely thank the reviewer for raising these important points and for the opportunity to clarify our experimental design and data analysis methods.

      Photoactivation versus photoinhibition parameters: The differences in photoactivation (25 Hz, 15 ms pulses) and photoinhibition (50 Hz, 20 ms pulses) protocols are based on the distinct physiological and technical requirements for activating versus inhibiting PMCESR1+ neurons. For photoactivation, 25 Hz stimulation aligns with the natural firing patterns of central neurons, allowing for intermittent activation without exceeding the neuronal refractory period. The shorter pulse duration (15 ms) minimizes phototoxicity and avoids overstimulation, as performed in previous studies (Keller et al., 2018). In contrast, photoinhibition requires sustained suppression of neuronal activity, achieved through higher frequencies (50 Hz) and longer pulses (20 ms) to ensure continuous coverage of neuronal activity.

      Calculation of pressure changes (ΔP) for photoactivation and photoinhibition: The differing methods for calculating pressure changes reflect the distinct physiological effects we aimed to capture. In photoactivation experiments (ΔP = P5 sec - P0 sec), the pressures before (P0 sec) and 5 seconds after (P5 sec) light delivery were compared to capture the immediate effect of light activation on bladder pressure, focusing on the onset and early dynamics of activation. In contrast, photoinhibition experiments assessed the immediate impact of light-induced suppression on bladder pressure during an ongoing voiding event. Here, Δpressure was calculated as Ppeak – Pmin to measure the rapid drop in pressure directly attributable to neuronal inhibition.

      We will expand these details in the methods section of the revised manuscript to provide greater transparency.

      (5) The discussion could further emphasize how PMCESR1+ cells coordinate bladder contraction and sphincter relaxation to control urination, highlighting their central role in the initiation and suspension of this process.

      We fully agree with this point. Additionally, in response to your and other reviewers’ suggestions, we are preparing a new round of experiments with projection-specific recording, and thus our discussion and conclusion will also be updated according to the newly obtained data.

      (6) In Figure 8, The authors analyze the temporal sequence of bladder pressure and EUS bursting during natural voiding and PMC activation-induced voiding. It would be acceptable to consider the existence of a lower spinal reflex circuit, however, the interpretation of the data contains speculation. Bladder pressure measurement is hard to say reflecting efferent pelvic nerve activity in real time. (As a biological system, bladder contraction is mediated by smooth muscle, and does not reflect real-time efferent pelvic nerve activity. As an experimental set-up, bladder pressure measurement has some delays to reflect bladder pressure because of tubing, but EUS bursting has no delay.) Especially for the inactivation experiment, these factors would contribute to the interpretation of data. This reviewer recommends a rewrite of the section considering these limitations. Most of the section is suitable for the results.

      Thank you for mentioning the possibility of bladder pressure measurement delay. We would prefer to perform a physical control test to quantify how much delay this measurement is under our experimental conditions. We will use a small ballon to mimic the bladder and use two identical pressure sensors, one with a very short tube inserted into the ballon and one with an extended tube same as in our animal experiments. We will then mimic both contraction initiation and halting, and quantify the delay between the two sensors.

      References

      • Chang HY, Cheng CL, Chen JJJ, de Groat WC. 2007. Serotonergic drugs and spinal cord transections indicate that different spinal circuits are involved in external urethral sphincter activity in rats. American Journal of Physiology-Renal Physiology 292: F1044-F1053. DOI: 10.1152/ajprenal.00175.2006

      • de Groat WC. 2009. Integrative control of the lower urinary tract: preclinical perspective. British Journal of Pharmacology 147. DOI: 10.1038/sj.bjp.0706604

      • de Groat WC, Yoshimura N. 2015. Anatomy and physiology of the lower urinary tract. Handb Clin Neurol 130: 61-108. DOI: 10.1016/B978-0-444-63247-0.00005-5

      • Kadekawa K, Yoshimura N, Majima T, Wada N, Shimizu T, Birder LA, Kanai AJ, de Groat WC, Sugaya K, Yoshiyama M. 2016. Characterization of bladder and external urethral activity in mice with or without spinal cord injury—a comparison study with rats. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 310: R752-R758. DOI: 10.1152/ajpregu.00450.2015

      • Karnup S. 2021. Spinal interneurons of the lower urinary tract circuits. Autonomic Neuroscience 235. DOI: 10.1016/j.autneu.2021.102861

      • Karnup SV, De Groat WC. 2020. Mapping of spinal interneurons involved in regulation of the lower urinary tract in juvenile male rats. IBRO Rep 9: 115-131. DOI: 10.1016/j.ibror.2020.07.002

      • Keller JA, Chen J, Simpson S, Wang EH-J, Lilascharoen V, George O, Lim BK, Stowers L. 2018. Voluntary urination control by brainstem neurons that relax the urethral sphincter. Nature Neuroscience 21: 1229-1238. DOI: 10.1038/s41593-018-0204-3             

      • Yao J, Zhang Q, Liao X, Li Q, Liang S, Li X, Zhang Y, Li X, Wang H, Qin H, Wang M, Li J, Zhang J, He W, Zhang W, Li T, Xu F, Gong H, Jia H, Xu X, Yan J, Chen X. 2018. A corticopontine circuit for initiation of urination. Nature Neuroscience 21: 1541-1550. DOI: 10.1038/s41593-018-0256-4

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public Review):

      Summary:

      The study aimed to better understand the role of the H3 protein of the Monkeypox virus (MPXV) in host cell adhesion, identifying a crucial α-helical domain for interaction with heparan sulfate (HS). Using a combination of advanced computational simulations and experimental validations, the authors discovered that this domain is essential for viral adhesion and potentially a new target for developing antiviral therapies.

      Strengths:

      The study's main strengths include the use of cutting-edge computational tools such as AlphaFold2 and molecular dynamics simulations, combined with robust experimental techniques like single-molecule force spectroscopy and flow cytometry. These methods provided a detailed and reliable view of the interactions between the H3 protein and HS. The study also highlighted the importance of the α-helical domain's electric charge and the influence of the Mg(II) ion in stabilizing this interaction. The work's impact on the field is significant, offering new perspectives for developing antiviral treatments for MPXV and potentially other viruses with similar adhesion mechanisms. The provided methods and data are highly useful for researchers working with viral proteins and protein-polysaccharide interactions, offering a solid foundation for future investigations and therapeutic innovations.

      Weaknesses:

      However, some limitations are notable. Despite the robust use of computational methodologies, the limitations of this approach are not discussed, such as potential sources of error, standard deviation rates, and known controls for the H3 protein to justify the claims. Additionally, validations with methodologies like X-ray crystallography would further benefit the visualization of the H3 and HS interaction.

      Thank you very much for the evaluation and appreciation of our work. In response to the identified weakness, we have conducted additional analyses to further assess the limitations of the computational methodologies used. Specifically, we predicted the MPXV H3 structure using two other AI-based protein structure prediction models, ESMFold and RoseTTAFold2. Both models also predicted an a-helical structure, which supports our conclusion. However, they yielded lower pLDDT scores (Figure S1A-C in the revised SI), indicating that some error may be present.

      We agree with this reviewer, as well as the other reviewers, that X-ray crystallography data for the H3 structure would be highly valuable. Unfortunately, we lack the expertise in structural biology to obtain these results at this stage. To complement this, we performed molecular dynamics (MD) simulations, which suggest that the helical domain is connected to the main domain via a flexible linker. This flexibility may help explain the challenges in obtaining a high-resolution X-ray structure. In fact, to date, the only structural data available for H3 is from the VAVC, which excludes the helical domain (The helical domain part is cleaved for the X-ray studies). We have added this point to the discussion and hope that experts in structural biology will be able to resolve the structure of this domain in the future.

      Reviewer #2 (Public Review):

      Summary:

      The manuscript presenting the discovery of a heparan-sulfate (HS) binding domain in monkeypox virus (MPXV) H3 protein as a new anti-poxviral drug target, presented by Bin Zhen and co-workers, is of interest, given that it offers a potentially broad antiviral substance to be used against poxviruses. Using new computational biology techniques, the authors identified a new alpha-helical domain in the H3 protein, which interacts with cell surface HS, and this domain seems to be crucial for H3-HS interaction. Given that this domain is conserved across orthopoxviruses, authors designed protein inhibitors. One of these inhibitors, AI-PoxBlock723, effectively disrupted the H3-HS interaction and inhibited infection with Monkeypox virus and Vaccinia virus. The presented data should be of interest to a diverse audience, given the possibility of an effective anti-poxviral drug.

      Strengths:

      In my opinion, the experiments done in this work were well-planned and executed. The authors put together several computational methods, to design poxvirus inhibitor molecules, and then they test these molecules for infection inhibition.

      Weaknesses:

      One thing that could be improved, is the presentation of results, to make them more easily understandable to readers, who may not be experts in protein modeling programs. For example, figures should be self-explanatory and understood on their own, without the need to revise text. Therefore, the figure legend should be more informative as to how the experiments were done.

      Thank you very much for your appreciation of our work and your support. In response to the identified weakness, we have carefully reviewed all the figure legends to ensure they are more informative.

      Reviewer #3 (Public Review):

      Summary:

      The article is an interesting approach to determining the MPOX receptor using "in silico" tools. The results show the presence of two regions of the H3 protein with a high probability of being involved in the interaction with the HS cell receptor. However, the α-helical region seems to be the most probable, since modifications in this region affect the virus binding to the HS receptor.

      Strengths:

      In my opinion, it is an informative article with interesting results, generated by a combination of "in silico" and wet science to test the theoretical results. This is a strong point of the article.

      Weaknesses:

      Has a crystal structure of the H3 protein been reported?

      The following text is in line 104: "which may represent a novel binding site for HS". It is unclear whether this means this "new binding site" is an alternative site to an old one or whether it is the true binding site that had not been previously elucidated.

      Thank you very much for your thoughtful evaluation and appreciation of our work.

      We agree with this reviewer, as well as the other reviewers, that X-ray crystallography data for the H3 structure would be highly valuable. Unfortunately, we are not experts in structural biology, and we have not yet been able to obtain these structural results. To date, the only structure available for H3 is the one from VAVC, which does not include the helical domain. We have included this point in the discussion and hope that experts in structural biology will be able to resolve the structure of this domain in the future.

      Regarding the "novel binding site," this term refers to "the true binding site that had not been previously elucidated." Previous research identified that H3 binds to heparan sulfate (HS), but the exact binding site had not been determined.

      Recommendations for the authors:

      Reviewer #1 (Recommendations For The Authors):

      Validation of Results with Other Experimental Methods: While single-molecule force spectroscopy and flow cytometry provide valuable data, including complementary methods such as X-ray crystallography could offer additional insights into the H3-HS interaction and the effectiveness of the inhibitors.

      Discussion of Computational Model Limitations: Although the use of AlphaFold2 and other advanced tools is a strength, it is important to discuss the limitations of these models in more detail, including potential sources of error and how they may impact the interpretation of the results.

      During the manuscript evaluation, it is not clear the protein localization (transmembrane?) since the protein`s end is very close to the virus membrane surface. All experiments demonstrated the protein without being anchored to the membrane, letting the interaction site always be exposed. If the protein is linked to the membrane, how would the site be exposed due to the limited space between it and the virus structure?

      Thank you for these insightful comments. As you pointed out, the H3 protein, particularly the helical domain at the C-terminal, is indeed located close to the membrane, which could limit the available space for H3 binding. To investigate this further, we modeled the full-length H3 protein in the context of the membrane and performed molecular dynamics (MD) simulations to assess the available space. Our results show that there is more than 1 nm of space between the helical domain and the membrane, which should be sufficient for potential heparan sulfate (HS) binding (see Figure 1E, and Figure S1D&E in the revised manuscript).

      Minor corrections:

      Line 31: "is an emerging zoonotic pathogen" should be revised to reflect that Mpox is a re-emerging virus, given its history of causing outbreaks, such as in 2003.

      Line 71 and Line 75: Adding an explanation of "Mg binding sites" and "GAG motifs" would enhance reader understanding, as these represent important points in the study. The current positioning of Figure 1 causes some confusion for the reader.

      Line 111: High score? What controls were used for the protein? Are there known inhibitors of H3? If so, why weren't they tested for structure comparison? Additionally, what about other molecules that H3 binds to, such as UDP-Glucose, as demonstrated in the base article for the Vaccinia virus H3 protein available in the PDB?

      Figure 2B: Improve the legend, as the colors of the lines are not clear.

      Thank you for your instructive comments. We have addressed most of them in the revised manuscript.

      Regarding the "high score," AlphaFold2 provides a confidence score for its protein structure predictions, with a maximum score of 100. A score above 80 indicates a high level of confidence in the prediction.

      There are known inhibitors (such as antibodies) of H3, and while the sequence is available, no structure has been reported so far. Previous s NMR titration measurements have shown that UDP-glucose binds to H3, but no structural data for the complex exist. To date, the only available crystal structure is of a truncated H3, which does not include the helical domain we identified from VAVC.

      Reviewer #2 (Recommendations For The Authors):

      The text described in the result section does not match the text presented in Figures. So, it is not easy to see what are the authors referring to when they mention the Figure. For example, the text referring to Figure S8 mentions the GB1 domain and the Cohesin module, but these are not mentioned in Figure S8.

      I do not understand the results presented in Figure 5B. It is not clear to me, from the Figure legend nor after reading the Material and Methods, how this experiment was done. Specifically, what is plotted on X, is it the amount of inhibitor or the amount of protein? These things have to be checked through the manuscript.

      It would be interesting to confirm if the inhibition of infection is based on the inhibition of viral binding to the cells. This should not be complicated to realize, and it could provide evidence for the mechanism of action.

      Extensive use of terms like "this domain" is not good in this type of article, like in lines 207, and 211. It is not always clear to what domain are authors referring to, so it may be much better to mention the domain in question by the exact name.

      Line 337, If I am not mistaken dilutions are serial not series.

      Line 613, in methods. Please use g force instead of rpm, it is more informative. Even if it is just to pellet cells.

      Thank you very much for your instructive comments. We have addressed most of them in the revised manuscript. For instance, the immobilization of the GB1 domain and the cohesin module is now mentioned in Figure S9. Additionally, in the previous Figure 5B, the "x" represents the concentration of the inhibitor. Serial and g force is updated.

      Reviewer #3 (Recommendations For The Authors):

      Line 190

      Did you mutate all the amino acids at the same time? What was the impact of all these mutations on the structure of the helical region? Or if you modeled the protein again after replacing these 7 amino acids, did you find that there was no difference? Regardless of your answer, you must include a superposition of the mutated structure and the wt.

      Thank you for the insightful comment. We have now also predicted the structure of the serine mutant using AlphaFold2 (AF2). As expected, the helical domain structure remains largely preserved with only minor differences. We have included these results in Figure S6, as suggested.

      Figure 2D

      In this graph, the authors should indicate the ΔG as a negative value. In fact, the graph does not match the text.

      Thanks for the reminder, it is corrected in the graph

      Figure 4B

      Is the difference in binding force significantly different? 28.8 vs 33.7 pN

      The absolute difference in binding force is not large (~5 pN). However, for a system with a relatively low binding force, this difference is significant. Specifically, the 5 pN difference accounts for approximately a 14% reduction in binding force. We have included this percentage in the revised manuscript.

      Figure 5

      If AI-PoxBlocks723 was the only peptide effective in inhibiting viral infection of MPOX and other related viruses but not with 100% effectiveness, do you think this could be a consequence of a low interaction efficiency or the existence of a different receptor? Or a secondary region of binding in the H3? Can you argue about this?

      It has been proposed that there are other adhesion proteins for MPXV, such as D8, in addition to H3. We believe this accounts for the observed less-than-100% effectiveness.

      The use of peptides as "inhibitory tools" could have an interesting effect in vitro, however, in vivo the immunological response against the peptide will reduce/eliminate it, how you may optimize the "drug" development with this system, as you state in line 387.

      Thank you for your thoughtful comment. You are correct that the use of peptides as inhibitory tools could induce an immune response in vivo, which might limit their effectiveness over time. To optimize this approach for drug development, conjugate the peptides with carrier molecules, such as liposomes, nanoparticles, or dendrimers, which can protect the peptides from immune detection and improve their delivery to target cells. This could allow for more controlled and sustained release of the peptide in vivo, reducing the chances of immune clearance. We have added this discussion in the revised manuscript.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Author Response

      Reviewer #1 (Public Review): 

      Weaknesses: 

      - Having demonstrated that NK cell IFNgamma is important for recruiting and activating DCs and T cells in their model, one is left to wonder whether it is important for the therapeutic effect, which was not tested. 

      We conducted a preliminary study to compare the pro-survival effect of WT NK and Ifng-/- NK cell therapies. We found that, in the 95-500 mg day-21 tumor group, the overall survival (OS) of mice receiving Ifng-/- NK cell therapy significantly decreased (p = 0.045) compared to mice receiving WT NK cell therapy up to 60 days after tumor inoculation, but there was no difference in OS beyond 65 days after tumor inoculation. Therefore, we have added the following sentences at the end of the second paragraph in our Discussion (Page 32):

      “However, although Ifng-/- NK cells induced less cDC activation compared to WT NK cells, the levels of CD86 on cDCs of mice that received Ifng-/- NK cells were higher than those of mice not subjected to NK cell transfer (Figure 4B). This outcome indicates the presence of IFN-g-independent or/and compensatory mechanism(s) for cDC activation by the transferred NK cells, which is in line with our preliminary result that Ifng-/- NK cell therapy does not significantly diminish the pro-survival effect in comparison to WT NK cell therapy beyond 60 days after tumor cell inoculation (data not shown).”

      - It was somewhat difficult to gauge the clinical trial results because the trial was early stage and therefore not controlled. Evaluation of the results therefore relies on historical comparisons. To evaluate how encouraging the results are, it would be valuable for the authors to provide some context on the prognoses and likely disease progression of these patients at the time of treatment. 

      We had already indicated in our Results that all six patients had an ECOG performance status of 0 (Page 25 and Table). We have now added in the Results that they had “a predicted survival of >3 months” (Page 25).

      Reviewer #1 (Recommendations For The Authors):

      Minor points: 

      (1) It would be helpful if the authors provided a rationale for why they derived their NK cell product from bone marrow cells instead of the more common source, spleen cells. 

      We now clarify that: “We used BM cells instead of splenocytes for NK cell culture because removal of T cells from BM cells before culturing is not necessary” (Page 35) to the section Ex vivo expansion of murine and human NK cells in our Materials and Methods.

      (2) It would have been helpful to provide summary results from replicates of the cytokine production data shown in Figure 1F. 

      We have now added a graphical panel on the relative ΔMFI of two independent experiments to Figure 1F and revised the figure legend accordingly (Page 7—8).

      (3) The role of conventional CD4+ T cells is a little unclear. The authors state in the discussion that they contribute to the antitumor response, which is consistent with their finding that depleting both CD4 T cells and CD8 T cells has a greater effect than depleting CD8 T cells. Depleting CD4 T cells alone trended towards improving the response, however. Probably Tregs are the culprit in the latter effect but a sentence or two would be helpful if the claim for a protective role for CD4 T cells is to remain.  

      We have now re-analyzed the data of Figure 3D by separating mice into two groups according to day 21 tumor weight, i.e., 95-600 mg and >600 mg (Page 13—14). We have revised our explanation of the Figure 3D data in the Results (Page 11—12) as follows:

      “Accordingly, we examined the role of T cells in NK cell therapy by depleting T cell subsets with antiCD4 or/and anti-CD8 antibodies two days before primary tumor resection (Figure 3D Schema and Figure 3-figure supplement 1). In the 95-600 mg tumor group, depletion of CD8+ cells alone or both CD4+ and CD8+ cells diminished the effect of NK cell therapy, whereas depletion of CD4+ cells alone did not affect OS (Figure 3D). This result indicates that CD8+ T cells are essential for the effect of NK cell therapy. In contrast, the >600 mg tumor group displayed a limited NK-cell treatment effect as expected, but did exhibit improved OS upon depleting CD4+ cells alone (Figure 3D). As the proportion of lung Foxp3+CD4+ T cells in CD45+ cells positively correlated with day 21 tumor weight (data not shown), depletion of Foxp3+CD4+ T cells by anti-CD4 antibody likely has a stronger effect in augmenting the immune response for the >600 mg tumor group than the 95-600 mg tumor group. Moreover, both tumor groups showed diminished OS upon depletion of both CD4+ and CD8+ cells than was the case for depletion of CD8+ cells alone, indicating a CD8+ T cell-independent anti-tumor effect of CD4+ T cells (Figure 3D).”

      (4) The schema in Figure 3E states that mice were inoculated with either EO771 tumor cells or B16F10 tumor cells, but it appears that the data only show EO771 tumor challenges. This should be corrected. 

      Corrected according to the reviewer’s comment.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public review):

      Summary:

      This paper reports fossil soft-tissue structures (tail vanes) of pterosaurs, and attempts to relate this to flight performance and other proposed functions for the tail

      Strengths:

      The paper presents new evidence for soft-tissue strengthening of vanes using exciting new methods.

      We thank Reviewer #1 for the positive assessment of our work.

      Weaknesses:

      There seems to be no discussion of bias in the sample selection method - even a simple consideration of whether discarded specimens were likely not to have had the cross-linking lattice, or if it was not visible.

      There seems to be no supporting evidence or theory to show how the lattice could have functioned, other than a narrative description. Moreover, there is no comparison to extant organisms where a comparison of function might be drawn.

      We note these weaknesses and have addressed them as part of the consensus of suggested edits given below (‘first option’). We thank the reviewer for this feedback.

      Reviewer #2 (Public review):

      Summary:

      The authors have set out to investigate and explain how early members of the Pterosauria were able to maintain stiffness in the vane of their tails. This stiffness, it is said, was crucial for flight in early members of this clade. Through the use Laser-Stimulated Fluorescence imaging, the authors have revealed that certain pterosaurs had a sophisticated dynamic tensioning system that has previously been unappreciated.

      Strengths:

      The choice of method of investigation for the key question is sound enough, and the execution of the same is excellent. Overall the paper is well written and well presented, and provides a very succinct, accessible and clear conclusion.

      We thank Reviewer #2 for their positive assessment of our work.

      Weaknesses:

      None

      We thank Reviewer #2 for their positive assessment of our work.

      Recommendations for the authors:

      The consensus between the reviewers and reviewing board is that this manuscript can be substantially strengthened and this can be achieved in two ways that are presented in order of preference.

      First option; resolve the following weaknesses:

      - Include a rigorous discussion of possible bias in the sample selection method with consideration of discarded specimens in relation to cross-linking lattice observation.

      - Include published biomechanics theory, supported by citations or a self-derived biomechanical model, to show how the lattice could have functioned biomechanically.

      - Discuss whether you found similar mechanisms in extant organisms for comparative functional interpretation.

      We thank the reviewers and reviewing board for taking the time to discuss the review and propose two consensus options for how to substantially strengthen the manuscript. We carefully considered both proposed options and decided to implement the first option in full. We have therefore made main text edits relating to all three points of the first option. The marked up article file shows exactly which parts of the text were edited in relation to the points.

      Second option; rewrite the manuscript so no mechanistic claims are made that are not supported by the information presented:

      - Accept the possibility of sampling bias and its limitation in the presentation of cross-linking lattice observation, outlining future work needed to address this.

      - Discuss biomechanics theory needs to be developed to show how the lattice could have functioned biomechanically and remove unsupported speculation about this. It is acceptable to present a new hypothesis, clearly outline the motivation for the hypothesis and how it can be tested with future biomechanical and comparative studies. Remove and replace all current speculative sections and phrasing accordingly and replace this with the framework supporting the idea of a new hypothesis.

      The first option was implemented instead of the second option.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews: 

      Reviewer #1 (Public Review): 

      Summary: 

      Previous work has shown that the evolutionarily-conserved division-orienting protein LGN/Pins (vertebrates/flies) participates in division orientation across a variety of cell types, perhaps most importantly those that undergo asymmetric divisions. Micromere formation in echinoids relies on asymmetric cell division at the 16-cell stage, and these authors previously demonstrated a role for the LGN/Pins homolog AGS in that ACD process. Here they extend that work by investigating and exploiting the question of why echinoids but not other echinoderms form micromeres. Starting with a phylogenetics approach, they determine that much of the difference in ACD and micromere formation in echinoids can be attributed to differences in the AGS Cterminus, in particular a GoLoco domain (GL1) that is missing in most other echinoderms.

      Thank you for the summary.

      Strengths: 

      There is a lot to like about this paper. It represents a superlative match of the problem with the model system and the findings it reports are a valuable addition to the literature. It is also an impressively thorough study; the authors should be commended for using a combination of experimental approaches (and consequently generating a mountain of data). 

      Thank you.

      Weaknesses: 

      There is an intriguing finding described in Figure 1. AGS in sea cucumbers looks identical to AGS in the pencil urchin, at least at the C terminus (including the GL1 domain). Nevertheless, there are no micromeres in sea cucumbers. Therefore another mechanism besides GL motif organization has arisen to support micromere formation. It is a consequential finding and an important consideration in interpreting the data, but I could not find any mention of it in the text. That is a missed opportunity and should be remedied, ideally not only through discussion but also experimentation. Specifically: does sea cucumber AGS (SbAGS) ever localize to the vegetal cortex in sea cucumbers? Can it do so in echinoids? Will that support micromere formation? 

      Thank you for pointing this out. 

      To respond to the Reviewer’s request, we synthesized sea cucumber (Sb) AGS based on the sequence available in the database and tested it in the sea urchin (Sp) embryos, which is enclosed in Fig. S3. We performed this experiment to confirm that SbAGS localizes less at the vegetal cortex than SpAGS as a proof of principle. However, we hesitate to conduct further studies using the synthetic sequence in this study. Sea cucumbers are an emerging yet understudied model. This species is not readily available or established as a model system for embryology. Even for the two species (A. japonicus in Japan and P. parvimensis in the USA) that were previously used for embryonic studies, their gametes are typically available only for 12 months in a year. Since some echinoderm researchers are aiming to establish sea cucumbers as a model system in the near future (see 2024 review: PMID: 38368336), we hope to be able to have better access to their embryos in the future. Yet, it may require a few more years to reach that condition.

      In this revised manuscript, we explained the above details and further added the discussion described below. All of the experimental models used in this study are wild animals obtained from the ocean, raising the standard for reproducibility. However, handling wild animals could come with challenges. We hope that the reviewer understands the unique benefits and challenges of this study.

      Discussion:

      Previous studies (PMIDs: 17726110; 21855794) suggest that GL1 is not involved in intramolecular interaction with TPR domains. This allows GL1 to interact independently with Gαi for cortical recruitment yet without influencing other GLs for AGS activation. To ensure GL1's independence, GL1 is typically located distantly from other GLs in Pins (flies), LGN (humans), and AGS (sea urchins). Based on this prior knowledge, we speculate three scenarios for sea cucumber (Sb) AGS not being able to localize or function during asymmetric cell division (ACD): 1) GL1 and GL2 are located too close to each other, compromising GL1's independence for recruitment. 2) A lack of GL4 loosens the autoinhibition state. 3) The GL1 sequence of SbAGS is quite different from that of echinoids’ AGS (Figure S2), compromising its recruiting efficacy. 

      For 1), we tested this possibility by making the SpAGS-GL1GL2 mutant that has GL1 and GL2 next to each other (Fig. 4G). This mutant indeed compromised its cortical localization and function in ACD. For 2), we showed that the lack of GL4 partially compromised ACD in SpAGS (Fig. 3F), suggesting that GL4 supports ACD. For 3), The results in Figure 4 indicate that the position but not the sequence of GL1 is critical for ACD. Based on these observations, we speculate a combination of 1) and 2) compromised SbAGS's ACD function. However, it is still possible that a significant difference in the GL1 sequence diminished its function as GL entirely. Future studies should address these remaining questions directly in the sea cucumber embryos once they are established as a model system in the near future (PMID: 38368336)

      The authors point out that AGS-PmGL demonstrates enrichment at the vegetal cortex (arrow in 5G, quantifications in 5H), unlike PmAGS. AGS-PmGL does not however support ACD. They interpret this result to indicate "that other elements of SpAGS outside of its C-terminus can drive its vegetal cortical localization but not function." This is a critical finding and deserves more attention. Put succinctly: Vegetal cortical localization of AGS is insufficient to promote ACD, even in echinoids. Why should this be?  

      Thank you for the suggestion. We revised our wording to be more succinct. Of note, as we noted in the text, AGS-PmGL has only two GL domains, which will likely not provide the full force to control ACD and result in insufficient ACD function.

      The authors did perform experiments to address this problem, hypothesizing that the difference might be explained by the linker region, which includes a conserved phosphorylation site that mediates binding to Dlg. They write "To test if this serine is essential for SpAGS localization, we mutated it to alanine (AGS-S389A in Fig. S3A). Compared to the Full AGS control, the mutant AGS-S389A showed reduced vegetal cortical localization (Fig. S3B-C) and function (Fig. S3D-E). Furthermore, we replaced the linker region of PmAGS with that of SpAGS (PmAGSSpLinker in Fig. S4A-B). However, this mutant did not show any cortical localization nor proper function in ACD (Fig. S4C-F). Therefore, the SpAGS C-terminus is the primary element that drives ACD, while the linker region serves as the secondary element to help cortical localization of AGS." 

      The experiments performed only make sense if the AGS-PmGL chimeric protein used in Figure 5 starts the PmGL sequence only after the Sp linker, or at least after the Sp phosphorylation site. I can't tell from the paper (Figure S3 indicates that it does, whereas S5 suggests otherwise), but it's a critical piece of information for the argument. 

      Thank you for the pointer, and we apologize for the confusion. AGS-PmGL contains the SpAGS linker domain. To clarify this point, we added the amino acid position at the junction of each chimeric construct diagram in Figs. 5 and S4. To clarify, Figure S5 is about the GL domain mutations (not about the Linker).  

      Another piece of missing information is whether the PmAGS can be phosphorylated at its own conserved phosphorylation site. The authors don't test this, which they could at least try using a phosphosite prediction algorithm, but they do show that the candidate phosphorylation site has a slightly different sequence in Pm than in Et and Sp (Fig. S4A). With impressive rigor, the authors go on to mutate the PmAGS phosphorylation site to make it identical to Sp. Nothing happens. Vegetal cortical localization does not increase over AGS-PmGL alone. Micromere formation is unrescued. 

      There is therefore a logic problem in the text, or at least in the way the text is written. The paragraph begins "Additionally, AGS-PmGL unexpectedly showed cortical localization (Figure 5G), while PmAGS showed no cortical localization (Figure 5B)." We want to understand why this is true, but the explanation provided in the remainder of the paragraph doesn't match the question: according to quite a bit of their own data, the phosphorylation site in the linker does not explain the difference. It might explain why AGS-PmGL fails to promote micromere formation, but only if the AGS-PmGL chimeric protein uses the Pm linker domain (see above).

      Thank you for the insightful suggestion. As suggested, we performed the phosphosite predictions using GPS 6.0 (PMID: 37158278) and enclosed the results in Fig. S4A (replacing the old Fig. S3A). The software predicts SpAGS and EtAGS have a predicted AuroraA phosphorylation site (RRRSMEN in Supplemental figure S4A) in their linker domain, while PmAGS does not. Sp and Et AGS also have the additional 5-7 predicted phosphorylation sites, while PmAGS has only three sites with low scores. Therefore, the linker domain is not conserved in PmAGS. 

      The PmAGS+SpLinker mutant does restore the predicted AuroraA phosphorylation site on the software, yet it does not restore the cortical localization or ACD function in the embryo. Therefore, other sites in the Linker region might also be necessary for cortical localization and ACD function of AGS. In this study, we did not perform further manipulations in the Linker domain. As the reviewer rightfully pointed out, even if we identify the Linker regions essential for AGS localization and function, it will be difficult to interpret the result unless we know what proteins interact with the Linker domain of AGS. Therefore, this is beyond the scope of the current manuscript. We discussed these remaining matters in the discussion section. 

      Another concern that is potentially related is the measurement of cortical signal. For example, in the control panel of Figure 5C, there is certainly a substantial amount of "non-cortical" signal that I believe is nuclear. I did not see a discussion of this signal or its implications. My impression of the pictures generally is that the nuclear signal and cortical signal are inversely correlated, which makes sense if they are derived from the same pool of total protein at different points of the cell cycle. If that's the case (and it might not be) I would expect some quantifications to be impacted. For example, the authors show in Figure S3B that AGS-S389A mutant does not localize to the cortex. However, this mutant shows a radically different localization pattern to the accompanying control picture (AGS), namely strong enrichment in what I assume to be the nucleus. Is the S389 mutant preventing AGS from making it to the cortex? Or are these pictures instead temporally distinct, meaning that AGS hasn't yet made it out of the nucleus? Notably, the work of Johnston et al. (Cell 2009), cited in the text, does not show or claim that the linker domain impacts Pins localization. Their model is rather that Pins is anchored at the cortex by Gαi, not Dlg, and that is the same model described in this manuscript.

      In agreement with that model and the results of Johnston et al., a later study (Neville et al. EMBO Reports 2023) failed to find a role for Dlg or the conserved phosphorylation site in Pins localization. 

      In the sea urchin embryo, the dye or GFP often appears in the nucleus randomly on top of the cytoplasm (for example, see Fig. S2b of PMID: 35444184). Further, embryos tend to incorporate exogenous genomic fragments more efficiently during early embryogenesis (PMID: 3165895). It is proposed that early embryos may have a loosened or incomplete nuclear envelope compared to adult cells as they divide rapidly (every 40 minutes). Therefore, any excess protein with no specific localization signal may randomly appear in the nucleus as it serves as an available space in the cell. As the Reviewer rightfully pointed out, we consider that the nuclear AGS signal is due to the lack of a specific destination since this signal pattern is not consistent across embryos. In contrast, the proteins that have nuclear localization (e.g., transcription factors) usually show a consistent nuclear signal across cells and embryos with less cytoplasmic signal. To avoid confusion, we replaced the S389A image in Fig. S3B (which is now Fig. S4C) as well as any other images that may create similar confusion.

      Reviewer #2 (Public Review): 

      This study from Dr. Emura and colleagues addresses the relevance of AGS3 mutations in the execution of asymmetric cell divisions promoting the formation of the micromere during seasearching development. To this aim, the authors use quantitative imaging approaches to evaluate the localisation of AGS3 mutants truncated at the N-terminal region or at the Cterminal region, and correlate these distributions with the formation of micromere and correct development of embryos to the pluteus stage. The authors also analyse the capacity of these mutated proteins to rescue developmental defects observed upon AGS3 depletion by morpholino antisense nucleotides (MO). Collectively these experiments revealed that the Cterminus of AGS3, coding for four GoLoco motifs binding to cortical Gaphai proteins, is the molecular determinant for cortical localisation of AGS3 at the micromeres and correct pluteus development. Further genetic dissections and expression of chimeric AGS3 mutants carrying shuffled copies of the GoLoco motifs or four copies of the same motifs revealed that the position of GoLoco1 is essential for AGS3 functioning. To understand whether the AGS3-GoLoco1 evolved specifically to promote asymmetric cell divisions, the authors analyse chimeric AGS3 variants in which they replaced the sea urchin GoLoco region with orthologs from other echinoids that do not form micromeres, or from Drosophila Pins or human LGN. These analyses corroborate the notion that the GoLoco1 position is crucial for asymmetric AGS3 functions. In the last part of the manuscript, the authors explore whether SpAGS3 interacts with the molecular machinery described to promote asymmetric cell division in eukaryotes, including Insc, NuMA, Par3, and Galphai, and show that all these proteins colocalize at the nascent micromere, together with the fate determinant Vasa. Collectively this evidence highlighted how evolutionarily selected AGS3 modifications are essential to sustain asymmetric divisions and specific developmental programs associated with them. 

      Thank you for the useful summary.

      Recommendations for the authors:

      Reviewer #1 (Recommendations For The Authors): 

      The quantifications of "vegetal cortical localization" are somewhat incomplete. As measured, "vegetal cortical localization" does not demonstrate particular enrichment at the vegetal cortex, only that some signal appears there. In other words, we can't tell for sure that there is any more signal at the vegetal cortex than anywhere else along the cortex, and in fact that's plainly true and even described for the ACS1111 and AGS2222 constructs. One solution would be to measure signal strength around the cell perimeter and see where it is strongest. 

      As suggested by the Reviewer, we added new measurements, focusing and comparing the signals on the animal versus vegetal cortices (Figs. 2C, 3D, 4C, 5C, &H, 9D & F, S3D, S4D &I). 

      A related issue is that the strength of cortical enrichment is indicated in this paper by the ratio of cortical to "non-cortical" signal, but "non-cortical" is not defined. Does it include the nuclear signal? 

      As described above, we replaced all measurements using the above animal vs. vegetal cortices to avoid confusion. The nuclear signal is thus not measured in these analyses.

      I'm enthusiastic about the results in Figure 7, but I can't really see them very well. Could you please consider changing the color scheme? For single-color figures, it would be helpful to view them as black on white rather than (for example) blue on black. That change is easily achieved with Fiji. 

      We revised the Figure as suggested.

      Page 3 Results section: "At the time of ACD, Insc recruits Pins/LGN to the cortex through Gαi": I understand this sentence to mean that Gαi is an intermediary protein that Insc uses to recruit Pins/LGN. I think the point should be made more clear. As shown in Figure 1, Insc binds to Pins/LGN directly and interacts with cortical polarity proteins directly. Recruitment therefore doesn't appear to require Gαi, but stable association with the membrane (a subsequent step) probably does. That model is shown and described in Figure 6A.

      Thank you for the pointer. We clarified our explanations as suggested.

      Reviewer #2 (Recommendations For The Authors): 

      The manuscript addresses an interesting question, and uses elegant genetic approaches associated with imaging analyses to elucidate the molecular mechanisms whereby AGS3 and spindle orientation proteins promote asymmetric divisions and specific developmental programs. This considered, it might be worth clarifying a few aspects of the reported findings. 

      (1) In some experimental settings, the presence of AGS3 mutants exacerbates the AGS3 deletion by MO (Figure 4F). Can the author speculate on what can be the molecular explanation? 

      Thank you for pointing this out. We speculate that AGS1111 and AGS2222 are unable to keep the auto-inhibited forms since they lack GL3 and GL4 as modeled in Figure 6. AGS-MO reduces the endogenous AGS, which compromises the vegetal polarity. In this embryo, constitutive active AGS likely further randomizes the polarity, as evidenced by AGS-OE results in Fig. S7, resulting in an even worse outcome. We elaborated on this part in the text.

      (2) Imaging analyses of Figure 4B-C suggest that the mutant AGS1111 does not localise at the vegetal cortex while AGS2222 does (Fig. 4C). However these mutants induce similar developmental defects (Figure 4F). What could be the reason? 

      We apologize for the confusion in Fig. 4C. The majority of embryos from both AGS1111 and 2222 groups failed to form micromeres and showed AGS localization across the cortex. Among the dozens we examined, 0 embryos from 1111 and 8 embryos from 2222 developed micromeres. Those 8 embryos still showed vegetal cortical localization, so the proportion appears high in Fig. 4B, yet it reflects the minority in the group. In contrast, Development was scored for all embryos (including those that failed to form micromeres), so the graph demonstrates the majority of embryos. To avoid this confusion, we replaced the old Fig. 4C with a new graph that analyzes the cortical signal levels at the vegetal versus animal cortices.

      (3) Figure 7 shows the crosstalk between AGS3 and other asymmetry players including NuMA. Vertebrate and Drosophila NuMA are ubiquitously present in tissues and localise to the spindle poles in mitosis. However, in Figures 7A and 7E NuMA seems expressed only in a subset of sea urchin embryonic cells. Is this the case? 

      As the Reviewer rightfully pointed out, Sea urchin NuMA is also present in all cells and localizes to the spindle (please see Fig. 2 of our previous paper PMID: 31439829). AGS is also slightly localized on the spindles of all cells. However, the PLA signal of AGS and NuMA mostly showed up in the vegetal cortex in this study, suggesting that major crosstalk may occur in the vegetal cortex. This does not rule out the possibility that minor interactions may also occur on the spindle or elsewhere in the cell, which was not quantifiable in this study. We clarified this point in the text.

    1. Author response:

      Reviewer #1 (Recommendations for the authors):

      (1) Storyline and Narrative Flow:

      Consider revising the manuscript to create a more coherent and consistent narrative. Clarify how each section of the study-particularly the transition from multi-omics data integration to single-cell RNA-seq validation-contributes to the overall research question. This will help readers better understand the logical flow of the study.

      In the upcoming revisions, we will optimize the logical connections between sections of the manuscript to clarify the role each part plays in the overall research question, making it easier for readers to follow.

      (2) Immune Cell Activity Analysis:

      Reevaluate the methods used to assess immune cell activities within the context of the tumor microenvironment. Consider providing additional justification for the relevance of using the cancer cell model for this analysis. If necessary, explore alternative methods or models that might offer more meaningful insights into immune-tumor interactions.

      We fully recognize the importance of using tumor models to analyze and validate immune activity results, and we are considering experimental research in this area in future projects.

      (3) Single-Cell RNA-Seq Validation:

      Expand the validation of your findings using single-cell RNA-seq data. This could include more in-depth analyses that explore the heterogeneity within the subtypes and confirm the robustness of your classification method at the single-cell level. This would strengthen the support for your claims about the relevance of the identified subtypes.

      In the current study, we have applied the obtained multi-omics profiling features to single-cell sequencing data to classify malignant cells. We analyzed the metabolic and cell communication differences between different subtypes of malignant cells and explored potential reasons for these differences. Next, we plan to conduct further analysis of the differences between malignant cell subtypes to identify additional clues and mechanisms underlying these variations.

      (4) Methodological Justification:

      Provide a more detailed rationale for the selection of machine learning algorithms and integration strategies used in the study. Explain why the chosen methods are particularly well-suited for this research, and discuss any potential limitations they might have.

      In the revised manuscript, we will include descriptions of the principles of these analytical methods, as well as examples of their application in other studies, to discuss the rationale and limitations of applying these methods in this research.

      (5) Figures and Visualizations:

      Improve the clarity of your figures by addressing the following:

      a) Figure 3A: Cluster the pathways to make the comparisons clearer and more meaningful.

      b) Figure 4A: Clearly explain the significance of the blue bar.

      c) Figure 4B: Ensure this figure is discussed in the main text to justify its inclusion.

      d) Figure 7C: Enhance the figure legend to provide more informative details.

      Additionally, ensure that figure descriptions go beyond the captions and provide detailed explanations that help the reader understand the significance of each figure.

      We fully agree with the reviewer’s suggestions regarding these figures, and we will make the necessary revisions in the revised manuscript.

      (6) Supplementary Materials:

      Consider including more detailed supplementary materials that provide additional validation data, extended methodological descriptions, and any other information that would support the robustness of your findings.

      When we submission the revised manuscript, we will include supplementary materials such as figures or tables that may enhance the presentation of the manuscript's completeness.

      (7) Recent Literature:

      a) Incorporate more recent studies in your discussion, especially those related to HCC subtypes and the application of machine learning in oncology. This will provide a more current context for your work and help position your findings within the broader field.

      We appreciate the reviewer's suggestion. We will incorporate more recent studies into the discussion section and optimize its content.

      (8) Data and Code Availability:

      Ensure that all data, code, and materials used in your study are made available in line with eLife's policies. Provide clear links to repositories where readers can access the data and code used in your analyses.

      We have indicated the sources of the data and tools used in the analysis process within the text, and these data and tools can be accessed through the websites or literature we have cited.

      Reviewer #2 (Recommendations for the authors):

      (1) While the computational findings are robust, further experimental validation of the two subtypes, particularly the role of the MIF signaling pathway, would strengthen the biological relevance of the findings. In vitro or in vivo validation could confirm the proposed mechanisms and their influence on patient prognosis.

      We fully recognize the importance of using tumor models to analyze and validate immune activity results, and we are considering experimental research in this area in future projects.

      (2) Consider testing the model on additional independent cohorts beyond the TCGA and ICGC datasets to further demonstrate its generalizability and applicability across different patient populations.

      We are considering looking for independent external datasets in the GEO database or other databases to validate our model.

      (3) Review the manuscript for long or complex sentences, which can be broken down into shorter, more readable parts.

      In the revised manuscript, we will address any grammatical issues present in the manuscript and modify long and complex sentences that may hinder reader comprehension.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Thank you for your assessment and constructive critique, which helped us to improve the manuscript and its clarity. Upon carefully reading through the comments, we noticed that, based on the Reviewer's questions, some of our answers were already available but “hidden” as supplementary data. Thus, we changed the following two figures and text accordingly to showcase our results to the reader better:

      A) To highlight how mobile service data can indicate the spread of highly prevalent variants, we added a high-prevalence subcluster to Figure 2 (previously shown in Supplementary Figures S4 and S5) and, in exchange, moved one low-prevalence subcluster from Figure 2 back into the supplement. The figure is now showing a low and a high prevalent subcluster instead of two low prevalent subclusters.

      B) Based on Reviewer 1’s question about where samples were taken in regards to the mobility data from the community of the first identification (negative controls), we now highlight all the mobility data that was available to us in Figure 3 (as triangles) instead of just a few top mobility hits for both - mobility guided and random surveillance (serving as a negative control for the former). This way, we think, it is clearer how random sampling was also performed in some regions where mobility was coming from the community of origin (as asked by Reviewer 1) - the detailed trips and sampling are now part of the supplement for data transparency reasons. We also noticed a typo in the GPS coordinates, aligning one of the arrows falsely, which is corrected in the improved Figure 3.

      We have also included the R-Scripts used to generate all the figures in the manuscript in an OSF repository (we updated the “Data sharing statement”). We also updated Figure 1 slightly and extended the supplemental material. The remaining comments to reviewers are addressed point-by-point below.

      Reviewer 1 (Public Review):

      In "1 Exploring the Spatial Distribution of Persistent SARS-CoV-2 Mutations -Leveraging mobility data for targeted sampling" Spott et al. combine SARS-CoV-2 genomic data alongside granular mobility data to retrospectively evaluate the spread of SARS-CoV-2 alpha lineages throughout Germany and specifically Thuringia. They further prospectively identified districts with strong mobility links to the first district in which BQ.1.1 was observed to direct additional surveillance efforts to these districts. The additional surveillance effort resulted in the earlier identification of BQ.1.1 in districts with strong links to the district in which BQ.1.1 was first observed.

      Thank you for taking the time to review our work.

      (1) It seems the mobility-guided increased surveillance included only districts with significant mobility links to the origin district and did not include any "control" districts (those without strong mobility links). As such, you can only conclude that increasing sampling depth increased the rate of detection for BQ.1.1., not necessarily that doing so in a mobility-guided fashion provided an additional benefit. I absolutely understand the challenges of doing this in a real-world setting and think that the work remains valuable even with this limitation, but I would like the lack of control districts to be more explicitly discussed.

      Thank you for the critical assessment of our work. We agree that a control is essential for interpreting the results. In our case, randomized surveillance (“the gold standard”) served as a control with a total sampling depth seven times higher than the mobility-guided sampling. To better reflect the sampling in regards to the available mobility data, we revisited Figure 3 and added all the mobility information from the origin that was available to us. We also added this information to the random surveillance to provide a clearer picture to the reader. This now clearly shows how randomized surveillance covered communities with varying degrees of incoming mobility from the community of first occurrences, thereby underlining its role as a negative control. We updated the manuscript to reflect these changes and included the October 2020 and June 2021 mobility datasets in Supplementary Table S6. We agree that the sampling depth increases the detection, which is the point of guided sampling to increase sampling, specifically in areas where mobility points towards a possible spread. In regards to the negative control: Random surveillance (not Mobility-guided) in October covered 40 samples in the northwest region of Thuringia (Mobility-guided covered 19 samples). Thus, random surveillance also contained 31 out of 132 samples with a mobility link towards the first occurrence of BQ1.1 but with varying amounts of mobility (low to high).

      We added this information to the main text:

      Line 270 to 293:

      Following its first Thuringian identification, we utilized the latest available dataset of the past two years of mobile service data (October 2020 and June 2021) to investigate the residential movements for the community of first detection. Considering the highest incoming mobility from both datasets, we identified 18 communities with high (> 10,000), 34 with medium (2,001-10,000), and 82 with low (30-2,000) number of incoming one-way trips from the originating community (purple triangles in Figure 3a). As a result, we specifically requested all the available samples from the eight communities with the highest incoming mobility. Still, we were restricted to the submission of third parties over whom we had no influence. This led to the inclusion of the following eight communities with the most residential movement from the originating community: four in central and three in NW of Thuringia, one in NW-neighboring state Saxony-Anhalt. The samples requested from central Thuringia were also due to their geographic arrangement as a “belt” in central Thuringia, linking three major cities (see Supplementary Figure S1). Subsequently, we collected 19 additional samples (isolated between the 17th and 25th of October 2022; see “Guided Sampling” for October 2022, Figure 3a) besides the randomized sampling strategy. Thus, the sampling depth was increased in communities with high incoming mobility from the first origin.

      As part of the general Thuringian surveillance, we collected 132 samples for October (covering dates between the 5th and 31st) and 69 samples in November (covering dates between the 1st and 25th; see Figure 3b and c). Randomized sampling was not influenced or adjusted based on the mobility-guided sample collection. Thus, it also contains samples from communities with a mobility link towards the first occurrence of BQ.1.1, as they were part of the regular random collection (see gray triangles in Figure 3b). A complete overview of all samples is provided in Supplementary Table S5. The mobility datasets from October 2020 and June 2021 for all sampled communities are provided in Supplementary Table S6.

      Line 305 to 313:

      Among the 19 samples specifically collected based on mobile service data, we identified one additional sample of the specific Omicron sublineage BQ.1.1 in a community with high incoming mobility (n = 14, number of trips = 37,499) with a distance of approximately 16 km between both towns. Our randomly sampled routine surveillance strategy did not detect another sample during the same period. This was despite a seven times higher overall sample rate, which included 31 samples from communities with an identified incoming mobility from the community of the first occurrence (October 2022, Figure 3b). Only in the one-month follow-up were four other samples identified across Thuringia through routine surveillance (November 2022, Figure 3c).

      Line 325 to 333:

      In summary, increasing the sampling depth in the suspected regions successfully identified the specified lineage using only a fraction of the samples from the randomized sampling. Conversely, randomized surveillance, the “gold standard” acting as our negative control, did not identify additional samples with similar sampling depths in regions with no or low incoming mobility or even in high mobility regions with less sampling depth. Implementing such an approach effectively under pandemic conditions poses difficult challenges due to the fluctuating sampling sizes. Although the finding of the sample may have been coincidental, our proof of concept demonstrated how we can leverage the potential of mobile service data for targeted surveillance sampling.

      (2) Line 313: While this work has reliably shown that the spread of Alpha was slower in Thuringia, I don't think there have been sufficient analyses to conclude that this is due to the lack of transportation hubs. My understanding is that only mobility within Thuringia has been evaluated here and not between Thuringia and other parts of Germany.

      Thank you for pointing this out. We noticed that the original sentence lacked the necessary clarity. The statement in line 313 was based on the observation that Alpha first occurred in federal states with major transport hubs, such as international airports and ports, which Thuringia lacks, as demonstrated in the Microreact dataset. For clarification, we adjusted the sentence as follows:

      Line 340 and following:

      A plausible explanation for the delayed spread of the Alpha lineage in Thuringia is the lack of major transport hubs, as Alpha first occurred in federal states with such hubs. Previous studies have already highlighted the impact of major transportation hubs in the spread of Sars-CoV-2.

      (3) Line 333 (and elsewhere): I'm not convinced, based on the results presented in Figure 2, that the authors have reliably identified a sampling bias here. This is only true if you assume (as in line 235) that the variant was in these districts, but that hasn't actually been demonstrated here. While I recognize that for high-prevalence variants, there is a strong correlation between inflow and variant prevalence, low-prevalence variants by definition spread less and may genuinely be missing from some districts. To support this conclusion that they identified a bias, I'd like to see some type of statistical model that is based e.g. on the number of sequences, prevalence of a given variant in other districts, etc. Alternatively, the language can be softened ("putative sampling bias").

      Thank you for addressing this legitimate point of criticism in our interpretation. Due to the retrospective nature of the analysis and the fact that we found no additional samples of the clusters after the specified timeframes, we were limited to the samples in our dataset. Therefore, it is impossible to demonstrate if a variant was present in the relevant districts afterward. We agree that the variant’s low prevalence means they may genuinely not have spread to some districts. For clarification, we added the following statements and changed the wording accordingly:

      Additional statement in line 248:

      However, due to their low prevalence, it is also possible that these subclusters have not spread to the indicated districts.

      Adjusted wording in line 361:

      We exemplified this approach with the Alpha lineage, where mobile service data indicated a putative sampling bias and partially predicted the spread of our Thuringian subclusters.

      Recommendations:

      (1) I applaud the use of the microreact page to make the data public, however, I don't see any reference to a GitHub or Zenodo repository with the analysis code. The NextStrain code is certainly appreciated but there is presumably additional code used to identify the clusters, generate figures, etc. I generally prefer this code be made public and it is recommended by eLife.

      Thank you for your appreciation. We have now included the R-scripts in the manuscript’s OSF repository. These were used to create the figures in the manuscript and supplement utilizing the supplementary tables 1-6, which are also stored in the repository. To clearly communicate which data is provided, we changed lines 513 and 514 of the “Data sharing statement” as follows:

      Line 513 and following:

      Supplementary tables and the R-scripts used to generate all figures are also provided in the repository under https://osf.io/n5qj6/. These include the mobile service data used in this study, which is available in processed and anonymized form.

      The subcluster identification was performed manually. By adding each sample's mutation profile to the Microreact metadata file, we visually screened the phylogenetic time tree for all non-Alpha specific mutations present in at least 20 Thuringian genomes. We then applied the criteria described in the Methods section to identify the nine Alpha subclusters. For clarification, we changed line 436:

      Line 436:

      We then manually screened for mutations present in at least 20 genomes with a small phylogenetic distance and a time occurrence of at least two months.

      Reviewer 2 (Public Review):

      In the manuscript, the authors combine SARS-CoV-2 sequence data from a state in Germany and mobility data to help in understanding the movement of the virus and the potential to help decide where to focus sequencing. The global expansion in sequencing capability is a key outcome of the public health response. However, there remains uncertainty about how to maximise the insights the sequence data can give. Improved ability to predict the movement of emergent variants would be a useful public health outcome. Also knowing where to focus sequencing to maximising insights is also key. The presented case study from one State in Germany is therefore a useful addition to the literature. Nevertheless, I have a few comments.

      Thank you for taking the time to review our work.

      (1) One of the key goals of the paper is to explore whether mobile phone data can help predict the spread of lineages. However, it appears unclear whether this was actually addressed in the analyses. To do this, the authors could hold out data from a period of time, and see whether they can predict where the variants end up being found.

      Based on your feedback, we noticed that the results of the other seven clusters presented in the supplement were not appropriately highlighted, causing them to be overlooked. We indeed demonstrated that predicting viral spread based on mobility data is possible, as shown for the high-prevalence subcluster 7 (Cluster “ORF1b:A520V”, 811 samples). This was briefly mentioned in lines 240-242, but the cluster was only shown in Supplementary Figures S4 and S5. Instead, we focused more on the putative sampling bias that the mobility for low-prevalence subclusters could indicate as an interesting use case of mobility data. This addresses a concrete problem of every surveillance: successfully identifying low-prevalence targets. However, based on your feedback, we revisited Figure 2, adding the plots of the high-prevalence subcluster: “ORF1b:A520V” from Supplementary Figures S4 and S5 while moving the low-prevalence subcluster “S:N185D” from Figure 2 into the Supplementary Figures S4 and S5. Additionally, we changed line 229 to highlight this result properly.

      line 229 and following:

      The mobile service data-based prediction of a subcluster’s spread aligned well with the subsequent regional coverage of fast-spreading, highly prevalent subclusters, such as subcluster 7, which covered 811 samples (see Figure 2). In contrast, the predicted spread for the low-prevalence subclusters did not correspond well with the actual occurrence.

      (2) The abstract presents the mobility-guided sampling as a success, however, the results provide a much more mixed result. Ultimately, it's unclear what having this strategy really achieved. In a quickly moving pandemic, it is unclear what hunting for extra sequences of a specific, already identified, variant really does. I'm not sure what public health action would result, especially given the variant has already been identified.

      Thank you for your critical assessment of the presented results and their interpretation.

      Here, we aimed to provide an alternative to the standard randomized surveillance strategy. Through mobility-guided sampling, we sought to increase identification chances while necessitating fewer samples and decreasing costs, ultimately enhancing surveillance efficiency. The Omicron-lineage BQ.1.1 was the perfect example to prove this concept under actual pandemic conditions. Yet, the strategy is not limited to low-prevalence sublineages but can be applied to virtually any surveillance case. However, from your question, we recognize that this conclusion was unclear from the text. Therefore, we adapted the conclusion to better communicate the real implications of our proof of concept. Additionally, we altered line 42 in the abstract for clarification.

      However, we did not assess the benefits of surveillance itself, as the German Robert Koch Institute (RKI) already had outlined its importance for tracking different viral variants. This tracking served several reasons, like monitoring vaccine escapism, mutational progress, and assessing available antibodies for treatment.

      Line 42:

      The latter concept was successfully implemented as a proof-of-concept for a mobility-guided sampling strategy in response to the surveillance of Omicron sublineage BQ.1.1.

      Line 364 to 374:

      Another approach is actively guiding the sampling process through mobile service data, which we demonstrated with our proof of principle focusing on the Omicron-lineage BQ.1.1 as a real-life example. This approach could allow for a flexible allocation of surveillance resources, enabling adaptation to specific circumstances and increasing sampling depth in regions where a variant is anticipated. By incorporating guided sampling, much fewer resources may be needed for unguided or random sampling, thereby reducing overall surveillance costs.

      Additionally, while this approach is particularly useful for identifying low-prevalence variants, it is not limited to such variants. Still, it can provide a guided, more cost-efficient, low-sampling alternative to general randomized surveillance that can also be applied to other viruses or lineages.

      (3) Relatedly, it is unclear to me whether simply relying on spatial distance would not be an alternative simpler approach than mobile phone data. From Figure 2, it seems clear that a simple proximity matrix would work well at reconstructing viral flow. The authors could compare the correlation of spatial, spatial proximity, and CDR data.

      Thank you for pointing this out. While proximity data might appear to be an obvious choice, it has significant limitations compared to mobility data, especially in the context of our study. Proximity data assumes that spatial distance alone can accurately represent movement patterns, which would only be true in a normally distributed traffic network. Geographic features such as mountains, cities, and highways affect traffic flows, leading to variability over distance and time, which are beyond the scope of spatial proximity but efficiently captured by mobility data. In Figure 2, we presented a simplified view of the mobility data. Hence, proximity and mobility data appear to provide the same insights. However, as shown in the updated Figure 3, a detailed overview of the available mobility data reveals obvious and non-obvious spatial connections that proximity data can not capture. Incorporating such a level of detail in Figure 2 would have cluttered the figure and reduced its clarity (e.g., adding triangles for each Thuringian community).

      While a comparison between proximity data and mobility data would indeed be informative, it is beyond the scope of our current study, as our primary focus was to examine the useability of mobility data in explaining our subcluster’s spread in the first place. However, we agree it would be a valuable direction for future research. We summarized our thoughts from above in the following additional sentence:

      Line 374:

      Pre-generated mobility networks automatically tailored to each state's unique infrastructure and population dynamics could provide better-targeted sampling guidance rather than simple geographical proximity.

      Recommendations:

      (1) Line 128: What do these percentages mean - the proportion of States with at least one Alpha variant? Please clarify.

      We clarified the values at their first appearance in the text:

      Line 127:

      By March, Alpha had spread to nearly all states and districts (districts are similar to counties or provinces) in Germany (Median: 76·47 % Alpha samples among a federal states total sequenced samples compared to 36·03 % in February, excluding Thuringia) and Thuringia (Median: 85·29 %, up from 50·00 % in February).

      (2) Line 134: It's a little strange to compare the dynamics of a state with that of the whole country. For it lagged as compared to all other States?

      Line 134: “In summary, the spread of the Alpha lineage in Thuringia lagged roughly two weeks behind the general spread in the rest of Germany but showed similar proportions.”

      Thank you for the feedback. The statement refers to the comparison of Alpha-lineage proportions across federal states, excluding Thuringia, in lines 118 to 130. To simplify, we collectively referred to these federal states as “Germany” in the text. However, we recognize that this formulation is misleading, so we adjusted line 135 for clarification:

      Line 135:

      In summary, the spread of the Alpha lineage in Thuringia lagged roughly two weeks behind the general spread of other German federal states but showed similar proportions.

    1. Author response:

      Reviewer #1 (Public review)

      Weaknesses:

      The main weakness of the manuscript is that to a large degree, one of its main conclusions (MAP symmetry underlies differences in regenerative capacity) relies mainly on a correlation, without firmly establishing a causal link. However, this weakness is relatively minor because (1) it is partially addressed with the Spastin KO and (2) there isn't a trivial way to show a causal relationship in this case.

      We thank Reviewer #1 for their positive assessment of our manuscript. To further strengthen the claim that MAP asymmetry underlies differences in regenerative capacity, we could investigate the effect of depleting other MAPs that lose asymmetry after conditioning lesion (CRMP5 and katanin). One expects that similarly to spastin, this would disrupt the physiological asymmetry of DRG axons and impair axon regeneration. We will further discuss this issue in the revised version of the manuscript.

      Reviewer #2 (Public review):

      Weaknesses:

      In order for the method to be used it needs to be better described. For instance what proportion of neurons develop just two axonal branches, one of which is different? How selective are the researchers in finding appropriate neurons?

      We thank Reviewer #2 for their positive assessment of our manuscript. As suggested, we will include further methodological details on the in vitro system in the revised version of the manuscript. We have evaluated the percentage of DRG neurons exhibiting different morphologies in our cultures: multipolar (4%), bipolar, (35%) bell-shaped (17%), and pseudo-unipolar neurons (43%). This will be included in the revised manuscript. All the pseudo-unipolar neurons analysed had distinct axonal branches in terms of diameter and microtubule dynamics. For imaging purposes, we selected pseuso-unipolar neurons with axons unobstructed from other cells or neurites within a distance of at least 20–30 μm from the bifurcation point, to ensure optimal imaging. In the case of laser axotomy experiments, this distance was increased to 100–200 μm to ensure clear analysis of regeneration. These selection criteria will be detailed in the Methods of the revised manuscript.

      Reviewer #3 (Public review):

      Weaknesses:

      While some of the data are compelling, experimental evidence only partially supports the main claims. In its current form, the study is primarily descriptive and lacks convincing mechanistic insights. It misses important controls and further validation using 3D in vitro models.

      We recognize the importance of further exploring the contribution of other MAPs to microtubule asymmetry and regenerative capacity of DRG axons. In future work, we plan to investigate this issue by using knockout mice for katanin and CRMP5. To understand the mechanisms underlying the differential localization of MAPs in DRG axons, we performed in-situ hybridization to assess the availability of axonal mRNA but no differences were found between central and peripheral DRG axons (Figure 4 – figure supplement 2). To address whether differences in protein transport exist, we attempted to transduce DRG neurons with GFP-tagged spastin both in vitro and in vivo. However, these experiments were inconclusive as very low levels of spastin-GFP were detected. We are actively optimizing these approaches and will address this challenge in future studies. This will be further discussed in the revised manuscript.

      Given the heterogeneity of dorsal root ganglion (DRG) neurons, it is unclear whether the in vitro model described in this study can be applied to all major classes of DRG neurons.

      We acknowledge the diversity of DRG neurons and agree that assessing the presence of different DRG subtypes in our culture system will enrich its future use. Despite this heterogeneity, we focused on DRG neuron features that are common to all subtypes i.e, pseudo-unipolarization and higher regenerative capacity of peripheral branches. This will be further discussed in the revised version of the manuscript.

      Also unclear is the inconsistency with embryonic DRG cultures with embryonic (E)16 from rats and E13 from mice (spastin knockout and wild-type controls).

      Given our previous experience in establishing DRG neuron cultures from Wistar rats and C57BL/6 mice, these developmental stages are equivalent, yielding cultures of DRG neurons with similar percentages of different morphologies. Of note, in our colonies, gestation length is ~19 days in C57BL/6 mice (background of the spastin knockout line) and ~22 days in Wistar Han rats. This will be further clarified in the Methods.

      Furthermore, the authors stated (line 393) that only a small subset of cultured DRG neurons exhibited a pseudo-unipolar morphology. The authors should include the percentage of the neurons that exhibit a pseudo-unipolar morphology.

      We have previously evaluated the percentage of DRG neurons exhibiting different morphologies in our cultures: multipolar (4%), bipolar, (35%) bell-shaped (17%), and pseudo-unipolar neurons (43%). This will be included in the revised manuscript. In line 393, we referred specifically to an experimental setup where DRG neuron transduction was done and 30 transduced neurons were randomly selected for longitudinal imaging. From these, the number of viable pseudo-unipolar DRG neurons was limited by both the random nature of viral transduction and light-induced toxicity as continuous imaging over seven consecutive days at hourly intervals was done. This will be clarified in the revised manuscript.

      The significance of studying microtubule polymerization to DRG asymmetry in vitro is questionable, especially considering the model's validity. The authors might consider eliminating the in vitro data and instead focus on characterizing DRG asymmetry in vivo both before and after a conditioning lesion. If the authors choose to retain the in vitro data, classifying the central and peripheral-like branches in cultured DRG neurons will require further in-depth characterization. Additional validation should be performed in adult DRG neuron cultures not aged in vitro.

      The in vitro system here presented reliably reproduces several key features of DRG neurons observed in vivo, including asymmetry in axon diameter, regenerative capacity, axonal transport, and microtubule dynamics. Of note, most studies in the field were developed using multipolar DRG neurons that do not recapitulate in vivo morphology and asymmetries. Thus, the current in vitro system serves as a versatile tool for advancing our understanding of DRG biology and associated diseases. This system is particularly suited to study axon regeneration, and enables research on mechanisms occurring at the stem axon bifurcation, which are challenging to examine in vivo due to the length of the stem axon and the difficulty of locating the DRG T-junction. Optimizing similar cultures using adult DRG neurons comes with challenges, such as lower cell viability and decreased percentage of pseudo-unipolarization. This is the case with multiple other neuron types for which the vast majority of cultures are obtained from embryonic tissue. These embryonic cultures (as is the case with cortical and hippocampal neurons) are widely used to understand neuronal polarization, axon growth and/or regeneration. This will be further addressed in the revised manuscript.

      The comparison of asymmetry associated with a regenerative response between in vitro and in vivo paradigms has significant limitations due to the nature of the in vitro culture system. When cultured in isolation, DRG neurons fail to form functional connections with appropriate postsynaptic target neurons (the central branch) or to differentiate the peripheral domains associated with the innervation of target organs. Rather than growing neurons on a flat, hard surface like glass, more physiologically relevant substrates and/or culturing conditions should be considered. This approach could help eliminate potential artifacts caused by plating adult DRG neurons on a flat surface. Additionally, the authors should consider replicating their findings in a 3D culture model or using dorsal root ganglia explants, where both centrally and peripherally projecting axons are present.

      We agree that a more sophisticated system, such as a compartmentalized culture, holds great potential for future research. In this respect, we are currently engaged in developing such models. A compartmentalized system would enable the separation of three compartments: central nervous system neurons, DRG neurons, and peripheral targets. While previous efforts to create compartmentalized DRG cultures have been reported, these systems have not demonstrated the development of pseudo-unipolar morphology. Incorporating non-neuronal DRG cells into the DRG neuron compartment, may successfully support the development of a pseudo-unipolar morphology.

      We also recognize the importance of dimensionality in fostering pseudo-unipolar morphology. Of note, our model provides a 3D-like environment, as DRG glial cells are continuously replicating over the 21 days in culture. In relation to DRG explants, we attempted their use but encountered limitations with confocal microscopy as the axial resolution was insufficient to resolve adequately processes at the DRG T-junction or within individual branches. While tissue clearing could improve resolution, it would be incompatible with live imaging, which is essential for our experiments.

      The above issues will be further discussed in the revised manuscript.

      Panels 5H-J require additional processing with astrocyte markers to accurately define the lesion borders. Furthermore, including a lower magnification would facilitate a direct comparison of the lesion site.

      In our study, we relied on the alignment of nuclei to delineate the lesion site as in our accumulated experience, this provides an accurate definition of the lesion boarder. Outside the lesion, the nuclei are well-aligned, while at the lesion site, they become randomly distributed. Additionally, CTB staining further supports the identification of the rostral boarder of the lesion, as most injured central DRG axons stop their growth at the injury site. This will be further detailed in the Methods.

      The use of cholera toxin subunit B (CTB) to trace dorsal column sensory axons is prone to misinterpretation, as the tracer accumulates at the axon's tip. This limitation makes it extremely challenging to distinguish between regenerating and degenerating axons.

      While alternative methods to trace or label regenerating axons exist, CTB is a well-established and widely used tracer for central sensory projections, as shown in multiple studies. Regarding the concern of possible CTB labeling in degenerating axons, we believe this is unlikely to be the case in our study as in spinal cord injury controls, CTB-positive axons are nearly absent. Also, as regeneration was investigated six weeks after injury, axon degeneration has most likely already occurred, as shown in (PMID: 15821747 and PMID: 25937174).

    1. Author response:

      Reviewer #1 (Public review):

      Summary:

      The manuscript by Rühling et al analyzes the mode of entry of S. aureus into mammalian cells in culture. The authors propose a novel mechanism of rapid entry that involves the release of calcium from lysosomes via NAADP-stimulated activation of TPC1, which in turn causes lysosomal exocytosis; exocytic release of lysosomal acid sphingomyelinase (ASM) is then envisaged to convert exofacial sphingomyelin to ceramide. These events not only induce the rapid entry of the bacteria into the host cells but are also described to alter the fate of the intracellular S. aureus, facilitating escape from the endocytic vacuole to the cytosol.

      Strengths:

      The proposed mechanism is novel and could have important biological consequences.

      Weaknesses:

      Unfortunately, the evidence provided is unconvincing and insufficient to document the multiple, complex steps suggested. In fact, there appear to be numerous internal inconsistencies that detract from the validity of the conclusions, which were reached mostly based on the use of pharmacological agents of imperfect specificity.

      We thank the reviewer for the detailed evaluation of our manuscript. We will address the criticism below.

      We agree with the reviewer that many of the experiments presented in our study rely on the usage of inhibitors. However, we want to emphasize that the main conclusion (invasion pathway affects the intracellular fate/phagosomal escape) was demonstrated without the use of inhibitors or genetic ablation in two key experiments (Figure4 G/H). These experiments were in line with the results we obtained with inhibitors (amitriptyline [Supp. Figure 4E], ARC39, PCK310, [Figure 4c] and Vacuolin-1 [Supp. Figure4f]). Importantly, the hypothesis was also supported by another key experiment, in which we showed the intracellular fate of bacteria is affected by removal of SM from the plasma membrane before invasion, but not by removal of SM from phagosomal membranes after bacteria internalization (Figure4d-f). Taken together, we thus believe that the main hypothesis is strongly supported by our data.

      Moreover, we either used different inhibitors for the same molecule (ASM was inhibited by ARC39, amitriptyline and PCK310 with similar outcome) or supported our hypothesis with gene-ablated cell pools (TPC1, Syt7, SARM1), as we will point out in more detail below.

      Firstly, the release of calcium from lysosomes is not demonstrated. Localized changes in the immediate vicinity of lysosomes need to be measured to ascertain that these organelles are the source of cytosolic calcium changes. In fact, 9-phenantrol, which the authors find to be the most potent inhibitor of invasion and hence of the putative calcium changes, is not a blocker of lysosomal calcium release but instead blocks plasmalemmal TRPM4 channels. On the other hand, invasion is seemingly independent of external calcium. These findings are inconsistent with each other and point to non-specific effects of 9-phenantrol. The fact that ionomycin decreases invasion efficiency is taken as additional evidence of the importance of lysosomal calcium release. It is not clear how these observations support involvement of lysosomal calcium release and exocytosis; in fact treatment with the ionophore should itself have induced lysosomal exocytosis and stimulated, rather than inhibited invasion. Yet, manipulations that increase and others that decrease cytosolic calcium both inhibited invasion.

      With respect to lysosomal Ca2+ release, we agree with the reviewer that direct visual demonstration of lysosomal Ca2+ release upon infection will improve the manuscript. We therefore will perform additional experimentation to show alterations of Ca2+ at the lysosomes during infection.

      As to the TRPM4 involvement in S. aureus host cell internalization, it has been reported that TRPM4 is activated by cytosolic Ca2+. However, the channel conducts monovalent cations such as K+ or Na+ but is impermeable for Ca2+ 1, 2. The following of our observations are supporting this:

      i) S. aureus invasion is dependent on intracellular Ca2+, but is independent from extracellular Ca2+  (Figure 1c).

      ii) 9-phenantrol treatment reduces S. aureus internalization by host cells, illustrating the dependence of this process on TRPM4 (Figure 1b). We therefore hypothesize that TRPM4 is activated by Ca2+ released from lysosomes (see above).

      TRPM4 is localized to focal adhesions and is connected to actin cytoskeleton3, 4 – a requisite of host cell entry of S. aureus.5, 6 This speaks for an important function of TRPM4 in uptake of S. aureus in general, but does not necessarily have to be involved exclusively in the rapid uptake pathway.

      TRPM4 itself is not permeable for Ca2+ but is activated by the cation.  Thus, it is unlikely to cause lysosomal exocytosis. The stronger bacterial uptake reduction by treatment with 9-phenantrol when compared to Ned19 thus may be caused by the involvement of TRPM4 in additional pathways of S. aureus host cell entry involving that association of TRPM4 with focal adhesions or, as pointed out by the reviewer, unspecific side effects of 9-phenantrol that we currently cannot exclude. We will include this information in the revised manuscript.

      Regarding the reduced S. aureus invasion after ionomycin treatment, we agree with the reviewer that ionomycin is known to lead to lysosomal exocytosis as was previously shown by others7 as well as our laboratory8.

      We hypothesized that pretreatment with ionomycin would trigger lysosomal exocytosis and thus would reduce the pool of lysosomes that can undergo exocytosis before host cells are contacted by S. aureus. As a result, we should observe a marked reduction of S. aureus internalization in such “lysosome-depleted cells”, if the lysosomal exocytosis is coupled to bacterial uptake. Our observation of reduced bacterial internalization after ionomycin treatment supports this hypothesis.

      However, ionomycin treatment and S. aureus infection of host cells are distinct processes.

      While ionomycin results in strong global and non-directional lysosomal exocytosis of all “releasable” lysosomes (~5-10 % of all lysosomes according to previous observations)7, we hypothesize that lysosomal exocytosis upon contact with S. aureus only involves a very small proportion of lysosomes at host-bacteria contact sites.

      Since ionomycin disturbs the overall cellular Ca2+ homeostasis, we agree with the reviewer that this does not directly show lysosomal Ca2+ liberation. We will discuss this in more detail in the revised manuscript.

      The proposed role of NAADP is based on the effects of "knocking out" TPC1 and on the pharmacological effects of Ned-19. It is noteworthy that TPC2, rather than TPC1, is generally believed to be the primary TPC isoform of lysosomes. Moreover, the gene ablation accomplished in the TPC1 "knockouts" is only partial and rather unsatisfactory. Definitive conclusions about the role of TPC1 can only be reached with proper, full knockouts. Even the pharmacological approach is unconvincing because the high doses of Ned-19 used should have blocked both TPC isoforms and presumably precluded invasion. Instead, invasion is reduced by only ≈50%. A much greater inhibition was reported using 9-phenantrol, the blocker of plasmalemmal calcium channels. How is the selective involvement of lysosomal TPC1 channels justified?

      As to partial gene ablation of TPC1: To avoid clonal variances, we usually perform pool sorting to obtain a cell population that predominantly contains cells -here- deficient in TPC1, but also a small proportion of wildtype cells as seen by the residual TPC1 protein on the Western blot. We observe a significant reduction of bacterial uptake in this cell pool suggesting that the uptake reduction in a pure K.O. population may be even larger.

      As to the inhibition by Ned19: We agree with the reviewer that Ned19 inhibits TPC1 and TPC2. Since ablation of TPC1 reduced invasion of S. aureus, we concluded that TPC1 is important for S. aureus host cell invasion. We thus agree with the reviewer that a role for TPC2 cannot be excluded. We will clarify this in the reviewed manuscript. It needs to be noted, however, that deficiency in either TPC1 or TPC2 alone was sufficient to prevent Ebola virus infection9, which is in line with our observations.

      The 50% reduction of invasion upon Ned19 treatment (Figure 1d) is comparable with the reduction caused by other compounds that influence the ASM-dependent pathway (such as amitriptyline, ARC39 [Figure 2c], BAPTA-AM [Figure 1c], Vacuolin-1 [Figure 2a], β-toxin [Figure 2e] and ionomycin [Figure 1a]). Further, the partial reduction of invasion is most likely due to the concurrent activity of multiple internalization pathways which are not all targeted by the used compounds.

      Invoking an elevation of NAADP as the mediator of calcium release requires measurements of the changes in NAADP concentration in response to the bacteria. This was not performed. Instead, the authors analyzed the possible contribution of putative NAADP-generating systems and reported that the most active of these, CD38, was without effect, while the elimination of SARM1, another potential source of NAADP, had a very modest (≈20%) inhibitory effect that may have been due to clonal variation, which was not ruled out. In view of these data, the conclusion that NAADP is involved in the invasion process seems unwarranted.

      Our results from two independent experimental set-ups (Ned19 [Figure 1d] and TPC1 K.O. [Figure 1e & Figure 2f]) indicate the involvement of NAADP in the process. However, the measurement of NAADP concentration is non-trivial. However, we can rule out clonal variation in the SARM1 mutant since experiments were conducted with a cell pool as described above in order to avoid clonal variation of single clones.

      The mechanism behind biosynthesis of NAADP is still debated. CD38 was the first enzyme discovered to possess the ability of producing NAADP. However, it requires acidic pH to produce NAADP10 -which does not match the characteristics of a cytosolic NAADP producer. HeLa cells do not express CD38 and hence, it is not surprising that inhibition of CD38 had no effect on S. aureus invasion in HeLa cells. However, NAADP production by HeLa cells was observed in absence of CD3811. Thus CD38-independent NAADP generation is likely. SARM1 can produce NAADP at neutral pH12 and is expressed in HeLa, thus providing a more promising candidate.

      We agree with the reviewer that the reduction of S. aureus internalization after ablation of SARM1 is less pronounced than in other experiments of ours. This may be explained by NAADP originating from other enzymes, such as the recently discovered DUOX1, DUOX2, NOX1 and NOX213, which – with exception of DUOX2- possess a low expression even in HeLa cells. We will discuss this in the revised manuscript.

      The involvement of lysosomal secretion is, again, predicated largely on the basis of pharmacological evidence. No direct evidence is provided for the insertion of lysosomal components into the plasma membrane, or for the release of lysosomal contents to the medium. Instead, inhibition of lysosomal exocytosis by vacuolin-1 is the sole source of evidence. However, vacuolin-1 is by no means a specific inhibitor of lysosomal secretion: it is now known to act primarily as a PIKfyve inhibitor and to cause massive distortion of the endocytic compartment, including gross swelling of endolysosomes. The modest (20-25%) inhibition observed when using synaptotagmin 7 knockout cells is similarly not convincing proof of the requirement for lysosomal secretion.

      We agree that the manuscript will strongly benefit from a functional analysis of lysosomal exocytosis. We therefore will conduct assays to investigate exocytosis in the revision. However, we previously showed i) by addition of specific antisera that LAMP1 transiently is exposed on the plasma membrane during ionomycin and pore-forming toxin challenge and ii) demonstrated the release of ASM activity into the culture medium under these conditions.8 Both measurements are not compatible with S. aureus infection, since LAMP1 antibodies also are non-specifically bound by protein A and another IgG-binding protein on the S. aureus surface, which would bias the results. Since protein A also serves as an adhesin, we cannot simply delete the ORF without changing other aspects of staphylococcal virulence. Further, FBS contains a ASM background activity that impedes activity measurements of cell culture medium. We previously removed this background activity by a specific heat-inactivation protocol.8 However, S. aureus invasion is strongly reduced in culture medium containing this heat-inactivated FBS.

      We agree with the reviewer that Vacuolin-1 has unspecific side effects. We will address this in the revised version of the manuscript.

      As to the involvement of synaptotagmin 7:

      Synaptotagmin 7 is not the only protein possibly involved in Ca-dependent exocytosis. For instance, SYT1 has been shown to possess an overlapping function.14 This may explain the discrepancy between our vacuolin-1 and SYT7 ablation experiments. We will add an according section to the discussion.

      ASM is proposed to play a central role in the rapid invasion process. As above, most of the evidence offered in this regard is pharmacological and often inconsistent between inhibitors or among cell types. Some drugs affect some of the cells, but not others. It is difficult to reach general conclusions regarding the role of ASM. The argument is made even more complex by the authors' use of exogenous sphingomyelinase (beta-toxin). Pretreatment with the toxin decreased invasion efficiency, a seemingly paradoxical result. Incidentally, the effectiveness of the added toxin is never quantified/validated by directly measuring the generation of ceramide or the disappearance of SM.

      Although pharmacological inhibitors can have unspecific side effects, we want to emphasize that the inhibitors used in our study act on the enzyme ASM by completely different mechanisms. Amitriptyline is a so called functional inhibitor of ASM (FIASMA) which induces the detachment of ASM from lysosomal membranes resulting in degradation of the enzyme.15 By contrast, ARC39 is a competitive inhibitor.16, 17

      We do not see inconsistencies in our data obtained with ASM inhibitors. Amitriptyline and ARC39 both reduce the invasion of S. aureus in HuLEC, HuVEC and HeLa cells (Figure 2c). ARC39 needs a longer pre-incubation, since its uptake by host cells is slower (data not shown). We observe a different outcome in 16HBE14o- and Ea.Hy 926 cells, with 16HBE14o- even demonstrating a slightly increased invasion of S. aureus upon ARC39 treatment. Amitriptyline had no effect (Figure 2c). Moreover, both inhibitors affected the invasion dynamics (Figure 3d), phagosomal escape (Figure 4c and Supp. Figure 4e) and Rab7 recruitment (Figure 4a and Supp. Figure 4b) in a similar fashion. Proper inhibition of ASM by both compounds in all cell lines used was validated by enzyme assays (Supp. Figure 2e), which suggests that the ASM-dependent pathway does only exist in specific cell lines. This also may serve as an argument that we here do not observe unspecific side effects of the compounds. We will clarify this in the revised manuscript.

      ASM is a key player for SM degradation and recycling. In clinical context, deficiency in ASM results in the so-called Niemann Pick disease type A/B. The lipid profile of ASM-deficient cells is massively altered18, which will result in severe side effects. Short-term inhibition by small molecules therefore poses a clear benefit when compared to the usage of ASM K.O. cells.

      As to the treatment with a bacterial sphingomyelinase:

      Treatment with the bacterial SMase (bSMase, here: β-toxin) was performed in two different ways:

      i) Pretreatment of host cells with β-toxin to remove SM from the host cell surface before infection. This removes the substrate of ASM from the cell surface prior to addition of the bacteria (Figure 2e, Figure 4d-f). Since SM is not present on the extracellular plasma membrane leaflet after treatment, a release of ASM cannot cause localized ceramide formation at the sites of lysosomal exocytosis. Similar observations were made by others.19

      ii) Addition of bSMase to host cells together with the bacteria to complement for the absence of ASM (Figure 2f).

      Removal of the ASM substrate before infection (i) prevents localized ASM-mediated conversion of SM to Cer during infection and resulted in a decreased invasion, while addition of the SMase during infection resulted in an increased invasion in TPC1 and SYT7 ablated cells. Thus, both experiments are consistent with each other and in line with our other observations.

      Removal of SM from the plasma membrane by β-toxin was indirectly demonstrated by the absence of Lysenin recruitment to phagosomes/escaped bacteria when host cells were pretreatment with the toxin before infection (Figure4F). In another publication, we recently quantified the effectiveness of β-toxin treatment, even though with slightly longer treatment times (75 min vs. 3h).20 We will repeat the measurements also for shorter treatment times.

      To clarify our experimental approaches to the readership we will add an explanatory section to the revised manuscript.

      As to the general conclusions regarding the role of ASM: ASM and lysosomal exocytosis has been shown to be involved in uptake of a variety of pathogens19, 21-25 supporting its role in the process.

      The use of fluorescent analogs of sphingomyelin and ceramide is not well justified and it is unclear what conclusions can be derived from these observations. Despite the low resolution of the images provided, it appears as if the labeled lipids are largely in endomembrane compartments, where they would presumably be inaccessible to the secreted ASM. Moreover, considering the location of the BODIPY probe, the authors would be unable to distinguish intact sphingomyelin from its breakdown product, ceramide. What can be concluded from these experiments? Incidentally, the authors report only 10% of BODIPY-positive events after 10 min. What are the implications of this finding? That 90% of the invasion events are unrelated to sphingomyelin, ASM, and ceramide?

      During the experiments with fluorescent SM analogues (Figure 3a,b), S. aureus was added to the samples immediately before start of video recording. Hence, bacteria are slowly trickling onto the host cells and we thus can image the initial contact between them and the bacteria, for instance, the bacteria depicted in Figure 3a contact the host cell about 9 min before becoming BODIPY-FL-positive (see Supp. Video 1, 55 min). Hence, we think that in these cases we see the formation of phagosomes around bacteria rather than bacteria in endomembrane compartments. Since generation of phagosomes happens at the plasma membrane, SM is accessible to secreted ASM.

      The “trickling” approach for infection is an experimental difference to our invasion measurements, in which we synchronized the infection by a very slow centrifugation. This ensures that all bacteria have contact to host cells and are not just floating in the culture medium. However, live cell imaging of initial bacterial-host contact and synchronization of infection is technically not combinable.

      In our invasion measurements -with synchronization-, we typically see internalization of ~20% of all added bacteria after 30 min. Hence, most bacteria that are visible in our videos likely are still extracellular and only a small proportion was internalized. This explains why only 10% of total bacteria are positive for BODIPY-FL-SM after 10 min. The proportion of internalized bacteria that are positive for BODIPY-FL-SM should be way higher but cannot be determined with this method.

      We agree with the reviewer that we cannot observe conversion of BODIPY-FL-SM by ASM. In order to do that, we attempted to visualize the conversion of a visible-range SM FRET probe (Supp. Figure 3), but the structure of the probe is not compatible with measurement of conversion on the plasma membrane, since the FITC fluorophore released into the culture medium by the ASM activity thereby gets lost for imaging. In general, the visualization of SM conversion with subcellular resolution is challenging and even with novel tools developed in our lab26 visualization of SM on the plasma membrane is difficult.

      The conclusion we draw from these experiments are that i.) S. aureus invasion is associated with SM and ii.) SM-associated invasion can be very fast, since bacteria are rapidly engulfed by BODIPY-FL-SM containing membranes.

      It is also unclear how the authors can distinguish lysenin entry into ruptured vacuoles from the entry of RFP-CWT, used as a criterion of bacterial escape. Surely the molecular weights of the probes are not sufficiently different to prevent the latter one from traversing the permeabilized membrane until such time that the bacteria escape from the vacuole.

      We here want to clarify that both, the Lysenin as well as the CWT reporter have access to rupture vacuoles (Figure 4b). We used the Lysenin reporter in these experiments for estimation of SM content of phagosomal membranes. If a vacuole is ruptured, both the bacteria and the luminal leaflet of the phagosomal membrane remnants get in contact with the cytosol and hence with the cytosolically expressed reporters YFP-Lysenin as well as RFP-CWT resulting in “Lysenin-positive escape” when phagosomes contained SM (see Figure 4f). By contrast, either β-toxin expression by S. aureus or pre-treatment with the bSMase resulted in absence of Lysenin recruitment suggesting that the phagosomal SM levels were decreased/undetectable (Figure 4f, Supp Figure 5f, g, i, j).

      This approach does not enable a quantitative measurement of phagosomal SM and rather gives a “yes or no” answer. However, we think this method is sufficient to show that β-toxin expression and pretreatment markedly decreased phagosomal SM levels in the host cells.

      The approach we used here to analyze “Lysenin-positive escape” can clearly be distinguished from Lysenin-based methods that were used by others.27 There Lysenin was used to show trans-bilayer movement of SM before rupture of bacteria-containing phagosomes.

      To clarify the function of Lysenin in our approach we will add an additional figure to the revised manuscript.

      Both SMase inhibitors (Figure 4C) and SMase pretreatment increased bacterial escape from the vacuole. The former should prevent SM hydrolysis and formation of ceramide, while the latter treatment should have the exact opposite effects, yet the end result is the same. What can one conclude regarding the need and role of the SMase products in the escape process?

      As pointed out above, pretreatment of host cells with SMase removes SM from the plasma membrane and hence, ASM does not have access to its substrate. Hence, both treatment with either ASM inhibitors or pretreatment with bacterial SMase prevent ASM from being active on the plasma membrane and hence block the ASM-dependent uptake (Figure 2 c, e). Although overall less bacteria were internalized by host cells under these conditions, the bacteria that invaded host cells did so in an ASM-independent manner.

      Since blockage of the ASM-dependent internalization pathway (with ASM inhibitor [Figure 4c], SMase pretreatment [Figure 4e] and Vacuolin-1[Supp. Fig.4f]) always resulted in enhanced phagosomal escape, we conclude that bacteria that were internalized in an ASM-independent fashion cause enhanced escape. Vice versa, bacteria that enter host cells in an ASM-dependent manner demonstrate lower escape rates.

      This is supported by comparing the escape rates of “early” and “late” invaders [Figure 4g/h], which in our opinion is a key experiment that supports this hypothesis. The “early” invaders are predominantly ASM-dependent (see e.g. Figure 3e) and thus, bacteria that entered host cell in the first 10 min of infection should have been internalized predominantly in an ASM-dependent fashion, while slower entry pathways are active later during infection. The early ASM dependent invaders possessed lower escape rates, which is in line with the data obtained with inhibitors (e.g. Figure 4c and Supp. Fig. 4f).

      We hypothesize that the activity of ASM on the plasma membrane during invasion mediates the recruitment of a specific subset of receptors, which then influence downstream phagosomal maturation and escape. This hypothesis is supported by the fact that the subset of receptors interacting with S. aureus is altered upon inhibition of the ASM-dependent uptake pathway. We describe this in another study that is currently under evaluation elsewhere.

      Reviewer #2 (Public review):

      Summary:

      In this manuscript, Ruhling et al propose a rapid uptake pathway that is dependent on lysosomal exocytosis, lysosomal Ca2+ and acid sphingomyelinase, and further suggest that the intracellular trafficking and fate of the pathogen is dictated by the mode of entry.

      The evidence provided is solid, methods used are appropriate and results largely support their conclusions, but can be substantiated further as detailed below. The weakness is a reliance on chemical inhibitors that can be non-specific to delineate critical steps.

      Specific comments:

      A large number of experiments rely on treatment with chemical inhibitors. While this approach is reasonable, many of the inhibitors employed such as amitriptyline and vacuolin1 have other or non-defined cellular targets and pleiotropic effects cannot be ruled out. Given the centrality of ASM for the manuscript, it will be important to replicate some key results with ASM KO cells.

      We thank the reviewer for the critical evaluation of our manuscript and plenty of constructive comments.

      We agree with the reviewer, that ASM inhibitors such as functional inhibitors of ASM (FIASMA) like amitriptyline used in our study have unspecific side effects given their mode-of-action. FIASMAs induce the detachment of ASM from lysosomal membranes resulting in degradation of the enzyme.15  However, we want to emphasize that we also used the competitive inhibitor ARC39 in our study16, 17 which acts on the enzyme by a completely different mechanism. All phenotypes (reduced invasion [Figure 2c, d], effect on invasion dynamics [Figure 3d], enhanced escape [Figure 4c and Supp Figure 4e] and differential recruitment of Rab7 [Supp. Figure 4b]) were observed with both inhibitors thereby supporting the role of ASM in the process.

      We further agree that experiments with genetic evidence usually support and improve scientific findings. However, ASM is a cellular key player for SM degradation and recycling. In a clinical context, deficiency in ASM results in a so-called Niemann Pick disease type A/B. The lipid profile of ASM-deficient cells is massively altered18, which in itself will result in severe side effects. Thus, the usage of inhibitors provides a clear benefit when compared to ASM K.O. cells, since ASM activity can be targeted in a short-term fashion thereby preventing larger alterations in cellular lipid composition.

      Most experiments are done in HeLa cells. Given the pathway is projected as generic, it will be important to further characterize cell type specificity for the process. Some evidence for a similar mechanism in other cell types S. aureus infects, perhaps phagocytic cell type, might be good.

      Whenever possible we performed the experiments not only in HeLa but also in HuLECs. For example, we refer to experiments concerning the role of Ca2+ (Figure 1c/Supp.Figure1e), lysosomal Ca2+/Ned19 (Figure1d/Supp Figure 1g), lysosomal exocytosis/Vacuolin-1 (Figure 2a/Supp. Figure2a), ASM/ARC39 and amitriptyline (Figure 2c), surface SM/β-toxin (Figure 2e/Supp. Figure 2g), analysis of invasion dynamics (complete Figure 3) and measurement of cell death during infection (Figure 5c-e, Supp. Figure 6a+b).

      HuLECs, however, are not really genetically amenable and hence we were not able to generate gene deletions in these cells and upon introduction of the fluorescence escape reporter the cells are not readily growing.

      As to ASM involvement in phagocytic cells: a role for ASM during the uptake of S. aureus by macrophages was previously reported by others.23 However, in professional phagocytes S. aureus does not escape from the phagosome and replicates within the vacuole.28

      I'm a little confused about the role of ASM on the surface. Presumably, it converts SM to ceramide, as the final model suggests. Overexpression of b-toxin results in the near complete absence of SM on phagosomes (having representative images will help appreciate this), but why is phagosomal SM detected at high levels in untreated conditions? If bacteria are engulfed by SM-containing membrane compartments, what role does ASM play on the surface? If surface SM is necessary for phagosomal escape within the cell, do the authors imply that ASM is tuning the surface SM levels to a certain optimal range? Alternatively, can there be additional roles for ASM on the cell surface? Can surface SM levels be visualized (for example, in Figure 4 E, F)?

      We initially hypothesized that we would detect higher phagosomal SM levels upon inhibition of ASM, since our model suggests SM cleavage by ASM on the host cell surface during bacterial cell entry. However, we did not detect any changes in our experiments (Supp. Figure 4d). We currently favor the following explanation: SM is the most abundant sphingolipid in human cells.29 If peripheral lysosomes are exocytosed and thereby release ASM, only a localized and relative small proportion of SM may get converted to Cer, which most likely is below our detection limit. In addition, the detection of cytosolically exposed phagosomal SM by YFP-Lysenin is not quantitative and provides a “Yes or No” measurement. Hence, we think that the rather limited SM to Cer conversion in combination with the high abundance of SM in cellular membranes does not visibly affect the recruitment of the Lysenin reporter.

      In our experiments that employ BODIPY-FL-SM (Figure 3a+b), we cannot distinguish between native SM and downstream metabolites such as Cer. Hence, again we cannot make any assumptions on the extent to which SM is converted on the surface during bacterial internalization. Although our laboratory recently used trifunctional sphingolipid analogs to analyze the SM to Cer conversion20, the visualization of this process on the plasma membrane is currently still challenging.

      Overall, we hypothesize that the localized generation of Cer on the surface by released ASM leads to generation of Cer-enriched platforms. Subsequently, a certain subset of receptors may be recruited to these platforms and influence the uptake process. These platforms are supposed to be very small, which also would explain that we did not detect changes in Lysenin recruitment.

      Related to that, why is ASM activity on the cell surface important? Its role in non-infectious or other contexts can be discussed.

      ASM release by lysosomal exocytosis is implied in plasma membrane repair upon injury. We will this discuss this in the revised version of the manuscript.

      If SM removal is so crucial for uptake, can exocytosis of lysosomes alone provide sufficient ASM for SM removal? How much or to what extent is lysosomal exocytosis enhanced by initial signaling events? Do the authors envisage the early events in their model happening in localized confines of the PM, this can be discussed.

      Ionomycin treatment led to a release of ~10 % of all lysosomes and also increased extracellular ASM activity.7, 8 However, it is currently unclear– to our knowledge -to which extent the released ASM affects surface SM levels. Also, it is unknown which percentage of the lysosomes is released during infection with S. aureus. However, one has to speculate that this will be only a fraction of the “releasable lysosomes” as we assume that the effects (lysosomal Ca2+ liberation, lysosomal exocytosis and ASM activity) are very localized and take place only at host-pathogen contact sites (see also above). In initial experimentation we attempted to visualize the local ASM activity on the cell surface by using a visible range FRET probe (Supp. Fig. 3). Cleavage of the probe by ASM on the surface leads to release of FITC into the cell culture medium which does not contribute a measurable signal at the surface.

      How are inhibitor doses determined? How efficient is the removal of extracellular bacteria at 10 min? It will be good to substantiate the cfu experiments for infectivity with imaging-based methods. Are the roles of TPC1 and TPC2 redundant? If so, why does silencing TPC1 alone result in a decrease in infectivity? For these and other assays, it would be better to show raw values for infectivity. Please show alterations in lysosomal Ca2+ at the doses of inhibitors indicated. Is lysosomal Ca2+ released upon S. aureus binding to the cell surface? Will be good to directly visualize this.

      Concerning the inhibitor concentrations, we either used values established in published studies or recommendations of the suppliers (e.g. 2-APB, Ned19, Vacuolin-1). For ASM inhibitors, we determined proper inhibition of ASM by activity assays. Concentrations of ionomycin resulting in Ca2+ influx and lysosomal exocytosis was determined in earlier studies of our lab.8, 30

      As to the removal of bacteria at 10 min p.i.: Lysostaphin is very efficient for removal of extracellular S. aureus and sterilizes the tissue culture supernatant. It significantly lyses bacteria within a few minutes, as determined by turbidity assays.31

      As to imaging-based infectivity assays: We will add an analysis of imaging-based invasion assays in the revised manuscript.

      Regarding the roles of TPC1 and TPC2: from our data we cannot conclude whether the roles of TPC1 and TPC2 are redundant. One could speculate that since blockage of TPC1 alone is sufficient to reduce internalization of bacteria, that both channels may have distinct roles. On the other hand, there might be a Ca2+ threshold in order to initiate lysosomal exocytosis that can only be attained if TPC1 and TPC2 are activated in parallel. Thus, our observations are in line with another study that shows reduced Ebola virus infection in absence of either TPC1 or TPC2.32

      As to raw CFU counts: whereas the observed effects upon blocking the invasion of S. aureus are stable, the number of internalized bacteria varies between individual biological replicates, for instance, by differences in host cell fitness or growth differences in bacterial cultures, which are prepared freshly for each experiment.

      With respect to visualization of lysosomal Ca2+ release: we agree with the reviewer that direct visual demonstration of lysosomal Ca2+ release upon infection will improve the manuscript. We therefore will perform additional experimentation to show alterations of Ca2+ at the lysosomes during infection.

      The precise identification of cytosolic vs phagosomal bacteria is not very easy to appreciate. The methods section indicates how this distinction is made, but how do the authors deal with partial overlaps and ambiguities generally associated with such analyses? Please show respective images. The number of events (individual bacteria) for the live cell imaging data should be clearly mentioned.

      We apologize for not having sufficiently explained the technology to detect escaped S. aureus. The cytosolic location of S. aureus is indicated by recruitment of RFP-CWT.33 CWT is the cell wall targeting domain of lysostaphin, which efficiently binds to the pentaglycine cross bridge in the peptidoglycan of S. aureus. This reporter is exclusively and homogenously expressed in the host cytosol. Only upon rupture of phagoendosomal membranes the reporter can be recruited to the cell wall of now cytosolically located bacteria. S. aureus mutants, for instance in the agr quorum sensing system, cannot break down the phagosomal membrane in non-professional phagocytes and thus stay unlabeled by the CWT-reporter.33 We will include respective images/movies of escape events and the bacteria numbers for live cell experiments in the revised version of the manuscript.

      In the phagosome maturation experiments, what is the proportion of bacteria in Rab5 or Rab7 compartments at each time point? Will the decreased Rab7 association be accompanied by increased Rab5? Showing raw values and images will help appreciate such differences. Given the expertise and tools available in live cell imaging, can the authors trace Rab5 and Rab7 positive compartment times for the same bacteria?

      We will include the proportion of Rab7-associated bacteria in the revised manuscript. Usually, we observe that Rab5 is only transiently (for a few minutes) present on phagosomes and only afterwards the phagosomes become positive for Rab7. We do not think that a decrease in Rab7-positive phagosomes would increase the proportion of Rab5-positive phagosomes. However, we cannot exclude this hypothesis with our data.

      We can achieve tracing of individual bacteria for recruitment of Rab5/Rab7 only manually, which impedes a quantitative evaluation. However, we will include information that illustrates the consecutive recruitment of the GTPases.

      The results with longer-term infection are interesting. Live cell imaging suggests that ASM-inhibited cells show accelerated phagosomal escape that reduces by 6 hpi. Where are the bacteria at this time point ? Presumably, they should have reached lysosomes. The relationship between cytosolic escape, replication, and host cell death is interesting, but the evidence, as presented is correlative for the populations. Given the use of live cell imaging, can the authors show these events in the same cell?

      We think that most bacteria-containing phagoendosomes should have fused with lysosomes 6 h p.i. as we have previously shown by acidification to pH of 5 and LAMP1 decoration.34

      We will provide images/videos to show the correlation between escape and replication in the revised manuscript.

      Given the inherent heterogeneity in uptake processes and the use of inhibitors in most experiments, the distinction between ASM-dependent and independent pathways might not be as clear-cut as the authors suggest. Some caution here will be good. Can the authors estimate what fraction of intracellular bacteria are taken up ASM-dependent?

      We agree with the reviewer that an overlap between internalization pathways is likely. A clear distinction is therefore certainly non-trivial. Alternative to ASM-dependent and ASM-independent pathways, the ASM activity may also accelerate one or several internalization pathways. We will address this limitation in the revised manuscript. 

      Early in infection (~10 min after contact with the cells), the proportion of bacteria that enter host cells ASM-dependently is relatively high amounting to roughly 75% in HuLEC. After 30 min, this proportion is decreasing to about 50%. We will include this information in the revised version of the manuscript.

      References

      (1) Launay, P. et al. TRPM4 Is a Ca2+-Activated Nonselective Cation Channel Mediating Cell Membrane Depolarization. Cell 109, 397-407 (2002).

      (2) Nilius, B. et al. The Ca<sup>2+</sup>‐activated cation channel TRPM4 is regulated by phosphatidylinositol 4,5‐biphosphate. The EMBO Journal 25, 467-478-478 (2006).

      (3) Cáceres, M. et al. TRPM4 Is a Novel Component of the Adhesome Required for Focal Adhesion Disassembly, Migration and Contractility. PLoS One 10, e0130540 (2015).

      (4) Silva, I., Brunett, M., Cáceres, M. & Cerda, O. TRPM4 modulates focal adhesion-associated calcium signals and dynamics. Biophysical Journal 123, 390a (2024).

      (5) Schlesier, T., Siegmund, A., Rescher, U. & Heilmann, C. Characterization of the Atl-mediated staphylococcal internalization mechanism. International Journal of Medical Microbiology 310, 151463 (2020).

      (6) Jevon, M. et al. Mechanisms of Internalization ofStaphylococcus aureus by Cultured Human Osteoblasts. Infection and Immunity 67, 2677-2681 (1999).

      (7) Rodriguez, A., Webster, P., Ortego, J. & Andrews, N.W. Lysosomes behave as Ca2+-regulated exocytic vesicles in fibroblasts and epithelial cells. J Cell Biol 137, 93-104 (1997).

      (8) Krones & Rühling et al. Staphylococcus aureus alpha-Toxin Induces Acid Sphingomyelinase Release From a Human Endothelial Cell Line. Front Microbiol 12, 694489 (2021).

      (9) Sakurai, Y. et al. Two-pore channels control Ebola virus host cell entry and are drug targets for disease treatment. Science 347, 995-998 (2015).

      (10) Aarhus, R., Graeff, R.M., Dickey, D.M., Walseth, T.F. & Lee, H.C. ADP-ribosyl cyclase and CD38 catalyze the synthesis of a calcium-mobilizing metabolite from NADP. J Biol Chem 270, 30327-30333 (1995).

      (11) Schmid, F., Fliegert, R., Westphal, T., Bauche, A. & Guse, A.H. Nicotinic acid adenine dinucleotide phosphate (NAADP) degradation by alkaline phosphatase. J Biol Chem 287, 32525-32534 (2012).

      (12) Angeletti, C. et al. SARM1 is a multi-functional NAD(P)ase with prominent base exchange activity, all regulated bymultiple physiologically relevant NAD metabolites. iScience 25, 103812 (2022).

      (13) Gu, F. et al. Dual NADPH oxidases DUOX1 and DUOX2 synthesize NAADP and are necessary for Ca(2+) signaling during T cell activation. Sci Signal 14, eabe3800 (2021).

      (14) Schonn, J.-S., Maximov, A., Lao, Y., Südhof, T.C. & Sørensen, J.B. Synaptotagmin-1 and -7 are functionally overlapping Ca<sup>2+</sup> sensors for exocytosis in adrenal chromaffin cells. Proceedings of the National Academy of Sciences 105, 3998-4003 (2008).

      (15) Kornhuber, J. et al. Functional Inhibitors of Acid Sphingomyelinase (FIASMAs): a novel pharmacological group of drugs with broad clinical applications. Cell Physiol Biochem 26, 9-20 (2010).

      (16) Naser, E. et al. Characterization of the small molecule ARC39, a direct and specific inhibitor of acid sphingomyelinase in vitro. J Lipid Res 61, 896-910 (2020).

      (17) Roth, A.G. et al. Potent and selective inhibition of acid sphingomyelinase by bisphosphonates. Angew Chem Int Ed Engl 48, 7560-7563 (2009).

      (18) Schuchman, E.H. & Desnick, R.J. Types A and B Niemann-Pick disease. Mol Genet Metab 120, 27-33 (2017).

      (19) Miller, M.E., Adhikary, S., Kolokoltsov, A.A. & Davey, R.A. Ebolavirus Requires Acid Sphingomyelinase Activity and Plasma Membrane Sphingomyelin for Infection. Journal of Virology 86, 7473-7483 (2012).

      (20) M. Rühling, L.K., F. Wagner, F. Schumacher, D. Wigger, D. A. Helmerich, T. Pfeuffer, R. Elflein, C. Kappe, M. Sauer, C. Arenz, B. Kleuser, T. Rudel, M. Fraunholz, J. Seibel Trifunctional sphingomyelin derivatives enable nanoscale resolution of sphingomyelin turnover in physiological and infection processes via expansion microscopy. Nat Commun accepted in principle (2024).

      (21) Peters, S. et al. Neisseria meningitidis Type IV Pili Trigger Ca(2+)-Dependent Lysosomal Trafficking of the Acid Sphingomyelinase To Enhance Surface Ceramide Levels. Infect Immun 87 (2019).

      (22) Grassmé, H. et al. Acidic sphingomyelinase mediates entry of N. gonorrhoeae into nonphagocytic cells. Cell 91, 605-615 (1997).

      (23) Li, C. et al. Regulation of Staphylococcus aureus Infection of Macrophages by CD44, Reactive Oxygen Species, and Acid Sphingomyelinase. Antioxid Redox Signal 28, 916-934 (2018).

      (24) Fernandes, M.C. et al. Trypanosoma cruzi subverts the sphingomyelinase-mediated plasma membrane repair pathway for cell invasion. J Exp Med 208, 909-921 (2011).

      (25) Luisoni, S. et al. Co-option of Membrane Wounding Enables Virus Penetration into Cells. Cell Host & Microbe 18, 75-85 (2015).

      (26) Rühling, M. et al. Trifunctional sphingomyelin derivatives enable nanoscale resolution of sphingomyelin turnover in physiological and infection processes via expansion microscopy. Nature Communications 15, 7456 (2024).

      (27) Ellison, C.J., Kukulski, W., Boyle, K.B., Munro, S. & Randow, F. Transbilayer Movement of Sphingomyelin Precedes Catastrophic Breakage of Enterobacteria-Containing Vacuoles. Curr Biol 30, 2974-2983 e2976 (2020).

      (28) Moldovan, A. & Fraunholz, M.J. In or out: Phagosomal escape of Staphylococcus aureus. Cell Microbiol 21, e12997 (2019).

      (29) Slotte, J.P. Biological functions of sphingomyelins. Progress in Lipid Research 52, 424-437 (2013).

      (30) Stelzner, K. et al. Intracellular Staphylococcus aureus Perturbs the Host Cell Ca(2+) Homeostasis To Promote Cell Death. mBio 11 (2020).

      (31) Kunz, T.C. et al. The Expandables: Cracking the Staphylococcal Cell Wall for Expansion Microscopy. Front Cell Infect Microbiol 11, 644750 (2021).

      (32) Sakurai, Y. et al. Ebola virus. Two-pore channels control Ebola virus host cell entry and are drug targets for disease treatment. Science 347, 995-998 (2015).

      (33) Grosz, M. et al. Cytoplasmic replication of Staphylococcus aureus upon phagosomal escape triggered by phenol-soluble modulin alpha. Cell Microbiol 16, 451-465 (2014).

      (34) Giese, B. et al. Staphylococcal alpha-toxin is not sufficient to mediate escape from phagolysosomes in upper-airway epithelial cells. Infect Immun 77, 3611-3625 (2009).

    1. Author response:

      Reviewer 1:

      (1) Free energy barriers appear to be very high for a substrate transport process. In Figure 3, the transitions from IF (Inward facing) to OF (Outward facing) state appear to have a barrier of 12 kcal/mol. Other systems with mutant or sodium unbound have even higher barriers. This does not seem consistent with previous studies where transport mechanisms of transporters have been explored using molecular dynamics. 

      First, in Figure 3, the transition from IF to OF state doesn’t have a barrier of 12 kcal/mol. The IFF to OFB transition is almost barrierless, and from OFB to OFF is ~5 kcal/mol, which is also evident in Figure 2.

      If the reviewer was referring to the transition from OFB to IFB states, the barrier is 6.8 kcal/mol (Na+ bound state), and the rate-limiting barrier in the entire sugar transport process (Na+ bound state) is 8.4 kcal/mol, as indicated in Figure 2 and Table 1, which is much lower than the 12 kcal/mol barrier the reviewer mentioned. When the Na+ is unbound, the barrier can be as high as 12 kcal/mol, but it is this high barrier that leads to our conclusion that the Na+ binding is essential for sugar transport, and the 12 kcal/mol barrier indicates an energetically unfavorable sugar translocation process when the Na+ is unbound, which is unlikely to be the major translocation process in nature. 

      Even for the 12 kcal/mol barrier reported for the Na+ unbound state, it is still not too high considering the experimentally measured MelB sugar active transport rate, which is estimated to be on the order of 10 to 100 s-1. This range of transport rate is typical for similar MFS transporters such as the lactose permease (LacY), which has an active transport rate of 20 s-1. The free energy barrier associated with the active transport is thus on the order of ~15-16 kcal/mol based on transition state theory assuming kBT/h as the prefactor. This experimentally estimated barrier is higher than all of our calculated barriers. Our calculated barrier for the sugar translocation with Na+ bound is 8.4 kcal/mol, which means an additional ~7-8 kcal/mol barrier is contributed by the Na+ release process after sugar release in the IFF state. This is a reasonable estimation of the Na+ unbinding barrier.

      Therefore, whether the calculated barrier is too high depends on the experimental kinetics measurements, which are often challenging to perform. Based on the existing experimental data, the MFS transporters are

      usually relatively slow in their active transport cycle. The calculated barrier thus falls within the reasonable range considering the experimentally measured active transport rates.

      (2) Figure 2b: The PMF between images 20-30 shows the conformation change from OF to IF, where the occluded (OC) state is the highest barrier for transition. However, OC state is usually a stable conformation and should be in a local minimum. There should be free energy barriers between OF and OC and in between OC and IF.  

      First, the occluded state (OCB) is not between images 20-30, it is between images 10 to 20. Second, there is no solid evidence that the OCB state is a stable conformation and a local minimum. Existing experimental structures of MFS transporters seldom have the fully occluded state resolved.

      (3) String method pathway is usually not the only transport pathway and alternate lower energy pathways should be explored. The free energy surface looks like it has not deviated from the string pathway. Longer simulations can help in the exploration of lower free energy pathways. 

      We agree with the reviewer that the string method pathway is usually not the only transport pathway and alternate lower energy pathways could exist. However, we also note that even if the fully occluded state is a local minimum and our free energy pathway does visit this missing local minimum after improved sampling, the overall free energy barrier will not be lowered from our current calculated value. This is because the current rate-limiting barrier arises from the transition from the OFB state to the IFF state, and the barrier top corresponds to the sugar molecule passing through the most constricted region in the cytoplasmic region, i.e., the IFC intermediate state visited after the IFB state is reached. Therefore, the free energy difference between the OFB state and the IFC state will not be changed by another hypothetical local minimum between the OFB and IFB states, i.e., the occluded OCB state. In other words, a hypothetical local minimum corresponding to the occluded state, even if it exists, will not decrease the overall rate-limiting barrier and may even increase it further, depending on the depth of the local minimum and the additional barriers of entering and escaping from this new minimum. 

      (4) The conformational change in transporters from OF to IF state is a complicated multi-step process. First, only 10 images in the string pathway are used to capture the transition from OF to IF state. I am not sure is this number is enough to capture the process. Second, the authors have used geodesic interpolation algorithm to generate the intermediate images. However, looking at Figure 3B, it looks like the transition pathway has not captured the occluded (OC) conformation, where the transport tunnel is closed at both the ends. Transporters typically follow a stepwise conformational change mechanism where OF state transitions to OC and then to IF state. It appears that the interpolation algorithm has created a hourglasslike state, where IF gates are opening and OF gates are closing simultaneously thereby creating a state where the transport tunnel is open on both sides of the membrane. These states are usually associated with high energy. References 30-42 cited in the manuscript reveal a distinct OC state for different transporters. 

      In our simulations, even with 10 initial images representing the OF to IF conformational transition, the occluded state is sampled in the final string pathway. There is an ensemble of snapshots where the extracellular and intracellular gates are both relatively narrower than the OF and IF states, preventing the sugar from leaking into either side of the bulk solution. In contrast to the reviewer’s guess, we never observed an hourglass-like state in our simulation where both gates are open. Figure 3B is a visual representation of the backbone structure of the OCB state without explicitly showing the actual radius of the gating region, which also depends on the side chain conformations. Thus, Figure 3B alone cannot be used to conclude that we are dominantly sampling an hourglass-like intermediate conformation instead of the occluded state, as mentioned by the reviewer. 

      Moreover, not all references in 30-42 have sampled the occluded state since many of them did not even simulate the substrate translocation process at all. For the ones that did sample substrate translocation processes, only two of them were studying the cation-coupled MFS family symporter (ref 38, 40) and they didn’t provide the PMF for the entire translocation process. There is no strong evidence for a stable minimum corresponding to a fully occluded state in these two studies.  In fact, different types of transporters with different coupling cations may exhibit different stability of the fully occluded state. For example, the fully occluded state has been experimentally observed for some MFS transporters, such as multidrug transporter EmrD, but not for others, such as lactose permease LacY. Thus, it is not generally true that a stable, fully-occluded state exists in all transporters, and it highly depends on the specific type of transporter and the coupling ion under study. 

      Reviewer 2:

      The manuscript by Liang and Guan provides an impressive attempt to characterize the conformational free energy landscape of a melibiose permease (MelB), a symporter member of major facilitator superfamily (MFS) of transporters. Although similar studies have been conducted previously for other members of MFS, each member or subfamily has its own unique features that make the employment of such methods quite challenging. While the methodology is indeed impressive, characterizing the coupling between large-scale conformational changes and substrate binding in membrane transporters is quite challenging and requires a sophisticated methodology. The conclusions obtained from the three sets of path-optimization and free energy calculations done by the authors are generally supported by the provided data and certainly add to our understanding of how sodium binding facilitates the transport of melibiose in MelB. However, the data is not generated reliably which questions the relevance of the conclusions as well. I particularly have some concerns regarding the implementation of the methodology that I will discuss below. 

      (1) In enhanced sampling techniques, often much attention is given to the sampling algorithm. Although the sampling algorithm is quite important and this manuscript has chosen an excellent pair: string method with swarms of trajectories (SMwST) and replica-exchange umbrella sampling (REUS) for this task, there are other important factors that must be taken into account. More specifically, the collective variables used and the preparation of initial conformations for sampling. I have objectives for both of these (particularly the latter) that I detail below. Overall, I am not confident that the free energy profiles generated (summarized in Figure 5) are reliable, and unfortunately, much of the data presented in this manuscript heavily relies on these free energy profiles. 

      Since comments (1) and (2) from this review are related, please see our response to (2) below. 

      (2) The authors state that they have had an advantage over other similar studies in that they had two endpoints of the string to work from experimental data. I agree that this is an advantage. However, this could lead to some dangerous flaws in the methodology if not appropriately taken into account. Proteins such as membrane transporters have many slow degrees of freedom that can be fully captured within tens of nanoseconds (90 ns was the simulation time used here for the REUS). Biased sampling allows us to overcome this challenge to some extent, but it is virtually impossible to take into account all slow degrees of freedom in the enhanced sampling protocol (e.g., the collective variables used here do not represent anything related to sidechain dynamics). Therefore, if one mixes initial conformations that form different initial structures (e.g., an OF state and an IF state from two different PDB files), it is very likely that despite all equilibration and relaxation during SMwST and REUS simulations, the conformations that come from different sources never truly mix. This is dangerous in that it is quite difficult to detect such inconsistencies and from a theoretical point of view it makes the free energy calculations impossible. Methods such as WHAM and its various offshoots all rely on overlap between neighboring windows to calculate the free energy difference between two windows and the overlap should be in all dimensions and not just the ones that we use for biasing. This is related to well-known issues such as hidden barriers and metastability. If one uses two different structures to generate the initial conformations, then the authors need to show their sampling has been long enough to allow the two sets of conformations to mix and overlap in all dimensions, which is a difficult task to do. 

      We partly agree with the reviewer in that it is challenging to investigate whether the structures generated from the two different initial structures are sufficiently mixed in terms of orthogonal degrees of freedom outside the CV space during our string method and REUS simulations. We acknowledge that our simulations are within 100 ns for each REUS window, and there could be some slow degrees of freedom that are not fully sampled within this timescale. However, the conjectures and concerns raised by the reviewer are somewhat subjective in that they are almost impossible to be completely disproven. In a sense, these concerns are essentially the same as the general suspicion that the biomolecular simulation results are not completely converged, which cannot be fully ruled out for relatively complex biomolecular systems in any computational study involving MD simulations.  We also note that comparison among the PMFs of different cation bound/unbound states will have some error cancellation effects because of the consistent use of the same sampling methods for all three systems. Our main conclusions regarding the cooperative binding and transport of the two substrates lie in such comparison of the PMFs and additionally on the unbiased MD simulations. Thus, although there could be insufficient sampling, our key conclusions based on the relative comparison between the PMFs are more robust and less likely to suffer from insufficient sampling.

      (3) I also have concerns regarding the choice of collective variables. The authors have split the residues in each transmembrane helix into the cyto- and periplasmic sides. Then they have calculated the mass center distance between the cytoplasmic sides of certain pairs of helices and have also done the same for the periplasmic side. Given the shape of a helix, this does not seem to be an ideal choice since rather than the rotational motion of the helix, this captures more the translational motion of the helix. However, the transmembrane helices are more likely to undergo rotational motion than the translational one. 

      Our choice of CVs not only captures the translational motion but also the rotational motion of the helix. Consider a pair of helices. If there is a relative rotation in the angle between the two helices, causing the extracellular halves of the two helices to get closer and the intracellular halves to be more separated, this rotational motion can be captured as the decrease of one CV describing the extracellular distance and increase in the other CV describing the intracellular distance between the two helices. Reversely, if one of the two CVs is forced to increase and the other one forced to decrease, it can, in principle, bias the relative rotation of the two helices with respect to each other. Indeed, comparing Figure 3 with Figure S4, the reorientation of the helices with respect to the membrane normal (Fig. S4) is accompanied by the simultaneous decrease and increase in the pairwise distances between different segments of the helices. Therefore, our choice of CVs in the string method and REUS are not biased against the rotation of the helices, as the reviewer assumed.

      (4) Convergence: String method convergence data does not show strong evidence for convergence (Figure S2) in my opinion. REUS convergence is also not discussed. No information is provided on the exchange rate or overlap between the windows.

      The convergence of string method, REUS, the exchange rate and overlap between windows will be discussed in the reviewed manuscript.

      Reviewer 3:

      The paper from Liang and Guan details the calculation of the potential mean force for the transition between two key states of the melibiose (Mel) transporter MelB. The authors used the string method along with replica-exchange umbrella sampling to model the transition between the outward and inwardfacing Mel-free states, including the binding and subsequent release of Mel. They find a barrier of ~6.8 kcal/mol and an overall free-energy difference of ~6.4 kcal/mol. They also investigate the same process without the co-transported Na+, finding a higher barrier, while in the D59C mutant, the barrier is nearly eliminated.

      For Na+ bound state, the rate-limiting barrier is 8.4 kcal/mol instead of 6.8 kcal/mol. The overall free energy difference is 3.7 kcal/mol instead of 6.4 kcal/mol. These numbers need to be corrected in the public review.

      I found this to be an interesting and technically competent paper. I was disappointed actually to see that the authors didn't try to complete the cycle. I realize this is beyond the scope of the study as presented.

      We agree with the reviewer that characterizing the complete cycle is our eventual goal. However, in order to characterize the complete cycle of the transporter, the free energy landscapes of the Na+ binding and unbinding process in the sugar-bound and unbound states, as well as the OF to IF conformational transition in the apo state. These additional calculations are expensive, and the amount of work devoted to these new calculations is estimated to be at least the same as the current study. Therefore, we prefer to carry out and analyze these new simulations in a future study.  

      The results are in qualitative agreement with expectations from experiments. Could the authors try to make this comparison more quantitative? For example, by determining the diffusivity along the path, the authors could estimate transition rates.

      In our revised manuscript, we will determine the diffusivity along the path and estimate transition rates.

      Relatedly, could the authors comment on how typical concentration gradients of Mel and Na+ would affect these numbers?

      The concentration gradient of Mel and Na+ can be varied in different experimental setups. In a typical active transport essay, the Na+ has a higher concentration outside the cell, and the melibiose has a higher concentration inside the cell. In the steady state, depending on the experiment setup, the extracellular Na+ concentration is in the range of 10-20 mM, and the intracellular concentration is self-balanced in the range of 3-4 mM due to the presence of other ion channels and pumps. In addition to the Na+ concentration gradient, there is also a transmembrane voltage potential of -200 mV (the intracellular side being more negative than the extracellular side), which facilitates the Na+ release into the intracellular side. In the steady state, the extracellular concentration of melibiose is ~0.4 mM, and the intracellular concentration is at least 1000 times the extracellular concentration, greater than 0.4 M. In this scenario, the free energy change of intracellular melibiose translocation will be increased by about ~5 kcal/mol at 300K temperature, leading to a total ∆𝐺 of ~8 kcal/mol. The total barrier for the melibiose translocation is expected to be increased by less than 5 kcal/mol. However, the increase in ∆𝐺 for intracellular melibiose translocation will be compensated by a decrease in ∆𝐺 of similar magnitude ( ~5 kcal/mol) for intracellular Na+ translocation. In a typical sugar self-exchange essay, there is no net gradient in the melibiose or Na+ across the membrane, and the overall free energy changes we calculated apply to this situation.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews: 

      Reviewer #1 (Public Review): 

      In their manuscript "PDGFRRa signaling regulates Srsf3 transcript binding to affect PI3K signaling and endosomal trafficking" Forman and colleagues use iMEPM cells to characterize the effects of PDGF signaling on alternative splicing. They first perform RNA-seq using a one-hour stimulation with Pdgf-AA in control and Srsf3 knockdown cells. While Srsf3 manipulation results in a sizeable number of DE genes, PDGF does not. They then turn to examine alternative splicing, due to findings from this lab. They find that both PDGF and Srsf3 contribute much more to splicing than transcription. They find that the vast majority of PDGF-mediated alternative splicing depends upon Srsf3 activity and that skipped exons are the most common events with PDGF stimulation typically promoting exon skipping in the presence of Srsf3. They used eCLIP to identify RNA regions bound to Srsf3. Under both PDGF conditions, the majority of peaks were in exons with +PDGF having a substantially greater number of these peaks. Interestingly, they find differential enrichment of sequence motifs and GC content in stimulated versus unstimulated cells. They examine 2 transcripts encoding PI3K pathway (enriched in their

      GO analysis) members: Becn1 and Wdr81. They then go on to examine PDGFRRa and Rab5, an endosomal marker, colocalization. They propose a model in which Srsf3 functions downstream of PDGFRRa signaling to, in part, regulate PDGFRa trafficking to the endosome. The findings are novel and shed light on the mechanisms of PDGF signaling and will be broadly of interest. This lab previously identified the importance of PDGF naling on alternative splicing. The combination of RNA-seq and eCLIP is an exceptional way to comprehensively analyze this effect. The results will be of great utility to those studying PDGF signaling or neural crest biology. There are some concerns that should be considered, however. 

      We thank the Reviewer for these supportive comments.

      (1) It took some time to make sense of the number of DE genes across the results section and Figure 1. The authors give the total number of DE genes across Srsf3 control and loss conditions as 1,629 with 1,042 of them overlapping across Pdgf treatment. If the authors would add verbiage to the point that this leaves 1,108 unique genes in the dataset, then the numbers in Figure 1D would instantly make sense. The same applies to PDGF in Figure 1F and the Venn diagrams in Figure 2. 

      We have edited the relevant sentence for Figure 1D as follows: “There was extensive overlap (521 out of 1,108; 47.0%) of Srsf3-dependent DE genes across ligand treatment conditions, resulting in a total of 1,108 unique genes within both datasets (Fig. 1C,D; Fig. S1A).” Similarly, we edited the relevant sentence for Figure 1F as follows: “There was limited overlap (4 out of 47; 8.51%) of PDGF-AA-dependent DE genes across Srsf3 conditions, resulting in a total of 47 unique genes within both datasets (Fig. 1E,F; Fig. S1B).” We edited the relevant sentence for Figure 2B as follows: “There was limited overlap (203 out of 1,705; 11.9%) of Srsf3-dependent alternatively-spliced transcripts across ligand treatment conditions, resulting in a total of 1,705 unique events within both datasets (Fig. 2A,B).” Finally, we edited the relevant sentence for Figure 2D as follows: “There was negligible overlap (9 out of 622; 1.45%) of PDGF-AA-dependent alternatively-spliced transcripts across Srsf3 conditions, resulting in a total of 622 unique events within both datasets (Fig. 2C,D).”

      (2) The percentage of skipped exons in the +DPSI on the righthand side of Figure 2F is not readable.  

      We have moved the label for the percentage of skipped exon events with a +DPSI for the -PDGF-AA vs +PDGF-AA (scramble) alternatively-spliced transcripts in Figure 2E so that it is legible.

      (3) It would be useful to have more information regarding the motif enrichment in Figure 3. What is the extent of enrichment? The authors should also provide a more complete list of enriched motifs, perhaps as a supplement. 

      We have added P values beneath the motifs in Figure 3F and 3G. Further, we have added a new Supplementary Figure, Figure S5, that lists the occurrence of the top 10 most enriched motifs in the unstimulated and, separately, stimulated samples in the eCLIP dataset and in a control dataset, as well as their P values.

      (4) It is unclear what subset of transcripts represent the "overlapping datasets" on lines 280-315. The authors state that there are 149 unique overlapping transcripts, but the Venn diagram shows 270. Also, it seems that the most interesting transcripts are the 233 that show alternative splicing and are bound by Srsf3. Would the results shown in Figure 5 change if the authors focused on these transcripts? 

      The Reviewer is correct that 233 of the alternatively-spliced transcripts had an Srsf3 eCLIP peak, as indicated in Figure 5A. However, several of these eCLIP peaks were a large distance from an alternatively-spliced element in the rMATS datasets, indicating that Srsf3 binding may not be contributing to the splicing outcomes in these cases. Instead, we correlated the eCLIP peaks with AS events by identifying transcripts in which Srsf3 bound within an alternatively-spliced exon or within 250 bp of the neighboring introns. We have added additional text clarifying this point in the Results: “We next sought to identify high-confidence transcripts for which Srsf3 binding had an increased likelihood of contributing to AS. Previous studies revealed enrichment of functional RBP motifs near alternatively-spliced exons (Yee et al., 2019). As such, we correlated the eCLIP peaks with AS events across all four treatment comparisons by identifying transcripts in which Srsf3 bound within an alternatively-spliced exon or within 250 bp of the neighboring introns (Tables S12-S15).” Further, we have relabeled Figure 5B as “Highconfidence, overlapping datasets biological process GO terms”.

      (5) In general, there is little validation of the sequencing results, performing qPCR on Arhgap12 and Cep55. The authors should additionally validate the PI3K pathway members that they analyze. Related, is Becn1 expression downregulated in the absence of Srsf3, as would be predicted if it is undergoing NMD? 

      We have added two new figure panels, Figure 5F-5G, assessing Wdr81 AS and Wdr81 protein sizes, as this gene has previously been implicated in craniofacial development. We have added the following text to the Results section: “Finally, as Wdr81 protein levels are predicted to regulate RTK trafficking between early and late endosomes, we confirmed the differential AS of Wdr81 transcripts between unstimulated scramble cells and scramble cells treated with PDGFAA ligand for 1 hour by qPCR using primers within constitutively-expressed exons flanking alternatively-spliced exon 9. This analysis revealed a decreased PSI for Wdr81 in each of three biological replicates upon PDGF-AA ligand treatment (Fig. 5F). Relatedly, we assessed the ratio of larger isoforms of Wdr81 protein (containing the WD3 domain) to smaller isoforms (missing the WD3 domain) via western blotting. Consistent with our RNA-seq and qPCR results, PDGFAA stimulation for 24 hours in the presence of Srsf3 led to an increase in smaller Wdr81 protein isoforms (Fig. 5G).”

      (6) What is the alternative splicing event for Acap3?  

      We have added the following text to the Results section and updated Figure 5E with Acap3 eCLIP peak visualization and the predicted alternative splicing outcome: “Finally, Acap3 is a GTPase-activating protein (GAP) for the small GTPase Arf6, converting Arf6 to an inactive, GDP-bound state (Miura et al., 2016). Arf6 localizes to the plasma membrane and endosomes, and has been shown to regulate endocytic membrane trafficking by increasing PI(4,5)P2 levels at the cell periphery (D’Souza-Schorey and Chavrier, 2006). Further, constitutive activation of Arf6 leads to upregulation of the gene encoding the p85 regulatory subunit of PI3K and increased activity of both PI3K and AKT (Yoo et al., 2019)… Srsf3 binding was additionally increased in Acap3 exon 19 upon PDGF-AA stimulation, at an enriched motif within the highconfidence, overlapping datasets, and we observed a corresponding increase in excision of adjacent intron 19 (Fig. 5D,E). As Acap3 intron 19 contains a PTC, this event is predicted to result in more transcripts encoding full-length protein (Fig. 5E).”

      (7) The insets in Figure 6 C"-H" are useful but difficult to see due to their small size. Perhaps these could be made as their own figure panels. 

      We have increased the size of the previous insets in new Figure 6 panels C’’’-H’’’.

      (8) In Figure 6A, it is not clear which groups have statistically significant differences. A clearer visualization system should be used. 

      We have added bracket shapes to Figure 6A indicating the statistically significant differences between scramble 0 minutes and scramble 60 minutes, and between scramble 60 minutes and shSrsf3 60 minutes.

      (9) Similarly in Figure 6B, is 15 vs 60 minutes in the shSrsf3 group the only significant difference? Is there a difference between scramble and shSrsf3 at 15 minutes? Is there a difference between 0 and 15 minutes for either group? 

      We have added a bracket shape to Figure 6B indicating the statistically significant difference between shSrsf3 at 15 minutes and shSrsf3 at 60 minutes. No other pairwise comparisons between treatments or timepoints were statistically significantly different.

      Reviewer #2 (Public Review): 

      Summary: 

      This manuscript builds upon the work of a previous study published by the group (Dennison, 2021) to further elucidate the coregulatory axis of Srsf3 and PDGFRa on craniofacial development. The authors in this study investigated the molecular mechanisms by which PDGFRa signaling activates the RNA-binding protein Srsf3 to regulate alternative splicing (AS) and gene expression (GE) necessary for craniofacial development. PDGFRa signaling-mediated Srsf3 phosphorylation drives its translocation into the nucleus and affects binding affinity to different proteins and RNA, but the exact molecular mechanisms were not known. The authors performed RNA sequencing on immortalized mouse embryonic mesenchyme (MEPM) cells treated with shRNA targeting 3' UTR of Srsf3 or scramble shRNA (to probe AS and DE events that are Srsf3 dependent) and with and without PDGF-AA ligand treatment (to probe AS and DE events that are PDGFRa signaling dependent). They found that PDGFRa signaling has more effect on AS than on DE. A matching eCLIP-seq experiment was performed to investigate how Srsf3 binding sites change with and without PDGFRa signaling. 

      Strengths: 

      (1) The work builds well upon the previous data and the authors employ a variety of appropriate techniques to answer their research questions. 

      (2) The authors show that Srsf3 binding pattern within the transcript as well as binding motifs change significantly upon PDGFRa signaling, providing a mechanistic explanation for the significant changes in AS. 

      (3) By combining RNA-seq and eCLIP datasets together, the authors identified a list of genes that are directly bound by Srsf3 and undergo changes in GE and/or AS. Two examples are Becn1 and Wdr81, which are involved in early endosomal trafficking.  We thank the Reviewer for these supportive comments.

      Weaknesses: 

      (1) The authors identify two genes whose AS are directly regulated by Srsf3 and involved in endosomal trafficking; however, they do not validate the differential AS results and whether changes in these genes can affect endosomal trafficking. In Figure 6, they show that PDGFRa signaling is involved in endosome size and Rab5 colocalization, but do not show how Srsf3 and the two genes are involved. 

      We have added two new figure panels, Figure 5F-5G, assessing Wdr81 AS and Wdr81 protein sizes, as this gene has previously been implicated in craniofacial development. We have added the following text to the Results section: “Finally, as Wdr81 protein levels are predicted to regulate RTK trafficking between early and late endosomes, we confirmed the differential AS of Wdr81 transcripts between unstimulated scramble cells and scramble cells treated with PDGFAA ligand for 1 hour by qPCR using primers within constitutively-expressed exons flanking alternatively-spliced exon 9. This analysis revealed a decreased PSI for Wdr81 in each of three biological replicates upon PDGF-AA ligand treatment (Fig. 5F). Relatedly, we assessed the ratio of larger isoforms of Wdr81 protein (containing the WD3 domain) to smaller isoforms (missing the WD3 domain) via western blotting. Consistent with our RNA-seq and qPCR results, PDGFAA stimulation for 24 hours in the presence of Srsf3 led to an increase in smaller Wdr81 protein isoforms (Fig. 5G).” The experiments in Figure 6 compare early endosome size, PDGFRa localization in early endosomes and phospho-Akt levels in response to PDGF-AA stimulation in scramble versus shSrsf3 cells, demonstrating that Srsf3-mediated PDGFRa signaling leads to enlarged early endosomes, retention of PDGFRa in early endosomes and increased downstream phospho-Akt signaling. Though we agree with the Reviewer that functionally linking the AS events to the endosomal phenotype would strengthen our conclusions, these are technically challenging experiments for several reasons. First, this approach has typically relied on tiling oligos against a region of interest to find the optimal sequence. We identified several transcripts that are bound by Srsf3 and undergo alternative splicing upon PDGFRa signaling to potentially contribute to the regulation of PI3K signaling and early endosomal trafficking. We do not expect that these effects are mediated by a single transcript but may instead by mediated by a combination of alternative splicing changes. As such, these experiments would require us to identify and validate multiple splice-switching antisense oligonucleotides (ASOs). Second, ASOs designed against a specific target may not lead to alternative splicing of that target, even in cases of high predicted binding affinities (Scharner et al., 2020, Nucleic Acid Res 48(2), 802816). Third, ASOs have been shown to result in off-target mis-splicing effects, which are hard to predict (Scharner et al., 2020, Nucleic Acid Res 48(2), 802-816). The design of functional ASOs is thus a long-standing challenge in the field, and likely beyond the scope of this manuscript. We have added the following text to the Discussion to highlight this potential future direction: “In the future, it will be worthwhile to attempt to functionally link the AS of transcripts such as Becn1, Wdr81 and/or Acap3 to the endosomal trafficking changes observed above using spliceswitching antisense oligonucleotides (ASOs).”

      (2) The proposed model does not account for other proteins mediating the activation of Srsf3 after Akt phosphorylation. How do we know this is a direct effect (and not a secondary or tertiary effect)? 

      This point is introduced in the Discussion: “Whether phosphorylation of Srsf3 directly influences its binding to target RNAs or acts to modulate Srsf3 protein-protein interactions which then contribute to differential RNA binding remains to be determined, though findings from Schmok et al., 2024 may argue for the latter mechanism. Studies identifying proteins that differentially interact with Srsf3 in response to PDGF-AA ligand stimulation are ongoing and will shed light on these mechanisms…. Again, this shift could be due to loss of RNA binding owing to electrostatic repulsion and/or changes in ribonucleoprotein composition and will be the subject of future studies.” We have added a potential change in Srsf3 protein-protein interactions upon Akt phosphorylation in the model in Figure 6J.

      Reviewer #2 (Recommendations For The Authors): 

      Suggestions: 

      (1) It would strengthen the paper and improve the connection with the other sections of the paper if the authors show: 

      a)  validation of PDGFRa signaling leading to AS of Becn1 and Wdr81 and corresponding changes in protein, and  

      We have added two new figure panels, Figure 5F-5G, assessing Wdr81 AS and Wdr81 protein sizes, as this gene has previously been implicated in craniofacial development. We have added the following text to the Results section: “Finally, as Wdr81 protein levels are predicted to regulate RTK trafficking between early and late endosomes, we confirmed the differential AS of Wdr81 transcripts between unstimulated scramble cells and scramble cells treated with PDGFAA ligand for 1 hour by qPCR using primers within constitutively-expressed exons flanking alternatively-spliced exon 9. This analysis revealed a decreased PSI for Wdr81 in each of three biological replicates upon PDGF-AA ligand treatment (Fig. 5F). Relatedly, we assessed the ratio of larger isoforms of Wdr81 protein (containing the WD3 domain) to smaller isoforms (missing the WD3 domain) via western blotting. Consistent with our RNA-seq and qPCR results, PDGFAA stimulation for 24 hours in the presence of Srsf3 led to an increase in smaller Wdr81 protein isoforms (Fig. 5G).”

      b)  functionally link the AS event(s) to endosomal phenotype using ASOs, etc. 

      Though we agree with the Reviewer that such results would strengthen our conclusions, these are technically challenging experiments for several reasons. First, this approach has typically relied on tiling oligos against a region of interest to find the optimal sequence. We identified several transcripts that are bound by Srsf3 and undergo alternative splicing upon PDGFRa signaling to potentially contribute to the regulation of PI3K signaling and early endosomal trafficking. We do not expect that these effects are mediated by a single transcript but may instead by mediated by a combination of alternative splicing changes. As such, these experiments would require us to identify and validate multiple splice-switching antisense oligonucleotides (ASOs). Second, ASOs designed against a specific target may not lead to alternative splicing of that target, even in cases of high predicted binding affinities (Scharner et al., 2020, Nucleic Acid Res 48(2), 802-816). Third, ASOs have been shown to result in off-target mis-splicing effects, which are hard to predict (Scharner et al., 2020, Nucleic Acid Res 48(2), 802-816). The design of functional ASOs is thus a long-standing challenge in the field, and likely beyond the scope of this manuscript. We have added the following text to the Discussion to highlight this potential future direction: “In the future, it will be worthwhile to attempt to functionally link the AS of transcripts such as Becn1, Wdr81 and/or Acap3 to the endosomal trafficking changes observed above using splice-switching antisense oligonucleotides (ASOs).”

      (2) The Venn diagram in Figure 5A and the description of the analysis the authors did to combine the RNA-seq and eCLIP-seq data are a little confusing. The authors say that they correlated eCLIP peaks with GE or AS events across all four treatment comparisons. The purpose of looking at both datasets was to find genes that are directly bound by Srsf3 and also have significantly affected GE and/or AS. Therefore, the data with and without PDGF-AA should be considered separately. For example, eCLIP peaks in the PDGF-AA condition can be correlated to Srsf3-dependent AS differences (comparing shSrsf3 and scramble) in the -PDGF-AA condition, and eCLIP peaks in the +PDGF-AA condition can be correlated to Srsf3-dependent AS differences in the +PDGF-AA condition. In the Venn diagram and the description, it seems like all comparisons were combined and it is not clear how the data were analyzed.

      As indicated in Figure 5A, 233 of the alternatively-spliced transcripts uniquely found in one of the four treatment comparisons had an Srsf3 eCLIP peak. However, several of these eCLIP peaks were a large distance from an alternatively-spliced element in the rMATS datasets, indicating that Srsf3 binding may not be contributing to the splicing outcomes in these cases. Instead, we correlated the eCLIP peaks with AS events by identifying transcripts in which Srsf3 bound within an alternatively-spliced exon or within 250 bp of the neighboring introns. We have added additional text clarifying this point in the Results: “We next sought to identify highconfidence transcripts for which Srsf3 binding had an increased likelihood of contributing to AS.

      Previous studies revealed enrichment of functional RBP motifs near alternatively-spliced exons (Yee et al., 2019). As such, we correlated the eCLIP peaks with AS events across all four treatment comparisons by identifying transcripts in which Srsf3 bound within an alternativelyspliced exon or within 250 bp of the neighboring introns (Tables S12-S15).” Further, we have relabeled Figure 5B as “High-confidence, overlapping datasets biological process GO terms”. We respectfully disagree with the Reviewer’s suggested comparisons. A comparison of the PDGF-AA eCLIP data with the scramble vs shSrsf3 (-PDGF-AA) data from the list of highconfidence transcripts resulted in only 7 transcripts. Similarly, a comparison of the +PDGF-AA eCLIP data with the scramble vs shSrsf3 (+PDGF-AA) data from the list of high-confidence transcripts resulted in only 14 transcripts. Separate gene ontology analyses of these lists of 7 and 14 transcripts revealed 21 and 40 significant terms for biological process, respectively, the majority of which encompassed one, and never more than two, transcripts. Had we separately examined the -PDGF-AA and +PDGF-AA data, we would not have detected the changes in Becn1, Wdr81 and Acap3 in Figure 5E.

    1. Author response:

      We appreciate the reviewer’s recognition of the strengths of our work as well as their constructive critiques and insightful suggestions for improvement. In this provisional response, we outline how we plan to address the reviewer’s comments in the revised manuscript. 

      (1) Viscosity and surface tension are not accurately measured. 

      We thank the reviewers for bringing up this important point. We are aware that FRAP is not the best method to accurately measure condensate viscoelasticity due to the problems the reviewers and others in the field have pointed out. More accurate methods of measuring fluorescent protein mobility, such as single-molecule tracking or fluorescence correlation spectroscopy, can be used; however, they cannot accurately reflect the time scale dependence of viscoelasticity in the condensate either. Other methods such as rheology and micropipette aspiration that have been used to measure condensate viscoelasticity in vitro are not accessible in living cells yet. Similarly, there is no readily available method to directly measure the surface tension of condensates in live cells. Therefore, we used FRAP and fusion assays to estimate the ratio of surface tension between the two condensates. This ratio was then used to determine the surface tension of the coiled coil condensates in the model after estimating the surface tension for disordered condensate from in vitro measurements (https://doi.org/10.1016/j.bpr.2021.100011). In the revision, we will adjust our FRAP fitting and use condensates with similar sizes to make our FRAP data more accurate. However, based on the large difference we observed for these two condensates, we do not believe these FRAP improvements would change the conclusions. 

      We are also aware that the stokes-einstein relation strictly applies to purely viscous systems. One can apply the generalized Stokes-Einstein relation, which links the diffusion coefficient to the complex viscoelastic modulus of the medium. However, the complex modulus is difficult to determine in cells through live imaging. We thus used the Stokes-Einstein relation to estimate the ratio of effective viscosities, assuming elastic deformations relax faster. In the revision, we will add these assumptions to our discussion. 

      (2) Justification of a Neo-Hookean elasticity model for chromatin. 

      We thank the reviewer for highlighting this important aspect of our work. The observation that the strains R/ξ in our initial model are of the order of 100 is valid and raises questions about the applicability of the Neo-Hookean model. While it is true that at such high strains, the pressure becomes nearly constant (5E/6), our model remains applicable within the range of strains relevant to chromatin, particularly for small droplets where R/ξ values are more moderate. This is explicitly considered in the section “Effect of mechanical heterogeneity on condensate nucleation and growth,” where we also account for heterogeneous mesh sizes correlated with local stiffness. While these points are discussed in the supplementary material, we acknowledge that these details are not clearly presented in the main text, and we will revise the manuscript to explicitly discuss the strain regime and model applicability.

      We agree that varying both the stiffness E and mesh size ξ would provide a more comprehensive understanding of the system, as both parameters are likely affected by experimental perturbations. We will revisit our analysis to incorporate variations in ξ alongside E and discuss the potential effects on our results.

      Furthermore, the stabilization of condensate size by chromatin elasticity arises from the size-dependent pressure exerted by the elastic network, which is a feature of strain-stiffening elastic media rather than a specific property of the Neo-Hookean model. However, we agree that exploring the robustness of our results under alternative elasticity models would strengthen the manuscript. In the revised version, we will analyze additional elasticity models, including strain stiffening and thinning, to evaluate how these might influence our conclusions and to provide a broader context for the predicted growth phases.

      The connection between the nucleation barrier and the cavitation barrier is particularly intriguing. The referenced study (https://doi.org/10.1073/pnas.2102014118) highlights non-linear elastic effects, including breakage and cavitation, which may be relevant in our system. We will explore whether cavitation effects due to elastic confinement play a role in the nucleation dynamics observed here and include a discussion of these mechanisms in the revised manuscript.

      (3) Unclear description of nucleation in the model. 

      We thank the reviewer for pointing out the lack of clarity in our description of nucleation. R_0​ represents the critical radius for nucleation, beyond which droplets grow spontaneously. The nucleation probability p_nuc​ is evaluated at R_0​, which depends on the free energy barrier ΔG, supersaturation S, and the elastic properties of the surrounding medium. We will include a clearer explanation of R_0​, its dependence on parameters, and its role in nucleation in the revised manuscript.

      We ensure that the stiffness is sampled from a truncated normal distribution, preventing negative stiffness values. Sampling is performed at fixed intervals, and we will clarify the protocol to avoid bias and ensure consistency in the simulations.

      Supersaturation S will be defined regarding solute and solvent concentrations, and we will discuss its influence on ΔG and R_0​.

      The dependence of the elastic pressure P_E​ on R_0​, with stiffer surroundings leading to smaller nucleated droplets, will be explicitly clarified. We also agree that Figure S4A may be misleading, as it suggests spatial correlations in stiffness. We will revise the figure and caption to better represent the model assumptions.

      (4) Limited data for the elastic ripening claim.

      We acknowledge the reviewer’s concern regarding the limitation of support for the claim in the current manuscript. We believe our data do indicate elastic ripening. Particularly, the data points very close to zero are not necessarily artifacts of the fitting, as the elastic ripening can be very slow due to small differences in the local stiffness values around the droplets. We have mentioned this at the end of the section “Condensate material properties and chromatin heterogeneity determine the modes of ripening”. We shall revisit these results and remedy this concern with more data and analysis in the revised manuscript. 

      (5) Confusion for dynamic regimes such as "fusion", "ripening", and "diffusion-based" and the problem with using “ripening time” to compare ripening speed.

      We will clear up our definitions of the dynamic regimes and ensure consistent language use. The ripening time was defined as the time it takes per length of droplets to shrink. This way, the size dependence of the absolute ripening time is decoupled and thus can be used to compare the speed of ripening between two condensates. This is not well-explained in our current version. In the revision, we will redefine the normalized ripening time to avoid this confusion. 

      (6) Chromatin should be excluded from the condensates 

      We have data to support that chromatin is excluded from the condensates. We will add the data in the revision. 

      (7) Effect of protein production on the diffusive growth process.

      From the experiment, we do not believe that protein production is a significant source of the diffusive growth because for coiled-coil condensates nucleated with Hotag3 there was little diffusive growth. In the model also, condensates can grow for hours in the absence of protein production, depending on chromatin stiffness and surface tension. We aim to address the effect of protein production on growth in the revised manuscript.

    1. Author response:

      We thank the anonymous very much for dedicating their time to thoroughly review our manuscript. We sincerely appreciate their thoughtful consideration and detailed assessment. Regarding the raised concerns, we acknowledge the importance of exploring the full scope of class IIb microcins, however, we believe that in depth characterization, purification, and in vivo application of the 12 novel compounds goes beyond the scope of this short report and discovery article.

      At the same time, the reviewers acknowledge that the analysis, experimental design, the expression system as well as the performed assays are “sound”, “convincing”, and “corroborated by suitable controls”. In the present manuscript we sought to identify novel antimicrobials and to comprehensively verify their antimicrobial activity in E. coli irrespective of the siderophore-dependent delivery mechanism. Notably, none of the reviewers questioned that we describe new antimicrobials, the characteristics we used to find them, that they are class IIb microcins, or that they do exhibit antimicrobial activity against Gram-negative ESKAPE and plant pathogens.

      We believe that our discovery study can serve as a steppingstone towards the application of bacterially produced antimicrobial compounds to target Gram negative pathogens in numerous plant and animal species, including humans.

    1. Author response:

      Our response to Reviewer #1:

      We appreciate the reviewer’s comments to clarify the strengths and weaknesses of our work. Whether the effect of GM-CSF/IL-3 on the bowel is pro-inflammatory or anti-inflammatory has been controversial. In the present study, we have shown that CD131 mediated a pro-inflammatory effect of GM-CSF on the intestine, which may have worked in synergy with tissue-infiltrating macrophages. While its down-stream signaling has been investigated back and forth, we did not put effort into it. Using macrophage-specific CD131-deficient animals is important to clarify the effects of macrophage-specific CD131 on bowel inflammation. Our present work is indeed incomplete, and we anticipate to work on it further in future research. Concerning the results on human subjects, it is indeed that results from animal experiments were not completely reproduced. We believe that CD131 does have an effect on ulcerative colitis; however, due to the use of biological agents (e.g. anti-TNFs), the need for surgery in the treatment of ulcerative colitis has dramatically decreased and we could not get enough samples to reach a more convincing statistical analysis. Twenty-nine patients shown in the present study were all that received surgical intervention at our center during the past decade, and more human subjects will be needed in future research, possibly from multi-center study.

      Our response to Reviewer #2:

      Many appreciations for the valuable reviewer’s comments and suggestions. We realized that the number of animals per group was not indicated in each figure; in order to clarify the experimental rigor, we have deposited data used to generate the results of the present study in Dryad. Concerning the heterozygous CD131 knock-out animals, we think that others have used the homozygous mice in their studies; however, we observed premature deaths in those animals and we could not get any single homozygous mouse. We could not tell the exact reason, but we did observe robust phenotypes in these heterozygous mice. We do realize that our present work is incomplete, and more experiments need to be done to establish a causal relationship between CD131 and down-stream effects. We anticipate to use macrophage-specific homozygous CD131-deficient mice in our future research, which we believe will produce more meaningful and convincing results.

    1. Author response:

      The following is the authors’ response to the previous reviews.

      Recommendations for the Authors:

      Reviewer #2:

      (1) In my previous review, I noted that using three different movies to conclude that different genres evoke different thought patterns is an overinterpretation with only one instance per genre. In the rebuttal letter, the authors state that they provide "evidence that is necessary but not sufficient to conclude that we can distinguish different genres of films" (page 15). Accordingly, I suggest refraining from statements such as "There was a significant main effect of movie genre on memory" (page 13) in the manuscript.

      Thank you for this point. We have removed any reference to genre.

      Page 18 (referring to page 13) [354-355] “First, there was a significant main effect of movie on memory, F(2, 254.12) = 49.33, p <.001, η2 = .28.”

      Reviewer #3:

      The revised manuscript is easier to read and better contextualized.

      Thank you for this comment and for your feedback to allow us to make the manuscript more clear.

      Public Reviews:

      Reviewer #1:

      The lack of direct interrogation of individual differences/reliability of the mDES scores warrants some pause.

      Our study's goal was to understand how group-level patterns of thought in one group of participants relate to brain activity in a different group of participants. To this end, we decomposed trial-level mDES data to show dimensions that are common across individuals, which demonstrated excellent split-half reliability. Then we used these data in two complementary ways. First, we established that these ratings reliably distinguished between the different films (showing that our approach is sensitive to manipulations of semantic and affective features in a film) and that these group-level patterns were also able to predict patterns of brain activity in a different group of participants (suggesting that mDES dimensions are also sensitive to the way brain activity emerges during movie watching). Second, we established that variation across individuals in their mDES scores predicted their comprehension of information from films. Thus our study establishes that when applied to movie-watching, mDES is sensitive to individual differences in the movie-watching experience (as determined by an individual's comprehension). Given the success of this study and the relative ease with which mDES can be performed, it will be possible in the future to conduct mDES studies that hone in on both the general features of the movie-watching experience, as well as aspects that are more unique to an individual.

      Reviewer #2:

      (1) The distinction between thinking and stimulus processing (in the sense of detecting and assigning meaning to features, modulated by factors such as attention) remains unclear. Is "thinking" a form of conscious access or a reportable read-out from sensory and higher-level stimulus processing? Or does it simply refer to the method used here to identify different processing states?

      Thank you for highlighting this first point, which is an important consideration when attempting to map cognitive states. We have added some additional comments to our discussion section to expand on this point.

      Page 35-36 [698-711] “It is possible, therefore, that the identification of regions of visual and auditory cortex by our study reflects the participants attention to sensory input, rather than the complex analysis of these inputs that may be required for certain features of the movie watching experience. On the other hand, it is possible that the movie-watching state is a qualitatively different type of mental state to those that emerge in typical task situations. For example, unlike tasks, the movie-watching state is characterized by multi-modal sensory input, semantically rich themes, that evolve together to reveal a continuous narrative to the viewer. It is possible, therefore, that movies engender an absorbed state which depends more on processing in sensory cortex than would occur in traditional task paradigms such as a working memory task (when systems in association cortex may be needed to maintain information related to task rules). Important headway into addressing this uncertainty can be achieved by using mDES to compare the types of states that occur in different contexts (including both movies and tasks) and comparing the topography of brain activity associated with different experiential states.”

      (2) The dimensions of thought appear to be directly linked to brain areas traditionally associated with core faculties of perception and cognition. For example, superior temporal cortex codes for speech information, which is also where thought reports on verbal detail localize in this study. This raises the question of whether the present study truly captures mechanisms specific to thinking and distinct from processing, especially given that individual variations in reports were not considered and movie-specific features were not controlled for.

      Thank you for this point, we have added an additional paragraph to the discussion to expand on this.

      Page 35 [692-698] “Finally, it is worth considering whether the patterns of brain activity identified by our analysis reflect the stimuli that are processed during movie watching, or the cognitive and affective processing of this information. On the one hand, the regions we found were often within regions of sensory cortex, areas of the brain which are often ascribed basic stimulus processing functions [1]. Moreover, according to perspectives on cognition derived from more traditional task paradigms, complex features of cognition, such as the regulation of thought, are often attributed to regions of association cortex, such as the dorsolateral prefrontal cortex [2].”

      Reviewer #3:

      This paper is framed as presenting a new paradigm but it does little to discuss what this paradigm serves, what are its limitations and how it should have been tested. The novelty appears to be in using experience sampling from 1 sample to model the responses of a second sample.

      Thank you for this comment, we have since made clear what the novelty of the methodology is, as you have correctly identified, by expanding this point beyond the methods section to clearly orient the reader to the application and limitation of our methodological approach with our paradigm.

      Page 7-8 [149-174] “One challenge that arises when attempting to map the dynamics of thought onto brain activity during movie-watching is accounting for the inherently disruptive nature of experience sampling: to measure experience with sufficient frequency to map experiential reports during movies would inherently disrupt the natural processes of the brain and alter the viewer’s experience (for example, by pausing the film at a moment of suspense). Therefore, if we periodically interrupt viewers to acquire a description of their thoughts while recording brain activity, this could impact on the ability to capture important dynamic features of the brain. On the other hand, if we measured fMRI activity continuously over movie-watching (as is usually the case), we would lack the capacity to directly relate brain signals to the corresponding experiential states. Thus, to overcome these obstacles, we developed a novel methodological approach using two independent samples of participants. In the current study, one set of 120 participants was probed with mDES five times across the three ten-minute movie clips (11 minutes total, no sampling in the first minute). We used a jittered sampling technique where probes were delivered at different intervals across the film for different people depending on the condition they were assigned. Probe orders were also counterbalanced to minimize the systematic impact of prior and later probes at any given sampling moment. We used these data to construct a precise description of the dynamics of experience for every 15 seconds of three ten-minute movie clips. These data were then combined with fMRI data from a different sample of 44 participants who had already watched these clips without experience sampling [3]. By combining data from two different groups of participants, our method allows us to describe the time series of different experiential states (as defined by mDES) and relate these to the time series of brain activity in another set of participants who watched the same films with no interruptions. In this way, our study set out to explicitly understand how the patterns of thoughts that dominate different moments in a film in one group of participants relate to the brain activity at these time points in a second set of participants and, therefore, better understand the contribution of different neural systems to the movie-watching experience.”

      Page 33-35 [658-691] “Importantly, our study provides a novel method for answering these questions and others regarding the brain basis of experiences during films that can be applied simply and cost-effectively. As we have shown, mDES can be combined with existing brain activity, allowing information about both brain activity and experience to be determined at a relatively low cost.  For example, the cost-effective nature of our paradigm makes it an ideal way to explore the relationship between cognition and neural activity during movie-watching during different genres of film. In neuroimaging, conclusions are often made using one film in naturalistic paradigm studies [4]. Although the current study only used three movie clips, restraining our ability to form strong conclusions regarding how different patterns of thought relate to specific genres of film, in the future, it will be possible to map cognition across a more extensive set of movies and discern whether there are specific types of experience that different genres of films engage. One of the major strengths of our approach, therefore, is the ability to map thoughts across groups of participants across a wide range of movies at a relatively low cost.

      Nonetheless, this paradigm is not without limitations. This is the first study, as far as we know, that attempts to compare experiential reports in one sample of participants with brain activity in a second set of participants, and while the utility of this method enables us to understand the relationship between thought and brain activity during movies, it will be important to extend our analysis to mDES data during movie-watching while brain activity is recorded. In addition, our study is correlational in nature, and in the future, it could be useful to generate a more mechanistic understanding of how brain activity maps onto the participants experience. Our analysis shows that mDES is able to discriminate between films, highlighting its broad sensitivity to variation in semantic or affective content. Armed with this knowledge, we propose that in the future, researchers could derive mechanistic insights into how the semantic features may influence the mDES data. For example, it may be possible to ask participants to watch movies in a scrambled order to understand how the structure of semantic or information influences the mapping between brains and ongoing experience as measured by mDES. Finally, our study focused on mapping group-level patterns of experience onto group-level descriptions of brain activity. In the future it may be possible to adopt a “precision-mapping” approach by measuring longer periods of experience using mDES and determining how the neural correlates of experience vary across individuals who watched the same movies while brain activity was collected [5]. In the future, we anticipate that the ease with which our method can be applied to different groups of individuals and different types of media will make it possible to build a more comprehensive and culturally inclusive understanding of the links between brain activity and movie-watching experience.”

      What are the considerations for treating high-order thought patterns that occur during film viewing as stable enough to use across participants? What would be the limitations of this method? (Do all people reading this paper think comparable thoughts reading through the sections?) This is briefly discussed in the revised manuscript and generally treated as an opportunity rather than as a limitation.

      It is likely, based on our study, that films can evoke both stereotyped thought patterns (i.e. thoughts that many people will share) and others that are individualistic. It is clear that, in principle, mDES is capable of capturing empirical information on both stereotypical thoughts and idiosyncratic thoughts. For example, clear differences in experiences across films and, in particular, during specific periods within a film, show that movie-watching can evoke broadly similar thought patterns in different groups of participants (see Figure 3 right-hand panel). On the other hand, the association between comprehension and the different mDES components indicate that certain individuals respond to the same film clip in different ways and that these differences are rooted in objective information (i.e. their memory of an event in a film clip). A clear example of these more idiosyncratic features of movie watching experience can be seen in the association between “Episodic Knowledge” and comprehension. We found that “Episodic Knowledge” was generally high in the romance clip from 500 Days of Summer but was especially high for individuals who performed the best, indicating they remembered the most information. Thus good comprehends responded to the 500 Days of Summer clip with responses that had more evidence of “Episodic Knowledge” In the future, since the mDES approach can account for both stereotyped and idiosyncratic features of experience, it will be an important tool in understanding the common and distinct features that movie watching experiences can have, especially given the cost effective manner with which these studies can be run.  

      In conclusion, this study tackles a highly interesting subject and does it creatively and expertly. It fails to discuss and establish the utility and appropriateness of its proposed method.

      Thank you very much for your feedback and critique. In our revision and our responses to these questions, we provided more information about the method's robustness utility and application to understanding cognition. Thank you for bringing these points to our attention.

      References

      (1) Kaas, J.H. and C.E. Collins, The organization of sensory cortex. Current Opinion in Neurobiology, 2001. 11(4): p. 498-504.

      (2) Turnbull, A., et al., Left dorsolateral prefrontal cortex supports context-dependent prioritisation of off-task thought. Nature Communications, 2019. 10.

      (3) Aliko, S., et al., A naturalistic neuroimaging database for understanding the brain using ecological stimuli. Scientific Data, 2020. 7(1).

      (4) Yang, E., et al., The default network dominates neural responses to evolving movie stories. Nature Communications, 2023. 14(1): p. 4197.

      (5) Gordon, E.M., et al., Precision Functional Mapping of Individual Human Brains. Neuron, 2017. 95(4): p. 791-807.e7.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public Review):

      Summary:

      This paper represents a huge amount of work on a condition whose patients' health and well-being have not always been prioritized, and only relatively recently has the immune dysregulation seen in patients with Down Syndrome (DS) been garnering major research interest.

      This paper provides an unparalleled examination of immune disorders in patients with DS. The authors also report the results from a clinical trial with the JAK inhibitor tofacitinib in DS patients.

      Strengths:

      This manuscript reports a herculean effort and provides an unparalleled examination of immune disorders in a large number of patients with DS.

      Weaknesses:

      Not a major weakness but, apart from finding an elevation of CD4 T central memory cells and more differentiated plasmablast, several of the alterations reported in this manuscript had already been suggested by a few case reports and a very small series. On the other hand, the number of patients (and controls) utilized for this study is remarkable and allows for drawing much firmer conclusions.

      We are grateful for the Reviewer’s very positive assessment of the work and results presented in this manuscript. We agree that many of the changes in the peripheral immune system reported here had been previously documented by our team and others using smaller sample sizes. However, as the Reviewer appreciated, this study involves an order of magnitude more research participants than previous studies (i.e., ~400 total participants, ~300 of them with trisomy 21 versus ~100 controls), which enabled us to investigate associations between immune changes and clinical variables, while also helping us draw much firmer conclusions.

      Reviewer #2 (Public Review):

      In this manuscript, Rachubinski and colleagues provide a comprehensive clinical, immunological, and autoantibody assessment of autoimmune/inflammatory manifestations of patients with Down syndrome (DS) in a large number of patients with this disorder. These analyses confirm prior results of excess interferon and cytokine signals in DS patients and extend these observations to highlight early-onset immunological aberrancies, far before symptoms occur, as well as characterizing novel autoantibody reactivities in this patient population. Then, the authors report the interim analysis of an open-label, Phase II, clinical trial of the JAK1/3 inhibitor, tofacitinib, that aims to define the safety, clinical efficacy, and immunological outcomes of DS patients who suffer from inflammatory conditions of the skin. The clinical trial analysis indicates that the treatment is tolerated without serious adverse effects and that the majority of patients have experienced clinical improvement or remission in their corresponding clinical cutaneous manifestations as well as improvement or normalization of aberrant immunological signals such as cytokines.

      The major strength of the study is the recruitment and uniform, systematic evaluation of an impressive number of DS patients. Moreover, the promising early results from the tofacitinib clinical trial pave the way for analysis of a larger number of patients within the Phase II trial and otherwise, which may lead to improved clinical outcomes for affected patients. An inherent weakness of such studies is the descriptive nature of several parameters and the relatively small size of tofacitinib-treated DS patients. However, the descriptive nature of some of the correlative research analyses is of scientific interest and is useful to generate hypotheses for future additional (including mechanistic) work, and treatment of 10 DS patients in a formal clinical trial at interim analysis is not a trivial task for a disease like this. The manuscript achieves the aims of the authors and the results support their conclusions. The authors appropriately acknowledge areas that require more research and areas that are not well understood. The results are represented in a useful manner and statistical methods and analyses appear sound.

      We appreciate the very positive evaluation by this Reviewer. We agree with the Reviewer on the descriptive nature of many of the analyses completed and on the value of a larger cohort of individuals with Down syndrome treated with a JAK inhibitor. The clinical trial will involve a total of 40 participants, and we look forward to reporting the results from the full cohort in the near future.

      Reviewer #3 (Public Review):

      Summary:

      Individuals with Down syndrome (DS) have high rates of autoimmunity and can have exaggerated immune responses to infection that can unfortunately cause significant medical complications. Prior studies from these authors and others have convincingly demonstrated that individuals with DS have immune dysregulation including increased Type I IFN activity, elevated production of inflammatory cytokines (hypercytokinemia), increased autoantibodies, and populations of dysregulated adaptive immune cells that pre-dispose to autoimmunity. Prior studies have demonstrated that using JAK inhibitors to treat patient samples in vitro, in small case series of patients, and in mouse models of DS leads to improvement of immune phenotype and/or clinical disease. This manuscript provides two major advances in our understanding of immune dysregulation and therapy for patients. First, they perform deep immune phenotyping on several hundred individuals with DS and demonstrate that immune dysregulation is present from infancy. Second, they report a promising interim analysis of a Phase II clinical trial of a JAK inhibitor in 10 people with DS and moderate to severe skin autoimmunity.

      Strengths and weaknesses:

      The relatively large cohort and careful clinical annotation here provide new insights into the immune phenotype of patients with DS. For example, it is interesting that regardless of autoimmune disease or autoantibody status, individuals with DS have elevated cytokines and CRP. Analysis of the cohorts by age demonstrated that some cytokines are significantly elevated in people with DS starting in infancy (e.g., IL-9 and IL-17C). Nearly all adults with DS in this study had autoantibodies (98%) and most had six or more autoantibodies (63%), which differed significantly from euploid study participants. This implies that all patients with DS might benefit from early intervention with therapy to reduce inflammation. However, it is also worth considering that an alternative interpretation that since hypercytokinemia does not vary based on disease state in individuals with DS, this may not be a key factor driving autoimmunity (although it may be relevant for other clinical symptoms such as neuroinflammation).

      Small case series have suggested the benefit of JAK inhibitors to treat autoimmunity in DS. This is the first report of a prospective clinical trial to test a JAK inhibitor in this setting. The clinical trial entry criteria included moderate to severe autoimmune skin disease in patients aged 12-50 years with DS, and treatment was with the JAK1/3 inhibitor tofacitinib. This clinical trial is a critically important step for the field. The early results support that treatment is well tolerated with an improvement of interferon scores in patients and reduction of autoantibodies. Most patients experienced clinical improvement, with alopecia areata having the greatest response. Treatment may not affect all skin diseases equally, for example of the 5 patients with hidradenitis suppurativa, only 1 showed clinical improvement based on skin score. While very promising, the clinical trial results reported here are preliminary and based on an interim analysis of 10 patients at 16 weeks. Individuals with DS have a lifelong risk of immune dysregulation and thus it is unclear how long therapy, if of benefit, would need to be continued. The results of longer-term therapy will be informative when considering the risks/benefits of this therapy.

      We thank the Reviewer for the very positive evaluation. We agree with the Reviewer that the hypercytokinemia of Down syndrome may contribute to other pathophysiological processes beyond autoimmune conditions. Although many cytokines elevated in Down syndrome have well demonstrated pathogenic roles in the etiology of autoimmune diseases in the general population (e.g., TNF-a, IL-6), their consistent upregulation in DS regardless of clinical evidence of autoimmune pathology indicates the existence of a prolonged pre-clinical period, where the hypercytokinemia likely precedes evident tissue damage and symptomology. Alternatively, it is possible that these elevated cytokines are contributing the overall pathophysiology of DS (e.g., neuroinflammation, cognitive impairments, complications from viral infections) without formal diagnosis of an autoimmune disease. We also agree with the Reviewer that not all immune skin conditions would respond equally to JAK inhibition. Based on recent approvals for JAK inhibitors in the immunodermatology field, it is expected that JAK inhibition would show the greatest benefits for alopecia areata, atopic dermatitis, and psoriasis, with less clear results for hidradenitis suppurativa. We hope to contribute to this field through the analysis of the full clinical trial cohort in the near future. Lastly, we strongly agree with the need to assess the value of long-term therapy with JAK inhibitors or other immune therapies in people with Down syndrome for various clinical endpoints.

      Recommendations for the authors:

      Reviewer #1 (Recommendations For The Authors):

      This paper represents a huge amount of work on a condition whose patients' health and well-being have not always been prioritized, and only relatively recently has the immune dysregulation seen in patients with Down Syndrome (DS) been garnering major research interest.

      This paper provides an unparalleled examination of immune disorder in patients with DS. In a truly herculean effort, the authors provided the cumulative examination of over 440 patients with DS, confirmed the alterations in immune cell subsets (n=292, 96 controls) and multi-organ autoimmunity seen in these patients as they age, and identified autoantibody production that could contribute to conditions co-occurring in patients with DS. They also sought to look at whether the early immunosenescence seen in DS was due to the inflammatory profile by comparing age-associated markers in DS patients and euploid controls separately, finding that several markers are regulated with age regardless of group, while comparing the effect of age versus DS status on cytokine status identified inflammatory markers elevated in DS patients across the lifespan that do not increase with age or that increase with age only in the DS cohort. This is very interesting in the context of DS in particular, and immunity during aging in general.

      The second part of the manuscript presents the results from a clinical trial with the JAK inhibitor tofacitinib in DS patients. While the number of DS patients treated with tofacitinib was small, the results were often quite striking. Treatment was well-tolerated and the improvement of dermatological conditions was clear. The less responsive patients AA4 and AA2 provide a very clear illustration that these patients are sensitive to immune triggers during treatment. Additionally, the demonstration that patients' IFN scores and cytokine levels decreased without clear immunosuppression with tofacitinib treatment is encouraging, since treatment with this drug would need to be continuous. I would be curious to see if the patients added past the cutoff for interim analysis follow a similar trajectory. I would not ask the authors to add any data; the paper is well-written and logically constructed.

      I only have a small comment: I really did not like how Figure 2 a, d, and g tethered the coloring to the magnitude of fold change to show the effect of DS particularly for 2a and 2g. Given that these fold changes are quite modest, the coloring is very light and hard to distinguish. The clear takeaway is that the effect on T cells is greatest, but there must be a better way to illustrate this. Perhaps displaying this graph on a non-white background could help with contrast.

      We are grateful for the Reviewer’s very positive assessment of the manuscript and constructive feedback. We want to assure the Reviewer that similar analyses will be completed in the future for the entire cohort recruited into the trial to determine if similar trajectories and results are observed with the larger sample size. Additionally, following Reviewer’s guidance, we have modified the color scales in Figures 2a, d and g so that each panel is on its own dynamic range, thus emphasizing the differences within each immune cell lineage.

      Reviewer #2 (Recommendations For The Authors):

      • Although the focus of the patients in the first part of the paper is on autoimmune/inflammatory conditions, it will be useful to also list the non-autoimmune infectious manifestations for reference with prevalence data. For example, otitis media, or lung infections (mentioned within the paper), or mucosal candidiasis. Same for other manifestations such as cardiac or malignant conditions. Given the impressive number of patients, it will be useful to the readers to have prevalence data for these as well, even in brief statements within the results.

      We appreciate this inquiry by the Reviewer. Following Reviewer’s guidance, we have included information on recurrent otitis media, frequent/recurrent pneumonia, congenital heart defects requiring repair, and various forms of leukemia. These additional data are presented in a revised Supplementary file 1 and briefly discussed in the results.

      • Have the authors looked at DN T cells and whether they may be enriched in DS patients, given their enrichment in some autoimmune conditions?

      Thanks for this inquiry. We did examine DN T cells (double negative T cells), which we referred to in our Figure 2 and Figure 2 – figure supplement 1 as non-CD4+ CD8+ T cells. Although this T cell subset is mildly elevated (in terms of frequency among T cells) in individuals with Down syndrome, the result did not reach statistical significance after multiple hypothesis correction. This negative result is shown in the heatmap in Figure 2 – figure supplement 1d.

      • It would be useful to move the segment of the discussion that discusses the interim predefined analysis of the phase 2 trial to the corresponding segment of the results. As this reviewer was reading the paper, it was unclear why the interim analysis was done, whether it was predefined and it was not until the discussion that it became apparent. I believe it will help the readers to have a brief mention that this interim analysis was predefined and set to occur at the first 10 DS enrollees. Also, it would be helpful to state what is the total number of DS patients planned for enrollment in the Phase 2 trial which is continuing recruitment.

      We appreciate this comment. Following the Reviewer’s guidance, we have revised the text to explain in the Results section that the interim analysis was predefined and triggered once the first 10 participants completed the 16 weeks of treatment. We also explain that the trial will be considered complete once a total of 40 participants undergo 16-weeks of treatment.

      • Although the authors present data on TPO autoantibodies before and after tofacitinib, it remains unclear whether the other non-TPO autoantibodies were altered during treatment or whether this was a TPO autoantibody-specific phenomenon. Was there an alteration in mature B cells or plasmablast populations after tofacitinib? If these data are available, they would further enhance the manuscript. If they are not available, it would be useful for the authors to discuss those in the discussion of the manuscript.

      We are grateful for this comment, which strongly aligns with our future research interests and plans for the analysis of the full cohort once the trial is completed. In the interim analysis, we analyzed only auto-antibodies related to autoimmune thyroid disease and celiac disease, as shown in the manuscript. However, we plan to complete a more comprehensive analysis of the effects of JAK inhibition on autoantibody production once the full sample set is available at the end of the trial. Likewise, the clinical trial protocol contemplates collection and processing of blood samples for immune mapping using mass cytometry, which will enable us to answer the question from the Reviewer about potential changes in B cells or plasmablast populations. Following Reviewer’s guidance, we discuss these planned analyses in the Discussion of the revised manuscript.

      Reviewer #3 (Recommendations For The Authors):

      (1) Cellular immune phenotyping data in Figure 2 presents a large number of patients with DS versus euploid controls (292 and 96 respectively). Given the relatively large cohort there would seem to be an opportunity to determine whether age or sex alters the immune phenotype shown, for example, TEMRAs, etc. Was the data analyzed in this way?

      We welcome this comment, which clearly aligns with our research interests and planned additional analyses of these datasets generated by the Human Trisome Project. We can share with the Reviewer that although sex as a biological variable has minimal impacts on the strong immune dysregulation observed in Down syndrome, there are clear age-dependent effects, with some immune changes occurring early during childhood versus others taking place later in adult life. A manuscript describing a complete analysis of age-dependent effects on the multi-omics datasets in the Human Trisome Project is currently under preparation.

      (2) The authors should strongly consider incorporating/discussing the findings from Gansa et al, Journal of Clinical Immunology May 2024 - where they reviewed the immune phenotype of 1299 patients with Down syndrome.

      Thanks for this publication to our attention, which is not cited in the revised manuscript.

      (3) It is difficult to differentiate patients Hs2 and Ps1 in Figure 5d.

      Thanks for this observation, we have modified the labels for greater clarity in the revised manuscript.

      (4) Given their finding of no correlation between cytokine levels/immune phenotype and autoimmunity, some additional discussion of the relevance of hypercytokinemia in the pathogenesis of autoimmunity would seem relevant (given that this was the basis for the clinical trial). The authors mention that cytokine levels may not be appropriate measures of disease in the patients.

      We welcome this suggestion and have revised the Discussion along these lines.

      (5) Data availability statement: appropriate.

    1. Author response:

      The following is the authors’ response to the original reviews.

      We greatly appreciate the opportunity to submit a revision of our manuscript entitled: "The Autophagy Protein, ATG14 Safeguards Against Unscheduled Pyroptosis Activation to Enable Embryo Transport During Early Pregnancy" by Popli et al. We thank all three Referees for underscoring the importance of our findings as well as the constructive critiques that we used to improve our paper. Most notably, we added the following new data:

      · To provide more insight into whether pyroptosis activation occurs distinctly in the oviduct, we looked for GSDMD, (primary executioner of the pyroptosis pathway) expression in the uterus and ovary too. We observed no signs of pyroptosis activation in response to ATG14 loss in either the uterus or ovary of Atg14 cKO mice compared to control ones suggesting that ATG14 plays a distinct role in regulating pyroptosis specifically in the oviduct (Revised Figure 5F).

      · To better understand the molecular mechanisms of pyroptosis activation in the oviducts, we examined various key markers of mitochondrial integrity, architecture, and function in control and Atg14 cKO oviducts. Our findings indicate a significant loss of mitochondrial structural and functional integrity, possibly contributing to the embryo retention phenotype via activating the pyroptosis pathway in the oviduct. (Revised Figure 5B & C).

      · To address the spatiotemporal and region-specific expression of ATG14 in the oviduct, we performed immunofluorescence analysis and observed the consistent expression of ATG14 in all the cellular compartments of oviducts including ciliary epithelial cells, secretory epithelial cells, and smooth muscle cells. Moreover, the region-specific expression analysis revealed that distinct expression of ATG14 in the ampullary region of cKO mice oviduct helps to preserve its structural integrity. Conversely, its loss in the isthmus region of the oviduct in concordance with active PR-cre activity causes completely distorted epithelial structures with luminal obliteration or narrowing resulting in an unorganized and obstructed lumen leading to embryo retention, suggesting that ATG14 is essential for maintaining the structural integrity of the oviduct (Revised Figure 3F & S2A).

      · Considering the expression of PR-cre in the pituitary, which could potentially influence hormonal secretion and ovulation, we evaluated the levels of E2 and P4 during pregnancy. Our findings show that these hormone levels remained unchanged in Atg14 cKO mice, indicating that the absence of ATG14 does not negatively affect the HPG axis or pituitary function (Revised Figure 2F).

      · ATG14 is an essential factor for the initiation of autophagy, and its loss can lead to reduced or inhibited autophagic activity. Consistently, we observed elevated levels of LC3b and p62 proteins, two well-known markers of autophagic flux in the oviducts of Atg14-deficient mice implying that loss of ATG14 leads to defective autophagy potentially disturbing the structural integrity of oviductal epithelial cells and impairing embryo transport. (New Supplementary Figure S2B).   

      Reviewer #1 (Public Review):

      This study by Popli et al. evaluated the function of Atg14, an autophagy protein, in reproductive function using a conditional knockout mouse model. The authors showed that female mice lacking Atg14 were infertile partly due to defective embryo transport function of the oviduct and faulty uterine receptivity and decidualization using PgrCre/+; Atg14f/f mice. The findings from this work are exciting and novel. The authors demonstrated that a loss of Atg14 led to an excessive pyroptosis in the oviductal epithelial cells that compromises cellular integrity and structure, impeding the transport function of the oviduct. In addition, the authors use both genetic and pharmacological approaches to test the hypothesis. Therefore, the findings from this study are high-impact and likely reproducible. However, there are multiple major concerns that need to be addressed to improve the quality of the work.

      Major comments:

      (1) It is interesting that deletion of Atg14 using PgrCre results in pyroptosis only in the oviduct; the authors should speculate/evaluate why the oviduct, but not the uterus or follicles. Is there any cellular specificity that is sensitive to autophagy/pyroptosis in the oviduct but not in other cell types? This has not been evaluated or discussed in the manuscript. Is it possible to include GSDMD IHC for the uterine section to ensure that there was no pyroptosis event in the cKO uteri?

      We performed GSDMD IHC and found that, unlike in the oviduct, the cKO uteri and ovaries do not exhibit detectable pyroptosis (Revised Figure 5F). Additionally, we have added text to the discussion section addressing possible reasons for the differential impact of Atg14 loss on pyroptosis along the reproductive tract continuum (Line number: 532-538)

      (2) Please include an explanation of how a loss of Atg14, important for the initiation process of autophagy (as indicated in line 88), can lead to pyroptosis. There was some discussion about inflammation. But the connection is still missing.

      We thank the reviewer for noting on this. We have now included a possible explanation of how autophagy could impact pyroptosis in the discussion section (Line number: 532-538)  

      (3) No expression data of ATG14 using IHC/IF analysis were included in the manuscript - this is missing. This is needed and important as the authors found that Foxj1Cre/+; Atg14f/f cKO mice had no fertility defect. Is it possible that ATG14 is not present in the ciliated epithelial cells of the oviduct? In addition, the data in Figure 5B also points to this speculation. This is because the GSDMD (the pyroptosis marker) is only observed in the isthmus region but not the ampulla.

      We thank the reviewer for this nice suggestion. We performed the immunofluorescence analysis for ATG14 expression in control and Atg14 cKO oviducts and observed the consistent expression of ATG14 in all the cellular compartments of oviducts including ciliary epithelial cells, secretory epithelial cells, and smooth muscle cells (New Supplementary Figure S2A). We also looked for α-tubulin expressions in the oviduct of Foxj1Cre/+; Atg14 f/f mice and control mice and observed that ciliated epithelial cells that were positive for acetylated α-tubulin staining did not appear to be different in Foxj1Cre/+; Atg14 f/f mice oviduct compared to controls (Revised Figure 4C). However, due to the unavailability of reliable fluorescent-labeled antibodies for both Foxj1 and Atg14, we were unable to conduct the co-localization study as intended. This limitation hindered our ability to precisely determine the spatial overlap of these proteins within the tissue.

      (4) In line with the previous comment, is ATG14 present in the human Fallopian tube? If so, which cell type? This needs to be addressed.

      Author’s Response: We appreciate the reviewer's valuable suggestion. While we currently lack access to human fallopian tube biopsies, the Human Protein Atlas (https://www.proteinatlas.org/ENSG00000126775-ATG14) demonstrates distinct ATG14 expression in various fallopian tube cell types, with localization in the cytoplasm, membrane, and nucleus.

      (5) As PgrCre is also expressed in the pituitary, is it possible that the deletion of Atg14 using PgrCre would affect pituitary function – hence a change in the FSH/LH secretion that subsequently affects ovulation? Although the uterine and ovarian histology in the Atg14 cKO looks similar to the controls, is it possible that cyclicity is also affected? The authors should evaluate whether the estrous cycle takes place regularly.

      Author’s Response: Thank you for the insightful comment. However, evaluating the estrous cycle requires significant time and effort and is beyond the scope of the current manuscript. Nonetheless, we have now shown that both P4 and E2 levels were not altered in Atg14 cKO mice, indicating that the loss of Atg14 did not adversely impact the HPG axis, and by extension, pituitary function (Revised Figure 2F).

      (6) The number of total embryos/oocytes in the cKO compared to the control has not been evaluated - this data must be included. Do the changes in autophagy in Atg14 cKO affect preimplantation embryo development? Please categorize the embryos found in the oviduct/uterus in both genotypes. i.e., % blastocyst, % morula, % developmentally delayed, % non-viable etc. It would be interesting to evaluate if the oviduct with heavy pyroptosis can support preimplantation embryo development.

      Author’s Response: We thank the reviewer for this nice suggestion. We categorized the embryos into different categories as suggested and included the data (Revised Figure 3C and Figure 6D).

      (7) It is unclear why the superovulation+mating experiment (Figure 3C) was performed. Please provide justification. Why was the data from natural mating (Figure 3A) insufficient?

      Author’s Response: In Figure 3C, superovulation was employed to complement the natural mating studies and to provide stronger evidence for the embryo retention phenotype observed in the oviduct.

      (8) In lines 297-298, the conclusion that "ATG14 is required for P4-mediated but not for E2-mediated actions during uterine receptivity" is not entirely correct. This is because the authors also observed that the downregulation of MUC1 (E2-target protein) is absent in the PgrCre/+;Atg14f/f cKO female uteri.

      We thank the reviewer for noting this. We detected more E2-induced targets in D-4 pregnant uterine samples and found no change in their expression in response to Atg14 depletion in cKO females (Revised Figure 2E).

      (9) Figure 3D: Please include an image that also represents the ampulla region. All images are from the isthmus region. It would be informative to see if the loss of cell boundaries also takes place at the ampulla region in the cKO oviduct.

      We thank the reviewer for this nice suggestion. We included the ampulla section from the cKO and control female oviducts (Revised Figure 3F). As PR-cre activity is limited to isthmus only [1, 2], we did not see any structural abnormality in ampulla sections of cKO oviducts.

      (10) Figure 3E: Please indicate which region the TEM was performed. Isthmus? Ampulla? Were the changes in mitochondrial phenotype observed across all oviductal regions?

      The TEM imaging was performed by the WashU Core services. Although we clearly mentioned the core person to look into the isthmus region only, we are not sure if they accurately follow the instructions.

      (11) Figure 4B; the evaluation of FOXJ1 IHC. The authors need to include sections that also have an ampulla region-especially in the cKO. In addition, it is misleading to state that there were fewer FOXJ1+ cells (line 361) in the cKO if the region being evaluated is the isthmus (which has a lot fewer ciliated epithelial cells in general) while the control image showed an ampulla where the abundancy of ciliated epithelial cells (FOXJ1+) is higher than that of the isthmus. The authors also need to include a higher resolution image (a zoom-in at the ciliated epithelial cells with FOXJ1+ signal) as well as the quantification of FOXJ1+ cells.

      We appreciate the reviewer for the suggestion. In Figure 4A, we have already shown the ampulla region from both control and cKO oviducts, wherein alpha-tubulin staining was evident in both oviducts.  

      We agree with the reviewer that the isthmus usually has fewer ciliary epithelial cells than the ampulla, however, as illustrated in Figures 4A and 4B, Atg14 depletion causes a marked disruption of structural integrity with loss of cell boundaries specifically in the isthmus, which is far more pronounced than in the ampulla. One reason for this is the reported Pgr Cre activity, which is much more robust in the isthmus than in the ampulla [1, 2] . This disruption leads to the substantial loss of both ciliated and secretory cells, compromising the epithelial architecture to such an extent that it is impossible to accurately quantify the Foxj1 signal as can be seen in higher resolution images in New Supplementary Figure S3.

      For more clarity, we modified the statement in the revised file (Line Number: 393-396)

      (12) All IHC/IF and embryo images need to include the scale bars.

      We thank the reviewer for this suggestion. We now included the scale bar in all the images.

      (13) Figure 5H: although IL1B is being discussed, there was no data in this study to support the figure.

      In Figure 5H, IL1B is presented as part of the pyroptosis signaling pathway. As we have already shown other key executioners of this pathway: Caspase 1 and GSDMD, we believe that additional IL1B data would not provide new insights beyond what has already been shown.

      Minor comments:

      (1) Please include n (sample size) for all data, including the histology image in the figure legends for all studies.

      We now included the sample size in figure legends for all data shown in the manuscript.

      (2) Line 32, did the authors mean to say, "Self-digestion of..." instead of "Self-digestion for..."?

      In Line 32, we meant, “Cellular self-digestion for female reproductive tract functions”. We have now corrected the statement.

      Fig. 1A - please include negative control.

      We included the negative control (Revised Figure 1)

      (3) Figure 1E left panel and Figure 4C - please label "Average no. of pups/female/litter" as each female has more than one litter over her reproductive lifespan. If the authors represent pups/females, then the number should be accumulative in the range of 35-40pups/females in the control group.

      We thank the reviewer for noting this. We now corrected the label in both Revised Figure 1E and Revised Figure 4E.

      (4) Line 273: please remove "& F" as there is no Figure F in the image.

      We removed “&F” from the Line 273.

      (5) The presence of CL is not always indicative of normal hormonal levels; therefore, the authors should include the measurement of progesterone levels at 3.5 dpc in the cKO compared to the control group. Hormonal regulation is also crucial for embryo transport.

      We thank the reviewer for this suggestion. We measured not only P4 but also E2 levels in D4 pregnant females and found no significant difference in their levels compared to corresponding controls (Revised Figure 2F).

      (6) Figure 2A shows that KRT expression is not present in the control uteri. Although the KRT8 levels may have decreased at 4 dpc, they should be present (see Figure S2A).

      We observed no decrease in KRT expression in control uteri on 5 dpc. We included better-resolution images for KRT expression (Revised Figure 2A).

      (7) The dotted white lines in Figure 2A are too thick. It's difficult to see the Ki67 positive signal in the luminal epithelial cells. Please also add a quantitative analysis of Ki67+ cells in the luminal epithelium vs. stromal cells.

      We now corrected the dotted lines in Revised Figure 2B. However, as the Ki-67 proliferation is evident in the representative images, we believe quantification analysis will not add anything new to the existing conclusion.

      (8) Figure 2D - the y-axis mentions the weight ratio. However, the figure legend describes the transcript levels of Atg14 - please correct this.

      We corrected the label in the revised manuscript.

      (9) Line 294 - Please correct Figure 2C to Figure 2B.

      We corrected it.

      (10) Line 308 - Please correct Figure 2E to Figure 2F.

      We corrected it.

      (11) Line 310 - Please correct Figure 2F to Figure 2G.

      We corrected it.

      (12) Line 311 - Please correct Figure 2F to Figure 2G.

      We corrected it.

      (13) Information in Figure S2A and S2B should be included in the main figure.

      We thank the reviewer for this nice suggestion. We now included the figures S2A and S2B in the main figure (Revised Figure 2C & D).

      (14) Figure 3C - due to a lot of cellular debris after flushing, it's difficult to see. But it seems like there are secondary follicles in the flushing of control oviducts - this is highly unlikely. This could be due to an artifact of an accidental poking of the ovaries during collection.

      We agree with the reviewer. It might be due to the unintentional poking of the ovaries. We will take extra care in future experiments to avoid this and ensure clean flushing to prevent any confusion from debris or artifacts.

      (15) Figure 2B and Figure 3D signals from DAPI are missing - it's black with no blue signal. This could be the data loss during file compression for manuscript submission.

      We included better-resolution pictures for the DAPI signal in Revised Figure 2B & Figure 3F.

      (16) Explain why some embryos in the cKO make it to the uterus when the females are superovulated.

      It might be due to the heightened hormonal stimulation provided by the superovulation which could facilitate the movement of some embryos through the oviduct despite any defects or abnormalities caused by the loss of ATG14 in the oviduct.

      Reviewer #2 (Public Review):

      Summary:

      In this manuscript, Popli et al investigated the roles of the autophagy-related gene, Atg14, in the female reproductive tract (FRT) using conditional knockout mouse models. By ablation of Atg14 in both oviduct and uterus with PR-Cre (Atg14 cKO), the authors discovered that such females are completely infertile. They went on to show that Atg14 cKO females have impaired embryo implantation and uterus receptivity due to impaired response to P4 stimulation and stromal decidualization. In addition to the uterus defect, the authors also discovered that early embryos are trapped inside the oviduct and cannot be efficiently transported to the uterus in these females. They went on to show that oviduct epithelium in Atg14 cKO females showed increased pyroptosis, which disrupts oviduct epithelial integrity and leads to obstructive oviduct lumen and impaired embryo transport. Therefore, the authors concluded that autophagy is critical for maintaining the oviduct homeostasis and keeping the inflammation under check to enable proper embryo transport.

      Strengths:

      This study revealed an important and unexpected role of the autophagy-related gene Atg14 in preventing pyroptosis and maintaining oviduct epithelial integrity, which is poorly studied in the field of reproductive biology. The study is well designed to test the roles ofATG14 in mouse oviduct and uterus. The experimental data in general support the conclusion and the interpretations are mostly accurate. This work should be of interest to reproductive biologists and scientists in the field of autophagy and pyroptosis.

      Weaknesses:

      Despite the strengths, there are several major weaknesses raising concerns. In addition, the mismatched figure panels, the undefined acronyms, and the poor description/presentation of some of the data significantly hinder the readability of the manuscript.

      (1) In the abstract, the authors stated that "autophagy is critical for maintaining the oviduct homeostasis and keeping the inflammation under check to enable embryo transport". This statement is not substantiated. Although Atg14 is an autophagy-related gene and plays a critical role in oviduct homeostasis, the authors did not show a direct link between autophagy and pyroptosis/oviduct integrity. In addition, the authors pointed out in the last paragraph of the introduction that none of the other autophagy-related genes (ATG16L, FIP200, BECN1) exhibited any discernable impact on oviduct function. Therefore, the oviduct defect is caused by Atg14 specifically, not necessarily by autophagy.

      We thank the reviewer for noting this. We corrected the statement in the revised manuscript (Line number: 53-54).

      (2) In lines 412-414, the authors stated that "Atg14 ablation in the oviduct causes activation of pyroptosis", which is also not supported by the experimental data. The authors did not show that Atg14 is expressed in oviduct cells. PR-Cre is also not specific in oviduct cells. It is possible that Atg14 knockout in other PR-expressing tissues (such as the uterus) indirectly activates pyroptosis in the oviduct. More experiments will be required to support this claim. In line with the no defect when Atg14 has knocked out in oviduct ciliary cells, it will be good to use the secretory cells Cre, such as Pax8-Cre, to demonstrate that Atg14 functions in the secretory cells of the oviduct thus supporting this conclusion.

      We now included the ATG14 expression data in the oviduct (New Supplementary Figure S2A). Consistent with previous studies reporting PR-cre activity in the isthmus [1, 2] , we observed that Atg14 depletion was more pronounced in the isthmus compared to the ampulla. However, generating a secretory Pax-8 cell Cre mice model will require a substantial amount of time and effort, and we respectfully note that this is beyond the scope of the current manuscript.

      (3) With FOXJ1-Cre, the authors attempted to specifically knockout Atg14 in ciliary cells, but there are no clear fertility and embryo implantation defects in Foxj1/Atg14 cKO mice. The author should provide verification data to show that Atg14 had been effectively depleted in ciliary cells if Atg14 is normally expressed.

      We understand the reviewer’s concern. We included new data for ATG14 expression in control and Atg14 cKO mice oviducts (New Supplementary Figure S2A). However, due to the unavailability of reliable fluorescent-labeled antibodies for both Foxj1 and Atg14, we could not conduct the co-localization studies as intended, and this limitation hindered our ability to precisely determine the spatial overlap of these proteins within the oviduct. Nonetheless, Foxj1-cre is a widely used mice model with reported cre-activity in ciliary epithelial cells including oviduct tissues [3]. Given the widespread expression of ATG14 in all the ciliary and secretory cells (New Supplementary Figure S2A) and distinct FOXJ1 expression in the oviduct (New Supplementary Figure S3), we are confident that Atg14 is deleted in the ciliary epithelial cells of Foxj1/Atg14 cKO mice oviducts.

      (4) In lines 307-313, the author tested whether ATG14 is required for the decidualization of HESCs. The author stated that "Control siRNA transfected cells when treated with EPC seemed to change their morphological transformation from fibroblastic to epithelioid (Fig. 2E) and had increased expression of the decidualization markers IGFBP1 and PRL by day three only (Fig. 2F)". First, the labels in Figure 2 are not corresponding to the description in the text. Second, the morphology of the HESCs in the control and Atg14 siRNA group showed no obvious difference even at day 3 and day 6. The author should point out the difference in each panel and explain in the text or figure legend.

      Decidualization is a post-implantation event, whereas our study primarily focuses on pre-implantation events in the oviduct. Therefore, we have removed all data related to human and mouse decidualization to enhance the clarity and precision of our study.

      (5) In lines 332-336, the authors pointed out that the cKO mice oviduct lining shows marked eosinophilic cytoplasmic change, but there's no data to support the claim. In addition, the authors further described that "some of the cells showed degenerative changes with cytoplasmic vacuolization and nuclear pyknosis, loss of nuclear polarity, and loss of distinct cell borders giving an appearance of fusion of cells (Fig. 3D)". First, Figure 3D did not show all these phenotypes, and it is likely a mismatch to Figure 3E. Even in Figure 3E, it is not obvious to notice all the phenotypes described here. The figure legend is overly simple, and there's no explanation of the arrowheads in the panel. More data/images are required to support the claim here and provide a clear indication and explanation in the figure legend.

      Dr. Ramya Masand, Chief pathologist in the Pathology Department at the Baylor College of Medicine, and a contributing author, assessed the H&E-stained oviduct sections from control and cKO mice. We have now included a new Supplementary Figure S3 with previous representative H&E images that depict the cellular alterations described in lines 332–336.

      (6) In lines 317-325, it is rather confusing about the description of the portion of embryos from the oviduct and uterus. In addition, the total number of embryos was not provided. I would recommend presenting the numerical data to show the average embryos from the oviduct and uterus instead of using the percentage data in Figures 3A and 5G.

      We thank the reviewer for this nice suggestion. We calculated the average number of embryos and found no difference in the number of embryos recovered from cKO or polyphyllin-treated pregnant mice at 4 dpc compared to their controls. (New Supplementary Figure S4A & B).

      (7) In lines 389-391, authors tested whether Polyphyllin VI treatment led to activated pyroptosis and blocked embryo transport. Although Figures 5F-G showed the expected embryo transport defect, the authors did not show the pyroptosis and oviduct morphology. It will be important to show that the Polyphyllin VI treatment indeed led to oviduct pyroptosis and lumen disruption.

      We performed the GSDMD staining IHC in Polyphyllin VI or vehicle-treated mice oviducts and observed elevated GSDMD expression with Polyphyllin V (New Figure 6E). However, no significant lumen disruption was detected, which may be attributed to the short-term exposure of the oviducts to pyroptosis induction, in contrast to the more pleiotropic effects observed in genetically induced models. Nonetheless, this observation clearly indicates that unscheduled or unwarranted activation of pyroptosis impedes embryo transport.

      (8) In line 378, it would be better to include a description of pyroptosis and its molecular mechanisms to help readers better understand your experiments. Alternatively, you can add it in the introduction.

      We thank the reviewer for this nice suggestion. We included literature on the pyroptosis pathway in the introduction section (Line Number: 105-118).

      (9) Please make sure to provide definitions for the acronyms such as FRT, HESCs, GSDMD, etc.

      We added definitions for the acronyms such as FRT, HESCs, and GSDMD used in the study.

      (10) It is rather confusing to use oviducal cell plasticity in this manuscript. The work illustrated the oviducal epithelial integrity, not the plasticity.

      We thank the reviewer for the suggestion. We have revised the manuscript accordingly to ensure clarity and precision in describing the oviductal epithelial structural changes observed in the absence of ATG14.

      A few of the additional comments for authors to consider improving the manuscript are listed below.

      (1) Some of the figures are missing scale bars, while others have inconsistent scale bars. It would be better to be consistent.

      We now included the scale bars in all images.

      (2) On a couple of occasions, the DAPI signal cannot be seen, such as in Figure 2B and Figure 3D.

      We now included better-resolution images for the DAPI signal in all fluorescent images shown in the revised manuscript.

      (3) Overall, the figure legends can be improved to provide more detailed information to help the reader to interpret the data.

      We included additional details in all the figure legends in the revised manuscript.

      (4) In Figure 2D, the Y-axis showed the stimulated/unstimulated uterine weight ratio, why did the author put "Atg14" at the top of the graph? At the same time, the X-axis title is missing in Figure 2D.

      We apologize for the typo error. We removed “Atg14” from the top of the graph and included the X-axis title in the revised manuscript.

      (5) In the left panel of Figure 2G, "ATG14" at the top should be "Atg14" to be consistent.

      In Figure 2G, we are representing “ATG14” according to human gene annotation.

      (6) In line 559, there miss "(A)" in front of Immunofluorescence analysis of GSDMD.

      We thank the reviewer for noting this. We corrected it in the revised manuscript.

      Reviewer #3 (Public Review):

      Summary:

      The manuscript by Pooja Popli and co-authors tested the importance of Atg14 in the female reproductive tract by conditionally deleting Atg14 using Pr Cre and also Foxj1cre. The authors showed that loss of Atg14 leads to infertility due to the retention of embryos within the oviduct. The authors further concluded that the retention of embryos within the oviduct is due to pyroptosis in oviduct cells leading to defective cellular integrity. The manuscript has some interesting findings, however there are also areas that could be improved.

      Strengths:

      The importance of Atg14 and autophagy in the female reproductive tract is incompletely understood. The manuscript also provide spatial evidence about a new mechanism linking Atg14 to pyroptosis.

      We thank the reviewer for the positive statements and constructive comments on our manuscript.

      Weaknesses:

      (1) It is not clear why the loss of Atg14 selectively induces Pyroptosis within oviduct cells but not in other cellular compartments. The authors should demonstrate that these events are not happening in uterine cells.

      We thank the reviewer for this nice suggestion. We performed GSDMD IHC and found that, unlike in the oviduct, the cKO uteri and ovaries do not exhibit detectable pyroptosis (Revised Figure 5F). Additionally, we have added text to the discussion section addressing possible reasons for the differential impact of Atg14 loss on pyroptosis along the reproductive tract continuum (Line number: 532-538)

      (2) The manuscript never showed any effect on the autophagy upon loss of Atg14. Is there any effect on autophagy upon Atg14 loss? If so, does that contribute to the observation?

      We thank the reviewer for the nice suggestion. We found LC3b and p62 protein levels, two well-known markers of autophagic flux are elevated due to Atg14 loss in the oviduct (New Supplementary Figure S2B).  Since, p62 accumulation is an indicative of the reduced autophagic flux [4], we posit loss of Atg14 results in defective autophagy in the oviduct. Importantly, this defective autophagy adversely impacted the structural integrity of oviductal epithelial cells, causing impairment in embryo transport.

      (3) It is not clear what the authors meant by cellular plasticity and integrity. There is no evidence provided in that aspect that the plasticity of oviduct cells is lost. Similarly, more experimental evidence is necessary for the conclusion about cellular integrity.

      We thank the reviewer for the suggestion. We have revised the text for clarity and precision in describing the oviductal epithelial structural changes observed in the absence of ATG14. To avoid ambiguity, we have removed the term "cellular plasticity." We have already provided extensive evidence, including multiple H&E stains and immunofluorescence analyses for KRT8 and smooth muscle actin to illustrate cellular integrity in both control and cKO oviducts. However, we respectfully believe that performing additional experiments on cellular integrity would not contribute further to the conclusions already drawn.

      (4) The mitochondrial phenotype shown in Figure 3 didn't appear as severe as it is described in the results section. The analyses should be more thorough. They should include multiple frames (in supplemental information) showing mitochondrial morphology in multiple cells. The authors should also test that aspect in uterine cells. The authors should measure Feret's diagram. Diff erence in membrane potential etc. for a definitive conclusion.

      We appreciate the reviewer’s suggestion. We carried out the TOM20 (mitochondrial structural marker) and cytochrome C (mitochondrial damage and cell death marker) immune-colocalization study and found loss of TOM20 signal with concomitant cytochrome c leakage into the peri-nuclear space (Revised Figure 5B). Additionally, we also observed reduced expression of mitochondrial structural and functional markers by qPCR analysis (Revised Figure 5C). However, we respectfully argue that conducting membrane potential studies on murine oviducts is extremely complex and is beyond the scope of this study.

      (5) The comment that the loss of Atg14 and pyroptosis leads to the narrowing of the lumen in the oviduct should be experimentally shown.

      We have now included a New Supplementary Figure S3 with representative previous immunofluorescence images that clearly show the narrowing of the lumen with Atg14 loss in the oviduct.

      (6) The manuscript never showed the proper mechanism through which Atg14 loss induces pyroptosis. The authors should link the mechanism.

      We respectfully disagree with the reviewer on this point. We have provided substantial evidence regarding the cellular mechanisms through which the loss of Atg14 may lead to the activation of pyroptosis as outlined below:

      (1) Cellular Changes: Loss of ATG14 in the oviduct results in cellular swelling and the formation of fused membranous structures, which are characteristic features of pyroptosis activation.

      (2) Expression of Key Pyroptosis Proteins: We observed an induced expression of GSDMD and Caspase-1, primary executioners of the pyroptotic pathway, in response to Atg14 loss.

      (3) Inflammatory Markers: Elevated levels of inflammatory markers such as TNF-α and CXCR3 were detected, both of which are known to promote pyroptosis [5, 6].

      (4) Mitochondrial Damage: We have added new data demonstrating disrupted colocalization of TOM20 (a mitochondrial structural marker) and Cytochrome c (a cell death marker), resulting in Cytochrome c leakage into the perinuclear space (Revised Figure 5B). Additionally, qPCR analysis revealed reduced expression of mitochondrial structural and functional markers in cKO oviduct tissues (Revised Figure 5C).

      Based on these evidences, we can clearly say that Atg14 has some direct or indirect link to inflammasome activation. However, understanding the complex rheostat between the Atg14-mediated autophagy and inflammation regulatory axis will necessitate future studies employing sophisticated models, such as combined knockout mice where ATG14 is deleted alongside key inflammatory regulators (e.g., NLRP3, GSDMD, or CASPASE-1). These dual knockout models could provide crucial insights into how ATG14 modulates inflammatory pathways.

      References:

      (1) Herrera, G.G.B., et al., Oviductal Retention of Embryos in Female Mice Lacking Estrogen Receptor alpha in the Isthmus and the Uterus. Endocrinology, 2020. 161(2).

      (2) Soyal, S.M., et al., Cre-mediated recombination in cell lineages that express the progesterone receptor. Genesis, 2005. 41(2): p. 58-66.

      (3) Zhang, Y., et al., A transgenic FOXJ1-Cre system for gene inactivation in ciliated epithelial cells. Am J Respir Cell Mol Biol, 2007. 36(5): p. 515-9.

      (4) Mizushima, N., T. Yoshimori, and B. Levine, Methods in mammalian autophagy research. Cell, 2010. 140(3): p. 313-26.

      (5) Vaher, H., Expanding the knowledge of tumour necrosis factor-alpha-induced gasdermin E-mediated pyroptosis in psoriasis. Br J Dermatol, 2024. 191(3): p. 319-320.

      (6) Liu, C., et al., CXCR4-BTK axis mediate pyroptosis and lipid peroxidation in early brain injury after subarachnoid hemorrhage via NLRP3 inflammasome and NF-kappaB pathway. Redox Biol, 2023. 68: p. 102960.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Reviewer #1 (Public Review):

      Summary:

      The anatomical connectivity of the claustrum and the role of its output projections has, thus far, not been studied in detail. The aim of this study was to map the outputs of the endopiriform (EN) region of the claustrum complex, and understand their functional role. Here the authors have combined sophisticated intersectional viral tracing techniques, and ex vivo electrophysiology to map the neural circuitry of EN outputs to vCA1, and shown that optogenetic inhibition of the EN→vCA1 projection impairs both social and object recognition memory. Interestingly the authors find that the EN neurons target inhibitory interneurons providing a mechanism for feedforward inhibition of vCA1.

      Strengths:

      The strength of this study was the application of a multilevel analysis approach combining a number of state-of-the-art techniques to dissect the contribution of the EN→vCA1 to memory function.

      Weaknesses:

      Some authors would disagree that the vCA1 represents a 'node for recognition of familiarity' especially for object recognition although that is not to say that it might play some role in discrimination, as shown by the authors. I note however that the references provided in the Introduction, concerning the role of vCA1 in memory refer to anxiety, social memory, temporal order memory, and not novel object recognition memory. Given the additional projections to the piriform cortex shown in the results, I wonder to what extent the observations may be explained by odour recognition effects.

      We have added references demonstrating that the ventral hippocampus contributes to object recognition memory in rodents (Broadbent NJ et al., Learn Mem 2010; Titulaer J et al., Front Behav Neurosci 2021).

      The odor recognition effect is an interesting perspective that we have also considered. However, in our object recognition test, the same odor (70% EtOH) was used for both objects, yet the mice were able to discriminate between the familiar and novel objects. This suggests that the likelihood of the odor cue contributing to their performance in object discrimination test is low.

      In addition, I wondered whether the impairments in discrimination following Chemogenetic inhibition of the EN→vCA1 were due to the subject treating the novel and familiar stimuli as either both novel- which might be observed as an increase in exploration, or both stimuli as familiar, with a decrease in overall exploration.

      We thank the reviewer for rising this interesting point. We analyzed the total exploration time (i.e., time in interaction zones in familiar and novel) during social discrimination test. The data is added to Fig. S9. Total exploration time was not affected by CNO treatment. This indicates inhibition of ENvCA1-proj. neurons reduced interaction time with the novel conspecific and increased interaction time with the familiar conspecific. The subject mice seem to give even weight on familiar and novel stimuli.

      Reviewer #2 (Public Review):

      Summary:

      Yamawaki et al., conducted a series of neuroanatomical tracing and whole-cell recording experiments to elucidate and characterise a relatively unknown pathway between the endopiriform (EN) and CA1 of the ventral hippocampus (vCA1) and to assess its functional role in social and object recognition using fibre photometry and dual vector chemogenetics. The main findings were that the EN sends robust projections to the vCA1 that colateralise to the prefrontal cortex, lateral entorhinal cortex, and piriform cortex, and these EN projection neurons terminate in the stratum lacunosum-moleculare (SLM) layer of distal vCA1, synapsing onto GABAergic neurons that span across the Pyramidal-Stratum Radiatum (SR) and SR-SML borders. It was also demonstrated that EN input disynaptically inhibits vCA1 pyramidal neurons. vCA1 projecting EN neurons receive afferent input from the piriform cortex, and from within EN. Finally, fibre photometry experiments revealed that vCA1 projecting EN neurons are most active when mice explore novel objects or conspecifics, and pathway-specific chemogenetic inhibition led to an impairment in the ability to discriminate between novel vs. familiar objects and conspecifics.

      This is an interesting mechanistic study that provides valuable insights into the function and connectivity patterns of afferent input from the endopiriform to the CA1 subfield of the ventral hippocampus. The authors propose that the EN input to the vCA1 interneurons provides a feedforward inhibition mechanism by which novelty detection could be promoted. The experiments appear to be carefully conducted, and the methodological approaches used are sound. The conclusions of the paper are supported by the data presented on the whole.

      We thank the reviewer for their positive comments on our work.

      The authors used dual retrograde tracing and observed that the highest percentage (~30%) of vCA1 projecting EN cells also projected to the PFC. They then employed an intersectional approach to show the presence of collaterals in other cortical areas such as the entorhinal cortex and piriform cortex in addition to the PFC. However, they state that 'Projection to prefrontal cortex was sparse relative to other areas, as expected based on the retrograde labeling data' (referring to Figure 2K) and subsequently appear to dismiss the initial data set indicating strong axonal projections to the PFC.

      Our interpretation is that 70% of the ENCA1-proj. population does not send collaterals to the PFC, suggesting that the PFC is not a major target for this population (unlike vCA1 where 100% of its population projects). This hypothesis is supported by our axon branching study, which showed lower axon density in the PFC compared to vCA1 (and other regions). We revised the text to 'much sparser relative to that of vCA1' (line 101) to facilitate a direct comparison with the retrograde and anterograde labeling study.

      Since this is a relatively unknown connection, it would be helpful if some evidence/discussion is provided for whether the EN projects to other subfields (CA3, DG) of the ventral hippocampus. This is important, as the retrograde tracer injections depicted in Figure 1B clearly show a spread of the tracer to vCA3 and potentially vDG and it is not possible to ascertain the regional specificity of the pathway.

      We addressed the potential caveat associated with the retrograde tracer injection, as mentioned by the reviewer, by performing intersectional axon branching analysis. This analysis demonstrated that EN axons are primarily located in the SLM of the distal CA1 subfield (Figs. 2, 3, S2). However, we occasionally observed very weak labeling in the CA3 or dentate gyrus. We modified our text (lines 106-108) and figure (Fig. S2D) to account for this.

      The vCA1 projecting EN cells appear to originate from an extensive range along the AP axis. Is there a topographical organization of these neurons within the vCA1? A detailed mapping of this kind would be valuable.

      This is an interesting question for future research. Our data show a non-uniform distribution of this cell type, suggesting the potential for topographic organization.

      Given this extensive range in the location of vCA1 EN originating cells, how were the targets (along the AP axis) in EP selected for the calcium imaging?

      Using our injection coordinates, ENvCA1-proj. neurons were consistently labeled at high density just posterior to the bregma (Fig. 1J). Therefore, we targeted this region for our imaging.

      The vCA1 has extensive reciprocal connections with the piriform cortex as well, which is in close proximity to the EN. How certain are the authors that the chemogenetic targeting was specific to the EN-vCA1 connection?

      We performed histology on every animal used in the behavioral study to examine the specificity of hM4D expression, and only included those with specific labeling in the EN.

      Raw data for the sociability and discrimination indices should be provided so that the readers can gain further insight into the nature of the impairment.

      The raw data for total interaction time during the social discrimination test has been added (Fig. S9F).

      Line 222: It is unclear how locomotor activity informs anxiety in the behavioral tests.

      The degree of exploratory behavior in a novel context is generally considered to infer anxiety levels in rodents. We have added a review paper (Ref 44, Prut, 2003) that discusses this point.

      Figure 7 title; It is stated that activity of EN neurons 'predict' social/object discrimination performance. However, caution must be exercised with this interpretation as the correlational data are underpowered (n=5-8). Furthermore, the results show a significant correlation between calcium event ratios and the discrimination index in the social discrimination test but not the object discrimination test.

      We added the sample size for EN calcium imaging during the object recognition memory test (Fig. 7G). The updated data indicate a significant correlation between EN activity and the object recognition index (N = 9, Pearson R = 0.8, p = 0.01).

      We have changed the title of Figure 7 to 'Activity of ENvCA1-proj. neurons correlates with social/object discrimination performance’.

      While both male and female mice were included in the anatomical tracing and recording experiments, only male mice were used for behavioral tests.

      The female behavior was highly inconsistent in the control condition of our social recognition memory paradigm; therefore, we decided to conduct the study with males. We will design a new behavioral paradigm for future studies to address this challenge.

      Reviewer #1 (Recommendations For The Authors):

      (1) It is not clear how the relative number of vCA1 projecting neurons in Figure 1H was acquired, not enough detail is presented in the methods section. To what extent could these data have been affected by differences in the size or anatomical position of the injection site in vCA1, which judging from the example fluorescent image in Figure 1B also appears to include CA3.

      We used AMaSiNe (Song et al. 2020) to semi-automatically quantify fluorescently labeled presynaptic neurons. This open-source software identifies the number and location of these cells across different regions based on the Allen Mouse Brain Common Framework. To control for transfection variability (e.g., due to slight differences in injection volume or site), we normalized the presynaptic cell count in each region by the total number of cells in regions of interest. We performed for N = 5 brain and found consistent trend as seen in Fig. 1H (grey lines).

      We have added the detailed method of quantification in the Materials and Methods section (line 393).

      (2) For a number of the results, the full statistical values are not presented in the Results section or figure legend.

      We have included the full statistical values in the figure legends of the revised manuscript.

      (3) It is not clear how much virus was injected in the different experiments (tract racing, electrophysiology, behaviour, etc.). The methods state 50-100ul, but there is no further detail in the results or figure legends.

      We have included the injected volumes of the virus in the revised manuscript.

      (4) Figure 2 mentions the CLA complex (line 702) but this is not defined in the text. Although the introduction does refer to the claustrum complex, there is no acronym.

      We have corrected the manuscript accordingly.

      (5) Line 131- 'we recorded from 3-4 GABAergic neurons' - presumably this is in each animal?

      We recorded 3 to 4 GABAergic neurons sequentially from the same slice to compare input strength. We have edited the text to clarify this (line 134).

      Reviewer #2 (Recommendations For The Authors):

      Figure 3C: It is not clear what the dashed lines labelled proximal and distal represent.

      It is the proximal and distal vCA1 regions where GFP signals were measured for Fig. 3D. We have modified the figure legend to clarify this (line 736).

      Figure 5D: what do the different colors represent? Different colors for one brain?

      I assume that the reviewer meant to refer to Fig. 4D instead of Fig. 5D. In Fig. 4D, one color indicates starter cells in one brain. To clarify this, we have edited the figure legend (line 748).

      Figure S6E: The images are low resolution and it is hard to decipher the exact locations of labeled neurons. Please provide more guidance (e/g/. labeling areas of interest).

      We have added reference lines and labels in Figure S6E.

      Some details are missing: what was the volume of AAV injected for each site/experiment; how was CNO made, and where was it purchased from?

      We have added this information (lines 330-331; 431-434).

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public Review):

      This work presents a replicable difference in predictive processing between subjects with and without tinnitus. In two independent MEG studies and using a passive listening paradigm, the authors identify an enhanced prediction score in tinnitus subjects compared to control subjects. In the second study, individuals with and without tinnitus were carefully matched for hearing levels (next to age and sex), increasing the probability that the identified differences could truly be attributed to the presence of tinnitus. Results from the first study could successfully be replicated in the second, although the effect size was notably smaller.

      Throughout the manuscript, the authors provide a thoughtful interpretation of their key findings and offer several interesting directions for future studies. Their conclusions are fully supported by their findings. Moreover, the authors are sufficiently aware of the inherent limitations of cross-sectional studies.

      Strengths:

      The robustness of the identified differences in prediction scores between individuals with and without tinnitus is remarkable, especially as successful replication studies are rare in the tinnitus field. Moreover, the authors provide several plausible explanations for the decline of the effect size observed in the second study.

      The rigorous matching for hearing loss, in addition to age and sex, in the second study is an important strength. This ensures that the identified differences cannot be attributed to differences in hearing levels between the groups.

      The used methodology is explained clearly and in detail, ensuring that the used paradigms may be employed by other researchers in future studies. Moreover, the registering of the data collection and analysis methods for Study 2 as a Registered Report should be commended, as the authors have clearly adhered to the methods as registered.

      Weaknesses:

      Although the authors have been careful to match their experimental groups for age, sex, and hearing loss, there are other factors that may confound the current results. For example, subjects with tinnitus might present with psychological comorbidities such as anxiety and depression. The authors' exclusion of distress as a candidate for explaining the found effects is based solely on an assessment of tinnitus-related distress, while it is currently not possible to exclude the effects of elevated anxiety or depression levels on the results. Additionally, as the authors address in the discussion, the presence of hyperacusis may also play a role in predictive processing in this population.

      The authors write that sound intensity was individually determined by presenting a short audio sequence to the participants and adjusting the loudness according to an individual pleasant volume. Neural measurements made during listening paradigms might be influenced by sound intensity levels. The intensity levels chosen by the participants might therefore also have an effect on the outcomes. The authors currently do not provide information on the sound intensity levels in the experimental groups, making it impossible to assess whether sound intensity levels might have played a role.

      Thank you very much for your favorable and constructive evaluation of our manuscript. We agree with you on various additional confounds that we did not consider and included a section in our discussion. It is also correct that we did not include the sound intensity levels in our analysis, which is also a potential confound. Unfortunately, we do not have the data on the individual sound intensity levels but we included a section regarding this issue in our discussion as well.

      Line 937-949:

      “In both studies, tinnitus distress was not correlated with the reported prediction effects. Nevertheless, tinnitus can also be characterized by other features such as its loudness, pitch or duration which were not included in the experimental assessment. Additionally, we solely used a short version of the Mini-TQ (Goebel and Hiller, 1992) in Study 2, which did not allow us to relate prediction scores to subscales like sleep disturbances which potentially influence cognitive functioning and thus predictive processing. Next to sleeping disorders and distress, tinnitus is often also accompanied by psychological comorbidities such as depression or anxiety (Langguth, 2011) which are potential confounds of the results. For the work described in this manuscript the replicability of the core finding was of main importance. More studies are needed taking into account to assess relate the prediction patterns in more detail to aspects of tinnitus sensation and distress.”

      Reviewer #2 (Public Review):  

      Summary:  

      This study aimed to test experimentally a theoretical framework that aims to explain the perception of tinnitus, i.e., the perception of a phantom sound in the absence of external stimuli, through differences in auditory predictive coding patterns. To this aim, the researchers compared the neural activity preceding and following the perception of a sound using MEG in two different studies. The sounds could be highly predictable or random, depending on the experimental condition. They revealed that individuals with tinnitus and controls had different anticipatory predictions. This finding is a major step in characterizing the top-down mechanisms underlying sound perception in individuals with tinnitus.

      Strengths:  

      This article uses an elegant, well-constructed paradigm to assess the neural dynamics underlying auditory prediction. The findings presented in the first experiment were partially replicated in the second experiment, which included 80 participants. This large number of participants for an MEG study ensures very good statistical power and a strong level of evidence. The authors used advanced analysis techniques - Multivariate Pattern Analysis (MVPA) and classifier weights projection - to determine the neural patterns underlying the anticipation and perception of a sound for individuals with or without tinnitus. The authors evidenced different auditory prediction patterns associated with tinnitus. Overall, the conclusions of this paper are well supported, and the limitations of the study are clearly addressed and discussed.  

      Weaknesses:  

      Even though the authors took care of matching the participants in age and sex, the control could be more precise. Tinnitus is associated with various comorbidities, such as hearing loss, anxiety, depression, or sleep disorders. The authors assessed individuals' hearing thresholds with a pure tone audiogram, but they did not take into account the high frequencies (6 kHz to 16 kHz) in the patient/control matching. Moreover, other hearing dysfunctions, such as speech-in-noise deficits or hyperacusis, could have been taken into account to reinforce their claim that the observed predictive pattern was not linked to hearing deficits. Mental health and sleep disorders could also have been considered more precisely, as they were accounted for only indirectly with the score of the 10-item mini-TQ questionnaire evaluating tinnitus distress. Lastly, testing the links between the individuals' scores in auditory prediction and tinnitus characteristics, such as pitch, loudness, duration, and occurrence (how often it is perceived during the day), would have been highly informative.

      Thank you very much for your careful and constructive evaluation. We agree with the weaknesses stated in our manuscript and aimed to highlight these aspects more in our analyses and discussion, so future studies can take them into account (see e.g., line 937949). 

      Recommendations for the authors:  

      Reviewer #1 (Recommendations For The Authors):

      I would strongly recommend the inclusion of data on the used sound intensity levels. It would be very useful to assess whether there are any group differences regarding sound intensity of the stimuli, to exclude any effects of sound intensity on the results.

      We agree with you that - next to experimental aspects like the stimulus frequencies and the number of trials - the sound intensity levels potentially influence the effects as well. Unfortunately, this data was not saved during the experimental procedure and we are not able to include this as a variable in our analyses. As we, however, acknowledge this issue and want to provide guidelines for future research, we added a section to our discussion targeting sound intensity levels. 

      Line 902-913:

      “Thirdly, both studies used individual sound intensity levels to ensure a comfortable listening situation for the participants. These differences in sound intensity levels are, however, a potential confound in the experimental design as well since sound intensity can have an impact on neural responses (Thaerig et al., 2008). Although in this design, we expect the intensity levels balanced equally to the hearing loss of the participants (which did not differ between groups), and basic decoding of sound frequency did not differ in both studies, we are not able to ultimately exclude the sound intensity level as a driver of our effects. Future studies should include a perceived loudness matching for each frequency and should compare the adapted sound intensity values between each group or integrate them into the analysis (e.g., using the logistic regression approach in Fig. 8).”

      Reviewer #2 (Recommendations For The Authors):

      Major comments

      Introduction

      • The authors wrote: "Overall, this situation calls for the pursuit of alternative or complementary models that place less emphasis on the hearing status of the individual." They clearly demonstrated that the altered-gain model focuses on hearing loss and does not overcome the three described limitations. However, they mentioned other models focusing on brain activity outside of the auditive pathway (noise cancellation, map reorganization, specific neural networks. The authors should better explain the novelty of their approach compared to the existing ones.

      Thank you for your input. The inconclusive results and open questions about the altered-gain framework let us search for a different theoretical foundation for this work. We agree with you, that there are other models such as the map reorganization theory or neural network models next to the altered gain model and recent literature showed results supporting these frameworks (see e.g., a review from our group discussing tinnitus research in MEG over the last 10 years, Reisinger et al. (2023)). Nevertheless, as we focus on prediction processes, the Bayesian inference framework in tinnitus (Sedley et al., 2016) fits best for our approach. As we stated in line 113-116 “The Bayesian inference framework could, therefore, explain the experience of tinnitus in lieu of any increase in neural activity in the auditory system, or indicate an additional alteration, on top of hearing loss, for tinnitus to be perceived”, this framework differs from the other models and demonstrate a novel approach in tinnitus research. The novelty in this work is our methodological approach, which allows for explicit analyses of predictive patterns, irrespective of the exact location in the brain. This is a first step towards our actual underlying question whether aberrant auditory prediction patterns act as a neural correlate of tinnitus or rather as a risk factor or disposition. In our opinion, this question is of crucial relevance for understanding tinnitus processes on a neural level and our robust effects highlight the necessity to investigate these predictive processes in a longitudinal manner. We included a paragraph in our manuscript to make this more apparent for the reader. 

      Line 128-137:

      “We utilized a powerful, recently established experimental approach (Demarchi et al., 2019) showing anticipatory activations of tonotopically specific auditory templates for regular tone sequences. This method allows us to explicitly investigate predictive patterns in line with the Bayesian inference framework (Sedley et al., 2016), leading towards the overall question whether alterations in predictive coding can be interpreted as a neural correlate of tinnitus or rather as a risk factor. Since this question can solely be targeted in a longitudinal manner, we aimed in a first step to investigate prediction patterns in tinnitus over two independent samples, deriving robust effects that should be considered in future research.”

      • "This conceptual model bridges several explanatory gaps: for example, the inconsistent findings in humans regarding the "altered gain" view which states enhanced neural activity in the auditory pathway". What are "the inconsistent findings in humans regarding the 'altered gain'"? It would be helpful if the authors were more explicit about their idea here and added reference(s) to support it.

      Thank you for pointing that out. We agree with you that this section lacks clarity and we aimed to be more precise. 

      Line 108-116:

      “This conceptual model bridges several explanatory gaps: for example, the inconsistent findings in humans regarding the “altered gain” view which states altered neural activity in the auditory pathway. Recent findings vary in both the targeted frequency bands and the direction of the reported power changes which impede consistent conclusions (Eggermont and Roberts, 2015; Elgohyen et al., 2015, Reisinger et al., 2023). The Bayesian inference framework could, therefore, explain the experience of tinnitus in lieu of any increase in neural activity in the auditory system, or indicate an additional alteration, on top of hearing loss, for tinnitus to be perceived.”

      • I suggest moving this part to the discussion:

      "However, alternative explanations cannot be excluded with certainty, such as tinnitus being the cause of altered prediction tendencies or that there is a third variable being responsible for predictions and tinnitus development. Furthermore, even if altered predictive tendencies were to be found, there could be various possibilities of exactly how they could be altered to contribute to the onset or persistence of tinnitus. Some further clarity might then be gained through longitudinal studies in humans or animals."

      Thank you for your suggestion, we moved this part to the corresponding section in the discussion.

      Line 742-756:

      “Distinct predictive processing patterns could e.g., either develop within an individual in contributing to chronification of tinnitus (e.g., shift of “default prediction” from silence to sound; Sedley, 2019). Alternatively, they could be conceived as sensory processing style, making certain individuals more vulnerable to develop tinnitus under certain conditions (e.g., hearing loss, aging), a notion reminiscent of the “strong prior” hypothesis of hallucinations (Corlett et al., 2019). Hence, the direction of the effect remains unclear and alternative explanations, such as a third variable being responsible for predictions and tinnitus development, cannot be excluded with certainty. Furthermore, even if altered predictive tendencies were to be found, there could be various possibilities of exactly how they could be altered to contribute to the onset or persistence of tinnitus. In any case, any more conclusive claims would require longitudinal data, ideally with a tinnitus-free baseline. As such research is challenging to implement, especially in humans, we first focused in this work on finding cross-sectional group differences between individuals with and without tinnitus.”

      Methods

      Participants

      • "We calculated the individual mean hearing ability based on the values for 500, 1000, 2000, and 4000 Hz, which is a common approach for averaging results of pure-tone audiometry". Even if this method has been used multiple times in the literature, I would not recommend it as it can hide differences. Hearing loss is usually larger at high frequencies (starting at 6 000 Hz). An average threshold calculated with those central frequencies is more relevant for clinical use than in research. I strongly recommend performing a linear model with the factors Frequency (including all tested frequencies), Group, Ear side, and their interactions to precisely test the group differences in hearing thresholds.

      Thank you for pointing that out. We agree with you that higher frequencies are of potential interest as well when analyzing hearing loss. We included your suggested linear model in our methods section and the results were in line with our assumption that the groups did not differ substantially. Additionally, we included another logistic regression model in our exploratory analyses when investigating the influence of hearing loss on the prediction scores. Once more, the addition of higher frequencies did not substantially influence the effects.

      Line 194-203:

      “We calculated the individual mean hearing ability based on the values for 500, 1000, 2000, and 4000 Hz, which is a common approach for averaging results of pure-tone audiometry (i.e., PTA-4, see for example Lin et al. (2011); Ozdek et al. (2010)). Using independent t-tests, we found no differences in hearing status over frequencies between groups for the left(t=-1.19, p=.238) and right ear (t=-1.72, p=.09). An additional linear regression including all frequencies from 125 Hz to 8000 Hz also showed that hearing thresholds did not differ between ears (b=0.311, SE=1.600, p=.846) and groups (b=1.702, SE=1.553, p=.273), but solely between frequencies (b=0.003, SE=0.000, p<.001). Interactions were not significant as well.”

      Line 712-725:

      “As these logistic regression models were computed using an average hearing score computed over the frequencies 500, 1000, 2000, and 4000 Hz (i.e., PTA-4, see for example Lin et al. (2011); Ozdek et al. (2010)), we questioned whether hearing loss in higher frequencies influenced our effects. We therefore computed an additional logistic regression including also the PTA values of 6000 and 8000 Hz. In this analysis, hearing loss was not a significant predictor of tinnitus but rather showed a trend with b\=0.211, SE\=0.111, p\=.062. Prediction scores, however, remained a significant predictor of tinnitus even after including high-frequency hearing loss (b\=0.232, SE\=0.111, p\=.040). In this analysis, odds ratios indicated an increase of 26% in the odds of having tinnitus with a one standard deviation increase in the prediction score. Overall, this analysis strongly supports the notion that the main effect genuinely reflects a process related to the experience or statistical risk of experiencing tinnitus.”

      Stimuli and experimental procedure

      • Can you explain the use of movies during sound listening? And not an active listening task with oddball events, for example, to ensure that the subject attention is directed to the sounds?

      Thank you for your comment. We agree with you that attention is a relevant factor and with our design we cannot exclude potential attention effects on our findings. We chose this paradigm since previous research in our group including this exact experimental design (Demarchi et al., 2019) impressively demonstrated the formation of feature-specific auditory predictions in the brain and we aimed to investigate to what extent this can be detected in the tinnitus brain.

      We acknowledged this issue in our discussion (see line 916-919): “In the current work, we used passive listening tasks including a movie to reduce attentional focus on the presented stimuli. Therefore, we cannot draw conclusions whether differences in attention had an influence on the effects. Future studies should include more manipulations of attention to investigate its relevance”. 

      Results

      Pre-stimulus effects are not related to hearing loss and tinnitus-related features

      • How was the hearing loss calculated for this analysis? I recommend a PCA on the hearing levels, to get individual scores with a data-driven approach. Usually, the first dimension will be an average of all the frequencies. The second should be a difference between low and high frequencies. The same comment applies to study 2.

      Thank you for pointing that out. In the first study, participant groups were not controlled for hearing loss and pure-tone audiograms were solely averaged over all frequencies and both ears. As we marked out throughout the manuscript, insufficient control for hearing loss was the key issue in study 1 which led to the implementation of study 2. Further, we do not have data about the hearing status of every participant in study 1 and we do therefore not believe that a more complex approach for calculating hearing loss will increase interpretability in study 1. Nevertheless, we agree with you that it is not apparent how hearing loss was calculated in study 1. The results of the pure-tone audiometry were averaged over all frequencies and both ears, but no cut-off values were defined to characterize hearing loss. We therefore highly appreciate your detailed revision of our manuscript and adjusted the phrasing in the corresponding section. With our approach, it is not justifiable to talk about hearing loss but rather hearing thresholds. As for study 2, the methodological approach was reviewed and accepted as a Registered Report and we therefore do not want to deviate drastically from our pre-registered approach.

      Line 162-165:

      “Standardized pure-tone audiometric testing for frequencies from 125Hz to 8kHz was performed in 31 out of 34 tinnitus participants using Interacoustic AS608 audiometer.

      Averages were computed over all frequencies and both ears.”

      Line 356-362:

      “In the whole sample of participants with tinnitus (n=34) we performed a Spearman correlation of the β-coefficient values corresponding to the time-point of the maximum and the minimum t-value in intergroup analysis (comprised of positive and negative significant clusters emerging in group comparison for sound trials) with hearing thresholds (averaged audiogram for both ears), tinnitus loudness (10-point scale) and tinnitus distress scores (TQ).”

      Line 463-464:

      See as well Line 471-481.

      Line 491-495:

      “Our main findings are: 1) basic processing of carrier frequencies are not altered in tinnitus; 2) with increasing regularity of the sequence, individuals with tinnitus show relatively enhanced predictions of frequency information; 3) the effect is not related to hearing thresholds and tinnitus distress or loudness in this sample.”

      • In the methods, the authors indicated that the volume was adjusted individually at a pleasant volume. Can authors test if the volume was related to the individual's accuracy? Did they test that all frequencies were audible for all participants?

      Thank you for your feedback. We agree with you that it would be interesting to see whether sound intensity levels were related to the accuracy. Unfortunately, data regarding the volume was not saved during the experimental procedure and we are not able to include this as a variable in our analyses. We acknowledge this issue and added a section to our discussion targeting sound intensity levels. As for the second question, the individual volume adjustment was also meant to guarantee that all frequencies were audible for the participant. We clarified this in the methods section. Overall, it is important to mention that we did not find any differences between groups in the decoding of random tones (see Fig. 2 and Fig. 6C), indicating that the volume did not substantially have an influence on one group compared to the other.

      Line 232-234:

      “Sound intensity was individually determined by presenting a short audio sequence to the participants and adjusting the loudness according to an individual pleasant volume with all four frequencies audible for the participant.”

      Line 902-913:

      “Thirdly, both studies used individual sound intensity levels to ensure a comfortable listening situation for the participants. These differences in sound intensity levels are, however, a potential confound in the experimental design as well since sound intensity can have an impact on neural responses (Thaerig et al., 2008). Although in this design, we expect the intensity levels balanced equally to the hearing loss of the participants (which did not differ between groups), and basic decoding of sound frequency did not differ in both studies, we are not able to ultimately exclude the sound intensity level as a driver of our effects. Future studies should include a perceived loudness matching for each frequency and should compare the adapted sound intensity values between each group or integrate them into the analysis (e.g., using the logistic regression approach in Fig. 8).”

      Pre-stimulus differences in ordered and random tone sequences are not related to tinnitus distress • Accuracy was not correlated with tinnitus distress. Could the authors test if the accuracy was related to other clinical data, such as tinnitus pitch, duration, and loudness? And at the subscales of the mini-TQ?

      We appreciate your constructive feedback and agree with you that other tinnitus features such as pitch, duration, or loudness are also interesting in this regard. Unfortunately, these features were not assessed in study 2 and we are therefore not able to provide this information. Additionally, we solely used a short version of the Mini-TQ in this study and did not assess all subscales but rather used all available items for calculating tinnitus distress. This is a limitation of our study design and we included it in the discussion.

      Line 937-949:

      “In both studies, tinnitus distress was not correlated with the reported prediction effects. Nevertheless, tinnitus can also be characterized by other features such as its loudness, pitch or duration which were not included in the experimental assessment. Additionally, we solely used a short version of the Mini-TQ (Goebel and Hiller, 1992) in Study 2, which did not allow us to relate prediction scores to subscales like sleep disturbances which potentially influence cognitive functioning and thus predictive processing. [...] More studies are needed taking into account to assess relate the prediction patterns in more detail to aspects of tinnitus sensation and distress.”

      The strength of group effects differs between the two studies

      • This section should be in the discussion, not the results

      Thank you for your valuable input. In this section, we show comparisons between the two studies and report Bayes factors over time for the differences in decoding accuracy (see Figure 7A). We introduce novel results and believe therefore that this section should remain in the results and is discussed later in the manuscript.  

      Discussion

      • Globally, the discussion is very long and a bit speculative. I recommend the authors shorten the discussion (especially the speculations), and delete the repetition.

      Thank you very much for your constructive feedback. We aimed to shorten our discussion and delete repetitions to increase clarity and readability.

      • The effect of hearing loss has been tested in this study, evaluated as the mean hearing threshold of 4 central frequencies. However, hearing abilities cannot be limited to a central audiogram. High frequencies, speech-in-noise abilities, or other hidden hearing loss can be impacted, even for individuals without hearing loss on 500Hz- 4000Hz. The conclusion on the prediction effect being independent of hearing loss should include this limitation.

      Thank you for pointing that out. We added this limitation to the discussion.

      Line 781-794:

      “In a complementary analysis, we used our prediction score in addition to hearing loss magnitudes as predictors of tinnitus in a logistic regression. Prediction related pre-activation levels were informative whether participants perceived tinnitus, also when statistically controlling for hearing loss. However, it has to be mentioned that we calculated hearing loss based on the PTA results of the frequencies between 500 and 4000 Hz. This does not reflect hearing impairments like high frequency hearing loss or hidden hearing loss (i.e., hearing difficulties despite a normal audiogram, Liberman (2015)). As for hidden hearing loss, we were not able to draw conclusions regarding our effects since this concept of hearing damage is difficult to measure objectively, especially in humans. However, we included an additional logistic regression expanding the frequency range up to 8000 Hz and again, hearing loss did not substantially impact the prediction score as an informative tinnitus predictor.”

      Line 712-723:

      “As these logistic regression models were computed using an average hearing score computed over the frequencies 500, 1000, 2000, and 4000 Hz (i.e., PTA-4, see for example Lin et al. (2011); Ozdek et al. (2010)), we questioned whether hearing loss in higher frequencies influenced our effects. We therefore computed an additional logistic regression including also the PTA values of 6000 and 8000 Hz. In this analysis, hearing loss was not a significant predictor of tinnitus but rather showed a trend with b\=0.211, SE\=0.111, p\=.062. Prediction scores, however, remained a significant predictor of tinnitus even after including high-frequency hearing loss (b\=0.232, SE\=0.111, p\=.040). In this analysis, odds ratios indicated an increase of 26% in the odds of having tinnitus with a one standard deviation increase in the prediction score.”

      • "An increased focus on hippocampal regions, e.g., in fMRI, patient, or animal studies, could be a worthwhile complement to our MEG work, given the outstanding relevance of medial temporal areas in the formation of associations in statistical learning paradigms (see e.g., Covington et al., (2018); Schapiro et al., (2016)).".

      in the opinion of this reviewer, this claim is not well introduced and should be removed.

      Thank you for pointing that out. In our opinion, an increased focus on hippocampal regions is an important consideration for future research and we decided to keep this part in the manuscript. However, we added a third reference highlighting the relevance of temporal areas in tinnitus to strengthen our claim. 

      Line 866-868:

      “... given the outstanding relevance of medial temporal areas in the formation of associations in statistical learning paradigms (see e.g., Covington et al., (2018); Paquette et al., (2017); Schapiro et al., (2016)).”

      References:

      Paquette, S., Fournier, P., Dupont, S., de Edelenyi, F. S., Galan, P., & Samson, S. (2017). Risk of tinnitus after medial temporal lobe surgery. JAMA neurology, 74(11), 1376-1377. https://doi.org/10.1001/jamaneurol.2017.2718.

      • "Overall, our work clearly underlines the true presence of differences, in terms of predictive processing, between individuals with and without tinnitus. At the same time, distinct design choices impact the strength of the effects which is not only apparent in the present work but was also reported recently by Yukhnovich and colleagues (2024). Further to controlling for basic variables (age, sex, hearing loss), future studies using our paradigm and analysis approach should opt for a broad frequency spacing (>2 octaves) and ideally more than 2000 trials per carrier frequency in the random sequence. These recommendations are likely even more important for efforts of testing this paradigm using EEG, which normally comes with inferior data quality as compared to MEG."

      This reviewer considers that the entire paragraph should be deleted, as the effects are already covered in the previous paragraph.

      Thank you very much for your feedback, however, we believe that this paragraph acts as a brief and accurate summary for our guidelines to improve future research in this field. This section therefore remained in the manuscript.

      Minor comments

      Introduction

      • "The onsets of tinnitus and hearing loss often do not occur at the same time ". This sentence should have a reference.

      We appreciate your careful evaluation of our manuscript and included a reference to the sentence pointing out hearing loss as a precursor of tinnitus.

      Line 95f.:

      “2) The onsets of tinnitus and hearing loss often do not occur at the same time (Roberts et al., 2010).” 

      Methods

      Participants

      • Participants' laterality needs to be mentioned.

      Thank you for your input. We agree with you that laterality is an interesting aspect that should be taken into account. Unfortunately, however, we did not assess this in the current design. We mentioned the lack of this information in the methods section.

      Line 158:

      “Laterality of the participants was not assessed.”

      176-177:

      “No participants with psychiatric or neurological diseases were included in the sample. Laterality of the participants was not assessed.”

      "Four individuals with tinnitus did not show any audiometric abnormality; four of the participants showed unilateral hearing impairments; 26 volunteers had high-frequency hearing loss; and six individuals were hearing impaired over most frequencies (i.e. hearing thresholds higher than 30 dB)."

      This part is not precise enough. "Unilateral hearing impairment": is it on one or multiple frequencies? "26 volunteers had high-frequency hearing loss". What is considered as highfrequency here? The precision "(i.e. hearing thresholds higher than 30 dB)" can be dropped as it was defined in the sentence just before.

      We appreciate your constructive feedback and added information to clarify the audiometric characteristics of our participants.

      Line 186-190:

      “Four individuals with tinnitus did not show any audiometric abnormality; four of the participants showed unilateral hearing impairments on at least one frequency; 26 volunteers had high-frequency hearing loss (i.e. hearing thresholds higher than 30 dB); and six individuals were hearing impaired over most frequencies (i.e. hearing thresholds higher than 30 dB).”

      Results

      • Figure 3C: are those group differences significant? It should be noted on the graphs.

      • Figure 6D: I would suggest to remove this figure, as the correlation is not significant.

      • Figure 7A: It would be useful to precise the number of trials for each study, in parenthesis.

      • Figure 8 is unnecessary.

      Thank you for your careful assessment of our figures. We agree with you that significance should be indicated in Figure 3C and that the precise number of trials is relevant information in Figure 7A. We corrected the figures accordingly. However, the Figures 6D and 8 remained in the manuscript since they were already part of our Registered Report and we do not want to remove graphical information that was reviewed and accepted already.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public Review):

      Summary:

      Kimura et al performed a saturation mutagenesis study of CDKN2A to assess the functionality of all possible missense variants and compare them to previously identified pathogenic variants. They also compared their assay result with those from in silico predictors.

      Strengths:

      CDKN2A is an important gene that modulates cell cycle and apoptosis, therefore it is critical to accurately assess the functionality of missense variants. Overall, the paper reads well and touches upon major discoveries in a logical manner.

      Weaknesses:

      The paper lacks proper details for experiments and basic data, leaving the results less convincing. Analyses are superficial and do not provide variant-level resolution.

      We thank the reviewer for their comments. We have updated the manuscript to include additional detail of experimental methods and variant level resolution of data and analyses. We have also conducted additional analyses to compare variant classifications using a gamma generalized linear model and log2 normalized fold change, establish the effect of low variant coverage on variant functional classifications, determine the performance of combining multiple in silico predictions, and determine the prevalence of functionally deleterious variants in gnomAD and functionally deleterious variants of uncertain significance in ClinVar compared all CDKN2A missense variants.

      Reviewer #2 (Public Review):

      This study describes a deep mutational scan across CDKN2A using suppression of cell proliferation in pancreatic adenocarcinoma cells as a readout for CDKN2A function. The results are also compared to in silico variant predictors currently utilized by the current diagnostic frameworks to gauge these predictors' performance. The authors also functionally classify CDKN2A somatic mutations in cancers across different tissues.

      This study is a potentially important contribution to the field of cancer variant interpretation for CDKN2A, but is almost impossible to review because of the severe lack of details regarding the methods and incompleteness of the data provided with the paper. We do believe that the cell proliferation suppression assay is robust and works, but when it comes to the screening of the library of CDKN2A variants the lack of primary data and experimental detail prevents assessment of the scientific merit and experimental rigor.

      We are grateful for the opportunity to clarify our experimental methods and to provide additional data in the revised manuscript. The manuscript has been updated to include, among other changes, additional information on assay design, analysis of variant representation in the library, inclusion of primary data with variant level resolution, and a comparison of variant classifications using a gamma generalized linear model and log2 normalized fold change.

      Recommendations for the authors:

      Reviewer #1 (Recommendations For The Authors):

      Major issues:

      (1) Can the pathogenicity values of individual amino acid changes be opened to the public? It would serve as a valuable asset to the community.

      Thank you for your suggestion. We are happy to provide this information. Individual variant data and functional classifications from the functional assay are given in Appendix 1-table 4.

      (2) In the method section, it is not clear (at least to the reviewer) whether the protocol describing the construction of the CDKN2A missense library was provided.

      Thank you for your comment. We have included additional information in the manuscript describing construction of the CDKN2A missense library.

      “CDKN2A expression plasmid libraries

      Codon-optimized CDKN2A cDNA using p16INK4A amino acid sequence (NP_000068.1), was designed (Appendix 1-table 12) and pLJM1 containing codon optimized CDKN2A (pLJM1-CDKN2A) generated by Twist Bioscience (South San Francisco, CA). 156 plasmid libraries were then synthesized by using pLJM1-CDKN2A, such that each library contained all possible 20 amino acids variants (19 missense and 1 synonymous) at a given position, generating 500 ng of each plasmid library (Twist Bioscience, South San Francisco, CA). The proportion of variant in each library was shown in Appendix 1-table 2. Variants with a representation of less than 1% in a plasmid library were individually generated using the Q5 Site-Directed Mutagenesis kit (New England Biolabs, Ipswich, MA; catalog no. E0552), and added to each library to a calculated proportion of 5%. Primers used for site-directed mutagenesis are given in Appendix 1-table 13. Each library was then amplified to generate at least 5 ug of plasmid DNA using QIAGEN Plasmid Midi Kit (QIAGEN, Germantown, MD; catalog no. 12143).”

      (3) The paper lacks basic experimental results. The results cover almost all possible missense variants, but it would be clearer if actual coverage values used for calculating relative enrichment were shown. Are all variants well covered? Isn't there any spurious signal due to low coverage? How many times were the experiments performed? Also, how many cells were used, what was the expected MOI, and what proportion of harvested cells is thought to have a single variant? How can you distinguish the effect of a single variant from a multiple variants effect?

      We thank the reviewer for their comment. We have provided additional information in the manuscript to address these issues. Briefly, in response to each issue:

      (1) We have provided read count data for all variants, used to determine functional classifications based on either gamma generalized linear model or normalized fold change, in Appendix 1-table 4.

      (2) To assess if low variant coverage resulted in spurious signals, we compared prevalence of functionally deleterious classifications among variants binned by coverage in the Day 9 cell pool. We did not identify any statistically significant differences based on variant coverage.

      “We also determined whether underrepresentation in the cell pool at Day 9 affected variant functional classifications. Fifty-three of 2,964 missense variants (1.8%) were present in the cell pool at Day 9 of the first assay replicate (experiment 1) at < 2%, as determined by the number of sequence reads supporting the variant (Figure 2 -figure supplement 4A, Appendix 1-table 4). There was no statistically significant difference in the proportion of variants classified as functionally deleterious for variants present in less than 2% of the cell pool at Day 9 (12 of 53 variants; 22.6%), and variants present in more than 2% of the cell pool (496 of 2,911 variants; 17.0%) (P value = 0.28) (Figure 2 -figure supplement 4B). We also found no significant differences in the proportion of variants classified as functionally deleterious for variants present in more than 2% of the cell pool at Day 9 when variants were binned in 1% intervals (Figure 2 -figure supplement 4B).”

      (3) The assay was repeated in duplicate for 28 CDKN2A residues. For the remaining 128 residues of CDKN2A, the assay was completed once. We found good agreement between variant classifications in assay repeats. We have added to the text as follows:

      “To confirm the reproducibility of our variant classifications, 28 amino acid residues were assayed in duplicate, and variants classified using the gamma GLM. The majority of missense variants, 452 of 560 (80.7%), had the same functional classification in each of the two replicates (Figure 2 -figure supplement 3A and B, Appendix 1-table 4).”

      We have also added discussion of this study limitation to the manuscript:

      “We repeated our functional assay twice for 28 CDKN2A residues. For the remaining 128 residues of CDKN2A, the functional assay was completed once. While we found general agreement between functional classifications from each replicate for the 28 residues assayed in duplicate, additional repeats for each residue are necessary to determine variability in variant functional classifications.”

      (4) We have added additional information about the number of cells used for transduction and MOI to the method section:

      “Lentiviral transduction

      PANC-1 cells were used for CDKN2A plasmid library and single variant CDKN2A expression plasmid transductions. PANC-1 cells previously transduced with pLJM1-CDKN2A (PANC-1CDKN2A) and selected with puromycin were used for CellTag library transductions. Briefly, 1 x 105 cells were cultured in media supplemented with 10 ug/ml polybrene and transduced with 4 x 107 transducing units per mL of lentivirus particles. Cells were then centrifuged at 1,200 x g for 1 hour. After 48 hours of culture at 37oC and 5% CO2, transduced cells were selected using 3 µg/ml puromycin (CDKN2A plasmid libraries and single variant CDKN2A expression plasmids) or 5 µg/ml blasticidin (CellTag plasmid library) for 7 days. Expected MOI was one. After selection, cells were trypsinized and 5 x 105 cells were seeded into T150 flasks. DNA was collected from remaining cells and this sample was named as (Day 9). T150 flasks were cultured until confluent and then DNA was collected. The time for cells to become confluent varied for each amino acid residue (Day 16 – 40, Appendix 1-table 5).”

      (5) Our assay was not designed to distinguish multiple variant effects. However, we do not anticipate multiple transductions to significantly impact variant classifications in our assay. We found that our functional classifications were consistent with previously reported classifications:

      “In general, our results were consistent with previously reported classifications. Of variants identified in patients with cancer and previously reported to be functionally deleterious in published literature and/or reported in ClinVar as pathogenic or likely pathogenic (benchmark pathogenic variants), 27 of 32 (84.4%) were functionally deleterious in our assay (Figure 2B, Figure 2 -figure supplement 1B and 1C, Appendix 1-table 4) (Chaffee et al., 2018; Chang et al., 2016; Horn et al., 2021; Hu et al., 2018; Kimura et al., 2022; McWilliams et al., 2018; Roberts et al., 2016; Zhen et al., 2015). Five benchmark pathogenic variants were characterized as indeterminate function, with log2 P values from -19.3 to -33.2. Of 156 synonymous variants and six missense variants previously reported to be functionally neutral in published literature and/or reported in ClinVar as benign or likely benign (benchmark benign variants), all were characterized as functionally neutral in our assay (Figure 2B, Figure 2 -figure supplement 1B and 1C, Appendix 1-table 4) (Kimura et al., 2022; McWilliams et al., 2018; Roberts et al., 2016). Of 31 VUSs previously reported to be functionally deleterious, 28 (90.3%) were functionally deleterious and 3 (9.7%) were of indeterminate function in our assay. Similarly, of 18 VUSs previously reported to be functionally neutral, 16 (88.9%) were functionally neutral and 2 (11.1%) were of indeterminate function in our assay, (Figure 2B, Figure 2 -figure supplement 1B and 1C, Appendix 1-table 4).”

      (4) Comparison of functional classifications (shown in Figure 3) from this study and other in silico tools is superficial. The analysis is based on the presumption that their result is gold-standard, thereby calculating the sensitivity, accuracy, and PPV of individual predictors. But apparently, this won't be true, so it would be more reasonable to check the "correlation" of the study results and other predictors: e.g. which variants show consistent results between this study and other predictors? Are there any indicators of consistent vs inconsistent results? How does the consistency change by protein sequences or domains? Etc

      Thank you for your comment. We have added additional analysis to our manuscript comparing our functional classifications with in silico variant effect predictions. Specifically, we have included analysis combining multiple predictors:

      “We also tested the effect of combining multiple in silico predictors. 904 missense variants had in silico predictions from all 7 algorithms. The remaining 2,060 missense variants had in silico predictions from 5 algorithms. Of variants with in silico predictions from all 7 algorithms, 378 (41.8%) had predictions of deleterious or pathogenic effect from a majority of algorithms (≥ 4), and of these, 137 (36.2%) were functionally deleterious in our assay. Similarly, of 2,060 missense variants that had in silico predictions from 5 algorithms, 1107 (53.7%) had predictions of deleterious or pathogenic effect from a majority of algorithms (≥ 3), of which, 361 (32.6%) were functionally deleterious in our assay (Appendix 1-table 7).”

      (5) Similarly, Figure 4 does not deliver much information, either. Rather than delivering a simple summary, it would be more informative if deeper analyses were conducted. e.g., do pathogenic variants show higher frequency among patients, or higher variant frequency in tumors (if data were available).

      We have included additional analysis of somatic alterations in the manuscript. We found pathogenic/likely pathogenic somatic mutations were enriched in patients. This was also the case for somatic mutations that were classified as functionally deleterious in our assay. We also found statistically significant depletion of functionally deleterious mutations in colorectal adenocarcinoma. Interestingly, no patients with a somatic mutation in a mismatch repair gene had a functionally deleterious CDKN2A missense somatic mutation. However, this observation was not statistically significant. Future studies will determine whether CDKN2A and MMR gene somatic mutations are mutually exclusive in colorectal adenocarcinoma.

      “We found that 34.2% - 53.4% of unique missense somatic mutations classified as functionally deleterious, with 61.4% - 67.6% of patients having a functionally deleterious somatic mutation (Figure 4A, Appendix 1-table 9). As with functionally deleterious variants, functionally deleterious missense somatic mutations were also not distributed evenly across CDKN2A, being enriched within the ankyrin repeat 3 (Figure 4B, Appendix 1-table 9). We found that 32.4% - 50.0% of all functionally deleterious missense somatic mutations occurred within ankyrin repeat 3, with 48.0% - 58.0% of patients in each cohort having a functionally deleterious missense somatic mutation in this domain. Notably, 65.7% - 76.0% of functionally deleterious missense somatic mutations in this domain were in residues 80-89 (Appendix 1-table 9).”

      “We were also able to determine the functional classification of CDKN2A missense somatic mutations in COSMIC, TCGA, JHU, and MSK-IMAPCT by cancer type. We found that 22.2% - 100% of CDKN2A missense somatic mutations were functionally deleterious depending on cancer type (Figure 4-figure supplement 2A-D). When considering missense somatic mutation reported in any database, there was a statistically significant depletion of functionally deleterious mutations in colorectal adenocarcinoma (20.4%; adjusted P value = 5.4 x 10-9) (Figure 4C). As the proportion of missense somatic mutations that were functionally deleterious was less in colorectal carcinoma compared to other types of cancer, we assessed whether somatic mutations in mismatch repair genes (MLH1, MLH3, MSH2, MSH6, PMS1, and PMS2) were associated with the functional status of CDKN2A missense somatic mutations. Thirty-five patients in COSMIC had a CDKN2A missense somatic mutation, of which 12 (34.3%) had a somatic mutation in a mismatch repair gene. We found that no patients with a somatic mutation in a mismatch repair gene had a functionally deleterious CDKN2A missense somatic mutation compared to 6 of 23 samples (26.1%) without a somatic mutation in a mismatch repair gene (P value = 0.062).”

      (6) It would be helpful to validate the neutral variants set. Are variants of UK biobank or gnomAD enriched on neutral population? Are synonymous variants exclusively found in neutral populations?

      Thank you for the suggestion. All synonymous variants were found to functionally neutral in our assay. We also assessed VUSs from gnomAD and found a lower prevalence of functionally deleterious variants compared to all CDKN2A variants and CDKN2A missense somatic mutations:

      “The Genome Aggregation Database (gnomAD) v4.1.0 reports 287 missense variants in CDKN2A, including the 13 pathogenic, 4 likely pathogenic, 3 likely benign, 3 benign, and 264 VUSs classified using ACMG variant interpretation guidelines (Figure 5A, Figure 5B, and Appendix 1-table 10). Of the 264 missense VUSs, 177 were functionally neutral (67.0%), 56 (21.2%) were indeterminate function, and 31 (11.7%) were functionally deleterious in our assay using the gamma GLM for classification (Figure 5C).”

      (7) They used a pancreatic cancer cell line and assayed for cell proliferation. The limitations of this method and the possibility of complementing the limitations should be discussed.

      Thank you for the suggestion. We have added discussion of this limitation to our manuscript:

      “We characterized variants based upon a broad cellular phenotype, cell proliferation, in a single PDAC cell line. It is possible that CDKN2A variant functional classifications are cell-specific and assay-specific. Our assay may not encompass all cellular functions of CDKN2A and an alternative assay of a specific CDKN2A function, such as CDK4 binding, may result in different variant functional classifications. Furthermore, CDKN2A variants may have different effects if alternative cell lines are used for the functional assay. However, cell-specific effects appear to be limited. In our previous study, we characterized 29 CDKN2A VUSs in three PDAC cell lines, using cell proliferation and cell cycle assays, and found agreement between all functional classifications (Kimura et al., 2022).”

      Minor issues:

      (1) Figures 2B, C: it would be more intuitive to plot significance by logging p-values than raw p-values.

      We used log2 P value (or log2 normalized fold change) for figures in the manuscript as appropriate.

      (2) Figure 2D: annotate protein domain information at the side. Supplementary Figure 2 shows the domains but it would be more informative to show it in Figure 2D heatmap.

      Thank you for the suggestion, we have annotated protein domain information on the left side of the heatmap in (the now) Figure 2C.

      Reviewer #2 (Recommendations For The Authors):

      Major Concerns:

      (1) How many replicates of the screen were performed? It seems like only one library infection/ proliferation assay was done. If so this is insufficient to obtain any idea of the uncertainty of measurement for each variant.

      The assay was repeated in duplicate for 28 CDKN2A residues. For the remaining 128 residues of CDKN2A, the assay was completed once. We found good agreement between variant classifications in assay repeats. We have added to the text as follows:

      “To confirm the reproducibility of our variant classifications, 28 amino acid residues were assayed in duplicate, and variants classified using the gamma GLM. The majority of missense variants, 452 of 560 (80.7%), had the same functional classification in each of the two replicates (Figure 2 -figure supplement 3A and B, Appendix 1-table 4).”

      We have also added discussion of this study limitation to the manuscript:

      “We repeated our functional assay twice for 28 CDKN2A residues. For the remaining 128 residues of CDKN2A, the functional assay was completed once. While we found general agreement between functional classifications from each replicate for the 28 residues assayed in duplicate, additional repeats for each residue are necessary to determine variability in variant functional classifications.”

      (2) The count data from the experiment and NGS pipeline to call variants need to be provided for each replication (i.e. the counts that were fed into the gamma model)

      Accompanying this should be information about the depth of sequencing of the cells, the number of cells infected with the library, and standard metrics for pooled screens.

      Quality metrics regarding the representation and completeness of the TWIST library need to be provided. See Brenan et al. Cell Reports (2016) Supplemental Figure 1

      Thank you for your suggestion. We are happy to provide this additional information. Sequence read counts for each variant are given in Appendix 1-table 4. We have provided addition detail in the methods section on functional assay, including number of cells infected with each library:

      “Lentiviral transduction

      PANC-1 cells were used for CDKN2A plasmid library and single variant CDKN2A expression plasmid transductions. PANC-1 cells previously transduced with pLJM1-CDKN2A (PANC-1CDKN2A) and selected with puromycin were used for CellTag library transductions. Briefly, 1 x 105 cells were cultured in media supplemented with 10 ug/ml polybrene and transduced with 4 x 107 transducing units per mL of lentivirus particles. Cells were then centrifuged at 1,200 x g for 1 hour. After 48 hours of culture at 37oC and 5% CO2, transduced cells were selected using 3 µg/ml puromycin (CDKN2A plasmid libraries and single variant CDKN2A expression plasmids) or 5 µg/ml blasticidin (CellTag plasmid library) for 7 days. Expected MOI was one. After selection, cells were trypsinized and 5 x 105 cells were seeded into T150 flasks. DNA was collected from remaining cells and this sample was named as (Day 9). T150 flasks were cultured until confluent and then DNA was collected. The time for cells to become confluent varied for each amino acid residue (Day 16 – 40, Appendix 1-table 5). DNA was extracted from PANC-1 cells using the PureLink Genomic DNA Mini Kit (Invitrogen, Carlsbad, CA; catalog no. K1820-01). The assay for CellTag library was repeated in triplicate. We repeated our CDKN2A assay in duplicate for 28 residues. For the remaining 128 CDKN2A residues the assay was completed once.”

      We have also provided additional information on the TWIST library:

      “CDKN2A expression plasmid libraries

      Codon-optimized CDKN2A cDNA using p16INK4A amino acid sequence (NP_000068.1), was designed (Appendix 1-table 12) and pLJM1 containing codon optimized CDKN2A (pLJM1-CDKN2A) generated by Twist Bioscience (South San Francisco, CA). 156 plasmid libraries were then synthesized by using pLJM1-CDKN2A, such that each library contained all possible 20 amino acids variants (19 missense and 1 synonymous) at a given position, generating 500 ng of each plasmid library (Twist Bioscience, South San Francisco, CA). The proportion of variant in each library was shown in Appendix 1-table 2. Variants with a representation of less than 1% in a plasmid library were individually generated using the Q5 Site-Directed Mutagenesis kit (New England Biolabs, Ipswich, MA; catalog no. E0552), and added to each library to a calculated proportion of 5%. Primers used for site-directed mutagenesis are given in Appendix 1-table 13. Each library was then amplified to generate at least 5 ug of plasmid DNA using QIAGEN Plasmid Midi Kit (QIAGEN, Germantown, MD; catalog no. 12143).”

      (3) It is unclear when barcode abundance is assessed in the cell proliferation assay/in the screen. The exact timepoints of "before and after in vitro culture" (line 91) need to be clarified in the text.

      We are happy to clarify. We collected DNA on Day 9 post transfection and at confluency. Day of confluency for each residue is detailed in Appendix 1-table 5. The text of the manuscript has been updated appropriately.

      (4) Is "before" day 9, as detailed in Figure 1 source data 1? If so, it is misleading to state that the experiment is in culture for 14 days but call day 9 "before... in vitro culture."

      The "before" sample should be obtained immediately after viral infection and selection with the library to provide a representation of library representation.

      We apologize for your confusion. We have clarified in the text and figures that our baseline measurement was at Day 9 post transfection. We also determined whether the proportion of each variant is maintained in the Day 9 cell pool compared to the amplified plasmid library for three CDKN2A amino acid residues (p.R24, p.H66, and p.A127) and updated the manuscript text:

      “To confirm that the representation of each variant was maintained after transduction, we transduced three lentiviral libraries (amino acid residues p.R24, p.H66, and p.A127) individually into PANC-1 cells and determined the proportion of each variant in the amplified plasmid library and in the cell pool at Day 9 post-transduction. The proportion of each variant in the amplified plasmid library and in the cell pool at Day 9 were highly correlated (Figure 1 -figure supplement 2C and D, Appendix 1-table 3).”

      (5) There is no information regarding the function of each variant, aside from just a p-value resulting from the final analysis with the gamma model. Some variants may cause loss of function, others may be neutral while others may be gain of function. Simply providing a p-value is not sufficient. The standard in the field is to provide a function score/ test-statistic giving the sign and magnitude of the effect. For proliferation assays at least a ratio of fold-change of (mut/ synonymous)[day 14] vs (mut/synonymous)[baseline] should be provided.

      Thank you for your comment. We have provided read counts, P values, and functional classifications for each variant using the gamma GLM in Appendix 1-table 4. We have also analyzed variants using log2 normalized fold change. This data is presented in the text and compared to our classifications with the gamma GLM. We have provided normalized fold change and resulting classification for each variant in Appendix 1-table 6.

      (6) A plot of the distribution of function scores for all variants is needed. This will serve as an effective visual to distinguish the control variants from those that are functionally deleterious or benign/neutral (see Findlay et al. Nature (2018) Figure 3A for an example visual).

      Thank you for your suggestion. We have provided additional figures to visualize distribution of assay outputs using the gamma GLM in Figure 2 -figure supplement 1.

      (7) Synonymous variants are used as a proxy for WT per variant library, but do all the synonymous variants truly behave like WT CDKN2A in their ability to suppress cell proliferation? A plot of the distribution of synonymous variant function relative to WT CDKN2A function would be effective here.

      All 156 synonymous variants suppressed cell proliferation and were classified as functionally neutral in our assay using the gamma GLM. The manuscript has been updated to reflect this:

      “Of 156 synonymous variants and six missense variants previously reported to be functionally neutral in published literature and/or reported in ClinVar as benign or likely benign (benchmark benign variants), all were characterized as functionally neutral in our assay (Figure 2B, Figure 2 -figure supplement 1B and 1C, Appendix 1-table 4)”

      (8) The gamma generalized linear model is not commonly used to analyze the results of saturation mutagenesis screens. Please provide a justification for the use of this analysis method vs using log fold change as other dms scan studies have done (PMID: 27760319, PMID: 30224644).

      Thank you for this important suggestion. We are happy to provide additional information. We used a gamma GLM to functionally characterize CDKN2A variants as it does not rely on an annotated set of pathogenic and benign variants to determine classification thresholds. Instead, classification thresholds are determined using the change in representation of 20 non-functional barcodes in a pool of PANC-1 cells stably expressing CDKN2A after a period of in vitro growth. As a gamma GLM is not commonly used for saturation mutagenesis screens, as noted by the reviewer, we also classified variants using log2 normalized fold change. We compared variant functional classifications using the gamma GLM and log2 normalized fold change and in general we found agreement between both methods with 98.5% of missense variants classified as functionally deleterious using a gamma GLM, similarly classified using log2 normalized fold change. We have updated the text to reflect this reasoning and additional analysis.

      (9) The statistical methods used to calculate enrichment of deleterious variants per region of CDKN2A (Figure 2 supplement 1B; lines 163-168) are not described anywhere in the paper. Additionally, the same statistical analysis is not applied to the variants in the subregions near the ankyrin repeats (lines 168-172).

      We are happy to clarify and have added text to the methods section:

      “Z-tests with multiple test correction performed with the Bonferroni method was used in the following comparisons: 1) proportion of functionally deleterious variants present in < 2% of the cell pool and ≥ 2% of the cell pool at Day 9 binned in 1% intervals, 2) proportion of variants in each domain predicted to have deleterious or pathogenic effect by the majority of algorithms, 3) proportion of functionally deleterious variants in each domain, and 4) proportion of functionally deleterious missense variants and somatic mutations.”

      Minor:

      (1) Please review the manuscript for spelling and grammatical errors.

      Sure.

    1. Author response:

      Reviewer #1:

      Weaknesses:

      However, the authors should conduct a more thorough computational analysis to complement their manuscript. While the identification of improved multi-point mutants is commendable, the manuscript lacks a detailed investigation into the mechanisms by which these mutations enhance protein properties. The authors briefly mention that some physicochemical characteristics of the mutants are unusual, but they do not delve into why these mutations result in improved performance. Could computational techniques, such as molecular dynamics simulations, be employed to explore the effects of these mutations?  Additionally, the authors claim that their method is efficient. However, the selected VHH is relatively short (<150 AA), resulting in lower computational costs. It remains unclear whether the computational cost of this approach would still be acceptable when designing larger proteins (>1000 AA). Besides, the design process involves a large number of prediction tasks, including the properties of both single-site saturation and multi-point mutants. The computational load is closely tied to the protein length and the number of mutation sites. Could the authors analyze the model's capability boundaries in this regard and discuss how scalable their approach is when dealing with larger proteins or more complex mutation tasks?

      We agree that further analysis of the mechanisms by which the identified mutations enhance protein performance would strengthen our study. In the revised manuscript, we plan to conduct molecular dynamics simulations to explore the physicochemical effects of these mutations in more details. This analysis will help elucidate how the observed structural and dynamic changes contribute to the improved resistance and stability of the designed VHH antibody.

      We acknowledge the need to assess the scalability of our method to larger proteins. To address this, we will include an analysis of the method’s performance when applied to longer proteins, including an estimation of computational cost and potential bottlenecks.

      Reviewer #2:

      (1) The writing throughout the paper is poor. This leaves the reader confused.

      (2) The main technical issue the authors address is whether AI can identify protein mutations that adapt to extreme environments based solely on natural protein data. However, the introduction could be more concise and focused on the key points to better clarify the significance of this question.

      (3) The authors did not develop a new model but instead used their previously developed Pro-PRIME model. This significantly weakens the novelty and contribution of this work.

      (4) The computational experiments are not well-justified. For instance, the authors used a zero-shot setting for single-point mutation experiments but opted for fine-tuning in multiple-point mutation experiments. There is no clear explanation for this discrepancy. How does the model perform in zero-shot settings for multiple-point mutations? How would fine-tuning affect single-point mutation results? The choice of these strategies seems arbitrary and lacks sufficient discussion.

      (1&2) We will revise the manuscript to improve the overall clarity and readability. Specifically, we will restructure the introduction to focus more concisely on the key scientific questions and contributions of our study.

      (3) While the Pro-PRIME model was previously developed, this work focuses on designing proteins with properties that do not naturally exist and are scarce in the natural world. To address the concern about novelty, we will expand the discussion to highlight this unique contribution and its implications for advancing protein design.

      (4) We appreciate the comment regarding the discrepancy between the zero-shot and fine-tuning strategies. In the revised manuscript, we will provide a detailed explanation for the choice of these settings, including an analysis of the trade-offs between zero-shot and fine-tuning approaches in multi-point mutation tasks. We will also explore the model’s performance in zero-shot settings for multi-point mutations and report these results in the supplementary materials to ensure completeness.

    1. Author response:

      The following is the authors’ response to the original reviews.

      Reviewer #1 (Public Review):

      Summary:

      Qin and colleagues analysed data from the Human Connectome Project on four right-handed subgroups with different gyrification patterns in Heschl's gyrus. Based on these groups, the authors highlight the structure-function relationship of planum temporale asymmetry in lateralised language processing at the group level and next at the individual level. In particular, the authors propose that especially microstructural asymmetries are related to functional auditory language asymmetries in the planum temporale.

      Strengths:

      The study is interesting because of an ongoing and long-standing debate about the relationship between structural and functional brain asymmetries, and in particular whether structural brain asymmetries can be seen as markers of functional language brain lateralisation.

      In this debate, the relationship between Heschl's gyrus asymmetry and planum temporale asymmetry is rare and therefore valuable here. A large sample size and inter-rater reliability support the findings.

      Weaknesses:

      In this case of multiple brain measures, it would be important to provide the reader with some sort of effect size (e.g. Cohen's d) to help interpret the results.

      Thank you for pointing this out. In the revised version, the effect size, i.e., Cohen's d, has been incorporated into the results (page 8, line 159-160; page 9, line 181-186, supplementary page 14, Table S14).

      In addition, the authors highlight the microstructural results in spite of the macrostructural results. However, the macrostructural surface results are also strong. I would suggest either reducing the emphasis on micro vs macrostructural results or adding information to justify the microstructural importance.

      In the original manuscript, we highlighted the results of microstructural measures because the correlations between PT microstructural and functional measures were more pronounced both within the hemispheres and in terms of asymmetry, compared with the significant results of surface area. Following your comments here, we now lowered the tone of microstructure results (page 2, line 40; page 14, line 267), and added relevant discussion regarding the macrostructural results in the revised version (page 18, line 363-370; as copied below):

      “As for macrostructural measures, the asymmetric PT surface area was also associated with speech comprehension AI. Given that the within-hemispheric coupling tendency between surface and speech comprehension existed only in the left PT, it was possible that the larger surface area of the left PT led to a less recruitment of its right homologous, and therefore the lateralization of functional activity would be more pronounced. Additionally, an opposite tendency was found between the correlation of speech perception and comprehension with surface area, potentially implying the segregation of the different speech processing in the PT area.”

      Recommendations for the authors:

      I have only some comments that I wish to be addressed by the authors:

      (1) Please always specify "structural" or "functional" asymmetry or lateralisation, as the reader may be confused.

      This has been done in relevant places.

      (2) Please state that the scale is not the same between the results in Figure 3.

      This have been specified, as suggested (see below).

      “Notably, we did not standardize these structural measures, so the scales differed between indicators.”

      (3) It may be of interest to the reader to learn more about interpretations of how Heschl's gyrus and planum temporale asymmetries are related.

      Thank you for this comment. Given that the asymmetry of Heschl's gyrus was not analyzed in the present study, we do not have direct data/results for such an interpretation. Also, we reviewed the literature but found no relevant results on how Heschl's gyrus and planum temporale asymmetries are related. To address this, specific investigation targeting on this topic is needed. This has now been added in the discussion (page 20, line 415-417).

      (4) As this manuscript builds somewhat on the Science Advances article by Ocklenburg et al. (2018), it would be important to discuss how this more liberal planum temporale definition might (or might not) affect the results compared to the more conservative planum temporale definition described here.

      Yes, the definition of planum temporale varies across studies. Our current manual one is relatively more conservative than the Ocklenburg et al. (2018), in which the planum temporale was automatically derived from the Destrieux atlas. We believe that the definition of the planum temporale likely have non-trivial impact on the results, and our current manual definition with the consideration of the HG duplication should be more reliable and accurate, therefore favored, relative to the other ones. This has been briefly discussed in the revision (page 15-16, line 300-304).

      (5) I would like the authors to briefly but critically discuss what exactly the MRI NODDI model measures and how this is interpreted as measuring microstructural properties of tissue.

      We now provided relevant information regarding the NODDI measures (page 26, line 552-558; as copied below).

      “NODDI is a highly effective method for detecting key features of neurite morphology, which employs a tissue model that detects three microstructural environments: the intracellular, extracellular and cerebrospinal fluid compartments (Zhang et al., 2012). In the grey matter of the cerebral cortex, the neurite density index (NDI) is an estimated volume fraction of the intracellular microstructural environment, with higher NDIs indicating greater neurite density (Jespersen et al., 2010; Zhang et al., 2012). The orientation dispersion index (ODI) is a measure of the alignment or dispersion of neurite, with higher ODIs indicating more dispersed neurite and lower ODIs indicating more aligned neurite (Jespersen et al., 2012; Zhang et al., 2012).”

      (6) While not mandatory, I would be interested to read the authors' thoughts on the evolution of such a functional/(micro)structural lateralisation link of the planum temporale, in light of the literature on planum temporale asymmetries in (newborn) non-human primate species.

      Thank you for this inspiring suggestion. We have incorporated relevant discussion into the revised version (page 15, line 281-288; as copied below).

      “Moreover, there exist evolutionary evidence supporting the role of the PT as an anatomical substrate for language lateralization. For example, the leftward structural asymmetry of the PT have been observed in multiple non-human primates, including chimpanzees, macaques, and baboons (Becker et al., 2024; Gannon et al., 1998; Xia et al., 2019). Particularly, recent studies on baboons further demonstrated that PT structural leftward asymmetry in newborn baboons could predict future development of communicative gestures, implying a key role of PT structural asymmetry in the lateralized communication system for human and non-human brain evolution (Becker et al., 2024, 2021).”

      Reference

      Becker Y, Phelipon R, Marie D, Bouziane S, Marchetti R, Sein J, Velly L, Renaud L, Cermolacce A, Anton J-L, Nazarian B, Coulon O, Meguerditchian A. 2024. Planum temporale asymmetry in newborn monkeys predicts the future development of gestural communication’s handedness. Nat Commun 15:4791. doi:10.1038/s41467-024-47277-6

      Becker Y, Sein J, Velly L, Giacomino L, Renaud L, Lacoste R, Anton J-L, Nazarian B, Berne C, Meguerditchian A. 2021. Early Left-Planum Temporale Asymmetry in newborn monkeys (Papio anubis): A longitudinal structural MRI study at two stages of development. NeuroImage 227:117575. doi:10.1016/j.neuroimage.2020.117575

      Gannon PJ, Holloway RL, Broadfield DC, Braun AR. 1998. Asymmetry of Chimpanzee Planum Temporale: Humanlike Pattern of Wernicke’s Brain Language Area Homolog. Science 279:220–222. doi:10.1126/science.279.5348.220

      Jespersen SN, Bjarkam CR, Nyengaard JR, Chakravarty MM, Hansen B, Vosegaard T, Østergaard L, Yablonskiy D, Nielsen NChr, Vestergaard-Poulsen P. 2010. Neurite density from magnetic resonance diffusion measurements at ultrahigh field: Comparison with light microscopy and electron microscopy. NeuroImage 49:205–216. doi:10.1016/j.neuroimage.2009.08.053

      Jespersen SN, Leigland LA, Cornea A, Kroenke CD. 2012. Determination of Axonal and Dendritic Orientation Distributions Within the Developing Cerebral Cortex by Diffusion Tensor Imaging. IEEE Trans Med Imaging 31:16–32. doi:10.1109/TMI.2011.2162099

      Xia J, Wang F, Wu Z, Wang L, Zhang C, Shen D, Li G. 2019. Mapping hemispheric asymmetries of the macaque cerebral cortex during early brain development. Hum Brain Mapp. doi:10.1002/hbm.24789

      Zhang H, Schneider T, Wheeler-Kingshott CA, Alexander DC. 2012. NODDI: Practical in vivo neurite orientation dispersion and density imaging of the human brain. NeuroImage 61:1000–1016. doi:10.1016/j.neuroimage.2012.03.072

      Reviewer #2 (Public Review):

      Summary:

      The authors assessed the link between structural and functional lateralization in area PT, one of the brain areas that is known to exhibit strong structural lateralization, and which is known to be implicated in speech processing. Importantly, they included the sulcal configuration of Heschl's gyrus (HG), presenting either as a single or duplicated HG, in their analysis. They found several significant associations between microstructural indices and task-based functional lateralization, some of which depended on the sulcal configuration.

      Strengths:

      A clear strength is the large sample size (n=907), an openly available database, and the fact that HG morphology was manually classified in each individual. This allows for robust statistical testing of the effects across morphological categories, which is not often seen in the literature.

      Weaknesses:

      - Unfortunately, no left-handers were included in the study. It would have been a valuable addition to the literature, to study the effect of handedness on the observed associations, as many previous studies on this topic were not adequately powered. The fact that only right-handers were studied should be pointed out clearly in the introduction or even the abstract.

      Thank for pointing this out. We have explicitly specified this in the Abstract and Introduction.

      - The tasks to quantify functional lateralization were not specifically designed to pick up lateralization. In the interest of the sample size, it is understandable that the authors used the available HCP-task-battery results, however, it would have been feasible to access another dataset for validation. A targeted subset of results, concerning for example the relationship between sulcal morphology and task-based functional lateralization, could be re-assessed using other open-access fMRI datasets.

      Yes, the fMRI task was not specifically designed to evaluate PT functional lateralization, which has been acknowledged in the discussion (page 17, line 330-342). Given the observed small effect size of our current structural-functional relationship, reproducing similar results with other datasets would require a cohort with a large sample size. This would induce a quite labor-intensive work given our current manual protocol for outlining PT and HG for everyone. The lack of validation with independent dataset has been discussed as a limitation in the revised version. We will try to conduct such a validation in future work, likely after developing an automatic pipeline for accurately extracting the PT and HG in the individual space (like the manual outlining protocol).

      - The study is mainly descriptive and the general discussion of the findings in the larger context of brain lateralization comes a bit short. For example, are the observed effects in line with what we know from other 'language-relevant' areas? What could be the putative mechanisms that give rise to functional lateralization based on the microstructural markers observed? And which mechanisms might be underlying the formation of a duplicated HG?

      Thank you for these insightful comments. As suggested, we strengthened the discussion as below:

      “Another possible explanation could be that higher myelin content and larger surface area in left PT potentially indicated more white matter connection with other language-related regions such as Broca’s area, and therefore is more involved in language tasks than its right homolog (Allendorfer et al., 2016; Catani et al., 2005; Giampiccolo and Duffau, 2022).

      The distinct roles of left and right PT in speech processing have been well-documented. A number of studies substantiated that PT of the left hemisphere responded more strongly to lexical-semantic and syntactic aspects of sentence processing, whereas the right hemisphere demonstrated a greater involvement in the speech melody (Albouy et al., 2020; Meyer et al., 2002).

      These findings are consistent with those reported for the arcuate fasciculus (AF). The left AF has been identified as a crucial structure for language function (Giampiccolo and Duffau, 2022; Zhang et al., 2021). Disruption to this pathway has been linked to multimodal phonological and semantic deficits (Agosta et al., 2010), while injuries in the right AF did not affect language function (Zeineh et al., 2015).”

      Regarding the mechanism underlying the formation of a duplicated HG, we did not come up with good thoughts after careful literature review. Also, we feel that this is kind of out of the scope of the present study and therefore did not add more discussion on this topic.

      Recommendations for the authors:

      (1) The data availability statement makes no explicit mention of the manual labels of HG configuration. Would the authors consider making available a list of HCP-subject-ID with a morphological group (L1/R1, L1/R2, etc.) for replicability and for re-use by other researchers?

      The list of HCP-subject-ID with a morphological group (L1/R1, L1/R2, etc.) is now available in the supplementary material 2. We have specified this in the revised version.

      (2) It would be helpful to state again the statistical tests associated with the p-value in the figure/table caption, e.g. Table 2.

      As suggested, we now specified the statistical method in the figure/table caption.

      (3) Sometimes, the y-axis labels are missing or not clear, for example in Figure S2.

      Sorry about these. We double-checked all the figures, and corrected the missing or unclear labels for Figure S2 and S3 in the revised version.

      (4) In a few instances the font sizes vary within a figure caption.

      This has been corrected in the revision.

      Reference

      Agosta F, Henry RG, Migliaccio R, Neuhaus J, Miller BL, Dronkers NF, Brambati SM, Filippi M, Ogar JM, Wilson SM, Gorno-Tempini ML. 2010. Language networks in semantic dementia. Brain J Neurol 133:286–299. doi:10.1093/brain/awp233

      Albouy P, Benjamin L, Morillon B, Zatorre RJ. 2020. Distinct sensitivity to spectrotemporal modulation supports brain asymmetry for speech and melody. Science 367:1043–1047. doi:10.1126/science.aaz3468

      Allendorfer JB, Hernando KA, Hossain S, Nenert R, Holland SK, Szaflarski JP. 2016. Arcuate fasciculus asymmetry has a hand in language function but not handedness. Hum Brain Mapp 37:3297–3309. doi:10.1002/hbm.23241

      Catani M, Jones DK, Ffytche DH. 2005. Perisylvian language networks of the human brain. Ann Neurol 57:8–16. doi:10.1002/ana.20319

      Giampiccolo D, Duffau H. 2022. Controversy over the temporal cortical terminations of the left arcuate fasciculus: a reappraisal. Brain J Neurol 145:1242–1256. doi:10.1093/brain/awac057

      Meyer M, Alter K, Friederici AD, Lohmann G, von Cramon DY. 2002. FMRI reveals brain regions mediating slow prosodic modulations in spoken sentences. Hum Brain Mapp 17:73–88. doi:10.1002/hbm.10042

      Zeineh MM, Kang J, Atlas SW, Raman MM, Reiss AL, Norris JL, Valencia I, Montoya JG. 2015. Right arcuate fasciculus abnormality in chronic fatigue syndrome. Radiology 274:517–526. doi:10.1148/radiol.14141079

      Zhang H, Schneider T, Wheeler-Kingshott CA, Alexander DC. 2012. NODDI: Practical in vivo neurite orientation dispersion and density imaging of the human brain. NeuroImage 61:1000–1016. doi:10.1016/j.neuroimage.2012.03.072

      Zhang J, Zhong S, Zhou L, Yu Yamei, Tan X, Wu M, Sun P, Zhang W, Li J, Cheng R, Wu Y, Yu Yanmei, Ye X, Luo B. 2021. Correlations between Dual-Pathway White Matter Alterations and Language Impairment in Patients with Aphasia: A Systematic Review and Meta-analysis. Neuropsychol Rev 31:402–418. doi:10.1007/s11065-021-09482-8

      Reviewing Editor:

      I encourage the authors to incorporate the suggestions of the reviewers, such as:

      (1) to provide more in-depth interpretations about how and why structural and functional lateralization relate,

      Done.

      (2) to provide statistical effect sizes,

      Done.

      (3) to make their sulcal-morphology classification openly available,

      Done.

      (4) to provide statistical effect sizes,

      Done

      (5) to discuss the possible impact of diverging PT definitions with regard to previous studies,

      Done.

      (6) to provide more in-depth interpretations about how and why structural and functional lateralization relate.

      Done.

      Detailed comments:

      In an impressive cohort of 907 human participants, the present paper presents a very interesting set of data on PT asymmetries not only at the macro-structural but also at the microstructural levels in order to investigate their potential correlates with PT functional asymmetry in relation to perceptual acoustic language tasks.

      I believe this is a key paper for the following reasons:

      (1) it provides critical data and results for addressing a controversial but important question: the relevance of measures of anatomical asymmetry for inferring its language-related functional hemispheric specialization;

      (2) to do so, the authors made a very impressive effort to manually trace the anatomical delineation of the planum temporale at different levels in every participant, the best (but crazy time-consuming) approach so far to document interindividual variability of the PT and to address such a question;

      (3) the contribution is particularly relevant regarding the statistical power of the study, the study and measures having been done in 907 participants!

      (4) I also found the study well designed and well written with great relevance of the findings for the field.

      As the results, the authors reported asymmetric measures of microstructural asymmetry (including intracortical myelin content, neurite density, and neurite orientation) but also of macrostructural asymmetries in relation to functional lateralization for language.

      Comments:

      I have only 2 additional minor comments of my own:

      (1) In agreement with reviewer 2, I don't understand why the authors seem to downplay the links they found between gross PT asymmetry and functional lateralization. I recommend the authors to highlight and discuss this important result, just as the microstructural PT asymmetries and their functional links.

      This has been done (page 18, line 363-370).

      (2) PT structural asymmetry (both micro & macro) has been well documented in nonhuman primates (and their functional link with manual lateralization for gestural communication). Without detailing this literature, I recommend the authors at least mention this literature as a comparative perspective in the introduction and/or discussion in order to make the question of PT asymmetry less anthropocentric.

      This has been done (page 15, line 281-288).

    1. Author response:

      We thank the reviewers for their feedback. We are currently revising the manuscript to address their questions and concerns. Here we briefly summarize our planned revisions.

      Reviewer 1 requested clarification on three points. We will clarify all these points with text edits. One point is brief enough to be addressed here: in cases when we pooled data from the left and right hemispheres, the reviewer wants to know how this was done. Simply put, we defined the “ipsi” side of the body as the side where the recorded DN resided, and we defined “contra” as the other side.

      Reviewer 2 requested clarification on two minor points. We will clarify these points with text edits and with an additional analysis.

      Reviewer 3 had a number of substantive concerns. Briefly:

      (1) The reviewer asks us to improve its discussion of some relevant literature. We will provide updated information on the DN steering network, and in particular, we will cite Bidaye et al. 2020 and Sapkal et al. 2024. We apologize for the oversight.

      (2) The reviewer asks us for immunofluorescent images documenting the expression patterns of our effector transgenes. With regard to GtACR1::eYPF expression, we will include these images in our resubmission. With regard to ReachR expression, we expressed this reagent stochastically under hs-FLP control, and so different brains had different expression patterns; however, we carefully documented the number of DNa02 cells that expressed ReachR in each brain. With regard to GFP expression, these expression patterns are available online from the FlyLight documentation associated with Namiki et al. eLife 2018 (https://splitgal4.janelia.org/precomputed/Descending%20Neurons%202018.html). The UAS-GFP transgene used by Namiki et al. 2018 (pJFRC200-10XUASIVS-myr::smGFP-HA in attP18) is different from the UAS-GFP transgene we used (10XUAS-IVS-mCD8::GFP(su(Hw)attP8), and so there may be minor differences in expression pattern. However, it should be noted that we only used GFP expression to target somata for patch clamp recording, and DNa01 and DNa02 somata have a distinctive location and a distinctive size; when we performed these recordings, we only targeted a soma in this location, and we verified that there were no “distractor” somata in this vicinity with similar size and appearance. The same applies to patch clamp recordings targeted via Halo7 expression (SiR110-HaloTag fluorescence). In paired recordings from both DNa02 and DN01, we verified the identity of each cell as described in Fig. S1.

      (3) The reviewer asks why we focused on DNa02 in the latter part of the manuscript, rather than DNa01. We made this decision because DNa02 is more highly predictive of steering behavior, as compared to DNa01 (Fig. 1H). Also, an impulse of DNa02 activity is followed by a relatively large turning maneuver, on average, whereas an impulse of DNa01 activity is followed by a relatively small turning maneuver (Fig. 1E-F). Moreover, DNa02 has many more synaptic inputs in the brain (Fig. 7A), and it has many more direct synaptic connections onto motor neurons (Fig. 1B).

      (4) The reviewer highlights difficulties in interpreting DN activity during backward movement (Figs. S3/S4). We included this material in the spirit of completeness, but we agree with the reviewer that it is difficult to interpret. In our revision, we will omit Fig. S3C and Fig. S4A-B, and we will revise these legends to improve clarity.

      (5) The reviewer asks why do a systematic analysis of paired DNa01 recordings, as we did for DNa02. It is difficult to get paired right/left recordings from two DNs of the same type in the same fly, while the fly is walking vigorously, and we were only able to get two such paired recordings from DNa01. We did not feel this was a sufficiently large sample size to support a systematic analysis. We chose not to invest more time in getting more paired DNa01 recordings because we thought that DNa02 was more important, for the reasons noted above.

      (6) The reviewer asks for an analysis of trials where bump-jump led to turning in the opposite direction to the DNa02 being recorded. We will provide this analysis in the revision.

      (7) The reviewer points out that “latent” steering drives might not be latent, as they might produce small postural changes we are not capturing. This is a fair point, and we will note this in our revision.

      (8) The reviewer asks for a systematic analysis of DNa01 inputs in Figure 7, similar to our analysis of DNa02 inputs. Here we would prefer to focus on DNa02, for three reasons. First, we think DNa02 is likely more important, for the reasons noted above. Second, there has been some uncertainty as to the identity of DNa01 in connectome data; indeed, in the hemibrain data set, the cell recently identified as DNa01 was annotated as VES006 (Schlegel et al. Nature 634: 139-152). Third, the cell now identified as DNa01 does not receive direct input from either the central complex or the mushroom body, and for this reason, we felt that the inputs to DNa01 might be less interesting to a general audience.

      (9) The reviewer wonders whether DNa01 is more involved in sideways movement, rather than rotational movement. Our data do not support this conclusion: rather, our data show that DNa01 is only weakly correlated with sideways movement. Thus, the forward filter (Fig. 1F) shows that an impulse of DNa01 activity is (on average) followed by a relatively small amount of sideways movement. Conversely, the reverse filter (in Fig. S2I) shows that an impulse of sideways movement is (on average) preceded by a relatively large amount of DNa01 activity.

      (10) The reviewer points out that the phenotype associated with optogenetic suppression in Fig. 8G is weak. We will highlight this point and discuss potential reasons for this weak phenotype in the revision.

    1. Author response:

      The following is the authors’ response to the original reviews.

      This study presents a valuable finding on sperm flagellum and HTCA stabilization. The evidence supporting the authors' claims is incomplete. The work will be of broad interest to cell and reproductive biologists working on cilium and sperm biology.

      We thank the Editor and the two reviewers for their time and thorough evaluation of our manuscript. We greatly appreciate their valuable guidance on improving our study. In the revised manuscript, we have conducted additional experiments and provided quantitative data in response to the reviewers' comments. Furthermore, we have refined the manuscript and added further context to elucidate the significance of our findings for the readers.

      Public Reviews:

      Reviewer #1 (Public Review):

      In this paper, Wu et al. investigated the physiological roles of CCDC113 in sperm flagellum and HTCA stabilization by using CRISPR/Cas knockouts mouse models, co-IP, and single sperm imaging. They find that CCDC113 localizes in the linker region among radial spokes, the nexin-dynein regulatory complex (N-DRC), and doublet microtubules (DMTs) RS, N-DRC, and DMTs and interacts with axoneme-associated proteins CFAP57 and CFAP91, acting as an adaptor protein that facilitates the linkage between RS, N-DRC, and DMTs within the sperm axoneme. They show the disruption of CCDC113 produced spermatozoa with disorganized sperm flagella and CFAP91, DRC2 could not colocalize with DMTs in Ccdc113-/- spermatozoa. Interestingly, the data also indicate that CCDC113 could localize on the HTCA region, and interact with HTCA-associated proteins. The knockout of Ccdc113 could also produce acephalic spermatozoa. By using Sun5 and Centlein knockout mouse models, the authors further find SUN5 and CENTLEIN are indispensable for the docking of CCDC113 to the implantation site on the sperm head. Overall, the experiments were designed properly and performed well to support the authors' observation in each part. Furthermore, the study's findings offer valuable insights into the physiological and developmental roles of CCDC113 in the male germ line, which can provide insight into impaired sperm development and male infertility. The conclusions of this paper are mostly well supported by data, but some points need to be clarified and discussed.

      We thank Reviewer #1 for his or her critical reading and the positive assessment.

      (1) In Figure 1, a sperm flagellum protein, which is far away from CCDC113, should be selected as a negative control to exclude artificial effects in co-IP experiments.

      We greatly appreciate Reviewer #1’s insightful suggestion. In response, we selected two sperm outer dense fiber proteins, ODF1 and ODF2, which are located distant from the sperm axoneme, as negative controls in the co-IP experiments. As shown in Figure 1- figure supplement 1A and B, neither ODF1 nor ODF2 bound to CCDC113, indicating the interaction observed in Figure 1 is not an artifact.

      (2) Whether the detachment of sperm head and tail in Ccdc113-/- mice is a secondary effect of the sperm flagellum defects? The author should discuss this point.

      Good question. Considering that CCDC113 is localized in the sperm neck region and interacts with SUN5 and CENTLEIN, it may play a direct role in connecting the sperm head and tail. Indeed, PAS staining revealed that Ccdc113–/– sperm heads exhibit abnormal orientation in stages V–VIII of the seminiferous epithelia (Figure 6C-D). Furthermore, transmission electron microscopy (TEM) analysis indicated that the absence of CCDC113 caused detachment of the damaged coupling apparatus from the sperm head in step 9–11 spermatids (Figure 6E). These results suggest that the detachment of the sperm head and tail in Ccdc113–/– mice may not be a secondary effect of sperm flagellum defects. We have discussed this point further below:

      “CCDC113 can interact with SUN5 and CENTLEIN, but not PMFBP1 (Figure 7A-C), and left on the tip of the decapitated tail in Sun5–/– and Centlein–/– spermatozoa (Figure 7K and L). Furthermore, CCDC113 colocalizes with SUN5 in the HTCA region, and immunofluorescence staining in spermatozoa shows that SUN5 is positioned closer to the sperm nucleus than CCDC113 (Figure 7G and H). Therefore, SUN5 and CENTLEIN may be closer to the sperm nucleus than CCDC113. PAS staining revealed that Ccdc113–/– sperm heads are abnormally oriented in stages V–VIII seminiferous epithelia (Figure6 C and D), and TEM analysis further demonstrated that the disruption of CCDC113 causes the detachment of the destroyed coupling apparatus from the sperm head in step 9–11 spermatids (Figure 6E). All these results suggest that the detachment of sperm head and tail in Ccdc113–/– mice may not be a secondary effect of sperm flagellum defects.”

      (3) Given that some cytoplasm materials could be observed in Ccdc113-/- spermatozoa (Fig. 5A), whether CCDC113 is also essential for cytoplasmic removal?

      Good question. Unremoved cytoplasm could be detected in spermatozoa by using transmission electron microscopy (TEM) analysis, including disrupted mitochondria, damaged axonemes, and large vacuoles. These observations indicate defects in cytoplasmic removal in Ccdc113–/– mice. We have discussed this point as below:

      “Moreover, TEM analysis detected excess residual cytoplasm in spermatozoa, including disrupted mitochondria, damaged axonemes, and large vacuoles, indicating defects in cytoplasmic removal in Ccdc113–/– mice (Figure 5A).”

      (4) Although CCDC113 could not bind to PMFBP1, the localization of CCDC113 in Pmfbp1-/- spermatozoa should be also detected to clarify the relationship between CCDC113 and SUN5-CENTLEIN-PMFBP1.

      We appreciate Reviewer #1’s suggestion. We have analyzed the localization of CCDC113 in Pmfbp1-/- spermatozoa and found that CCDC113 was located at the tip of the decapitated tail in Pmfbp1-/- spermatozoa (Figure 7K and L). This finding has been incorporated into the revised manuscript as below:

      “To further elucidate the functional relationships among CCDC113, SUN5, CENTLEIN, and PMFBP1 at the sperm HTCA, we examined the localization of CCDC113 in Sun5-/-, Centlein–/–, and Pmfbp1–/– spermatozoa. Compared to the control group, CCDC113 was predominantly localized on the decapitated flagellum in Sun5-/-, Centlein–/–, and Pmfnp1–/– spermatozoa (Figure 7K and L), indicating SUN5, CENTLEIN, and PMFBP1 are crucial for the proper docking of CCDC113 to the implantation site on the sperm head. Taken together, these data demonstrate that CCDC113 cooperates with SUN5 and CENTLEIN to stabilize the sperm HTCA and anchor the sperm head to the tail.”

      Reviewer #2 (Public Review):

      Summary:

      In the present study, the authors select the coiled-coil protein CCDC113 and revealed its expression in the stages of spermatogenesis in the testis as well as in the different steps of spermiogenesis with expression also mapped in the different parts of the epididymis. Gene deletion led to male infertility in CRISPR-Cas9 KO mice and PAS staining showed defects mapped in the different stages of the seminiferous cycle and through the different steps of spermiogenesis. EM and IF with several markers of testis germ cells and spermatozoa in the epididymis indicated defects in flagella and head-to-tail coupling for flagella as well as acephaly. The authors' co-IP experiments of expressed CCDC113 in HEK293T cells indicated an association with CFAP91 and DRC2 as well as SUN5 and CENTLEIN.

      The authors propose that CCDC113 connects CFAP91 and DRC2 to doublet microtubules of the axoneme and CCDC113's association with SUN5 and CENTLEIN to stabilize the sperm flagellum head-to-tail coupling apparatus. Extensive experiments mapping CCDC13 during postnatal development are reported as well as negative co-IP experiments and studies with SUN5 KO mice as well as CENTLEIN KO mice.

      Strengths:

      The authors provide compelling observations to indicate the relevance of CCDC113 to flagellum formation with potential protein partners. The data are relevant to sperm flagella formation and its coupling to the sperm head.

      We are grateful to Reviewer #2 for his or her recognition of the strength of this study.

      Weaknesses:

      The authors' observations are consistent with the model proposed but the authors' conclusions for the mechanism may require direct demonstration in sperm flagella. The Walton et al paper shows human CCDC96/113 in cilia of human respiratory epithelia. An application of such methodology to the proteins indicated by Wu et al for the sperm axoneme and head-tail coupling apparatus is eagerly awaited as a follow-up study.

      We thank Reviewer 2 for his/her kindly help in improving the manuscript.  We now understand that directly detection of CCDC113 precise localization in sperm axoneme and head-tail coupling apparatus (HTCA) using cryo-electron microscopy (cryo-EM) could powerfully strengthen our model. Recent advances in cryo-EM have indeed advanced our understanding of axonemal structures analysis of axonemal structures and determined the structures of native axonemal DMTs from mouse, bovine, and human sperm (Leung et al., 2023; Zhou et al., 2023). However, high-resolution structures of sperm axoneme and HTCA regions, including those involving CCDC113, have yet to be fully characterized. Thus, we would like to discuss this point and consider it a valuable direction for future research.

      “Given that the cryo-EM of sperm axoneme and HTCA could powerfully strengthen the role of CCDC113 in stabilizing sperm axoneme and head-tail coupling apparatus, it a valuable direction for future research.”

      References:

      Bazan, R., Schröfel, A., Joachimiak, E., Poprzeczko, M., Pigino, G., & Wloga, D. (2021). Ccdc113/Ccdc96 complex, a novel regulator of ciliary beating that connects radial spoke 3 to dynein g and the nexin link. PLoS Genet, 17(3), e1009388.

      Ghanaeian, A., Majhi, S., McCafferty, C. L., Nami, B., Black, C. S., Yang, S. K., Legal, T., Papoulas, O., Janowska, M., Valente-Paterno, M., Marcotte, E. M., Wloga, D., & Bui, K. H. (2023). Integrated modeling of the Nexin-dynein regulatory complex reveals its regulatory mechanism. Nat Commun, 14(1), 5741.

      Leung, M. R., Zeng, J., Wang, X., Roelofs, M. C., Huang, W., Zenezini Chiozzi, R., Hevler, J. F., Heck, A. J. R., Dutcher, S. K., Brown, A., Zhang, R., & Zeev-Ben-Mordehai, T.  (2023). Structural specializations of the sperm tail. Cell, 186(13), 2880-2896.e2817

      Walton, T., Gui, M., Velkova, S., Fassad, M. R., Hirst, R. A., Haarman, E., O'Callaghan, C., Bottier, M., Burgoyne, T., Mitchison, H. M., & Brown, A. (2023). Axonemal structures reveal mechanoregulatory and disease mechanisms. Nature, 618(7965), 625-633.

      Zhou, L., Liu, H., Liu, S., Yang, X., Dong, Y., Pan, Y., Xiao, Z., Zheng, B., Sun, Y., Huang, P., Zhang, X., Hu, J., Sun, R., Feng, S., Zhu, Y., Liu, M., Gui, M., & Wu, J. (2023). Structures of sperm flagellar doublet microtubules expand the genetic spectrum of male infertility. Cell, 186(13), 2897-2910.e2819.

      Recommendations for the authors:

      Reviewer #1 (Recommendations For The Authors):

      (1) Please provide full gel for the Figure 2C experiment (could be as a supplementary file).

      Thanks for your insightful suggestions. We have replaced Figure 2C and provided the full gel in Figure 2-figure supplement 1A.

      (2) The authors write on Line 163 "In contrast, the flagellum staining appeared reduced in Ccdc113-/- seminiferous tubules (Fig. 2J, red asterisk)." However, the magnification of the pictures is not sufficient to distinguish anything in the panel mentioned, please provide others.

      Many thanks for pointing this out. We have provided the iconic figure to show the flagella defect in seminiferous tubules.

      (3) Please add statistical p-values for figures.

      Thanks for your valuable advice. We have added statistical p-values to the figures in the revised manuscript.

      (4) Line 128: Should "speculate" be "speculated"?

      Thank you for pointing out this problem. We have corrected it in the revised manuscript, as shown below:

      “Given that CFAP91 has been reported to stabilize RS on the DMTs (Bicka et al., 2022; Dymek et al., 2011; Gui et al., 2021) and cryo-EM analysis shows that CCDC113 is closed to DMTs, we speculated that CCDC113 may connect RS to DMTs by binding to CFAP91 and microtubules.”

      (5) In lines 384-385, more "-" is typed.

      Thank you for pointing out this problem. We have corrected it in the revised manuscript, as shown below:

      “Furthermore, CCDC113 colocalizes with SUN5 in the HTCA region, and immunofluorescence staining in spermatozoa shows that SUN5 is closer to the sperm nucleus than CCDC113 (Figure 7G and H). Therefore, SUN5 and CENTLEIN may be closer to the sperm nucleus than CCDC113.”

      (6) In general, the article has many typos and should be professionally proofread.

      Many thanks for pointing this out. We have thoroughly revised the manuscript with the assistance professional proofreading.

      Reviewer #2 (Recommendations For The Authors):

      Can the authors indicate in the Materials and Methods if n=3 biological replicates were done for all co-IP, EM, LM, and IF studies? The statistical analysis section indicates this but quantification is missing for most figures including co-IP, most IF, PAS staining, EM, etc.

      We thank Reviewer 2 for the insightful comments and guidance to improve our data quality. All the experiments in this study were repeated at least three times to ensure reproducibility. We have quantified the co-IP experiments in Figures 1C-H and 7A-F, the IF data in Figures 2K, 5C, and 5D, as well as the PAS staining in Figure 6C. Since electron microscopy samples require very little testicular tissue and the sections obtained are very thin, the likelihood of capturing sections specifically at the sperm head-tail junction is considerably low. This challenge makes it difficult to perform quantitative analysis and statistical evaluation in the TEM experiment. To address this limitation, we have quantified the percentage of _Ccdc113-/-_sperm heads with abnormal orientation in stages V–VIII of the seminiferous epithelium to indicate impaired head-to-tail anchorage.

      Figure S2 is compelling and might be indicated as a major figure instead of a supplementary figure.

      We appreciate the positive comment. We have included it as a major figure in Figure 3F.

      Figure 4A may be incomplete. Data sets for RNA expression suggest high expression in the ovary and other organs in males and females including the brain and are not indicated by the authors. Figure 4A may be considered for removal with a more complete study for another paper.

      Thank you for pointing out this issue. We reviewed RNA expression data from various tissues using RNA-Seq data from Mouse ENCODE (https://www.ncbi.nlm.nih.gov/gene/244608) and found that CCDC113 is highly expressed in the testis, but not significantly in the ovary and brain (Figure 4- figure supplement 1A). Additionally, we re-evaluated CCDC113 protein levels in the spleen, lung, kidney, testis, intestine, stomach, brain, and ovary, confirming that it is highly expressed in the testes, with negligible expression in the ovary and brain (Figure 4- figure supplement 1B). In line with Reviewer 2's suggestion, we have removed Figure 4A in the revised manuscript.

      There are grammatical errors throughout the manuscript and Figure 7 is truncated.

      Thank you for pointing out this problem. We have thoroughly revised the manuscript with the assistance professional proofreading.

      The Introduction and Discussion parts of the paper may need some clarification for the general reader. The material in the "Additional Context " section of the critique below may be a helpful place to introduce what a stage is, and the steps in germ cell development in the testis with the latter of course where and when the flagellum develops.

      We appreciate your valuable suggestions. We have referred to the material in the “Additional Context” section to introduce the stages of spermatogenesis and the steps in germ cell development in the testis in the introduction and results.

      “Male fertility relies on the continuous production of spermatozoa through a complex developmental process known as spermatogenesis. Spermatogenesis involves three primary stages: spermatogonia mitosis, spermatocyte meiosis, and spermiogenesis. During spermiogenesis, spermatids undergo complex differentiation processes to develop into spermatozoa, which includes nuclear elongation, chromatin remodeling, acrosome formation, cytoplasm elimination, and flagellum development (Hermo et al., 2010).”

      Hermo, L., Pelletier, R. M., Cyr, D. G., & Smith, C. E. (2010). Surfing the wave, cycle, life history, and genes/proteins expressed by testicular germ cells. Part 1: background to spermatogenesis, spermatogonia, and spermatocytes. Microscopy research and technique, 73(4), 241–278. https://doi.org/10.1002/jemt.20783

      “Pioneering work in the mid-1950s used the PAS stain in histologic sections of mouse testis to visualize glycoproteins of the acrosome and Golgi in seminiferous tubules (Oakberg, 1956). The pioneers discovered in cross-sectioned seminiferous tubules the association of differentiating germ cells with successive layers to define different stages that in mice are twelve, indicated as Roman numerals (XII). For each stage, different associations of maturing germ cells were always the same with early cells in differentiation at the periphery and more mature cells near the lumen. In this way, progressive differentiation from stem cells to mitotic, meiotic, acrosome-forming, and post-acrosome maturing spermatocytes was mapped to define spermatogenesis with the XII stages in mice representing the seminiferous cycle. The maturation process from acrosome-forming cells to mature spermatocytes is defined as spermiogenesis with 16 different steps that are morphologically distinct spermatids (O'Donnell L, 2015).”

      Oakberg, E. F. (1956). A description of spermiogenesis in the mouse and its use in analysis of the cycle of the seminiferous epithelium and germ cell renewal. The American journal of anatomy, 99(3), 391-413. https://doi.org/10.1002/aja.1000990303

      O'Donnell L. (2015). Mechanisms of spermiogenesis and spermiation and how they are disturbed. Spermatogenesis, 4(2), e979623. https://doi.org/10.4161/21565562.2014.979623

      For the Discussion, the authors indicate that the function of CCDC113 in mammals is unknown yet the authors point to the work of Walton et al on human respiratory epithelia that points to a function for CCDC96/113. The work in the manuscript here does indicate a role in sperm flagella and the head-to-tail coupling apparatus but remains descriptive until the methodology of Walton et al is applied. Hopefully, the authors will consider it for a follow-up study.

      Thank you for pointing out this problem. We have revised this part and highlighted the Walton et al’s work in the Discussion.

      “CCDC113 is a highly evolutionarily conserved component of motile cilia/flagella. Studies in the model organism, Tetrahymena thermophila, have revealed that CCDC113 connects RS3 to dynein g and the N-DRC, which plays essential role in cilia motility (Bazan et al., 2021; Ghanaeian et al., 2023). Recent studies have also identified the localization of CCDC113 within the 96-nm repeat structure of the human respiratory epithelial axoneme, and localizes to the linker region among RS, N-DRC and DMTs (Walton et al., 2023). In this study, we reveal that CCDC113 is indispensable for male fertility, as Ccdc113 knockout mice produce spermatozoa with flagellar defects and head-tail linkage detachment (Figure 3D).”

      “Overall, we identified CCDC113 as a structural component of both the flagellar axoneme and the HTCA, where it performs dual roles in stabilizing the sperm axonemal structure and maintaining the structural integrity of HTCA. Given that the cryo-EM of sperm axoneme and HTCA could powerfully strengthen the role of CCDC113 in stabilizing sperm axoneme and head-tail coupling apparatus, it a valuable direction for future research.”

      The Discussion may be focused on the key aspects of CCDC113 related to sperm flagella and the head-to-tail coupling apparatus that represent a genuine advance. The more speculative parts of the Discussion that have not been addressed by experimentation in the Results section may be considered for removal in the Discussion section.

      Thank you for pointing out this. We have removed the speculative parts of the Discussion that have not been addressed by experimentation in the Results section.

      Additional Context to help readers understand the significance of the work:

      Pioneering work in the mid-1950s used the periodic acid Schiff (PAS) stain in histologic sections of rodent testis to visualize glycoproteins of the acrosome and Golgi in seminiferous tubules. The pioneers discovered in cross-sectioned seminiferous tubules the association of differentiating germ cells with successive layers to define different stages that in mice are twelve, indicated as Roman numerals (XII). For each stage, different associations of maturing germ cells were always the same with early cells in differentiation at the periphery and more mature cells near the lumen. In this way, progressive differentiation from stem cells to mitotic, meiotic, acrosome-forming, and post-acrosome maturing spermatocytes was mapped to define spermatogenesis with the XII stages in mice representing the seminiferous cycle. The maturation process from acrosome-forming cells to mature spermatocytes is defined as spermiogenesis with 19 different steps that are morphologically distinct spermatids. It is from steps 8-19 of spermiogenesis that the formation of the flagellum takes place. Final maturation occurs in the epididymis as sperm move through the caput, corpus, and cauda of the organ with motile spermatozoa generated.

      Thank you very much!

    1. Author response:

      The following is the authors’ response to the original reviews.

      Public Reviews:

      Reviewer #1 (Public Review):

      Summary:

      The authors aimed to investigate the oscillatory activity of GnRH neurones in freely behaving mice. By utilising GCaMP fiber photometry, they sought to record real-time neuronal activity to understand the patterns and dynamics of GnRH neuron firing and their implications for reproductive physiology.

      Strengths:

      (1) The use of GCaMP fiber photometry allows for high temporal resolution recordings of neuronal activity, providing real-time data on the dynamics of GnRH neurones.

      (2) Recording in freely behaving animals ensures that the findings are physiologically relevant and not artifacts of a controlled laboratory environment.

      (3) The authors used statistical methods to characterise the oscillatory patterns, ensuring the reliability of their findings.

      Weaknesses:

      (1) While the study identifies distinct oscillatory patterns in GnRH neurones' calcium dynamics, it falls short in exploring the functional implications of these patterns for GnRH pulsatility and overall reproductive physiology.

      The functional roles of pulsatile and surge patterns of GnRH release are extremely well established. We have found perfect correlations between GnRH neuron dendron GCaMP activity and LH pulses as well as the LH surge clearly indicating the function of these activity patterns. We do not know the functional role of the clustered high-frequency basal activity that we have discovered and, as noted in the Discussion, are unsure of its physiological importance. Although it may be minor, it will require future investigation.

      (2) The study lacks a broader discussion to include comparisons with existing studies on GnRH neurone activity and pulsatility and highlight how the findings of this study align with or differ from previous research and what novel contributions are made.

      The Reviewer fails to recognise that these are first recordings of GnRH neurons in vivo. There are no prior studies for comparison. We have noted the only other in vivo study (undertaken by ourselves) many years ago in anaesthetized mice. It was never expected that electrophysiological recordings of GnRH neurons in acute brain slices (by ourselves and others) would reflect their activity in vivo. Now that we know this to be the case, it would be churlish to point this out explicitly. We have made some modifications to the Discussion by comparing the present data more thoroughly with other in vivo GnRH secretion and kisspeptin neuron activity studies.

      (3) The authors aimed to characterise the oscillatory activity of GnRH neurons and successfully identified distinct oscillatory patterns. The results support the conclusion that GnRH neurons exhibit complex oscillatory behaviours, which are critical for understanding their role in reproductive physiology. However, it has not been made clear what exactly the authors mean by "multi-dimensional oscillatory patterns" and how has this been shown.

      The study shows three types of GnRH neuron activity; two of which would be classified as oscillatory in nature and these show different temporal dimensions.

      Reviewer #2 (Public Review):

      Summary:

      In this manuscript, the authors report GCaMP fiber-photometry recordings from the GnRH neuron distal projections in the ventral arcuate nucleus. The recordings are taken from intact, male and female, freely behaving mice. The report three patterns of neuronal activity:

      (1) Abrupt increases in the Ca2+ signals that are perfectly correlated with LH pulses.

      (2) A gradual, yet fluctuating (with a slow ultradian frequency), increase in activity, which is associated with the onset of the LH surge in female animals.

      (3) Clustered (high frequency) baseline activity in both female and male animals.

      Strengths:

      The GCaMP fiber-photometry recordings reported here are the first direct recordings from GnRH neurones in vivo. These recordings have uncovered a rich repertoire of activity suggesting the integration of distinct "surge" and "pulse" generation signals, and an ultradian rhythm during the onset of the surge.

      Weaknesses:

      The data analysis method used for the characterisation of the ultradian rhythm observed during the onset of the surge is not detailed enough. Hence, I'm left wondering whether this rhythm is in any way correlated with the clusters of activity observed during the rest of the cycle and which have similar duration.

      We have provided further information on the characterisation of the ultradian rhythm observed at the time of the surge. Whether this is related to the clustered basal activity is an interesting point but very difficult to resolve. We note that the “basal” and “surge” ultradian oscillations have very different durations of ~30 and ~80 min suggesting that they may be independent phenomenon. However, the only way to really exclude a similar genesis will be to establish the origin of each type of oscillatory activity. Preliminary data in the lab show that the RP3V kisspeptin neurons exhibit an identical pattern of ultradian oscillation at the time of the surge leading us to suspect that the surge oscillation is driven by this input. As noted in the Discussion it is presently difficult to determine where the high basal activity originates.

      Recommendations for the authors:

      Reviewer #1 (Recommendations For The Authors):

      (1) Evidence of Multi-Dimensional Oscillatory Patterns: The manuscript presents data showing the oscillatory activity of GnRH neurones with distinct frequency and amplitude characteristics. The analysis includes statistical tests that illustrate the variability in neuronal firing patterns. However, the multi-dimensional nature of this activity has not been demonstrated. It is not clear what is meant by "dimension" with regard to the calcium recordings (oscillatory activity). If the authors refer to the frequency content of the calcium signal then a proper Fourier or Wavelet analysis should be carried out to characterise the multiple frequencies present in the calcium dynamics in male mice and during various stages of the cycle in female mice

      The study shows three types of GnRH neuron activity; two of which would be classified as oscillatory in nature. One occurs for ~10 min every hour or so and the other occurs for ~ 12 hours once every 4-5 days. This does not require any analysis to distinguish between the two or claim that they are different i.e. multidimensional. 

      (2) Data Interpretation: Expand the discussion on the physiological relevance of the identified oscillatory patterns. Specifically, explore how these patterns might influence GnRH pulsatility, hormone secretion dynamics, and reproductive cycles.

      The functional roles of pulsatile and surge patterns of GnRH release are extremely well established. We have found perfect correlations between GnRH neuron dendron GCaMP activity and LH pulses as well as the LH surge clearly indicating the function of these activity patterns. We do not know the functional role of the clustered high-frequency basal activity that we have discovered and, as noted in the Discussion, are unsure of its physiological importance. Although it may be minor, it will require future investigation.

      (3) Literature Contextualisation: Broaden the discussion to include comparisons with existing studies on GnRH neuron activity and pulsatility. Highlight how the findings of this study align with or differ from previous research and what novel contributions are made.

      The Reviewer fails to recognise that these are first recordings of GnRH neurons in vivo. There are no prior studies for comparison. We have noted the only other in vivo study (undertaken by ourselves) many years ago in anaesthetized mice. It would be naive to expect that electrophysiological recordings of GnRH neurons in acute brain slices (by ourselves and others) would reflect their activity in vivo. Now that we know this to be the case, it would be churlish to point this out explicitly. We have made some modifications to the Discussion by comparing the present data more thoroughly with other in vivo GnRH secretion and kisspeptin neuron activity studies.

      (4) Future Directions: Suggest potential follow-up experiments to explore the regulatory mechanisms underlying the observed oscillatory patterns. This could include investigating the role of neurotransmitters, hormonal feedback mechanisms, and other factors that might influence GnRH neuron activity.

      By addressing these recommendations, the authors can further strengthen their manuscript and enhance its impact on the field.

      Reviewer #2 (Recommendations For The Authors):

      Suggestions:

      (1) The authors might want to analyse their inter-peak interval data by fitting them to a simple parametric statistical model (the gamma distribution would be a good choice to capture the skewness of these data). This way they would be able to describe the observed variability, and if the fits are not good back up to their claims "The dSEs occurred on average ... and showed no clear modal distribution pattern (Fig. 2D)".

      Thank you for the suggestion. We have carried out Shapiro-Wilk tests for male inter-peak interval distribution and found a W value of 0.87 and P value <0.0001****, providing strong evidence that the data is not normally distributed. Skewness and Kurtosis values are 1.39 and 1.81 respectively, indicating that the distribution is right-skewed with a platykurtic distribution, indicating that the data is less peaked and more spread out than the normal distribution (with a kurtosis of 3). This has now been added to the manuscript.

      (2) If I understand correctly, in Figure 3D, inter-peak intervals from all 4 stages of the estrus cycle are pooled together. It would also be interesting if the authors gave the interval histograms for the different stages of the cycle separately.

      We have now plotted the inter-peak interval distribution histograms for each individual cycle next to the example traces in Figure 3. The descriptions of the distribution pattern are also updated in the figure legends.

      (3) In Figure 3C, one can see the mean interval for different animals (as open circles), is that right? Is the statistical test run on these animals mean, or is the entire dSEs dataset used? In any case, it's not clear to the reader how variable intervals are in individual recordings from each animal. Could the authors add this information (could be easily added in the figure caption)?

      The reviewer is correct, that each open circle is the mean interval for each animal. The statistical test was run on the animals mean. Now this information is added to the figure legend.

      (4) The authors should explain how they identify the regions (clusters) of high-frequency baseline activity, which they present in Figure 4.

      The relevant information is now added to the methods section under the heading ‘GCaMP6 fiber photometry and blood sampling’.

      (5) The authors should detail how to identify and characterise the ultradian rhythm they observe at the onset of the surge.

      The relevant information is now added to the methods section under the heading ‘GCaMP6 fiber photometry and blood sampling’.

      (6) The author could perform some kind of wavelet-type analysis to quantify and analyse how the frequency content of the observed Ca2+ signal changes over the cycle. From their current analysis, I am not sure whether the ultradian oscillations they observe during the surge are related to the low-activity cluster events they observe during the other stages of the cycle.

      This is an interesting point but very difficult to resolve. We note that the “basal” and “surge” ultradian oscillations have very different durations of ~30 and ~80 min suggesting that they may be independent phenomenon. However, the only way to really exclude a similar genesis will be to establish the origin of each type of oscillatory activity. Preliminary data in the lab show that the RP3V kisspeptin neurons exhibit an identical pattern of ultradian oscillation at the time of the surge leading us to suspect that the surge oscillation is driven by this input. As noted in the Discussion it is presently difficult to determine where the high basal activity originates.